,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
880,GO:0002237,1.0875051487938e-25,1,46,212,response to molecule of bacterial origin,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;ZC3H12A;CXCL1;CXCL3;CSF2;TICAM1;TNF;CXCL8;CCL20;PTGS2;TNIP1;NFKB1;PRDM1;NFKB2;NOCT;EDN1;IRAK2;CLDN1;TNFRSF10B;CXCL5;TRIB1;IL24;JUN;CD274;JUNB;RELT;CEBPB;PELI1;BCL10;DUSP10;PPARD;BDKRB1;ZFP36;CYP27B1;CD55;RIPK2;GCH1;NFKBIB;ADM;WNT5A;ADAM9;TNFRSF10A;RELA
7923,GO:0032496,1.30573162327723e-25,1,45,203,response to lipopolysaccharide,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;ZC3H12A;CXCL1;CXCL3;CSF2;TICAM1;TNF;CXCL8;CCL20;PTGS2;TNIP1;NFKB1;PRDM1;NFKB2;NOCT;EDN1;IRAK2;CLDN1;TNFRSF10B;CXCL5;TRIB1;IL24;JUN;CD274;JUNB;RELT;CEBPB;PELI1;DUSP10;PPARD;BDKRB1;ZFP36;CYP27B1;CD55;RIPK2;GCH1;NFKBIB;ADM;WNT5A;ADAM9;TNFRSF10A;RELA
12686,GO:0050896,1.96726758662326e-25,1,284,5525,response to stimulus,BP,NFKBIA;NFKBIZ;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;CXCL3;BTG2;IL36G;BIRC3;HBEGF;PLAU;NFKBID;CSF2;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;CXCL8;REL;SERPINB2;PPIF;IER3;NUAK2;CCL20;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;TRPV3;NOCT;PLEKHF1;EFNA1;TGFA;KDM6B;IRF6;EDN1;ODC1;SEMA7A;ERRFI1;IL1RN;IRAK2;CLDN1;KLF7;PANX1;DAPP1;CPEB2;HCAR2;TNFRSF10B;EFNB2;EPHA2;RELB;GADD45A;CXCL5;MAFF;LIF;TRIB1;KCTD11;CD83;SQSTM1;IFNGR2;RRAD;BMP2;PHLDA2;IL24;CAB39;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;RGMB;PHLDB2;CLDN4;TJP2;CD274;JUNB;BCL3;CSRNP1;NAMPT;AMPD3;IRF1;TAF4B;BCL2L2;ZFP36L1;RELT;RND3;ADRB2;CEBPB;DUSP16;ARNTL2;PPP1R15A;MAST4;RUNX1;N4BP1;CDKN2B;GJB4;HMGCS1;TRIM16;EREG;SOD2;PELI1;ALDH1A3;EHD1;NEDD9;ZSWIM4;DUSP8;B4GALT1;TFPI2;DUSP1;BCL10;FGD6;DCUN1D3;TRAF1;PPP1R10;PIM3;TMEM265;IL6ST;G0S2;NABP1;DLX2;SLC6A14;TXNRD1;CYLD;ADAM8;LDLR;VEGFC;KLF3;HCAR3;ZNF217;TACSTD2;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;PIM1;WISP1;ITGA5;TFRC;LIPG;CREB1;EFNB1;GJB3;F3;STK40;HIVEP2;PPARD;SLC25A25;SERPINB1;SOCS3;RAET1L;IL16;BDKRB1;RAPH1;ZFP36;SLC9A1;MAFK;CYP27B1;CD55;IFNAR2;ANTXR2;JAG1;PLAGL2;RIPK2;AMOTL2;PHKG2;SAA1;PPP1R15B;USP53;NDRG1;ITGAV;PIP5K1A;TP53BP2;NRARP;SOX9;STX1A;NRG1;ZNF451;PML;POU2F2;RASA2;FERMT1;NCOA7;ELK3;POLR3A;SLC7A2;CDC42EP1;PTPN11;MAP3K8;UHRF1;ARHGEF3;DCBLD2;RHOB;SPAG9;GCH1;FEM1B;SOX4;TRAF4;VCL;OXCT1;AREG;FAM83G;AKAP2;TNFAIP1;HDAC9;ADAMTS1;HIVEP1;NFKBIB;KLF10;AEN;TIFA;SKIL;COTL1;IL7R;CDK6;IER5;PTPN1;SQLE;TFE3;CORO1C;PRPF19;ADM;MAFG;ABL2;MTF1;ATP6V1C2;HLA-E;OSMR;WNT5A;NUP153;MAOA;INSIG1;ADAM9;PDPK1;TNFRSF10A;CTSC;ERO1A;KDM6A;NFE2L2;YWHAH;SGK1;B3GNT2;TSC22D2;CYTH1;RELA;AGFG1;NOTCH2NL;BACH1;POLR3D;YWHAG;TDG;ELF4;RAB22A;CREG1;SFN;ITM2B;ERN1;UPP1;ISG20;ATXN7;IFIH1;CXCL16;PABPC4;TAP1;AHCY;GPR156;RAB24
4262,GO:0009605,7.47393409995632e-25,1,118,1336,response to external stimulus,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;ZC3H12A;CXCL1;PLAUR;CXCL3;BTG2;BIRC3;HBEGF;PLAU;CSF2;TICAM1;ETS1;TNF;CXCL8;SERPINB2;NUAK2;CCL20;BHLHE40;PTGS2;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;NFKB2;NOCT;PLEKHF1;EFNA1;EDN1;ODC1;SEMA7A;IRAK2;CLDN1;KLF7;PANX1;TNFRSF10B;EFNB2;EPHA2;GADD45A;CXCL5;TRIB1;IFNGR2;IL24;JUN;BIRC2;CDKN1A;PHLDB2;CD274;JUNB;BCL3;IRF1;RELT;ADRB2;CEBPB;ARNTL2;CDKN2B;HMGCS1;PELI1;ALDH1A3;ZSWIM4;BCL10;IL6ST;ADAM8;LDLR;VEGFC;SMAD3;IL23A;DUSP10;PIM1;LIPG;CREB1;EFNB1;F3;PPARD;SLC25A25;SOCS3;IL16;BDKRB1;ZFP36;SLC9A1;CYP27B1;CD55;IFNAR2;RIPK2;SAA1;USP53;ITGAV;PIP5K1A;SOX9;NRG1;PML;POLR3A;SLC7A2;PTPN11;GCH1;OXCT1;NFKBIB;KLF10;COTL1;CDK6;ADM;HLA-E;OSMR;WNT5A;ADAM9;TNFRSF10A;NFE2L2;B3GNT2;RELA;POLR3D;UPP1;ISG20;IFIH1;CXCL16;AHCY
3271,GO:0006950,1.99753229668209e-24,1,176,2658,response to stress,BP,NFKBIA;NFKBIZ;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;CXCL3;BTG2;IL36G;BIRC3;HBEGF;PLAU;NFKBID;CSF2;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;CXCL8;REL;SERPINB2;PPIF;IER3;NUAK2;CCL20;PTGS2;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;TRPV3;PLEKHF1;KDM6B;IRF6;EDN1;SEMA7A;ERRFI1;IL1RN;IRAK2;CLDN1;PANX1;CPEB2;TNFRSF10B;EPHA2;RELB;GADD45A;CXCL5;MAFF;TRIB1;CD83;SQSTM1;IFNGR2;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;BIRC2;CDKN1A;PHLDB2;JUNB;BCL3;IRF1;BCL2L2;ZFP36L1;RELT;ADRB2;CEBPB;PPP1R15A;EREG;SOD2;PELI1;EHD1;B4GALT1;TFPI2;DUSP1;BCL10;PPP1R10;IL6ST;NABP1;TXNRD1;CYLD;ADAM8;LDLR;VEGFC;OXSR1;SMAD3;IL23A;DUSP10;PLK2;BBC3;PLK3;ITGA5;CREB1;F3;PPARD;SOCS3;RAET1L;BDKRB1;ZFP36;SLC9A1;MAFK;CYP27B1;CD55;IFNAR2;RIPK2;SAA1;PPP1R15B;NDRG1;NRG1;PML;NCOA7;ELK3;POLR3A;SLC7A2;PTPN11;MAP3K8;UHRF1;DCBLD2;RHOB;SPAG9;GCH1;FEM1B;SOX4;TRAF4;VCL;OXCT1;AREG;HDAC9;KLF10;AEN;SKIL;COTL1;CDK6;IER5;PTPN1;PRPF19;ADM;MAFG;ABL2;MTF1;HLA-E;OSMR;WNT5A;NUP153;INSIG1;ADAM9;PDPK1;TNFRSF10A;ERO1A;NFE2L2;SGK1;TSC22D2;RELA;BACH1;POLR3D;TDG;ELF4;SFN;ERN1;UPP1;ISG20;IFIH1;CXCL16;PABPC4;TAP1;AHCY
12247,GO:0048522,2.53245531523159e-24,1,212,3480,positive regulation of cellular process,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;CXCL3;BTG2;BIRC3;HBEGF;PLAU;NFKBID;CSF2;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;CXCL8;REL;PPIF;KLF6;CCL20;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;PLEKHF1;EFNA1;TGFA;KDM6B;IRF6;EDN1;ODC1;SEMA7A;HAS3;IRAK2;CLDN1;KLF7;PANX1;CREB5;EHF;HCAR2;TNFRSF10B;EFNB2;EPHA2;RELB;GADD45A;CXCL5;MAFF;LIF;TRIB1;KCTD11;CD83;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;BIRC2;CDKN1A;RGMB;PHLDB2;SERTAD2;CD274;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ENC1;ADRB2;CEBPB;ARNTL2;UGCG;PPP1R15A;RUNX1;CDKN2B;TRIM16;EREG;SOD2;PELI1;ALDH1A3;EHD1;ANKLE2;B4GALT1;DUSP1;BCL10;DCUN1D3;PPP1R10;IL6ST;G0S2;DLX2;CYLD;ADAM8;LDLR;VEGFC;TACSTD2;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;PIM1;ITGA5;TFRC;CREB1;EFNB1;F3;PPARD;SOCS3;USP36;BDKRB1;ZFP36;SLC9A1;LARP4B;CYP27B1;CD55;JAG1;PLAGL2;RIPK2;PHKG2;NAV3;SAA1;PPP1R15B;NDRG1;ITGAV;TP53BP2;NRARP;SOX9;STX1A;NRG1;PML;POU2F2;FERMT1;NCOA7;ELK3;CDC42EP1;FOXN2;PTPN11;MAP3K8;UHRF1;ARHGEF3;RHOB;SPAG9;SOX4;FOSL2;TRAF4;OXCT1;AREG;CCNL1;TNFAIP1;HDAC9;KLF10;SKIL;IL7R;RBM3;CDK6;IER5;SAMD4A;PTPN1;TFE3;CORO1C;PRPF19;ADM;MAFG;ABL2;MTF1;ATP6V1C2;HLA-E;OSMR;QKI;WNT5A;INSIG1;ADAM9;PDPK1;TNFRSF10A;ADAMTS9;RNF19A;CTSC;NFE2L2;YWHAH;RELA;BACH1;YWHAG;ELF4;SFN;ERN1;ATXN7;IFIH1;CXCL16;FUBP3;SMPD3
8593,GO:0034097,4.27493238274248e-24,1,86,812,response to cytokine,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;CXCL3;IL36G;BIRC3;CSF2;ETS1;TNF;CXCL8;REL;SERPINB2;CCL20;PTGS2;NFKB1;FOSL1;NFKB2;IRF6;EDN1;IL1RN;IRAK2;CLDN1;TNFRSF10B;RELB;CXCL5;LIF;SQSTM1;IFNGR2;IL24;JUN;BIRC2;CDKN1A;TJP2;CD274;JUNB;IRF1;ZFP36L1;RELT;CEBPB;RUNX1;EREG;SOD2;PELI1;TRAF1;IL6ST;CYLD;VEGFC;SMAD3;RC3H1;IL23A;PIM1;TFRC;CREB1;F3;SOCS3;IL16;ZFP36;CYP27B1;IFNAR2;RIPK2;SAA1;SOX9;STX1A;PML;PTPN11;MAP3K8;GCH1;SKIL;IL7R;PTPN1;HLA-E;OSMR;WNT5A;MAOA;ADAM9;TNFRSF10A;NFE2L2;B3GNT2;RELA;ISG20;IFIH1;CXCL16
9867,GO:0042127,7.76127202419898e-24,1,100,1034,regulation of cell proliferation,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;IL1A;CXCL1;CXCL3;BTG2;HBEGF;PLAU;CSF2;INHBA;TICAM1;SDC4;ETS1;TNF;CXCL8;PTGS2;PRDM1;FOSL1;TBX3;TGFA;IRF6;EDN1;ODC1;ERRFI1;TNFRSF10B;EFNB2;CXCL5;LIF;TRIB1;KCTD11;BMP2;PHLDA2;IL24;JUN;BIRC2;CDKN1A;CD274;JUNB;OVOL1;NAMPT;IRF1;ZFP36L1;RELT;CEBPB;CDKN2B;EREG;SOD2;PELI1;B4GALT1;IL6ST;VEGFC;TACSTD2;SMAD3;RC3H1;IL23A;DUSP10;PIM1;TFRC;CREB1;EFNB1;F3;PPARD;ZFP36;CYP27B1;CD55;JAG1;RIPK2;NDRG1;ITGAV;NRARP;SOX9;NRG1;PML;FERMT1;SOX4;FOSL2;AREG;ADAMTS1;KLF10;IL7R;CDK6;IER5;EMP3;BTG3;TOB2;ADM;MAFG;ABL2;HLA-E;OSMR;WNT5A;PDPK1;TNFRSF10A;SGK1;SAT1;RELA;SFN;ERN1
3274,GO:0006954,9.91605614106817e-24,1,57,364,inflammatory response,BP,NFKBIA;NFKBIZ;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;CXCL3;IL36G;BIRC3;NFKBID;TICAM1;ELF3;ETS1;TNF;CXCL8;REL;CCL20;PTGS2;TNIP1;NFKB1;NFKB2;KDM6B;SEMA7A;IL1RN;IRAK2;TNFRSF10B;RELB;CXCL5;BMP2;MAP2K3;BIRC2;RELT;CEBPB;B4GALT1;IL6ST;ADAM8;LDLR;SMAD3;IL23A;DUSP10;F3;PPARD;SOCS3;BDKRB1;CD55;RIPK2;SAA1;SLC7A2;HDAC9;OSMR;WNT5A;TNFRSF10A;NFE2L2;RELA;AHCY
12243,GO:0048518,4.47002575719563e-23,1,224,3893,positive regulation of biological process,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;CXCL3;BTG2;BIRC3;HBEGF;PLAU;NFKBID;CSF2;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;CXCL8;REL;PPIF;KLF6;CCL20;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;TRPV3;NOCT;PLEKHF1;EFNA1;TGFA;KDM6B;IRF6;EDN1;ODC1;SEMA7A;HAS3;IRAK2;CLDN1;KLF7;PANX1;CREB5;EHF;HCAR2;TNFRSF10B;EFNB2;EPHA2;RELB;GADD45A;CXCL5;MAFF;LIF;TRIB1;KCTD11;CD83;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;BIRC2;CDKN1A;RGMB;PHLDB2;SERTAD2;CD274;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ENC1;ADRB2;CEBPB;ARNTL2;UGCG;PPP1R15A;RUNX1;CDKN2B;TRIM16;EREG;SOD2;PELI1;ALDH1A3;EHD1;ANKLE2;B4GALT1;DUSP1;BCL10;DCUN1D3;TRAF1;PPP1R10;IL6ST;G0S2;DLX2;CYLD;ADAM8;LDLR;VEGFC;TACSTD2;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;PIM1;ITGA5;TFRC;LIPG;CREB1;EFNB1;F3;PPARD;SOCS3;USP36;IL16;BDKRB1;ZFP36;SLC9A1;LARP4B;CYP27B1;CD55;AZIN1;JAG1;PLAGL2;RIPK2;PHKG2;NAV3;SAA1;PPP1R15B;NDRG1;ITGAV;TP53BP2;NRARP;SOX9;STX1A;NRG1;PML;POU2F2;FERMT1;NCOA7;ELK3;POLR3A;CDC42EP1;FOXN2;PTPN11;MAP3K8;UHRF1;ARHGEF3;RHOB;SPAG9;GCH1;SOX4;FOSL2;TRAF4;OXCT1;AREG;CCNL1;TNFAIP1;HDAC9;NFKBIB;KLF10;SKIL;IL7R;RBM3;CDK6;IER5;SAMD4A;PTPN1;TFE3;CORO1C;PRPF19;TOB2;ADM;MAFG;ABL2;MTF1;ATP6V1C2;HLA-E;OSMR;QKI;WNT5A;INSIG1;ADAM9;PDPK1;TNFRSF10A;ADAMTS9;RNF19A;CTSC;KDM6A;NFE2L2;YWHAH;SGK1;RELA;BACH1;POLR3D;YWHAG;ELF4;SFN;ERN1;ATXN7;IFIH1;CXCL16;FUBP3;SMPD3
3272,GO:0006952,9.06707858290584e-23,1,90,911,defense response,BP,NFKBIA;NFKBIZ;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;CXCL3;IL36G;BIRC3;NFKBID;INHBA;TICAM1;ELF3;ETS1;TNF;CXCL8;REL;CCL20;PTGS2;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;NFKB2;KDM6B;IRF6;EDN1;SEMA7A;IL1RN;IRAK2;CLDN1;TNFRSF10B;RELB;CXCL5;CD83;IFNGR2;BMP2;MAP2K3;BIRC2;BCL3;IRF1;RELT;CEBPB;EREG;PELI1;B4GALT1;BCL10;IL6ST;CYLD;ADAM8;LDLR;SMAD3;IL23A;DUSP10;F3;PPARD;SOCS3;RAET1L;BDKRB1;CYP27B1;CD55;IFNAR2;RIPK2;SAA1;PML;POLR3A;SLC7A2;PTPN11;GCH1;HDAC9;COTL1;PTPN1;ABL2;HLA-E;OSMR;WNT5A;PDPK1;TNFRSF10A;NFE2L2;RELA;POLR3D;ELF4;ISG20;IFIH1;CXCL16;TAP1;AHCY
3744,GO:0008283,9.62624087578172e-23,1,114,1331,cell proliferation,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;IL1A;CXCL1;CXCL3;BTG2;HBEGF;PLAU;CSF2;INHBA;TICAM1;SDC4;ETS1;TNF;CXCL8;PTGS2;PRDM1;FOSL1;TBX3;TGFA;IRF6;EDN1;ODC1;ERRFI1;EHF;TNFRSF10B;EFNB2;EPHA2;CXCL5;LIF;TRIB1;KCTD11;BMP2;PHLDA2;IL24;JUN;BIRC2;CDKN1A;CD274;JUNB;OVOL1;NAMPT;IRF1;BCL2L2;ZFP36L1;RELT;CEBPB;RUNX1;CDKN2B;EREG;SOD2;PELI1;B4GALT1;CDV3;IL6ST;TXNRD1;VEGFC;TACSTD2;SMAD3;RC3H1;IL23A;DUSP10;PIM1;TFRC;LIPG;CREB1;EFNB1;F3;PPARD;ZFP36;CYP27B1;CD55;JAG1;RIPK2;NDRG1;ITGAV;NRARP;SOX9;NRG1;PML;FERMT1;UHRF1;MXD1;SOX4;FOSL2;AREG;ADAMTS1;KLF10;IL7R;CDK6;IER5;EMP3;BTG3;PRPF19;TOB2;ADM;MAFG;ABL2;HLA-E;OSMR;WNT5A;INSIG1;PDPK1;TNFRSF10A;SGK1;SAT1;RELA;ELF4;CREG1;SFN;ERN1;ISG20
4269,GO:0009617,2.30466632274674e-22,1,49,296,response to bacterium,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;ZC3H12A;CXCL1;CXCL3;CSF2;TICAM1;TNF;CXCL8;CCL20;PTGS2;TNIP1;NFKB1;PRDM1;NFKB2;NOCT;EDN1;IRAK2;CLDN1;TNFRSF10B;CXCL5;TRIB1;IL24;JUN;CD274;JUNB;BCL3;RELT;CEBPB;PELI1;BCL10;IL23A;DUSP10;PPARD;BDKRB1;ZFP36;CYP27B1;CD55;RIPK2;GCH1;NFKBIB;ADM;HLA-E;WNT5A;ADAM9;TNFRSF10A;RELA
4263,GO:0009607,3.32917622123424e-22,1,67,548,response to biotic stimulus,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;ZC3H12A;CXCL1;CXCL3;BIRC3;CSF2;TICAM1;TNF;CXCL8;CCL20;PTGS2;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;NFKB2;NOCT;EDN1;ODC1;IRAK2;CLDN1;TNFRSF10B;CXCL5;TRIB1;IFNGR2;IL24;JUN;BIRC2;CD274;JUNB;BCL3;IRF1;RELT;CEBPB;PELI1;BCL10;TMEM265;SMAD3;IL23A;DUSP10;PPARD;BDKRB1;ZFP36;CYP27B1;CD55;IFNAR2;RIPK2;PPP1R15B;PML;POLR3A;GCH1;NFKBIB;COTL1;CDK6;ADM;HLA-E;WNT5A;ADAM9;TNFRSF10A;RELA;POLR3D;ISG20;IFIH1
10384,GO:0043207,3.87224400695779e-22,1,65,521,response to external biotic stimulus,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;ZC3H12A;CXCL1;CXCL3;BIRC3;CSF2;TICAM1;TNF;CXCL8;CCL20;PTGS2;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;NFKB2;NOCT;EDN1;ODC1;IRAK2;CLDN1;TNFRSF10B;CXCL5;TRIB1;IFNGR2;IL24;JUN;BIRC2;CD274;JUNB;BCL3;IRF1;RELT;CEBPB;PELI1;BCL10;SMAD3;IL23A;DUSP10;PPARD;BDKRB1;ZFP36;CYP27B1;CD55;IFNAR2;RIPK2;PML;POLR3A;GCH1;NFKBIB;COTL1;CDK6;ADM;HLA-E;WNT5A;ADAM9;TNFRSF10A;RELA;POLR3D;ISG20;IFIH1
13144,GO:0051707,3.87224400695779e-22,1,65,521,response to other organism,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;ZC3H12A;CXCL1;CXCL3;BIRC3;CSF2;TICAM1;TNF;CXCL8;CCL20;PTGS2;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;NFKB2;NOCT;EDN1;ODC1;IRAK2;CLDN1;TNFRSF10B;CXCL5;TRIB1;IFNGR2;IL24;JUN;BIRC2;CD274;JUNB;BCL3;IRF1;RELT;CEBPB;PELI1;BCL10;SMAD3;IL23A;DUSP10;PPARD;BDKRB1;ZFP36;CYP27B1;CD55;IFNAR2;RIPK2;PML;POLR3A;GCH1;NFKBIB;COTL1;CDK6;ADM;HLA-E;WNT5A;ADAM9;TNFRSF10A;RELA;POLR3D;ISG20;IFIH1
3386,GO:0007165,8.68110220272549e-22,1,213,3664,signal transduction,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;CXCL3;BTG2;IL36G;BIRC3;HBEGF;PLAU;NFKBID;CSF2;INHBA;TICAM1;ELF3;SDC4;TNF;CXCL8;REL;SERPINB2;PPIF;IER3;NUAK2;CCL20;PTGS2;PMAIP1;TNIP1;NFKB1;PRDM1;NFKB2;PLEKHF1;EFNA1;TGFA;IRF6;EDN1;SEMA7A;ERRFI1;IL1RN;IRAK2;DAPP1;HCAR2;TNFRSF10B;EFNB2;EPHA2;RELB;GADD45A;CXCL5;LIF;TRIB1;KCTD11;CD83;SQSTM1;IFNGR2;RRAD;BMP2;PHLDA2;IL24;CAB39;MAP2K3;JUN;RAP2B;BIRC2;CDKN1A;RGMB;CLDN4;TJP2;CD274;JUNB;BCL3;CSRNP1;NAMPT;IRF1;TAF4B;BCL2L2;ZFP36L1;RELT;RND3;ADRB2;CEBPB;DUSP16;PPP1R15A;MAST4;RUNX1;CDKN2B;TRIM16;EREG;SOD2;PELI1;NEDD9;DUSP8;DUSP1;BCL10;FGD6;TRAF1;IL6ST;G0S2;DLX2;TXNRD1;CYLD;ADAM8;VEGFC;HCAR3;ZNF217;TACSTD2;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;PIM1;WISP1;ITGA5;CREB1;EFNB1;F3;STK40;HIVEP2;PPARD;SOCS3;IL16;BDKRB1;RAPH1;ZFP36;SLC9A1;CYP27B1;CD55;IFNAR2;ANTXR2;JAG1;PLAGL2;RIPK2;AMOTL2;PHKG2;SAA1;PPP1R15B;NDRG1;ITGAV;PIP5K1A;TP53BP2;NRARP;SOX9;STX1A;NRG1;ZNF451;PML;RASA2;FERMT1;ELK3;CDC42EP1;PTPN11;MAP3K8;ARHGEF3;DCBLD2;RHOB;SPAG9;FEM1B;SOX4;TRAF4;AREG;FAM83G;AKAP2;TNFAIP1;ADAMTS1;HIVEP1;NFKBIB;KLF10;AEN;TIFA;SKIL;IL7R;CDK6;PTPN1;CORO1C;PRPF19;ADM;ABL2;ATP6V1C2;HLA-E;OSMR;WNT5A;MAOA;INSIG1;ADAM9;PDPK1;TNFRSF10A;CTSC;ERO1A;KDM6A;NFE2L2;YWHAH;SGK1;CYTH1;RELA;AGFG1;NOTCH2NL;YWHAG;RAB22A;SFN;ITM2B;ERN1;ISG20;ATXN7;IFIH1;CXCL16;GPR156;RAB24
957,GO:0002376,1.2712276041532e-21,1,135,1855,immune system process,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;CXCL3;IL36G;BIRC3;PLAU;NFKBID;CSF2;INHBA;TICAM1;SDC4;ETS1;TNF;CXCL8;REL;KLF6;CCL20;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;NFKB2;KDM6B;IRF6;EDN1;SEMA7A;IL1RN;IRAK2;CLDN1;HCAR2;TNFRSF10B;EFNB2;EPHA2;RELB;CXCL5;LIF;TRIB1;CD83;SQSTM1;IFNGR2;CAB39;JUN;RAP2B;BIRC2;CDKN1A;TJP2;CD274;JUNB;BCL3;AMPD3;IRF1;ZFP36L1;RELT;CEBPB;RUNX1;CDKN2B;EREG;PELI1;B4GALT1;BCL10;IL6ST;CYLD;ADAM8;LDLR;VEGFC;SMAD3;RC3H1;IL23A;DUSP10;ITGA5;TFRC;CREB1;EFNB1;SERPINB1;SOCS3;RAET1L;IL16;BDKRB1;ZFP36;CYP27B1;CD55;IFNAR2;JAG1;RIPK2;SAA1;NDRG1;ITGAV;NRARP;SOX9;PML;POU2F2;POLR3A;SLC7A2;PTPN11;MAP3K8;GCH1;SOX4;VCL;TNFAIP1;HDAC9;KLF10;SKIL;COTL1;IL7R;CDK6;PTPN1;TFE3;TOB2;ABL2;HLA-E;WNT5A;ADAM9;PDPK1;TNFRSF10A;CTSC;NFE2L2;RELA;POLR3D;ELF4;CREG1;ISG20;IFIH1;CXCL16;PABPC4;TAP1;AHCY;RAB24;SMPD3
12858,GO:0051173,1.69128034423951e-21,1,149,2093,positive regulation of nitrogen compound metabolic process,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;HBEGF;CSF2;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;REL;KLF6;CCL20;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;FOSL1;TBX3;NFKB2;EFNA1;TGFA;KDM6B;IRF6;EDN1;SEMA7A;HAS3;IRAK2;KLF7;CREB5;EHF;TNFRSF10B;EPHA2;RELB;GADD45A;MAFF;LIF;TRIB1;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;BIRC2;CDKN1A;RGMB;SERTAD2;JUNB;BCL3;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ADRB2;CEBPB;ARNTL2;PPP1R15A;RUNX1;CDKN2B;TRIM16;EREG;PELI1;ANKLE2;BCL10;DCUN1D3;PPP1R10;IL6ST;DLX2;ADAM8;LDLR;VEGFC;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;PLK2;BBC3;PLK3;ITGA5;TFRC;CREB1;F3;PPARD;SOCS3;ZFP36;SLC9A1;LARP4B;JAG1;PLAGL2;RIPK2;SAA1;PPP1R15B;ITGAV;SOX9;NRG1;PML;POU2F2;NCOA7;ELK3;FOXN2;PTPN11;MAP3K8;UHRF1;SPAG9;SOX4;FOSL2;TRAF4;AREG;CCNL1;TNFAIP1;KLF10;RBM3;IER5;SAMD4A;PTPN1;TFE3;PRPF19;ADM;MAFG;MTF1;QKI;WNT5A;INSIG1;ADAM9;PDPK1;TNFRSF10A;RNF19A;CTSC;NFE2L2;YWHAH;RELA;BACH1;ELF4;ERN1;ATXN7;FUBP3;SMPD3
9902,GO:0042221,5.37459530350155e-21,1,174,2777,response to chemical,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;CXCL3;BTG2;IL36G;BIRC3;HBEGF;PLAU;CSF2;INHBA;TICAM1;ETS1;TNF;CXCL8;REL;SERPINB2;PPIF;CCL20;PTGS2;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;NFKB2;NOCT;EFNA1;KDM6B;IRF6;EDN1;SEMA7A;ERRFI1;IL1RN;IRAK2;CLDN1;KLF7;PANX1;CPEB2;TNFRSF10B;EFNB2;EPHA2;RELB;CXCL5;LIF;TRIB1;CD83;SQSTM1;IFNGR2;BMP2;IL24;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;RGMB;CLDN4;TJP2;CD274;JUNB;NAMPT;IRF1;ZFP36L1;RELT;ADRB2;CEBPB;PPP1R15A;RUNX1;CDKN2B;GJB4;HMGCS1;TRIM16;EREG;SOD2;PELI1;EHD1;ZSWIM4;DUSP1;BCL10;TRAF1;PIM3;IL6ST;SLC6A14;TXNRD1;CYLD;ADAM8;LDLR;VEGFC;KLF3;NEDD4L;SMAD3;RC3H1;IL23A;DUSP10;PLK3;PIM1;ITGA5;TFRC;LIPG;CREB1;EFNB1;GJB3;F3;PPARD;SLC25A25;SOCS3;IL16;BDKRB1;ZFP36;SLC9A1;CYP27B1;CD55;IFNAR2;JAG1;RIPK2;SAA1;PPP1R15B;NDRG1;ITGAV;PIP5K1A;SOX9;STX1A;NRG1;ZNF451;PML;FERMT1;NCOA7;SLC7A2;PTPN11;MAP3K8;RHOB;GCH1;SOX4;OXCT1;AREG;FAM83G;HDAC9;NFKBIB;KLF10;SKIL;IL7R;PTPN1;SQLE;ADM;ABL2;MTF1;ATP6V1C2;HLA-E;OSMR;WNT5A;MAOA;INSIG1;ADAM9;PDPK1;TNFRSF10A;CTSC;ERO1A;NFE2L2;YWHAH;B3GNT2;RELA;BACH1;YWHAG;ERN1;ISG20;IFIH1;CXCL16;AHCY
3375,GO:0007154,6.16059564894412e-21,1,222,3951,cell communication,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;CXCL3;BTG2;IL36G;BIRC3;HBEGF;PLAU;NFKBID;CSF2;INHBA;TICAM1;ELF3;SDC4;TNF;CXCL8;REL;SERPINB2;PPIF;IER3;NUAK2;CCL20;PTGS2;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;PLEKHF1;EFNA1;TGFA;IRF6;EDN1;SEMA7A;ERRFI1;IL1RN;IRAK2;PANX1;DAPP1;HCAR2;TNFRSF10B;EFNB2;EPHA2;RELB;GADD45A;CXCL5;LIF;TRIB1;KCTD11;CD83;SQSTM1;IFNGR2;RRAD;BMP2;PHLDA2;IL24;CAB39;MAP2K3;JUN;RAP2B;BIRC2;CDKN1A;RGMB;CLDN4;TJP2;CD274;JUNB;BCL3;CSRNP1;NAMPT;IRF1;TAF4B;BCL2L2;ZFP36L1;RELT;RND3;ADRB2;CEBPB;DUSP16;PPP1R15A;MAST4;RUNX1;CDKN2B;GJB4;TRIM16;EREG;SOD2;PELI1;NEDD9;DUSP8;DUSP1;BCL10;FGD6;TRAF1;PIM3;IL6ST;G0S2;DLX2;TXNRD1;CYLD;ADAM8;VEGFC;HCAR3;ZNF217;TACSTD2;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;PIM1;WISP1;ITGA5;CREB1;EFNB1;GJB3;F3;STK40;HIVEP2;PPARD;SOCS3;IL16;BDKRB1;RAPH1;ZFP36;SLC9A1;CYP27B1;CD55;IFNAR2;ANTXR2;JAG1;PLAGL2;RIPK2;AMOTL2;PHKG2;SAA1;PPP1R15B;NDRG1;ITGAV;PIP5K1A;TP53BP2;NRARP;SOX9;STX1A;NRG1;ZNF451;PML;RASA2;FERMT1;ELK3;CDC42EP1;PTPN11;MAP3K8;ARHGEF3;DCBLD2;RHOB;SPAG9;FEM1B;SOX4;TRAF4;OXCT1;AREG;FAM83G;AKAP2;TNFAIP1;ADAMTS1;HIVEP1;NFKBIB;KLF10;AEN;TIFA;SKIL;IL7R;CDK6;PTPN1;CORO1C;PRPF19;ADM;ABL2;ATP6V1C2;HLA-E;OSMR;WNT5A;MAOA;INSIG1;ADAM9;PDPK1;TNFRSF10A;CTSC;ERO1A;KDM6A;NFE2L2;YWHAH;SGK1;CYTH1;RELA;AGFG1;NOTCH2NL;YWHAG;RAB22A;SFN;ITM2B;ERN1;UPP1;ISG20;ATXN7;IFIH1;CXCL16;GPR156;RAB24;SMPD3
4534,GO:0010604,1.06407380035811e-20,1,152,2216,positive regulation of macromolecule metabolic process,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;HBEGF;CSF2;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;REL;KLF6;CCL20;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;SEMA7A;HAS3;IRAK2;KLF7;CREB5;EHF;TNFRSF10B;EPHA2;RELB;GADD45A;MAFF;LIF;TRIB1;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;BIRC2;CDKN1A;RGMB;SERTAD2;JUNB;BCL3;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ADRB2;CEBPB;ARNTL2;PPP1R15A;RUNX1;CDKN2B;TRIM16;EREG;PELI1;ANKLE2;BCL10;DCUN1D3;PPP1R10;IL6ST;DLX2;ADAM8;LDLR;VEGFC;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;PLK2;BBC3;PLK3;ITGA5;TFRC;CREB1;F3;PPARD;SOCS3;ZFP36;SLC9A1;LARP4B;JAG1;PLAGL2;RIPK2;PHKG2;SAA1;PPP1R15B;ITGAV;SOX9;NRG1;PML;POU2F2;NCOA7;ELK3;FOXN2;PTPN11;MAP3K8;UHRF1;SPAG9;SOX4;FOSL2;TRAF4;AREG;CCNL1;TNFAIP1;KLF10;IL7R;RBM3;IER5;SAMD4A;PTPN1;TFE3;PRPF19;MAFG;MTF1;QKI;WNT5A;INSIG1;ADAM9;PDPK1;TNFRSF10A;RNF19A;CTSC;KDM6A;NFE2L2;YWHAH;RELA;BACH1;ELF4;ERN1;ATXN7;FUBP3
4342,GO:0009893,1.25661169383703e-20,1,158,2360,positive regulation of metabolic process,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;HBEGF;CSF2;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;REL;KLF6;CCL20;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;PLEKHF1;EFNA1;TGFA;KDM6B;IRF6;EDN1;SEMA7A;HAS3;IRAK2;KLF7;CREB5;EHF;TNFRSF10B;EPHA2;RELB;GADD45A;MAFF;LIF;TRIB1;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;BIRC2;CDKN1A;RGMB;SERTAD2;JUNB;BCL3;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ADRB2;CEBPB;ARNTL2;PPP1R15A;RUNX1;CDKN2B;TRIM16;EREG;PELI1;ANKLE2;BCL10;DCUN1D3;PPP1R10;IL6ST;DLX2;ADAM8;LDLR;VEGFC;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;PLK2;BBC3;PLK3;ITGA5;TFRC;CREB1;F3;PPARD;SOCS3;ZFP36;SLC9A1;LARP4B;CYP27B1;JAG1;PLAGL2;RIPK2;PHKG2;SAA1;PPP1R15B;ITGAV;SOX9;NRG1;PML;POU2F2;NCOA7;ELK3;FOXN2;PTPN11;MAP3K8;UHRF1;SPAG9;GCH1;SOX4;FOSL2;TRAF4;AREG;CCNL1;TNFAIP1;KLF10;IL7R;RBM3;IER5;SAMD4A;PTPN1;TFE3;PRPF19;ADM;MAFG;ABL2;MTF1;QKI;WNT5A;INSIG1;ADAM9;PDPK1;TNFRSF10A;RNF19A;CTSC;KDM6A;NFE2L2;YWHAH;RELA;BACH1;ELF4;ERN1;ATXN7;FUBP3;SMPD3
6649,GO:0023052,2.02257658813388e-20,1,220,3925,signaling,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;CXCL3;BTG2;IL36G;BIRC3;HBEGF;PLAU;NFKBID;CSF2;INHBA;TICAM1;ELF3;SDC4;TNF;CXCL8;REL;SERPINB2;PPIF;IER3;NUAK2;CCL20;PTGS2;PMAIP1;TNIP1;NFKB1;PRDM1;TBX3;NFKB2;PLEKHF1;EFNA1;TGFA;IRF6;EDN1;SEMA7A;ERRFI1;IL1RN;IRAK2;PANX1;DAPP1;HCAR2;TNFRSF10B;EFNB2;EPHA2;RELB;GADD45A;CXCL5;LIF;TRIB1;KCTD11;CD83;SQSTM1;IFNGR2;RRAD;BMP2;PHLDA2;IL24;CAB39;MAP2K3;JUN;RAP2B;BIRC2;CDKN1A;RGMB;CLDN4;TJP2;CD274;JUNB;BCL3;CSRNP1;NAMPT;IRF1;TAF4B;BCL2L2;ZFP36L1;RELT;RND3;ADRB2;CEBPB;DUSP16;PPP1R15A;MAST4;RUNX1;CDKN2B;TRIM16;EREG;SOD2;PELI1;NEDD9;DUSP8;DUSP1;BCL10;FGD6;TRAF1;PIM3;IL6ST;G0S2;DLX2;TXNRD1;CYLD;ADAM8;VEGFC;HCAR3;ZNF217;TACSTD2;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;PIM1;WISP1;ITGA5;CREB1;EFNB1;F3;STK40;HIVEP2;PPARD;SOCS3;IL16;BDKRB1;RAPH1;ZFP36;SLC9A1;CYP27B1;CD55;IFNAR2;ANTXR2;JAG1;PLAGL2;RIPK2;AMOTL2;PHKG2;SAA1;PPP1R15B;NDRG1;ITGAV;PIP5K1A;TP53BP2;NRARP;SOX9;STX1A;NRG1;ZNF451;PML;RASA2;FERMT1;ELK3;CDC42EP1;PTPN11;MAP3K8;ARHGEF3;DCBLD2;RHOB;SPAG9;FEM1B;SOX4;TRAF4;OXCT1;AREG;FAM83G;AKAP2;TNFAIP1;ADAMTS1;HIVEP1;NFKBIB;KLF10;AEN;TIFA;SKIL;IL7R;CDK6;PTPN1;TMEM65;CORO1C;PRPF19;TOB2;ADM;ABL2;ATP6V1C2;HLA-E;OSMR;WNT5A;MAOA;INSIG1;ADAM9;PDPK1;TNFRSF10A;CTSC;ERO1A;KDM6A;NFE2L2;YWHAH;SGK1;CYTH1;RELA;AGFG1;NOTCH2NL;YWHAG;RAB22A;SFN;ITM2B;ERN1;ISG20;ATXN7;IFIH1;CXCL16;GPR156;RAB24;SMPD3
7317,GO:0031325,3.07887133913713e-20,1,150,2176,positive regulation of cellular metabolic process,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;HBEGF;CSF2;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;REL;KLF6;CCL20;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;FOSL1;TBX3;NFKB2;PLEKHF1;EFNA1;TGFA;KDM6B;IRF6;EDN1;SEMA7A;HAS3;IRAK2;KLF7;CREB5;EHF;TNFRSF10B;EPHA2;RELB;GADD45A;MAFF;LIF;TRIB1;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;BIRC2;CDKN1A;RGMB;SERTAD2;JUNB;BCL3;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ADRB2;CEBPB;ARNTL2;PPP1R15A;RUNX1;CDKN2B;TRIM16;EREG;PELI1;ANKLE2;BCL10;DCUN1D3;PPP1R10;IL6ST;DLX2;ADAM8;LDLR;VEGFC;OXSR1;SMAD3;RC3H1;IL23A;PLK2;BBC3;PLK3;ITGA5;TFRC;CREB1;F3;PPARD;SOCS3;ZFP36;SLC9A1;LARP4B;JAG1;PLAGL2;RIPK2;PHKG2;SAA1;PPP1R15B;ITGAV;SOX9;NRG1;PML;POU2F2;NCOA7;ELK3;FOXN2;PTPN11;MAP3K8;UHRF1;SPAG9;SOX4;FOSL2;TRAF4;AREG;CCNL1;TNFAIP1;KLF10;RBM3;IER5;SAMD4A;PTPN1;TFE3;PRPF19;ADM;MAFG;MTF1;QKI;WNT5A;INSIG1;ADAM9;PDPK1;TNFRSF10A;RNF19A;CTSC;NFE2L2;YWHAH;RELA;BACH1;ELF4;ERN1;ATXN7;FUBP3;SMPD3
4763,GO:0010941,1.6205706767921e-19,1,100,1190,regulation of cell death,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;NFKBID;CSF2;INHBA;TNF;REL;SERPINB2;PPIF;IER3;NUAK2;PTGS2;PMAIP1;NFKB1;FOSL1;TBX3;PLEKHF1;EFNA1;EDN1;HCAR2;TNFRSF10B;EFNB2;EPHA2;GADD45A;SQSTM1;BMP2;MAP2K3;JUN;BIRC2;CDKN1A;CD274;JUNB;BCL3;BCL2L2;ZFP36L1;RELT;CEBPB;SOD2;ALDH1A3;ANKLE2;B4GALT1;DUSP1;BCL10;DCUN1D3;TRAF1;PPP1R10;PIM3;IL6ST;G0S2;CYLD;ADAM8;OXSR1;SMAD3;PLK2;BBC3;PLK3;PIM1;WISP1;ITGA5;CREB1;F3;STK40;PPARD;SOCS3;ZFP36;SLC9A1;PLAGL2;RIPK2;NDRG1;ITGAV;TP53BP2;SOX9;PML;NCOA7;MAP3K8;ARHGEF3;RHOB;FEM1B;SOX4;TRAF4;SKIL;PTPN1;ADM;ABL2;WNT5A;PDPK1;TNFRSF10A;CTSC;NFE2L2;YWHAH;SGK1;RELA;YWHAG;SFN
17753,GO:1901700,1.66726839669573e-19,1,92,1023,response to oxygen-containing compound,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;ZC3H12A;CXCL1;CXCL3;BTG2;CSF2;INHBA;TICAM1;ETS1;TNF;CXCL8;PPIF;CCL20;PTGS2;TNIP1;NFKB1;PRDM1;FOSL1;NFKB2;NOCT;KDM6B;EDN1;ERRFI1;IRAK2;CLDN1;PANX1;CPEB2;TNFRSF10B;CXCL5;TRIB1;IL24;JUN;BIRC2;CDKN1A;CLDN4;CD274;JUNB;ZFP36L1;RELT;ADRB2;CEBPB;HMGCS1;TRIM16;EREG;SOD2;PELI1;DUSP1;PIM3;TXNRD1;LDLR;KLF3;DUSP10;PLK3;PIM1;CREB1;GJB3;PPARD;SOCS3;BDKRB1;ZFP36;SLC9A1;CYP27B1;CD55;JAG1;RIPK2;PPP1R15B;SOX9;PTPN11;RHOB;GCH1;SOX4;OXCT1;AREG;HDAC9;NFKBIB;KLF10;PTPN1;ADM;ABL2;ATP6V1C2;WNT5A;INSIG1;ADAM9;PDPK1;TNFRSF10A;NFE2L2;RELA;YWHAG;ERN1
3710,GO:0008219,2.07644078945646e-19,1,118,1570,cell death,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;NFKBID;CSF2;INHBA;TICAM1;TNF;REL;SERPINB2;PPIF;IER3;NUAK2;SPRR2D;PTGS2;PMAIP1;NFKB1;FOSL1;TBX3;PLEKHF1;EFNA1;EDN1;PHLDA1;SPRR2A;HCAR2;TNFRSF10B;EFNB2;EPHA2;GADD45A;SQSTM1;BMP2;PHLDA2;IL24;MAP2K3;JUN;BIRC2;CDKN1A;CD274;JUNB;BCL3;CSRNP1;IRF1;BCL2L2;ZFP36L1;RELT;CEBPB;PPP1R15A;SOD2;ALDH1A3;ANKLE2;B4GALT1;DUSP1;BCL10;DCUN1D3;TRAF1;PPP1R10;PIM3;IL6ST;G0S2;CYLD;ADAM8;OXSR1;SMAD3;PLK2;BBC3;PLK3;PIM1;WISP1;ITGA5;CREB1;F3;STK40;PPARD;KRT34;SOCS3;ZFP36;SLC9A1;PLAGL2;RIPK2;USP53;NDRG1;ITGAV;TP53BP2;SOX9;PML;NCOA7;MAP3K8;ARHGEF3;RHOB;FEM1B;SOX4;FOSL2;TRAF4;TNFAIP1;AEN;SKIL;EMP3;PTPN1;ADM;ABL2;WNT5A;PDPK1;TNFRSF10A;CTSC;ERO1A;NFE2L2;YWHAH;SGK1;RELA;YWHAG;SFN;ITM2B;ERN1
10246,GO:0042981,2.41198651863491e-19,1,95,1099,regulation of apoptotic process,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;NFKBID;CSF2;INHBA;TNF;SERPINB2;PPIF;IER3;NUAK2;PTGS2;PMAIP1;NFKB1;FOSL1;TBX3;PLEKHF1;EFNA1;EDN1;HCAR2;TNFRSF10B;EPHA2;GADD45A;SQSTM1;BMP2;MAP2K3;JUN;BIRC2;CDKN1A;CD274;BCL3;BCL2L2;ZFP36L1;RELT;CEBPB;SOD2;ALDH1A3;ANKLE2;B4GALT1;DUSP1;BCL10;DCUN1D3;TRAF1;PPP1R10;PIM3;IL6ST;G0S2;CYLD;ADAM8;OXSR1;SMAD3;PLK2;BBC3;PLK3;PIM1;ITGA5;CREB1;F3;STK40;PPARD;SOCS3;ZFP36;SLC9A1;PLAGL2;RIPK2;NDRG1;ITGAV;TP53BP2;SOX9;PML;MAP3K8;ARHGEF3;RHOB;FEM1B;SOX4;TRAF4;SKIL;PTPN1;ADM;ABL2;WNT5A;PDPK1;TNFRSF10A;CTSC;NFE2L2;YWHAH;SGK1;RELA;YWHAG;SFN
12244,GO:0048519,3.39843136088133e-19,1,203,3631,negative regulation of biological process,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;BTG2;BIRC3;HBEGF;PLAU;NFKBID;CSF2;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;CXCL8;REL;SERPINB2;PPIF;IER3;NUAK2;BHLHE40;PTGS2;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;TRPV3;NOCT;PLEKHF1;EFNA1;IRF6;EDN1;SEMA7A;ERRFI1;IL1RN;IRAK2;CPEB2;HCAR2;TNFRSF10B;EFNB2;EPHA2;RELB;GADD45A;LIF;TRIB1;KCTD11;CD83;SQSTM1;RRAD;BMP2;IL24;CAB39;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;PHLDB2;TJP2;SERTAD2;CD274;JUNB;BCL3;OVOL1;ETS2;IRF1;BCL2L2;ZFP36L1;ENC1;ADRB2;CEBPB;DUSP16;PPP1R15A;N4BP1;CDKN2B;NAB1;EREG;SOD2;PELI1;ANKLE2;DUSP8;B4GALT1;TFPI2;DUSP1;BCL10;DCUN1D3;PPP1R10;PIM3;SACS;IL6ST;NABP1;DLX2;CYLD;ADAM8;LDLR;VEGFC;KLF3;ZNF217;TACSTD2;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;PLK3;PIM1;WISP1;ITGA5;CREB1;SERPINB8;STK40;PPARD;SERPINB1;SOCS3;CCDC85B;BDKRB1;ZFP36;SLC9A1;MAFK;CYP27B1;CD55;PNRC1;AZIN1;JAG1;RIPK2;NAV3;SAA1;PPP1R15B;NDRG1;ITGAV;TP53BP2;NRARP;SOX9;NRG1;ZNF451;PML;RASA2;FERMT1;NCOA7;ELK3;PTPN11;UHRF1;MXD1;DCBLD2;RHOB;ABCA5;FEM1B;SOX4;VCL;AREG;TNFAIP1;HDAC9;ADAMTS1;HIVEP1;KLF10;SKIL;IL7R;CDK6;YRDC;SAMD4A;EMP3;PTPN1;BTG3;CORO1C;PRPF19;TOB2;ADM;HLA-E;QKI;CELF1;WNT5A;NUP153;INSIG1;PDPK1;TNFRSF10A;ADAMTS9;ERO1A;ZBTB21;NFE2L2;YWHAH;RELA;BACH1;BTAF1;YWHAG;TDG;CREG1;SFN;ITM2B;ERN1;SH3RF2;ISG20;ATXN7;IFIH1;PABPC4
10303,GO:0043067,5.02986420304825e-19,1,95,1111,regulation of programmed cell death,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;NFKBID;CSF2;INHBA;TNF;SERPINB2;PPIF;IER3;NUAK2;PTGS2;PMAIP1;NFKB1;FOSL1;TBX3;PLEKHF1;EFNA1;EDN1;HCAR2;TNFRSF10B;EPHA2;GADD45A;SQSTM1;BMP2;MAP2K3;JUN;BIRC2;CDKN1A;CD274;BCL3;BCL2L2;ZFP36L1;RELT;CEBPB;SOD2;ALDH1A3;ANKLE2;B4GALT1;DUSP1;BCL10;DCUN1D3;TRAF1;PPP1R10;PIM3;IL6ST;G0S2;CYLD;ADAM8;OXSR1;SMAD3;PLK2;BBC3;PLK3;PIM1;ITGA5;CREB1;F3;STK40;PPARD;SOCS3;ZFP36;SLC9A1;PLAGL2;RIPK2;NDRG1;ITGAV;TP53BP2;SOX9;PML;MAP3K8;ARHGEF3;RHOB;FEM1B;SOX4;TRAF4;SKIL;PTPN1;ADM;ABL2;WNT5A;PDPK1;TNFRSF10A;CTSC;NFE2L2;YWHAH;SGK1;RELA;YWHAG;SFN
13151,GO:0051716,6.5230106846808e-19,1,241,4662,cellular response to stimulus,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;CXCL3;BTG2;IL36G;BIRC3;HBEGF;PLAU;NFKBID;CSF2;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;CXCL8;REL;SERPINB2;PPIF;IER3;NUAK2;CCL20;PTGS2;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;PLEKHF1;EFNA1;TGFA;KDM6B;IRF6;EDN1;SEMA7A;ERRFI1;IL1RN;IRAK2;CLDN1;DAPP1;CPEB2;HCAR2;TNFRSF10B;EFNB2;EPHA2;RELB;GADD45A;CXCL5;LIF;TRIB1;KCTD11;CD83;SQSTM1;IFNGR2;RRAD;BMP2;PHLDA2;IL24;CAB39;MAP2K3;JUN;RAP2B;BIRC2;CDKN1A;RGMB;CLDN4;TJP2;CD274;JUNB;BCL3;CSRNP1;NAMPT;IRF1;TAF4B;BCL2L2;ZFP36L1;RELT;RND3;ADRB2;CEBPB;DUSP16;PPP1R15A;MAST4;RUNX1;N4BP1;CDKN2B;HMGCS1;TRIM16;EREG;SOD2;PELI1;EHD1;NEDD9;DUSP8;TFPI2;DUSP1;BCL10;FGD6;TRAF1;PPP1R10;PIM3;IL6ST;G0S2;NABP1;DLX2;TXNRD1;CYLD;ADAM8;LDLR;VEGFC;KLF3;HCAR3;ZNF217;TACSTD2;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;PIM1;WISP1;ITGA5;TFRC;CREB1;EFNB1;GJB3;F3;STK40;HIVEP2;PPARD;SOCS3;IL16;BDKRB1;RAPH1;ZFP36;SLC9A1;CYP27B1;CD55;IFNAR2;ANTXR2;JAG1;PLAGL2;RIPK2;AMOTL2;PHKG2;SAA1;PPP1R15B;NDRG1;ITGAV;PIP5K1A;TP53BP2;NRARP;SOX9;STX1A;NRG1;ZNF451;PML;RASA2;FERMT1;NCOA7;ELK3;CDC42EP1;PTPN11;MAP3K8;UHRF1;ARHGEF3;DCBLD2;RHOB;SPAG9;GCH1;FEM1B;SOX4;TRAF4;OXCT1;AREG;FAM83G;AKAP2;TNFAIP1;HDAC9;ADAMTS1;HIVEP1;NFKBIB;KLF10;AEN;TIFA;SKIL;IL7R;CDK6;IER5;PTPN1;CORO1C;PRPF19;ADM;ABL2;ATP6V1C2;HLA-E;OSMR;WNT5A;NUP153;MAOA;INSIG1;ADAM9;PDPK1;TNFRSF10A;CTSC;ERO1A;KDM6A;NFE2L2;YWHAH;SGK1;B3GNT2;CYTH1;RELA;AGFG1;NOTCH2NL;BACH1;YWHAG;TDG;RAB22A;SFN;ITM2B;ERN1;UPP1;ISG20;ATXN7;IFIH1;CXCL16;GPR156;RAB24
6074,GO:0019221,6.62377263617631e-19,1,60,530,cytokine-mediated signaling pathway,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;IL1A;CXCL1;CXCL3;IL36G;BIRC3;CSF2;TNF;CXCL8;SERPINB2;CCL20;PTGS2;NFKB1;IRF6;EDN1;IL1RN;IRAK2;TNFRSF10B;CXCL5;LIF;SQSTM1;IFNGR2;IL24;BIRC2;CDKN1A;TJP2;JUNB;IRF1;RELT;RUNX1;EREG;SOD2;PELI1;TRAF1;IL6ST;CYLD;IL23A;PIM1;F3;SOCS3;IL16;IFNAR2;RIPK2;SAA1;STX1A;PML;PTPN11;MAP3K8;IL7R;PTPN1;HLA-E;OSMR;WNT5A;MAOA;TNFRSF10A;RELA;ISG20
4383,GO:0010033,6.73569953729892e-19,1,144,2167,response to organic substance,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;CXCL3;BTG2;IL36G;BIRC3;CSF2;INHBA;TICAM1;ETS1;TNF;CXCL8;REL;SERPINB2;CCL20;PTGS2;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;NFKB2;NOCT;IRF6;EDN1;ERRFI1;IL1RN;IRAK2;CLDN1;PANX1;CPEB2;TNFRSF10B;EPHA2;RELB;CXCL5;LIF;TRIB1;CD83;SQSTM1;IFNGR2;BMP2;IL24;MAP2K3;JUN;BIRC2;CDKN1A;RGMB;CLDN4;TJP2;CD274;JUNB;NAMPT;IRF1;ZFP36L1;RELT;ADRB2;CEBPB;PPP1R15A;RUNX1;CDKN2B;HMGCS1;TRIM16;EREG;SOD2;PELI1;EHD1;DUSP1;BCL10;TRAF1;PIM3;IL6ST;CYLD;LDLR;VEGFC;KLF3;SMAD3;RC3H1;IL23A;DUSP10;PIM1;ITGA5;TFRC;CREB1;GJB3;F3;PPARD;SOCS3;IL16;BDKRB1;ZFP36;SLC9A1;CYP27B1;CD55;IFNAR2;JAG1;RIPK2;SAA1;PPP1R15B;SOX9;STX1A;ZNF451;PML;FERMT1;PTPN11;MAP3K8;GCH1;SOX4;OXCT1;AREG;FAM83G;HDAC9;NFKBIB;KLF10;SKIL;IL7R;PTPN1;SQLE;ADM;ABL2;ATP6V1C2;HLA-E;OSMR;WNT5A;MAOA;INSIG1;ADAM9;PDPK1;TNFRSF10A;CTSC;ERO1A;NFE2L2;YWHAH;B3GNT2;RELA;YWHAG;ERN1;ISG20;IFIH1;CXCL16
2224,GO:0005125,7.63290640097333e-19,1,24,78,cytokine activity,MF,CXCL2;IL1B;IL1A;CXCL1;CXCL3;IL36G;CSF2;INHBA;TNF;CXCL8;CCL20;EDN1;IL1RN;CXCL5;LIF;BMP2;IL24;NAMPT;IL23A;IL16;NRG1;AREG;WNT5A;CXCL16
7928,GO:0032501,8.58230119055416e-19,1,225,4171,multicellular organismal process,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;BTG2;BIRC3;HBEGF;PLAU;NFKBID;CSF2;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;CXCL8;REL;SERPINB2;KLF6;CCL20;SPRR2D;BHLHE40;PTGS2;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;TRPV3;NOCT;EFNA1;KDM6B;IRF6;EDN1;ODC1;SEMA7A;ERRFI1;IL1RN;CLDN1;KLF7;PANX1;EHF;SPRR2A;HCAR2;TNFRSF10B;EFNB2;EPHA2;RELB;MAFF;LIF;TRIB1;KCTD11;CD83;BMP2;PHLDA2;ZNF267;N4BP3;MAP2K3;JUN;RAP2B;BIRC2;CDKN1A;PHLDB2;CLDN4;TJP2;CD274;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;BCL2L2;ZFP36L1;ENC1;RELT;ADRB2;CEBPB;RUNX1;CDKN2B;GJB4;NAB1;HMGCS1;TRIM16;EREG;SOD2;PELI1;ALDH1A3;EHD1;ZSWIM4;ANKLE2;B4GALT1;TFPI2;DUSP1;BCL10;IL6ST;B3GNT5;VMP1;DLX2;TXNRD1;CYLD;ADAM8;LDLR;VEGFC;KLF3;ZNF217;TACSTD2;NEDD4L;SMAD3;RC3H1;IL23A;DUSP10;PLK2;DIEXF;PIM1;ITGA5;TFRC;LIPG;CREB1;EFNB1;GJB3;F3;STK40;HIVEP2;PPARD;KRT34;SLC25A25;SOCS3;KRTAP2-3;BDKRB1;RAPH1;ZFP36;SLC9A1;MAFK;CYP27B1;CD55;JAG1;PLAGL2;RIPK2;AMOTL2;NAV3;SAA1;USP53;NDRG1;ITGAV;PIP5K1A;NRARP;SOX9;NRG1;PML;POU2F2;FERMT1;ELK3;POLR3A;SLC7A2;FOXN2;PTPN11;MXD1;RHOB;SPAG9;ABCA5;GCH1;FEM1B;SOX4;FOSL2;TRAF4;VCL;OXCT1;AREG;HDAC9;ADAMTS1;HIVEP1;KLF10;SKIL;IL7R;CDK6;TFE3;TMEM65;CORO1C;PRPF19;TOB2;ADM;MAFG;ABL2;HLA-E;QKI;CELF1;WNT5A;INSIG1;ADAM9;LCE1C;PDPK1;TNFRSF10A;ADAMTS9;ERO1A;KDM6A;SMTN;NFE2L2;YWHAH;SGK1;B3GNT2;SAT1;RELA;AGFG1;NOTCH2NL;POLR3D;YWHAG;TDG;CREG1;SFN;ITM2B;ATXN7;IFIH1;LAMB3;BRD2;PABPC4;PDLIM5;SMPD3
8559,GO:0033993,9.38973119062757e-19,1,66,590,response to lipid,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;ZC3H12A;CXCL1;CXCL3;CSF2;INHBA;TICAM1;ETS1;TNF;CXCL8;CCL20;PTGS2;TNIP1;NFKB1;PRDM1;FOSL1;NFKB2;NOCT;EDN1;ERRFI1;IL1RN;IRAK2;CLDN1;TNFRSF10B;CXCL5;TRIB1;IL24;JUN;CDKN1A;CLDN4;CD274;JUNB;ZFP36L1;RELT;CEBPB;RUNX1;HMGCS1;TRIM16;PELI1;DUSP1;LDLR;DUSP10;PIM1;CREB1;GJB3;PPARD;BDKRB1;ZFP36;CYP27B1;CD55;RIPK2;SOX9;GCH1;AREG;NFKBIB;ADM;ABL2;WNT5A;INSIG1;ADAM9;TNFRSF10A;YWHAH;RELA
15196,GO:0071345,1.26023304904882e-18,1,73,745,cellular response to cytokine stimulus,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;CXCL3;IL36G;BIRC3;CSF2;TNF;CXCL8;SERPINB2;CCL20;PTGS2;NFKB1;IRF6;EDN1;IL1RN;IRAK2;CLDN1;TNFRSF10B;CXCL5;LIF;SQSTM1;IFNGR2;IL24;BIRC2;CDKN1A;TJP2;JUNB;IRF1;ZFP36L1;RELT;CEBPB;RUNX1;EREG;SOD2;PELI1;TRAF1;IL6ST;CYLD;VEGFC;SMAD3;RC3H1;IL23A;PIM1;TFRC;CREB1;F3;SOCS3;IL16;ZFP36;IFNAR2;RIPK2;SAA1;SOX9;STX1A;PML;PTPN11;MAP3K8;IL7R;PTPN1;HLA-E;OSMR;WNT5A;MAOA;TNFRSF10A;NFE2L2;B3GNT2;RELA;ISG20
3253,GO:0006915,1.66354010512528e-18,1,108,1395,apoptotic process,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;NFKBID;CSF2;INHBA;TICAM1;TNF;SERPINB2;PPIF;IER3;NUAK2;PTGS2;PMAIP1;NFKB1;FOSL1;TBX3;PLEKHF1;EFNA1;EDN1;PHLDA1;HCAR2;TNFRSF10B;EPHA2;GADD45A;SQSTM1;BMP2;PHLDA2;IL24;MAP2K3;JUN;BIRC2;CDKN1A;CD274;BCL3;CSRNP1;IRF1;BCL2L2;ZFP36L1;RELT;CEBPB;PPP1R15A;SOD2;ALDH1A3;ANKLE2;B4GALT1;DUSP1;BCL10;DCUN1D3;TRAF1;PPP1R10;PIM3;IL6ST;G0S2;CYLD;ADAM8;OXSR1;SMAD3;PLK2;BBC3;PLK3;PIM1;ITGA5;CREB1;F3;STK40;PPARD;SOCS3;ZFP36;SLC9A1;PLAGL2;RIPK2;USP53;NDRG1;ITGAV;TP53BP2;SOX9;PML;MAP3K8;ARHGEF3;RHOB;FEM1B;SOX4;TRAF4;TNFAIP1;AEN;SKIL;PTPN1;ADM;ABL2;WNT5A;PDPK1;TNFRSF10A;CTSC;ERO1A;NFE2L2;YWHAH;SGK1;RELA;YWHAG;SFN;ITM2B;ERN1
12901,GO:0051240,2.44340555682046e-18,1,89,981,positive regulation of multicellular organismal process,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;BIRC3;HBEGF;CSF2;INHBA;TICAM1;ETS1;TNF;CXCL8;CCL20;PTGS2;NFKB1;PRDM1;NFKB2;EDN1;SEMA7A;PANX1;HCAR2;EFNB2;LIF;TRIB1;KCTD11;CD83;BMP2;MAP2K3;JUN;BIRC2;PHLDB2;CD274;BCL3;IRF1;ZFP36L1;ENC1;ADRB2;CEBPB;RUNX1;TRIM16;EREG;PELI1;B4GALT1;BCL10;IL6ST;DLX2;CYLD;ADAM8;LDLR;VEGFC;NEDD4L;SMAD3;IL23A;DUSP10;PLK2;PIM1;ITGA5;TFRC;LIPG;CREB1;F3;SLC9A1;CYP27B1;JAG1;RIPK2;SAA1;SOX9;NRG1;FERMT1;POLR3A;RHOB;SPAG9;GCH1;HDAC9;KLF10;SKIL;IL7R;PRPF19;TOB2;ADM;ABL2;HLA-E;WNT5A;ADAM9;PDPK1;NFE2L2;RELA;POLR3D;IFIH1
3275,GO:0006955,2.75466813677626e-18,1,98,1222,immune response,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;CXCL3;IL36G;BIRC3;PLAU;CSF2;TICAM1;ETS1;TNF;CXCL8;REL;CCL20;RNF19B;TNIP1;NFKB1;PRDM1;NFKB2;KDM6B;IRF6;EDN1;SEMA7A;IL1RN;IRAK2;CLDN1;TNFRSF10B;RELB;CXCL5;LIF;CD83;IFNGR2;CAB39;JUN;RAP2B;BIRC2;CD274;BCL3;AMPD3;IRF1;RELT;CEBPB;RUNX1;EREG;PELI1;B4GALT1;BCL10;IL6ST;CYLD;ADAM8;SMAD3;RC3H1;IL23A;DUSP10;TFRC;SERPINB1;SOCS3;RAET1L;IL16;CYP27B1;CD55;IFNAR2;JAG1;RIPK2;SAA1;ITGAV;PML;POU2F2;POLR3A;PTPN11;GCH1;VCL;TNFAIP1;COTL1;IL7R;PTPN1;TFE3;ABL2;HLA-E;WNT5A;PDPK1;TNFRSF10A;CTSC;RELA;POLR3D;ELF4;CREG1;ISG20;IFIH1;CXCL16;TAP1;AHCY;RAB24
4807,GO:0012501,4.53674725776806e-18,1,111,1484,programmed cell death,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;NFKBID;CSF2;INHBA;TICAM1;TNF;SERPINB2;PPIF;IER3;NUAK2;SPRR2D;PTGS2;PMAIP1;NFKB1;FOSL1;TBX3;PLEKHF1;EFNA1;EDN1;PHLDA1;SPRR2A;HCAR2;TNFRSF10B;EPHA2;GADD45A;SQSTM1;BMP2;PHLDA2;IL24;MAP2K3;JUN;BIRC2;CDKN1A;CD274;BCL3;CSRNP1;IRF1;BCL2L2;ZFP36L1;RELT;CEBPB;PPP1R15A;SOD2;ALDH1A3;ANKLE2;B4GALT1;DUSP1;BCL10;DCUN1D3;TRAF1;PPP1R10;PIM3;IL6ST;G0S2;CYLD;ADAM8;OXSR1;SMAD3;PLK2;BBC3;PLK3;PIM1;ITGA5;CREB1;F3;STK40;PPARD;KRT34;SOCS3;ZFP36;SLC9A1;PLAGL2;RIPK2;USP53;NDRG1;ITGAV;TP53BP2;SOX9;PML;MAP3K8;ARHGEF3;RHOB;FEM1B;SOX4;TRAF4;TNFAIP1;AEN;SKIL;PTPN1;ADM;ABL2;WNT5A;PDPK1;TNFRSF10A;CTSC;ERO1A;NFE2L2;YWHAH;SGK1;RELA;YWHAG;SFN;ITM2B;ERN1
12616,GO:0050794,5.72414717784537e-18,1,317,7108,regulation of cellular process,BP,NFKBIA;NFKBIZ;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;CXCL3;BTG2;IL36G;BIRC3;HBEGF;PLAU;NFKBID;CSF2;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;CXCL8;REL;SERPINB2;PPIF;IER3;KLF6;NUAK2;CCL20;ZNF697;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;PLEKHF1;EFNA1;TGFA;KDM6B;IRF6;EDN1;ODC1;SEMA7A;HAS3;ERRFI1;IL1RN;IRAK2;CLDN1;KLF7;PANX1;CREB5;DAPP1;CPEB2;EHF;HCAR2;TNFRSF10B;EFNB2;EPHA2;RELB;GADD45A;CXCL5;MAFF;LIF;TRIB1;KCTD11;CD83;SQSTM1;IFNGR2;RRAD;BMP2;PHLDA2;IL24;CAB39;ZNF267;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;RGMB;PHLDB2;CLDN4;TJP2;SERTAD2;CD274;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;BCL2L2;ZFP36L1;ENC1;RELT;RND3;ADRB2;CEBPB;DUSP16;ARNTL2;UGCG;PPP1R15A;MAST4;RUNX1;N4BP1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;ALDH1A3;EHD1;NEDD9;ZSWIM4;ANKLE2;DUSP8;B4GALT1;TFPI2;DUSP1;BCL10;FGD6;DCUN1D3;TRAF1;PPP1R10;PIM3;SACS;IL6ST;G0S2;NABP1;DLX2;TXNRD1;VGLL3;CYLD;ADAM8;LDLR;VEGFC;KLF3;HCAR3;ZNF217;TACSTD2;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;PIM1;WISP1;ITGA5;TFRC;LIPG;KLHL21;CREB1;SERPINB8;EFNB1;F3;STK40;HIVEP2;PPARD;SERPINB1;SOCS3;CCDC85B;USP36;IL16;BDKRB1;RAPH1;ZFP36;SLC9A1;MAFK;LARP4B;CYP27B1;CD55;PNRC1;IFNAR2;ELL2;ANTXR2;AZIN1;JAG1;PLAGL2;RIPK2;AMOTL2;PHKG2;NAV3;SAA1;PPP1R15B;NDRG1;ITGAV;PIP5K1A;CLK4;TP53BP2;NRARP;SOX9;STX1A;NRG1;ZNF451;PML;POU2F2;RASA2;FERMT1;NCOA7;ELK3;SLC7A2;ZNF460;CDC42EP1;FOXN2;PTPN11;MAP3K8;UHRF1;ARHGEF3;MXD1;DCBLD2;RHOB;SPAG9;ABCA5;GCH1;FEM1B;SOX4;FOSL2;TRAF4;VCL;EIF1;OXCT1;AREG;CCNL1;FAM83G;AKAP2;TNFAIP1;HDAC9;ADAMTS1;HIVEP1;NFKBIB;KLF10;AEN;TIFA;SKIL;IL7R;RBM3;CDK6;IER5;SAMD4A;EMP3;PTPN1;TFE3;BTG3;CORO1C;PRPF19;TOB2;ADM;MAFG;ABL2;MTF1;ATP6V1C2;HLA-E;OSMR;QKI;CELF1;WNT5A;NUP153;MAOA;INSIG1;ADAM9;PDPK1;TNFRSF10A;ADAMTS9;RNF19A;CTSC;ERO1A;KDM6A;FRMD6;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;CYTH1;SAT1;RELA;AGFG1;NOTCH2NL;BACH1;BTAF1;YWHAG;TDG;ELF4;RAB22A;CREG1;SFN;ITM2B;ERN1;SH3RF2;ISG20;ATXN7;IFIH1;BRD2;CXCL16;PABPC4;PDLIM5;FUBP3;GPR156;RAB24;SMPD3
12276,GO:0048584,1.07535372631893e-17,1,109,1437,positive regulation of response to stimulus,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;CXCL3;BIRC3;HBEGF;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;CXCL8;REL;PPIF;CCL20;PTGS2;PMAIP1;TNIP1;NFKB1;PLEKHF1;EFNA1;TGFA;EDN1;SEMA7A;IRAK2;TNFRSF10B;EPHA2;RELB;GADD45A;CXCL5;LIF;BMP2;IL24;MAP2K3;JUN;BIRC2;IRF1;ADRB2;PPP1R15A;RUNX1;CDKN2B;TRIM16;EREG;PELI1;BCL10;IL6ST;G0S2;CYLD;ADAM8;LDLR;VEGFC;SMAD3;RC3H1;IL23A;PLK2;BBC3;ITGA5;TFRC;F3;PPARD;SOCS3;IL16;SLC9A1;CYP27B1;CD55;JAG1;PLAGL2;RIPK2;SAA1;ITGAV;TP53BP2;NRARP;SOX9;STX1A;NRG1;PML;FERMT1;PTPN11;MAP3K8;SPAG9;SOX4;TRAF4;OXCT1;SKIL;IL7R;IER5;PTPN1;ATP6V1C2;HLA-E;OSMR;WNT5A;ADAM9;PDPK1;TNFRSF10A;CTSC;NFE2L2;YWHAH;RELA;POLR3D;YWHAG;SFN;ERN1;IFIH1
12069,GO:0048018,2.11536695326019e-17,1,32,166,receptor ligand activity,MF,CXCL2;IL1B;IL1A;CXCL1;CXCL3;IL36G;HBEGF;CSF2;INHBA;TNF;CXCL8;CCL20;TGFA;EDN1;SEMA7A;IL1RN;CXCL5;LIF;BMP2;IL24;NAMPT;EREG;VEGFC;IL23A;IL16;JAG1;SAA1;NRG1;AREG;ADM;WNT5A;CXCL16
15970,GO:0080090,2.16319742419727e-17,1,232,4499,regulation of primary metabolic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;HBEGF;NFKBID;CSF2;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;REL;SERPINB2;PPIF;KLF6;CCL20;ZNF697;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;ODC1;SEMA7A;HAS3;ERRFI1;IRAK2;KLF7;CREB5;CPEB2;EHF;HCAR2;TNFRSF10B;EPHA2;RELB;GADD45A;MAFF;LIF;TRIB1;SQSTM1;BMP2;PHLDA2;IL24;CAB39;ZNF267;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ENC1;ADRB2;CEBPB;DUSP16;ARNTL2;PPP1R15A;RUNX1;N4BP1;CDKN2B;NAB1;HMGCS1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;ANKLE2;DUSP8;TFPI2;DUSP1;BCL10;DCUN1D3;TRAF1;PPP1R10;IL6ST;G0S2;DLX2;TXNRD1;VGLL3;CYLD;ADAM8;LDLR;VEGFC;KLF3;ZNF217;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;PIM1;ITGA5;TFRC;LIPG;CREB1;SERPINB8;F3;STK40;HIVEP2;PPARD;SERPINB1;SOCS3;CCDC85B;USP36;IL16;BDKRB1;ZFP36;SLC9A1;MAFK;LARP4B;CYP27B1;CD55;PNRC1;ELL2;AZIN1;JAG1;PLAGL2;RIPK2;PHKG2;SAA1;PPP1R15B;ITGAV;CLK4;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;ZNF460;FOXN2;PTPN11;MAP3K8;UHRF1;MXD1;SPAG9;FEM1B;SOX4;FOSL2;TRAF4;EIF1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;IL7R;RBM3;CDK6;IER5;SAMD4A;PTPN1;SQLE;TFE3;CORO1C;PRPF19;TOB2;ADM;MAFG;MTF1;QKI;CELF1;WNT5A;NUP153;INSIG1;ADAM9;PDPK1;TNFRSF10A;RNF19A;CTSC;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;RELA;BACH1;BTAF1;ALAS1;YWHAG;TDG;ELF4;CREG1;SFN;ITM2B;ERN1;SH3RF2;ATXN7;BRD2;PABPC4;FUBP3;SMPD3
4363,GO:0009966,2.83995693446083e-17,1,141,2142,regulation of signal transduction,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;CXCL3;IL36G;BIRC3;HBEGF;PLAU;NFKBID;CSF2;INHBA;TICAM1;ELF3;TNF;CXCL8;REL;PPIF;IER3;CCL20;PTGS2;PMAIP1;TNIP1;NFKB1;PRDM1;PLEKHF1;EFNA1;TGFA;EDN1;SEMA7A;ERRFI1;IL1RN;IRAK2;TNFRSF10B;EPHA2;GADD45A;CXCL5;LIF;TRIB1;KCTD11;SQSTM1;IFNGR2;BMP2;PHLDA2;IL24;MAP2K3;JUN;BIRC2;BCL3;NAMPT;IRF1;TAF4B;BCL2L2;ADRB2;DUSP16;PPP1R15A;RUNX1;CDKN2B;TRIM16;EREG;SOD2;PELI1;DUSP8;DUSP1;BCL10;FGD6;TRAF1;IL6ST;G0S2;DLX2;CYLD;ADAM8;VEGFC;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;ITGA5;F3;STK40;PPARD;SOCS3;IL16;SLC9A1;CYP27B1;CD55;IFNAR2;JAG1;PLAGL2;RIPK2;SAA1;PPP1R15B;ITGAV;PIP5K1A;TP53BP2;NRARP;SOX9;STX1A;NRG1;ZNF451;PML;RASA2;FERMT1;PTPN11;MAP3K8;ARHGEF3;RHOB;SPAG9;FEM1B;SOX4;TRAF4;AREG;TNFAIP1;SKIL;IL7R;PTPN1;ADM;ATP6V1C2;WNT5A;INSIG1;ADAM9;PDPK1;TNFRSF10A;CTSC;NFE2L2;YWHAH;CYTH1;RELA;AGFG1;YWHAG;SFN;ERN1;ATXN7;CXCL16
1095,GO:0002682,3.29248741263837e-17,1,81,926,regulation of immune system process,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;CXCL3;BIRC3;NFKBID;CSF2;INHBA;TICAM1;SDC4;ETS1;TNF;CXCL8;CCL20;TNIP1;NFKB1;PRDM1;EDN1;SEMA7A;IRAK2;HCAR2;EFNB2;RELB;CXCL5;LIF;TRIB1;CD83;IFNGR2;JUN;BIRC2;CDKN1A;TJP2;CD274;IRF1;ZFP36L1;CEBPB;RUNX1;EREG;PELI1;BCL10;IL6ST;CYLD;ADAM8;LDLR;VEGFC;SMAD3;RC3H1;IL23A;DUSP10;TFRC;CREB1;EFNB1;SOCS3;BDKRB1;ZFP36;CD55;IFNAR2;JAG1;RIPK2;NRARP;SOX9;SLC7A2;PTPN11;MAP3K8;KLF10;IL7R;CDK6;PTPN1;TFE3;TOB2;HLA-E;WNT5A;PDPK1;NFE2L2;RELA;POLR3D;IFIH1
12248,GO:0048523,3.8939075337763e-17,1,186,3283,negative regulation of cellular process,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;BTG2;BIRC3;HBEGF;NFKBID;CSF2;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;CXCL8;REL;SERPINB2;PPIF;IER3;NUAK2;BHLHE40;PTGS2;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;PLEKHF1;EFNA1;IRF6;EDN1;SEMA7A;ERRFI1;IL1RN;CPEB2;TNFRSF10B;EFNB2;EPHA2;RELB;GADD45A;LIF;TRIB1;KCTD11;SQSTM1;BMP2;IL24;CAB39;JUN;RAP2B;BIRC2;CDKN1A;PHLDB2;TJP2;SERTAD2;CD274;JUNB;BCL3;OVOL1;ETS2;IRF1;BCL2L2;ZFP36L1;ENC1;ADRB2;CEBPB;DUSP16;PPP1R15A;N4BP1;CDKN2B;NAB1;EREG;SOD2;PELI1;ANKLE2;DUSP8;B4GALT1;TFPI2;DUSP1;BCL10;DCUN1D3;PPP1R10;PIM3;SACS;IL6ST;NABP1;DLX2;CYLD;ADAM8;LDLR;VEGFC;KLF3;ZNF217;TACSTD2;NEDD4L;OXSR1;SMAD3;RC3H1;DUSP10;PLK2;PLK3;PIM1;WISP1;ITGA5;CREB1;SERPINB8;STK40;PPARD;SERPINB1;SOCS3;CCDC85B;BDKRB1;ZFP36;SLC9A1;MAFK;CYP27B1;CD55;JAG1;RIPK2;NAV3;PPP1R15B;NDRG1;ITGAV;TP53BP2;NRARP;SOX9;NRG1;ZNF451;PML;RASA2;FERMT1;NCOA7;ELK3;PTPN11;UHRF1;MXD1;DCBLD2;RHOB;ABCA5;FEM1B;SOX4;VCL;AREG;TNFAIP1;HDAC9;ADAMTS1;HIVEP1;KLF10;SKIL;CDK6;SAMD4A;EMP3;PTPN1;BTG3;CORO1C;PRPF19;TOB2;ADM;QKI;CELF1;WNT5A;NUP153;INSIG1;PDPK1;TNFRSF10A;ADAMTS9;ERO1A;ZBTB21;NFE2L2;YWHAH;RELA;BACH1;BTAF1;YWHAG;TDG;CREG1;SFN;ITM2B;ERN1;SH3RF2;ATXN7
3460,GO:0007275,4.20172438478639e-17,1,189,3302,multicellular organism development,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;CXCL1;BTG2;HBEGF;NFKBID;CSF2;INHBA;ELF3;SDC4;ETS1;TNF;CXCL8;KLF6;SPRR2D;PTGS2;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;KDM6B;IRF6;EDN1;ODC1;SEMA7A;ERRFI1;IL1RN;CLDN1;KLF7;EHF;SPRR2A;TNFRSF10B;EFNB2;EPHA2;RELB;MAFF;LIF;TRIB1;KCTD11;CD83;BMP2;PHLDA2;ZNF267;N4BP3;JUN;BIRC2;CDKN1A;PHLDB2;CLDN4;TJP2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;IRF1;BCL2L2;ZFP36L1;ENC1;RELT;ADRB2;CEBPB;RUNX1;CDKN2B;NAB1;HMGCS1;TRIM16;EREG;ALDH1A3;EHD1;ZSWIM4;ANKLE2;B4GALT1;DUSP1;BCL10;IL6ST;B3GNT5;VMP1;DLX2;TXNRD1;CYLD;ADAM8;LDLR;VEGFC;KLF3;ZNF217;TACSTD2;NEDD4L;SMAD3;RC3H1;IL23A;DUSP10;PLK2;DIEXF;PIM1;ITGA5;TFRC;CREB1;EFNB1;GJB3;F3;STK40;HIVEP2;PPARD;KRT34;SLC25A25;SOCS3;KRTAP2-3;RAPH1;ZFP36;SLC9A1;MAFK;CYP27B1;JAG1;PLAGL2;RIPK2;AMOTL2;NAV3;NDRG1;ITGAV;PIP5K1A;NRARP;SOX9;NRG1;PML;POU2F2;FERMT1;ELK3;FOXN2;PTPN11;MXD1;RHOB;SPAG9;FEM1B;SOX4;FOSL2;TRAF4;VCL;OXCT1;AREG;HDAC9;ADAMTS1;HIVEP1;KLF10;SKIL;IL7R;CDK6;TFE3;TMEM65;CORO1C;PRPF19;TOB2;ADM;MAFG;ABL2;QKI;CELF1;WNT5A;INSIG1;ADAM9;LCE1C;PDPK1;TNFRSF10A;ADAMTS9;ERO1A;KDM6A;SMTN;NFE2L2;YWHAH;SGK1;B3GNT2;SAT1;RELA;AGFG1;NOTCH2NL;YWHAG;TDG;CREG1;SFN;ITM2B;LAMB3;PABPC4;PDLIM5;SMPD3
12612,GO:0050789,4.49654135075461e-17,1,325,7500,regulation of biological process,BP,NFKBIA;NFKBIZ;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;CXCL3;BTG2;IL36G;BIRC3;HBEGF;PLAU;NFKBID;CSF2;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;CXCL8;REL;SERPINB2;PPIF;IER3;KLF6;NUAK2;CCL20;ZNF697;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;TRPV3;NOCT;PLEKHF1;EFNA1;TGFA;KDM6B;IRF6;EDN1;ODC1;SEMA7A;HAS3;ERRFI1;IL1RN;IRAK2;CLDN1;KLF7;PANX1;CREB5;DAPP1;CPEB2;EHF;HCAR2;TNFRSF10B;EFNB2;EPHA2;RELB;GADD45A;CXCL5;MAFF;LIF;TRIB1;KCTD11;CD83;SQSTM1;IFNGR2;RRAD;BMP2;PHLDA2;IL24;CAB39;ZNF267;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;RGMB;PHLDB2;CLDN4;TJP2;SERTAD2;CD274;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;BCL2L2;ZFP36L1;ENC1;RELT;RND3;ADRB2;CEBPB;DUSP16;ARNTL2;UGCG;PPP1R15A;MAST4;RUNX1;N4BP1;CDKN2B;NAB1;HMGCS1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;ALDH1A3;EHD1;NEDD9;ZSWIM4;ANKLE2;DUSP8;B4GALT1;TFPI2;DUSP1;BCL10;FGD6;DCUN1D3;TRAF1;PPP1R10;PIM3;SACS;IL6ST;G0S2;NABP1;DLX2;TXNRD1;VGLL3;CYLD;ADAM8;LDLR;VEGFC;KLF3;HCAR3;ZNF217;TACSTD2;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;PIM1;WISP1;ITGA5;TFRC;LIPG;KLHL21;CREB1;SERPINB8;EFNB1;F3;STK40;HIVEP2;PPARD;SERPINB1;SOCS3;CCDC85B;USP36;IL16;BDKRB1;RAPH1;ZFP36;SLC9A1;MAFK;LARP4B;CYP27B1;CD55;PNRC1;IFNAR2;ELL2;ANTXR2;AZIN1;JAG1;PLAGL2;RIPK2;AMOTL2;PHKG2;NAV3;SAA1;PPP1R15B;NDRG1;ITGAV;PIP5K1A;CLK4;TP53BP2;NRARP;SOX9;STX1A;NRG1;ZNF451;PML;POU2F2;RASA2;FERMT1;NCOA7;ELK3;POLR3A;SLC7A2;ZNF460;CDC42EP1;FOXN2;PTPN11;MAP3K8;UHRF1;ARHGEF3;MXD1;DCBLD2;RHOB;SPAG9;ABCA5;GCH1;FEM1B;SOX4;FOSL2;TRAF4;VCL;EIF1;OXCT1;AREG;CCNL1;FAM83G;AKAP2;TNFAIP1;HDAC9;ADAMTS1;HIVEP1;NFKBIB;KLF10;AEN;TIFA;SKIL;IL7R;RBM3;CDK6;IER5;YRDC;SAMD4A;EMP3;PTPN1;SQLE;TFE3;BTG3;TMEM65;CORO1C;PRPF19;TOB2;ADM;MAFG;ABL2;MTF1;ATP6V1C2;HLA-E;OSMR;QKI;CELF1;WNT5A;NUP153;MAOA;INSIG1;ADAM9;PDPK1;TNFRSF10A;ADAMTS9;RNF19A;CTSC;ERO1A;KDM6A;FRMD6;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;CYTH1;SAT1;RELA;AGFG1;NOTCH2NL;BACH1;BTAF1;POLR3D;ALAS1;YWHAG;TDG;ELF4;RAB22A;CREG1;SFN;ITM2B;ERN1;SH3RF2;ISG20;ATXN7;IFIH1;BRD2;CXCL16;PABPC4;PDLIM5;FUBP3;GPR156;RAB24;SMPD3
12900,GO:0051239,4.51755261699677e-17,1,127,1830,regulation of multicellular organismal process,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BIRC3;HBEGF;PLAU;NFKBID;CSF2;INHBA;TICAM1;ETS1;TNF;CXCL8;REL;SERPINB2;CCL20;PTGS2;NFKB1;PRDM1;TBX3;NFKB2;TRPV3;NOCT;EFNA1;EDN1;SEMA7A;ERRFI1;IL1RN;PANX1;HCAR2;EFNB2;EPHA2;RELB;MAFF;LIF;TRIB1;KCTD11;CD83;BMP2;PHLDA2;MAP2K3;JUN;BIRC2;PHLDB2;TJP2;CD274;BCL3;IRF1;ZFP36L1;ENC1;ADRB2;CEBPB;RUNX1;TRIM16;EREG;PELI1;ZSWIM4;B4GALT1;BCL10;IL6ST;DLX2;CYLD;ADAM8;LDLR;VEGFC;TACSTD2;NEDD4L;SMAD3;RC3H1;IL23A;DUSP10;PLK2;PIM1;ITGA5;TFRC;LIPG;CREB1;F3;PPARD;ZFP36;SLC9A1;CYP27B1;JAG1;RIPK2;NAV3;SAA1;NRARP;SOX9;NRG1;PML;FERMT1;POLR3A;PTPN11;RHOB;SPAG9;GCH1;AREG;HDAC9;KLF10;SKIL;IL7R;CDK6;TFE3;TMEM65;CORO1C;PRPF19;TOB2;ADM;MAFG;ABL2;HLA-E;WNT5A;ADAM9;PDPK1;ADAMTS9;NFE2L2;YWHAH;SGK1;RELA;POLR3D;YWHAG;SFN;IFIH1;PDLIM5
9792,GO:0040012,6.48433903015009e-17,1,66,619,regulation of locomotion,BP,CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;CXCL3;HBEGF;PLAU;SDC4;ETS1;TNF;CXCL8;CCL20;PTGS2;EFNA1;EDN1;SEMA7A;EFNB2;EPHA2;CXCL5;TRIB1;BMP2;PHLDA2;IL24;MAP2K3;JUN;RAP2B;PHLDB2;CD274;RND3;EREG;SOD2;ZSWIM4;ADAM8;VEGFC;TACSTD2;SMAD3;IL23A;DUSP10;PLK2;ITGA5;F3;PPARD;IL16;BDKRB1;JAG1;AMOTL2;NAV3;ITGAV;SOX9;NRG1;PML;RHOB;SPAG9;VCL;HDAC9;CDK6;CORO1C;ABL2;WNT5A;ADAM9;PDPK1;ADAMTS9;NFE2L2;SGK1;CXCL16
6739,GO:0030155,1.03775429189866e-16,1,53,421,regulation of cell adhesion,BP,IL1B;PLAU;NFKBID;SDC4;ETS1;TNF;CXCL8;EFNA1;IL1RN;EFNB2;EPHA2;CD83;BMP2;PHLDB2;CD274;IRF1;CEBPB;PELI1;BCL10;IL6ST;CYLD;ADAM8;VEGFC;TACSTD2;SMAD3;RC3H1;IL23A;DUSP10;ITGA5;TFRC;EFNB1;SLC9A1;CD55;JAG1;RIPK2;SAA1;ITGAV;NRARP;SOX9;PML;FERMT1;PTPN11;MAP3K8;IL7R;CDK6;TFE3;CORO1C;ABL2;HLA-E;WNT5A;ADAM9;PDPK1;CYTH1
14975,GO:0070887,1.74754990411696e-16,1,136,2119,cellular response to chemical stimulus,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;CXCL3;IL36G;BIRC3;HBEGF;CSF2;INHBA;TICAM1;ETS1;TNF;CXCL8;SERPINB2;PPIF;CCL20;PTGS2;PMAIP1;TNIP1;NFKB1;PRDM1;KDM6B;IRF6;EDN1;ERRFI1;IL1RN;IRAK2;CLDN1;CPEB2;TNFRSF10B;EPHA2;CXCL5;LIF;TRIB1;SQSTM1;IFNGR2;BMP2;IL24;MAP2K3;JUN;BIRC2;CDKN1A;RGMB;TJP2;CD274;JUNB;IRF1;ZFP36L1;RELT;ADRB2;CEBPB;PPP1R15A;RUNX1;CDKN2B;HMGCS1;EREG;SOD2;PELI1;EHD1;DUSP1;TRAF1;PIM3;IL6ST;TXNRD1;CYLD;ADAM8;LDLR;VEGFC;KLF3;SMAD3;RC3H1;IL23A;PLK3;PIM1;ITGA5;TFRC;CREB1;GJB3;F3;PPARD;SOCS3;IL16;ZFP36;SLC9A1;CYP27B1;CD55;IFNAR2;RIPK2;SAA1;PPP1R15B;NDRG1;PIP5K1A;SOX9;STX1A;ZNF451;PML;FERMT1;NCOA7;PTPN11;MAP3K8;RHOB;GCH1;SOX4;OXCT1;FAM83G;HDAC9;NFKBIB;KLF10;SKIL;IL7R;PTPN1;ABL2;ATP6V1C2;HLA-E;OSMR;WNT5A;MAOA;INSIG1;ADAM9;PDPK1;TNFRSF10A;ERO1A;NFE2L2;YWHAH;B3GNT2;RELA;BACH1;YWHAG;ERN1;ISG20;IFIH1;CXCL16
19760,GO:2000145,2.65293013664185e-16,1,62,571,regulation of cell motility,BP,CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;CXCL3;HBEGF;PLAU;SDC4;ETS1;TNF;CXCL8;CCL20;PTGS2;EFNA1;EDN1;SEMA7A;EPHA2;CXCL5;TRIB1;BMP2;PHLDA2;IL24;MAP2K3;JUN;RAP2B;PHLDB2;CD274;RND3;EREG;SOD2;ADAM8;VEGFC;TACSTD2;SMAD3;IL23A;DUSP10;PLK2;ITGA5;F3;PPARD;BDKRB1;JAG1;AMOTL2;NAV3;ITGAV;SOX9;NRG1;RHOB;SPAG9;VCL;HDAC9;CDK6;CORO1C;ABL2;WNT5A;ADAM9;PDPK1;ADAMTS9;NFE2L2;SGK1;CXCL16
4337,GO:0009888,2.88171057020962e-16,1,97,1227,tissue development,BP,IL1B;BTG2;HBEGF;INHBA;ELF3;SDC4;TNF;SPRR2D;PTGS2;PRDM1;TBX3;EFNA1;KDM6B;IRF6;EDN1;SEMA7A;ERRFI1;CLDN1;EHF;SPRR2A;EFNB2;EPHA2;MAFF;LIF;BMP2;PHLDA2;JUN;CDKN1A;PHLDB2;TJP2;JUNB;OVOL1;ETS2;ZFP36L1;ADRB2;CEBPB;UGCG;RUNX1;NAB1;TRIM16;EREG;ALDH1A3;B4GALT1;DUSP1;BCL10;DLX2;TXNRD1;VEGFC;TACSTD2;SMAD3;DUSP10;PIM1;ITGA5;CREB1;EFNB1;PPARD;KRT34;SLC25A25;SOCS3;KRTAP2-3;ZFP36;SLC9A1;CYP27B1;JAG1;ITGAV;PIP5K1A;NRARP;SOX9;NRG1;PML;FERMT1;FOXN2;RHOB;FEM1B;SOX4;FOSL2;VCL;OXCT1;AREG;HDAC9;KLF10;SKIL;CDK6;CORO1C;ADM;MAFG;WNT5A;ADAM9;LCE1C;PDPK1;ADAMTS9;KDM6A;FRMD6;RELA;SFN;LAMB3;PDLIM5
12275,GO:0048583,3.21025082545299e-16,1,162,2711,regulation of response to stimulus,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;CXCL3;IL36G;BIRC3;HBEGF;PLAU;NFKBID;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;CXCL8;REL;SERPINB2;PPIF;IER3;CCL20;PTGS2;PMAIP1;TNIP1;NFKB1;PRDM1;PLEKHF1;EFNA1;TGFA;EDN1;SEMA7A;ERRFI1;IL1RN;IRAK2;TNFRSF10B;EFNB2;EPHA2;RELB;GADD45A;CXCL5;LIF;TRIB1;KCTD11;SQSTM1;IFNGR2;BMP2;PHLDA2;IL24;MAP2K3;JUN;BIRC2;PHLDB2;BCL3;NAMPT;IRF1;TAF4B;BCL2L2;ADRB2;DUSP16;PPP1R15A;RUNX1;CDKN2B;TRIM16;EREG;SOD2;PELI1;ZSWIM4;DUSP8;DUSP1;BCL10;FGD6;TRAF1;PPP1R10;PIM3;IL6ST;G0S2;DLX2;CYLD;ADAM8;LDLR;VEGFC;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;ITGA5;TFRC;F3;STK40;PPARD;SOCS3;IL16;SLC9A1;CYP27B1;CD55;IFNAR2;JAG1;PLAGL2;RIPK2;SAA1;PPP1R15B;ITGAV;PIP5K1A;TP53BP2;NRARP;SOX9;STX1A;NRG1;ZNF451;PML;RASA2;FERMT1;NCOA7;SLC7A2;PTPN11;MAP3K8;ARHGEF3;RHOB;SPAG9;GCH1;FEM1B;SOX4;TRAF4;OXCT1;AREG;TNFAIP1;SKIL;IL7R;CDK6;IER5;PTPN1;ADM;ATP6V1C2;HLA-E;OSMR;WNT5A;NUP153;INSIG1;ADAM9;PDPK1;TNFRSF10A;CTSC;NFE2L2;YWHAH;CYTH1;RELA;AGFG1;POLR3D;YWHAG;SFN;ERN1;ATXN7;IFIH1;CXCL16
6938,GO:0030545,3.7140548200654e-16,1,32,182,receptor regulator activity,MF,CXCL2;IL1B;IL1A;CXCL1;CXCL3;IL36G;HBEGF;CSF2;INHBA;TNF;CXCL8;CCL20;TGFA;EDN1;SEMA7A;IL1RN;CXCL5;LIF;BMP2;IL24;NAMPT;EREG;VEGFC;IL23A;IL16;JAG1;SAA1;NRG1;AREG;ADM;WNT5A;CXCL16
12923,GO:0051270,5.57109158131534e-16,1,64,613,regulation of cellular component movement,BP,CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;CXCL3;HBEGF;PLAU;SDC4;ETS1;TNF;CXCL8;CCL20;PTGS2;EFNA1;EDN1;SEMA7A;EPHA2;CXCL5;TRIB1;BMP2;PHLDA2;IL24;MAP2K3;JUN;RAP2B;PHLDB2;CD274;RND3;EREG;SOD2;ZSWIM4;B4GALT1;ADAM8;VEGFC;TACSTD2;SMAD3;IL23A;DUSP10;PLK2;ITGA5;F3;PPARD;BDKRB1;JAG1;AMOTL2;NAV3;ITGAV;SOX9;NRG1;RHOB;SPAG9;VCL;HDAC9;CDK6;CORO1C;ABL2;WNT5A;ADAM9;PDPK1;ADAMTS9;NFE2L2;SGK1;CXCL16
4566,GO:0010646,7.54175930019554e-16,1,145,2313,regulation of cell communication,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;CXCL3;IL36G;BIRC3;HBEGF;PLAU;NFKBID;CSF2;INHBA;TICAM1;ELF3;TNF;CXCL8;REL;PPIF;IER3;CCL20;PTGS2;PMAIP1;TNIP1;NFKB1;PRDM1;PLEKHF1;EFNA1;TGFA;EDN1;SEMA7A;ERRFI1;IL1RN;IRAK2;HCAR2;TNFRSF10B;EPHA2;GADD45A;CXCL5;LIF;TRIB1;KCTD11;SQSTM1;IFNGR2;BMP2;PHLDA2;IL24;MAP2K3;JUN;BIRC2;BCL3;NAMPT;IRF1;TAF4B;BCL2L2;ADRB2;DUSP16;PPP1R15A;RUNX1;CDKN2B;TRIM16;EREG;SOD2;PELI1;DUSP8;DUSP1;BCL10;FGD6;TRAF1;PIM3;IL6ST;G0S2;DLX2;CYLD;ADAM8;VEGFC;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;ITGA5;CREB1;F3;STK40;PPARD;SOCS3;IL16;SLC9A1;CYP27B1;CD55;IFNAR2;JAG1;PLAGL2;RIPK2;SAA1;PPP1R15B;ITGAV;PIP5K1A;TP53BP2;NRARP;SOX9;STX1A;NRG1;ZNF451;PML;RASA2;FERMT1;PTPN11;MAP3K8;ARHGEF3;RHOB;SPAG9;FEM1B;SOX4;TRAF4;OXCT1;AREG;TNFAIP1;SKIL;IL7R;PTPN1;ADM;ATP6V1C2;WNT5A;INSIG1;ADAM9;PDPK1;TNFRSF10A;CTSC;NFE2L2;YWHAH;CYTH1;RELA;AGFG1;YWHAG;SFN;ERN1;ATXN7;CXCL16
1097,GO:0002684,8.04737506799592e-16,1,62,616,positive regulation of immune system process,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;CXCL3;BIRC3;INHBA;TICAM1;ETS1;TNF;CXCL8;CCL20;TNIP1;NFKB1;PRDM1;EDN1;SEMA7A;IRAK2;HCAR2;EFNB2;RELB;CXCL5;LIF;TRIB1;CD83;JUN;BIRC2;CDKN1A;CD274;IRF1;ZFP36L1;RUNX1;EREG;PELI1;BCL10;IL6ST;CYLD;ADAM8;VEGFC;RC3H1;IL23A;DUSP10;TFRC;CREB1;EFNB1;BDKRB1;CD55;JAG1;RIPK2;PTPN11;MAP3K8;KLF10;IL7R;HLA-E;WNT5A;PDPK1;RELA;POLR3D;IFIH1
6648,GO:0023051,1.01701012891219e-15,1,146,2345,regulation of signaling,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;CXCL3;IL36G;BIRC3;HBEGF;PLAU;NFKBID;CSF2;INHBA;TICAM1;ELF3;TNF;CXCL8;REL;PPIF;IER3;CCL20;PTGS2;PMAIP1;TNIP1;NFKB1;PRDM1;PLEKHF1;EFNA1;TGFA;EDN1;SEMA7A;ERRFI1;IL1RN;IRAK2;HCAR2;TNFRSF10B;EPHA2;GADD45A;CXCL5;LIF;TRIB1;KCTD11;SQSTM1;IFNGR2;BMP2;PHLDA2;IL24;MAP2K3;JUN;BIRC2;BCL3;NAMPT;IRF1;TAF4B;BCL2L2;ADRB2;DUSP16;PPP1R15A;RUNX1;CDKN2B;TRIM16;EREG;SOD2;PELI1;DUSP8;DUSP1;BCL10;FGD6;TRAF1;PIM3;IL6ST;G0S2;DLX2;CYLD;ADAM8;VEGFC;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;ITGA5;CREB1;F3;STK40;PPARD;SOCS3;IL16;SLC9A1;CYP27B1;CD55;IFNAR2;JAG1;PLAGL2;RIPK2;SAA1;PPP1R15B;ITGAV;PIP5K1A;TP53BP2;NRARP;SOX9;STX1A;NRG1;ZNF451;PML;RASA2;FERMT1;PTPN11;MAP3K8;ARHGEF3;RHOB;SPAG9;FEM1B;SOX4;TRAF4;OXCT1;AREG;TNFAIP1;SKIL;IL7R;PTPN1;TMEM65;ADM;ATP6V1C2;WNT5A;INSIG1;ADAM9;PDPK1;TNFRSF10A;CTSC;NFE2L2;YWHAH;CYTH1;RELA;AGFG1;YWHAG;SFN;ERN1;ATXN7;CXCL16
12856,GO:0051171,1.18236697831361e-15,1,223,4382,regulation of nitrogen compound metabolic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;HBEGF;NFKBID;CSF2;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;REL;SERPINB2;PPIF;KLF6;CCL20;ZNF697;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;ODC1;SEMA7A;HAS3;ERRFI1;IRAK2;KLF7;CREB5;CPEB2;EHF;TNFRSF10B;EPHA2;RELB;GADD45A;MAFF;LIF;TRIB1;SQSTM1;BMP2;IL24;CAB39;ZNF267;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ENC1;ADRB2;CEBPB;DUSP16;ARNTL2;PPP1R15A;RUNX1;N4BP1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;ANKLE2;DUSP8;TFPI2;DUSP1;BCL10;DCUN1D3;TRAF1;PPP1R10;IL6ST;DLX2;VGLL3;CYLD;ADAM8;LDLR;VEGFC;KLF3;ZNF217;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;PIM1;ITGA5;TFRC;LIPG;CREB1;SERPINB8;F3;STK40;HIVEP2;PPARD;SERPINB1;SOCS3;CCDC85B;USP36;IL16;BDKRB1;ZFP36;SLC9A1;MAFK;LARP4B;CD55;PNRC1;ELL2;AZIN1;JAG1;PLAGL2;RIPK2;SAA1;PPP1R15B;ITGAV;CLK4;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;ZNF460;FOXN2;PTPN11;MAP3K8;UHRF1;MXD1;SPAG9;FEM1B;SOX4;FOSL2;TRAF4;EIF1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;IL7R;RBM3;CDK6;IER5;SAMD4A;PTPN1;TFE3;CORO1C;PRPF19;TOB2;ADM;MAFG;MTF1;QKI;CELF1;WNT5A;NUP153;INSIG1;ADAM9;PDPK1;TNFRSF10A;RNF19A;CTSC;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;RELA;BACH1;BTAF1;YWHAG;TDG;ELF4;CREG1;SFN;ITM2B;ERN1;SH3RF2;ATXN7;BRD2;PABPC4;FUBP3;SMPD3
6865,GO:0030334,1.27765752349728e-15,1,59,540,regulation of cell migration,BP,CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;CXCL3;HBEGF;PLAU;SDC4;ETS1;TNF;CXCL8;CCL20;PTGS2;EFNA1;EDN1;SEMA7A;EPHA2;CXCL5;TRIB1;BMP2;PHLDA2;IL24;MAP2K3;JUN;RAP2B;PHLDB2;CD274;RND3;SOD2;ADAM8;VEGFC;TACSTD2;SMAD3;IL23A;DUSP10;PLK2;ITGA5;F3;PPARD;BDKRB1;JAG1;AMOTL2;NAV3;ITGAV;SOX9;NRG1;RHOB;SPAG9;VCL;HDAC9;CORO1C;WNT5A;ADAM9;PDPK1;ADAMTS9;NFE2L2;SGK1;CXCL16
4474,GO:0010469,1.56302629365791e-15,1,34,214,regulation of signaling receptor activity,BP,CXCL2;IL1B;IL1A;CXCL1;CXCL3;IL36G;HBEGF;PLAU;CSF2;INHBA;TNF;CXCL8;CCL20;TGFA;EDN1;ERRFI1;IL1RN;CXCL5;LIF;BMP2;PHLDA2;IL24;NAMPT;ADRB2;EREG;VEGFC;IL23A;IL16;JAG1;NRG1;AREG;ADM;WNT5A;CXCL16
3376,GO:0007155,1.67936371212344e-15,1,74,796,cell adhesion,BP,IL1B;PLAU;NFKBID;SDC4;ETS1;TNF;CXCL8;TNIP1;EFNA1;HAS3;IL1RN;CLDN1;EFNB2;EPHA2;CD83;BMP2;RAP2B;RGMB;PHLDB2;CLDN4;CD274;IRF1;ZFP36L1;RND3;CEBPB;PELI1;NEDD9;B4GALT1;BCL10;IL6ST;VMP1;CYLD;ADAM8;VEGFC;TACSTD2;SMAD3;RC3H1;IL23A;DUSP10;WISP1;ITGA5;TFRC;SERPINB8;EFNB1;PPARD;SLC9A1;CD55;JAG1;RIPK2;SAA1;ITGAV;PIP5K1A;NRARP;SOX9;PML;FERMT1;CDC42EP1;PTPN11;MAP3K8;RHOB;VCL;IL7R;CDK6;TFE3;CORO1C;ABL2;HLA-E;WNT5A;ADAM9;PDPK1;ADAMTS9;CYTH1;LAMB3;PDLIM5
12410,GO:0048856,1.90487292199951e-15,1,196,3611,anatomical structure development,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;CXCL1;BTG2;HBEGF;NFKBID;CSF2;INHBA;ELF3;SDC4;ETS1;TNF;CXCL8;IER3;KLF6;SPRR2D;PTGS2;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;KDM6B;IRF6;EDN1;ODC1;SEMA7A;ERRFI1;IL1RN;CLDN1;KLF7;EHF;SPRR2A;TNFRSF10B;EFNB2;EPHA2;RELB;MAFF;LIF;TRIB1;KCTD11;CD83;BMP2;PHLDA2;ZNF267;N4BP3;JUN;BIRC2;CDKN1A;PHLDB2;CLDN4;TJP2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;IRF1;TAF4B;BCL2L2;ZFP36L1;ENC1;RELT;RND3;ADRB2;CEBPB;UGCG;RUNX1;CDKN2B;NAB1;HMGCS1;TRIM16;EREG;ALDH1A3;EHD1;ZSWIM4;ANKLE2;B4GALT1;DUSP1;BCL10;FGD6;IL6ST;B3GNT5;VMP1;DLX2;TXNRD1;CYLD;ADAM8;LDLR;VEGFC;KLF3;ZNF217;TACSTD2;NEDD4L;SMAD3;RC3H1;IL23A;DUSP10;PLK2;DIEXF;PIM1;ITGA5;TFRC;CREB1;EFNB1;GJB3;F3;STK40;HIVEP2;PPARD;KRT34;SLC25A25;SOCS3;KRTAP2-3;RAPH1;ZFP36;SLC9A1;MAFK;CYP27B1;JAG1;PLAGL2;RIPK2;AMOTL2;NAV3;NDRG1;ITGAV;PIP5K1A;NRARP;SOX9;NRG1;PML;POU2F2;FERMT1;ELK3;CDC42EP1;FOXN2;PTPN11;MXD1;RHOB;SPAG9;FEM1B;SOX4;FOSL2;TRAF4;VCL;OXCT1;AREG;HDAC9;ADAMTS1;HIVEP1;KLF10;SKIL;IL7R;CDK6;TFE3;TMEM65;CORO1C;PRPF19;TOB2;ADM;MAFG;ABL2;QKI;CELF1;WNT5A;INSIG1;ADAM9;LCE1C;PDPK1;TNFRSF10A;ADAMTS9;ERO1A;KDM6A;FRMD6;SMTN;NFE2L2;YWHAH;SGK1;B3GNT2;SAT1;RELA;AGFG1;NOTCH2NL;YWHAG;TDG;CREG1;SFN;ITM2B;LAMB3;PABPC4;PDLIM5;SMPD3
6596,GO:0022610,1.99384431672546e-15,1,74,799,biological adhesion,BP,IL1B;PLAU;NFKBID;SDC4;ETS1;TNF;CXCL8;TNIP1;EFNA1;HAS3;IL1RN;CLDN1;EFNB2;EPHA2;CD83;BMP2;RAP2B;RGMB;PHLDB2;CLDN4;CD274;IRF1;ZFP36L1;RND3;CEBPB;PELI1;NEDD9;B4GALT1;BCL10;IL6ST;VMP1;CYLD;ADAM8;VEGFC;TACSTD2;SMAD3;RC3H1;IL23A;DUSP10;WISP1;ITGA5;TFRC;SERPINB8;EFNB1;PPARD;SLC9A1;CD55;JAG1;RIPK2;SAA1;ITGAV;PIP5K1A;NRARP;SOX9;PML;FERMT1;CDC42EP1;PTPN11;MAP3K8;RHOB;VCL;IL7R;CDK6;TFE3;CORO1C;ABL2;HLA-E;WNT5A;ADAM9;PDPK1;ADAMTS9;CYTH1;LAMB3;PDLIM5
14511,GO:0065007,2.03147921587717e-15,1,332,7896,biological regulation,BP,NFKBIA;NFKBIZ;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;CXCL3;BTG2;IL36G;BIRC3;HBEGF;PLAU;NFKBID;CSF2;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;CXCL8;REL;SERPINB2;PPIF;IER3;KLF6;NUAK2;CCL20;ZNF697;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;TRPV3;NOCT;PLEKHF1;EFNA1;TGFA;KDM6B;IRF6;EDN1;ODC1;SEMA7A;HAS3;ERRFI1;IL1RN;IRAK2;CLDN1;KLF7;PANX1;CREB5;DAPP1;CPEB2;EHF;HCAR2;TNFRSF10B;EFNB2;EPHA2;RELB;GADD45A;CXCL5;MAFF;LIF;TRIB1;KCTD11;CD83;SQSTM1;IFNGR2;RRAD;BMP2;PHLDA2;IL24;CAB39;ZNF267;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;RGMB;PHLDB2;CLDN4;TJP2;SERTAD2;CD274;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;BCL2L2;ZFP36L1;ENC1;RELT;RND3;ADRB2;CEBPB;DUSP16;ARNTL2;UGCG;PPP1R15A;MAST4;RUNX1;N4BP1;CDKN2B;NAB1;HMGCS1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;ALDH1A3;EHD1;NEDD9;ZSWIM4;ANKLE2;DUSP8;B4GALT1;TFPI2;DUSP1;BCL10;FGD6;DCUN1D3;TRAF1;PPP1R10;PIM3;SACS;IL6ST;G0S2;NABP1;DLX2;TXNRD1;VGLL3;CYLD;ADAM8;LDLR;VEGFC;KLF3;HCAR3;ZNF217;TACSTD2;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;PIM1;WISP1;ITGA5;TFRC;LIPG;KLHL21;CREB1;SERPINB8;EFNB1;F3;STK40;HIVEP2;PPARD;SERPINB1;SOCS3;CCDC85B;USP36;IL16;BDKRB1;RAPH1;ZFP36;SLC9A1;MAFK;LARP4B;CYP27B1;CD55;PNRC1;IFNAR2;ELL2;ANTXR2;AZIN1;JAG1;PLAGL2;RIPK2;AMOTL2;PHKG2;NAV3;SAA1;PPP1R15B;USP53;NDRG1;ITGAV;PIP5K1A;CLK4;TP53BP2;NRARP;SOX9;STX1A;NRG1;ZNF451;PML;POU2F2;RASA2;FERMT1;NCOA7;ELK3;POLR3A;SLC7A2;ZNF460;CDC42EP1;FOXN2;PTPN11;MAP3K8;UHRF1;ARHGEF3;MXD1;DCBLD2;RHOB;SPAG9;ABCA5;GCH1;FEM1B;SOX4;FOSL2;TRAF4;VCL;EIF1;OXCT1;AREG;CCNL1;FAM83G;AKAP2;TNFAIP1;HDAC9;ADAMTS1;HIVEP1;NFKBIB;KLF10;AEN;TIFA;SKIL;IL7R;DENND2C;RBM3;CDK6;IER5;YRDC;SAMD4A;EMP3;PTPN1;SQLE;TFE3;BTG3;TMEM65;CORO1C;STEAP4;PRPF19;TOB2;ADM;MAFG;ABL2;MTF1;ATP6V1C2;HLA-E;RAB3IP;OSMR;QKI;CELF1;WNT5A;NUP153;MAOA;INSIG1;ADAM9;PDPK1;TNFRSF10A;ADAMTS9;RNF19A;CTSC;ERO1A;KDM6A;FRMD6;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;CYTH1;SAT1;RELA;AGFG1;NOTCH2NL;BACH1;BTAF1;POLR3D;ALAS1;YWHAG;TDG;ELF4;RAB22A;CREG1;SFN;ITM2B;ERN1;SH3RF2;ISG20;ATXN7;IFIH1;ATP13A3;BRD2;CXCL16;PABPC4;STX12;PDLIM5;FUBP3;GPR156;RAB24;SMPD3
15128,GO:0071222,2.15004018311862e-15,1,25,105,cellular response to lipopolysaccharide,BP,NFKBIA;TNFAIP3;IL1B;ZC3H12A;CSF2;TICAM1;TNF;CXCL8;CCL20;TNIP1;NFKB1;PRDM1;IRAK2;TRIB1;IL24;CD274;CEBPB;PPARD;ZFP36;CD55;RIPK2;NFKBIB;WNT5A;ADAM9;RELA
8153,GO:0032879,2.22863714261467e-15,1,117,1686,regulation of localization,BP,NFKBIA;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;CXCL3;HBEGF;PLAU;INHBA;SDC4;ETS1;TNF;CXCL8;PPIF;CCL20;PTGS2;PMAIP1;NFKB1;TRPV3;EFNA1;EDN1;SEMA7A;PANX1;HCAR2;EPHA2;CXCL5;LIF;TRIB1;SQSTM1;RRAD;BMP2;PHLDA2;IL24;CAB39;MAP2K3;JUN;RAP2B;CDKN1A;PHLDB2;CD274;ZFP36L1;RND3;ADRB2;UGCG;TRIM16;EREG;SOD2;EHD1;ZSWIM4;B4GALT1;PIM3;CYLD;ADAM8;LDLR;VEGFC;TACSTD2;NEDD4L;OXSR1;SMAD3;IL23A;DUSP10;PLK2;BBC3;PLK3;ITGA5;LIPG;CREB1;F3;PPARD;USP36;IL16;BDKRB1;ZFP36;SLC9A1;AZIN1;JAG1;PLAGL2;RIPK2;AMOTL2;NAV3;SAA1;ITGAV;TP53BP2;SOX9;STX1A;NRG1;PML;FERMT1;PTPN11;RHOB;SPAG9;SOX4;VCL;OXCT1;HDAC9;CDK6;YRDC;PTPN1;CORO1C;ABL2;HLA-E;WNT5A;NUP153;INSIG1;ADAM9;PDPK1;ADAMTS9;ERO1A;NFE2L2;YWHAH;SGK1;YWHAG;SFN;IFIH1;CXCL16;SMPD3
7315,GO:0031323,2.60212063690224e-15,1,230,4607,regulation of cellular metabolic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;HBEGF;NFKBID;CSF2;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;REL;SERPINB2;PPIF;KLF6;CCL20;ZNF697;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;PLEKHF1;EFNA1;TGFA;KDM6B;IRF6;EDN1;ODC1;SEMA7A;HAS3;ERRFI1;IRAK2;KLF7;CREB5;CPEB2;EHF;TNFRSF10B;EPHA2;RELB;GADD45A;MAFF;LIF;TRIB1;SQSTM1;BMP2;PHLDA2;IL24;CAB39;ZNF267;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ENC1;ADRB2;CEBPB;DUSP16;ARNTL2;PPP1R15A;RUNX1;N4BP1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;ANKLE2;DUSP8;TFPI2;DUSP1;BCL10;DCUN1D3;TRAF1;PPP1R10;IL6ST;DLX2;VGLL3;CYLD;ADAM8;LDLR;VEGFC;KLF3;ZNF217;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;PIM1;ITGA5;TFRC;LIPG;CREB1;SERPINB8;F3;STK40;HIVEP2;PPARD;SERPINB1;SOCS3;CCDC85B;USP36;IL16;BDKRB1;ZFP36;SLC9A1;MAFK;LARP4B;CYP27B1;CD55;PNRC1;ELL2;AZIN1;JAG1;PLAGL2;RIPK2;PHKG2;SAA1;PPP1R15B;ITGAV;CLK4;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;ZNF460;FOXN2;PTPN11;MAP3K8;UHRF1;MXD1;SPAG9;GCH1;FEM1B;SOX4;FOSL2;TRAF4;EIF1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;IL7R;RBM3;CDK6;IER5;SAMD4A;PTPN1;TFE3;CORO1C;PRPF19;TOB2;ADM;MAFG;ABL2;MTF1;ATP6V1C2;QKI;CELF1;WNT5A;NUP153;INSIG1;ADAM9;PDPK1;TNFRSF10A;RNF19A;CTSC;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;RELA;BACH1;BTAF1;YWHAG;TDG;ELF4;CREG1;SFN;ITM2B;ERN1;SH3RF2;ATXN7;BRD2;PABPC4;FUBP3;SMPD3
15173,GO:0071310,3.12321867161116e-15,1,120,1803,cellular response to organic substance,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;CXCL3;IL36G;BIRC3;CSF2;INHBA;TICAM1;TNF;CXCL8;SERPINB2;CCL20;PTGS2;TNIP1;NFKB1;PRDM1;IRF6;EDN1;ERRFI1;IL1RN;IRAK2;CLDN1;CPEB2;TNFRSF10B;CXCL5;LIF;TRIB1;SQSTM1;IFNGR2;BMP2;IL24;MAP2K3;JUN;BIRC2;CDKN1A;RGMB;TJP2;CD274;JUNB;IRF1;ZFP36L1;RELT;ADRB2;CEBPB;PPP1R15A;RUNX1;CDKN2B;HMGCS1;EREG;SOD2;PELI1;EHD1;DUSP1;TRAF1;PIM3;IL6ST;CYLD;LDLR;VEGFC;KLF3;SMAD3;RC3H1;IL23A;PIM1;ITGA5;TFRC;CREB1;GJB3;F3;PPARD;SOCS3;IL16;ZFP36;SLC9A1;CYP27B1;CD55;IFNAR2;RIPK2;SAA1;PPP1R15B;SOX9;STX1A;ZNF451;PML;FERMT1;PTPN11;MAP3K8;SOX4;OXCT1;FAM83G;HDAC9;NFKBIB;KLF10;SKIL;IL7R;PTPN1;ABL2;ATP6V1C2;HLA-E;OSMR;WNT5A;MAOA;INSIG1;ADAM9;PDPK1;TNFRSF10A;ERO1A;NFE2L2;YWHAH;B3GNT2;RELA;YWHAG;ERN1;ISG20;IFIH1
6075,GO:0019222,6.42355085127131e-15,1,238,4903,regulation of metabolic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;HBEGF;NFKBID;CSF2;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;REL;SERPINB2;PPIF;KLF6;CCL20;ZNF697;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;PLEKHF1;EFNA1;TGFA;KDM6B;IRF6;EDN1;ODC1;SEMA7A;HAS3;ERRFI1;IRAK2;KLF7;CREB5;CPEB2;EHF;HCAR2;TNFRSF10B;EPHA2;RELB;GADD45A;MAFF;LIF;TRIB1;SQSTM1;BMP2;PHLDA2;IL24;CAB39;ZNF267;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ENC1;ADRB2;CEBPB;DUSP16;ARNTL2;PPP1R15A;RUNX1;N4BP1;CDKN2B;NAB1;HMGCS1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;ANKLE2;DUSP8;TFPI2;DUSP1;BCL10;DCUN1D3;TRAF1;PPP1R10;IL6ST;G0S2;DLX2;TXNRD1;VGLL3;CYLD;ADAM8;LDLR;VEGFC;KLF3;ZNF217;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;PIM1;ITGA5;TFRC;LIPG;CREB1;SERPINB8;F3;STK40;HIVEP2;PPARD;SERPINB1;SOCS3;CCDC85B;USP36;IL16;BDKRB1;ZFP36;SLC9A1;MAFK;LARP4B;CYP27B1;CD55;PNRC1;ELL2;AZIN1;JAG1;PLAGL2;RIPK2;PHKG2;SAA1;PPP1R15B;ITGAV;CLK4;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;FERMT1;NCOA7;ELK3;ZNF460;FOXN2;PTPN11;MAP3K8;UHRF1;MXD1;SPAG9;GCH1;FEM1B;SOX4;FOSL2;TRAF4;EIF1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;IL7R;RBM3;CDK6;IER5;SAMD4A;PTPN1;SQLE;TFE3;CORO1C;PRPF19;TOB2;ADM;MAFG;ABL2;MTF1;ATP6V1C2;QKI;CELF1;WNT5A;NUP153;INSIG1;ADAM9;PDPK1;TNFRSF10A;RNF19A;CTSC;KDM6A;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;RELA;BACH1;BTAF1;ALAS1;YWHAG;TDG;ELF4;CREG1;SFN;ITM2B;ERN1;SH3RF2;ATXN7;BRD2;PABPC4;FUBP3;SMPD3
9182,GO:0035556,6.57850006393232e-15,1,129,1985,intracellular signal transduction,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;BTG2;BIRC3;HBEGF;NFKBID;CSF2;INHBA;TICAM1;TNF;CXCL8;REL;PPIF;IER3;NUAK2;CCL20;PTGS2;PMAIP1;TNIP1;NFKB1;NFKB2;PLEKHF1;EFNA1;TGFA;EDN1;SEMA7A;ERRFI1;IRAK2;TNFRSF10B;EPHA2;RELB;GADD45A;LIF;TRIB1;SQSTM1;RRAD;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;BIRC2;CDKN1A;TJP2;BCL3;TAF4B;BCL2L2;ZFP36L1;RND3;ADRB2;CEBPB;DUSP16;PPP1R15A;MAST4;EREG;SOD2;PELI1;DUSP8;DUSP1;BCL10;FGD6;IL6ST;CYLD;ADAM8;OXSR1;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;CREB1;F3;STK40;PPARD;SOCS3;ZFP36;SLC9A1;IFNAR2;PLAGL2;RIPK2;AMOTL2;PHKG2;SAA1;NDRG1;ITGAV;PIP5K1A;TP53BP2;SOX9;NRG1;PML;RASA2;CDC42EP1;PTPN11;MAP3K8;ARHGEF3;RHOB;SPAG9;SOX4;TRAF4;TNFAIP1;AEN;TIFA;SKIL;IL7R;PTPN1;PRPF19;ADM;WNT5A;ADAM9;PDPK1;TNFRSF10A;ERO1A;NFE2L2;SGK1;CYTH1;RELA;AGFG1;RAB22A;SFN;ERN1;IFIH1;RAB24
15125,GO:0071219,7.4670110581126e-15,1,25,110,cellular response to molecule of bacterial origin,BP,NFKBIA;TNFAIP3;IL1B;ZC3H12A;CSF2;TICAM1;TNF;CXCL8;CCL20;TNIP1;NFKB1;PRDM1;IRAK2;TRIB1;IL24;CD274;CEBPB;PPARD;ZFP36;CD55;RIPK2;NFKBIB;WNT5A;ADAM9;RELA
7929,GO:0032502,1.12830921406012e-14,1,204,3894,developmental process,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;CXCL1;BTG2;HBEGF;NFKBID;CSF2;INHBA;ELF3;SDC4;ETS1;TNF;CXCL8;IER3;KLF6;SPRR2D;PTGS2;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;KDM6B;IRF6;EDN1;ODC1;SEMA7A;ERRFI1;IL1RN;CLDN1;KLF7;EHF;SPRR2A;TNFRSF10B;EFNB2;EPHA2;RELB;MAFF;LIF;TRIB1;KCTD11;CD83;SQSTM1;BMP2;PHLDA2;ZNF267;N4BP3;JUN;BIRC2;CDKN1A;PHLDB2;CLDN4;TJP2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;IRF1;TAF4B;BCL2L2;ZFP36L1;ENC1;RELT;RND3;ADRB2;CEBPB;UGCG;RUNX1;CDKN2B;NAB1;HMGCS1;TRIM16;EREG;SOD2;ALDH1A3;EHD1;ZSWIM4;ANKLE2;B4GALT1;DUSP1;BCL10;FGD6;IL6ST;B3GNT5;VMP1;DLX2;TXNRD1;CYLD;ADAM8;LDLR;VEGFC;KLF3;ZNF217;TACSTD2;NEDD4L;SMAD3;RC3H1;IL23A;DUSP10;PLK2;DIEXF;PIM1;ITGA5;TFRC;CREB1;EFNB1;GJB3;F3;STK40;HIVEP2;PPARD;KRT34;SLC25A25;SOCS3;CCDC85B;KRTAP2-3;RAPH1;ZFP36;SLC9A1;MAFK;CYP27B1;JAG1;PLAGL2;RIPK2;AMOTL2;NAV3;NDRG1;ITGAV;PIP5K1A;NRARP;SOX9;NRG1;PML;POU2F2;FERMT1;ELK3;CDC42EP1;FOXN2;PTPN11;MXD1;RHOB;SPAG9;ABCA5;FEM1B;SOX4;FOSL2;TRAF4;VCL;OXCT1;AREG;HDAC9;ADAMTS1;HIVEP1;KLF10;SKIL;IL7R;CDK6;TFE3;TMEM65;CORO1C;STEAP4;PRPF19;TOB2;ADM;MAFG;ABL2;QKI;CELF1;WNT5A;INSIG1;ADAM9;LCE1C;PDPK1;TNFRSF10A;ADAMTS9;CTSC;ERO1A;KDM6A;FRMD6;SMTN;NFE2L2;YWHAH;SGK1;B3GNT2;SAT1;RELA;AGFG1;NOTCH2NL;YWHAG;TDG;ELF4;CREG1;SFN;ITM2B;LAMB3;PABPC4;PDLIM5;SMPD3
630,GO:0001817,1.25458271679686e-14,1,48,413,regulation of cytokine production,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;BIRC3;CSF2;INHBA;TICAM1;TNF;REL;CCL20;PTGS2;NFKB1;NFKB2;SEMA7A;ERRFI1;PANX1;RELB;CD83;MAP2K3;BIRC2;CD274;BCL3;IRF1;CEBPB;RUNX1;TRIM16;EREG;PELI1;BCL10;IL6ST;CYLD;ADAM8;SMAD3;IL23A;CREB1;ZFP36;RIPK2;NAV3;SAA1;PML;FERMT1;POLR3A;HLA-E;WNT5A;RELA;POLR3D;IFIH1
3387,GO:0007166,1.26799035989887e-14,1,122,1866,cell surface receptor signaling pathway,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;CXCL3;IL36G;BIRC3;HBEGF;CSF2;INHBA;TICAM1;ELF3;TNF;CXCL8;SERPINB2;CCL20;PTGS2;PMAIP1;NFKB1;PRDM1;EFNA1;TGFA;IRF6;EDN1;SEMA7A;ERRFI1;IL1RN;IRAK2;TNFRSF10B;EFNB2;EPHA2;RELB;CXCL5;LIF;TRIB1;KCTD11;SQSTM1;IFNGR2;BMP2;IL24;JUN;BIRC2;CDKN1A;RGMB;TJP2;CD274;JUNB;CSRNP1;IRF1;BCL2L2;RELT;ADRB2;RUNX1;CDKN2B;EREG;SOD2;PELI1;NEDD9;BCL10;TRAF1;IL6ST;G0S2;DLX2;CYLD;VEGFC;TACSTD2;SMAD3;RC3H1;IL23A;PIM1;WISP1;ITGA5;CREB1;EFNB1;F3;SOCS3;IL16;CD55;IFNAR2;JAG1;RIPK2;AMOTL2;SAA1;ITGAV;NRARP;SOX9;STX1A;NRG1;ZNF451;PML;FERMT1;PTPN11;MAP3K8;FEM1B;SOX4;AREG;FAM83G;AKAP2;ADAMTS1;KLF10;SKIL;IL7R;PTPN1;ABL2;ATP6V1C2;HLA-E;OSMR;WNT5A;MAOA;ADAM9;PDPK1;TNFRSF10A;KDM6A;RELA;NOTCH2NL;ITM2B;ISG20;ATXN7
632,GO:0001819,1.28596171313084e-14,1,37,254,positive regulation of cytokine production,BP,IL1B;IL1A;BIRC3;CSF2;TICAM1;TNF;CCL20;PTGS2;NFKB1;NFKB2;SEMA7A;PANX1;CD83;BIRC2;CD274;BCL3;IRF1;CEBPB;RUNX1;TRIM16;EREG;PELI1;BCL10;IL6ST;ADAM8;SMAD3;IL23A;CREB1;RIPK2;SAA1;FERMT1;POLR3A;HLA-E;WNT5A;RELA;POLR3D;IFIH1
12903,GO:0051246,1.40862270311292e-14,1,127,2015,regulation of protein metabolic process,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;HBEGF;CSF2;INHBA;TICAM1;SDC4;TNF;SERPINB2;CCL20;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;EFNA1;TGFA;EDN1;ODC1;SEMA7A;ERRFI1;IRAK2;CPEB2;TNFRSF10B;EPHA2;GADD45A;LIF;TRIB1;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;BIRC2;CDKN1A;BCL3;IRF1;ZFP36L1;ENC1;ADRB2;CEBPB;DUSP16;PPP1R15A;N4BP1;CDKN2B;EREG;PELI1;ANKLE2;DUSP8;TFPI2;DUSP1;BCL10;DCUN1D3;PPP1R10;IL6ST;ADAM8;LDLR;VEGFC;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;ITGA5;LIPG;SERPINB8;F3;STK40;SERPINB1;SOCS3;BDKRB1;ZFP36;LARP4B;CD55;AZIN1;RIPK2;SAA1;PPP1R15B;ITGAV;SOX9;NRG1;ZNF451;PML;NCOA7;PTPN11;MAP3K8;UHRF1;SPAG9;FEM1B;SOX4;TRAF4;EIF1;AREG;CCNL1;RBM3;CDK6;SAMD4A;PTPN1;CORO1C;QKI;CELF1;WNT5A;NUP153;ADAM9;PDPK1;TNFRSF10A;RNF19A;CTSC;NFE2L2;RELA;YWHAG;SFN;ITM2B;ERN1;SH3RF2
7755,GO:0032270,1.90140798617858e-14,1,85,1080,positive regulation of cellular protein metabolic process,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BIRC3;HBEGF;CSF2;INHBA;TICAM1;SDC4;TNF;CCL20;PTGS2;RNF19B;PMAIP1;TNIP1;EFNA1;TGFA;EDN1;SEMA7A;IRAK2;TNFRSF10B;EPHA2;GADD45A;LIF;TRIB1;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;BIRC2;CDKN1A;BCL3;ADRB2;PPP1R15A;EREG;PELI1;ANKLE2;BCL10;DCUN1D3;IL6ST;ADAM8;LDLR;VEGFC;OXSR1;SMAD3;IL23A;PLK2;BBC3;PLK3;ITGA5;F3;SOCS3;LARP4B;RIPK2;SAA1;PPP1R15B;ITGAV;SOX9;NRG1;PML;PTPN11;MAP3K8;UHRF1;SPAG9;SOX4;TRAF4;AREG;CCNL1;RBM3;SAMD4A;PTPN1;WNT5A;ADAM9;PDPK1;TNFRSF10A;RNF19A;CTSC;NFE2L2;ERN1
13705,GO:0060255,2.03870628210376e-14,1,225,4565,regulation of macromolecule metabolic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;HBEGF;NFKBID;CSF2;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;REL;SERPINB2;KLF6;CCL20;ZNF697;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;ODC1;SEMA7A;HAS3;ERRFI1;IRAK2;KLF7;CREB5;CPEB2;EHF;TNFRSF10B;EPHA2;RELB;GADD45A;MAFF;LIF;TRIB1;SQSTM1;BMP2;PHLDA2;IL24;CAB39;ZNF267;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ENC1;ADRB2;CEBPB;DUSP16;ARNTL2;PPP1R15A;RUNX1;N4BP1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;ANKLE2;DUSP8;TFPI2;DUSP1;BCL10;DCUN1D3;TRAF1;PPP1R10;IL6ST;DLX2;VGLL3;CYLD;ADAM8;LDLR;VEGFC;KLF3;ZNF217;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;PIM1;ITGA5;TFRC;LIPG;CREB1;SERPINB8;F3;STK40;HIVEP2;PPARD;SERPINB1;SOCS3;CCDC85B;USP36;IL16;BDKRB1;ZFP36;SLC9A1;MAFK;LARP4B;CD55;PNRC1;ELL2;AZIN1;JAG1;PLAGL2;RIPK2;PHKG2;SAA1;PPP1R15B;ITGAV;CLK4;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;FERMT1;NCOA7;ELK3;ZNF460;FOXN2;PTPN11;MAP3K8;UHRF1;MXD1;SPAG9;FEM1B;SOX4;FOSL2;TRAF4;EIF1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;IL7R;RBM3;CDK6;IER5;SAMD4A;PTPN1;TFE3;CORO1C;PRPF19;TOB2;MAFG;MTF1;QKI;CELF1;WNT5A;NUP153;INSIG1;ADAM9;PDPK1;TNFRSF10A;RNF19A;CTSC;KDM6A;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;RELA;BACH1;BTAF1;YWHAG;TDG;ELF4;CREG1;SFN;ITM2B;ERN1;SH3RF2;ATXN7;BRD2;PABPC4;FUBP3;SMPD3
629,GO:0001816,2.44786434257689e-14,1,50,452,cytokine production,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;BIRC3;CSF2;INHBA;TICAM1;TNF;REL;CCL20;PTGS2;NFKB1;NFKB2;SEMA7A;ERRFI1;PANX1;RELB;CD83;MAP2K3;BIRC2;CD274;BCL3;IRF1;CEBPB;RUNX1;TRIM16;EREG;PELI1;BCL10;IL6ST;CYLD;ADAM8;SMAD3;IL23A;CREB1;ZFP36;CD55;RIPK2;NAV3;SAA1;ITGAV;PML;FERMT1;POLR3A;HLA-E;WNT5A;RELA;POLR3D;IFIH1
12904,GO:0051247,3.03450808123054e-14,1,88,1150,positive regulation of protein metabolic process,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BIRC3;HBEGF;CSF2;INHBA;TICAM1;SDC4;TNF;CCL20;PTGS2;RNF19B;PMAIP1;TNIP1;EFNA1;TGFA;EDN1;SEMA7A;IRAK2;TNFRSF10B;EPHA2;GADD45A;LIF;TRIB1;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;BIRC2;CDKN1A;BCL3;IRF1;ADRB2;PPP1R15A;EREG;PELI1;ANKLE2;BCL10;DCUN1D3;IL6ST;ADAM8;LDLR;VEGFC;NEDD4L;OXSR1;SMAD3;IL23A;PLK2;BBC3;PLK3;ITGA5;F3;SOCS3;LARP4B;RIPK2;SAA1;PPP1R15B;ITGAV;SOX9;NRG1;PML;PTPN11;MAP3K8;UHRF1;SPAG9;SOX4;TRAF4;AREG;CCNL1;RBM3;SAMD4A;PTPN1;WNT5A;ADAM9;PDPK1;TNFRSF10A;RNF19A;CTSC;NFE2L2;RELA;ERN1
12803,GO:0051094,3.34942584465926e-14,1,73,831,positive regulation of developmental process,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;CSF2;INHBA;ETS1;TNF;CXCL8;PTGS2;NFKB1;PRDM1;NOCT;EDN1;SEMA7A;EFNB2;LIF;TRIB1;KCTD11;CD83;BMP2;JUN;PHLDB2;JUNB;ZFP36L1;ENC1;ADRB2;CEBPB;RUNX1;TRIM16;EHD1;B4GALT1;IL6ST;DLX2;CYLD;ADAM8;VEGFC;TACSTD2;NEDD4L;SMAD3;IL23A;DUSP10;PLK2;PIM1;ITGA5;TFRC;CREB1;F3;PPARD;SOCS3;ZFP36;CYP27B1;JAG1;RIPK2;SOX9;NRG1;RHOB;SPAG9;HDAC9;KLF10;SKIL;IL7R;CORO1C;PRPF19;ADM;ABL2;WNT5A;ADAM9;PDPK1;ADAMTS9;NFE2L2;RELA;SFN
3746,GO:0008285,5.06990960066793e-14,1,51,471,negative regulation of cell proliferation,BP,TNFAIP3;IL1B;IL1A;CXCL1;BTG2;INHBA;SDC4;ETS1;TNF;CXCL8;PTGS2;PRDM1;FOSL1;IRF6;EFNB2;LIF;TRIB1;KCTD11;BMP2;IL24;JUN;CDKN1A;CD274;OVOL1;IRF1;CEBPB;CDKN2B;EREG;SOD2;PELI1;B4GALT1;VEGFC;SMAD3;RC3H1;DUSP10;PPARD;CYP27B1;NDRG1;SOX9;PML;FERMT1;SOX4;ADAMTS1;KLF10;CDK6;EMP3;BTG3;TOB2;ADM;WNT5A;SFN
15123,GO:0071216,5.10039506311667e-14,1,26,128,cellular response to biotic stimulus,BP,NFKBIA;TNFAIP3;IL1B;ZC3H12A;CSF2;TICAM1;TNF;CXCL8;CCL20;TNIP1;NFKB1;PRDM1;IRAK2;TRIB1;IL24;CD274;CEBPB;PPARD;ZFP36;CD55;RIPK2;PPP1R15B;NFKBIB;WNT5A;ADAM9;RELA
4567,GO:0010647,6.84231563293499e-14,1,87,1148,positive regulation of cell communication,BP,IL1B;IL1A;ZC3H12A;PLAUR;BIRC3;HBEGF;CSF2;INHBA;TICAM1;ELF3;TNF;REL;PPIF;CCL20;PTGS2;PMAIP1;NFKB1;PLEKHF1;EFNA1;TGFA;EDN1;SEMA7A;IRAK2;HCAR2;TNFRSF10B;EPHA2;GADD45A;LIF;SQSTM1;BMP2;IL24;MAP2K3;JUN;BIRC2;ADRB2;CDKN2B;TRIM16;EREG;PELI1;BCL10;IL6ST;G0S2;CYLD;ADAM8;SMAD3;RC3H1;IL23A;PLK2;BBC3;ITGA5;CREB1;F3;PPARD;SOCS3;SLC9A1;CYP27B1;JAG1;PLAGL2;RIPK2;SAA1;ITGAV;TP53BP2;NRARP;SOX9;STX1A;NRG1;PML;FERMT1;PTPN11;MAP3K8;SPAG9;SOX4;TRAF4;OXCT1;SKIL;IL7R;PTPN1;ATP6V1C2;WNT5A;ADAM9;TNFRSF10A;CTSC;YWHAH;RELA;YWHAG;SFN;ERN1
7753,GO:0032268,8.00427275118431e-14,1,120,1897,regulation of cellular protein metabolic process,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;HBEGF;CSF2;INHBA;TICAM1;SDC4;TNF;SERPINB2;CCL20;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;EFNA1;TGFA;EDN1;SEMA7A;ERRFI1;IRAK2;CPEB2;TNFRSF10B;EPHA2;GADD45A;LIF;TRIB1;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;BIRC2;CDKN1A;BCL3;ZFP36L1;ENC1;ADRB2;DUSP16;PPP1R15A;N4BP1;CDKN2B;EREG;PELI1;ANKLE2;DUSP8;TFPI2;DUSP1;BCL10;DCUN1D3;PPP1R10;IL6ST;ADAM8;LDLR;VEGFC;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;ITGA5;SERPINB8;F3;STK40;SERPINB1;SOCS3;BDKRB1;ZFP36;LARP4B;CD55;RIPK2;SAA1;PPP1R15B;ITGAV;SOX9;NRG1;ZNF451;PML;NCOA7;PTPN11;MAP3K8;UHRF1;SPAG9;FEM1B;SOX4;TRAF4;EIF1;AREG;CCNL1;RBM3;CDK6;SAMD4A;PTPN1;CORO1C;QKI;CELF1;WNT5A;NUP153;ADAM9;PDPK1;TNFRSF10A;RNF19A;CTSC;NFE2L2;RELA;YWHAG;SFN;ERN1;SH3RF2
6650,GO:0023056,9.32351935823691e-14,1,87,1154,positive regulation of signaling,BP,IL1B;IL1A;ZC3H12A;PLAUR;BIRC3;HBEGF;CSF2;INHBA;TICAM1;ELF3;TNF;REL;PPIF;CCL20;PTGS2;PMAIP1;NFKB1;PLEKHF1;EFNA1;TGFA;EDN1;SEMA7A;IRAK2;HCAR2;TNFRSF10B;EPHA2;GADD45A;LIF;SQSTM1;BMP2;IL24;MAP2K3;JUN;BIRC2;ADRB2;CDKN2B;TRIM16;EREG;PELI1;BCL10;IL6ST;G0S2;CYLD;ADAM8;SMAD3;RC3H1;IL23A;PLK2;BBC3;ITGA5;CREB1;F3;PPARD;SOCS3;SLC9A1;CYP27B1;JAG1;PLAGL2;RIPK2;SAA1;ITGAV;TP53BP2;NRARP;SOX9;STX1A;NRG1;PML;FERMT1;PTPN11;MAP3K8;SPAG9;SOX4;TRAF4;OXCT1;SKIL;IL7R;PTPN1;ATP6V1C2;WNT5A;ADAM9;TNFRSF10A;CTSC;YWHAH;RELA;YWHAG;SFN;ERN1
11478,GO:0045935,1.0647598185101e-13,1,94,1276,positive regulation of nucleobase-containing compound metabolic process,BP,NFKBIA;IL1B;IL1A;ZC3H12A;BTG2;CSF2;INHBA;ELF3;ETS1;TNF;REL;KLF6;TNIP1;NFKB1;FOSL1;TBX3;NFKB2;KDM6B;IRF6;EDN1;HAS3;KLF7;CREB5;EHF;RELB;MAFF;LIF;SQSTM1;BMP2;MAP2K3;JUN;RGMB;SERTAD2;JUNB;BCL3;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ADRB2;CEBPB;ARNTL2;RUNX1;CDKN2B;TRIM16;EREG;BCL10;PPP1R10;DLX2;SMAD3;RC3H1;IL23A;TFRC;CREB1;PPARD;ZFP36;SLC9A1;JAG1;PLAGL2;RIPK2;SOX9;NRG1;PML;POU2F2;NCOA7;ELK3;FOXN2;UHRF1;SOX4;FOSL2;AREG;CCNL1;TNFAIP1;KLF10;IER5;PTPN1;TFE3;PRPF19;ADM;MAFG;MTF1;QKI;WNT5A;INSIG1;NFE2L2;YWHAH;RELA;BACH1;ELF4;ERN1;ATXN7;FUBP3
12355,GO:0048731,1.3623511214804e-13,1,165,2940,system development,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;CXCL1;BTG2;HBEGF;NFKBID;CSF2;INHBA;ELF3;SDC4;ETS1;TNF;CXCL8;KLF6;SPRR2D;PTGS2;PRDM1;FOSL1;TBX3;NFKB2;EFNA1;KDM6B;IRF6;EDN1;ODC1;SEMA7A;ERRFI1;CLDN1;KLF7;SPRR2A;EFNB2;EPHA2;RELB;MAFF;LIF;TRIB1;KCTD11;CD83;BMP2;PHLDA2;N4BP3;JUN;BIRC2;CDKN1A;PHLDB2;CLDN4;TJP2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;IRF1;BCL2L2;ZFP36L1;ENC1;ADRB2;CEBPB;RUNX1;CDKN2B;NAB1;HMGCS1;TRIM16;EREG;ALDH1A3;EHD1;ZSWIM4;ANKLE2;B4GALT1;BCL10;IL6ST;B3GNT5;DLX2;CYLD;ADAM8;LDLR;VEGFC;TACSTD2;NEDD4L;SMAD3;RC3H1;IL23A;DUSP10;PLK2;PIM1;ITGA5;TFRC;CREB1;EFNB1;GJB3;F3;STK40;PPARD;KRT34;SLC25A25;SOCS3;KRTAP2-3;RAPH1;ZFP36;SLC9A1;MAFK;CYP27B1;JAG1;RIPK2;AMOTL2;NAV3;NDRG1;ITGAV;PIP5K1A;NRARP;SOX9;NRG1;PML;POU2F2;FERMT1;ELK3;FOXN2;PTPN11;RHOB;SPAG9;FEM1B;SOX4;FOSL2;TRAF4;VCL;OXCT1;AREG;HDAC9;ADAMTS1;KLF10;SKIL;IL7R;CDK6;TFE3;TMEM65;CORO1C;PRPF19;TOB2;ADM;ABL2;QKI;WNT5A;INSIG1;ADAM9;LCE1C;PDPK1;ADAMTS9;ERO1A;KDM6A;SMTN;NFE2L2;YWHAH;SGK1;B3GNT2;SAT1;RELA;YWHAG;SFN;ITM2B;PABPC4;PDLIM5;SMPD3
14513,GO:0065009,1.46566564890297e-13,1,135,2244,regulation of molecular function,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;CXCL3;IL36G;BIRC3;HBEGF;PLAU;NFKBID;CSF2;INHBA;TICAM1;SDC4;TNF;CXCL8;SERPINB2;PPIF;CCL20;BHLHE40;PTGS2;PMAIP1;NFKB1;FOSL1;NFKB2;PLEKHF1;EFNA1;TGFA;EDN1;ERRFI1;IL1RN;IRAK2;CPEB2;TNFRSF10B;EPHA2;GADD45A;CXCL5;LIF;TRIB1;RRAD;BMP2;PHLDA2;IL24;CAB39;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;BCL3;NAMPT;ADRB2;DUSP16;PPP1R15A;CDKN2B;EREG;PELI1;ANKLE2;DUSP8;TFPI2;DUSP1;BCL10;FGD6;DCUN1D3;TRAF1;PPP1R10;CYLD;ADAM8;VEGFC;NEDD4L;OXSR1;SMAD3;IL23A;DUSP10;PLK2;BBC3;PIM1;SERPINB8;F3;SERPINB1;SOCS3;IL16;ZFP36;SLC9A1;CYP27B1;AZIN1;JAG1;RIPK2;SAA1;PPP1R15B;PIP5K1A;STX1A;NRG1;PML;RASA2;CDC42EP1;PTPN11;MAP3K8;UHRF1;ARHGEF3;SPAG9;GCH1;FEM1B;TRAF4;AREG;CCNL1;NFKBIB;DENND2C;CDK6;PTPN1;CORO1C;ADM;ABL2;RAB3IP;WNT5A;ADAM9;PDPK1;TNFRSF10A;YWHAH;SGK1;CYTH1;RELA;AGFG1;BTAF1;YWHAG;TDG;SFN;ERN1;SH3RF2;CXCL16
11196,GO:0045321,1.4850047426831e-13,1,66,766,leukocyte activation,BP,TNFAIP3;IL1B;ZC3H12A;CXCL1;PLAUR;PLAU;NFKBID;CSF2;INHBA;TICAM1;SDC4;CXCL8;KLF6;NFKB1;PRDM1;EDN1;EFNB2;RELB;CD83;CAB39;JUN;RAP2B;CDKN1A;CD274;BCL3;AMPD3;IRF1;ZFP36L1;CEBPB;RUNX1;PELI1;B4GALT1;BCL10;IL6ST;CYLD;ADAM8;LDLR;SMAD3;RC3H1;IL23A;DUSP10;TFRC;EFNB1;SERPINB1;CD55;RIPK2;NDRG1;ITGAV;NRARP;POU2F2;SLC7A2;PTPN11;MAP3K8;SOX4;VCL;HDAC9;COTL1;IL7R;HLA-E;WNT5A;ADAM9;PDPK1;CTSC;ELF4;CREG1;RAB24
4364,GO:0009967,1.49536653532367e-13,1,82,1063,positive regulation of signal transduction,BP,IL1B;IL1A;ZC3H12A;PLAUR;BIRC3;HBEGF;CSF2;INHBA;TICAM1;ELF3;TNF;REL;PPIF;CCL20;PMAIP1;NFKB1;PLEKHF1;EFNA1;TGFA;EDN1;SEMA7A;IRAK2;TNFRSF10B;EPHA2;GADD45A;LIF;BMP2;IL24;MAP2K3;JUN;BIRC2;ADRB2;CDKN2B;TRIM16;EREG;PELI1;BCL10;IL6ST;G0S2;CYLD;ADAM8;SMAD3;RC3H1;IL23A;PLK2;BBC3;ITGA5;F3;PPARD;SOCS3;SLC9A1;CYP27B1;JAG1;PLAGL2;RIPK2;SAA1;ITGAV;TP53BP2;NRARP;SOX9;STX1A;NRG1;PML;FERMT1;PTPN11;MAP3K8;SPAG9;SOX4;TRAF4;SKIL;IL7R;PTPN1;ATP6V1C2;WNT5A;ADAM9;TNFRSF10A;CTSC;YWHAH;RELA;YWHAG;SFN;ERN1
11284,GO:0045595,1.88046347210411e-13,1,87,1155,regulation of cell differentiation,BP,NFKBIA;IL1B;ZC3H12A;NFKBID;CSF2;INHBA;ETS1;TNF;PTGS2;NFKB1;PRDM1;TBX3;NOCT;EFNA1;EDN1;SEMA7A;ERRFI1;EFNB2;MAFF;LIF;TRIB1;KCTD11;CD83;BMP2;JUN;BIRC2;PHLDB2;TJP2;JUNB;IRF1;ZFP36L1;ENC1;CEBPB;RUNX1;TRIM16;EREG;EHD1;ZSWIM4;IL6ST;DLX2;CYLD;ADAM8;LDLR;VEGFC;TACSTD2;NEDD4L;SMAD3;RC3H1;IL23A;DUSP10;PLK2;CREB1;PPARD;SOCS3;CCDC85B;ZFP36;CYP27B1;JAG1;RIPK2;ITGAV;NRARP;SOX9;NRG1;SPAG9;ABCA5;AREG;HDAC9;KLF10;SKIL;IL7R;CDK6;TFE3;CORO1C;PRPF19;TOB2;ADM;MAFG;ABL2;WNT5A;INSIG1;ADAMTS9;NFE2L2;YWHAH;RELA;YWHAG;SFN;PDLIM5
13834,GO:0060429,2.1187125935e-13,1,69,809,epithelium development,BP,IL1B;HBEGF;INHBA;ELF3;SDC4;TNF;SPRR2D;PRDM1;TBX3;KDM6B;IRF6;EDN1;ERRFI1;CLDN1;EHF;SPRR2A;EFNB2;EPHA2;MAFF;LIF;BMP2;JUN;CDKN1A;PHLDB2;TJP2;ZFP36L1;CEBPB;RUNX1;TRIM16;EREG;ALDH1A3;B4GALT1;BCL10;VEGFC;TACSTD2;SMAD3;DUSP10;ITGA5;CREB1;KRT34;SOCS3;KRTAP2-3;ZFP36;CYP27B1;JAG1;PIP5K1A;NRARP;SOX9;NRG1;PML;FERMT1;RHOB;FEM1B;SOX4;FOSL2;VCL;AREG;SKIL;CDK6;ADM;MAFG;WNT5A;ADAM9;LCE1C;PDPK1;KDM6A;FRMD6;RELA;SFN
12911,GO:0051254,2.1866019037655e-13,1,86,1118,positive regulation of RNA metabolic process,BP,NFKBIA;IL1B;IL1A;ZC3H12A;BTG2;INHBA;ELF3;ETS1;TNF;REL;KLF6;TNIP1;NFKB1;FOSL1;TBX3;NFKB2;KDM6B;IRF6;EDN1;HAS3;KLF7;CREB5;EHF;RELB;MAFF;LIF;SQSTM1;BMP2;MAP2K3;JUN;RGMB;SERTAD2;JUNB;BCL3;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ADRB2;CEBPB;ARNTL2;RUNX1;CDKN2B;TRIM16;BCL10;DLX2;SMAD3;RC3H1;IL23A;CREB1;PPARD;ZFP36;SLC9A1;JAG1;PLAGL2;RIPK2;SOX9;NRG1;PML;POU2F2;NCOA7;ELK3;FOXN2;UHRF1;SOX4;FOSL2;CCNL1;KLF10;IER5;TFE3;PRPF19;MAFG;MTF1;QKI;WNT5A;INSIG1;NFE2L2;YWHAH;RELA;BACH1;ELF4;ERN1;ATXN7;FUBP3
17754,GO:1901701,2.53274236240743e-13,1,64,715,cellular response to oxygen-containing compound,BP,NFKBIA;TNFAIP3;IL1B;ZC3H12A;CSF2;INHBA;TICAM1;ETS1;TNF;CXCL8;PPIF;CCL20;PTGS2;TNIP1;NFKB1;PRDM1;KDM6B;EDN1;ERRFI1;IRAK2;CLDN1;CPEB2;TRIB1;IL24;JUN;CD274;ZFP36L1;ADRB2;CEBPB;HMGCS1;SOD2;PIM3;LDLR;KLF3;PIM1;CREB1;GJB3;PPARD;SOCS3;ZFP36;SLC9A1;CYP27B1;CD55;RIPK2;SOX9;PTPN11;RHOB;GCH1;SOX4;OXCT1;HDAC9;NFKBIB;KLF10;PTPN1;ABL2;ATP6V1C2;WNT5A;INSIG1;ADAM9;PDPK1;NFE2L2;RELA;YWHAG;ERN1
11484,GO:0045944,2.6808170575624e-13,1,69,791,positive regulation of transcription by RNA polymerase II,BP,NFKBIA;IL1B;IL1A;ZC3H12A;INHBA;ELF3;ETS1;TNF;REL;KLF6;TNIP1;NFKB1;FOSL1;NFKB2;KDM6B;IRF6;EDN1;KLF7;EHF;RELB;MAFF;LIF;SQSTM1;BMP2;JUN;JUNB;BCL3;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ADRB2;CEBPB;ARNTL2;RUNX1;CDKN2B;DLX2;SMAD3;IL23A;CREB1;PPARD;SLC9A1;JAG1;PLAGL2;RIPK2;SOX9;NRG1;PML;POU2F2;NCOA7;ELK3;UHRF1;SOX4;FOSL2;CCNL1;KLF10;IER5;TFE3;MAFG;MTF1;WNT5A;INSIG1;NFE2L2;RELA;BACH1;ELF4;ATXN7;FUBP3
6738,GO:0030154,2.88253350694679e-13,1,147,2519,cell differentiation,BP,NFKBIA;IL1B;IL1A;ZC3H12A;BTG2;NFKBID;CSF2;INHBA;ELF3;SDC4;ETS1;TNF;KLF6;SPRR2D;PTGS2;NFKB1;PRDM1;TBX3;NFKB2;NOCT;EFNA1;KDM6B;IRF6;EDN1;SEMA7A;ERRFI1;CLDN1;KLF7;EHF;SPRR2A;EFNB2;EPHA2;RELB;MAFF;LIF;TRIB1;KCTD11;CD83;SQSTM1;BMP2;JUN;BIRC2;CDKN1A;PHLDB2;TJP2;JUNB;BCL3;ETS2;IRF1;TAF4B;ZFP36L1;ENC1;ADRB2;CEBPB;RUNX1;CDKN2B;NAB1;TRIM16;EREG;EHD1;ZSWIM4;B4GALT1;IL6ST;DLX2;CYLD;ADAM8;LDLR;VEGFC;TACSTD2;NEDD4L;SMAD3;RC3H1;IL23A;DUSP10;PLK2;ITGA5;TFRC;CREB1;EFNB1;PPARD;KRT34;SOCS3;CCDC85B;KRTAP2-3;RAPH1;ZFP36;SLC9A1;CYP27B1;JAG1;RIPK2;NDRG1;ITGAV;PIP5K1A;NRARP;SOX9;NRG1;PML;POU2F2;ELK3;FOXN2;PTPN11;RHOB;SPAG9;ABCA5;FEM1B;SOX4;FOSL2;VCL;AREG;HDAC9;KLF10;SKIL;IL7R;CDK6;TFE3;CORO1C;STEAP4;PRPF19;TOB2;ADM;MAFG;ABL2;QKI;CELF1;WNT5A;INSIG1;ADAM9;LCE1C;PDPK1;ADAMTS9;ERO1A;KDM6A;FRMD6;NFE2L2;YWHAH;SGK1;B3GNT2;RELA;AGFG1;NOTCH2NL;YWHAG;ELF4;SFN;LAMB3;PABPC4;PDLIM5;SMPD3
16492,GO:0097190,3.98044388685386e-13,1,48,470,apoptotic signaling pathway,BP,TNFAIP3;IL1B;IL1A;PLAUR;CSF2;INHBA;TICAM1;TNF;PPIF;PTGS2;PMAIP1;PLEKHF1;TNFRSF10B;EPHA2;JUN;CDKN1A;BCL3;BCL2L2;RELT;CEBPB;PPP1R15A;SOD2;BCL10;TRAF1;G0S2;CYLD;SMAD3;BBC3;PPARD;PLAGL2;ITGAV;TP53BP2;PML;FEM1B;AEN;SKIL;PTPN1;PDPK1;TNFRSF10A;CTSC;ERO1A;NFE2L2;YWHAH;RELA;YWHAG;SFN;ITM2B;ERN1
7069,GO:0030855,4.46999418387972e-13,1,47,434,epithelial cell differentiation,BP,IL1B;ELF3;TNF;SPRR2D;PRDM1;TBX3;KDM6B;IRF6;ERRFI1;CLDN1;EHF;SPRR2A;EPHA2;MAFF;LIF;BMP2;JUN;CDKN1A;TJP2;ZFP36L1;CEBPB;RUNX1;TRIM16;EREG;B4GALT1;SMAD3;CREB1;KRT34;KRTAP2-3;ZFP36;CYP27B1;JAG1;PIP5K1A;SOX9;NRG1;FEM1B;SOX4;FOSL2;SKIL;CDK6;MAFG;WNT5A;ADAM9;LCE1C;PDPK1;FRMD6;SFN
3380,GO:0007159,5.02071600430475e-13,1,30,189,leukocyte cell-cell adhesion,BP,IL1B;NFKBID;SDC4;ETS1;TNF;TNIP1;EFNB2;CD83;CD274;IRF1;CEBPB;PELI1;BCL10;IL6ST;CYLD;ADAM8;RC3H1;IL23A;DUSP10;ITGA5;TFRC;EFNB1;CD55;RIPK2;NRARP;PTPN11;MAP3K8;IL7R;HLA-E;PDPK1
7673,GO:0032101,5.28522350456427e-13,1,47,437,regulation of response to external stimulus,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;ZC3H12A;CXCL1;PLAUR;CXCL3;BIRC3;PLAU;TICAM1;ETS1;TNF;CXCL8;SERPINB2;PTGS2;TNIP1;NFKB1;PRDM1;EDN1;SEMA7A;EFNB2;CXCL5;TRIB1;BIRC2;PHLDB2;ZSWIM4;IL6ST;ADAM8;LDLR;VEGFC;SMAD3;IL23A;DUSP10;F3;PPARD;SOCS3;IL16;CYP27B1;CD55;RIPK2;SAA1;SLC7A2;OSMR;WNT5A;NFE2L2;RELA
1107,GO:0002694,5.67550168111696e-13,1,37,284,regulation of leukocyte activation,BP,TNFAIP3;IL1B;ZC3H12A;NFKBID;INHBA;TICAM1;SDC4;PRDM1;EFNB2;CD83;CDKN1A;CD274;IRF1;ZFP36L1;CEBPB;RUNX1;PELI1;BCL10;IL6ST;CYLD;ADAM8;LDLR;RC3H1;IL23A;DUSP10;TFRC;EFNB1;CD55;RIPK2;NRARP;SLC7A2;PTPN11;MAP3K8;IL7R;HLA-E;WNT5A;PDPK1
12240,GO:0048513,6.89793275590137e-13,1,129,2133,animal organ development,BP,NFKBIA;TNFAIP3;IL1B;BTG2;HBEGF;NFKBID;CSF2;INHBA;ELF3;SDC4;ETS1;TNF;CXCL8;KLF6;SPRR2D;PTGS2;PRDM1;FOSL1;TBX3;NFKB2;EFNA1;KDM6B;IRF6;EDN1;ODC1;SEMA7A;ERRFI1;CLDN1;SPRR2A;EFNB2;EPHA2;RELB;MAFF;LIF;TRIB1;CD83;BMP2;PHLDA2;JUN;BIRC2;CDKN1A;PHLDB2;CLDN4;TJP2;JUNB;BCL3;OVOL1;CSRNP1;IRF1;BCL2L2;ZFP36L1;ADRB2;CEBPB;RUNX1;CDKN2B;NAB1;HMGCS1;TRIM16;EREG;ALDH1A3;B4GALT1;B3GNT5;DLX2;CYLD;ADAM8;VEGFC;TACSTD2;SMAD3;RC3H1;IL23A;DUSP10;PIM1;TFRC;CREB1;EFNB1;GJB3;STK40;PPARD;KRT34;SLC25A25;SOCS3;KRTAP2-3;ZFP36;SLC9A1;CYP27B1;JAG1;RIPK2;PIP5K1A;NRARP;SOX9;NRG1;PML;POU2F2;FERMT1;FOXN2;PTPN11;FEM1B;SOX4;FOSL2;TRAF4;OXCT1;AREG;HDAC9;ADAMTS1;KLF10;SKIL;IL7R;CDK6;TFE3;TMEM65;CORO1C;TOB2;ADM;WNT5A;INSIG1;ADAM9;LCE1C;PDPK1;ADAMTS9;ERO1A;KDM6A;SMTN;NFE2L2;YWHAH;RELA;SFN;PABPC4;PDLIM5;SMPD3
13142,GO:0051704,7.39150408736814e-13,1,102,1581,multi-organism process,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;ZC3H12A;CXCL1;CXCL3;BIRC3;CSF2;INHBA;TICAM1;ETS1;TNF;CXCL8;CCL20;PTGS2;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;NFKB2;NOCT;EDN1;ODC1;IRAK2;CLDN1;TNFRSF10B;EFNB2;EPHA2;CXCL5;MAFF;LIF;TRIB1;SQSTM1;IFNGR2;IL24;MAP2K3;JUN;BIRC2;CLDN4;CD274;JUNB;BCL3;OVOL1;NAMPT;IRF1;TAF4B;BCL2L2;RELT;CEBPB;EREG;PELI1;B4GALT1;BCL10;IL6ST;VMP1;LDLR;NEDD4L;SMAD3;IL23A;DUSP10;ITGA5;TFRC;CREB1;GJB3;PPARD;RAET1L;IL16;BDKRB1;ZFP36;CYP27B1;CD55;IFNAR2;RIPK2;ITGAV;SOX9;PML;POLR3A;SPAG9;GCH1;ADAMTS1;NFKBIB;SKIL;COTL1;CDK6;TOB2;ADM;HLA-E;QKI;CELF1;WNT5A;NUP153;ADAM9;TNFRSF10A;RELA;AGFG1;POLR3D;ISG20;IFIH1;BRD2;TAP1
4549,GO:0010628,8.53163347720989e-13,1,95,1364,positive regulation of gene expression,BP,NFKBIA;IL1B;IL1A;ZC3H12A;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;KLF6;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;KDM6B;IRF6;EDN1;HAS3;KLF7;CREB5;EHF;RELB;MAFF;LIF;SQSTM1;BMP2;MAP2K3;JUN;RGMB;SERTAD2;JUNB;BCL3;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ADRB2;CEBPB;ARNTL2;PPP1R15A;RUNX1;CDKN2B;TRIM16;BCL10;DLX2;ADAM8;LDLR;SMAD3;IL23A;CREB1;PPARD;ZFP36;SLC9A1;LARP4B;JAG1;PLAGL2;RIPK2;SOX9;NRG1;PML;POU2F2;NCOA7;ELK3;FOXN2;UHRF1;SOX4;FOSL2;CCNL1;KLF10;IL7R;RBM3;IER5;SAMD4A;TFE3;PRPF19;MAFG;MTF1;QKI;WNT5A;INSIG1;KDM6A;NFE2L2;YWHAH;RELA;BACH1;ELF4;ERN1;ATXN7;FUBP3
12615,GO:0050793,9.52664251782875e-13,1,109,1657,regulation of developmental process,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;NFKBID;CSF2;INHBA;ETS1;TNF;CXCL8;PTGS2;NFKB1;PRDM1;TBX3;NOCT;EFNA1;EDN1;SEMA7A;ERRFI1;IL1RN;EFNB2;EPHA2;MAFF;LIF;TRIB1;KCTD11;CD83;BMP2;PHLDA2;JUN;BIRC2;PHLDB2;TJP2;JUNB;IRF1;ZFP36L1;ENC1;RND3;ADRB2;CEBPB;RUNX1;NAB1;TRIM16;EREG;EHD1;ZSWIM4;B4GALT1;FGD6;IL6ST;DLX2;CYLD;ADAM8;LDLR;VEGFC;TACSTD2;NEDD4L;SMAD3;RC3H1;IL23A;DUSP10;PLK2;PIM1;ITGA5;TFRC;CREB1;F3;PPARD;SOCS3;CCDC85B;ZFP36;CYP27B1;JAG1;RIPK2;ITGAV;NRARP;SOX9;NRG1;PML;FERMT1;CDC42EP1;PTPN11;RHOB;SPAG9;ABCA5;AREG;HDAC9;KLF10;SKIL;IL7R;CDK6;TFE3;CORO1C;PRPF19;TOB2;ADM;MAFG;ABL2;WNT5A;INSIG1;ADAM9;PDPK1;ADAMTS9;NFE2L2;YWHAH;RELA;YWHAG;SFN;PDLIM5
5517,GO:0016477,1.07583828021653e-12,1,73,886,cell migration,BP,CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;CXCL3;HBEGF;PLAU;SDC4;ETS1;TNF;CXCL8;CCL20;PTGS2;EFNA1;EDN1;SEMA7A;TNFRSF10B;EFNB2;EPHA2;CXCL5;TRIB1;BMP2;PHLDA2;IL24;MAP2K3;JUN;RAP2B;PHLDB2;CD274;RND3;SOD2;NEDD9;B4GALT1;ADAM8;VEGFC;TACSTD2;SMAD3;IL23A;DUSP10;PLK2;ITGA5;EFNB1;F3;PPARD;IL16;BDKRB1;SLC9A1;JAG1;AMOTL2;NAV3;SAA1;ITGAV;PIP5K1A;SOX9;NRG1;PML;FERMT1;PTPN11;RHOB;SPAG9;VCL;TNFAIP1;HDAC9;CORO1C;WNT5A;ADAM9;PDPK1;TNFRSF10A;ADAMTS9;NFE2L2;SGK1;CXCL16
19704,GO:2000026,1.22308697560296e-12,1,91,1275,regulation of multicellular organismal development,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;NFKBID;CSF2;INHBA;ETS1;TNF;CXCL8;PTGS2;PRDM1;TBX3;NOCT;EFNA1;EDN1;SEMA7A;ERRFI1;IL1RN;EFNB2;EPHA2;MAFF;LIF;TRIB1;KCTD11;CD83;BMP2;PHLDA2;JUN;PHLDB2;TJP2;IRF1;ZFP36L1;ENC1;ADRB2;CEBPB;RUNX1;TRIM16;ZSWIM4;B4GALT1;IL6ST;DLX2;CYLD;ADAM8;LDLR;VEGFC;TACSTD2;NEDD4L;SMAD3;RC3H1;IL23A;DUSP10;PLK2;PIM1;ITGA5;TFRC;CREB1;F3;PPARD;ZFP36;CYP27B1;JAG1;RIPK2;NRARP;SOX9;NRG1;PML;FERMT1;RHOB;SPAG9;HDAC9;KLF10;SKIL;IL7R;CDK6;TFE3;PRPF19;TOB2;ADM;MAFG;ABL2;WNT5A;PDPK1;ADAMTS9;NFE2L2;YWHAH;RELA;YWHAG;SFN;PDLIM5
18234,GO:1903037,1.38194447453045e-12,1,28,171,regulation of leukocyte cell-cell adhesion,BP,IL1B;NFKBID;SDC4;ETS1;TNF;EFNB2;CD83;CD274;IRF1;CEBPB;PELI1;BCL10;IL6ST;CYLD;ADAM8;RC3H1;IL23A;DUSP10;TFRC;EFNB1;CD55;RIPK2;NRARP;PTPN11;MAP3K8;IL7R;HLA-E;PDPK1
609,GO:0001775,1.38681163257327e-12,1,69,861,cell activation,BP,TNFAIP3;IL1B;ZC3H12A;CXCL1;PLAUR;PLAU;NFKBID;CSF2;INHBA;TICAM1;SDC4;CXCL8;KLF6;NFKB1;PRDM1;NFKB2;EDN1;EFNB2;RELB;CD83;CAB39;JUN;RAP2B;CDKN1A;CD274;BCL3;AMPD3;IRF1;ZFP36L1;CEBPB;RUNX1;PELI1;B4GALT1;BCL10;IL6ST;CYLD;ADAM8;LDLR;SMAD3;RC3H1;IL23A;DUSP10;TFRC;EFNB1;SERPINB1;CD55;RIPK2;SAA1;NDRG1;ITGAV;NRARP;POU2F2;SLC7A2;PTPN11;MAP3K8;RHOB;SOX4;VCL;HDAC9;COTL1;IL7R;HLA-E;WNT5A;ADAM9;PDPK1;CTSC;ELF4;CREG1;RAB24
11286,GO:0045597,1.58718437843743e-12,1,57,601,positive regulation of cell differentiation,BP,IL1B;ZC3H12A;CSF2;INHBA;ETS1;TNF;PTGS2;NFKB1;PRDM1;NOCT;EDN1;SEMA7A;EFNB2;LIF;TRIB1;KCTD11;CD83;BMP2;JUN;JUNB;ZFP36L1;ENC1;CEBPB;RUNX1;TRIM16;EHD1;IL6ST;DLX2;CYLD;ADAM8;VEGFC;TACSTD2;NEDD4L;SMAD3;IL23A;DUSP10;CREB1;PPARD;SOCS3;ZFP36;CYP27B1;JAG1;RIPK2;SOX9;NRG1;SPAG9;KLF10;SKIL;IL7R;PRPF19;ADM;ABL2;WNT5A;ADAMTS9;NFE2L2;RELA;SFN
12902,GO:0051241,1.65004779576116e-12,1,60,679,negative regulation of multicellular organismal process,BP,NFKBIA;TNFAIP3;IL1B;ZC3H12A;PLAUR;PLAU;NFKBID;INHBA;TNF;REL;SERPINB2;PTGS2;NFKB1;TRPV3;NOCT;EFNA1;EDN1;SEMA7A;ERRFI1;EFNB2;RELB;TRIB1;KCTD11;CD83;BMP2;TJP2;CD274;BCL3;IRF1;ZFP36L1;ADRB2;DLX2;CYLD;LDLR;TACSTD2;SMAD3;RC3H1;IL23A;DUSP10;PLK2;ZFP36;JAG1;NAV3;NRARP;SOX9;NRG1;PML;FERMT1;PTPN11;AREG;CDK6;CORO1C;PRPF19;TOB2;ADM;WNT5A;ADAMTS9;NFE2L2;YWHAH;IFIH1
13907,GO:0060548,1.80762470667061e-12,1,60,689,negative regulation of cell death,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;CSF2;TNF;REL;SERPINB2;PPIF;IER3;NUAK2;PTGS2;NFKB1;TBX3;EFNA1;EDN1;TNFRSF10B;EPHA2;SQSTM1;JUN;BIRC2;CDKN1A;BCL3;BCL2L2;CEBPB;SOD2;ANKLE2;DUSP1;BCL10;PPP1R10;PIM3;IL6ST;ADAM8;SMAD3;PLK2;PLK3;PIM1;WISP1;ITGA5;CREB1;STK40;PPARD;SOCS3;SLC9A1;RIPK2;ITGAV;SOX9;NCOA7;SOX4;PTPN1;WNT5A;PDPK1;TNFRSF10A;NFE2L2;RELA;SFN
12421,GO:0048870,1.86626787345434e-12,1,76,957,cell motility,BP,CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;CXCL3;HBEGF;PLAU;SDC4;ETS1;TNF;CXCL8;CCL20;PTGS2;EFNA1;EDN1;SEMA7A;TNFRSF10B;EFNB2;EPHA2;CXCL5;TRIB1;BMP2;PHLDA2;IL24;MAP2K3;JUN;RAP2B;PHLDB2;CD274;RND3;EREG;SOD2;NEDD9;B4GALT1;ADAM8;VEGFC;TACSTD2;SMAD3;IL23A;DUSP10;PLK2;ITGA5;EFNB1;F3;PPARD;IL16;BDKRB1;SLC9A1;JAG1;AMOTL2;NAV3;SAA1;ITGAV;PIP5K1A;SOX9;NRG1;PML;FERMT1;PTPN11;RHOB;SPAG9;VCL;TNFAIP1;HDAC9;CDK6;CORO1C;ABL2;WNT5A;ADAM9;PDPK1;TNFRSF10A;ADAMTS9;NFE2L2;SGK1;CXCL16
13131,GO:0051674,1.86626787345434e-12,1,76,957,localization of cell,BP,CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;CXCL3;HBEGF;PLAU;SDC4;ETS1;TNF;CXCL8;CCL20;PTGS2;EFNA1;EDN1;SEMA7A;TNFRSF10B;EFNB2;EPHA2;CXCL5;TRIB1;BMP2;PHLDA2;IL24;MAP2K3;JUN;RAP2B;PHLDB2;CD274;RND3;EREG;SOD2;NEDD9;B4GALT1;ADAM8;VEGFC;TACSTD2;SMAD3;IL23A;DUSP10;PLK2;ITGA5;EFNB1;F3;PPARD;IL16;BDKRB1;SLC9A1;JAG1;AMOTL2;NAV3;SAA1;ITGAV;PIP5K1A;SOX9;NRG1;PML;FERMT1;PTPN11;RHOB;SPAG9;VCL;TNFAIP1;HDAC9;CDK6;CORO1C;ABL2;WNT5A;ADAM9;PDPK1;TNFRSF10A;ADAMTS9;NFE2L2;SGK1;CXCL16
3745,GO:0008284,2.01675200164079e-12,1,52,543,positive regulation of cell proliferation,BP,TNFAIP3;IL1B;HBEGF;CSF2;TICAM1;ETS1;TNF;PTGS2;FOSL1;TBX3;TGFA;EDN1;ODC1;EFNB2;CXCL5;LIF;BMP2;IL24;JUN;CDKN1A;CD274;NAMPT;EREG;PELI1;B4GALT1;IL6ST;VEGFC;IL23A;PIM1;TFRC;EFNB1;F3;PPARD;CD55;RIPK2;ITGAV;NRARP;SOX9;NRG1;PML;SOX4;FOSL2;AREG;IL7R;CDK6;ADM;HLA-E;OSMR;WNT5A;PDPK1;RELA;ERN1
6866,GO:0030335,2.31781083606447e-12,1,39,316,positive regulation of cell migration,BP,CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;CXCL3;HBEGF;PLAU;ETS1;TNF;CXCL8;CCL20;PTGS2;EDN1;SEMA7A;CXCL5;BMP2;MAP2K3;JUN;CD274;SOD2;ADAM8;VEGFC;SMAD3;IL23A;PLK2;ITGA5;F3;BDKRB1;ITGAV;SOX9;RHOB;SPAG9;HDAC9;WNT5A;ADAM9;PDPK1;NFE2L2;CXCL16
364,GO:0000982,2.46658266676335e-12,1,36,267,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,BTG2;ELF3;ETS1;KLF6;BHLHE40;PRDM1;FOSL1;TBX3;NFKB2;KLF7;EHF;JUN;JUNB;OVOL1;ETS2;IRF1;CEBPB;ARNTL2;ZNF217;CREB1;PLAGL2;SOX9;POU2F2;ELK3;MXD1;SOX4;FOSL2;KLF10;SKIL;TFE3;MAFG;MTF1;RELA;BACH1;ELF4;FUBP3
7320,GO:0031328,2.52448642752774e-12,1,92,1308,positive regulation of cellular biosynthetic process,BP,NFKBIA;IL1B;IL1A;ZC3H12A;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;KLF6;CCL20;PTGS2;TNIP1;NFKB1;FOSL1;TBX3;NFKB2;KDM6B;IRF6;EDN1;HAS3;KLF7;CREB5;EHF;RELB;MAFF;LIF;SQSTM1;BMP2;MAP2K3;JUN;RGMB;SERTAD2;JUNB;BCL3;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ADRB2;CEBPB;ARNTL2;PPP1R15A;RUNX1;CDKN2B;TRIM16;EREG;BCL10;DLX2;LDLR;SMAD3;IL23A;CREB1;PPARD;SLC9A1;LARP4B;JAG1;PLAGL2;RIPK2;SOX9;NRG1;PML;POU2F2;NCOA7;ELK3;FOXN2;UHRF1;SOX4;FOSL2;AREG;CCNL1;TNFAIP1;KLF10;RBM3;IER5;SAMD4A;TFE3;MAFG;MTF1;WNT5A;INSIG1;NFE2L2;YWHAH;RELA;BACH1;ELF4;ATXN7;FUBP3;SMPD3
16785,GO:0098609,2.62641890697412e-12,1,47,442,cell-cell adhesion,BP,IL1B;NFKBID;SDC4;ETS1;TNF;TNIP1;IL1RN;CLDN1;EFNB2;CD83;BMP2;RAP2B;CLDN4;CD274;IRF1;ZFP36L1;CEBPB;PELI1;BCL10;IL6ST;VMP1;CYLD;ADAM8;TACSTD2;RC3H1;IL23A;DUSP10;ITGA5;TFRC;SERPINB8;EFNB1;CD55;JAG1;RIPK2;ITGAV;NRARP;SOX9;CDC42EP1;PTPN11;MAP3K8;VCL;IL7R;HLA-E;WNT5A;ADAM9;PDPK1;PDLIM5
12857,GO:0051172,2.71129048587671e-12,1,111,1772,negative regulation of nitrogen compound metabolic process,BP,TNFAIP3;IL1B;ZC3H12A;PLAUR;BTG2;BIRC3;HBEGF;CSF2;INHBA;ELF3;TNF;REL;SERPINB2;PPIF;BHLHE40;PTGS2;TNIP1;NFKB1;PRDM1;TBX3;NFKB2;NOCT;EFNA1;EDN1;ERRFI1;CPEB2;TNFRSF10B;RELB;GADD45A;LIF;TRIB1;SQSTM1;BMP2;JUN;BIRC2;CDKN1A;JUNB;BCL3;OVOL1;ETS2;IRF1;ZFP36L1;ENC1;CEBPB;DUSP16;PPP1R15A;N4BP1;CDKN2B;NAB1;EREG;DUSP8;TFPI2;DUSP1;PPP1R10;DLX2;LDLR;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;DUSP10;PLK3;CREB1;SERPINB8;PPARD;SERPINB1;SOCS3;CCDC85B;BDKRB1;ZFP36;MAFK;CD55;AZIN1;PPP1R15B;ITGAV;NRARP;SOX9;NRG1;ZNF451;PML;NCOA7;ELK3;UHRF1;MXD1;SOX4;HDAC9;HIVEP1;KLF10;SKIL;CDK6;SAMD4A;PTPN1;CORO1C;TOB2;QKI;CELF1;WNT5A;NUP153;PDPK1;TNFRSF10A;ZBTB21;RELA;BACH1;BTAF1;YWHAG;TDG;CREG1;SFN;ITM2B;SH3RF2
9822,GO:0042035,2.74396213341886e-12,1,17,57,regulation of cytokine biosynthetic process,BP,IL1B;IL1A;INHBA;TICAM1;TNF;CCL20;NFKB1;ERRFI1;MAP2K3;BCL3;IRF1;CEBPB;EREG;BCL10;ZFP36;WNT5A;RELA
2865,GO:0006357,2.74538585145385e-12,1,105,1594,regulation of transcription by RNA polymerase II,BP,NFKBIA;NFKBIZ;IL1B;IL1A;ZC3H12A;BTG2;NFKBID;INHBA;ELF3;ETS1;TNF;REL;KLF6;BHLHE40;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;EFNA1;TGFA;KDM6B;IRF6;EDN1;KLF7;CREB5;EHF;RELB;MAFF;LIF;SQSTM1;BMP2;ZNF267;JUN;CDKN1A;RGMB;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ADRB2;CEBPB;ARNTL2;RUNX1;CDKN2B;ELMSAN1;SOD2;DLX2;VGLL3;KLF3;ZNF217;NEDD4L;SMAD3;IL23A;PLK3;CREB1;HIVEP2;PPARD;ZFP36;SLC9A1;MAFK;JAG1;PLAGL2;RIPK2;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;FOXN2;UHRF1;MXD1;SOX4;FOSL2;CCNL1;FAM83G;HDAC9;HIVEP1;KLF10;SKIL;IER5;TFE3;MAFG;MTF1;WNT5A;INSIG1;NFE2L2;TSC22D2;RELA;BACH1;TDG;ELF4;CREG1;ATXN7;BRD2;FUBP3
2225,GO:0005126,2.8699032425569e-12,1,24,135,cytokine receptor binding,MF,CXCL2;IL1B;IL1A;CXCL1;CXCL3;IL36G;CSF2;INHBA;TNF;CXCL8;CCL20;IL1RN;CXCL5;LIF;BMP2;TRAF1;IL6ST;VEGFC;SMAD3;IL23A;ITGA5;FEM1B;TRAF4;CXCL16
4508,GO:0010557,3.34031129843826e-12,1,89,1249,positive regulation of macromolecule biosynthetic process,BP,NFKBIA;IL1B;IL1A;ZC3H12A;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;KLF6;CCL20;TNIP1;NFKB1;FOSL1;TBX3;NFKB2;KDM6B;IRF6;EDN1;HAS3;KLF7;CREB5;EHF;RELB;MAFF;LIF;SQSTM1;BMP2;MAP2K3;JUN;RGMB;SERTAD2;JUNB;BCL3;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ADRB2;CEBPB;ARNTL2;PPP1R15A;RUNX1;CDKN2B;TRIM16;EREG;BCL10;DLX2;SMAD3;IL23A;CREB1;PPARD;SLC9A1;LARP4B;JAG1;PLAGL2;RIPK2;SOX9;NRG1;PML;POU2F2;NCOA7;ELK3;FOXN2;UHRF1;SOX4;FOSL2;AREG;CCNL1;TNFAIP1;KLF10;RBM3;IER5;SAMD4A;TFE3;MAFG;MTF1;WNT5A;INSIG1;NFE2L2;YWHAH;RELA;BACH1;ELF4;ATXN7;FUBP3
19762,GO:2000147,3.39324865721736e-12,1,39,321,positive regulation of cell motility,BP,CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;CXCL3;HBEGF;PLAU;ETS1;TNF;CXCL8;CCL20;PTGS2;EDN1;SEMA7A;CXCL5;BMP2;MAP2K3;JUN;CD274;SOD2;ADAM8;VEGFC;SMAD3;IL23A;PLK2;ITGA5;F3;BDKRB1;ITGAV;SOX9;RHOB;SPAG9;HDAC9;WNT5A;ADAM9;PDPK1;NFE2L2;CXCL16
12420,GO:0048869,3.49952707924924e-12,1,150,2675,cellular developmental process,BP,NFKBIA;IL1B;IL1A;ZC3H12A;BTG2;NFKBID;CSF2;INHBA;ELF3;SDC4;ETS1;TNF;KLF6;SPRR2D;PTGS2;NFKB1;PRDM1;TBX3;NFKB2;NOCT;EFNA1;KDM6B;IRF6;EDN1;SEMA7A;ERRFI1;CLDN1;KLF7;EHF;SPRR2A;EFNB2;EPHA2;RELB;MAFF;LIF;TRIB1;KCTD11;CD83;SQSTM1;BMP2;JUN;BIRC2;CDKN1A;PHLDB2;TJP2;JUNB;BCL3;ETS2;IRF1;TAF4B;ZFP36L1;ENC1;RND3;ADRB2;CEBPB;RUNX1;CDKN2B;NAB1;TRIM16;EREG;EHD1;ZSWIM4;B4GALT1;FGD6;IL6ST;DLX2;CYLD;ADAM8;LDLR;VEGFC;TACSTD2;NEDD4L;SMAD3;RC3H1;IL23A;DUSP10;PLK2;ITGA5;TFRC;CREB1;EFNB1;PPARD;KRT34;SOCS3;CCDC85B;KRTAP2-3;RAPH1;ZFP36;SLC9A1;CYP27B1;JAG1;RIPK2;NDRG1;ITGAV;PIP5K1A;NRARP;SOX9;NRG1;PML;POU2F2;ELK3;CDC42EP1;FOXN2;PTPN11;RHOB;SPAG9;ABCA5;FEM1B;SOX4;FOSL2;VCL;AREG;HDAC9;KLF10;SKIL;IL7R;CDK6;TFE3;CORO1C;STEAP4;PRPF19;TOB2;ADM;MAFG;ABL2;QKI;CELF1;WNT5A;INSIG1;ADAM9;LCE1C;PDPK1;ADAMTS9;ERO1A;KDM6A;FRMD6;NFE2L2;YWHAH;SGK1;B3GNT2;RELA;AGFG1;NOTCH2NL;YWHAG;ELF4;SFN;LAMB3;PABPC4;PDLIM5;SMPD3
4340,GO:0009891,4.34568694509052e-12,1,92,1322,positive regulation of biosynthetic process,BP,NFKBIA;IL1B;IL1A;ZC3H12A;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;KLF6;CCL20;PTGS2;TNIP1;NFKB1;FOSL1;TBX3;NFKB2;KDM6B;IRF6;EDN1;HAS3;KLF7;CREB5;EHF;RELB;MAFF;LIF;SQSTM1;BMP2;MAP2K3;JUN;RGMB;SERTAD2;JUNB;BCL3;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ADRB2;CEBPB;ARNTL2;PPP1R15A;RUNX1;CDKN2B;TRIM16;EREG;BCL10;DLX2;LDLR;SMAD3;IL23A;CREB1;PPARD;SLC9A1;LARP4B;JAG1;PLAGL2;RIPK2;SOX9;NRG1;PML;POU2F2;NCOA7;ELK3;FOXN2;UHRF1;SOX4;FOSL2;AREG;CCNL1;TNFAIP1;KLF10;RBM3;IER5;SAMD4A;TFE3;MAFG;MTF1;WNT5A;INSIG1;NFE2L2;YWHAH;RELA;BACH1;ELF4;ATXN7;FUBP3;SMPD3
12906,GO:0051249,4.96029769368985e-12,1,33,248,regulation of lymphocyte activation,BP,TNFAIP3;IL1B;NFKBID;INHBA;TICAM1;SDC4;PRDM1;EFNB2;CD83;CDKN1A;CD274;IRF1;ZFP36L1;CEBPB;RUNX1;PELI1;BCL10;IL6ST;CYLD;ADAM8;RC3H1;IL23A;DUSP10;TFRC;EFNB1;CD55;RIPK2;NRARP;PTPN11;MAP3K8;IL7R;HLA-E;PDPK1
6582,GO:0022407,5.49321167704031e-12,1,32,231,regulation of cell-cell adhesion,BP,IL1B;NFKBID;SDC4;ETS1;TNF;IL1RN;EFNB2;CD83;BMP2;CD274;IRF1;CEBPB;PELI1;BCL10;IL6ST;CYLD;ADAM8;RC3H1;IL23A;DUSP10;TFRC;EFNB1;CD55;JAG1;RIPK2;NRARP;PTPN11;MAP3K8;IL7R;HLA-E;WNT5A;PDPK1
9791,GO:0040011,6.21969613884905e-12,1,82,1101,locomotion,BP,CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;CXCL3;HBEGF;PLAU;SDC4;ETS1;TNF;CXCL8;CCL20;PTGS2;FOSL1;EFNA1;EDN1;SEMA7A;KLF7;TNFRSF10B;EFNB2;EPHA2;CXCL5;TRIB1;BMP2;PHLDA2;IL24;MAP2K3;JUN;RAP2B;PHLDB2;CD274;RND3;EREG;SOD2;NEDD9;ZSWIM4;B4GALT1;ADAM8;VEGFC;TACSTD2;SMAD3;IL23A;DUSP10;PLK2;ITGA5;CREB1;EFNB1;F3;PPARD;IL16;BDKRB1;SLC9A1;JAG1;AMOTL2;NAV3;SAA1;ITGAV;PIP5K1A;SOX9;NRG1;PML;FERMT1;PTPN11;RHOB;SPAG9;VCL;TNFAIP1;HDAC9;CDK6;CORO1C;ABL2;WNT5A;ADAM9;PDPK1;TNFRSF10A;ADAMTS9;NFE2L2;SGK1;B3GNT2;CXCL16
15977,GO:0080134,7.17773476044078e-12,1,74,984,regulation of response to stress,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BIRC3;HBEGF;PLAU;TICAM1;ETS1;TNF;SERPINB2;IER3;PTGS2;PMAIP1;TNIP1;NFKB1;EDN1;SEMA7A;ERRFI1;IRAK2;RELB;GADD45A;IFNGR2;BMP2;BIRC2;PHLDB2;IRF1;PPP1R15A;EREG;SOD2;PELI1;BCL10;PPP1R10;IL6ST;CYLD;ADAM8;LDLR;SMAD3;IL23A;DUSP10;PLK2;F3;PPARD;SOCS3;CD55;IFNAR2;RIPK2;SAA1;PPP1R15B;PML;NCOA7;SLC7A2;PTPN11;SPAG9;GCH1;FEM1B;TRAF4;SKIL;CDK6;IER5;PTPN1;HLA-E;OSMR;WNT5A;NUP153;INSIG1;PDPK1;NFE2L2;RELA;POLR3D;ERN1;IFIH1
10302,GO:0043066,7.33287611553331e-12,1,55,618,negative regulation of apoptotic process,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;CSF2;TNF;SERPINB2;PPIF;IER3;NUAK2;PTGS2;NFKB1;TBX3;EFNA1;EDN1;TNFRSF10B;EPHA2;SQSTM1;JUN;BIRC2;CDKN1A;BCL3;BCL2L2;CEBPB;SOD2;ANKLE2;DUSP1;BCL10;PPP1R10;PIM3;IL6ST;ADAM8;SMAD3;PLK2;PLK3;PIM1;ITGA5;STK40;PPARD;SOCS3;SLC9A1;RIPK2;ITGAV;SOX9;PTPN1;WNT5A;PDPK1;TNFRSF10A;NFE2L2;RELA;SFN
12664,GO:0050865,7.57078704053521e-12,1,37,309,regulation of cell activation,BP,TNFAIP3;IL1B;ZC3H12A;NFKBID;INHBA;TICAM1;SDC4;PRDM1;EFNB2;CD83;CDKN1A;CD274;IRF1;ZFP36L1;CEBPB;RUNX1;PELI1;BCL10;IL6ST;CYLD;ADAM8;LDLR;RC3H1;IL23A;DUSP10;TFRC;EFNB1;CD55;RIPK2;NRARP;SLC7A2;PTPN11;MAP3K8;IL7R;HLA-E;WNT5A;PDPK1
12925,GO:0051272,7.65662388782853e-12,1,39,330,positive regulation of cellular component movement,BP,CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;CXCL3;HBEGF;PLAU;ETS1;TNF;CXCL8;CCL20;PTGS2;EDN1;SEMA7A;CXCL5;BMP2;MAP2K3;JUN;CD274;SOD2;ADAM8;VEGFC;SMAD3;IL23A;PLK2;ITGA5;F3;BDKRB1;ITGAV;SOX9;RHOB;SPAG9;HDAC9;WNT5A;ADAM9;PDPK1;NFE2L2;CXCL16
9797,GO:0040017,8.22935500213098e-12,1,40,346,positive regulation of locomotion,BP,CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;CXCL3;HBEGF;PLAU;ETS1;TNF;CXCL8;CCL20;PTGS2;EDN1;SEMA7A;CXCL5;BMP2;MAP2K3;JUN;CD274;SOD2;ADAM8;VEGFC;SMAD3;IL23A;PLK2;ITGA5;F3;IL16;BDKRB1;ITGAV;SOX9;RHOB;SPAG9;HDAC9;WNT5A;ADAM9;PDPK1;NFE2L2;CXCL16
18029,GO:1902531,8.73557794860925e-12,1,91,1313,regulation of intracellular signal transduction,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BIRC3;HBEGF;NFKBID;CSF2;INHBA;TICAM1;TNF;REL;PPIF;IER3;CCL20;PTGS2;PMAIP1;TNIP1;PLEKHF1;EFNA1;TGFA;EDN1;SEMA7A;ERRFI1;IRAK2;TNFRSF10B;EPHA2;GADD45A;LIF;TRIB1;SQSTM1;BMP2;IL24;MAP2K3;JUN;BIRC2;BCL3;TAF4B;BCL2L2;ADRB2;DUSP16;EREG;SOD2;PELI1;DUSP8;DUSP1;BCL10;FGD6;IL6ST;CYLD;ADAM8;RC3H1;IL23A;DUSP10;PLK2;PLK3;F3;STK40;PPARD;SOCS3;SLC9A1;PLAGL2;RIPK2;SAA1;ITGAV;PIP5K1A;TP53BP2;SOX9;NRG1;PML;RASA2;PTPN11;MAP3K8;ARHGEF3;RHOB;SPAG9;TRAF4;TNFAIP1;SKIL;IL7R;PTPN1;WNT5A;ADAM9;PDPK1;TNFRSF10A;NFE2L2;CYTH1;RELA;AGFG1;ERN1
12662,GO:0050863,8.90006049723894e-12,1,28,184,regulation of T cell activation,BP,IL1B;NFKBID;SDC4;PRDM1;EFNB2;CD83;CD274;IRF1;CEBPB;RUNX1;PELI1;BCL10;IL6ST;CYLD;ADAM8;RC3H1;IL23A;DUSP10;TFRC;EFNB1;CD55;RIPK2;NRARP;PTPN11;MAP3K8;IL7R;HLA-E;PDPK1
11446,GO:0045893,1.01993924734977e-11,1,79,1056,positive regulation of transcription, DNA-templated,BP,NFKBIA;IL1B;IL1A;ZC3H12A;INHBA;ELF3;ETS1;TNF;REL;KLF6;TNIP1;NFKB1;FOSL1;TBX3;NFKB2;KDM6B;IRF6;EDN1;HAS3;KLF7;CREB5;EHF;RELB;MAFF;LIF;SQSTM1;BMP2;MAP2K3;JUN;RGMB;SERTAD2;JUNB;BCL3;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ADRB2;CEBPB;ARNTL2;RUNX1;CDKN2B;TRIM16;BCL10;DLX2;SMAD3;IL23A;CREB1;PPARD;SLC9A1;JAG1;PLAGL2;RIPK2;SOX9;NRG1;PML;POU2F2;NCOA7;ELK3;FOXN2;UHRF1;SOX4;FOSL2;CCNL1;KLF10;IER5;TFE3;MAFG;MTF1;WNT5A;INSIG1;NFE2L2;YWHAH;RELA;BACH1;ELF4;ATXN7;FUBP3
18429,GO:1903508,1.01993924734977e-11,1,79,1056,positive regulation of nucleic acid-templated transcription,BP,NFKBIA;IL1B;IL1A;ZC3H12A;INHBA;ELF3;ETS1;TNF;REL;KLF6;TNIP1;NFKB1;FOSL1;TBX3;NFKB2;KDM6B;IRF6;EDN1;HAS3;KLF7;CREB5;EHF;RELB;MAFF;LIF;SQSTM1;BMP2;MAP2K3;JUN;RGMB;SERTAD2;JUNB;BCL3;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ADRB2;CEBPB;ARNTL2;RUNX1;CDKN2B;TRIM16;BCL10;DLX2;SMAD3;IL23A;CREB1;PPARD;SLC9A1;JAG1;PLAGL2;RIPK2;SOX9;NRG1;PML;POU2F2;NCOA7;ELK3;FOXN2;UHRF1;SOX4;FOSL2;CCNL1;KLF10;IER5;TFE3;MAFG;MTF1;WNT5A;INSIG1;NFE2L2;YWHAH;RELA;BACH1;ELF4;ATXN7;FUBP3
18082,GO:1902680,1.0678140775993e-11,1,79,1057,positive regulation of RNA biosynthetic process,BP,NFKBIA;IL1B;IL1A;ZC3H12A;INHBA;ELF3;ETS1;TNF;REL;KLF6;TNIP1;NFKB1;FOSL1;TBX3;NFKB2;KDM6B;IRF6;EDN1;HAS3;KLF7;CREB5;EHF;RELB;MAFF;LIF;SQSTM1;BMP2;MAP2K3;JUN;RGMB;SERTAD2;JUNB;BCL3;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ADRB2;CEBPB;ARNTL2;RUNX1;CDKN2B;TRIM16;BCL10;DLX2;SMAD3;IL23A;CREB1;PPARD;SLC9A1;JAG1;PLAGL2;RIPK2;SOX9;NRG1;PML;POU2F2;NCOA7;ELK3;FOXN2;UHRF1;SOX4;FOSL2;CCNL1;KLF10;IER5;TFE3;MAFG;MTF1;WNT5A;INSIG1;NFE2L2;YWHAH;RELA;BACH1;ELF4;ATXN7;FUBP3
7360,GO:0031401,1.1034962809274e-11,1,65,790,positive regulation of protein modification process,BP,IL1B;IL1A;ZC3H12A;PLAUR;BIRC3;HBEGF;CSF2;INHBA;TICAM1;SDC4;TNF;CCL20;PTGS2;TNIP1;EFNA1;TGFA;EDN1;SEMA7A;IRAK2;TNFRSF10B;EPHA2;GADD45A;LIF;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;BIRC2;CDKN1A;ADRB2;PPP1R15A;EREG;PELI1;ANKLE2;BCL10;DCUN1D3;IL6ST;ADAM8;VEGFC;OXSR1;IL23A;ITGA5;SOCS3;RIPK2;SAA1;PPP1R15B;ITGAV;SOX9;NRG1;PTPN11;MAP3K8;SPAG9;SOX4;TRAF4;AREG;CCNL1;PTPN1;WNT5A;ADAM9;PDPK1;TNFRSF10A;ERN1
12307,GO:0048646,1.23290132986898e-11,1,61,693,anatomical structure formation involved in morphogenesis,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;INHBA;SDC4;ETS1;TNF;CXCL8;PTGS2;TBX3;NFKB2;EFNA1;KDM6B;EDN1;EFNB2;EPHA2;JUN;PHLDB2;JUNB;BCL3;ETS2;RUNX1;EREG;ALDH1A3;EHD1;B4GALT1;DUSP1;BCL10;TXNRD1;ADAM8;VEGFC;SMAD3;RC3H1;PLK2;PIM1;ITGA5;F3;JAG1;AMOTL2;ITGAV;NRARP;SOX9;PML;ELK3;PTPN11;RHOB;SOX4;HDAC9;ADAMTS1;SKIL;ADM;WNT5A;ADAM9;PDPK1;ADAMTS9;KDM6A;NFE2L2;SAT1;AGFG1;LAMB3
10304,GO:0043068,1.42052623273727e-11,1,46,470,positive regulation of programmed cell death,BP,ZC3H12A;PLAUR;NFKBID;INHBA;TNF;PPIF;PTGS2;PMAIP1;FOSL1;PLEKHF1;HCAR2;TNFRSF10B;GADD45A;SQSTM1;BMP2;JUN;CDKN1A;CD274;ALDH1A3;B4GALT1;DUSP1;BCL10;DCUN1D3;G0S2;CYLD;ADAM8;SMAD3;BBC3;CREB1;F3;SLC9A1;PLAGL2;RIPK2;TP53BP2;PML;ARHGEF3;RHOB;SOX4;SKIL;ADM;WNT5A;TNFRSF10A;CTSC;YWHAH;YWHAG;SFN
9843,GO:0042089,1.49021744449222e-11,1,17,63,cytokine biosynthetic process,BP,IL1B;IL1A;INHBA;TICAM1;TNF;CCL20;NFKB1;ERRFI1;MAP2K3;BCL3;IRF1;CEBPB;EREG;BCL10;ZFP36;WNT5A;RELA
10305,GO:0043069,1.6024936182296e-11,1,55,631,negative regulation of programmed cell death,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;CSF2;TNF;SERPINB2;PPIF;IER3;NUAK2;PTGS2;NFKB1;TBX3;EFNA1;EDN1;TNFRSF10B;EPHA2;SQSTM1;JUN;BIRC2;CDKN1A;BCL3;BCL2L2;CEBPB;SOD2;ANKLE2;DUSP1;BCL10;PPP1R10;PIM3;IL6ST;ADAM8;SMAD3;PLK2;PLK3;PIM1;ITGA5;STK40;PPARD;SOCS3;SLC9A1;RIPK2;ITGAV;SOX9;PTPN1;WNT5A;PDPK1;TNFRSF10A;NFE2L2;RELA;SFN
7316,GO:0031324,1.64255830956774e-11,1,114,1887,negative regulation of cellular metabolic process,BP,TNFAIP3;IL1B;ZC3H12A;PLAUR;BTG2;BIRC3;HBEGF;CSF2;INHBA;ELF3;TNF;REL;SERPINB2;PPIF;BHLHE40;PTGS2;TNIP1;NFKB1;PRDM1;TBX3;NFKB2;NOCT;PLEKHF1;EFNA1;EDN1;ERRFI1;CPEB2;TNFRSF10B;RELB;GADD45A;LIF;TRIB1;SQSTM1;BMP2;JUN;BIRC2;CDKN1A;JUNB;BCL3;OVOL1;ETS2;IRF1;ZFP36L1;ENC1;CEBPB;DUSP16;PPP1R15A;N4BP1;CDKN2B;NAB1;EREG;ANKLE2;DUSP8;TFPI2;DUSP1;PPP1R10;DLX2;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;DUSP10;PLK3;CREB1;SERPINB8;PPARD;SERPINB1;SOCS3;CCDC85B;BDKRB1;ZFP36;MAFK;CYP27B1;CD55;PPP1R15B;ITGAV;NRARP;SOX9;NRG1;ZNF451;PML;NCOA7;ELK3;UHRF1;MXD1;SOX4;HDAC9;HIVEP1;KLF10;SKIL;CDK6;SAMD4A;PTPN1;CORO1C;TOB2;QKI;CELF1;WNT5A;NUP153;INSIG1;PDPK1;TNFRSF10A;ZBTB21;RELA;BACH1;BTAF1;YWHAG;TDG;CREG1;SFN;ITM2B;SH3RF2;ATXN7
12576,GO:0050727,1.64867404341112e-11,1,27,179,regulation of inflammatory response,BP,NFKBIA;TNFAIP3;IL1B;ZC3H12A;BIRC3;TICAM1;ETS1;TNF;PTGS2;TNIP1;NFKB1;SEMA7A;BIRC2;IL6ST;ADAM8;LDLR;SMAD3;IL23A;DUSP10;PPARD;SOCS3;CD55;SAA1;SLC7A2;OSMR;WNT5A;RELA
9860,GO:0042110,1.76311783952626e-11,1,34,270,T cell activation,BP,IL1B;NFKBID;SDC4;PRDM1;EFNB2;RELB;CD83;CD274;BCL3;IRF1;ZFP36L1;CEBPB;RUNX1;PELI1;BCL10;IL6ST;CYLD;ADAM8;SMAD3;RC3H1;IL23A;DUSP10;TFRC;EFNB1;CD55;RIPK2;NRARP;PTPN11;MAP3K8;SOX4;IL7R;HLA-E;PDPK1;ELF4
4513,GO:0010562,1.78218161290636e-11,1,60,700,positive regulation of phosphorus metabolic process,BP,IL1B;IL1A;ZC3H12A;PLAUR;HBEGF;CSF2;INHBA;SDC4;TNF;CCL20;PTGS2;EFNA1;TGFA;EDN1;SEMA7A;IRAK2;TNFRSF10B;EPHA2;GADD45A;LIF;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;CDKN1A;ADRB2;PPP1R15A;EREG;ANKLE2;BCL10;IL6ST;ADAM8;VEGFC;OXSR1;SMAD3;IL23A;ITGA5;SOCS3;RIPK2;SAA1;PPP1R15B;ITGAV;SOX9;NRG1;PTPN11;MAP3K8;SPAG9;TRAF4;AREG;CCNL1;PTPN1;ADM;WNT5A;ADAM9;PDPK1;TNFRSF10A;ERN1
11480,GO:0045937,1.78218161290636e-11,1,60,700,positive regulation of phosphate metabolic process,BP,IL1B;IL1A;ZC3H12A;PLAUR;HBEGF;CSF2;INHBA;SDC4;TNF;CCL20;PTGS2;EFNA1;TGFA;EDN1;SEMA7A;IRAK2;TNFRSF10B;EPHA2;GADD45A;LIF;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;CDKN1A;ADRB2;PPP1R15A;EREG;ANKLE2;BCL10;IL6ST;ADAM8;VEGFC;OXSR1;SMAD3;IL23A;ITGA5;SOCS3;RIPK2;SAA1;PPP1R15B;ITGAV;SOX9;NRG1;PTPN11;MAP3K8;SPAG9;TRAF4;AREG;CCNL1;PTPN1;ADM;WNT5A;ADAM9;PDPK1;TNFRSF10A;ERN1
9857,GO:0042107,1.88616037648359e-11,1,17,64,cytokine metabolic process,BP,IL1B;IL1A;INHBA;TICAM1;TNF;CCL20;NFKB1;ERRFI1;MAP2K3;BCL3;IRF1;CEBPB;EREG;BCL10;ZFP36;WNT5A;RELA
455,GO:0001228,1.92913395591453e-11,1,34,260,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,ELF3;ETS1;REL;KLF6;NFKB1;FOSL1;NFKB2;IRF6;KLF7;EHF;MAFF;JUN;JUNB;CSRNP1;IRF1;CEBPB;RUNX1;DLX2;CREB1;PLAGL2;SOX9;POU2F2;ELK3;SOX4;FOSL2;KLF10;TFE3;MAFG;MTF1;NFE2L2;RELA;BACH1;ELF4;FUBP3
11398,GO:0045785,1.93871350300267e-11,1,32,239,positive regulation of cell adhesion,BP,IL1B;SDC4;ETS1;TNF;EFNB2;CD83;CD274;BCL10;IL6ST;CYLD;ADAM8;VEGFC;SMAD3;IL23A;DUSP10;ITGA5;TFRC;EFNB1;CD55;RIPK2;SAA1;ITGAV;FERMT1;PTPN11;MAP3K8;IL7R;CDK6;TFE3;HLA-E;WNT5A;ADAM9;PDPK1
17872,GO:1902105,1.94189880752511e-11,1,26,161,regulation of leukocyte differentiation,BP,NFKBID;INHBA;TNF;PRDM1;LIF;TRIB1;CD83;JUN;TJP2;IRF1;ZFP36L1;CEBPB;RUNX1;CYLD;ADAM8;RC3H1;IL23A;DUSP10;CREB1;RIPK2;NRARP;KLF10;IL7R;CDK6;TFE3;TOB2
358,GO:0000976,2.32538470033215e-11,1,49,495,transcription regulatory region sequence-specific DNA binding,MF,ELF3;ETS1;REL;KLF6;BHLHE40;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;KDM6B;KLF7;EHF;RELB;GADD45A;JUN;JUNB;OVOL1;ETS2;IRF1;CEBPB;ARNTL2;RUNX1;DLX2;KLF3;ZNF217;SMAD3;CREB1;PPARD;MAFK;SOX9;POU2F2;ELK3;UHRF1;MXD1;SOX4;FOSL2;HIVEP1;KLF10;SKIL;TFE3;MAFG;MTF1;KDM6A;NFE2L2;RELA;BACH1;ELF4;FUBP3
359,GO:0000977,2.36611672109405e-11,1,45,432,RNA polymerase II regulatory region sequence-specific DNA binding,MF,ELF3;ETS1;REL;KLF6;BHLHE40;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;KDM6B;KLF7;EHF;RELB;GADD45A;JUN;JUNB;OVOL1;ETS2;IRF1;CEBPB;ARNTL2;RUNX1;DLX2;KLF3;ZNF217;SMAD3;CREB1;PPARD;POU2F2;ELK3;MXD1;FOSL2;HIVEP1;KLF10;SKIL;TFE3;MAFG;MTF1;KDM6A;NFE2L2;RELA;BACH1;ELF4;FUBP3
18031,GO:1902533,2.37734299102377e-11,1,57,663,positive regulation of intracellular signal transduction,BP,IL1B;IL1A;ZC3H12A;BIRC3;HBEGF;CSF2;TICAM1;TNF;REL;CCL20;PMAIP1;PLEKHF1;EFNA1;TGFA;EDN1;SEMA7A;IRAK2;TNFRSF10B;EPHA2;GADD45A;LIF;BMP2;IL24;MAP2K3;JUN;BIRC2;ADRB2;EREG;PELI1;BCL10;IL6ST;ADAM8;RC3H1;IL23A;PLK2;F3;PPARD;SOCS3;SLC9A1;PLAGL2;RIPK2;SAA1;ITGAV;SOX9;NRG1;PTPN11;MAP3K8;SPAG9;TRAF4;SKIL;IL7R;PTPN1;WNT5A;ADAM9;TNFRSF10A;RELA;ERN1
7358,GO:0031399,2.4323781993927e-11,1,87,1261,regulation of protein modification process,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BIRC3;HBEGF;CSF2;INHBA;TICAM1;SDC4;TNF;CCL20;PTGS2;TNIP1;EFNA1;TGFA;EDN1;SEMA7A;ERRFI1;IRAK2;TNFRSF10B;EPHA2;GADD45A;LIF;TRIB1;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;BIRC2;CDKN1A;ADRB2;DUSP16;PPP1R15A;N4BP1;CDKN2B;EREG;PELI1;ANKLE2;DUSP8;DUSP1;BCL10;DCUN1D3;PPP1R10;IL6ST;ADAM8;VEGFC;OXSR1;IL23A;DUSP10;ITGA5;STK40;SOCS3;BDKRB1;RIPK2;SAA1;PPP1R15B;ITGAV;SOX9;NRG1;ZNF451;PML;NCOA7;PTPN11;MAP3K8;SPAG9;FEM1B;SOX4;TRAF4;AREG;CCNL1;CDK6;PTPN1;CORO1C;WNT5A;ADAM9;PDPK1;TNFRSF10A;RELA;YWHAG;SFN;ERN1;SH3RF2
1023,GO:0002521,2.59444760007381e-11,1,36,299,leukocyte differentiation,BP,NFKBID;CSF2;INHBA;TNF;KLF6;PRDM1;EPHA2;RELB;LIF;TRIB1;CD83;JUN;TJP2;JUNB;BCL3;IRF1;ZFP36L1;CEBPB;RUNX1;CYLD;ADAM8;RC3H1;IL23A;DUSP10;TFRC;CREB1;RIPK2;NRARP;POU2F2;SOX4;HDAC9;KLF10;IL7R;CDK6;TFE3;TOB2
4764,GO:0010942,2.69855560154067e-11,1,47,496,positive regulation of cell death,BP,ZC3H12A;PLAUR;NFKBID;INHBA;TNF;PPIF;PTGS2;PMAIP1;FOSL1;PLEKHF1;HCAR2;TNFRSF10B;EFNB2;GADD45A;SQSTM1;BMP2;JUN;CDKN1A;CD274;ALDH1A3;B4GALT1;DUSP1;BCL10;DCUN1D3;G0S2;CYLD;ADAM8;SMAD3;BBC3;CREB1;F3;SLC9A1;PLAGL2;RIPK2;TP53BP2;PML;ARHGEF3;RHOB;SOX4;SKIL;ADM;WNT5A;TNFRSF10A;CTSC;YWHAH;YWHAG;SFN
12905,GO:0051248,2.72019266298783e-11,1,67,885,negative regulation of protein metabolic process,BP,TNFAIP3;IL1B;ZC3H12A;PLAUR;BTG2;BIRC3;HBEGF;INHBA;TNF;SERPINB2;PTGS2;TNIP1;NFKB1;EFNA1;EDN1;ERRFI1;CPEB2;TNFRSF10B;GADD45A;LIF;TRIB1;JUN;BIRC2;CDKN1A;BCL3;ZFP36L1;ENC1;DUSP16;PPP1R15A;N4BP1;CDKN2B;DUSP8;TFPI2;DUSP1;PPP1R10;LDLR;SMAD3;RC3H1;DUSP10;SERPINB8;SERPINB1;SOCS3;BDKRB1;ZFP36;CD55;AZIN1;PPP1R15B;ITGAV;NRG1;ZNF451;PML;NCOA7;SOX4;CDK6;SAMD4A;PTPN1;CORO1C;QKI;CELF1;NUP153;PDPK1;TNFRSF10A;RELA;YWHAG;SFN;ITM2B;SH3RF2
8364,GO:0033256,2.87960925218867e-11,1,7,7,I-kappaB/NF-kappaB complex,CC,NFKBIA;REL;NFKB1;NFKB2;RELB;BCL3;RELA
380,GO:0001012,3.07463529157829e-11,1,45,435,RNA polymerase II regulatory region DNA binding,MF,ELF3;ETS1;REL;KLF6;BHLHE40;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;KDM6B;KLF7;EHF;RELB;GADD45A;JUN;JUNB;OVOL1;ETS2;IRF1;CEBPB;ARNTL2;RUNX1;DLX2;KLF3;ZNF217;SMAD3;CREB1;PPARD;POU2F2;ELK3;MXD1;FOSL2;HIVEP1;KLF10;SKIL;TFE3;MAFG;MTF1;KDM6A;NFE2L2;RELA;BACH1;ELF4;FUBP3
3906,GO:0008544,3.17220448634173e-11,1,33,269,epidermis development,BP,INHBA;ELF3;TNF;SPRR2D;IRF6;ERRFI1;SPRR2A;EPHA2;MAFF;OVOL1;ZFP36L1;UGCG;RUNX1;NAB1;TRIM16;EREG;PPARD;KRT34;KRTAP2-3;ZFP36;CYP27B1;JAG1;PIP5K1A;SOX9;FERMT1;FOSL2;MAFG;WNT5A;ADAM9;LCE1C;RELA;SFN;LAMB3
7675,GO:0032103,3.7410300897999e-11,1,25,161,positive regulation of response to external stimulus,BP,NFKBIA;CXCL2;IL1B;CXCL1;CXCL3;TICAM1;ETS1;TNF;CXCL8;PTGS2;TNIP1;EDN1;CXCL5;IL6ST;ADAM8;LDLR;VEGFC;SMAD3;IL23A;F3;IL16;CYP27B1;RIPK2;OSMR;WNT5A
10301,GO:0043065,3.91887675271748e-11,1,45,467,positive regulation of apoptotic process,BP,ZC3H12A;PLAUR;NFKBID;INHBA;TNF;PPIF;PTGS2;PMAIP1;FOSL1;PLEKHF1;HCAR2;TNFRSF10B;GADD45A;SQSTM1;BMP2;JUN;CD274;ALDH1A3;B4GALT1;DUSP1;BCL10;DCUN1D3;G0S2;CYLD;ADAM8;SMAD3;BBC3;CREB1;F3;SLC9A1;PLAGL2;RIPK2;TP53BP2;PML;ARHGEF3;RHOB;SOX4;SKIL;ADM;WNT5A;TNFRSF10A;CTSC;YWHAH;YWHAG;SFN
709,GO:0001932,4.43085864780733e-11,1,71,938,regulation of protein phosphorylation,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;HBEGF;CSF2;INHBA;SDC4;TNF;CCL20;PTGS2;TNIP1;EFNA1;TGFA;EDN1;SEMA7A;ERRFI1;IRAK2;TNFRSF10B;EPHA2;GADD45A;LIF;TRIB1;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;CDKN1A;ADRB2;DUSP16;CDKN2B;EREG;DUSP8;DUSP1;IL6ST;ADAM8;VEGFC;OXSR1;IL23A;DUSP10;ITGA5;STK40;SOCS3;BDKRB1;RIPK2;SAA1;PPP1R15B;ITGAV;SOX9;NRG1;PML;PTPN11;MAP3K8;SPAG9;TRAF4;AREG;CCNL1;CDK6;PTPN1;CORO1C;WNT5A;ADAM9;PDPK1;TNFRSF10A;YWHAG;SFN;ERN1
9955,GO:0042325,4.67538386164174e-11,1,76,1039,regulation of phosphorylation,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;HBEGF;CSF2;INHBA;SDC4;TNF;PPIF;CCL20;PTGS2;TNIP1;EFNA1;TGFA;EDN1;SEMA7A;ERRFI1;IRAK2;TNFRSF10B;EPHA2;GADD45A;LIF;TRIB1;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;CDKN1A;ADRB2;DUSP16;CDKN2B;EREG;ANKLE2;DUSP8;DUSP1;BCL10;IL6ST;ADAM8;VEGFC;OXSR1;IL23A;DUSP10;ITGA5;STK40;SOCS3;BDKRB1;RIPK2;SAA1;PPP1R15B;ITGAV;SOX9;NRG1;PML;PTPN11;MAP3K8;SPAG9;TRAF4;AREG;CCNL1;CDK6;PTPN1;CORO1C;WNT5A;NUP153;ADAM9;PDPK1;TNFRSF10A;YWHAG;SFN;ERN1;ATXN7
11787,GO:0046649,5.20980109859723e-11,1,41,392,lymphocyte activation,BP,TNFAIP3;IL1B;NFKBID;INHBA;TICAM1;SDC4;KLF6;PRDM1;EFNB2;RELB;CD83;CDKN1A;CD274;BCL3;IRF1;ZFP36L1;CEBPB;RUNX1;PELI1;BCL10;IL6ST;CYLD;ADAM8;SMAD3;RC3H1;IL23A;DUSP10;TFRC;EFNB1;CD55;RIPK2;NRARP;POU2F2;PTPN11;MAP3K8;SOX4;HDAC9;IL7R;HLA-E;PDPK1;ELF4
15763,GO:0072359,5.38768979638927e-11,1,59,681,circulatory system development,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;ETS1;CXCL8;PTGS2;PRDM1;FOSL1;TBX3;EFNA1;KDM6B;EDN1;ERRFI1;EFNB2;EPHA2;LIF;BMP2;JUN;JUNB;ZFP36L1;RUNX1;EREG;B4GALT1;ADAM8;VEGFC;SMAD3;PLK2;PIM1;ITGA5;CREB1;F3;PPARD;SOCS3;SLC9A1;JAG1;AMOTL2;ITGAV;NRARP;SOX9;NRG1;PML;ELK3;PTPN11;RHOB;SOX4;OXCT1;HDAC9;ADAMTS1;TMEM65;ADM;QKI;WNT5A;PDPK1;ADAMTS9;KDM6A;NFE2L2;SAT1;PDLIM5
11285,GO:0045596,5.80136789738795e-11,1,43,422,negative regulation of cell differentiation,BP,NFKBIA;NFKBID;INHBA;TNF;TBX3;NOCT;EFNA1;SEMA7A;EFNB2;TRIB1;KCTD11;BMP2;TJP2;IRF1;ZFP36L1;EREG;DLX2;CYLD;LDLR;TACSTD2;SMAD3;RC3H1;DUSP10;PLK2;PPARD;CCDC85B;ZFP36;JAG1;ITGAV;NRARP;SOX9;NRG1;ABCA5;AREG;SKIL;CDK6;CORO1C;PRPF19;TOB2;WNT5A;INSIG1;NFE2L2;YWHAH
15236,GO:0071396,5.95393892786983e-11,1,41,387,cellular response to lipid,BP,NFKBIA;TNFAIP3;IL1B;ZC3H12A;CSF2;INHBA;TICAM1;TNF;CXCL8;CCL20;TNIP1;NFKB1;PRDM1;EDN1;ERRFI1;IRAK2;CLDN1;TRIB1;IL24;CD274;ZFP36L1;CEBPB;RUNX1;HMGCS1;LDLR;PIM1;CREB1;GJB3;PPARD;ZFP36;CYP27B1;CD55;RIPK2;SOX9;NFKBIB;ABL2;WNT5A;INSIG1;ADAM9;YWHAH;RELA
2872,GO:0006366,6.23202675715275e-11,1,108,1760,transcription by RNA polymerase II,BP,NFKBIA;NFKBIZ;IL1B;IL1A;ZC3H12A;BTG2;NFKBID;INHBA;ELF3;ETS1;TNF;REL;KLF6;BHLHE40;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;KLF7;CREB5;EHF;RELB;MAFF;LIF;SQSTM1;BMP2;ZNF267;JUN;CDKN1A;RGMB;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ADRB2;CEBPB;ARNTL2;RUNX1;CDKN2B;ELMSAN1;SOD2;NABP1;DLX2;VGLL3;KLF3;ZNF217;NEDD4L;SMAD3;IL23A;PLK3;CREB1;HIVEP2;PPARD;ZFP36;SLC9A1;MAFK;ELL2;JAG1;PLAGL2;RIPK2;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;FOXN2;UHRF1;MXD1;SOX4;FOSL2;CCNL1;FAM83G;HDAC9;HIVEP1;KLF10;SKIL;IER5;TFE3;MAFG;MTF1;WNT5A;INSIG1;NFE2L2;TSC22D2;RELA;BACH1;TDG;ELF4;CREG1;ATXN7;BRD2;FUBP3
6073,GO:0019220,6.53997244868457e-11,1,83,1192,regulation of phosphate metabolic process,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;HBEGF;CSF2;INHBA;SDC4;TNF;PPIF;CCL20;PTGS2;TNIP1;PLEKHF1;EFNA1;TGFA;EDN1;SEMA7A;ERRFI1;IRAK2;TNFRSF10B;EPHA2;GADD45A;LIF;TRIB1;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;CDKN1A;ADRB2;DUSP16;PPP1R15A;CDKN2B;EREG;ANKLE2;DUSP8;DUSP1;BCL10;PPP1R10;IL6ST;ADAM8;LDLR;VEGFC;OXSR1;SMAD3;IL23A;DUSP10;ITGA5;STK40;SOCS3;BDKRB1;RIPK2;SAA1;PPP1R15B;ITGAV;SOX9;NRG1;PML;PTPN11;MAP3K8;SPAG9;TRAF4;AREG;CCNL1;CDK6;PTPN1;CORO1C;ADM;WNT5A;NUP153;ADAM9;PDPK1;TNFRSF10A;YWHAG;SFN;ERN1;SH3RF2;ATXN7
12778,GO:0051050,9.09193452559968e-11,1,53,608,positive regulation of transport,BP,NFKBIA;IL1B;IL1A;ZC3H12A;INHBA;SDC4;TNF;PTGS2;PMAIP1;TRPV3;EDN1;PANX1;HCAR2;CD274;ADRB2;UGCG;TRIM16;EHD1;ADAM8;LDLR;VEGFC;NEDD4L;BBC3;PLK3;LIPG;CREB1;PPARD;USP36;BDKRB1;SLC9A1;AZIN1;PLAGL2;RIPK2;SAA1;ITGAV;TP53BP2;STX1A;NRG1;FERMT1;PTPN11;SOX4;OXCT1;HLA-E;WNT5A;ADAM9;PDPK1;NFE2L2;YWHAH;SGK1;YWHAG;SFN;IFIH1;SMPD3
4341,GO:0009892,9.76016800224657e-11,1,121,2160,negative regulation of metabolic process,BP,TNFAIP3;IL1B;ZC3H12A;PLAUR;BTG2;BIRC3;HBEGF;CSF2;INHBA;ELF3;TNF;REL;SERPINB2;PPIF;BHLHE40;PTGS2;TNIP1;NFKB1;PRDM1;TBX3;NFKB2;NOCT;PLEKHF1;EFNA1;EDN1;ERRFI1;CPEB2;HCAR2;TNFRSF10B;RELB;GADD45A;LIF;TRIB1;SQSTM1;BMP2;JUN;BIRC2;CDKN1A;JUNB;BCL3;OVOL1;ETS2;IRF1;ZFP36L1;ENC1;CEBPB;DUSP16;PPP1R15A;N4BP1;CDKN2B;NAB1;EREG;ANKLE2;DUSP8;TFPI2;DUSP1;PPP1R10;DLX2;LDLR;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;DUSP10;PLK3;CREB1;SERPINB8;PPARD;SERPINB1;SOCS3;CCDC85B;BDKRB1;ZFP36;MAFK;CYP27B1;CD55;PNRC1;AZIN1;PPP1R15B;ITGAV;NRARP;SOX9;NRG1;ZNF451;PML;FERMT1;NCOA7;ELK3;UHRF1;MXD1;SOX4;HDAC9;HIVEP1;KLF10;SKIL;CDK6;SAMD4A;PTPN1;CORO1C;TOB2;QKI;CELF1;WNT5A;NUP153;INSIG1;PDPK1;TNFRSF10A;ZBTB21;RELA;BACH1;BTAF1;YWHAG;TDG;CREG1;SFN;ITM2B;ERN1;SH3RF2;ATXN7;PABPC4
12277,GO:0048585,1.06129337871207e-10,1,77,1099,negative regulation of response to stimulus,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;HBEGF;PLAU;NFKBID;CSF2;TICAM1;ETS1;TNF;CXCL8;SERPINB2;PPIF;PTGS2;TNIP1;NFKB1;PRDM1;EFNA1;EDN1;SEMA7A;ERRFI1;IL1RN;TNFRSF10B;EPHA2;LIF;TRIB1;KCTD11;BMP2;PHLDB2;BCL3;BCL2L2;ADRB2;DUSP16;PPP1R15A;EREG;SOD2;DUSP8;DUSP1;PPP1R10;PIM3;DLX2;CYLD;SMAD3;RC3H1;DUSP10;PLK2;PPARD;SOCS3;CD55;SAA1;PPP1R15B;ITGAV;NRARP;SOX9;NRG1;ZNF451;RASA2;FERMT1;NCOA7;PTPN11;TNFAIP1;SKIL;IL7R;CDK6;PTPN1;ADM;HLA-E;WNT5A;INSIG1;PDPK1;TNFRSF10A;NFE2L2;RELA;ATXN7
711,GO:0001934,1.11924623998167e-10,1,54,621,positive regulation of protein phosphorylation,BP,IL1B;IL1A;ZC3H12A;PLAUR;HBEGF;CSF2;INHBA;SDC4;TNF;CCL20;PTGS2;EFNA1;TGFA;EDN1;SEMA7A;IRAK2;TNFRSF10B;EPHA2;GADD45A;LIF;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;CDKN1A;ADRB2;EREG;IL6ST;ADAM8;VEGFC;OXSR1;IL23A;ITGA5;SOCS3;RIPK2;SAA1;ITGAV;SOX9;NRG1;PTPN11;MAP3K8;SPAG9;TRAF4;AREG;CCNL1;PTPN1;WNT5A;ADAM9;PDPK1;TNFRSF10A;ERN1
12859,GO:0051174,1.14769093074485e-10,1,83,1205,regulation of phosphorus metabolic process,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;HBEGF;CSF2;INHBA;SDC4;TNF;PPIF;CCL20;PTGS2;TNIP1;PLEKHF1;EFNA1;TGFA;EDN1;SEMA7A;ERRFI1;IRAK2;TNFRSF10B;EPHA2;GADD45A;LIF;TRIB1;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;CDKN1A;ADRB2;DUSP16;PPP1R15A;CDKN2B;EREG;ANKLE2;DUSP8;DUSP1;BCL10;PPP1R10;IL6ST;ADAM8;LDLR;VEGFC;OXSR1;SMAD3;IL23A;DUSP10;ITGA5;STK40;SOCS3;BDKRB1;RIPK2;SAA1;PPP1R15B;ITGAV;SOX9;NRG1;PML;PTPN11;MAP3K8;SPAG9;TRAF4;AREG;CCNL1;CDK6;PTPN1;CORO1C;ADM;WNT5A;NUP153;ADAM9;PDPK1;TNFRSF10A;YWHAG;SFN;ERN1;SH3RF2;ATXN7
20271,GO:2001233,1.17725967422666e-10,1,34,308,regulation of apoptotic signaling pathway,BP,TNFAIP3;IL1B;IL1A;PLAUR;CSF2;INHBA;TNF;PPIF;PTGS2;PMAIP1;PLEKHF1;TNFRSF10B;BCL2L2;SOD2;BCL10;TRAF1;G0S2;CYLD;SMAD3;BBC3;PLAGL2;ITGAV;TP53BP2;PML;FEM1B;SKIL;PTPN1;TNFRSF10A;CTSC;NFE2L2;YWHAH;RELA;YWHAG;SFN
10766,GO:0044212,1.22230794542829e-10,1,54,607,transcription regulatory region DNA binding,MF,ELF3;ETS1;TNF;REL;KLF6;BHLHE40;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;KDM6B;IRF6;KLF7;EHF;RELB;GADD45A;JUN;JUNB;OVOL1;ETS2;IRF1;CEBPB;ARNTL2;RUNX1;ELMSAN1;DLX2;KLF3;ZNF217;SMAD3;CREB1;HIVEP2;PPARD;MAFK;SOX9;POU2F2;ELK3;UHRF1;MXD1;SOX4;FOSL2;HIVEP1;KLF10;SKIL;TFE3;MAFG;MTF1;WNT5A;KDM6A;NFE2L2;RELA;BACH1;ELF4;FUBP3
396,GO:0001067,1.31041711080604e-10,1,54,608,regulatory region nucleic acid binding,MF,ELF3;ETS1;TNF;REL;KLF6;BHLHE40;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;KDM6B;IRF6;KLF7;EHF;RELB;GADD45A;JUN;JUNB;OVOL1;ETS2;IRF1;CEBPB;ARNTL2;RUNX1;ELMSAN1;DLX2;KLF3;ZNF217;SMAD3;CREB1;HIVEP2;PPARD;MAFK;SOX9;POU2F2;ELK3;UHRF1;MXD1;SOX4;FOSL2;HIVEP1;KLF10;SKIL;TFE3;MAFG;MTF1;WNT5A;KDM6A;NFE2L2;RELA;BACH1;ELF4;FUBP3
2940,GO:0006468,1.35186479515433e-10,1,88,1319,protein phosphorylation,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;HBEGF;CSF2;INHBA;SDC4;TNF;NUAK2;CCL20;PTGS2;TNIP1;NFKB1;EFNA1;TGFA;EDN1;SEMA7A;ERRFI1;IRAK2;TNFRSF10B;EPHA2;GADD45A;LIF;TRIB1;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;CDKN1A;ZFP36L1;ADRB2;DUSP16;MAST4;CDKN2B;EREG;PELI1;DUSP8;DUSP1;PIM3;IL6ST;ADAM8;VEGFC;OXSR1;IL23A;DUSP10;PLK2;PLK3;PIM1;ITGA5;CREB1;STK40;SOCS3;BDKRB1;ZFP36;RIPK2;PHKG2;SAA1;PPP1R15B;ITGAV;CLK4;SOX9;NRG1;PML;RASA2;PTPN11;MAP3K8;SPAG9;TRAF4;AREG;CCNL1;CDK6;PTPN1;CORO1C;ABL2;WNT5A;ADAM9;PDPK1;TNFRSF10A;SGK1;ANKK1;YWHAG;SFN;ERN1
366,GO:0000987,1.45893671844256e-10,1,35,295,proximal promoter sequence-specific DNA binding,MF,ELF3;ETS1;KLF6;BHLHE40;PRDM1;FOSL1;TBX3;NFKB2;KDM6B;KLF7;EHF;JUN;JUNB;OVOL1;ETS2;IRF1;CEBPB;ARNTL2;ZNF217;SMAD3;CREB1;POU2F2;ELK3;UHRF1;MXD1;FOSL2;KLF10;SKIL;TFE3;MAFG;MTF1;KDM6A;RELA;ELF4;FUBP3
12532,GO:0050673,1.52001626279952e-10,1,32,258,epithelial cell proliferation,BP,TNFAIP3;TNF;TGFA;IRF6;ERRFI1;EHF;EFNB2;EPHA2;BMP2;JUN;BCL2L2;ZFP36L1;CEBPB;CDKN2B;EREG;B4GALT1;VEGFC;TACSTD2;SMAD3;DUSP10;F3;PPARD;ZFP36;NRARP;SOX9;FERMT1;AREG;CDK6;WNT5A;PDPK1;SFN;ERN1
7338,GO:0031347,1.62572993760104e-10,1,43,454,regulation of defense response,BP,NFKBIA;TNFAIP3;IL1B;ZC3H12A;BIRC3;TICAM1;ETS1;TNF;PTGS2;TNIP1;NFKB1;SEMA7A;IRAK2;RELB;IFNGR2;BIRC2;IRF1;EREG;PELI1;BCL10;IL6ST;CYLD;ADAM8;LDLR;SMAD3;IL23A;DUSP10;PPARD;SOCS3;CD55;IFNAR2;RIPK2;SAA1;SLC7A2;PTPN11;PTPN1;HLA-E;OSMR;WNT5A;PDPK1;RELA;POLR3D;IFIH1
11086,GO:0045087,1.71577644161594e-10,1,48,555,innate immune response,BP,NFKBIA;TNFAIP3;IL36G;BIRC3;TICAM1;REL;CCL20;TNIP1;NFKB1;PRDM1;NFKB2;IRF6;EDN1;IRAK2;CLDN1;RELB;IFNGR2;BIRC2;IRF1;EREG;PELI1;BCL10;CYLD;ADAM8;IL23A;DUSP10;SOCS3;RAET1L;CYP27B1;CD55;IFNAR2;RIPK2;SAA1;PML;POLR3A;PTPN11;GCH1;PTPN1;ABL2;HLA-E;WNT5A;PDPK1;RELA;POLR3D;ELF4;ISG20;IFIH1;CXCL16
4535,GO:0010605,1.76273009776096e-10,1,114,2011,negative regulation of macromolecule metabolic process,BP,TNFAIP3;IL1B;ZC3H12A;PLAUR;BTG2;BIRC3;HBEGF;CSF2;INHBA;ELF3;TNF;REL;SERPINB2;BHLHE40;PTGS2;TNIP1;NFKB1;PRDM1;TBX3;NFKB2;NOCT;EFNA1;EDN1;ERRFI1;CPEB2;TNFRSF10B;RELB;GADD45A;LIF;TRIB1;SQSTM1;BMP2;JUN;BIRC2;CDKN1A;JUNB;BCL3;OVOL1;ETS2;IRF1;ZFP36L1;ENC1;CEBPB;DUSP16;PPP1R15A;N4BP1;CDKN2B;NAB1;EREG;DUSP8;TFPI2;DUSP1;PPP1R10;DLX2;LDLR;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;DUSP10;PLK3;CREB1;SERPINB8;PPARD;SERPINB1;SOCS3;CCDC85B;BDKRB1;ZFP36;MAFK;CD55;PNRC1;AZIN1;PPP1R15B;ITGAV;NRARP;SOX9;NRG1;ZNF451;PML;FERMT1;NCOA7;ELK3;UHRF1;MXD1;SOX4;HDAC9;HIVEP1;KLF10;SKIL;CDK6;SAMD4A;PTPN1;CORO1C;TOB2;QKI;CELF1;WNT5A;NUP153;PDPK1;TNFRSF10A;ZBTB21;RELA;BACH1;BTAF1;YWHAG;TDG;CREG1;SFN;ITM2B;ERN1;SH3RF2;PABPC4
9834,GO:0042060,2.01362475328726e-10,1,37,344,wound healing,BP,TNFAIP3;IL1A;PLAUR;HBEGF;PLAU;SDC4;ETS1;SERPINB2;CCL20;EDN1;MAFF;IL24;RAP2B;PHLDB2;IRF1;EREG;EHD1;B4GALT1;TFPI2;SMAD3;DUSP10;ITGA5;F3;PPARD;MAFK;SAA1;NRG1;ELK3;PTPN11;DCBLD2;RHOB;VCL;MAFG;WNT5A;PDPK1;NFE2L2;PABPC4
19647,GO:1990837,2.26968870366343e-10,1,49,528,sequence-specific double-stranded DNA binding,MF,ELF3;ETS1;REL;KLF6;BHLHE40;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;KDM6B;KLF7;EHF;RELB;GADD45A;JUN;JUNB;OVOL1;ETS2;IRF1;CEBPB;ARNTL2;RUNX1;DLX2;KLF3;ZNF217;SMAD3;CREB1;PPARD;MAFK;SOX9;POU2F2;ELK3;UHRF1;MXD1;SOX4;FOSL2;HIVEP1;KLF10;SKIL;TFE3;MAFG;MTF1;KDM6A;NFE2L2;RELA;BACH1;ELF4;FUBP3
363,GO:0000981,2.34313443272912e-10,1,59,713,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,BTG2;ELF3;ETS1;REL;KLF6;BHLHE40;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;IRF6;KLF7;CREB5;EHF;RELB;MAFF;ZNF267;JUN;JUNB;OVOL1;CSRNP1;ETS2;IRF1;TAF4B;ZFP36L1;CEBPB;ARNTL2;RUNX1;ELMSAN1;DLX2;VGLL3;ZNF217;SMAD3;CREB1;HIVEP2;PPARD;MAFK;PLAGL2;SOX9;ZNF451;POU2F2;ELK3;FOXN2;MXD1;SOX4;FOSL2;HIVEP1;KLF10;SKIL;TFE3;MAFG;MTF1;NFE2L2;TSC22D2;RELA;BACH1;ELF4;FUBP3
4266,GO:0009611,2.5529347261304e-10,1,41,417,response to wounding,BP,TNFAIP3;IL1A;PLAUR;HBEGF;PLAU;SDC4;ETS1;SERPINB2;CCL20;EDN1;MAFF;IL24;JUN;RAP2B;PHLDB2;IRF1;ZFP36L1;EREG;EHD1;B4GALT1;TFPI2;SMAD3;DUSP10;ITGA5;F3;PPARD;ZFP36;MAFK;SAA1;NRG1;ELK3;PTPN11;DCBLD2;RHOB;VCL;ADM;MAFG;WNT5A;PDPK1;NFE2L2;PABPC4
360,GO:0000978,2.87015932178498e-10,1,34,288,RNA polymerase II proximal promoter sequence-specific DNA binding,MF,ELF3;ETS1;KLF6;BHLHE40;PRDM1;FOSL1;TBX3;NFKB2;KDM6B;KLF7;EHF;JUN;JUNB;OVOL1;ETS2;IRF1;CEBPB;ARNTL2;ZNF217;SMAD3;CREB1;POU2F2;ELK3;MXD1;FOSL2;KLF10;SKIL;TFE3;MAFG;MTF1;KDM6A;RELA;ELF4;FUBP3
9957,GO:0042327,3.06375171288485e-10,1,55,655,positive regulation of phosphorylation,BP,IL1B;IL1A;ZC3H12A;PLAUR;HBEGF;CSF2;INHBA;SDC4;TNF;CCL20;PTGS2;EFNA1;TGFA;EDN1;SEMA7A;IRAK2;TNFRSF10B;EPHA2;GADD45A;LIF;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;CDKN1A;ADRB2;EREG;BCL10;IL6ST;ADAM8;VEGFC;OXSR1;IL23A;ITGA5;SOCS3;RIPK2;SAA1;ITGAV;SOX9;NRG1;PTPN11;MAP3K8;SPAG9;TRAF4;AREG;CCNL1;PTPN1;WNT5A;ADAM9;PDPK1;TNFRSF10A;ERN1
1096,GO:0002683,3.27275746053767e-10,1,31,266,negative regulation of immune system process,BP,NFKBIA;TNFAIP3;ZC3H12A;NFKBID;INHBA;TICAM1;SDC4;TNF;PRDM1;TRIB1;TJP2;CD274;IRF1;ZFP36L1;CEBPB;PELI1;BCL10;CYLD;LDLR;RC3H1;DUSP10;ZFP36;CD55;NRARP;SOX9;IL7R;CDK6;TOB2;HLA-E;PDPK1;NFE2L2
18067,GO:1902624,3.72087165422949e-10,0.999999999990811,9,18,positive regulation of neutrophil migration,BP,CXCL2;IL1A;CXCL1;CXCL3;CXCL8;EDN1;CXCL5;ADAM8;IL23A
15762,GO:0072358,3.75901371120103e-10,1,45,463,cardiovascular system development,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;ETS1;CXCL8;PTGS2;PRDM1;FOSL1;TBX3;EFNA1;EDN1;ERRFI1;EFNB2;EPHA2;LIF;JUN;JUNB;ZFP36L1;RUNX1;EREG;B4GALT1;ADAM8;VEGFC;PLK2;ITGA5;F3;SOCS3;JAG1;AMOTL2;ITGAV;NRARP;PML;ELK3;RHOB;SOX4;HDAC9;ADM;QKI;WNT5A;PDPK1;ADAMTS9;KDM6A;NFE2L2;SAT1
18236,GO:1903039,4.5618448473123e-10,0.999999999940398,21,123,positive regulation of leukocyte cell-cell adhesion,BP,IL1B;ETS1;TNF;EFNB2;CD83;CD274;BCL10;IL6ST;CYLD;ADAM8;IL23A;DUSP10;TFRC;EFNB1;CD55;RIPK2;PTPN11;MAP3K8;IL7R;HLA-E;PDPK1
4272,GO:0009628,4.83072687592758e-10,1,64,869,response to abiotic stimulus,BP,NFKBIA;IL1B;IL1A;BTG2;PLAU;ETS1;TNF;BHLHE40;PTGS2;PMAIP1;NFKB1;FOSL1;TRPV3;EDN1;ERRFI1;CLDN1;CPEB2;TNFRSF10B;RELB;GADD45A;BMP2;CAB39;JUN;BIRC2;CDKN1A;JUNB;BCL3;IRF1;ZFP36L1;ADRB2;N4BP1;HMGCS1;DUSP1;BCL10;DCUN1D3;NABP1;ADAM8;VEGFC;OXSR1;SMAD3;PLK3;CREB1;PPARD;BDKRB1;SLC9A1;USP53;NDRG1;SOX9;STX1A;PML;PTPN11;RHOB;AEN;IER5;ADM;NUP153;PDPK1;TNFRSF10A;ERO1A;NFE2L2;TSC22D2;RELA;BACH1;AHCY
3439,GO:0007249,7.34718550842419e-10,1,27,207,I-kappaB kinase/NF-kappaB signaling,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;BIRC3;NFKBID;TICAM1;TNF;REL;TNIP1;NFKB1;NFKB2;IRAK2;TNFRSF10B;RELB;SQSTM1;BIRC2;BCL3;PELI1;BCL10;PLK2;RIPK2;TIFA;WNT5A;PDPK1;RELA
9025,GO:0035239,7.6919495258289e-10,1,49,541,tube morphogenesis,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;SDC4;ETS1;TNF;CXCL8;PTGS2;PRDM1;TBX3;EFNA1;EDN1;EFNB2;EPHA2;BMP2;JUN;JUNB;ZFP36L1;RUNX1;EREG;B4GALT1;BCL10;ADAM8;VEGFC;TACSTD2;SMAD3;PLK2;ITGA5;F3;JAG1;AMOTL2;ITGAV;NRARP;SOX9;PML;ELK3;RHOB;SOX4;AREG;HDAC9;ADM;QKI;WNT5A;PDPK1;ADAMTS9;KDM6A;NFE2L2;SAT1
720,GO:0001944,8.18567964640148e-10,1,44,457,vasculature development,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;ETS1;CXCL8;PTGS2;PRDM1;FOSL1;TBX3;EFNA1;EDN1;ERRFI1;EFNB2;EPHA2;LIF;JUN;JUNB;ZFP36L1;RUNX1;EREG;B4GALT1;ADAM8;VEGFC;PLK2;ITGA5;F3;SOCS3;JAG1;AMOTL2;ITGAV;NRARP;PML;ELK3;RHOB;SOX4;HDAC9;ADM;QKI;WNT5A;PDPK1;ADAMTS9;NFE2L2;SAT1
9062,GO:0035295,9.76872471550798e-10,1,55,656,tube development,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;SDC4;ETS1;TNF;CXCL8;PTGS2;PRDM1;TBX3;EFNA1;EDN1;ERRFI1;EFNB2;EPHA2;LIF;BMP2;JUN;CDKN1A;JUNB;ZFP36L1;RUNX1;EREG;B4GALT1;BCL10;ADAM8;VEGFC;TACSTD2;SMAD3;PLK2;ITGA5;CREB1;F3;STK40;JAG1;AMOTL2;ITGAV;NRARP;SOX9;PML;ELK3;RHOB;SOX4;TRAF4;AREG;HDAC9;ADM;QKI;WNT5A;PDPK1;ADAMTS9;KDM6A;NFE2L2;SAT1
10609,GO:0043588,9.78042940695991e-10,1,29,239,skin development,BP,INHBA;TNF;SPRR2D;IRF6;ERRFI1;CLDN1;SPRR2A;EPHA2;CLDN4;OVOL1;ZFP36L1;RUNX1;TRIM16;EREG;GJB3;KRT34;KRTAP2-3;ZFP36;CYP27B1;JAG1;PIP5K1A;SOX9;FERMT1;FOSL2;WNT5A;ADAM9;LCE1C;RELA;SFN
548,GO:0001667,1.01145273617745e-09,1,32,272,ameboidal-type cell migration,BP,ZC3H12A;HBEGF;SDC4;ETS1;PTGS2;EFNA1;EDN1;SEMA7A;EFNB2;EPHA2;MAP2K3;JUN;VEGFC;TACSTD2;DUSP10;PLK2;EFNB1;PPARD;AMOTL2;PIP5K1A;SOX9;PML;FERMT1;PTPN11;RHOB;HDAC9;CORO1C;WNT5A;ADAM9;PDPK1;ADAMTS9;NFE2L2
12241,GO:0048514,1.10361876736272e-09,1,39,378,blood vessel morphogenesis,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;ETS1;CXCL8;PTGS2;PRDM1;EFNA1;EDN1;EFNB2;EPHA2;JUN;JUNB;ZFP36L1;RUNX1;EREG;B4GALT1;ADAM8;VEGFC;PLK2;ITGA5;F3;JAG1;AMOTL2;ITGAV;NRARP;PML;ELK3;RHOB;SOX4;HDAC9;ADM;QKI;WNT5A;PDPK1;ADAMTS9;NFE2L2;SAT1
5445,GO:0016310,1.5512025195114e-09,1,98,1644,phosphorylation,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;HBEGF;CSF2;ITPKC;INHBA;SDC4;TNF;PPIF;NUAK2;CCL20;PTGS2;TNIP1;NFKB1;EFNA1;TGFA;EDN1;SEMA7A;ERRFI1;IRAK2;TNFRSF10B;EPHA2;GADD45A;LIF;TRIB1;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;CDKN1A;ZFP36L1;ADRB2;DUSP16;MAST4;CDKN2B;EREG;PELI1;ANKLE2;DUSP8;DUSP1;BCL10;PIM3;IL6ST;SGMS2;ADAM8;VEGFC;OXSR1;IL23A;DUSP10;PLK2;PLK3;PIM1;ITGA5;CREB1;STK40;SOCS3;BDKRB1;ZFP36;RIPK2;PHKG2;SAA1;PPP1R15B;ITGAV;PIP5K1A;CLK4;SOX9;NRG1;PML;RASA2;PTPN11;MAP3K8;PANK3;SPAG9;TRAF4;AREG;CCNL1;CDK6;PTPN1;CORO1C;ABL2;WNT5A;NUP153;ADAM9;PDPK1;TNFRSF10A;SGK1;ANKK1;YWHAG;SFN;ERN1;ETNK1;ATXN7
12908,GO:0051251,1.57106778779559e-09,0.999999999725641,23,158,positive regulation of lymphocyte activation,BP,IL1B;TICAM1;PRDM1;EFNB2;CD83;CDKN1A;CD274;PELI1;BCL10;IL6ST;CYLD;ADAM8;IL23A;DUSP10;TFRC;EFNB1;CD55;RIPK2;PTPN11;MAP3K8;IL7R;HLA-E;PDPK1
6584,GO:0022409,1.75150816121135e-09,0.999999999707085,22,143,positive regulation of cell-cell adhesion,BP,IL1B;ETS1;TNF;EFNB2;CD83;CD274;BCL10;IL6ST;CYLD;ADAM8;IL23A;DUSP10;TFRC;EFNB1;CD55;RIPK2;PTPN11;MAP3K8;IL7R;HLA-E;WNT5A;PDPK1
6636,GO:0023014,1.7900824782624e-09,1,51,623,signal transduction by protein phosphorylation,BP,IL1B;IL1A;ZC3H12A;HBEGF;CSF2;INHBA;TNF;CCL20;TNIP1;NFKB1;EFNA1;TGFA;EDN1;SEMA7A;ERRFI1;IRAK2;TNFRSF10B;EPHA2;GADD45A;LIF;TRIB1;BMP2;CAB39;MAP2K3;JUN;ZFP36L1;ADRB2;DUSP16;EREG;DUSP8;DUSP1;ADAM8;OXSR1;DUSP10;STK40;ZFP36;RIPK2;SAA1;ITGAV;SOX9;NRG1;RASA2;PTPN11;MAP3K8;SPAG9;TRAF4;PTPN1;WNT5A;ADAM9;TNFRSF10A;ERN1
1109,GO:0002696,2.15120375045412e-09,0.999999999600655,24,174,positive regulation of leukocyte activation,BP,IL1B;TICAM1;PRDM1;EFNB2;CD83;CDKN1A;CD274;PELI1;BCL10;IL6ST;CYLD;ADAM8;IL23A;DUSP10;TFRC;EFNB1;CD55;RIPK2;PTPN11;MAP3K8;IL7R;HLA-E;WNT5A;PDPK1
19498,GO:1990266,2.46599007819452e-09,0.9999999998282,12,43,neutrophil migration,BP,CXCL2;IL1B;IL1A;CXCL1;CXCL3;CXCL8;CCL20;EDN1;CXCL5;ADAM8;IL23A;SAA1
506,GO:0001568,2.4787114391627e-09,1,42,438,blood vessel development,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;ETS1;CXCL8;PTGS2;PRDM1;FOSL1;TBX3;EFNA1;EDN1;EFNB2;EPHA2;JUN;JUNB;ZFP36L1;RUNX1;EREG;B4GALT1;ADAM8;VEGFC;PLK2;ITGA5;F3;SOCS3;JAG1;AMOTL2;ITGAV;NRARP;PML;ELK3;RHOB;SOX4;HDAC9;ADM;QKI;WNT5A;PDPK1;ADAMTS9;NFE2L2;SAT1
12802,GO:0051093,2.5524323879678e-09,1,48,565,negative regulation of developmental process,BP,NFKBIA;NFKBID;INHBA;TNF;TBX3;NOCT;EFNA1;SEMA7A;EFNB2;TRIB1;KCTD11;BMP2;PHLDB2;TJP2;IRF1;ZFP36L1;ADRB2;EREG;DLX2;CYLD;LDLR;TACSTD2;SMAD3;RC3H1;DUSP10;PLK2;PPARD;CCDC85B;ZFP36;JAG1;ITGAV;NRARP;SOX9;NRG1;PML;FERMT1;ABCA5;AREG;SKIL;CDK6;CORO1C;PRPF19;TOB2;WNT5A;INSIG1;ADAMTS9;NFE2L2;YWHAH
10735,GO:0044092,2.78150023636596e-09,1,56,748,negative regulation of molecular function,BP,NFKBIA;TNFAIP3;IL1B;ZC3H12A;PLAUR;BIRC3;NFKBID;TNF;SERPINB2;PPIF;BHLHE40;PTGS2;NFKB1;PLEKHF1;ERRFI1;IRAK2;CPEB2;TNFRSF10B;GADD45A;TRIB1;RRAD;CAB39;JUN;BIRC2;NFKBIE;CDKN1A;ADRB2;DUSP16;PPP1R15A;CDKN2B;PELI1;DUSP8;TFPI2;DUSP1;PPP1R10;CYLD;NEDD4L;OXSR1;DUSP10;PIM1;SERPINB8;SERPINB1;SOCS3;ZFP36;CYP27B1;SPAG9;CDK6;PTPN1;CORO1C;PDPK1;TNFRSF10A;BTAF1;YWHAG;TDG;SFN;SH3RF2
18065,GO:1902622,2.91578311419599e-09,0.999999999901033,9,21,regulation of neutrophil migration,BP,CXCL2;IL1A;CXCL1;CXCL3;CXCL8;EDN1;CXCL5;ADAM8;IL23A
3258,GO:0006928,2.94473810420572e-09,1,83,1267,movement of cell or subcellular component,BP,CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;CXCL3;HBEGF;PLAU;SDC4;ETS1;TNF;CXCL8;CCL20;PTGS2;EFNA1;EDN1;SEMA7A;KLF7;TNFRSF10B;EFNB2;EPHA2;CXCL5;TRIB1;BMP2;PHLDA2;IL24;MAP2K3;JUN;RAP2B;PHLDB2;CD274;RND3;EREG;SOD2;NEDD9;ZSWIM4;B4GALT1;ADAM8;VEGFC;TACSTD2;NEDD4L;SMAD3;IL23A;DUSP10;PLK2;ITGA5;CREB1;EFNB1;F3;PPARD;IL16;BDKRB1;SLC9A1;JAG1;AMOTL2;NAV3;SAA1;ITGAV;PIP5K1A;SOX9;NRG1;PML;FERMT1;PTPN11;RHOB;SPAG9;VCL;TNFAIP1;HDAC9;CDK6;CORO1C;ABL2;WNT5A;ADAM9;PDPK1;TNFRSF10A;ADAMTS9;FRMD6;NFE2L2;SGK1;B3GNT2;MYO1B;CXCL16
4286,GO:0009653,4.27131791452518e-09,1,102,1703,anatomical structure morphogenesis,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;HBEGF;INHBA;ELF3;SDC4;ETS1;TNF;CXCL8;IER3;PTGS2;PRDM1;TBX3;NFKB2;EFNA1;KDM6B;EDN1;SEMA7A;ERRFI1;IL1RN;KLF7;EFNB2;EPHA2;LIF;BMP2;PHLDA2;JUN;PHLDB2;JUNB;BCL3;CSRNP1;ETS2;ZFP36L1;RND3;CEBPB;RUNX1;NAB1;EREG;ALDH1A3;EHD1;ZSWIM4;B4GALT1;DUSP1;BCL10;FGD6;DLX2;TXNRD1;ADAM8;VEGFC;TACSTD2;NEDD4L;SMAD3;RC3H1;PLK2;PIM1;ITGA5;CREB1;EFNB1;F3;STK40;SOCS3;RAPH1;JAG1;AMOTL2;ITGAV;NRARP;SOX9;NRG1;PML;ELK3;CDC42EP1;PTPN11;RHOB;FEM1B;SOX4;VCL;AREG;HDAC9;ADAMTS1;SKIL;IL7R;CORO1C;ADM;QKI;WNT5A;INSIG1;ADAM9;PDPK1;ADAMTS9;KDM6A;FRMD6;NFE2L2;YWHAH;SGK1;B3GNT2;SAT1;RELA;AGFG1;LAMB3;PDLIM5
4267,GO:0009612,4.30017327983054e-09,0.999999999267987,21,133,response to mechanical stimulus,BP,NFKBIA;IL1B;BTG2;ETS1;PTGS2;NFKB1;FOSL1;EDN1;TNFRSF10B;GADD45A;JUN;JUNB;IRF1;BCL10;BDKRB1;SLC9A1;USP53;SOX9;PTPN11;TNFRSF10A;RELA
2213,GO:0005102,4.34554071995277e-09,1,62,879,signaling receptor binding,MF,CXCL2;IL1B;IL1A;CXCL1;PLAUR;CXCL3;IL36G;HBEGF;CSF2;INHBA;TNF;CXCL8;CCL20;EFNA1;TGFA;EDN1;SEMA7A;IL1RN;PANX1;EFNB2;CXCL5;LIF;SQSTM1;BMP2;IL24;ETS2;NAMPT;CEBPB;EREG;TRAF1;IL6ST;VEGFC;SMAD3;IL23A;WISP1;ITGA5;EFNB1;RAET1L;IL16;JAG1;RIPK2;SAA1;ITGAV;NRG1;NCOA7;PTPN11;FEM1B;TRAF4;AREG;PTPN1;TOB2;ADM;ABL2;HLA-E;WNT5A;ADAM9;PDPK1;YWHAH;YWHAG;ERN1;CXCL16;TAP1
1456,GO:0003690,4.58321680599527e-09,1,50,600,double-stranded DNA binding,MF,ELF3;ETS1;REL;KLF6;BHLHE40;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;KDM6B;KLF7;EHF;RELB;GADD45A;JUN;JUNB;OVOL1;ETS2;IRF1;CEBPB;ARNTL2;RUNX1;DLX2;KLF3;ZNF217;SMAD3;CREB1;PPARD;MAFK;SOX9;POU2F2;ELK3;UHRF1;MXD1;SOX4;FOSL2;HIVEP1;KLF10;SKIL;TFE3;MAFG;MTF1;KDM6A;NFE2L2;RELA;BACH1;TDG;ELF4;FUBP3
82,GO:0000165,4.74722836191355e-09,1,49,605,MAPK cascade,BP,IL1B;IL1A;ZC3H12A;HBEGF;CSF2;INHBA;TNF;CCL20;TNIP1;NFKB1;EFNA1;TGFA;EDN1;SEMA7A;ERRFI1;IRAK2;TNFRSF10B;EPHA2;GADD45A;LIF;TRIB1;BMP2;MAP2K3;JUN;ZFP36L1;ADRB2;DUSP16;EREG;DUSP8;DUSP1;ADAM8;DUSP10;STK40;ZFP36;RIPK2;SAA1;ITGAV;SOX9;NRG1;RASA2;PTPN11;MAP3K8;SPAG9;TRAF4;PTPN1;WNT5A;ADAM9;TNFRSF10A;ERN1
12666,GO:0050867,4.91990372424018e-09,0.999999999022592,24,181,positive regulation of cell activation,BP,IL1B;TICAM1;PRDM1;EFNB2;CD83;CDKN1A;CD274;PELI1;BCL10;IL6ST;CYLD;ADAM8;IL23A;DUSP10;TFRC;EFNB1;CD55;RIPK2;PTPN11;MAP3K8;IL7R;HLA-E;WNT5A;PDPK1
401,GO:0001077,5.49461065880564e-09,0.999999998906603,24,170,transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,ELF3;ETS1;KLF6;FOSL1;NFKB2;KLF7;EHF;JUN;JUNB;IRF1;CEBPB;CREB1;PLAGL2;SOX9;POU2F2;ELK3;SOX4;KLF10;TFE3;MAFG;MTF1;RELA;ELF4;FUBP3
6700,GO:0030097,5.51971866286915e-09,1,47,590,hemopoiesis,BP,NFKBIA;NFKBID;CSF2;INHBA;ETS1;TNF;KLF6;PRDM1;EPHA2;RELB;LIF;TRIB1;CD83;JUN;TJP2;JUNB;BCL3;IRF1;ZFP36L1;CEBPB;RUNX1;CDKN2B;CYLD;ADAM8;RC3H1;IL23A;DUSP10;TFRC;CREB1;ZFP36;JAG1;RIPK2;NRARP;PML;POU2F2;PTPN11;SOX4;HDAC9;KLF10;IL7R;CDK6;TFE3;TOB2;WNT5A;NFE2L2;PABPC4;SMPD3
12669,GO:0050870,5.75658268209393e-09,0.999999999109415,19,116,positive regulation of T cell activation,BP,IL1B;EFNB2;CD83;CD274;BCL10;IL6ST;CYLD;ADAM8;IL23A;DUSP10;TFRC;EFNB1;CD55;RIPK2;PTPN11;MAP3K8;IL7R;HLA-E;PDPK1
18527,GO:1903708,5.83172003986028e-09,0.999999999098481,19,114,positive regulation of hemopoiesis,BP,INHBA;ETS1;TNF;PRDM1;LIF;TRIB1;CD83;JUN;ZFP36L1;RUNX1;CYLD;ADAM8;IL23A;DUSP10;CREB1;JAG1;RIPK2;KLF10;IL7R
9858,GO:0042108,5.91912833143323e-09,0.999999999632513,11,33,positive regulation of cytokine biosynthetic process,BP,IL1B;IL1A;TICAM1;TNF;CCL20;BCL3;IRF1;EREG;BCL10;WNT5A;RELA
18525,GO:1903706,6.25762821130655e-09,0.999999998682522,32,330,regulation of hemopoiesis,BP,NFKBIA;NFKBID;CSF2;INHBA;ETS1;TNF;PRDM1;LIF;TRIB1;CD83;JUN;TJP2;IRF1;ZFP36L1;CEBPB;RUNX1;CYLD;ADAM8;RC3H1;IL23A;DUSP10;CREB1;ZFP36;JAG1;RIPK2;NRARP;KLF10;IL7R;CDK6;TFE3;TOB2;NFE2L2
1049,GO:0002573,6.51431979613131e-09,0.999999998923167,20,124,myeloid leukocyte differentiation,BP,CSF2;INHBA;TNF;EPHA2;RELB;LIF;TRIB1;JUN;TJP2;JUNB;ZFP36L1;CEBPB;RUNX1;IL23A;TFRC;CREB1;KLF10;CDK6;TFE3;TOB2
4507,GO:0010556,6.69687977703413e-09,1,160,3253,regulation of macromolecule biosynthetic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;BTG2;HBEGF;NFKBID;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;KLF6;CCL20;ZNF697;BHLHE40;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;HAS3;ERRFI1;IRAK2;KLF7;CREB5;CPEB2;EHF;RELB;MAFF;LIF;TRIB1;SQSTM1;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ENC1;ADRB2;CEBPB;ARNTL2;PPP1R15A;RUNX1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;DUSP1;BCL10;TRAF1;DLX2;VGLL3;CYLD;ADAM8;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;IL23A;PLK3;PIM1;CREB1;HIVEP2;PPARD;CCDC85B;IL16;ZFP36;SLC9A1;MAFK;LARP4B;PNRC1;ELL2;JAG1;PLAGL2;RIPK2;PPP1R15B;ITGAV;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;ZNF460;FOXN2;UHRF1;MXD1;SOX4;FOSL2;EIF1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;RBM3;IER5;SAMD4A;TFE3;TOB2;MAFG;MTF1;QKI;CELF1;WNT5A;NUP153;INSIG1;PDPK1;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;RELA;BACH1;BTAF1;TDG;ELF4;CREG1;ITM2B;ERN1;ATXN7;BRD2;FUBP3;SMPD3
4551,GO:0010631,7.37936277508185e-09,0.999999998653258,26,203,epithelial cell migration,BP,ZC3H12A;HBEGF;ETS1;PTGS2;EFNA1;EDN1;EFNB2;EPHA2;MAP2K3;JUN;VEGFC;TACSTD2;DUSP10;PLK2;PPARD;SOX9;FERMT1;PTPN11;RHOB;HDAC9;CORO1C;WNT5A;ADAM9;PDPK1;ADAMTS9;NFE2L2
4338,GO:0009889,7.60544270293925e-09,1,165,3397,regulation of biosynthetic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;BTG2;HBEGF;NFKBID;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;KLF6;CCL20;ZNF697;BHLHE40;PTGS2;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;HAS3;ERRFI1;IRAK2;KLF7;CREB5;CPEB2;EHF;RELB;MAFF;LIF;TRIB1;SQSTM1;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ENC1;ADRB2;CEBPB;ARNTL2;PPP1R15A;RUNX1;CDKN2B;NAB1;HMGCS1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;DUSP1;BCL10;TRAF1;DLX2;VGLL3;CYLD;ADAM8;LDLR;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;IL23A;PLK3;PIM1;CREB1;HIVEP2;PPARD;CCDC85B;IL16;ZFP36;SLC9A1;MAFK;LARP4B;CYP27B1;PNRC1;ELL2;JAG1;PLAGL2;RIPK2;PPP1R15B;ITGAV;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;ZNF460;FOXN2;UHRF1;MXD1;SOX4;FOSL2;EIF1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;RBM3;IER5;SAMD4A;SQLE;TFE3;TOB2;MAFG;MTF1;QKI;CELF1;WNT5A;NUP153;INSIG1;PDPK1;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;RELA;BACH1;BTAF1;TDG;ELF4;CREG1;ITM2B;ERN1;ATXN7;BRD2;FUBP3;SMPD3
16131,GO:0090132,8.32501481690890e-09,0.999999998472463,26,204,epithelium migration,BP,ZC3H12A;HBEGF;ETS1;PTGS2;EFNA1;EDN1;EFNB2;EPHA2;MAP2K3;JUN;VEGFC;TACSTD2;DUSP10;PLK2;PPARD;SOX9;FERMT1;PTPN11;RHOB;HDAC9;CORO1C;WNT5A;ADAM9;PDPK1;ADAMTS9;NFE2L2
480,GO:0001525,8.35702298239959e-09,0.999999998163792,34,322,angiogenesis,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;ETS1;CXCL8;PTGS2;EFNA1;EDN1;EFNB2;EPHA2;JUN;RUNX1;EREG;B4GALT1;ADAM8;VEGFC;PLK2;ITGA5;F3;JAG1;AMOTL2;ITGAV;NRARP;PML;ELK3;RHOB;HDAC9;ADM;WNT5A;PDPK1;ADAMTS9;NFE2L2;SAT1
8828,GO:0034612,9.05192134765778e-09,0.999999998107525,25,216,response to tumor necrosis factor,BP,NFKBIA;TNFAIP3;ZC3H12A;BIRC3;TNF;CXCL8;CCL20;PTGS2;NFKB1;EDN1;CLDN1;TNFRSF10B;BIRC2;TJP2;ZFP36L1;RELT;TRAF1;CYLD;ZFP36;GCH1;ADAM9;TNFRSF10A;NFE2L2;RELA;CXCL16
1022,GO:0002520,9.24121870362191e-09,1,50,656,immune system development,BP,NFKBIA;TNFAIP3;NFKBID;CSF2;INHBA;ETS1;TNF;KLF6;PRDM1;NFKB2;EPHA2;RELB;LIF;TRIB1;CD83;JUN;TJP2;JUNB;BCL3;IRF1;ZFP36L1;CEBPB;RUNX1;CDKN2B;CYLD;ADAM8;SMAD3;RC3H1;IL23A;DUSP10;TFRC;CREB1;ZFP36;JAG1;RIPK2;NRARP;PML;POU2F2;PTPN11;SOX4;HDAC9;KLF10;IL7R;CDK6;TFE3;TOB2;WNT5A;NFE2L2;PABPC4;SMPD3
16129,GO:0090130,9.32038537253262e-09,0.999999997993437,26,205,tissue migration,BP,ZC3H12A;HBEGF;ETS1;PTGS2;EFNA1;EDN1;EFNB2;EPHA2;MAP2K3;JUN;VEGFC;TACSTD2;DUSP10;PLK2;PPARD;SOX9;FERMT1;PTPN11;RHOB;HDAC9;CORO1C;WNT5A;ADAM9;PDPK1;ADAMTS9;NFE2L2
12253,GO:0048534,9.60712889727544e-09,1,48,619,hematopoietic or lymphoid organ development,BP,NFKBIA;NFKBID;CSF2;INHBA;ETS1;TNF;KLF6;PRDM1;NFKB2;EPHA2;RELB;LIF;TRIB1;CD83;JUN;TJP2;JUNB;BCL3;IRF1;ZFP36L1;CEBPB;RUNX1;CDKN2B;CYLD;ADAM8;RC3H1;IL23A;DUSP10;TFRC;CREB1;ZFP36;JAG1;RIPK2;NRARP;PML;POU2F2;PTPN11;SOX4;HDAC9;KLF10;IL7R;CDK6;TFE3;TOB2;WNT5A;NFE2L2;PABPC4;SMPD3
7754,GO:0032269,1.0071859509204e-08,1,59,847,negative regulation of cellular protein metabolic process,BP,TNFAIP3;IL1B;ZC3H12A;PLAUR;BTG2;BIRC3;TNF;SERPINB2;PTGS2;TNIP1;NFKB1;EFNA1;EDN1;ERRFI1;CPEB2;TNFRSF10B;GADD45A;LIF;TRIB1;JUN;BIRC2;CDKN1A;ZFP36L1;ENC1;DUSP16;PPP1R15A;N4BP1;CDKN2B;DUSP8;TFPI2;DUSP1;PPP1R10;SMAD3;RC3H1;DUSP10;SERPINB8;SERPINB1;SOCS3;BDKRB1;ZFP36;CD55;PPP1R15B;ZNF451;PML;NCOA7;SOX4;CDK6;SAMD4A;PTPN1;CORO1C;QKI;CELF1;NUP153;PDPK1;TNFRSF10A;RELA;YWHAG;SFN;SH3RF2
3587,GO:0008009,1.34114005564036e-08,0.999999999716371,7,14,chemokine activity,MF,CXCL2;CXCL1;CXCL3;CXCL8;CCL20;CXCL5;CXCL16
7318,GO:0031326,1.57420542026507e-08,1,162,3347,regulation of cellular biosynthetic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;BTG2;HBEGF;NFKBID;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;KLF6;CCL20;ZNF697;BHLHE40;PTGS2;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;HAS3;ERRFI1;IRAK2;KLF7;CREB5;CPEB2;EHF;RELB;MAFF;LIF;TRIB1;SQSTM1;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ENC1;ADRB2;CEBPB;ARNTL2;PPP1R15A;RUNX1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;DUSP1;BCL10;TRAF1;DLX2;VGLL3;CYLD;ADAM8;LDLR;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;IL23A;PLK3;PIM1;CREB1;HIVEP2;PPARD;CCDC85B;IL16;ZFP36;SLC9A1;MAFK;LARP4B;CYP27B1;PNRC1;ELL2;JAG1;PLAGL2;RIPK2;PPP1R15B;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;ZNF460;FOXN2;UHRF1;MXD1;SOX4;FOSL2;EIF1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;RBM3;IER5;SAMD4A;TFE3;TOB2;MAFG;MTF1;QKI;CELF1;WNT5A;NUP153;INSIG1;PDPK1;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;RELA;BACH1;BTAF1;TDG;ELF4;CREG1;ITM2B;ERN1;ATXN7;BRD2;FUBP3;SMPD3
1155,GO:0002761,1.7987523857263e-08,0.999999997799373,15,73,regulation of myeloid leukocyte differentiation,BP,INHBA;TNF;LIF;TRIB1;JUN;TJP2;ZFP36L1;CEBPB;RUNX1;IL23A;CREB1;KLF10;CDK6;TFE3;TOB2
11287,GO:0045598,1.90763217845299e-08,0.999999997433111,16,83,regulation of fat cell differentiation,BP,ZC3H12A;TNF;PTGS2;NOCT;BMP2;ZFP36L1;CEBPB;SMAD3;DUSP10;CREB1;PPARD;CCDC85B;ZFP36;JAG1;WNT5A;INSIG1
18448,GO:1903532,1.97971395723319e-08,0.99999999556412,26,219,positive regulation of secretion by cell,BP,IL1B;IL1A;INHBA;SDC4;TNF;EDN1;PANX1;HCAR2;CD274;TRIM16;ADAM8;VEGFC;CREB1;PPARD;RIPK2;SAA1;STX1A;FERMT1;PTPN11;SOX4;OXCT1;HLA-E;WNT5A;ADAM9;IFIH1;SMPD3
17874,GO:1902107,2.26447945968893e-08,0.999999996893811,16,88,positive regulation of leukocyte differentiation,BP,TNF;PRDM1;LIF;TRIB1;CD83;JUN;ZFP36L1;RUNX1;CYLD;ADAM8;IL23A;DUSP10;CREB1;RIPK2;KLF10;IL7R
1026,GO:0002526,2.44442581965171e-08,0.999999997511346,13,59,acute inflammatory response,BP,IL1B;IL1A;TNF;PTGS2;IL1RN;CEBPB;B4GALT1;IL6ST;ADAM8;F3;CD55;SAA1;OSMR
7340,GO:0031349,2.7326089203504e-08,0.999999993043863,30,298,positive regulation of defense response,BP,NFKBIA;TNFAIP3;IL1B;BIRC3;TICAM1;ETS1;TNF;PTGS2;TNIP1;NFKB1;IRAK2;RELB;BIRC2;IRF1;EREG;PELI1;BCL10;IL6ST;CYLD;ADAM8;LDLR;IL23A;RIPK2;HLA-E;OSMR;WNT5A;PDPK1;RELA;POLR3D;IFIH1
1100,GO:0002687,2.75777411879094e-08,0.999999996801465,14,71,positive regulation of leukocyte migration,BP,CXCL2;IL1A;CXCL1;CXCL3;TNF;CXCL8;CCL20;EDN1;CXCL5;ADAM8;VEGFC;IL23A;BDKRB1;WNT5A
10596,GO:0043565,2.82303048097022e-08,1,56,752,sequence-specific DNA binding,MF,ELF3;ETS1;REL;KLF6;BHLHE40;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;KDM6B;IRF6;KLF7;EHF;RELB;GADD45A;MAFF;JUN;JUNB;OVOL1;CSRNP1;ETS2;IRF1;CEBPB;ARNTL2;RUNX1;DLX2;KLF3;ZNF217;SMAD3;CREB1;HIVEP2;PPARD;MAFK;PLAGL2;SOX9;POU2F2;ELK3;FOXN2;UHRF1;MXD1;SOX4;FOSL2;HIVEP1;KLF10;SKIL;TFE3;MAFG;MTF1;KDM6A;ZBTB21;NFE2L2;RELA;BACH1;ELF4;FUBP3
4552,GO:0010632,2.94335513470225e-08,0.999999994043227,22,159,regulation of epithelial cell migration,BP,ZC3H12A;HBEGF;ETS1;PTGS2;EFNA1;EDN1;EPHA2;MAP2K3;JUN;VEGFC;TACSTD2;DUSP10;PLK2;SOX9;RHOB;HDAC9;CORO1C;WNT5A;ADAM9;PDPK1;ADAMTS9;NFE2L2
4568,GO:0010648,3.00229744644248e-08,1,63,934,negative regulation of cell communication,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;HBEGF;NFKBID;CSF2;INHBA;TICAM1;TNF;CXCL8;PPIF;PTGS2;TNIP1;PRDM1;EFNA1;EDN1;ERRFI1;IL1RN;TNFRSF10B;EPHA2;LIF;TRIB1;KCTD11;BMP2;BCL3;BCL2L2;ADRB2;DUSP16;PPP1R15A;EREG;SOD2;DUSP8;DUSP1;PIM3;DLX2;CYLD;SMAD3;DUSP10;PLK2;SOCS3;PPP1R15B;ITGAV;NRARP;SOX9;NRG1;ZNF451;RASA2;FERMT1;PTPN11;TNFAIP1;SKIL;PTPN1;ADM;WNT5A;INSIG1;PDPK1;TNFRSF10A;NFE2L2;RELA;ATXN7
20273,GO:2001235,3.27067597359169e-08,0.999999993918376,20,150,positive regulation of apoptotic signaling pathway,BP,PLAUR;INHBA;PPIF;PMAIP1;PLEKHF1;TNFRSF10B;BCL10;G0S2;CYLD;SMAD3;BBC3;PLAGL2;TP53BP2;PML;SKIL;TNFRSF10A;CTSC;YWHAH;YWHAG;SFN
6651,GO:0023057,3.39458713197491e-08,1,63,937,negative regulation of signaling,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;HBEGF;NFKBID;CSF2;INHBA;TICAM1;TNF;CXCL8;PPIF;PTGS2;TNIP1;PRDM1;EFNA1;EDN1;ERRFI1;IL1RN;TNFRSF10B;EPHA2;LIF;TRIB1;KCTD11;BMP2;BCL3;BCL2L2;ADRB2;DUSP16;PPP1R15A;EREG;SOD2;DUSP8;DUSP1;PIM3;DLX2;CYLD;SMAD3;DUSP10;PLK2;SOCS3;PPP1R15B;ITGAV;NRARP;SOX9;NRG1;ZNF451;RASA2;FERMT1;PTPN11;TNFAIP1;SKIL;PTPN1;ADM;WNT5A;INSIG1;PDPK1;TNFRSF10A;NFE2L2;RELA;ATXN7
16493,GO:0097191,3.41741385677073e-08,0.999999992989301,22,171,extrinsic apoptotic signaling pathway,BP,TNFAIP3;IL1B;IL1A;CSF2;INHBA;TNF;PMAIP1;TNFRSF10B;BCL2L2;BCL10;TRAF1;G0S2;CYLD;SMAD3;ITGAV;PML;FEM1B;SKIL;PDPK1;TNFRSF10A;RELA;ITM2B
11349,GO:0045682,3.49444799827359e-08,0.999999995889411,14,68,regulation of epidermis development,BP,TNF;ERRFI1;MAFF;ZFP36L1;RUNX1;NAB1;TRIM16;PPARD;ZFP36;CYP27B1;FERMT1;MAFG;WNT5A;SFN
10505,GO:0043408,3.71686875904331e-08,0.999999990539198,41,475,regulation of MAPK cascade,BP,IL1B;IL1A;ZC3H12A;INHBA;TNF;CCL20;TNIP1;EFNA1;TGFA;EDN1;SEMA7A;ERRFI1;IRAK2;TNFRSF10B;EPHA2;GADD45A;LIF;TRIB1;BMP2;MAP2K3;JUN;ADRB2;DUSP16;DUSP8;DUSP1;ADAM8;DUSP10;STK40;RIPK2;SAA1;ITGAV;NRG1;PTPN11;MAP3K8;SPAG9;TRAF4;PTPN1;WNT5A;ADAM9;TNFRSF10A;ERN1
3263,GO:0006935,3.79582139235794e-08,0.999999989366242,34,353,chemotaxis,BP,CXCL2;IL1B;CXCL1;PLAUR;CXCL3;HBEGF;PLAU;CXCL8;CCL20;FOSL1;EFNA1;EDN1;SEMA7A;KLF7;EFNB2;EPHA2;CXCL5;ZSWIM4;ADAM8;VEGFC;SMAD3;IL23A;CREB1;EFNB1;F3;IL16;SAA1;ITGAV;PIP5K1A;NRG1;PTPN11;WNT5A;B3GNT2;CXCL16
11433,GO:0045859,3.93815102439112e-08,1,46,583,regulation of protein kinase activity,BP,TNFAIP3;IL1B;SDC4;TNF;EFNA1;TGFA;EDN1;ERRFI1;IRAK2;TNFRSF10B;GADD45A;TRIB1;BMP2;CAB39;MAP2K3;RAP2B;CDKN1A;ADRB2;DUSP16;CDKN2B;EREG;DUSP8;DUSP1;ADAM8;OXSR1;IL23A;DUSP10;SOCS3;RIPK2;SAA1;NRG1;PTPN11;MAP3K8;SPAG9;TRAF4;CCNL1;CDK6;PTPN1;CORO1C;WNT5A;ADAM9;PDPK1;TNFRSF10A;YWHAG;SFN;ERN1
9959,GO:0042330,3.97473014031947e-08,0.999999988843698,34,354,taxis,BP,CXCL2;IL1B;CXCL1;PLAUR;CXCL3;HBEGF;PLAU;CXCL8;CCL20;FOSL1;EFNA1;EDN1;SEMA7A;KLF7;EFNB2;EPHA2;CXCL5;ZSWIM4;ADAM8;VEGFC;SMAD3;IL23A;CREB1;EFNB1;F3;IL16;SAA1;ITGAV;PIP5K1A;NRG1;PTPN11;WNT5A;B3GNT2;CXCL16
6957,GO:0030593,4.00929997603648e-08,0.999999997318139,10,36,neutrophil chemotaxis,BP,CXCL2;IL1B;CXCL1;CXCL3;CXCL8;CCL20;EDN1;CXCL5;IL23A;SAA1
886,GO:0002250,4.05675904308332e-08,0.999999990876358,24,197,adaptive immune response,BP,TNFAIP3;IL1B;TNF;RNF19B;PRDM1;NFKB2;RELB;BCL3;IRF1;BCL10;IL6ST;RC3H1;IL23A;DUSP10;TFRC;CD55;JAG1;RIPK2;POU2F2;IL7R;TFE3;HLA-E;CTSC;TAP1
15519,GO:0071900,4.1737181316292e-08,0.999999987845037,36,392,regulation of protein serine/threonine kinase activity,BP,TNFAIP3;IL1B;TNF;TGFA;EDN1;IRAK2;TNFRSF10B;GADD45A;TRIB1;BMP2;CAB39;MAP2K3;CDKN1A;ADRB2;DUSP16;CDKN2B;DUSP8;DUSP1;ADAM8;DUSP10;RIPK2;SAA1;NRG1;PTPN11;MAP3K8;SPAG9;TRAF4;CCNL1;CDK6;PTPN1;WNT5A;ADAM9;TNFRSF10A;YWHAG;SFN;ERN1
3177,GO:0006796,4.18914261455129e-08,1,119,2288,phosphate-containing compound metabolic process,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;HBEGF;CSF2;ITPKC;INHBA;SDC4;TNF;PPIF;NUAK2;CCL20;PTGS2;TNIP1;NFKB1;PLEKHF1;EFNA1;TGFA;EDN1;SEMA7A;ERRFI1;IRAK2;DAPP1;TNFRSF10B;EPHA2;GADD45A;LIF;TRIB1;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;CDKN1A;NMNAT2;TJP2;NAMPT;AMPD3;ZFP36L1;ADRB2;DUSP16;PPP1R15A;MAST4;CDKN2B;HMGCS1;EREG;PELI1;ANKLE2;DUSP8;DUSP1;BCL10;PPP1R10;PIM3;IL6ST;SGMS2;ADAM8;LDLR;VEGFC;OXSR1;SMAD3;IL23A;DUSP10;PLK2;PLK3;PIM1;ITGA5;LIPG;CREB1;STK40;PPARD;SLC25A25;SOCS3;BDKRB1;ZFP36;RIPK2;PHKG2;SAA1;PPP1R15B;ITGAV;PIP5K1A;CLK4;SOX9;NRG1;PML;RASA2;PPTC7;PTPN11;MAP3K8;PANK3;SPAG9;GCH1;TRAF4;AREG;CCNL1;CDK6;PTPN1;CORO1C;ADM;ABL2;WNT5A;NUP153;ADAM9;PDPK1;TNFRSF10A;SGK1;ANKK1;YWHAG;TDG;SFN;ERN1;ETNK1;SH3RF2;UPP1;ATXN7;SMPD3
16853,GO:0098772,4.20156821480249e-08,1,71,1128,molecular function regulator,MF,CXCL2;IL1B;IL1A;CXCL1;CXCL3;IL36G;BIRC3;HBEGF;CSF2;INHBA;TNF;CXCL8;SERPINB2;CCL20;TGFA;EDN1;SEMA7A;ERRFI1;IL1RN;CPEB2;CXCL5;LIF;TRIB1;BMP2;IL24;CAB39;JUN;BIRC2;CDKN1A;NAMPT;ADRB2;PPP1R15A;CDKN2B;EREG;ANKLE2;TFPI2;BCL10;FGD6;PPP1R10;VEGFC;NEDD4L;IL23A;SERPINB8;SERPINB1;SOCS3;IL16;AZIN1;JAG1;SAA1;PPP1R15B;STX1A;NRG1;RASA2;CDC42EP1;ARHGEF3;AREG;CCNL1;DENND2C;ADM;RAB3IP;WNT5A;PDPK1;CTSC;YWHAH;SGK1;CYTH1;AGFG1;YWHAG;SFN;SH3RF2;CXCL16
16065,GO:0090023,4.26561964811071e-08,0.999999998881217,7,15,positive regulation of neutrophil chemotaxis,BP,CXCL2;CXCL1;CXCL3;CXCL8;EDN1;CXCL5;IL23A
19745,GO:2000112,4.29598741850352e-08,1,155,3204,regulation of cellular macromolecule biosynthetic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;BTG2;HBEGF;NFKBID;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;KLF6;ZNF697;BHLHE40;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;HAS3;IRAK2;KLF7;CREB5;CPEB2;EHF;RELB;MAFF;LIF;TRIB1;SQSTM1;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ENC1;ADRB2;CEBPB;ARNTL2;PPP1R15A;RUNX1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;DUSP1;BCL10;TRAF1;DLX2;VGLL3;CYLD;ADAM8;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;IL23A;PLK3;PIM1;CREB1;HIVEP2;PPARD;CCDC85B;IL16;ZFP36;SLC9A1;MAFK;LARP4B;PNRC1;ELL2;JAG1;PLAGL2;RIPK2;PPP1R15B;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;ZNF460;FOXN2;UHRF1;MXD1;SOX4;FOSL2;EIF1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;RBM3;IER5;SAMD4A;TFE3;MAFG;MTF1;QKI;CELF1;WNT5A;NUP153;INSIG1;PDPK1;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;RELA;BACH1;BTAF1;TDG;ELF4;CREG1;ITM2B;ERN1;ATXN7;BRD2;FUBP3
18674,GO:1904018,4.54545664969024e-08,0.999999992381868,18,112,positive regulation of vasculature development,BP,IL1B;IL1A;ZC3H12A;ETS1;CXCL8;PTGS2;EFNB2;RUNX1;VEGFC;PLK2;ITGA5;F3;RHOB;HDAC9;ADM;WNT5A;PDPK1;NFE2L2
11390,GO:0045766,4.58224185045995e-08,0.999999992828537,17,100,positive regulation of angiogenesis,BP,IL1B;IL1A;ZC3H12A;ETS1;CXCL8;PTGS2;RUNX1;VEGFC;PLK2;ITGA5;F3;RHOB;HDAC9;ADM;WNT5A;PDPK1;NFE2L2
15198,GO:0071347,4.78262007943967e-08,0.999999991868911,18,128,cellular response to interleukin-1,BP,NFKBIA;IL1B;IL1A;ZC3H12A;CXCL8;CCL20;NFKB1;EDN1;IL1RN;IRAK2;SQSTM1;CEBPB;PELI1;RC3H1;RIPK2;SOX9;MAP3K8;RELA
14874,GO:0070663,5.23252248965566e-08,0.999999991081867,18,122,regulation of leukocyte proliferation,BP,TNFAIP3;IL1B;TICAM1;SDC4;PRDM1;CDKN1A;CD274;IRF1;CEBPB;PELI1;IL6ST;RC3H1;IL23A;TFRC;EFNB1;CD55;RIPK2;HLA-E
6072,GO:0019219,5.28052004261921e-08,1,157,3264,regulation of nucleobase-containing compound metabolic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;BTG2;NFKBID;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;PPIF;KLF6;ZNF697;BHLHE40;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;HAS3;IRAK2;KLF7;CREB5;EHF;RELB;MAFF;LIF;TRIB1;SQSTM1;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ADRB2;CEBPB;ARNTL2;RUNX1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;DUSP1;BCL10;TRAF1;PPP1R10;DLX2;VGLL3;CYLD;ADAM8;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;IL23A;PLK3;PIM1;TFRC;CREB1;HIVEP2;PPARD;CCDC85B;USP36;IL16;ZFP36;SLC9A1;MAFK;PNRC1;ELL2;JAG1;PLAGL2;RIPK2;CLK4;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;ZNF460;FOXN2;UHRF1;MXD1;SOX4;FOSL2;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;IL7R;IER5;SAMD4A;PTPN1;TFE3;PRPF19;TOB2;ADM;MAFG;MTF1;QKI;CELF1;WNT5A;NUP153;INSIG1;PDPK1;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;RELA;BACH1;BTAF1;TDG;ELF4;CREG1;ERN1;ATXN7;BRD2;PABPC4;FUBP3
12775,GO:0051047,5.43083326241327e-08,0.999999986764068,26,231,positive regulation of secretion,BP,IL1B;IL1A;INHBA;SDC4;TNF;EDN1;PANX1;HCAR2;CD274;TRIM16;ADAM8;VEGFC;CREB1;PPARD;RIPK2;SAA1;STX1A;FERMT1;PTPN11;SOX4;OXCT1;HLA-E;WNT5A;ADAM9;IFIH1;SMPD3
19073,GO:1904951,5.60847565868977e-08,0.999999984621261,32,332,positive regulation of establishment of protein localization,BP,IL1B;IL1A;ZC3H12A;TNF;PTGS2;PMAIP1;PANX1;HCAR2;CD274;UGCG;TRIM16;ADAM8;VEGFC;BBC3;PLK3;PPARD;USP36;PLAGL2;RIPK2;SAA1;TP53BP2;NRG1;FERMT1;SOX4;OXCT1;HLA-E;WNT5A;ADAM9;YWHAH;YWHAG;SFN;IFIH1
6782,GO:0030216,5.87731056906738e-08,0.999999988653581,20,151,keratinocyte differentiation,BP,SPRR2D;IRF6;ERRFI1;SPRR2A;EPHA2;ZFP36L1;RUNX1;TRIM16;EREG;KRT34;KRTAP2-3;ZFP36;CYP27B1;JAG1;PIP5K1A;FOSL2;WNT5A;ADAM9;LCE1C;SFN
16495,GO:0097193,6.34179411075472e-08,0.99999998437604,26,245,intrinsic apoptotic signaling pathway,BP,PLAUR;TNF;PPIF;PTGS2;PMAIP1;PLEKHF1;TNFRSF10B;EPHA2;CDKN1A;BCL3;BCL2L2;CEBPB;PPP1R15A;SOD2;CYLD;BBC3;PLAGL2;TP53BP2;PML;AEN;SKIL;PTPN1;ERO1A;NFE2L2;SFN;ERN1
20274,GO:2001236,6.50375869514902e-08,0.999999988755452,18,121,regulation of extrinsic apoptotic signaling pathway,BP,TNFAIP3;IL1B;IL1A;CSF2;INHBA;TNF;PMAIP1;TNFRSF10B;BCL10;TRAF1;G0S2;CYLD;ITGAV;PML;FEM1B;SKIL;TNFRSF10A;RELA
15379,GO:0071624,6.54484567503894e-08,0.999999998105431,7,16,positive regulation of granulocyte chemotaxis,BP,CXCL2;CXCL1;CXCL3;CXCL8;EDN1;CXCL5;IL23A
12578,GO:0050729,6.75741011675762e-08,0.999999992406361,13,63,positive regulation of inflammatory response,BP,NFKBIA;IL1B;TICAM1;ETS1;TNF;PTGS2;TNIP1;IL6ST;ADAM8;LDLR;IL23A;OSMR;WNT5A
14818,GO:0070555,6.7746963965162e-08,0.99999998746079,19,144,response to interleukin-1,BP,NFKBIA;IL1B;IL1A;ZC3H12A;ETS1;CXCL8;CCL20;NFKB1;EDN1;IL1RN;IRAK2;SQSTM1;CEBPB;PELI1;RC3H1;RIPK2;SOX9;MAP3K8;RELA
4473,GO:0010468,8.25817201366201e-08,1,164,3511,regulation of gene expression,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;BTG2;BIRC3;NFKBID;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;KLF6;ZNF697;BHLHE40;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;HAS3;IRAK2;KLF7;CREB5;CPEB2;EHF;RELB;MAFF;LIF;TRIB1;SQSTM1;BMP2;PHLDA2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ENC1;ADRB2;CEBPB;ARNTL2;PPP1R15A;RUNX1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;BCL10;TRAF1;DLX2;VGLL3;CYLD;ADAM8;LDLR;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;IL23A;PLK3;PIM1;CREB1;STK40;HIVEP2;PPARD;CCDC85B;USP36;IL16;ZFP36;SLC9A1;MAFK;LARP4B;CD55;PNRC1;ELL2;JAG1;PLAGL2;RIPK2;PPP1R15B;CLK4;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;FERMT1;NCOA7;ELK3;ZNF460;FOXN2;UHRF1;MXD1;SOX4;FOSL2;EIF1;CCNL1;FAM83G;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;IL7R;RBM3;CDK6;IER5;SAMD4A;TFE3;PRPF19;TOB2;MAFG;MTF1;QKI;CELF1;WNT5A;NUP153;INSIG1;PDPK1;KDM6A;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;RELA;BACH1;BTAF1;TDG;ELF4;CREG1;ERN1;ATXN7;BRD2;PABPC4;FUBP3
16654,GO:0097530,8.32361654385012e-08,0.999999991544904,12,56,granulocyte migration,BP,CXCL2;IL1B;IL1A;CXCL1;CXCL3;CXCL8;CCL20;EDN1;CXCL5;ADAM8;IL23A;SAA1
10790,GO:0044260,8.85637376444138e-08,1,255,6220,cellular macromolecule metabolic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;HBEGF;NFKBID;CSF2;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;CXCL8;REL;SERPINB2;PPIF;KLF6;NUAK2;CCL20;SPRR2D;ZNF697;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;SEMA7A;PHLDA1;HAS3;ERRFI1;IRAK2;KLF7;CREB5;DAPP1;CPEB2;EHF;SPRR2A;TNFRSF10B;EPHA2;RELB;GADD45A;MAFF;LIF;TRIB1;KCTD11;SQSTM1;BMP2;PHLDA2;IL24;CAB39;ZNF267;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ENC1;ADRB2;CEBPB;DUSP16;ARNTL2;PPP1R15A;MAST4;RUNX1;N4BP1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;ANKLE2;DUSP8;B4GALT1;TFPI2;DUSP1;BCL10;DCUN1D3;TRAF1;PPP1R10;PIM3;IL6ST;B3GNT5;NABP1;DLX2;VGLL3;CYLD;ADAM8;LDLR;VEGFC;KLF3;ZNF217;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;PIM1;ITGA5;TFRC;KLHL21;CREB1;SERPINB8;F3;STK40;HIVEP2;PPARD;SERPINB1;SOCS3;CCDC85B;RAET1L;USP36;IL16;BDKRB1;ZFP36;SLC9A1;MAFK;LARP4B;CD55;PNRC1;ELL2;JAG1;PLAGL2;RIPK2;PHKG2;SAA1;PPP1R15B;USP53;ITGAV;CLK4;NRARP;SOX9;NRG1;ZNF451;FEM1C;PML;POU2F2;RASA2;PPTC7;NCOA7;ELK3;POLR3A;ZNF460;FOXN2;PTPN11;MAP3K8;UHRF1;MXD1;SPAG9;FEM1B;SOX4;USP31;FOSL2;TRAF4;EIF1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;IL7R;RBM3;CDK6;IER5;SAMD4A;PTPN1;TFE3;CORO1C;PRPF19;ADM;MAFG;ABL2;MTF1;QKI;CELF1;PMM2;WNT5A;NUP153;INSIG1;ADAM9;LCE1C;PDPK1;TNFRSF10A;ADAMTS9;RNF19A;CTSC;ERO1A;KDM6A;ZBTB21;NFE2L2;YWHAH;SGK1;B3GNT2;TSC22D2;RELA;RNF11;BACH1;BTAF1;ANKK1;GINS3;POLR3D;YWHAG;TDG;ELF4;CREG1;SFN;ITM2B;ERN1;SH3RF2;ISG20;TMEM132A;ATXN7;IFIH1;BRD2;PABPC4;DSE;FUBP3
12909,GO:0051252,9.16392785107965e-08,1,147,3021,regulation of RNA metabolic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;BTG2;NFKBID;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;KLF6;ZNF697;BHLHE40;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;HAS3;IRAK2;KLF7;CREB5;EHF;RELB;MAFF;LIF;TRIB1;SQSTM1;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ADRB2;CEBPB;ARNTL2;RUNX1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;BCL10;TRAF1;DLX2;VGLL3;CYLD;ADAM8;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;IL23A;PLK3;PIM1;CREB1;HIVEP2;PPARD;CCDC85B;USP36;IL16;ZFP36;SLC9A1;MAFK;PNRC1;ELL2;JAG1;PLAGL2;RIPK2;CLK4;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;ZNF460;FOXN2;UHRF1;MXD1;SOX4;FOSL2;CCNL1;FAM83G;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;IER5;SAMD4A;TFE3;PRPF19;TOB2;MAFG;MTF1;QKI;CELF1;WNT5A;INSIG1;PDPK1;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;RELA;BACH1;BTAF1;TDG;ELF4;CREG1;ERN1;ATXN7;BRD2;PABPC4;FUBP3
4349,GO:0009913,9.19315313217691e-08,0.999999979902957,22,183,epidermal cell differentiation,BP,SPRR2D;IRF6;ERRFI1;SPRR2A;EPHA2;MAFF;ZFP36L1;RUNX1;TRIM16;EREG;KRT34;KRTAP2-3;ZFP36;CYP27B1;JAG1;PIP5K1A;FOSL2;MAFG;WNT5A;ADAM9;LCE1C;SFN
15432,GO:0071706,1.01515569705297e-07,0.999999986797838,14,74,tumor necrosis factor superfamily cytokine production,BP,TNFAIP3;ZC3H12A;TICAM1;ERRFI1;CD274;BCL3;BCL10;ADAM8;IL23A;ZFP36;RIPK2;HLA-E;WNT5A;IFIH1
7070,GO:0030856,1.02221761769864e-07,0.999999984170019,16,94,regulation of epithelial cell differentiation,BP,IL1B;TNF;TBX3;ERRFI1;MAFF;LIF;ZFP36L1;CEBPB;RUNX1;TRIM16;ZFP36;CYP27B1;JAG1;SOX9;MAFG;SFN
7996,GO:0032612,1.09567918185706e-07,0.999999988605375,12,55,interleukin-1 production,BP,TNFAIP3;IL1B;ZC3H12A;CCL20;ERRFI1;PANX1;TRIM16;SMAD3;RIPK2;SAA1;PML;WNT5A
14872,GO:0070661,1.13452319193329e-07,0.999999977085124,20,157,leukocyte proliferation,BP,TNFAIP3;IL1B;TICAM1;SDC4;PRDM1;CDKN1A;CD274;IRF1;CEBPB;PELI1;IL6ST;RC3H1;IL23A;TFRC;EFNB1;CD55;RIPK2;IL7R;HLA-E;ELF4
12688,GO:0050900,1.15252366095641e-07,0.999999971639012,25,227,leukocyte migration,BP,CXCL2;IL1B;IL1A;CXCL1;CXCL3;SDC4;TNF;CXCL8;CCL20;EDN1;TNFRSF10B;CXCL5;B4GALT1;ADAM8;VEGFC;IL23A;ITGA5;IL16;BDKRB1;SAA1;ITGAV;PTPN11;WNT5A;TNFRSF10A;CXCL16
11244,GO:0045444,1.27170194212767e-07,0.999999974236444,20,147,fat cell differentiation,BP,ZC3H12A;TNF;PTGS2;NOCT;BMP2;ZFP36L1;ADRB2;CEBPB;SMAD3;DUSP10;CREB1;PPARD;CCDC85B;ZFP36;JAG1;STEAP4;WNT5A;INSIG1;ERO1A;LAMB3
11389,GO:0045765,1.60320741367022e-07,0.999999963854595,22,175,regulation of angiogenesis,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;ETS1;CXCL8;PTGS2;EFNA1;EPHA2;RUNX1;VEGFC;PLK2;ITGA5;F3;PML;RHOB;HDAC9;ADM;WNT5A;PDPK1;ADAMTS9;NFE2L2
12529,GO:0050670,1.61073381563989e-07,0.999999972016143,17,117,regulation of lymphocyte proliferation,BP,IL1B;TICAM1;SDC4;PRDM1;CDKN1A;CD274;IRF1;CEBPB;PELI1;IL6ST;RC3H1;IL23A;TFRC;EFNB1;CD55;RIPK2;HLA-E
10507,GO:0043410,1.72650359645808e-07,0.999999948092134,32,335,positive regulation of MAPK cascade,BP,IL1B;IL1A;ZC3H12A;TNF;CCL20;EFNA1;TGFA;EDN1;SEMA7A;IRAK2;TNFRSF10B;EPHA2;GADD45A;LIF;BMP2;MAP2K3;JUN;ADRB2;ADAM8;RIPK2;SAA1;ITGAV;NRG1;PTPN11;MAP3K8;SPAG9;TRAF4;PTPN1;WNT5A;ADAM9;TNFRSF10A;ERN1
18427,GO:1903506,1.78956835655276e-07,1,139,2843,regulation of nucleic acid-templated transcription,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;BTG2;NFKBID;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;KLF6;ZNF697;BHLHE40;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;HAS3;IRAK2;KLF7;CREB5;EHF;RELB;MAFF;LIF;TRIB1;SQSTM1;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ADRB2;CEBPB;ARNTL2;RUNX1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;BCL10;TRAF1;DLX2;VGLL3;CYLD;ADAM8;KLF3;ZNF217;NEDD4L;SMAD3;IL23A;PLK3;PIM1;CREB1;HIVEP2;PPARD;CCDC85B;IL16;ZFP36;SLC9A1;MAFK;PNRC1;ELL2;JAG1;PLAGL2;RIPK2;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;ZNF460;FOXN2;UHRF1;MXD1;SOX4;FOSL2;CCNL1;FAM83G;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;IER5;TFE3;TOB2;MAFG;MTF1;WNT5A;INSIG1;PDPK1;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;RELA;BACH1;BTAF1;TDG;ELF4;CREG1;ERN1;ATXN7;BRD2;FUBP3
8199,GO:0032944,1.82619405097201e-07,0.99999996794843,17,118,regulation of mononuclear cell proliferation,BP,IL1B;TICAM1;SDC4;PRDM1;CDKN1A;CD274;IRF1;CEBPB;PELI1;IL6ST;RC3H1;IL23A;TFRC;EFNB1;CD55;RIPK2;HLA-E
7493,GO:0031663,1.83476487308212e-07,0.999999985400598,10,37,lipopolysaccharide-mediated signaling pathway,BP,NFKBIA;TNFAIP3;IL1B;TICAM1;TNF;PRDM1;IRAK2;TRIB1;CD55;RIPK2
17632,GO:1901342,1.84430576761225e-07,0.999999956326218,23,191,regulation of vasculature development,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;ETS1;CXCL8;PTGS2;EFNA1;EFNB2;EPHA2;RUNX1;VEGFC;PLK2;ITGA5;F3;PML;RHOB;HDAC9;ADM;WNT5A;PDPK1;ADAMTS9;NFE2L2
20220,GO:2001141,1.85112553205026e-07,1,139,2845,regulation of RNA biosynthetic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;BTG2;NFKBID;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;KLF6;ZNF697;BHLHE40;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;HAS3;IRAK2;KLF7;CREB5;EHF;RELB;MAFF;LIF;TRIB1;SQSTM1;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ADRB2;CEBPB;ARNTL2;RUNX1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;BCL10;TRAF1;DLX2;VGLL3;CYLD;ADAM8;KLF3;ZNF217;NEDD4L;SMAD3;IL23A;PLK3;PIM1;CREB1;HIVEP2;PPARD;CCDC85B;IL16;ZFP36;SLC9A1;MAFK;PNRC1;ELL2;JAG1;PLAGL2;RIPK2;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;ZNF460;FOXN2;UHRF1;MXD1;SOX4;FOSL2;CCNL1;FAM83G;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;IER5;TFE3;TOB2;MAFG;MTF1;WNT5A;INSIG1;PDPK1;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;RELA;BACH1;BTAF1;TDG;ELF4;CREG1;ERN1;ATXN7;BRD2;FUBP3
3176,GO:0006793,2.04854382636629e-07,1,119,2359,phosphorus metabolic process,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;HBEGF;CSF2;ITPKC;INHBA;SDC4;TNF;PPIF;NUAK2;CCL20;PTGS2;TNIP1;NFKB1;PLEKHF1;EFNA1;TGFA;EDN1;SEMA7A;ERRFI1;IRAK2;DAPP1;TNFRSF10B;EPHA2;GADD45A;LIF;TRIB1;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;CDKN1A;NMNAT2;TJP2;NAMPT;AMPD3;ZFP36L1;ADRB2;DUSP16;PPP1R15A;MAST4;CDKN2B;HMGCS1;EREG;PELI1;ANKLE2;DUSP8;DUSP1;BCL10;PPP1R10;PIM3;IL6ST;SGMS2;ADAM8;LDLR;VEGFC;OXSR1;SMAD3;IL23A;DUSP10;PLK2;PLK3;PIM1;ITGA5;LIPG;CREB1;STK40;PPARD;SLC25A25;SOCS3;BDKRB1;ZFP36;RIPK2;PHKG2;SAA1;PPP1R15B;ITGAV;PIP5K1A;CLK4;SOX9;NRG1;PML;RASA2;PPTC7;PTPN11;MAP3K8;PANK3;SPAG9;GCH1;TRAF4;AREG;CCNL1;CDK6;PTPN1;CORO1C;ADM;ABL2;WNT5A;NUP153;ADAM9;PDPK1;TNFRSF10A;SGK1;ANKK1;YWHAG;TDG;SFN;ERN1;ETNK1;SH3RF2;UPP1;ATXN7;SMPD3
11087,GO:0045088,2.08499551515469e-07,0.999999941592385,28,288,regulation of innate immune response,BP,NFKBIA;TNFAIP3;BIRC3;TICAM1;TNIP1;NFKB1;IRAK2;RELB;IFNGR2;BIRC2;IRF1;EREG;PELI1;BCL10;CYLD;ADAM8;DUSP10;SOCS3;IFNAR2;RIPK2;PTPN11;PTPN1;HLA-E;WNT5A;PDPK1;RELA;POLR3D;IFIH1
6702,GO:0030099,2.15350986467634e-07,0.999999939540539,28,292,myeloid cell differentiation,BP,NFKBIA;CSF2;INHBA;ETS1;TNF;EPHA2;RELB;LIF;TRIB1;JUN;TJP2;JUNB;ZFP36L1;CEBPB;RUNX1;CDKN2B;IL23A;TFRC;CREB1;ZFP36;JAG1;PML;PTPN11;KLF10;CDK6;TFE3;TOB2;PABPC4
2863,GO:0006355,2.22955496556525e-07,1,138,2826,regulation of transcription, DNA-templated,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;BTG2;NFKBID;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;KLF6;ZNF697;BHLHE40;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;HAS3;IRAK2;KLF7;CREB5;EHF;RELB;MAFF;LIF;TRIB1;SQSTM1;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ADRB2;CEBPB;ARNTL2;RUNX1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;BCL10;TRAF1;DLX2;VGLL3;CYLD;ADAM8;KLF3;ZNF217;NEDD4L;SMAD3;IL23A;PLK3;PIM1;CREB1;HIVEP2;PPARD;CCDC85B;IL16;ZFP36;SLC9A1;MAFK;PNRC1;ELL2;JAG1;PLAGL2;RIPK2;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;ZNF460;FOXN2;UHRF1;MXD1;SOX4;FOSL2;CCNL1;FAM83G;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;IER5;TFE3;MAFG;MTF1;WNT5A;INSIG1;PDPK1;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;RELA;BACH1;BTAF1;TDG;ELF4;CREG1;ERN1;ATXN7;BRD2;FUBP3
8021,GO:0032652,2.31599312061701e-07,0.999999977359336,11,48,regulation of interleukin-1 production,BP,TNFAIP3;ZC3H12A;CCL20;ERRFI1;PANX1;TRIM16;SMAD3;RIPK2;SAA1;PML;WNT5A
4313,GO:0009790,2.46834309783527e-07,0.99999992826457,50,673,embryo development,BP,CSF2;INHBA;ELF3;SDC4;TNF;CXCL8;PRDM1;FOSL1;TBX3;NOCT;EFNA1;KDM6B;EDN1;IL1RN;MAFF;LIF;BMP2;PHLDA2;PHLDB2;JUNB;ETS2;ZFP36L1;CEBPB;ALDH1A3;DUSP1;BCL10;DLX2;TXNRD1;VEGFC;SMAD3;ITGA5;EFNB1;GJB3;SOCS3;ITGAV;NRARP;SOX9;NRG1;SOX4;SKIL;PRPF19;ADM;MAFG;CELF1;WNT5A;INSIG1;KDM6A;NFE2L2;TDG;LAMB3
11788,GO:0046651,2.62271350495816e-07,0.999999946683141,19,150,lymphocyte proliferation,BP,IL1B;TICAM1;SDC4;PRDM1;CDKN1A;CD274;IRF1;CEBPB;PELI1;IL6ST;RC3H1;IL23A;TFRC;EFNB1;CD55;RIPK2;IL7R;HLA-E;ELF4
12580,GO:0050731,2.65365562905368e-07,0.99999995541517,16,103,positive regulation of peptidyl-tyrosine phosphorylation,BP,HBEGF;CSF2;EFNA1;TGFA;LIF;IL24;EREG;IL6ST;VEGFC;IL23A;ITGA5;SOCS3;RIPK2;NRG1;AREG;PTPN1
4365,GO:0009968,2.65721453882105e-07,1,58,885,negative regulation of signal transduction,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;HBEGF;NFKBID;CSF2;TICAM1;TNF;CXCL8;PPIF;PTGS2;TNIP1;PRDM1;EFNA1;ERRFI1;IL1RN;TNFRSF10B;EPHA2;LIF;TRIB1;KCTD11;BMP2;BCL3;BCL2L2;ADRB2;DUSP16;PPP1R15A;EREG;SOD2;DUSP8;DUSP1;DLX2;CYLD;SMAD3;DUSP10;SOCS3;PPP1R15B;ITGAV;NRARP;SOX9;NRG1;ZNF451;RASA2;FERMT1;TNFAIP1;SKIL;PTPN1;ADM;WNT5A;INSIG1;PDPK1;TNFRSF10A;NFE2L2;RELA;ATXN7
2381,GO:0005515,2.71648560803566e-07,1,316,8305,protein binding,MF,NFKBIA;NFKBIZ;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;CXCL3;BTG2;IL36G;BIRC3;HBEGF;PLAU;NFKBID;CSF2;ITPKC;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;CXCL8;REL;PPIF;IER3;KLF6;NUAK2;CCL20;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;PLEKHF1;EFNA1;TGFA;KDM6B;IRF6;LGALSL;EDN1;ODC1;SEMA7A;PHLDA1;ERRFI1;IL1RN;IRAK2;CLDN1;PANX1;CREB5;DAPP1;SPRR2A;TNFRSF10B;EFNB2;EPHA2;RELB;GADD45A;CXCL5;MAFF;LIF;TRIB1;KCTD11;CD83;SQSTM1;RRAD;BMP2;IL24;CAB39;N4BP3;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;TMCC3;RGMB;PHLDB2;CLDN4;TJP2;CD274;JUNB;BCL3;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;BCL2L2;ZFP36L1;ENC1;RND3;ADRB2;CEBPB;ARNTL2;TRAF3IP3;PPP1R15A;RUNX1;N4BP1;CDKN2B;NAB1;HMGCS1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;ALDH1A3;C3ORF52;EHD1;NEDD9;ANKLE2;B4GALT1;DUSP1;BCL10;FGD6;DCUN1D3;TMCC1;TRAF1;PPP1R10;PIM3;SACS;IL6ST;G0S2;VMP1;NABP1;DLX2;TXNRD1;CYLD;ADAM8;LDLR;VEGFC;KLF3;ZNF217;TACSTD2;NEDD4L;OXSR1;SMAD3;IL23A;DUSP10;PLK2;BBC3;PLK3;DIEXF;PIM1;WISP1;ITGA5;TFRC;AKIRIN1;KLHL21;CREB1;SERPINB8;EFNB1;F3;STK40;PPARD;SOCS3;CCDC85B;KRTAP2-3;RAET1L;USP36;IL16;BDKRB1;RAPH1;ZFP36;SLC9A1;MAFK;LARP4B;CD55;PNRC1;IFNAR2;ELL2;ANTXR2;AZIN1;KIAA0040;JAG1;RIPK2;AMOTL2;PHKG2;NAV3;SAA1;PPP1R15B;USP53;NDRG1;ITGAV;PIP5K1A;CLK4;TP53BP2;SOX9;STX1A;NRG1;ZNF451;FEM1C;PML;POU2F2;NCOA7;ELK3;ZNF460;CDC42EP1;FOXN2;PTPN11;MAP3K8;UHRF1;EFHD2;ARHGEF3;MXD1;IRGQ;DCBLD2;RHOB;SPAG9;GCH1;FEM1B;SOX4;FOSL2;TRAF4;VCL;EIF1;OXCT1;AREG;CCNL1;FAM83G;AKAP2;TNFAIP1;HDAC9;HIVEP1;NFKBIB;KLF10;AEN;C11ORF68;TIFA;SKIL;COTL1;IL7R;DENND2C;RBM3;CDK6;IER5;SAMD4A;EMP3;PTPN1;TFE3;BTG3;CORO1C;MSANTD3;PRPF19;TOB2;ADM;MAFG;ABL2;MTF1;ATP6V1C2;HLA-E;RAB3IP;OSMR;QKI;CELF1;PMM2;WNT5A;NUP153;INSIG1;ADAM9;PDPK1;TNFRSF10A;RNF19A;CTSC;ERO1A;KDM6A;FRMD6;ZBTB21;SMTN;NFE2L2;YWHAH;SGK1;CYTH1;SAT1;RELA;AGFG1;RNF11;NOTCH2NL;BACH1;GINS3;ALAS1;YWHAG;TDG;ELF4;RAB22A;CREG1;SFN;ITM2B;ERN1;ETNK1;SH3RF2;ATXN7;IFIH1;LAMB3;MYO1B;BRD2;IPO4;CXCL16;PABPC4;TAP1;GPATCH2L;AHCY;STX12;PDLIM5;FUBP3;RAB24;SMPD3
8198,GO:0032943,2.91304362898749e-07,0.999999940333047,19,151,mononuclear cell proliferation,BP,IL1B;TICAM1;SDC4;PRDM1;CDKN1A;CD274;IRF1;CEBPB;PELI1;IL6ST;RC3H1;IL23A;TFRC;EFNB1;CD55;RIPK2;IL7R;HLA-E;ELF4
16064,GO:0090022,2.92973475210575e-07,0.999999988788239,7,18,regulation of neutrophil chemotaxis,BP,CXCL2;CXCL1;CXCL3;CXCL8;EDN1;CXCL5;IL23A
4509,GO:0010558,3.02047188682021e-07,1,70,1160,negative regulation of macromolecule biosynthetic process,BP,ZC3H12A;BTG2;HBEGF;CSF2;INHBA;ELF3;TNF;REL;BHLHE40;NFKB1;PRDM1;TBX3;NFKB2;EFNA1;EDN1;ERRFI1;CPEB2;RELB;SQSTM1;BMP2;JUN;JUNB;BCL3;OVOL1;ETS2;IRF1;ZFP36L1;ENC1;CEBPB;NAB1;EREG;DUSP1;DLX2;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;PLK3;CREB1;PPARD;CCDC85B;ZFP36;MAFK;ITGAV;NRARP;SOX9;NRG1;ZNF451;PML;ELK3;UHRF1;MXD1;HDAC9;HIVEP1;KLF10;SKIL;SAMD4A;TOB2;QKI;CELF1;WNT5A;NUP153;ZBTB21;RELA;BACH1;BTAF1;TDG;CREG1;ITM2B
1461,GO:0003705,3.34910553028574e-07,0.9999999612079,12,55,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,REL;BHLHE40;NFKB1;JUN;CEBPB;VGLL3;CREB1;SOX9;HIVEP1;NFE2L2;RELA;BACH1
1089,GO:0002675,3.61005811331282e-07,0.999999991871363,6,11,positive regulation of acute inflammatory response,BP,IL1B;TNF;PTGS2;IL6ST;ADAM8;OSMR
8435,GO:0033554,3.61978439042745e-07,1,88,1619,cellular response to stress,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;BTG2;ETS1;TNF;CXCL8;REL;PPIF;IER3;NUAK2;PTGS2;PMAIP1;NFKB1;TBX3;PLEKHF1;KDM6B;EDN1;ERRFI1;IRAK2;CPEB2;TNFRSF10B;EPHA2;RELB;GADD45A;TRIB1;SQSTM1;BMP2;CAB39;MAP2K3;JUN;CDKN1A;JUNB;BCL3;BCL2L2;ZFP36L1;CEBPB;PPP1R15A;SOD2;TFPI2;PPP1R10;NABP1;TXNRD1;ADAM8;OXSR1;DUSP10;PLK2;BBC3;PLK3;PPARD;ZFP36;SLC9A1;RIPK2;PPP1R15B;NDRG1;PML;NCOA7;PTPN11;MAP3K8;UHRF1;RHOB;SPAG9;GCH1;FEM1B;SOX4;TRAF4;KLF10;AEN;SKIL;CDK6;IER5;PTPN1;PRPF19;ADM;WNT5A;NUP153;INSIG1;ERO1A;NFE2L2;SGK1;RELA;BACH1;TDG;SFN;ERN1;UPP1
18463,GO:1903555,3.62423365770078e-07,0.999999951998422,13,70,regulation of tumor necrosis factor superfamily cytokine production,BP,TNFAIP3;ZC3H12A;TICAM1;ERRFI1;CD274;BCL3;ADAM8;IL23A;ZFP36;RIPK2;HLA-E;WNT5A;IFIH1
12533,GO:0050678,3.82031193788638e-07,0.999999901960858,24,219,regulation of epithelial cell proliferation,BP,TNFAIP3;TNF;TGFA;ERRFI1;EFNB2;BMP2;JUN;ZFP36L1;CDKN2B;EREG;B4GALT1;VEGFC;TACSTD2;SMAD3;DUSP10;F3;PPARD;ZFP36;NRARP;SOX9;CDK6;WNT5A;PDPK1;SFN
11169,GO:0045236,3.90889945326546e-07,0.999999996198518,5,7,CXCR chemokine receptor binding,MF,CXCL2;CXCL1;CXCL3;CXCL8;CXCL5
4339,GO:0009890,3.90930546995309e-07,1,72,1218,negative regulation of biosynthetic process,BP,ZC3H12A;BTG2;HBEGF;CSF2;INHBA;ELF3;TNF;REL;BHLHE40;NFKB1;PRDM1;TBX3;NFKB2;EFNA1;EDN1;ERRFI1;CPEB2;RELB;SQSTM1;BMP2;JUN;JUNB;BCL3;OVOL1;ETS2;IRF1;ZFP36L1;ENC1;CEBPB;NAB1;EREG;DUSP1;DLX2;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;PLK3;CREB1;PPARD;CCDC85B;ZFP36;MAFK;CYP27B1;ITGAV;NRARP;SOX9;NRG1;ZNF451;PML;ELK3;UHRF1;MXD1;HDAC9;HIVEP1;KLF10;SKIL;SAMD4A;TOB2;QKI;CELF1;WNT5A;NUP153;INSIG1;ZBTB21;RELA;BACH1;BTAF1;TDG;CREG1;ITM2B
14033,GO:0060759,4.05491554700733e-07,0.999999919639742,18,135,regulation of response to cytokine stimulus,BP,TNFAIP3;BIRC3;TNF;EDN1;IL1RN;IRAK2;IFNGR2;BIRC2;RUNX1;TRAF1;CYLD;SOCS3;IFNAR2;RIPK2;PTPN11;PTPN1;WNT5A;IFIH1
6959,GO:0030595,4.12017838941598e-07,0.999999932987064,15,102,leukocyte chemotaxis,BP,CXCL2;IL1B;CXCL1;CXCL3;CXCL8;CCL20;EDN1;CXCL5;ADAM8;VEGFC;IL23A;IL16;SAA1;WNT5A;CXCL16
3273,GO:0006953,4.16528335911626e-07,0.99999998358197,7,17,acute-phase response,BP,IL1B;IL1A;TNF;PTGS2;IL1RN;CEBPB;SAA1
12565,GO:0050714,4.26259740856199e-07,0.999999910586823,19,146,positive regulation of protein secretion,BP,IL1B;IL1A;TNF;PANX1;HCAR2;CD274;TRIM16;ADAM8;VEGFC;PPARD;RIPK2;SAA1;FERMT1;SOX4;OXCT1;HLA-E;WNT5A;ADAM9;IFIH1
10585,GO:0043549,4.29042837850203e-07,0.999999876005315,47,642,regulation of kinase activity,BP,TNFAIP3;IL1B;SDC4;TNF;EFNA1;TGFA;EDN1;ERRFI1;IRAK2;TNFRSF10B;EPHA2;GADD45A;TRIB1;BMP2;CAB39;MAP2K3;RAP2B;CDKN1A;ADRB2;DUSP16;CDKN2B;EREG;DUSP8;DUSP1;ADAM8;OXSR1;IL23A;DUSP10;SOCS3;RIPK2;SAA1;NRG1;PTPN11;MAP3K8;SPAG9;TRAF4;CCNL1;CDK6;PTPN1;CORO1C;WNT5A;ADAM9;PDPK1;TNFRSF10A;YWHAG;SFN;ERN1
13755,GO:0060326,4.48967214033345e-07,0.999999910079744,18,142,cell chemotaxis,BP,CXCL2;IL1B;CXCL1;CXCL3;HBEGF;CXCL8;CCL20;EDN1;EPHA2;CXCL5;ADAM8;VEGFC;IL23A;IL16;SAA1;PIP5K1A;WNT5A;CXCL16
4554,GO:0010634,4.54158101661686e-07,0.999999920454046,16,103,positive regulation of epithelial cell migration,BP,ZC3H12A;HBEGF;ETS1;PTGS2;EDN1;MAP2K3;JUN;VEGFC;PLK2;SOX9;RHOB;HDAC9;WNT5A;ADAM9;PDPK1;NFE2L2
12777,GO:0051049,4.77278508439597e-07,1,68,1112,regulation of transport,BP,NFKBIA;IL1B;IL1A;ZC3H12A;INHBA;SDC4;TNF;PPIF;PTGS2;PMAIP1;NFKB1;TRPV3;EDN1;PANX1;HCAR2;LIF;RRAD;CAB39;CDKN1A;CD274;ADRB2;UGCG;TRIM16;EHD1;PIM3;ADAM8;LDLR;VEGFC;NEDD4L;OXSR1;BBC3;PLK3;LIPG;CREB1;PPARD;USP36;IL16;BDKRB1;SLC9A1;AZIN1;PLAGL2;RIPK2;SAA1;ITGAV;TP53BP2;STX1A;NRG1;PML;FERMT1;PTPN11;SOX4;OXCT1;YRDC;PTPN1;ABL2;HLA-E;WNT5A;NUP153;INSIG1;ADAM9;PDPK1;NFE2L2;YWHAH;SGK1;YWHAG;SFN;IFIH1;SMPD3
11319,GO:0045639,5.04788955187967e-07,0.999999938573251,12,59,positive regulation of myeloid cell differentiation,BP,INHBA;ETS1;TNF;LIF;TRIB1;JUN;ZFP36L1;RUNX1;IL23A;CREB1;JAG1;KLF10
16701,GO:0097659,5.11865435013301e-07,1,142,2986,nucleic acid-templated transcription,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;BTG2;NFKBID;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;KLF6;ZNF697;BHLHE40;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;HAS3;IRAK2;KLF7;CREB5;EHF;RELB;MAFF;LIF;TRIB1;SQSTM1;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ADRB2;CEBPB;ARNTL2;RUNX1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;BCL10;TRAF1;NABP1;DLX2;VGLL3;CYLD;ADAM8;KLF3;ZNF217;NEDD4L;SMAD3;IL23A;PLK3;PIM1;CREB1;HIVEP2;PPARD;CCDC85B;IL16;ZFP36;SLC9A1;MAFK;PNRC1;ELL2;JAG1;PLAGL2;RIPK2;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;POLR3A;ZNF460;FOXN2;UHRF1;MXD1;SOX4;FOSL2;CCNL1;FAM83G;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;IER5;TFE3;TOB2;MAFG;MTF1;WNT5A;INSIG1;PDPK1;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;RELA;BACH1;BTAF1;POLR3D;TDG;ELF4;CREG1;ERN1;ATXN7;BRD2;FUBP3
9869,GO:0042129,5.3835666220954e-07,0.999999917931779,14,87,regulation of T cell proliferation,BP,IL1B;SDC4;CD274;IRF1;CEBPB;PELI1;IL6ST;RC3H1;IL23A;TFRC;EFNB1;CD55;RIPK2;HLA-E
8093,GO:0032774,6.12536127918634e-07,1,142,2996,RNA biosynthetic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;BTG2;NFKBID;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;KLF6;ZNF697;BHLHE40;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;HAS3;IRAK2;KLF7;CREB5;EHF;RELB;MAFF;LIF;TRIB1;SQSTM1;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ADRB2;CEBPB;ARNTL2;RUNX1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;BCL10;TRAF1;NABP1;DLX2;VGLL3;CYLD;ADAM8;KLF3;ZNF217;NEDD4L;SMAD3;IL23A;PLK3;PIM1;CREB1;HIVEP2;PPARD;CCDC85B;IL16;ZFP36;SLC9A1;MAFK;PNRC1;ELL2;JAG1;PLAGL2;RIPK2;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;POLR3A;ZNF460;FOXN2;UHRF1;MXD1;SOX4;FOSL2;CCNL1;FAM83G;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;IER5;TFE3;TOB2;MAFG;MTF1;WNT5A;INSIG1;PDPK1;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;RELA;BACH1;BTAF1;POLR3D;TDG;ELF4;CREG1;ERN1;ATXN7;BRD2;FUBP3
542,GO:0001660,6.63623380383871e-07,0.999999992797631,5,7,fever generation,BP,IL1B;IL1A;TNF;PTGS2;IL1RN
4369,GO:0009986,6.75694649256612e-07,0.999999776163271,33,375,cell surface,CC,PLAUR;HBEGF;PLAU;SDC4;TNF;TGFA;SEMA7A;TNFRSF10B;EPHA2;CD83;BMP2;CD274;B4GALT1;IL6ST;ADAM8;LDLR;ITGA5;TFRC;LIPG;F3;SLC9A1;CD55;ANTXR2;ITGAV;NRG1;DCBLD2;AREG;IL7R;HLA-E;WNT5A;ADAM9;TNFRSF10A;ADAMTS9
2859,GO:0006351,6.76933221772372e-07,1,141,2972,transcription, DNA-templated,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;BTG2;NFKBID;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;KLF6;ZNF697;BHLHE40;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;HAS3;IRAK2;KLF7;CREB5;EHF;RELB;MAFF;LIF;TRIB1;SQSTM1;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ADRB2;CEBPB;ARNTL2;RUNX1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;BCL10;TRAF1;NABP1;DLX2;VGLL3;CYLD;ADAM8;KLF3;ZNF217;NEDD4L;SMAD3;IL23A;PLK3;PIM1;CREB1;HIVEP2;PPARD;CCDC85B;IL16;ZFP36;SLC9A1;MAFK;PNRC1;ELL2;JAG1;PLAGL2;RIPK2;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;POLR3A;ZNF460;FOXN2;UHRF1;MXD1;SOX4;FOSL2;CCNL1;FAM83G;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;IER5;TFE3;MAFG;MTF1;WNT5A;INSIG1;PDPK1;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;RELA;BACH1;BTAF1;POLR3D;TDG;ELF4;CREG1;ERN1;ATXN7;BRD2;FUBP3
3625,GO:0008083,7.64743545629938e-07,0.999999901611542,12,67,growth factor activity,MF,CXCL1;HBEGF;CSF2;INHBA;TGFA;LIF;BMP2;EREG;VEGFC;JAG1;NRG1;AREG
15207,GO:0071356,7.76815909136208e-07,0.999999812419294,21,202,cellular response to tumor necrosis factor,BP,NFKBIA;TNFAIP3;ZC3H12A;BIRC3;TNF;CXCL8;CCL20;NFKB1;EDN1;CLDN1;TNFRSF10B;BIRC2;TJP2;ZFP36L1;RELT;TRAF1;CYLD;ZFP36;TNFRSF10A;NFE2L2;RELA
888,GO:0002252,7.78039332129513e-07,0.999999706711632,50,749,immune effector process,BP,TNFAIP3;IL1B;ZC3H12A;CXCL1;PLAUR;BIRC3;PLAU;TICAM1;TNF;PMAIP1;NFKB1;SEMA7A;RELB;CXCL5;CAB39;RAP2B;BIRC2;BCL3;AMPD3;IRF1;B4GALT1;BCL10;ADAM8;RC3H1;IL23A;DUSP10;TFRC;SERPINB1;RAET1L;CD55;IFNAR2;JAG1;RIPK2;ITGAV;PML;POU2F2;POLR3A;VCL;COTL1;IL7R;HLA-E;WNT5A;PDPK1;CTSC;RELA;POLR3D;CREG1;ISG20;IFIH1;RAB24
7319,GO:0031327,7.89388592759914e-07,0.999999739277257,71,1202,negative regulation of cellular biosynthetic process,BP,ZC3H12A;BTG2;HBEGF;CSF2;INHBA;ELF3;TNF;REL;BHLHE40;NFKB1;PRDM1;TBX3;NFKB2;EFNA1;EDN1;ERRFI1;CPEB2;RELB;SQSTM1;BMP2;JUN;JUNB;BCL3;OVOL1;ETS2;IRF1;ZFP36L1;ENC1;CEBPB;NAB1;EREG;DUSP1;DLX2;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;PLK3;CREB1;PPARD;CCDC85B;ZFP36;MAFK;CYP27B1;NRARP;SOX9;NRG1;ZNF451;PML;ELK3;UHRF1;MXD1;HDAC9;HIVEP1;KLF10;SKIL;SAMD4A;TOB2;QKI;CELF1;WNT5A;NUP153;INSIG1;ZBTB21;RELA;BACH1;BTAF1;TDG;CREG1;ITM2B
732,GO:0001959,8.02021958598309e-07,0.999999842082227,17,127,regulation of cytokine-mediated signaling pathway,BP,TNFAIP3;BIRC3;TNF;EDN1;IL1RN;IRAK2;IFNGR2;BIRC2;RUNX1;TRAF1;CYLD;SOCS3;IFNAR2;RIPK2;PTPN11;PTPN1;WNT5A
11301,GO:0045619,8.06774062611896e-07,0.999999861696683,15,99,regulation of lymphocyte differentiation,BP,NFKBID;INHBA;PRDM1;CD83;IRF1;ZFP36L1;RUNX1;CYLD;ADAM8;RC3H1;IL23A;DUSP10;RIPK2;NRARP;IL7R
7995,GO:0032611,8.08744240073045e-07,0.999999922160514,10,42,interleukin-1 beta production,BP,TNFAIP3;IL1B;ZC3H12A;ERRFI1;PANX1;TRIM16;SMAD3;RIPK2;PML;WNT5A
7695,GO:0032147,8.28893695095456e-07,0.999999769782442,25,238,activation of protein kinase activity,BP,IL1B;TNF;TGFA;IRAK2;TNFRSF10B;GADD45A;BMP2;CAB39;MAP2K3;ADRB2;OXSR1;IL23A;RIPK2;SAA1;NRG1;PTPN11;MAP3K8;SPAG9;TRAF4;PTPN1;WNT5A;ADAM9;PDPK1;TNFRSF10A;ERN1
11317,GO:0045637,8.29341237504282e-07,0.999999807487506,20,183,regulation of myeloid cell differentiation,BP,NFKBIA;CSF2;INHBA;ETS1;TNF;LIF;TRIB1;JUN;TJP2;ZFP36L1;CEBPB;RUNX1;IL23A;CREB1;ZFP36;JAG1;KLF10;CDK6;TFE3;TOB2
18526,GO:1903707,8.82867779814793e-07,0.999999858457925,14,95,negative regulation of hemopoiesis,BP,NFKBIA;NFKBID;INHBA;TRIB1;TJP2;IRF1;ZFP36L1;CYLD;RC3H1;ZFP36;NRARP;CDK6;TOB2;NFE2L2
1172,GO:0002793,8.96541640668883e-07,0.999999801371405,19,154,positive regulation of peptide secretion,BP,IL1B;IL1A;TNF;PANX1;HCAR2;CD274;TRIM16;ADAM8;VEGFC;PPARD;RIPK2;SAA1;FERMT1;SOX4;OXCT1;HLA-E;WNT5A;ADAM9;IFIH1
4385,GO:0010035,9.0971653561855e-07,0.999999710332243,30,346,response to inorganic substance,BP,TNFAIP3;IL1A;ZC3H12A;CSF2;ETS1;TNF;PPIF;PTGS2;FOSL1;KDM6B;EDN1;CLDN1;JUN;JUNB;HMGCS1;SOD2;DUSP1;TXNRD1;NEDD4L;CREB1;PPP1R15B;NDRG1;RHOB;GCH1;AREG;MTF1;WNT5A;ADAM9;NFE2L2;RELA
148,GO:0000302,9.80744901073655e-07,0.99999978049302,19,165,response to reactive oxygen species,BP,TNFAIP3;ETS1;TNF;PPIF;FOSL1;KDM6B;EDN1;JUN;SOD2;DUSP1;TXNRD1;PLK3;PPP1R15B;RHOB;GCH1;AREG;ADAM9;NFE2L2;RELA
9984,GO:0042379,9.83402851493329e-07,0.999999951594854,7,22,chemokine receptor binding,MF,CXCL2;CXCL1;CXCL3;CXCL8;CCL20;CXCL5;CXCL16
15376,GO:0071621,1.03596202871975e-06,0.999999895337836,10,48,granulocyte chemotaxis,BP,CXCL2;IL1B;CXCL1;CXCL3;CXCL8;CCL20;EDN1;CXCL5;IL23A;SAA1
12613,GO:0050790,1.05373068121592e-06,0.99999963398594,88,1614,regulation of catalytic activity,BP,TNFAIP3;IL1B;CXCL1;PLAUR;BIRC3;SDC4;TNF;SERPINB2;PPIF;CCL20;PTGS2;PMAIP1;NFKB1;PLEKHF1;EFNA1;TGFA;EDN1;ERRFI1;IRAK2;CPEB2;TNFRSF10B;EPHA2;GADD45A;TRIB1;BMP2;CAB39;MAP2K3;JUN;RAP2B;BIRC2;CDKN1A;ADRB2;DUSP16;PPP1R15A;CDKN2B;EREG;ANKLE2;DUSP8;TFPI2;DUSP1;BCL10;FGD6;DCUN1D3;PPP1R10;ADAM8;OXSR1;SMAD3;IL23A;DUSP10;BBC3;SERPINB8;F3;SERPINB1;SOCS3;ZFP36;CYP27B1;AZIN1;RIPK2;SAA1;PPP1R15B;PIP5K1A;NRG1;PML;RASA2;CDC42EP1;PTPN11;MAP3K8;UHRF1;SPAG9;GCH1;FEM1B;TRAF4;CCNL1;CDK6;PTPN1;CORO1C;ABL2;WNT5A;ADAM9;PDPK1;TNFRSF10A;SGK1;AGFG1;YWHAG;TDG;SFN;ERN1;SH3RF2
12959,GO:0051338,1.1413374430462e-06,0.999999564799819,50,732,regulation of transferase activity,BP,TNFAIP3;IL1B;SDC4;TNF;EFNA1;TGFA;EDN1;ERRFI1;IRAK2;TNFRSF10B;EPHA2;GADD45A;TRIB1;BMP2;CAB39;MAP2K3;RAP2B;CDKN1A;ADRB2;DUSP16;CDKN2B;EREG;DUSP8;DUSP1;DCUN1D3;ADAM8;OXSR1;IL23A;DUSP10;SOCS3;ZFP36;RIPK2;SAA1;NRG1;PTPN11;MAP3K8;SPAG9;FEM1B;TRAF4;CCNL1;CDK6;PTPN1;CORO1C;WNT5A;ADAM9;PDPK1;TNFRSF10A;YWHAG;SFN;ERN1
14629,GO:0070201,1.26774492898688e-06,0.999999525124117,39,515,regulation of establishment of protein localization,BP,IL1B;IL1A;ZC3H12A;TNF;PTGS2;PMAIP1;PANX1;HCAR2;CDKN1A;CD274;UGCG;TRIM16;PIM3;ADAM8;VEGFC;BBC3;PLK3;PPARD;USP36;PLAGL2;RIPK2;SAA1;TP53BP2;STX1A;NRG1;PML;FERMT1;PTPN11;SOX4;OXCT1;PTPN1;HLA-E;WNT5A;INSIG1;ADAM9;YWHAH;YWHAG;SFN;IFIH1
12984,GO:0051384,1.27947877829014e-06,0.999999788889652,14,91,response to glucocorticoid,BP,TNF;PTGS2;FOSL1;EDN1;ERRFI1;IL1RN;CLDN1;CDKN1A;ZFP36L1;DUSP1;ZFP36;AREG;ADM;ADAM9
4372,GO:0009991,1.28698685607833e-06,0.999999583054294,30,343,response to extracellular stimulus,BP,IL1B;ZC3H12A;NUAK2;PTGS2;PMAIP1;FOSL1;NOCT;PLEKHF1;PANX1;JUN;CDKN1A;ADRB2;CDKN2B;HMGCS1;BCL10;LDLR;PIM1;LIPG;CREB1;PPARD;SLC25A25;ZFP36;CYP27B1;OXCT1;KLF10;ADM;NFE2L2;RELA;UPP1;AHCY
3281,GO:0006970,1.30288507926747e-06,0.999999845254296,11,53,response to osmotic stress,BP,TNF;PTGS2;ERRFI1;CLDN1;RELB;CAB39;ZFP36L1;OXSR1;PLK3;PDPK1;TSC22D2
9851,GO:0042098,1.37929019531951e-06,0.999999751298039,15,107,T cell proliferation,BP,IL1B;SDC4;CD274;IRF1;CEBPB;PELI1;IL6ST;RC3H1;IL23A;TFRC;EFNB1;CD55;RIPK2;HLA-E;ELF4
1108,GO:0002695,1.38054764674103e-06,0.999999770909699,14,90,negative regulation of leukocyte activation,BP,TNFAIP3;ZC3H12A;NFKBID;INHBA;SDC4;PRDM1;CD274;IRF1;CEBPB;PELI1;CYLD;LDLR;RC3H1;NRARP
1157,GO:0002763,1.40119757677612e-06,0.999999879622769,9,35,positive regulation of myeloid leukocyte differentiation,BP,TNF;LIF;TRIB1;JUN;ZFP36L1;RUNX1;IL23A;CREB1;KLF10
4276,GO:0009636,1.45301806335961e-06,0.999999546424481,28,324,response to toxic substance,BP,TNFAIP3;ZC3H12A;ETS1;TNF;PPIF;PTGS2;NFKB1;FOSL1;KDM6B;EDN1;CLDN1;JUN;BIRC2;CDKN1A;SOD2;DUSP1;SLC6A14;TXNRD1;CREB1;PPP1R15B;RHOB;GCH1;OXCT1;AREG;HDAC9;ADAM9;NFE2L2;RELA
11434,GO:0045860,1.48737771119723e-06,0.999999495094032,32,371,positive regulation of protein kinase activity,BP,IL1B;SDC4;TNF;EFNA1;TGFA;EDN1;IRAK2;TNFRSF10B;GADD45A;BMP2;CAB39;MAP2K3;CDKN1A;ADRB2;EREG;ADAM8;OXSR1;IL23A;RIPK2;SAA1;NRG1;PTPN11;MAP3K8;SPAG9;TRAF4;CCNL1;PTPN1;WNT5A;ADAM9;PDPK1;TNFRSF10A;ERN1
10796,GO:0044271,1.51950959754309e-06,0.999999422803181,172,3945,cellular nitrogen compound biosynthetic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;BTG2;NFKBID;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;KLF6;ZNF697;BHLHE40;PTGS2;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;ODC1;HAS3;IRAK2;KLF7;CREB5;CPEB2;EHF;RELB;MAFF;LIF;TRIB1;SQSTM1;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;NMNAT2;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;ZFP36L1;ENC1;ADRB2;CEBPB;ARNTL2;UGCG;PPP1R15A;RUNX1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;DUSP1;BCL10;TRAF1;SGMS2;NABP1;DLX2;VGLL3;CYLD;ADAM8;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;IL23A;PLK3;PIM1;CREB1;HIVEP2;PPARD;CCDC85B;IL16;ZFP36;SLC9A1;MAFK;LARP4B;PNRC1;ELL2;AZIN1;JAG1;PLAGL2;RIPK2;PPP1R15B;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;POLR3A;SLC7A2;ZNF460;FOXN2;UHRF1;PANK3;MXD1;GCH1;SOX4;FOSL2;EIF1;CCNL1;FAM83G;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;RBM3;IER5;SAMD4A;TFE3;TOB2;ADM;MAFG;MTF1;QKI;CELF1;PMM2;WNT5A;NUP153;INSIG1;PDPK1;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;SAT1;RELA;BACH1;BTAF1;POLR3D;ALAS1;TDG;ELF4;CREG1;ERN1;UPP1;ATXN7;BRD2;PABPC4;FUBP3;SMPD3
11274,GO:0045580,1.52567085563623e-06,0.999999766779201,13,78,regulation of T cell differentiation,BP,NFKBID;PRDM1;CD83;IRF1;RUNX1;CYLD;ADAM8;RC3H1;IL23A;DUSP10;RIPK2;NRARP;IL7R
12530,GO:0050671,1.54898712924051e-06,0.999999785113505,12,71,positive regulation of lymphocyte proliferation,BP,IL1B;TICAM1;CDKN1A;CD274;PELI1;IL6ST;IL23A;TFRC;EFNB1;CD55;RIPK2;HLA-E
11775,GO:0046633,1.56781677814808e-06,0.999999948753788,6,13,alpha-beta T cell proliferation,BP,IRF1;IL23A;CD55;RIPK2;HLA-E;ELF4
4859,GO:0014070,1.56966276565944e-06,0.999999379195566,45,634,response to organic cyclic compound,BP,NFKBIA;IL1B;ZC3H12A;BTG2;INHBA;TICAM1;ETS1;TNF;PTGS2;PMAIP1;NFKB1;FOSL1;EDN1;ERRFI1;IL1RN;CLDN1;PANX1;CD83;BMP2;JUN;BIRC2;CDKN1A;CLDN4;JUNB;NAMPT;ZFP36L1;CEBPB;RUNX1;HMGCS1;PELI1;DUSP1;SMAD3;PIM1;PPARD;ZFP36;SLC9A1;CYP27B1;RIPK2;AREG;ADM;INSIG1;ADAM9;YWHAH;RELA;IFIH1
15303,GO:0071496,1.58858728932974e-06,0.999999554378028,24,238,cellular response to external stimulus,BP,IL1B;ZC3H12A;NUAK2;PTGS2;PMAIP1;NFKB1;FOSL1;PLEKHF1;TNFRSF10B;GADD45A;JUN;CDKN1A;IRF1;CDKN2B;BCL10;PIM1;SLC9A1;CYP27B1;SOX9;PTPN11;KLF10;TNFRSF10A;NFE2L2;UPP1
12218,GO:0048468,1.60223228138167e-06,0.999999299873894,77,1294,cell development,BP,IL1B;IL1A;BTG2;INHBA;SDC4;TNF;PRDM1;TBX3;EFNA1;IRF6;EDN1;SEMA7A;CLDN1;KLF7;EFNB2;EPHA2;LIF;TRIB1;KCTD11;BMP2;JUN;CDKN1A;TJP2;TAF4B;ENC1;RUNX1;EREG;EHD1;ZSWIM4;B4GALT1;IL6ST;DLX2;LDLR;VEGFC;TACSTD2;NEDD4L;SMAD3;DUSP10;PLK2;CREB1;EFNB1;RAPH1;JAG1;NDRG1;ITGAV;SOX9;NRG1;POU2F2;PTPN11;SPAG9;FEM1B;SOX4;FOSL2;VCL;AREG;HDAC9;SKIL;CDK6;CORO1C;PRPF19;ADM;ABL2;QKI;CELF1;WNT5A;PDPK1;FRMD6;NFE2L2;YWHAH;SGK1;B3GNT2;RELA;AGFG1;YWHAG;SFN;PABPC4;PDLIM5
7486,GO:0031649,1.6168084808155e-06,0.999999946864361,6,13,heat generation,BP,IL1B;IL1A;TNF;PTGS2;IL1RN;ADRB2
16653,GO:0097529,1.63701988139882e-06,0.999999746396377,13,84,myeloid leukocyte migration,BP,CXCL2;IL1B;IL1A;CXCL1;CXCL3;CXCL8;CCL20;EDN1;CXCL5;ADAM8;VEGFC;IL23A;SAA1
17724,GO:1901652,1.7928881206743e-06,0.999999409403836,30,340,response to peptide,BP,NFKBIA;TNFAIP3;IL1B;BTG2;PTGS2;NFKB1;EDN1;ERRFI1;CPEB2;ZFP36L1;ADRB2;TRIM16;EREG;KLF3;CREB1;SOCS3;SLC9A1;JAG1;RIPK2;PTPN11;AREG;HDAC9;KLF10;PTPN1;ADM;ATP6V1C2;PDPK1;NFE2L2;RELA;YWHAG
8201,GO:0032946,1.81372768972317e-06,0.999999744076296,12,72,positive regulation of mononuclear cell proliferation,BP,IL1B;TICAM1;CDKN1A;CD274;PELI1;IL6ST;IL23A;TFRC;EFNB1;CD55;RIPK2;HLA-E
8020,GO:0032651,1.85948096206753e-06,0.999999833643615,9,36,regulation of interleukin-1 beta production,BP,TNFAIP3;ZC3H12A;ERRFI1;PANX1;TRIM16;SMAD3;RIPK2;PML;WNT5A
17308,GO:0140110,2.01770858664379e-06,0.999999302954278,80,1400,transcription regulator activity,MF,NFKBIZ;BTG2;NFKBID;ELF3;ETS1;REL;KLF6;BHLHE40;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;KDM6B;IRF6;KLF7;CREB5;EHF;RELB;MAFF;ZNF267;JUN;BIRC2;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;IRF1;TAF4B;ZFP36L1;CEBPB;ARNTL2;RUNX1;NAB1;ELMSAN1;BCL10;DLX2;VGLL3;KLF3;ZNF217;SMAD3;CREB1;HIVEP2;PPARD;MAFK;PLAGL2;SOX9;NRG1;ZNF451;POU2F2;NCOA7;ELK3;FOXN2;UHRF1;MXD1;SOX4;FOSL2;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;TFE3;TOB2;MAFG;MTF1;WNT5A;KDM6A;NFE2L2;TSC22D2;RELA;BACH1;BTAF1;TDG;ELF4;CREG1;FUBP3
12579,GO:0050730,2.10987307433244e-06,0.999999526000554,18,149,regulation of peptidyl-tyrosine phosphorylation,BP,HBEGF;CSF2;EFNA1;TGFA;ERRFI1;LIF;IL24;RAP2B;EREG;IL6ST;VEGFC;IL23A;ITGA5;SOCS3;RIPK2;NRG1;AREG;PTPN1
998,GO:0002460,2.1099712898256e-06,0.999999551166974,17,135,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,TNFAIP3;IL1B;TNF;NFKB2;RELB;BCL3;BCL10;RC3H1;IL23A;TFRC;CD55;JAG1;RIPK2;POU2F2;IL7R;HLA-E;CTSC
12603,GO:0050776,2.11500344212085e-06,0.999999169782405,41,577,regulation of immune response,BP,NFKBIA;TNFAIP3;IL1B;ZC3H12A;BIRC3;TICAM1;TNF;TNIP1;NFKB1;SEMA7A;IRAK2;RELB;IFNGR2;JUN;BIRC2;IRF1;RUNX1;EREG;PELI1;BCL10;IL6ST;CYLD;ADAM8;SMAD3;RC3H1;IL23A;DUSP10;TFRC;SOCS3;CD55;IFNAR2;RIPK2;PTPN11;IL7R;PTPN1;HLA-E;WNT5A;PDPK1;RELA;POLR3D;IFIH1
1098,GO:0002685,2.21508555327058e-06,0.999999613533464,14,100,regulation of leukocyte migration,BP,CXCL2;IL1A;CXCL1;CXCL3;TNF;CXCL8;CCL20;EDN1;CXCL5;ADAM8;VEGFC;IL23A;BDKRB1;WNT5A
10329,GO:0043122,2.27881026433992e-06,0.999999433979464,20,181,regulation of I-kappaB kinase/NF-kappaB signaling,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;BIRC3;NFKBID;TICAM1;TNF;REL;TNIP1;TNFRSF10B;SQSTM1;BIRC2;PELI1;BCL10;PLK2;RIPK2;WNT5A;PDPK1;RELA
8009,GO:0032635,2.30031290119602e-06,0.99999966959474,12,68,interleukin-6 production,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;TICAM1;TNF;CEBPB;EREG;BCL10;RIPK2;WNT5A;IFIH1
10357,GO:0043170,2.3335992515023e-06,0.999999112763318,269,6844,macromolecule metabolic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;HBEGF;PLAU;NFKBID;CSF2;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;CXCL8;REL;SERPINB2;PPIF;KLF6;NUAK2;CCL20;ZC3H12C;SPRR2D;ZNF697;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;ODC1;SEMA7A;PHLDA1;HAS3;ERRFI1;IRAK2;KLF7;CREB5;DAPP1;CPEB2;EHF;SPRR2A;TNFRSF10B;EPHA2;RELB;GADD45A;MAFF;LIF;TRIB1;KCTD11;SQSTM1;BMP2;PHLDA2;IL24;CAB39;ZNF267;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ENC1;ADRB2;CEBPB;DUSP16;ARNTL2;PPP1R15A;MAST4;RUNX1;N4BP1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;ANKLE2;DUSP8;B4GALT1;TFPI2;DUSP1;BCL10;DCUN1D3;TRAF1;PPP1R10;PIM3;IL6ST;B3GNT5;NABP1;DLX2;VGLL3;CYLD;ADAM8;LDLR;VEGFC;KLF3;ZNF217;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;DIEXF;PIM1;ITGA5;TFRC;LIPG;KLHL21;CREB1;SERPINB8;F3;STK40;HIVEP2;PPARD;SERPINB1;SOCS3;CCDC85B;RAET1L;USP36;IL16;BDKRB1;ZFP36;SLC9A1;MAFK;LARP4B;CD55;PNRC1;ELL2;AZIN1;JAG1;PLAGL2;RIPK2;PHKG2;SAA1;PPP1R15B;USP53;ITGAV;CLK4;NRARP;SOX9;NRG1;ZNF451;FEM1C;PML;POU2F2;RASA2;PPTC7;FERMT1;NCOA7;ELK3;POLR3A;ZNF460;FOXN2;PTPN11;MAP3K8;UHRF1;MXD1;SPAG9;FEM1B;SOX4;USP31;FOSL2;TRAF4;EIF1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;ADAMTS1;HIVEP1;NFKBIB;KLF10;AEN;SKIL;IL7R;RBM3;CDK6;IER5;YRDC;SAMD4A;PTPN1;TFE3;CORO1C;PRPF19;TOB2;ADM;MAFG;ABL2;MTF1;QKI;CELF1;PMM2;WNT5A;NUP153;INSIG1;ADAM9;LCE1C;PDPK1;TNFRSF10A;ADAMTS9;RNF19A;CTSC;ERO1A;KDM6A;ZBTB21;NFE2L2;YWHAH;SGK1;B3GNT2;TSC22D2;RELA;AGFG1;RNF11;BACH1;BTAF1;ANKK1;GINS3;POLR3D;YWHAG;TDG;ELF4;CREG1;SFN;ITM2B;ERN1;SH3RF2;ISG20;TMEM132A;ATXN7;IFIH1;ADAMTS6;BRD2;PABPC4;DSE;FUBP3;SMPD3
9426,GO:0035994,2.56090196865936e-06,0.999999908694098,6,13,response to muscle stretch,BP,NFKBIA;NFKB1;EDN1;JUN;SLC9A1;RELA
12887,GO:0051222,2.60158568950805e-06,0.999999181675243,27,300,positive regulation of protein transport,BP,IL1B;IL1A;ZC3H12A;TNF;PTGS2;PANX1;HCAR2;CD274;UGCG;TRIM16;ADAM8;VEGFC;PLK3;PPARD;USP36;PLAGL2;RIPK2;SAA1;NRG1;FERMT1;SOX4;OXCT1;HLA-E;WNT5A;ADAM9;SFN;IFIH1
9788,GO:0040007,2.63461190871466e-06,0.999998928440773,46,653,growth,BP,HBEGF;INHBA;TNF;EDN1;SEMA7A;KCTD11;SQSTM1;PHLDA2;CDKN1A;SERTAD2;ZFP36L1;ADRB2;EREG;NEDD9;DCUN1D3;NEDD4L;SMAD3;DUSP10;PIM1;WISP1;CREB1;STK40;PPARD;SLC25A25;SOCS3;CCDC85B;BDKRB1;RAPH1;SLC9A1;CYP27B1;SOX9;NRG1;PML;PTPN11;DCBLD2;VCL;AREG;PRPF19;ADM;WNT5A;KDM6A;SGK1;CREG1;SFN;CXCL16;PDLIM5
2938,GO:0006464,2.71181251075377e-06,0.999998668150569,144,3079,cellular protein modification process,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;HBEGF;CSF2;INHBA;TICAM1;SDC4;TNF;PPIF;NUAK2;CCL20;SPRR2D;PTGS2;RNF19B;TNIP1;NFKB1;EFNA1;TGFA;KDM6B;EDN1;SEMA7A;ERRFI1;IRAK2;DAPP1;SPRR2A;TNFRSF10B;EPHA2;GADD45A;LIF;TRIB1;KCTD11;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;BIRC2;CDKN1A;ZFP36L1;ENC1;ADRB2;DUSP16;PPP1R15A;MAST4;N4BP1;CDKN2B;TRIM16;EREG;PELI1;ANKLE2;DUSP8;B4GALT1;DUSP1;BCL10;DCUN1D3;PPP1R10;PIM3;IL6ST;B3GNT5;CYLD;ADAM8;VEGFC;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;PLK3;PIM1;ITGA5;KLHL21;CREB1;STK40;SOCS3;RAET1L;USP36;BDKRB1;ZFP36;RIPK2;PHKG2;SAA1;PPP1R15B;USP53;ITGAV;CLK4;SOX9;NRG1;ZNF451;FEM1C;PML;RASA2;PPTC7;NCOA7;PTPN11;MAP3K8;UHRF1;SPAG9;FEM1B;SOX4;USP31;TRAF4;AREG;CCNL1;TNFAIP1;HDAC9;CDK6;PTPN1;CORO1C;PRPF19;ABL2;PMM2;WNT5A;NUP153;ADAM9;LCE1C;PDPK1;TNFRSF10A;RNF19A;ERO1A;KDM6A;NFE2L2;SGK1;B3GNT2;RELA;RNF11;BACH1;ANKK1;YWHAG;SFN;ERN1;SH3RF2;TMEM132A;ATXN7;IFIH1
9516,GO:0036211,2.71181251075377e-06,0.999998668150569,144,3079,protein modification process,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;HBEGF;CSF2;INHBA;TICAM1;SDC4;TNF;PPIF;NUAK2;CCL20;SPRR2D;PTGS2;RNF19B;TNIP1;NFKB1;EFNA1;TGFA;KDM6B;EDN1;SEMA7A;ERRFI1;IRAK2;DAPP1;SPRR2A;TNFRSF10B;EPHA2;GADD45A;LIF;TRIB1;KCTD11;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;BIRC2;CDKN1A;ZFP36L1;ENC1;ADRB2;DUSP16;PPP1R15A;MAST4;N4BP1;CDKN2B;TRIM16;EREG;PELI1;ANKLE2;DUSP8;B4GALT1;DUSP1;BCL10;DCUN1D3;PPP1R10;PIM3;IL6ST;B3GNT5;CYLD;ADAM8;VEGFC;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;PLK3;PIM1;ITGA5;KLHL21;CREB1;STK40;SOCS3;RAET1L;USP36;BDKRB1;ZFP36;RIPK2;PHKG2;SAA1;PPP1R15B;USP53;ITGAV;CLK4;SOX9;NRG1;ZNF451;FEM1C;PML;RASA2;PPTC7;NCOA7;PTPN11;MAP3K8;UHRF1;SPAG9;FEM1B;SOX4;USP31;TRAF4;AREG;CCNL1;TNFAIP1;HDAC9;CDK6;PTPN1;CORO1C;PRPF19;ABL2;PMM2;WNT5A;NUP153;ADAM9;LCE1C;PDPK1;TNFRSF10A;RNF19A;ERO1A;KDM6A;NFE2L2;SGK1;B3GNT2;RELA;RNF11;BACH1;ANKK1;YWHAG;SFN;ERN1;SH3RF2;TMEM132A;ATXN7;IFIH1
14876,GO:0070665,2.86301716329312e-06,0.999999575621834,12,75,positive regulation of leukocyte proliferation,BP,IL1B;TICAM1;CDKN1A;CD274;PELI1;IL6ST;IL23A;TFRC;EFNB1;CD55;RIPK2;HLA-E
15148,GO:0071260,2.95706839588861e-06,0.999999612436279,11,58,cellular response to mechanical stimulus,BP,IL1B;PTGS2;NFKB1;TNFRSF10B;GADD45A;IRF1;BCL10;SLC9A1;SOX9;PTPN11;TNFRSF10A
14955,GO:0070851,2.97007124085386e-06,0.999999515103761,13,81,growth factor receptor binding,MF,IL1B;IL1A;IL36G;HBEGF;CSF2;TGFA;IL1RN;EREG;IL6ST;VEGFC;ITGA5;AREG;ERN1
14566,GO:0070098,2.99846190752354e-06,0.999999824753341,7,22,chemokine-mediated signaling pathway,BP,CXCL2;CXCL1;CXCL3;CXCL8;CCL20;EDN1;CXCL5
9688,GO:0038066,3.10488634451855e-06,0.999999761586786,8,28,p38MAPK cascade,BP,IL1B;ZC3H12A;GADD45A;BMP2;MAP2K3;ZFP36L1;DUSP10;ZFP36
7497,GO:0031667,3.24125407885016e-06,0.999998942792892,28,320,response to nutrient levels,BP,IL1B;ZC3H12A;NUAK2;PTGS2;PMAIP1;PLEKHF1;PANX1;JUN;CDKN1A;ADRB2;CDKN2B;HMGCS1;BCL10;LDLR;PIM1;LIPG;CREB1;PPARD;SLC25A25;ZFP36;CYP27B1;OXCT1;KLF10;ADM;NFE2L2;RELA;UPP1;AHCY
4268,GO:0009615,3.48395034504119e-06,0.999999036200016,22,223,response to virus,BP,TNFAIP3;IL1B;ZC3H12A;BIRC3;TICAM1;TNF;PMAIP1;FOSL1;ODC1;IFNGR2;BIRC2;BCL3;IRF1;IL23A;IFNAR2;PML;POLR3A;CDK6;RELA;POLR3D;ISG20;IFIH1
12799,GO:0051090,3.61541507693965e-06,0.999998841082035,27,304,regulation of DNA binding transcription factor activity,BP,NFKBIA;TNFAIP3;IL1B;ZC3H12A;NFKBID;TICAM1;TNF;BHLHE40;NFKB1;FOSL1;NFKB2;EDN1;IRAK2;TRIB1;JUN;NFKBIE;PELI1;BCL10;TRAF1;CYLD;ADAM8;PIM1;RIPK2;NFKBIB;WNT5A;SGK1;RELA
4346,GO:0009897,3.82529900799083e-06,0.999999247527915,15,109,external side of plasma membrane,CC,TNF;SEMA7A;CD83;CD274;B4GALT1;IL6ST;LDLR;ITGA5;TFRC;F3;ANTXR2;ITGAV;NRG1;IL7R;ADAM9
6783,GO:0030217,4.01401302860234e-06,0.999999102331619,17,136,T cell differentiation,BP,NFKBID;PRDM1;RELB;CD83;BCL3;IRF1;ZFP36L1;RUNX1;CYLD;ADAM8;RC3H1;IL23A;DUSP10;RIPK2;NRARP;SOX4;IL7R
15521,GO:0071902,4.4616913383861e-06,0.999998626139975,25,265,positive regulation of protein serine/threonine kinase activity,BP,IL1B;TNF;TGFA;EDN1;IRAK2;TNFRSF10B;GADD45A;BMP2;CAB39;MAP2K3;ADRB2;ADAM8;RIPK2;SAA1;NRG1;PTPN11;MAP3K8;SPAG9;TRAF4;CCNL1;PTPN1;WNT5A;ADAM9;TNFRSF10A;ERN1
19746,GO:2000113,4.71452595852687e-06,0.999997798502901,65,1114,negative regulation of cellular macromolecule biosynthetic process,BP,ZC3H12A;BTG2;HBEGF;CSF2;ELF3;TNF;REL;BHLHE40;NFKB1;PRDM1;TBX3;NFKB2;EFNA1;EDN1;CPEB2;RELB;SQSTM1;BMP2;JUN;JUNB;BCL3;OVOL1;ETS2;IRF1;ZFP36L1;ENC1;CEBPB;NAB1;EREG;DUSP1;DLX2;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;PLK3;CREB1;PPARD;CCDC85B;ZFP36;MAFK;NRARP;SOX9;NRG1;ZNF451;PML;ELK3;UHRF1;MXD1;HDAC9;HIVEP1;KLF10;SKIL;SAMD4A;QKI;CELF1;WNT5A;NUP153;ZBTB21;RELA;BACH1;BTAF1;TDG;ITM2B
10310,GO:0043086,4.76350568990657e-06,0.99999811841992,38,535,negative regulation of catalytic activity,BP,TNFAIP3;IL1B;PLAUR;BIRC3;TNF;SERPINB2;PPIF;PTGS2;NFKB1;PLEKHF1;ERRFI1;CPEB2;TNFRSF10B;GADD45A;TRIB1;BIRC2;CDKN1A;DUSP16;PPP1R15A;CDKN2B;DUSP8;TFPI2;DUSP1;PPP1R10;DUSP10;SERPINB8;SERPINB1;SOCS3;ZFP36;CYP27B1;CDK6;PTPN1;CORO1C;PDPK1;TNFRSF10A;YWHAG;SFN;SH3RF2
11479,GO:0045936,5.0511096597362e-06,0.999998108330589,34,439,negative regulation of phosphate metabolic process,BP,TNFAIP3;IL1B;ZC3H12A;INHBA;TNF;PPIF;TNIP1;PLEKHF1;EFNA1;ERRFI1;GADD45A;LIF;TRIB1;JUN;CDKN1A;DUSP16;PPP1R15A;CDKN2B;ANKLE2;DUSP8;DUSP1;PPP1R10;DUSP10;SOCS3;BDKRB1;PPP1R15B;CDK6;PTPN1;CORO1C;PDPK1;YWHAG;SFN;SH3RF2;ATXN7
13910,GO:0060558,5.05704052304516e-06,0.999999967081652,4,5,regulation of calcidiol 1-monooxygenase activity,BP,IL1B;TNF;NFKB1;CYP27B1
12706,GO:0050921,5.07580676902897e-06,0.99999920123637,12,77,positive regulation of chemotaxis,BP,CXCL2;CXCL1;CXCL3;CXCL8;EDN1;CXCL5;VEGFC;SMAD3;IL23A;F3;IL16;WNT5A
4531,GO:0010595,5.11279235234935e-06,0.999999199810001,12,72,positive regulation of endothelial cell migration,BP,ZC3H12A;ETS1;PTGS2;EDN1;MAP2K3;VEGFC;PLK2;RHOB;HDAC9;WNT5A;PDPK1;NFE2L2
3288,GO:0006979,5.12253908800443e-06,0.999998321783135,27,324,response to oxidative stress,BP,TNFAIP3;ZC3H12A;ETS1;TNF;PPIF;PTGS2;FOSL1;KDM6B;EDN1;CPEB2;JUN;SOD2;DUSP1;TXNRD1;OXSR1;PLK3;PPP1R15B;PML;NCOA7;RHOB;GCH1;AREG;MTF1;ADAM9;ERO1A;NFE2L2;RELA
11289,GO:0045600,5.23972396117189e-06,0.999999458590997,9,39,positive regulation of fat cell differentiation,BP,ZC3H12A;PTGS2;NOCT;BMP2;ZFP36L1;CEBPB;CREB1;PPARD;ZFP36
6701,GO:0030098,5.24738392960875e-06,0.999998562897693,21,202,lymphocyte differentiation,BP,NFKBID;INHBA;KLF6;PRDM1;RELB;CD83;BCL3;IRF1;ZFP36L1;RUNX1;CYLD;ADAM8;RC3H1;IL23A;DUSP10;RIPK2;NRARP;POU2F2;SOX4;HDAC9;IL7R
4514,GO:0010563,5.27709246268126e-06,0.99999801934614,34,440,negative regulation of phosphorus metabolic process,BP,TNFAIP3;IL1B;ZC3H12A;INHBA;TNF;PPIF;TNIP1;PLEKHF1;EFNA1;ERRFI1;GADD45A;LIF;TRIB1;JUN;CDKN1A;DUSP16;PPP1R15A;CDKN2B;ANKLE2;DUSP8;DUSP1;PPP1R10;DUSP10;SOCS3;BDKRB1;PPP1R15B;CDK6;PTPN1;CORO1C;PDPK1;YWHAG;SFN;SH3RF2;ATXN7
7593,GO:0031960,5.39515489269938e-06,0.999998978808641,14,103,response to corticosteroid,BP,TNF;PTGS2;FOSL1;EDN1;ERRFI1;IL1RN;CLDN1;CDKN1A;ZFP36L1;DUSP1;ZFP36;AREG;ADM;ADAM9
1169,GO:0002790,5.46768977332593e-06,0.999998122903825,29,346,peptide secretion,BP,IL1B;IL1A;ZC3H12A;TNF;EDN1;IL1RN;PANX1;HCAR2;CD274;TRIM16;PIM3;ADAM8;VEGFC;PPARD;RIPK2;SAA1;ITGAV;STX1A;PML;POU2F2;FERMT1;PTPN11;SOX4;OXCT1;HLA-E;WNT5A;ADAM9;IFIH1;SMPD3
1254,GO:0003006,5.51984630034515e-06,0.999997958020712,33,414,developmental process involved in reproduction,BP,IL1B;IL1A;CSF2;INHBA;PTGS2;PRDM1;FOSL1;TBX3;LIF;PHLDA2;BIRC2;JUNB;TAF4B;BCL2L2;ZFP36L1;CEBPB;HMGCS1;EREG;B4GALT1;GJB3;PPARD;SOCS3;CYP27B1;SOX9;PTPN11;FEM1B;AREG;ADAMTS1;ADM;QKI;CELF1;WNT5A;AGFG1
6292,GO:0019900,5.62497857252889e-06,0.999997676757685,42,586,kinase binding,MF,TNFAIP3;TICAM1;SDC4;TNIP1;ERRFI1;EPHA2;RELB;GADD45A;TRIB1;SQSTM1;CAB39;MAP2K3;CDKN1A;RND3;CEBPB;PPP1R15A;CDKN2B;BCL10;CYLD;SMAD3;DUSP10;ZFP36;IFNAR2;ITGAV;PIP5K1A;SOX9;STX1A;NRG1;PTPN11;RHOB;SPAG9;GCH1;TRAF4;HDAC9;PTPN1;ADAM9;PDPK1;RELA;YWHAG;TDG;SFN;PDLIM5
12774,GO:0051046,5.70982208269946e-06,0.999997882780237,33,424,regulation of secretion,BP,IL1B;IL1A;ZC3H12A;INHBA;SDC4;TNF;EDN1;PANX1;HCAR2;LIF;CD274;TRIM16;PIM3;ADAM8;VEGFC;CREB1;PPARD;RIPK2;SAA1;STX1A;NRG1;PML;FERMT1;PTPN11;SOX4;OXCT1;HLA-E;WNT5A;ADAM9;PDPK1;SGK1;IFIH1;SMPD3
6849,GO:0030316,5.72453736193299e-06,0.999999191309671,11,60,osteoclast differentiation,BP,TNF;EPHA2;TJP2;JUNB;CEBPB;IL23A;TFRC;CREB1;KLF10;TFE3;TOB2
6592,GO:0022603,5.81207018610451e-06,0.999997459114337,48,713,regulation of anatomical structure morphogenesis,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;ETS1;TNF;CXCL8;PTGS2;EFNA1;EDN1;SEMA7A;IL1RN;EFNB2;EPHA2;LIF;BMP2;PHLDB2;RND3;RUNX1;EHD1;ZSWIM4;B4GALT1;FGD6;VEGFC;TACSTD2;NEDD4L;RC3H1;PLK2;PIM1;ITGA5;F3;NRARP;SOX9;NRG1;PML;CDC42EP1;RHOB;HDAC9;SKIL;CORO1C;ADM;WNT5A;ADAM9;PDPK1;ADAMTS9;NFE2L2;YWHAH;PDLIM5
4530,GO:0010594,5.89823091747146e-06,0.999998794553075,15,111,regulation of endothelial cell migration,BP,ZC3H12A;ETS1;PTGS2;EFNA1;EDN1;EPHA2;MAP2K3;VEGFC;PLK2;RHOB;HDAC9;WNT5A;PDPK1;ADAMTS9;NFE2L2
15430,GO:0071704,5.96526836608278e-06,0.999997745853644,298,7900,organic substance metabolic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;HBEGF;PLAU;NFKBID;CSF2;ITPKC;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;CXCL8;REL;SERPINB2;PPIF;KLF6;NUAK2;CCL20;ZC3H12C;SPRR2D;ZNF697;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;ODC1;SEMA7A;PHLDA1;HAS3;ERRFI1;IL1RN;IRAK2;KLF7;CREB5;DAPP1;CPEB2;EHF;SPRR2A;HCAR2;TNFRSF10B;EPHA2;RELB;GADD45A;MAFF;LIF;TRIB1;KCTD11;SQSTM1;BMP2;PHLDA2;IL24;CAB39;ZNF267;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;NMNAT2;RGMB;TJP2;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;ZFP36L1;ENC1;ADRB2;CEBPB;DUSP16;ARNTL2;UGCG;PPP1R15A;MAST4;RUNX1;N4BP1;CDKN2B;NAB1;HMGCS1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;ALDH1A3;ANKLE2;DUSP8;B4GALT1;HAL;TFPI2;DUSP1;BCL10;DCUN1D3;TRAF1;PPP1R10;PIM3;IL6ST;G0S2;B3GNT5;SGMS2;NABP1;DLX2;SLC6A14;TXNRD1;VGLL3;CYLD;ADAM8;LDLR;VEGFC;KLF3;ZNF217;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;DIEXF;PIM1;ITGA5;TFRC;LIPG;KLHL21;CREB1;SERPINB8;F3;STK40;HIVEP2;PPARD;SLC25A25;SERPINB1;SOCS3;CCDC85B;RAET1L;USP36;IL16;BDKRB1;ZFP36;SLC9A1;MAFK;LARP4B;CYP27B1;CD55;PNRC1;ELL2;AZIN1;JAG1;PLAGL2;RIPK2;PHKG2;SAA1;PPP1R15B;USP53;ITGAV;PIP5K1A;CLK4;NRARP;SOX9;NRG1;ZNF451;FEM1C;PML;POU2F2;RASA2;PPTC7;FERMT1;NCOA7;ELK3;POLR3A;SLC7A2;ZNF460;FOXN2;PTPN11;MAP3K8;UHRF1;PANK3;MXD1;SPAG9;GCH1;FEM1B;SOX4;USP31;FOSL2;TRAF4;EIF1;OXCT1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;ADAMTS1;HIVEP1;NFKBIB;KLF10;AEN;SKIL;IL7R;HEXDC;RBM3;CDK6;IER5;YRDC;SAMD4A;PTPN1;SQLE;TFE3;CORO1C;PRPF19;TOB2;ADM;MAFG;ABL2;MTF1;QKI;CELF1;PMM2;WNT5A;NUP153;MAOA;INSIG1;ADAM9;LCE1C;PDPK1;TNFRSF10A;ADAMTS9;RNF19A;CTSC;ERO1A;KDM6A;ZBTB21;NFE2L2;YWHAH;SGK1;B3GNT2;TSC22D2;SAT1;RELA;AGFG1;RNF11;BACH1;BTAF1;ANKK1;GINS3;POLR3D;ALAS1;YWHAG;TDG;ELF4;CREG1;SFN;ITM2B;ERN1;ETNK1;SH3RF2;UPP1;ISG20;TMEM132A;ATXN7;IFIH1;ADAMTS6;BRD2;PABPC4;DSE;AHCY;FUBP3;SMPD3
15377,GO:0071622,6.04494573718864e-06,0.999999589564599,7,26,regulation of granulocyte chemotaxis,BP,CXCL2;CXCL1;CXCL3;CXCL8;EDN1;CXCL5;IL23A
9956,GO:0042326,6.18693907628053e-06,0.999997861093687,29,349,negative regulation of phosphorylation,BP,TNFAIP3;IL1B;ZC3H12A;INHBA;PPIF;TNIP1;EFNA1;ERRFI1;GADD45A;LIF;TRIB1;JUN;CDKN1A;DUSP16;CDKN2B;ANKLE2;DUSP8;DUSP1;DUSP10;SOCS3;BDKRB1;PPP1R15B;CDK6;PTPN1;CORO1C;PDPK1;YWHAG;SFN;ATXN7
547,GO:0001666,6.55484250096125e-06,0.999998043726207,23,255,response to hypoxia,BP,PLAU;ETS1;PTGS2;PMAIP1;EDN1;CPEB2;BMP2;BIRC2;ZFP36L1;ADAM8;VEGFC;SMAD3;PLK3;CREB1;PPARD;SLC9A1;NDRG1;PML;ADM;ERO1A;NFE2L2;BACH1;AHCY
16757,GO:0098542,6.58640421903314e-06,0.99999803231265,23,260,defense response to other organism,BP,TNFAIP3;IL1B;ZC3H12A;BIRC3;TICAM1;TNF;CCL20;PMAIP1;BIRC2;BCL3;IRF1;CEBPB;IL23A;IFNAR2;RIPK2;PML;POLR3A;COTL1;HLA-E;RELA;POLR3D;ISG20;IFIH1
3182,GO:0006807,6.64459064297977e-06,0.999996685364276,282,7371,nitrogen compound metabolic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;HBEGF;PLAU;NFKBID;CSF2;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;REL;SERPINB2;PPIF;KLF6;NUAK2;CCL20;ZC3H12C;SPRR2D;ZNF697;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;ODC1;SEMA7A;PHLDA1;HAS3;ERRFI1;IRAK2;KLF7;CREB5;DAPP1;CPEB2;EHF;SPRR2A;TNFRSF10B;EPHA2;RELB;GADD45A;MAFF;LIF;TRIB1;KCTD11;SQSTM1;BMP2;IL24;CAB39;ZNF267;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;NMNAT2;RGMB;TJP2;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;ZFP36L1;ENC1;ADRB2;CEBPB;DUSP16;ARNTL2;UGCG;PPP1R15A;MAST4;RUNX1;N4BP1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;ANKLE2;DUSP8;B4GALT1;HAL;TFPI2;DUSP1;BCL10;DCUN1D3;TRAF1;PPP1R10;PIM3;IL6ST;B3GNT5;SGMS2;NABP1;DLX2;SLC6A14;TXNRD1;VGLL3;CYLD;ADAM8;LDLR;VEGFC;KLF3;ZNF217;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;DIEXF;PIM1;ITGA5;TFRC;LIPG;KLHL21;CREB1;SERPINB8;F3;STK40;HIVEP2;PPARD;SLC25A25;SERPINB1;SOCS3;CCDC85B;RAET1L;USP36;IL16;BDKRB1;ZFP36;SLC9A1;MAFK;LARP4B;CD55;PNRC1;ELL2;AZIN1;JAG1;PLAGL2;RIPK2;PHKG2;SAA1;PPP1R15B;USP53;ITGAV;CLK4;NRARP;SOX9;NRG1;ZNF451;FEM1C;PML;POU2F2;RASA2;PPTC7;NCOA7;ELK3;POLR3A;SLC7A2;ZNF460;FOXN2;PTPN11;MAP3K8;UHRF1;PANK3;MXD1;SPAG9;GCH1;FEM1B;SOX4;USP31;FOSL2;TRAF4;EIF1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;ADAMTS1;HIVEP1;NFKBIB;KLF10;AEN;SKIL;IL7R;RBM3;CDK6;IER5;YRDC;SAMD4A;PTPN1;TFE3;CORO1C;PRPF19;TOB2;ADM;MAFG;ABL2;MTF1;QKI;CELF1;PMM2;WNT5A;NUP153;MAOA;INSIG1;ADAM9;LCE1C;PDPK1;TNFRSF10A;ADAMTS9;RNF19A;CTSC;ERO1A;KDM6A;ZBTB21;NFE2L2;YWHAH;SGK1;B3GNT2;TSC22D2;SAT1;RELA;RNF11;BACH1;BTAF1;ANKK1;GINS3;POLR3D;ALAS1;YWHAG;TDG;ELF4;CREG1;SFN;ITM2B;ERN1;SH3RF2;UPP1;ISG20;TMEM132A;ATXN7;IFIH1;ADAMTS6;BRD2;PABPC4;DSE;AHCY;FUBP3;SMPD3
12559,GO:0050708,6.79419493174147e-06,0.99999790975204,24,259,regulation of protein secretion,BP,IL1B;IL1A;ZC3H12A;TNF;PANX1;HCAR2;CD274;TRIM16;PIM3;ADAM8;VEGFC;PPARD;RIPK2;SAA1;STX1A;PML;FERMT1;PTPN11;SOX4;OXCT1;HLA-E;WNT5A;ADAM9;IFIH1
14746,GO:0070423,6.97477597796671e-06,0.99999938747012,8,31,nucleotide-binding oligomerization domain containing signaling pathway,BP,NFKBIA;TNFAIP3;BIRC3;IRAK2;BIRC2;CYLD;RIPK2;RELA
8496,GO:0033674,7.11935327159426e-06,0.999997332326697,33,415,positive regulation of kinase activity,BP,IL1B;SDC4;TNF;EFNA1;TGFA;EDN1;IRAK2;TNFRSF10B;EPHA2;GADD45A;BMP2;CAB39;MAP2K3;CDKN1A;ADRB2;EREG;ADAM8;OXSR1;IL23A;RIPK2;SAA1;NRG1;PTPN11;MAP3K8;SPAG9;TRAF4;CCNL1;PTPN1;WNT5A;ADAM9;PDPK1;TNFRSF10A;ERN1
12995,GO:0051403,7.12958864674612e-06,0.999998005667841,21,204,stress-activated MAPK cascade,BP,IL1B;IL1A;ZC3H12A;TNF;NFKB1;EDN1;IRAK2;GADD45A;TRIB1;BMP2;MAP2K3;ZFP36L1;DUSP10;ZFP36;RIPK2;MAP3K8;SPAG9;TRAF4;PTPN1;WNT5A;ERN1
598,GO:0001763,7.37564283706288e-06,0.999998270191446,17,136,morphogenesis of a branching structure,BP,TNF;PRDM1;TBX3;EDN1;EPHA2;BMP2;B4GALT1;DLX2;TACSTD2;SOCS3;NRARP;SOX9;PML;FEM1B;AREG;ADM;WNT5A
682,GO:0001890,7.63237104149314e-06,0.999998400476826,15,116,placenta development,BP,CSF2;PTGS2;PRDM1;FOSL1;LIF;PHLDA2;BIRC2;JUNB;ZFP36L1;CEBPB;GJB3;PPARD;SOCS3;CYP27B1;ADM
1460,GO:0003700,7.6514259507576e-06,0.999996377248051,65,1082,DNA binding transcription factor activity,MF,BTG2;ELF3;ETS1;REL;KLF6;BHLHE40;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;IRF6;KLF7;CREB5;EHF;RELB;MAFF;ZNF267;JUN;JUNB;BCL3;OVOL1;CSRNP1;ETS2;IRF1;TAF4B;ZFP36L1;CEBPB;ARNTL2;RUNX1;ELMSAN1;DLX2;VGLL3;KLF3;ZNF217;SMAD3;CREB1;HIVEP2;PPARD;MAFK;PLAGL2;SOX9;ZNF451;POU2F2;ELK3;FOXN2;UHRF1;MXD1;SOX4;FOSL2;HIVEP1;KLF10;SKIL;TFE3;MAFG;MTF1;WNT5A;NFE2L2;TSC22D2;RELA;BACH1;BTAF1;ELF4;FUBP3
14512,GO:0065008,8.04894010944235e-06,0.999995692391274,115,2386,regulation of biological quality,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;PLAU;INHBA;TICAM1;ETS1;TNF;SERPINB2;PPIF;PTGS2;PMAIP1;NFKB1;TBX3;NOCT;EFNA1;EDN1;SEMA7A;IL1RN;CLDN1;HCAR2;MAFF;LIF;SQSTM1;BMP2;JUN;RAP2B;NFKBIE;CDKN1A;CLDN4;TJP2;BCL3;AMPD3;IRF1;ZFP36L1;RND3;ADRB2;PPP1R15A;SOD2;ALDH1A3;EHD1;TFPI2;BCL10;FGD6;PPP1R10;PIM3;TXNRD1;CYLD;ADAM8;LDLR;VEGFC;NEDD4L;SMAD3;RC3H1;PLK2;BBC3;TFRC;LIPG;CREB1;F3;PPARD;USP36;BDKRB1;ZFP36;SLC9A1;MAFK;CYP27B1;CD55;SAA1;USP53;ITGAV;TP53BP2;SOX9;STX1A;NRG1;PML;SLC7A2;CDC42EP1;PTPN11;RHOB;GCH1;SOX4;VCL;OXCT1;SKIL;IL7R;CDK6;YRDC;SAMD4A;STEAP4;ADM;MAFG;ABL2;ATP6V1C2;QKI;WNT5A;MAOA;INSIG1;PDPK1;ERO1A;NFE2L2;YWHAH;SGK1;YWHAG;RAB22A;SFN;ERN1;ATP13A3;PABPC4;STX12;PDLIM5;SMPD3
12566,GO:0050715,8.41964988657412e-06,0.99999874915321,11,65,positive regulation of cytokine secretion,BP,IL1B;IL1A;TNF;PANX1;CD274;TRIM16;RIPK2;SAA1;FERMT1;WNT5A;IFIH1
8028,GO:0032663,8.49039006819059e-06,0.99999922887589,8,32,regulation of interleukin-2 production,BP,TNFAIP3;IL1B;IL1A;CD83;RUNX1;ZFP36;RIPK2;NAV3
8033,GO:0032675,8.49107557310771e-06,0.999998739355804,11,64,regulation of interleukin-6 production,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;TICAM1;TNF;CEBPB;EREG;RIPK2;WNT5A;IFIH1
9360,GO:0035872,8.68867606785187e-06,0.999999208301545,8,32,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,NFKBIA;TNFAIP3;BIRC3;IRAK2;BIRC2;CYLD;RIPK2;RELA
12665,GO:0050866,8.85919801514444e-06,0.999998243859142,14,105,negative regulation of cell activation,BP,TNFAIP3;ZC3H12A;NFKBID;INHBA;SDC4;PRDM1;CD274;IRF1;CEBPB;PELI1;CYLD;LDLR;RC3H1;NRARP
17751,GO:1901698,8.98758433860363e-06,0.999996002682445,48,738,response to nitrogen compound,BP,NFKBIA;TNFAIP3;IL1B;ZC3H12A;BTG2;TICAM1;TNF;PTGS2;PMAIP1;NFKB1;FOSL1;EDN1;ERRFI1;PANX1;CPEB2;JUN;BIRC2;CDKN1A;JUNB;ZFP36L1;ADRB2;CEBPB;HMGCS1;TRIM16;EREG;PELI1;DUSP1;LDLR;KLF3;SMAD3;CREB1;SOCS3;SLC9A1;JAG1;RIPK2;SOX9;PTPN11;AREG;HDAC9;KLF10;PTPN1;ADM;ATP6V1C2;PDPK1;NFE2L2;RELA;YWHAG;IFIH1
798,GO:0002064,9.1305663380279e-06,0.999997817595232,17,141,epithelial cell development,BP,IL1B;TNF;PRDM1;CLDN1;EPHA2;CDKN1A;TJP2;B4GALT1;JAG1;SOX9;FEM1B;FOSL2;CDK6;WNT5A;PDPK1;FRMD6;SFN
1103,GO:0002690,9.13113657946358e-06,0.999998960323378,9,47,positive regulation of leukocyte chemotaxis,BP,CXCL2;CXCL1;CXCL3;CXCL8;EDN1;CXCL5;VEGFC;IL23A;WNT5A
6150,GO:0019438,9.22070872813403e-06,0.999994873734328,153,3425,aromatic compound biosynthetic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;BTG2;NFKBID;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;KLF6;ZNF697;BHLHE40;PTGS2;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;HAS3;IRAK2;KLF7;CREB5;EHF;RELB;MAFF;LIF;TRIB1;SQSTM1;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;NMNAT2;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;ZFP36L1;ADRB2;CEBPB;ARNTL2;RUNX1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;DUSP1;BCL10;TRAF1;NABP1;DLX2;VGLL3;CYLD;ADAM8;KLF3;ZNF217;NEDD4L;SMAD3;IL23A;PLK3;PIM1;CREB1;HIVEP2;PPARD;CCDC85B;IL16;ZFP36;SLC9A1;MAFK;PNRC1;ELL2;JAG1;PLAGL2;RIPK2;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;POLR3A;ZNF460;FOXN2;UHRF1;PANK3;MXD1;GCH1;SOX4;FOSL2;CCNL1;FAM83G;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;IER5;TFE3;TOB2;ADM;MAFG;MTF1;PMM2;WNT5A;NUP153;INSIG1;PDPK1;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;RELA;BACH1;BTAF1;POLR3D;ALAS1;TDG;ELF4;CREG1;ERN1;UPP1;ATXN7;BRD2;FUBP3
12555,GO:0050704,9.35688614209549e-06,0.999999325530585,7,25,regulation of interleukin-1 secretion,BP,ZC3H12A;PANX1;TRIM16;RIPK2;SAA1;PML;WNT5A
5910,GO:0018130,9.46136402521488e-06,0.999994737382906,153,3428,heterocycle biosynthetic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;BTG2;NFKBID;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;KLF6;ZNF697;BHLHE40;PTGS2;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;HAS3;IRAK2;KLF7;CREB5;EHF;RELB;MAFF;LIF;TRIB1;SQSTM1;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;NMNAT2;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;ZFP36L1;ADRB2;CEBPB;ARNTL2;RUNX1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;DUSP1;BCL10;TRAF1;NABP1;DLX2;VGLL3;CYLD;ADAM8;KLF3;ZNF217;NEDD4L;SMAD3;IL23A;PLK3;PIM1;CREB1;HIVEP2;PPARD;CCDC85B;IL16;ZFP36;SLC9A1;MAFK;PNRC1;ELL2;JAG1;PLAGL2;RIPK2;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;POLR3A;ZNF460;FOXN2;UHRF1;PANK3;MXD1;GCH1;SOX4;FOSL2;CCNL1;FAM83G;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;IER5;TFE3;TOB2;ADM;MAFG;MTF1;PMM2;WNT5A;NUP153;INSIG1;PDPK1;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;RELA;BACH1;BTAF1;POLR3D;ALAS1;TDG;ELF4;CREG1;ERN1;UPP1;ATXN7;BRD2;FUBP3
9789,GO:0040008,9.53845017849644e-06,0.999996311691324,34,450,regulation of growth,BP,HBEGF;INHBA;TNF;EDN1;SEMA7A;KCTD11;SQSTM1;PHLDA2;CDKN1A;SERTAD2;ADRB2;NEDD9;DCUN1D3;NEDD4L;SMAD3;DUSP10;PIM1;WISP1;CREB1;PPARD;SOCS3;CCDC85B;BDKRB1;SLC9A1;CYP27B1;NRG1;PML;PTPN11;DCBLD2;WNT5A;SGK1;CREG1;SFN;CXCL16
12705,GO:0050920,9.6084233147985e-06,0.999997940402537,15,121,regulation of chemotaxis,BP,CXCL2;CXCL1;CXCL3;CXCL8;EDN1;SEMA7A;EFNB2;CXCL5;ZSWIM4;VEGFC;SMAD3;IL23A;F3;IL16;WNT5A
17873,GO:1902106,9.89714888836858e-06,0.99999868575477,10,53,negative regulation of leukocyte differentiation,BP,NFKBID;INHBA;TRIB1;TJP2;IRF1;CYLD;RC3H1;NRARP;CDK6;TOB2
7359,GO:0031400,1.00770532494666e-05,0.999996091232356,34,457,negative regulation of protein modification process,BP,TNFAIP3;IL1B;ZC3H12A;TNF;TNIP1;EFNA1;ERRFI1;GADD45A;LIF;TRIB1;JUN;CDKN1A;DUSP16;PPP1R15A;N4BP1;CDKN2B;DUSP8;DUSP1;PPP1R10;DUSP10;SOCS3;BDKRB1;PPP1R15B;ZNF451;NCOA7;SOX4;CDK6;PTPN1;CORO1C;PDPK1;RELA;YWHAG;SFN;SH3RF2
8036,GO:0032680,1.03330525395994e-05,0.999998425530946,11,67,regulation of tumor necrosis factor production,BP,TNFAIP3;ZC3H12A;TICAM1;ERRFI1;BCL3;IL23A;ZFP36;RIPK2;HLA-E;WNT5A;IFIH1
4345,GO:0009896,1.06164009107025e-05,0.999996295385322,28,331,positive regulation of catabolic process,BP,TNFAIP3;IL1B;ZC3H12A;BTG2;TICAM1;TNF;RNF19B;PLEKHF1;TRIB1;ZFP36L1;ADRB2;ADAM8;LDLR;NEDD4L;RC3H1;PLK2;PLK3;ZFP36;RIPK2;PHKG2;SOX9;PTPN1;QKI;WNT5A;ADAM9;RNF19A;CTSC;NFE2L2
17639,GO:1901362,1.0813748935639e-05,0.999993674916443,156,3521,organic cyclic compound biosynthetic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;BTG2;NFKBID;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;KLF6;ZNF697;BHLHE40;PTGS2;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;HAS3;IRAK2;KLF7;CREB5;EHF;RELB;MAFF;LIF;TRIB1;SQSTM1;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;NMNAT2;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;ZFP36L1;ADRB2;CEBPB;ARNTL2;RUNX1;CDKN2B;NAB1;HMGCS1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;DUSP1;BCL10;TRAF1;NABP1;DLX2;VGLL3;CYLD;ADAM8;KLF3;ZNF217;NEDD4L;SMAD3;IL23A;PLK3;PIM1;CREB1;HIVEP2;PPARD;CCDC85B;IL16;ZFP36;SLC9A1;MAFK;CYP27B1;PNRC1;ELL2;JAG1;PLAGL2;RIPK2;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;POLR3A;ZNF460;FOXN2;UHRF1;PANK3;MXD1;GCH1;SOX4;FOSL2;CCNL1;FAM83G;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;IER5;SQLE;TFE3;TOB2;ADM;MAFG;MTF1;PMM2;WNT5A;NUP153;INSIG1;PDPK1;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;RELA;BACH1;BTAF1;POLR3D;ALAS1;TDG;ELF4;CREG1;ERN1;UPP1;ATXN7;BRD2;FUBP3
10502,GO:0043405,1.08189401883549e-05,0.999996572608696,24,261,regulation of MAP kinase activity,BP,IL1B;TNF;TGFA;EDN1;IRAK2;GADD45A;TRIB1;BMP2;MAP2K3;DUSP16;DUSP8;DUSP1;ADAM8;DUSP10;RIPK2;SAA1;NRG1;PTPN11;MAP3K8;SPAG9;PTPN1;WNT5A;ADAM9;ERN1
10040,GO:0042493,1.08467882748868e-05,0.999995393972647,41,610,response to drug,BP,NFKBIA;TNFAIP3;IL1B;ZC3H12A;INHBA;ETS1;TNF;PPIF;PTGS2;NFKB1;FOSL1;KDM6B;EDN1;ERRFI1;CLDN1;PANX1;JUN;BIRC2;NFKBIE;CDKN1A;CLDN4;JUNB;HMGCS1;DUSP1;VEGFC;TFRC;CREB1;SLC25A25;JAG1;RIPK2;PPP1R15B;SOX9;SLC7A2;PTPN11;RHOB;OXCT1;AREG;HDAC9;ADAM9;NFE2L2;RELA
1174,GO:0002819,1.08801077295992e-05,0.999998141900698,12,81,regulation of adaptive immune response,BP,TNFAIP3;IL1B;TNF;IRF1;IL6ST;RC3H1;IL23A;DUSP10;TFRC;RIPK2;IL7R;HLA-E
12907,GO:0051250,1.11521405990654e-05,0.99999809257731,12,80,negative regulation of lymphocyte activation,BP,TNFAIP3;NFKBID;INHBA;SDC4;PRDM1;CD274;IRF1;CEBPB;PELI1;CYLD;RC3H1;NRARP
12523,GO:0050663,1.16013954858336e-05,0.999997640001304,14,107,cytokine secretion,BP,IL1B;IL1A;ZC3H12A;TNF;PANX1;CD274;TRIM16;RIPK2;SAA1;ITGAV;PML;FERMT1;WNT5A;IFIH1
9540,GO:0036293,1.17244447006739e-05,0.999996363388922,23,263,response to decreased oxygen levels,BP,PLAU;ETS1;PTGS2;PMAIP1;EDN1;CPEB2;BMP2;BIRC2;ZFP36L1;ADAM8;VEGFC;SMAD3;PLK3;CREB1;PPARD;SLC9A1;NDRG1;PML;ADM;ERO1A;NFE2L2;BACH1;AHCY
8018,GO:0032649,1.20056449030535e-05,0.999998584320258,9,47,regulation of interferon-gamma production,BP,IL1B;ZC3H12A;INHBA;TNF;CD274;BCL3;IL23A;RIPK2;WNT5A
18446,GO:1903530,1.20389456477989e-05,0.999995510854311,31,399,regulation of secretion by cell,BP,IL1B;IL1A;ZC3H12A;INHBA;SDC4;TNF;EDN1;PANX1;HCAR2;LIF;CD274;TRIM16;PIM3;ADAM8;VEGFC;CREB1;PPARD;RIPK2;SAA1;STX1A;PML;FERMT1;PTPN11;SOX4;OXCT1;HLA-E;WNT5A;ADAM9;PDPK1;IFIH1;SMPD3
8857,GO:0034654,1.2077789483311e-05,0.99999294283195,151,3379,nucleobase-containing compound biosynthetic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;BTG2;NFKBID;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;KLF6;ZNF697;BHLHE40;PTGS2;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;HAS3;IRAK2;KLF7;CREB5;EHF;RELB;MAFF;LIF;TRIB1;SQSTM1;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;NMNAT2;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;ZFP36L1;ADRB2;CEBPB;ARNTL2;RUNX1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;DUSP1;BCL10;TRAF1;NABP1;DLX2;VGLL3;CYLD;ADAM8;KLF3;ZNF217;NEDD4L;SMAD3;IL23A;PLK3;PIM1;CREB1;HIVEP2;PPARD;CCDC85B;IL16;ZFP36;SLC9A1;MAFK;PNRC1;ELL2;JAG1;PLAGL2;RIPK2;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;POLR3A;ZNF460;FOXN2;UHRF1;PANK3;MXD1;SOX4;FOSL2;CCNL1;FAM83G;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;IER5;TFE3;TOB2;ADM;MAFG;MTF1;PMM2;WNT5A;NUP153;INSIG1;PDPK1;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;RELA;BACH1;BTAF1;POLR3D;TDG;ELF4;CREG1;ERN1;UPP1;ATXN7;BRD2;FUBP3
12558,GO:0050707,1.20974415507744e-05,0.999997714453114,13,94,regulation of cytokine secretion,BP,IL1B;IL1A;ZC3H12A;TNF;PANX1;CD274;TRIM16;RIPK2;SAA1;PML;FERMT1;WNT5A;IFIH1
97,GO:0000187,1.22703052019682e-05,0.999997495940404,14,104,activation of MAPK activity,BP,IL1B;TNF;TGFA;IRAK2;BMP2;MAP2K3;RIPK2;SAA1;NRG1;PTPN11;SPAG9;PTPN1;WNT5A;ERN1
7208,GO:0031098,1.24355439174391e-05,0.999996257160128,22,227,stress-activated protein kinase signaling cascade,BP,IL1B;IL1A;ZC3H12A;TNF;NFKB1;EDN1;IRAK2;GADD45A;TRIB1;BMP2;MAP2K3;ZFP36L1;OXSR1;DUSP10;ZFP36;RIPK2;MAP3K8;SPAG9;TRAF4;PTPN1;WNT5A;ERN1
11399,GO:0045786,1.2478262276592e-05,0.999994894836515,37,536,negative regulation of cell cycle,BP,TNFAIP3;BTG2;INHBA;TNF;CXCL8;PTGS2;IRF6;GADD45A;LIF;BMP2;CAB39;CDKN1A;OVOL1;IRF1;ZFP36L1;PPP1R15A;CDKN2B;DUSP1;DCUN1D3;PPP1R10;NABP1;SMAD3;PLK2;PLK3;NDRG1;TP53BP2;PML;PTPN11;RHOB;FEM1B;SOX4;SKIL;CDK6;BTG3;PRPF19;SFN;ERN1
14777,GO:0070482,1.27185163102135e-05,0.99999591813475,24,283,response to oxygen levels,BP,PLAU;ETS1;PTGS2;PMAIP1;EDN1;CPEB2;BMP2;BIRC2;CDKN1A;ZFP36L1;ADAM8;VEGFC;SMAD3;PLK3;CREB1;PPARD;SLC9A1;NDRG1;PML;ADM;ERO1A;NFE2L2;BACH1;AHCY
12787,GO:0051059,1.28491947524327e-05,0.999999010264351,7,27,NF-kappaB binding,MF,NFKBIA;NFKBID;TAF4B;BCL10;PPARD;TP53BP2;RELA
11088,GO:0045089,1.29319089995948e-05,0.999996087329176,22,243,positive regulation of innate immune response,BP,NFKBIA;TNFAIP3;BIRC3;TICAM1;TNIP1;NFKB1;IRAK2;RELB;BIRC2;IRF1;EREG;PELI1;BCL10;CYLD;ADAM8;RIPK2;HLA-E;WNT5A;PDPK1;RELA;POLR3D;IFIH1
10957,GO:0044706,1.29937719014369e-05,0.999996962093103,16,136,multi-multicellular organism process,BP,IL1B;ETS1;PTGS2;PRDM1;FOSL1;EDN1;MAFF;LIF;CLDN4;JUNB;NAMPT;B4GALT1;VMP1;PPARD;CYP27B1;ADM
19896,GO:2000379,1.3041256241202e-05,0.999998196265912,10,57,positive regulation of reactive oxygen species metabolic process,BP,IL1B;ZC3H12A;TICAM1;TNF;PTGS2;EDN1;GADD45A;CDKN1A;SMAD3;NFE2L2
11773,GO:0046631,1.32295145263055e-05,0.999997931828929,11,66,alpha-beta T cell activation,BP,PRDM1;RELB;CD83;BCL3;IRF1;RC3H1;IL23A;CD55;RIPK2;HLA-E;ELF4
8154,GO:0032880,1.33757438456846e-05,0.999994040780033,45,690,regulation of protein localization,BP,IL1B;IL1A;ZC3H12A;TNF;PTGS2;PMAIP1;PANX1;HCAR2;EPHA2;LIF;SQSTM1;CDKN1A;CD274;UGCG;TRIM16;PIM3;CYLD;ADAM8;VEGFC;NEDD4L;BBC3;PLK3;PPARD;USP36;PLAGL2;RIPK2;SAA1;TP53BP2;STX1A;NRG1;PML;FERMT1;PTPN11;SOX4;OXCT1;PTPN1;HLA-E;WNT5A;INSIG1;ADAM9;PDPK1;YWHAH;YWHAG;SFN;IFIH1
11782,GO:0046640,1.35934780735414e-05,0.999999555362394,5,11,regulation of alpha-beta T cell proliferation,BP,IRF1;IL23A;CD55;RIPK2;HLA-E
3184,GO:0006809,1.3705879830575e-05,0.999998365157627,9,45,nitric oxide biosynthetic process,BP,IL1B;ZC3H12A;TICAM1;TNF;PTGS2;EDN1;SMAD3;SLC7A2;GCH1
13908,GO:0060556,1.38819240197702e-05,0.999999822397386,4,6,regulation of vitamin D biosynthetic process,BP,IL1B;TNF;NFKB1;CYP27B1
1170,GO:0002791,1.39881713880674e-05,0.999995490278619,24,271,regulation of peptide secretion,BP,IL1B;IL1A;ZC3H12A;TNF;PANX1;HCAR2;CD274;TRIM16;PIM3;ADAM8;VEGFC;PPARD;RIPK2;SAA1;STX1A;PML;FERMT1;PTPN11;SOX4;OXCT1;HLA-E;WNT5A;ADAM9;IFIH1
4028,GO:0009059,1.40351143835396e-05,0.999991670622334,175,4112,macromolecule biosynthetic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;HBEGF;NFKBID;CSF2;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;REL;KLF6;CCL20;ZNF697;BHLHE40;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;PHLDA1;HAS3;ERRFI1;IRAK2;KLF7;CREB5;CPEB2;EHF;RELB;MAFF;LIF;TRIB1;SQSTM1;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ENC1;ADRB2;CEBPB;ARNTL2;PPP1R15A;RUNX1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;B4GALT1;DUSP1;BCL10;TRAF1;B3GNT5;NABP1;DLX2;VGLL3;CYLD;ADAM8;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;IL23A;PLK3;PIM1;CREB1;HIVEP2;PPARD;CCDC85B;RAET1L;IL16;ZFP36;SLC9A1;MAFK;LARP4B;PNRC1;ELL2;JAG1;PLAGL2;RIPK2;PHKG2;PPP1R15B;ITGAV;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;POLR3A;ZNF460;FOXN2;UHRF1;MXD1;SOX4;FOSL2;EIF1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;RBM3;IER5;SAMD4A;TFE3;TOB2;MAFG;MTF1;QKI;CELF1;PMM2;WNT5A;NUP153;INSIG1;PDPK1;ZBTB21;NFE2L2;YWHAH;SGK1;B3GNT2;TSC22D2;RELA;BACH1;BTAF1;GINS3;POLR3D;TDG;ELF4;CREG1;ITM2B;ERN1;ATXN7;BRD2;PABPC4;DSE;FUBP3;SMPD3
12353,GO:0048729,1.41188961823223e-05,0.999994428211971,34,449,tissue morphogenesis,BP,HBEGF;INHBA;SDC4;TNF;TBX3;KDM6B;EDN1;EFNB2;EPHA2;LIF;BMP2;PHLDB2;ALDH1A3;B4GALT1;BCL10;TXNRD1;VEGFC;TACSTD2;SMAD3;ITGA5;SOCS3;JAG1;NRARP;SOX9;NRG1;PML;RHOB;FEM1B;SOX4;VCL;AREG;ADM;WNT5A;KDM6A
14162,GO:0061041,1.41558219307795e-05,0.99999751875575,12,80,regulation of wound healing,BP,TNFAIP3;PLAUR;HBEGF;PLAU;SERPINB2;EDN1;PHLDB2;SMAD3;DUSP10;F3;PPARD;NFE2L2
5904,GO:0018108,1.4254481204676e-05,0.999995667340238,22,231,peptidyl-tyrosine phosphorylation,BP,HBEGF;CSF2;EFNA1;TGFA;ERRFI1;EPHA2;LIF;IL24;MAP2K3;RAP2B;EREG;IL6ST;VEGFC;IL23A;ITGA5;SOCS3;RIPK2;CLK4;NRG1;AREG;PTPN1;ABL2
18081,GO:1902679,1.4344791595545e-05,0.999993094202707,55,924,negative regulation of RNA biosynthetic process,BP,BTG2;CSF2;ELF3;TNF;REL;BHLHE40;NFKB1;PRDM1;TBX3;NFKB2;EFNA1;EDN1;RELB;SQSTM1;BMP2;JUN;JUNB;BCL3;OVOL1;ETS2;IRF1;CEBPB;NAB1;EREG;DLX2;KLF3;ZNF217;NEDD4L;SMAD3;PLK3;CREB1;PPARD;CCDC85B;ZFP36;MAFK;NRARP;SOX9;NRG1;ZNF451;PML;ELK3;UHRF1;MXD1;HDAC9;HIVEP1;KLF10;SKIL;TOB2;WNT5A;ZBTB21;RELA;BACH1;BTAF1;TDG;CREG1
18428,GO:1903507,1.4344791595545e-05,0.999993094202707,55,924,negative regulation of nucleic acid-templated transcription,BP,BTG2;CSF2;ELF3;TNF;REL;BHLHE40;NFKB1;PRDM1;TBX3;NFKB2;EFNA1;EDN1;RELB;SQSTM1;BMP2;JUN;JUNB;BCL3;OVOL1;ETS2;IRF1;CEBPB;NAB1;EREG;DLX2;KLF3;ZNF217;NEDD4L;SMAD3;PLK3;CREB1;PPARD;CCDC85B;ZFP36;MAFK;NRARP;SOX9;NRG1;ZNF451;PML;ELK3;UHRF1;MXD1;HDAC9;HIVEP1;KLF10;SKIL;TOB2;WNT5A;ZBTB21;RELA;BACH1;BTAF1;TDG;CREG1
6175,GO:0019538,1.45704618784418e-05,0.999991340092515,177,4204,protein metabolic process,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;HBEGF;PLAU;CSF2;INHBA;TICAM1;SDC4;TNF;SERPINB2;PPIF;NUAK2;CCL20;SPRR2D;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;EFNA1;TGFA;KDM6B;EDN1;ODC1;SEMA7A;PHLDA1;ERRFI1;IRAK2;DAPP1;CPEB2;SPRR2A;TNFRSF10B;EPHA2;GADD45A;LIF;TRIB1;KCTD11;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;BIRC2;CDKN1A;BCL3;IRF1;ZFP36L1;ENC1;ADRB2;CEBPB;DUSP16;PPP1R15A;MAST4;N4BP1;CDKN2B;TRIM16;EREG;PELI1;ANKLE2;DUSP8;B4GALT1;TFPI2;DUSP1;BCL10;DCUN1D3;PPP1R10;PIM3;IL6ST;B3GNT5;CYLD;ADAM8;LDLR;VEGFC;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;PIM1;ITGA5;LIPG;KLHL21;CREB1;SERPINB8;F3;STK40;PPARD;SERPINB1;SOCS3;RAET1L;USP36;BDKRB1;ZFP36;LARP4B;CD55;AZIN1;JAG1;RIPK2;PHKG2;SAA1;PPP1R15B;USP53;ITGAV;CLK4;SOX9;NRG1;ZNF451;FEM1C;PML;RASA2;PPTC7;NCOA7;PTPN11;MAP3K8;UHRF1;SPAG9;FEM1B;SOX4;USP31;TRAF4;EIF1;AREG;CCNL1;TNFAIP1;HDAC9;ADAMTS1;RBM3;CDK6;SAMD4A;PTPN1;CORO1C;PRPF19;ABL2;QKI;CELF1;PMM2;WNT5A;NUP153;ADAM9;LCE1C;PDPK1;TNFRSF10A;ADAMTS9;RNF19A;CTSC;ERO1A;KDM6A;NFE2L2;SGK1;B3GNT2;RELA;RNF11;BACH1;ANKK1;YWHAG;SFN;ITM2B;ERN1;SH3RF2;TMEM132A;ATXN7;IFIH1;ADAMTS6;PABPC4;DSE
873,GO:0002221,1.52684429033415e-05,0.999996590738978,15,122,pattern recognition receptor signaling pathway,BP,NFKBIA;TNFAIP3;BIRC3;TICAM1;TNIP1;IRAK2;BIRC2;IRF1;PELI1;BCL10;CYLD;RIPK2;PDPK1;RELA;IFIH1
9854,GO:0042102,1.54094823085801e-05,0.999998114288891,9,49,positive regulation of T cell proliferation,BP,IL1B;CD274;IL6ST;IL23A;TFRC;EFNB1;CD55;RIPK2;HLA-E
3388,GO:0007167,1.55428282399838e-05,0.99999297454487,46,692,enzyme linked receptor protein signaling pathway,BP,IL1B;PLAUR;HBEGF;INHBA;EFNA1;TGFA;ERRFI1;EFNB2;EPHA2;LIF;BMP2;JUN;RGMB;CSRNP1;ADRB2;CDKN2B;EREG;NEDD9;IL6ST;VEGFC;SMAD3;ITGA5;CREB1;EFNB1;F3;SOCS3;ITGAV;SOX9;NRG1;ZNF451;PML;FERMT1;PTPN11;AREG;FAM83G;AKAP2;KLF10;SKIL;PTPN1;ABL2;ATP6V1C2;WNT5A;ADAM9;PDPK1;RELA;ATXN7
8012,GO:0032640,1.58550197833397e-05,0.999997457514443,11,70,tumor necrosis factor production,BP,TNFAIP3;ZC3H12A;TICAM1;ERRFI1;BCL3;IL23A;ZFP36;RIPK2;HLA-E;WNT5A;IFIH1
17687,GO:1901564,1.59255775365139e-05,0.999990467993601,199,4902,organonitrogen compound metabolic process,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;HBEGF;PLAU;CSF2;INHBA;TICAM1;SDC4;TNF;SERPINB2;PPIF;NUAK2;CCL20;SPRR2D;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;EFNA1;TGFA;KDM6B;EDN1;ODC1;SEMA7A;PHLDA1;HAS3;ERRFI1;IRAK2;DAPP1;CPEB2;SPRR2A;TNFRSF10B;EPHA2;GADD45A;LIF;TRIB1;KCTD11;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;BIRC2;CDKN1A;NMNAT2;TJP2;BCL3;NAMPT;AMPD3;IRF1;ZFP36L1;ENC1;ADRB2;CEBPB;DUSP16;UGCG;PPP1R15A;MAST4;N4BP1;CDKN2B;TRIM16;EREG;PELI1;ANKLE2;DUSP8;B4GALT1;HAL;TFPI2;DUSP1;BCL10;DCUN1D3;PPP1R10;PIM3;IL6ST;B3GNT5;SGMS2;SLC6A14;CYLD;ADAM8;LDLR;VEGFC;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;PIM1;ITGA5;LIPG;KLHL21;CREB1;SERPINB8;F3;STK40;PPARD;SLC25A25;SERPINB1;SOCS3;RAET1L;USP36;BDKRB1;ZFP36;SLC9A1;LARP4B;CD55;AZIN1;JAG1;RIPK2;PHKG2;SAA1;PPP1R15B;USP53;ITGAV;CLK4;SOX9;NRG1;ZNF451;FEM1C;PML;RASA2;PPTC7;NCOA7;SLC7A2;PTPN11;MAP3K8;UHRF1;PANK3;SPAG9;GCH1;FEM1B;SOX4;USP31;TRAF4;EIF1;AREG;CCNL1;TNFAIP1;HDAC9;ADAMTS1;RBM3;CDK6;SAMD4A;PTPN1;CORO1C;PRPF19;ADM;ABL2;QKI;CELF1;PMM2;WNT5A;NUP153;MAOA;ADAM9;LCE1C;PDPK1;TNFRSF10A;ADAMTS9;RNF19A;CTSC;ERO1A;KDM6A;NFE2L2;SGK1;B3GNT2;SAT1;RELA;RNF11;BACH1;ANKK1;ALAS1;YWHAG;TDG;SFN;ITM2B;ERN1;SH3RF2;UPP1;TMEM132A;ATXN7;IFIH1;ADAMTS6;PABPC4;DSE;AHCY;SMPD3
631,GO:0001818,1.67754526704141e-05,0.999995762895934,17,160,negative regulation of cytokine production,BP,TNFAIP3;ZC3H12A;INHBA;TNF;REL;NFKB1;ERRFI1;RELB;CD83;CD274;BCL3;CYLD;IL23A;ZFP36;NAV3;PML;IFIH1
7323,GO:0031331,1.69400094266478e-05,0.999994328424302,25,284,positive regulation of cellular catabolic process,BP,TNFAIP3;IL1B;ZC3H12A;BTG2;TICAM1;TNF;RNF19B;PLEKHF1;TRIB1;ZFP36L1;ADRB2;ADAM8;LDLR;RC3H1;PLK2;PLK3;ZFP36;RIPK2;PHKG2;PTPN1;QKI;ADAM9;RNF19A;CTSC;NFE2L2
10508,GO:0043412,1.7054916380179e-05,0.99998975523446,146,3237,macromolecule modification,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;HBEGF;CSF2;INHBA;TICAM1;SDC4;TNF;PPIF;NUAK2;CCL20;SPRR2D;PTGS2;RNF19B;TNIP1;NFKB1;EFNA1;TGFA;KDM6B;EDN1;SEMA7A;ERRFI1;IRAK2;DAPP1;SPRR2A;TNFRSF10B;EPHA2;GADD45A;LIF;TRIB1;KCTD11;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;BIRC2;CDKN1A;ZFP36L1;ENC1;ADRB2;DUSP16;PPP1R15A;MAST4;N4BP1;CDKN2B;TRIM16;EREG;PELI1;ANKLE2;DUSP8;B4GALT1;DUSP1;BCL10;DCUN1D3;PPP1R10;PIM3;IL6ST;B3GNT5;CYLD;ADAM8;VEGFC;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;PLK3;PIM1;ITGA5;KLHL21;CREB1;STK40;SOCS3;RAET1L;USP36;BDKRB1;ZFP36;RIPK2;PHKG2;SAA1;PPP1R15B;USP53;ITGAV;CLK4;SOX9;NRG1;ZNF451;FEM1C;PML;RASA2;PPTC7;NCOA7;PTPN11;MAP3K8;UHRF1;SPAG9;FEM1B;SOX4;USP31;TRAF4;AREG;CCNL1;TNFAIP1;HDAC9;CDK6;YRDC;PTPN1;CORO1C;PRPF19;ABL2;PMM2;WNT5A;NUP153;ADAM9;LCE1C;PDPK1;TNFRSF10A;RNF19A;ERO1A;KDM6A;NFE2L2;SGK1;B3GNT2;RELA;RNF11;BACH1;ANKK1;YWHAG;TDG;SFN;ERN1;SH3RF2;TMEM132A;ATXN7;IFIH1
5936,GO:0018212,1.7267592141921e-05,0.999994680763356,22,234,peptidyl-tyrosine modification,BP,HBEGF;CSF2;EFNA1;TGFA;ERRFI1;EPHA2;LIF;IL24;MAP2K3;RAP2B;EREG;IL6ST;VEGFC;IL23A;ITGA5;SOCS3;RIPK2;CLK4;NRG1;AREG;PTPN1;ABL2
14372,GO:0061614,1.81539053242674e-05,0.999998153879937,8,33,pri-miRNA transcription by RNA polymerase II,BP,ETS1;FOSL1;BMP2;JUN;SMAD3;PPARD;SOX9;RELA
14718,GO:0070371,1.88457414960747e-05,0.999994752333107,19,186,ERK1 and ERK2 cascade,BP,IL1B;IL1A;TNF;CCL20;TNIP1;SEMA7A;ERRFI1;EPHA2;LIF;BMP2;JUN;ZFP36L1;DUSP1;DUSP10;RIPK2;ITGAV;SOX9;PTPN11;PTPN1
2201,GO:0005080,1.88611087745146e-05,0.999998052349853,8,35,protein kinase C binding,MF,SDC4;SQSTM1;ITGAV;HDAC9;ADAM9;YWHAG;TDG;PDLIM5
4200,GO:0009306,1.93846989152941e-05,0.999993133245655,27,331,protein secretion,BP,IL1B;IL1A;ZC3H12A;TNF;IL1RN;PANX1;HCAR2;CD274;TRIM16;PIM3;ADAM8;VEGFC;PPARD;RIPK2;SAA1;ITGAV;STX1A;PML;POU2F2;FERMT1;PTPN11;SOX4;OXCT1;HLA-E;WNT5A;ADAM9;IFIH1
13158,GO:0051726,1.99140766305565e-05,0.999990125641883,58,1003,regulation of cell cycle,BP,TNFAIP3;IL1B;IL1A;BTG2;INHBA;TNF;CXCL8;PTGS2;FOSL1;TBX3;TGFA;IRF6;EDN1;GADD45A;LIF;BMP2;CAB39;MAP2K3;JUN;BIRC2;CDKN1A;JUNB;OVOL1;IRF1;ZFP36L1;PPP1R15A;CDKN2B;EREG;DUSP1;DCUN1D3;PPP1R10;PIM3;NABP1;CYLD;OXSR1;SMAD3;PLK2;PLK3;PIM1;KLHL21;NDRG1;TP53BP2;SOX9;PML;PTPN11;MAP3K8;RHOB;FEM1B;SOX4;CCNL1;SKIL;CDK6;BTG3;PRPF19;WNT5A;YWHAG;SFN;ERN1
10781,GO:0044238,1.99788631068257e-05,0.999988366223673,290,7688,primary metabolic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;HBEGF;PLAU;NFKBID;CSF2;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;REL;SERPINB2;PPIF;KLF6;NUAK2;CCL20;ZC3H12C;SPRR2D;ZNF697;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;ODC1;SEMA7A;PHLDA1;HAS3;ERRFI1;IL1RN;IRAK2;KLF7;CREB5;DAPP1;CPEB2;EHF;SPRR2A;HCAR2;TNFRSF10B;EPHA2;RELB;GADD45A;MAFF;LIF;TRIB1;KCTD11;SQSTM1;BMP2;PHLDA2;IL24;CAB39;ZNF267;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;NMNAT2;RGMB;TJP2;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;ZFP36L1;ENC1;ADRB2;CEBPB;DUSP16;ARNTL2;UGCG;PPP1R15A;MAST4;RUNX1;N4BP1;CDKN2B;NAB1;HMGCS1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;ALDH1A3;ANKLE2;DUSP8;B4GALT1;HAL;TFPI2;DUSP1;BCL10;DCUN1D3;TRAF1;PPP1R10;PIM3;IL6ST;G0S2;B3GNT5;SGMS2;NABP1;DLX2;SLC6A14;TXNRD1;VGLL3;CYLD;ADAM8;LDLR;VEGFC;KLF3;ZNF217;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;DIEXF;PIM1;ITGA5;TFRC;LIPG;KLHL21;CREB1;SERPINB8;F3;STK40;HIVEP2;PPARD;SLC25A25;SERPINB1;SOCS3;CCDC85B;RAET1L;USP36;IL16;BDKRB1;ZFP36;SLC9A1;MAFK;LARP4B;CYP27B1;CD55;PNRC1;ELL2;AZIN1;JAG1;PLAGL2;RIPK2;PHKG2;SAA1;PPP1R15B;USP53;ITGAV;PIP5K1A;CLK4;NRARP;SOX9;NRG1;ZNF451;FEM1C;PML;POU2F2;RASA2;PPTC7;NCOA7;ELK3;POLR3A;SLC7A2;ZNF460;FOXN2;PTPN11;MAP3K8;UHRF1;PANK3;MXD1;SPAG9;FEM1B;SOX4;USP31;FOSL2;TRAF4;EIF1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;ADAMTS1;HIVEP1;NFKBIB;KLF10;AEN;SKIL;IL7R;HEXDC;RBM3;CDK6;IER5;YRDC;SAMD4A;PTPN1;SQLE;TFE3;CORO1C;PRPF19;TOB2;ADM;MAFG;ABL2;MTF1;QKI;CELF1;PMM2;WNT5A;NUP153;INSIG1;ADAM9;LCE1C;PDPK1;TNFRSF10A;ADAMTS9;RNF19A;CTSC;ERO1A;KDM6A;ZBTB21;NFE2L2;YWHAH;SGK1;B3GNT2;TSC22D2;RELA;RNF11;BACH1;BTAF1;ANKK1;GINS3;POLR3D;ALAS1;YWHAG;TDG;ELF4;CREG1;SFN;ITM2B;ERN1;ETNK1;SH3RF2;UPP1;ISG20;TMEM132A;ATXN7;IFIH1;ADAMTS6;BRD2;PABPC4;DSE;AHCY;FUBP3;SMPD3
10620,GO:0043616,2.02250189901199e-05,0.999997900648392,8,34,keratinocyte proliferation,BP,IRF6;EFNB2;ZFP36L1;EREG;PPARD;ZFP36;FERMT1;SFN
14541,GO:0070059,2.08901341644356e-05,0.999997341102931,9,49,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,PMAIP1;TNFRSF10B;CEBPB;PPP1R15A;BBC3;PML;PTPN1;ERO1A;ERN1
12801,GO:0051092,2.10393634734579e-05,0.999995460496391,14,114,positive regulation of NF-kappaB transcription factor activity,BP,NFKBIA;IL1B;TICAM1;TNF;NFKB1;NFKB2;IRAK2;BCL10;TRAF1;ADAM8;RIPK2;NFKBIB;WNT5A;RELA
4425,GO:0010243,2.10899930593114e-05,0.999990593416312,43,653,response to organonitrogen compound,BP,NFKBIA;TNFAIP3;IL1B;BTG2;TICAM1;TNF;PTGS2;NFKB1;FOSL1;EDN1;ERRFI1;PANX1;CPEB2;JUN;BIRC2;CDKN1A;JUNB;ZFP36L1;ADRB2;CEBPB;HMGCS1;TRIM16;EREG;DUSP1;LDLR;KLF3;CREB1;SOCS3;SLC9A1;JAG1;RIPK2;SOX9;PTPN11;AREG;HDAC9;KLF10;PTPN1;ADM;ATP6V1C2;PDPK1;NFE2L2;RELA;YWHAG
11445,GO:0045892,2.1618214142526e-05,0.999989562582333,53,891,negative regulation of transcription, DNA-templated,BP,BTG2;CSF2;ELF3;TNF;REL;BHLHE40;NFKB1;PRDM1;TBX3;NFKB2;EFNA1;EDN1;RELB;SQSTM1;BMP2;JUN;JUNB;BCL3;OVOL1;ETS2;IRF1;CEBPB;NAB1;EREG;DLX2;KLF3;ZNF217;NEDD4L;SMAD3;PLK3;CREB1;PPARD;CCDC85B;ZFP36;MAFK;NRARP;SOX9;NRG1;ZNF451;PML;ELK3;UHRF1;MXD1;HDAC9;HIVEP1;KLF10;SKIL;WNT5A;ZBTB21;RELA;BACH1;BTAF1;TDG
12888,GO:0051223,2.17530293121523e-05,0.999991212085626,34,476,regulation of protein transport,BP,IL1B;IL1A;ZC3H12A;TNF;PTGS2;PANX1;HCAR2;CDKN1A;CD274;UGCG;TRIM16;PIM3;ADAM8;VEGFC;PLK3;PPARD;USP36;PLAGL2;RIPK2;SAA1;STX1A;NRG1;PML;FERMT1;PTPN11;SOX4;OXCT1;PTPN1;HLA-E;WNT5A;INSIG1;ADAM9;SFN;IFIH1
11293,GO:0045604,2.28870500108605e-05,0.99999705935642,9,48,regulation of epidermal cell differentiation,BP,ERRFI1;MAFF;ZFP36L1;RUNX1;TRIM16;ZFP36;CYP27B1;MAFG;SFN
10058,GO:0042542,2.4085721341161e-05,0.999995096974247,13,105,response to hydrogen peroxide,BP,TNFAIP3;ETS1;PPIF;FOSL1;KDM6B;JUN;DUSP1;PPP1R15B;RHOB;AREG;ADAM9;NFE2L2;RELA
14225,GO:0061158,2.41840773506995e-05,0.999999105941189,5,11,3'-UTR-mediated mRNA destabilization,BP,ZC3H12A;ZFP36L1;RC3H1;ZFP36;QKI
12605,GO:0050778,2.45756053401627e-05,0.999990299837699,32,447,positive regulation of immune response,BP,NFKBIA;TNFAIP3;IL1B;ZC3H12A;BIRC3;TICAM1;TNF;TNIP1;NFKB1;SEMA7A;IRAK2;RELB;BIRC2;IRF1;RUNX1;EREG;PELI1;BCL10;IL6ST;CYLD;ADAM8;RC3H1;IL23A;TFRC;CD55;RIPK2;HLA-E;WNT5A;PDPK1;RELA;POLR3D;IFIH1
11603,GO:0046209,2.49553743512877e-05,0.999996757339739,9,48,nitric oxide metabolic process,BP,IL1B;ZC3H12A;TICAM1;TNF;PTGS2;EDN1;SMAD3;SLC7A2;GCH1
8066,GO:0032732,2.50255805509953e-05,0.999997842145199,7,28,positive regulation of interleukin-1 production,BP,CCL20;PANX1;TRIM16;SMAD3;RIPK2;SAA1;WNT5A
10578,GO:0043542,2.54313837583824e-05,0.999993696628018,16,141,endothelial cell migration,BP,ZC3H12A;ETS1;PTGS2;EFNA1;EDN1;EFNB2;EPHA2;MAP2K3;VEGFC;PLK2;RHOB;HDAC9;WNT5A;PDPK1;ADAMTS9;NFE2L2
6982,GO:0030656,2.57012382423728e-05,0.999999533058141,4,7,regulation of vitamin metabolic process,BP,IL1B;TNF;NFKB1;CYP27B1
14001,GO:0060712,2.65254131239736e-05,0.99999895426947,5,12,spongiotrophoblast layer development,BP,LIF;PHLDA2;ZFP36L1;SOCS3;ADM
7260,GO:0031226,2.65838413174473e-05,0.999987352396016,49,771,intrinsic component of plasma membrane,CC,PLAUR;HBEGF;SDC4;TNF;TRPV3;EFNA1;TGFA;HAS3;CLDN1;TNFRSF10B;EFNB2;EPHA2;CD83;IFNGR2;BMP2;BIRC2;RGMB;CLDN4;RELT;ADRB2;EREG;IL6ST;SGMS2;SLC6A14;ADAM8;LDLR;HCAR3;TACSTD2;ITGA5;TFRC;EFNB1;F3;BDKRB1;SLC9A1;CD55;IFNAR2;JAG1;ITGAV;STX1A;NRG1;RASA2;SLC7A2;SLC28A3;DCBLD2;STEAP4;OSMR;ADAM9;TNFRSF10A;ATP13A3
11783,GO:0046641,2.66228995832093e-05,0.999999511854757,4,7,positive regulation of alpha-beta T cell proliferation,BP,IL23A;CD55;RIPK2;HLA-E
12910,GO:0051253,2.7619941963214e-05,0.999986215748355,57,990,negative regulation of RNA metabolic process,BP,ZC3H12A;BTG2;CSF2;ELF3;TNF;REL;BHLHE40;NFKB1;PRDM1;TBX3;NFKB2;NOCT;EFNA1;EDN1;RELB;SQSTM1;BMP2;JUN;JUNB;BCL3;OVOL1;ETS2;IRF1;CEBPB;NAB1;EREG;DLX2;KLF3;ZNF217;NEDD4L;SMAD3;PLK3;CREB1;PPARD;CCDC85B;ZFP36;MAFK;NRARP;SOX9;NRG1;ZNF451;PML;ELK3;UHRF1;MXD1;HDAC9;HIVEP1;KLF10;SKIL;TOB2;WNT5A;ZBTB21;RELA;BACH1;BTAF1;TDG;CREG1
9977,GO:0042368,2.79037177715895e-05,0.999999482068108,4,7,vitamin D biosynthetic process,BP,IL1B;TNF;NFKB1;CYP27B1
3335,GO:0007050,2.86043430385691e-05,0.999991442288591,20,216,cell cycle arrest,BP,BTG2;INHBA;CXCL8;IRF6;GADD45A;CAB39;CDKN1A;IRF1;PPP1R15A;CDKN2B;DUSP1;SMAD3;PLK2;PLK3;PML;SOX4;SKIL;CDK6;SFN;ERN1
8003,GO:0032623,2.88096357403299e-05,0.999996799776486,8,38,interleukin-2 production,BP,TNFAIP3;IL1B;IL1A;CD83;RUNX1;ZFP36;RIPK2;NAV3
1087,GO:0002673,2.92009347625525e-05,0.999997387163718,7,30,regulation of acute inflammatory response,BP,IL1B;TNF;PTGS2;IL6ST;ADAM8;CD55;OSMR
11802,GO:0046683,2.96584343182736e-05,0.999994359134097,12,85,response to organophosphorus,BP,IL1B;PTGS2;FOSL1;PANX1;JUN;BIRC2;JUNB;ZFP36L1;TRIM16;DUSP1;AREG;RELA
11079,GO:0045080,2.99737236321539e-05,0.999999433168651,4,7,positive regulation of chemokine biosynthetic process,BP,IL1B;TICAM1;TNF;WNT5A
16760,GO:0098552,3.1121370617306e-05,0.999989707957745,23,263,side of membrane,CC,TNF;SEMA7A;ERRFI1;CD83;BIRC2;CD274;B4GALT1;IL6ST;CYLD;LDLR;ITGA5;TFRC;F3;ANTXR2;ITGAV;NRG1;RASA2;IL7R;PTPN1;ABL2;HLA-E;ADAM9;CYTH1
10197,GO:0042802,3.32720370383642e-05,0.999982767983181,63,1164,identical protein binding,MF,NFKBIA;TNFAIP3;INHBA;SDC4;ETS1;TNF;BHLHE40;PTGS2;TNIP1;NFKB1;ODC1;IRAK2;CLDN1;RELB;GADD45A;CXCL5;KCTD11;SQSTM1;JUN;RGMB;CLDN4;NAMPT;BCL2L2;ADRB2;CEBPB;HMGCS1;SOD2;ALDH1A3;EHD1;BCL10;TMCC1;TRAF1;IL6ST;LDLR;OXSR1;SMAD3;TFRC;CREB1;RIPK2;AMOTL2;TP53BP2;PML;UHRF1;GCH1;TRAF4;OXCT1;IER5;MSANTD3;PRPF19;NUP153;CTSC;KDM6A;YWHAH;SAT1;RELA;ALAS1;YWHAG;TDG;SFN;ERN1;IFIH1;TAP1;AHCY
14750,GO:0070427,3.32865139900415e-05,1,3,3,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,NFKBIA;TNFAIP3;RIPK2
12557,GO:0050706,3.35207643931251e-05,0.999997761643324,6,20,regulation of interleukin-1 beta secretion,BP,ZC3H12A;PANX1;TRIM16;RIPK2;PML;WNT5A
541,GO:0001659,3.41435481560278e-05,0.999997712387516,6,20,temperature homeostasis,BP,IL1B;IL1A;TNF;PTGS2;IL1RN;ADRB2
12286,GO:0048608,3.4941508451713e-05,0.999987737337519,25,299,reproductive structure development,BP,CSF2;INHBA;PTGS2;PRDM1;FOSL1;TBX3;LIF;PHLDA2;BIRC2;JUNB;BCL2L2;ZFP36L1;CEBPB;HMGCS1;EREG;GJB3;PPARD;SOCS3;CYP27B1;SOX9;PTPN11;FEM1B;ADAMTS1;ADM;WNT5A
8479,GO:0033627,3.58535217954229e-05,0.999995890203003,8,38,cell adhesion mediated by integrin,BP,PLAU;EFNA1;EPHA2;ITGA5;ITGAV;FERMT1;PTPN11;ADAM9
10794,GO:0044267,3.61370133914151e-05,0.999977157167237,165,3915,cellular protein metabolic process,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;HBEGF;CSF2;INHBA;TICAM1;SDC4;TNF;SERPINB2;PPIF;NUAK2;CCL20;SPRR2D;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;EFNA1;TGFA;KDM6B;EDN1;SEMA7A;ERRFI1;IRAK2;DAPP1;CPEB2;SPRR2A;TNFRSF10B;EPHA2;GADD45A;LIF;TRIB1;KCTD11;SQSTM1;BMP2;IL24;CAB39;MAP2K3;JUN;RAP2B;BIRC2;CDKN1A;BCL3;ZFP36L1;ENC1;ADRB2;DUSP16;PPP1R15A;MAST4;N4BP1;CDKN2B;TRIM16;EREG;PELI1;ANKLE2;DUSP8;B4GALT1;TFPI2;DUSP1;BCL10;DCUN1D3;PPP1R10;PIM3;IL6ST;B3GNT5;CYLD;ADAM8;LDLR;VEGFC;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;PIM1;ITGA5;KLHL21;CREB1;SERPINB8;F3;STK40;SERPINB1;SOCS3;RAET1L;USP36;BDKRB1;ZFP36;LARP4B;CD55;JAG1;RIPK2;PHKG2;SAA1;PPP1R15B;USP53;ITGAV;CLK4;SOX9;NRG1;ZNF451;FEM1C;PML;RASA2;PPTC7;NCOA7;PTPN11;MAP3K8;UHRF1;SPAG9;FEM1B;SOX4;USP31;TRAF4;EIF1;AREG;CCNL1;TNFAIP1;HDAC9;RBM3;CDK6;SAMD4A;PTPN1;CORO1C;PRPF19;ABL2;QKI;CELF1;PMM2;WNT5A;NUP153;ADAM9;LCE1C;PDPK1;TNFRSF10A;RNF19A;CTSC;ERO1A;KDM6A;NFE2L2;SGK1;B3GNT2;RELA;RNF11;BACH1;ANKK1;YWHAG;SFN;ITM2B;ERN1;SH3RF2;TMEM132A;ATXN7;IFIH1;PABPC4
4293,GO:0009719,3.62923595992229e-05,0.999981193153315,61,1067,response to endogenous stimulus,BP,IL1B;BTG2;INHBA;TICAM1;ETS1;TNF;CXCL8;PTGS2;NFKB1;FOSL1;EDN1;ERRFI1;IL1RN;CLDN1;CPEB2;BMP2;JUN;CDKN1A;RGMB;CLDN4;JUNB;ZFP36L1;ADRB2;CEBPB;RUNX1;CDKN2B;HMGCS1;TRIM16;EREG;EHD1;DUSP1;LDLR;KLF3;SMAD3;CREB1;PPARD;SOCS3;ZFP36;SLC9A1;RIPK2;SOX9;ZNF451;PML;FERMT1;PTPN11;OXCT1;AREG;FAM83G;HDAC9;KLF10;SKIL;PTPN1;ADM;ATP6V1C2;WNT5A;ADAM9;PDPK1;NFE2L2;YWHAH;RELA;YWHAG
12552,GO:0050701,3.6534157840355e-05,0.999996611639922,7,30,interleukin-1 secretion,BP,ZC3H12A;PANX1;TRIM16;RIPK2;SAA1;PML;WNT5A
7993,GO:0032609,3.67575978931074e-05,0.999994920494761,9,53,interferon-gamma production,BP,IL1B;ZC3H12A;INHBA;TNF;CD274;BCL3;IL23A;RIPK2;WNT5A
765,GO:0002009,3.71003650384095e-05,0.999985524397811,30,394,morphogenesis of an epithelium,BP,HBEGF;SDC4;TNF;TBX3;EDN1;EFNB2;EPHA2;LIF;BMP2;PHLDB2;ALDH1A3;B4GALT1;BCL10;VEGFC;TACSTD2;SMAD3;ITGA5;SOCS3;JAG1;NRARP;SOX9;PML;RHOB;FEM1B;SOX4;VCL;AREG;ADM;WNT5A;KDM6A
17696,GO:1901576,3.78116134915983e-05,0.999975812130401,199,4894,organic substance biosynthetic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;HBEGF;NFKBID;CSF2;ITPKC;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;REL;KLF6;CCL20;ZNF697;BHLHE40;PTGS2;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;ODC1;PHLDA1;HAS3;ERRFI1;IRAK2;KLF7;CREB5;CPEB2;EHF;RELB;MAFF;LIF;TRIB1;SQSTM1;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;NMNAT2;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;ZFP36L1;ENC1;ADRB2;CEBPB;ARNTL2;UGCG;PPP1R15A;RUNX1;CDKN2B;NAB1;HMGCS1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;ALDH1A3;B4GALT1;DUSP1;BCL10;TRAF1;B3GNT5;SGMS2;NABP1;DLX2;VGLL3;CYLD;ADAM8;LDLR;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;IL23A;PLK3;PIM1;CREB1;HIVEP2;PPARD;CCDC85B;RAET1L;IL16;ZFP36;SLC9A1;MAFK;LARP4B;CYP27B1;PNRC1;ELL2;AZIN1;JAG1;PLAGL2;RIPK2;PHKG2;PPP1R15B;ITGAV;PIP5K1A;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;POLR3A;ZNF460;FOXN2;PTPN11;UHRF1;PANK3;MXD1;GCH1;SOX4;FOSL2;EIF1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;RBM3;IER5;SAMD4A;SQLE;TFE3;PRPF19;TOB2;ADM;MAFG;MTF1;QKI;CELF1;PMM2;WNT5A;NUP153;INSIG1;PDPK1;ZBTB21;NFE2L2;YWHAH;SGK1;B3GNT2;TSC22D2;SAT1;RELA;BACH1;BTAF1;GINS3;POLR3D;ALAS1;TDG;ELF4;CREG1;ITM2B;ERN1;ETNK1;UPP1;ATXN7;BRD2;PABPC4;DSE;AHCY;FUBP3;SMPD3
16105,GO:0090087,3.80058060828375e-05,0.999984180550439,34,490,regulation of peptide transport,BP,IL1B;IL1A;ZC3H12A;TNF;PTGS2;PANX1;HCAR2;CDKN1A;CD274;UGCG;TRIM16;PIM3;ADAM8;VEGFC;PLK3;PPARD;USP36;PLAGL2;RIPK2;SAA1;STX1A;NRG1;PML;FERMT1;PTPN11;SOX4;OXCT1;PTPN1;HLA-E;WNT5A;INSIG1;ADAM9;SFN;IFIH1
11471,GO:0045926,3.92844885830725e-05,0.999989348950896,17,166,negative regulation of growth,BP,INHBA;TNF;SEMA7A;SQSTM1;CDKN1A;SERTAD2;ADRB2;DCUN1D3;SMAD3;DUSP10;PPARD;CCDC85B;BDKRB1;CYP27B1;PML;DCBLD2;WNT5A
4376,GO:0010001,3.93460099024008e-05,0.999990402245675,15,132,glial cell differentiation,BP,LIF;BMP2;NAB1;IL6ST;DLX2;LDLR;DUSP10;NDRG1;SOX9;NRG1;PTPN11;SOX4;CDK6;PRPF19;RELA
14317,GO:0061458,4.03550463947563e-05,0.999985702886776,25,302,reproductive system development,BP,CSF2;INHBA;PTGS2;PRDM1;FOSL1;TBX3;LIF;PHLDA2;BIRC2;JUNB;BCL2L2;ZFP36L1;CEBPB;HMGCS1;EREG;GJB3;PPARD;SOCS3;CYP27B1;SOX9;PTPN11;FEM1B;ADAMTS1;ADM;WNT5A
11436,GO:0045862,4.08559666411031e-05,0.999986210610775,23,281,positive regulation of proteolysis,BP,IL1B;ZC3H12A;TNF;RNF19B;PMAIP1;TNIP1;EFNA1;TNFRSF10B;TRIB1;BCL10;ADAM8;SMAD3;PLK2;BBC3;PLK3;F3;RIPK2;PML;ADAM9;TNFRSF10A;RNF19A;CTSC;NFE2L2
20206,GO:2001057,4.13769333614007e-05,0.999994216302774,9,51,reactive nitrogen species metabolic process,BP,IL1B;ZC3H12A;TICAM1;TNF;PTGS2;EDN1;SMAD3;SLC7A2;GCH1
875,GO:0002224,4.16268892615758e-05,0.999991761092959,12,90,toll-like receptor signaling pathway,BP,NFKBIA;TNFAIP3;BIRC3;TICAM1;TNIP1;IRAK2;BIRC2;IRF1;PELI1;BCL10;RIPK2;PDPK1
10780,GO:0044237,4.23966899836769e-05,0.999974418273625,294,7883,cellular metabolic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;HBEGF;NFKBID;CSF2;ITPKC;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;CXCL8;REL;SERPINB2;PPIF;KLF6;NUAK2;CCL20;ZC3H12C;SPRR2D;ZNF697;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;PLEKHF1;EFNA1;TGFA;KDM6B;IRF6;EDN1;ODC1;SEMA7A;PHLDA1;HAS3;ERRFI1;IRAK2;KLF7;CREB5;DAPP1;CPEB2;EHF;SPRR2A;TNFRSF10B;EPHA2;RELB;GADD45A;MAFF;LIF;TRIB1;KCTD11;SQSTM1;BMP2;PHLDA2;IL24;CAB39;ZNF267;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;NMNAT2;RGMB;TJP2;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;ZFP36L1;ENC1;ADRB2;CEBPB;DUSP16;ARNTL2;UGCG;PPP1R15A;MAST4;RUNX1;N4BP1;CDKN2B;NAB1;HMGCS1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;ALDH1A3;ANKLE2;DUSP8;B4GALT1;HAL;TFPI2;DUSP1;BCL10;DCUN1D3;TRAF1;PPP1R10;PIM3;IL6ST;B3GNT5;SGMS2;VMP1;NABP1;DLX2;SLC6A14;TXNRD1;VGLL3;CYLD;ADAM8;LDLR;VEGFC;KLF3;ZNF217;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;DIEXF;PIM1;ITGA5;TFRC;LIPG;KLHL21;CREB1;SERPINB8;F3;STK40;HIVEP2;PPARD;SLC25A25;SERPINB1;SOCS3;CCDC85B;RAET1L;USP36;IL16;BDKRB1;ZFP36;SLC9A1;MAFK;LARP4B;CYP27B1;CD55;PNRC1;ELL2;AZIN1;JAG1;PLAGL2;RIPK2;PHKG2;SAA1;PPP1R15B;USP53;ITGAV;PIP5K1A;CLK4;NRARP;SOX9;NRG1;ZNF451;FEM1C;PML;POU2F2;RASA2;PPTC7;NCOA7;ELK3;POLR3A;SLC7A2;ZNF460;FOXN2;PTPN11;MAP3K8;UHRF1;PANK3;MXD1;SPAG9;GCH1;FEM1B;SOX4;USP31;FOSL2;TRAF4;EIF1;OXCT1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;HIVEP1;NFKBIB;KLF10;AEN;SKIL;IL7R;RBM3;CDK6;IER5;YRDC;SAMD4A;PTPN1;SQLE;TFE3;CORO1C;PRPF19;TOB2;ADM;MAFG;ABL2;MTF1;ATP6V1C2;QKI;CELF1;PMM2;WNT5A;NUP153;MAOA;INSIG1;ADAM9;LCE1C;PDPK1;TNFRSF10A;ADAMTS9;RNF19A;CTSC;ERO1A;KDM6A;ZBTB21;NFE2L2;YWHAH;SGK1;B3GNT2;TSC22D2;SAT1;RELA;RNF11;BACH1;BTAF1;ANKK1;GINS3;POLR3D;ALAS1;YWHAG;TDG;ELF4;CREG1;SFN;ITM2B;ERN1;ETNK1;SH3RF2;UPP1;ISG20;TMEM132A;ATXN7;IFIH1;BRD2;PABPC4;DSE;AHCY;STX12;FUBP3;RAB24;SMPD3
4027,GO:0009058,4.26455981747098e-05,0.9999726438792,200,4934,biosynthetic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;HBEGF;NFKBID;CSF2;ITPKC;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;REL;KLF6;CCL20;ZNF697;BHLHE40;PTGS2;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;ODC1;PHLDA1;HAS3;ERRFI1;IRAK2;KLF7;CREB5;CPEB2;EHF;RELB;MAFF;LIF;TRIB1;SQSTM1;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;NMNAT2;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;ZFP36L1;ENC1;ADRB2;CEBPB;ARNTL2;UGCG;PPP1R15A;RUNX1;CDKN2B;NAB1;HMGCS1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;ALDH1A3;B4GALT1;DUSP1;BCL10;TRAF1;B3GNT5;SGMS2;NABP1;DLX2;VGLL3;CYLD;ADAM8;LDLR;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;IL23A;PLK3;PIM1;CREB1;HIVEP2;PPARD;CCDC85B;RAET1L;IL16;ZFP36;SLC9A1;MAFK;LARP4B;CYP27B1;PNRC1;ELL2;AZIN1;JAG1;PLAGL2;RIPK2;PHKG2;PPP1R15B;ITGAV;PIP5K1A;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;POLR3A;SLC7A2;ZNF460;FOXN2;PTPN11;UHRF1;PANK3;MXD1;GCH1;SOX4;FOSL2;EIF1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;RBM3;IER5;SAMD4A;SQLE;TFE3;PRPF19;TOB2;ADM;MAFG;MTF1;QKI;CELF1;PMM2;WNT5A;NUP153;INSIG1;PDPK1;ZBTB21;NFE2L2;YWHAH;SGK1;B3GNT2;TSC22D2;SAT1;RELA;BACH1;BTAF1;GINS3;POLR3D;ALAS1;TDG;ELF4;CREG1;ITM2B;ERN1;ETNK1;UPP1;ATXN7;BRD2;PABPC4;DSE;AHCY;FUBP3;SMPD3
7922,GO:0032495,4.32336129290566e-05,0.999998107823572,5,12,response to muramyl dipeptide,BP,NFKBIA;TNFAIP3;JAG1;RIPK2;RELA
11346,GO:0045670,4.3404799168102e-05,0.999994866962996,8,39,regulation of osteoclast differentiation,BP,TNF;TJP2;CEBPB;IL23A;CREB1;KLF10;TFE3;TOB2
11776,GO:0046634,4.4693654443291e-05,0.999994674014924,8,40,regulation of alpha-beta T cell activation,BP,PRDM1;CD83;IRF1;RC3H1;IL23A;CD55;RIPK2;HLA-E
3663,GO:0008152,4.62637737772651e-05,0.99997304667137,305,8257,metabolic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;BIRC3;HBEGF;PLAU;NFKBID;CSF2;ITPKC;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;CXCL8;REL;SERPINB2;PPIF;KLF6;NUAK2;CCL20;ZC3H12C;SPRR2D;ZNF697;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;PLEKHF1;EFNA1;TGFA;KDM6B;IRF6;EDN1;ODC1;SEMA7A;PHLDA1;HAS3;ERRFI1;IL1RN;IRAK2;KLF7;CREB5;DAPP1;CPEB2;EHF;SPRR2A;HCAR2;TNFRSF10B;EPHA2;RELB;GADD45A;MAFF;LIF;TRIB1;KCTD11;SQSTM1;BMP2;PHLDA2;IL24;CAB39;ZNF267;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;NMNAT2;RGMB;TJP2;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;ZFP36L1;ENC1;ADRB2;CEBPB;DUSP16;ARNTL2;UGCG;PPP1R15A;MAST4;RUNX1;N4BP1;CDKN2B;NAB1;HMGCS1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;ALDH1A3;ANKLE2;DUSP8;B4GALT1;HAL;TFPI2;DUSP1;BCL10;DCUN1D3;HEPHL1;TRAF1;PPP1R10;PIM3;IL6ST;G0S2;B3GNT5;SGMS2;VMP1;NABP1;DLX2;SLC6A14;TXNRD1;VGLL3;CYLD;ADAM8;LDLR;VEGFC;KLF3;ZNF217;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;DIEXF;PIM1;ITGA5;TFRC;LIPG;KLHL21;CREB1;SERPINB8;F3;STK40;HIVEP2;PPARD;SLC25A25;SERPINB1;SOCS3;CCDC85B;RAET1L;USP36;IL16;BDKRB1;ZFP36;SLC9A1;MAFK;LARP4B;CYP27B1;CD55;PNRC1;ELL2;AZIN1;JAG1;PLAGL2;RIPK2;PHKG2;SAA1;PPP1R15B;USP53;ITGAV;PIP5K1A;CLK4;NRARP;SOX9;NRG1;ZNF451;FEM1C;PML;POU2F2;RASA2;PPTC7;FERMT1;NCOA7;ELK3;POLR3A;SLC7A2;ZNF460;FOXN2;PTPN11;MAP3K8;UHRF1;PANK3;MXD1;SPAG9;GCH1;FEM1B;SOX4;USP31;FOSL2;TRAF4;EIF1;OXCT1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;ADAMTS1;HIVEP1;NFKBIB;KLF10;AEN;SKIL;IL7R;HEXDC;RBM3;CDK6;IER5;YRDC;SAMD4A;PTPN1;SQLE;TFE3;CORO1C;STEAP4;PRPF19;TOB2;ADM;MAFG;ABL2;MTF1;ATP6V1C2;QKI;CELF1;PMM2;WNT5A;NUP153;MAOA;INSIG1;ADAM9;LCE1C;PDPK1;TNFRSF10A;ADAMTS9;RNF19A;CTSC;ERO1A;KDM6A;ZBTB21;NFE2L2;YWHAH;SGK1;B3GNT2;TSC22D2;SAT1;RELA;AGFG1;RNF11;BACH1;BTAF1;ANKK1;GINS3;POLR3D;ALAS1;YWHAG;TDG;ELF4;CREG1;SFN;ITM2B;ERN1;ETNK1;SH3RF2;UPP1;ISG20;TMEM132A;ATXN7;IFIH1;ADAMTS6;BRD2;PABPC4;DSE;AHCY;STX12;FUBP3;RAB24;SMPD3
1148,GO:0002753,4.72001100826215e-05,0.999993301543376,9,50,cytoplasmic pattern recognition receptor signaling pathway,BP,NFKBIA;TNFAIP3;BIRC3;IRAK2;BIRC2;CYLD;RIPK2;RELA;IFIH1
7908,GO:0032479,4.80494810598048e-05,0.999989513885516,13,107,regulation of type I interferon production,BP,TNFAIP3;TICAM1;REL;NFKB1;NFKB2;RELB;IRF1;CYLD;RIPK2;POLR3A;RELA;POLR3D;IFIH1
6745,GO:0030162,4.82535201042945e-05,0.999979637267486,34,518,regulation of proteolysis,BP,IL1B;ZC3H12A;PLAUR;BIRC3;TNF;SERPINB2;PTGS2;RNF19B;PMAIP1;TNIP1;EFNA1;TNFRSF10B;TRIB1;BIRC2;N4BP1;TFPI2;BCL10;ADAM8;SMAD3;PLK2;BBC3;PLK3;SERPINB8;F3;SERPINB1;CD55;RIPK2;PML;ADAM9;TNFRSF10A;RNF19A;CTSC;NFE2L2;SFN
1323,GO:0003170,5.12267848734011e-05,0.999995044539307,7,28,heart valve development,BP,PRDM1;EFNA1;BMP2;JAG1;SOX9;SOX4;ADAMTS9
7990,GO:0032606,5.15418033352529e-05,0.99998866611321,13,108,type I interferon production,BP,TNFAIP3;TICAM1;REL;NFKB1;NFKB2;RELB;IRF1;CYLD;RIPK2;POLR3A;RELA;POLR3D;IFIH1
12968,GO:0051347,5.2259153543105e-05,0.999977886925705,34,483,positive regulation of transferase activity,BP,IL1B;SDC4;TNF;EFNA1;TGFA;EDN1;IRAK2;TNFRSF10B;EPHA2;GADD45A;BMP2;CAB39;MAP2K3;CDKN1A;ADRB2;EREG;DCUN1D3;ADAM8;OXSR1;IL23A;RIPK2;SAA1;NRG1;PTPN11;MAP3K8;SPAG9;TRAF4;CCNL1;PTPN1;WNT5A;ADAM9;PDPK1;TNFRSF10A;ERN1
11072,GO:0045073,5.32748548709327e-05,0.999998690428766,4,8,regulation of chemokine biosynthetic process,BP,IL1B;TICAM1;TNF;WNT5A
7674,GO:0032102,5.33436955555371e-05,0.999984486350103,18,188,negative regulation of response to external stimulus,BP,TNFAIP3;ZC3H12A;PLAUR;PLAU;ETS1;SERPINB2;NFKB1;PRDM1;EDN1;SEMA7A;TRIB1;PHLDB2;SMAD3;DUSP10;PPARD;SOCS3;SAA1;WNT5A
6597,GO:0022612,5.36119266023747e-05,0.999989135817678,12,86,gland morphogenesis,BP,TNFAIP3;ELF3;TNF;TBX3;EPHA2;CEBPB;B4GALT1;SOX9;PML;FEM1B;AREG;WNT5A
8017,GO:0032648,5.56365628017005e-05,0.999993134299488,8,41,regulation of interferon-beta production,BP,TICAM1;REL;RELB;IRF1;RIPK2;POLR3A;POLR3D;IFIH1
12712,GO:0050927,5.57913914961385e-05,0.999997253425949,5,14,positive regulation of positive chemotaxis,BP,CXCL8;VEGFC;SMAD3;F3;IL16
10503,GO:0043406,5.70395855058803e-05,0.999982682939775,19,197,positive regulation of MAP kinase activity,BP,IL1B;TNF;TGFA;EDN1;IRAK2;GADD45A;BMP2;MAP2K3;ADAM8;RIPK2;SAA1;NRG1;PTPN11;MAP3K8;SPAG9;PTPN1;WNT5A;ADAM9;ERN1
9893,GO:0042176,5.70794376662258e-05,0.999979779781934,24,300,regulation of protein catabolic process,BP,TNFAIP3;IL1B;TNF;RNF19B;EFNA1;ODC1;TRIB1;N4BP1;ADAM8;LDLR;NEDD4L;SMAD3;PLK2;PLK3;AZIN1;SOX9;NRG1;PML;WNT5A;ADAM9;RNF19A;CTSC;NFE2L2;RELA
14178,GO:0061061,5.7760898385307e-05,0.999977276526001,29,380,muscle structure development,BP,BTG2;HBEGF;TNF;TBX3;KDM6B;EDN1;EFNB2;MAFF;LIF;BMP2;ZFP36L1;EREG;EHD1;SMAD3;PIM1;CREB1;PPARD;SLC9A1;JAG1;SOX9;NRG1;FOXN2;SPAG9;HDAC9;ADM;QKI;WNT5A;SMTN;PDLIM5
14211,GO:0061138,5.88504306008817e-05,0.999985131064509,15,129,morphogenesis of a branching epithelium,BP,TNF;TBX3;EDN1;EPHA2;BMP2;B4GALT1;TACSTD2;SOCS3;NRARP;SOX9;PML;FEM1B;AREG;ADM;WNT5A
12345,GO:0048708,5.98721487232712e-05,0.999992532438718,8,41,astrocyte differentiation,BP,LIF;BMP2;IL6ST;LDLR;SOX9;PTPN11;CDK6;PRPF19
6821,GO:0030278,6.01868052966487e-05,0.999985634734563,14,118,regulation of ossification,BP,TNF;NOCT;BMP2;ADRB2;CEBPB;IL6ST;SMAD3;CYP27B1;JAG1;SOX9;AREG;CDK6;TOB2;WNT5A
12672,GO:0050873,6.10374622137891e-05,0.999995302471655,6,23,brown fat cell differentiation,BP,PTGS2;ADRB2;CEBPB;DUSP10;ERO1A;LAMB3
10736,GO:0044093,6.16071408440705e-05,0.999966302180514,68,1258,positive regulation of molecular function,BP,NFKBIA;IL1B;CXCL1;PLAUR;TICAM1;SDC4;TNF;CCL20;PMAIP1;NFKB1;FOSL1;NFKB2;EFNA1;TGFA;EDN1;ERRFI1;IRAK2;TNFRSF10B;EPHA2;GADD45A;BMP2;CAB39;MAP2K3;JUN;CDKN1A;ADRB2;PPP1R15A;EREG;BCL10;DCUN1D3;TRAF1;ADAM8;OXSR1;SMAD3;IL23A;PLK2;BBC3;F3;SLC9A1;CYP27B1;AZIN1;RIPK2;SAA1;PPP1R15B;PIP5K1A;NRG1;PML;RASA2;CDC42EP1;PTPN11;MAP3K8;UHRF1;SPAG9;GCH1;TRAF4;CCNL1;NFKBIB;PTPN1;CORO1C;ABL2;WNT5A;ADAM9;PDPK1;TNFRSF10A;SGK1;RELA;AGFG1;ERN1
11352,GO:0045685,6.31868037424647e-05,0.999992032972643,8,42,regulation of glial cell differentiation,BP,LIF;BMP2;IL6ST;DLX2;LDLR;DUSP10;PRPF19;RELA
4550,GO:0010629,6.34868150287728e-05,0.99996469157819,72,1429,negative regulation of gene expression,BP,ZC3H12A;BTG2;BIRC3;CSF2;ELF3;TNF;REL;BHLHE40;NFKB1;PRDM1;TBX3;NFKB2;NOCT;EFNA1;EDN1;CPEB2;RELB;SQSTM1;BMP2;JUN;BIRC2;CDKN1A;JUNB;BCL3;OVOL1;ETS2;IRF1;ZFP36L1;ENC1;CEBPB;NAB1;EREG;DLX2;LDLR;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;PLK3;CREB1;PPARD;CCDC85B;ZFP36;MAFK;CD55;PNRC1;NRARP;SOX9;NRG1;ZNF451;PML;FERMT1;ELK3;UHRF1;MXD1;HDAC9;HIVEP1;KLF10;SKIL;SAMD4A;QKI;CELF1;WNT5A;NUP153;ZBTB21;RELA;BACH1;BTAF1;TDG;ERN1;PABPC4
12779,GO:0051051,6.50695754458715e-05,0.999977945685449,22,264,negative regulation of transport,BP,IL1B;ZC3H12A;INHBA;TNF;PPIF;PTGS2;NFKB1;EDN1;LIF;RRAD;CAB39;PIM3;NEDD4L;OXSR1;ITGAV;NRG1;PML;PTPN11;SOX4;YRDC;NUP153;INSIG1
14646,GO:0070234,6.56384320060705e-05,0.999998164477743,4,9,positive regulation of T cell apoptotic process,BP,NFKBID;CD274;ADAM8;WNT5A
3554,GO:0007596,6.74930973494726e-05,0.999979178765965,19,213,blood coagulation,BP,PLAUR;PLAU;SERPINB2;EDN1;MAFF;RAP2B;IRF1;EHD1;TFPI2;F3;MAFK;SAA1;PTPN11;RHOB;VCL;MAFG;PDPK1;NFE2L2;PABPC4
13099,GO:0051607,6.85933907736299e-05,0.999981375943009,16,159,defense response to virus,BP,TNFAIP3;IL1B;ZC3H12A;BIRC3;TICAM1;PMAIP1;BIRC2;IRF1;IL23A;IFNAR2;PML;POLR3A;RELA;POLR3D;ISG20;IFIH1
4370,GO:0009987,7.00145935243273e-05,0.999976711800692,368,10468,cellular process,BP,NFKBIA;NFKBIZ;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;CXCL3;BTG2;IL36G;BIRC3;HBEGF;PLAU;NFKBID;CSF2;ITPKC;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;CXCL8;REL;SERPINB2;PPIF;IER3;KLF6;NUAK2;CCL20;ZC3H12C;SPRR2D;ZNF697;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;PLEKHF1;EFNA1;TGFA;KDM6B;IRF6;EDN1;ODC1;SEMA7A;PHLDA1;HAS3;ERRFI1;IL1RN;IRAK2;CLDN1;KLF7;PANX1;CREB5;DAPP1;CPEB2;EHF;SPRR2A;HCAR2;TNFRSF10B;EFNB2;EPHA2;RELB;GADD45A;CXCL5;MAFF;LIF;TRIB1;KCTD11;CD83;SQSTM1;IFNGR2;RRAD;BMP2;PHLDA2;IL24;CAB39;ZNF267;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;NMNAT2;RGMB;PHLDB2;CLDN4;TJP2;SERTAD2;CD274;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;BCL2L2;ZFP36L1;ENC1;RELT;RND3;ADRB2;CEBPB;DUSP16;ARNTL2;UGCG;PPP1R15A;MAST4;RUNX1;N4BP1;CDKN2B;GJB4;NAB1;HMGCS1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;ALDH1A3;EHD1;NEDD9;ZSWIM4;ANKLE2;DUSP8;B4GALT1;HAL;TFPI2;DUSP1;BCL10;FGD6;DCUN1D3;TMCC1;TRAF1;PPP1R10;PIM3;SACS;IL6ST;G0S2;B3GNT5;SGMS2;VMP1;NABP1;DLX2;SLC6A14;TXNRD1;VGLL3;CYLD;ADAM8;LDLR;VEGFC;KLF3;HCAR3;ZNF217;TACSTD2;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;DIEXF;PIM1;WISP1;ITGA5;TFRC;LIPG;KLHL21;CREB1;SERPINB8;EFNB1;GJB3;F3;STK40;HIVEP2;PPARD;KRT34;SLC25A25;SERPINB1;SOCS3;CCDC85B;KRTAP2-3;RAET1L;USP36;IL16;BDKRB1;RAPH1;ZFP36;SLC9A1;MAFK;LARP4B;CYP27B1;CD55;PNRC1;IFNAR2;ELL2;ANTXR2;AZIN1;JAG1;PLAGL2;RIPK2;AMOTL2;PHKG2;NAV3;SAA1;PPP1R15B;USP53;NDRG1;ITGAV;PIP5K1A;CLK4;TP53BP2;NRARP;SOX9;STX1A;NRG1;ZNF451;FEM1C;PML;POU2F2;RASA2;PPTC7;FERMT1;NCOA7;ELK3;POLR3A;SLC7A2;ZNF460;CDC42EP1;FOXN2;PTPN11;MAP3K8;UHRF1;PANK3;ARHGEF3;MXD1;DCBLD2;RHOB;SPAG9;ABCA5;GCH1;FEM1B;SOX4;USP31;FOSL2;TRAF4;VCL;EIF1;OXCT1;AREG;CCNL1;FAM83G;AKAP2;TNFAIP1;HDAC9;ADAMTS1;HIVEP1;NFKBIB;KLF10;AEN;TIFA;SKIL;COTL1;IL7R;RBM3;CDK6;IER5;YRDC;SAMD4A;EMP3;PTPN1;SQLE;TFE3;BTG3;CORO1C;STEAP4;PRPF19;TOB2;ADM;MAFG;ABL2;MTF1;ATP6V1C2;HLA-E;RAB3IP;OSMR;QKI;CELF1;PMM2;WNT5A;NUP153;MAOA;INSIG1;ADAM9;LCE1C;PDPK1;TNFRSF10A;ADAMTS9;RNF19A;CTSC;ERO1A;KDM6A;FRMD6;ZBTB21;NFE2L2;YWHAH;SGK1;B3GNT2;TSC22D2;CYTH1;SAT1;RELA;AGFG1;RNF11;NOTCH2NL;BACH1;BTAF1;ANKK1;GINS3;POLR3D;ALAS1;YWHAG;TDG;ELF4;RAB22A;CREG1;SFN;ITM2B;ERN1;ETNK1;SH3RF2;UPP1;ISG20;TMEM132A;ATXN7;IFIH1;LAMB3;ATP13A3;MYO1B;BRD2;IPO4;CXCL16;PABPC4;TAP1;DSE;AHCY;STX12;PDLIM5;FUBP3;GPR156;RAB24;SMPD3
1101,GO:0002688,7.06988517724456e-05,0.999989223138629,9,60,regulation of leukocyte chemotaxis,BP,CXCL2;CXCL1;CXCL3;CXCL8;EDN1;CXCL5;VEGFC;IL23A;WNT5A
8850,GO:0034645,7.07371203864881e-05,0.999954257932886,169,4041,cellular macromolecule biosynthetic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;HBEGF;NFKBID;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;KLF6;ZNF697;BHLHE40;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;PHLDA1;HAS3;IRAK2;KLF7;CREB5;CPEB2;EHF;RELB;MAFF;LIF;TRIB1;SQSTM1;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ENC1;ADRB2;CEBPB;ARNTL2;PPP1R15A;RUNX1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;B4GALT1;DUSP1;BCL10;TRAF1;B3GNT5;NABP1;DLX2;VGLL3;CYLD;ADAM8;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;IL23A;PLK3;PIM1;CREB1;HIVEP2;PPARD;CCDC85B;RAET1L;IL16;ZFP36;SLC9A1;MAFK;LARP4B;PNRC1;ELL2;JAG1;PLAGL2;RIPK2;PHKG2;PPP1R15B;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;POLR3A;ZNF460;FOXN2;UHRF1;MXD1;SOX4;FOSL2;EIF1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;RBM3;IER5;SAMD4A;TFE3;MAFG;MTF1;QKI;CELF1;PMM2;WNT5A;NUP153;INSIG1;PDPK1;ZBTB21;NFE2L2;YWHAH;SGK1;B3GNT2;TSC22D2;RELA;BACH1;BTAF1;GINS3;POLR3D;TDG;ELF4;CREG1;ITM2B;ERN1;ATXN7;BRD2;PABPC4;DSE;FUBP3
3526,GO:0007507,7.08964346020686e-05,0.999972289429046,28,356,heart development,BP,PRDM1;TBX3;EFNA1;KDM6B;EDN1;EFNB2;BMP2;JUN;ZFP36L1;SMAD3;PIM1;CREB1;PPARD;SLC9A1;JAG1;SOX9;NRG1;PTPN11;SOX4;OXCT1;HDAC9;ADAMTS1;TMEM65;ADM;WNT5A;ADAMTS9;KDM6A;PDLIM5
12633,GO:0050817,7.29863390726469e-05,0.9999773430976,19,214,coagulation,BP,PLAUR;PLAU;SERPINB2;EDN1;MAFF;RAP2B;IRF1;EHD1;TFPI2;F3;MAFK;SAA1;PTPN11;RHOB;VCL;MAFG;PDPK1;NFE2L2;PABPC4
10572,GO:0043535,7.3105517098647e-05,0.99998737971099,10,66,regulation of blood vessel endothelial cell migration,BP,ETS1;PTGS2;EFNA1;EPHA2;MAP2K3;VEGFC;PLK2;HDAC9;PDPK1;NFE2L2
11800,GO:0046677,7.39848807298988e-05,0.999976997342213,19,217,response to antibiotic,BP,TNFAIP3;ZC3H12A;ETS1;PPIF;FOSL1;KDM6B;EDN1;CLDN1;JUN;BIRC2;DUSP1;SLC9A1;PPP1R15B;RHOB;OXCT1;AREG;ADAM9;NFE2L2;RELA
6293,GO:0019901,7.43016881818103e-05,0.999967135594102,36,526,protein kinase binding,MF,TICAM1;SDC4;TNIP1;ERRFI1;EPHA2;RELB;TRIB1;SQSTM1;MAP2K3;CDKN1A;RND3;PPP1R15A;CDKN2B;BCL10;CYLD;SMAD3;DUSP10;ZFP36;IFNAR2;ITGAV;SOX9;NRG1;PTPN11;RHOB;SPAG9;GCH1;TRAF4;HDAC9;PTPN1;ADAM9;PDPK1;RELA;YWHAG;TDG;SFN;PDLIM5
14788,GO:0070498,7.54765971316227e-05,0.999985272708587,11,93,interleukin-1-mediated signaling pathway,BP,NFKBIA;IL1B;IL1A;NFKB1;IL1RN;IRAK2;SQSTM1;PELI1;RIPK2;MAP3K8;RELA
4861,GO:0014074,7.63910576401201e-05,0.999983834367529,12,93,response to purine-containing compound,BP,IL1B;PTGS2;FOSL1;PANX1;JUN;BIRC2;JUNB;ZFP36L1;HMGCS1;DUSP1;AREG;RELA
14753,GO:0070431,7.74437029595791e-05,0.999997899878394,4,8,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,NFKBIA;TNFAIP3;RIPK2;RELA
7992,GO:0032608,7.7921831748614e-05,0.999989841153383,8,43,interferon-beta production,BP,TICAM1;REL;RELB;IRF1;RIPK2;POLR3A;POLR3D;IFIH1
8078,GO:0032755,7.81116649309115e-05,0.999989812781505,8,43,positive regulation of interleukin-6 production,BP,IL1B;IL1A;TICAM1;TNF;EREG;RIPK2;WNT5A;IFIH1
10573,GO:0043536,7.8922186972099e-05,0.99998972080957,8,42,positive regulation of blood vessel endothelial cell migration,BP,ETS1;PTGS2;MAP2K3;VEGFC;PLK2;HDAC9;PDPK1;NFE2L2
20272,GO:2001234,7.9925272550163e-05,0.999977960368262,16,167,negative regulation of apoptotic signaling pathway,BP,TNFAIP3;IL1B;IL1A;PLAUR;CSF2;TNF;PPIF;PTGS2;TNFRSF10B;BCL2L2;SOD2;ITGAV;PTPN1;TNFRSF10A;NFE2L2;RELA
3557,GO:0007599,8.0251949069218e-05,0.999974894528263,19,216,hemostasis,BP,PLAUR;PLAU;SERPINB2;EDN1;MAFF;RAP2B;IRF1;EHD1;TFPI2;F3;MAFK;SAA1;PTPN11;RHOB;VCL;MAFG;PDPK1;NFE2L2;PABPC4
9821,GO:0042033,8.02843441961537e-05,0.999997633067482,4,9,chemokine biosynthetic process,BP,IL1B;TICAM1;TNF;WNT5A
12587,GO:0050755,8.02843441961537e-05,0.999997633067482,4,9,chemokine metabolic process,BP,IL1B;TICAM1;TNF;WNT5A
10787,GO:0044249,8.17616773199424e-05,0.999946522901971,195,4829,cellular biosynthetic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;PLAUR;BTG2;HBEGF;NFKBID;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;KLF6;CCL20;ZNF697;BHLHE40;PTGS2;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;ODC1;PHLDA1;HAS3;ERRFI1;IRAK2;KLF7;CREB5;CPEB2;EHF;RELB;MAFF;LIF;TRIB1;SQSTM1;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;NMNAT2;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;ZFP36L1;ENC1;ADRB2;CEBPB;ARNTL2;UGCG;PPP1R15A;RUNX1;CDKN2B;NAB1;HMGCS1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;ALDH1A3;B4GALT1;DUSP1;BCL10;TRAF1;B3GNT5;SGMS2;NABP1;DLX2;VGLL3;CYLD;ADAM8;LDLR;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;IL23A;PLK3;PIM1;CREB1;HIVEP2;PPARD;CCDC85B;RAET1L;IL16;ZFP36;SLC9A1;MAFK;LARP4B;CYP27B1;PNRC1;ELL2;AZIN1;JAG1;PLAGL2;RIPK2;PHKG2;PPP1R15B;PIP5K1A;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;POLR3A;SLC7A2;ZNF460;FOXN2;PTPN11;UHRF1;PANK3;MXD1;GCH1;SOX4;FOSL2;EIF1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;RBM3;IER5;SAMD4A;TFE3;TOB2;ADM;MAFG;MTF1;QKI;CELF1;PMM2;WNT5A;NUP153;INSIG1;PDPK1;ZBTB21;NFE2L2;YWHAH;SGK1;B3GNT2;TSC22D2;SAT1;RELA;BACH1;BTAF1;GINS3;POLR3D;ALAS1;TDG;ELF4;CREG1;ITM2B;ERN1;ETNK1;UPP1;ATXN7;BRD2;PABPC4;DSE;AHCY;FUBP3;SMPD3
11126,GO:0045165,8.37213028718215e-05,0.999979345494042,14,121,cell fate commitment,BP,PRDM1;TBX3;KDM6B;BMP2;ETS2;CEBPB;DLX2;CYLD;IL23A;JAG1;SOX9;NRG1;PML;WNT5A
11872,GO:0046879,8.39969875800961e-05,0.999975695275438,17,173,hormone secretion,BP,IL1B;INHBA;TNF;TBX3;EDN1;IL1RN;HCAR2;LIF;PIM3;CREB1;PPARD;STX1A;PTPN11;SOX4;OXCT1;ADM;SMPD3
12674,GO:0050878,8.75323437213007e-05,0.99996807448256,24,307,regulation of body fluid levels,BP,PLAUR;PLAU;SERPINB2;EDN1;CLDN1;MAFF;RAP2B;CLDN4;IRF1;EHD1;TFPI2;CREB1;F3;MAFK;SAA1;PTPN11;RHOB;VCL;ADM;MAFG;PDPK1;NFE2L2;SFN;PABPC4
12711,GO:0050926,8.79302462938657e-05,0.999995114007767,5,15,regulation of positive chemotaxis,BP,CXCL8;VEGFC;SMAD3;F3;IL16
8148,GO:0032874,9.1273960226366e-05,0.99997874787903,13,107,positive regulation of stress-activated MAPK cascade,BP,IL1B;IL1A;ZC3H12A;TNF;EDN1;GADD45A;BMP2;RIPK2;SPAG9;TRAF4;PTPN1;WNT5A;ERN1
12356,GO:0048732,9.46144404422731e-05,0.999965347023374,24,296,gland development,BP,NFKBIA;TNFAIP3;ELF3;ETS1;TNF;TBX3;IRF6;CLDN1;EPHA2;BMP2;JUN;CEBPB;HMGCS1;ALDH1A3;B4GALT1;SMAD3;CREB1;SOX9;NRG1;PML;FEM1B;AREG;WNT5A;RELA
710,GO:0001933,9.46548711494977e-05,0.999964489321033,25,325,negative regulation of protein phosphorylation,BP,TNFAIP3;IL1B;ZC3H12A;TNIP1;EFNA1;ERRFI1;GADD45A;LIF;TRIB1;JUN;CDKN1A;DUSP16;CDKN2B;DUSP8;DUSP1;DUSP10;SOCS3;BDKRB1;PPP1R15B;CDK6;PTPN1;CORO1C;PDPK1;YWHAG;SFN
4295,GO:0009725,9.56003585362386e-05,0.999954829276473,41,651,response to hormone,BP,IL1B;BTG2;INHBA;ETS1;TNF;PTGS2;NFKB1;FOSL1;EDN1;ERRFI1;IL1RN;CLDN1;CPEB2;JUN;CDKN1A;CLDN4;JUNB;ZFP36L1;RUNX1;HMGCS1;TRIM16;EREG;DUSP1;CREB1;PPARD;SOCS3;ZFP36;SLC9A1;PTPN11;OXCT1;AREG;HDAC9;PTPN1;ADM;ATP6V1C2;ADAM9;PDPK1;NFE2L2;YWHAH;RELA;YWHAG
897,GO:0002274,9.58796788309754e-05,0.999961021237103,29,427,myeloid leukocyte activation,BP,ZC3H12A;CXCL1;PLAUR;PLAU;CSF2;TICAM1;CXCL8;NFKB1;RELB;CAB39;JUN;RAP2B;AMPD3;B4GALT1;ADAM8;LDLR;SERPINB1;CD55;NDRG1;ITGAV;SLC7A2;VCL;COTL1;WNT5A;ADAM9;PDPK1;CTSC;CREG1;RAB24
3381,GO:0007160,9.61795065117849e-05,0.999973180306239,16,149,cell-matrix adhesion,BP,PLAU;SDC4;PHLDB2;VEGFC;SMAD3;SLC9A1;JAG1;ITGAV;PIP5K1A;FERMT1;VCL;CDK6;CORO1C;ADAM9;PDPK1;ADAMTS9
59,GO:0000122,9.70293142460701e-05,0.999954991139974,39,602,negative regulation of transcription by RNA polymerase II,BP,BTG2;TNF;REL;BHLHE40;NFKB1;PRDM1;TBX3;NFKB2;EFNA1;EDN1;RELB;SQSTM1;BMP2;JUN;JUNB;OVOL1;ETS2;CEBPB;DLX2;KLF3;ZNF217;NEDD4L;SMAD3;PLK3;PPARD;ZFP36;MAFK;NRARP;SOX9;ZNF451;UHRF1;MXD1;HDAC9;HIVEP1;KLF10;SKIL;RELA;BACH1;TDG
9973,GO:0042362,9.8642936237091e-05,0.999996929903439,4,9,fat-soluble vitamin biosynthetic process,BP,IL1B;TNF;NFKB1;CYP27B1
9835,GO:0042063,9.96843428134566e-05,0.999970721705417,17,175,gliogenesis,BP,LIF;BMP2;NAB1;IL6ST;DLX2;LDLR;DUSP10;CREB1;NDRG1;SOX9;NRG1;PTPN11;SOX4;AREG;CDK6;PRPF19;RELA
6583,GO:0022408,9.99776901718009e-05,0.999978133777866,12,99,negative regulation of cell-cell adhesion,BP,NFKBID;SDC4;IL1RN;BMP2;CD274;IRF1;CEBPB;PELI1;CYLD;RC3H1;JAG1;NRARP
14685,GO:0070304,0.000100625363166579,0.999976323027809,13,108,positive regulation of stress-activated protein kinase signaling cascade,BP,IL1B;IL1A;ZC3H12A;TNF;EDN1;GADD45A;BMP2;RIPK2;SPAG9;TRAF4;PTPN1;WNT5A;ERN1
11889,GO:0046903,0.000101712181930367,0.999946633159815,55,996,secretion,BP,IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;PLAU;CSF2;INHBA;SDC4;TNF;NFKB1;TBX3;EDN1;IL1RN;PANX1;HCAR2;LIF;CAB39;RAP2B;CD274;AMPD3;TRIM16;B4GALT1;PIM3;VMP1;ADAM8;VEGFC;CREB1;PPARD;SERPINB1;CD55;RIPK2;SAA1;ITGAV;STX1A;NRG1;PML;POU2F2;FERMT1;PTPN11;SOX4;VCL;OXCT1;COTL1;ADM;HLA-E;WNT5A;ADAM9;PDPK1;CTSC;SGK1;CREG1;IFIH1;RAB24;SMPD3
9874,GO:0042136,0.000101957842666021,0.999983755017007,9,57,neurotransmitter biosynthetic process,BP,IL1B;ZC3H12A;TICAM1;TNF;PTGS2;EDN1;SMAD3;SLC7A2;GCH1
9683,GO:0038061,0.00010278193414363,0.999977305668542,12,111,NIK/NF-kappaB signaling,BP,BIRC3;TNF;REL;NFKB1;NFKB2;TNFRSF10B;RELB;BIRC2;RC3H1;TRAF4;TNFRSF10A;RELA
4350,GO:0009914,0.000106513355672442,0.999968532220423,17,176,hormone transport,BP,IL1B;INHBA;TNF;TBX3;EDN1;IL1RN;HCAR2;LIF;PIM3;CREB1;PPARD;STX1A;PTPN11;SOX4;OXCT1;ADM;SMPD3
2941,GO:0006469,0.00010930689466101,0.99996623357301,18,200,negative regulation of protein kinase activity,BP,TNFAIP3;IL1B;ERRFI1;GADD45A;TRIB1;CDKN1A;DUSP16;CDKN2B;DUSP8;DUSP1;DUSP10;SOCS3;CDK6;PTPN1;CORO1C;PDPK1;YWHAG;SFN
12703,GO:0050918,0.00010931671951862,0.999987604472136,7,35,positive chemotaxis,BP,CXCL8;VEGFC;SMAD3;F3;IL16;SAA1;WNT5A
10571,GO:0043534,0.000110029597304208,0.999977765607877,11,82,blood vessel endothelial cell migration,BP,ETS1;PTGS2;EFNA1;EFNB2;EPHA2;MAP2K3;VEGFC;PLK2;HDAC9;PDPK1;NFE2L2
4624,GO:0010743,0.000112395362879942,0.999993285582409,5,16,regulation of macrophage derived foam cell differentiation,BP,NFKBIA;CSF2;NFKB1;ITGAV;ABCA5
8196,GO:0032940,0.000112428706197979,0.999941704769785,52,932,secretion by cell,BP,IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;PLAU;INHBA;SDC4;TNF;NFKB1;TBX3;EDN1;IL1RN;PANX1;HCAR2;LIF;CAB39;RAP2B;CD274;AMPD3;TRIM16;B4GALT1;PIM3;VMP1;ADAM8;VEGFC;CREB1;PPARD;SERPINB1;CD55;RIPK2;SAA1;ITGAV;STX1A;PML;POU2F2;FERMT1;PTPN11;SOX4;VCL;OXCT1;COTL1;ADM;HLA-E;WNT5A;ADAM9;PDPK1;CTSC;CREG1;IFIH1;RAB24;SMPD3
524,GO:0001618,0.000116349691711009,0.999983868055212,8,44,virus receptor activity,MF,CLDN1;EFNB2;EPHA2;LDLR;ITGA5;TFRC;CD55;ITGAV
17186,GO:0104005,0.000116349691711009,0.999983868055212,8,44,hijacked molecular function,MF,CLDN1;EFNB2;EPHA2;LDLR;ITGA5;TFRC;CD55;ITGAV
7464,GO:0031620,0.000116837956822597,0.999999076441965,3,4,regulation of fever generation,BP,IL1B;TNF;PTGS2
7465,GO:0031622,0.000116837956822597,0.999999076441965,3,4,positive regulation of fever generation,BP,IL1B;TNF;PTGS2
1110,GO:0002697,0.000118099249986202,0.999963272318801,18,202,regulation of immune effector process,BP,TNFAIP3;IL1B;ZC3H12A;BIRC3;TNF;SEMA7A;BIRC2;BCL10;RC3H1;IL23A;DUSP10;TFRC;CD55;RIPK2;IL7R;HLA-E;WNT5A;PDPK1
465,GO:0001503,0.000119304928262479,0.999958987672226,21,242,ossification,BP,TNF;PTGS2;NOCT;SEMA7A;EPHA2;BMP2;JUNB;ADRB2;CEBPB;RUNX1;NAB1;IL6ST;SMAD3;CYP27B1;JAG1;SOX9;AREG;KLF10;CDK6;TOB2;WNT5A
12553,GO:0050702,0.000120600085350848,0.999989382424703,6,24,interleukin-1 beta secretion,BP,ZC3H12A;PANX1;TRIM16;RIPK2;PML;WNT5A
1447,GO:0003674,0.000121797089659265,1,387,11300,molecular_function,MF,NFKBIA;NFKBIZ;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;CXCL3;BTG2;IL36G;BIRC3;HBEGF;PLAU;NFKBID;CSF2;ITPKC;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;CXCL8;REL;SERPINB2;PPIF;IER3;KLF6;NUAK2;CCL20;ZC3H12C;SPRR2D;ZNF697;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;TRPV3;NOCT;PLEKHF1;EFNA1;TGFA;KDM6B;IRF6;LGALSL;EDN1;ODC1;SEMA7A;PHLDA1;HAS3;ERRFI1;IL1RN;IRAK2;CLDN1;KLF7;PANX1;CREB5;DAPP1;CPEB2;EHF;SPRR2A;HCAR2;TNFRSF10B;EFNB2;EPHA2;RELB;GADD45A;CXCL5;MAFF;LIF;TRIB1;KCTD11;CD83;SQSTM1;IFNGR2;RRAD;BMP2;IL24;CAB39;ZNF267;N4BP3;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;TMCC3;NMNAT2;RGMB;PHLDB2;CLDN4;TJP2;SERTAD2;CD274;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;BCL2L2;ZFP36L1;ENC1;RELT;RND3;ADRB2;CEBPB;DUSP16;ARNTL2;UGCG;TRAF3IP3;PPP1R15A;MAST4;RUNX1;N4BP1;CDKN2B;NAB1;HMGCS1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;ALDH1A3;C3ORF52;EHD1;NEDD9;ZSWIM4;ANKLE2;DUSP8;B4GALT1;HAL;TFPI2;DUSP1;BCL10;FGD6;DCUN1D3;HEPHL1;TMCC1;TRAF1;PPP1R10;PIM3;CDV3;SACS;IL6ST;G0S2;B3GNT5;SGMS2;VMP1;NABP1;DLX2;SLC6A14;TXNRD1;VGLL3;CYLD;ADAM8;LDLR;VEGFC;KLF3;HCAR3;ZNF217;TACSTD2;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;SLC43A3;DUSP10;PLK2;BBC3;PLK3;DIEXF;PIM1;WISP1;ITGA5;TFRC;LIPG;AKIRIN1;KLHL21;CREB1;SERPINB8;EFNB1;GJB3;F3;STK40;HIVEP2;PPARD;KRT34;SLC25A25;SERPINB1;SOCS3;CCDC85B;KRTAP2-3;RAET1L;USP36;IL16;BDKRB1;RAPH1;ZFP36;SLC9A1;MAFK;LARP4B;CYP27B1;IFFO2;CD55;PNRC1;IFNAR2;ELL2;ANTXR2;AZIN1;KIAA0040;JAG1;PLAGL2;RIPK2;AMOTL2;PHKG2;NAV3;SAA1;PPP1R15B;STARD5;USP53;NDRG1;ITGAV;PIP5K1A;CLK4;TP53BP2;SOX9;STX1A;NRG1;ZNF451;FEM1C;PML;POU2F2;RASA2;PPTC7;NCOA7;ELK3;POLR3A;SLC7A2;ZNF460;CDC42EP1;SLC28A3;FOXN2;PTPN11;MAP3K8;UHRF1;PANK3;EFHD2;ARHGEF3;MXD1;IRGQ;DCBLD2;RHOB;SPAG9;ABCA5;GCH1;FEM1B;SOX4;USP31;FOSL2;TRAF4;VCL;EIF1;OXCT1;AREG;CCNL1;FAM83G;AKAP2;TNFAIP1;HDAC9;ADAMTS1;HIVEP1;NFKBIB;KLF10;AEN;C11ORF68;TIFA;SKIL;COTL1;IL7R;DENND2C;HEXDC;RBM3;CDK6;IER5;YRDC;SAMD4A;EMP3;PTPN1;SQLE;TFE3;BTG3;CORO1C;STEAP4;MSANTD3;PRPF19;TOB2;ADM;MAFG;ABL2;MTF1;ATP6V1C2;HLA-E;RAB3IP;OSMR;QKI;CELF1;PMM2;WNT5A;NUP153;MAOA;INSIG1;ADAM9;LCE1C;PDPK1;TNFRSF10A;ADAMTS9;RNF19A;CTSC;ERO1A;KDM6A;FRMD6;ZBTB21;SMTN;NFE2L2;YWHAH;SGK1;B3GNT2;TSC22D2;CYTH1;SAT1;RELA;AGFG1;RNF11;NOTCH2NL;BACH1;BTAF1;ANKK1;GINS3;POLR3D;ALAS1;YWHAG;TDG;ELF4;RAB22A;CREG1;SFN;ITM2B;ERN1;ETNK1;SH3RF2;UPP1;ISG20;TMEM132A;ATXN7;IFIH1;LAMB3;ATP13A3;ADAMTS6;MYO1B;BRD2;IPO4;CXCL16;PABPC4;TAP1;DSE;GPATCH2L;AHCY;STX12;PDLIM5;FUBP3;GPR156;RAB24;SMPD3
19418,GO:1905952,0.000123717166747709,0.999977046493446,10,72,regulation of lipid localization,BP,NFKBIA;IL1B;ZC3H12A;TNF;NFKB1;EDN1;EHD1;LIPG;ITGAV;PTPN11
9861,GO:0042113,0.000124093233117548,0.9999662227554,15,145,B cell activation,BP,TNFAIP3;INHBA;TICAM1;KLF6;PRDM1;CDKN1A;BCL3;ZFP36L1;PELI1;CYLD;RC3H1;TFRC;POU2F2;HDAC9;IL7R
565,GO:0001704,0.000124327254611011,0.999974586546228,11,79,formation of primary germ layer,BP,INHBA;KDM6B;ETS2;DUSP1;TXNRD1;SMAD3;ITGA5;ITGAV;WNT5A;KDM6A;LAMB3
8702,GO:0034341,0.00012664478790057,0.999969261425551,13,124,response to interferon-gamma,BP,CCL20;IRF6;EDN1;CLDN1;IFNGR2;IRF1;SOCS3;CYP27B1;PML;GCH1;HLA-E;WNT5A;CXCL16
2240,GO:0005149,0.000129654970136306,0.99999566273016,4,9,interleukin-1 receptor binding,MF,IL1B;IL1A;IL36G;IL1RN
12663,GO:0050864,0.000130301997366617,0.999975668120661,10,72,regulation of B cell activation,BP,TNFAIP3;INHBA;TICAM1;PRDM1;CDKN1A;ZFP36L1;PELI1;CYLD;RC3H1;TFRC
18231,GO:1903034,0.000132075391419462,0.999970208581684,12,100,regulation of response to wounding,BP,TNFAIP3;PLAUR;HBEGF;PLAU;SERPINB2;EDN1;PHLDB2;SMAD3;DUSP10;F3;PPARD;NFE2L2
13914,GO:0060562,0.00013416968694872,0.999954894211813,20,222,epithelial tube morphogenesis,BP,SDC4;TNF;TBX3;EDN1;EFNB2;EPHA2;BMP2;B4GALT1;BCL10;TACSTD2;SMAD3;NRARP;SOX9;PML;RHOB;SOX4;AREG;ADM;WNT5A;KDM6A
11242,GO:0045428,0.00013513434607671,0.999984134451427,7,35,regulation of nitric oxide biosynthetic process,BP,IL1B;ZC3H12A;TICAM1;TNF;PTGS2;EDN1;SMAD3
2594,GO:0005887,0.000139455684197653,0.999930511879922,45,734,integral component of plasma membrane,CC,PLAUR;HBEGF;SDC4;TNF;TRPV3;EFNA1;TGFA;HAS3;CLDN1;TNFRSF10B;EFNB2;EPHA2;CD83;IFNGR2;BMP2;BIRC2;CLDN4;RELT;ADRB2;EREG;IL6ST;SGMS2;SLC6A14;ADAM8;LDLR;HCAR3;TACSTD2;ITGA5;TFRC;EFNB1;BDKRB1;SLC9A1;CD55;IFNAR2;JAG1;ITGAV;STX1A;NRG1;SLC7A2;SLC28A3;DCBLD2;STEAP4;OSMR;TNFRSF10A;ATP13A3
11477,GO:0045934,0.000139983450984039,0.999923896685223,59,1095,negative regulation of nucleobase-containing compound metabolic process,BP,ZC3H12A;BTG2;CSF2;ELF3;TNF;REL;PPIF;BHLHE40;NFKB1;PRDM1;TBX3;NFKB2;NOCT;EFNA1;EDN1;RELB;SQSTM1;BMP2;JUN;JUNB;BCL3;OVOL1;ETS2;IRF1;CEBPB;NAB1;EREG;DUSP1;DLX2;KLF3;ZNF217;NEDD4L;SMAD3;PLK3;CREB1;PPARD;CCDC85B;ZFP36;MAFK;NRARP;SOX9;NRG1;ZNF451;PML;ELK3;UHRF1;MXD1;HDAC9;HIVEP1;KLF10;SKIL;TOB2;WNT5A;ZBTB21;RELA;BACH1;BTAF1;TDG;CREG1
12667,GO:0050868,0.000141868744875516,0.999976258879586,9,60,negative regulation of T cell activation,BP,NFKBID;SDC4;CD274;IRF1;CEBPB;PELI1;CYLD;RC3H1;NRARP
4343,GO:0009894,0.000145553102466598,0.999927275753105,45,769,regulation of catabolic process,BP,TNFAIP3;IL1B;ZC3H12A;BTG2;TICAM1;TNF;RNF19B;NOCT;PLEKHF1;EFNA1;ODC1;HCAR2;TRIB1;ZFP36L1;ADRB2;N4BP1;ADAM8;LDLR;NEDD4L;SMAD3;RC3H1;PLK2;PLK3;USP36;ZFP36;AZIN1;RIPK2;PHKG2;SOX9;NRG1;PML;SAMD4A;PTPN1;ABL2;ATP6V1C2;QKI;WNT5A;NUP153;ADAM9;RNF19A;CTSC;NFE2L2;RELA;ERN1;PABPC4
12309,GO:0048660,0.000147721031149436,0.999969009305089,11,86,regulation of smooth muscle cell proliferation,BP,TNFAIP3;HBEGF;TNF;PTGS2;EDN1;TRIB1;JUN;NAMPT;EREG;PPARD;ERN1
7454,GO:0031589,0.000148497623538065,0.999949669888823,20,224,cell-substrate adhesion,BP,PLAU;SDC4;EFNA1;PHLDB2;VEGFC;TACSTD2;SMAD3;ITGA5;PPARD;SLC9A1;JAG1;ITGAV;PIP5K1A;FERMT1;VCL;CDK6;CORO1C;ADAM9;PDPK1;ADAMTS9
454,GO:0001227,0.000150170182400966,0.999956291135118,16,160,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,BTG2;BHLHE40;NFKB1;PRDM1;TBX3;OVOL1;ETS2;CEBPB;ZNF217;PPARD;MAFK;MXD1;HIVEP1;SKIL;RELA;BACH1
10300,GO:0043062,0.000154550866419553,0.999945837274071,21,242,extracellular structure organization,BP,ELF3;SDC4;ETS1;TNF;NFKB2;HAS3;PHLDB2;BCL3;B4GALT1;ADAM8;SMAD3;ITGA5;LIPG;PLAGL2;ITGAV;SOX9;FERMT1;ABCA5;ADAMTS9;ERO1A;LAMB3
5325,GO:0016049,0.000155878700461265,0.999938268468599,26,349,cell growth,BP,HBEGF;INHBA;EDN1;SEMA7A;CDKN1A;SERTAD2;DCUN1D3;NEDD4L;SMAD3;WISP1;PPARD;CCDC85B;BDKRB1;RAPH1;SLC9A1;CYP27B1;SOX9;NRG1;PML;DCBLD2;VCL;WNT5A;SGK1;SFN;CXCL16;PDLIM5
12106,GO:0048146,0.000157579331379643,0.999980887565506,7,37,positive regulation of fibroblast proliferation,BP,JUN;CDKN1A;EREG;PML;FOSL2;CDK6;WNT5A
11302,GO:0045620,0.000157796295295961,0.999985179324713,6,26,negative regulation of lymphocyte differentiation,BP,NFKBID;INHBA;IRF1;CYLD;RC3H1;NRARP
4472,GO:0010467,0.000162225039173526,0.999892131645727,174,4264,gene expression,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;BTG2;BIRC3;PLAU;NFKBID;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;KLF6;ZNF697;BHLHE40;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;HAS3;IRAK2;KLF7;CREB5;CPEB2;EHF;RELB;MAFF;LIF;TRIB1;SQSTM1;BMP2;PHLDA2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ENC1;ADRB2;CEBPB;ARNTL2;PPP1R15A;RUNX1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;BCL10;TRAF1;NABP1;DLX2;VGLL3;CYLD;ADAM8;LDLR;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;IL23A;PLK3;DIEXF;PIM1;CREB1;F3;STK40;HIVEP2;PPARD;CCDC85B;USP36;IL16;ZFP36;SLC9A1;MAFK;LARP4B;CD55;PNRC1;ELL2;JAG1;PLAGL2;RIPK2;PPP1R15B;CLK4;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;FERMT1;NCOA7;ELK3;POLR3A;ZNF460;FOXN2;UHRF1;MXD1;SOX4;FOSL2;EIF1;CCNL1;FAM83G;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;IL7R;RBM3;CDK6;IER5;YRDC;SAMD4A;TFE3;PRPF19;TOB2;MAFG;MTF1;QKI;CELF1;WNT5A;NUP153;INSIG1;PDPK1;ERO1A;KDM6A;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;RELA;AGFG1;BACH1;BTAF1;POLR3D;TDG;ELF4;CREG1;ERN1;ISG20;ATXN7;BRD2;PABPC4;FUBP3
12308,GO:0048659,0.000163714681024558,0.999965212709163,11,87,smooth muscle cell proliferation,BP,TNFAIP3;HBEGF;TNF;PTGS2;EDN1;TRIB1;JUN;NAMPT;EREG;PPARD;ERN1
11243,GO:0045429,0.000164172967408667,0.999984572299105,6,25,positive regulation of nitric oxide biosynthetic process,BP,IL1B;TICAM1;TNF;PTGS2;EDN1;SMAD3
18829,GO:1904407,0.000164172967408667,0.999984572299105,6,25,positive regulation of nitric oxide metabolic process,BP,IL1B;TICAM1;TNF;PTGS2;EDN1;SMAD3
11812,GO:0046697,0.000165453160489764,0.999989248120689,5,16,decidualization,BP,PTGS2;LIF;JUNB;PPARD;CYP27B1
12567,GO:0050716,0.000168064438227236,0.999988861259018,5,17,positive regulation of interleukin-1 secretion,BP,PANX1;TRIM16;RIPK2;SAA1;WNT5A
7086,GO:0030879,0.00017122739131184,0.999960286756171,12,99,mammary gland development,BP,ELF3;TBX3;IRF6;EPHA2;CEBPB;B4GALT1;CREB1;SOX9;NRG1;PML;AREG;WNT5A
15336,GO:0071560,0.000175606210927274,0.999948109754722,16,164,cellular response to transforming growth factor beta stimulus,BP,EDN1;CLDN1;JUN;ZFP36L1;CDKN2B;SMAD3;CREB1;SOX9;ZNF451;PML;FERMT1;KLF10;SKIL;WNT5A;ADAM9;PDPK1
563,GO:0001701,0.000180021666769806,0.999936108809727,21,251,in utero embryonic development,BP,CSF2;ELF3;PRDM1;FOSL1;TBX3;EDN1;MAFF;LIF;BMP2;PHLDA2;JUNB;ZFP36L1;CEBPB;SMAD3;GJB3;SOCS3;SKIL;PRPF19;ADM;MAFG;KDM6A
17510,GO:1900739,0.000181502559571252,0.99998228832659,6,28,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,PMAIP1;BBC3;TP53BP2;YWHAH;YWHAG;SFN
17511,GO:1900740,0.000181502559571252,0.99998228832659,6,28,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,PMAIP1;BBC3;TP53BP2;YWHAH;YWHAG;SFN
3522,GO:0007498,0.000182034456463715,0.999964591244826,10,71,mesoderm development,BP,INHBA;TBX3;KDM6B;OVOL1;ETS2;ZFP36L1;TXNRD1;SMAD3;WNT5A;KDM6A
17725,GO:1901653,0.000184037123851943,0.999934542828028,21,255,cellular response to peptide,BP,IL1B;NFKB1;EDN1;ERRFI1;CPEB2;ZFP36L1;ADRB2;KLF3;CREB1;SOCS3;SLC9A1;RIPK2;PTPN11;HDAC9;KLF10;PTPN1;ATP6V1C2;PDPK1;NFE2L2;RELA;YWHAG
14953,GO:0070848,0.000187783286879919,0.999916896420217,32,471,response to growth factor,BP,IL1B;CXCL8;EDN1;ERRFI1;CLDN1;EPHA2;BMP2;MAP2K3;JUN;RGMB;ZFP36L1;CDKN2B;EHD1;VEGFC;SMAD3;ITGA5;CREB1;ZFP36;SOX9;ZNF451;PML;FERMT1;PTPN11;FAM83G;KLF10;SKIL;PTPN1;WNT5A;ADAM9;PDPK1;RELA;ERN1
8480,GO:0033628,0.00019081666894001,0.999981311420596,6,27,regulation of cell adhesion mediated by integrin,BP,PLAU;EFNA1;EPHA2;FERMT1;PTPN11;ADAM9
4670,GO:0010817,0.000191454798425876,0.99992975666338,22,281,regulation of hormone levels,BP,IL1B;INHBA;TNF;NFKB1;TBX3;EDN1;IL1RN;HCAR2;LIF;BMP2;ALDH1A3;PIM3;CREB1;PPARD;CYP27B1;STX1A;PTPN11;SOX4;OXCT1;ADM;YWHAH;SMPD3
4336,GO:0009887,0.000191507164685407,0.999907113001058,40,643,animal organ morphogenesis,BP,TNFAIP3;INHBA;ELF3;TNF;PRDM1;TBX3;EFNA1;EDN1;ERRFI1;EFNB2;EPHA2;LIF;BMP2;PHLDA2;JUN;CSRNP1;CEBPB;NAB1;EREG;ALDH1A3;B4GALT1;DLX2;VEGFC;TACSTD2;SMAD3;PIM1;STK40;JAG1;SOX9;NRG1;PML;FEM1B;SOX4;AREG;ADAMTS1;ADM;WNT5A;INSIG1;KDM6A;RELA
1152,GO:0002758,0.000191838813365818,0.999940144884537,17,196,innate immune response-activating signal transduction,BP,NFKBIA;TNFAIP3;BIRC3;TICAM1;TNIP1;NFKB1;IRAK2;RELB;BIRC2;IRF1;PELI1;BCL10;CYLD;RIPK2;PDPK1;RELA;IFIH1
402,GO:0001078,0.000193998279316798,0.999954354426372,12,100,transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,BTG2;BHLHE40;PRDM1;TBX3;OVOL1;ETS2;CEBPB;ZNF217;MXD1;SKIL;RELA;BACH1
15283,GO:0071470,0.000198376728514904,0.999980550831221,6,26,cellular response to osmotic stress,BP,PTGS2;ERRFI1;RELB;CAB39;ZFP36L1;OXSR1
12862,GO:0051179,0.000201030382264336,0.999865232002197,178,4308,localization,BP,NFKBIA;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;CXCL3;HBEGF;PLAU;CSF2;INHBA;SDC4;ETS1;TNF;CXCL8;PPIF;CCL20;PTGS2;PMAIP1;NFKB1;TBX3;TRPV3;PLEKHF1;EFNA1;TGFA;EDN1;SEMA7A;IL1RN;CLDN1;PANX1;HCAR2;TNFRSF10B;EFNB2;EPHA2;CXCL5;LIF;TRIB1;SQSTM1;RRAD;BMP2;PHLDA2;IL24;CAB39;MAP2K3;JUN;RAP2B;NFKBIE;CDKN1A;PHLDB2;CLDN4;TJP2;CD274;BCL3;AMPD3;ZFP36L1;RND3;ADRB2;DUSP16;UGCG;PPP1R15A;TRIM16;EREG;SOD2;EHD1;NEDD9;ZSWIM4;B4GALT1;HEPHL1;PPP1R10;PIM3;VMP1;SLC6A14;CYLD;ADAM8;LDLR;VEGFC;TACSTD2;NEDD4L;OXSR1;SMAD3;IL23A;SLC43A3;DUSP10;PLK2;BBC3;PLK3;ITGA5;TFRC;LIPG;KLHL21;CREB1;EFNB1;GJB3;F3;PPARD;SLC25A25;SERPINB1;USP36;IL16;BDKRB1;ZFP36;SLC9A1;CYP27B1;CD55;ANTXR2;AZIN1;JAG1;PLAGL2;RIPK2;AMOTL2;NAV3;SAA1;STARD5;ITGAV;PIP5K1A;TP53BP2;SOX9;STX1A;NRG1;PML;POU2F2;FERMT1;SLC7A2;SLC28A3;PTPN11;RHOB;SPAG9;ABCA5;SOX4;VCL;OXCT1;AREG;TNFAIP1;HDAC9;COTL1;CDK6;YRDC;PTPN1;CORO1C;STEAP4;PRPF19;ADM;ABL2;ATP6V1C2;HLA-E;RAB3IP;QKI;PMM2;WNT5A;NUP153;INSIG1;ADAM9;PDPK1;TNFRSF10A;ADAMTS9;CTSC;ERO1A;FRMD6;NFE2L2;YWHAH;SGK1;CYTH1;AGFG1;YWHAG;RAB22A;CREG1;SFN;IFIH1;ATP13A3;MYO1B;IPO4;CXCL16;TAP1;STX12;RAB24;SMPD3
1256,GO:0003008,0.000201321480031241,0.999896323512683,47,801,system process,BP,IL1B;ZC3H12A;BTG2;HBEGF;INHBA;PTGS2;FOSL1;TBX3;EDN1;ERRFI1;HCAR2;MAP2K3;JUN;CLDN4;TJP2;ADRB2;CEBPB;GJB4;SOD2;ALDH1A3;IL6ST;LDLR;VEGFC;TACSTD2;NEDD4L;SMAD3;PLK2;ITGA5;CREB1;STK40;PPARD;BDKRB1;SLC9A1;USP53;SOX9;NRG1;PTPN11;GCH1;VCL;TMEM65;ADM;KDM6A;SMTN;SGK1;B3GNT2;ATXN7;PDLIM5
8062,GO:0032728,0.00020293481717697,0.999980018765057,6,26,positive regulation of interferon-beta production,BP,TICAM1;IRF1;RIPK2;POLR3A;POLR3D;IFIH1
3652,GO:0008134,0.000203296453519341,0.999908351780233,33,505,transcription factor binding,MF,NFKBIA;NFKBID;ETS1;BHLHE40;NFKB1;TBX3;TRIB1;JUN;JUNB;BCL3;ETS2;TAF4B;CEBPB;NAB1;ELMSAN1;BCL10;SMAD3;PIM1;CREB1;PPARD;MAFK;TP53BP2;SOX9;NCOA7;HDAC9;TOB2;TNFRSF10A;RNF19A;NFE2L2;YWHAH;RELA;TDG;CREG1
13846,GO:0060443,0.000207253830656858,0.999973883743756,7,35,mammary gland morphogenesis,BP,ELF3;TBX3;EPHA2;B4GALT1;PML;AREG;WNT5A
9631,GO:0036499,0.000211184111628131,0.999985079391049,5,18,PERK-mediated unfolded protein response,BP,CXCL8;PPP1R15A;PPP1R15B;PTPN1;NFE2L2
13366,GO:0052548,0.000211740735243626,0.999925823936733,20,267,regulation of endopeptidase activity,BP,PLAUR;BIRC3;TNF;SERPINB2;PTGS2;PMAIP1;EFNA1;TNFRSF10B;BIRC2;TFPI2;BCL10;SMAD3;BBC3;SERPINB8;F3;SERPINB1;RIPK2;PML;TNFRSF10A;SFN
12347,GO:0048710,0.000212497368141834,0.999984966203777,5,18,regulation of astrocyte differentiation,BP,LIF;BMP2;IL6ST;LDLR;PRPF19
6844,GO:0030308,0.000214143066306085,0.999945159483642,13,122,negative regulation of cell growth,BP,INHBA;SEMA7A;CDKN1A;SERTAD2;DCUN1D3;SMAD3;PPARD;CCDC85B;BDKRB1;CYP27B1;PML;DCBLD2;WNT5A
685,GO:0001893,0.000214786405600924,0.999978624673606,6,26,maternal placenta development,BP,PTGS2;PRDM1;LIF;JUNB;PPARD;CYP27B1
8610,GO:0034121,0.000215221588813659,0.999972608034147,7,36,regulation of toll-like receptor signaling pathway,BP,TNFAIP3;BIRC3;TICAM1;BIRC2;IRF1;PELI1;PDPK1
9823,GO:0042036,0.000216449778182331,0.999984624614757,5,18,negative regulation of cytokine biosynthetic process,BP,INHBA;NFKB1;ERRFI1;BCL3;ZFP36
15335,GO:0071559,0.00021766863766039,0.999934370677116,16,167,response to transforming growth factor beta,BP,EDN1;CLDN1;JUN;ZFP36L1;CDKN2B;SMAD3;CREB1;SOX9;ZNF451;PML;FERMT1;KLF10;SKIL;WNT5A;ADAM9;PDPK1
7910,GO:0032481,0.000218630271333407,0.999961037964278,9,63,positive regulation of type I interferon production,BP,TICAM1;NFKB1;NFKB2;IRF1;RIPK2;POLR3A;RELA;POLR3D;IFIH1
12423,GO:0048872,0.000221238001803142,0.999933117228976,16,172,homeostasis of number of cells,BP,TNFAIP3;INHBA;ETS1;PMAIP1;HCAR2;AMPD3;ZFP36L1;BCL10;CYLD;RC3H1;ZFP36;SOX9;PTPN11;SKIL;IL7R;CDK6
3541,GO:0007565,0.00022184701791064,0.999942975915807,13,122,female pregnancy,BP,IL1B;ETS1;PTGS2;PRDM1;FOSL1;LIF;CLDN4;JUNB;NAMPT;VMP1;PPARD;CYP27B1;ADM
15213,GO:0071363,0.000222045190646676,0.999902132644455,31,454,cellular response to growth factor stimulus,BP,IL1B;CXCL8;EDN1;ERRFI1;CLDN1;BMP2;MAP2K3;JUN;RGMB;ZFP36L1;CDKN2B;EHD1;VEGFC;SMAD3;ITGA5;CREB1;ZFP36;SOX9;ZNF451;PML;FERMT1;PTPN11;FAM83G;KLF10;SKIL;PTPN1;WNT5A;ADAM9;PDPK1;RELA;ERN1
18235,GO:1903038,0.000223921312588099,0.999959914122291,9,64,negative regulation of leukocyte cell-cell adhesion,BP,NFKBID;SDC4;CD274;IRF1;CEBPB;PELI1;CYLD;RC3H1;NRARP
8495,GO:0033673,0.000232123340791148,0.999923519543668,18,212,negative regulation of kinase activity,BP,TNFAIP3;IL1B;ERRFI1;GADD45A;TRIB1;CDKN1A;DUSP16;CDKN2B;DUSP8;DUSP1;DUSP10;SOCS3;CDK6;PTPN1;CORO1C;PDPK1;YWHAG;SFN
1329,GO:0003179,0.000235524755285524,0.999976312432247,6,25,heart valve morphogenesis,BP,EFNA1;BMP2;JAG1;SOX9;SOX4;ADAMTS9
10519,GO:0043434,0.000235642293766129,0.999910032104132,23,298,response to peptide hormone,BP,IL1B;BTG2;PTGS2;NFKB1;EDN1;ERRFI1;CPEB2;ZFP36L1;TRIM16;EREG;CREB1;SOCS3;SLC9A1;PTPN11;AREG;HDAC9;PTPN1;ADM;ATP6V1C2;PDPK1;NFE2L2;RELA;YWHAG
15871,GO:0072593,0.000235734854579148,0.999931469988677,15,165,reactive oxygen species metabolic process,BP,IL1B;ZC3H12A;TICAM1;TNF;PTGS2;PMAIP1;EDN1;GADD45A;BIRC2;CDKN1A;SOD2;SMAD3;SLC7A2;GCH1;NFE2L2
14642,GO:0070230,0.000236242056811642,0.999989518806653,4,12,positive regulation of lymphocyte apoptotic process,BP,NFKBID;CD274;ADAM8;WNT5A
9905,GO:0042226,0.0002377430410873,0.999990152461191,4,10,interleukin-6 biosynthetic process,BP,IL1B;CEBPB;EREG;BCL10
10309,GO:0043085,0.000239179052521418,0.999868922503737,56,1025,positive regulation of catalytic activity,BP,IL1B;CXCL1;SDC4;TNF;CCL20;PMAIP1;EFNA1;TGFA;EDN1;ERRFI1;IRAK2;TNFRSF10B;EPHA2;GADD45A;BMP2;CAB39;MAP2K3;JUN;CDKN1A;ADRB2;PPP1R15A;EREG;BCL10;DCUN1D3;ADAM8;OXSR1;SMAD3;IL23A;BBC3;F3;CYP27B1;AZIN1;RIPK2;SAA1;PPP1R15B;PIP5K1A;NRG1;PML;RASA2;CDC42EP1;PTPN11;MAP3K8;UHRF1;SPAG9;GCH1;TRAF4;CCNL1;PTPN1;CORO1C;ABL2;WNT5A;ADAM9;PDPK1;TNFRSF10A;AGFG1;ERN1
9075,GO:0035326,0.00024089711235624,0.999951255258169,10,75,enhancer binding,MF,REL;NFKB1;JUN;SMAD3;CREB1;SOX9;HIVEP1;NFE2L2;RELA;BACH1
3383,GO:0007162,0.000240944007653023,0.999926643482122,16,169,negative regulation of cell adhesion,BP,NFKBID;SDC4;IL1RN;BMP2;PHLDB2;CD274;IRF1;CEBPB;PELI1;CYLD;TACSTD2;RC3H1;JAG1;NRARP;PTPN11;CORO1C
12969,GO:0051348,0.000242307339902069,0.99991699995344,19,235,negative regulation of transferase activity,BP,TNFAIP3;IL1B;ERRFI1;GADD45A;TRIB1;CDKN1A;DUSP16;CDKN2B;DUSP8;DUSP1;DUSP10;SOCS3;ZFP36;CDK6;PTPN1;CORO1C;PDPK1;YWHAG;SFN
14185,GO:0061081,0.000244471190056186,0.999996342036787,3,5,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,SEMA7A;BCL10;WNT5A
14719,GO:0070372,0.000247363268945402,0.999924455963651,16,172,regulation of ERK1 and ERK2 cascade,BP,IL1B;IL1A;TNF;CCL20;TNIP1;SEMA7A;ERRFI1;EPHA2;LIF;BMP2;JUN;DUSP1;DUSP10;RIPK2;PTPN11;PTPN1
13722,GO:0060284,0.000247968381940952,0.999881654681943,37,571,regulation of cell development,BP,IL1B;TNF;EFNA1;EDN1;SEMA7A;EFNB2;LIF;TRIB1;KCTD11;BMP2;TJP2;ENC1;ZSWIM4;IL6ST;DLX2;LDLR;VEGFC;TACSTD2;NEDD4L;DUSP10;PLK2;CREB1;JAG1;SOX9;NRG1;SPAG9;HDAC9;SKIL;CORO1C;PRPF19;ABL2;WNT5A;NFE2L2;YWHAH;RELA;YWHAG;PDLIM5
656,GO:0001844,0.000249295850086828,0.99997391450045,6,30,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,PMAIP1;BBC3;TP53BP2;YWHAH;YWHAG;SFN
8063,GO:0032729,0.00025132280586027,0.999973789390365,6,29,positive regulation of interferon-gamma production,BP,IL1B;TNF;BCL3;IL23A;RIPK2;WNT5A
19741,GO:2000108,0.000251827947264888,0.999981080932068,5,20,positive regulation of leukocyte apoptotic process,BP,NFKBID;HCAR2;CD274;ADAM8;WNT5A
9322,GO:0035794,0.000251931024059032,0.999959939319137,8,55,positive regulation of mitochondrial membrane permeability,BP,PPIF;PMAIP1;BBC3;SLC9A1;TP53BP2;YWHAH;YWHAG;SFN
19351,GO:1905710,0.000251931024059032,0.999959939319137,8,55,positive regulation of membrane permeability,BP,PPIF;PMAIP1;BBC3;SLC9A1;TP53BP2;YWHAH;YWHAG;SFN
8044,GO:0032691,0.000251972202618384,0.999988972979425,4,11,negative regulation of interleukin-1 beta production,BP,TNFAIP3;ZC3H12A;ERRFI1;PML
11878,GO:0046885,0.000257321876956987,0.999981276337227,5,17,regulation of hormone biosynthetic process,BP,IL1B;TNF;NFKB1;BMP2;CYP27B1
12238,GO:0048511,0.0002660833105339,0.999914705975058,17,188,rhythmic process,BP,CSF2;INHBA;ETS1;BHLHE40;NFKB2;NOCT;RELB;JUN;CLDN4;NAMPT;ARNTL2;EREG;CREB1;PML;ADAMTS1;KLF10;AHCY
9862,GO:0042116,0.000268090270957348,0.999964368295456,7,38,macrophage activation,BP,ZC3H12A;CSF2;TICAM1;JUN;LDLR;SLC7A2;WNT5A
9673,GO:0038034,0.000268967232786473,0.999956875515326,8,54,signal transduction in absence of ligand,BP,IL1B;IL1A;CSF2;INHBA;TNF;BCL2L2;ITGAV;ITM2B
16494,GO:0097192,0.000268967232786473,0.999956875515326,8,54,extrinsic apoptotic signaling pathway in absence of ligand,BP,IL1B;IL1A;CSF2;INHBA;TNF;BCL2L2;ITGAV;ITM2B
12577,GO:0050728,0.000271024071041151,0.999950019140993,9,67,negative regulation of inflammatory response,BP,TNFAIP3;ZC3H12A;ETS1;NFKB1;SMAD3;DUSP10;PPARD;SOCS3;SAA1
18393,GO:1903409,0.000279029979196997,0.999948393889955,9,66,reactive oxygen species biosynthetic process,BP,IL1B;ZC3H12A;TICAM1;TNF;PTGS2;EDN1;SMAD3;SLC7A2;GCH1
11303,GO:0045621,0.000279036935542682,0.999955086354649,8,53,positive regulation of lymphocyte differentiation,BP,PRDM1;CD83;CYLD;ADAM8;IL23A;DUSP10;RIPK2;IL7R
362,GO:0000980,0.000280099623724484,0.999955046697021,8,51,RNA polymerase II distal enhancer sequence-specific DNA binding,MF,REL;NFKB1;JUN;CREB1;HIVEP1;NFE2L2;RELA;BACH1
4820,GO:0014013,0.00028263332640984,0.999947758210583,9,64,regulation of gliogenesis,BP,LIF;BMP2;IL6ST;DLX2;LDLR;DUSP10;CREB1;PRPF19;RELA
431,GO:0001158,0.000284362904339519,0.999947394260816,9,64,enhancer sequence-specific DNA binding,MF,REL;NFKB1;JUN;CREB1;SOX9;HIVEP1;NFE2L2;RELA;BACH1
1000,GO:0002467,0.000285295407437485,0.999987593267582,4,10,germinal center formation,BP,TNFAIP3;NFKB2;BCL3;RC3H1
6588,GO:0022414,0.00028541354231794,0.999850530861342,47,826,reproductive process,BP,IL1B;IL1A;BIRC3;CSF2;INHBA;ETS1;PTGS2;PRDM1;FOSL1;TBX3;EDN1;MAFF;LIF;PHLDA2;BIRC2;CLDN4;JUNB;OVOL1;NAMPT;TAF4B;BCL2L2;ZFP36L1;CEBPB;HMGCS1;EREG;B4GALT1;DUSP1;VMP1;GJB3;PPARD;SOCS3;CYP27B1;ANTXR2;SOX9;PTPN11;SPAG9;FEM1B;AREG;ADAMTS1;SKIL;TOB2;ADM;QKI;CELF1;WNT5A;AGFG1;BRD2
5790,GO:0017017,0.000287355924228921,0.999986975957722,4,11,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,DUSP16;DUSP8;DUSP1;DUSP10
14650,GO:0070243,0.000293126085911294,0.999986643706614,4,11,regulation of thymocyte apoptotic process,BP,NFKBID;EFNA1;ADAM8;WNT5A
2,GO:0000003,0.000294034484695123,0.999845796958563,47,827,reproduction,BP,IL1B;IL1A;BIRC3;CSF2;INHBA;ETS1;PTGS2;PRDM1;FOSL1;TBX3;EDN1;MAFF;LIF;PHLDA2;BIRC2;CLDN4;JUNB;OVOL1;NAMPT;TAF4B;BCL2L2;ZFP36L1;CEBPB;HMGCS1;EREG;B4GALT1;DUSP1;VMP1;GJB3;PPARD;SOCS3;CYP27B1;ANTXR2;SOX9;PTPN11;SPAG9;FEM1B;AREG;ADAMTS1;SKIL;TOB2;ADM;QKI;CELF1;WNT5A;AGFG1;BRD2
12144,GO:0048247,0.000299553529328924,0.999976399035359,5,21,lymphocyte chemotaxis,BP,CCL20;ADAM8;SAA1;WNT5A;CXCL16
11369,GO:0045732,0.000309108302386408,0.999903568240793,16,176,positive regulation of protein catabolic process,BP,TNFAIP3;IL1B;TNF;RNF19B;TRIB1;ADAM8;LDLR;NEDD4L;PLK2;PLK3;SOX9;WNT5A;ADAM9;RNF19A;CTSC;NFE2L2
502,GO:0001558,0.000310038172056942,0.999882030731043,22,289,regulation of cell growth,BP,HBEGF;INHBA;EDN1;SEMA7A;CDKN1A;SERTAD2;DCUN1D3;NEDD4L;SMAD3;WISP1;PPARD;CCDC85B;BDKRB1;SLC9A1;CYP27B1;NRG1;PML;DCBLD2;WNT5A;SGK1;SFN;CXCL16
19050,GO:1904894,0.000310663230148614,0.999957099009398,7,43,positive regulation of STAT cascade,BP,CSF2;LIF;IL24;IL6ST;IL23A;SOCS3;IL7R
10669,GO:0043900,0.000312458055409529,0.999883950899555,21,283,regulation of multi-organism process,BP,TNFAIP3;IL1B;ZC3H12A;BIRC3;INHBA;TNF;CXCL8;TNIP1;PRDM1;TRIB1;SQSTM1;JUN;BIRC2;B4GALT1;IL23A;ZFP36;CD55;RIPK2;ITGAV;PML;ISG20
14652,GO:0070245,0.000312692841070543,0.999994905196078,3,5,positive regulation of thymocyte apoptotic process,BP,NFKBID;ADAM8;WNT5A
19894,GO:2000377,0.000313233584548916,0.999921708946872,12,114,regulation of reactive oxygen species metabolic process,BP,IL1B;ZC3H12A;TICAM1;TNF;PTGS2;EDN1;GADD45A;BIRC2;CDKN1A;SMAD3;GCH1;NFE2L2
15121,GO:0071214,0.000315715712804167,0.99988956631975,19,230,cellular response to abiotic stimulus,BP,IL1B;PTGS2;NFKB1;ERRFI1;TNFRSF10B;RELB;GADD45A;CAB39;CDKN1A;IRF1;ZFP36L1;N4BP1;BCL10;OXSR1;SLC9A1;SOX9;PTPN11;RHOB;TNFRSF10A
17185,GO:0104004,0.000315715712804167,0.99988956631975,19,230,cellular response to environmental stimulus,BP,IL1B;PTGS2;NFKB1;ERRFI1;TNFRSF10B;RELB;GADD45A;CAB39;CDKN1A;IRF1;ZFP36L1;N4BP1;BCL10;OXSR1;SLC9A1;SOX9;PTPN11;RHOB;TNFRSF10A
18465,GO:1903557,0.000326029248044629,0.999954958193571,7,40,positive regulation of tumor necrosis factor superfamily cytokine production,BP,TICAM1;ADAM8;IL23A;RIPK2;HLA-E;WNT5A;IFIH1
11627,GO:0046330,0.000340322539432996,0.999920920766309,11,91,positive regulation of JNK cascade,BP,IL1B;IL1A;TNF;EDN1;GADD45A;RIPK2;SPAG9;TRAF4;PTPN1;WNT5A;ERN1
20020,GO:2000630,0.000341201625184652,0.999994269854225,3,5,positive regulation of miRNA metabolic process,BP,ZC3H12A;NFKB1;RELA
9793,GO:0040013,0.000343808212105159,0.999882944006803,18,209,negative regulation of locomotion,BP,SEMA7A;TRIB1;IL24;RAP2B;PHLDB2;TACSTD2;DUSP10;PPARD;JAG1;NAV3;NRG1;PML;RHOB;VCL;CORO1C;WNT5A;ADAMTS9;NFE2L2
14662,GO:0070266,0.000344600768266463,0.999961662616787,6,30,necroptotic process,BP,BIRC3;TICAM1;TNF;PPIF;BIRC2;CYLD
18616,GO:1903898,0.000348032248017149,0.999994114782539,3,5,negative regulation of PERK-mediated unfolded protein response,BP,PPP1R15A;PPP1R15B;PTPN1
16334,GO:0090559,0.000348088866911339,0.999933274672701,9,71,regulation of membrane permeability,BP,PPIF;PMAIP1;TJP2;BBC3;SLC9A1;TP53BP2;YWHAH;YWHAG;SFN
15520,GO:0071901,0.00035150381781143,0.999910959786854,12,115,negative regulation of protein serine/threonine kinase activity,BP,TNFAIP3;IL1B;CDKN1A;DUSP16;CDKN2B;DUSP8;DUSP1;DUSP10;CDK6;PTPN1;YWHAG;SFN
4722,GO:0010883,0.000354618755602986,0.999960522644597,6,29,regulation of lipid storage,BP,NFKBIA;ZC3H12A;TNF;NFKB1;EHD1;ITGAV
9871,GO:0042133,0.000361538915363535,0.999922549485028,10,81,neurotransmitter metabolic process,BP,IL1B;ZC3H12A;TICAM1;TNF;PTGS2;EDN1;SMAD3;SLC7A2;GCH1;MAOA
12879,GO:0051204,0.000363612883660519,0.99995878037221,6,32,protein insertion into mitochondrial membrane,BP,PMAIP1;BBC3;TP53BP2;YWHAH;YWHAG;SFN
18152,GO:1902893,0.000373936946866505,0.999958403595382,6,27,regulation of pri-miRNA transcription by RNA polymerase II,BP,BMP2;JUN;SMAD3;PPARD;SOX9;RELA
11351,GO:0045684,0.000374490126590445,0.999957308566544,6,32,positive regulation of epidermis development,BP,TNF;TRIM16;PPARD;CYP27B1;WNT5A;SFN
12348,GO:0048711,0.000377783790995787,0.999981002297222,4,12,positive regulation of astrocyte differentiation,BP,LIF;BMP2;IL6ST;PRPF19
10090,GO:0042592,0.00037816595647291,0.99978748529519,57,1101,homeostatic process,BP,TNFAIP3;IL1B;IL1A;INHBA;ETS1;TNF;PTGS2;PMAIP1;EDN1;IL1RN;CLDN1;HCAR2;CLDN4;AMPD3;ZFP36L1;ADRB2;SOD2;EHD1;BCL10;PPP1R10;PIM3;TXNRD1;CYLD;ADAM8;LDLR;NEDD4L;SMAD3;RC3H1;TFRC;LIPG;BDKRB1;ZFP36;SLC9A1;CYP27B1;CD55;SAA1;ITGAV;SOX9;PML;PTPN11;SOX4;OXCT1;SKIL;IL7R;CDK6;STEAP4;ADM;MAFG;ABL2;ATP6V1C2;INSIG1;PDPK1;ERO1A;NFE2L2;SFN;ERN1;ATP13A3
12284,GO:0048598,0.000385791181082799,0.999834650721206,27,380,embryonic morphogenesis,BP,INHBA;SDC4;TBX3;EFNA1;KDM6B;EDN1;IL1RN;PHLDB2;ETS2;ZFP36L1;ALDH1A3;DUSP1;BCL10;DLX2;TXNRD1;VEGFC;SMAD3;ITGA5;SOCS3;ITGAV;SOX9;SOX4;ADM;WNT5A;INSIG1;KDM6A;LAMB3
12274,GO:0048570,0.00038776473293072,0.999993191919288,3,5,notochord morphogenesis,BP,EFNA1;WNT5A;KDM6A
7108,GO:0030903,0.000396019188773125,0.999980441126621,4,11,notochord development,BP,EFNA1;SOX9;WNT5A;KDM6A
4623,GO:0010742,0.000400223959961705,0.999966697358335,5,20,macrophage derived foam cell differentiation,BP,NFKBIA;CSF2;NFKB1;ITGAV;ABCA5
16096,GO:0090077,0.000400223959961705,0.999966697358335,5,20,foam cell differentiation,BP,NFKBIA;CSF2;NFKB1;ITGAV;ABCA5
994,GO:0002449,0.000400932487439755,0.999889801585718,13,134,lymphocyte mediated immunity,BP,IL1B;TNF;BCL3;BCL10;IL23A;TFRC;RAET1L;CD55;JAG1;POU2F2;IL7R;HLA-E;CTSC
12800,GO:0051091,0.000402056811758948,0.999871302190977,16,183,positive regulation of DNA binding transcription factor activity,BP,NFKBIA;IL1B;TICAM1;TNF;NFKB1;FOSL1;NFKB2;EDN1;IRAK2;BCL10;TRAF1;ADAM8;RIPK2;NFKBIB;WNT5A;RELA
11276,GO:0045582,0.000410549475154421,0.999940583329182,7,43,positive regulation of T cell differentiation,BP,CD83;CYLD;ADAM8;IL23A;DUSP10;RIPK2;IL7R
16523,GO:0097237,0.00041120672950067,0.999879731407887,14,160,cellular response to toxic substance,BP,TNFAIP3;ZC3H12A;ETS1;TNF;PPIF;PTGS2;NFKB1;KDM6B;SOD2;TXNRD1;RHOB;GCH1;NFE2L2;RELA
12369,GO:0048754,0.00041271082996745,0.999893985532544,12,106,branching morphogenesis of an epithelial tube,BP,TNF;TBX3;EDN1;EPHA2;BMP2;B4GALT1;TACSTD2;NRARP;SOX9;PML;AREG;WNT5A
8751,GO:0034405,0.000416577351990302,0.999951948999633,6,30,response to fluid shear stress,BP,CSF2;ETS1;PTGS2;TFPI2;ADAM9;NFE2L2
9051,GO:0035270,0.000417901477127135,0.999918255505883,9,66,endocrine system development,BP,ETS1;BMP2;SMAD3;CREB1;SOX9;SOX4;CDK6;WNT5A;PDPK1
10670,GO:0043901,0.000424316172040455,0.999890025164253,12,119,negative regulation of multi-organism process,BP,TNFAIP3;ZC3H12A;TNF;TNIP1;PRDM1;TRIB1;SQSTM1;JUN;ZFP36;ITGAV;PML;ISG20
6862,GO:0030330,0.000426280090324662,0.999897628201146,11,101,DNA damage response, signal transduction by p53 class mediator,BP,BTG2;PMAIP1;GADD45A;CDKN1A;BCL3;PLK2;PLK3;NDRG1;PML;SOX4;SFN
19420,GO:1905954,0.00043011112687063,0.999937260675137,7,43,positive regulation of lipid localization,BP,NFKBIA;IL1B;ZC3H12A;NFKB1;EDN1;EHD1;LIPG
11275,GO:0045581,0.000436161567293389,0.999963007696238,5,20,negative regulation of T cell differentiation,BP,NFKBID;IRF1;CYLD;RC3H1;NRARP
9387,GO:0035925,0.0004376392084745,0.999977796968983,4,11,mRNA 3'-UTR AU-rich region binding,MF,ZC3H12A;CPEB2;ZFP36L1;ZFP36
12379,GO:0048771,0.000438327632666103,0.999894671767414,11,96,tissue remodeling,BP,TNFAIP3;IL1A;ELF3;EPHA2;LIF;ADRB2;B4GALT1;ADAM8;IL23A;TFRC;JAG1
8073,GO:0032743,0.000439962156633095,0.9999626133533,5,20,positive regulation of interleukin-2 production,BP,IL1B;IL1A;CD83;RUNX1;RIPK2
12974,GO:0051353,0.000443005273212632,0.999947853089331,6,32,positive regulation of oxidoreductase activity,BP,IL1B;TNF;EDN1;CYP27B1;GCH1;ABL2
150,GO:0000305,0.000444791839920953,0.99996114586625,5,23,response to oxygen radical,BP,TNF;SOD2;TXNRD1;GCH1;NFE2L2
12772,GO:0051044,0.000447837180981982,0.999976427489902,4,12,positive regulation of membrane protein ectodomain proteolysis,BP,IL1B;TNF;ADAM8;ADAM9
648,GO:0001836,0.000447982247206976,0.99993328618884,7,50,release of cytochrome c from mitochondria,BP,PLAUR;PPIF;PMAIP1;JUN;SOD2;BBC3;SFN
3708,GO:0008217,0.000448624853975449,0.999901028902344,10,83,regulation of blood pressure,BP,PTGS2;EDN1;ADRB2;SOD2;VEGFC;SMAD3;BDKRB1;GCH1;ADM;SGK1
8432,GO:0033549,0.000450998144143058,0.9999762161765,4,12,MAP kinase phosphatase activity,MF,DUSP16;DUSP8;DUSP1;DUSP10
4315,GO:0009792,0.000454389999198284,0.999796618869218,29,426,embryo development ending in birth or egg hatching,BP,CSF2;ELF3;SDC4;PRDM1;FOSL1;TBX3;EDN1;MAFF;LIF;BMP2;PHLDA2;JUNB;ZFP36L1;CEBPB;BCL10;DLX2;SMAD3;GJB3;SOCS3;NRARP;SOX9;SOX4;SKIL;PRPF19;ADM;MAFG;CELF1;WNT5A;KDM6A
9844,GO:0042090,0.000455237806824277,0.999991548166431,3,5,interleukin-12 biosynthetic process,BP,NFKB1;IRF1;RELA
11074,GO:0045075,0.000455237806824277,0.999991548166431,3,5,regulation of interleukin-12 biosynthetic process,BP,NFKB1;IRF1;RELA
3489,GO:0007369,0.00046579789394598,0.999870453430364,13,122,gastrulation,BP,INHBA;KDM6B;IL1RN;PHLDB2;ETS2;DUSP1;TXNRD1;SMAD3;ITGA5;ITGAV;WNT5A;KDM6A;LAMB3
12924,GO:0051271,0.00046580783630795,0.999842810290016,17,197,negative regulation of cellular component movement,BP,SEMA7A;TRIB1;IL24;RAP2B;PHLDB2;TACSTD2;DUSP10;PPARD;JAG1;NAV3;NRG1;RHOB;VCL;CORO1C;WNT5A;ADAMTS9;NFE2L2
15787,GO:0072401,0.000469959616318946,0.999905976924365,9,72,signal transduction involved in DNA integrity checkpoint,BP,BTG2;GADD45A;CDKN1A;PLK2;PLK3;PML;SOX4;PRPF19;SFN
15791,GO:0072422,0.000469959616318946,0.999905976924365,9,72,signal transduction involved in DNA damage checkpoint,BP,BTG2;GADD45A;CDKN1A;PLK2;PLK3;PML;SOX4;PRPF19;SFN
3286,GO:0006977,0.000470199019520521,0.999917351995477,8,59,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,BTG2;GADD45A;CDKN1A;PLK2;PLK3;PML;SOX4;SFN
871,GO:0002218,0.000471572144267512,0.999840330207587,17,211,activation of innate immune response,BP,NFKBIA;TNFAIP3;BIRC3;TICAM1;TNIP1;NFKB1;IRAK2;RELB;BIRC2;IRF1;PELI1;BCL10;CYLD;RIPK2;PDPK1;RELA;IFIH1
13365,GO:0052547,0.000473938653968846,0.999822716709168,20,284,regulation of peptidase activity,BP,PLAUR;BIRC3;TNF;SERPINB2;PTGS2;PMAIP1;EFNA1;TNFRSF10B;BIRC2;TFPI2;BCL10;SMAD3;BBC3;SERPINB8;F3;SERPINB1;RIPK2;PML;TNFRSF10A;SFN
20280,GO:2001242,0.000477089232411357,0.999874280587739,12,128,regulation of intrinsic apoptotic signaling pathway,BP,PLAUR;PPIF;PTGS2;PMAIP1;PLEKHF1;BCL2L2;SOD2;CYLD;PLAGL2;SKIL;PTPN1;NFE2L2
18401,GO:1903428,0.000489674990344836,0.999941483756743,6,31,positive regulation of reactive oxygen species biosynthetic process,BP,IL1B;TICAM1;TNF;PTGS2;EDN1;SMAD3
15178,GO:0071316,0.000494146947059755,0.999988798870979,3,6,cellular response to nicotine,BP,TNF;NFKB1;RELA
14158,GO:0061036,0.000496047000379671,0.99995716017816,5,19,positive regulation of cartilage development,BP,BMP2;SMAD3;SOX9;WNT5A;RELA
799,GO:0002065,0.000499153935793031,0.999899684470061,9,68,columnar/cuboidal epithelial cell differentiation,BP,PRDM1;BMP2;CDKN1A;CEBPB;JAG1;SOX4;CDK6;WNT5A;PDPK1
446,GO:0001205,0.000514302500801493,0.999954750347814,5,20,transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding,MF,REL;NFKB1;NFE2L2;RELA;BACH1
11774,GO:0046632,0.00052632149143738,0.999906544677849,8,54,alpha-beta T cell differentiation,BP,PRDM1;RELB;CD83;BCL3;IRF1;RC3H1;IL23A;RIPK2
15785,GO:0072395,0.000534749845813013,0.999890958897445,9,73,signal transduction involved in cell cycle checkpoint,BP,BTG2;GADD45A;CDKN1A;PLK2;PLK3;PML;SOX4;PRPF19;SFN
14730,GO:0070391,0.000539526476953423,0.999987390435626,3,6,response to lipoteichoic acid,BP,CCL20;RIPK2;RELA
15129,GO:0071223,0.000539526476953423,0.999987390435626,3,6,cellular response to lipoteichoic acid,BP,CCL20;RIPK2;RELA
9852,GO:0042100,0.000544739705835288,0.999916922787589,7,45,B cell proliferation,BP,TICAM1;PRDM1;CDKN1A;PELI1;RC3H1;TFRC;IL7R
15796,GO:0072431,0.00054527408623051,0.999901830475873,8,60,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,BTG2;GADD45A;CDKN1A;PLK2;PLK3;PML;SOX4;SFN
17984,GO:1902400,0.00054527408623051,0.999901830475873,8,60,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,BTG2;GADD45A;CDKN1A;PLK2;PLK3;PML;SOX4;SFN
6867,GO:0030336,0.000551986840898559,0.999825784352656,15,165,negative regulation of cell migration,BP,TRIB1;IL24;RAP2B;PHLDB2;TACSTD2;DUSP10;PPARD;JAG1;NAV3;NRG1;RHOB;VCL;CORO1C;ADAMTS9;NFE2L2
12272,GO:0048568,0.00055653569763467,0.99978399784234,21,273,embryonic organ development,BP,CSF2;TNF;CXCL8;PRDM1;TBX3;EFNA1;EDN1;LIF;PHLDA2;JUNB;ZFP36L1;CEBPB;ALDH1A3;DLX2;SMAD3;SOCS3;SOX9;ADM;WNT5A;INSIG1;KDM6A
1177,GO:0002822,0.000561258890306975,0.999884771409915,9,73,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,TNFAIP3;IL1B;TNF;RC3H1;IL23A;TFRC;RIPK2;IL7R;HLA-E
20276,GO:2001238,0.000561921761729177,0.999913671518434,7,46,positive regulation of extrinsic apoptotic signaling pathway,BP,INHBA;PMAIP1;BCL10;G0S2;CYLD;PML;SKIL
8059,GO:0032722,0.000563115809676594,0.999930328878482,6,33,positive regulation of chemokine production,BP,IL1B;IL1A;TICAM1;TNF;RIPK2;WNT5A
3162,GO:0006775,0.00057241487557697,0.999946754865854,5,24,fat-soluble vitamin metabolic process,BP,IL1B;TNF;NFKB1;PPARD;CYP27B1
18543,GO:1903749,0.000585930284046275,0.999865454728214,10,91,positive regulation of establishment of protein localization to mitochondrion,BP,PMAIP1;UGCG;BBC3;USP36;PLAGL2;TP53BP2;NRG1;YWHAH;YWHAG;SFN
11582,GO:0046136,0.000589716339189411,1,2,2,positive regulation of vitamin metabolic process,BP,IL1B;TNF
13909,GO:0060557,0.000589716339189411,1,2,2,positive regulation of vitamin D biosynthetic process,BP,IL1B;TNF
13911,GO:0060559,0.000589716339189411,1,2,2,positive regulation of calcidiol 1-monooxygenase activity,BP,IL1B;TNF
14643,GO:0070231,0.000593750340657258,0.99992527555941,6,35,T cell apoptotic process,BP,NFKBID;EFNA1;CD274;BCL10;ADAM8;WNT5A
11395,GO:0045778,0.000598156505488104,0.999891509148758,8,55,positive regulation of ossification,BP,BMP2;ADRB2;CEBPB;IL6ST;SMAD3;JAG1;TOB2;WNT5A
8065,GO:0032731,0.000600041256130676,0.999944845980414,5,21,positive regulation of interleukin-1 beta production,BP,PANX1;TRIM16;SMAD3;RIPK2;WNT5A
8349,GO:0033209,0.000601334430943321,0.999836794957155,12,138,tumor necrosis factor-mediated signaling pathway,BP,NFKBIA;TNFAIP3;BIRC3;TNF;TNFRSF10B;BIRC2;TJP2;RELT;TRAF1;CYLD;TNFRSF10A;RELA
5335,GO:0016070,0.000603809001940583,0.999586634391877,154,3757,RNA metabolic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;BTG2;NFKBID;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;KLF6;ZNF697;BHLHE40;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;HAS3;IRAK2;KLF7;CREB5;EHF;RELB;MAFF;LIF;TRIB1;SQSTM1;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ADRB2;CEBPB;ARNTL2;RUNX1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;BCL10;TRAF1;NABP1;DLX2;VGLL3;CYLD;ADAM8;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;IL23A;PLK3;DIEXF;PIM1;CREB1;HIVEP2;PPARD;CCDC85B;USP36;IL16;ZFP36;SLC9A1;MAFK;PNRC1;ELL2;JAG1;PLAGL2;RIPK2;CLK4;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;POLR3A;ZNF460;FOXN2;UHRF1;MXD1;SOX4;FOSL2;CCNL1;FAM83G;HDAC9;HIVEP1;NFKBIB;KLF10;SKIL;RBM3;IER5;YRDC;SAMD4A;TFE3;PRPF19;TOB2;MAFG;MTF1;QKI;CELF1;WNT5A;INSIG1;PDPK1;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;RELA;BACH1;BTAF1;POLR3D;TDG;ELF4;CREG1;ERN1;ISG20;ATXN7;BRD2;PABPC4;FUBP3
10178,GO:0042770,0.00060529618230872,0.99983650235272,12,121,signal transduction in response to DNA damage,BP,BTG2;PMAIP1;GADD45A;CDKN1A;BCL3;PLK2;PLK3;NDRG1;PML;SOX4;PRPF19;SFN
6291,GO:0019899,0.000606140861611152,0.999617361001101,87,1825,enzyme binding,MF,NFKBIA;TNFAIP3;PLAUR;HBEGF;CSF2;TICAM1;SDC4;ETS1;TNF;PTGS2;RNF19B;TNIP1;PRDM1;ERRFI1;PANX1;EPHA2;RELB;GADD45A;TRIB1;SQSTM1;CAB39;MAP2K3;JUN;CDKN1A;RND3;ADRB2;CEBPB;PPP1R15A;CDKN2B;EREG;EHD1;ANKLE2;BCL10;FGD6;DCUN1D3;TRAF1;CYLD;LDLR;SMAD3;DUSP10;BBC3;CREB1;F3;ZFP36;SLC9A1;IFNAR2;RIPK2;PHKG2;NDRG1;ITGAV;PIP5K1A;SOX9;STX1A;NRG1;PML;CDC42EP1;PTPN11;ARHGEF3;RHOB;SPAG9;GCH1;TRAF4;VCL;TNFAIP1;HDAC9;COTL1;DENND2C;PTPN1;CORO1C;MTF1;RAB3IP;ADAM9;PDPK1;TNFRSF10A;RNF19A;CTSC;YWHAH;CYTH1;RELA;AGFG1;YWHAG;TDG;SFN;ERN1;SH3RF2;IPO4;PDLIM5
10048,GO:0042531,0.000606718428148096,0.999923325180494,6,35,positive regulation of tyrosine phosphorylation of STAT protein,BP,CSF2;LIF;IL24;IL6ST;IL23A;SOCS3
12188,GO:0048332,0.000610458185592287,0.999905952477255,7,41,mesoderm morphogenesis,BP,INHBA;TBX3;KDM6B;TXNRD1;SMAD3;WNT5A;KDM6A
9970,GO:0042359,0.000610971962911909,0.999963436987963,4,14,vitamin D metabolic process,BP,IL1B;TNF;NFKB1;CYP27B1
684,GO:0001892,0.000611315655635336,0.99987332739178,9,70,embryonic placenta development,BP,CSF2;PRDM1;LIF;PHLDA2;JUNB;ZFP36L1;CEBPB;SOCS3;ADM
9043,GO:0035259,0.000611781096221227,0.999964971831977,4,12,glucocorticoid receptor binding,MF,ETS2;CEBPB;SMAD3;YWHAH
13847,GO:0060444,0.000615472801513141,0.999943630858472,5,20,branching involved in mammary gland duct morphogenesis,BP,TBX3;EPHA2;PML;AREG;WNT5A
15789,GO:0072413,0.000618201954249339,0.999886390953386,8,61,signal transduction involved in mitotic cell cycle checkpoint,BP,BTG2;GADD45A;CDKN1A;PLK2;PLK3;PML;SOX4;SFN
17985,GO:1902402,0.000618201954249339,0.999886390953386,8,61,signal transduction involved in mitotic DNA damage checkpoint,BP,BTG2;GADD45A;CDKN1A;PLK2;PLK3;PML;SOX4;SFN
17986,GO:1902403,0.000618201954249339,0.999886390953386,8,61,signal transduction involved in mitotic DNA integrity checkpoint,BP,BTG2;GADD45A;CDKN1A;PLK2;PLK3;PML;SOX4;SFN
8067,GO:0032733,0.000619956770292197,0.999962752819861,4,14,positive regulation of interleukin-10 production,BP,CD83;CD274;BCL3;IL23A
7017,GO:0030728,0.000623759159961749,0.999964098121947,4,12,ovulation,BP,INHBA;PTGS2;EREG;ADAMTS1
11237,GO:0045414,0.000624489194848001,0.999984641120768,3,6,regulation of interleukin-8 biosynthetic process,BP,TNF;BCL3;BCL10
14875,GO:0070664,0.000627003979059302,0.999902054753914,7,45,negative regulation of leukocyte proliferation,BP,TNFAIP3;SDC4;PRDM1;CD274;CEBPB;PELI1;RC3H1
8677,GO:0034250,0.000632863426707429,0.99982805190749,12,123,positive regulation of cellular amide metabolic process,BP,ZC3H12A;TNF;EFNA1;BCL3;PPP1R15A;PLK3;LARP4B;SOX4;RBM3;SAMD4A;NFE2L2;SMPD3
988,GO:0002443,0.000639501398923059,0.999702532157685,30,501,leukocyte mediated immunity,BP,IL1B;CXCL1;PLAUR;PLAU;TNF;NFKB1;CXCL5;CAB39;RAP2B;BCL3;AMPD3;B4GALT1;BCL10;ADAM8;IL23A;TFRC;SERPINB1;RAET1L;CD55;JAG1;ITGAV;POU2F2;VCL;COTL1;IL7R;HLA-E;PDPK1;CTSC;CREG1;RAB24
14644,GO:0070232,0.000648869523340844,0.999937929171475,5,24,regulation of T cell apoptotic process,BP,NFKBID;EFNA1;CD274;ADAM8;WNT5A
17535,GO:1901030,0.000650508416316031,0.999916679102524,6,35,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,PMAIP1;BBC3;TP53BP2;YWHAH;YWHAG;SFN
10268,GO:0043009,0.00065752797319486,0.999702924827796,28,416,chordate embryonic development,BP,CSF2;ELF3;SDC4;PRDM1;FOSL1;TBX3;EDN1;MAFF;LIF;BMP2;PHLDA2;JUNB;ZFP36L1;CEBPB;BCL10;DLX2;SMAD3;GJB3;SOCS3;NRARP;SOX9;SOX4;SKIL;PRPF19;ADM;MAFG;WNT5A;KDM6A
9278,GO:0035710,0.000661725412483002,0.999895896099915,7,44,CD4-positive, alpha-beta T cell activation,BP,RELB;CD83;BCL3;RC3H1;IL23A;CD55;RIPK2
725,GO:0001952,0.000667643339014822,0.999844986029947,10,82,regulation of cell-matrix adhesion,BP,PLAU;SDC4;PHLDB2;VEGFC;SMAD3;SLC9A1;JAG1;FERMT1;CDK6;CORO1C
8823,GO:0034599,0.000668488620064434,0.999766130272843,17,219,cellular response to oxidative stress,BP,TNFAIP3;ZC3H12A;ETS1;TNF;PPIF;KDM6B;CPEB2;JUN;SOD2;TXNRD1;PML;NCOA7;RHOB;GCH1;ERO1A;NFE2L2;RELA
10543,GO:0043491,0.000672497918845351,0.999793626926562,14,150,protein kinase B signaling,BP,IL1B;HBEGF;TNF;EPHA2;CDKN1A;ZFP36L1;EREG;ADAM8;PLK3;CREB1;F3;SOX9;NRG1;PTPN11
16545,GO:0097300,0.000672684463782419,0.999913279128138,6,35,programmed necrotic cell death,BP,BIRC3;TICAM1;TNF;PPIF;BIRC2;CYLD
6302,GO:0019915,0.000683828278581243,0.999891579569851,7,45,lipid storage,BP,NFKBIA;IL1B;ZC3H12A;TNF;NFKB1;EHD1;ITGAV
8986,GO:0035094,0.000688664698235539,0.999934173527648,5,22,response to nicotine,BP,TNF;NFKB1;EDN1;CREB1;RELA
3544,GO:0007568,0.000689290096423167,0.999758380514312,17,213,aging,BP,PTGS2;TBX3;NFKB2;EDN1;CLDN1;JUN;CDKN1A;SOD2;PLK2;CREB1;PML;CDK6;ADM;CTSC;ERO1A;NFE2L2;RELA
12310,GO:0048661,0.000690054404908941,0.99987167415266,8,57,positive regulation of smooth muscle cell proliferation,BP,HBEGF;TNF;PTGS2;EDN1;JUN;NAMPT;EREG;ERN1
8233,GO:0033002,0.000693537012080032,0.99980999977585,12,117,muscle cell proliferation,BP,TNFAIP3;HBEGF;TNF;PTGS2;EDN1;TRIB1;JUN;NAMPT;EREG;PIM1;PPARD;ERN1
4246,GO:0009445,0.000695206439889479,0.999980407947565,3,7,putrescine metabolic process,BP,ODC1;AZIN1;SAT1
10468,GO:0043331,0.000717792472354859,0.999847414468937,9,73,response to dsRNA,BP,NFKBIA;ZC3H12A;TICAM1;PMAIP1;NFKB1;PELI1;SMAD3;RIPK2;IFIH1
19964,GO:2000516,0.00071821700546716,0.999955098231035,4,14,positive regulation of CD4-positive, alpha-beta T cell activation,BP,CD83;IL23A;CD55;RIPK2
11881,GO:0046888,0.000720174766028952,0.999906562779263,6,33,negative regulation of hormone secretion,BP,IL1B;INHBA;EDN1;LIF;PIM3;PTPN11
11318,GO:0045638,0.000726873876805332,0.999862147348314,8,67,negative regulation of myeloid cell differentiation,BP,NFKBIA;INHBA;TRIB1;TJP2;ZFP36L1;ZFP36;CDK6;TOB2
7298,GO:0031295,0.000740296375235004,0.999903437705363,6,33,T cell costimulation,BP,EFNB2;CD274;EFNB1;PTPN11;MAP3K8;PDPK1
14224,GO:0061157,0.000741631911973658,0.999928512986341,5,21,mRNA destabilization,BP,ZC3H12A;ZFP36L1;RC3H1;ZFP36;QKI
545,GO:0001664,0.000758020786282106,0.999789559560955,12,125,G-protein coupled receptor binding,MF,CXCL2;CXCL1;CXCL3;CXCL8;CCL20;EDN1;CXCL5;SAA1;PTPN11;ADM;WNT5A;CXCL16
4607,GO:0010721,0.000781003093904416,0.999723497563153,17,203,negative regulation of cell development,BP,EFNA1;SEMA7A;EFNB2;KCTD11;TJP2;DLX2;LDLR;TACSTD2;DUSP10;PLK2;JAG1;SOX9;NRG1;CORO1C;PRPF19;WNT5A;YWHAH
20275,GO:2001237,0.00080485539930265,0.999825653136006,9,76,negative regulation of extrinsic apoptotic signaling pathway,BP,TNFAIP3;IL1B;IL1A;CSF2;TNF;TNFRSF10B;ITGAV;TNFRSF10A;RELA
12105,GO:0048145,0.000806095157086044,0.999845462779687,8,62,regulation of fibroblast proliferation,BP,JUN;CDKN1A;EREG;CREB1;PML;FOSL2;CDK6;WNT5A
7297,GO:0031294,0.00082136321320598,0.999890294788162,6,34,lymphocyte costimulation,BP,EFNB2;CD274;EFNB1;PTPN11;MAP3K8;PDPK1
15273,GO:0071456,0.000830404447418362,0.999751813800668,13,151,cellular response to hypoxia,BP,PTGS2;PMAIP1;EDN1;CPEB2;ZFP36L1;ADAM8;PLK3;PPARD;SLC9A1;NDRG1;ERO1A;NFE2L2;BACH1
14166,GO:0061045,0.000839961215262282,0.999861749258269,7,46,negative regulation of wound healing,BP,PLAUR;PLAU;SERPINB2;EDN1;PHLDB2;SMAD3;DUSP10
13058,GO:0051546,0.000841019209153243,0.999946206573968,4,13,keratinocyte migration,BP,HBEGF;PPARD;FERMT1;ADAM9
18583,GO:1903827,0.0008739487567367,0.99960330768116,27,417,regulation of cellular protein localization,BP,IL1B;ZC3H12A;TNF;PTGS2;PMAIP1;EPHA2;LIF;SQSTM1;CDKN1A;UGCG;CYLD;NEDD4L;BBC3;PLK3;USP36;PLAGL2;TP53BP2;NRG1;PTPN11;SOX4;PTPN1;WNT5A;INSIG1;PDPK1;YWHAH;YWHAG;SFN
6839,GO:0030301,0.000877123432541121,0.999854001744399,7,48,cholesterol transport,BP,NFKBIA;NFKB1;LDLR;LIPG;STARD5;ABCA5;STX12
7094,GO:0030888,0.000880017730082334,0.999880480893549,6,35,regulation of B cell proliferation,BP,TICAM1;PRDM1;CDKN1A;PELI1;RC3H1;TFRC
19753,GO:2000134,0.000883003695476309,0.99978574438344,10,93,negative regulation of G1/S transition of mitotic cell cycle,BP,BTG2;GADD45A;CDKN1A;CDKN2B;DCUN1D3;PLK2;PLK3;PML;SOX4;SFN
19218,GO:1905331,0.000890644828309502,0.999942136125768,4,13,negative regulation of morphogenesis of an epithelium,BP,TNF;PHLDB2;TACSTD2;WNT5A
19748,GO:2000116,0.000892407735566405,0.999703090085652,15,191,regulation of cysteine-type endopeptidase activity,BP,PLAUR;BIRC3;TNF;PTGS2;PMAIP1;TNFRSF10B;BIRC2;BCL10;SMAD3;BBC3;F3;RIPK2;PML;TNFRSF10A;SFN
11888,GO:0046902,0.000892618291124986,0.999825391396537,8,66,regulation of mitochondrial membrane permeability,BP,PPIF;PMAIP1;BBC3;SLC9A1;TP53BP2;YWHAH;YWHAG;SFN
13139,GO:0051701,0.000899472604384202,0.999714822129229,14,159,interaction with host,BP,ZC3H12A;CXCL8;TNIP1;CLDN1;EFNB2;EPHA2;LDLR;SMAD3;ITGA5;TFRC;CD55;ITGAV;PML;NUP153
14747,GO:0070424,0.000915811450546739,0.99997424393527,3,6,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,TNFAIP3;BIRC3;BIRC2
12104,GO:0048144,0.00091662125227262,0.999820514841399,8,63,fibroblast proliferation,BP,JUN;CDKN1A;EREG;CREB1;PML;FOSL2;CDK6;WNT5A
16711,GO:0097696,0.000922119309041547,0.999774836341377,10,94,STAT cascade,BP,CSF2;LIF;IL24;BCL3;IL6ST;IL23A;SOCS3;IFNAR2;IL7R;PTPN1
12606,GO:0050779,0.000924128125333432,0.999905616447978,5,22,RNA destabilization,BP,ZC3H12A;ZFP36L1;RC3H1;ZFP36;QKI
8624,GO:0034142,0.000927139178399011,0.999937874657127,4,14,toll-like receptor 4 signaling pathway,BP,NFKBIA;TNFAIP3;PELI1;RIPK2
18898,GO:1904580,0.000931245626865713,1,2,2,regulation of intracellular mRNA localization,BP,ZFP36L1;ZFP36
18899,GO:1904582,0.000931245626865713,1,2,2,positive regulation of intracellular mRNA localization,BP,ZFP36L1;ZFP36
4572,GO:0010656,0.000937787575200481,0.999903192909164,5,23,negative regulation of muscle cell apoptotic process,BP,ZC3H12A;EDN1;PPP1R10;PDPK1;NFE2L2
11338,GO:0045662,0.000937920635378987,0.999935893661266,4,15,negative regulation of myoblast differentiation,BP,TNF;TBX3;PPARD;SOX9
11348,GO:0045672,0.000944435778857481,0.999935326612202,4,15,positive regulation of osteoclast differentiation,BP,TNF;IL23A;CREB1;KLF10
11393,GO:0045776,0.000957902845933253,0.999899978678156,5,24,negative regulation of blood pressure,BP,ADRB2;SOD2;VEGFC;BDKRB1;GCH1
7802,GO:0032350,0.000960881920581708,0.999900261588436,5,23,regulation of hormone metabolic process,BP,IL1B;TNF;NFKB1;BMP2;CYP27B1
12535,GO:0050680,0.00096596200804205,0.999763659782176,10,87,negative regulation of epithelial cell proliferation,BP,TNF;EFNB2;CDKN2B;EREG;DUSP10;PPARD;SOX9;CDK6;WNT5A;SFN
17512,GO:1900744,0.000972615164525728,0.999898766025282,5,23,regulation of p38MAPK cascade,BP,IL1B;ZC3H12A;GADD45A;BMP2;DUSP10
895,GO:0002266,0.000974161943649819,1,2,2,follicular dendritic cell activation,BP,NFKB2;BCL3
896,GO:0002268,0.000974161943649819,1,2,2,follicular dendritic cell differentiation,BP,NFKB2;BCL3
8365,GO:0033257,0.000974161943649819,1,2,2,Bcl3/NF-kappaB2 complex,CC,NFKB2;BCL3
19761,GO:2000146,0.000974783156298322,0.999673728840788,15,175,negative regulation of cell motility,BP,TRIB1;IL24;RAP2B;PHLDB2;TACSTD2;DUSP10;PPARD;JAG1;NAV3;NRG1;RHOB;VCL;CORO1C;ADAMTS9;NFE2L2
17587,GO:1901222,0.000984759295856033,0.999832768759949,7,48,regulation of NIK/NF-kappaB signaling,BP,TNF;TNFRSF10B;BIRC2;RC3H1;TRAF4;TNFRSF10A;RELA
9297,GO:0035740,0.000988581515696963,1,2,2,CD8-positive, alpha-beta T cell proliferation,BP,IRF1;HLA-E
19983,GO:2000564,0.000988581515696963,1,2,2,regulation of CD8-positive, alpha-beta T cell proliferation,BP,IRF1;HLA-E
13768,GO:0060341,0.00100047882965581,0.999487651690288,36,618,regulation of cellular localization,BP,IL1B;ZC3H12A;TNF;PTGS2;PMAIP1;EPHA2;LIF;SQSTM1;CDKN1A;ZFP36L1;UGCG;EHD1;PIM3;CYLD;NEDD4L;BBC3;PLK3;USP36;BDKRB1;ZFP36;PLAGL2;TP53BP2;STX1A;NRG1;PML;PTPN11;SOX4;OXCT1;PTPN1;WNT5A;NUP153;INSIG1;PDPK1;YWHAH;YWHAG;SFN
3443,GO:0007254,0.0010009924005381,0.999679338346337,14,155,JNK cascade,BP,IL1B;IL1A;TNF;EDN1;IRAK2;GADD45A;TRIB1;DUSP10;RIPK2;SPAG9;TRAF4;PTPN1;WNT5A;ERN1
415,GO:0001102,0.00100373582790031,0.999860132598694,6,35,RNA polymerase II activating transcription factor binding,MF,BHLHE40;TBX3;JUN;SMAD3;CREB1;NFE2L2
11288,GO:0045599,0.00100566829555156,0.999860267242987,6,34,negative regulation of fat cell differentiation,BP,TNF;SMAD3;CCDC85B;JAG1;WNT5A;INSIG1
18512,GO:1903672,0.00100589475187701,0.999894501436797,5,23,positive regulation of sprouting angiogenesis,BP,PTGS2;PLK2;ITGA5;HDAC9;PDPK1
1176,GO:0002821,0.00101152666831633,0.999826832861072,7,50,positive regulation of adaptive immune response,BP,IL1B;TNF;IL6ST;IL23A;TFRC;RIPK2;HLA-E
12372,GO:0048762,0.00101665156624921,0.999690438899863,13,137,mesenchymal cell differentiation,BP,IL1B;EFNA1;EDN1;SEMA7A;BMP2;PHLDB2;SMAD3;EFNB1;JAG1;SOX9;NRG1;CORO1C;WNT5A
14910,GO:0070741,0.00102411078458303,0.999892942513871,5,22,response to interleukin-6,BP,NFKB1;IL6ST;SOCS3;PTPN11;RELA
15205,GO:0071354,0.00102411078458303,0.999892942513871,5,22,cellular response to interleukin-6,BP,NFKB1;IL6ST;SOCS3;PTPN11;RELA
11883,GO:0046890,0.00102724317593027,0.999704419916991,12,126,regulation of lipid biosynthetic process,BP,IL1B;TNF;PTGS2;NFKB1;BMP2;HMGCS1;LDLR;CREB1;CYP27B1;SQLE;INSIG1;SMPD3
3548,GO:0007584,0.00102900001944048,0.999685553730754,13,145,response to nutrient,BP,IL1B;PTGS2;PANX1;CDKN2B;HMGCS1;PIM1;LIPG;CREB1;PPARD;CYP27B1;OXCT1;RELA;AHCY
12569,GO:0050718,0.00103673917191134,0.999928380964105,4,14,positive regulation of interleukin-1 beta secretion,BP,PANX1;TRIM16;RIPK2;WNT5A
11298,GO:0045616,0.00104136519132488,0.999853839984157,6,35,regulation of keratinocyte differentiation,BP,ERRFI1;ZFP36L1;RUNX1;TRIM16;ZFP36;CYP27B1
18124,GO:1902807,0.00106033686808287,0.9997359394767,10,96,negative regulation of cell cycle G1/S phase transition,BP,BTG2;GADD45A;CDKN1A;CDKN2B;DCUN1D3;PLK2;PLK3;PML;SOX4;SFN
11777,GO:0046635,0.00106150916718785,0.999885869212194,5,25,positive regulation of alpha-beta T cell activation,BP,CD83;IL23A;CD55;RIPK2;HLA-E
13764,GO:0060337,0.00106831214516112,0.999784648235431,8,68,type I interferon signaling pathway,BP,IRF6;IRF1;IFNAR2;PTPN11;PTPN1;HLA-E;WNT5A;ISG20
15208,GO:0071357,0.00106831214516112,0.999784648235431,8,68,cellular response to type I interferon,BP,IRF6;IRF1;IFNAR2;PTPN11;PTPN1;HLA-E;WNT5A;ISG20
14126,GO:0060986,0.00107477104876135,0.999885571858881,5,23,endocrine hormone secretion,BP,IL1B;INHBA;TBX3;HCAR2;PTPN11
3134,GO:0006725,0.00108707816722037,0.999233979578921,184,4721,cellular aromatic compound metabolic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;BTG2;NFKBID;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;PPIF;KLF6;ZC3H12C;ZNF697;BHLHE40;PTGS2;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;HAS3;IRAK2;KLF7;CREB5;EHF;EPHA2;RELB;GADD45A;MAFF;LIF;TRIB1;SQSTM1;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;NMNAT2;RGMB;TJP2;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;ZFP36L1;ADRB2;CEBPB;ARNTL2;RUNX1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;HAL;DUSP1;BCL10;TRAF1;PPP1R10;NABP1;DLX2;TXNRD1;VGLL3;CYLD;ADAM8;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;IL23A;PLK3;DIEXF;PIM1;TFRC;CREB1;HIVEP2;PPARD;SLC25A25;CCDC85B;USP36;IL16;ZFP36;SLC9A1;MAFK;PNRC1;ELL2;JAG1;PLAGL2;RIPK2;CLK4;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;POLR3A;ZNF460;FOXN2;UHRF1;PANK3;MXD1;GCH1;SOX4;FOSL2;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;HIVEP1;NFKBIB;KLF10;AEN;SKIL;IL7R;RBM3;IER5;YRDC;SAMD4A;PTPN1;SQLE;TFE3;PRPF19;TOB2;ADM;MAFG;MTF1;QKI;CELF1;PMM2;WNT5A;NUP153;MAOA;INSIG1;PDPK1;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;RELA;BACH1;BTAF1;GINS3;POLR3D;ALAS1;TDG;ELF4;CREG1;ERN1;UPP1;ISG20;ATXN7;BRD2;PABPC4;AHCY;FUBP3
18085,GO:1902686,0.00110747952020221,0.999806515548095,7,53,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,PPIF;PMAIP1;BBC3;TP53BP2;YWHAH;YWHAG;SFN
15978,GO:0080135,0.0011080473805409,0.999452700997315,32,536,regulation of cellular response to stress,BP,IL1B;IL1A;ZC3H12A;TNF;IER3;PTGS2;PMAIP1;EDN1;GADD45A;BMP2;PPP1R15A;SOD2;PPP1R10;DUSP10;PLK2;RIPK2;PPP1R15B;PML;NCOA7;SPAG9;GCH1;FEM1B;TRAF4;SKIL;CDK6;IER5;PTPN1;WNT5A;NUP153;INSIG1;NFE2L2;ERN1
19497,GO:1990264,0.00111435704039966,1,2,2,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,DUSP10;PTPN1
11419,GO:0045833,0.00111776878162511,0.999805617351833,7,49,negative regulation of lipid metabolic process,BP,IL1B;TNF;NFKB1;HCAR2;BMP2;CYP27B1;INSIG1
18541,GO:1903747,0.00113139411890779,0.999715357188248,10,99,regulation of establishment of protein localization to mitochondrion,BP,PMAIP1;UGCG;BBC3;USP36;PLAGL2;TP53BP2;NRG1;YWHAH;YWHAG;SFN
11824,GO:0046718,0.00114614724278694,0.999738382436704,9,78,viral entry into host cell,BP,CLDN1;EFNB2;EPHA2;LDLR;ITGA5;TFRC;CD55;ITGAV;NUP153
19419,GO:1905953,0.00114824576007729,0.999875075304091,5,24,negative regulation of lipid localization,BP,NFKBIA;TNF;NFKB1;ITGAV;PTPN11
17513,GO:1900745,0.00115886940882578,0.999916085681842,4,15,positive regulation of p38MAPK cascade,BP,IL1B;ZC3H12A;GADD45A;BMP2
6147,GO:0019430,0.00116118087272344,0.99991363826196,4,17,removal of superoxide radicals,BP,TNF;SOD2;GCH1;NFE2L2
4732,GO:0010894,0.00116119081734955,0.999915871543804,4,15,negative regulation of steroid biosynthetic process,BP,NFKB1;BMP2;CYP27B1;INSIG1
19962,GO:2000514,0.00116751356691895,0.999871731067643,5,25,regulation of CD4-positive, alpha-beta T cell activation,BP,CD83;RC3H1;IL23A;CD55;RIPK2
9906,GO:0042228,0.00117432030812816,0.999960231906595,3,7,interleukin-8 biosynthetic process,BP,TNF;BCL3;BCL10
10435,GO:0043281,0.00117619312363416,0.999615016373368,14,176,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,PLAUR;BIRC3;TNF;PTGS2;PMAIP1;TNFRSF10B;BIRC2;BCL10;SMAD3;BBC3;F3;PML;TNFRSF10A;SFN
7494,GO:0031664,0.00118787678309206,0.999913401362343,4,15,regulation of lipopolysaccharide-mediated signaling pathway,BP,TNFAIP3;PRDM1;TRIB1;CD55
11876,GO:0046883,0.00119237574426121,0.999629683728345,13,144,regulation of hormone secretion,BP,IL1B;INHBA;TNF;EDN1;HCAR2;LIF;PIM3;CREB1;PPARD;STX1A;PTPN11;SOX4;OXCT1
1186,GO:0002831,0.00120200397221708,0.999695747827598,10,95,regulation of response to biotic stimulus,BP,TNFAIP3;IL1B;ZC3H12A;BIRC3;PRDM1;TRIB1;BIRC2;IL23A;CD55;RIPK2
14661,GO:0070265,0.00120353129200254,0.999823847210722,6,40,necrotic cell death,BP,BIRC3;TICAM1;TNF;PPIF;BIRC2;CYLD
20019,GO:2000628,0.00120682440960184,0.999958736289612,3,7,regulation of miRNA metabolic process,BP,ZC3H12A;NFKB1;RELA
3397,GO:0007178,0.00120876632226837,0.999553727969209,17,212,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,INHBA;BMP2;JUN;RGMB;CDKN2B;SMAD3;CREB1;ZNF451;PML;FERMT1;FAM83G;AKAP2;KLF10;SKIL;WNT5A;ADAM9;PDPK1
13898,GO:0060537,0.00121028804753953,0.999538554986948,18,227,muscle tissue development,BP,BTG2;TBX3;KDM6B;EDN1;EFNB2;MAFF;BMP2;SMAD3;PIM1;CREB1;SLC9A1;SOX9;NRG1;FOXN2;HDAC9;WNT5A;ADAMTS9;PDLIM5
8045,GO:0032692,0.0012148507294363,0.999909624785798,4,16,negative regulation of interleukin-1 production,BP,TNFAIP3;ZC3H12A;ERRFI1;PML
13086,GO:0051591,0.00122795445913396,0.999748806563411,8,61,response to cAMP,BP,FOSL1;JUN;BIRC2;JUNB;ZFP36L1;DUSP1;AREG;RELA
6810,GO:0030260,0.00123026350270235,0.999687788353489,10,94,entry into host cell,BP,CXCL8;CLDN1;EFNB2;EPHA2;LDLR;ITGA5;TFRC;CD55;ITGAV;NUP153
10874,GO:0044409,0.00123026350270235,0.999687788353489,10,94,entry into host,BP,CXCL8;CLDN1;EFNB2;EPHA2;LDLR;ITGA5;TFRC;CD55;ITGAV;NUP153
13199,GO:0051806,0.00123026350270235,0.999687788353489,10,94,entry into cell of other organism involved in symbiotic interaction,BP,CXCL8;CLDN1;EFNB2;EPHA2;LDLR;ITGA5;TFRC;CD55;ITGAV;NUP153
13206,GO:0051828,0.00123026350270235,0.999687788353489,10,94,entry into other organism involved in symbiotic interaction,BP,CXCL8;CLDN1;EFNB2;EPHA2;LDLR;ITGA5;TFRC;CD55;ITGAV;NUP153
18399,GO:1903426,0.00123621527746057,0.999780498561715,7,51,regulation of reactive oxygen species biosynthetic process,BP,IL1B;ZC3H12A;TICAM1;TNF;PTGS2;EDN1;SMAD3
2608,GO:0005911,0.00123856031408312,0.999475014701651,22,301,cell-cell junction,CC,CLDN1;PANX1;RAP2B;CLDN4;TJP2;GJB4;B4GALT1;TACSTD2;ITGA5;GJB3;SLC9A1;AMOTL2;USP53;NDRG1;CDC42EP1;TRAF4;VCL;TMEM65;FRMD6;YWHAH;CYTH1;PDLIM5
6071,GO:0019218,0.00124261256135852,0.999712603854139,9,80,regulation of steroid metabolic process,BP,IL1B;TNF;NFKB1;BMP2;HMGCS1;LDLR;CYP27B1;SQLE;INSIG1
3946,GO:0008637,0.00125251852389625,0.999679677135214,10,105,apoptotic mitochondrial changes,BP,PLAUR;PPIF;PMAIP1;JUN;SOD2;BBC3;TP53BP2;YWHAH;YWHAG;SFN
6688,GO:0030054,0.00125309699309324,0.999293376756611,47,871,cell junction,CC,PLAUR;PLAU;SDC4;IRF6;CLDN1;PANX1;HCAR2;EFNB2;EPHA2;RAP2B;PHLDB2;CLDN4;TJP2;NAMPT;RND3;GJB4;NEDD9;B4GALT1;HCAR3;TACSTD2;ITGA5;GJB3;SLC9A1;JAG1;AMOTL2;USP53;NDRG1;ITGAV;PIP5K1A;TP53BP2;STX1A;FERMT1;SLC7A2;CDC42EP1;RHOB;TRAF4;VCL;SAMD4A;TMEM65;CORO1C;ADAM9;PDPK1;FRMD6;YWHAH;CYTH1;YWHAG;PDLIM5
12715,GO:0050930,0.00126115178956481,0.999953293618202,3,8,induction of positive chemotaxis,BP,CXCL8;VEGFC;IL16
4772,GO:0010956,0.00126632568051083,1,2,2,negative regulation of calcidiol 1-monooxygenase activity,BP,NFKB1;CYP27B1
14640,GO:0070228,0.00128844538897352,0.999808874091944,6,40,regulation of lymphocyte apoptotic process,BP,NFKBID;EFNA1;CD274;BCL10;ADAM8;WNT5A
2593,GO:0005886,0.00129200601247695,0.999115993246585,123,2818,plasma membrane,CC,NFKBIA;PLAUR;HBEGF;PLAU;SDC4;TNF;SERPINB2;SPRR2D;PTGS2;FOSL1;TRPV3;EFNA1;TGFA;SEMA7A;HAS3;ERRFI1;IL1RN;IRAK2;CLDN1;PANX1;DAPP1;SPRR2A;HCAR2;TNFRSF10B;EFNB2;EPHA2;CD83;IFNGR2;RRAD;BMP2;RAP2B;BIRC2;RGMB;PHLDB2;CLDN4;TJP2;CD274;BCL3;ETS2;RELT;RND3;ADRB2;GJB4;TRIM16;EREG;ALDH1A3;EHD1;NEDD9;B4GALT1;BCL10;DCUN1D3;CDV3;IL6ST;SGMS2;VMP1;SLC6A14;CYLD;ADAM8;LDLR;HCAR3;TACSTD2;NEDD4L;SMAD3;PIM1;ITGA5;TFRC;EFNB1;GJB3;F3;RAET1L;IL16;BDKRB1;RAPH1;SLC9A1;CD55;IFNAR2;ANTXR2;JAG1;AMOTL2;NDRG1;ITGAV;PIP5K1A;STX1A;NRG1;RASA2;FERMT1;SLC7A2;CDC42EP1;SLC28A3;DCBLD2;RHOB;TRAF4;VCL;IL7R;EMP3;PTPN1;TMEM65;CORO1C;STEAP4;ABL2;HLA-E;OSMR;WNT5A;ADAM9;LCE1C;PDPK1;TNFRSF10A;FRMD6;NFE2L2;YWHAH;SGK1;CYTH1;TDG;RAB22A;ITM2B;ETNK1;ATP13A3;MYO1B;CXCL16;PDLIM5;GPR156;RAB24;SMPD3
11343,GO:0045667,0.00129585160150743,0.999699126695204,9,77,regulation of osteoblast differentiation,BP,TNF;NOCT;BMP2;CEBPB;IL6ST;SMAD3;JAG1;AREG;CDK6
12880,GO:0051205,0.00130771380008833,0.999805448069721,6,40,protein insertion into membrane,BP,PMAIP1;BBC3;TP53BP2;YWHAH;YWHAG;SFN
18351,GO:1903320,0.00131272186156957,0.999546071367707,15,188,regulation of protein modification by small protein conjugation or removal,BP,TNFAIP3;ZC3H12A;BIRC3;TICAM1;TNIP1;BIRC2;ADRB2;N4BP1;PELI1;BCL10;DCUN1D3;RIPK2;FEM1B;SOX4;RELA
18464,GO:1903556,0.00131323971586757,0.99985025210371,5,27,negative regulation of tumor necrosis factor superfamily cytokine production,BP,TNFAIP3;ZC3H12A;ERRFI1;CD274;BCL3
6778,GO:0030212,0.00133132221552012,0.999849295604879,5,25,hyaluronan metabolic process,BP,IL1B;NFKB1;HAS3;PIM1;SLC9A1
7442,GO:0031571,0.00136414985031065,0.99971419622321,8,68,mitotic G1 DNA damage checkpoint,BP,BTG2;GADD45A;CDKN1A;PLK2;PLK3;PML;SOX4;SFN
11005,GO:0044819,0.00136414985031065,0.99971419622321,8,68,mitotic G1/S transition checkpoint,BP,BTG2;GADD45A;CDKN1A;PLK2;PLK3;PML;SOX4;SFN
9541,GO:0036294,0.00136872729295926,0.99956682558035,13,158,cellular response to decreased oxygen levels,BP,PTGS2;PMAIP1;EDN1;CPEB2;ZFP36L1;ADAM8;PLK3;PPARD;SLC9A1;NDRG1;ERO1A;NFE2L2;BACH1
2603,GO:0005900,0.00136920892744088,1,2,2,oncostatin-M receptor complex,CC,IL6ST;OSMR
8146,GO:0032872,0.00138147673567569,0.999541465812307,14,160,regulation of stress-activated MAPK cascade,BP,IL1B;IL1A;ZC3H12A;TNF;EDN1;GADD45A;BMP2;DUSP10;RIPK2;SPAG9;TRAF4;PTPN1;WNT5A;ERN1
368,GO:0000989,0.00139175788226569,0.999310557085215,31,518,transcription factor activity, transcription factor binding,MF,NFKBIZ;NFKBID;ELF3;BHLHE40;NFKB2;KDM6B;KLF7;RELB;JUN;BIRC2;SERTAD2;JUNB;TAF4B;NAB1;BCL10;SMAD3;CREB1;PPARD;NRG1;ZNF451;NCOA7;ELK3;MXD1;SOX4;HDAC9;NFKBIB;TOB2;MTF1;KDM6A;TDG;CREG1
14649,GO:0070242,0.00141175993736288,0.999890561228011,4,16,thymocyte apoptotic process,BP,NFKBID;EFNA1;ADAM8;WNT5A
7159,GO:0031018,0.00142384818312837,0.999836329337466,5,25,endocrine pancreas development,BP,SOX9;SOX4;CDK6;WNT5A;PDPK1
8830,GO:0034614,0.00143053187164494,0.999597717575414,11,121,cellular response to reactive oxygen species,BP,TNFAIP3;ETS1;TNF;PPIF;KDM6B;JUN;SOD2;RHOB;GCH1;NFE2L2;RELA
8846,GO:0034641,0.00146209028627236,0.998958528314578,196,5139,cellular nitrogen compound metabolic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;BTG2;NFKBID;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;PPIF;KLF6;ZC3H12C;ZNF697;BHLHE40;PTGS2;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;ODC1;HAS3;IRAK2;KLF7;CREB5;CPEB2;EHF;EPHA2;RELB;GADD45A;MAFF;LIF;TRIB1;SQSTM1;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;NMNAT2;RGMB;TJP2;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;ZFP36L1;ENC1;ADRB2;CEBPB;ARNTL2;UGCG;PPP1R15A;RUNX1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;HAL;DUSP1;BCL10;TRAF1;PPP1R10;SGMS2;NABP1;DLX2;TXNRD1;VGLL3;CYLD;ADAM8;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;IL23A;PLK3;DIEXF;PIM1;TFRC;CREB1;HIVEP2;PPARD;SLC25A25;CCDC85B;USP36;IL16;ZFP36;SLC9A1;MAFK;LARP4B;PNRC1;ELL2;AZIN1;JAG1;PLAGL2;RIPK2;PPP1R15B;CLK4;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;POLR3A;SLC7A2;ZNF460;FOXN2;UHRF1;PANK3;MXD1;GCH1;SOX4;FOSL2;EIF1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;HIVEP1;NFKBIB;KLF10;AEN;SKIL;IL7R;RBM3;IER5;YRDC;SAMD4A;PTPN1;TFE3;PRPF19;TOB2;ADM;MAFG;MTF1;QKI;CELF1;PMM2;WNT5A;NUP153;MAOA;INSIG1;PDPK1;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;SAT1;RELA;BACH1;BTAF1;GINS3;POLR3D;ALAS1;TDG;ELF4;CREG1;ERN1;UPP1;ISG20;ATXN7;BRD2;PABPC4;AHCY;FUBP3;SMPD3
15214,GO:0071364,0.00146438667996833,0.999779525926976,6,36,cellular response to epidermal growth factor stimulus,BP,ERRFI1;ZFP36L1;ZFP36;SOX9;PTPN11;PDPK1
14683,GO:0070302,0.00146801587134713,0.999509439865372,14,161,regulation of stress-activated protein kinase signaling cascade,BP,IL1B;IL1A;ZC3H12A;TNF;EDN1;GADD45A;BMP2;DUSP10;RIPK2;SPAG9;TRAF4;PTPN1;WNT5A;ERN1
12628,GO:0050810,0.00146918511386529,0.99968943766982,8,65,regulation of steroid biosynthetic process,BP,IL1B;TNF;NFKB1;BMP2;HMGCS1;CYP27B1;SQLE;INSIG1
13491,GO:0055025,0.00147079402238038,0.999829673750272,5,25,positive regulation of cardiac muscle tissue development,BP,EDN1;EFNB2;PIM1;CREB1;NRG1
10912,GO:0044459,0.00148319688718595,0.999067974644637,71,1449,plasma membrane part,CC,PLAUR;HBEGF;SDC4;TNF;PTGS2;FOSL1;TRPV3;EFNA1;TGFA;SEMA7A;HAS3;ERRFI1;CLDN1;TNFRSF10B;EFNB2;EPHA2;CD83;IFNGR2;BMP2;BIRC2;RGMB;CLDN4;CD274;RELT;ADRB2;GJB4;EREG;EHD1;B4GALT1;BCL10;IL6ST;SGMS2;SLC6A14;CYLD;ADAM8;LDLR;HCAR3;TACSTD2;ITGA5;TFRC;EFNB1;GJB3;F3;BDKRB1;SLC9A1;CD55;IFNAR2;ANTXR2;JAG1;AMOTL2;ITGAV;PIP5K1A;STX1A;NRG1;RASA2;FERMT1;SLC7A2;SLC28A3;DCBLD2;RHOB;IL7R;CORO1C;STEAP4;ABL2;HLA-E;OSMR;ADAM9;TNFRSF10A;CYTH1;ATP13A3;PDLIM5
11481,GO:0045939,0.00149027916706915,0.99988274290605,4,16,negative regulation of steroid metabolic process,BP,NFKB1;BMP2;CYP27B1;INSIG1
17589,GO:1901224,0.00149911576501511,0.999771994782725,6,38,positive regulation of NIK/NF-kappaB signaling,BP,TNF;TNFRSF10B;RC3H1;TRAF4;TNFRSF10A;RELA
19751,GO:2000121,0.00149922752686329,0.999940987557972,3,8,regulation of removal of superoxide radicals,BP,TNF;GCH1;NFE2L2
18030,GO:1902532,0.00150521992659964,0.999312228952306,25,390,negative regulation of intracellular signal transduction,BP,TNFAIP3;IL1B;ZC3H12A;PLAUR;NFKBID;PPIF;PTGS2;TNIP1;EFNA1;ERRFI1;EPHA2;LIF;BCL3;BCL2L2;DUSP16;SOD2;DUSP8;DUSP1;DUSP10;SOCS3;RASA2;TNFAIP1;PTPN1;NFE2L2;RELA
36,GO:0000075,0.00150734567825552,0.999450217144637,16,208,cell cycle checkpoint,BP,BTG2;GADD45A;CDKN1A;CDKN2B;DUSP1;PPP1R10;NABP1;PLK2;PLK3;NDRG1;PML;PTPN11;FEM1B;SOX4;PRPF19;SFN
996,GO:0002456,0.00151268659204218,0.999720524390481,7,54,T cell mediated immunity,BP,IL1B;IL23A;CD55;JAG1;IL7R;HLA-E;CTSC
8081,GO:0032760,0.00151751078023465,0.999768638772471,6,38,positive regulation of tumor necrosis factor production,BP,TICAM1;IL23A;RIPK2;HLA-E;WNT5A;IFIH1
7803,GO:0032351,0.00152143429098489,0.999943545077992,3,7,negative regulation of hormone metabolic process,BP,NFKB1;BMP2;CYP27B1
7805,GO:0032353,0.00152143429098489,0.999943545077992,3,7,negative regulation of hormone biosynthetic process,BP,NFKB1;BMP2;CYP27B1
15247,GO:0071417,0.00152151560525294,0.999304655112941,25,378,cellular response to organonitrogen compound,BP,IL1B;TNF;PTGS2;NFKB1;EDN1;ERRFI1;CPEB2;ZFP36L1;ADRB2;CEBPB;KLF3;CREB1;SOCS3;SLC9A1;RIPK2;SOX9;PTPN11;HDAC9;KLF10;PTPN1;ATP6V1C2;PDPK1;NFE2L2;RELA;YWHAG
10986,GO:0044783,0.00152420231158734,0.999674690138493,8,69,G1 DNA damage checkpoint,BP,BTG2;GADD45A;CDKN1A;PLK2;PLK3;PML;SOX4;SFN
1112,GO:0002699,0.00154738858164336,0.999593525878121,10,101,positive regulation of immune effector process,BP,IL1B;TNF;SEMA7A;BCL10;IL23A;TFRC;RIPK2;HLA-E;WNT5A;PDPK1
16851,GO:0098770,0.00154778082576449,1,2,2,FBXO family protein binding,MF,BIRC2;CDK6
14147,GO:0061014,0.00155815234896052,0.999762504167348,6,36,positive regulation of mRNA catabolic process,BP,ZC3H12A;BTG2;ZFP36L1;RC3H1;ZFP36;QKI
10474,GO:0043367,0.00156137891223847,0.999761239222641,6,37,CD4-positive, alpha-beta T cell differentiation,BP,RELB;CD83;BCL3;RC3H1;IL23A;RIPK2
12826,GO:0051128,0.00157117160741977,0.998977707650686,84,1805,regulation of cellular component organization,BP,IL1B;IL1A;PLAUR;HBEGF;CSF2;INHBA;SDC4;ETS1;TNF;PPIF;PMAIP1;FOSL1;EFNA1;TGFA;EDN1;SEMA7A;HAS3;CLDN1;EFNB2;EPHA2;LIF;SQSTM1;JUN;BIRC2;CDKN1A;PHLDB2;SERTAD2;ENC1;RND3;ADRB2;UGCG;PPP1R15A;RUNX1;EREG;EHD1;ZSWIM4;DUSP1;FGD6;DCUN1D3;PPP1R10;SACS;CYLD;LDLR;TACSTD2;NEDD4L;SMAD3;PLK2;BBC3;WISP1;CREB1;PPARD;CCDC85B;USP36;BDKRB1;SLC9A1;CYP27B1;PLAGL2;NAV3;ITGAV;TP53BP2;SOX9;STX1A;NRG1;ZNF451;PML;CDC42EP1;PTPN11;UHRF1;DCBLD2;RHOB;SKIL;PTPN1;CORO1C;ABL2;WNT5A;INSIG1;ADAM9;NFE2L2;YWHAH;SGK1;YWHAG;SFN;CXCL16;PDLIM5
7489,GO:0031652,0.00159335252047936,0.999935918980928,3,8,positive regulation of heat generation,BP,IL1B;TNF;PTGS2
367,GO:0000988,0.00160936776864766,0.999194987075063,31,523,transcription factor activity, protein binding,MF,NFKBIZ;NFKBID;ELF3;BHLHE40;NFKB2;KDM6B;KLF7;RELB;JUN;BIRC2;SERTAD2;JUNB;TAF4B;NAB1;BCL10;SMAD3;CREB1;PPARD;NRG1;ZNF451;NCOA7;ELK3;MXD1;SOX4;HDAC9;NFKBIB;TOB2;MTF1;KDM6A;TDG;CREG1
7495,GO:0031665,0.00162096743139887,0.999934411142449,3,8,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,TNFAIP3;PRDM1;TRIB1
11245,GO:0045445,0.00162867651929477,0.99969601083219,7,52,myoblast differentiation,BP,TNF;TBX3;ZFP36L1;PPARD;JAG1;SOX9;NRG1
15268,GO:0071450,0.00163536459028897,0.999863748889392,4,19,cellular response to oxygen radical,BP,TNF;SOD2;GCH1;NFE2L2
15269,GO:0071451,0.00163536459028897,0.999863748889392,4,19,cellular response to superoxide,BP,TNF;SOD2;GCH1;NFE2L2
8180,GO:0032916,0.00163568981976101,1,2,2,positive regulation of transforming growth factor beta3 production,BP,SMAD3;CREB1
10956,GO:0044703,0.00164805766878866,0.999164694833106,32,548,multi-organism reproductive process,BP,IL1B;BIRC3;INHBA;ETS1;PTGS2;PRDM1;FOSL1;EDN1;MAFF;LIF;CLDN4;JUNB;OVOL1;NAMPT;TAF4B;BCL2L2;EREG;B4GALT1;VMP1;GJB3;PPARD;CYP27B1;SOX9;SPAG9;ADAMTS1;SKIL;TOB2;ADM;QKI;CELF1;AGFG1;BRD2
19627,GO:1990776,0.00164932176398832,0.99986655370954,4,16,response to angiotensin,BP,PTGS2;NFKB1;NFE2L2;RELA
4675,GO:0010822,0.00167135830762301,0.999488345669547,12,140,positive regulation of mitochondrion organization,BP,PLAUR;PPIF;PMAIP1;UGCG;BBC3;USP36;PLAGL2;TP53BP2;NRG1;YWHAH;YWHAG;SFN
2245,GO:0005154,0.00167646780415977,0.999798854301074,5,26,epidermal growth factor receptor binding,MF,HBEGF;TGFA;EREG;ITGA5;AREG
13871,GO:0060485,0.00168308492763238,0.99942895440903,14,163,mesenchyme development,BP,IL1B;EFNA1;EDN1;SEMA7A;BMP2;PHLDB2;ZFP36L1;SMAD3;EFNB1;JAG1;SOX9;NRG1;CORO1C;WNT5A
2745,GO:0006139,0.00168612933335544,0.998797624731349,179,4605,nucleobase-containing compound metabolic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;BTG2;NFKBID;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;PPIF;KLF6;ZC3H12C;ZNF697;BHLHE40;PTGS2;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;HAS3;IRAK2;KLF7;CREB5;EHF;EPHA2;RELB;GADD45A;MAFF;LIF;TRIB1;SQSTM1;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;NMNAT2;RGMB;TJP2;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;ZFP36L1;ADRB2;CEBPB;ARNTL2;RUNX1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;DUSP1;BCL10;TRAF1;PPP1R10;NABP1;DLX2;TXNRD1;VGLL3;CYLD;ADAM8;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;IL23A;PLK3;DIEXF;PIM1;TFRC;CREB1;HIVEP2;PPARD;SLC25A25;CCDC85B;USP36;IL16;ZFP36;SLC9A1;MAFK;PNRC1;ELL2;JAG1;PLAGL2;RIPK2;CLK4;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;POLR3A;ZNF460;FOXN2;UHRF1;PANK3;MXD1;SOX4;FOSL2;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;HIVEP1;NFKBIB;KLF10;AEN;SKIL;IL7R;RBM3;IER5;YRDC;SAMD4A;PTPN1;TFE3;PRPF19;TOB2;ADM;MAFG;MTF1;QKI;CELF1;PMM2;WNT5A;NUP153;INSIG1;PDPK1;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;RELA;BACH1;BTAF1;GINS3;POLR3D;TDG;ELF4;CREG1;ERN1;UPP1;ISG20;ATXN7;BRD2;PABPC4;AHCY;FUBP3
17637,GO:1901360,0.00169684759316892,0.998787597814176,187,4854,organic cyclic compound metabolic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;BTG2;NFKBID;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;PPIF;KLF6;ZC3H12C;ZNF697;BHLHE40;PTGS2;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;HAS3;IRAK2;KLF7;CREB5;EHF;EPHA2;RELB;GADD45A;MAFF;LIF;TRIB1;SQSTM1;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;NMNAT2;RGMB;TJP2;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;ZFP36L1;ADRB2;CEBPB;ARNTL2;RUNX1;CDKN2B;NAB1;HMGCS1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;HAL;DUSP1;BCL10;TRAF1;PPP1R10;NABP1;DLX2;TXNRD1;VGLL3;CYLD;ADAM8;LDLR;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;IL23A;PLK3;DIEXF;PIM1;TFRC;CREB1;HIVEP2;PPARD;SLC25A25;CCDC85B;USP36;IL16;ZFP36;SLC9A1;MAFK;CYP27B1;PNRC1;ELL2;JAG1;PLAGL2;RIPK2;CLK4;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;POLR3A;ZNF460;FOXN2;UHRF1;PANK3;MXD1;GCH1;SOX4;FOSL2;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;HIVEP1;NFKBIB;KLF10;AEN;SKIL;IL7R;RBM3;IER5;YRDC;SAMD4A;PTPN1;SQLE;TFE3;PRPF19;TOB2;ADM;MAFG;MTF1;QKI;CELF1;PMM2;WNT5A;NUP153;MAOA;INSIG1;PDPK1;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;RELA;BACH1;BTAF1;GINS3;POLR3D;ALAS1;TDG;ELF4;CREG1;ERN1;UPP1;ISG20;ATXN7;BRD2;PABPC4;AHCY;FUBP3
3332,GO:0007044,0.00171423280873626,0.999586003036991,9,75,cell-substrate junction assembly,BP,SDC4;PHLDB2;SMAD3;ITGA5;SLC9A1;PIP5K1A;CORO1C;PDPK1;LAMB3
19739,GO:2000106,0.00172143265812794,0.999674194371235,7,55,regulation of leukocyte apoptotic process,BP,NFKBID;EFNA1;HCAR2;CD274;BCL10;ADAM8;WNT5A
11354,GO:0045687,0.00172511293067097,0.999790619945003,5,27,positive regulation of glial cell differentiation,BP,LIF;BMP2;IL6ST;PRPF19;RELA
11664,GO:0046427,0.00172672569739909,0.999727399724315,6,42,positive regulation of JAK-STAT cascade,BP,CSF2;LIF;IL24;IL6ST;IL23A;SOCS3
11075,GO:0045076,0.00174436192001691,0.999927561803343,3,8,regulation of interleukin-2 biosynthetic process,BP,IL1B;IL1A;ZFP36
5461,GO:0016338,0.00175353908433275,0.999923656934933,3,9,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,CLDN1;BMP2;CLDN4
18585,GO:1903829,0.00176470252460919,0.999263118355444,20,288,positive regulation of cellular protein localization,BP,IL1B;ZC3H12A;TNF;PTGS2;PMAIP1;EPHA2;LIF;SQSTM1;UGCG;CYLD;BBC3;PLK3;USP36;PLAGL2;TP53BP2;NRG1;PDPK1;YWHAH;YWHAG;SFN
5666,GO:0016773,0.00176635363075347,0.99907315871648,35,582,phosphotransferase activity, alcohol group as acceptor,MF,HBEGF;CSF2;ITPKC;NUAK2;IRAK2;EPHA2;SQSTM1;CAB39;MAP2K3;CDKN1A;MAST4;EREG;PELI1;PIM3;OXSR1;PLK2;PLK3;PIM1;STK40;RIPK2;PHKG2;PIP5K1A;CLK4;SOX9;NRG1;PTPN11;MAP3K8;PANK3;CDK6;ABL2;PDPK1;SGK1;ANKK1;ERN1;ETNK1
1965,GO:0004672,0.00180347754197733,0.999102767451708,30,475,protein kinase activity,MF,HBEGF;CSF2;NUAK2;IRAK2;EPHA2;SQSTM1;CAB39;MAP2K3;CDKN1A;MAST4;EREG;PELI1;PIM3;OXSR1;PLK2;PLK3;PIM1;STK40;RIPK2;PHKG2;CLK4;SOX9;NRG1;MAP3K8;CDK6;ABL2;PDPK1;SGK1;ANKK1;ERN1
8701,GO:0034340,0.00180348822921521,0.999603281106921,8,73,response to type I interferon,BP,IRF6;IRF1;IFNAR2;PTPN11;PTPN1;HLA-E;WNT5A;ISG20
17533,GO:1901028,0.00180800930056569,0.99971136536343,6,43,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,PMAIP1;BBC3;TP53BP2;YWHAH;YWHAG;SFN
6765,GO:0030198,0.00181914949811809,0.999301701469511,17,213,extracellular matrix organization,BP,ELF3;ETS1;TNF;NFKB2;HAS3;PHLDB2;BCL3;B4GALT1;ADAM8;SMAD3;ITGA5;ITGAV;SOX9;FERMT1;ADAMTS9;ERO1A;LAMB3
15302,GO:0071495,0.00182622306674266,0.998943498280954,48,909,cellular response to endogenous stimulus,BP,IL1B;INHBA;TNF;CXCL8;PTGS2;NFKB1;EDN1;ERRFI1;CLDN1;CPEB2;BMP2;JUN;RGMB;JUNB;ZFP36L1;ADRB2;CEBPB;RUNX1;CDKN2B;HMGCS1;EHD1;DUSP1;KLF3;SMAD3;CREB1;PPARD;SOCS3;ZFP36;SLC9A1;RIPK2;SOX9;ZNF451;PML;FERMT1;PTPN11;FAM83G;HDAC9;KLF10;SKIL;PTPN1;ATP6V1C2;WNT5A;ADAM9;PDPK1;NFE2L2;YWHAH;RELA;YWHAG
11695,GO:0046483,0.00183847572128222,0.99868443821713,182,4707,heterocycle metabolic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;BTG2;NFKBID;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;PPIF;KLF6;ZC3H12C;ZNF697;BHLHE40;PTGS2;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;HAS3;IRAK2;KLF7;CREB5;EHF;EPHA2;RELB;GADD45A;MAFF;LIF;TRIB1;SQSTM1;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;NMNAT2;RGMB;TJP2;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;ZFP36L1;ADRB2;CEBPB;ARNTL2;RUNX1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;HAL;DUSP1;BCL10;TRAF1;PPP1R10;NABP1;DLX2;TXNRD1;VGLL3;CYLD;ADAM8;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;IL23A;PLK3;DIEXF;PIM1;TFRC;CREB1;HIVEP2;PPARD;SLC25A25;CCDC85B;USP36;IL16;ZFP36;SLC9A1;MAFK;PNRC1;ELL2;JAG1;PLAGL2;RIPK2;CLK4;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;POLR3A;ZNF460;FOXN2;UHRF1;PANK3;MXD1;GCH1;SOX4;FOSL2;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;HIVEP1;NFKBIB;KLF10;AEN;SKIL;IL7R;RBM3;IER5;YRDC;SAMD4A;PTPN1;TFE3;PRPF19;TOB2;ADM;MAFG;MTF1;QKI;CELF1;PMM2;WNT5A;NUP153;INSIG1;PDPK1;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;RELA;BACH1;BTAF1;GINS3;POLR3D;ALAS1;TDG;ELF4;CREG1;ERN1;UPP1;ISG20;ATXN7;BRD2;PABPC4;AHCY;FUBP3
12962,GO:0051341,0.00183962514519046,0.999647708845856,7,55,regulation of oxidoreductase activity,BP,IL1B;TNF;NFKB1;EDN1;CYP27B1;GCH1;ABL2
3437,GO:0007229,0.00186420522895278,0.999591922893047,8,62,integrin-mediated signaling pathway,BP,SEMA7A;NEDD9;ITGA5;ITGAV;FERMT1;PTPN11;ADAMTS1;ADAM9
4865,GO:0014706,0.00187071005514314,0.999279498740346,17,218,striated muscle tissue development,BP,BTG2;TBX3;KDM6B;EDN1;EFNB2;MAFF;BMP2;SMAD3;PIM1;CREB1;SLC9A1;NRG1;FOXN2;HDAC9;WNT5A;ADAMTS9;PDLIM5
7198,GO:0031086,0.00188622378339233,0.999919469527055,3,8,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,ZFP36L1;ZFP36;PNRC1
4332,GO:0009880,0.00188962242922903,0.999700699496122,6,36,embryonic pattern specification,BP,TBX3;SMAD3;EFNB1;NRARP;WNT5A;KDM6A
4062,GO:0009110,0.00189915383658092,0.999838304902964,4,17,vitamin biosynthetic process,BP,IL1B;TNF;NFKB1;CYP27B1
12359,GO:0048738,0.00190060234484652,0.999411492229405,12,126,cardiac muscle tissue development,BP,TBX3;KDM6B;EDN1;EFNB2;BMP2;PIM1;CREB1;SLC9A1;NRG1;WNT5A;ADAMTS9;PDLIM5
5440,GO:0016301,0.00190457522271732,0.998977295121711,37,635,kinase activity,MF,HBEGF;CSF2;ITPKC;NUAK2;IRAK2;EPHA2;SQSTM1;CAB39;MAP2K3;CDKN1A;TJP2;MAST4;EREG;PELI1;PIM3;SGMS2;OXSR1;PLK2;PLK3;PIM1;STK40;RIPK2;PHKG2;PIP5K1A;CLK4;SOX9;NRG1;PTPN11;MAP3K8;PANK3;CDK6;ABL2;PDPK1;SGK1;ANKK1;ERN1;ETNK1
7816,GO:0032368,0.00190699988225436,0.999632952923349,7,54,regulation of lipid transport,BP,NFKBIA;IL1B;NFKB1;EDN1;LIPG;ITGAV;PTPN11
8068,GO:0032735,0.00191728860411327,0.999834617948926,4,18,positive regulation of interleukin-12 production,BP,IRF1;IL23A;RIPK2;RELA
11344,GO:0045668,0.00191814204825145,0.999761438440306,5,27,negative regulation of osteoblast differentiation,BP,TNF;NOCT;SMAD3;AREG;CDK6
11625,GO:0046328,0.0019233721769913,0.999403014286058,12,129,regulation of JNK cascade,BP,IL1B;IL1A;TNF;EDN1;GADD45A;DUSP10;RIPK2;SPAG9;TRAF4;PTPN1;WNT5A;ERN1
3828,GO:0008426,0.00192883098474228,0.999983335198773,2,3,protein kinase C inhibitor activity,MF,YWHAG;SFN
15219,GO:0071375,0.00193585350298913,0.999251383369214,17,224,cellular response to peptide hormone stimulus,BP,IL1B;NFKB1;EDN1;ERRFI1;CPEB2;ZFP36L1;CREB1;SOCS3;SLC9A1;PTPN11;HDAC9;PTPN1;ATP6V1C2;PDPK1;NFE2L2;RELA;YWHAG
6930,GO:0030522,0.0019834857335982,0.999231259878228,17,223,intracellular receptor signaling pathway,BP,NFKBIA;TNFAIP3;BIRC3;IRAK2;BIRC2;RUNX1;TRIM16;CYLD;PIM1;PPARD;CYP27B1;RIPK2;PML;DCBLD2;YWHAH;RELA;IFIH1
13942,GO:0060603,0.00198882512031562,0.999753131538924,5,25,mammary gland duct morphogenesis,BP,TBX3;EPHA2;PML;AREG;WNT5A
17752,GO:1901699,0.00202954735340945,0.999007543345578,28,452,cellular response to nitrogen compound,BP,IL1B;ZC3H12A;TNF;PTGS2;NFKB1;EDN1;ERRFI1;CPEB2;ZFP36L1;ADRB2;CEBPB;KLF3;SMAD3;CREB1;SOCS3;SLC9A1;RIPK2;SOX9;PTPN11;HDAC9;KLF10;PTPN1;ATP6V1C2;PDPK1;NFE2L2;RELA;YWHAG;IFIH1
3577,GO:0007623,0.00206728825925316,0.999351745835239,12,134,circadian rhythm,BP,CSF2;BHLHE40;NOCT;RELB;JUN;CLDN4;NAMPT;ARNTL2;CREB1;PML;KLF10;AHCY
12260,GO:0048545,0.00209063492584935,0.999136076796532,19,270,response to steroid hormone,BP,TNF;PTGS2;FOSL1;EDN1;ERRFI1;IL1RN;CLDN1;CDKN1A;CLDN4;ZFP36L1;RUNX1;DUSP1;PPARD;ZFP36;AREG;ADM;ADAM9;YWHAH;RELA
13475,GO:0055007,0.00209419340412179,0.99953142255013,8,65,cardiac muscle cell differentiation,BP,TBX3;KDM6B;EDN1;EFNB2;BMP2;SLC9A1;NRG1;PDLIM5
984,GO:0002439,0.00211426877219892,0.999980851399593,2,3,chronic inflammatory response to antigenic stimulus,BP,TNF;AHCY
4897,GO:0014823,0.00212336014303594,0.999652170255603,6,40,response to activity,BP,KDM6B;EDN1;CREB1;PPARD;SLC25A25;OXCT1
12807,GO:0051098,0.00214570446538201,0.999110265857835,19,283,regulation of binding,BP,NFKBIA;PLAUR;TICAM1;LIF;BMP2;PHLDA2;JUN;BCL3;ADRB2;CYLD;SMAD3;PLK2;RIPK2;NRG1;SPAG9;TRAF4;WNT5A;BTAF1;TDG
3291,GO:0006984,0.00215254565443717,0.999646422814863,6,40,ER-nucleus signaling pathway,BP,CXCL8;PPP1R15A;PPP1R15B;PTPN1;INSIG1;NFE2L2
10047,GO:0042509,0.00216154372120876,0.999641719861331,6,44,regulation of tyrosine phosphorylation of STAT protein,BP,CSF2;LIF;IL24;IL6ST;IL23A;SOCS3
149,GO:0000303,0.00217236384809573,0.999802663715108,4,20,response to superoxide,BP,TNF;SOD2;GCH1;NFE2L2
8471,GO:0033613,0.00218924074215729,0.999568146355025,7,54,activating transcription factor binding,MF,BHLHE40;TBX3;JUN;SMAD3;CREB1;NFE2L2;RELA
15386,GO:0071636,0.00218974726357287,0.999901420116341,3,8,positive regulation of transforming growth factor beta production,BP,PTGS2;SMAD3;CREB1
10330,GO:0043123,0.00219412441113108,0.999305668958719,12,141,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,IL1A;BIRC3;TICAM1;TNF;REL;TNFRSF10B;BIRC2;PELI1;BCL10;PLK2;RIPK2;RELA
3390,GO:0007169,0.00221360962666944,0.998882369089976,30,497,transmembrane receptor protein tyrosine kinase signaling pathway,BP,IL1B;PLAUR;HBEGF;EFNA1;TGFA;ERRFI1;EFNB2;EPHA2;BMP2;CSRNP1;ADRB2;EREG;NEDD9;VEGFC;ITGA5;EFNB1;F3;SOCS3;ITGAV;SOX9;NRG1;PTPN11;AREG;PTPN1;ABL2;ATP6V1C2;WNT5A;PDPK1;RELA;ATXN7
3453,GO:0007267,0.00221390862620465,0.99871301101062,47,906,cell-cell signaling,BP,IL1B;IL36G;INHBA;TNF;CCL20;PTGS2;NFKB1;TBX3;EFNA1;EDN1;IL1RN;PANX1;HCAR2;EFNB2;CXCL5;LIF;SQSTM1;BMP2;NAMPT;ADRB2;RUNX1;EREG;PIM3;CYLD;SMAD3;PLK2;WISP1;CREB1;EFNB1;PPARD;AMOTL2;NRARP;SOX9;STX1A;FERMT1;PTPN11;SOX4;OXCT1;AREG;KLF10;ADM;ATP6V1C2;WNT5A;KDM6A;YWHAH;YWHAG;SMPD3
17799,GO:1901888,0.00221436914001819,0.999500038204137,8,65,regulation of cell junction assembly,BP,SDC4;TNF;CLDN1;PHLDB2;RUNX1;SMAD3;SLC9A1;CORO1C
14954,GO:0070849,0.00224531509127972,0.999628917660593,6,39,response to epidermal growth factor,BP,ERRFI1;ZFP36L1;ZFP36;SOX9;PTPN11;PDPK1
10518,GO:0043433,0.00224632418208209,0.999331002477376,11,120,negative regulation of DNA binding transcription factor activity,BP,NFKBIA;TNFAIP3;ZC3H12A;NFKBID;BHLHE40;IRAK2;TRIB1;NFKBIE;PELI1;CYLD;PIM1
5272,GO:0015918,0.00224766777749901,0.999553946806483,7,55,sterol transport,BP,NFKBIA;NFKB1;LDLR;LIPG;STARD5;ABCA5;STX12
12681,GO:0050886,0.00225138662684953,0.999626839172613,6,40,endocrine process,BP,IL1B;INHBA;TBX3;EDN1;HCAR2;PTPN11
3254,GO:0006919,0.00226374695256359,0.999481962816175,8,77,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,TNF;PMAIP1;TNFRSF10B;SMAD3;BBC3;F3;PML;TNFRSF10A
12534,GO:0050679,0.00227897198237553,0.999320010912096,11,120,positive regulation of epithelial cell proliferation,BP,TNFAIP3;TGFA;BMP2;JUN;B4GALT1;VEGFC;F3;NRARP;SOX9;WNT5A;PDPK1
11337,GO:0045661,0.0022829501277314,0.999701830914972,5,29,regulation of myoblast differentiation,BP,TNF;TBX3;ZFP36L1;PPARD;SOX9
11113,GO:0045136,0.00229617476247092,0.999890003387959,3,9,development of secondary sexual characteristics,BP,B4GALT1;AREG;WNT5A
11880,GO:0046887,0.00231098974280344,0.999472193035186,8,70,positive regulation of hormone secretion,BP,INHBA;EDN1;HCAR2;CREB1;PPARD;PTPN11;SOX4;OXCT1
14230,GO:0061180,0.00235783048076594,0.999529318420845,7,53,mammary gland epithelium development,BP,TBX3;IRF6;EPHA2;CEBPB;PML;AREG;WNT5A
4355,GO:0009948,0.00238764213159135,0.999686201901066,5,28,anterior/posterior axis specification,BP,TBX3;ETS2;NRARP;WNT5A;KDM6A
695,GO:0001913,0.00241141825314759,0.999774509382522,4,20,T cell mediated cytotoxicity,BP,IL23A;IL7R;HLA-E;CTSC
12958,GO:0051336,0.00242186725409513,0.998593168003859,46,896,regulation of hydrolase activity,BP,PLAUR;BIRC3;TNF;SERPINB2;PPIF;CCL20;PTGS2;PMAIP1;PLEKHF1;EFNA1;ERRFI1;CPEB2;TNFRSF10B;EPHA2;BMP2;JUN;BIRC2;PPP1R15A;ANKLE2;TFPI2;BCL10;FGD6;PPP1R10;SMAD3;BBC3;SERPINB8;F3;SERPINB1;RIPK2;PPP1R15B;PIP5K1A;PML;RASA2;CDC42EP1;UHRF1;PTPN1;CORO1C;ABL2;WNT5A;PDPK1;TNFRSF10A;AGFG1;TDG;SFN;ERN1;SH3RF2
6554,GO:0021983,0.00242283710858311,0.999779288775725,4,17,pituitary gland development,BP,ETS1;BMP2;CREB1;WNT5A
3497,GO:0007399,0.00246504104871109,0.998416602657416,71,1468,nervous system development,BP,ZC3H12A;CXCL1;BTG2;INHBA;SDC4;ETS1;PRDM1;TBX3;EFNA1;KDM6B;SEMA7A;CLDN1;KLF7;EFNB2;LIF;KCTD11;BMP2;N4BP3;JUN;ZFP36L1;ENC1;CEBPB;RUNX1;NAB1;HMGCS1;ALDH1A3;EHD1;ZSWIM4;ANKLE2;BCL10;IL6ST;B3GNT5;DLX2;LDLR;VEGFC;NEDD4L;DUSP10;PLK2;CREB1;EFNB1;PPARD;RAPH1;MAFK;JAG1;NAV3;NDRG1;SOX9;NRG1;PTPN11;SPAG9;SOX4;VCL;OXCT1;AREG;HDAC9;SKIL;CDK6;PRPF19;ADM;ABL2;QKI;WNT5A;KDM6A;NFE2L2;YWHAH;SGK1;B3GNT2;RELA;YWHAG;ITM2B;PDLIM5
15197,GO:0071346,0.00248533428770426,0.999300671979444,10,110,cellular response to interferon-gamma,BP,CCL20;IRF6;EDN1;CLDN1;IFNGR2;IRF1;SOCS3;PML;HLA-E;WNT5A
10053,GO:0042536,0.00250238633584017,0.999975283610765,2,3,negative regulation of tumor necrosis factor biosynthetic process,BP,ERRFI1;BCL3
8507,GO:0033687,0.00250867270338874,0.999769240499915,4,17,osteoblast proliferation,BP,BMP2;JUNB;SMAD3;ITGAV
11435,GO:0045861,0.00251044471890523,0.999068435091053,15,210,negative regulation of proteolysis,BP,PLAUR;BIRC3;SERPINB2;PTGS2;EFNA1;TNFRSF10B;BIRC2;N4BP1;TFPI2;SERPINB8;SERPINB1;CD55;PML;TNFRSF10A;SFN
7487,GO:0031650,0.00251403954041307,0.999875616342744,3,9,regulation of heat generation,BP,IL1B;TNF;PTGS2
3482,GO:0007346,0.00252739921825648,0.998681422949559,32,578,regulation of mitotic cell cycle,BP,IL1B;IL1A;BTG2;TNF;TGFA;EDN1;GADD45A;MAP2K3;CDKN1A;OVOL1;ZFP36L1;CDKN2B;EREG;DUSP1;DCUN1D3;PPP1R10;PIM3;NABP1;CYLD;OXSR1;SMAD3;PLK2;PLK3;PIM1;PML;PTPN11;MAP3K8;SOX4;CDK6;BTG3;YWHAG;SFN
568,GO:0001707,0.00253628997127503,0.999570409733305,6,39,mesoderm formation,BP,INHBA;KDM6B;TXNRD1;SMAD3;WNT5A;KDM6A
20293,GO:2001267,0.00253758279717576,0.999759322053265,4,20,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,PLAUR;TNFRSF10B;SMAD3;TNFRSF10A
3943,GO:0008630,0.00253804738070572,0.999342529645652,9,94,intrinsic apoptotic signaling pathway in response to DNA damage,BP,TNF;EPHA2;CDKN1A;BCL3;BCL2L2;PML;AEN;SKIL;SFN
10722,GO:0044057,0.00253995751586787,0.998960383796814,18,249,regulation of system process,BP,IL1B;ZC3H12A;HBEGF;INHBA;PTGS2;EDN1;ERRFI1;HCAR2;ADRB2;IL6ST;SMAD3;SLC9A1;NRG1;PTPN11;GCH1;TMEM65;ADM;SGK1
8969,GO:0035051,0.00255079149721579,0.999343181139237,9,82,cardiocyte differentiation,BP,TBX3;KDM6B;EDN1;EFNB2;BMP2;SLC9A1;JAG1;NRG1;PDLIM5
15604,GO:0072091,0.00257931031097576,0.999560613055234,6,40,regulation of stem cell proliferation,BP,TBX3;KCTD11;OVOL1;ZFP36L1;VEGFC;FERMT1
15907,GO:0072679,0.00258536591530821,0.9999740311947,2,3,thymocyte migration,BP,CCL20;ADAM8
8474,GO:0033619,0.00260577264605965,0.999468991846686,7,55,membrane protein proteolysis,BP,IL1B;TNF;NFKB1;ADAM8;JAG1;ADAM9;RELA
11473,GO:0045930,0.00260997056095293,0.998926471678965,18,275,negative regulation of mitotic cell cycle,BP,BTG2;TNF;GADD45A;CDKN1A;OVOL1;ZFP36L1;CDKN2B;DUSP1;DCUN1D3;PPP1R10;NABP1;SMAD3;PLK2;PLK3;PML;SOX4;BTG3;SFN
4829,GO:0014032,0.0026146493100533,0.999467549327455,7,54,neural crest cell development,BP,EDN1;SEMA7A;EFNB1;JAG1;SOX9;NRG1;CORO1C
770,GO:0002020,0.00262040897730254,0.999319694432404,9,89,protease binding,MF,TNFAIP3;TNF;PANX1;BCL10;LDLR;F3;RIPK2;ITGAV;TNFRSF10A
10016,GO:0042446,0.00263461549837129,0.999544763985851,6,45,hormone biosynthetic process,BP,IL1B;TNF;NFKB1;BMP2;CYP27B1;ADM
4467,GO:0010460,0.00264552698457078,0.999862143112993,3,10,positive regulation of heart rate,BP,EDN1;GCH1;ADM
6822,GO:0030279,0.00265886904377317,0.999543265675136,6,41,negative regulation of ossification,BP,TNF;NOCT;SMAD3;SOX9;AREG;CDK6
18353,GO:1903322,0.00265948250092749,0.999245466992372,10,107,positive regulation of protein modification by small protein conjugation or removal,BP,ZC3H12A;BIRC3;TICAM1;TNIP1;BIRC2;ADRB2;PELI1;BCL10;DCUN1D3;RIPK2
4626,GO:0010745,0.0026882323099405,0.999863781252829,3,9,negative regulation of macrophage derived foam cell differentiation,BP,NFKBIA;ITGAV;ABCA5
12828,GO:0051130,0.00269408336913265,0.998417204280092,47,909,positive regulation of cellular component organization,BP,IL1B;IL1A;PLAUR;CSF2;SDC4;TNF;PPIF;PMAIP1;FOSL1;TGFA;EDN1;SEMA7A;HAS3;CLDN1;LIF;JUN;PHLDB2;ENC1;ADRB2;UGCG;PPP1R15A;EREG;EHD1;PPP1R10;LDLR;NEDD4L;SMAD3;BBC3;CREB1;USP36;PLAGL2;NAV3;ITGAV;TP53BP2;SOX9;NRG1;PML;CDC42EP1;SKIL;CORO1C;ABL2;WNT5A;ADAM9;NFE2L2;YWHAH;YWHAG;SFN
11400,GO:0045787,0.00272172458713369,0.998818255163046,20,303,positive regulation of cell cycle,BP,IL1B;IL1A;BTG2;FOSL1;TBX3;TGFA;EDN1;GADD45A;CDKN1A;OVOL1;EREG;PPP1R10;PLK2;PLK3;PML;PTPN11;SOX4;CCNL1;WNT5A;SFN
16248,GO:0090304,0.00275010371989668,0.998018360643544,164,4171,nucleic acid metabolic process,BP,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;BTG2;NFKBID;CSF2;INHBA;TICAM1;ELF3;ETS1;TNF;REL;KLF6;ZC3H12C;ZNF697;BHLHE40;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;EFNA1;TGFA;KDM6B;IRF6;EDN1;HAS3;IRAK2;KLF7;CREB5;EHF;RELB;GADD45A;MAFF;LIF;TRIB1;SQSTM1;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;RGMB;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ADRB2;CEBPB;ARNTL2;RUNX1;CDKN2B;NAB1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;DUSP1;BCL10;TRAF1;PPP1R10;NABP1;DLX2;VGLL3;CYLD;ADAM8;KLF3;ZNF217;NEDD4L;SMAD3;RC3H1;IL23A;PLK3;DIEXF;PIM1;TFRC;CREB1;HIVEP2;PPARD;CCDC85B;USP36;IL16;ZFP36;SLC9A1;MAFK;PNRC1;ELL2;JAG1;PLAGL2;RIPK2;CLK4;NRARP;SOX9;NRG1;ZNF451;PML;POU2F2;NCOA7;ELK3;POLR3A;ZNF460;FOXN2;UHRF1;MXD1;SOX4;FOSL2;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;HIVEP1;NFKBIB;KLF10;AEN;SKIL;IL7R;RBM3;IER5;YRDC;SAMD4A;TFE3;PRPF19;TOB2;MAFG;MTF1;QKI;CELF1;WNT5A;INSIG1;PDPK1;ZBTB21;NFE2L2;YWHAH;SGK1;TSC22D2;RELA;BACH1;BTAF1;GINS3;POLR3D;TDG;ELF4;CREG1;ERN1;ISG20;ATXN7;BRD2;PABPC4;FUBP3
18615,GO:1903897,0.00276333355119012,0.999858590975003,3,9,regulation of PERK-mediated unfolded protein response,BP,PPP1R15A;PPP1R15B;PTPN1
1255,GO:0003007,0.0027667699537441,0.999052449270649,13,150,heart morphogenesis,BP,TBX3;EFNA1;BMP2;JUN;SMAD3;PIM1;JAG1;SOX9;NRG1;SOX4;ADAMTS1;WNT5A;KDM6A
8023,GO:0032655,0.00277145144160924,0.999618541917386,5,31,regulation of interleukin-12 production,BP,NFKB1;IRF1;IL23A;RIPK2;RELA
11234,GO:0045408,0.00279708463864938,0.999856241573954,3,9,regulation of interleukin-6 biosynthetic process,BP,IL1B;CEBPB;EREG
8200,GO:0032945,0.00280131276503785,0.999511711113817,6,43,negative regulation of mononuclear cell proliferation,BP,SDC4;PRDM1;CD274;CEBPB;PELI1;RC3H1
12531,GO:0050672,0.00280131276503785,0.999511711113817,6,43,negative regulation of lymphocyte proliferation,BP,SDC4;PRDM1;CD274;CEBPB;PELI1;RC3H1
2113,GO:0004896,0.00282658270830211,0.999506409532345,6,43,cytokine receptor activity,MF,IFNGR2;IL6ST;F3;IFNAR2;IL7R;OSMR
17581,GO:1901203,0.00283870026057311,0.999859793922509,3,8,positive regulation of extracellular matrix assembly,BP,PHLDB2;SMAD3;SOX9
8014,GO:0032642,0.002842345494329,0.999501277801982,6,45,regulation of chemokine production,BP,IL1B;IL1A;TICAM1;TNF;RIPK2;WNT5A
13997,GO:0060708,0.00285500354148739,0.99996981736995,2,3,spongiotrophoblast differentiation,BP,LIF;SOCS3
3448,GO:0007260,0.00285800839438972,0.999497118957957,6,46,tyrosine phosphorylation of STAT protein,BP,CSF2;LIF;IL24;IL6ST;IL23A;SOCS3
13832,GO:0060426,0.002871363538226,0.999969554752165,2,3,lung vasculature development,BP,ERRFI1;LIF
18347,GO:1903313,0.00293694505785823,0.999387691483994,7,56,positive regulation of mRNA metabolic process,BP,ZC3H12A;BTG2;ZFP36L1;RC3H1;ZFP36;PRPF19;QKI
9267,GO:0035690,0.0029784034294477,0.998796436779862,17,242,cellular response to drug,BP,TNFAIP3;IL1B;ZC3H12A;ETS1;TNF;PPIF;PTGS2;NFKB1;KDM6B;EDN1;ERRFI1;TFRC;RIPK2;SOX9;RHOB;NFE2L2;RELA
10092,GO:0042594,0.00298320197917078,0.999019938485672,12,140,response to starvation,BP,ZC3H12A;NUAK2;PMAIP1;PLEKHF1;JUN;CDKN1A;ZFP36;OXCT1;KLF10;ADM;NFE2L2;UPP1
15270,GO:0071453,0.00300066025545469,0.998957938674406,13,172,cellular response to oxygen levels,BP,PTGS2;PMAIP1;EDN1;CPEB2;ZFP36L1;ADAM8;PLK3;PPARD;SLC9A1;NDRG1;ERO1A;NFE2L2;BACH1
18232,GO:1903035,0.00300506729479055,0.999370133954945,7,57,negative regulation of response to wounding,BP,PLAUR;PLAU;SERPINB2;EDN1;PHLDB2;SMAD3;DUSP10
12735,GO:0050995,0.00301074463492059,0.999835701648689,3,10,negative regulation of lipid catabolic process,BP,IL1B;TNF;HCAR2
10477,GO:0043370,0.00301284412724168,0.999702603786049,4,19,regulation of CD4-positive, alpha-beta T cell differentiation,BP,CD83;RC3H1;IL23A;RIPK2
337,GO:0000932,0.00302016906154932,0.99927716956394,8,74,P-body,CC,ZC3H12A;NOCT;SQSTM1;ZFP36L1;RC3H1;ZFP36;PNRC1;SAMD4A
4767,GO:0010950,0.003034576766651,0.999055979380298,11,135,positive regulation of endopeptidase activity,BP,TNF;PMAIP1;EFNA1;TNFRSF10B;BCL10;SMAD3;BBC3;F3;RIPK2;PML;TNFRSF10A
11779,GO:0046637,0.00303913269909559,0.999574100431996,5,30,regulation of alpha-beta T cell differentiation,BP,PRDM1;CD83;RC3H1;IL23A;RIPK2
7363,GO:0031404,0.00303980598156233,0.999966805730721,2,3,chloride ion binding,MF,CTSC;TDG
19804,GO:2000241,0.00304339834204504,0.999270163751812,8,75,regulation of reproductive process,BP,INHBA;LIF;PHLDA2;OVOL1;B4GALT1;DUSP1;SOX9;WNT5A
8598,GO:0034105,0.00305080839650609,0.999697798122901,4,19,positive regulation of tissue remodeling,BP,B4GALT1;ADAM8;IL23A;TFRC
12668,GO:0050869,0.00305194521591534,0.999700370384629,4,18,negative regulation of B cell activation,BP,TNFAIP3;INHBA;PRDM1;RC3H1
1464,GO:0003712,0.00307646558026049,0.998469142895156,27,457,transcription cofactor activity,MF,NFKBIZ;NFKBID;ELF3;BHLHE40;NFKB2;KLF7;RELB;JUN;BIRC2;SERTAD2;JUNB;TAF4B;BCL10;CREB1;PPARD;NRG1;ZNF451;NCOA7;ELK3;MXD1;SOX4;HDAC9;NFKBIB;TOB2;MTF1;TDG;CREG1
4768,GO:0010951,0.00308014480071285,0.999039927479298,11,135,negative regulation of endopeptidase activity,BP,PLAUR;BIRC3;SERPINB2;PTGS2;TNFRSF10B;BIRC2;TFPI2;SERPINB8;SERPINB1;TNFRSF10A;SFN
982,GO:0002437,0.00309072074482889,0.999688059421664,4,21,inflammatory response to antigenic stimulus,BP,IL1B;TNF;KDM6B;AHCY
712,GO:0001935,0.00309227360576379,0.999176937627512,9,89,endothelial cell proliferation,BP,TNF;BMP2;JUN;VEGFC;F3;NRARP;WNT5A;PDPK1;ERN1
12776,GO:0051048,0.00313150573324534,0.999090310809936,10,109,negative regulation of secretion,BP,IL1B;ZC3H12A;INHBA;TNF;EDN1;LIF;PIM3;NRG1;PML;PTPN11
10546,GO:0043496,0.00313189153120866,0.99968497524513,4,20,regulation of protein homodimerization activity,BP,TICAM1;NRG1;SPAG9;TRAF4
12771,GO:0051043,0.00314359187677438,0.999685981069435,4,19,regulation of membrane protein ectodomain proteolysis,BP,IL1B;TNF;ADAM8;ADAM9
1156,GO:0002762,0.00315468162200699,0.999555718012235,5,29,negative regulation of myeloid leukocyte differentiation,BP,INHBA;TRIB1;TJP2;CDK6;TOB2
11882,GO:0046889,0.00316854074497461,0.999432658040302,6,44,positive regulation of lipid biosynthetic process,BP,IL1B;TNF;PTGS2;LDLR;CREB1;SMPD3
14088,GO:0060907,0.00318252817533163,0.999964413174028,2,3,positive regulation of macrophage cytokine production,BP,SEMA7A;WNT5A
3447,GO:0007259,0.00320941369251156,0.999139170659332,9,93,JAK-STAT cascade,BP,CSF2;LIF;IL24;BCL3;IL6ST;IL23A;SOCS3;IFNAR2;PTPN1
7998,GO:0032615,0.00322698082577461,0.999538250139858,5,32,interleukin-12 production,BP,NFKB1;IRF1;IL23A;RIPK2;RELA
8144,GO:0032869,0.00323166067308432,0.998870884009806,13,158,cellular response to insulin stimulus,BP,IL1B;ERRFI1;CPEB2;ZFP36L1;SOCS3;SLC9A1;PTPN11;HDAC9;PTPN1;ATP6V1C2;PDPK1;RELA;YWHAG
15105,GO:0071158,0.00325650454795174,0.999208700316539,8,78,positive regulation of cell cycle arrest,BP,BTG2;GADD45A;CDKN1A;PLK2;PLK3;PML;SOX4;SFN
4773,GO:0010957,0.00326811609172307,0.999962951088061,2,3,negative regulation of vitamin D biosynthetic process,BP,NFKB1;CYP27B1
11583,GO:0046137,0.00326811609172307,0.999962951088061,2,3,negative regulation of vitamin metabolic process,BP,NFKB1;CYP27B1
1179,GO:0002824,0.00329080322673527,0.999404149122735,6,46,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,IL1B;TNF;IL23A;TFRC;RIPK2;HLA-E
4828,GO:0014031,0.00330910241944809,0.999295019527667,7,56,mesenchymal cell development,BP,EDN1;SEMA7A;EFNB1;JAG1;SOX9;NRG1;CORO1C
20277,GO:2001239,0.0033161560775832,0.999519622698293,5,34,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,IL1B;IL1A;CSF2;INHBA;TNF
15540,GO:0071944,0.00332662578926893,0.997648266026541,123,2890,cell periphery,CC,NFKBIA;PLAUR;HBEGF;PLAU;SDC4;TNF;SERPINB2;SPRR2D;PTGS2;FOSL1;TRPV3;EFNA1;TGFA;SEMA7A;HAS3;ERRFI1;IL1RN;IRAK2;CLDN1;PANX1;DAPP1;SPRR2A;HCAR2;TNFRSF10B;EFNB2;EPHA2;CD83;IFNGR2;RRAD;BMP2;RAP2B;BIRC2;RGMB;PHLDB2;CLDN4;TJP2;CD274;BCL3;ETS2;RELT;RND3;ADRB2;GJB4;TRIM16;EREG;ALDH1A3;EHD1;NEDD9;B4GALT1;BCL10;DCUN1D3;CDV3;IL6ST;SGMS2;VMP1;SLC6A14;CYLD;ADAM8;LDLR;HCAR3;TACSTD2;NEDD4L;SMAD3;PIM1;ITGA5;TFRC;EFNB1;GJB3;F3;RAET1L;IL16;BDKRB1;RAPH1;SLC9A1;CD55;IFNAR2;ANTXR2;JAG1;AMOTL2;NDRG1;ITGAV;PIP5K1A;STX1A;NRG1;RASA2;FERMT1;SLC7A2;CDC42EP1;SLC28A3;DCBLD2;RHOB;TRAF4;VCL;IL7R;EMP3;PTPN1;TMEM65;CORO1C;STEAP4;ABL2;HLA-E;OSMR;WNT5A;ADAM9;LCE1C;PDPK1;TNFRSF10A;FRMD6;NFE2L2;YWHAH;SGK1;CYTH1;TDG;RAB22A;ITM2B;ETNK1;ATP13A3;MYO1B;CXCL16;PDLIM5;GPR156;RAB24;SMPD3
11239,GO:0045416,0.00333004198467861,0.999961880622468,2,3,positive regulation of interleukin-8 biosynthetic process,BP,TNF;BCL10
12422,GO:0048871,0.00335707049719913,0.998716939376618,15,199,multicellular organismal homeostasis,BP,TNFAIP3;IL1B;IL1A;TNF;PTGS2;IL1RN;CLDN1;CLDN4;AMPD3;ADRB2;ADAM8;TFRC;SOX9;PTPN11;SFN
4471,GO:0010466,0.00337406256923548,0.998935084894152,11,137,negative regulation of peptidase activity,BP,PLAUR;BIRC3;SERPINB2;PTGS2;TNFRSF10B;BIRC2;TFPI2;SERPINB8;SERPINB1;TNFRSF10A;SFN
6824,GO:0030282,0.00338495018816585,0.999276775827727,7,55,bone mineralization,BP,PTGS2;BMP2;ADRB2;SMAD3;CYP27B1;SOX9;KLF10
11083,GO:0045084,0.00341464928142947,0.999960401168334,2,3,positive regulation of interleukin-12 biosynthetic process,BP,IRF1;RELA
17853,GO:1902041,0.00343316634896836,0.999374037323978,6,45,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,TNFAIP3;PMAIP1;TNFRSF10B;FEM1B;SKIL;TNFRSF10A
1903,GO:0004586,0.00344302024472928,0.999959900731654,2,3,ornithine decarboxylase activity,MF,ODC1;AZIN1
8412,GO:0033387,0.00344302024472928,0.999959900731654,2,3,putrescine biosynthetic process from ornithine,BP,ODC1;AZIN1
12416,GO:0048864,0.00345446894598011,0.999257390144437,7,57,stem cell development,BP,EDN1;SEMA7A;EFNB1;JAG1;SOX9;NRG1;CORO1C
12179,GO:0048305,0.00350809737536544,0.999792459953044,3,11,immunoglobulin secretion,BP,TNF;POU2F2;HLA-E
10479,GO:0043372,0.00351198773371959,0.999792147252756,3,11,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,CD83;IL23A;RIPK2
8603,GO:0034113,0.00351266300659708,0.999490724806762,5,30,heterotypic cell-cell adhesion,BP,IL1B;TNF;IL1RN;ITGA5;ITGAV
17527,GO:1901017,0.00352901350412176,0.999802864305341,3,9,negative regulation of potassium ion transmembrane transporter activity,BP,CAB39;NEDD4L;OXSR1
17646,GO:1901380,0.00352901350412176,0.999802864305341,3,9,negative regulation of potassium ion transmembrane transport,BP,CAB39;NEDD4L;OXSR1
15130,GO:0071224,0.00359397518015665,0.999957201811785,2,3,cellular response to peptidoglycan,BP,RIPK2;RELA
13173,GO:0051767,0.00360847897509102,0.999789882188013,3,10,nitric-oxide synthase biosynthetic process,BP,CCL20;EDN1;NAMPT
13174,GO:0051769,0.00360847897509102,0.999789882188013,3,10,regulation of nitric-oxide synthase biosynthetic process,BP,CCL20;EDN1;NAMPT
6762,GO:0030193,0.0036248152591667,0.999330593737644,6,46,regulation of blood coagulation,BP,PLAUR;PLAU;SERPINB2;EDN1;F3;NFE2L2
17356,GO:1900046,0.0036248152591667,0.999330593737644,6,46,regulation of hemostasis,BP,PLAUR;PLAU;SERPINB2;EDN1;F3;NFE2L2
16562,GO:0097345,0.00363387910739933,0.999325487993111,6,49,mitochondrial outer membrane permeabilization,BP,PMAIP1;BBC3;TP53BP2;YWHAH;YWHAG;SFN
531,GO:0001649,0.00364374447874054,0.998772445759926,12,141,osteoblast differentiation,BP,TNF;NOCT;SEMA7A;EPHA2;BMP2;JUNB;CEBPB;IL6ST;SMAD3;JAG1;AREG;CDK6
13183,GO:0051785,0.00364446131231622,0.999327351927807,6,45,positive regulation of nuclear division,BP,IL1B;IL1A;TGFA;EDN1;EREG;WNT5A
715,GO:0001938,0.00367966770440205,0.999197178538263,7,60,positive regulation of endothelial cell proliferation,BP,BMP2;JUN;VEGFC;F3;NRARP;WNT5A;PDPK1
38,GO:0000077,0.00378056982710563,0.998718640985807,12,147,DNA damage checkpoint,BP,BTG2;GADD45A;CDKN1A;PPP1R10;PLK2;PLK3;PML;PTPN11;FEM1B;SOX4;PRPF19;SFN
8698,GO:0034333,0.00379484093756276,0.999060589716397,8,69,adherens junction assembly,BP,SDC4;PHLDB2;SMAD3;SLC9A1;PIP5K1A;VCL;CORO1C;PDPK1
12595,GO:0050768,0.00384230857646735,0.998567383719297,14,178,negative regulation of neurogenesis,BP,EFNA1;SEMA7A;EFNB2;KCTD11;DLX2;LDLR;DUSP10;PLK2;JAG1;SOX9;NRG1;PRPF19;WNT5A;YWHAH
4949,GO:0014916,0.00384265827867508,0.999952625008731,2,3,regulation of lung blood pressure,BP,SMAD3;GCH1
665,GO:0001866,0.00385609446371489,0.999932935274479,2,4,NK T cell proliferation,BP,IL23A;ELF4
7339,GO:0031348,0.00385697475941148,0.998844047794018,10,114,negative regulation of defense response,BP,TNFAIP3;ZC3H12A;ETS1;NFKB1;SMAD3;DUSP10;PPARD;SOCS3;SAA1;HLA-E
20205,GO:2001056,0.00387405974306573,0.998836311978265,10,119,positive regulation of cysteine-type endopeptidase activity,BP,TNF;PMAIP1;TNFRSF10B;BCL10;SMAD3;BBC3;F3;RIPK2;PML;TNFRSF10A
17557,GO:1901099,0.00390172952123316,0.999576893082992,4,22,negative regulation of signal transduction in absence of ligand,BP,IL1B;IL1A;CSF2;TNF
20278,GO:2001240,0.00390172952123316,0.999576893082992,4,22,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,IL1B;IL1A;CSF2;TNF
20032,GO:2000647,0.0039126760447379,0.99976544193687,3,10,negative regulation of stem cell proliferation,BP,KCTD11;OVOL1;FERMT1
12338,GO:0048699,0.00391592259461756,0.997627662357996,49,943,generation of neurons,BP,BTG2;INHBA;SDC4;PRDM1;EFNA1;SEMA7A;KLF7;EFNB2;LIF;KCTD11;BMP2;JUN;ENC1;CEBPB;RUNX1;EHD1;ZSWIM4;IL6ST;DLX2;LDLR;VEGFC;NEDD4L;DUSP10;PLK2;CREB1;EFNB1;RAPH1;JAG1;SOX9;NRG1;PTPN11;SPAG9;SOX4;VCL;AREG;HDAC9;SKIL;CDK6;PRPF19;ADM;ABL2;WNT5A;NFE2L2;YWHAH;SGK1;B3GNT2;RELA;YWHAG;PDLIM5
2969,GO:0006508,0.00392777047398751,0.997524554805711,58,1252,proteolysis,BP,NFKBIA;TNFAIP3;IL1B;ZC3H12A;PLAUR;BIRC3;PLAU;TNF;SERPINB2;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;EFNA1;TNFRSF10B;TRIB1;SQSTM1;MAP2K3;BIRC2;ENC1;ADRB2;N4BP1;TFPI2;BCL10;CYLD;ADAM8;NEDD4L;SMAD3;PLK2;BBC3;PLK3;SERPINB8;F3;SERPINB1;USP36;CD55;JAG1;RIPK2;USP53;PML;UHRF1;USP31;TNFAIP1;ADAMTS1;PRPF19;ADAM9;TNFRSF10A;ADAMTS9;RNF19A;CTSC;NFE2L2;RELA;RNF11;SFN;ATXN7;IFIH1;ADAMTS6
12287,GO:0048609,0.00392914107691536,0.998008414784715,27,459,multicellular organismal reproductive process,BP,BIRC3;INHBA;ETS1;PTGS2;PRDM1;FOSL1;EDN1;LIF;JUNB;OVOL1;TAF4B;BCL2L2;EREG;B4GALT1;GJB3;PPARD;CYP27B1;SOX9;PTPN11;SPAG9;ADAMTS1;SKIL;TOB2;QKI;CELF1;AGFG1;BRD2
15603,GO:0072089,0.00394742573284387,0.999014772679143,8,71,stem cell proliferation,BP,TBX3;KCTD11;OVOL1;ZFP36L1;RUNX1;VEGFC;FERMT1;WNT5A
7125,GO:0030947,0.00395708389417405,0.99957825778505,4,19,regulation of vascular endothelial growth factor receptor signaling pathway,BP,IL1B;VEGFC;ITGA5;PTPN1
14728,GO:0070384,0.00395810771356159,0.999950446153998,2,3,Harderian gland development,BP,ALDH1A3;SOX9
8171,GO:0032907,0.00397211112536808,0.999950179571446,2,3,transforming growth factor beta3 production,BP,SMAD3;CREB1
8174,GO:0032910,0.00397211112536808,0.999950179571446,2,3,regulation of transforming growth factor beta3 production,BP,SMAD3;CREB1
3180,GO:0006801,0.00398557314925006,0.999394025592554,5,36,superoxide metabolic process,BP,TNF;EDN1;SOD2;GCH1;NFE2L2
19905,GO:2000389,0.00399351193113953,0.999949771209548,2,3,regulation of neutrophil extravasation,BP,IL1A;ADAM8
19906,GO:2000391,0.00399351193113953,0.999949771209548,2,3,positive regulation of neutrophil extravasation,BP,IL1A;ADAM8
3042,GO:0006596,0.00399470776814269,0.999747208729875,3,12,polyamine biosynthetic process,BP,ODC1;AZIN1;SAT1
4523,GO:0010575,0.00405396691972481,0.999564966239271,4,19,positive regulation of vascular endothelial growth factor production,BP,IL1B;IL1A;PTGS2;IL6ST
4830,GO:0014033,0.00406911539020335,0.999097654733006,7,58,neural crest cell differentiation,BP,EDN1;SEMA7A;EFNB1;JAG1;SOX9;NRG1;CORO1C
19285,GO:1905477,0.00409180409471229,0.998860601152014,9,94,positive regulation of protein localization to membrane,BP,PMAIP1;EPHA2;SQSTM1;BBC3;TP53BP2;PDPK1;YWHAH;YWHAG;SFN
4663,GO:0010810,0.00409530498129855,0.998600614895169,12,139,regulation of cell-substrate adhesion,BP,PLAU;SDC4;PHLDB2;VEGFC;TACSTD2;SMAD3;ITGA5;SLC9A1;JAG1;FERMT1;CDK6;CORO1C
785,GO:0002040,0.00412370808312277,0.998962444284587,8,72,sprouting angiogenesis,BP,PTGS2;EFNB2;PLK2;ITGA5;NRARP;HDAC9;PDPK1;ADAMTS9
10599,GO:0043569,0.00413121713543401,0.999947116122901,2,3,negative regulation of insulin-like growth factor receptor signaling pathway,BP,BMP2;ATXN7
12967,GO:0051346,0.00413524659915558,0.998222264771074,18,277,negative regulation of hydrolase activity,BP,PLAUR;BIRC3;TNF;SERPINB2;PPIF;PTGS2;PLEKHF1;CPEB2;TNFRSF10B;BIRC2;PPP1R15A;TFPI2;PPP1R10;SERPINB8;SERPINB1;TNFRSF10A;SFN;SH3RF2
7988,GO:0032602,0.00413686819367657,0.999210353709311,6,50,chemokine production,BP,IL1B;IL1A;TICAM1;TNF;RIPK2;WNT5A
8022,GO:0032653,0.00414545697440228,0.999542709643143,4,22,regulation of interleukin-10 production,BP,CD83;CD274;BCL3;IL23A
3518,GO:0007492,0.00416016851839724,0.999074755154588,7,57,endoderm development,BP,INHBA;ZFP36L1;DUSP1;SMAD3;ITGA5;ITGAV;LAMB3
3355,GO:0007093,0.00416283362676322,0.998569751292454,12,154,mitotic cell cycle checkpoint,BP,BTG2;GADD45A;CDKN1A;CDKN2B;DUSP1;PPP1R10;NABP1;PLK2;PLK3;PML;SOX4;SFN
9712,GO:0038127,0.00417762524323523,0.998647927868512,11,125,ERBB signaling pathway,BP,PLAUR;HBEGF;TGFA;ERRFI1;EREG;SOX9;NRG1;PTPN11;AREG;ABL2;PDPK1
19048,GO:1904892,0.00422123592629228,0.998927234998013,8,81,regulation of STAT cascade,BP,CSF2;LIF;IL24;BCL3;IL6ST;IL23A;SOCS3;IL7R
18510,GO:1903670,0.00422695569543537,0.999197134738773,6,44,regulation of sprouting angiogenesis,BP,PTGS2;PLK2;ITGA5;HDAC9;PDPK1;ADAMTS9
13639,GO:0060135,0.00423095215290604,0.999196219115558,6,44,maternal process involved in female pregnancy,BP,PTGS2;PRDM1;LIF;JUNB;PPARD;CYP27B1
18154,GO:1902895,0.00424537666051432,0.999538435248042,4,19,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,BMP2;JUN;SMAD3;RELA
2129,GO:0004924,0.00425587072220907,0.999944672132733,2,3,oncostatin-M receptor activity,MF,IL6ST;OSMR
9724,GO:0038165,0.00425587072220907,0.999944672132733,2,3,oncostatin-M-mediated signaling pathway,BP,IL6ST;OSMR
6653,GO:0023061,0.00428091063095812,0.998206171580103,17,243,signal release,BP,IL1B;INHBA;TNF;TBX3;EDN1;IL1RN;HCAR2;LIF;PIM3;CREB1;PPARD;STX1A;PTPN11;SOX4;OXCT1;ADM;SMPD3
13996,GO:0060707,0.00428206641905896,0.999734814208538,3,10,trophoblast giant cell differentiation,BP,PRDM1;LIF;SOCS3
1037,GO:0002544,0.00431354289013248,0.999719390002836,3,12,chronic inflammatory response,BP,TNFAIP3;TNF;AHCY
16471,GO:0097154,0.00431901366281242,0.999920348199464,2,4,GABAergic neuron differentiation,BP,INHBA;DLX2
9848,GO:0042094,0.00432590028724466,0.999724060934449,3,11,interleukin-2 biosynthetic process,BP,IL1B;IL1A;ZFP36
3393,GO:0007173,0.00434041976705909,0.998679931782749,10,108,epidermal growth factor receptor signaling pathway,BP,PLAUR;HBEGF;TGFA;ERRFI1;EREG;SOX9;PTPN11;AREG;ABL2;PDPK1
7930,GO:0032504,0.00440936810708954,0.997744904958278,27,464,multicellular organism reproduction,BP,BIRC3;INHBA;ETS1;PTGS2;PRDM1;FOSL1;EDN1;LIF;JUNB;OVOL1;TAF4B;BCL2L2;EREG;B4GALT1;GJB3;PPARD;CYP27B1;SOX9;PTPN11;SPAG9;ADAMTS1;SKIL;TOB2;QKI;CELF1;AGFG1;BRD2
5824,GO:0017091,0.00441126484458349,0.999507868254982,4,21,AU-rich element binding,MF,ZC3H12A;CPEB2;ZFP36L1;ZFP36
10749,GO:0044130,0.00442429983468952,0.999917382531482,2,4,negative regulation of growth of symbiont in host,BP,TNF;SQSTM1
10752,GO:0044146,0.00442429983468952,0.999917382531482,2,4,negative regulation of growth of symbiont involved in interaction with host,BP,TNF;SQSTM1
12279,GO:0048589,0.00443553300568942,0.997796224323958,25,396,developmental growth,BP,EDN1;SEMA7A;PHLDA2;ZFP36L1;ADRB2;EREG;NEDD4L;SMAD3;DUSP10;PIM1;CREB1;STK40;PPARD;SLC25A25;RAPH1;SOX9;NRG1;PTPN11;VCL;AREG;PRPF19;ADM;WNT5A;KDM6A;PDLIM5
16560,GO:0097343,0.00446775141700717,0.999940430999954,2,3,ripoptosome assembly,BP,BIRC2;CYLD
17532,GO:1901026,0.00446775141700717,0.999940430999954,2,3,ripoptosome assembly involved in necroptotic process,BP,BIRC2;CYLD
7498,GO:0031668,0.00447900941621406,0.99829787351204,14,188,cellular response to extracellular stimulus,BP,ZC3H12A;NUAK2;PTGS2;PMAIP1;FOSL1;PLEKHF1;JUN;CDKN1A;CDKN2B;PIM1;CYP27B1;KLF10;NFE2L2;UPP1
17877,GO:1902110,0.00448150897659858,0.999129207014627,6,51,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,PMAIP1;BBC3;TP53BP2;YWHAH;YWHAG;SFN
11936,GO:0046982,0.00448251334328644,0.997958470481745,20,352,protein heterodimerization activity,MF,INHBA;BHLHE40;NFKB1;IRAK2;PANX1;GADD45A;BMP2;JUN;TAF4B;BCL2L2;CEBPB;TMCC1;SMAD3;PPARD;SOX9;STX1A;SOX4;MAFG;YWHAH;RELA
19711,GO:2000045,0.0044968331698451,0.998525796037065,11,136,regulation of G1/S transition of mitotic cell cycle,BP,BTG2;GADD45A;CDKN1A;CDKN2B;DCUN1D3;PLK2;PLK3;PML;SOX4;CDK6;SFN
10882,GO:0044421,0.00450333673364447,0.996863711343684,99,2509,extracellular region part,CC,TNFAIP3;CXCL2;IL1B;IL1A;CXCL1;PLAUR;CXCL3;BTG2;IL36G;HBEGF;PLAU;CSF2;INHBA;SDC4;TNF;CXCL8;SERPINB2;CCL20;EFNA1;TGFA;IRF6;EDN1;SEMA7A;HAS3;IL1RN;CREB5;CXCL5;LIF;SQSTM1;BMP2;IL24;CAB39;RAP2B;CD274;NAMPT;BCL2L2;RELT;RND3;EREG;SOD2;ALDH1A3;EHD1;B4GALT1;TFPI2;IL6ST;SLC6A14;TXNRD1;LDLR;VEGFC;TACSTD2;NEDD4L;OXSR1;IL23A;WISP1;TFRC;LIPG;SERPINB8;EFNB1;F3;KRT34;SLC25A25;SERPINB1;IL16;SLC9A1;CD55;SAA1;NDRG1;ITGAV;NRG1;RHOB;SPAG9;VCL;AREG;ADAMTS1;COTL1;STEAP4;ADM;ATP6V1C2;HLA-E;PMM2;WNT5A;ADAM9;ADAMTS9;CTSC;YWHAH;B3GNT2;RNF11;YWHAG;RAB22A;CREG1;SFN;ITM2B;TMEM132A;LAMB3;ADAMTS6;MYO1B;CXCL16;AHCY;STX12
10724,GO:0044060,0.00452209304702125,0.999495498415571,4,20,regulation of endocrine process,BP,IL1B;INHBA;HCAR2;PTPN11
13017,GO:0051447,0.00453981315568086,0.999712853792905,3,10,negative regulation of meiotic cell cycle,BP,LIF;OVOL1;DUSP1
10440,GO:0043296,0.00456151995061723,0.998605554322004,10,103,apical junction complex,CC,CLDN1;RAP2B;CLDN4;TJP2;TACSTD2;AMOTL2;USP53;TRAF4;FRMD6;CYTH1
5665,GO:0016772,0.00458304744929508,0.997322597560754,41,778,transferase activity, transferring phosphorus-containing groups,MF,HBEGF;CSF2;ITPKC;NUAK2;IRAK2;EPHA2;SQSTM1;CAB39;MAP2K3;CDKN1A;NMNAT2;TJP2;MAST4;EREG;PELI1;PIM3;SGMS2;OXSR1;PLK2;PLK3;PIM1;STK40;RIPK2;PHKG2;PIP5K1A;CLK4;SOX9;NRG1;POLR3A;PTPN11;MAP3K8;PANK3;CDK6;YRDC;ABL2;PDPK1;SGK1;ANKK1;POLR3D;ERN1;ETNK1
713,GO:0001936,0.00461369279815171,0.998812159894352,8,78,regulation of endothelial cell proliferation,BP,TNF;BMP2;JUN;VEGFC;F3;NRARP;WNT5A;PDPK1
7499,GO:0031669,0.0046319989435318,0.998307762666508,13,167,cellular response to nutrient levels,BP,ZC3H12A;NUAK2;PTGS2;PMAIP1;PLEKHF1;JUN;CDKN1A;CDKN2B;PIM1;CYP27B1;KLF10;NFE2L2;UPP1
4715,GO:0010876,0.00466965773380298,0.998085406090786,16,222,lipid localization,BP,NFKBIA;IL1B;ZC3H12A;INHBA;TNF;NFKB1;EDN1;EHD1;LDLR;LIPG;PPARD;STARD5;ITGAV;PTPN11;ABCA5;STX12
19398,GO:1905898,0.00468139320541028,0.999264366366988,5,34,positive regulation of response to endoplasmic reticulum stress,BP,PMAIP1;PPP1R15A;PTPN1;NFE2L2;ERN1
8675,GO:0034248,0.004691201833291,0.997690004828984,24,425,regulation of cellular amide metabolic process,BP,ZC3H12A;BTG2;TNF;EFNA1;CPEB2;BCL3;ZFP36L1;ENC1;PPP1R15A;SMAD3;RC3H1;PLK3;ZFP36;LARP4B;PPP1R15B;SOX4;EIF1;RBM3;SAMD4A;QKI;CELF1;NUP153;NFE2L2;SMPD3
8694,GO:0034329,0.0046960418029866,0.998209380286586,14,175,cell junction assembly,BP,SDC4;TNF;CLDN1;PHLDB2;RUNX1;VMP1;SMAD3;ITGA5;SLC9A1;PIP5K1A;VCL;CORO1C;PDPK1;LAMB3
98,GO:0000188,0.0046972380897566,0.999463179301908,4,22,inactivation of MAPK activity,BP,DUSP16;DUSP8;DUSP1;DUSP10
7660,GO:0032088,0.00473481228785254,0.998913877090988,7,64,negative regulation of NF-kappaB transcription factor activity,BP,NFKBIA;TNFAIP3;ZC3H12A;NFKBID;IRAK2;PELI1;CYLD
9379,GO:0035909,0.00477725902881885,0.999462899908258,4,19,aorta morphogenesis,BP,EFNB2;JAG1;SOX4;ADAMTS9
10133,GO:0042692,0.00480545696944137,0.998089225332947,15,203,muscle cell differentiation,BP,TBX3;KDM6B;EDN1;EFNB2;BMP2;EREG;EHD1;SLC9A1;SOX9;NRG1;SPAG9;HDAC9;ADM;QKI;PDLIM5
10981,GO:0044773,0.00483219344240661,0.99861647096066,9,99,mitotic DNA damage checkpoint,BP,BTG2;GADD45A;CDKN1A;PPP1R10;PLK2;PLK3;PML;SOX4;SFN
12634,GO:0050818,0.00483983336315439,0.999047095868881,6,49,regulation of coagulation,BP,PLAUR;PLAU;SERPINB2;EDN1;F3;NFE2L2
3542,GO:0007566,0.00495861021691528,0.999207983452981,5,35,embryo implantation,BP,IL1B;PTGS2;LIF;VMP1;PPARD
18447,GO:1903531,0.00497349303728844,0.998570259267282,9,98,negative regulation of secretion by cell,BP,IL1B;ZC3H12A;INHBA;TNF;EDN1;LIF;PIM3;PML;PTPN11
12653,GO:0050854,0.00497999854706379,0.999205841206591,5,34,regulation of antigen receptor-mediated signaling pathway,BP,RUNX1;BCL10;CYLD;RC3H1;RELA
18854,GO:1904467,0.00503393857717885,0.999669464623394,3,10,regulation of tumor necrosis factor secretion,BP,ZC3H12A;WNT5A;IFIH1
11271,GO:0045577,0.00503843039496474,0.999416269827293,4,21,regulation of B cell differentiation,BP,INHBA;PRDM1;ZFP36L1;CYLD
16737,GO:0097755,0.00505212441908913,0.999189446352218,5,35,positive regulation of blood vessel diameter,BP,ADRB2;SOD2;PPARD;GCH1;ADM
3776,GO:0008330,0.00505631623194885,0.999898810982519,2,4,protein tyrosine/threonine phosphatase activity,MF,DUSP1;DUSP10
1312,GO:0003158,0.00506644443861296,0.998677575237315,8,75,endothelium development,BP,IL1B;TNF;KDM6B;CLDN1;TJP2;JAG1;NRG1;RHOB
7321,GO:0031329,0.00508556947292307,0.997114963581524,36,691,regulation of cellular catabolic process,BP,TNFAIP3;IL1B;ZC3H12A;BTG2;TICAM1;TNF;RNF19B;NOCT;PLEKHF1;EFNA1;TRIB1;ZFP36L1;ADRB2;N4BP1;ADAM8;LDLR;RC3H1;PLK2;PLK3;USP36;ZFP36;RIPK2;PHKG2;PML;SAMD4A;PTPN1;ABL2;ATP6V1C2;QKI;NUP153;ADAM9;RNF19A;CTSC;NFE2L2;ERN1;PABPC4
907,GO:0002287,0.00509417493581016,0.999185517205907,5,33,alpha-beta T cell activation involved in immune response,BP,RELB;BCL3;RC3H1;IL23A;RIPK2
910,GO:0002293,0.00509417493581016,0.999185517205907,5,33,alpha-beta T cell differentiation involved in immune response,BP,RELB;BCL3;RC3H1;IL23A;RIPK2
911,GO:0002294,0.00509417493581016,0.999185517205907,5,33,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,RELB;BCL3;RC3H1;IL23A;RIPK2
9847,GO:0042093,0.00509417493581016,0.999185517205907,5,33,T-helper cell differentiation,BP,RELB;BCL3;RC3H1;IL23A;RIPK2
3940,GO:0008625,0.00514503389280722,0.998799435302847,7,66,extrinsic apoptotic signaling pathway via death domain receptors,BP,TNFAIP3;TNF;PMAIP1;TNFRSF10B;FEM1B;SKIL;TNFRSF10A
2615,GO:0005923,0.00515462791395776,0.998516296693686,9,89,bicellular tight junction,CC,CLDN1;RAP2B;CLDN4;TJP2;TACSTD2;AMOTL2;USP53;TRAF4;CYTH1
4026,GO:0009057,0.00518152954272828,0.996764993121113,52,1127,macromolecule catabolic process,BP,TNFAIP3;IL1B;ZC3H12A;BTG2;SDC4;TNF;RNF19B;PMAIP1;NOCT;EFNA1;ODC1;TRIB1;SQSTM1;BIRC2;ZFP36L1;ENC1;N4BP1;CYLD;ADAM8;LDLR;NEDD4L;SMAD3;RC3H1;PLK2;PLK3;USP36;ZFP36;SLC9A1;PNRC1;AZIN1;PHKG2;SOX9;NRG1;PML;UHRF1;USP31;TNFAIP1;SAMD4A;PTPN1;PRPF19;QKI;WNT5A;ADAM9;ADAMTS9;RNF19A;CTSC;NFE2L2;RELA;RNF11;ERN1;ISG20;PABPC4
3398,GO:0007179,0.00530252007342931,0.998225826076746,11,129,transforming growth factor beta receptor signaling pathway,BP,JUN;CDKN2B;SMAD3;CREB1;ZNF451;PML;FERMT1;KLF10;SKIL;ADAM9;PDPK1
7793,GO:0032332,0.00532912399690625,0.999642770140815,3,10,positive regulation of chondrocyte differentiation,BP,SMAD3;SOX9;RELA
7096,GO:0030890,0.00533373110296205,0.999364422746424,4,23,positive regulation of B cell proliferation,BP,TICAM1;CDKN1A;PELI1;TFRC
6779,GO:0030213,0.00533722876265253,0.999632683918595,3,11,hyaluronan biosynthetic process,BP,IL1B;NFKB1;HAS3
1151,GO:0002757,0.00533977412393221,0.997532028237025,20,326,immune response-activating signal transduction,BP,NFKBIA;TNFAIP3;ZC3H12A;BIRC3;TICAM1;TNIP1;NFKB1;IRAK2;RELB;BIRC2;IRF1;RUNX1;PELI1;BCL10;CYLD;RC3H1;RIPK2;PDPK1;RELA;IFIH1
16543,GO:0097296,0.00535968918084241,0.999622894810894,3,12,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,TNFRSF10B;SMAD3;TNFRSF10A
9995,GO:0042406,0.00536354639188825,0.999889322182864,2,4,extrinsic component of endoplasmic reticulum membrane,CC,ZC3H12A;PML
4659,GO:0010803,0.00536443777311397,0.998916736303762,6,52,regulation of tumor necrosis factor-mediated signaling pathway,BP,TNFAIP3;BIRC3;TNF;BIRC2;TRAF1;CYLD
4202,GO:0009309,0.00537581879473222,0.999614925955142,3,13,amine biosynthetic process,BP,ODC1;AZIN1;SAT1
9991,GO:0042401,0.00537581879473222,0.999614925955142,3,13,cellular biogenic amine biosynthetic process,BP,ODC1;AZIN1;SAT1
9943,GO:0042303,0.00538397357581683,0.998576464079766,8,79,molting cycle,BP,INHBA;TNF;PTGS2;TRPV3;SOX9;FERMT1;WNT5A;RELA
10114,GO:0042633,0.00538397357581683,0.998576464079766,8,79,hair cycle,BP,INHBA;TNF;PTGS2;TRPV3;SOX9;FERMT1;WNT5A;RELA
17376,GO:1900102,0.00541549132199226,0.999625324342903,3,11,negative regulation of endoplasmic reticulum unfolded protein response,BP,PPP1R15A;PPP1R15B;PTPN1
14639,GO:0070227,0.00545416744493823,0.998894809983703,6,52,lymphocyte apoptotic process,BP,NFKBID;EFNA1;CD274;BCL10;ADAM8;WNT5A
9842,GO:0042088,0.00547775298094871,0.999342283029498,4,23,T-helper 1 type immune response,BP,RELB;BCL3;IL23A;RIPK2
7072,GO:0030858,0.00551473618106889,0.999096515627729,5,35,positive regulation of epithelial cell differentiation,BP,LIF;TRIM16;CYP27B1;SOX9;SFN
2406,GO:0005576,0.00551754547968223,0.996082979184532,108,2791,extracellular region,CC,TNFAIP3;CXCL2;IL1B;IL1A;CXCL1;PLAUR;CXCL3;BTG2;IL36G;HBEGF;PLAU;CSF2;INHBA;SDC4;TNF;CXCL8;SERPINB2;CCL20;NFKB1;EFNA1;TGFA;IRF6;EDN1;SEMA7A;HAS3;IL1RN;CREB5;CXCL5;LIF;SQSTM1;BMP2;IL24;CAB39;RAP2B;CD274;NAMPT;AMPD3;BCL2L2;RELT;RND3;EREG;SOD2;ALDH1A3;EHD1;B4GALT1;TFPI2;IL6ST;SLC6A14;TXNRD1;LDLR;VEGFC;TACSTD2;NEDD4L;OXSR1;IL23A;WISP1;TFRC;LIPG;SERPINB8;EFNB1;F3;KRT34;SLC25A25;SERPINB1;RAET1L;IL16;SLC9A1;CD55;IFNAR2;ANTXR2;JAG1;SAA1;NDRG1;ITGAV;STX1A;NRG1;RHOB;SPAG9;VCL;AREG;ADAMTS1;COTL1;IL7R;STEAP4;ADM;ATP6V1C2;HLA-E;PMM2;WNT5A;ADAM9;ADAMTS9;CTSC;YWHAH;B3GNT2;RNF11;NOTCH2NL;YWHAG;RAB22A;CREG1;SFN;ITM2B;TMEM132A;LAMB3;ADAMTS6;MYO1B;CXCL16;AHCY;STX12
696,GO:0001914,0.00553280049808689,0.999599529438865,3,13,regulation of T cell mediated cytotoxicity,BP,IL23A;IL7R;HLA-E
3041,GO:0006595,0.00555822312085511,0.999591341370179,3,14,polyamine metabolic process,BP,ODC1;AZIN1;SAT1
6760,GO:0030183,0.0055690401804245,0.99851909242556,8,79,B cell differentiation,BP,INHBA;KLF6;PRDM1;BCL3;ZFP36L1;CYLD;POU2F2;HDAC9
11268,GO:0045569,0.00561850633222985,0.99988122665097,2,4,TRAIL binding,MF,TNFRSF10B;TNFRSF10A
12594,GO:0050767,0.00580409782754434,0.996894555136218,29,498,regulation of neurogenesis,BP,EFNA1;SEMA7A;EFNB2;LIF;KCTD11;BMP2;ENC1;ZSWIM4;IL6ST;DLX2;LDLR;VEGFC;NEDD4L;DUSP10;PLK2;CREB1;JAG1;SOX9;NRG1;SPAG9;SKIL;PRPF19;ABL2;WNT5A;NFE2L2;YWHAH;RELA;YWHAG;PDLIM5
1158,GO:0002764,0.00580532094837816,0.997239948176468,21,350,immune response-regulating signaling pathway,BP,NFKBIA;TNFAIP3;ZC3H12A;BIRC3;TICAM1;TNIP1;NFKB1;IRAK2;RELB;JUN;BIRC2;IRF1;RUNX1;PELI1;BCL10;CYLD;RC3H1;RIPK2;PDPK1;RELA;IFIH1
12752,GO:0051017,0.00582644085956116,0.998149742079843,10,110,actin filament bundle assembly,BP,SDC4;PHLDB2;RND3;NEDD9;TACSTD2;SMAD3;SLC9A1;RHOB;TNFAIP1;MYO1B
3662,GO:0008150,0.00583462491330538,0.997170753375205,381,11215,biological_process,BP,NFKBIA;NFKBIZ;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;CXCL3;BTG2;IL36G;BIRC3;HBEGF;PLAU;NFKBID;CSF2;ITPKC;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;CXCL8;REL;SERPINB2;PPIF;IER3;KLF6;NUAK2;CCL20;ZC3H12C;SPRR2D;ZNF697;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;TRPV3;NOCT;PLEKHF1;EFNA1;TGFA;KDM6B;IRF6;EDN1;ODC1;SEMA7A;PHLDA1;HAS3;ERRFI1;IL1RN;IRAK2;CLDN1;KLF7;PANX1;CREB5;DAPP1;CPEB2;EHF;SPRR2A;HCAR2;TNFRSF10B;EFNB2;EPHA2;RELB;GADD45A;CXCL5;MAFF;LIF;TRIB1;KCTD11;CD83;SQSTM1;IFNGR2;RRAD;BMP2;PHLDA2;IL24;CAB39;ZNF267;N4BP3;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;NMNAT2;RGMB;PHLDB2;CLDN4;TJP2;SERTAD2;CD274;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;BCL2L2;ZFP36L1;ENC1;RELT;RND3;ADRB2;CEBPB;DUSP16;ARNTL2;UGCG;PPP1R15A;MAST4;RUNX1;N4BP1;CDKN2B;GJB4;NAB1;HMGCS1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;ALDH1A3;EHD1;NEDD9;ZSWIM4;ANKLE2;DUSP8;B4GALT1;HAL;TFPI2;DUSP1;BCL10;FGD6;DCUN1D3;HEPHL1;TMCC1;TRAF1;PPP1R10;PIM3;TMEM265;CDV3;SACS;IL6ST;G0S2;B3GNT5;SGMS2;VMP1;NABP1;DLX2;SLC6A14;TXNRD1;VGLL3;CYLD;ADAM8;LDLR;VEGFC;KLF3;HCAR3;ZNF217;TACSTD2;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;SLC43A3;DUSP10;PLK2;BBC3;PLK3;DIEXF;PIM1;WISP1;ITGA5;TFRC;LIPG;KLHL21;CREB1;SERPINB8;EFNB1;GJB3;F3;STK40;HIVEP2;PPARD;KRT34;SLC25A25;SERPINB1;SOCS3;CCDC85B;KRTAP2-3;RAET1L;USP36;IL16;BDKRB1;RAPH1;ZFP36;SLC9A1;MAFK;LARP4B;CYP27B1;CD55;PNRC1;IFNAR2;ELL2;ANTXR2;AZIN1;JAG1;PLAGL2;RIPK2;AMOTL2;PHKG2;NAV3;SAA1;PPP1R15B;STARD5;USP53;NDRG1;ITGAV;PIP5K1A;CLK4;TP53BP2;NRARP;SOX9;STX1A;NRG1;ZNF451;FEM1C;PML;POU2F2;RASA2;PPTC7;FERMT1;NCOA7;ELK3;POLR3A;SLC7A2;ZNF460;CDC42EP1;SLC28A3;FOXN2;PTPN11;MAP3K8;UHRF1;PANK3;ARHGEF3;MXD1;DCBLD2;RHOB;SPAG9;ABCA5;GCH1;FEM1B;SOX4;USP31;FOSL2;TRAF4;VCL;EIF1;OXCT1;AREG;CCNL1;FAM83G;AKAP2;TNFAIP1;HDAC9;ADAMTS1;HIVEP1;NFKBIB;KLF10;AEN;TIFA;SKIL;COTL1;IL7R;DENND2C;HEXDC;RBM3;CDK6;IER5;YRDC;SAMD4A;EMP3;PTPN1;SQLE;TFE3;BTG3;TMEM65;CORO1C;STEAP4;PRPF19;TOB2;ADM;MAFG;ABL2;MTF1;ATP6V1C2;HLA-E;RAB3IP;OSMR;QKI;CELF1;PMM2;WNT5A;NUP153;MAOA;INSIG1;ADAM9;LCE1C;PDPK1;TNFRSF10A;ADAMTS9;RNF19A;CTSC;ERO1A;KDM6A;FRMD6;ZBTB21;SMTN;NFE2L2;YWHAH;SGK1;B3GNT2;TSC22D2;CYTH1;SAT1;RELA;AGFG1;RNF11;NOTCH2NL;BACH1;BTAF1;ANKK1;GINS3;POLR3D;ALAS1;YWHAG;TDG;ELF4;RAB22A;CREG1;SFN;ITM2B;ERN1;ETNK1;SH3RF2;UPP1;ISG20;TMEM132A;ATXN7;IFIH1;LAMB3;ATP13A3;ADAMTS6;MYO1B;BRD2;IPO4;CXCL16;PABPC4;TAP1;DSE;AHCY;STX12;PDLIM5;FUBP3;GPR156;RAB24;SMPD3
17875,GO:1902108,0.00590597078779461,0.998780366795182,6,54,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,PMAIP1;BBC3;TP53BP2;YWHAH;YWHAG;SFN
20246,GO:2001185,0.00592201361269393,0.999871334237271,2,4,regulation of CD8-positive, alpha-beta T cell activation,BP,IRF1;HLA-E
7997,GO:0032613,0.00592838172697405,0.999268196462152,4,24,interleukin-10 production,BP,CD83;CD274;BCL3;IL23A
13490,GO:0055024,0.00593141175251751,0.998785246948467,6,47,regulation of cardiac muscle tissue development,BP,EDN1;EFNB2;BMP2;PIM1;CREB1;NRG1
14597,GO:0070160,0.00593347398221889,0.998252423681874,9,91,occluding junction,CC,CLDN1;RAP2B;CLDN4;TJP2;TACSTD2;AMOTL2;USP53;TRAF4;CYTH1
6564,GO:0022008,0.00594025945102698,0.996282541027217,51,1015,neurogenesis,BP,BTG2;INHBA;SDC4;PRDM1;EFNA1;SEMA7A;KLF7;EFNB2;LIF;KCTD11;BMP2;JUN;ENC1;CEBPB;RUNX1;NAB1;EHD1;ZSWIM4;IL6ST;DLX2;LDLR;VEGFC;NEDD4L;DUSP10;PLK2;CREB1;EFNB1;RAPH1;JAG1;NDRG1;SOX9;NRG1;PTPN11;SPAG9;SOX4;VCL;AREG;HDAC9;SKIL;CDK6;PRPF19;ADM;ABL2;WNT5A;NFE2L2;YWHAH;SGK1;B3GNT2;RELA;YWHAG;PDLIM5
20083,GO:2000727,0.00596478802293157,0.999563710105213,3,12,positive regulation of cardiac muscle cell differentiation,BP,EDN1;EFNB2;NRG1
3279,GO:0006959,0.00598462446445988,0.998548614028788,7,82,humoral immune response,BP,TNF;CD83;BCL3;CD55;POU2F2;TFE3;HLA-E
3589,GO:0008015,0.00599165380195017,0.997399960270001,17,250,blood circulation,BP,ZC3H12A;HBEGF;PTGS2;EDN1;MAP2K3;ADRB2;SOD2;VEGFC;NEDD4L;SMAD3;PPARD;BDKRB1;SLC9A1;GCH1;TMEM65;ADM;SGK1
10285,GO:0043031,0.00600192392259917,0.999868684258185,2,4,negative regulation of macrophage activation,BP,ZC3H12A;LDLR
4522,GO:0010574,0.0060201429398077,0.999261547184122,4,22,regulation of vascular endothelial growth factor production,BP,IL1B;IL1A;PTGS2;IL6ST
14720,GO:0070373,0.00602343593936926,0.998758796853103,6,49,negative regulation of ERK1 and ERK2 cascade,BP,TNIP1;ERRFI1;LIF;DUSP1;DUSP10;PTPN1
9870,GO:0042130,0.00606164215037887,0.998981649029057,5,36,negative regulation of T cell proliferation,BP,SDC4;CD274;CEBPB;PELI1;RC3H1
2094,GO:0004857,0.00610387922160847,0.99750006551958,15,230,enzyme inhibitor activity,MF,BIRC3;SERPINB2;CPEB2;TRIB1;BIRC2;CDKN1A;CDKN2B;TFPI2;PPP1R10;SERPINB8;SERPINB1;SOCS3;YWHAG;SFN;SH3RF2
11871,GO:0046875,0.0061171657094396,0.999246199481026,4,22,ephrin receptor binding,MF,EFNA1;EFNB2;EFNB1;PTPN1
3048,GO:0006606,0.00613644510761538,0.998033175953084,10,115,protein import into nucleus,BP,NFKBIA;ZC3H12A;TNF;PTGS2;CDKN1A;BCL3;PPP1R10;PML;NUP153;IPO4
10284,GO:0043030,0.00617276453712625,0.999233078687909,4,23,regulation of macrophage activation,BP,ZC3H12A;LDLR;SLC7A2;WNT5A
14354,GO:0061572,0.00619436703497691,0.998014562645874,10,111,actin filament bundle organization,BP,SDC4;PHLDB2;RND3;NEDD9;TACSTD2;SMAD3;SLC9A1;RHOB;TNFAIP1;MYO1B
2433,GO:0005615,0.00621360253323747,0.995646668155599,94,2400,extracellular space,CC,TNFAIP3;CXCL2;IL1B;IL1A;CXCL1;PLAUR;CXCL3;BTG2;IL36G;HBEGF;PLAU;CSF2;INHBA;SDC4;TNF;CXCL8;SERPINB2;CCL20;EFNA1;TGFA;IRF6;EDN1;SEMA7A;IL1RN;CREB5;CXCL5;LIF;SQSTM1;BMP2;IL24;CAB39;RAP2B;CD274;NAMPT;BCL2L2;RELT;RND3;EREG;SOD2;ALDH1A3;EHD1;B4GALT1;IL6ST;SLC6A14;TXNRD1;LDLR;VEGFC;TACSTD2;NEDD4L;OXSR1;IL23A;WISP1;TFRC;LIPG;SERPINB8;EFNB1;F3;KRT34;SLC25A25;SERPINB1;IL16;SLC9A1;CD55;SAA1;NDRG1;ITGAV;NRG1;RHOB;SPAG9;VCL;AREG;COTL1;STEAP4;ADM;ATP6V1C2;HLA-E;PMM2;WNT5A;ADAM9;ADAMTS9;CTSC;YWHAH;B3GNT2;RNF11;YWHAG;RAB22A;CREG1;SFN;ITM2B;TMEM132A;MYO1B;CXCL16;AHCY;STX12
18431,GO:1903510,0.00621778839827369,0.998315349987078,8,79,mucopolysaccharide metabolic process,BP,IL1B;NFKB1;HAS3;B4GALT1;PIM1;SLC9A1;B3GNT2;DSE
6447,GO:0021761,0.00625039066721611,0.998490228717844,7,64,limbic system development,BP,BTG2;ETS1;TBX3;KDM6B;ALDH1A3;DLX2;CDK6
3333,GO:0007045,0.0062837447106909,0.998486368139039,7,60,cell-substrate adherens junction assembly,BP,SDC4;PHLDB2;SMAD3;SLC9A1;PIP5K1A;CORO1C;PDPK1
12087,GO:0048041,0.0062837447106909,0.998486368139039,7,60,focal adhesion assembly,BP,SDC4;PHLDB2;SMAD3;SLC9A1;PIP5K1A;CORO1C;PDPK1
8920,GO:0034763,0.00630671459371415,0.998471467938923,7,66,negative regulation of transmembrane transport,BP,IL1B;TNF;PPIF;RRAD;CAB39;NEDD4L;OXSR1
10434,GO:0043280,0.00632851373706603,0.998103233286778,9,109,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,TNF;PMAIP1;TNFRSF10B;BCL10;SMAD3;BBC3;F3;PML;TNFRSF10A
7783,GO:0032306,0.00637978845102849,0.99983307412463,2,5,regulation of prostaglandin secretion,BP,IL1B;EDN1
7784,GO:0032308,0.00637978845102849,0.99983307412463,2,5,positive regulation of prostaglandin secretion,BP,IL1B;EDN1
16179,GO:0090200,0.00638222134811948,0.999185046018174,4,27,positive regulation of release of cytochrome c from mitochondria,BP,PLAUR;PPIF;PMAIP1;BBC3
15509,GO:0071887,0.00641138049452432,0.998437638431778,7,69,leukocyte apoptotic process,BP,NFKBID;EFNA1;HCAR2;CD274;BCL10;ADAM8;WNT5A
8064,GO:0032730,0.00647895869638625,0.999829113432508,2,5,positive regulation of interleukin-1 alpha production,BP,CCL20;PANX1
7441,GO:0031570,0.00651465092433808,0.997628501641114,12,157,DNA integrity checkpoint,BP,BTG2;GADD45A;CDKN1A;PPP1R10;PLK2;PLK3;PML;PTPN11;FEM1B;SOX4;PRPF19;SFN
32,GO:0000060,0.00653313499926517,0.998879907097002,5,37,protein import into nucleus, translocation,BP,NFKBIA;TNF;CDKN1A;BCL3;IPO4
4796,GO:0010986,0.00654178992836326,0.999850296454807,2,4,positive regulation of lipoprotein particle clearance,BP,LDLR;LIPG
9063,GO:0035296,0.00654940652256429,0.998401366086981,7,66,regulation of tube diameter,BP,PTGS2;EDN1;ADRB2;SOD2;PPARD;GCH1;ADM
16732,GO:0097746,0.00654940652256429,0.998401366086981,7,66,regulation of blood vessel diameter,BP,PTGS2;EDN1;ADRB2;SOD2;PPARD;GCH1;ADM
1261,GO:0003013,0.0065616638969967,0.997125167392491,17,252,circulatory system process,BP,ZC3H12A;HBEGF;PTGS2;EDN1;MAP2K3;ADRB2;SOD2;VEGFC;NEDD4L;SMAD3;PPARD;BDKRB1;SLC9A1;GCH1;TMEM65;ADM;SGK1
7367,GO:0031410,0.00659435430155492,0.995567409908893,71,1603,cytoplasmic vesicle,CC,IL1B;CXCL1;PLAUR;HBEGF;PLAU;TICAM1;TNF;NFKB1;PLEKHF1;TGFA;EDN1;PHLDA1;IRAK2;SQSTM1;IFNGR2;CAB39;N4BP3;RAP2B;NMNAT2;AMPD3;RND3;ADRB2;DUSP16;EHD1;B4GALT1;ADAM8;LDLR;VEGFC;NEDD4L;ITGA5;TFRC;LIPG;SERPINB1;CD55;ANTXR2;AMOTL2;SAA1;NDRG1;ITGAV;STX1A;PML;RHOB;SPAG9;ABCA5;GCH1;VCL;AREG;TNFAIP1;ADAMTS1;SKIL;COTL1;IL7R;PTPN1;STEAP4;HLA-E;WNT5A;PDPK1;CTSC;YWHAH;AGFG1;RNF11;YWHAG;RAB22A;CREG1;SFN;ITM2B;MYO1B;TAP1;AHCY;STX12;RAB24
8143,GO:0032868,0.00660159380825059,0.997373973379016,14,193,response to insulin,BP,IL1B;ERRFI1;CPEB2;ZFP36L1;SOCS3;SLC9A1;PTPN11;HDAC9;PTPN1;ADM;ATP6V1C2;PDPK1;RELA;YWHAG
14682,GO:0070301,0.00666821049673939,0.998361835590631,7,70,cellular response to hydrogen peroxide,BP,TNFAIP3;ETS1;PPIF;KDM6B;RHOB;NFE2L2;RELA
11325,GO:0045649,0.00668236096383251,0.999490580693478,3,12,regulation of macrophage differentiation,BP,INHBA;LIF;TRIB1
11937,GO:0046983,0.00671654583834624,0.996003101223437,40,855,protein dimerization activity,MF,INHBA;BHLHE40;PTGS2;NFKB1;ODC1;IRAK2;PANX1;GADD45A;SQSTM1;BMP2;JUN;NAMPT;TAF4B;BCL2L2;ADRB2;CEBPB;ARNTL2;HMGCS1;ALDH1A3;TMCC1;IL6ST;SMAD3;TFRC;PPARD;RIPK2;SOX9;STX1A;PML;MXD1;GCH1;SOX4;OXCT1;TFE3;MAFG;ATP6V1C2;YWHAH;RELA;TDG;ERN1;TAP1
19626,GO:1990774,0.00673059901622872,0.999495976512356,3,11,tumor necrosis factor secretion,BP,ZC3H12A;WNT5A;IFIH1
909,GO:0002292,0.00676652430791024,0.998835544734633,5,35,T cell differentiation involved in immune response,BP,RELB;BCL3;RC3H1;IL23A;RIPK2
12655,GO:0050856,0.0068261147136458,0.999122604335494,4,24,regulation of T cell receptor signaling pathway,BP,BCL10;CYLD;RC3H1;RELA
16715,GO:0097708,0.00682794493055275,0.995402792950947,71,1605,intracellular vesicle,CC,IL1B;CXCL1;PLAUR;HBEGF;PLAU;TICAM1;TNF;NFKB1;PLEKHF1;TGFA;EDN1;PHLDA1;IRAK2;SQSTM1;IFNGR2;CAB39;N4BP3;RAP2B;NMNAT2;AMPD3;RND3;ADRB2;DUSP16;EHD1;B4GALT1;ADAM8;LDLR;VEGFC;NEDD4L;ITGA5;TFRC;LIPG;SERPINB1;CD55;ANTXR2;AMOTL2;SAA1;NDRG1;ITGAV;STX1A;PML;RHOB;SPAG9;ABCA5;GCH1;VCL;AREG;TNFAIP1;ADAMTS1;SKIL;COTL1;IL7R;PTPN1;STEAP4;HLA-E;WNT5A;PDPK1;CTSC;YWHAH;AGFG1;RNF11;YWHAG;RAB22A;CREG1;SFN;ITM2B;MYO1B;TAP1;AHCY;STX12;RAB24
7355,GO:0031396,0.00684052200921986,0.997491757170983,12,162,regulation of protein ubiquitination,BP,TNFAIP3;BIRC3;TICAM1;BIRC2;ADRB2;N4BP1;PELI1;BCL10;DCUN1D3;RIPK2;FEM1B;SOX4
6952,GO:0030578,0.00687479710085968,0.99983854228702,2,4,PML body organization,BP,ETS1;PML
10115,GO:0042634,0.00689897173652744,0.999115020931192,4,23,regulation of hair cycle,BP,TNF;TRPV3;FERMT1;WNT5A
9831,GO:0042056,0.00690279395841454,0.999450940465024,3,14,chemoattractant activity,MF,VEGFC;SAA1;WNT5A
8051,GO:0032703,0.00694018518545788,0.999463563163815,3,12,negative regulation of interleukin-2 production,BP,TNFAIP3;ZFP36;NAV3
8034,GO:0032677,0.00694647955442355,0.998786202364586,5,39,regulation of interleukin-8 production,BP,IL1B;TNF;BCL3;BCL10;WNT5A
9881,GO:0042149,0.00699699934562625,0.998783135578695,5,36,cellular response to glucose starvation,BP,ZC3H12A;NUAK2;PMAIP1;NFE2L2;UPP1
3568,GO:0007613,0.00701707920729115,0.998267769994431,7,64,memory,BP,PTGS2;CEBPB;LDLR;PLK2;ITGA5;CREB1;SGK1
4583,GO:0010667,0.00702279378328895,0.999454826120844,3,12,negative regulation of cardiac muscle cell apoptotic process,BP,PPP1R10;PDPK1;NFE2L2
11726,GO:0046533,0.00703419524390612,0.999832807287808,2,4,negative regulation of photoreceptor cell differentiation,BP,DLX2;SOX9
20081,GO:2000725,0.00703572068986658,0.999092361627011,4,23,regulation of cardiac muscle cell differentiation,BP,EDN1;EFNB2;BMP2;NRG1
12414,GO:0048861,0.00705184232773519,0.999832168081042,2,4,leukemia inhibitory factor signaling pathway,BP,LIF;IL6ST
9412,GO:0035976,0.00706666923499373,0.999804989401797,2,5,transcription factor AP-1 complex,CC,JUN;JUNB
889,GO:0002253,0.00707318998819992,0.996574898798891,21,357,activation of immune response,BP,NFKBIA;TNFAIP3;ZC3H12A;BIRC3;TICAM1;TNIP1;NFKB1;IRAK2;RELB;BIRC2;IRF1;RUNX1;PELI1;BCL10;CYLD;RC3H1;CD55;RIPK2;PDPK1;RELA;IFIH1
4521,GO:0010573,0.00710600198364902,0.999080664755749,4,23,vascular endothelial growth factor production,BP,IL1B;IL1A;PTGS2;IL6ST
13277,GO:0051961,0.00712879298478917,0.997139661033922,14,190,negative regulation of nervous system development,BP,EFNA1;SEMA7A;EFNB2;KCTD11;DLX2;LDLR;DUSP10;PLK2;JAG1;SOX9;NRG1;PRPF19;WNT5A;YWHAH
12937,GO:0051291,0.00718753925493422,0.997983705750981,8,100,protein heterooligomerization,BP,BIRC3;CLDN1;SQSTM1;CAB39;BIRC2;BCL10;TMCC1;GCH1
6789,GO:0030224,0.00719719467326427,0.999060697830466,4,24,monocyte differentiation,BP,CSF2;JUN;ZFP36L1;CDK6
18269,GO:1903131,0.00719719467326427,0.999060697830466,4,24,mononuclear cell differentiation,BP,CSF2;JUN;ZFP36L1;CDK6
5235,GO:0015850,0.00720746069427538,0.997801499224756,9,101,organic hydroxy compound transport,BP,NFKBIA;NFKB1;LDLR;LIPG;STARD5;STX1A;PTPN11;ABCA5;STX12
14029,GO:0060750,0.00722634380868089,0.999825801737868,2,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,AREG;WNT5A
10982,GO:0044774,0.00723229018914409,0.997789394832879,9,105,mitotic DNA integrity checkpoint,BP,BTG2;GADD45A;CDKN1A;PPP1R10;PLK2;PLK3;PML;SOX4;SFN
4769,GO:0010952,0.00723290806111345,0.997462129259108,11,151,positive regulation of peptidase activity,BP,TNF;PMAIP1;EFNA1;TNFRSF10B;BCL10;SMAD3;BBC3;F3;RIPK2;PML;TNFRSF10A
17579,GO:1901201,0.00723372953894476,0.999443820645567,3,11,regulation of extracellular matrix assembly,BP,PHLDB2;SMAD3;SOX9
14598,GO:0070161,0.00724332244074717,0.996195974521815,26,464,anchoring junction,CC,PLAUR;PLAU;SDC4;EFNB2;EPHA2;PHLDB2;TJP2;RND3;NEDD9;B4GALT1;ITGA5;SLC9A1;JAG1;NDRG1;ITGAV;PIP5K1A;FERMT1;CDC42EP1;RHOB;VCL;CORO1C;ADAM9;PDPK1;CYTH1;YWHAG;PDLIM5
10349,GO:0043154,0.00727056619638828,0.998183258274392,7,71,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,PLAUR;BIRC3;PTGS2;TNFRSF10B;BIRC2;TNFRSF10A;SFN
243,GO:0000578,0.00731566270461185,0.999050877081736,4,22,embryonic axis specification,BP,TBX3;NRARP;WNT5A;KDM6A
15238,GO:0071398,0.00735748689050237,0.998707917663857,5,35,cellular response to fatty acid,BP,ZC3H12A;EDN1;CLDN1;LDLR;CREB1
11353,GO:0045686,0.00743333709664422,0.999400927204493,3,13,negative regulation of glial cell differentiation,BP,DLX2;LDLR;DUSP10
4822,GO:0014015,0.00743855935161658,0.998684024961242,5,37,positive regulation of gliogenesis,BP,LIF;BMP2;IL6ST;PRPF19;RELA
4723,GO:0010884,0.00747327419951493,0.999406509215036,3,12,positive regulation of lipid storage,BP,ZC3H12A;NFKB1;EHD1
2641,GO:0005976,0.007480535016511,0.9979055245552,8,81,polysaccharide metabolic process,BP,NFKB1;HAS3;PHLDA2;IL6ST;B3GNT5;STK40;PHKG2;B3GNT2
11877,GO:0046884,0.00748946664565506,0.999816047023088,2,4,follicle-stimulating hormone secretion,BP,INHBA;TBX3
12830,GO:0051132,0.00754254747914094,0.999784658657164,2,5,NK T cell activation,BP,IL23A;ELF4
4727,GO:0010888,0.00757907793303904,0.999384827252088,3,13,negative regulation of lipid storage,BP,NFKBIA;TNF;ITGAV
15906,GO:0072678,0.00765730240412664,0.998977929032722,4,25,T cell migration,BP,CCL20;ADAM8;WNT5A;CXCL16
39,GO:0000079,0.00767104189937585,0.998062346631568,7,72,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,TNFAIP3;GADD45A;CDKN1A;CDKN2B;CCNL1;CDK6;SFN
681,GO:0001889,0.00770632963393134,0.997623329628603,9,102,liver development,BP,NFKBIA;TNFAIP3;CLDN1;JUN;CEBPB;HMGCS1;SMAD3;SOX9;RELA
4674,GO:0010821,0.00774283358497782,0.996977043012737,13,190,regulation of mitochondrion organization,BP,PLAUR;PPIF;PMAIP1;SQSTM1;UGCG;BBC3;USP36;PLAGL2;TP53BP2;NRG1;YWHAH;YWHAG;SFN
16906,GO:0098869,0.00775059130758062,0.998290823190576,6,63,cellular oxidant detoxification,BP,TNF;PTGS2;SOD2;TXNRD1;GCH1;NFE2L2
620,GO:0001787,0.00778861806371959,0.999773873483458,2,5,natural killer cell proliferation,BP,IL23A;ELF4
2672,GO:0006022,0.00790595423991549,0.997367369725607,10,118,aminoglycan metabolic process,BP,IL1B;SDC4;NFKB1;HAS3;B4GALT1;B3GNT5;PIM1;SLC9A1;B3GNT2;DSE
12897,GO:0051235,0.00791404926180497,0.996665789585893,15,220,maintenance of location,BP,NFKBIA;IL1B;ZC3H12A;TNF;NFKB1;NFKBIE;BCL3;EHD1;BDKRB1;ITGAV;PML;SOX4;INSIG1;PDPK1;ERO1A
11322,GO:0045646,0.00792141080380259,0.998577030736513,5,37,regulation of erythrocyte differentiation,BP,INHBA;ETS1;ZFP36L1;ZFP36;CDK6
18123,GO:1902806,0.00792791591304098,0.997184912988155,11,147,regulation of cell cycle G1/S phase transition,BP,BTG2;GADD45A;CDKN1A;CDKN2B;DCUN1D3;PLK2;PLK3;PML;SOX4;CDK6;SFN
4558,GO:0010638,0.00794547311453869,0.995690293875298,28,515,positive regulation of organelle organization,BP,IL1B;IL1A;PLAUR;CSF2;SDC4;TNF;PPIF;PMAIP1;TGFA;EDN1;LIF;ADRB2;UGCG;EREG;PPP1R10;SMAD3;BBC3;USP36;PLAGL2;NAV3;TP53BP2;NRG1;PML;CDC42EP1;WNT5A;YWHAH;YWHAG;SFN
2609,GO:0005912,0.00797913056256769,0.995832337369601,25,447,adherens junction,CC,PLAUR;PLAU;SDC4;EFNB2;EPHA2;PHLDB2;TJP2;RND3;NEDD9;ITGA5;SLC9A1;JAG1;NDRG1;ITGAV;PIP5K1A;FERMT1;CDC42EP1;RHOB;VCL;CORO1C;ADAM9;PDPK1;CYTH1;YWHAG;PDLIM5
17688,GO:1901565,0.00803022842382758,0.995001663006767,46,979,organonitrogen compound catabolic process,BP,TNFAIP3;IL1B;SDC4;TNF;RNF19B;PMAIP1;EFNA1;ODC1;TRIB1;SQSTM1;BIRC2;AMPD3;ENC1;N4BP1;HAL;CYLD;ADAM8;LDLR;NEDD4L;SMAD3;PLK2;PLK3;USP36;SLC9A1;AZIN1;SOX9;NRG1;PML;UHRF1;USP31;TNFAIP1;PRPF19;WNT5A;MAOA;ADAM9;ADAMTS9;RNF19A;CTSC;NFE2L2;SAT1;RELA;RNF11;TDG;UPP1;AHCY;SMPD3
15134,GO:0071229,0.00803182361155215,0.997149063033262,11,137,cellular response to acid chemical,BP,ZC3H12A;TNF;EDN1;CLDN1;CEBPB;LDLR;CREB1;GJB3;SOX9;ABL2;WNT5A
5384,GO:0016202,0.00810030889430141,0.997700621117449,8,81,regulation of striated muscle tissue development,BP,EDN1;EFNB2;BMP2;SMAD3;PIM1;CREB1;NRG1;HDAC9
17791,GO:1901861,0.00810030889430141,0.997700621117449,8,81,regulation of muscle tissue development,BP,EDN1;EFNB2;BMP2;SMAD3;PIM1;CREB1;NRG1;HDAC9
1392,GO:0003300,0.00811369974849276,0.99821962577135,6,49,cardiac muscle hypertrophy,BP,EDN1;ERRFI1;IL6ST;SMAD3;SLC9A1;PDLIM5
4938,GO:0014897,0.00811369974849276,0.99821962577135,6,49,striated muscle hypertrophy,BP,EDN1;ERRFI1;IL6ST;SMAD3;SLC9A1;PDLIM5
15900,GO:0072672,0.00815496371276884,0.999790559836295,2,4,neutrophil extravasation,BP,IL1A;ADAM8
4539,GO:0010611,0.00822128329189857,0.998513118543703,5,36,regulation of cardiac muscle hypertrophy,BP,EDN1;ERRFI1;IL6ST;SMAD3;SLC9A1
4882,GO:0014743,0.00822128329189857,0.998513118543703,5,36,regulation of muscle hypertrophy,BP,EDN1;ERRFI1;IL6ST;SMAD3;SLC9A1
9376,GO:0035904,0.00822138917562763,0.998520488219841,5,34,aorta development,BP,PRDM1;EFNB2;JAG1;SOX4;ADAMTS9
9678,GO:0038044,0.00830151136852666,0.999784793465921,2,4,transforming growth factor-beta secretion,BP,ITGAV;FERMT1
8058,GO:0032720,0.00831924294867183,0.998857839978063,4,26,negative regulation of tumor necrosis factor production,BP,TNFAIP3;ZC3H12A;ERRFI1;BCL3
12255,GO:0048536,0.0083667524206308,0.998859454340224,4,24,spleen development,BP,NFKB2;BCL3;CDKN2B;RC3H1
15162,GO:0071284,0.00838605451173727,0.999781441991825,2,4,cellular response to lead ion,BP,PTGS2;CLDN1
17375,GO:1900101,0.00839077447408809,0.998849977286439,4,25,regulation of endoplasmic reticulum unfolded protein response,BP,PPP1R15A;PPP1R15B;PTPN1;ERN1
8088,GO:0032768,0.00839186207771784,0.998464822324279,5,39,regulation of monooxygenase activity,BP,IL1B;TNF;NFKB1;CYP27B1;GCH1
949,GO:0002366,0.00840383234344465,0.995588472435081,25,468,leukocyte activation involved in immune response,BP,CXCL1;PLAUR;PLAU;TICAM1;NFKB1;RELB;CAB39;RAP2B;BCL3;AMPD3;B4GALT1;ADAM8;RC3H1;IL23A;TFRC;SERPINB1;CD55;RIPK2;ITGAV;VCL;COTL1;PDPK1;CTSC;CREG1;RAB24
8289,GO:0033116,0.00844096843033796,0.998118549448121,6,55,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,TGFA;VMP1;CD55;AREG;CTSC;TAP1
4937,GO:0014896,0.00846122398507027,0.998124200721102,6,50,muscle hypertrophy,BP,EDN1;ERRFI1;IL6ST;SMAD3;SLC9A1;PDLIM5
18244,GO:1903053,0.00846306370316482,0.998848289160531,4,23,regulation of extracellular matrix organization,BP,ETS1;PHLDB2;SMAD3;SOX9
18246,GO:1903055,0.00848311580974401,0.999294230240466,3,12,positive regulation of extracellular matrix organization,BP,PHLDB2;SMAD3;SOX9
12542,GO:0050688,0.00852156611978001,0.998100959498569,6,53,regulation of defense response to virus,BP,TNFAIP3;IL1B;ZC3H12A;BIRC3;BIRC2;IL23A
15137,GO:0071236,0.00852652882519197,0.997323729810334,9,106,cellular response to antibiotic,BP,TNFAIP3;ZC3H12A;ETS1;PPIF;KDM6B;SLC9A1;RHOB;NFE2L2;RELA
12250,GO:0048525,0.0085295827755774,0.997801663507522,7,72,negative regulation of viral process,BP,ZC3H12A;TNF;TNIP1;JUN;ZFP36;PML;ISG20
10165,GO:0042752,0.00854497690762823,0.997803200486949,7,68,regulation of circadian rhythm,BP,CSF2;BHLHE40;NOCT;ARNTL2;CREB1;PML;KLF10
6069,GO:0019216,0.00855006443936848,0.996145601534874,17,261,regulation of lipid metabolic process,BP,IL1B;TNF;PTGS2;NFKB1;HCAR2;BMP2;HMGCS1;G0S2;TXNRD1;LDLR;CREB1;PPARD;CYP27B1;SQLE;INSIG1;ALAS1;SMPD3
11331,GO:0045655,0.00855931685344454,0.999273572099709,3,13,regulation of monocyte differentiation,BP,JUN;ZFP36L1;CDK6
10117,GO:0042636,0.00858764448517827,0.999773377665842,2,4,negative regulation of hair cycle,BP,TRPV3;FERMT1
10747,GO:0044126,0.00859202368166142,0.999737404366043,2,5,regulation of growth of symbiont in host,BP,TNF;SQSTM1
10750,GO:0044144,0.00859202368166142,0.999737404366043,2,5,modulation of growth of symbiont involved in interaction with host,BP,TNF;SQSTM1
10467,GO:0043330,0.00860292716376834,0.998807351978601,4,26,response to exogenous dsRNA,BP,NFKBIA;TICAM1;RIPK2;IFIH1
15389,GO:0071639,0.00861795725716397,0.999736195728342,2,5,positive regulation of monocyte chemotactic protein-1 production,BP,IL1B;IL1A
14810,GO:0070542,0.00863857529081372,0.998071556086733,6,52,response to fatty acid,BP,ZC3H12A;PTGS2;EDN1;CLDN1;LDLR;CREB1
10119,GO:0042640,0.00865155539482431,0.999770799691859,2,4,anagen,BP,FERMT1;WNT5A
13227,GO:0051884,0.00865155539482431,0.999770799691859,2,4,regulation of timing of anagen,BP,FERMT1;WNT5A
8965,GO:0035035,0.00873161906397982,0.998794866335199,4,24,histone acetyltransferase binding,MF,ETS1;CEBPB;CREB1;MTF1
4752,GO:0010922,0.00873625172156565,0.998800079171531,4,23,positive regulation of phosphatase activity,BP,BMP2;PPP1R15A;SMAD3;PPP1R15B
12296,GO:0048634,0.00874360722153104,0.99748347676414,8,82,regulation of muscle organ development,BP,EDN1;EFNB2;BMP2;SMAD3;PIM1;CREB1;NRG1;HDAC9
14143,GO:0061008,0.00877876839951724,0.997233651452062,9,104,hepaticobiliary system development,BP,NFKBIA;TNFAIP3;CLDN1;JUN;CEBPB;HMGCS1;SMAD3;SOX9;RELA
8604,GO:0034114,0.00886444744833047,0.999227313695766,3,14,regulation of heterotypic cell-cell adhesion,BP,IL1B;TNF;IL1RN
8010,GO:0032637,0.00886587652558382,0.998350111954102,5,41,interleukin-8 production,BP,IL1B;TNF;BCL3;BCL10;WNT5A
8831,GO:0034616,0.0089109080475964,0.999232451208844,3,13,response to laminar fluid shear stress,BP,ETS1;ADAM9;NFE2L2
1967,GO:0004674,0.00893103803821741,0.995362115508633,24,397,protein serine/threonine kinase activity,MF,NUAK2;IRAK2;EPHA2;SQSTM1;CAB39;MAP2K3;CDKN1A;MAST4;PELI1;PIM3;OXSR1;PLK2;PLK3;PIM1;STK40;RIPK2;PHKG2;CLK4;MAP3K8;CDK6;PDPK1;SGK1;ANKK1;ERN1
16063,GO:0090009,0.00893683417728557,0.999759168453429,2,4,primitive streak formation,BP,ETS2;WNT5A
10135,GO:0042695,0.00895345599795478,0.999720386065046,2,5,thelarche,BP,AREG;WNT5A
14024,GO:0060744,0.00895345599795478,0.999720386065046,2,5,mammary gland branching involved in thelarche,BP,AREG;WNT5A
6697,GO:0030072,0.00897254447129708,0.996761831357995,11,142,peptide hormone secretion,BP,IL1B;TNF;EDN1;IL1RN;PIM3;PPARD;STX1A;PTPN11;SOX4;OXCT1;SMPD3
8213,GO:0032966,0.0090045677289562,0.999717949419405,2,5,negative regulation of collagen biosynthetic process,BP,ERRFI1;PPARD
11426,GO:0045840,0.00900730339656053,0.998323506420317,5,39,positive regulation of mitotic nuclear division,BP,IL1B;IL1A;TGFA;EDN1;EREG
3510,GO:0007422,0.00902126748701562,0.9979674029735,6,52,peripheral nervous system development,BP,CLDN1;RUNX1;NAB1;NDRG1;NRG1;RELA
13591,GO:0060055,0.00902602689297786,0.999218852286966,3,13,angiogenesis involved in wound healing,BP,TNFAIP3;ETS1;B4GALT1
9005,GO:0035150,0.00905841621008506,0.997641668441133,7,70,regulation of tube size,BP,PTGS2;EDN1;ADRB2;SOD2;PPARD;GCH1;ADM
12676,GO:0050880,0.00905841621008506,0.997641668441133,7,70,regulation of blood vessel size,BP,PTGS2;EDN1;ADRB2;SOD2;PPARD;GCH1;ADM
14186,GO:0061082,0.00906181078320208,0.99920368728741,3,14,myeloid leukocyte cytokine production,BP,SEMA7A;BCL10;WNT5A
10492,GO:0043393,0.00907251016979411,0.996543715607146,12,169,regulation of protein binding,BP,TICAM1;BMP2;PHLDA2;ADRB2;CYLD;PLK2;RIPK2;NRG1;SPAG9;TRAF4;WNT5A;TDG
8031,GO:0032673,0.00913229092669552,0.999195202651316,3,14,regulation of interleukin-4 production,BP,CD83;CEBPB;HLA-E
11246,GO:0045446,0.00915446857197274,0.997619042867002,7,66,endothelial cell differentiation,BP,IL1B;TNF;KDM6B;CLDN1;TJP2;JAG1;NRG1
8019,GO:0032650,0.00915973747593875,0.999685551193173,2,6,regulation of interleukin-1 alpha production,BP,CCL20;PANX1
2116,GO:0004904,0.00916294851076907,0.999710352152798,2,5,interferon receptor activity,MF,IFNGR2;IFNAR2
16539,GO:0097283,0.00919329813022364,0.99970888828424,2,5,keratinocyte apoptotic process,BP,ZFP36L1;ZFP36
17891,GO:1902172,0.00919329813022364,0.99970888828424,2,5,regulation of keratinocyte apoptotic process,BP,ZFP36L1;ZFP36
414,GO:0001101,0.00921697659182417,0.99604568861921,15,227,response to acid chemical,BP,ZC3H12A;TNF;PTGS2;EDN1;CLDN1;CEBPB;TRIM16;DUSP1;LDLR;CREB1;GJB3;SOX9;ABL2;WNT5A;RELA
893,GO:0002263,0.00923266549967162,0.995114393625572,25,471,cell activation involved in immune response,BP,CXCL1;PLAUR;PLAU;TICAM1;NFKB1;RELB;CAB39;RAP2B;BCL3;AMPD3;B4GALT1;ADAM8;RC3H1;IL23A;TFRC;SERPINB1;CD55;RIPK2;ITGAV;VCL;COTL1;PDPK1;CTSC;CREG1;RAB24
11475,GO:0045932,0.00923621166016882,0.999182647132611,3,14,negative regulation of muscle contraction,BP,ZC3H12A;PTGS2;ADRB2
9827,GO:0042045,0.00928160952419668,0.999704614058235,2,5,epithelial fluid transport,BP,CSF2;EDN1
14167,GO:0061046,0.00930130363608705,0.999703657904502,2,5,regulation of branching involved in lung morphogenesis,BP,TNF;SOX9
800,GO:0002066,0.00930407129972621,0.998257965759086,5,38,columnar/cuboidal epithelial cell development,BP,PRDM1;CDKN1A;CDK6;WNT5A;PDPK1
12167,GO:0048286,0.00934729016553563,0.998690609290648,4,23,lung alveolus development,BP,ERRFI1;LIF;CREB1;STK40
18169,GO:1902930,0.00935917069643676,0.99787211695648,6,53,regulation of alcohol biosynthetic process,BP,IL1B;TNF;NFKB1;HMGCS1;CYP27B1;SQLE
14157,GO:0061035,0.0093637937095975,0.998247757223216,5,37,regulation of cartilage development,BP,BMP2;SMAD3;SOX9;WNT5A;RELA
4247,GO:0009446,0.00937304166764907,0.99970016587688,2,5,putrescine biosynthetic process,BP,ODC1;AZIN1
12564,GO:0050713,0.00937961332517558,0.999699845269856,2,5,negative regulation of interleukin-1 beta secretion,BP,ZC3H12A;PML
18684,GO:1904029,0.00938642210850546,0.997531492631508,7,75,regulation of cyclin-dependent protein kinase activity,BP,TNFAIP3;GADD45A;CDKN1A;CDKN2B;CCNL1;CDK6;SFN
15140,GO:0071243,0.00946217569868481,0.999136658966864,3,16,cellular response to arsenic-containing substance,BP,ZC3H12A;PPIF;CPEB2
8079,GO:0032757,0.00948733185244294,0.998641595628531,4,27,positive regulation of interleukin-8 production,BP,IL1B;TNF;BCL10;WNT5A
4576,GO:0010660,0.00949866206285545,0.998212477634378,5,38,regulation of muscle cell apoptotic process,BP,ZC3H12A;EDN1;PPP1R10;PDPK1;NFE2L2
2369,GO:0005488,0.00952343183636061,0.993754137688517,351,10129,binding,MF,NFKBIA;NFKBIZ;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;CXCL3;BTG2;IL36G;BIRC3;HBEGF;PLAU;NFKBID;CSF2;ITPKC;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;CXCL8;REL;PPIF;IER3;KLF6;NUAK2;CCL20;ZC3H12C;ZNF697;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;PLEKHF1;EFNA1;TGFA;KDM6B;IRF6;LGALSL;EDN1;ODC1;SEMA7A;PHLDA1;ERRFI1;IL1RN;IRAK2;CLDN1;KLF7;PANX1;CREB5;DAPP1;CPEB2;EHF;SPRR2A;TNFRSF10B;EFNB2;EPHA2;RELB;GADD45A;CXCL5;MAFF;LIF;TRIB1;KCTD11;CD83;SQSTM1;RRAD;BMP2;IL24;CAB39;ZNF267;N4BP3;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;TMCC3;NMNAT2;RGMB;PHLDB2;CLDN4;TJP2;CD274;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;BCL2L2;ZFP36L1;ENC1;RND3;ADRB2;CEBPB;ARNTL2;TRAF3IP3;PPP1R15A;MAST4;RUNX1;N4BP1;CDKN2B;NAB1;HMGCS1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;ALDH1A3;C3ORF52;EHD1;NEDD9;ZSWIM4;ANKLE2;B4GALT1;DUSP1;BCL10;FGD6;DCUN1D3;HEPHL1;TMCC1;TRAF1;PPP1R10;PIM3;SACS;IL6ST;G0S2;VMP1;NABP1;DLX2;TXNRD1;CYLD;ADAM8;LDLR;VEGFC;KLF3;ZNF217;TACSTD2;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;DIEXF;PIM1;WISP1;ITGA5;TFRC;LIPG;AKIRIN1;KLHL21;CREB1;SERPINB8;EFNB1;F3;STK40;HIVEP2;PPARD;SLC25A25;SOCS3;CCDC85B;KRTAP2-3;RAET1L;USP36;IL16;BDKRB1;RAPH1;ZFP36;SLC9A1;MAFK;LARP4B;CYP27B1;CD55;PNRC1;IFNAR2;ELL2;ANTXR2;AZIN1;KIAA0040;JAG1;PLAGL2;RIPK2;AMOTL2;PHKG2;NAV3;SAA1;PPP1R15B;STARD5;USP53;NDRG1;ITGAV;PIP5K1A;CLK4;TP53BP2;SOX9;STX1A;NRG1;ZNF451;FEM1C;PML;POU2F2;RASA2;PPTC7;NCOA7;ELK3;POLR3A;ZNF460;CDC42EP1;FOXN2;PTPN11;MAP3K8;UHRF1;PANK3;EFHD2;ARHGEF3;MXD1;IRGQ;DCBLD2;RHOB;SPAG9;ABCA5;GCH1;FEM1B;SOX4;FOSL2;TRAF4;VCL;EIF1;OXCT1;AREG;CCNL1;FAM83G;AKAP2;TNFAIP1;HDAC9;ADAMTS1;HIVEP1;NFKBIB;KLF10;AEN;C11ORF68;TIFA;SKIL;COTL1;IL7R;DENND2C;RBM3;CDK6;IER5;YRDC;SAMD4A;EMP3;PTPN1;SQLE;TFE3;BTG3;CORO1C;STEAP4;MSANTD3;PRPF19;TOB2;ADM;MAFG;ABL2;MTF1;ATP6V1C2;HLA-E;RAB3IP;OSMR;QKI;CELF1;PMM2;WNT5A;NUP153;INSIG1;ADAM9;PDPK1;TNFRSF10A;ADAMTS9;RNF19A;CTSC;ERO1A;KDM6A;FRMD6;ZBTB21;SMTN;NFE2L2;YWHAH;SGK1;CYTH1;SAT1;RELA;AGFG1;RNF11;NOTCH2NL;BACH1;BTAF1;ANKK1;GINS3;POLR3D;ALAS1;YWHAG;TDG;ELF4;RAB22A;CREG1;SFN;ITM2B;ERN1;ETNK1;SH3RF2;ISG20;ATXN7;IFIH1;LAMB3;ATP13A3;ADAMTS6;MYO1B;BRD2;IPO4;CXCL16;PABPC4;TAP1;GPATCH2L;AHCY;STX12;PDLIM5;FUBP3;RAB24;SMPD3
15488,GO:0071850,0.00954779953993848,0.999144682032286,3,14,mitotic cell cycle arrest,BP,GADD45A;CDKN1A;DUSP1
15904,GO:0072676,0.00955596843064412,0.998188761185609,5,41,lymphocyte migration,BP,CCL20;ADAM8;SAA1;WNT5A;CXCL16
18820,GO:1904385,0.00957746527274642,0.999141042676638,3,14,cellular response to angiotensin,BP,NFKB1;NFE2L2;RELA
9104,GO:0035376,0.00960256239504833,0.999688897614835,2,5,sterol import,BP,LDLR;STARD5
14791,GO:0070508,0.00960256239504833,0.999688897614835,2,5,cholesterol import,BP,LDLR;STARD5
3185,GO:0006810,0.00963108748613734,0.992868884588839,132,3348,transport,BP,NFKBIA;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;PLAU;CSF2;INHBA;SDC4;TNF;CXCL8;PPIF;PTGS2;PMAIP1;NFKB1;TBX3;TRPV3;TGFA;EDN1;IL1RN;CLDN1;PANX1;HCAR2;LIF;SQSTM1;RRAD;CAB39;RAP2B;NFKBIE;CDKN1A;CLDN4;TJP2;CD274;BCL3;AMPD3;ZFP36L1;ADRB2;DUSP16;UGCG;TRIM16;EHD1;B4GALT1;HEPHL1;PPP1R10;PIM3;VMP1;SLC6A14;ADAM8;LDLR;VEGFC;NEDD4L;OXSR1;SLC43A3;BBC3;PLK3;TFRC;LIPG;CREB1;GJB3;PPARD;SLC25A25;SERPINB1;USP36;IL16;BDKRB1;ZFP36;SLC9A1;CYP27B1;CD55;ANTXR2;AZIN1;PLAGL2;RIPK2;SAA1;STARD5;ITGAV;PIP5K1A;TP53BP2;STX1A;NRG1;PML;POU2F2;FERMT1;SLC7A2;SLC28A3;PTPN11;RHOB;SPAG9;ABCA5;SOX4;VCL;OXCT1;AREG;COTL1;YRDC;PTPN1;CORO1C;STEAP4;ADM;ABL2;ATP6V1C2;HLA-E;RAB3IP;QKI;PMM2;WNT5A;NUP153;INSIG1;ADAM9;PDPK1;ADAMTS9;CTSC;ERO1A;NFE2L2;YWHAH;SGK1;CYTH1;AGFG1;YWHAG;RAB22A;CREG1;SFN;IFIH1;ATP13A3;MYO1B;IPO4;CXCL16;TAP1;STX12;RAB24;SMPD3
13033,GO:0051480,0.0097271206050994,0.996448652692274,11,143,regulation of cytosolic calcium ion concentration,BP,EDN1;SMAD3;BDKRB1;CD55;SAA1;ITGAV;PML;ADM;ABL2;PDPK1;ERO1A
727,GO:0001954,0.00978242739092397,0.998145715977722,5,38,positive regulation of cell-matrix adhesion,BP,SDC4;VEGFC;SMAD3;FERMT1;CDK6
14315,GO:0061448,0.00985219315117058,0.996398830372163,11,140,connective tissue development,BP,EDN1;BMP2;RUNX1;DLX2;SMAD3;PPARD;SLC25A25;SOX9;OXCT1;WNT5A;RELA
6911,GO:0030500,0.0098773579426845,0.998127242173283,5,37,regulation of bone mineralization,BP,BMP2;ADRB2;SMAD3;CYP27B1;SOX9
10033,GO:0042482,0.00991680730637122,0.999673235354204,2,5,positive regulation of odontogenesis,BP,EDN1;BMP2
3304,GO:0007006,0.00996342761975218,0.997043659367119,8,99,mitochondrial membrane organization,BP,PPIF;PMAIP1;BBC3;SLC9A1;TP53BP2;YWHAH;YWHAG;SFN
7068,GO:0030854,0.00997340383043608,0.999670385983483,2,5,positive regulation of granulocyte differentiation,BP,TRIB1;RUNX1
7357,GO:0031398,0.00999227871375981,0.997043170721573,8,91,positive regulation of protein ubiquitination,BP,BIRC3;TICAM1;BIRC2;ADRB2;PELI1;BCL10;DCUN1D3;RIPK2
8277,GO:0033081,0.010087444219139,0.999067015936425,3,15,regulation of T cell differentiation in thymus,BP,NFKBID;ADAM8;IL7R
1090,GO:0002676,0.0101298793513515,0.999633410750996,2,6,regulation of chronic inflammatory response,BP,TNFAIP3;TNF
13512,GO:0055078,0.0101554186435864,0.999082020911212,3,13,sodium ion homeostasis,BP,EDN1;NEDD4L;SLC9A1
8459,GO:0033598,0.0101620468812439,0.998521165461372,4,26,mammary gland epithelial cell proliferation,BP,EPHA2;CEBPB;AREG;WNT5A
3334,GO:0007049,0.0101769308913093,0.993063895015387,68,1548,cell cycle,BP,TNFAIP3;IL1B;IL1A;BTG2;BIRC3;INHBA;TNF;CXCL8;PTGS2;FOSL1;TBX3;TGFA;IRF6;EDN1;PHLDA1;GADD45A;LIF;KCTD11;BMP2;CAB39;MAP2K3;JUN;BIRC2;CDKN1A;JUNB;OVOL1;IRF1;ZFP36L1;RND3;PPP1R15A;CDKN2B;EREG;NEDD9;ANKLE2;DUSP1;DCUN1D3;PPP1R10;PIM3;NABP1;CYLD;OXSR1;SMAD3;PLK2;PLK3;PIM1;KLHL21;CYP27B1;NDRG1;TP53BP2;SOX9;PML;PTPN11;MAP3K8;UHRF1;RHOB;FEM1B;SOX4;CCNL1;SKIL;CDK6;BTG3;WNT5A;NUP153;BACH1;YWHAG;SFN;ERN1;SMPD3
10892,GO:0044433,0.0101774398773035,0.993512958071557,48,1039,cytoplasmic vesicle part,CC,CXCL1;PLAUR;HBEGF;PLAU;TICAM1;NFKB1;PLEKHF1;TGFA;IRAK2;IFNGR2;CAB39;RAP2B;AMPD3;ADRB2;EHD1;B4GALT1;ADAM8;LDLR;VEGFC;TFRC;SERPINB1;CD55;ANTXR2;SAA1;NDRG1;ITGAV;STX1A;PML;RHOB;ABCA5;VCL;AREG;COTL1;IL7R;STEAP4;HLA-E;WNT5A;CTSC;YWHAH;YWHAG;RAB22A;CREG1;SFN;ITM2B;MYO1B;TAP1;STX12;RAB24
10423,GO:0043267,0.0101898532025279,0.9990777540176,3,13,negative regulation of potassium ion transport,BP,CAB39;NEDD4L;OXSR1
11370,GO:0045736,0.0102223007060382,0.998509822458349,4,26,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,TNFAIP3;CDKN1A;CDKN2B;CDK6
18704,GO:1904063,0.0102379548942478,0.99802987046218,5,40,negative regulation of cation transmembrane transport,BP,PPIF;RRAD;CAB39;NEDD4L;OXSR1
3187,GO:0006812,0.0102738444190245,0.994189997970669,30,576,cation transport,BP,CSF2;PPIF;PTGS2;TRPV3;EDN1;PANX1;RRAD;CAB39;NFKBIE;ADRB2;HEPHL1;NEDD4L;OXSR1;TFRC;SLC25A25;IL16;BDKRB1;SLC9A1;CYP27B1;ITGAV;PML;SLC7A2;SLC28A3;STEAP4;ATP6V1C2;PDPK1;ERO1A;YWHAH;SGK1;ATP13A3
20295,GO:2001269,0.0103924508163967,0.999028174688378,3,15,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,TNFRSF10B;SMAD3;TNFRSF10A
19614,GO:1990748,0.0104291287869937,0.99754272251164,6,67,cellular detoxification,BP,TNF;PTGS2;SOD2;TXNRD1;GCH1;NFE2L2
8284,GO:0033089,0.0104303129054373,0.99964706738968,2,5,positive regulation of T cell differentiation in thymus,BP,ADAM8;IL7R
19775,GO:2000178,0.0105308394443206,0.999021848488774,3,14,negative regulation of neural precursor cell proliferation,BP,BTG2;KCTD11;WNT5A
12402,GO:0048844,0.0105364311991468,0.997970214931803,5,37,artery morphogenesis,BP,PRDM1;EFNB2;JAG1;SOX4;ADAMTS9
5589,GO:0016605,0.0105967278486901,0.996837685565399,8,87,PML body,CC,SQSTM1;N4BP1;TRIM16;ZNF451;PML;TDG;ELF4;ISG20
6462,GO:0021781,0.0106754330401333,0.999634328695956,2,5,glial cell fate commitment,BP,SOX9;NRG1
19749,GO:2000117,0.0106762061970872,0.997118575399028,7,77,negative regulation of cysteine-type endopeptidase activity,BP,PLAUR;BIRC3;PTGS2;TNFRSF10B;BIRC2;TNFRSF10A;SFN
610,GO:0001776,0.0106846582225719,0.997492524153518,6,56,leukocyte homeostasis,BP,TNFAIP3;PMAIP1;HCAR2;BCL10;RC3H1;SKIL
11104,GO:0045121,0.0107221113247085,0.9954751883735,14,202,membrane raft,CC,BIRC3;SDC4;TNF;PTGS2;RAP2B;BIRC2;RGMB;BCL10;EFNB1;SLC9A1;CD55;EFHD2;CORO1C;STX12
13422,GO:0052813,0.0107476125036495,0.997924008528031,5,36,phosphatidylinositol bisphosphate kinase activity,MF,HBEGF;EREG;PIP5K1A;NRG1;PTPN11
11589,GO:0046165,0.0107719953311868,0.996483402589005,9,111,alcohol biosynthetic process,BP,IL1B;ITPKC;TNF;NFKB1;HMGCS1;CYP27B1;GCH1;SQLE;INSIG1
19756,GO:2000138,0.0107816808408799,0.999628757979155,2,5,positive regulation of cell proliferation involved in heart morphogenesis,BP,PIM1;SOX9
11067,GO:0045066,0.0108137851879206,0.998985658841488,3,14,regulatory T cell differentiation,BP,IRF1;RUNX1;DUSP10
11281,GO:0045589,0.0108137851879206,0.998985658841488,3,14,regulation of regulatory T cell differentiation,BP,IRF1;RUNX1;DUSP10
17413,GO:1900151,0.0108188534366342,0.998985007272792,3,14,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,BTG2;ZFP36L1;ZFP36
17415,GO:1900153,0.0108188534366342,0.998985007272792,3,14,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,BTG2;ZFP36L1;ZFP36
14604,GO:0070167,0.0109227364820726,0.997872501461992,5,38,regulation of biomineral tissue development,BP,BMP2;ADRB2;SMAD3;CYP27B1;SOX9
9072,GO:0035313,0.0109569799308691,0.99898129181884,3,13,wound healing, spreading of epidermal cells,BP,HBEGF;PHLDB2;ITGA5
10151,GO:0042730,0.0109578112673669,0.998955031794376,3,15,fibrinolysis,BP,PLAUR;PLAU;SERPINB2
7994,GO:0032610,0.0110293935514266,0.999559812911146,2,7,interleukin-1 alpha production,BP,CCL20;PANX1
14030,GO:0060751,0.0110399938599681,0.9996150914044,2,5,branch elongation involved in mammary gland duct branching,BP,AREG;WNT5A
9930,GO:0042277,0.0110957585783557,0.995655799196211,12,172,peptide binding,MF,NFKBIA;INHBA;PPIF;ADRB2;LDLR;BDKRB1;ITGAV;HLA-E;NUP153;ITM2B;IPO4;TAP1
7786,GO:0032310,0.0111083156026356,0.999578054215088,2,6,prostaglandin secretion,BP,IL1B;EDN1
6759,GO:0030182,0.0111142057625758,0.993055159777286,43,850,neuron differentiation,BP,BTG2;INHBA;SDC4;PRDM1;EFNA1;SEMA7A;KLF7;EFNB2;LIF;KCTD11;BMP2;JUN;ENC1;CEBPB;RUNX1;EHD1;ZSWIM4;DLX2;NEDD4L;PLK2;CREB1;EFNB1;RAPH1;JAG1;SOX9;NRG1;PTPN11;SPAG9;SOX4;VCL;AREG;HDAC9;SKIL;PRPF19;ADM;ABL2;WNT5A;NFE2L2;YWHAH;SGK1;B3GNT2;YWHAG;PDLIM5
2673,GO:0006023,0.0111505073573641,0.996642429915002,8,87,aminoglycan biosynthetic process,BP,IL1B;SDC4;NFKB1;HAS3;B4GALT1;B3GNT5;B3GNT2;DSE
9068,GO:0035306,0.011158169493672,0.997810797671607,5,39,positive regulation of dephosphorylation,BP,BMP2;PPP1R15A;ANKLE2;SMAD3;PPP1R15B
4599,GO:0010713,0.0112027997745869,0.999572565449616,2,6,negative regulation of collagen metabolic process,BP,ERRFI1;PPARD
1449,GO:0003677,0.0112048771125996,0.992100156451485,82,1910,DNA binding,MF,TNFAIP3;ZC3H12A;ELF3;ETS1;TNF;REL;KLF6;ZNF697;BHLHE40;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;KDM6B;IRF6;KLF7;CREB5;EHF;RELB;GADD45A;MAFF;ZNF267;JUN;JUNB;BCL3;OVOL1;CSRNP1;ETS2;IRF1;TAF4B;ZFP36L1;CEBPB;ARNTL2;RUNX1;TRIM16;ELMSAN1;PPP1R10;NABP1;DLX2;KLF3;ZNF217;SMAD3;CREB1;HIVEP2;PPARD;ZFP36;MAFK;PLAGL2;SOX9;PML;POU2F2;ELK3;POLR3A;ZNF460;FOXN2;UHRF1;MXD1;SOX4;FOSL2;TRAF4;HIVEP1;KLF10;SKIL;TFE3;MAFG;MTF1;WNT5A;NUP153;KDM6A;ZBTB21;NFE2L2;RELA;AGFG1;RNF11;BACH1;BTAF1;POLR3D;TDG;ELF4;IFIH1;FUBP3
9553,GO:0036315,0.0112209200158663,0.998947492503801,3,13,cellular response to sterol,BP,INHBA;HMGCS1;INSIG1
16902,GO:0098857,0.011223795380089,0.995236437061104,14,203,membrane microdomain,CC,BIRC3;SDC4;TNF;PTGS2;RAP2B;BIRC2;RGMB;BCL10;EFNB1;SLC9A1;CD55;EFHD2;CORO1C;STX12
20281,GO:2001243,0.011233773410058,0.996934730738225,7,79,negative regulation of intrinsic apoptotic signaling pathway,BP,PLAUR;PPIF;PTGS2;BCL2L2;SOD2;PTPN1;NFE2L2
19917,GO:2000406,0.0112666097345144,0.998914465295652,3,15,positive regulation of T cell migration,BP,CCL20;ADAM8;WNT5A
10742,GO:0044110,0.0113079832407484,0.999566425934868,2,6,growth involved in symbiotic interaction,BP,TNF;SQSTM1
10745,GO:0044116,0.0113079832407484,0.999566425934868,2,6,growth of symbiont involved in interaction with host,BP,TNF;SQSTM1
10746,GO:0044117,0.0113079832407484,0.999566425934868,2,6,growth of symbiont in host,BP,TNF;SQSTM1
14195,GO:0061097,0.0113285605722596,0.997307593716889,6,56,regulation of protein tyrosine kinase activity,BP,EFNA1;TGFA;ERRFI1;RAP2B;EREG;PTPN1
15103,GO:0071156,0.0113951306981531,0.996540779288988,8,97,regulation of cell cycle arrest,BP,BTG2;GADD45A;CDKN1A;PLK2;PLK3;PML;SOX4;SFN
4285,GO:0009651,0.0114189415137841,0.998894296146007,3,15,response to salt stress,BP,TNF;CLDN1;ZFP36L1
7256,GO:0031214,0.0114239044069696,0.996892125299113,7,69,biomineral tissue development,BP,PTGS2;BMP2;ADRB2;SMAD3;CYP27B1;SOX9;KLF10
14570,GO:0070102,0.011444505021585,0.998918621746031,3,13,interleukin-6-mediated signaling pathway,BP,IL6ST;SOCS3;PTPN11
985,GO:0002440,0.0114603747820335,0.996219627113423,9,112,production of molecular mediator of immune response,BP,TNF;SEMA7A;BCL10;TFRC;CD55;POU2F2;IL7R;HLA-E;WNT5A
4775,GO:0010959,0.0114863364587496,0.995288450282363,13,187,regulation of metal ion transport,BP,PTGS2;TRPV3;RRAD;CAB39;ADRB2;NEDD4L;OXSR1;IL16;BDKRB1;SLC9A1;PML;PDPK1;YWHAH
11770,GO:0046627,0.0115869524481117,0.998240977862303,4,27,negative regulation of insulin receptor signaling pathway,BP,IL1B;SOCS3;PTPN1;RELA
14599,GO:0070162,0.0115928517091155,0.99958526305708,2,5,adiponectin secretion,BP,IL1B;HCAR2
14600,GO:0070163,0.0115928517091155,0.99958526305708,2,5,regulation of adiponectin secretion,BP,IL1B;HCAR2
8319,GO:0033157,0.0116318504792317,0.995036144786354,14,213,regulation of intracellular protein transport,BP,IL1B;ZC3H12A;PTGS2;CDKN1A;UGCG;PLK3;USP36;PLAGL2;NRG1;PTPN11;SOX4;PTPN1;INSIG1;SFN
1400,GO:0003323,0.0116385018427188,0.998878124003177,3,14,type B pancreatic cell development,BP,CDK6;WNT5A;PDPK1
1070,GO:0002634,0.0116637339878932,0.999581382362887,2,5,regulation of germinal center formation,BP,TNFAIP3;RC3H1
11804,GO:0046685,0.0117259725469559,0.99820160099145,4,29,response to arsenic-containing substance,BP,ZC3H12A;PPIF;CPEB2;CDKN1A
10506,GO:0043409,0.0117756435668597,0.995824581906729,10,129,negative regulation of MAPK cascade,BP,IL1B;TNIP1;EFNA1;ERRFI1;LIF;DUSP16;DUSP8;DUSP1;DUSP10;PTPN1
3029,GO:0006576,0.0117971712005067,0.998182044636531,4,30,cellular biogenic amine metabolic process,BP,ODC1;AZIN1;MAOA;SAT1
12545,GO:0050691,0.0117996802505746,0.998192783170815,4,28,regulation of defense response to virus by host,BP,TNFAIP3;IL1B;ZC3H12A;IL23A
4386,GO:0010038,0.0118298415468023,0.994938609141066,14,218,response to metal ion,BP,IL1A;PPIF;PTGS2;EDN1;CLDN1;JUN;JUNB;DUSP1;NEDD4L;CREB1;NDRG1;MTF1;WNT5A;ADAM9
4689,GO:0010837,0.011857243935955,0.998201952071747,4,25,regulation of keratinocyte proliferation,BP,EFNB2;ZFP36L1;ZFP36;SFN
7157,GO:0031016,0.0118698165831029,0.997630764284333,5,40,pancreas development,BP,SOX9;SOX4;CDK6;WNT5A;PDPK1
6012,GO:0019058,0.0119062547988822,0.994577280073958,16,255,viral life cycle,BP,ZC3H12A;TNF;CXCL8;TNIP1;CLDN1;EFNB2;EPHA2;LDLR;NEDD4L;ITGA5;TFRC;CD55;ITGAV;PML;NUP153;ISG20
5334,GO:0016064,0.0119681926004597,0.997115928542172,6,58,immunoglobulin mediated immune response,BP,TNF;BCL3;BCL10;TFRC;CD55;POU2F2
6211,GO:0019724,0.0119681926004597,0.997115928542172,6,58,B cell mediated immunity,BP,TNF;BCL3;BCL10;TFRC;CD55;POU2F2
7817,GO:0032369,0.0119781517839966,0.998832970415637,3,14,negative regulation of lipid transport,BP,NFKB1;ITGAV;PTPN11
4948,GO:0014912,0.0119870332033972,0.998818177064152,3,15,negative regulation of smooth muscle cell migration,BP,TRIB1;PPARD;NFE2L2
7921,GO:0032494,0.0120138008551265,0.999562031046757,2,5,response to peptidoglycan,BP,RIPK2;RELA
11725,GO:0046532,0.0120649240842707,0.999559179308501,2,5,regulation of photoreceptor cell differentiation,BP,DLX2;SOX9
3283,GO:0006972,0.0121377645872665,0.998811580324254,3,14,hyperosmotic response,BP,ERRFI1;CLDN1;PDPK1
12754,GO:0051019,0.0121708755390947,0.998132448519834,4,26,mitogen-activated protein kinase binding,MF,TNIP1;DUSP10;SPAG9;GCH1
2617,GO:0005925,0.0122048171475655,0.993886483493033,20,355,focal adhesion,CC,PLAUR;PLAU;SDC4;EFNB2;EPHA2;PHLDB2;RND3;NEDD9;ITGA5;SLC9A1;ITGAV;PIP5K1A;FERMT1;CDC42EP1;RHOB;VCL;CORO1C;ADAM9;PDPK1;YWHAG
19095,GO:1904996,0.012266053128365,0.999547896867883,2,5,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,ETS1;TNF
6654,GO:0030001,0.0122794095989627,0.993345329224942,25,452,metal ion transport,BP,PTGS2;TRPV3;PANX1;RRAD;CAB39;ADRB2;HEPHL1;NEDD4L;OXSR1;TFRC;SLC25A25;IL16;BDKRB1;SLC9A1;CYP27B1;ITGAV;PML;SLC28A3;STEAP4;ATP6V1C2;PDPK1;ERO1A;YWHAH;SGK1;ATP13A3
15988,GO:0085029,0.0122894331497542,0.998116618894622,4,25,extracellular matrix assembly,BP,HAS3;PHLDB2;SMAD3;SOX9
13015,GO:0051445,0.0123179398197517,0.998095995560569,4,27,regulation of meiotic cell cycle,BP,LIF;OVOL1;DUSP1;WNT5A
19805,GO:2000242,0.0123536656717818,0.998076018570691,4,29,negative regulation of reproductive process,BP,LIF;OVOL1;DUSP1;WNT5A
16871,GO:0098802,0.0123967862315881,0.996196447710125,8,87,plasma membrane receptor complex,CC,BMP2;BIRC2;BCL10;IL6ST;ITGA5;TFRC;ITGAV;OSMR
2616,GO:0005924,0.0124641761456976,0.993743298636489,20,356,cell-substrate adherens junction,CC,PLAUR;PLAU;SDC4;EFNB2;EPHA2;PHLDB2;RND3;NEDD9;ITGA5;SLC9A1;ITGAV;PIP5K1A;FERMT1;CDC42EP1;RHOB;VCL;CORO1C;ADAM9;PDPK1;YWHAG
12896,GO:0051234,0.0125113763237273,0.990630476818277,134,3432,establishment of localization,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;PLAU;CSF2;INHBA;SDC4;TNF;CXCL8;PPIF;PTGS2;PMAIP1;NFKB1;TBX3;TRPV3;TGFA;EDN1;IL1RN;CLDN1;PANX1;HCAR2;LIF;SQSTM1;RRAD;CAB39;RAP2B;NFKBIE;CDKN1A;PHLDB2;CLDN4;TJP2;CD274;BCL3;AMPD3;ZFP36L1;ADRB2;DUSP16;UGCG;TRIM16;EHD1;B4GALT1;HEPHL1;PPP1R10;PIM3;VMP1;SLC6A14;ADAM8;LDLR;VEGFC;NEDD4L;OXSR1;SLC43A3;BBC3;PLK3;TFRC;LIPG;CREB1;GJB3;PPARD;SLC25A25;SERPINB1;USP36;IL16;BDKRB1;ZFP36;SLC9A1;CYP27B1;CD55;ANTXR2;AZIN1;PLAGL2;RIPK2;SAA1;STARD5;ITGAV;PIP5K1A;TP53BP2;STX1A;NRG1;PML;POU2F2;FERMT1;SLC7A2;SLC28A3;PTPN11;RHOB;SPAG9;ABCA5;SOX4;VCL;OXCT1;AREG;COTL1;YRDC;PTPN1;CORO1C;STEAP4;ADM;ABL2;ATP6V1C2;HLA-E;RAB3IP;QKI;PMM2;WNT5A;NUP153;INSIG1;ADAM9;PDPK1;ADAMTS9;CTSC;ERO1A;NFE2L2;YWHAH;SGK1;CYTH1;AGFG1;YWHAG;RAB22A;CREG1;SFN;IFIH1;ATP13A3;MYO1B;IPO4;CXCL16;TAP1;STX12;RAB24;SMPD3
891,GO:0002260,0.0125597112649831,0.99744475966514,5,43,lymphocyte homeostasis,BP,TNFAIP3;PMAIP1;BCL10;RC3H1;SKIL
10552,GO:0043506,0.0125884807601471,0.99650750506186,7,70,regulation of JUN kinase activity,BP,TNF;EDN1;DUSP10;SPAG9;PTPN1;WNT5A;ERN1
8508,GO:0033688,0.012825293555272,0.998718216345603,3,14,regulation of osteoblast proliferation,BP,BMP2;SMAD3;ITGAV
18685,GO:1904030,0.012825655513645,0.99798674954407,4,28,negative regulation of cyclin-dependent protein kinase activity,BP,TNFAIP3;CDKN1A;CDKN2B;CDK6
2456,GO:0005667,0.0128402175536258,0.994099888513139,16,259,transcription factor complex,CC,ETS1;REL;JUN;JUNB;TAF4B;CEBPB;ARNTL2;ELMSAN1;SMAD3;CREB1;PPARD;SOX9;SOX4;HDAC9;RELA;CREG1
16607,GO:0097443,0.0128655622292817,0.999513675599928,2,5,sorting endosome,CC,LDLR;PTPN1
6831,GO:0030291,0.012908497341852,0.997957313863594,4,30,protein serine/threonine kinase inhibitor activity,MF,CDKN1A;CDKN2B;YWHAG;SFN
14196,GO:0061098,0.0130104175867543,0.997956191968321,4,27,positive regulation of protein tyrosine kinase activity,BP,EFNA1;TGFA;EREG;PTPN1
6788,GO:0030223,0.0130354740013798,0.999461292128684,2,6,neutrophil differentiation,BP,CSF2;TRIB1
6746,GO:0030163,0.0131793181340527,0.992014980555853,36,741,protein catabolic process,BP,TNFAIP3;IL1B;TNF;RNF19B;PMAIP1;EFNA1;ODC1;TRIB1;SQSTM1;BIRC2;ENC1;N4BP1;CYLD;ADAM8;LDLR;NEDD4L;SMAD3;PLK2;PLK3;USP36;AZIN1;SOX9;NRG1;PML;UHRF1;USP31;TNFAIP1;PRPF19;WNT5A;ADAM9;ADAMTS9;RNF19A;CTSC;NFE2L2;RELA;RNF11
16083,GO:0090050,0.0132127854979403,0.998649235903464,3,15,positive regulation of cell migration involved in sprouting angiogenesis,BP,PTGS2;PLK2;HDAC9
5569,GO:0016579,0.0132359105413406,0.994067909560561,15,243,protein deubiquitination,BP,NFKBIA;TNFAIP3;ZC3H12A;BIRC3;TNIP1;BIRC2;ADRB2;CYLD;SMAD3;USP36;RIPK2;USP53;USP31;ATXN7;IFIH1
11844,GO:0046822,0.0132556793612491,0.995874829794264,8,92,regulation of nucleocytoplasmic transport,BP,IL1B;ZC3H12A;PTGS2;CDKN1A;PTPN11;SOX4;NUP153;SFN
4573,GO:0010657,0.0132888451783665,0.997267034385223,5,41,muscle cell apoptotic process,BP,ZC3H12A;EDN1;PPP1R10;PDPK1;NFE2L2
8145,GO:0032870,0.0133274379219943,0.992633758743879,26,476,cellular response to hormone stimulus,BP,IL1B;INHBA;NFKB1;EDN1;ERRFI1;CPEB2;JUN;JUNB;ZFP36L1;RUNX1;HMGCS1;DUSP1;CREB1;PPARD;SOCS3;ZFP36;SLC9A1;PTPN11;HDAC9;PTPN1;ATP6V1C2;PDPK1;NFE2L2;YWHAH;RELA;YWHAG
13760,GO:0060333,0.013340213430504,0.996694449696056,6,63,interferon-gamma-mediated signaling pathway,BP,IRF6;IFNGR2;IRF1;SOCS3;PML;HLA-E
10015,GO:0042445,0.0133577056925127,0.995475222379486,9,117,hormone metabolic process,BP,IL1B;TNF;NFKB1;BMP2;ALDH1A3;CYP27B1;PTPN11;ADM;YWHAH
17363,GO:1900077,0.0135132332788088,0.997845784078744,4,28,negative regulation of cellular response to insulin stimulus,BP,IL1B;SOCS3;PTPN1;RELA
12644,GO:0050839,0.0135195364244592,0.992920332758498,22,394,cell adhesion molecule binding,MF,IL1B;SEMA7A;EPHA2;PHLDB2;TJP2;EHD1;ADAM8;TACSTD2;WISP1;ITGA5;NDRG1;ITGAV;NRG1;CDC42EP1;PTPN11;EFHD2;VCL;PTPN1;ADAM9;SFN;MYO1B;PDLIM5
8596,GO:0034103,0.0136183693499149,0.997177356401013,5,42,regulation of tissue remodeling,BP,TNFAIP3;B4GALT1;ADAM8;IL23A;TFRC
3529,GO:0007517,0.0136857593270487,0.993850650190595,15,227,muscle organ development,BP,BTG2;HBEGF;EDN1;EFNB2;MAFF;LIF;BMP2;SMAD3;PIM1;CREB1;NRG1;FOXN2;HDAC9;WNT5A;SMTN
4544,GO:0010616,0.0137709041613627,0.999460348951937,2,5,negative regulation of cardiac muscle adaptation,BP,ERRFI1;SMAD3
18317,GO:1903243,0.0137709041613627,0.999460348951937,2,5,negative regulation of cardiac muscle hypertrophy in response to stress,BP,ERRFI1;SMAD3
1331,GO:0003181,0.013843678182748,0.998576363471654,3,14,atrioventricular valve morphogenesis,BP,EFNA1;BMP2;SOX4
11374,GO:0045740,0.0138701998000511,0.997107376238252,5,43,positive regulation of DNA replication,BP,CSF2;JUN;EREG;AREG;TNFAIP1
7909,GO:0032480,0.0139010029065364,0.997094978158466,5,44,negative regulation of type I interferon production,BP,TNFAIP3;REL;RELB;CYLD;IFIH1
11662,GO:0046425,0.0139147892103747,0.996039445602966,7,80,regulation of JAK-STAT cascade,BP,CSF2;LIF;IL24;BCL3;IL6ST;IL23A;SOCS3
11304,GO:0045622,0.0139356605612603,0.99853228907757,3,16,regulation of T-helper cell differentiation,BP,RC3H1;IL23A;RIPK2
8805,GO:0034511,0.0140208046060051,0.999397809304408,2,6,U3 snoRNA binding,MF,DIEXF;ISG20
4580,GO:0010664,0.0140645366485553,0.998528203394349,3,15,negative regulation of striated muscle cell apoptotic process,BP,PPP1R10;PDPK1;NFE2L2
7851,GO:0032410,0.0140687466517026,0.997060157377662,5,42,negative regulation of transporter activity,BP,PPIF;RRAD;CAB39;NEDD4L;OXSR1
1397,GO:0003309,0.0140893869977849,0.998524628707459,3,15,type B pancreatic cell differentiation,BP,CDK6;WNT5A;PDPK1
9664,GO:0038023,0.0141112613969736,0.992582820898295,22,386,signaling receptor activity,MF,PLAUR;SDC4;HCAR2;TNFRSF10B;EPHA2;IFNGR2;RGMB;CLDN4;RELT;ADRB2;IL6ST;HCAR3;F3;PPARD;BDKRB1;IFNAR2;ANTXR2;ITGAV;IL7R;OSMR;TNFRSF10A;GPR156
13620,GO:0060089,0.0141112613969736,0.992582820898295,22,386,molecular transducer activity,MF,PLAUR;SDC4;HCAR2;TNFRSF10B;EPHA2;IFNGR2;RGMB;CLDN4;RELT;ADRB2;IL6ST;HCAR3;F3;PPARD;BDKRB1;IFNAR2;ANTXR2;ITGAV;IL7R;OSMR;TNFRSF10A;GPR156
15333,GO:0071557,0.0142177904726212,0.999433310299067,2,5,histone H3-K27 demethylation,BP,KDM6B;KDM6A
15334,GO:0071558,0.0142177904726212,0.999433310299067,2,5,histone demethylase activity (H3-K27 specific),MF,KDM6B;KDM6A
12839,GO:0051146,0.0142260230000142,0.994510359477824,11,148,striated muscle cell differentiation,BP,TBX3;KDM6B;EDN1;EFNB2;BMP2;EHD1;SLC9A1;NRG1;SPAG9;HDAC9;PDLIM5
3417,GO:0007204,0.0142671664646332,0.994786392349226,10,132,positive regulation of cytosolic calcium ion concentration,BP,EDN1;BDKRB1;CD55;SAA1;ITGAV;PML;ADM;ABL2;PDPK1;ERO1A
4273,GO:0009629,0.0142708838775186,0.999381303532232,2,6,response to gravity,BP,FOSL1;STX1A
2183,GO:0005031,0.014313180855033,0.998464325744043,3,17,tumor necrosis factor-activated receptor activity,MF,TNFRSF10B;RELT;TNFRSF10A
2185,GO:0005035,0.014313180855033,0.998464325744043,3,17,death receptor activity,MF,TNFRSF10B;RELT;TNFRSF10A
6689,GO:0030055,0.0143204824099808,0.992710186784938,20,360,cell-substrate junction,CC,PLAUR;PLAU;SDC4;EFNB2;EPHA2;PHLDB2;RND3;NEDD9;ITGA5;SLC9A1;ITGAV;PIP5K1A;FERMT1;CDC42EP1;RHOB;VCL;CORO1C;ADAM9;PDPK1;YWHAG
14073,GO:0060850,0.0143531694396083,0.999375838117381,2,6,regulation of transcription involved in cell fate commitment,BP,CEBPB;DLX2
3469,GO:0007292,0.0143580534840488,0.995899388599043,7,75,female gamete generation,BP,INHBA;PTGS2;FOSL1;TAF4B;EREG;ADAMTS1;TOB2
3190,GO:0006816,0.0143609197205715,0.993711310767853,14,211,calcium ion transport,BP,PTGS2;TRPV3;PANX1;RRAD;SLC25A25;IL16;BDKRB1;SLC9A1;CYP27B1;ITGAV;PML;PDPK1;ERO1A;ATP13A3
10792,GO:0044264,0.0143901687793958,0.995893421758831,7,73,cellular polysaccharide metabolic process,BP,HAS3;PHLDA2;IL6ST;B3GNT5;STK40;PHKG2;B3GNT2
9023,GO:0035234,0.0144102029946089,0.999372039989613,2,6,ectopic germ cell programmed cell death,BP,IL1B;IL1A
12855,GO:0051170,0.0144502286895747,0.994705558308721,10,135,import into nucleus,BP,NFKBIA;ZC3H12A;TNF;PTGS2;CDKN1A;BCL3;PPP1R10;PML;NUP153;IPO4
11430,GO:0045844,0.0144549840065709,0.996963909254682,5,41,positive regulation of striated muscle tissue development,BP,EDN1;EFNB2;PIM1;CREB1;NRG1
12298,GO:0048636,0.0144549840065709,0.996963909254682,5,41,positive regulation of muscle organ development,BP,EDN1;EFNB2;PIM1;CREB1;NRG1
17793,GO:1901863,0.0144549840065709,0.996963909254682,5,41,positive regulation of muscle tissue development,BP,EDN1;EFNB2;PIM1;CREB1;NRG1
14503,GO:0062012,0.0145250537863947,0.992737683441884,19,335,regulation of small molecule metabolic process,BP,IL1B;TNF;PPIF;PTGS2;PMAIP1;NFKB1;ODC1;BMP2;PHLDA2;HMGCS1;LDLR;CYP27B1;AZIN1;PHKG2;SQLE;ADM;WNT5A;NUP153;INSIG1
12734,GO:0050994,0.0146084297390824,0.997616672080644,4,28,regulation of lipid catabolic process,BP,IL1B;TNF;HCAR2;LDLR
7065,GO:0030851,0.0146584945992824,0.998426679013095,3,16,granulocyte differentiation,BP,CSF2;TRIB1;RUNX1
19879,GO:2000352,0.0146608800978,0.998441752774374,3,15,negative regulation of endothelial cell apoptotic process,BP,TNFAIP3;PDPK1;NFE2L2
567,GO:0001706,0.0146995518522277,0.996899498409351,5,41,endoderm formation,BP,INHBA;DUSP1;ITGA5;ITGAV;LAMB3
1115,GO:0002702,0.0147941325594676,0.996850929025049,5,46,positive regulation of production of molecular mediator of immune response,BP,SEMA7A;BCL10;TFRC;HLA-E;WNT5A
13941,GO:0060602,0.0148592340003602,0.998412692146793,3,15,branch elongation of an epithelium,BP,SOX9;AREG;WNT5A
16247,GO:0090303,0.014885982339303,0.997549958390515,4,29,positive regulation of wound healing,BP,HBEGF;F3;PPARD;NFE2L2
8042,GO:0032689,0.0149502549007243,0.998369626319107,3,17,negative regulation of interferon-gamma production,BP,ZC3H12A;INHBA;CD274
11415,GO:0045823,0.0149752979869299,0.998365871336687,3,17,positive regulation of heart contraction,BP,EDN1;GCH1;ADM
16777,GO:0098589,0.0149760484421919,0.993408232490335,14,210,membrane region,CC,BIRC3;SDC4;TNF;PTGS2;RAP2B;BIRC2;RGMB;BCL10;EFNB1;SLC9A1;CD55;EFHD2;CORO1C;STX12
10158,GO:0042742,0.0149927341963961,0.995644762296348,7,93,defense response to bacterium,BP,TNF;CCL20;BCL3;CEBPB;IL23A;RIPK2;HLA-E
447,GO:0001206,0.0150268810326323,0.999383178022959,2,5,transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,HIVEP1;BACH1
6764,GO:0030195,0.0150504035675928,0.997507444567855,4,30,negative regulation of blood coagulation,BP,PLAUR;PLAU;SERPINB2;EDN1
17357,GO:1900047,0.0150504035675928,0.997507444567855,4,30,negative regulation of hemostasis,BP,PLAUR;PLAU;SERPINB2;EDN1
10548,GO:0043500,0.0150532371909924,0.996182549975941,6,59,muscle adaptation,BP,IL1B;EDN1;ERRFI1;IL6ST;SMAD3;SLC9A1
13575,GO:0060039,0.0151017970446269,0.998395483530364,3,14,pericardium development,BP,BMP2;SMAD3;WNT5A
801,GO:0002067,0.015156083622952,0.997500066703591,4,28,glandular epithelial cell differentiation,BP,BMP2;CDK6;WNT5A;PDPK1
365,GO:0000983,0.0151953330874536,0.998363107181882,3,15,transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding,MF,TAF4B;SMAD3;RELA
11333,GO:0045657,0.015263330199643,0.999314262775392,2,6,positive regulation of monocyte differentiation,BP,JUN;ZFP36L1
10624,GO:0043621,0.0152868669096547,0.996733137398369,5,43,protein self-association,MF,TNFAIP3;BCL10;ADAM8;CTSC;TDG
6770,GO:0030203,0.0153105428661532,0.994704390292569,9,111,glycosaminoglycan metabolic process,BP,IL1B;SDC4;NFKB1;HAS3;B4GALT1;PIM1;SLC9A1;B3GNT2;DSE
12846,GO:0051153,0.0154307663444061,0.996061972145365,6,60,regulation of striated muscle cell differentiation,BP,EDN1;EFNB2;BMP2;EHD1;NRG1;HDAC9
11236,GO:0045410,0.0155116673387332,0.999297108599162,2,6,positive regulation of interleukin-6 biosynthetic process,BP,IL1B;EREG
2228,GO:0005129,0.0155244194336633,1,1,1,granulocyte macrophage colony-stimulating factor receptor binding,MF,CSF2
8562,GO:0034021,0.0155244194336633,1,1,1,response to silicon dioxide,BP,CSF2
16089,GO:0090068,0.0155886720931565,0.993097099875993,14,220,positive regulation of cell cycle process,BP,IL1B;IL1A;BTG2;TGFA;EDN1;GADD45A;CDKN1A;EREG;PLK2;PLK3;PML;SOX4;WNT5A;SFN
12189,GO:0048333,0.0156121550847205,0.998301020014467,3,15,mesodermal cell differentiation,BP,INHBA;KDM6B;KDM6A
17820,GO:1901976,0.0156127313805629,0.997385889961864,4,30,regulation of cell cycle checkpoint,BP,DUSP1;PPP1R10;NDRG1;FEM1B
15633,GO:0072132,0.0156378414252854,0.997405332396083,4,27,mesenchyme morphogenesis,BP,BMP2;SMAD3;SOX9;WNT5A
2613,GO:0005921,0.0156459719749944,0.998279126962221,3,16,gap junction,CC,PANX1;GJB4;GJB3
19172,GO:1905209,0.0156515349954836,0.998278285226744,3,16,positive regulation of cardiocyte differentiation,BP,EDN1;EFNB2;NRG1
12840,GO:0051147,0.0156573829069337,0.994973455678228,8,95,regulation of muscle cell differentiation,BP,EDN1;EFNB2;BMP2;EREG;EHD1;NRG1;SPAG9;HDAC9
1121,GO:0002708,0.015704652479651,0.996606523451931,5,46,positive regulation of lymphocyte mediated immunity,BP,IL1B;TNF;IL23A;TFRC;HLA-E
15157,GO:0071277,0.0158789169697683,0.996579322683306,5,42,cellular response to calcium ion,BP,PPIF;EDN1;JUN;JUNB;WNT5A
14504,GO:0062013,0.0158894000048597,0.994885396284441,8,95,positive regulation of small molecule metabolic process,BP,IL1B;TNF;PTGS2;PMAIP1;NFKB1;PHKG2;ADM;WNT5A
9367,GO:0035883,0.015959785283112,0.998231463286723,3,16,enteroendocrine cell differentiation,BP,CDK6;WNT5A;PDPK1
17830,GO:1901988,0.0160293488902138,0.993112672782434,13,215,negative regulation of cell cycle phase transition,BP,BTG2;GADD45A;CDKN1A;OVOL1;ZFP36L1;CDKN2B;DUSP1;DCUN1D3;PLK2;PLK3;PML;SOX4;SFN
12162,GO:0048273,0.0160390984235148,0.999260180749266,2,6,mitogen-activated protein kinase p38 binding,MF,DUSP10;SPAG9
3440,GO:0007250,0.0160745933787644,0.998213934044914,3,16,activation of NF-kappaB-inducing kinase activity,BP,TNFRSF10B;TRAF4;TNFRSF10A
1122,GO:0002709,0.0161741483352928,0.997248702616917,4,32,regulation of T cell mediated immunity,BP,IL1B;IL23A;IL7R;HLA-E
11375,GO:0045741,0.0161930431658445,0.9992492765228,2,6,positive regulation of epidermal growth factor-activated receptor activity,BP,TGFA;EREG
12570,GO:0050719,0.0162344591183169,1,1,1,interleukin-1 alpha biosynthetic process,BP,CCL20
12572,GO:0050721,0.0162344591183169,1,1,1,regulation of interleukin-1 alpha biosynthetic process,BP,CCL20
12575,GO:0050726,0.0162344591183169,1,1,1,positive regulation of interleukin-1 alpha biosynthetic process,BP,CCL20
12427,GO:0048878,0.0162681560577105,0.990288987213005,32,647,chemical homeostasis,BP,EDN1;CLDN1;CLDN4;SOD2;EHD1;PIM3;LDLR;NEDD4L;SMAD3;TFRC;LIPG;BDKRB1;SLC9A1;CYP27B1;CD55;SAA1;ITGAV;PML;PTPN11;SOX4;OXCT1;STEAP4;ADM;MAFG;ABL2;ATP6V1C2;INSIG1;PDPK1;ERO1A;SFN;ERN1;ATP13A3
10504,GO:0043407,0.0162759424375192,0.995786880521159,6,63,negative regulation of MAP kinase activity,BP,IL1B;DUSP16;DUSP8;DUSP1;DUSP10;PTPN1
19914,GO:2000403,0.0163210149649103,0.998160576917988,3,17,positive regulation of lymphocyte migration,BP,CCL20;ADAM8;WNT5A
995,GO:0002455,0.0163536435898114,0.998141749700494,3,18,humoral immune response mediated by circulating immunoglobulin,BP,TNF;BCL3;CD55
18369,GO:1903364,0.0163808187184972,0.994261625704859,9,116,positive regulation of cellular protein catabolic process,BP,TNFAIP3;RNF19B;TRIB1;LDLR;PLK2;PLK3;RNF19A;CTSC;NFE2L2
14261,GO:0061311,0.0163840752174396,0.998166439168671,3,16,cell surface receptor signaling pathway involved in heart development,BP,BMP2;JAG1;WNT5A
6296,GO:0019904,0.016409655886199,0.990461445946818,29,560,protein domain specific binding,MF,IL1B;PLAUR;BHLHE40;ERRFI1;DAPP1;SQSTM1;JUN;RAP2B;TJP2;ETS2;BCL2L2;TRIM16;MAFK;RIPK2;TP53BP2;STX1A;POU2F2;PTPN11;TRAF4;TNFAIP1;QKI;WNT5A;ADAM9;NFE2L2;YWHAH;RELA;YWHAG;TDG;SFN
9949,GO:0042311,0.0164130218591221,0.998132460953164,3,18,vasodilation,BP,ADRB2;SOD2;GCH1
13526,GO:0055094,0.016524829180836,0.998144722070717,3,16,response to lipoprotein particle,BP,TICAM1;HMGCS1;LDLR
18214,GO:1903003,0.0165372943190183,0.999224688520014,2,6,positive regulation of protein deubiquitination,BP,ZC3H12A;TNIP1
1182,GO:0002827,0.0165428418001592,0.999182235820076,2,7,positive regulation of T-helper 1 type immune response,BP,IL23A;RIPK2
11814,GO:0046703,0.0166107263943391,0.999122474476045,2,9,natural killer cell lectin-like receptor binding,MF,RAET1L;HLA-E
12966,GO:0051345,0.0166886962171704,0.990285616397048,29,561,positive regulation of hydrolase activity,BP,TNF;CCL20;PMAIP1;EFNA1;ERRFI1;TNFRSF10B;EPHA2;BMP2;JUN;PPP1R15A;BCL10;SMAD3;BBC3;F3;RIPK2;PPP1R15B;PIP5K1A;PML;RASA2;CDC42EP1;UHRF1;PTPN1;CORO1C;ABL2;WNT5A;PDPK1;TNFRSF10A;AGFG1;ERN1
7939,GO:0032525,0.0166960776237103,0.999213253009975,2,6,somite rostral/caudal axis specification,BP,NRARP;KDM6A
16844,GO:0098754,0.0167169446904927,0.99561378589605,6,75,detoxification,BP,TNF;PTGS2;SOD2;TXNRD1;GCH1;NFE2L2
3391,GO:0007171,0.0167605790591502,0.999208590687236,2,6,activation of transmembrane receptor protein tyrosine kinase activity,BP,ADRB2;NRG1
15591,GO:0072073,0.016770507816434,0.994557601727256,8,91,kidney epithelium development,BP,SDC4;EFNB2;LIF;BMP2;TACSTD2;SMAD3;JAG1;SOX9
5920,GO:0018193,0.0168822964939181,0.989098602506957,44,944,peptidyl-amino acid modification,BP,IL1B;HBEGF;CSF2;TNF;PPIF;PTGS2;EFNA1;TGFA;ERRFI1;EPHA2;LIF;IL24;CAB39;MAP2K3;RAP2B;MAST4;TRIM16;EREG;IL6ST;VEGFC;OXSR1;IL23A;PLK2;ITGA5;SOCS3;RIPK2;PHKG2;CLK4;NRG1;ZNF451;NCOA7;SOX4;AREG;HDAC9;PTPN1;ABL2;WNT5A;NUP153;PDPK1;KDM6A;SGK1;RELA;ERN1;IFIH1
15143,GO:0071248,0.0168946683991298,0.994490917207219,8,100,cellular response to metal ion,BP,PPIF;PTGS2;EDN1;CLDN1;JUN;JUNB;CREB1;WNT5A
8126,GO:0032814,0.0169116210647607,0.99805395045404,3,18,regulation of natural killer cell activation,BP,TICAM1;PRDM1;IL23A
4191,GO:0009267,0.016918557638283,0.994042744420939,9,115,cellular response to starvation,BP,ZC3H12A;NUAK2;PMAIP1;PLEKHF1;JUN;CDKN1A;KLF10;NFE2L2;UPP1
1394,GO:0003306,0.0169255320528223,0.999196623061004,2,6,Wnt signaling pathway involved in heart development,BP,BMP2;WNT5A
7491,GO:0031658,0.0169259638584555,0.99915305775125,2,7,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,CDKN2B;CDK6
15365,GO:0071605,0.0169264136159108,0.999153023285677,2,7,monocyte chemotactic protein-1 production,BP,IL1B;IL1A
15387,GO:0071637,0.0169264136159108,0.999153023285677,2,7,regulation of monocyte chemotactic protein-1 production,BP,IL1B;IL1A
18687,GO:1904035,0.0169427885304338,0.99628395703024,5,43,regulation of epithelial cell apoptotic process,BP,TNFAIP3;ZFP36L1;ZFP36;PDPK1;NFE2L2
8007,GO:0032633,0.0169980080252012,0.998054750002318,3,17,interleukin-4 production,BP,CD83;CEBPB;HLA-E
16797,GO:0098641,0.0170393596162986,0.998020770746129,3,19,cadherin binding involved in cell-cell adhesion,MF,TACSTD2;CDC42EP1;PDLIM5
10080,GO:0042581,0.0171623995770161,0.994385683787671,8,101,specific granule,CC,CXCL1;PLAUR;PLAU;NFKB1;RAP2B;ADAM8;ITGAV;VCL
12916,GO:0051259,0.0171665086275262,0.991093548241878,20,378,protein complex oligomerization,BP,TNFAIP3;ZC3H12A;BIRC3;PMAIP1;CLDN1;PANX1;KCTD11;SQSTM1;CAB39;BIRC2;SOD2;ALDH1A3;EHD1;B4GALT1;BCL10;TMCC1;SLC9A1;SPAG9;GCH1;TNFAIP1
10199,GO:0042805,0.0172780144503404,0.998046509373649,3,15,actinin binding,MF,NFKB1;RELA;PDLIM5
10402,GO:0043235,0.0172838743280423,0.992526463753701,13,183,receptor complex,CC,TRPV3;EPHA2;BMP2;BIRC2;ADRB2;BCL10;IL6ST;LDLR;SMAD3;ITGA5;TFRC;ITGAV;OSMR
18170,GO:1902931,0.0172906050053604,0.999124952070737,2,7,negative regulation of alcohol biosynthetic process,BP,NFKB1;CYP27B1
8510,GO:0033690,0.0173030580519446,0.99916899372826,2,6,positive regulation of osteoblast proliferation,BP,BMP2;ITGAV
19170,GO:1905207,0.0173066666790032,0.997020293546778,4,29,regulation of cardiocyte differentiation,BP,EDN1;EFNB2;BMP2;NRG1
19757,GO:2000142,0.0173105587817565,0.997010688703546,4,30,regulation of DNA-templated transcription, initiation,BP,FOSL1;JUN;CREB1;ZNF451
7818,GO:0032370,0.0173198720464421,0.996992846503309,4,32,positive regulation of lipid transport,BP,NFKBIA;IL1B;EDN1;LIPG
12059,GO:0048008,0.0174584350821688,0.996153963324663,5,41,platelet-derived growth factor receptor signaling pathway,BP,CSRNP1;F3;PTPN11;PTPN1;ABL2
13765,GO:0060338,0.017469602750772,0.996983763710082,4,29,regulation of type I interferon-mediated signaling pathway,BP,IFNAR2;PTPN11;PTPN1;WNT5A
6365,GO:0021544,0.0175129228759973,0.997990255112886,3,16,subpallium development,BP,INHBA;ALDH1A3;DLX2
3990,GO:0008859,0.0175721911650075,1,1,1,exoribonuclease II activity,MF,ISG20
9604,GO:0036464,0.0175727637683682,0.992991415306276,11,160,cytoplasmic ribonucleoprotein granule,CC,NFKBIZ;ZC3H12A;NOCT;SQSTM1;ZFP36L1;RC3H1;ZFP36;LARP4B;PNRC1;SAMD4A;PABPC4
12604,GO:0050777,0.0176145063911762,0.994739267942154,7,83,negative regulation of immune response,BP,TNFAIP3;TNF;RC3H1;DUSP10;CD55;IL7R;HLA-E
12670,GO:0050871,0.0177358382384673,0.996042816576342,5,47,positive regulation of B cell activation,BP,TICAM1;PRDM1;CDKN1A;PELI1;TFRC
16262,GO:0090322,0.017740627830237,0.997907780158976,3,19,regulation of superoxide metabolic process,BP,TNF;GCH1;NFE2L2
12635,GO:0050819,0.0177853248601387,0.996887361857844,4,32,negative regulation of coagulation,BP,PLAUR;PLAU;SERPINB2;EDN1
19969,GO:2000535,0.0178329723751917,0.999129655010054,2,6,regulation of entry of bacterium into host cell,BP,CXCL8;ITGAV
16393,GO:0097011,0.0178416707950839,0.999081863486022,2,7,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,CSF2;ZFP36
16394,GO:0097012,0.0178416707950839,0.999081863486022,2,7,response to granulocyte macrophage colony-stimulating factor,BP,CSF2;ZFP36
8620,GO:0034138,0.0179120652344646,0.99790924516749,3,17,toll-like receptor 3 signaling pathway,BP,TNFAIP3;TICAM1;PELI1
13061,GO:0051549,0.0179441217312376,0.999121321870688,2,6,positive regulation of keratinocyte migration,BP,HBEGF;ADAM9
634,GO:0001821,0.0179843638496741,0.999035676211652,2,8,histamine secretion,BP,CSF2;EDN1
4625,GO:0010744,0.018065843367,0.999064125635809,2,7,positive regulation of macrophage derived foam cell differentiation,BP,CSF2;NFKB1
8060,GO:0032725,0.0180723789197186,0.999063606697803,2,7,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,IL1B;IL23A
10553,GO:0043507,0.0181343702146867,0.995216119315297,6,57,positive regulation of JUN kinase activity,BP,TNF;EDN1;SPAG9;PTPN1;WNT5A;ERN1
8090,GO:0032770,0.018139915460908,0.997856704547272,3,18,positive regulation of monooxygenase activity,BP,IL1B;TNF;GCH1
8695,GO:0034330,0.0181567647559915,0.991816195672099,14,205,cell junction organization,BP,SDC4;TNF;CLDN1;PHLDB2;RUNX1;VMP1;SMAD3;ITGA5;SLC9A1;PIP5K1A;VCL;CORO1C;PDPK1;LAMB3
8374,GO:0033273,0.018187424208524,0.995174580132044,6,63,response to vitamin,BP,PTGS2;HMGCS1;PIM1;PPARD;CYP27B1;RELA
12661,GO:0050862,0.0182096803632037,0.999052681047403,2,7,positive regulation of T cell receptor signaling pathway,BP,CYLD;RELA
1994,GO:0004713,0.0182641987507089,0.993493083103436,9,111,protein tyrosine kinase activity,MF,HBEGF;CSF2;EPHA2;MAP2K3;EREG;RIPK2;CLK4;NRG1;ABL2
15304,GO:0071498,0.0183091131327259,0.997845122276603,3,17,cellular response to fluid shear stress,BP,PTGS2;TFPI2;NFE2L2
458,GO:0001306,0.0183479311234367,1,1,1,age-dependent response to oxidative stress,BP,SOD2
459,GO:0001315,0.0183479311234367,1,1,1,age-dependent response to reactive oxygen species,BP,SOD2
1276,GO:0003068,0.0183479311234367,1,1,1,regulation of systemic arterial blood pressure by acetylcholine,BP,SOD2
1277,GO:0003069,0.0183479311234367,1,1,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,SOD2
1278,GO:0003070,0.0183479311234367,1,1,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,SOD2
3546,GO:0007571,0.0183479311234367,1,1,1,age-dependent general metabolic decline,BP,SOD2
6321,GO:0019966,0.0183828197549551,0.999038839548656,2,7,interleukin-1 binding,MF,IL1RN;TRIM16
11263,GO:0045519,0.0185404076461202,1,1,1,interleukin-23 receptor binding,MF,IL23A
14912,GO:0070743,0.0185404076461202,1,1,1,interleukin-23 complex,CC,IL23A
3039,GO:0006591,0.0185450632828829,0.999025804474752,2,7,ornithine metabolic process,BP,ODC1;AZIN1
4232,GO:0009409,0.0185659454310008,0.996716801100327,4,31,response to cold,BP,NFKBIA;ADRB2;SLC9A1;ADM
1362,GO:0003231,0.0185891567064649,0.99441148229726,7,75,cardiac ventricle development,BP,PRDM1;TBX3;JAG1;NRG1;SOX4;TMEM65;WNT5A
17709,GO:1901617,0.0186461951991297,0.992496629522456,11,161,organic hydroxy compound biosynthetic process,BP,IL1B;ITPKC;TNF;NFKB1;BMP2;HMGCS1;CYP27B1;GCH1;SQLE;WNT5A;INSIG1
8125,GO:0032813,0.018670812585335,0.996676475198979,4,33,tumor necrosis factor receptor superfamily binding,MF,TNF;TRAF1;FEM1B;TRAF4
15244,GO:0071407,0.0189356629600442,0.989607504573038,23,421,cellular response to organic cyclic compound,BP,NFKBIA;IL1B;ZC3H12A;INHBA;TNF;PTGS2;NFKB1;EDN1;ERRFI1;BMP2;ZFP36L1;CEBPB;RUNX1;HMGCS1;SMAD3;PIM1;PPARD;ZFP36;SLC9A1;CYP27B1;INSIG1;YWHAH;IFIH1
15872,GO:0072594,0.0189401948197934,0.989734692735318,22,462,establishment of protein localization to organelle,BP,NFKBIA;TNFAIP3;ZC3H12A;TNF;PTGS2;PMAIP1;CDKN1A;BCL3;UGCG;PPP1R10;BBC3;USP36;PLAGL2;TP53BP2;NRG1;PML;PMM2;NUP153;YWHAH;YWHAG;SFN;IPO4
2264,GO:0005178,0.0189970816363233,0.994257426782402,7,77,integrin binding,MF,IL1B;SEMA7A;WISP1;ITGA5;ITGAV;NRG1;ADAM9
8089,GO:0032769,0.0191190308487944,0.998979191783267,2,7,negative regulation of monooxygenase activity,BP,NFKB1;CYP27B1
7259,GO:0031225,0.0191322973162151,0.994841813279044,6,70,anchored component of membrane,CC,PLAUR;EFNA1;SEMA7A;RGMB;RAET1L;CD55
13592,GO:0060056,0.0191613923800985,0.998975720910047,2,7,mammary gland involution,BP,ELF3;B4GALT1
3566,GO:0007611,0.0191639426257066,0.992663291128362,10,134,learning or memory,BP,BTG2;PTGS2;FOSL1;JUN;CEBPB;LDLR;PLK2;ITGA5;CREB1;SGK1
15858,GO:0072577,0.0191761234461343,0.996594843126542,4,29,endothelial cell apoptotic process,BP,TNFAIP3;TNF;PDPK1;NFE2L2
17695,GO:1901575,0.019203662238452,0.986498922730429,67,1625,organic substance catabolic process,BP,TNFAIP3;IL1B;ZC3H12A;BTG2;SDC4;TNF;RNF19B;PMAIP1;NOCT;EFNA1;ODC1;HCAR2;TRIB1;SQSTM1;BIRC2;AMPD3;ZFP36L1;ENC1;N4BP1;HAL;CYLD;ADAM8;LDLR;NEDD4L;SMAD3;RC3H1;PLK2;PLK3;LIPG;PPARD;USP36;ZFP36;SLC9A1;CYP27B1;PNRC1;AZIN1;PHKG2;SOX9;NRG1;PML;UHRF1;USP31;OXCT1;TNFAIP1;SAMD4A;PTPN1;PRPF19;QKI;WNT5A;NUP153;MAOA;ADAM9;ADAMTS9;RNF19A;CTSC;NFE2L2;YWHAH;SAT1;RELA;RNF11;TDG;ERN1;UPP1;ISG20;PABPC4;AHCY;SMPD3
1260,GO:0003012,0.019369994480994,0.991182815288282,14,221,muscle system process,BP,IL1B;ZC3H12A;PTGS2;EDN1;ERRFI1;MAP2K3;ADRB2;IL6ST;NEDD4L;SMAD3;SLC9A1;VCL;SMTN;PDLIM5
1324,GO:0003171,0.0193975034064592,0.997686173832571,3,16,atrioventricular valve development,BP,EFNA1;BMP2;SOX4
13194,GO:0051797,0.0195121852239423,0.997630086484409,3,18,regulation of hair follicle development,BP,TNF;FERMT1;WNT5A
7704,GO:0032182,0.0195385509509662,0.994045057223563,7,82,ubiquitin-like protein binding,MF,TNFAIP3;SQSTM1;BIRC2;DCUN1D3;SMAD3;PML;TDG
14721,GO:0070374,0.0195426747107535,0.992943559263922,9,118,positive regulation of ERK1 and ERK2 cascade,BP,IL1A;TNF;CCL20;SEMA7A;EPHA2;BMP2;JUN;RIPK2;PTPN11
12889,GO:0051224,0.0197462629306602,0.99336632105344,8,104,negative regulation of protein transport,BP,IL1B;ZC3H12A;TNF;PIM3;PML;PTPN11;SOX4;INSIG1
11367,GO:0045727,0.0197593225040811,0.993359049827378,8,105,positive regulation of translation,BP,ZC3H12A;TNF;BCL3;PPP1R15A;LARP4B;SOX4;RBM3;SAMD4A
15555,GO:0072001,0.0198744335265355,0.991234709880858,13,192,renal system development,BP,SDC4;ODC1;EFNB2;LIF;BMP2;OVOL1;TACSTD2;SMAD3;JAG1;SOX9;SOX4;ADAMTS1;WNT5A
698,GO:0001916,0.020051784259649,0.998860661916959,2,8,positive regulation of T cell mediated cytotoxicity,BP,IL23A;HLA-E
18442,GO:1903524,0.0201191655385609,0.996345601603165,4,32,positive regulation of blood circulation,BP,PTGS2;EDN1;GCH1;ADM
802,GO:0002068,0.0201496718867559,0.997540829449969,3,17,glandular epithelial cell development,BP,CDK6;WNT5A;PDPK1
8727,GO:0034375,0.0201692021269981,0.99885041362316,2,8,high-density lipoprotein particle remodeling,BP,LIPG;ABCA5
11732,GO:0046543,0.0201843391270126,0.9988906421744,2,7,development of secondary female sexual characteristics,BP,AREG;WNT5A
7140,GO:0030971,0.0201973591010396,0.995353901936039,5,45,receptor tyrosine kinase binding,MF,SQSTM1;NRG1;PTPN11;PTPN1;YWHAG
3445,GO:0007257,0.0203782765707696,0.996325682859995,4,28,activation of JUN kinase activity,BP,SPAG9;PTPN1;WNT5A;ERN1
4540,GO:0010612,0.0203792018834547,0.998931794133354,2,6,regulation of cardiac muscle adaptation,BP,ERRFI1;SMAD3
18316,GO:1903242,0.0203792018834547,0.998931794133354,2,6,regulation of cardiac muscle hypertrophy in response to stress,BP,ERRFI1;SMAD3
10604,GO:0043583,0.0204042077426096,0.992584214409682,9,115,ear development,BP,SDC4;EDN1;BMP2;ALDH1A3;JAG1;SOX9;PTPN11;WNT5A;INSIG1
17800,GO:1901889,0.0204777916697361,0.997506478482792,3,16,negative regulation of cell junction assembly,BP,TNF;PHLDB2;CORO1C
3116,GO:0006694,0.0204979682049836,0.992523770509531,9,126,steroid biosynthetic process,BP,IL1B;TNF;NFKB1;BMP2;HMGCS1;CYP27B1;SQLE;ADM;INSIG1
9449,GO:0036037,0.0205190250218306,0.998862284226078,2,7,CD8-positive, alpha-beta T cell activation,BP,IRF1;HLA-E
906,GO:0002286,0.0206361726240081,0.995214297722819,5,47,T cell activation involved in immune response,BP,RELB;BCL3;RC3H1;IL23A;RIPK2
8697,GO:0034332,0.0206960058142371,0.993017034648281,8,92,adherens junction organization,BP,SDC4;PHLDB2;SMAD3;SLC9A1;PIP5K1A;VCL;CORO1C;PDPK1
13937,GO:0060598,0.02071390092045,1,1,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,AREG
19093,GO:1904994,0.0207201423508896,0.998845121026119,2,7,regulation of leukocyte adhesion to vascular endothelial cell,BP,ETS1;TNF
9391,GO:0035929,0.0207233726746136,0.998844844604852,2,7,steroid hormone secretion,BP,INHBA;PTPN11
4546,GO:0010623,0.0207812338838391,0.998839889378864,2,7,programmed cell death involved in cell development,BP,IL1B;IL1A
806,GO:0002072,0.0208416146963076,0.998894329947345,2,6,optic cup morphogenesis involved in camera-type eye development,BP,ALDH1A3;WNT5A
766,GO:0002011,0.0209178924166203,0.995151454498172,5,44,morphogenesis of an epithelial sheet,BP,HBEGF;PHLDB2;ITGA5;JAG1;WNT5A
13276,GO:0051960,0.0209302664862739,0.987588703361208,29,548,regulation of nervous system development,BP,EFNA1;SEMA7A;EFNB2;LIF;KCTD11;BMP2;ENC1;ZSWIM4;IL6ST;DLX2;LDLR;VEGFC;NEDD4L;DUSP10;PLK2;CREB1;JAG1;SOX9;NRG1;SPAG9;SKIL;PRPF19;ABL2;WNT5A;NFE2L2;YWHAH;RELA;YWHAG;PDLIM5
14002,GO:0060713,0.0209582422205445,0.997384415714382,3,18,labyrinthine layer morphogenesis,BP,ZFP36L1;SOCS3;ADM
5457,GO:0016331,0.0209584381279794,0.99234788015173,9,115,morphogenesis of embryonic epithelium,BP,SDC4;ALDH1A3;BCL10;VEGFC;SOX9;SOX4;ADM;WNT5A;KDM6A
12704,GO:0050919,0.0210494231697193,0.996167137590325,4,28,negative chemotaxis,BP,SEMA7A;ITGAV;NRG1;WNT5A
11879,GO:0046886,0.0210646639259987,0.998815507300422,2,7,positive regulation of hormone biosynthetic process,BP,IL1B;TNF
7199,GO:0031087,0.0211015679214382,0.998812319323816,2,7,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,ZFP36;PNRC1
2286,GO:0005243,0.0211152539133421,0.998811136272302,2,7,gap junction channel activity,MF,PANX1;GJB3
2265,GO:0005179,0.0212321277357631,0.997304283504906,3,20,hormone activity,MF,INHBA;EDN1;ADM
13233,GO:0051893,0.0212645208822111,0.995050238559748,5,44,regulation of focal adhesion assembly,BP,SDC4;PHLDB2;SMAD3;SLC9A1;CORO1C
16120,GO:0090109,0.0212645208822111,0.995050238559748,5,44,regulation of cell-substrate junction assembly,BP,SDC4;PHLDB2;SMAD3;SLC9A1;CORO1C
19806,GO:2000243,0.0213610643406136,0.996048950048588,4,32,positive regulation of reproductive process,BP,INHBA;OVOL1;SOX9;WNT5A
15888,GO:0072655,0.0214182227738602,0.991618126784694,10,158,establishment of protein localization to mitochondrion,BP,PMAIP1;UGCG;BBC3;USP36;PLAGL2;TP53BP2;NRG1;YWHAH;YWHAG;SFN
19769,GO:2000171,0.0214329741895608,0.997322029126521,3,17,negative regulation of dendrite development,BP,EFNA1;PLK2;YWHAH
11085,GO:0045086,0.0214563186231687,0.998781518187923,2,7,positive regulation of interleukin-2 biosynthetic process,BP,IL1B;IL1A
18675,GO:1904019,0.021501706845181,0.994081549227936,6,62,epithelial cell apoptotic process,BP,TNFAIP3;TNF;ZFP36L1;ZFP36;PDPK1;NFE2L2
691,GO:0001909,0.0215192840307026,0.994922497155481,5,53,leukocyte mediated cytotoxicity,BP,IL23A;RAET1L;IL7R;HLA-E;CTSC
537,GO:0001655,0.0215226895291532,0.99007505165654,14,215,urogenital system development,BP,SDC4;ODC1;EFNB2;LIF;BMP2;OVOL1;TACSTD2;SMAD3;JAG1;SOX9;FEM1B;SOX4;ADAMTS1;WNT5A
14866,GO:0070646,0.0215415974017202,0.989748073726058,15,258,protein modification by small protein removal,BP,NFKBIA;TNFAIP3;ZC3H12A;BIRC3;TNIP1;BIRC2;ADRB2;CYLD;SMAD3;USP36;RIPK2;USP53;USP31;ATXN7;IFIH1
2906,GO:0006417,0.0218021934935368,0.988402768842628,20,387,regulation of translation,BP,ZC3H12A;BTG2;TNF;CPEB2;BCL3;ZFP36L1;ENC1;PPP1R15A;SMAD3;RC3H1;ZFP36;LARP4B;PPP1R15B;SOX4;EIF1;RBM3;SAMD4A;QKI;CELF1;NUP153
10864,GO:0044387,0.0218694749745057,0.99874529211144,2,7,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,DUSP10;CORO1C
15384,GO:0071634,0.0220324857414203,0.997218005183925,3,17,regulation of transforming growth factor beta production,BP,PTGS2;SMAD3;CREB1
14687,GO:0070306,0.0222881649049735,0.997173297002401,3,17,lens fiber cell differentiation,BP,EPHA2;SMAD3;SKIL
19397,GO:1905897,0.0223986864921055,0.993755238614844,6,67,regulation of response to endoplasmic reticulum stress,BP,PMAIP1;PPP1R15A;PPP1R15B;PTPN1;NFE2L2;ERN1
12848,GO:0051155,0.0224022285886339,0.99578615753579,4,33,positive regulation of striated muscle cell differentiation,BP,EDN1;EFNB2;EHD1;NRG1
17833,GO:1901991,0.0224496034506051,0.990275207040498,12,202,negative regulation of mitotic cell cycle phase transition,BP,BTG2;GADD45A;CDKN1A;ZFP36L1;CDKN2B;DUSP1;DCUN1D3;PLK2;PLK3;PML;SOX4;SFN
20130,GO:2000810,0.0224804525087014,0.997139539066816,3,17,regulation of bicellular tight junction assembly,BP,TNF;CLDN1;RUNX1
3220,GO:0006869,0.0226873093958831,0.989805564681095,13,199,lipid transport,BP,NFKBIA;IL1B;INHBA;NFKB1;EDN1;LDLR;LIPG;PPARD;STARD5;ITGAV;PTPN11;ABCA5;STX12
7834,GO:0032386,0.0228595303136663,0.988236827479495,18,320,regulation of intracellular transport,BP,IL1B;ZC3H12A;PTGS2;CDKN1A;UGCG;EHD1;PLK3;USP36;PLAGL2;STX1A;NRG1;PTPN11;SOX4;PTPN1;NUP153;INSIG1;PDPK1;SFN
6882,GO:0030377,0.0228664186900192,1,1,1,urokinase plasminogen activator receptor activity,MF,PLAUR
9740,GO:0038195,0.0228664186900192,1,1,1,urokinase plasminogen activator signaling pathway,BP,PLAUR
7516,GO:0031700,0.022959296836874,1,1,1,adrenomedullin receptor binding,MF,ADM
8801,GO:0034504,0.0230033400653702,0.989637552189995,13,205,protein localization to nucleus,BP,NFKBIA;ZC3H12A;TNF;PTGS2;LIF;CDKN1A;BCL3;PPP1R10;SOX9;PML;SOX4;NUP153;IPO4
1124,GO:0002711,0.0230506924662757,0.996980344085787,3,20,positive regulation of T cell mediated immunity,BP,IL1B;IL23A;HLA-E
13508,GO:0055074,0.0230677875094598,0.98960456651796,13,205,calcium ion homeostasis,BP,EDN1;SMAD3;BDKRB1;CYP27B1;CD55;SAA1;ITGAV;PML;ADM;ABL2;PDPK1;ERO1A;ATP13A3
8345,GO:0033198,0.0231064128076565,0.996987604916787,3,19,response to ATP,BP,IL1B;PTGS2;PANX1
12673,GO:0050877,0.0231100105476899,0.987248164725996,22,408,nervous system process,BP,BTG2;PTGS2;FOSL1;EDN1;JUN;CEBPB;GJB4;SOD2;ALDH1A3;LDLR;TACSTD2;PLK2;ITGA5;CREB1;BDKRB1;SLC9A1;USP53;NRG1;GCH1;SGK1;B3GNT2;ATXN7
15241,GO:0071402,0.0232115866576822,0.996988160265014,3,18,cellular response to lipoprotein particle stimulus,BP,TICAM1;HMGCS1;LDLR
7782,GO:0032305,0.0232783343127588,0.998567401166548,2,8,positive regulation of icosanoid secretion,BP,IL1B;EDN1
19781,GO:2000193,0.0232783343127588,0.998567401166548,2,8,positive regulation of fatty acid transport,BP,IL1B;EDN1
15288,GO:0071476,0.0232808691070782,0.998618704517921,2,7,cellular hypotonic response,BP,CAB39;OXSR1
6988,GO:0030665,0.0232914525698576,0.993448604824601,6,67,clathrin-coated vesicle membrane,CC,HBEGF;ADRB2;LDLR;TFRC;IL7R;WNT5A
2251,GO:0005164,0.023418826488601,0.996897610844788,3,21,tumor necrosis factor receptor binding,MF,TNF;TRAF1;TRAF4
13087,GO:0051592,0.0234592949534843,0.992576869709812,7,83,response to calcium ion,BP,PPIF;EDN1;JUN;JUNB;DUSP1;WNT5A;ADAM9
9151,GO:0035504,0.0234914331741905,1,1,1,regulation of myosin light chain kinase activity,BP,IL1B
9152,GO:0035505,0.0234914331741905,1,1,1,positive regulation of myosin light chain kinase activity,BP,IL1B
4581,GO:0010665,0.0235817133701508,0.996921559179754,3,18,regulation of cardiac muscle cell apoptotic process,BP,PPP1R10;PDPK1;NFE2L2
8114,GO:0032800,0.023639296423062,0.996891156407175,3,19,receptor biosynthetic process,BP,TNF;EDN1;ITGAV
12560,GO:0050709,0.0236946929903174,0.993304869757474,6,68,negative regulation of protein secretion,BP,IL1B;ZC3H12A;TNF;PIM3;PML;PTPN11
13175,GO:0051770,0.0237100723173737,0.998579351173458,2,7,positive regulation of nitric-oxide synthase biosynthetic process,BP,CCL20;NAMPT
1342,GO:0003199,0.0237999195767577,1,1,1,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,EFNA1
4826,GO:0014028,0.0237999195767577,1,1,1,notochord formation,BP,EFNA1
3655,GO:0008138,0.023809204064455,0.995427596699273,4,34,protein tyrosine/serine/threonine phosphatase activity,MF,DUSP16;DUSP8;DUSP1;DUSP10
10198,GO:0042803,0.0238503990692406,0.986107388778434,26,530,protein homodimerization activity,MF,BHLHE40;PTGS2;NFKB1;ODC1;IRAK2;GADD45A;SQSTM1;JUN;NAMPT;BCL2L2;ADRB2;CEBPB;HMGCS1;ALDH1A3;TMCC1;IL6ST;SMAD3;TFRC;RIPK2;PML;GCH1;OXCT1;RELA;TDG;ERN1;TAP1
9624,GO:0036491,0.0238743786147542,0.998564181306855,2,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,PPP1R15A;PPP1R15B
19915,GO:2000404,0.0238862157444583,0.996828033601906,3,20,regulation of T cell migration,BP,CCL20;ADAM8;WNT5A
19249,GO:1905404,0.0238954466997762,1,1,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,CD274
5177,GO:0015732,0.0239412878439146,0.998504220348138,2,8,prostaglandin transport,BP,IL1B;EDN1
12562,GO:0050711,0.0239891998975619,0.998499616478213,2,8,negative regulation of interleukin-1 secretion,BP,ZC3H12A;PML
6986,GO:0030662,0.0241360146572052,0.990944837170828,9,127,coated vesicle membrane,CC,HBEGF;TGFA;ADRB2;LDLR;TFRC;AREG;IL7R;HLA-E;WNT5A
15877,GO:0072604,0.0242074353367349,0.996787370795175,3,19,interleukin-6 secretion,BP,IL1B;ZC3H12A;IFIH1
2259,GO:0005172,0.0242204384766323,0.998477325579293,2,8,vascular endothelial growth factor receptor binding,MF,VEGFC;ITGA5
8606,GO:0034116,0.0242678521069169,0.998472740464928,2,8,positive regulation of heterotypic cell-cell adhesion,BP,IL1B;TNF
17228,GO:0110020,0.0243705730975923,0.993093404251082,6,63,regulation of actomyosin structure organization,BP,SDC4;EDN1;PHLDB2;TACSTD2;SMAD3;SLC9A1
14884,GO:0070673,0.0243725113514982,0.998462601955694,2,8,response to interleukin-18,BP,CLDN1;RIPK2
12397,GO:0048839,0.0243909099170236,0.991492917561871,8,99,inner ear development,BP,SDC4;BMP2;ALDH1A3;JAG1;SOX9;PTPN11;WNT5A;INSIG1
19072,GO:1904950,0.0244399438747192,0.991448466437415,8,108,negative regulation of establishment of protein localization,BP,IL1B;ZC3H12A;TNF;PIM3;PML;PTPN11;SOX4;INSIG1
11295,GO:0045606,0.0244651169936782,0.996721250468657,3,20,positive regulation of epidermal cell differentiation,BP,TRIM16;CYP27B1;SFN
1310,GO:0003156,0.0244826907729275,0.996717992965246,3,20,regulation of animal organ formation,BP,BMP2;PIM1;WNT5A
12758,GO:0051023,0.0244984867834073,0.998407874563699,2,9,regulation of immunoglobulin secretion,BP,TNF;HLA-E
7759,GO:0032274,0.0245199027992581,0.998504024505195,2,7,gonadotropin secretion,BP,INHBA;TBX3
14743,GO:0070417,0.024526206646819,0.998503432681818,2,7,cellular response to cold,BP,NFKBIA;SLC9A1
10805,GO:0044291,0.0245608797569022,0.994057687276378,5,45,cell-cell contact zone,CC,RAP2B;SLC9A1;VCL;TMEM65;YWHAH
950,GO:0002367,0.0245852070491823,0.994002106207339,5,52,cytokine production involved in immune response,BP,TNF;SEMA7A;BCL10;CD55;WNT5A
8185,GO:0032922,0.0245921133677864,0.994040337656624,5,46,circadian regulation of gene expression,BP,BHLHE40;NOCT;RELB;NAMPT;PML
12985,GO:0051385,0.0245922613380947,0.996697661803222,3,20,response to mineralocorticoid,BP,FOSL1;EDN1;CDKN1A
7989,GO:0032604,0.0246080862093574,0.998439693583193,2,8,granulocyte macrophage colony-stimulating factor production,BP,IL1B;IL23A
8015,GO:0032645,0.0246080862093574,0.998439693583193,2,8,regulation of granulocyte macrophage colony-stimulating factor production,BP,IL1B;IL23A
14839,GO:0070585,0.0246826150645177,0.990114130482145,10,161,protein localization to mitochondrion,BP,PMAIP1;UGCG;BBC3;USP36;PLAGL2;TP53BP2;NRG1;YWHAH;YWHAG;SFN
3280,GO:0006968,0.0246993118639255,0.996696728910026,3,19,cellular defense response,BP,FOSL1;BCL10;RELA
1171,GO:0002792,0.0247309487855342,0.992939327992722,6,69,negative regulation of peptide secretion,BP,IL1B;ZC3H12A;TNF;PIM3;PML;PTPN11
8056,GO:0032715,0.0247484494272501,0.996687634115989,3,19,negative regulation of interleukin-6 production,BP,TNFAIP3;ZC3H12A;TNF
15746,GO:0072332,0.0247900708428547,0.992902290232427,6,73,intrinsic apoptotic signaling pathway by p53 class mediator,BP,PMAIP1;CDKN1A;BCL3;TP53BP2;PML;AEN
18233,GO:1903036,0.0247942144486881,0.99517902308694,4,34,positive regulation of response to wounding,BP,HBEGF;F3;PPARD;NFE2L2
3646,GO:0008120,0.0248162158720967,1,1,1,ceramide glucosyltransferase activity,MF,UGCG
17168,GO:0102769,0.0248162158720967,1,1,1,dihydroceramide glucosyltransferase activity,MF,UGCG
719,GO:0001942,0.0248311370234931,0.992917805655152,6,66,hair follicle development,BP,INHBA;TNF;SOX9;FERMT1;WNT5A;RELA
7127,GO:0030949,0.0249184990539548,0.998466437998864,2,7,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,IL1B;ITGA5
16390,GO:0097006,0.0249580057440606,0.993893481114693,5,51,regulation of plasma lipoprotein particle levels,BP,EHD1;LDLR;LIPG;PLAGL2;ABCA5
8721,GO:0034368,0.0250711017070248,0.99835031552173,2,9,protein-lipid complex remodeling,BP,LIPG;ABCA5
8722,GO:0034369,0.0250711017070248,0.99835031552173,2,9,plasma lipoprotein particle remodeling,BP,LIPG;ABCA5
1212,GO:0002876,0.0251364975008161,1,1,1,positive regulation of chronic inflammatory response to antigenic stimulus,BP,TNF
1239,GO:0002925,0.0251364975008161,1,1,1,positive regulation of humoral immune response mediated by circulating immunoglobulin,BP,TNF
14169,GO:0061048,0.0251364975008161,1,1,1,negative regulation of branching involved in lung morphogenesis,BP,TNF
15849,GO:0072564,0.0251364975008161,1,1,1,blood microparticle formation,BP,TNF
19098,GO:1904999,0.0251364975008161,1,1,1,positive regulation of leukocyte adhesion to arterial endothelial cell,BP,TNF
19865,GO:2000332,0.0251364975008161,1,1,1,regulation of blood microparticle formation,BP,TNF
19866,GO:2000334,0.0251364975008161,1,1,1,positive regulation of blood microparticle formation,BP,TNF
19283,GO:1905475,0.0251800911638732,0.990485786542431,9,126,regulation of protein localization to membrane,BP,PMAIP1;EPHA2;SQSTM1;BBC3;TP53BP2;PDPK1;YWHAH;YWHAG;SFN
5354,GO:0016114,0.0251987870871729,0.998381718776761,2,8,terpenoid biosynthetic process,BP,HMGCS1;ALDH1A3
13100,GO:0051608,0.0252158221419316,0.998335652598942,2,9,histamine transport,BP,CSF2;EDN1
190,GO:0000407,0.0252613481223994,0.99508209890581,4,32,phagophore assembly site,CC,PLEKHF1;SQSTM1;VMP1;STX12
7843,GO:0032398,0.0252617180224434,1,1,1,MHC class Ib protein complex,CC,HLA-E
8011,GO:0032639,0.0252617180224434,1,1,1,TRAIL production,BP,HLA-E
8035,GO:0032679,0.0252617180224434,1,1,1,regulation of TRAIL production,BP,HLA-E
8080,GO:0032759,0.0252617180224434,1,1,1,positive regulation of TRAIL production,BP,HLA-E
19984,GO:2000566,0.0252617180224434,1,1,1,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,HLA-E
20248,GO:2001187,0.0252617180224434,1,1,1,positive regulation of CD8-positive, alpha-beta T cell activation,BP,HLA-E
9312,GO:0035770,0.0254595436518047,0.98925146700782,11,169,ribonucleoprotein granule,CC,NFKBIZ;ZC3H12A;NOCT;SQSTM1;ZFP36L1;RC3H1;ZFP36;LARP4B;PNRC1;SAMD4A;PABPC4
1266,GO:0003018,0.0254661923569757,0.991801616480896,7,84,vascular process in circulatory system,BP,PTGS2;EDN1;ADRB2;SOD2;PPARD;GCH1;ADM
2674,GO:0006024,0.0254807266842894,0.991803462799324,7,82,glycosaminoglycan biosynthetic process,BP,IL1B;SDC4;NFKB1;HAS3;B4GALT1;B3GNT2;DSE
9329,GO:0035809,0.0255791704374869,0.998343985403354,2,8,regulation of urine volume,BP,EDN1;ADM
3695,GO:0008202,0.0255941378954317,0.98870857478711,12,197,steroid metabolic process,BP,IL1B;TNF;NFKB1;BMP2;HMGCS1;LDLR;PPARD;CYP27B1;SQLE;ADM;INSIG1;YWHAH
16142,GO:0090154,0.0257129460173135,0.998330640974179,2,8,positive regulation of sphingolipid biosynthetic process,BP,TNF;SMPD3
19842,GO:2000304,0.0257129460173135,0.998330640974179,2,8,positive regulation of ceramide biosynthetic process,BP,TNF;SMPD3
6698,GO:0030073,0.0257240761897866,0.990246326429783,9,125,insulin secretion,BP,IL1B;TNF;IL1RN;PIM3;PPARD;STX1A;PTPN11;SOX4;OXCT1
1111,GO:0002698,0.0258177225879226,0.992547580271608,6,71,negative regulation of immune effector process,BP,TNF;RC3H1;DUSP10;CD55;IL7R;HLA-E
11084,GO:0045085,0.0258607882400785,1,1,1,negative regulation of interleukin-2 biosynthetic process,BP,ZFP36
16839,GO:0098745,0.0258607882400785,1,1,1,Dcp1-Dcp2 complex,CC,ZFP36
17777,GO:1901834,0.0258607882400785,1,1,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,ZFP36
17778,GO:1901835,0.0258607882400785,1,1,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,ZFP36
18764,GO:1904246,0.0258607882400785,1,1,1,negative regulation of polynucleotide adenylyltransferase activity,BP,ZFP36
13915,GO:0060563,0.0258688052667265,0.994915206805144,4,33,neuroepithelial cell differentiation,BP,BMP2;CEBPB;JAG1;SOX4
11512,GO:0046007,0.0259435016074244,0.998307552334145,2,8,negative regulation of activated T cell proliferation,BP,CD274;RC3H1
442,GO:0001190,0.0260329928893042,0.993588948165249,5,47,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,KDM6B;JUN;CREB1;SOX4;KDM6A
15364,GO:0071604,0.0261340403160609,0.996451108983922,3,18,transforming growth factor beta production,BP,PTGS2;SMAD3;CREB1
11218,GO:0045352,0.0262343389842134,1,1,1,interleukin-1 Type I receptor antagonist activity,MF,IL1RN
11219,GO:0045353,0.0262343389842134,1,1,1,interleukin-1 Type II receptor antagonist activity,MF,IL1RN
3130,GO:0006713,0.0262991622842225,1,1,1,glucocorticoid catabolic process,BP,YWHAH
10050,GO:0042533,0.0263078095847828,0.998270837462512,2,8,tumor necrosis factor biosynthetic process,BP,ERRFI1;BCL3
10051,GO:0042534,0.0263078095847828,0.998270837462512,2,8,regulation of tumor necrosis factor biosynthetic process,BP,ERRFI1;BCL3
15047,GO:0070997,0.0264066689000838,0.987472899673534,14,234,neuron death,BP,BTG2;REL;EFNB2;JUN;CEBPB;SOD2;ADAM8;CREB1;SLC9A1;USP53;TP53BP2;NCOA7;WNT5A;PDPK1
2124,GO:0004917,0.0264467176326894,1,1,1,interleukin-7 receptor activity,MF,IL7R
2088,GO:0004850,0.0265018314403138,1,1,1,uridine phosphorylase activity,MF,UPP1
2785,GO:0006218,0.0265018314403138,1,1,1,uridine catabolic process,BP,UPP1
11563,GO:0046108,0.0265018314403138,1,1,1,uridine metabolic process,BP,UPP1
1010,GO:0002483,0.026569317222978,0.998244308480003,2,8,antigen processing and presentation of endogenous peptide antigen,BP,HLA-E;TAP1
6357,GO:0021536,0.0265997798472876,0.994726521581697,4,33,diencephalon development,BP,ETS1;BMP2;CREB1;WNT5A
12583,GO:0050746,0.0267302477570928,0.99822791054581,2,8,regulation of lipoprotein metabolic process,BP,LIPG;ITGAV
3834,GO:0008432,0.0267627057775586,0.998224596607641,2,8,JUN kinase binding,MF,DUSP10;SPAG9
13583,GO:0060047,0.026823465066014,0.989755148146987,9,125,heart contraction,BP,ZC3H12A;HBEGF;EDN1;MAP2K3;NEDD4L;SLC9A1;GCH1;TMEM65;ADM
11323,GO:0045647,0.026830545243186,0.998217663058222,2,8,negative regulation of erythrocyte differentiation,BP,ZFP36L1;ZFP36
6558,GO:0021988,0.0268326131869776,0.99631902806971,3,18,olfactory lobe development,BP,SEMA7A;DLX2;WNT5A
10652,GO:0043691,0.0268869944784351,0.998211886238045,2,8,reverse cholesterol transport,BP,LIPG;ABCA5
7937,GO:0032515,0.026942625919858,0.994614975006047,4,35,negative regulation of phosphoprotein phosphatase activity,BP,TNF;PPP1R15A;PPP1R10;SH3RF2
16178,GO:0090199,0.0269483667486549,0.994567559977857,4,40,regulation of release of cytochrome c from mitochondria,BP,PLAUR;PPIF;PMAIP1;BBC3
8232,GO:0032996,0.0270104649386476,1,1,1,Bcl3-Bcl10 complex,CC,BCL3
11081,GO:0045082,0.0270104649386476,1,1,1,positive regulation of interleukin-10 biosynthetic process,BP,BCL3
4650,GO:0010771,0.0270298826202984,0.992150413493197,6,64,negative regulation of cell morphogenesis involved in differentiation,BP,EFNA1;SEMA7A;TACSTD2;CORO1C;WNT5A;YWHAH
4759,GO:0010935,0.0270787601170711,0.998192211393638,2,8,regulation of macrophage cytokine production,BP,SEMA7A;WNT5A
12192,GO:0048340,0.0271441494903385,0.998250479254065,2,7,paraxial mesoderm morphogenesis,BP,SMAD3;WNT5A
1269,GO:0003044,0.0271736169664328,0.99618903643479,3,21,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,EDN1;ADRB2;SOD2
13981,GO:0060688,0.0271829579193726,0.994563066572164,4,34,regulation of morphogenesis of a branching structure,BP,TNF;TACSTD2;SOX9;WNT5A
10267,GO:0043008,0.0273255782858407,0.99816677433094,2,8,ATP-dependent protein binding,MF,PLK2;STX1A
18856,GO:1904469,0.0273545562080864,0.998229536503626,2,7,positive regulation of tumor necrosis factor secretion,BP,WNT5A;IFIH1
2104,GO:0004871,0.0273647789379954,0.982846024962866,33,678,signal transducer activity,MF,PLAUR;TICAM1;SDC4;HCAR2;TNFRSF10B;EPHA2;IFNGR2;MAP2K3;RGMB;CLDN4;RELT;RND3;ADRB2;IL6ST;HCAR3;OXSR1;SMAD3;PLK2;F3;PPARD;BDKRB1;IFNAR2;ANTXR2;RIPK2;ITGAV;NRG1;MAP3K8;RHOB;NFKBIB;IL7R;OSMR;TNFRSF10A;GPR156
14021,GO:0060740,0.0274210316768164,0.996206696013055,3,18,prostate gland epithelium morphogenesis,BP,SOX9;FEM1B;WNT5A
16294,GO:0090398,0.0274589946244915,0.993105408972648,5,52,cellular senescence,BP,TBX3;CDKN1A;PLK2;PML;CDK6
2004,GO:0004726,0.027716608656968,0.998126213323239,2,8,non-membrane spanning protein tyrosine phosphatase activity,MF,DUSP1;PTPN11
7528,GO:0031731,0.0277378770521991,0.99980543986188,1,2,CCR6 chemokine receptor binding,MF,CCL20
1542,GO:0003933,0.0277757335629411,1,1,1,GTP cyclohydrolase activity,MF,GCH1
1543,GO:0003934,0.0277757335629411,1,1,1,GTP cyclohydrolase I activity,MF,GCH1
9428,GO:0035998,0.0277757335629411,1,1,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,GCH1
2096,GO:0004860,0.0278322335968483,0.991826563688608,6,71,protein kinase inhibitor activity,MF,TRIB1;CDKN1A;CDKN2B;SOCS3;YWHAG;SFN
12651,GO:0050852,0.0278946524004999,0.989240814011371,9,140,T cell receptor signaling pathway,BP,NFKBIA;ZC3H12A;NFKB1;BCL10;CYLD;RC3H1;RIPK2;PDPK1;RELA
3293,GO:0006987,0.0279673949353325,0.998100031610478,2,8,activation of signaling protein activity involved in unfolded protein response,BP,PTPN1;ERN1
7940,GO:0032526,0.028033519620398,0.991753800955772,6,71,response to retinoic acid,BP,TRIM16;DUSP1;GJB3;SOX9;ABL2;WNT5A
18384,GO:1903391,0.0281134303384715,0.992935982394367,5,47,regulation of adherens junction organization,BP,SDC4;PHLDB2;SMAD3;SLC9A1;CORO1C
8353,GO:0033218,0.0281573455285709,0.987403442250229,12,198,amide binding,MF,NFKBIA;INHBA;PPIF;ADRB2;LDLR;BDKRB1;ITGAV;HLA-E;NUP153;ITM2B;IPO4;TAP1
11780,GO:0046638,0.0282317768539061,0.995981915941717,3,21,positive regulation of alpha-beta T cell differentiation,BP,CD83;IL23A;RIPK2
1028,GO:0002532,0.028300013147344,0.994257281506546,4,35,production of molecular mediator involved in inflammatory response,BP,ZC3H12A;TICAM1;DUSP10;SLC7A2
16854,GO:0098773,0.0284270464627844,0.991626131054879,6,68,skin epidermis development,BP,INHBA;TNF;SOX9;FERMT1;WNT5A;RELA
773,GO:0002025,0.0284910992726588,1,1,1,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,ADRB2
2135,GO:0004939,0.0284910992726588,1,1,1,beta-adrenergic receptor activity,MF,ADRB2
2136,GO:0004941,0.0284910992726588,1,1,1,beta2-adrenergic receptor activity,MF,ADRB2
12981,GO:0051380,0.0284910992726588,1,1,1,norepinephrine binding,MF,ADRB2
14478,GO:0061884,0.0284910992726588,1,1,1,regulation of mini excitatory postsynaptic potential,BP,ADRB2
14479,GO:0061885,0.0284910992726588,1,1,1,positive regulation of mini excitatory postsynaptic potential,BP,ADRB2
16880,GO:0098816,0.0284910992726588,1,1,1,mini excitatory postsynaptic potential,BP,ADRB2
635,GO:0001822,0.0285250513784792,0.987237607659885,12,182,kidney development,BP,SDC4;ODC1;EFNB2;LIF;BMP2;OVOL1;TACSTD2;SMAD3;JAG1;SOX9;SOX4;ADAMTS1
138,GO:0000288,0.0285282897878053,0.991569686742557,6,72,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,BTG2;NOCT;ZFP36L1;RC3H1;ZFP36;SAMD4A
10709,GO:0044003,0.0286322329133152,0.99418061253076,4,34,modification by symbiont of host morphology or physiology,BP,ZC3H12A;TNIP1;SMAD3;ITGAV
467,GO:0001505,0.0286361311536867,0.987692215610494,11,168,regulation of neurotransmitter levels,BP,IL1B;ZC3H12A;TICAM1;TNF;PTGS2;EDN1;SMAD3;STX1A;SLC7A2;GCH1;MAOA
14084,GO:0060900,0.0286501680189998,0.998098608876415,2,7,embryonic camera-type eye formation,BP,ALDH1A3;WNT5A
12783,GO:0051055,0.0286595765783984,0.994161581447933,4,35,negative regulation of lipid biosynthetic process,BP,NFKB1;BMP2;CYP27B1;INSIG1
17689,GO:1901566,0.0286684849874877,0.979725300550829,60,1531,organonitrogen compound biosynthetic process,BP,IL1B;IL1A;ZC3H12A;PLAUR;BTG2;HBEGF;INHBA;TICAM1;SDC4;TNF;CCL20;PTGS2;TNIP1;NFKB1;ODC1;PHLDA1;HAS3;CPEB2;NMNAT2;BCL3;NAMPT;AMPD3;ZFP36L1;ENC1;CEBPB;UGCG;PPP1R15A;EREG;B4GALT1;BCL10;B3GNT5;SGMS2;RC3H1;RAET1L;ZFP36;LARP4B;AZIN1;PPP1R15B;ITGAV;PANK3;GCH1;SOX4;EIF1;RBM3;SAMD4A;ADM;QKI;CELF1;PMM2;NUP153;NFE2L2;B3GNT2;SAT1;ALAS1;ITM2B;UPP1;PABPC4;DSE;AHCY;SMPD3
12618,GO:0050796,0.0286693829494746,0.98966573509134,8,107,regulation of insulin secretion,BP,IL1B;TNF;PIM3;PPARD;STX1A;PTPN11;SOX4;OXCT1
12650,GO:0050851,0.0287259331583192,0.988207634379727,10,161,antigen receptor-mediated signaling pathway,BP,NFKBIA;ZC3H12A;NFKB1;RUNX1;BCL10;CYLD;RC3H1;RIPK2;PDPK1;RELA
6579,GO:0022404,0.0288498504775222,0.991472607559073,6,68,molting cycle process,BP,INHBA;TNF;SOX9;FERMT1;WNT5A;RELA
6580,GO:0022405,0.0288498504775222,0.991472607559073,6,68,hair cycle process,BP,INHBA;TNF;SOX9;FERMT1;WNT5A;RELA
10369,GO:0043185,0.0288588691761349,1,1,1,vascular endothelial growth factor receptor 3 binding,MF,VEGFC
6363,GO:0021542,0.0289131469301785,0.998000123831427,2,8,dentate gyrus development,BP,BTG2;CDK6
8923,GO:0034766,0.0289510899692458,0.992636625571538,5,51,negative regulation of ion transmembrane transport,BP,PPIF;RRAD;CAB39;NEDD4L;OXSR1
2101,GO:0004866,0.0289896423860936,0.991379555729131,6,77,endopeptidase inhibitor activity,MF,BIRC3;SERPINB2;BIRC2;TFPI2;SERPINB8;SERPINB1
6889,GO:0030414,0.0289896423860936,0.991379555729131,6,77,peptidase inhibitor activity,MF,BIRC3;SERPINB2;BIRC2;TFPI2;SERPINB8;SERPINB1
18949,GO:1904707,0.0289933464115325,0.995875512615398,3,19,positive regulation of vascular smooth muscle cell proliferation,BP,TNF;JUN;ERN1
4900,GO:0014826,0.0289951529007397,1,1,1,vein smooth muscle contraction,BP,EDN1
6761,GO:0030185,0.0289951529007397,1,1,1,nitric oxide transport,BP,EDN1
7449,GO:0031583,0.0289951529007397,1,1,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,EDN1
7520,GO:0031705,0.0289951529007397,1,1,1,bombesin receptor binding,MF,EDN1
7521,GO:0031707,0.0289951529007397,1,1,1,endothelin A receptor binding,MF,EDN1
7522,GO:0031708,0.0289951529007397,1,1,1,endothelin B receptor binding,MF,EDN1
9335,GO:0035815,0.0289951529007397,1,1,1,positive regulation of renal sodium excretion,BP,EDN1
9950,GO:0042313,0.0289951529007397,1,1,1,protein kinase C deactivation,BP,EDN1
10365,GO:0043179,0.0289951529007397,1,1,1,rhythmic excitation,BP,EDN1
13922,GO:0060576,0.0290267818246252,0.997933110935531,2,9,intestinal epithelial cell development,BP,PRDM1;CDKN1A
7630,GO:0032028,0.029073216591107,1,1,1,myosin head/neck binding,MF,STX1A
1113,GO:0002700,0.0291085057950357,0.991358220355563,6,72,regulation of production of molecular mediator of immune response,BP,TNF;SEMA7A;BCL10;TFRC;HLA-E;WNT5A
1119,GO:0002706,0.0292001248725723,0.991320028221451,6,73,regulation of lymphocyte mediated immunity,BP,IL1B;TNF;IL23A;TFRC;IL7R;HLA-E
19821,GO:2000273,0.0292067455104496,0.995788292852001,3,21,positive regulation of signaling receptor activity,BP,TGFA;ADRB2;EREG
12352,GO:0048715,0.0292826467943047,0.997904973909938,2,9,negative regulation of oligodendrocyte differentiation,BP,DLX2;DUSP10
8621,GO:0034139,0.0294261790479497,0.9979451582951,2,8,regulation of toll-like receptor 3 signaling pathway,BP,TNFAIP3;PELI1
15431,GO:0071705,0.0294498571023697,0.978708690167972,69,1705,nitrogen compound transport,BP,NFKBIA;IL1B;IL1A;ZC3H12A;CSF2;TNF;PTGS2;EDN1;IL1RN;PANX1;HCAR2;NFKBIE;CDKN1A;CD274;BCL3;ZFP36L1;DUSP16;UGCG;TRIM16;EHD1;PPP1R10;PIM3;SLC6A14;ADAM8;VEGFC;PLK3;TFRC;PPARD;SLC25A25;USP36;ZFP36;AZIN1;PLAGL2;RIPK2;SAA1;ITGAV;STX1A;NRG1;PML;POU2F2;FERMT1;SLC7A2;SLC28A3;PTPN11;RHOB;SOX4;OXCT1;PTPN1;ATP6V1C2;HLA-E;RAB3IP;QKI;PMM2;WNT5A;NUP153;INSIG1;ADAM9;ADAMTS9;YWHAH;AGFG1;YWHAG;RAB22A;SFN;IFIH1;IPO4;TAP1;STX12;RAB24;SMPD3
7762,GO:0032277,0.0295914651895255,1,1,1,negative regulation of gonadotropin secretion,BP,INHBA
10555,GO:0043509,0.0295914651895255,1,1,1,activin A complex,CC,INHBA
10556,GO:0043511,0.0295914651895255,1,1,1,inhibin complex,CC,INHBA
10557,GO:0043512,0.0295914651895255,1,1,1,inhibin A complex,CC,INHBA
11076,GO:0045077,0.0295914651895255,1,1,1,negative regulation of interferon-gamma biosynthetic process,BP,INHBA
11875,GO:0046882,0.0295914651895255,1,1,1,negative regulation of follicle-stimulating hormone secretion,BP,INHBA
12120,GO:0048180,0.0295914651895255,1,1,1,activin complex,CC,INHBA
13717,GO:0060278,0.0295914651895255,1,1,1,regulation of ovulation,BP,INHBA
13718,GO:0060279,0.0295914651895255,1,1,1,positive regulation of ovulation,BP,INHBA
10270,GO:0043011,0.0296867733411274,0.997860253899555,2,9,myeloid dendritic cell differentiation,BP,CSF2;RELB
10113,GO:0042632,0.0297101766703452,0.993868148037979,4,36,cholesterol homeostasis,BP,EHD1;LDLR;LIPG;INSIG1
13524,GO:0055092,0.0297101766703452,0.993868148037979,4,36,sterol homeostasis,BP,EHD1;LDLR;LIPG;INSIG1
15745,GO:0072331,0.0297192396800508,0.985665259320439,14,247,signal transduction by p53 class mediator,BP,BTG2;PMAIP1;GADD45A;CDKN1A;BCL3;TAF4B;PLK2;PLK3;NDRG1;TP53BP2;PML;SOX4;AEN;SFN
2247,GO:0005158,0.0297403403207691,0.99575454073042,3,18,insulin receptor binding,MF,PTPN11;PTPN1;PDPK1
1263,GO:0003015,0.0297633702103005,0.988418206959409,9,127,heart process,BP,ZC3H12A;HBEGF;EDN1;MAP2K3;NEDD4L;SLC9A1;GCH1;TMEM65;ADM
2504,GO:0005753,0.0297902933501322,1,1,1,mitochondrial proton-transporting ATP synthase complex,CC,PPIF
4696,GO:0010849,0.0297902933501322,1,1,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,PPIF
19823,GO:2000276,0.0297902933501322,1,1,1,negative regulation of oxidative phosphorylation uncoupler activity,BP,PPIF
7876,GO:0032436,0.0298111173889589,0.991105712383971,6,71,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,RNF19B;TRIB1;PLK2;PLK3;RNF19A;NFE2L2
19425,GO:1990001,0.0299307183884488,0.997890579245967,2,8,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,BIRC3;BIRC2
6257,GO:0019838,0.0299420537040162,0.990023980180519,7,86,growth factor binding,MF,IL1RN;TRIM16;DUSP1;IL6ST;WISP1;ITGAV;OSMR
6590,GO:0022600,0.0299914391158137,0.993816141173889,4,34,digestive system process,BP,TJP2;LDLR;SOX9;SGK1
5105,GO:0015389,0.0300027538244917,1,1,1,pyrimidine- and adenine-specific:sodium symporter activity,MF,SLC28A3
5106,GO:0015390,0.0300027538244917,1,1,1,purine-specific nucleoside:sodium symporter activity,MF,SLC28A3
5107,GO:0015391,0.0300027538244917,1,1,1,nucleobase:cation symporter activity,MF,SLC28A3
7586,GO:0031952,0.0300526489672963,0.993812862487346,4,33,regulation of protein autophosphorylation,BP,ERRFI1;JUN;RAP2B;VEGFC
11014,GO:0044848,0.0301069266226584,0.997871396077611,2,8,biological phase,BP,FERMT1;WNT5A
11016,GO:0044851,0.0301069266226584,0.997871396077611,2,8,hair cycle phase,BP,FERMT1;WNT5A
12393,GO:0048819,0.0301069266226584,0.997871396077611,2,8,regulation of hair follicle maturation,BP,FERMT1;WNT5A
19114,GO:1905042,0.030150849668243,1,1,1,negative regulation of epithelium regeneration,BP,DUSP10
12884,GO:0051216,0.030154678160442,0.989035261366953,8,104,cartilage development,BP,EDN1;BMP2;RUNX1;DLX2;SMAD3;SOX9;WNT5A;RELA
13237,GO:0051897,0.0302599671255441,0.989895857261568,7,86,positive regulation of protein kinase B signaling,BP,HBEGF;TNF;EREG;ADAM8;F3;NRG1;PTPN11
4864,GO:0014704,0.0302770770924838,0.993766507948781,4,32,intercalated disc,CC,SLC9A1;VCL;TMEM65;YWHAH
11341,GO:0045665,0.0303028201764949,0.987484232140919,10,144,negative regulation of neuron differentiation,BP,EFNA1;SEMA7A;EFNB2;DLX2;PLK2;JAG1;SOX9;PRPF19;WNT5A;YWHAH
4640,GO:0010761,0.0303712509034383,0.993726753510147,4,33,fibroblast migration,BP,SDC4;PIP5K1A;PML;CORO1C
14151,GO:0061028,0.0304818011043246,0.99369680553546,4,33,establishment of endothelial barrier,BP,IL1B;TNF;CLDN1;TJP2
1344,GO:0003205,0.0305117283054384,0.988887409858058,8,102,cardiac chamber development,BP,PRDM1;TBX3;JAG1;NRG1;SOX4;ADAMTS1;TMEM65;WNT5A
6163,GO:0019510,0.0305350079362129,1,1,1,S-adenosylhomocysteine catabolic process,BP,AHCY
15154,GO:0071268,0.0305350079362129,1,1,1,homocysteine biosynthetic process,BP,AHCY
18348,GO:1903317,0.0305352281676198,0.992108794652964,5,53,regulation of protein maturation,BP,BIRC3;BIRC2;ADAM8;CD55;SOX4
11248,GO:0045453,0.030619936613905,0.99363299872566,4,35,bone resorption,BP,TNFAIP3;ADRB2;ADAM8;TFRC
4854,GO:0014065,0.0307545021033643,0.989700295115818,7,85,phosphatidylinositol 3-kinase signaling,BP,IER3;EDN1;ZFP36L1;PPARD;PIP5K1A;SOX9;NRG1
40,GO:0000082,0.0308164558028385,0.985524192496486,13,222,G1/S transition of mitotic cell cycle,BP,BTG2;INHBA;GADD45A;CDKN1A;CDKN2B;DCUN1D3;PLK2;PLK3;PML;SOX4;CDK6;BACH1;SFN
1106,GO:0002693,0.0308215531766075,0.997792955295958,2,8,positive regulation of cellular extravasation,BP,IL1A;ADAM8
17347,GO:1900036,0.030866408619382,1,1,1,positive regulation of cellular response to heat,BP,IER5
1512,GO:0003870,0.0308887775922613,1,1,1,5-aminolevulinate synthase activity,MF,ALAS1
5656,GO:0016749,0.0308887775922613,1,1,1,N-succinyltransferase activity,MF,ALAS1
9552,GO:0036314,0.0309215533610137,0.995490016973363,3,19,response to sterol,BP,INHBA;HMGCS1;INSIG1
3556,GO:0007598,0.0309853760648508,1,1,1,blood coagulation, extrinsic pathway,BP,F3
6878,GO:0030371,0.0309928710459387,0.995449894210909,3,20,translation repressor activity,MF,CPEB2;SAMD4A;CELF1
16271,GO:0090335,0.0310055573356535,0.997772592146859,2,8,regulation of brown fat cell differentiation,BP,PTGS2;DUSP10
13056,GO:0051543,0.0310297771437014,1,1,1,regulation of elastin biosynthetic process,BP,HBEGF
13057,GO:0051545,0.0310297771437014,1,1,1,negative regulation of elastin biosynthetic process,BP,HBEGF
18955,GO:1904716,0.0310961623794168,1,1,1,positive regulation of chaperone-mediated autophagy,BP,PLK3
11860,GO:0046849,0.0310997762644307,0.991939605582418,5,51,bone remodeling,BP,TNFAIP3;EPHA2;ADRB2;ADAM8;TFRC
15216,GO:0071372,0.0311545827158902,0.997756050381072,2,8,cellular response to follicle-stimulating hormone stimulus,BP,INHBA;HMGCS1
9629,GO:0036497,0.0311915940256428,1,1,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,PPP1R15A
17959,GO:1902310,0.0311915940256428,1,1,1,positive regulation of peptidyl-serine dephosphorylation,BP,PPP1R15A
18627,GO:1903916,0.0311915940256428,1,1,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,PPP1R15A
18628,GO:1903917,0.0311915940256428,1,1,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,PPP1R15A
6490,GO:0021840,0.0311989125060511,1,1,1,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,NRG1
6491,GO:0021842,0.0311989125060511,1,1,1,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,NRG1
6845,GO:0030309,0.031205367967377,0.997689183634437,2,9,poly-N-acetyllactosamine metabolic process,BP,B3GNT5;B3GNT2
6846,GO:0030311,0.031205367967377,0.997689183634437,2,9,poly-N-acetyllactosamine biosynthetic process,BP,B3GNT5;B3GNT2
13884,GO:0060512,0.0312080545389268,0.995431887311251,3,19,prostate gland morphogenesis,BP,SOX9;FEM1B;WNT5A
16873,GO:0098805,0.0312222039442421,0.978326402107517,52,1197,whole membrane,CC,PLAUR;BIRC3;HBEGF;PLAU;TICAM1;SDC4;TNF;PTGS2;PMAIP1;PLEKHF1;TGFA;IRAK2;RAP2B;BIRC2;RGMB;BCL2L2;ADRB2;PPP1R15A;EHD1;B4GALT1;BCL10;VMP1;ADAM8;LDLR;TFRC;EFNB1;SLC9A1;CYP27B1;CD55;ANTXR2;NAV3;NDRG1;ITGAV;STX1A;PML;EFHD2;RHOB;ABCA5;AREG;IL7R;CORO1C;STEAP4;ATP6V1C2;HLA-E;WNT5A;MAOA;RAB22A;ITM2B;MYO1B;TAP1;STX12;RAB24
1285,GO:0003085,0.0312333989842979,0.997685981382017,2,9,negative regulation of systemic arterial blood pressure,BP,ADRB2;SOD2
3429,GO:0007219,0.0312493769091772,0.987732381656355,9,128,Notch signaling pathway,BP,NFKBIA;ELF3;BMP2;IL6ST;DLX2;JAG1;NRARP;SOX9;NOTCH2NL
7780,GO:0032303,0.0312740844165902,0.997681330640122,2,9,regulation of icosanoid secretion,BP,IL1B;EDN1
3282,GO:0006971,0.0313551690917807,0.997733715420824,2,8,hypotonic response,BP,CAB39;OXSR1
17666,GO:1901522,0.0313953672167339,0.995367646303781,3,20,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,BMP2;NFE2L2;RELA
9623,GO:0036490,0.0314005402188713,0.997728652308981,2,8,regulation of translation in response to endoplasmic reticulum stress,BP,PPP1R15A;PPP1R15B
4578,GO:0010662,0.0314668171047052,0.995353000974807,3,20,regulation of striated muscle cell apoptotic process,BP,PPP1R10;PDPK1;NFE2L2
17585,GO:1901215,0.031477002358337,0.987622015589217,9,130,negative regulation of neuron death,BP,BTG2;REL;JUN;CEBPB;SOD2;ADAM8;CREB1;NCOA7;PDPK1
9865,GO:0042119,0.0317447831791111,0.983018957540071,18,356,neutrophil activation,BP,CXCL1;PLAUR;PLAU;CXCL8;NFKB1;CAB39;RAP2B;AMPD3;B4GALT1;ADAM8;SERPINB1;CD55;ITGAV;VCL;COTL1;CTSC;CREG1;RAB24
6064,GO:0019210,0.0318436623696999,0.990342358323783,6,73,kinase inhibitor activity,MF,TRIB1;CDKN1A;CDKN2B;SOCS3;YWHAG;SFN
1335,GO:0003188,0.0319667968337509,0.997665118135445,2,8,heart valve formation,BP,EFNA1;SOX9
1844,GO:0004498,0.0319844468901065,1,1,1,calcidiol 1-monooxygenase activity,MF,CYP27B1
4575,GO:0010659,0.0320088548925758,0.995241458822176,3,20,cardiac muscle cell apoptotic process,BP,PPP1R10;PDPK1;NFE2L2
3228,GO:0006883,0.0320531853792126,0.997655369507326,2,8,cellular sodium ion homeostasis,BP,NEDD4L;SLC9A1
508,GO:0001570,0.0321538078111549,0.991610304730183,5,49,vasculogenesis,BP,JUNB;ZFP36L1;ITGAV;ADM;QKI
8720,GO:0034367,0.0322080484747233,0.997523030971275,2,10,protein-containing complex remodeling,BP,LIPG;ABCA5
4606,GO:0010720,0.0322348594363092,0.982436292803507,19,341,positive regulation of cell development,BP,EDN1;SEMA7A;LIF;TRIB1;KCTD11;BMP2;ENC1;IL6ST;DLX2;VEGFC;NEDD4L;NRG1;SPAG9;SKIL;PRPF19;ABL2;WNT5A;NFE2L2;RELA
5901,GO:0018105,0.0322505092590517,0.984769812780781,13,210,peptidyl-serine phosphorylation,BP,TNF;PTGS2;LIF;IL24;CAB39;MAST4;PLK2;RIPK2;PHKG2;WNT5A;PDPK1;SGK1;ERN1
898,GO:0002275,0.0324232505018224,0.98229578987462,19,380,myeloid cell activation involved in immune response,BP,CXCL1;PLAUR;PLAU;TICAM1;NFKB1;CAB39;RAP2B;AMPD3;B4GALT1;ADAM8;SERPINB1;CD55;ITGAV;VCL;COTL1;PDPK1;CTSC;CREG1;RAB24
14023,GO:0060743,0.0324237668443635,1,1,1,epithelial cell maturation involved in prostate gland development,BP,FEM1B
2738,GO:0006117,0.0325818214426498,1,1,1,acetaldehyde metabolic process,BP,RELA
9170,GO:0035525,0.0325818214426498,1,1,1,NF-kappaB p50/p65 complex,CC,RELA
10236,GO:0042942,0.0326052120331611,1,1,1,D-serine transport,BP,NFKBIE
2102,GO:0004867,0.0326141311664048,0.993025601833487,4,40,serine-type endopeptidase inhibitor activity,MF,SERPINB2;TFPI2;SERPINB8;SERPINB1
8285,GO:0033091,0.0326585308431476,1,1,1,positive regulation of immature T cell proliferation,BP,RIPK2
1332,GO:0003183,0.0327409426292479,0.997577234409126,2,8,mitral valve morphogenesis,BP,EFNA1;SOX4
14137,GO:0061000,0.0327445110842491,0.997576826580432,2,8,negative regulation of dendritic spine development,BP,EFNA1;PLK2
4821,GO:0014014,0.0327539837479055,0.99503953592392,3,22,negative regulation of gliogenesis,BP,DLX2;LDLR;DUSP10
11306,GO:0045624,0.0328272666016486,0.997449188371704,2,10,positive regulation of T-helper cell differentiation,BP,IL23A;RIPK2
7854,GO:0032413,0.0328399801446274,0.993007769954862,4,36,negative regulation of ion transmembrane transporter activity,BP,RRAD;CAB39;NEDD4L;OXSR1
4671,GO:0010818,0.0328918934885646,0.99749367862017,2,9,T cell chemotaxis,BP,WNT5A;CXCL16
4761,GO:0010939,0.0329025336002502,0.994968963428614,3,24,regulation of necrotic cell death,BP,BIRC3;PPIF;BIRC2
13995,GO:0060706,0.0330637790403243,0.994996999902192,3,21,cell differentiation involved in embryonic placenta development,BP,PRDM1;LIF;SOCS3
2970,GO:0006509,0.0330781146272305,0.992941162420002,4,36,membrane protein ectodomain proteolysis,BP,IL1B;TNF;ADAM8;ADAM9
11290,GO:0045601,0.0331836630009984,0.99499706690148,3,20,regulation of endothelial cell differentiation,BP,IL1B;TNF;JAG1
4589,GO:0010692,0.0333381120919291,0.997508639311723,2,8,regulation of alkaline phosphatase activity,BP,TNF;SMAD3
4525,GO:0010586,0.0333946955774125,0.994927281584387,3,21,miRNA metabolic process,BP,ZC3H12A;NFKB1;RELA
19122,GO:1905062,0.0334215484168876,1,1,1,positive regulation of cardioblast proliferation,BP,PIM1
6679,GO:0030038,0.0334313843688231,0.989774435465986,6,68,contractile actin filament bundle assembly,BP,SDC4;PHLDB2;TACSTD2;SMAD3;SLC9A1;TNFAIP1
10347,GO:0043149,0.0334313843688231,0.989774435465986,6,68,stress fiber assembly,BP,SDC4;PHLDB2;TACSTD2;SMAD3;SLC9A1;TNFAIP1
13664,GO:0060174,0.0334354042271648,0.997497397820088,2,8,limb bud formation,BP,SOX9;SOX4
9554,GO:0036316,0.0334591764016619,1,1,1,SREBP-SCAP complex retention in endoplasmic reticulum,BP,INSIG1
17616,GO:1901303,0.0334591764016619,1,1,1,negative regulation of cargo loading into COPII-coated vesicle,BP,INSIG1
11472,GO:0045927,0.0335341266401305,0.985223226066845,11,171,positive regulation of growth,BP,HBEGF;EDN1;SEMA7A;NEDD4L;PIM1;CREB1;PPARD;SLC9A1;NRG1;SFN;CXCL16
11510,GO:0045995,0.0335467233269647,0.988553938909071,7,86,regulation of embryonic development,BP,NOCT;IL1RN;PHLDA2;PHLDB2;NRARP;WNT5A;NFE2L2
10488,GO:0043385,0.033614745124728,1,1,1,mycotoxin metabolic process,BP,NFE2L2
10489,GO:0043387,0.033614745124728,1,1,1,mycotoxin catabolic process,BP,NFE2L2
11606,GO:0046222,0.033614745124728,1,1,1,aflatoxin metabolic process,BP,NFE2L2
11607,GO:0046223,0.033614745124728,1,1,1,aflatoxin catabolic process,BP,NFE2L2
17643,GO:1901376,0.033614745124728,1,1,1,organic heteropentacyclic compound metabolic process,BP,NFE2L2
17644,GO:1901377,0.033614745124728,1,1,1,organic heteropentacyclic compound catabolic process,BP,NFE2L2
18564,GO:1903786,0.033614745124728,1,1,1,regulation of glutathione biosynthetic process,BP,NFE2L2
18565,GO:1903788,0.033614745124728,1,1,1,positive regulation of glutathione biosynthetic process,BP,NFE2L2
9937,GO:0042288,0.0336201545594042,0.997407490188654,2,9,MHC class I protein binding,MF,HLA-E;TAP1
13059,GO:0051547,0.0336261113926761,0.997475309475465,2,8,regulation of keratinocyte migration,BP,HBEGF;ADAM9
12415,GO:0048863,0.0336345075238229,0.98512480992693,11,200,stem cell differentiation,BP,EDN1;SEMA7A;LIF;RUNX1;TACSTD2;EFNB1;JAG1;SOX9;NRG1;CORO1C;NFE2L2
13025,GO:0051457,0.0338183718596347,0.994814154894218,3,22,maintenance of protein location in nucleus,BP,BCL3;PML;SOX4
17485,GO:1900407,0.0338403294864782,0.990997598711601,5,55,regulation of cellular response to oxidative stress,BP,TNF;SOD2;NCOA7;GCH1;NFE2L2
9420,GO:0035987,0.0339497170120991,0.992724187204987,4,34,endodermal cell differentiation,BP,INHBA;ITGA5;ITGAV;LAMB3
4541,GO:0010613,0.0340298321892743,0.994818835045382,3,20,positive regulation of cardiac muscle hypertrophy,BP,EDN1;IL6ST;SLC9A1
4881,GO:0014742,0.0340298321892743,0.994818835045382,3,20,positive regulation of muscle hypertrophy,BP,EDN1;IL6ST;SLC9A1
14306,GO:0061436,0.0340629056558119,0.994785642659093,3,21,establishment of skin barrier,BP,CLDN1;CLDN4;SFN
10427,GO:0043271,0.0340984157941452,0.989503701123211,6,71,negative regulation of ion transport,BP,PPIF;PTGS2;RRAD;CAB39;NEDD4L;OXSR1
6062,GO:0019208,0.0341018560076415,0.989496610592872,6,72,phosphatase regulator activity,MF,BMP2;PPP1R15A;ANKLE2;PPP1R10;PPP1R15B;SH3RF2
9184,GO:0035562,0.0341500648370693,0.997414260886908,2,8,negative regulation of chromatin binding,BP,BTAF1;TDG
20282,GO:2001244,0.0342613955687065,0.992520863137157,4,44,positive regulation of intrinsic apoptotic signaling pathway,BP,PMAIP1;PLEKHF1;PLAGL2;SKIL
7664,GO:0032092,0.0342927251494674,0.989418370073522,6,73,positive regulation of protein binding,BP,TICAM1;BMP2;PLK2;RIPK2;TRAF4;WNT5A
14974,GO:0070886,0.0343365954374374,0.997321672911589,2,9,positive regulation of calcineurin-NFAT signaling cascade,BP,SLC9A1;NRG1
17208,GO:0106058,0.0343365954374374,0.997321672911589,2,9,positive regulation of calcineurin-mediated signaling,BP,SLC9A1;NRG1
11463,GO:0045918,0.0343812039900403,0.999700062708033,1,2,negative regulation of cytolysis,BP,CSF2
15480,GO:0071827,0.0344149305376037,0.994686559317923,3,22,plasma lipoprotein particle organization,BP,LIPG;PLAGL2;ABCA5
3931,GO:0008610,0.0344419605840668,0.979460643080439,25,511,lipid biosynthetic process,BP,IL1B;PLAUR;TNF;PTGS2;NFKB1;EDN1;BMP2;UGCG;HMGCS1;ALDH1A3;B3GNT5;SGMS2;LDLR;CREB1;PPARD;CYP27B1;PIP5K1A;PTPN11;SQLE;PRPF19;ADM;QKI;INSIG1;ETNK1;SMPD3
8046,GO:0032693,0.0345289533590823,0.997242246203904,2,10,negative regulation of interleukin-10 production,BP,CD274;IL23A
4431,GO:0010260,0.0345300217206527,1,1,1,animal organ senescence,BP,ERO1A
14602,GO:0070165,0.0345300217206527,1,1,1,positive regulation of adiponectin secretion,BP,HCAR2
14817,GO:0070553,0.0345300217206527,1,1,1,nicotinic acid receptor activity,MF,HCAR2
18367,GO:1903362,0.0345459127147236,0.984068677619135,12,201,regulation of cellular protein catabolic process,BP,TNFAIP3;RNF19B;EFNA1;TRIB1;N4BP1;LDLR;PLK2;PLK3;PML;RNF19A;CTSC;NFE2L2
10973,GO:0044753,0.0345869087791525,1,1,1,amphisome,CC,SQSTM1
14000,GO:0060711,0.0346553390127852,0.992482817563812,4,37,labyrinthine layer development,BP,JUNB;ZFP36L1;SOCS3;ADM
693,GO:0001911,0.0346661039539633,0.997225313366147,2,10,negative regulation of leukocyte mediated cytotoxicity,BP,IL7R;HLA-E
989,GO:0002444,0.0346909481907934,0.980911187437355,19,383,myeloid leukocyte mediated immunity,BP,CXCL1;PLAUR;PLAU;NFKB1;CXCL5;CAB39;RAP2B;AMPD3;B4GALT1;ADAM8;SERPINB1;CD55;ITGAV;VCL;COTL1;PDPK1;CTSC;CREG1;RAB24
991,GO:0002446,0.0346973215514633,0.981245294542016,18,359,neutrophil mediated immunity,BP,CXCL1;PLAUR;PLAU;NFKB1;CXCL5;CAB39;RAP2B;AMPD3;B4GALT1;ADAM8;SERPINB1;CD55;ITGAV;VCL;COTL1;CTSC;CREG1;RAB24
2515,GO:0005767,0.0347028827560025,0.997220766197642,2,10,secondary lysosome,CC,SQSTM1;ADAM8
3543,GO:0007567,0.0347287652559153,0.997274268934955,2,9,parturition,BP,EDN1;MAFF
9524,GO:0036230,0.0347387630702949,0.981219595454515,18,360,granulocyte activation,BP,CXCL1;PLAUR;PLAU;CXCL8;NFKB1;CAB39;RAP2B;AMPD3;B4GALT1;ADAM8;SERPINB1;CD55;ITGAV;VCL;COTL1;CTSC;CREG1;RAB24
12842,GO:0051149,0.0348055597876754,0.990671321693656,5,55,positive regulation of muscle cell differentiation,BP,EDN1;EFNB2;EHD1;NRG1;SPAG9
8403,GO:0033344,0.0348083023126144,0.994601926203355,3,22,cholesterol efflux,BP,NFKBIA;ABCA5;STX12
14034,GO:0060760,0.0348315396174139,0.992432582935747,4,37,positive regulation of response to cytokine stimulus,BP,EDN1;RIPK2;WNT5A;IFIH1
4190,GO:0009266,0.0349645874351907,0.984480001385582,11,177,response to temperature stimulus,BP,NFKBIA;IL1A;PTGS2;TRPV3;CDKN1A;ADRB2;SLC9A1;IER5;ADM;NUP153;ERO1A
13159,GO:0051728,0.0350688344710356,1,1,1,cell cycle switching, mitotic to meiotic cell cycle,BP,OVOL1
13160,GO:0051729,0.0350688344710356,1,1,1,germline cell cycle switching, mitotic to meiotic cell cycle,BP,OVOL1
13669,GO:0060184,0.0350688344710356,1,1,1,cell cycle switching,BP,OVOL1
1849,GO:0004506,0.0350850383916425,1,1,1,squalene monooxygenase activity,MF,SQLE
6704,GO:0030101,0.0350980381578316,0.992320372488643,4,40,natural killer cell activation,BP,TICAM1;PRDM1;IL23A;ELF4
15873,GO:0072595,0.0351510676067284,0.992328560397921,4,38,maintenance of protein localization in organelle,BP,BCL3;PML;SOX4;INSIG1
11340,GO:0045664,0.0351820772209119,0.979739040309193,22,410,regulation of neuron differentiation,BP,EFNA1;SEMA7A;EFNB2;KCTD11;BMP2;ENC1;ZSWIM4;DLX2;NEDD4L;PLK2;JAG1;SOX9;NRG1;SPAG9;SKIL;PRPF19;ABL2;WNT5A;NFE2L2;YWHAH;YWHAG;PDLIM5
1410,GO:0003342,0.0352243203546794,1,1,1,proepicardium development,BP,ZFP36L1
1411,GO:0003343,0.0352243203546794,1,1,1,septum transversum development,BP,ZFP36L1
16590,GO:0097403,0.0352243203546794,1,1,1,cellular response to raffinose,BP,ZFP36L1
17679,GO:1901545,0.0352243203546794,1,1,1,response to raffinose,BP,ZFP36L1
16236,GO:0090287,0.0354621863765739,0.984237849792968,11,170,regulation of cellular response to growth factor stimulus,BP,IL1B;CDKN2B;VEGFC;SMAD3;ITGA5;ZNF451;FERMT1;SKIL;PTPN1;WNT5A;PDPK1
8076,GO:0032753,0.0355212025207513,0.997118895464168,2,10,positive regulation of interleukin-4 production,BP,CEBPB;HLA-E
9070,GO:0035308,0.0355462267066741,0.992215076415539,4,38,negative regulation of protein dephosphorylation,BP,TNF;PPP1R15A;PPP1R10;SH3RF2
10046,GO:0042501,0.0356187937844402,0.997106657781879,2,10,serine phosphorylation of STAT protein,BP,LIF;IL24
8086,GO:0032765,0.0356501158868219,1,1,1,positive regulation of mast cell cytokine production,BP,BCL10
12601,GO:0050774,0.0356723244796924,0.997158981246873,2,9,negative regulation of dendrite morphogenesis,BP,EFNA1;YWHAH
10550,GO:0043502,0.0356984029499609,0.99039323326555,5,52,regulation of muscle adaptation,BP,EDN1;ERRFI1;IL6ST;SMAD3;SLC9A1
10331,GO:0043124,0.0357764024168625,0.992190096168404,4,35,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,TNFAIP3;ZC3H12A;NFKBID;TNIP1
3396,GO:0007176,0.035810840303316,0.994384465538432,3,22,regulation of epidermal growth factor-activated receptor activity,BP,TGFA;ERRFI1;EREG
8970,GO:0035054,0.0358849918279083,1,1,1,embryonic heart tube anterior/posterior pattern specification,BP,BMP2
12769,GO:0051040,0.0358849918279083,1,1,1,regulation of calcium-independent cell-cell adhesion,BP,BMP2
12770,GO:0051042,0.0358849918279083,1,1,1,negative regulation of calcium-independent cell-cell adhesion,BP,BMP2
13636,GO:0060128,0.0358849918279083,1,1,1,corticotropin hormone secreting cell differentiation,BP,BMP2
14051,GO:0060804,0.0358849918279083,1,1,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,BMP2
14901,GO:0070724,0.0358849918279083,1,1,1,BMP receptor complex,CC,BMP2
14209,GO:0061135,0.0358886693739849,0.988760386255878,6,82,endopeptidase regulator activity,MF,BIRC3;SERPINB2;BIRC2;TFPI2;SERPINB8;SERPINB1
7684,GO:0032127,0.0358948388853193,1,1,1,dense core granule membrane,CC,ADAM8
15082,GO:0071065,0.0358948388853193,1,1,1,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,ADAM8
15096,GO:0071133,0.0358948388853193,1,1,1,alpha9-beta1 integrin-ADAM8 complex,CC,ADAM8
15830,GO:0072535,0.0358948388853193,1,1,1,tumor necrosis factor (ligand) superfamily member 11 production,BP,ADAM8
15908,GO:0072680,0.0358948388853193,1,1,1,extracellular matrix-dependent thymocyte migration,BP,ADAM8
15909,GO:0072681,0.0358948388853193,1,1,1,fibronectin-dependent thymocyte migration,BP,ADAM8
19843,GO:2000307,0.0358948388853193,1,1,1,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,ADAM8
19844,GO:2000309,0.0358948388853193,1,1,1,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,ADAM8
19920,GO:2000410,0.0358948388853193,1,1,1,regulation of thymocyte migration,BP,ADAM8
19921,GO:2000412,0.0358948388853193,1,1,1,positive regulation of thymocyte migration,BP,ADAM8
19922,GO:2000413,0.0358948388853193,1,1,1,regulation of fibronectin-dependent thymocyte migration,BP,ADAM8
19923,GO:2000415,0.0358948388853193,1,1,1,positive regulation of fibronectin-dependent thymocyte migration,BP,ADAM8
9894,GO:0042177,0.035895516445858,0.987526965326314,7,97,negative regulation of protein catabolic process,BP,EFNA1;N4BP1;SMAD3;AZIN1;NRG1;PML;RELA
13179,GO:0051781,0.0359057257523358,0.990304683886378,5,54,positive regulation of cell division,BP,IL1B;IL1A;TGFA;EREG;VEGFC
1785,GO:0004397,0.0359194038915835,1,1,1,histidine ammonia-lyase activity,MF,HAL
6183,GO:0019556,0.0359194038915835,1,1,1,histidine catabolic process to glutamate and formamide,BP,HAL
6184,GO:0019557,0.0359194038915835,1,1,1,histidine catabolic process to glutamate and formate,BP,HAL
10616,GO:0043606,0.0359194038915835,1,1,1,formamide metabolic process,BP,HAL
9290,GO:0035729,0.0359363349470536,0.997126413068804,2,9,cellular response to hepatocyte growth factor stimulus,BP,CREB1;RELA
7210,GO:0031100,0.0359488105700341,0.99026564751582,5,57,animal organ regeneration,BP,NFKBIA;CLDN1;CDKN1A;CEBPB;ADM
7804,GO:0032352,0.0360585872548313,0.997111286336151,2,9,positive regulation of hormone metabolic process,BP,IL1B;TNF
2127,GO:0004921,0.036122786291439,1,1,1,interleukin-11 receptor activity,MF,IL6ST
6322,GO:0019970,0.036122786291439,1,1,1,interleukin-11 binding,MF,IL6ST
9718,GO:0038154,0.036122786291439,1,1,1,interleukin-11-mediated signaling pathway,BP,IL6ST
12596,GO:0050769,0.0362719447140033,0.980704366741379,17,298,positive regulation of neurogenesis,BP,SEMA7A;LIF;KCTD11;BMP2;ENC1;IL6ST;DLX2;VEGFC;NEDD4L;NRG1;SPAG9;SKIL;PRPF19;ABL2;WNT5A;NFE2L2;RELA
10657,GO:0043739,0.0363626541510517,1,1,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,TDG
1180,GO:0002825,0.0364116466553511,0.997006539186533,2,10,regulation of T-helper 1 type immune response,BP,IL23A;RIPK2
15989,GO:0085032,0.036504669323766,1,1,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,TNIP1
12976,GO:0051365,0.0366792838485336,1,1,1,cellular response to potassium ion starvation,BP,JUN
616,GO:0001782,0.0366985564801203,0.994189815320534,3,22,B cell homeostasis,BP,TNFAIP3;BCL10;RC3H1
10516,GO:0043425,0.0367351731041695,0.994207930871823,3,21,bHLH transcription factor binding,MF,BHLHE40;SMAD3;SOX9
5817,GO:0017080,0.0367477835847622,0.994178964172555,3,22,sodium channel regulator activity,MF,NEDD4L;YWHAH;SGK1
1682,GO:0004145,0.0367542437146892,0.999656810406049,1,2,diamine N-acetyltransferase activity,MF,SAT1
6245,GO:0019809,0.0367542437146892,0.999656810406049,1,2,spermidine binding,MF,SAT1
8181,GO:0032917,0.0367542437146892,0.999656810406049,1,2,polyamine acetylation,BP,SAT1
8182,GO:0032918,0.0367542437146892,0.999656810406049,1,2,spermidine acetylation,BP,SAT1
16332,GO:0090557,0.0367824836001868,0.997099594827047,2,8,establishment of endothelial intestinal barrier,BP,CLDN1;TJP2
1133,GO:0002720,0.0368157819400054,0.994140104009284,3,23,positive regulation of cytokine production involved in immune response,BP,SEMA7A;BCL10;WNT5A
8625,GO:0034143,0.0368181139032868,0.997016660818404,2,9,regulation of toll-like receptor 4 signaling pathway,BP,TNFAIP3;PELI1
15855,GO:0072574,0.0368656115047573,0.997010706452749,2,9,hepatocyte proliferation,BP,TNFAIP3;CEBPB
15856,GO:0072575,0.0368656115047573,0.997010706452749,2,9,epithelial cell proliferation involved in liver morphogenesis,BP,TNFAIP3;CEBPB
7375,GO:0031424,0.0368829389411786,0.988360908087429,6,85,keratinization,BP,SPRR2D;SPRR2A;KRT34;KRTAP2-3;LCE1C;SFN
13016,GO:0051446,0.0370614922549173,0.99698610484952,2,9,positive regulation of meiotic cell cycle,BP,OVOL1;WNT5A
4657,GO:0010800,0.037066850084777,0.994134989406365,3,21,positive regulation of peptidyl-threonine phosphorylation,BP,CAB39;RIPK2;WNT5A
14449,GO:0061772,0.0371065162687389,1,1,1,drug transport across blood-nerve barrier,BP,CLDN1
18457,GO:1903544,0.0371065162687389,1,1,1,response to butyrate,BP,CLDN1
18458,GO:1903545,0.0371065162687389,1,1,1,cellular response to butyrate,BP,CLDN1
6950,GO:0030575,0.0372070922647004,0.996967770625688,2,9,nuclear body organization,BP,ETS1;PML
9763,GO:0039528,0.0373270295918953,0.994077583150678,3,21,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,BIRC3;BIRC2;IFIH1
17680,GO:1901550,0.0373332257535858,0.996951854885599,2,9,regulation of endothelial cell development,BP,IL1B;TNF
18272,GO:1903140,0.0373332257535858,0.996951854885599,2,9,regulation of establishment of endothelial barrier,BP,IL1B;TNF
1794,GO:0004421,0.0373763811545706,1,1,1,hydroxymethylglutaryl-CoA synthase activity,MF,HMGCS1
4280,GO:0009645,0.0373763811545706,1,1,1,response to low light intensity stimulus,BP,HMGCS1
4405,GO:0010142,0.0373763811545706,1,1,1,farnesyl diphosphate biosynthetic process, mevalonate pathway,BP,HMGCS1
11809,GO:0046690,0.0373763811545706,1,1,1,response to tellurium ion,BP,HMGCS1
18114,GO:1902767,0.0373763811545706,1,1,1,isoprenoid biosynthetic process via mevalonate,BP,HMGCS1
6452,GO:0021768,0.0374388947279261,1,1,1,nucleus accumbens development,BP,ALDH1A3
14808,GO:0070539,0.0374968271119191,1,1,1,linoleic acid binding,MF,PPARD
7066,GO:0030852,0.037612047097888,0.996916564949053,2,9,regulation of granulocyte differentiation,BP,TRIB1;RUNX1
11282,GO:0045590,0.0376592938626016,1,1,1,negative regulation of regulatory T cell differentiation,BP,IRF1
11152,GO:0045208,0.0376926234361371,1,1,1,MAPK phosphatase export from nucleus,BP,DUSP16
11153,GO:0045209,0.0376926234361371,1,1,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,DUSP16
3727,GO:0008260,0.0376963123237645,1,1,1,3-oxoacid CoA-transferase activity,MF,OXCT1
11906,GO:0046934,0.0377000774415364,0.991649816739047,4,34,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,HBEGF;EREG;NRG1;PTPN11
11106,GO:0045124,0.037701666372869,0.993994633350473,3,21,regulation of bone resorption,BP,TNFAIP3;ADAM8;TFRC
10161,GO:0042745,0.0377348225103522,0.996784754134691,2,11,circadian sleep/wake cycle,BP,CSF2;AHCY
1488,GO:0003823,0.0377613780472814,0.993907012184979,3,24,antigen binding,MF,IL7R;HLA-E;TAP1
8483,GO:0033631,0.0378176815683123,0.996890443242483,2,9,cell-cell adhesion mediated by integrin,BP,ITGA5;ADAM9
13905,GO:0060546,0.0378524412901976,0.9968860197746,2,9,negative regulation of necroptotic process,BP,BIRC3;BIRC2
3222,GO:0006874,0.0378894925047732,0.982289005531048,12,198,cellular calcium ion homeostasis,BP,EDN1;SMAD3;BDKRB1;CD55;SAA1;ITGAV;PML;ADM;ABL2;PDPK1;ERO1A;ATP13A3
12836,GO:0051140,0.0379022454521836,0.999634820696113,1,2,regulation of NK T cell proliferation,BP,IL23A
12837,GO:0051142,0.0379022454521836,0.999634820696113,1,2,positive regulation of NK T cell proliferation,BP,IL23A
6787,GO:0030222,0.0379088720007394,1,1,1,eosinophil differentiation,BP,TRIB1
11320,GO:0045643,0.0379088720007394,1,1,1,regulation of eosinophil differentiation,BP,TRIB1
11321,GO:0045645,0.0379088720007394,1,1,1,positive regulation of eosinophil differentiation,BP,TRIB1
13966,GO:0060669,0.0379192714094135,0.993918979698538,3,22,embryonic placenta morphogenesis,BP,ZFP36L1;SOCS3;ADM
10730,GO:0044087,0.0380419194567622,0.975662833468618,32,667,regulation of cellular component biogenesis,BP,CSF2;SDC4;TNF;PMAIP1;FOSL1;EDN1;HAS3;CLDN1;EPHA2;JUN;BIRC2;PHLDB2;RUNX1;SACS;CYLD;TACSTD2;SMAD3;PLK2;CREB1;USP36;SLC9A1;NAV3;SOX9;STX1A;ZNF451;CDC42EP1;PTPN11;CORO1C;WNT5A;INSIG1;PDLIM5;SMPD3
13419,GO:0052810,0.0382722102895408,1,1,1,1-phosphatidylinositol-5-kinase activity,MF,PIP5K1A
17996,GO:1902442,0.0382850313830726,1,1,1,regulation of ripoptosome assembly involved in necroptotic process,BP,BIRC2
17997,GO:1902443,0.0382850313830726,1,1,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,BIRC2
3484,GO:0007351,0.0383534985878766,0.996822001273444,2,9,tripartite regional subdivision,BP,TBX3;WNT5A
3925,GO:0008595,0.0383534985878766,0.996822001273444,2,9,anterior/posterior axis specification, embryo,BP,TBX3;WNT5A
19759,GO:2000144,0.0383555911737925,0.993796095815795,3,23,positive regulation of DNA-templated transcription, initiation,BP,FOSL1;JUN;CREB1
14821,GO:0070561,0.038423354777331,0.996813038202456,2,9,vitamin D receptor signaling pathway,BP,PIM1;CYP27B1
16788,GO:0098625,0.0384779856365902,1,1,1,methylselenol reductase activity,MF,TXNRD1
16789,GO:0098626,0.0384779856365902,1,1,1,methylseleninic acid reductase activity,MF,TXNRD1
771,GO:0002021,0.0386017332643287,0.996723600208011,2,10,response to dietary excess,BP,ADRB2;SLC25A25
4504,GO:0010536,0.0387538157345545,0.999618059147357,1,2,positive regulation of activation of Janus kinase activity,BP,IL23A
17743,GO:1901676,0.0388073511580531,1,1,1,positive regulation of histone H3-K27 acetylation,BP,LIF
3897,GO:0008532,0.0388189144219869,0.99669503696242,2,10,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,B3GNT5;B3GNT2
4832,GO:0014036,0.0388262100850709,1,1,1,neural crest cell fate specification,BP,SOX9
9232,GO:0035622,0.0388262100850709,1,1,1,intrahepatic bile duct development,BP,SOX9
12418,GO:0048866,0.0388262100850709,1,1,1,stem cell fate specification,BP,SOX9
13558,GO:0060018,0.0388262100850709,1,1,1,astrocyte fate commitment,BP,SOX9
13689,GO:0060221,0.0388262100850709,1,1,1,retinal rod cell differentiation,BP,SOX9
13886,GO:0060516,0.0388262100850709,1,1,1,primary prostatic bud elongation,BP,SOX9
13887,GO:0060517,0.0388262100850709,1,1,1,epithelial cell proliferation involved in prostatic bud elongation,BP,SOX9
14046,GO:0060784,0.0388262100850709,1,1,1,regulation of cell proliferation involved in tissue homeostasis,BP,SOX9
11411,GO:0045819,0.0388529157395688,1,1,1,positive regulation of glycogen catabolic process,BP,PHKG2
18460,GO:1903547,0.0388721532469953,0.999615699537217,1,2,regulation of growth hormone activity,BP,PHLDA2
8667,GO:0034238,0.0389923471978955,1,1,1,macrophage fusion,BP,ADAM9
8668,GO:0034239,0.0389923471978955,1,1,1,regulation of macrophage fusion,BP,ADAM9
8669,GO:0034241,0.0389923471978955,1,1,1,positive regulation of macrophage fusion,BP,ADAM9
10116,GO:0042635,0.0390311295944512,0.996612370211719,2,11,positive regulation of hair cycle,BP,TNF;WNT5A
13195,GO:0051798,0.0390311295944512,0.996612370211719,2,11,positive regulation of hair follicle development,BP,TNF;WNT5A
4884,GO:0014745,0.0390380878782671,0.996733766316684,2,9,negative regulation of muscle adaptation,BP,ERRFI1;SMAD3
9538,GO:0036290,0.0390760141835156,1,1,1,protein trans-autophosphorylation,BP,ERN1
19505,GO:1990332,0.0390760141835156,1,1,1,Ire1 complex,CC,ERN1
19572,GO:1990579,0.0390760141835156,1,1,1,peptidyl-serine trans-autophosphorylation,BP,ERN1
19585,GO:1990630,0.0390760141835156,1,1,1,IRE1-RACK1-PP2A complex,CC,ERN1
19630,GO:1990782,0.0390874560453845,0.989212314097512,5,53,protein tyrosine kinase binding,MF,SQSTM1;NRG1;PTPN11;PTPN1;YWHAG
8611,GO:0034122,0.039228063404767,0.993653167871739,3,21,negative regulation of toll-like receptor signaling pathway,BP,TNFAIP3;TICAM1;PDPK1
11082,GO:0045083,0.0392593847770891,1,1,1,negative regulation of interleukin-12 biosynthetic process,BP,NFKB1
4317,GO:0009798,0.0392809697195891,0.989134788278216,5,54,axis specification,BP,TBX3;ETS2;NRARP;WNT5A;KDM6A
3849,GO:0008457,0.0392974964050192,1,1,1,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,B3GNT5
11976,GO:0047256,0.0392974964050192,1,1,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,B3GNT5
11847,GO:0046825,0.039364194536951,0.991083534047306,4,39,regulation of protein export from nucleus,BP,IL1B;PTPN11;SOX4;SFN
19211,GO:1905314,0.0393740455021747,0.996690143091486,2,9,semi-lunar valve development,BP,EFNA1;JAG1
11133,GO:0045178,0.039482710251992,0.991092290544631,4,36,basal part of cell,CC,EDN1;PHLDB2;CLDN4;TACSTD2
4207,GO:0009314,0.0394943799588019,0.978340538121477,18,341,response to radiation,BP,BHLHE40;PTGS2;GADD45A;JUN;CDKN1A;JUNB;BCL3;N4BP1;HMGCS1;DUSP1;DCUN1D3;NABP1;PLK3;CREB1;PML;RHOB;AEN;RELA
5453,GO:0016323,0.039496869718486,0.983834495521151,9,127,basolateral plasma membrane,CC,TGFA;CLDN1;CLDN4;B4GALT1;LDLR;TACSTD2;TFRC;SLC9A1;ADAM9
15081,GO:0071062,0.0395995631986532,1,1,1,alphav-beta3 integrin-vitronectin complex,CC,ITGA5
5854,GO:0017148,0.0396094710399688,0.981330667403553,12,216,negative regulation of translation,BP,ZC3H12A;BTG2;CPEB2;ZFP36L1;ENC1;SMAD3;RC3H1;ZFP36;SAMD4A;QKI;CELF1;NUP153
13809,GO:0060395,0.0396361076360368,0.991046696344448,4,36,SMAD protein signal transduction,BP,INHBA;BMP2;JUN;SMAD3
9034,GO:0035250,0.0397408372131984,0.993481713145843,3,23,UDP-galactosyltransferase activity,MF,B4GALT1;B3GNT5;B3GNT2
7019,GO:0030730,0.0397523718465111,0.996571243051344,2,10,sequestering of triglyceride,BP,IL1B;TNF
9258,GO:0035666,0.0397646006041978,0.993452153579673,3,24,TRIF-dependent toll-like receptor signaling pathway,BP,BIRC3;TICAM1;BIRC2
2614,GO:0005922,0.0397685716811775,0.996569079987683,2,10,connexin complex,CC,GJB4;GJB3
8628,GO:0034146,0.039852962884703,1,1,1,toll-like receptor 5 signaling pathway,BP,TNFAIP3
8629,GO:0034147,0.039852962884703,1,1,1,regulation of toll-like receptor 5 signaling pathway,BP,TNFAIP3
8630,GO:0034148,0.039852962884703,1,1,1,negative regulation of toll-like receptor 5 signaling pathway,BP,TNFAIP3
14748,GO:0070425,0.039852962884703,1,1,1,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,TNFAIP3
14751,GO:0070428,0.039852962884703,1,1,1,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,TNFAIP3
14752,GO:0070429,0.039852962884703,1,1,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,TNFAIP3
14755,GO:0070433,0.039852962884703,1,1,1,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,TNFAIP3
15854,GO:0072573,0.039852962884703,1,1,1,tolerance induction to lipopolysaccharide,BP,TNFAIP3
16240,GO:0090291,0.039852962884703,1,1,1,negative regulation of osteoclast proliferation,BP,TNFAIP3
19877,GO:2000349,0.039852962884703,1,1,1,negative regulation of CD40 signaling pathway,BP,TNFAIP3
8616,GO:0034134,0.0398997545155921,0.99655154558955,2,10,toll-like receptor 2 signaling pathway,BP,TNFAIP3;RIPK2
10179,GO:0042771,0.0399192449563091,0.990868171052547,4,43,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,CDKN1A;BCL3;PML;AEN
9345,GO:0035853,0.0399253015081549,1,1,1,chromosome passenger complex localization to spindle midzone,BP,KLHL21
4443,GO:0010335,0.0399408837050517,1,1,1,response to non-ionic osmotic stress,BP,PTGS2
15284,GO:0071471,0.0399408837050517,1,1,1,cellular response to non-ionic osmotic stress,BP,PTGS2
960,GO:0002380,0.0399434526393778,1,1,1,immunoglobulin secretion involved in immune response,BP,POU2F2
9195,GO:0035579,0.0399695502021197,0.988882943305184,5,55,specific granule membrane,CC,PLAUR;PLAU;RAP2B;ADAM8;ITGAV
18781,GO:1904290,0.0399859115194964,1,1,1,negative regulation of mitotic DNA damage checkpoint,BP,PPP1R10
16020,GO:0086040,0.0400386590099898,1,1,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,SLC9A1
16052,GO:0086092,0.0400386590099898,1,1,1,regulation of the force of heart contraction by cardiac conduction,BP,SLC9A1
11981,GO:0047280,0.0400465192706336,1,1,1,nicotinamide phosphoribosyltransferase activity,MF,NAMPT
10138,GO:0042700,0.0400928196637975,1,1,1,luteinizing hormone signaling pathway,BP,EREG
12111,GO:0048160,0.0400928196637975,1,1,1,primary follicle stage,BP,EREG
1475,GO:0003730,0.0401643545305313,0.988823696723951,5,54,mRNA 3'-UTR binding,MF,ZC3H12A;CPEB2;ZFP36L1;RC3H1;ZFP36
10214,GO:0042835,0.0401711100632975,1,1,1,BRE binding,MF,CELF1
10029,GO:0042474,0.0401769868968473,0.996457275922381,2,11,middle ear morphogenesis,BP,EDN1;INSIG1
1321,GO:0003167,0.0402110481403086,1,1,1,atrioventricular bundle cell differentiation,BP,TBX3
13936,GO:0060596,0.0402110481403086,1,1,1,mammary placode formation,BP,TBX3
14102,GO:0060932,0.0402110481403086,1,1,1,His-Purkinje system cell differentiation,BP,TBX3
4378,GO:0010008,0.0402352300945467,0.977496010130418,19,367,endosome membrane,CC,TICAM1;PLEKHF1;IRAK2;RAP2B;ADRB2;EHD1;LDLR;TFRC;ANTXR2;NDRG1;PML;RHOB;ABCA5;STEAP4;HLA-E;RAB22A;ITM2B;MYO1B;STX12
3923,GO:0008593,0.0402531208894571,0.987094602490979,6,74,regulation of Notch signaling pathway,BP,NFKBIA;ELF3;IL6ST;DLX2;JAG1;NRARP
20101,GO:2000759,0.0402962764315572,1,1,1,regulation of N-terminal peptidyl-lysine acetylation,BP,SOX4
20102,GO:2000761,0.0402962764315572,1,1,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,SOX4
8278,GO:0033082,0.0403247869330167,1,1,1,regulation of extrathymic T cell differentiation,BP,PRDM1
19590,GO:1990654,0.0403247869330167,1,1,1,sebum secreting cell proliferation,BP,PRDM1
787,GO:0002042,0.0403419156108799,0.990820191200703,4,37,cell migration involved in sprouting angiogenesis,BP,PTGS2;EFNB2;PLK2;HDAC9
12975,GO:0051354,0.0403789192688415,0.996487221312036,2,10,negative regulation of oxidoreductase activity,BP,NFKB1;CYP27B1
13229,GO:0051886,0.0404296163395301,1,1,1,negative regulation of timing of anagen,BP,FERMT1
20257,GO:2001203,0.0404296163395301,1,1,1,positive regulation of transforming growth factor-beta secretion,BP,FERMT1
2165,GO:0004998,0.0404315587307083,1,1,1,transferrin receptor activity,MF,TFRC
4976,GO:0015091,0.0404315587307083,1,1,1,ferric iron transmembrane transporter activity,MF,TFRC
8446,GO:0033570,0.0404315587307083,1,1,1,transferrin transmembrane transporter activity,MF,TFRC
15811,GO:0072510,0.0404315587307083,1,1,1,trivalent inorganic cation transmembrane transporter activity,MF,TFRC
14481,GO:0061889,0.0404583300335222,1,1,1,negative regulation of astrocyte activation,BP,LDLR
18664,GO:1903979,0.0404583300335222,1,1,1,negative regulation of microglial cell activation,BP,LDLR
55,GO:0000117,0.0404915833044923,1,1,1,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,BACH1
1031,GO:0002537,0.040492363095957,1,1,1,nitric oxide production involved in inflammatory response,BP,SLC7A2
1071,GO:0002635,0.040492363095957,1,1,1,negative regulation of germinal center formation,BP,RC3H1
1969,GO:0004676,0.040492363095957,1,1,1,3-phosphoinositide-dependent protein kinase activity,MF,PDPK1
2220,GO:0005115,0.040492363095957,1,1,1,receptor tyrosine kinase-like orphan receptor binding,MF,WNT5A
7594,GO:0031962,0.040492363095957,1,1,1,mineralocorticoid receptor binding,MF,SMAD3
8868,GO:0034670,0.040492363095957,1,1,1,chemotaxis to arachidonic acid,BP,CREB1
8875,GO:0034683,0.040492363095957,1,1,1,integrin alphav-beta3 complex,CC,ITGAV
9647,GO:0036517,0.040492363095957,1,1,1,chemoattraction of serotonergic neuron axon,BP,WNT5A
11357,GO:0045715,0.040492363095957,1,1,1,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,ITGAV
12585,GO:0050748,0.040492363095957,1,1,1,negative regulation of lipoprotein metabolic process,BP,ITGAV
13030,GO:0051463,0.040492363095957,1,1,1,negative regulation of cortisol secretion,BP,PTPN11
13228,GO:0051885,0.040492363095957,1,1,1,positive regulation of timing of anagen,BP,WNT5A
13311,GO:0052066,0.040492363095957,1,1,1,entry of symbiont into host cell by promotion of host phagocytosis,BP,ITGAV
13321,GO:0052190,0.040492363095957,1,1,1,modulation by symbiont of host phagocytosis,BP,ITGAV
13322,GO:0052191,0.040492363095957,1,1,1,positive regulation by symbiont of host phagocytosis,BP,ITGAV
13332,GO:0052231,0.040492363095957,1,1,1,modulation of phagocytosis in other organism involved in symbiotic interaction,BP,ITGAV
13348,GO:0052370,0.040492363095957,1,1,1,entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction,BP,ITGAV
13364,GO:0052522,0.040492363095957,1,1,1,positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction,BP,ITGAV
13570,GO:0060031,0.040492363095957,1,1,1,mediolateral intercalation,BP,WNT5A
13601,GO:0060067,0.040492363095957,1,1,1,cervix development,BP,WNT5A
13633,GO:0060125,0.040492363095957,1,1,1,negative regulation of growth hormone secretion,BP,PTPN11
13725,GO:0060290,0.040492363095957,1,1,1,transdifferentiation,BP,SMAD3
13938,GO:0060599,0.040492363095957,1,1,1,lateral sprouting involved in mammary gland duct morphogenesis,BP,WNT5A
14045,GO:0060775,0.040492363095957,1,1,1,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,WNT5A
14052,GO:0060809,0.040492363095957,1,1,1,mesodermal to mesenchymal transition involved in gastrulation,BP,WNT5A
14277,GO:0061347,0.040492363095957,1,1,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,WNT5A
14278,GO:0061348,0.040492363095957,1,1,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,WNT5A
14279,GO:0061349,0.040492363095957,1,1,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,WNT5A
14280,GO:0061350,0.040492363095957,1,1,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,WNT5A
14282,GO:0061354,0.040492363095957,1,1,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,WNT5A
14313,GO:0061444,0.040492363095957,1,1,1,endocardial cushion cell development,BP,JAG1
14318,GO:0061459,0.040492363095957,1,1,1,L-arginine transmembrane transporter activity,MF,SLC7A2
14390,GO:0061642,0.040492363095957,1,1,1,chemoattraction of axon,BP,WNT5A
14444,GO:0061767,0.040492363095957,1,1,1,negative regulation of lung blood pressure,BP,SMAD3
16370,GO:0090673,0.040492363095957,1,1,1,endothelial cell-matrix adhesion,BP,ADAMTS9
16680,GO:0097625,0.040492363095957,1,1,1,low-affinity basic amino acid transmembrane transporter activity,MF,SLC7A2
16681,GO:0097626,0.040492363095957,1,1,1,low-affinity L-arginine transmembrane transporter activity,MF,SLC7A2
16682,GO:0097627,0.040492363095957,1,1,1,high-affinity L-ornithine transmembrane transporter activity,MF,SLC7A2
16691,GO:0097639,0.040492363095957,1,1,1,L-lysine import across plasma membrane,BP,SLC7A2
16692,GO:0097640,0.040492363095957,1,1,1,L-ornithine import across plasma membrane,BP,SLC7A2
17978,GO:1902379,0.040492363095957,1,1,1,chemoattractant activity involved in axon guidance,MF,WNT5A
19066,GO:1904933,0.040492363095957,1,1,1,regulation of cell proliferation in midbrain,BP,WNT5A
19067,GO:1904934,0.040492363095957,1,1,1,negative regulation of cell proliferation in midbrain,BP,WNT5A
19076,GO:1904955,0.040492363095957,1,1,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT5A
19263,GO:1905438,0.040492363095957,1,1,1,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT5A
19388,GO:1905878,0.040492363095957,1,1,1,invadopodium disassembly,BP,NAV3
19408,GO:1905927,0.040492363095957,1,1,1,regulation of invadopodium disassembly,BP,NAV3
19409,GO:1905929,0.040492363095957,1,1,1,positive regulation of invadopodium disassembly,BP,NAV3
19970,GO:2000536,0.040492363095957,1,1,1,negative regulation of entry of bacterium into host cell,BP,ITGAV
20306,GO:2001288,0.040492363095957,1,1,1,positive regulation of caveolin-mediated endocytosis,BP,NEDD4L
6065,GO:0019211,0.0405031735639573,0.996470470172486,2,10,phosphatase activator activity,MF,BMP2;PPP1R15A
2097,GO:0004861,0.0406943770666645,0.996386418045831,2,11,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,CDKN1A;CDKN2B
1325,GO:0003174,0.0408833054168512,0.996491570209236,2,9,mitral valve development,BP,EFNA1;SOX4
1118,GO:0002705,0.0408924273308525,0.988520332366642,5,59,positive regulation of leukocyte mediated immunity,BP,IL1B;TNF;IL23A;TFRC;HLA-E
5912,GO:0018149,0.0408982205074121,0.993092229885376,3,29,peptide cross-linking,BP,SPRR2D;SPRR2A;LCE1C
6912,GO:0030501,0.0409188142683404,0.993238243284686,3,22,positive regulation of bone mineralization,BP,BMP2;ADRB2;SMAD3
14606,GO:0070169,0.0409188142683404,0.993238243284686,3,22,positive regulation of biomineral tissue development,BP,BMP2;ADRB2;SMAD3
11501,GO:0045986,0.0410055499394656,0.996402446287171,2,10,negative regulation of smooth muscle contraction,BP,PTGS2;ADRB2
4574,GO:0010658,0.0411808348116441,0.993177769116537,3,22,striated muscle cell apoptotic process,BP,PPP1R10;PDPK1;NFE2L2
19640,GO:1990823,0.0412422231692118,0.986701001347941,6,74,response to leukemia inhibitory factor,BP,VEGFC;TFRC;CREB1;SOCS3;PML;B3GNT2
19643,GO:1990830,0.0412422231692118,0.986701001347941,6,74,cellular response to leukemia inhibitory factor,BP,VEGFC;TFRC;CREB1;SOCS3;PML;B3GNT2
2942,GO:0006470,0.041318557592103,0.979164639796617,14,244,protein dephosphorylation,BP,TNF;DAPP1;DUSP16;PPP1R15A;ANKLE2;DUSP8;DUSP1;PPP1R10;DUSP10;PPP1R15B;PPTC7;PTPN11;PTPN1;SH3RF2
6081,GO:0019233,0.041374402689263,0.99046522035673,4,40,sensory perception of pain,BP,PTGS2;EDN1;BDKRB1;SLC9A1
7696,GO:0032148,0.0414463243797261,0.993062900630738,3,24,activation of protein kinase B activity,BP,NRG1;WNT5A;PDPK1
13967,GO:0060670,0.0414492053671065,0.996341978957514,2,10,branching involved in labyrinthine layer morphogenesis,BP,SOCS3;ADM
16775,GO:0098586,0.0415220902859231,0.990464780139907,4,37,cellular response to virus,BP,ZC3H12A;BIRC3;BIRC2;IFIH1
1145,GO:0002739,0.041592234819121,0.996322406356107,2,10,regulation of cytokine secretion involved in immune response,BP,TNF;WNT5A
8380,GO:0033280,0.0417125999314608,0.993054547125328,3,22,response to vitamin D,BP,PTGS2;PIM1;CYP27B1
18703,GO:1904062,0.0417586807100496,0.981764035851064,10,157,regulation of cation transmembrane transport,BP,PPIF;RRAD;CAB39;ADRB2;NEDD4L;OXSR1;BDKRB1;SLC9A1;PDPK1;YWHAH
6677,GO:0030036,0.041786406727927,0.974890052892417,24,469,actin cytoskeleton organization,BP,CXCL1;SDC4;TNF;NUAK2;EDN1;PHLDB2;RND3;NEDD9;FGD6;TACSTD2;SMAD3;SLC9A1;AMOTL2;PIP5K1A;CDC42EP1;RHOB;AKAP2;TNFAIP1;PTPN1;CORO1C;ABL2;PDPK1;FRMD6;MYO1B
4794,GO:0010984,0.0417948680567011,0.996234004112111,2,11,regulation of lipoprotein particle clearance,BP,LDLR;LIPG
1131,GO:0002718,0.041819776084002,0.990316357405486,4,41,regulation of cytokine production involved in immune response,BP,TNF;SEMA7A;BCL10;WNT5A
6061,GO:0019207,0.041985996088747,0.981635206579541,10,162,kinase regulator activity,MF,TRIB1;CAB39;CDKN1A;CDKN2B;BCL10;SOCS3;NRG1;CCNL1;YWHAG;SFN
17739,GO:1901671,0.0420215310213685,0.999550173936753,1,2,positive regulation of superoxide dismutase activity,BP,TNF
19014,GO:1904833,0.0420215310213685,0.999550173936753,1,2,positive regulation of removal of superoxide radicals,BP,TNF
7333,GO:0031342,0.042056970648006,0.996197364959354,2,11,negative regulation of cell killing,BP,IL7R;HLA-E
3565,GO:0007610,0.0421050596351849,0.977172440649545,17,313,behavior,BP,BTG2;CSF2;PTGS2;FOSL1;JUN;ADRB2;CEBPB;GJB4;ALDH1A3;LDLR;PLK2;ITGA5;CREB1;NRG1;MAFG;SGK1;AHCY
11511,GO:0046006,0.0421380024380663,0.992855047600471,3,26,regulation of activated T cell proliferation,BP,CD274;RC3H1;IL23A
7611,GO:0031996,0.0421542434501345,0.996245129290485,2,10,thioesterase binding,MF,TRAF1;TRAF4
14893,GO:0070696,0.0422297276499589,0.996234705257068,2,10,transmembrane receptor protein serine/threonine kinase binding,MF,INHBA;BMP2
689,GO:0001906,0.0425697557822156,0.98785801391711,5,67,cell killing,BP,IL23A;RAET1L;IL7R;HLA-E;CTSC
4758,GO:0010934,0.0426061282848958,0.996182567966246,2,10,macrophage cytokine production,BP,SEMA7A;WNT5A
10597,GO:0043567,0.042649149834193,0.996176592076776,2,10,regulation of insulin-like growth factor receptor signaling pathway,BP,BMP2;ATXN7
8919,GO:0034762,0.042662385423168,0.977829218381392,15,265,regulation of transmembrane transport,BP,IL1B;TNF;PPIF;RRAD;CAB39;ADRB2;NEDD4L;OXSR1;BDKRB1;SLC9A1;AZIN1;PTPN11;PDPK1;NFE2L2;YWHAH
4512,GO:0010561,0.0428119151821029,0.996091107544069,2,11,negative regulation of glycoprotein biosynthetic process,BP,HBEGF;ITM2B
17362,GO:1900076,0.043198856419924,0.987729700121441,5,55,regulation of cellular response to insulin stimulus,BP,IL1B;SOCS3;PTPN11;PTPN1;RELA
13906,GO:0060547,0.0432044514345456,0.996099150722695,2,10,negative regulation of necrotic cell death,BP,BIRC3;BIRC2
15464,GO:0071803,0.0432213796979391,0.996096780989876,2,10,positive regulation of podosome assembly,BP,CSF2;TNF
9622,GO:0036488,0.0432800435100933,0.999522515452141,1,2,CHOP-C/EBP complex,CC,CEBPB
8441,GO:0033561,0.0434281447093272,0.992622847504884,3,23,regulation of water loss via skin,BP,CLDN1;CLDN4;SFN
133,GO:0000278,0.0434928603239049,0.970518406203736,40,914,mitotic cell cycle,BP,IL1B;IL1A;BTG2;BIRC3;INHBA;TNF;TGFA;EDN1;PHLDA1;GADD45A;MAP2K3;BIRC2;CDKN1A;OVOL1;ZFP36L1;CDKN2B;EREG;ANKLE2;DUSP1;DCUN1D3;PPP1R10;PIM3;NABP1;CYLD;OXSR1;SMAD3;PLK2;PLK3;PIM1;PML;PTPN11;MAP3K8;RHOB;SOX4;CDK6;BTG3;NUP153;BACH1;YWHAG;SFN
2186,GO:0005041,0.0434969795893282,0.996137762658021,2,9,low-density lipoprotein particle receptor activity,MF,LDLR;CXCL16
18036,GO:1902554,0.0435714678780245,0.985737626038946,6,78,serine/threonine protein kinase complex,CC,CAB39;CDKN1A;PHKG2;CCNL1;CDK6;ERN1
12641,GO:0050830,0.0435942607922314,0.992387775995111,3,33,defense response to Gram-positive bacterium,BP,TNF;RIPK2;HLA-E
13833,GO:0060428,0.0436059390513236,0.99258064218299,3,23,lung epithelium development,BP,ERRFI1;CREB1;SOX9
17584,GO:1901214,0.0436312115693879,0.979150971557607,12,205,regulation of neuron death,BP,BTG2;REL;EFNB2;JUN;CEBPB;SOD2;ADAM8;CREB1;TP53BP2;NCOA7;WNT5A;PDPK1
15478,GO:0071825,0.043698686316307,0.992531244695537,3,24,protein-lipid complex subunit organization,BP,LIPG;PLAGL2;ABCA5
12946,GO:0051302,0.0437117439266154,0.982865199262314,8,116,regulation of cell division,BP,IL1B;IL1A;TGFA;EREG;VEGFC;PLK3;KLHL21;SFN
12998,GO:0051412,0.0437197814386121,0.996026774791432,2,10,response to corticosterone,BP,FOSL1;CDKN1A
11013,GO:0044843,0.0437325417222445,0.978386322977654,13,234,cell cycle G1/S phase transition,BP,BTG2;INHBA;GADD45A;CDKN1A;CDKN2B;DCUN1D3;PLK2;PLK3;PML;SOX4;CDK6;BACH1;SFN
4751,GO:0010921,0.0437821344870957,0.981716349445997,9,134,regulation of phosphatase activity,BP,TNF;PLEKHF1;BMP2;PPP1R15A;ANKLE2;PPP1R10;SMAD3;PPP1R15B;SH3RF2
10425,GO:0043269,0.0438451169989219,0.976590953416003,16,296,regulation of ion transport,BP,IL1B;PPIF;PTGS2;TRPV3;EDN1;RRAD;CAB39;ADRB2;NEDD4L;OXSR1;IL16;BDKRB1;SLC9A1;PML;PDPK1;YWHAH
9082,GO:0035335,0.0439164455788534,0.985624774822147,6,74,peptidyl-tyrosine dephosphorylation,BP,DUSP16;DUSP8;DUSP1;DUSP10;PTPN11;PTPN1
6312,GO:0019955,0.0443849103241822,0.987269698151284,5,58,cytokine binding,MF,IL1RN;TRIM16;IL6ST;ZFP36;ITGAV
7209,GO:0031099,0.0444136409147626,0.982523366644753,8,119,regeneration,BP,NFKBIA;CLDN1;JUN;CDKN1A;CEBPB;DUSP10;PPARD;ADM
3549,GO:0007585,0.0444352154275015,0.989539860122967,4,39,respiratory gaseous exchange,BP,EDN1;STK40;TRAF4;KDM6A
13503,GO:0055065,0.0445514371539688,0.975663893091059,17,325,metal ion homeostasis,BP,EDN1;NEDD4L;SMAD3;TFRC;BDKRB1;SLC9A1;CYP27B1;CD55;SAA1;ITGAV;PML;STEAP4;ADM;ABL2;PDPK1;ERO1A;ATP13A3
12682,GO:0050890,0.0445834222925961,0.980314414209961,10,156,cognition,BP,BTG2;PTGS2;FOSL1;JUN;CEBPB;LDLR;PLK2;ITGA5;CREB1;SGK1
649,GO:0001837,0.0446488466756375,0.983760832360766,7,94,epithelial to mesenchymal transition,BP,IL1B;EFNA1;BMP2;PHLDB2;SMAD3;SOX9;WNT5A
14944,GO:0070838,0.044747609923461,0.977182966925656,14,245,divalent metal ion transport,BP,PTGS2;TRPV3;PANX1;RRAD;SLC25A25;IL16;BDKRB1;SLC9A1;CYP27B1;ITGAV;PML;PDPK1;ERO1A;ATP13A3
7296,GO:0031293,0.0448047883534159,0.992294188757918,3,23,membrane protein intracellular domain proteolysis,BP,NFKB1;JAG1;RELA
15138,GO:0071241,0.0448073665254788,0.982333803495628,8,120,cellular response to inorganic substance,BP,PPIF;PTGS2;EDN1;CLDN1;JUN;JUNB;CREB1;WNT5A
14065,GO:0060840,0.0451049854964883,0.987059415848163,5,53,artery development,BP,PRDM1;EFNB2;JAG1;SOX4;ADAMTS9
18619,GO:1903901,0.0451309219878933,0.986969442636739,5,61,negative regulation of viral life cycle,BP,ZC3H12A;TNF;TNIP1;PML;ISG20
4344,GO:0009895,0.0451509213962567,0.97830769243807,12,207,negative regulation of catabolic process,BP,IL1B;TNF;NOCT;EFNA1;HCAR2;N4BP1;SMAD3;ZFP36;AZIN1;NRG1;PML;RELA
4283,GO:0009649,0.0451636329071533,0.992179239509171,3,24,entrainment of circadian clock,BP,BHLHE40;ARNTL2;PML
12386,GO:0048806,0.0451673919855959,0.992238234462082,3,22,genitalia development,BP,TBX3;PTPN11;WNT5A
13831,GO:0060425,0.0454380724244764,0.989227219547906,4,39,lung morphogenesis,BP,TNF;LIF;STK40;SOX9
11138,GO:0045184,0.0455191673602314,0.966656772202897,63,1582,establishment of protein localization,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;TNF;PTGS2;PMAIP1;IL1RN;PANX1;HCAR2;CDKN1A;PHLDB2;CD274;BCL3;DUSP16;UGCG;TRIM16;EHD1;PPP1R10;PIM3;ADAM8;VEGFC;BBC3;PLK3;TFRC;PPARD;USP36;PLAGL2;RIPK2;SAA1;ITGAV;TP53BP2;STX1A;NRG1;PML;POU2F2;FERMT1;PTPN11;RHOB;SOX4;OXCT1;PTPN1;CORO1C;ATP6V1C2;HLA-E;RAB3IP;PMM2;WNT5A;NUP153;INSIG1;ADAM9;ADAMTS9;YWHAH;AGFG1;YWHAG;RAB22A;SFN;IFIH1;IPO4;TAP1;STX12;RAB24
3203,GO:0006839,0.0455508334740662,0.977329548535377,13,250,mitochondrial transport,BP,PPIF;PMAIP1;UGCG;BBC3;SLC25A25;USP36;SLC9A1;PLAGL2;TP53BP2;NRG1;YWHAH;YWHAG;SFN
11327,GO:0045651,0.0455968358095213,0.995759040843892,2,10,positive regulation of macrophage differentiation,BP,LIF;TRIB1
11105,GO:0045123,0.0456564343523835,0.992088736460908,3,23,cellular extravasation,BP,IL1A;TNF;ADAM8
11715,GO:0046513,0.0456737805024244,0.98912266810719,4,41,ceramide biosynthetic process,BP,TNF;UGCG;SGMS2;SMPD3
18688,GO:1904036,0.0457915887968566,0.992055983108068,3,23,negative regulation of epithelial cell apoptotic process,BP,TNFAIP3;PDPK1;NFE2L2
1030,GO:0002536,0.045993333634924,0.99946001094255,1,2,respiratory burst involved in inflammatory response,BP,DUSP10
13710,GO:0060264,0.045993333634924,0.99946001094255,1,2,regulation of respiratory burst involved in inflammatory response,BP,DUSP10
13712,GO:0060266,0.045993333634924,0.99946001094255,1,2,negative regulation of respiratory burst involved in inflammatory response,BP,DUSP10
14267,GO:0061323,0.0460126371463274,0.995628806695668,2,11,cell proliferation involved in heart morphogenesis,BP,PIM1;SOX9
804,GO:0002070,0.0460581061871326,0.995622103174696,2,11,epithelial cell maturation,BP,CDKN1A;FEM1B
463,GO:0001501,0.0460639944083443,0.974749762524745,17,310,skeletal system development,BP,TBX3;EDN1;BMP2;TJP2;CSRNP1;ETS2;RUNX1;NAB1;DLX2;SMAD3;SOX9;PTPN11;SOX4;KLF10;WNT5A;INSIG1;RELA
19855,GO:2000321,0.0460826338752271,0.999457886892762,1,2,positive regulation of T-helper 17 cell differentiation,BP,IL23A
19863,GO:2000330,0.0460826338752271,0.999457886892762,1,2,positive regulation of T-helper 17 cell lineage commitment,BP,IL23A
16110,GO:0090092,0.0461943730536441,0.980507729781379,9,137,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,INHBA;BMP2;CDKN2B;SMAD3;ZNF451;FERMT1;SKIL;WNT5A;PDPK1
3251,GO:0006913,0.046209662175722,0.9751526718393,16,303,nucleocytoplasmic transport,BP,NFKBIA;IL1B;ZC3H12A;TNF;PTGS2;CDKN1A;BCL3;DUSP16;PPP1R10;PML;PTPN11;SOX4;NUP153;AGFG1;SFN;IPO4
2003,GO:0004725,0.0462406066538161,0.984668029645969,6,75,protein tyrosine phosphatase activity,MF,DUSP16;DUSP8;DUSP1;DUSP10;PTPN11;PTPN1
15812,GO:0072511,0.0462455309438922,0.976308875021693,14,246,divalent inorganic cation transport,BP,PTGS2;TRPV3;PANX1;RRAD;SLC25A25;IL16;BDKRB1;SLC9A1;CYP27B1;ITGAV;PML;PDPK1;ERO1A;ATP13A3
14677,GO:0070293,0.0462888757380831,0.995588022452517,2,11,renal absorption,BP,CLDN4;SGK1
10476,GO:0043369,0.0463242139042498,0.995653571688447,2,10,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,CYLD;IL23A
15857,GO:0072576,0.0464075782021395,0.995641423019778,2,10,liver morphogenesis,BP,TNFAIP3;CEBPB
19822,GO:2000275,0.0465949222546766,0.999445619349722,1,2,regulation of oxidative phosphorylation uncoupler activity,BP,PPIF
14842,GO:0070588,0.0466812150579225,0.979224611571018,10,156,calcium ion transmembrane transport,BP,TRPV3;PANX1;RRAD;SLC25A25;BDKRB1;SLC9A1;ITGAV;PDPK1;ERO1A;ATP13A3
18223,GO:1903019,0.0466996569706142,0.995468009132677,2,12,negative regulation of glycoprotein metabolic process,BP,HBEGF;ITM2B
15809,GO:0072507,0.0468793150727393,0.976603605850395,13,229,divalent inorganic cation homeostasis,BP,EDN1;SMAD3;BDKRB1;CYP27B1;CD55;SAA1;ITGAV;PML;ADM;ABL2;PDPK1;ERO1A;ATP13A3
4816,GO:0014009,0.0469332646461287,0.991777698140539,3,23,glial cell proliferation,BP,CREB1;SOX4;AREG
7095,GO:0030889,0.0469908166518901,0.995556078531757,2,10,negative regulation of B cell proliferation,BP,PRDM1;RC3H1
4766,GO:0010948,0.0470277287904764,0.975200271892424,15,295,negative regulation of cell cycle process,BP,BTG2;GADD45A;LIF;CDKN1A;OVOL1;ZFP36L1;CDKN2B;DUSP1;DCUN1D3;PPP1R10;PLK2;PLK3;PML;SOX4;SFN
11420,GO:0045834,0.0470413411880812,0.984323236780073,6,77,positive regulation of lipid metabolic process,BP,IL1B;TNF;PTGS2;LDLR;CREB1;SMPD3
13252,GO:0051924,0.0471037716665552,0.98125162012344,8,118,regulation of calcium ion transport,BP,PTGS2;TRPV3;RRAD;IL16;BDKRB1;SLC9A1;PML;PDPK1
10727,GO:0044068,0.0471094900130835,0.991704260674025,3,24,modulation by symbiont of host cellular process,BP,ZC3H12A;TNIP1;ITGAV
6843,GO:0030307,0.0471145305793465,0.981242355693998,8,119,positive regulation of cell growth,BP,HBEGF;EDN1;SEMA7A;NEDD4L;SLC9A1;NRG1;SFN;CXCL16
14208,GO:0061134,0.0471373282249474,0.982583747459836,7,108,peptidase regulator activity,MF,BIRC3;SERPINB2;BIRC2;TFPI2;SERPINB8;SERPINB1;CTSC
14859,GO:0070633,0.0472375849961858,0.995446894718079,2,11,transepithelial transport,BP,CSF2;EDN1
1149,GO:0002755,0.0472664727051133,0.991665577241613,3,24,MyD88-dependent toll-like receptor signaling pathway,BP,TNIP1;IRAK2;IRF1
6936,GO:0030540,0.0473697507930526,0.995500302969756,2,10,female genitalia development,BP,TBX3;WNT5A
6358,GO:0021537,0.047413260879124,0.978836189350545,10,158,telencephalon development,BP,BTG2;INHBA;KDM6B;SEMA7A;BMP2;ALDH1A3;DLX2;NRG1;CDK6;WNT5A
7587,GO:0031953,0.0474503781771446,0.995488402262105,2,10,negative regulation of protein autophosphorylation,BP,ERRFI1;JUN
16226,GO:0090276,0.0474695345334722,0.981076938389134,8,118,regulation of peptide hormone secretion,BP,IL1B;TNF;PIM3;PPARD;STX1A;PTPN11;SOX4;OXCT1
16103,GO:0090085,0.0474758604185708,0.995411192640616,2,11,regulation of protein deubiquitination,BP,ZC3H12A;TNIP1
18243,GO:1903052,0.0476174702148697,0.982410354807016,7,99,positive regulation of proteolysis involved in cellular protein catabolic process,BP,RNF19B;TRIB1;PLK2;PLK3;RNF19A;CTSC;NFE2L2
20088,GO:2000738,0.0477272347904058,0.995447449581028,2,10,positive regulation of stem cell differentiation,BP,TACSTD2;SOX9
6790,GO:0030225,0.0477439869093267,0.991547577463588,3,24,macrophage differentiation,BP,INHBA;LIF;TRIB1
1315,GO:0003161,0.0478111707363181,0.995435006776937,2,10,cardiac conduction system development,BP,TBX3;NRG1
1116,GO:0002703,0.0480767412696562,0.982188324817525,7,102,regulation of leukocyte mediated immunity,BP,IL1B;TNF;IL23A;TFRC;IL7R;HLA-E;PDPK1
12656,GO:0050857,0.0481775820923158,0.995305453830212,2,11,positive regulation of antigen receptor-mediated signaling pathway,BP,CYLD;RELA
3511,GO:0007423,0.0482583502596349,0.973392503669374,17,310,sensory organ development,BP,INHBA;SDC4;PRDM1;EDN1;EPHA2;BMP2;JUN;ALDH1A3;DLX2;SMAD3;SLC25A25;JAG1;SOX9;PTPN11;SKIL;WNT5A;INSIG1
10136,GO:0042698,0.0482693587077718,0.988331924716854,4,39,ovulation cycle,BP,INHBA;ETS1;EREG;ADAMTS1
1281,GO:0003073,0.0482709464525951,0.988298518486092,4,41,regulation of systemic arterial blood pressure,BP,EDN1;ADRB2;SOD2;ADM
15106,GO:0071159,0.048294310759185,0.999403917326347,1,2,NF-kappaB complex,CC,RELA
6281,GO:0019883,0.0483177365624486,0.995284228325001,2,11,antigen processing and presentation of endogenous antigen,BP,HLA-E;TAP1
8304,GO:0033138,0.0483731042196153,0.985776010363875,5,60,positive regulation of peptidyl-serine phosphorylation,BP,TNF;PTGS2;LIF;RIPK2;WNT5A
3874,GO:0008499,0.048449584870425,0.995264228486005,2,11,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,B3GNT5;B3GNT2
19754,GO:2000136,0.048517704933782,0.99525388323359,2,11,regulation of cell proliferation involved in heart morphogenesis,BP,PIM1;SOX9
19878,GO:2000351,0.0485178519934714,0.991386725108847,3,23,regulation of endothelial cell apoptotic process,BP,TNFAIP3;PDPK1;NFE2L2
5548,GO:0016538,0.0485215900459664,0.991252028577868,3,28,cyclin-dependent protein serine/threonine kinase regulator activity,MF,CDKN1A;CDKN2B;CCNL1
3403,GO:0007186,0.048574352598284,0.972221113216284,19,377,G-protein coupled receptor signaling pathway,BP,CXCL2;CXCL1;CXCL3;CXCL8;CCL20;EDN1;HCAR2;CXCL5;ADRB2;EREG;HCAR3;BDKRB1;SAA1;ARHGEF3;RHOB;AREG;ADM;CXCL16;GPR156
3550,GO:0007586,0.0486678558377488,0.988171206228774,4,41,digestion,BP,TJP2;LDLR;SOX9;SGK1
286,GO:0000790,0.0487252467971872,0.974171387526633,15,304,nuclear chromatin,CC,KDM6B;JUN;JUNB;IRF1;ENC1;CEBPB;SMAD3;CREB1;PPARD;UHRF1;MXD1;KDM6A;RELA;POLR3D;IPO4
5263,GO:0015893,0.048772950039343,0.981884006144578,7,100,drug transport,BP,INHBA;EDN1;CLDN1;NFKBIE;SLC25A25;SLC7A2;PTPN11
7819,GO:0032371,0.0487865627046425,0.991232535208853,3,26,regulation of sterol transport,BP,NFKBIA;NFKB1;LIPG
7822,GO:0032374,0.0487865627046425,0.991232535208853,3,26,regulation of cholesterol transport,BP,NFKBIA;NFKB1;LIPG
3223,GO:0006875,0.0488255212355747,0.974138544983243,15,282,cellular metal ion homeostasis,BP,EDN1;NEDD4L;SMAD3;TFRC;BDKRB1;SLC9A1;CD55;SAA1;ITGAV;PML;ADM;ABL2;PDPK1;ERO1A;ATP13A3
11070,GO:0045071,0.0488501469630935,0.988055106210856,4,45,negative regulation of viral genome replication,BP,ZC3H12A;TNF;TNIP1;ISG20
8470,GO:0033612,0.0488631389389924,0.995201294699837,2,11,receptor serine/threonine kinase binding,MF,INHBA;BMP2
14867,GO:0070647,0.0490933696326224,0.966252575087535,41,946,protein modification by small protein conjugation or removal,BP,NFKBIA;TNFAIP3;ZC3H12A;BIRC3;TICAM1;RNF19B;TNIP1;KCTD11;BIRC2;ENC1;ADRB2;N4BP1;PELI1;BCL10;DCUN1D3;CYLD;NEDD4L;SMAD3;RC3H1;KLHL21;SOCS3;USP36;RIPK2;USP53;ZNF451;FEM1C;UHRF1;FEM1B;SOX4;USP31;TNFAIP1;PRPF19;NUP153;RNF19A;NFE2L2;RELA;RNF11;BACH1;SH3RF2;ATXN7;IFIH1
8744,GO:0034394,0.0490982183454446,0.988049119726613,4,40,protein localization to cell surface,BP,TNF;NEDD4L;NRG1;VCL
12854,GO:0051169,0.0491705312671173,0.973343122368589,16,306,nuclear transport,BP,NFKBIA;IL1B;ZC3H12A;TNF;PTGS2;CDKN1A;BCL3;DUSP16;PPP1R10;PML;PTPN11;SOX4;NUP153;AGFG1;SFN;IPO4
777,GO:0002029,0.0492561513227676,0.995077154289073,2,12,desensitization of G-protein coupled receptor protein signaling pathway,BP,ADRB2;ADM
6577,GO:0022401,0.0492561513227676,0.995077154289073,2,12,negative adaptation of signaling pathway,BP,ADRB2;ADM
13681,GO:0060211,0.0492732270971398,0.99513858580124,2,11,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,BTG2;ZFP36
13683,GO:0060213,0.0492732270971398,0.99513858580124,2,11,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,BTG2;ZFP36
1146,GO:0002740,0.0492923971657806,0.999378701922702,1,2,negative regulation of cytokine secretion involved in immune response,BP,TNF
1210,GO:0002874,0.0492923971657806,0.999378701922702,1,2,regulation of chronic inflammatory response to antigenic stimulus,BP,TNF
5797,GO:0017038,0.0492955847494914,0.977821430969638,10,167,protein import,BP,NFKBIA;ZC3H12A;TNF;PTGS2;CDKN1A;BCL3;PPP1R10;PML;NUP153;IPO4
6733,GO:0030145,0.0494003687156733,0.987935310922163,4,41,manganese ion binding,MF,SOD2;B4GALT1;PIM1;ABL2
17391,GO:1900119,0.0494209956148736,0.995051544180015,2,12,positive regulation of execution phase of apoptosis,BP,ZC3H12A;TP53BP2
20140,GO:2000826,0.0494302112713253,0.991126929304976,3,24,regulation of heart morphogenesis,BP,BMP2;PIM1;SOX9
11376,GO:0045742,0.0494651645668458,0.99108859793384,3,25,positive regulation of epidermal growth factor receptor signaling pathway,BP,PLAUR;TGFA;EREG
18146,GO:1902882,0.0495727409122221,0.985315159800084,5,61,regulation of response to oxidative stress,BP,TNF;SOD2;NCOA7;GCH1;NFE2L2
322,GO:0000900,0.049666101177007,0.995156841181286,2,10,translation repressor activity, mRNA regulatory element binding,MF,CPEB2;CELF1
6286,GO:0019888,0.0498157410865498,0.985223356633072,5,61,protein phosphatase regulator activity,MF,PPP1R15A;ANKLE2;PPP1R10;PPP1R15B;SH3RF2
10454,GO:0043312,0.0498499600758388,0.972357850550863,17,350,neutrophil degranulation,BP,CXCL1;PLAUR;PLAU;NFKB1;CAB39;RAP2B;AMPD3;B4GALT1;ADAM8;SERPINB1;CD55;ITGAV;VCL;COTL1;CTSC;CREG1;RAB24
16596,GO:0097421,0.0498967300868142,0.990926738625968,3,27,liver regeneration,BP,NFKBIA;CLDN1;CEBPB
16214,GO:0090257,0.0501598556785428,0.979778767075332,8,119,regulation of muscle system process,BP,ZC3H12A;PTGS2;EDN1;ERRFI1;ADRB2;IL6ST;SMAD3;SLC9A1
6285,GO:0019887,0.0503220585845688,0.978395881535623,9,146,protein kinase regulator activity,MF,TRIB1;CAB39;CDKN1A;CDKN2B;SOCS3;NRG1;CCNL1;YWHAG;SFN
1430,GO:0003401,0.0503460891788948,0.990928909307247,3,23,axis elongation,BP,SOX9;AREG;WNT5A
2263,GO:0005176,0.0503491847450148,0.999351419249628,1,2,ErbB-2 class receptor binding,MF,NRG1
2111,GO:0004888,0.0504542470383369,0.972010816117163,17,322,transmembrane signaling receptor activity,MF,HCAR2;TNFRSF10B;EPHA2;IFNGR2;CLDN4;RELT;ADRB2;IL6ST;HCAR3;F3;BDKRB1;IFNAR2;ANTXR2;IL7R;OSMR;TNFRSF10A;GPR156
15429,GO:0071702,0.0505641831766057,0.961827771956579,76,1935,organic substance transport,BP,NFKBIA;IL1B;IL1A;ZC3H12A;CSF2;INHBA;TNF;PTGS2;NFKB1;EDN1;IL1RN;PANX1;HCAR2;NFKBIE;CDKN1A;CD274;BCL3;ZFP36L1;DUSP16;UGCG;TRIM16;EHD1;PPP1R10;PIM3;SLC6A14;ADAM8;LDLR;VEGFC;PLK3;TFRC;LIPG;PPARD;SLC25A25;USP36;ZFP36;AZIN1;PLAGL2;RIPK2;SAA1;STARD5;ITGAV;STX1A;NRG1;PML;POU2F2;FERMT1;SLC7A2;SLC28A3;PTPN11;RHOB;ABCA5;SOX4;OXCT1;PTPN1;ATP6V1C2;HLA-E;RAB3IP;QKI;PMM2;WNT5A;NUP153;INSIG1;ADAM9;ADAMTS9;NFE2L2;YWHAH;AGFG1;YWHAG;RAB22A;SFN;IFIH1;IPO4;TAP1;STX12;RAB24;SMPD3
1708,GO:0004222,0.05059219496378,0.984971802354861,5,57,metalloendopeptidase activity,MF,ADAM8;ADAMTS1;ADAM9;ADAMTS9;ADAMTS6
4771,GO:0010955,0.0507082131329262,0.990745433759512,3,26,negative regulation of protein processing,BP,BIRC3;BIRC2;CD55
18349,GO:1903318,0.0507082131329262,0.990745433759512,3,26,negative regulation of protein maturation,BP,BIRC3;BIRC2;CD55
13513,GO:0055080,0.0508396275461047,0.970765156437983,19,381,cation homeostasis,BP,EDN1;NEDD4L;SMAD3;TFRC;BDKRB1;SLC9A1;CYP27B1;CD55;SAA1;ITGAV;PML;STEAP4;ADM;MAFG;ABL2;ATP6V1C2;PDPK1;ERO1A;ATP13A3
14819,GO:0070557,0.0509962296566752,0.999334417705411,1,2,PCNA-p21 complex,CC,CDKN1A
17572,GO:1901184,0.050998731342046,0.982653898273414,6,79,regulation of ERBB signaling pathway,BP,PLAUR;HBEGF;TGFA;ERRFI1;EREG;NRG1
904,GO:0002283,0.0510952270617063,0.971578167749907,17,351,neutrophil activation involved in immune response,BP,CXCL1;PLAUR;PLAU;NFKB1;CAB39;RAP2B;AMPD3;B4GALT1;ADAM8;SERPINB1;CD55;ITGAV;VCL;COTL1;CTSC;CREG1;RAB24
16541,GO:0097286,0.0511087545173513,0.994854235611635,2,11,iron ion import,BP,TFRC;STEAP4
4731,GO:0010893,0.0511102423523337,0.994854002703531,2,11,positive regulation of steroid biosynthetic process,BP,IL1B;TNF
9146,GO:0035497,0.0511947095540792,0.994840773668398,2,11,cAMP response element binding,MF,JUN;CREB1
19246,GO:1905397,0.0512415660473645,0.999327912276603,1,2,activated CD8-positive, alpha-beta T cell apoptotic process,BP,CD274
19247,GO:1905402,0.0512415660473645,0.999327912276603,1,2,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,CD274
1150,GO:0002756,0.0512867109615705,0.990597250221463,3,26,MyD88-independent toll-like receptor signaling pathway,BP,BIRC3;TICAM1;BIRC2
15227,GO:0071385,0.0513278914225506,0.987276800673693,4,43,cellular response to glucocorticoid stimulus,BP,EDN1;ERRFI1;ZFP36L1;ZFP36
6313,GO:0019956,0.0513849110825444,0.994810938757074,2,11,chemokine binding,MF,ZFP36;ITGAV
1923,GO:0004615,0.0513854327822551,0.999324082343774,1,2,phosphomannomutase activity,MF,PMM2
10442,GO:0043299,0.0514433705441793,0.970840579775641,18,376,leukocyte degranulation,BP,CXCL1;PLAUR;PLAU;NFKB1;CAB39;RAP2B;AMPD3;B4GALT1;ADAM8;SERPINB1;CD55;ITGAV;VCL;COTL1;PDPK1;CTSC;CREG1;RAB24
9903,GO:0042222,0.0514652986407476,0.999321951380226,1,2,interleukin-1 biosynthetic process,BP,CCL20
11226,GO:0045360,0.0514652986407476,0.999321951380226,1,2,regulation of interleukin-1 biosynthetic process,BP,CCL20
11227,GO:0045362,0.0514652986407476,0.999321951380226,1,2,positive regulation of interleukin-1 biosynthetic process,BP,CCL20
11177,GO:0045259,0.0515233496490764,0.99932040031439,1,2,proton-transporting ATP synthase complex,CC,PPIF
2537,GO:0005793,0.0515360390301201,0.980614948206633,7,102,endoplasmic reticulum-Golgi intermediate compartment,CC,TGFA;RGMB;VMP1;CD55;AREG;CTSC;TAP1
19723,GO:2000060,0.0515453759362751,0.982415088098426,6,80,positive regulation of ubiquitin-dependent protein catabolic process,BP,RNF19B;TRIB1;PLK2;PLK3;RNF19A;NFE2L2
3757,GO:0008298,0.0516235822050455,0.994704668854201,2,12,intracellular mRNA localization,BP,ZFP36L1;ZFP36
17783,GO:1901842,0.0517328710178545,0.999314786971942,1,2,negative regulation of high voltage-gated calcium channel activity,BP,RRAD
1345,GO:0003206,0.0518205555280772,0.982329408381675,6,76,cardiac chamber morphogenesis,BP,TBX3;JAG1;NRG1;SOX4;ADAMTS1;WNT5A
6792,GO:0030228,0.0518460234698668,0.994822218234248,2,10,lipoprotein particle receptor activity,MF,LDLR;CXCL16
5818,GO:0017081,0.0518852157704363,0.994662889840788,2,12,chloride channel regulator activity,MF,STX1A;SGK1
392,GO:0001047,0.0520018157167226,0.978897989822647,8,116,core promoter binding,MF,RELB;GADD45A;CEBPB;RUNX1;SOX9;SOX4;KLF10;MTF1
18032,GO:1902544,0.0520138900432311,0.999307220884239,1,2,regulation of DNA N-glycosylase activity,BP,TDG
3461,GO:0007276,0.0520260728114047,0.970006839744609,19,375,gamete generation,BP,BIRC3;INHBA;PTGS2;PRDM1;FOSL1;OVOL1;TAF4B;BCL2L2;EREG;GJB3;SOX9;SPAG9;ADAMTS1;SKIL;TOB2;QKI;CELF1;AGFG1;BRD2
17854,GO:1902042,0.0520683760601365,0.990369067799005,3,27,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,TNFAIP3;TNFRSF10B;TNFRSF10A
6991,GO:0030669,0.0520721016239398,0.990424023867186,3,25,clathrin-coated endocytic vesicle membrane,CC,HBEGF;LDLR;WNT5A
2250,GO:0005161,0.0520728953966244,0.994786918136823,2,10,platelet-derived growth factor receptor binding,MF,ITGA5;ERN1
12788,GO:0051066,0.0520746439844399,0.999305579550085,1,2,dihydrobiopterin metabolic process,BP,GCH1
10032,GO:0042481,0.0521391655242002,0.994692000458881,2,11,regulation of odontogenesis,BP,EDN1;BMP2
13515,GO:0055082,0.0521695390542438,0.969025845273434,21,433,cellular chemical homeostasis,BP,EDN1;PIM3;NEDD4L;SMAD3;TFRC;BDKRB1;SLC9A1;CD55;SAA1;ITGAV;PML;SOX4;OXCT1;ADM;MAFG;ABL2;ATP6V1C2;PDPK1;ERO1A;ERN1;ATP13A3
81,GO:0000164,0.0521809354746476,0.994685384588298,2,11,protein phosphatase type 1 complex,CC,PPP1R15A;PPP1R15B
5119,GO:0015459,0.0522363334258144,0.990381676277468,3,25,potassium channel regulator activity,MF,ADRB2;NEDD4L;SGK1
16557,GO:0097340,0.0523375168101019,0.994660556747703,2,11,inhibition of cysteine-type endopeptidase activity,BP,BIRC3;BIRC2
16558,GO:0097341,0.0523375168101019,0.994660556747703,2,11,zymogen inhibition,BP,BIRC3;BIRC2
12270,GO:0048565,0.0524557215761487,0.982068115815457,6,75,digestive tract development,BP,TNF;CXCL8;PRDM1;CDKN1A;SMAD3;WNT5A
12137,GO:0048237,0.052519666127797,0.999293495954336,1,2,rough endoplasmic reticulum lumen,CC,EDN1
19721,GO:2000058,0.0526386287169768,0.978550852842818,8,124,regulation of ubiquitin-dependent protein catabolic process,BP,RNF19B;TRIB1;N4BP1;PLK2;PLK3;PML;RNF19A;NFE2L2
6855,GO:0030323,0.0526559144708013,0.978583642762468,8,115,respiratory tube development,BP,TNF;ERRFI1;LIF;CREB1;STK40;SOX9;TRAF4;WNT5A
17862,GO:1902074,0.0529952839965806,0.99448427983143,2,12,response to salt,BP,ZC3H12A;EDN1
9289,GO:0035728,0.0531538122277846,0.994530429575262,2,11,response to hepatocyte growth factor,BP,CREB1;RELA
10825,GO:0044319,0.0532007462820984,0.990131863133083,3,25,wound healing, spreading of cells,BP,HBEGF;PHLDB2;ITGA5
16320,GO:0090505,0.0532007462820984,0.990131863133083,3,25,epiboly involved in wound healing,BP,HBEGF;PHLDB2;ITGA5
13495,GO:0055037,0.0532134410242446,0.97692632382096,9,143,recycling endosome,CC,TNF;RAP2B;EHD1;TFRC;AMOTL2;NDRG1;HLA-E;RNF11;STX12
1402,GO:0003334,0.0532780238456233,0.994510526952128,2,11,keratinocyte development,BP,FOSL2;SFN
594,GO:0001756,0.0532902041251525,0.986699854529312,4,39,somitogenesis,BP,SMAD3;NRARP;WNT5A;KDM6A
12299,GO:0048638,0.0533301280228038,0.973728409757194,12,199,regulation of developmental growth,BP,EDN1;SEMA7A;PHLDA2;ADRB2;NEDD4L;DUSP10;PIM1;CREB1;PPARD;NRG1;PTPN11;WNT5A
2249,GO:0005160,0.0534033883682091,0.990079126459074,3,25,transforming growth factor beta receptor binding,MF,INHBA;BMP2;SMAD3
12254,GO:0048535,0.0534570501299574,0.994409341393107,2,12,lymph node development,BP,RC3H1;IL7R
12311,GO:0048662,0.053486015021372,0.989999653195138,3,27,negative regulation of smooth muscle cell proliferation,BP,TNFAIP3;TRIB1;PPARD
7850,GO:0032409,0.0534865487803254,0.976800721926391,9,139,regulation of transporter activity,BP,PPIF;RRAD;CAB39;ADRB2;NEDD4L;OXSR1;SLC9A1;YWHAH;SGK1
4664,GO:0010811,0.0536417270367649,0.98154533333452,6,77,positive regulation of cell-substrate adhesion,BP,SDC4;VEGFC;SMAD3;ITGA5;FERMT1;CDK6
3656,GO:0008139,0.0536533628263199,0.990082799112875,3,23,nuclear localization sequence binding,MF,NFKBIA;NUP153;IPO4
9628,GO:0036496,0.0536754153531348,0.999261613641105,1,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,PPP1R15A
8128,GO:0032816,0.0537885731096577,0.994355308620956,2,12,positive regulation of natural killer cell activation,BP,TICAM1;IL23A
4487,GO:0010508,0.0539686203353181,0.979516634692837,7,98,positive regulation of autophagy,BP,ZC3H12A;TICAM1;PLEKHF1;ADRB2;PLK2;PLK3;RIPK2
18153,GO:1902894,0.0539734843004387,0.994487713562343,2,10,negative regulation of pri-miRNA transcription by RNA polymerase II,BP,PPARD;SOX9
8257,GO:0033036,0.0540789498345028,0.958357995724618,88,2264,macromolecule localization,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;INHBA;TNF;PTGS2;PMAIP1;NFKB1;PLEKHF1;EDN1;IL1RN;PANX1;HCAR2;EPHA2;LIF;SQSTM1;NFKBIE;CDKN1A;PHLDB2;CD274;BCL3;ZFP36L1;DUSP16;UGCG;PPP1R15A;TRIM16;EHD1;PPP1R10;PIM3;CYLD;ADAM8;LDLR;VEGFC;NEDD4L;BBC3;PLK3;TFRC;LIPG;KLHL21;PPARD;USP36;ZFP36;PLAGL2;RIPK2;SAA1;STARD5;ITGAV;PIP5K1A;TP53BP2;SOX9;STX1A;NRG1;PML;POU2F2;FERMT1;PTPN11;RHOB;ABCA5;SOX4;VCL;OXCT1;PTPN1;CORO1C;PRPF19;ATP6V1C2;HLA-E;RAB3IP;QKI;PMM2;WNT5A;NUP153;INSIG1;ADAM9;PDPK1;ADAMTS9;FRMD6;YWHAH;AGFG1;YWHAG;RAB22A;SFN;IFIH1;IPO4;TAP1;STX12;RAB24
287,GO:0000791,0.0541911762895865,0.989788154056261,3,28,euchromatin,CC,JUN;CREB1;UHRF1
13921,GO:0060575,0.0542023847035571,0.994287593888552,2,12,intestinal epithelial cell differentiation,BP,PRDM1;CDKN1A
16170,GO:0090191,0.0542255885283203,0.999246182463754,1,2,negative regulation of branching involved in ureteric bud morphogenesis,BP,TACSTD2
11326,GO:0045650,0.0543397151879551,0.999242960903183,1,2,negative regulation of macrophage differentiation,BP,INHBA
4682,GO:0010829,0.0544445006711061,0.994247835970375,2,12,negative regulation of glucose transmembrane transport,BP,IL1B;TNF
6656,GO:0030003,0.0544596644636674,0.969477835602147,17,336,cellular cation homeostasis,BP,EDN1;NEDD4L;SMAD3;TFRC;BDKRB1;SLC9A1;CD55;SAA1;ITGAV;PML;ADM;MAFG;ABL2;ATP6V1C2;PDPK1;ERO1A;ATP13A3
13957,GO:0060644,0.0545152194842726,0.994236203900481,2,12,mammary gland epithelial cell differentiation,BP,IRF6;CEBPB
1237,GO:0002923,0.0546445168823237,0.999234322345632,1,2,regulation of humoral immune response mediated by circulating immunoglobulin,BP,TNF
14152,GO:0061029,0.0547252298918978,0.994276666715114,2,11,eyelid development in camera-type eye,BP,INHBA;JUN
1340,GO:0003197,0.0547598635215958,0.989757745127111,3,24,endocardial cushion development,BP,BMP2;JAG1;SOX9
19373,GO:1905809,0.0547738441196294,0.994268748084812,2,11,negative regulation of synapse organization,BP,EFNA1;WNT5A
13644,GO:0060143,0.0547743778819919,0.994193502089497,2,12,positive regulation of syncytium formation by plasma membrane fusion,BP,EHD1;ADAM9
11794,GO:0046660,0.0547768706330779,0.981041553999215,6,79,female sex differentiation,BP,INHBA;TBX3;CEBPB;EREG;ADAMTS1;WNT5A
10954,GO:0044666,0.0547779864971392,0.99426807315668,2,11,MLL3/4 complex,CC,KDM6B;KDM6A
14359,GO:0061578,0.0549421915462009,0.99424129500183,2,11,Lys63-specific deubiquitinase activity,MF,TNFAIP3;CYLD
11769,GO:0046626,0.0549569180780325,0.986089461700617,4,42,regulation of insulin receptor signaling pathway,BP,IL1B;SOCS3;PTPN1;RELA
11156,GO:0045213,0.054957827998272,0.999225390070436,1,2,neurotransmitter receptor metabolic process,BP,NRG1
779,GO:0002032,0.0550634952114007,0.99922236555672,1,2,desensitization of G-protein coupled receptor protein signaling pathway by arrestin,BP,ADRB2
10498,GO:0043400,0.0553784185937577,0.999213315534302,1,2,cortisol secretion,BP,PTPN11
13029,GO:0051462,0.0553784185937577,0.999213315534302,1,2,regulation of cortisol secretion,BP,PTPN11
13561,GO:0060021,0.0555970334010542,0.983048651832497,5,57,roof of mouth development,BP,INHBA;TBX3;CSRNP1;WNT5A;INSIG1
5933,GO:0018209,0.0556641803271136,0.971505622654373,13,228,peptidyl-serine modification,BP,TNF;PTGS2;LIF;IL24;CAB39;MAST4;PLK2;RIPK2;PHKG2;WNT5A;PDPK1;SGK1;ERN1
11629,GO:0046332,0.0557739577810288,0.982979686721365,5,57,SMAD binding,MF,BMP2;JUN;SMAD3;PML;SKIL
15595,GO:0072077,0.0558397479990435,0.994094104727175,2,11,renal vesicle morphogenesis,BP,LIF;SOX9
15601,GO:0072087,0.0558397479990435,0.994094104727175,2,11,renal vesicle development,BP,LIF;SOX9
9575,GO:0036378,0.0558478666379677,0.999199724866562,1,2,calcitriol biosynthetic process from calciol,BP,CYP27B1
11158,GO:0045216,0.0559069209532616,0.973240183555886,11,174,cell-cell junction organization,BP,SDC4;TNF;CLDN1;PHLDB2;RUNX1;SMAD3;SLC9A1;PIP5K1A;VCL;CORO1C;PDPK1
4481,GO:0010494,0.0559335337076967,0.985798383878969,4,40,cytoplasmic stress granule,CC,RC3H1;ZFP36;LARP4B;PABPC4
20100,GO:2000758,0.0561454537463214,0.989295411740161,3,27,positive regulation of peptidyl-lysine acetylation,BP,IL1B;LIF;SOX4
6984,GO:0030659,0.0561536790393498,0.965184254733858,24,507,cytoplasmic vesicle membrane,CC,PLAUR;HBEGF;PLAU;TGFA;IFNGR2;RAP2B;ADRB2;B4GALT1;ADAM8;LDLR;TFRC;CD55;ITGAV;STX1A;AREG;IL7R;HLA-E;WNT5A;YWHAH;YWHAG;RAB22A;SFN;TAP1;RAB24
19696,GO:2000010,0.0561578883527262,0.993963564393809,2,12,positive regulation of protein localization to cell surface,BP,TNF;NRG1
9826,GO:0042044,0.0562512844412314,0.993947922618752,2,12,fluid transport,BP,CSF2;EDN1
3126,GO:0006706,0.0562926477263897,0.993875282491821,2,13,steroid catabolic process,BP,CYP27B1;YWHAH
17466,GO:1900273,0.0564160315473944,0.993998872470895,2,11,positive regulation of long-term synaptic potentiation,BP,SQSTM1;CREB1
4946,GO:0014910,0.0564533122273928,0.985603699747252,4,41,regulation of smooth muscle cell migration,BP,PLAU;TRIB1;PPARD;NFE2L2
10021,GO:0042454,0.056647152680569,0.993758675940175,2,14,ribonucleoside catabolic process,BP,UPP1;AHCY
131,GO:0000271,0.0566852632498187,0.982586215598326,5,60,polysaccharide biosynthetic process,BP,NFKB1;HAS3;B3GNT5;PHKG2;B3GNT2
2491,GO:0005737,0.0567843357268226,0.955007620128845,288,8352,cytoplasm,CC,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;BTG2;BIRC3;HBEGF;PLAU;ITPKC;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;REL;SERPINB2;PPIF;IER3;KLF6;NUAK2;SPRR2D;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;NFKB2;NOCT;PLEKHF1;TGFA;IRF6;EDN1;ODC1;PHLDA1;HAS3;ERRFI1;IL1RN;IRAK2;CLDN1;PANX1;DAPP1;CPEB2;EHF;SPRR2A;EPHA2;RELB;GADD45A;MAFF;LIF;TRIB1;KCTD11;SQSTM1;IFNGR2;PHLDA2;CAB39;N4BP3;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;NMNAT2;RGMB;PHLDB2;TJP2;SERTAD2;BCL3;ETS2;NAMPT;AMPD3;IRF1;TAF4B;BCL2L2;ZFP36L1;ENC1;RELT;RND3;ADRB2;CEBPB;DUSP16;ARNTL2;UGCG;PPP1R15A;MAST4;RUNX1;CDKN2B;HMGCS1;TRIM16;SOD2;PELI1;ALDH1A3;C3ORF52;EHD1;NEDD9;ANKLE2;DUSP8;B4GALT1;HAL;DUSP1;BCL10;FGD6;DCUN1D3;TMCC1;TRAF1;PIM3;CDV3;SACS;G0S2;B3GNT5;SGMS2;VMP1;NABP1;TXNRD1;CYLD;ADAM8;LDLR;VEGFC;ZNF217;TACSTD2;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;PIM1;WISP1;ITGA5;TFRC;LIPG;KLHL21;CREB1;SERPINB8;EFNB1;GJB3;STK40;KRT34;SLC25A25;SERPINB1;SOCS3;CCDC85B;KRTAP2-3;RAET1L;IL16;BDKRB1;RAPH1;ZFP36;SLC9A1;LARP4B;CYP27B1;CD55;PNRC1;ANTXR2;AZIN1;RIPK2;AMOTL2;PHKG2;SAA1;PPP1R15B;STARD5;NDRG1;ITGAV;PIP5K1A;TP53BP2;STX1A;NRG1;FEM1C;PML;POU2F2;RASA2;PPTC7;FERMT1;ELK3;POLR3A;CDC42EP1;SLC28A3;PTPN11;MAP3K8;PANK3;ARHGEF3;C15ORF39;MXD1;RHOB;SPAG9;ABCA5;GCH1;FEM1B;SOX4;TRAF4;VCL;EIF1;OXCT1;AREG;FAM83G;TNFAIP1;HDAC9;ADAMTS1;HIVEP1;NFKBIB;SKIL;COTL1;IL7R;HEXDC;RBM3;CDK6;IER5;YRDC;SAMD4A;PTPN1;SQLE;TFE3;BTG3;TMEM65;CORO1C;STEAP4;PRPF19;TOB2;ADM;ABL2;ATP6V1C2;HLA-E;RAB3IP;QKI;CELF1;PMM2;WNT5A;NUP153;MAOA;INSIG1;LCE1C;PDPK1;ADAMTS9;RNF19A;CTSC;ERO1A;FRMD6;ZBTB21;SMTN;NFE2L2;YWHAH;SGK1;B3GNT2;TSC22D2;CYTH1;SAT1;RELA;AGFG1;RNF11;NOTCH2NL;BACH1;POLR3D;ALAS1;YWHAG;RAB22A;CREG1;SFN;ITM2B;ERN1;ETNK1;UPP1;ISG20;TMEM132A;ATXN7;IFIH1;MYO1B;BRD2;IPO4;PABPC4;TAP1;DSE;AHCY;STX12;PDLIM5;FUBP3;RAB24;SMPD3
8482,GO:0033630,0.056834550897516,0.993849897997319,2,12,positive regulation of cell adhesion mediated by integrin,BP,FERMT1;ADAM9
14007,GO:0060720,0.0569350308377266,0.999167790914114,1,2,spongiotrophoblast cell proliferation,BP,PHLDA2
14008,GO:0060721,0.0569350308377266,0.999167790914114,1,2,regulation of spongiotrophoblast cell proliferation,BP,PHLDA2
14009,GO:0060722,0.0569350308377266,0.999167790914114,1,2,cell proliferation involved in embryonic placenta development,BP,PHLDA2
14010,GO:0060723,0.0569350308377266,0.999167790914114,1,2,regulation of cell proliferation involved in embryonic placenta development,BP,PHLDA2
16190,GO:0090214,0.0569350308377266,0.999167790914114,1,2,spongiotrophoblast layer developmental growth,BP,PHLDA2
17301,GO:0140096,0.0570942972926564,0.95701693447715,70,1699,catalytic activity, acting on a protein,MF,TNFAIP3;ZC3H12A;BIRC3;HBEGF;PLAU;CSF2;PPIF;NUAK2;RNF19B;KDM6B;IRAK2;EPHA2;SQSTM1;CAB39;MAP2K3;BIRC2;CDKN1A;DUSP16;MAST4;EREG;PELI1;DUSP8;DUSP1;PIM3;CYLD;ADAM8;NEDD4L;OXSR1;RC3H1;DUSP10;PLK2;PLK3;PIM1;KLHL21;F3;STK40;USP36;RIPK2;PHKG2;CLK4;SOX9;NRG1;ZNF451;PPTC7;PTPN11;MAP3K8;UHRF1;FEM1B;USP31;TNFAIP1;HDAC9;ADAMTS1;CDK6;PTPN1;PRPF19;ABL2;ADAM9;PDPK1;ADAMTS9;RNF19A;CTSC;ERO1A;KDM6A;SGK1;RNF11;BACH1;ANKK1;ERN1;ATXN7;ADAMTS6
19666,GO:1990911,0.0571481231745441,0.9991614562003,1,2,response to psychosocial stress,BP,ADRB2
7490,GO:0031657,0.0572721271767778,0.993775973836477,2,12,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,CDKN2B;CDK6
11397,GO:0045780,0.0573200002413139,0.993848348642276,2,11,positive regulation of bone resorption,BP,ADAM8;TFRC
11863,GO:0046852,0.0573200002413139,0.993848348642276,2,11,positive regulation of bone remodeling,BP,ADAM8;TFRC
2132,GO:0004935,0.0573306535212075,0.999156010347795,1,2,adrenergic receptor activity,MF,ADRB2
13496,GO:0055038,0.0574860559006978,0.982237033870418,5,63,recycling endosome membrane,CC,RAP2B;EHD1;NDRG1;HLA-E;STX12
17801,GO:1901890,0.0574928762321031,0.988996869468735,3,25,positive regulation of cell junction assembly,BP,SDC4;CLDN1;SMAD3
7128,GO:0030950,0.0575177141637434,0.993734340317581,2,12,establishment or maintenance of actin cytoskeleton polarity,BP,RND3;RHOB
19912,GO:2000401,0.057566089030125,0.988913303621044,3,27,regulation of lymphocyte migration,BP,CCL20;ADAM8;WNT5A
13970,GO:0060674,0.0576445603399423,0.988922788668185,3,26,placenta blood vessel development,BP,FOSL1;JUNB;SOCS3
16238,GO:0090289,0.0576454539252415,0.999146575509674,1,2,regulation of osteoclast proliferation,BP,TNFAIP3
6652,GO:0023058,0.0576615474704237,0.993641780925806,2,13,adaptation of signaling pathway,BP,ADRB2;ADM
14527,GO:0070032,0.0576818878419958,0.99914548006559,1,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,STX1A
14528,GO:0070033,0.0576818878419958,0.99914548006559,1,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,STX1A
19774,GO:2000177,0.0577901746326435,0.985130794669574,4,42,regulation of neural precursor cell proliferation,BP,BTG2;KCTD11;VEGFC;WNT5A
7791,GO:0032330,0.057839389365888,0.988903612073678,3,25,regulation of chondrocyte differentiation,BP,SMAD3;SOX9;RELA
8771,GO:0034450,0.0578945551243183,0.993670254801499,2,12,ubiquitin-ubiquitin ligase activity,MF,PELI1;PRPF19
13039,GO:0051492,0.0579076234436994,0.982116961269499,5,59,regulation of stress fiber assembly,BP,SDC4;PHLDB2;TACSTD2;SMAD3;SLC9A1
11345,GO:0045669,0.0579419108826928,0.98507898080608,4,42,positive regulation of osteoblast differentiation,BP,BMP2;CEBPB;IL6ST;JAG1
20111,GO:2000777,0.057955412014961,0.999137233004553,1,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,PLK3
12593,GO:0050766,0.0580898489636797,0.988771402280037,3,27,positive regulation of phagocytosis,BP,IL1B;TNF;ITGAV
7874,GO:0032434,0.0581920089310849,0.97749922905573,7,105,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,RNF19B;TRIB1;N4BP1;PLK2;PLK3;RNF19A;NFE2L2
12980,GO:0051379,0.0582099006875666,0.999129523232637,1,2,epinephrine binding,MF,ADRB2
2118,GO:0004906,0.0583172294195104,0.999126261096803,1,2,interferon-gamma receptor activity,MF,IFNGR2
10359,GO:0043173,0.0584242767162046,0.993451137489779,2,14,nucleotide salvage,BP,AMPD3;UPP1
4503,GO:0010533,0.0584261899674858,0.998834501502262,1,3,regulation of activation of Janus kinase activity,BP,IL23A
13946,GO:0060612,0.0584581659615656,0.988702572104228,3,26,adipose tissue development,BP,PPARD;SLC25A25;OXCT1
7071,GO:0030857,0.0584726207669401,0.988732570931509,3,25,negative regulation of epithelial cell differentiation,BP,TBX3;JAG1;SOX9
9332,GO:0035812,0.0584800686971412,0.999121299772989,1,2,renal sodium excretion,BP,EDN1
9333,GO:0035813,0.0584800686971412,0.999121299772989,1,2,regulation of renal sodium excretion,BP,EDN1
3801,GO:0008378,0.058684125382896,0.988609731370074,3,27,galactosyltransferase activity,MF,B4GALT1;B3GNT5;B3GNT2
5788,GO:0017015,0.0587533259757138,0.979303759397646,6,80,regulation of transforming growth factor beta receptor signaling pathway,BP,CDKN2B;SMAD3;ZNF451;FERMT1;SKIL;PDPK1
4418,GO:0010193,0.0587573593041869,0.999112818070752,1,2,response to ozone,BP,EDN1
1034,GO:0002541,0.058766704584069,0.999112531487951,1,2,activation of plasma proteins involved in acute inflammatory response,BP,F3
10672,GO:0043903,0.0587942708959794,0.972685542329687,10,178,regulation of symbiosis, encompassing mutualism through parasitism,BP,ZC3H12A;TNF;CXCL8;TNIP1;SQSTM1;JUN;ZFP36;ITGAV;PML;ISG20
4390,GO:0010042,0.0589876631827414,0.993482988822284,2,12,response to manganese ion,BP,PTGS2;ADAM9
11378,GO:0045744,0.0590081825629576,0.988491960441569,3,28,negative regulation of G-protein coupled receptor protein signaling pathway,BP,CXCL8;ADRB2;ADM
14440,GO:0061757,0.0590098410322291,0.999105058685522,1,2,leukocyte adhesion to arterial endothelial cell,BP,TNF
19096,GO:1904997,0.0590098410322291,0.999105058685522,1,2,regulation of leukocyte adhesion to arterial endothelial cell,BP,TNF
13658,GO:0060166,0.059261861940426,0.999097278722608,1,2,olfactory pit development,BP,ALDH1A3
17574,GO:1901186,0.059269325301074,0.988449842287993,3,27,positive regulation of ERBB signaling pathway,BP,PLAUR;TGFA;EREG
16315,GO:0090500,0.0594157454742252,0.999092511218166,1,2,endocardial cushion to mesenchymal transition,BP,EFNA1
6613,GO:0022829,0.0594163798425152,0.993337715358143,2,13,wide pore channel activity,MF,PANX1;GJB3
16319,GO:0090504,0.0596270640461634,0.988383884113085,3,26,epiboly,BP,HBEGF;PHLDB2;ITGA5
16141,GO:0090153,0.0596929493223176,0.9932893112679,2,13,regulation of sphingolipid biosynthetic process,BP,TNF;SMPD3
19110,GO:1905038,0.0596929493223176,0.9932893112679,2,13,regulation of membrane lipid metabolic process,BP,TNF;SMPD3
19841,GO:2000303,0.0596929493223176,0.9932893112679,2,13,regulation of ceramide biosynthetic process,BP,TNF;SMPD3
6301,GO:0019912,0.059745732519937,0.999082244147312,1,2,cyclin-dependent protein kinase activating kinase activity,MF,CDKN1A
2138,GO:0004947,0.059861048440007,0.999078642213441,1,2,bradykinin receptor activity,MF,BDKRB1
5242,GO:0015864,0.0599091308994481,0.99907713819118,1,2,pyrimidine nucleoside transport,BP,SLC28A3
6510,GO:0021882,0.0600989302682625,0.999071188900413,1,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,DLX2
6518,GO:0021893,0.0600989302682625,0.999071188900413,1,2,cerebral cortex GABAergic interneuron fate commitment,BP,DLX2
9366,GO:0035881,0.0600989302682625,0.999071188900413,1,2,amacrine cell differentiation,BP,DLX2
14181,GO:0061074,0.0600989302682625,0.999071188900413,1,2,regulation of neural retina development,BP,DLX2
14182,GO:0061075,0.0600989302682625,0.999071188900413,1,2,positive regulation of neural retina development,BP,DLX2
18142,GO:1902866,0.0600989302682625,0.999071188900413,1,2,regulation of retina development in camera-type eye,BP,DLX2
18143,GO:1902868,0.0600989302682625,0.999071188900413,1,2,positive regulation of retina development in camera-type eye,BP,DLX2
18144,GO:1902869,0.0600989302682625,0.999071188900413,1,2,regulation of amacrine cell differentiation,BP,DLX2
18145,GO:1902871,0.0600989302682625,0.999071188900413,1,2,positive regulation of amacrine cell differentiation,BP,DLX2
10026,GO:0042471,0.0602266462493832,0.9811827496847,5,60,ear morphogenesis,BP,EDN1;ALDH1A3;SOX9;WNT5A;INSIG1
650,GO:0001838,0.0602344020807653,0.976568101805144,7,99,embryonic epithelial tube formation,BP,SDC4;BCL10;SOX9;SOX4;ADM;WNT5A;KDM6A
14824,GO:0070564,0.0603275714679455,0.99906399591969,1,2,positive regulation of vitamin D receptor signaling pathway,BP,CYP27B1
1465,GO:0003713,0.0603464532568602,0.967862416902101,14,261,transcription coactivator activity,MF,ELF3;NFKB2;KLF7;JUN;BIRC2;SERTAD2;JUNB;TAF4B;BCL10;PPARD;NCOA7;SOX4;NFKBIB;MTF1
16148,GO:0090162,0.0604044484194441,0.988205861309396,3,25,establishment of epithelial cell polarity,BP,FERMT1;WNT5A;CYTH1
18241,GO:1903050,0.0604140028721239,0.971809659008123,10,174,regulation of proteolysis involved in cellular protein catabolic process,BP,RNF19B;EFNA1;TRIB1;N4BP1;PLK2;PLK3;PML;RNF19A;CTSC;NFE2L2
9482,GO:0036117,0.0604152295032013,0.999061230634266,1,2,hyaluranon cable,CC,HAS3
18763,GO:1904245,0.0604718779984446,0.999059441346079,1,2,regulation of polynucleotide adenylyltransferase activity,BP,ZFP36
11368,GO:0045730,0.0605085290576523,0.993083476394945,2,14,respiratory burst,BP,DUSP10;CD55
18024,GO:1902524,0.0607029805575733,0.999052123572282,1,2,positive regulation of protein K48-linked ubiquitination,BP,BIRC2
8940,GO:0034976,0.0607090213105583,0.968484525080446,13,242,response to endoplasmic reticulum stress,BP,CXCL8;PMAIP1;TNFRSF10B;JUN;CEBPB;PPP1R15A;BBC3;PPP1R15B;PML;PTPN1;ERO1A;NFE2L2;ERN1
8882,GO:0034696,0.060721981288874,0.999051520619621,1,2,response to prostaglandin F,BP,EDN1
607,GO:0001773,0.0607438449731073,0.993041497484459,2,14,myeloid dendritic cell activation,BP,CSF2;RELB
16852,GO:0098771,0.0608595400474058,0.964232710668397,19,389,inorganic ion homeostasis,BP,EDN1;NEDD4L;SMAD3;TFRC;BDKRB1;SLC9A1;CYP27B1;CD55;SAA1;ITGAV;PML;STEAP4;ADM;MAFG;ABL2;ATP6V1C2;PDPK1;ERO1A;ATP13A3
2351,GO:0005415,0.0609282234369225,0.999044963182057,1,2,nucleoside:sodium symporter activity,MF,SLC28A3
5240,GO:0015860,0.0609282234369225,0.999044963182057,1,2,purine nucleoside transmembrane transport,BP,SLC28A3
7266,GO:0031233,0.0609364068623948,0.99307007454919,2,13,intrinsic component of external side of plasma membrane,CC,F3;ADAM9
6508,GO:0021879,0.0611097981421346,0.987942574184447,3,27,forebrain neuron differentiation,BP,INHBA;DLX2;WNT5A
1241,GO:0002931,0.0611370816974598,0.987935004289734,3,27,response to ischemia,BP,PPIF;PANX1;SQSTM1
15226,GO:0071384,0.0611540971235055,0.98389875813833,4,46,cellular response to corticosteroid stimulus,BP,EDN1;ERRFI1;ZFP36L1;ZFP36
956,GO:0002374,0.0611583193726473,0.993105113278922,2,12,cytokine secretion involved in immune response,BP,TNF;WNT5A
1299,GO:0003130,0.0611891605414622,0.99903663331549,1,2,BMP signaling pathway involved in heart induction,BP,BMP2
1301,GO:0003133,0.0611891605414622,0.99903663331549,1,2,endodermal-mesodermal cell signaling,BP,BMP2
1302,GO:0003134,0.0611891605414622,0.99903663331549,1,2,endodermal-mesodermal cell signaling involved in heart induction,BP,BMP2
15639,GO:0072138,0.0611891605414622,0.99903663331549,1,2,mesenchymal cell proliferation involved in ureteric bud development,BP,BMP2
17901,GO:1902202,0.0612515232377785,0.99903463699051,1,2,regulation of hepatocyte growth factor receptor signaling pathway,BP,PTPN1
4248,GO:0009447,0.0612559596493717,0.998717179852822,1,3,putrescine catabolic process,BP,SAT1
1396,GO:0003308,0.0613672582447437,0.999030926484261,1,2,negative regulation of Wnt signaling pathway involved in heart development,BP,BMP2
1320,GO:0003166,0.0613685076062511,0.999030886389196,1,2,bundle of His development,BP,TBX3
15168,GO:0071300,0.0613835323775444,0.983853082432565,4,44,cellular response to retinoic acid,BP,GJB3;SOX9;ABL2;WNT5A
19199,GO:1905286,0.06139975336167,0.999029883358046,1,2,serine-type peptidase complex,CC,F3
17969,GO:1902359,0.0614204437268308,0.999029218874518,1,2,Notch signaling pathway involved in somitogenesis,BP,NRARP
17973,GO:1902366,0.0614204437268308,0.999029218874518,1,2,regulation of Notch signaling pathway involved in somitogenesis,BP,NRARP
17974,GO:1902367,0.0614204437268308,0.999029218874518,1,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,NRARP
15598,GO:0072080,0.0614674530683195,0.980684997405012,5,60,nephron tubule development,BP,LIF;BMP2;TACSTD2;JAG1;SOX9
796,GO:0002062,0.0615133129535913,0.980679707455765,5,59,chondrocyte differentiation,BP,BMP2;RUNX1;SMAD3;SOX9;RELA
7354,GO:0031394,0.0615774166214381,0.99902416994563,1,2,positive regulation of prostaglandin biosynthetic process,BP,PTGS2
20303,GO:2001280,0.0615774166214381,0.99902416994563,1,2,positive regulation of unsaturated fatty acid biosynthetic process,BP,PTGS2
15237,GO:0071397,0.061591250083598,0.993118482736159,2,11,cellular response to cholesterol,BP,INHBA;HMGCS1
14505,GO:0062014,0.0616378784356163,0.980567889940493,5,64,negative regulation of small molecule metabolic process,BP,PPIF;NFKB1;BMP2;CYP27B1;INSIG1
2517,GO:0005769,0.0616476752188191,0.96707351532421,14,258,early endosome,CC,ADRB2;EHD1;LDLR;TFRC;LIPG;PML;RHOB;PTPN1;STEAP4;HLA-E;RNF11;RAB22A;MYO1B;STX12
17625,GO:1901329,0.0616988483777343,0.99902025489888,1,2,regulation of odontoblast differentiation,BP,CEBPB
6314,GO:0019957,0.0617027005333285,0.999020130570201,1,2,C-C chemokine binding,MF,ZFP36
10429,GO:0043274,0.0617703401570794,0.993087214484934,2,11,phospholipase binding,MF,PTPN11;PDPK1
6838,GO:0030299,0.0618324097473784,0.999015939439082,1,2,intestinal cholesterol absorption,BP,LDLR
10782,GO:0044241,0.0618324097473784,0.999015939439082,1,2,lipid digestion,BP,LDLR
16901,GO:0098856,0.0618324097473784,0.999015939439082,1,2,intestinal lipid absorption,BP,LDLR
9714,GO:0038129,0.0618604120650148,0.999015033423262,1,2,ERBB3 signaling pathway,BP,NRG1
3106,GO:0006684,0.0621060030448411,0.992861465470941,2,13,sphingomyelin metabolic process,BP,SGMS2;SMPD3
2117,GO:0004905,0.0621864327335351,0.999004453329769,1,2,type I interferon receptor activity,MF,IFNAR2
13643,GO:0060142,0.0622587809524731,0.992834045351267,2,13,regulation of syncytium formation by plasma membrane fusion,BP,EHD1;ADAM9
19527,GO:1990410,0.0624044482242862,0.998997345673131,1,2,adrenomedullin receptor signaling pathway,BP,ADM
9058,GO:0035282,0.0624423738615782,0.98029175480628,5,60,segmentation,BP,TBX3;SMAD3;NRARP;WNT5A;KDM6A
13753,GO:0060324,0.0625459923654791,0.983484501271406,4,42,face development,BP,CSRNP1;ALDH1A3;PTPN11;WNT5A
8041,GO:0032688,0.0625886284587453,0.992774711221208,2,13,negative regulation of interferon-beta production,BP,REL;RELB
4357,GO:0009952,0.0626916014327463,0.973540919394022,8,122,anterior/posterior pattern specification,BP,BTG2;TBX3;BMP2;ETS2;SMAD3;NRARP;WNT5A;KDM6A
12251,GO:0048531,0.0627487926951687,0.992745834281032,2,13,beta-1,3-galactosyltransferase activity,MF,B3GNT5;B3GNT2
8676,GO:0034249,0.0627774885409673,0.968185286755475,12,232,negative regulation of cellular amide metabolic process,BP,ZC3H12A;BTG2;CPEB2;ZFP36L1;ENC1;SMAD3;RC3H1;ZFP36;SAMD4A;QKI;CELF1;NUP153
6671,GO:0030029,0.062826706559913,0.960204514548438,25,513,actin filament-based process,BP,CXCL1;SDC4;TNF;NUAK2;EDN1;PHLDB2;RND3;NEDD9;FGD6;TACSTD2;NEDD4L;SMAD3;SLC9A1;AMOTL2;PIP5K1A;CDC42EP1;RHOB;AKAP2;TNFAIP1;PTPN1;CORO1C;ABL2;PDPK1;FRMD6;MYO1B
3702,GO:0008211,0.0628302508446593,0.992731131174349,2,13,glucocorticoid metabolic process,BP,BMP2;YWHAH
8163,GO:0032892,0.0628456275036267,0.992728354453228,2,13,positive regulation of organic acid transport,BP,IL1B;EDN1
958,GO:0002377,0.0628962720405673,0.980058369274838,5,64,immunoglobulin production,BP,TNF;TFRC;POU2F2;IL7R;HLA-E
2239,GO:0005146,0.0629103776941585,0.998980750921145,1,2,leukemia inhibitory factor receptor binding,MF,LIF
19238,GO:1905371,0.0630641389372804,0.998975679588321,1,2,ceramide phosphoethanolamine metabolic process,BP,SGMS2
19239,GO:1905373,0.0630641389372804,0.998975679588321,1,2,ceramide phosphoethanolamine biosynthetic process,BP,SGMS2
2241,GO:0005150,0.0630681042054888,0.998975548634389,1,2,interleukin-1, Type I receptor binding,MF,IL1RN
168,GO:0000349,0.0631136454781052,0.998974044002904,1,2,generation of catalytic spliceosome for first transesterification step,BP,PRPF19
13236,GO:0051896,0.0631518170574548,0.973301294334553,8,123,regulation of protein kinase B signaling,BP,HBEGF;TNF;EPHA2;EREG;ADAM8;F3;NRG1;PTPN11
4025,GO:0009056,0.0631605445094542,0.951685549495849,76,1984,catabolic process,BP,TNFAIP3;IL1B;ZC3H12A;BTG2;TICAM1;SDC4;TNF;RNF19B;PMAIP1;NOCT;PLEKHF1;EFNA1;ODC1;HCAR2;TRIB1;SQSTM1;BIRC2;AMPD3;ZFP36L1;ENC1;ADRB2;N4BP1;HAL;VMP1;CYLD;ADAM8;LDLR;NEDD4L;SMAD3;RC3H1;PLK2;PLK3;LIPG;PPARD;USP36;ZFP36;SLC9A1;CYP27B1;PNRC1;AZIN1;RIPK2;PHKG2;SOX9;NRG1;PML;UHRF1;USP31;OXCT1;TNFAIP1;SAMD4A;PTPN1;PRPF19;ABL2;ATP6V1C2;QKI;WNT5A;NUP153;MAOA;ADAM9;ADAMTS9;RNF19A;CTSC;NFE2L2;YWHAH;SAT1;RELA;RNF11;TDG;ERN1;UPP1;ISG20;PABPC4;AHCY;STX12;RAB24;SMPD3
8712,GO:0034356,0.0632796064491926,0.992728184015121,2,12,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,PTGS2;NAMPT
4603,GO:0010717,0.0633075788675455,0.979915335435302,5,62,regulation of epithelial to mesenchymal transition,BP,IL1B;EFNA1;BMP2;PHLDB2;SMAD3
1004,GO:0002476,0.0633670947517761,0.998965649485308,1,2,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,HLA-E
16479,GO:0097164,0.0634777380721753,0.973086480703111,8,133,ammonium ion metabolic process,BP,ODC1;SGMS2;LDLR;AZIN1;GCH1;MAOA;SAT1;SMPD3
1091,GO:0002677,0.0636450995002623,0.998956401011459,1,2,negative regulation of chronic inflammatory response,BP,TNFAIP3
17998,GO:1902445,0.06365150318587,0.998613333523753,1,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,PPIF
18590,GO:1903844,0.0637600097201291,0.977062618498825,6,82,regulation of cellular response to transforming growth factor beta stimulus,BP,CDKN2B;SMAD3;ZNF451;FERMT1;SKIL;PDPK1
7105,GO:0030900,0.063824852891552,0.96664113357402,13,230,forebrain development,BP,BTG2;INHBA;ETS1;TBX3;KDM6B;SEMA7A;BMP2;ALDH1A3;DLX2;CREB1;NRG1;CDK6;WNT5A
17726,GO:1901654,0.0638317979894111,0.972928850329969,8,128,response to ketone,BP,FOSL1;EDN1;ERRFI1;CLDN1;CDKN1A;CLDN4;DUSP1;RELA
9845,GO:0042091,0.0638652587753872,0.9989490467127,1,2,interleukin-10 biosynthetic process,BP,BCL3
11073,GO:0045074,0.0638652587753872,0.9989490467127,1,2,regulation of interleukin-10 biosynthetic process,BP,BCL3
692,GO:0001910,0.0638921319518338,0.987072227431373,3,30,regulation of leukocyte mediated cytotoxicity,BP,IL23A;IL7R;HLA-E
14130,GO:0060993,0.0639026786542897,0.979699225815469,5,60,kidney morphogenesis,BP,LIF;BMP2;TACSTD2;SOX9;SOX4
19694,GO:2000008,0.0640188134470331,0.987094664503577,3,28,regulation of protein localization to cell surface,BP,TNF;NEDD4L;NRG1
15667,GO:0072190,0.0640533732856566,0.99894274170343,1,2,ureter urothelium development,BP,SOX9
15668,GO:0072191,0.0640533732856566,0.99894274170343,1,2,ureter smooth muscle development,BP,SOX9
15670,GO:0072193,0.0640533732856566,0.99894274170343,1,2,ureter smooth muscle cell differentiation,BP,SOX9
15672,GO:0072197,0.0640533732856566,0.99894274170343,1,2,ureter morphogenesis,BP,SOX9
5655,GO:0016748,0.0641256308281916,0.998940314675005,1,2,succinyltransferase activity,MF,ALAS1
2334,GO:0005350,0.0641882918787693,0.998938207650219,1,2,pyrimidine nucleobase transmembrane transporter activity,MF,SLC28A3
5238,GO:0015855,0.0641882918787693,0.998938207650219,1,2,pyrimidine nucleobase transport,BP,SLC28A3
19009,GO:1904823,0.0641882918787693,0.998938207650219,1,2,purine nucleobase transmembrane transport,BP,SLC28A3
3101,GO:0006679,0.0642293847153728,0.998936824698174,1,2,glucosylceramide biosynthetic process,BP,UGCG
15806,GO:0072503,0.0644920274542326,0.967207876468524,12,218,cellular divalent inorganic cation homeostasis,BP,EDN1;SMAD3;BDKRB1;CD55;SAA1;ITGAV;PML;ADM;ABL2;PDPK1;ERO1A;ATP13A3
16807,GO:0098655,0.0645134213684045,0.961266675515138,20,414,cation transmembrane transport,BP,PPIF;TRPV3;PANX1;RRAD;CAB39;ADRB2;NEDD4L;OXSR1;SLC25A25;BDKRB1;SLC9A1;ITGAV;SLC7A2;SLC28A3;STEAP4;ATP6V1C2;PDPK1;ERO1A;YWHAH;ATP13A3
8613,GO:0034124,0.064587564851329,0.998924730974375,1,2,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,IRF1
11509,GO:0045994,0.0646092594593104,0.998923996198217,1,2,positive regulation of translational initiation by iron,BP,TNF
10097,GO:0042605,0.0646251837649196,0.99233550413218,2,14,peptide antigen binding,MF,HLA-E;TAP1
395,GO:0001056,0.0647019668882164,0.992261901428537,2,15,RNA polymerase III activity,MF,POLR3A;POLR3D
12619,GO:0050798,0.0647205918612818,0.98683570866996,3,30,activated T cell proliferation,BP,CD274;RC3H1;IL23A
17536,GO:1901031,0.064723213263976,0.98686357719898,3,29,regulation of response to reactive oxygen species,BP,TNF;GCH1;NFE2L2
14146,GO:0061013,0.0648183294473913,0.970758374628667,9,160,regulation of mRNA catabolic process,BP,ZC3H12A;BTG2;NOCT;ZFP36L1;RC3H1;ZFP36;SAMD4A;QKI;PABPC4
8274,GO:0033078,0.0648456732416387,0.998915972258883,1,2,extrathymic T cell differentiation,BP,PRDM1
19574,GO:1990589,0.0650864688721133,0.998907767906644,1,2,ATF4-CREB1 transcription factor complex,CC,CREB1
3221,GO:0006873,0.0652106172495331,0.962583210590994,17,344,cellular ion homeostasis,BP,EDN1;NEDD4L;SMAD3;TFRC;BDKRB1;SLC9A1;CD55;SAA1;ITGAV;PML;ADM;MAFG;ABL2;ATP6V1C2;PDPK1;ERO1A;ATP13A3
11811,GO:0046696,0.0652742843822449,0.99890134647542,1,2,lipopolysaccharide receptor complex,CC,BCL10
11064,GO:0045063,0.0653988187965052,0.992344157573801,2,12,T-helper 1 cell differentiation,BP,RELB;RIPK2
8843,GO:0034637,0.0654009747953941,0.979047335754329,5,63,cellular carbohydrate biosynthetic process,BP,HAS3;B4GALT1;B3GNT5;PHKG2;B3GNT2
892,GO:0002262,0.0654085496399349,0.974032799518804,7,106,myeloid cell homeostasis,BP,INHBA;ETS1;HCAR2;AMPD3;ZFP36L1;ZFP36;CDK6
16168,GO:0090189,0.0654990588388312,0.992243274889579,2,13,regulation of branching involved in ureteric bud morphogenesis,BP,TACSTD2;SOX9
12561,GO:0050710,0.0655769345873957,0.986618968250536,3,29,negative regulation of cytokine secretion,BP,ZC3H12A;TNF;PML
14270,GO:0061326,0.0656057419747146,0.978989241924829,5,61,renal tubule development,BP,LIF;BMP2;TACSTD2;JAG1;SOX9
17341,GO:1900025,0.0656298375380398,0.992301846515013,2,12,negative regulation of substrate adhesion-dependent cell spreading,BP,TACSTD2;CORO1C
2242,GO:0005151,0.0656461183733523,0.998888575995982,1,2,interleukin-1, Type II receptor binding,MF,IL1RN
4855,GO:0014066,0.0657734067820092,0.978907061187913,5,62,regulation of phosphatidylinositol 3-kinase signaling,BP,IER3;PPARD;PIP5K1A;SOX9;NRG1
11407,GO:0045807,0.0658233366449202,0.976113864353676,6,84,positive regulation of endocytosis,BP,IL1B;TNF;LDLR;NEDD4L;ITGAV;WNT5A
15243,GO:0071404,0.0658357939799608,0.992264051708595,2,12,cellular response to low-density lipoprotein particle stimulus,BP,HMGCS1;LDLR
16117,GO:0090103,0.0659151166464039,0.992249476738909,2,12,cochlea morphogenesis,BP,SOX9;WNT5A
18326,GO:1903279,0.0660779396258866,0.998873649441787,1,2,regulation of calcium:sodium antiporter activity,BP,SLC9A1
18327,GO:1903281,0.0660779396258866,0.998873649441787,1,2,positive regulation of calcium:sodium antiporter activity,BP,SLC9A1
16697,GO:0097647,0.0664080548759025,0.998488681131205,1,3,amylin receptor signaling pathway,BP,ADM
7806,GO:0032354,0.0664613762827706,0.992148825435729,2,12,response to follicle-stimulating hormone,BP,INHBA;HMGCS1
20010,GO:2000616,0.0664807625202157,0.998859632350151,1,2,negative regulation of histone H3-K9 acetylation,BP,ZNF451
400,GO:0001076,0.0664857765060651,0.969911513524657,9,147,transcription factor activity, RNA polymerase II transcription factor binding,MF,BHLHE40;KDM6B;JUN;CREB1;PPARD;ZNF451;SOX4;KDM6A;TDG
3483,GO:0007350,0.0665350757450497,0.992135208511132,2,12,blastoderm segmentation,BP,TBX3;WNT5A
18092,GO:1902714,0.0668427121710812,0.998846960988438,1,2,negative regulation of interferon-gamma secretion,BP,ZC3H12A
9978,GO:0042369,0.0668451465575133,0.998846875518515,1,2,vitamin D catabolic process,BP,CYP27B1
6485,GO:0021826,0.0668847511343064,0.998845484563678,1,2,substrate-independent telencephalic tangential migration,BP,NRG1
6488,GO:0021830,0.0668847511343064,0.998845484563678,1,2,interneuron migration from the subpallium to the cortex,BP,NRG1
6492,GO:0021843,0.0668847511343064,0.998845484563678,1,2,substrate-independent telencephalic tangential interneuron migration,BP,NRG1
14569,GO:0070101,0.0669006772239545,0.998844924977769,1,2,positive regulation of chemokine-mediated signaling pathway,BP,EDN1
19735,GO:2000097,0.067004307213842,0.998841280361546,1,2,regulation of smooth muscle cell-matrix adhesion,BP,PLAU
3728,GO:0008263,0.0670655599190705,0.998839123338712,1,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,TDG
17377,GO:1900103,0.0672552777552758,0.991915787183574,2,13,positive regulation of endoplasmic reticulum unfolded protein response,BP,PTPN1;ERN1
19355,GO:1905719,0.0672899421126576,0.998831203946375,1,2,protein localization to perinuclear region of cytoplasm,BP,SQSTM1
1813,GO:0004461,0.0673608184327645,0.998828696628774,1,2,lactose synthase activity,MF,B4GALT1
12268,GO:0048562,0.0673835178112272,0.967966907230598,10,166,embryonic organ morphogenesis,BP,TBX3;EFNA1;EDN1;ALDH1A3;DLX2;SMAD3;SOX9;WNT5A;INSIG1;KDM6A
7967,GO:0032570,0.0675188668937364,0.986057417958498,3,29,response to progesterone,BP,FOSL1;CLDN4;RELA
4222,GO:0009395,0.0675562808600175,0.986079076558866,3,28,phospholipid catabolic process,BP,LDLR;LIPG;SMPD3
16792,GO:0098632,0.0675597741341966,0.98604551237403,3,29,cell-cell adhesion mediator activity,MF,TACSTD2;CDC42EP1;PDLIM5
4594,GO:0010701,0.0676610946282935,0.998818043205524,1,2,positive regulation of norepinephrine secretion,BP,STX1A
19926,GO:2000418,0.0676632217466218,0.998817967559846,1,2,positive regulation of eosinophil migration,BP,ADAM8
872,GO:0002220,0.0676668287969753,0.975180805603905,6,96,innate immune response activating cell surface receptor signaling pathway,BP,NFKBIA;NFKB1;RELB;BCL10;PDPK1;RELA
874,GO:0002223,0.0676668287969753,0.975180805603905,6,96,stimulatory C-type lectin receptor signaling pathway,BP,NFKBIA;NFKB1;RELB;BCL10;PDPK1;RELA
13927,GO:0060584,0.0677744957275524,0.998814006881031,1,2,regulation of prostaglandin-endoperoxide synthase activity,BP,EDN1
13928,GO:0060585,0.0677744957275524,0.998814006881031,1,2,positive regulation of prostaglandin-endoperoxide synthase activity,BP,EDN1
20165,GO:2000969,0.0678326017555134,0.998811935931709,1,2,positive regulation of AMPA receptor activity,BP,ADRB2
16282,GO:0090362,0.0678517815657722,0.998811251935822,1,2,positive regulation of platelet-derived growth factor production,BP,PTGS2
8013,GO:0032641,0.0679284277972013,0.998808516520418,1,2,lymphotoxin A production,BP,BCL10
9859,GO:0042109,0.0679284277972013,0.998808516520418,1,2,lymphotoxin A biosynthetic process,BP,BCL10
7310,GO:0031312,0.0680173240407799,0.985944975672209,3,28,extrinsic component of organelle membrane,CC,ZC3H12A;PLEKHF1;PML
17662,GO:1901492,0.0681855148296015,0.998799317598296,1,2,positive regulation of lymphangiogenesis,BP,VEGFC
13564,GO:0060024,0.0683130954293625,0.998794738984548,1,2,rhythmic synaptic transmission,BP,EDN1
13733,GO:0060298,0.0683162930865214,0.998794624111026,1,2,positive regulation of sarcomere organization,BP,EDN1
20242,GO:2001181,0.0683824682954413,0.998395994351124,1,3,positive regulation of interleukin-10 secretion,BP,CD274
13511,GO:0055077,0.0685297262935599,0.99878694385255,1,2,gap junction hemi-channel activity,MF,PANX1
11166,GO:0045226,0.0685563675307947,0.998785983410248,1,2,extracellular polysaccharide biosynthetic process,BP,HAS3
11648,GO:0046379,0.0685563675307947,0.998785983410248,1,2,extracellular polysaccharide metabolic process,BP,HAS3
4792,GO:0010982,0.0686686575823963,0.998781930916959,1,2,regulation of high-density lipoprotein particle clearance,BP,LIPG
4793,GO:0010983,0.0686686575823963,0.998781930916959,1,2,positive regulation of high-density lipoprotein particle clearance,BP,LIPG
7500,GO:0031670,0.0687584785599444,0.981183096326927,4,46,cellular response to nutrient,BP,PTGS2;CDKN2B;PIM1;CYP27B1
14660,GO:0070262,0.0687992146625083,0.991548078688868,2,14,peptidyl-serine dephosphorylation,BP,PPP1R15A;PPP1R15B
10139,GO:0042701,0.068888516064207,0.998773976065482,1,2,progesterone secretion,BP,INHBA
14894,GO:0070697,0.068888516064207,0.998773976065482,1,2,activin receptor binding,MF,INHBA
14895,GO:0070699,0.068888516064207,0.998773976065482,1,2,type II activin receptor binding,MF,INHBA
6591,GO:0022602,0.0689335942699894,0.98575222953579,3,26,ovulation cycle process,BP,INHBA;EREG;ADAMTS1
8921,GO:0034764,0.0689898807974092,0.972300313620569,7,103,positive regulation of transmembrane transport,BP,ADRB2;BDKRB1;SLC9A1;AZIN1;PTPN11;PDPK1;NFE2L2
10540,GO:0043488,0.0690395414943428,0.970179062544566,8,141,regulation of mRNA stability,BP,ZC3H12A;NOCT;ZFP36L1;RC3H1;ZFP36;SAMD4A;QKI;PABPC4
9239,GO:0035633,0.0690462722537876,0.998768251643521,1,2,maintenance of permeability of blood-brain barrier,BP,PTGS2
2244,GO:0005153,0.0690687404162428,0.998767435227968,1,2,interleukin-8 receptor binding,MF,CXCL8
8951,GO:0035004,0.0691089052756684,0.981162962945223,4,41,phosphatidylinositol 3-kinase activity,MF,HBEGF;EREG;NRG1;PTPN11
10979,GO:0044771,0.0691247935156464,0.99876539722941,1,2,meiotic cell cycle phase transition,BP,OVOL1
17835,GO:1901993,0.0691247935156464,0.99876539722941,1,2,regulation of meiotic cell cycle phase transition,BP,OVOL1
17836,GO:1901994,0.0691247935156464,0.99876539722941,1,2,negative regulation of meiotic cell cycle phase transition,BP,OVOL1
11482,GO:0045940,0.069384811147707,0.991435301996295,2,14,positive regulation of steroid metabolic process,BP,IL1B;TNF
19113,GO:1905041,0.0694253029771118,0.9987544414391,1,2,regulation of epithelium regeneration,BP,DUSP10
19517,GO:1990399,0.0694253029771118,0.9987544414391,1,2,epithelium regeneration,BP,DUSP10
8378,GO:0033277,0.0695367072080764,0.998750367183198,1,2,abortive mitotic cell cycle,BP,PTPN11
15657,GO:0072175,0.0696341888859562,0.971989966068311,7,102,epithelial tube formation,BP,SDC4;BCL10;SOX9;SOX4;ADM;WNT5A;KDM6A
3539,GO:0007548,0.0697660189246967,0.966610201803995,10,170,sex differentiation,BP,INHBA;TBX3;BCL2L2;CEBPB;HMGCS1;EREG;SOX9;PTPN11;ADAMTS1;WNT5A
4422,GO:0010225,0.0698430739214488,0.991424002952927,2,13,response to UV-C,BP,BCL3;DCUN1D3
10896,GO:0044440,0.06984693844405,0.958246984813958,19,394,endosomal part,CC,TICAM1;PLEKHF1;IRAK2;RAP2B;ADRB2;EHD1;LDLR;TFRC;ANTXR2;NDRG1;PML;RHOB;ABCA5;STEAP4;HLA-E;RAB22A;ITM2B;MYO1B;STX12
1036,GO:0002543,0.0699770557856275,0.99873419530326,1,2,activation of blood coagulation via clotting cascade,BP,F3
12684,GO:0050892,0.0700548154900689,0.991474604891165,2,12,intestinal absorption,BP,TJP2;LDLR
13873,GO:0060487,0.0701573850408132,0.99136352772951,2,13,lung epithelial cell differentiation,BP,CREB1;SOX9
818,GO:0002088,0.0701715762134607,0.980728830118745,4,43,lens development in camera-type eye,BP,EPHA2;SMAD3;SKIL;WNT5A
2248,GO:0005159,0.0702669813104321,0.991342403088569,2,13,insulin-like growth factor receptor binding,MF,YWHAH;YWHAG
13055,GO:0051542,0.0702687241810408,0.998723424360538,1,2,elastin biosynthetic process,BP,HBEGF
2304,GO:0005287,0.0703324276312172,0.998721065575492,1,2,high-affinity basic amino acid transmembrane transporter activity,MF,SLC7A2
2305,GO:0005289,0.0703324276312172,0.998721065575492,1,2,high-affinity arginine transmembrane transporter activity,MF,SLC7A2
2307,GO:0005292,0.0703324276312172,0.998721065575492,1,2,high-affinity lysine transmembrane transporter activity,MF,SLC7A2
16082,GO:0090049,0.07039886338307,0.985245978128637,3,28,regulation of cell migration involved in sprouting angiogenesis,BP,PTGS2;PLK2;HDAC9
7853,GO:0032412,0.0704114355643995,0.969542293876157,8,125,regulation of ion transmembrane transporter activity,BP,PPIF;RRAD;CAB39;ADRB2;NEDD4L;OXSR1;SLC9A1;YWHAH
20024,GO:2000638,0.0704663327706204,0.998716100028324,1,2,regulation of SREBP signaling pathway,BP,INSIG1
20025,GO:2000639,0.0704663327706204,0.998716100028324,1,2,negative regulation of SREBP signaling pathway,BP,INSIG1
10647,GO:0043666,0.0705501626837743,0.97393159640109,6,86,regulation of phosphoprotein phosphatase activity,BP,TNF;PPP1R15A;ANKLE2;PPP1R10;PPP1R15B;SH3RF2
8877,GO:0034685,0.0706125429337874,0.998710666780789,1,2,integrin alphav-beta6 complex,CC,ITGAV
13474,GO:0055006,0.0707129653562556,0.980530388847786,4,43,cardiac cell development,BP,TBX3;EDN1;JAG1;PDLIM5
4790,GO:0010979,0.070881150108117,0.998700654175744,1,2,regulation of vitamin D 24-hydroxylase activity,BP,CYP27B1
4791,GO:0010980,0.070881150108117,0.998700654175744,1,2,positive regulation of vitamin D 24-hydroxylase activity,BP,CYP27B1
6795,GO:0030234,0.0708943349334104,0.952024784266171,32,733,enzyme regulator activity,MF,CXCL1;BIRC3;SERPINB2;ERRFI1;CPEB2;TRIB1;BMP2;CAB39;JUN;BIRC2;CDKN1A;PPP1R15A;CDKN2B;ANKLE2;TFPI2;BCL10;PPP1R10;SERPINB8;SERPINB1;SOCS3;AZIN1;PPP1R15B;NRG1;RASA2;CDC42EP1;CCNL1;PDPK1;CTSC;AGFG1;YWHAG;SFN;SH3RF2
1352,GO:0003215,0.0710240344568408,0.991289182556756,2,12,cardiac right ventricle morphogenesis,BP,JAG1;SOX4
4537,GO:0010608,0.0710344200195885,0.955743326324912,22,506,posttranscriptional regulation of gene expression,BP,ZC3H12A;BTG2;TNF;NOCT;CPEB2;BCL3;ZFP36L1;ENC1;PPP1R15A;SMAD3;RC3H1;ZFP36;LARP4B;PPP1R15B;SOX4;EIF1;RBM3;SAMD4A;QKI;CELF1;NUP153;PABPC4
677,GO:0001885,0.0712189857332009,0.980322144216333,4,44,endothelial cell development,BP,IL1B;TNF;CLDN1;TJP2
11260,GO:0045509,0.071254930911144,0.998686654242857,1,2,interleukin-27 receptor activity,MF,IL6ST
3186,GO:0006811,0.0713806092120189,0.95033129806146,37,861,ion transport,BP,IL1B;CSF2;PPIF;PTGS2;TRPV3;EDN1;PANX1;RRAD;CAB39;NFKBIE;CLDN4;ADRB2;HEPHL1;SLC6A14;LDLR;NEDD4L;OXSR1;TFRC;PPARD;SLC25A25;IL16;BDKRB1;SLC9A1;CYP27B1;STARD5;ITGAV;STX1A;PML;SLC7A2;SLC28A3;STEAP4;ATP6V1C2;PDPK1;ERO1A;YWHAH;SGK1;ATP13A3
12491,GO:0050473,0.0715324186059825,0.998676210604013,1,2,arachidonate 15-lipoxygenase activity,MF,PTGS2
1104,GO:0002691,0.0716703754528827,0.991070180783527,2,13,regulation of cellular extravasation,BP,IL1A;ADAM8
4835,GO:0014040,0.0717580699348594,0.998667686248331,1,2,positive regulation of Schwann cell differentiation,BP,RELA
12204,GO:0048382,0.071784109031486,0.998666700750382,1,2,mesendoderm development,BP,ZFP36L1
18454,GO:1903541,0.0717884270907874,0.99096652674239,2,14,regulation of exosomal secretion,BP,SDC4;SMPD3
18456,GO:1903543,0.0717884270907874,0.99096652674239,2,14,positive regulation of exosomal secretion,BP,SDC4;SMPD3
6244,GO:0019808,0.0718568644907845,0.998225968428229,1,3,polyamine binding,MF,SAT1
11602,GO:0046208,0.0718850111339622,0.998224554869375,1,3,spermine catabolic process,BP,SAT1
14538,GO:0070053,0.0719334907008806,0.998661039814751,1,2,thrombospondin receptor activity,MF,SDC4
16198,GO:0090231,0.0720013632895316,0.990924544404152,2,14,regulation of spindle checkpoint,BP,DUSP1;NDRG1
20017,GO:2000625,0.0721931162742233,0.998651171474504,1,2,regulation of miRNA catabolic process,BP,ZC3H12A
20018,GO:2000627,0.0721931162742233,0.998651171474504,1,2,positive regulation of miRNA catabolic process,BP,ZC3H12A
17615,GO:1901301,0.0721964724469582,0.998651043660445,1,2,regulation of cargo loading into COPII-coated vesicle,BP,INSIG1
13541,GO:0055123,0.0722103378750683,0.97320020186793,6,82,digestive system development,BP,TNF;CXCL8;PRDM1;CDKN1A;SMAD3;WNT5A
15462,GO:0071801,0.072360934038887,0.990935063543083,2,13,regulation of podosome assembly,BP,CSF2;TNF
14180,GO:0061073,0.0725518139795245,0.998637475510504,1,2,ciliary body morphogenesis,BP,JAG1
143,GO:0000294,0.0725873890072415,0.998636113251953,1,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,ZC3H12A
11924,GO:0046967,0.0726187084695132,0.998634913364768,1,2,cytosol to ER transport,BP,TAP1
19385,GO:1905863,0.0726359815189593,0.998634251378553,1,2,invadopodium organization,BP,NAV3
16133,GO:0090136,0.0726769867723376,0.990969484968708,2,12,epithelial cell-cell adhesion,BP,SERPINB8;VCL
10244,GO:0042978,0.0727800027791194,0.998628725303881,1,2,ornithine decarboxylase activator activity,MF,AZIN1
17940,GO:1902269,0.0727800027791194,0.998628725303881,1,2,positive regulation of polyamine transmembrane transport,BP,AZIN1
10975,GO:0044764,0.0729200289806227,0.984458628366013,3,29,multi-organism cellular process,BP,BIRC3;BIRC2;IFIH1
6079,GO:0019229,0.0729208344511612,0.984494395070647,3,28,regulation of vasoconstriction,BP,PTGS2;EDN1;ADM
5456,GO:0016328,0.0730337320497993,0.97962868398358,4,45,lateral plasma membrane,CC,CLDN1;CLDN4;TACSTD2;CORO1C
19982,GO:2000563,0.0730879387282746,0.998616870964366,1,2,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,CD55
16552,GO:0097325,0.0731056448363072,0.998616187736626,1,2,melanocyte proliferation,BP,WNT5A
18350,GO:1903319,0.0731687709710566,0.990776026574523,2,13,positive regulation of protein maturation,BP,ADAM8;SOX4
6763,GO:0030194,0.073176333708597,0.990691567796315,2,14,positive regulation of blood coagulation,BP,F3;NFE2L2
17358,GO:1900048,0.073176333708597,0.990691567796315,2,14,positive regulation of hemostasis,BP,F3;NFE2L2
637,GO:0001824,0.0732472263186038,0.979488958535884,4,48,blastocyst development,BP,ELF3;JUNB;SKIL;PRPF19
3748,GO:0008287,0.0732572343386891,0.979524480232841,4,46,protein serine/threonine phosphatase complex,CC,PPP1R15A;PPP1R10;PPP1R15B;IER5
18334,GO:1903293,0.0732572343386891,0.979524480232841,4,46,phosphatase complex,CC,PPP1R15A;PPP1R10;PPP1R15B;IER5
13637,GO:0060129,0.0732663525957816,0.998609978472172,1,2,thyroid-stimulating hormone-secreting cell differentiation,BP,BMP2
10279,GO:0043024,0.0735384503039462,0.990619316698541,2,14,ribosomal small subunit binding,MF,CPEB2;PIM1
11861,GO:0046850,0.0735708346701852,0.984338070161993,3,27,regulation of bone remodeling,BP,TNFAIP3;ADAM8;TFRC
19452,GO:1990108,0.0736275676532187,0.99859596949593,1,2,protein linear deubiquitination,BP,CYLD
18780,GO:1904289,0.0736350967495427,0.998595676719065,1,2,regulation of mitotic DNA damage checkpoint,BP,PPP1R10
7661,GO:0032089,0.0736468081122078,0.99859522124732,1,2,NACHT domain binding,MF,TRIM16
947,GO:0002360,0.0736620097189788,0.990678409602166,2,13,T cell lineage commitment,BP,CYLD;IL23A
1474,GO:0003729,0.0737752731203918,0.964293852109169,10,180,mRNA binding,MF,ZC3H12A;NOCT;CPEB2;ZFP36L1;RC3H1;ZFP36;SAMD4A;QKI;CELF1;PABPC4
9648,GO:0036518,0.0739108583060641,0.998584931582811,1,2,chemorepulsion of dopaminergic neuron axon,BP,WNT5A
14391,GO:0061643,0.0739108583060641,0.998584931582811,1,2,chemorepulsion of axon,BP,WNT5A
13235,GO:0051895,0.0739510878530798,0.990720092131859,2,12,negative regulation of focal adhesion assembly,BP,PHLDB2;CORO1C
14312,GO:0061443,0.0739903034147903,0.998581828082176,1,2,endocardial cushion cell differentiation,BP,JAG1
14439,GO:0061756,0.0740210452120454,0.990607108193406,2,13,leukocyte adhesion to vascular endothelial cell,BP,ETS1;TNF
2123,GO:0004915,0.0740340422095435,0.998580117930501,1,2,interleukin-6 receptor activity,MF,IL6ST
2600,GO:0005896,0.0740340422095435,0.998580117930501,1,2,interleukin-6 receptor complex,CC,IL6ST
6323,GO:0019981,0.0740340422095435,0.998580117930501,1,2,interleukin-6 binding,MF,IL6ST
14574,GO:0070110,0.0740340422095435,0.998580117930501,1,2,ciliary neurotrophic factor receptor complex,CC,IL6ST
1309,GO:0003151,0.0741232725683977,0.979222183084012,4,45,outflow tract morphogenesis,BP,TBX3;JUN;JAG1;WNT5A
5150,GO:0015682,0.0742903139251109,0.983948188446349,3,32,ferric iron transport,BP,TFRC;STEAP4;ATP6V1C2
15813,GO:0072512,0.0742903139251109,0.983948188446349,3,32,trivalent inorganic cation transport,BP,TFRC;STEAP4;ATP6V1C2
15486,GO:0071847,0.0743056681825426,0.998569473592038,1,2,TNFSF11-mediated signaling pathway,BP,TJP2
3120,GO:0006700,0.0744009664959722,0.990373123207982,2,15,C21-steroid hormone biosynthetic process,BP,BMP2;ADM
16114,GO:0090100,0.0744167546968286,0.975225638160365,5,66,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,INHBA;BMP2;CDKN2B;SMAD3;FERMT1
1452,GO:0003682,0.0744331370413382,0.953960263900292,21,437,chromatin binding,MF,ZC3H12A;REL;NFKB1;PRDM1;NFKB2;KDM6B;RELB;JUN;CEBPB;DLX2;SMAD3;SOX9;POLR3A;UHRF1;FOSL2;SKIL;KDM6A;RELA;POLR3D;ATXN7;BRD2
17573,GO:1901185,0.0745104592387384,0.979015684540704,4,48,negative regulation of ERBB signaling pathway,BP,HBEGF;ERRFI1;EREG;NRG1
539,GO:0001657,0.0745292970260028,0.975219232609221,5,63,ureteric bud development,BP,SDC4;BMP2;TACSTD2;SMAD3;SOX9
12831,GO:0051133,0.0745436323533848,0.998088408498718,1,3,regulation of NK T cell activation,BP,IL23A
12832,GO:0051135,0.0745436323533848,0.998088408498718,1,3,positive regulation of NK T cell activation,BP,IL23A
1092,GO:0002678,0.0745695855986488,0.998087053790229,1,3,positive regulation of chronic inflammatory response,BP,TNF
10997,GO:0044798,0.0747087603108773,0.96537297819095,9,157,nuclear transcription factor complex,CC,JUN;JUNB;TAF4B;CEBPB;SMAD3;CREB1;PPARD;SOX9;SOX4
10322,GO:0043112,0.0748109033568557,0.967197041673772,8,130,receptor metabolic process,BP,TNF;CXCL8;EDN1;TFRC;ITGAV;NRG1;PTPN1;ADM
1390,GO:0003298,0.0748720137115134,0.9904372917942,2,13,physiological muscle hypertrophy,BP,EDN1;PDLIM5
1393,GO:0003301,0.0748720137115134,0.9904372917942,2,13,physiological cardiac muscle hypertrophy,BP,EDN1;PDLIM5
14170,GO:0061049,0.0748720137115134,0.9904372917942,2,13,cell growth involved in cardiac muscle cell development,BP,EDN1;PDLIM5
3616,GO:0008065,0.0748934687555319,0.99854629767075,1,2,establishment of blood-nerve barrier,BP,CLDN1
17738,GO:1901668,0.0751041021175219,0.998059042579101,1,3,regulation of superoxide dismutase activity,BP,TNF
2128,GO:0004923,0.0751559881175772,0.998535884441381,1,2,leukemia inhibitory factor receptor activity,MF,IL6ST
566,GO:0001705,0.0752126624153772,0.998533631296744,1,2,ectoderm formation,BP,ETS2
573,GO:0001712,0.0752126624153772,0.998533631296744,1,2,ectodermal cell fate commitment,BP,ETS2
5226,GO:0015833,0.0752370150985256,0.943534642223032,59,1519,peptide transport,BP,NFKBIA;IL1B;IL1A;ZC3H12A;TNF;PTGS2;EDN1;IL1RN;PANX1;HCAR2;CDKN1A;CD274;BCL3;DUSP16;UGCG;TRIM16;EHD1;PPP1R10;PIM3;ADAM8;VEGFC;PLK3;TFRC;PPARD;USP36;PLAGL2;RIPK2;SAA1;ITGAV;STX1A;NRG1;PML;POU2F2;FERMT1;PTPN11;RHOB;SOX4;OXCT1;PTPN1;ATP6V1C2;HLA-E;RAB3IP;PMM2;WNT5A;NUP153;INSIG1;ADAM9;ADAMTS9;YWHAH;AGFG1;YWHAG;RAB22A;SFN;IFIH1;IPO4;TAP1;STX12;RAB24;SMPD3
18171,GO:1902932,0.0752747788199127,0.990356515472464,2,13,positive regulation of alcohol biosynthetic process,BP,IL1B;TNF
8961,GO:0035026,0.0752837047373529,0.99853080439191,1,2,leading edge cell differentiation,BP,JUN
18947,GO:1904705,0.0752876817216192,0.983740997674659,3,29,regulation of vascular smooth muscle cell proliferation,BP,TNF;JUN;ERN1
19655,GO:1990874,0.0752876817216192,0.983740997674659,3,29,vascular smooth muscle cell proliferation,BP,TNF;JUN;ERN1
12620,GO:0050801,0.0753227416293817,0.953915192855634,20,425,ion homeostasis,BP,EDN1;NEDD4L;SMAD3;TFRC;LIPG;BDKRB1;SLC9A1;CYP27B1;CD55;SAA1;ITGAV;PML;STEAP4;ADM;MAFG;ABL2;ATP6V1C2;PDPK1;ERO1A;ATP13A3
20145,GO:2000832,0.0754612383840254,0.998523727622137,1,2,negative regulation of steroid hormone secretion,BP,PTPN11
20152,GO:2000847,0.0754612383840254,0.998523727622137,1,2,negative regulation of corticosteroid hormone secretion,BP,PTPN11
20155,GO:2000850,0.0754612383840254,0.998523727622137,1,2,negative regulation of glucocorticoid secretion,BP,PTPN11
10917,GO:0044501,0.0754758856808908,0.998523142968173,1,2,modulation of signal transduction in other organism,BP,TNIP1
13300,GO:0052027,0.0754758856808908,0.998523142968173,1,2,modulation by symbiont of host signal transduction pathway,BP,TNIP1
13334,GO:0052250,0.0754758856808908,0.998523142968173,1,2,modulation of signal transduction in other organism involved in symbiotic interaction,BP,TNIP1
8155,GO:0032881,0.0757649777700707,0.983673802043414,3,27,regulation of polysaccharide metabolic process,BP,NFKB1;PHLDA2;PHKG2
12278,GO:0048588,0.0758125012219619,0.964827642258079,9,143,developmental cell growth,BP,EDN1;SEMA7A;NEDD4L;RAPH1;SOX9;NRG1;VCL;WNT5A;PDLIM5
8876,GO:0034684,0.0759515741251594,0.998504090172252,1,2,integrin alphav-beta5 complex,CC,ITGAV
4421,GO:0010224,0.0759562491225283,0.990131507772391,2,14,response to UV-B,BP,CDKN1A;RELA
1391,GO:0003299,0.0759696100945041,0.990319730854822,2,12,muscle hypertrophy in response to stress,BP,ERRFI1;SMAD3
4931,GO:0014887,0.0759696100945041,0.990319730854822,2,12,cardiac muscle adaptation,BP,ERRFI1;SMAD3
4939,GO:0014898,0.0759696100945041,0.990319730854822,2,12,cardiac muscle hypertrophy in response to stress,BP,ERRFI1;SMAD3
15723,GO:0072289,0.0760080717438821,0.998501818826715,1,2,metanephric nephron tubule formation,BP,SOX9
2651,GO:0005988,0.0760359558895313,0.998500697153598,1,2,lactose metabolic process,BP,B4GALT1
2652,GO:0005989,0.0760359558895313,0.998500697153598,1,2,lactose biosynthetic process,BP,B4GALT1
11638,GO:0046351,0.0760359558895313,0.998500697153598,1,2,disaccharide biosynthetic process,BP,B4GALT1
726,GO:0001953,0.0760503833017301,0.983586765066086,3,27,negative regulation of cell-matrix adhesion,BP,PHLDB2;JAG1;CORO1C
3363,GO:0007113,0.0760681736212884,0.998007987368344,1,3,endomitotic cell cycle,BP,PLK3
15572,GO:0072034,0.0760938083566094,0.998498368575912,1,2,renal vesicle induction,BP,SOX9
9356,GO:0035868,0.076123680468563,0.99849716547921,1,2,alphav-beta3 integrin-HMGB1 complex,CC,ITGAV
4468,GO:0010463,0.0761527765664514,0.98355550405567,3,27,mesenchymal cell proliferation,BP,BMP2;SOX9;WNT5A
13044,GO:0051497,0.0763691268167788,0.990135739309329,2,13,negative regulation of stress fiber assembly,BP,PHLDB2;TACSTD2
1517,GO:0003876,0.0765030533096612,0.998481842655129,1,2,AMP deaminase activity,MF,AMPD3
12021,GO:0047623,0.0765030533096612,0.998481842655129,1,2,adenosine-phosphate deaminase activity,MF,AMPD3
4809,GO:0012506,0.0765062442725214,0.95094705340022,24,524,vesicle membrane,CC,PLAUR;HBEGF;PLAU;TGFA;IFNGR2;RAP2B;ADRB2;B4GALT1;ADAM8;LDLR;TFRC;CD55;ITGAV;STX1A;AREG;IL7R;HLA-E;WNT5A;YWHAH;YWHAG;RAB22A;SFN;TAP1;RAB24
16813,GO:0098662,0.076565048351959,0.954383535584423,18,373,inorganic cation transmembrane transport,BP,PPIF;TRPV3;PANX1;RRAD;CAB39;NEDD4L;OXSR1;SLC25A25;BDKRB1;SLC9A1;ITGAV;SLC28A3;STEAP4;ATP6V1C2;PDPK1;ERO1A;YWHAH;ATP13A3
7163,GO:0031032,0.076569971208963,0.966303779671305,8,123,actomyosin structure organization,BP,SDC4;EDN1;PHLDB2;TACSTD2;SMAD3;SLC9A1;TNFAIP1;FRMD6
3590,GO:0008016,0.0765824096394041,0.968479745351633,7,107,regulation of heart contraction,BP,ZC3H12A;HBEGF;EDN1;SLC9A1;GCH1;TMEM65;ADM
11335,GO:0045659,0.0766682279675978,0.99847514599412,1,2,negative regulation of neutrophil differentiation,BP,TRIB1
18023,GO:1902523,0.076694257054289,0.998474089300233,1,2,positive regulation of protein K63-linked ubiquitination,BP,BIRC2
3267,GO:0006940,0.0767212008241019,0.983265782583451,3,30,regulation of smooth muscle contraction,BP,PTGS2;EDN1;ADRB2
6444,GO:0021756,0.0767753151679736,0.990053311625312,2,13,striatum development,BP,INHBA;ALDH1A3
19591,GO:1990666,0.0768875070808411,0.998466232080874,1,2,PCSK9-LDLR complex,CC,LDLR
16260,GO:0090316,0.076910462211236,0.964149849500633,9,157,positive regulation of intracellular protein transport,BP,IL1B;ZC3H12A;PTGS2;UGCG;PLK3;USP36;PLAGL2;NRG1;SFN
13894,GO:0060532,0.0769680630998801,0.998462950606806,1,2,bronchus cartilage development,BP,SOX9
14214,GO:0061145,0.0769680630998801,0.998462950606806,1,2,lung smooth muscle development,BP,SOX9
17774,GO:1901800,0.0770357423583522,0.970857494716868,6,90,positive regulation of proteasomal protein catabolic process,BP,RNF19B;TRIB1;PLK2;PLK3;RNF19A;NFE2L2
13255,GO:0051930,0.0770754678039056,0.989902533735008,2,14,regulation of sensory perception of pain,BP,EDN1;SLC9A1
13256,GO:0051931,0.0770754678039056,0.989902533735008,2,14,regulation of sensory perception,BP,EDN1;SLC9A1
8595,GO:0034101,0.0770765909882252,0.970847247100117,6,89,erythrocyte homeostasis,BP,INHBA;ETS1;AMPD3;ZFP36L1;ZFP36;CDK6
13421,GO:0052812,0.0771242765373363,0.998456576801316,1,2,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,PIP5K1A
4831,GO:0014034,0.0771795159271184,0.998454319643159,1,2,neural crest cell fate commitment,BP,SOX9
12066,GO:0048015,0.0771997368920366,0.968190240608231,7,104,phosphatidylinositol-mediated signaling,BP,IER3;EDN1;ZFP36L1;PPARD;PIP5K1A;SOX9;NRG1
3666,GO:0008157,0.0772066489096641,0.989875565762368,2,14,protein phosphatase 1 binding,MF,PPP1R15A;SH3RF2
18440,GO:1903522,0.07722046392739,0.965925670843893,8,128,regulation of blood circulation,BP,ZC3H12A;HBEGF;PTGS2;EDN1;SLC9A1;GCH1;TMEM65;ADM
14689,GO:0070309,0.0772551620731902,0.998451225850846,1,2,lens fiber cell morphogenesis,BP,EPHA2
2773,GO:0006196,0.0773313500674361,0.998448106642765,1,2,AMP catabolic process,BP,AMPD3
12625,GO:0050806,0.0773362231589488,0.970762945164159,6,85,positive regulation of synaptic transmission,BP,PTGS2;SQSTM1;ADRB2;PLK2;CREB1;STX1A
154,GO:0000309,0.0773485429380571,0.998447402298669,1,2,nicotinamide-nucleotide adenylyltransferase activity,MF,NMNAT2
6113,GO:0019355,0.0773485429380571,0.998447402298669,1,2,nicotinamide nucleotide biosynthetic process from aspartate,BP,NMNAT2
8838,GO:0034627,0.0773485429380571,0.998447402298669,1,2,'de novo' NAD biosynthetic process,BP,NMNAT2
8839,GO:0034628,0.0773485429380571,0.998447402298669,1,2,'de novo' NAD biosynthetic process from aspartate,BP,NMNAT2
15215,GO:0071371,0.0773675620807711,0.989932660432612,2,13,cellular response to gonadotropin stimulus,BP,INHBA;HMGCS1
6633,GO:0022898,0.0774452009380151,0.965805547630626,8,128,regulation of transmembrane transporter activity,BP,PPIF;RRAD;CAB39;ADRB2;NEDD4L;OXSR1;SLC9A1;YWHAH
18163,GO:1902911,0.0774826590059332,0.970654503110197,6,89,protein kinase complex,CC,CAB39;CDKN1A;PHKG2;CCNL1;CDK6;ERN1
2149,GO:0004965,0.0776377456262009,0.998435529526929,1,2,G-protein coupled GABA receptor activity,MF,GPR156
4945,GO:0014909,0.0776580613168263,0.977865992321982,4,46,smooth muscle cell migration,BP,PLAU;TRIB1;PPARD;NFE2L2
3537,GO:0007538,0.0777391642980652,0.998431354785684,1,2,primary sex determination,BP,SOX9
3538,GO:0007542,0.0777391642980652,0.998431354785684,1,2,primary sex determination, germ-line,BP,SOX9
5994,GO:0018992,0.0777391642980652,0.998431354785684,1,2,germ-line sex determination,BP,SOX9
6034,GO:0019100,0.0777391642980652,0.998431354785684,1,2,male germ-line sex determination,BP,SOX9
6517,GO:0021892,0.0777399626646863,0.997917823899304,1,3,cerebral cortex GABAergic interneuron differentiation,BP,DLX2
3564,GO:0007608,0.0778133835604161,0.989750479172055,2,14,sensory perception of smell,BP,GJB4;B3GNT2
11139,GO:0045185,0.0778572259180685,0.97047646078983,6,89,maintenance of protein location,BP,NFKBIA;NFKBIE;BCL3;PML;SOX4;INSIG1
12039,GO:0047757,0.0779875936856266,0.998421104100012,1,2,chondroitin-glucuronate 5-epimerase activity,MF,DSE
13835,GO:0060430,0.07806716089817,0.998417813648311,1,2,lung saccule development,BP,CREB1
13176,GO:0051771,0.0781192210072869,0.997897081633866,1,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,EDN1
14361,GO:0061582,0.0782106982811852,0.99841186872715,1,2,intestinal epithelial cell migration,BP,PTPN11
19705,GO:2000027,0.0783143512674293,0.961666168006332,10,184,regulation of organ morphogenesis,BP,TNFAIP3;TNF;EDN1;LIF;BMP2;B4GALT1;TACSTD2;PIM1;SOX9;WNT5A
12391,GO:0048817,0.0784556577544871,0.998401696361357,1,2,negative regulation of hair follicle maturation,BP,FERMT1
10269,GO:0043010,0.0784661353755466,0.96015296088545,11,190,camera-type eye development,BP,INHBA;EPHA2;JUN;ALDH1A3;DLX2;SMAD3;SLC25A25;JAG1;SOX9;SKIL;WNT5A
452,GO:0001225,0.0785407382467257,0.998398155330448,1,2,RNA polymerase II transcription coactivator binding,MF,CREB1
18593,GO:1903847,0.0785650543805101,0.998397142548359,1,2,regulation of aorta morphogenesis,BP,EFNB2
18594,GO:1903849,0.0785650543805101,0.998397142548359,1,2,positive regulation of aorta morphogenesis,BP,EFNB2
11724,GO:0046530,0.0786134350286609,0.982755831114743,3,28,photoreceptor cell differentiation,BP,PRDM1;DLX2;SOX9
9046,GO:0035264,0.0786741214383077,0.967433224331015,7,105,multicellular organism growth,BP,ZFP36L1;ADRB2;CREB1;STK40;SLC25A25;PTPN11;KDM6A
1962,GO:0004666,0.0787191117858036,0.998390718211938,1,2,prostaglandin-endoperoxide synthase activity,MF,PTGS2
15961,GO:0075732,0.078806021439662,0.998387088091995,1,2,viral penetration into host nucleus,BP,NUP153
18053,GO:1902594,0.078806021439662,0.998387088091995,1,2,multi-organism nuclear import,BP,NUP153
16224,GO:0090271,0.0788198419321212,0.998386510432622,1,2,positive regulation of fibroblast growth factor production,BP,PTGS2
12568,GO:0050717,0.0788856193590053,0.997854840539518,1,3,positive regulation of interleukin-1 alpha secretion,BP,PANX1
496,GO:0001550,0.0789628305229563,0.998380527568578,1,2,ovarian cumulus expansion,BP,EREG
12113,GO:0048165,0.0789628305229563,0.998380527568578,1,2,fused antrum stage,BP,EREG
13653,GO:0060157,0.0789760001492992,0.998379975950748,1,2,urinary bladder development,BP,WNT5A
19027,GO:1904862,0.0789813516188917,0.998379751773212,1,2,inhibitory synapse assembly,BP,WNT5A
1317,GO:0003163,0.0790715854444123,0.998375969368829,1,2,sinoatrial node development,BP,TBX3
14096,GO:0060921,0.0790715854444123,0.998375969368829,1,2,sinoatrial node cell differentiation,BP,TBX3
14101,GO:0060931,0.0790715854444123,0.998375969368829,1,2,sinoatrial node cell development,BP,TBX3
15649,GO:0072163,0.0791291785980913,0.973217491292465,5,64,mesonephric epithelium development,BP,SDC4;BMP2;TACSTD2;SMAD3;SOX9
15650,GO:0072164,0.0791291785980913,0.973217491292465,5,64,mesonephric tubule development,BP,SDC4;BMP2;TACSTD2;SMAD3;SOX9
1419,GO:0003357,0.0791608774183875,0.998372221920617,1,2,noradrenergic neuron differentiation,BP,SOX4
20255,GO:2001201,0.0792888306255898,0.998366844072822,1,2,regulation of transforming growth factor-beta secretion,BP,FERMT1
1250,GO:0002949,0.0793153640916941,0.997830963862104,1,3,tRNA threonylcarbamoyladenosine modification,BP,YRDC
19158,GO:1905167,0.0793163843359605,0.998365684786213,1,2,positive regulation of lysosomal protein catabolic process,BP,LDLR
10591,GO:0043558,0.0793164088532838,0.989438101586693,2,14,regulation of translational initiation in response to stress,BP,PPP1R15A;PPP1R15B
14274,GO:0061341,0.0793285291122678,0.998365173674385,1,2,non-canonical Wnt signaling pathway involved in heart development,BP,WNT5A
14276,GO:0061346,0.0793285291122678,0.998365173674385,1,2,planar cell polarity pathway involved in heart morphogenesis,BP,WNT5A
11154,GO:0045210,0.0793399149984209,0.998364694424736,1,2,FasL biosynthetic process,BP,PHLDA1
17459,GO:1900248,0.0793471741143618,0.998364388839046,1,2,negative regulation of cytoplasmic translational elongation,BP,CPEB2
7742,GO:0032240,0.0793489181188247,0.998364315417572,1,2,negative regulation of nucleobase-containing compound transport,BP,NUP153
11851,GO:0046832,0.0793489181188247,0.998364315417572,1,2,negative regulation of RNA export from nucleus,BP,NUP153
1350,GO:0003213,0.0793490425213726,0.998364310180239,1,2,cardiac right atrium morphogenesis,BP,WNT5A
1435,GO:0003408,0.0793490425213726,0.998364310180239,1,2,optic cup formation involved in camera-type eye development,BP,WNT5A
8878,GO:0034686,0.0793490425213726,0.998364310180239,1,2,integrin alphav-beta8 complex,CC,ITGAV
9354,GO:0035866,0.0793490425213726,0.998364310180239,1,2,alphav-beta3 integrin-PKCalpha complex,CC,ITGAV
12073,GO:0048022,0.0793490425213726,0.998364310180239,1,2,negative regulation of melanin biosynthetic process,BP,WNT5A
12405,GO:0048850,0.0793490425213726,0.998364310180239,1,2,hypophysis morphogenesis,BP,WNT5A
15100,GO:0071144,0.0793490425213726,0.998364310180239,1,2,heteromeric SMAD protein complex,CC,SMAD3
16690,GO:0097638,0.0793490425213726,0.998364310180239,1,2,L-arginine import across plasma membrane,BP,SLC7A2
17480,GO:1900377,0.0793490425213726,0.998364310180239,1,2,negative regulation of secondary metabolite biosynthetic process,BP,WNT5A
19538,GO:1990430,0.0793490425213726,0.998364310180239,1,2,extracellular matrix protein binding,MF,ITGAV
12305,GO:0048644,0.0796011933737222,0.977145892454982,4,45,muscle organ morphogenesis,BP,LIF;BMP2;NRG1;WNT5A
8273,GO:0033077,0.0796185130676021,0.977072521047491,4,48,T cell differentiation in thymus,BP,NFKBID;ZFP36L1;ADAM8;IL7R
12300,GO:0048639,0.0799237378201401,0.966795490394785,7,105,positive regulation of developmental growth,BP,EDN1;SEMA7A;NEDD4L;PIM1;CREB1;PPARD;NRG1
976,GO:0002428,0.0801501880476988,0.997784188878054,1,3,antigen processing and presentation of peptide antigen via MHC class Ib,BP,HLA-E
19861,GO:2000328,0.0802329115819892,0.997779525692353,1,3,regulation of T-helper 17 cell lineage commitment,BP,IL23A
7705,GO:0032183,0.0805039896147212,0.989284532650328,2,13,SUMO binding,MF,PML;TDG
10486,GO:0043382,0.0807515718137479,0.99775017244797,1,3,positive regulation of memory T cell differentiation,BP,IL23A
4691,GO:0010839,0.0807786643837047,0.989227040436641,2,13,negative regulation of keratinocyte proliferation,BP,EFNB2;SFN
13278,GO:0051962,0.0808055244829125,0.952322770394147,17,330,positive regulation of nervous system development,BP,SEMA7A;LIF;KCTD11;BMP2;ENC1;IL6ST;DLX2;VEGFC;NEDD4L;NRG1;SPAG9;SKIL;PRPF19;ABL2;WNT5A;NFE2L2;RELA
4665,GO:0010812,0.0808513664625458,0.976664564291195,4,45,negative regulation of cell-substrate adhesion,BP,PHLDB2;TACSTD2;JAG1;CORO1C
9770,GO:0039535,0.0808791995848434,0.98920596805551,2,13,regulation of RIG-I signaling pathway,BP,BIRC3;BIRC2
2455,GO:0005666,0.0809656270554973,0.988872159575668,2,17,DNA-directed RNA polymerase III complex,CC,POLR3A;POLR3D
13866,GO:0060479,0.0809890006008552,0.989086300554641,2,14,lung cell differentiation,BP,CREB1;SOX9
8713,GO:0034358,0.0810316988005255,0.988921528330319,2,16,plasma lipoprotein particle,CC,LDLR;SAA1
19628,GO:1990777,0.0810316988005255,0.988921528330319,2,16,lipoprotein particle,CC,LDLR;SAA1
13778,GO:0060353,0.0811433888921119,0.997727865086879,1,3,regulation of cell adhesion molecule production,BP,IL1B
13779,GO:0060355,0.0811433888921119,0.997727865086879,1,3,positive regulation of cell adhesion molecule production,BP,IL1B
608,GO:0001774,0.0811744049252174,0.989144001613252,2,13,microglial cell activation,BP,JUN;LDLR
20108,GO:2000773,0.0817351088239043,0.988927955392037,2,14,negative regulation of cellular senescence,BP,PLK2;CDK6
7467,GO:0031624,0.0817718336064285,0.981766602328524,3,28,ubiquitin conjugating enzyme binding,MF,RNF19B;DCUN1D3;RNF19A
4542,GO:0010614,0.0818042651447184,0.988913234426929,2,14,negative regulation of cardiac muscle hypertrophy,BP,ERRFI1;SMAD3
4880,GO:0014741,0.0818042651447184,0.988913234426929,2,14,negative regulation of muscle hypertrophy,BP,ERRFI1;SMAD3
19779,GO:2000191,0.082028856186311,0.988865375360665,2,14,regulation of fatty acid transport,BP,IL1B;EDN1
636,GO:0001823,0.0822617994973622,0.971827318152181,5,65,mesonephros development,BP,SDC4;BMP2;TACSTD2;SMAD3;SOX9
7915,GO:0032486,0.0823468061196147,0.988896568371307,2,13,Rap protein signal transduction,BP,RAP2B;PLK2
17895,GO:1902176,0.0826022175805126,0.9885825497245,2,16,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,SOD2;NFE2L2
11102,GO:0045117,0.0829055939469928,0.988516621290182,2,16,azole transport,BP,CSF2;EDN1
10098,GO:0042608,0.0830645658953871,0.997616831000874,1,3,T cell receptor binding,MF,HLA-E
11380,GO:0045746,0.0830904622639125,0.981194021053626,3,32,negative regulation of Notch signaling pathway,BP,NFKBIA;DLX2;NRARP
4736,GO:0010899,0.0832339232417786,0.997606910960927,1,3,regulation of phosphatidylcholine catabolic process,BP,LDLR
5639,GO:0016722,0.0833625435475841,0.988579555646727,2,14,oxidoreductase activity, oxidizing metal ions,MF,HEPHL1;STEAP4
2446,GO:0005654,0.0835026456346391,0.932772961966775,112,3043,nucleoplasm,CC,NFKBIZ;ZC3H12A;BIRC3;ITPKC;ELF3;ETS1;REL;BHLHE40;TNIP1;NFKB1;PRDM1;FOSL1;NFKB2;NOCT;KDM6B;EHF;RELB;GADD45A;MAFF;SQSTM1;MAP2K3;JUN;CDKN1A;TJP2;SERTAD2;JUNB;BCL3;ETS2;NAMPT;IRF1;TAF4B;ENC1;CEBPB;DUSP16;RUNX1;N4BP1;TRIM16;ELMSAN1;NEDD9;PPP1R10;NABP1;TXNRD1;KLF3;ZNF217;NEDD4L;SMAD3;DUSP10;PLK3;DIEXF;PIM1;AKIRIN1;CREB1;STK40;HIVEP2;PPARD;USP36;IL16;RAPH1;SLC9A1;MAFK;ELL2;PIP5K1A;TP53BP2;SOX9;NRG1;ZNF451;FEM1C;PML;POU2F2;ELK3;POLR3A;PTPN11;MXD1;GCH1;FEM1B;SOX4;FOSL2;OXCT1;CCNL1;HDAC9;HIVEP1;AEN;SKIL;RBM3;CDK6;TFE3;PRPF19;MAFG;MTF1;CELF1;NUP153;PDPK1;CTSC;KDM6A;ZBTB21;NFE2L2;SGK1;RELA;RNF11;BTAF1;GINS3;POLR3D;ALAS1;TDG;ELF4;ETNK1;SH3RF2;UPP1;ISG20;ATXN7;BRD2;DSE
2043,GO:0004784,0.0837611011867558,0.997279495819082,1,4,superoxide dismutase activity,MF,SOD2
5638,GO:0016721,0.0837611011867558,0.997279495819082,1,4,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,SOD2
8074,GO:0032747,0.083764061530198,0.997575719821236,1,3,positive regulation of interleukin-23 production,BP,CSF2
15004,GO:0070936,0.0839615791951686,0.975362369267568,4,49,protein K48-linked ubiquitination,BP,TNFAIP3;BIRC2;PELI1;NEDD4L
17628,GO:1901338,0.0839797882521282,0.997562967233947,1,3,catecholamine binding,MF,ADRB2
9409,GO:0035970,0.08408669135925,0.988335171629744,2,15,peptidyl-threonine dephosphorylation,BP,DUSP1;DUSP10
5409,GO:0016247,0.0842631853013643,0.970840443383558,5,72,channel regulator activity,MF,ADRB2;NEDD4L;STX1A;YWHAH;SGK1
9069,GO:0035307,0.0843461315449975,0.980863322655823,3,30,positive regulation of protein dephosphorylation,BP,PPP1R15A;ANKLE2;PPP1R15B
1093,GO:0002679,0.0846168355261917,0.997525105349859,1,3,respiratory burst involved in defense response,BP,DUSP10
13714,GO:0060268,0.0846278347206869,0.997524448964086,1,3,negative regulation of respiratory burst,BP,DUSP10
20098,GO:2000756,0.0846969108478151,0.975051991148884,4,50,regulation of peptidyl-lysine acetylation,BP,IL1B;LIF;ZNF451;SOX4
3002,GO:0006548,0.0850239982288904,0.997500747221205,1,3,histidine catabolic process,BP,HAL
13418,GO:0052805,0.0850239982288904,0.997500747221205,1,3,imidazole-containing compound catabolic process,BP,HAL
774,GO:0002026,0.0850298097673451,0.988218365124569,2,14,regulation of the force of heart contraction,BP,SLC9A1;ADM
10725,GO:0044062,0.0850453984715418,0.997499463538619,1,3,regulation of excretion,BP,EDN1
12636,GO:0050820,0.0851330149551852,0.988106179326196,2,15,positive regulation of coagulation,BP,F3;NFE2L2
17006,GO:0099106,0.0852151599452148,0.974827021575584,4,51,ion channel regulator activity,MF,ADRB2;NEDD4L;STX1A;SGK1
11300,GO:0045618,0.0855499517994332,0.988014457066998,2,15,positive regulation of keratinocyte differentiation,BP,TRIM16;CYP27B1
7678,GO:0032106,0.0856956105009327,0.997460297354302,1,3,positive regulation of response to extracellular stimulus,BP,CYP27B1
7681,GO:0032109,0.0856956105009327,0.997460297354302,1,3,positive regulation of response to nutrient levels,BP,CYP27B1
14448,GO:0061771,0.0857952854196125,0.997454265330042,1,3,response to caloric restriction,BP,LDLR
18385,GO:1903392,0.0858409033878803,0.98814656712732,2,13,negative regulation of adherens junction organization,BP,PHLDB2;CORO1C
1298,GO:0003129,0.0860042775627341,0.997441593578134,1,3,heart induction,BP,BMP2
7737,GO:0032231,0.086392775529019,0.969972271354297,5,66,regulation of actin filament bundle assembly,BP,SDC4;PHLDB2;TACSTD2;SMAD3;SLC9A1
17127,GO:0102148,0.0864707699000673,0.997413190743267,1,3,N-acetyl-beta-D-galactosaminidase activity,MF,HEXDC
10220,GO:0042886,0.0865899040934675,0.934369687926887,59,1533,amide transport,BP,NFKBIA;IL1B;IL1A;ZC3H12A;TNF;PTGS2;EDN1;IL1RN;PANX1;HCAR2;CDKN1A;CD274;BCL3;DUSP16;UGCG;TRIM16;EHD1;PPP1R10;PIM3;ADAM8;VEGFC;PLK3;TFRC;PPARD;USP36;PLAGL2;RIPK2;SAA1;ITGAV;STX1A;NRG1;PML;POU2F2;FERMT1;PTPN11;RHOB;SOX4;OXCT1;PTPN1;ATP6V1C2;HLA-E;RAB3IP;PMM2;WNT5A;NUP153;INSIG1;ADAM9;ADAMTS9;YWHAH;AGFG1;YWHAG;RAB22A;SFN;IFIH1;IPO4;TAP1;STX12;RAB24;SMPD3
6451,GO:0021766,0.0866358821113429,0.974305653904535,4,49,hippocampus development,BP,BTG2;KDM6B;DLX2;CDK6
8452,GO:0033590,0.0868199975171588,0.997391820809962,1,3,response to cobalamin,BP,RELA
18926,GO:1904659,0.0868988160024973,0.969744919501905,5,66,glucose transmembrane transport,BP,IL1B;TNF;PPARD;PTPN11;NFE2L2
12068,GO:0048017,0.0869317184427361,0.963154857615518,7,107,inositol lipid-mediated signaling,BP,IER3;EDN1;ZFP36L1;PPARD;PIP5K1A;SOX9;NRG1
8732,GO:0034381,0.0870371309483189,0.979880540092358,3,33,plasma lipoprotein particle clearance,BP,EHD1;LDLR;LIPG
846,GO:0002158,0.0873777831308385,0.997357498867615,1,3,osteoclast proliferation,BP,TNFAIP3
9713,GO:0038128,0.0876075011517568,0.97976536209621,3,31,ERBB2 signaling pathway,BP,HBEGF;EREG;NRG1
17486,GO:1900408,0.0876097561696968,0.979692487153,3,33,negative regulation of cellular response to oxidative stress,BP,SOD2;NCOA7;NFE2L2
18297,GO:1903202,0.0876097561696968,0.979692487153,3,33,negative regulation of oxidative stress-induced cell death,BP,SOD2;NCOA7;NFE2L2
9923,GO:0042270,0.0876475981957568,0.997340812594411,1,3,protection from natural killer cell mediated cytotoxicity,BP,HLA-E
5712,GO:0016841,0.087650906373459,0.997340607666014,1,3,ammonia-lyase activity,MF,HAL
15254,GO:0071425,0.0877541930273867,0.987618940503488,2,14,hematopoietic stem cell proliferation,BP,RUNX1;WNT5A
14246,GO:0061218,0.0877850178584966,0.997332293068191,1,3,negative regulation of mesonephros development,BP,TACSTD2
6706,GO:0030104,0.0879073039050696,0.973821977332942,4,48,water homeostasis,BP,CLDN1;CLDN4;NEDD4L;SFN
6729,GO:0030139,0.0879337175044821,0.954378507212238,11,208,endocytic vesicle,CC,HBEGF;ADAM8;LDLR;SAA1;ITGAV;HLA-E;WNT5A;RAB22A;TAP1;STX12;RAB24
5289,GO:0015942,0.0879565119432108,0.997321641135233,1,3,formate metabolic process,BP,HAL
3163,GO:0006776,0.0882974836162005,0.997300396812235,1,3,vitamin A metabolic process,BP,PPARD
13680,GO:0060205,0.088365910968523,0.954049229845231,11,229,cytoplasmic vesicle lumen,CC,CXCL1;NFKB1;CAB39;AMPD3;VEGFC;SERPINB1;SAA1;VCL;COTL1;CTSC;CREG1
4483,GO:0010499,0.0884330513709202,0.986956723330766,2,22,proteasomal ubiquitin-independent protein catabolic process,BP,ENC1;NFE2L2
7738,GO:0032232,0.0885130038505445,0.987449959042518,2,14,negative regulation of actin filament bundle assembly,BP,PHLDB2;TACSTD2
17526,GO:1901016,0.0885477797252969,0.979496786348746,3,30,regulation of potassium ion transmembrane transporter activity,BP,CAB39;NEDD4L;OXSR1
4553,GO:0010633,0.0886821654135514,0.973488894640505,4,49,negative regulation of epithelial cell migration,BP,TACSTD2;DUSP10;CORO1C;ADAMTS9
15170,GO:0071305,0.0886968925950599,0.987408876022903,2,14,cellular response to vitamin D,BP,PIM1;CYP27B1
10539,GO:0043487,0.0890019422207839,0.959401553577602,8,148,regulation of RNA stability,BP,ZC3H12A;NOCT;ZFP36L1;RC3H1;ZFP36;SAMD4A;QKI;PABPC4
7656,GO:0032075,0.0890395276384596,0.987152782014472,2,16,positive regulation of nuclease activity,BP,PTPN1;ERN1
653,GO:0001841,0.0890938396715047,0.965048791441256,6,87,neural tube formation,BP,SDC4;BCL10;SOX4;ADM;WNT5A;KDM6A
12281,GO:0048593,0.08920527647596,0.968703328586993,5,66,camera-type eye morphogenesis,BP,EPHA2;ALDH1A3;JAG1;SOX9;WNT5A
15619,GO:0072108,0.0892301201951332,0.997241841689474,1,3,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,LIF
15328,GO:0071548,0.0893438062433985,0.979119648452702,3,33,response to dexamethasone,BP,EDN1;ERRFI1;CLDN1
7938,GO:0032516,0.0894142518943673,0.987248116225771,2,14,positive regulation of phosphoprotein phosphatase activity,BP,PPP1R15A;PPP1R15B
10758,GO:0044194,0.0894512826904995,0.997227860019171,1,3,cytolytic granule,CC,RNF19B
14972,GO:0070884,0.0894960777807016,0.987133051448497,2,15,regulation of calcineurin-NFAT signaling cascade,BP,SLC9A1;NRG1
17206,GO:0106056,0.0894960777807016,0.987133051448497,2,15,regulation of calcineurin-mediated signaling,BP,SLC9A1;NRG1
9601,GO:0036459,0.0896046161317143,0.964796325385456,6,87,thiol-dependent ubiquitinyl hydrolase activity,MF,TNFAIP3;ZC3H12A;CYLD;USP36;USP31;ATXN7
17110,GO:0101005,0.0896046161317143,0.964796325385456,6,87,ubiquitinyl hydrolase activity,MF,TNFAIP3;ZC3H12A;CYLD;USP36;USP31;ATXN7
536,GO:0001654,0.0897590270620897,0.951819758730533,12,218,eye development,BP,INHBA;PRDM1;EPHA2;JUN;ALDH1A3;DLX2;SMAD3;SLC25A25;JAG1;SOX9;SKIL;WNT5A
9395,GO:0035933,0.0898061348849679,0.997205349591938,1,3,glucocorticoid secretion,BP,PTPN11
20154,GO:2000849,0.0898061348849679,0.997205349591938,1,3,regulation of glucocorticoid secretion,BP,PTPN11
9225,GO:0035613,0.0899510602922231,0.987029888444457,2,15,RNA stem-loop binding,MF,ZC3H12A;RC3H1
473,GO:0001516,0.0899586158053273,0.986868985150028,2,17,prostaglandin biosynthetic process,BP,PTGS2;EDN1
11675,GO:0046457,0.0899586158053273,0.986868985150028,2,17,prostanoid biosynthetic process,BP,PTGS2;EDN1
11238,GO:0045415,0.0900110503486184,0.997192307317613,1,3,negative regulation of interleukin-8 biosynthetic process,BP,BCL3
15696,GO:0072234,0.0901396531860161,0.987084757725541,2,14,metanephric nephron tubule development,BP,LIF;SOX9
16487,GO:0097178,0.0902316274514678,0.978860686607264,3,32,ruffle assembly,BP,TACSTD2;PIP5K1A;CORO1C
14144,GO:0061009,0.0904057171665196,0.997167098668065,1,3,common bile duct development,BP,SOX9
8729,GO:0034378,0.0904345436352734,0.997165252822146,1,3,chylomicron assembly,BP,PLAGL2
1395,GO:0003307,0.0905008863710493,0.997161002313567,1,3,regulation of Wnt signaling pathway involved in heart development,BP,BMP2
4886,GO:0014805,0.0905709233533689,0.996809492695333,1,4,smooth muscle adaptation,BP,IL1B
7604,GO:0031983,0.0905844197962558,0.952686219377404,11,230,vesicle lumen,CC,CXCL1;NFKB1;CAB39;AMPD3;VEGFC;SERPINB1;SAA1;VCL;COTL1;CTSC;CREG1
10565,GO:0043524,0.0905951165305383,0.964250837747912,6,92,negative regulation of neuron apoptotic process,BP,BTG2;JUN;CEBPB;SOD2;ADAM8;PDPK1
13821,GO:0060412,0.0907086084339225,0.978782457608639,3,30,ventricular septum morphogenesis,BP,TBX3;SOX4;WNT5A
11934,GO:0046979,0.0907737142272201,0.997143487595558,1,3,TAP2 binding,MF,TAP1
12280,GO:0048592,0.0907819938785449,0.964224566138554,6,86,eye morphogenesis,BP,PRDM1;EPHA2;ALDH1A3;JAG1;SOX9;WNT5A
1226,GO:0002901,0.0908385309076983,0.996790227349185,1,4,mature B cell apoptotic process,BP,BCL10
1230,GO:0002905,0.0908385309076983,0.996790227349185,1,4,regulation of mature B cell apoptotic process,BP,BCL10
1231,GO:0002906,0.0908385309076983,0.996790227349185,1,4,negative regulation of mature B cell apoptotic process,BP,BCL10
17828,GO:1901985,0.0910229674967616,0.978560145313083,3,33,positive regulation of protein acetylation,BP,IL1B;LIF;SOX4
6726,GO:0030135,0.0910442180014464,0.95247376425745,11,208,coated vesicle,CC,HBEGF;TGFA;EDN1;ADRB2;LDLR;TFRC;AREG;IL7R;HLA-E;WNT5A;CTSC
13553,GO:0060011,0.0912743967381737,0.997111199062891,1,3,Sertoli cell proliferation,BP,BCL2L2
3479,GO:0007341,0.0916138654033427,0.997089199302731,1,3,penetration of zona pellucida,BP,B4GALT1
13820,GO:0060411,0.0916557352489631,0.972313693775424,4,48,cardiac septum morphogenesis,BP,TBX3;JAG1;SOX4;WNT5A
4961,GO:0015035,0.0916743860046493,0.986290210679381,2,20,protein disulfide oxidoreductase activity,MF,TXNRD1;ERO1A
12917,GO:0051260,0.0918378205498809,0.951964860058429,11,214,protein homooligomerization,BP,CLDN1;KCTD11;SOD2;ALDH1A3;EHD1;B4GALT1;BCL10;TMCC1;SPAG9;GCH1;TNFAIP1
11205,GO:0045337,0.0918828443606325,0.997071705864791,1,3,farnesyl diphosphate biosynthetic process,BP,HMGCS1
11845,GO:0046823,0.091961362680645,0.9864826760923,2,16,negative regulation of nucleocytoplasmic transport,BP,SOX4;NUP153
16811,GO:0098660,0.0919774075194565,0.943055757887956,19,406,inorganic ion transmembrane transport,BP,PPIF;TRPV3;PANX1;RRAD;CAB39;CLDN4;NEDD4L;OXSR1;SLC25A25;BDKRB1;SLC9A1;ITGAV;SLC28A3;STEAP4;ATP6V1C2;PDPK1;ERO1A;YWHAH;ATP13A3
14850,GO:0070613,0.092107751548597,0.972038786671848,4,52,regulation of protein processing,BP,BIRC3;BIRC2;ADAM8;CD55
11309,GO:0045627,0.0921860126045064,0.99705192327827,1,3,positive regulation of T-helper 1 cell differentiation,BP,RIPK2
6731,GO:0030141,0.0925552584990005,0.939916208405138,23,538,secretory granule,CC,IL1B;CXCL1;PLAUR;PLAU;NFKB1;EDN1;CAB39;RAP2B;AMPD3;B4GALT1;ADAM8;VEGFC;SERPINB1;CD55;ITGAV;STX1A;SPAG9;VCL;SKIL;COTL1;CTSC;CREG1;RAB24
13593,GO:0060057,0.0927123068650942,0.997017415905366,1,3,apoptotic process involved in mammary gland involution,BP,B4GALT1
13594,GO:0060058,0.0927123068650942,0.997017415905366,1,3,positive regulation of apoptotic process involved in mammary gland involution,BP,B4GALT1
17966,GO:1902339,0.0927123068650942,0.997017415905366,1,3,positive regulation of apoptotic process involved in morphogenesis,BP,B4GALT1
18438,GO:1903519,0.0927123068650942,0.997017415905366,1,3,regulation of mammary gland involution,BP,B4GALT1
18439,GO:1903521,0.0927123068650942,0.997017415905366,1,3,positive regulation of mammary gland involution,BP,B4GALT1
18970,GO:1904747,0.0927123068650942,0.997017415905366,1,3,positive regulation of apoptotic process involved in development,BP,B4GALT1
4477,GO:0010481,0.0932011482863939,0.996985176298364,1,3,epidermal cell division,BP,SFN
4478,GO:0010482,0.0932011482863939,0.996985176298364,1,3,regulation of epidermal cell division,BP,SFN
8893,GO:0034711,0.0933085062156898,0.996978071681363,1,3,inhibin binding,MF,INHBA
7332,GO:0031341,0.0935291149137682,0.977615411475539,3,36,regulation of cell killing,BP,IL23A;IL7R;HLA-E
11068,GO:0045069,0.093604054846211,0.966556549986333,5,75,regulation of viral genome replication,BP,ZC3H12A;TNF;CXCL8;TNIP1;ISG20
12417,GO:0048865,0.0938104845228808,0.996944736363401,1,3,stem cell fate commitment,BP,SOX9
9936,GO:0042287,0.0938307752178751,0.98604709108417,2,16,MHC protein binding,MF,HLA-E;TAP1
18921,GO:1904636,0.0938370331711761,0.996942968003491,1,3,response to ionomycin,BP,ZC3H12A
18922,GO:1904637,0.0938370331711761,0.996942968003491,1,3,cellular response to ionomycin,BP,ZC3H12A
11864,GO:0046854,0.0938774200977509,0.966566872599385,5,66,phosphatidylinositol phosphorylation,BP,HBEGF;EREG;PIP5K1A;NRG1;PTPN11
7821,GO:0032373,0.0938918116662729,0.986032779574822,2,16,positive regulation of sterol transport,BP,NFKBIA;LIPG
7824,GO:0032376,0.0938918116662729,0.986032779574822,2,16,positive regulation of cholesterol transport,BP,NFKBIA;LIPG
14863,GO:0070640,0.0940835590736961,0.996926521801065,1,3,vitamin D3 metabolic process,BP,CYP27B1
8083,GO:0032762,0.0941547082782015,0.996921766730309,1,3,mast cell cytokine production,BP,BCL10
8084,GO:0032763,0.0941547082782015,0.996921766730309,1,3,regulation of mast cell cytokine production,BP,BCL10
15602,GO:0072088,0.0941722351895042,0.971263089895506,4,49,nephron epithelium morphogenesis,BP,LIF;BMP2;TACSTD2;SOX9
14245,GO:0061217,0.0942244203834354,0.985954691833585,2,16,regulation of mesonephros development,BP,TACSTD2;SOX9
12191,GO:0048339,0.0944459603974057,0.986098593025631,2,14,paraxial mesoderm development,BP,SMAD3;WNT5A
14242,GO:0061209,0.0945020973624247,0.996898494713366,1,3,cell proliferation involved in mesonephros development,BP,BMP2
16280,GO:0090360,0.0946410105772028,0.996889163104763,1,3,platelet-derived growth factor production,BP,PTGS2
16281,GO:0090361,0.0946410105772028,0.996889163104763,1,3,regulation of platelet-derived growth factor production,BP,PTGS2
12494,GO:0050501,0.0946984137376647,0.996885302721658,1,3,hyaluronan synthase activity,MF,HAS3
11823,GO:0046717,0.0947747258439441,0.970991676883981,4,50,acid secretion,BP,IL1B;EDN1;STX1A;SGK1
12064,GO:0048013,0.0948622166199582,0.96601582467608,5,72,ephrin receptor signaling pathway,BP,EFNA1;EFNB2;EPHA2;EFNB1;PTPN11
6523,GO:0021898,0.0949085209000722,0.996871151593928,1,3,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,DLX2
2702,GO:0006066,0.0949396395238826,0.948500442670787,12,234,alcohol metabolic process,BP,IL1B;ITPKC;TNF;NFKB1;HMGCS1;ALDH1A3;LDLR;PPARD;CYP27B1;GCH1;SQLE;INSIG1
13239,GO:0051899,0.0950089594438275,0.970872088820099,4,51,membrane depolarization,BP,EDN1;JUN;NEDD4L;YWHAH
2385,GO:0005520,0.095116325297136,0.985744468183168,2,16,insulin-like growth factor binding,MF,WISP1;ITGAV
17957,GO:1902308,0.0951380270395392,0.996855655580438,1,3,regulation of peptidyl-serine dephosphorylation,BP,PPP1R15A
18976,GO:1904753,0.0953062497100138,0.996844271938719,1,3,negative regulation of vascular associated smooth muscle cell migration,BP,NFE2L2
15051,GO:0071006,0.0953385768363683,0.99684208189542,1,3,U2-type catalytic step 1 spliceosome,CC,PRPF19
6210,GO:0019722,0.0954078231737361,0.961830416958727,6,93,calcium-mediated signaling,BP,CXCL8;CCL20;EDN1;SLC9A1;NRG1;PDPK1
1853,GO:0004514,0.0954220482048437,0.996836423344617,1,3,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,NAMPT
13901,GO:0060541,0.0954240284752396,0.955919771675364,8,131,respiratory system development,BP,TNF;ERRFI1;LIF;ALDH1A3;CREB1;STK40;SOX9;WNT5A
7137,GO:0030968,0.0954439818069769,0.958563068146589,7,117,endoplasmic reticulum unfolded protein response,BP,CXCL8;PPP1R15A;PPP1R15B;PTPN1;ERO1A;NFE2L2;ERN1
11416,GO:0045824,0.0954897080572507,0.977012399890702,3,34,negative regulation of innate immune response,BP,TNFAIP3;DUSP10;HLA-E
11474,GO:0045931,0.0955776403619457,0.958507339094667,7,115,positive regulation of mitotic cell cycle,BP,IL1B;IL1A;TGFA;EDN1;EREG;PPP1R10;PTPN11
17845,GO:1902022,0.0956226168714744,0.996822805071886,1,3,L-lysine transport,BP,SLC7A2
18389,GO:1903401,0.0956226168714744,0.996822805071886,1,3,L-lysine transmembrane transport,BP,SLC7A2
15561,GO:0072009,0.0956577919029244,0.965709178248056,5,68,nephron epithelium development,BP,LIF;BMP2;TACSTD2;JAG1;SOX9
3819,GO:0008410,0.0956735446462631,0.996819342292055,1,3,CoA-transferase activity,MF,OXCT1
4230,GO:0009407,0.0957007507549567,0.996429657352387,1,4,toxin catabolic process,BP,NFE2L2
4834,GO:0014038,0.0958112284749234,0.996809970750411,1,3,regulation of Schwann cell differentiation,BP,RELA
7621,GO:0032010,0.0958794079723542,0.996805324728805,1,3,phagolysosome,CC,ADAM8
7412,GO:0031493,0.0959076155562893,0.996803401517794,1,3,nucleosomal histone binding,MF,UHRF1
16404,GO:0097028,0.0959109627151491,0.985474229694127,2,17,dendritic cell differentiation,BP,CSF2;RELB
3634,GO:0008104,0.0961146640161707,0.924341382915627,78,2055,protein localization,BP,NFKBIA;TNFAIP3;IL1B;IL1A;ZC3H12A;TNF;PTGS2;PMAIP1;PLEKHF1;IL1RN;PANX1;HCAR2;EPHA2;LIF;SQSTM1;NFKBIE;CDKN1A;PHLDB2;CD274;BCL3;DUSP16;UGCG;PPP1R15A;TRIM16;EHD1;PPP1R10;PIM3;CYLD;ADAM8;VEGFC;NEDD4L;BBC3;PLK3;TFRC;KLHL21;PPARD;USP36;PLAGL2;RIPK2;SAA1;ITGAV;PIP5K1A;TP53BP2;SOX9;STX1A;NRG1;PML;POU2F2;FERMT1;PTPN11;RHOB;SOX4;VCL;OXCT1;PTPN1;CORO1C;PRPF19;ATP6V1C2;HLA-E;RAB3IP;PMM2;WNT5A;NUP153;INSIG1;ADAM9;PDPK1;ADAMTS9;FRMD6;YWHAH;AGFG1;YWHAG;RAB22A;SFN;IFIH1;IPO4;TAP1;STX12;RAB24
694,GO:0001912,0.0961815775126623,0.985409535416262,2,17,positive regulation of leukocyte mediated cytotoxicity,BP,IL23A;HLA-E
18078,GO:1902667,0.0964360583897087,0.976900261662959,3,29,regulation of axon guidance,BP,SEMA7A;ZSWIM4;WNT5A
697,GO:0001915,0.0964603151422383,0.996765595933593,1,3,negative regulation of T cell mediated cytotoxicity,BP,IL7R
14480,GO:0061888,0.0964705851835376,0.996764891244694,1,3,regulation of astrocyte activation,BP,LDLR
12067,GO:0048016,0.0965991863301582,0.976750745179562,3,31,inositol phosphate-mediated signaling,BP,EDN1;SLC9A1;NRG1
18026,GO:1902527,0.0966310886520255,0.996358383554009,1,4,positive regulation of protein monoubiquitination,BP,BIRC2
20112,GO:2000778,0.0967423251578636,0.985358121660138,2,16,positive regulation of interleukin-6 secretion,BP,IL1B;IFIH1
10027,GO:0042472,0.0968760176029023,0.970174624636697,4,48,inner ear morphogenesis,BP,ALDH1A3;SOX9;WNT5A;INSIG1
4648,GO:0010769,0.0969128430187573,0.948888547979233,11,197,regulation of cell morphogenesis involved in differentiation,BP,EFNA1;SEMA7A;ZSWIM4;TACSTD2;NEDD4L;NRG1;SKIL;CORO1C;WNT5A;YWHAH;PDLIM5
19687,GO:2000001,0.0970374877691218,0.98528756180128,2,16,regulation of DNA damage checkpoint,BP,PPP1R10;FEM1B
14011,GO:0060729,0.0970739714232256,0.996723348288599,1,3,intestinal epithelial structure maintenance,BP,SOX9
5850,GO:0017144,0.0970797711895637,0.93723951824777,22,534,drug metabolic process,BP,IL1B;ZC3H12A;TICAM1;TNF;PPIF;PTGS2;EDN1;BMP2;AMPD3;HAL;SMAD3;SLC25A25;CYP27B1;SLC7A2;GCH1;OXCT1;ADM;NUP153;MAOA;SAT1;DSE;AHCY
11833,GO:0046777,0.0971544179084687,0.950550529921622,10,172,protein autophosphorylation,BP,ERRFI1;JUN;RAP2B;PIM3;VEGFC;PIM1;CLK4;ABL2;PDPK1;ERN1
9483,GO:0036118,0.0971609120441762,0.996717339587716,1,3,hyaluranon cable assembly,BP,HAS3
17378,GO:1900104,0.0971609120441762,0.996717339587716,1,3,regulation of hyaluranon cable assembly,BP,HAS3
17379,GO:1900106,0.0971609120441762,0.996717339587716,1,3,positive regulation of hyaluranon cable assembly,BP,HAS3
13961,GO:0060664,0.0975911042761265,0.996687523037648,1,3,epithelial cell proliferation involved in salivary gland morphogenesis,BP,TNF
3503,GO:0007411,0.0977106086384503,0.950223959071154,10,170,axon guidance,BP,EFNA1;SEMA7A;KLF7;EFNB2;ZSWIM4;CREB1;EFNB1;PTPN11;WNT5A;B3GNT2
734,GO:0001961,0.0977314408402029,0.97627845481754,3,33,positive regulation of cytokine-mediated signaling pathway,BP,EDN1;RIPK2;WNT5A
17851,GO:1902037,0.097736213892416,0.996677433681266,1,3,negative regulation of hematopoietic stem cell differentiation,BP,NFE2L2
136,GO:0000285,0.0977951866118566,0.996673328764127,1,3,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,PIP5K1A
1384,GO:0003281,0.0978496564256087,0.969770780701893,4,48,ventricular septum development,BP,PRDM1;TBX3;SOX4;WNT5A
2243,GO:0005152,0.0979349785837318,0.996663587656601,1,3,interleukin-1 receptor antagonist activity,MF,IL1RN
14495,GO:0061945,0.098006693386827,0.996658584574854,1,3,regulation of protein K48-linked ubiquitination,BP,BIRC2
16272,GO:0090336,0.0980615783031402,0.996654752954755,1,3,positive regulation of brown fat cell differentiation,BP,PTGS2
1870,GO:0004532,0.0981983380545583,0.976078850469899,3,34,exoribonuclease activity,MF,ZC3H12A;NOCT;ISG20
14678,GO:0070294,0.098256103050846,0.996641154295933,1,3,renal sodium ion absorption,BP,SGK1
12394,GO:0048820,0.0982700884831083,0.985088271244194,2,15,hair follicle maturation,BP,FERMT1;WNT5A
1073,GO:0002637,0.0983082114092954,0.976040731104038,3,34,regulation of immunoglobulin production,BP,TNF;TFRC;HLA-E
1730,GO:0004322,0.0983231451689344,0.996636460882607,1,3,ferroxidase activity,MF,HEPHL1
5641,GO:0016724,0.0983231451689344,0.996636460882607,1,3,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,HEPHL1
19714,GO:2000049,0.0983944015777762,0.996631468677256,1,3,positive regulation of cell-cell adhesion mediated by cadherin,BP,WNT5A
17855,GO:1902043,0.0985240479574709,0.985027361455417,2,15,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,PMAIP1;SKIL
18855,GO:1904468,0.0985534102791652,0.996620314588176,1,3,negative regulation of tumor necrosis factor secretion,BP,ZC3H12A
16729,GO:0097734,0.0986455973288323,0.984815382239064,2,17,extracellular exosome biogenesis,BP,SDC4;SMPD3
19480,GO:1990182,0.0986455973288323,0.984815382239064,2,17,exosomal secretion,BP,SDC4;SMPD3
11461,GO:0045916,0.0986800697852088,0.996611415900879,1,3,negative regulation of complement activation,BP,CD55
19815,GO:2000258,0.0986800697852088,0.996611415900879,1,3,negative regulation of protein activation cascade,BP,CD55
11503,GO:0045988,0.0987737223577677,0.996604828292508,1,3,negative regulation of striated muscle contraction,BP,ZC3H12A
13538,GO:0055118,0.0987737223577677,0.996604828292508,1,3,negative regulation of cardiac muscle contraction,BP,ZC3H12A
4238,GO:0009435,0.0987981819789858,0.97587050426142,3,34,NAD biosynthetic process,BP,PTGS2;NMNAT2;NAMPT
1817,GO:0004465,0.09880021968594,0.996602963229729,1,3,lipoprotein lipase activity,MF,LIPG
14164,GO:0061043,0.098874411394161,0.996597738256823,1,3,regulation of vascular wound healing,BP,TNFAIP3
4194,GO:0009298,0.0988806494290674,0.996183002469247,1,4,GDP-mannose biosynthetic process,BP,PMM2
4833,GO:0014037,0.0989187185437594,0.975951643911234,3,31,Schwann cell differentiation,BP,NAB1;NDRG1;RELA
1251,GO:0002950,0.0989940744304876,0.99658930208827,1,3,ceramide phosphoethanolamine synthase activity,MF,SGMS2
8340,GO:0033188,0.0989940744304876,0.99658930208827,1,3,sphingomyelin synthase activity,MF,SGMS2
12006,GO:0047493,0.0989940744304876,0.99658930208827,1,3,ceramide cholinephosphotransferase activity,MF,SGMS2
12759,GO:0051024,0.099115204016483,0.996164467969372,1,4,positive regulation of immunoglobulin secretion,BP,HLA-E
7863,GO:0032422,0.099270810816354,0.996569750420846,1,3,purine-rich negative regulatory element binding,MF,ELK3
3773,GO:0008327,0.0993699768815075,0.984725366736967,2,16,methyl-CpG binding,MF,UHRF1;ZBTB21
1318,GO:0003164,0.0993814214344516,0.996561919304614,1,3,His-Purkinje system development,BP,TBX3
4408,GO:0010159,0.0994180100122988,0.996559326812103,1,3,specification of animal organ position,BP,TBX3
4403,GO:0010138,0.0994404653346674,0.996138688200425,1,4,pyrimidine ribonucleotide salvage,BP,UPP1
10760,GO:0044206,0.0994404653346674,0.996138688200425,1,4,UMP salvage,BP,UPP1
596,GO:0001758,0.0995008815828666,0.996553451141062,1,3,retinal dehydrogenase activity,MF,ALDH1A3
2226,GO:0005127,0.0995559647666218,0.996549542786093,1,3,ciliary neurotrophic factor receptor binding,MF,IL6ST
10441,GO:0043297,0.099603003831039,0.969012958793067,4,49,apical junction assembly,BP,TNF;CLDN1;RUNX1;VCL
12556,GO:0050705,0.0998858778483861,0.996103239005958,1,4,regulation of interleukin-1 alpha secretion,BP,PANX1
14754,GO:0070432,0.100018938401282,0.996516601342103,1,3,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,TNFAIP3
13590,GO:0060054,0.100187442746238,0.996504571219662,1,3,positive regulation of epithelial cell proliferation involved in wound healing,BP,B4GALT1
7130,GO:0030952,0.100225140832283,0.984517207065508,2,16,establishment or maintenance of cytoskeleton polarity,BP,RND3;RHOB
15570,GO:0072028,0.100245108138217,0.968717956837678,4,50,nephron morphogenesis,BP,LIF;BMP2;TACSTD2;SOX9
9377,GO:0035905,0.100296169977167,0.99649679725751,1,3,ascending aorta development,BP,SOX4
9380,GO:0035910,0.100296169977167,0.99649679725751,1,3,ascending aorta morphogenesis,BP,SOX4
16627,GO:0097485,0.100321215667706,0.948631478009596,10,171,neuron projection guidance,BP,EFNA1;SEMA7A;KLF7;EFNB2;ZSWIM4;CREB1;EFNB1;PTPN11;WNT5A;B3GNT2
8129,GO:0032817,0.100378055623735,0.996063870958128,1,4,regulation of natural killer cell proliferation,BP,IL23A
8130,GO:0032819,0.100378055623735,0.996063870958128,1,4,positive regulation of natural killer cell proliferation,BP,IL23A
11917,GO:0046952,0.10050389400297,0.996481919884508,1,3,ketone body catabolic process,BP,OXCT1
6670,GO:0030027,0.100580854799112,0.950551822485837,9,155,lamellipodium,CC,EPHA2;NEDD9;FGD6;RAPH1;SLC9A1;ITGAV;PIP5K1A;CORO1C;RAB3IP
6856,GO:0030324,0.100660920576456,0.955795873356352,7,111,lung development,BP,TNF;ERRFI1;LIF;CREB1;STK40;SOX9;WNT5A
391,GO:0001046,0.100693015337266,0.96330094175605,5,71,core promoter sequence-specific DNA binding,MF,GADD45A;CEBPB;SOX9;SOX4;KLF10
12860,GO:0051176,0.100908790668563,0.99645282581871,1,3,positive regulation of sulfur metabolic process,BP,NFE2L2
4850,GO:0014061,0.100909572940091,0.996452769486569,1,3,regulation of norepinephrine secretion,BP,STX1A
8231,GO:0032994,0.100941664977035,0.984175228477222,2,18,protein-lipid complex,CC,LDLR;SAA1
7761,GO:0032276,0.101145911213654,0.996435729054516,1,3,regulation of gonadotropin secretion,BP,INHBA
7763,GO:0032278,0.101145911213654,0.996435729054516,1,3,positive regulation of gonadotropin secretion,BP,INHBA
11873,GO:0046880,0.101145911213654,0.996435729054516,1,3,regulation of follicle-stimulating hormone secretion,BP,INHBA
11874,GO:0046881,0.101145911213654,0.996435729054516,1,3,positive regulation of follicle-stimulating hormone secretion,BP,INHBA
8733,GO:0034382,0.101207452876489,0.995997061427715,1,4,chylomicron remnant clearance,BP,LDLR
15481,GO:0071830,0.101207452876489,0.995997061427715,1,4,triglyceride-rich lipoprotein particle clearance,BP,LDLR
12271,GO:0048566,0.101239411869434,0.984268903716906,2,16,embryonic digestive tract development,BP,TNF;CXCL8
14139,GO:0061002,0.101261911744244,0.996427349530041,1,3,negative regulation of dendritic spine morphogenesis,BP,EFNA1
9065,GO:0035303,0.101300842029774,0.950107822971906,9,158,regulation of dephosphorylation,BP,TNF;PLEKHF1;BMP2;PPP1R15A;ANKLE2;PPP1R10;SMAD3;PPP1R15B;SH3RF2
1205,GO:0002863,0.101314670689991,0.995988381909204,1,4,positive regulation of inflammatory response to antigenic stimulus,BP,TNF
2505,GO:0005757,0.101526190275577,0.995971230102576,1,4,mitochondrial permeability transition pore complex,CC,PPIF
9800,GO:0040020,0.10153452597324,0.984196369172942,2,16,regulation of meiotic nuclear division,BP,LIF;WNT5A
18147,GO:1902883,0.101921611090892,0.974738688348678,3,35,negative regulation of response to oxidative stress,BP,SOD2;NCOA7;NFE2L2
107,GO:0000221,0.101927256001243,0.996379087688509,1,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,ATP6V1C2
2929,GO:0006447,0.101944445804708,0.99637783629578,1,3,regulation of translational initiation by iron,BP,TNF
4590,GO:0010693,0.101968066830424,0.99637611634938,1,3,negative regulation of alkaline phosphatase activity,BP,TNF
8195,GO:0032937,0.102087437795333,0.996367417893965,1,3,SREBP-SCAP-Insig complex,CC,INSIG1
13978,GO:0060685,0.102216347605351,0.996358012063288,1,3,regulation of prostatic bud formation,BP,WNT5A
13979,GO:0060686,0.102216347605351,0.996358012063288,1,3,negative regulation of prostatic bud formation,BP,WNT5A
19924,GO:2000416,0.102241850996441,0.996356149710755,1,3,regulation of eosinophil migration,BP,ADAM8
10426,GO:0043270,0.102328045894634,0.954808972794461,7,120,positive regulation of ion transport,BP,IL1B;TRPV3;EDN1;ADRB2;BDKRB1;SLC9A1;PDPK1
15652,GO:0072170,0.102337473236076,0.984101215070726,2,15,metanephric tubule development,BP,LIF;SOX9
17419,GO:1900165,0.102339535521117,0.996349011801909,1,3,negative regulation of interleukin-6 secretion,BP,ZC3H12A
7138,GO:0030969,0.102406609031931,0.996344106427045,1,3,mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response,BP,ERN1
14539,GO:0070054,0.102406609031931,0.996344106427045,1,3,mRNA splicing, via endonucleolytic cleavage and ligation,BP,ERN1
14540,GO:0070055,0.102406609031931,0.996344106427045,1,3,mRNA endonucleolytic cleavage involved in unfolded protein response,BP,ERN1
6311,GO:0019953,0.102494926794184,0.934820312694262,20,438,sexual reproduction,BP,BIRC3;INHBA;PTGS2;PRDM1;FOSL1;OVOL1;TAF4B;BCL2L2;EREG;B4GALT1;GJB3;SOX9;SPAG9;ADAMTS1;SKIL;TOB2;QKI;CELF1;AGFG1;BRD2
11334,GO:0045658,0.102626777425658,0.996327980269786,1,3,regulation of neutrophil differentiation,BP,TRIB1
14956,GO:0070852,0.102640186443806,0.996326996927587,1,3,cell body fiber,CC,SACS
20034,GO:2000649,0.102698617723395,0.974585075878329,3,32,regulation of sodium ion transmembrane transporter activity,BP,NEDD4L;SLC9A1;YWHAH
15702,GO:0072243,0.102882909468666,0.983966987156861,2,15,metanephric nephron epithelium development,BP,LIF;SOX9
16318,GO:0090503,0.102886510780196,0.974397050204461,3,35,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,ZC3H12A;NOCT;ISG20
12623,GO:0050804,0.102917893267349,0.946982256301075,10,183,modulation of chemical synaptic transmission,BP,IL1B;PTGS2;EDN1;SQSTM1;ADRB2;PLK2;CREB1;STX1A;YWHAH;YWHAG
17023,GO:0099177,0.102917893267349,0.946982256301075,10,183,regulation of trans-synaptic signaling,BP,IL1B;PTGS2;EDN1;SQSTM1;ADRB2;PLK2;CREB1;STX1A;YWHAH;YWHAG
14255,GO:0061302,0.103004707711375,0.996300212037123,1,3,smooth muscle cell-matrix adhesion,BP,PLAU
14223,GO:0061156,0.103125139431966,0.996291340306942,1,3,pulmonary artery morphogenesis,BP,JAG1
3195,GO:0006825,0.103299475109777,0.983587276605292,2,18,copper ion transport,BP,HEPHL1;STEAP4
16866,GO:0098797,0.103380859311806,0.940249801038133,14,278,plasma membrane protein complex,CC,BMP2;BIRC2;GJB4;BCL10;IL6ST;ADAM8;ITGA5;TFRC;GJB3;ITGAV;STX1A;CORO1C;HLA-E;OSMR
17287,GO:0140052,0.103530924921517,0.996261365569124,1,3,cellular response to oxidised low-density lipoprotein particle stimulus,BP,TICAM1
7797,GO:0032345,0.103774942889658,0.996243279340439,1,3,negative regulation of aldosterone metabolic process,BP,BMP2
7800,GO:0032348,0.103774942889658,0.996243279340439,1,3,negative regulation of aldosterone biosynthetic process,BP,BMP2
19725,GO:2000065,0.103774942889658,0.996243279340439,1,3,negative regulation of cortisol biosynthetic process,BP,BMP2
6305,GO:0019932,0.103810864065267,0.94858701019784,9,163,second-messenger-mediated signaling,BP,CXCL8;CCL20;EDN1;ADRB2;SLC9A1;SOX9;NRG1;ADM;PDPK1
3949,GO:0008645,0.104002867638648,0.961745027962452,5,70,hexose transmembrane transport,BP,IL1B;TNF;PPARD;PTPN11;NFE2L2
9677,GO:0038042,0.104103351713004,0.995759174562994,1,4,dimeric G-protein coupled receptor signaling pathway,BP,ADM
16696,GO:0097646,0.104103351713004,0.995759174562994,1,4,calcitonin family receptor signaling pathway,BP,ADM
3132,GO:0006721,0.104788348531261,0.966694875995987,4,54,terpenoid metabolic process,BP,SDC4;HMGCS1;ALDH1A3;PPARD
2085,GO:0004843,0.104882983776594,0.961324130953278,5,70,thiol-dependent ubiquitin-specific protease activity,MF,TNFAIP3;ZC3H12A;CYLD;USP36;USP31
9004,GO:0035148,0.105113861889328,0.953341290849221,7,113,tube formation,BP,SDC4;BCL10;SOX9;SOX4;ADM;WNT5A;KDM6A
8615,GO:0034128,0.105283901151603,0.996130418958075,1,3,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,TICAM1
9764,GO:0039529,0.105329338708112,0.983359548588611,2,15,RIG-I signaling pathway,BP,BIRC3;BIRC2
5903,GO:0018107,0.105336631500177,0.956758966295207,6,92,peptidyl-threonine phosphorylation,BP,CAB39;OXSR1;RIPK2;PHKG2;WNT5A;PDPK1
19577,GO:1990597,0.105551130947619,0.996110248894784,1,3,AIP1-IRE1 complex,CC,ERN1
152,GO:0000307,0.105557526783013,0.97337148887506,3,37,cyclin-dependent protein kinase holoenzyme complex,CC,CDKN1A;CCNL1;CDK6
10255,GO:0042994,0.105608476199408,0.983003453030189,2,18,cytoplasmic sequestering of transcription factor,BP,NFKBIA;NFKBIE
7481,GO:0031644,0.105692975985825,0.973476388956633,3,33,regulation of neurological system process,BP,EDN1;SLC9A1;NRG1
6937,GO:0030544,0.105768078128211,0.97333080092137,3,36,Hsp70 protein binding,MF,SACS;CREB1;ERN1
11846,GO:0046824,0.105825347621358,0.966297806762963,4,52,positive regulation of nucleocytoplasmic transport,BP,IL1B;ZC3H12A;PTGS2;SFN
7401,GO:0031463,0.105931923030926,0.966277484429619,4,51,Cul3-RING ubiquitin ligase complex,CC,ENC1;KLHL21;TNFAIP1;BACH1
10235,GO:0042940,0.10597170884392,0.996078392723693,1,3,D-amino acid transport,BP,NFKBIE
10967,GO:0044729,0.105988541478542,0.996077114913194,1,3,hemi-methylated DNA-binding,MF,UHRF1
19580,GO:1990604,0.106035525293493,0.996073547087726,1,3,IRE1-TRAF2-ASK1 complex,CC,ERN1
13732,GO:0060297,0.106048945473003,0.996072527682061,1,3,regulation of sarcomere organization,BP,EDN1
1597,GO:0004013,0.106083316637226,0.996069916191405,1,3,adenosylhomocysteinase activity,MF,AHCY
5688,GO:0016802,0.106083316637226,0.996069916191405,1,3,trialkylsulfonium hydrolase activity,MF,AHCY
17397,GO:1900127,0.10620578280833,0.996060603901321,1,3,positive regulation of hyaluronan biosynthetic process,BP,NFKB1
4725,GO:0010886,0.106232330598109,0.996058583687405,1,3,positive regulation of cholesterol storage,BP,EHD1
95,GO:0000185,0.106330391548472,0.98299952886805,2,16,activation of MAPKKK activity,BP,TNF;GADD45A
879,GO:0002230,0.106423552100565,0.982880196541007,2,17,positive regulation of defense response to virus by host,BP,ZC3H12A;IL23A
12406,GO:0048852,0.106553831143532,0.99603407514447,1,3,diencephalon morphogenesis,BP,WNT5A
6456,GO:0021773,0.106598049929684,0.996030698020386,1,3,striatal medium spiny neuron differentiation,BP,INHBA
3044,GO:0006598,0.106694370598202,0.995251824188317,1,5,polyamine catabolic process,BP,SAT1
18360,GO:1903348,0.106701471917967,0.996022793464333,1,3,positive regulation of bicellular tight junction assembly,BP,CLDN1
2289,GO:0005246,0.106778194806751,0.982704670689085,2,18,calcium channel regulator activity,MF,STX1A;SGK1
19852,GO:2000318,0.10691973138077,0.995520914142465,1,4,positive regulation of T-helper 17 type immune response,BP,IL23A
3651,GO:0008131,0.107112851343702,0.99599126979791,1,3,primary amine oxidase activity,MF,MAOA
10209,GO:0042825,0.10735609505154,0.99597256864303,1,3,TAP complex,CC,TAP1
14135,GO:0060998,0.107464464544863,0.965644836820077,4,50,regulation of dendritic spine development,BP,EFNA1;PLK2;NRG1;PDLIM5
6836,GO:0030297,0.107708510267662,0.995945392887064,1,3,transmembrane receptor protein tyrosine kinase activator activity,MF,NRG1
18388,GO:1903400,0.107983625517778,0.995924111115346,1,3,L-arginine transmembrane transport,BP,SLC7A2
4960,GO:0015031,0.108011322647805,0.917147015178296,57,1501,protein transport,BP,NFKBIA;IL1B;IL1A;ZC3H12A;TNF;PTGS2;IL1RN;PANX1;HCAR2;CDKN1A;CD274;BCL3;DUSP16;UGCG;TRIM16;EHD1;PPP1R10;PIM3;ADAM8;VEGFC;PLK3;TFRC;PPARD;USP36;PLAGL2;RIPK2;SAA1;ITGAV;STX1A;NRG1;PML;POU2F2;FERMT1;PTPN11;RHOB;SOX4;OXCT1;PTPN1;ATP6V1C2;HLA-E;RAB3IP;PMM2;WNT5A;NUP153;INSIG1;ADAM9;ADAMTS9;YWHAH;AGFG1;YWHAG;RAB22A;SFN;IFIH1;IPO4;TAP1;STX12;RAB24
11893,GO:0046912,0.108021358847288,0.995921187650079,1,3,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,HMGCS1
16791,GO:0098631,0.108250716252723,0.972470987927416,3,35,cell adhesion mediator activity,MF,TACSTD2;CDC42EP1;PDLIM5
12114,GO:0048167,0.108369940276189,0.955164886171643,6,93,regulation of synaptic plasticity,BP,PTGS2;SQSTM1;PLK2;CREB1;YWHAH;YWHAG
1360,GO:0003229,0.108470035916463,0.972521694460024,3,32,ventricular cardiac muscle tissue development,BP,TBX3;NRG1;ADAMTS9
8704,GO:0034343,0.108545309344655,0.995880479513146,1,3,type III interferon production,BP,IFIH1
8705,GO:0034344,0.108545309344655,0.995880479513146,1,3,regulation of type III interferon production,BP,IFIH1
12838,GO:0051145,0.108737606029569,0.972334885575322,3,34,smooth muscle cell differentiation,BP,EREG;SOX9;ADM
14741,GO:0070412,0.108742939977571,0.982497309073374,2,15,R-SMAD binding,MF,JUN;SMAD3
19336,GO:1905651,0.109050278932428,0.995841044677474,1,3,regulation of artery morphogenesis,BP,EFNB2
19337,GO:1905653,0.109050278932428,0.995841044677474,1,3,positive regulation of artery morphogenesis,BP,EFNB2
12061,GO:0048010,0.109129998558354,0.959224284988732,5,73,vascular endothelial growth factor receptor signaling pathway,BP,IL1B;VEGFC;ITGA5;ITGAV;PTPN1
4896,GO:0014821,0.109161063936519,0.99532641754146,1,4,phasic smooth muscle contraction,BP,EDN1
593,GO:0001755,0.109371741692636,0.972147913559114,3,33,neural crest cell migration,BP,SEMA7A;EFNB1;CORO1C
8622,GO:0034140,0.109394242300776,0.995814070106166,1,3,negative regulation of toll-like receptor 3 signaling pathway,BP,TNFAIP3
16115,GO:0090101,0.109446253027038,0.959070575675241,5,73,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,SMAD3;ZNF451;SKIL;WNT5A;PDPK1
5187,GO:0015749,0.109461012357454,0.959097972907429,5,71,monosaccharide transmembrane transport,BP,IL1B;TNF;PPARD;PTPN11;NFE2L2
4110,GO:0009164,0.109481118403498,0.98185711047851,2,20,nucleoside catabolic process,BP,UPP1;AHCY
10867,GO:0044390,0.109559948411444,0.972079383116334,3,33,ubiquitin-like protein conjugating enzyme binding,MF,RNF19B;DCUN1D3;RNF19A
10695,GO:0043974,0.109584404216787,0.995799117654399,1,3,histone H3-K27 acetylation,BP,LIF
17741,GO:1901674,0.109584404216787,0.995799117654399,1,3,regulation of histone H3-K27 acetylation,BP,LIF
16097,GO:0090079,0.109717842874823,0.982033546942835,2,17,translation regulator activity, nucleic acid binding,MF,CPEB2;CELF1
7785,GO:0032309,0.109806088760898,0.982010648141818,2,17,icosanoid secretion,BP,IL1B;EDN1
4270,GO:0009620,0.109906258265256,0.981745450903164,2,20,response to fungus,BP,BCL10;COTL1
5317,GO:0016032,0.110098780349517,0.92459328390761,27,679,viral process,BP,NFKBIA;ZC3H12A;TNF;CXCL8;TNIP1;CLDN1;EFNB2;EPHA2;JUN;IL6ST;LDLR;NEDD4L;SMAD3;ITGA5;TFRC;CREB1;RAET1L;IL16;ZFP36;CD55;ITGAV;PML;NUP153;RELA;ISG20;IFIH1;TAP1
13920,GO:0060574,0.11016891822325,0.995237543844619,1,4,intestinal epithelial cell maturation,BP,CDKN1A
10740,GO:0044107,0.110205157645585,0.995234331838964,1,4,cellular alcohol metabolic process,BP,CYP27B1
10741,GO:0044108,0.110205157645585,0.995234331838964,1,4,cellular alcohol biosynthetic process,BP,CYP27B1
4680,GO:0010827,0.110229244274608,0.964418769172295,4,51,regulation of glucose transmembrane transport,BP,IL1B;TNF;PTPN11;NFE2L2
3694,GO:0008201,0.110264279155033,0.958623566265816,5,76,heparin binding,MF,HBEGF;WISP1;LIPG;SAA1;ADAMTS1
8061,GO:0032727,0.110312507700976,0.981980054055681,2,16,positive regulation of interferon-alpha production,BP,RIPK2;IFIH1
7234,GO:0031128,0.110409611000246,0.981853735391059,2,17,developmental induction,BP,BMP2;SOX9
3699,GO:0008207,0.110459597783383,0.981671306586563,2,19,C21-steroid hormone metabolic process,BP,BMP2;ADM
5759,GO:0016917,0.11077505950921,0.995704857652474,1,3,GABA receptor activity,MF,GPR156
6921,GO:0030512,0.110896194493568,0.964075022808554,4,53,negative regulation of transforming growth factor beta receptor signaling pathway,BP,SMAD3;ZNF451;SKIL;PDPK1
10281,GO:0043027,0.110931256338771,0.981717680961813,2,17,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,BIRC3;BIRC2
9131,GO:0035456,0.111000709018509,0.981456773177753,2,20,response to interferon-beta,BP,IRF1;IFNAR2
20217,GO:2001137,0.111131742794511,0.995676405709835,1,3,positive regulation of endocytic recycling,BP,EHD1
13254,GO:0051928,0.111142065932081,0.96391853270848,4,55,positive regulation of calcium ion transport,BP,TRPV3;BDKRB1;SLC9A1;PDPK1
12797,GO:0051088,0.111155736529525,0.995674488221565,1,3,PMA-inducible membrane protein ectodomain proteolysis,BP,ADAM9
6329,GO:0020016,0.111230265354815,0.995668529302898,1,3,ciliary pocket,CC,EHD1
6330,GO:0020018,0.111230265354815,0.995668529302898,1,3,ciliary pocket membrane,CC,EHD1
1387,GO:0003289,0.111263850886971,0.995665842573533,1,3,atrial septum primum morphogenesis,BP,SOX4
8618,GO:0034136,0.111412992131868,0.995653901168413,1,3,negative regulation of toll-like receptor 2 signaling pathway,BP,TNFAIP3
4656,GO:0010799,0.111465433578046,0.971382473369087,3,33,regulation of peptidyl-threonine phosphorylation,BP,CAB39;RIPK2;WNT5A
2516,GO:0005768,0.111478961630117,0.922548751068486,29,677,endosome,CC,TICAM1;TNF;PLEKHF1;IRAK2;SQSTM1;RAP2B;NMNAT2;ADRB2;EHD1;LDLR;NEDD4L;TFRC;LIPG;ANTXR2;AMOTL2;NDRG1;PML;RHOB;ABCA5;TNFAIP1;PTPN1;STEAP4;HLA-E;RNF11;RAB22A;ITM2B;MYO1B;STX12;RAB24
7733,GO:0032227,0.111515686581997,0.9956456685854,1,3,negative regulation of synaptic transmission, dopaminergic,BP,PTGS2
2114,GO:0004897,0.111535688859517,0.995644064131166,1,3,ciliary neurotrophic factor receptor activity,MF,IL6ST
14576,GO:0070120,0.111535688859517,0.995644064131166,1,3,ciliary neurotrophic factor-mediated signaling pathway,BP,IL6ST
16237,GO:0090288,0.111558382157464,0.953475155929541,6,94,negative regulation of cellular response to growth factor stimulus,BP,SMAD3;ZNF451;SKIL;PTPN1;WNT5A;PDPK1
15435,GO:0071711,0.111729574641048,0.981729006382762,2,15,basement membrane organization,BP,PHLDB2;FERMT1
15656,GO:0072174,0.111837499321324,0.995619817007979,1,3,metanephric tubule formation,BP,SOX9
244,GO:0000700,0.111871895846358,0.995085374119419,1,4,mismatch base pair DNA N-glycosylase activity,MF,TDG
12554,GO:0050703,0.112007366934014,0.994755067111566,1,5,interleukin-1 alpha secretion,BP,PANX1
9237,GO:0035630,0.112155544359183,0.995594188814075,1,3,bone mineralization involved in bone maturation,BP,BMP2
451,GO:0001224,0.112230904477123,0.995588104712278,1,3,RNA polymerase II transcription cofactor binding,MF,CREB1
19402,GO:1905907,0.112260802991404,0.995050270442996,1,4,negative regulation of amyloid fibril formation,BP,LDLR
8512,GO:0033692,0.112279178028321,0.963468650841061,4,53,cellular polysaccharide biosynthetic process,BP,HAS3;B3GNT5;PHKG2;B3GNT2
4708,GO:0010869,0.11285356518185,0.981212880119306,2,17,regulation of receptor biosynthetic process,BP,EDN1;ITGAV
18475,GO:1903573,0.112959556860071,0.970702742919216,3,36,negative regulation of response to endoplasmic reticulum stress,BP,PPP1R15A;PPP1R15B;PTPN1
4463,GO:0010455,0.113124315662662,0.994971858053948,1,4,positive regulation of cell fate commitment,BP,IL23A
20087,GO:2000737,0.113125617987321,0.981245923489448,2,16,negative regulation of stem cell differentiation,BP,JAG1;NFE2L2
9766,GO:0039531,0.113203124934384,0.981225534159103,2,16,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,BIRC3;BIRC2
6793,GO:0030229,0.113253888586799,0.995505077219366,1,3,very-low-density lipoprotein particle receptor activity,MF,LDLR
11151,GO:0045204,0.113597386860257,0.995477015004187,1,3,MAPK export from nucleus,BP,DUSP16
20184,GO:2001024,0.113623544149196,0.980915724882944,2,18,negative regulation of response to drug,BP,PTPN11;NFE2L2
13196,GO:0051799,0.113750006303781,0.995464517130627,1,3,negative regulation of hair follicle development,BP,FERMT1
4299,GO:0009743,0.113786740292277,0.94524567853204,8,146,response to carbohydrate,BP,IL1B;PTGS2;ZFP36L1;PIM3;PPARD;SOX4;OXCT1;ERN1
13202,GO:0051817,0.113882066246659,0.956832602418338,5,77,modification of morphology or physiology of other organism involved in symbiotic interaction,BP,ZC3H12A;TNIP1;JUN;SMAD3;ITGAV
9485,GO:0036120,0.113890988924002,0.981044200563496,2,16,cellular response to platelet-derived growth factor stimulus,BP,ERRFI1;CREB1
18088,GO:1902692,0.113910836847466,0.981038958127103,2,16,regulation of neuroblast proliferation,BP,KCTD11;VEGFC
7117,GO:0030916,0.113957253267323,0.995447516717181,1,3,otic vesicle formation,BP,SOX9
14019,GO:0060737,0.113957253267323,0.995447516717181,1,3,prostate gland morphogenetic growth,BP,SOX9
15361,GO:0071600,0.113957253267323,0.995447516717181,1,3,otic vesicle morphogenesis,BP,SOX9
18220,GO:1903011,0.114094385634161,0.995436249329314,1,3,negative regulation of bone development,BP,TJP2
20259,GO:2001205,0.114094385634161,0.995436249329314,1,3,negative regulation of osteoclast development,BP,TJP2
1187,GO:0002832,0.11423341644287,0.970228904393606,3,36,negative regulation of response to biotic stimulus,BP,TNFAIP3;PRDM1;TRIB1
20043,GO:2000660,0.114252834766696,0.994868403966862,1,4,negative regulation of interleukin-1-mediated signaling pathway,BP,IL1RN
12282,GO:0048596,0.114405885614673,0.981029577256485,2,15,embryonic camera-type eye morphogenesis,BP,ALDH1A3;WNT5A
9196,GO:0035580,0.114531576454865,0.970006851155274,3,39,specific granule lumen,CC,CXCL1;NFKB1;VCL
6317,GO:0019960,0.114676215810578,0.995388280090427,1,3,C-X3-C chemokine binding,MF,ITGAV
20091,GO:2000741,0.114687350111046,0.995387359535871,1,3,positive regulation of mesenchymal stem cell differentiation,BP,SOX9
704,GO:0001922,0.114703162544455,0.995386052038928,1,3,B-1 B cell homeostasis,BP,TNFAIP3
1854,GO:0004515,0.114715534876529,0.995385028860309,1,3,nicotinate-nucleotide adenylyltransferase activity,MF,NMNAT2
11316,GO:0045636,0.114888389180867,0.995370721465953,1,3,positive regulation of melanocyte differentiation,BP,ADAMTS9
6505,GO:0021872,0.115244693631463,0.969892619118731,3,35,forebrain generation of neurons,BP,INHBA;DLX2;WNT5A
10485,GO:0043380,0.115290798070143,0.994772272210669,1,4,regulation of memory T cell differentiation,BP,IL23A
14198,GO:0061101,0.115359958106398,0.994765833526986,1,4,neuroendocrine cell differentiation,BP,BMP2
2431,GO:0005610,0.115450210462743,0.99532405715347,1,3,laminin-5 complex,CC,LAMB3
7975,GO:0032587,0.115783705538712,0.95597761736007,5,72,ruffle membrane,CC,EPHA2;ITGA5;ITGAV;PIP5K1A;FERMT1
12072,GO:0048021,0.115836493414802,0.995291829434664,1,3,regulation of melanin biosynthetic process,BP,WNT5A
15541,GO:0071947,0.115906523993022,0.995285974236967,1,3,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,TNFAIP3
10245,GO:0042979,0.116017686252281,0.994704391572014,1,4,ornithine decarboxylase regulator activity,MF,AZIN1
17938,GO:1902267,0.116017686252281,0.994704391572014,1,4,regulation of polyamine transmembrane transport,BP,AZIN1
1178,GO:0002823,0.116092659296937,0.980253635202684,2,18,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,RC3H1;IL7R
16222,GO:0090269,0.116127457743915,0.99526747695243,1,3,fibroblast growth factor production,BP,PTGS2
16223,GO:0090270,0.116127457743915,0.99526747695243,1,3,regulation of fibroblast growth factor production,BP,PTGS2
16834,GO:0098735,0.116218166949239,0.995259871402199,1,3,positive regulation of the force of heart contraction,BP,SLC9A1
20068,GO:2000698,0.116223795346447,0.994685060098421,1,4,positive regulation of epithelial cell differentiation involved in kidney development,BP,LIF
4753,GO:0010923,0.116250305597865,0.955710336740658,5,74,negative regulation of phosphatase activity,BP,TNF;PLEKHF1;PPP1R15A;PPP1R10;SH3RF2
10475,GO:0043368,0.116252232553596,0.980307243345953,2,17,positive T cell selection,BP,CYLD;IL23A
15484,GO:0071839,0.116351979530969,0.994673018681321,1,4,apoptotic process in bone marrow,BP,PLK2
14095,GO:0060920,0.116369646879941,0.995247156118233,1,3,cardiac pacemaker cell differentiation,BP,TBX3
14099,GO:0060926,0.116369646879941,0.995247156118233,1,3,cardiac pacemaker cell development,BP,TBX3
3265,GO:0006937,0.116398984415028,0.955570154639464,5,78,regulation of muscle contraction,BP,ZC3H12A;PTGS2;EDN1;ADRB2;SLC9A1
6594,GO:0022605,0.116468504791441,0.994662060031555,1,4,mammalian oogenesis stage,BP,EREG
15715,GO:0072273,0.116470847855399,0.980248416830805,2,17,metanephric nephron morphogenesis,BP,LIF;SOX9
1428,GO:0003383,0.11649210257937,0.99523686398164,1,3,apical constriction,BP,FRMD6
1422,GO:0003365,0.116516387034866,0.995234821527723,1,3,establishment of cell polarity involved in ameboidal cell migration,BP,AMOTL2
8307,GO:0033141,0.116603054969348,0.994649391467117,1,4,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,LIF
9355,GO:0035867,0.116635951995747,0.995224758720233,1,3,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,ITGAV
6620,GO:0022840,0.117005127736668,0.994611440052455,1,4,leak channel activity,MF,PANX1
6622,GO:0022842,0.117005127736668,0.994611440052455,1,4,narrow pore channel activity,MF,PANX1
8407,GO:0033365,0.11716030966187,0.918127407103366,29,731,protein localization to organelle,BP,NFKBIA;TNFAIP3;ZC3H12A;TNF;PTGS2;PMAIP1;LIF;CDKN1A;BCL3;UGCG;PPP1R15A;EHD1;PPP1R10;BBC3;KLHL21;USP36;PLAGL2;TP53BP2;SOX9;NRG1;PML;SOX4;PMM2;NUP153;INSIG1;YWHAH;YWHAG;SFN;IPO4
15835,GO:0072540,0.117354508782298,0.994578347413564,1,4,T-helper 17 cell lineage commitment,BP,IL23A
18441,GO:1903523,0.117395660496466,0.979998798660852,2,17,negative regulation of blood circulation,BP,ZC3H12A;ADM
17559,GO:1901136,0.117456137881974,0.946297124844491,7,129,carbohydrate derivative catabolic process,BP,SDC4;AMPD3;SLC9A1;ADAMTS9;TDG;UPP1;AHCY
4892,GO:0014812,0.117502418609315,0.961125933987861,4,54,muscle cell migration,BP,PLAU;TRIB1;PPARD;NFE2L2
3266,GO:0006939,0.117588387683592,0.961087450394669,4,54,smooth muscle contraction,BP,PTGS2;EDN1;ADRB2;SMTN
11347,GO:0045671,0.117662622744491,0.980037795284247,2,16,negative regulation of osteoclast differentiation,BP,TJP2;TOB2
905,GO:0002285,0.117719144374915,0.950130651317774,6,99,lymphocyte activation involved in immune response,BP,RELB;BCL3;RC3H1;IL23A;TFRC;RIPK2
4234,GO:0009411,0.11776171060529,0.946174020122625,7,123,response to UV,BP,PTGS2;CDKN1A;BCL3;N4BP1;DCUN1D3;PML;RELA
19941,GO:2000463,0.118135377017377,0.979798252635066,2,17,positive regulation of excitatory postsynaptic potential,BP,ADRB2;STX1A
17344,GO:1900028,0.11815421214882,0.994502199206695,1,4,negative regulation of ruffle assembly,BP,TACSTD2
5446,GO:0016311,0.118230529026582,0.926379867391026,17,360,dephosphorylation,BP,TNF;PLEKHF1;DAPP1;BMP2;DUSP16;PPP1R15A;ANKLE2;DUSP8;DUSP1;PPP1R10;SMAD3;DUSP10;PPP1R15B;PPTC7;PTPN11;PTPN1;SH3RF2
3816,GO:0008406,0.118261010932945,0.942614355742775,8,144,gonad development,BP,INHBA;BCL2L2;CEBPB;HMGCS1;EREG;SOX9;ADAMTS1;WNT5A
11206,GO:0045338,0.118298530817147,0.994488397466925,1,4,farnesyl diphosphate metabolic process,BP,HMGCS1
17826,GO:1901983,0.118313984041785,0.960687431392553,4,57,regulation of protein acetylation,BP,IL1B;LIF;ZNF451;SOX4
14534,GO:0070044,0.118467645306634,0.994472201195157,1,4,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,STX1A
16778,GO:0098590,0.118938697611498,0.917352731601438,28,624,plasma membrane region,CC,PLAUR;PTGS2;FOSL1;TGFA;CLDN1;EPHA2;CLDN4;ADRB2;EHD1;B4GALT1;SLC6A14;LDLR;TACSTD2;ITGA5;TFRC;SLC9A1;JAG1;AMOTL2;ITGAV;PIP5K1A;STX1A;NRG1;FERMT1;RHOB;CORO1C;OSMR;ADAM9;PDLIM5
13903,GO:0060544,0.119001873736277,0.979372953300721,2,19,regulation of necroptotic process,BP,BIRC3;BIRC2
3507,GO:0007417,0.11901324671601,0.918437540275553,26,587,central nervous system development,BP,BTG2;INHBA;ETS1;TBX3;KDM6B;SEMA7A;LIF;BMP2;HMGCS1;ALDH1A3;ANKLE2;IL6ST;B3GNT5;DLX2;LDLR;DUSP10;CREB1;SOX9;NRG1;PTPN11;SOX4;OXCT1;CDK6;PRPF19;WNT5A;YWHAH
20294,GO:2001268,0.119016222220141,0.994059971008805,1,5,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,PLAUR
8279,GO:0033083,0.119049127688991,0.994416320791212,1,4,regulation of immature T cell proliferation,BP,RIPK2
1161,GO:0002768,0.119229185969105,0.932668561098524,12,252,immune response-regulating cell surface receptor signaling pathway,BP,NFKBIA;ZC3H12A;NFKB1;RELB;JUN;RUNX1;BCL10;CYLD;RC3H1;RIPK2;PDPK1;RELA
14882,GO:0070671,0.119247729235112,0.968154897413315,3,41,response to interleukin-12,BP,SERPINB2;SOD2;RIPK2
3264,GO:0006936,0.119264181583017,0.939184821583996,9,168,muscle contraction,BP,ZC3H12A;PTGS2;EDN1;MAP2K3;ADRB2;NEDD4L;SLC9A1;VCL;SMTN
756,GO:0001993,0.119308879704601,0.99439126286277,1,4,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,ADRB2
17309,GO:0140112,0.119357318830643,0.979275018259521,2,19,extracellular vesicle biogenesis,BP,SDC4;SMPD3
8660,GO:0034219,0.119708690868701,0.954003500933108,5,73,carbohydrate transmembrane transport,BP,IL1B;TNF;PPARD;PTPN11;NFE2L2
7836,GO:0032388,0.11986288501286,0.936340000424939,10,195,positive regulation of intracellular transport,BP,IL1B;ZC3H12A;PTGS2;UGCG;EHD1;PLK3;USP36;PLAGL2;NRG1;SFN
10001,GO:0042417,0.119895972359462,0.979216496302959,2,18,dopamine metabolic process,BP,GCH1;MAOA
283,GO:0000785,0.119937443334763,0.923013135741714,19,458,chromatin,CC,KDM6B;JUN;JUNB;IRF1;ENC1;CEBPB;PPP1R10;SMAD3;PLK2;CREB1;PPARD;PML;UHRF1;MXD1;KDM6A;NFE2L2;RELA;POLR3D;IPO4
7666,GO:0032094,0.120110400372372,0.979157401584185,2,18,response to food,BP,BCL10;SLC25A25
9392,GO:0035930,0.120267593476474,0.994298264539076,1,4,corticosteroid hormone secretion,BP,PTPN11
20151,GO:2000846,0.120267593476474,0.994298264539076,1,4,regulation of corticosteroid hormone secretion,BP,PTPN11
1327,GO:0003176,0.120283394285718,0.994296725050304,1,4,aortic valve development,BP,EFNA1
1330,GO:0003180,0.120283394285718,0.994296725050304,1,4,aortic valve morphogenesis,BP,EFNA1
10872,GO:0044403,0.120285375715738,0.916235227479604,28,714,symbiont process,BP,NFKBIA;ZC3H12A;TNF;CXCL8;TNIP1;CLDN1;EFNB2;EPHA2;SQSTM1;JUN;IL6ST;LDLR;NEDD4L;SMAD3;ITGA5;TFRC;CREB1;RAET1L;IL16;ZFP36;CD55;ITGAV;PML;NUP153;RELA;ISG20;IFIH1;TAP1
13054,GO:0051541,0.120377703099963,0.994287531886705,1,4,elastin metabolic process,BP,HBEGF
12392,GO:0048818,0.12065084856292,0.994260861750036,1,4,positive regulation of hair follicle maturation,BP,WNT5A
18591,GO:1903845,0.12072779537868,0.959648139541594,4,55,negative regulation of cellular response to transforming growth factor beta stimulus,BP,SMAD3;ZNF451;SKIL;PDPK1
2126,GO:0004920,0.120826800435196,0.994243646951144,1,4,interleukin-10 receptor activity,MF,IFNGR2
1551,GO:0003945,0.121000207881243,0.994226654467281,1,4,N-acetyllactosamine synthase activity,MF,B4GALT1
3766,GO:0008310,0.12102530152136,0.994224193310085,1,4,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,ISG20
977,GO:0002429,0.121026381027489,0.933388258660334,11,229,immune response-activating cell surface receptor signaling pathway,BP,NFKBIA;ZC3H12A;NFKB1;RELB;RUNX1;BCL10;CYLD;RC3H1;RIPK2;PDPK1;RELA
7273,GO:0031252,0.121145507441338,0.926789250541997,15,301,cell leading edge,CC,EPHA2;PHLDB2;NEDD9;FGD6;ITGA5;RAPH1;SLC9A1;ITGAV;PIP5K1A;NRG1;FERMT1;CDK6;CORO1C;RAB3IP;RAB22A
268,GO:0000738,0.121184040525913,0.994208611529188,1,4,DNA catabolic process, exonucleolytic,BP,ISG20
448,GO:0001221,0.121233663852323,0.967625569833237,3,35,transcription cofactor binding,MF,CREB1;MAFK;NFE2L2
11502,GO:0045987,0.121544683226218,0.978760423998686,2,18,positive regulation of smooth muscle contraction,BP,PTGS2;EDN1
7749,GO:0032262,0.121645014452699,0.993787514329683,1,5,pyrimidine nucleotide salvage,BP,UPP1
740,GO:0001968,0.121762446481764,0.978803532458738,2,17,fibronectin binding,MF,SDC4;ITGAV
8748,GO:0034399,0.121961096336361,0.943813344623604,7,119,nuclear periphery,CC,ENC1;CEBPB;PML;UHRF1;NUP153;ATXN7;IPO4
577,GO:0001726,0.122133593093216,0.940351722227638,8,138,ruffle,CC,EPHA2;FGD6;ITGA5;ITGAV;PIP5K1A;FERMT1;CDK6;RAB22A
7751,GO:0032264,0.122304671080028,0.994097979963572,1,4,IMP salvage,BP,AMPD3
9698,GO:0038095,0.122397751934576,0.947488480652991,6,109,Fc-epsilon receptor signaling pathway,BP,NFKBIA;NFKB1;JUN;BCL10;PDPK1;RELA
10003,GO:0042420,0.12251595074865,0.994076997993523,1,4,dopamine catabolic process,BP,MAOA
1292,GO:0003100,0.122673870469449,0.994061289458921,1,4,regulation of systemic arterial blood pressure by endothelin,BP,EDN1
7820,GO:0032372,0.122794743032305,0.99404925121615,1,4,negative regulation of sterol transport,BP,NFKB1
7823,GO:0032375,0.122794743032305,0.99404925121615,1,4,negative regulation of cholesterol transport,BP,NFKB1
748,GO:0001976,0.123077710537966,0.994021018837378,1,4,neurological system process involved in regulation of systemic arterial blood pressure,BP,SOD2
11272,GO:0045578,0.123156032007168,0.994013192031881,1,4,negative regulation of B cell differentiation,BP,INHBA
15492,GO:0071865,0.123181156809589,0.994010680118998,1,4,regulation of apoptotic process in bone marrow,BP,PLK2
15493,GO:0071866,0.123181156809589,0.994010680118998,1,4,negative regulation of apoptotic process in bone marrow,BP,PLK2
937,GO:0002335,0.123256107861728,0.978188830378706,2,19,mature B cell differentiation,BP,BCL3;POU2F2
1908,GO:0004594,0.123316927684244,0.99399709646332,1,4,pantothenate kinase activity,MF,PANK3
10590,GO:0043555,0.123456102466118,0.978226797841433,2,18,regulation of translation in response to stress,BP,PPP1R15A;PPP1R15B
11204,GO:0045335,0.12350591410739,0.946926322773158,6,105,phagocytic vesicle,CC,ADAM8;ITGAV;HLA-E;RAB22A;TAP1;STX12
17253,GO:0120035,0.123586869315248,0.919489553968402,20,429,regulation of plasma membrane bounded cell projection organization,BP,EFNA1;SEMA7A;EFNB2;EPHA2;ENC1;ZSWIM4;CYLD;TACSTD2;NEDD4L;PLK2;NAV3;NRG1;CDC42EP1;SKIL;CORO1C;ABL2;WNT5A;NFE2L2;YWHAH;PDLIM5
1289,GO:0003096,0.123701869164219,0.993958495269453,1,4,renal sodium ion transport,BP,SGK1
1264,GO:0003016,0.123807216450541,0.97823445828245,2,17,respiratory system process,BP,STK40;KDM6A
1715,GO:0004305,0.123869628371832,0.99394163178156,1,4,ethanolamine kinase activity,MF,ETNK1
1993,GO:0004712,0.123942039405131,0.966536902428996,3,36,protein serine/threonine/tyrosine kinase activity,MF,MAP2K3;CLK4;SGK1
19541,GO:1990441,0.124026306731486,0.993925859723403,1,4,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,JUN
1120,GO:0002707,0.124410219159775,0.977777595032631,2,20,negative regulation of lymphocyte mediated immunity,BP,IL7R;HLA-E
16634,GO:0097494,0.124456642270435,0.993882428359285,1,4,regulation of vesicle size,BP,RAB22A
139,GO:0000289,0.124594461389587,0.966329860356834,3,35,nuclear-transcribed mRNA poly(A) tail shortening,BP,BTG2;ZFP36;SAMD4A
11449,GO:0045900,0.124701569225184,0.993857636184959,1,4,negative regulation of translational elongation,BP,CPEB2
4303,GO:0009750,0.12472261459114,0.993855503442018,1,4,response to fructose,BP,PTGS2
16162,GO:0090183,0.125026264499424,0.966115844122211,3,36,regulation of kidney development,BP,LIF;TACSTD2;SOX9
14174,GO:0061053,0.125206908118157,0.957692686522911,4,52,somite development,BP,SMAD3;NRARP;WNT5A;KDM6A
15449,GO:0071772,0.12526857906175,0.946072629775106,6,96,response to BMP,BP,BMP2;RGMB;SOX9;FAM83G;SKIL;WNT5A
15450,GO:0071773,0.12526857906175,0.946072629775106,6,96,cellular response to BMP stimulus,BP,BMP2;RGMB;SOX9;FAM83G;SKIL;WNT5A
11599,GO:0046189,0.125303663167569,0.977706032929256,2,18,phenol-containing compound biosynthetic process,BP,GCH1;WNT5A
10332,GO:0043125,0.125446274075483,0.993781929333531,1,4,ErbB-3 class receptor binding,MF,NRG1
9484,GO:0036119,0.125569144225245,0.977739323786039,2,17,response to platelet-derived growth factor,BP,ERRFI1;CREB1
15461,GO:0071800,0.125922033056917,0.977530647691812,2,18,podosome assembly,BP,CSF2;TNF
12424,GO:0048873,0.126019200974774,0.977405824324868,2,19,homeostasis of number of cells within a tissue,BP,SOX9;PTPN11
14036,GO:0060762,0.126078278169477,0.993717294731268,1,4,regulation of branching involved in mammary gland duct morphogenesis,BP,WNT5A
15317,GO:0071535,0.126158023595965,0.99370911409605,1,4,RING-like zinc finger domain binding,MF,MAFK
9066,GO:0035304,0.126282245239833,0.945452231409322,6,101,regulation of protein dephosphorylation,BP,TNF;PPP1R15A;ANKLE2;PPP1R10;PPP1R15B;SH3RF2
11932,GO:0046977,0.126324137197626,0.993692055346679,1,4,TAP binding,MF,TAP1
11933,GO:0046978,0.126324137197626,0.993692055346679,1,4,TAP1 binding,MF,TAP1
3567,GO:0007612,0.126416845889123,0.950571652597247,5,75,learning,BP,BTG2;PTGS2;FOSL1;JUN;CREB1
12624,GO:0050805,0.126445718377804,0.965561973788482,3,36,negative regulation of synaptic transmission,BP,IL1B;PTGS2;PLK2
3121,GO:0006701,0.126724264981315,0.993650864536257,1,4,progesterone biosynthetic process,BP,ADM
679,GO:0001887,0.1268385048535,0.993639078168885,1,4,selenium compound metabolic process,BP,TXNRD1
12315,GO:0048666,0.127027927694841,0.909478263587906,31,705,neuron development,BP,BTG2;SDC4;PRDM1;EFNA1;SEMA7A;KLF7;EFNB2;LIF;JUN;ENC1;RUNX1;EHD1;ZSWIM4;NEDD4L;PLK2;CREB1;EFNB1;RAPH1;NRG1;PTPN11;VCL;AREG;SKIL;ADM;ABL2;WNT5A;NFE2L2;YWHAH;SGK1;B3GNT2;PDLIM5
15681,GO:0072207,0.127313500078265,0.97724478500547,2,17,metanephric epithelium development,BP,LIF;SOX9
8253,GO:0033031,0.127346173497629,0.993586560937647,1,4,positive regulation of neutrophil apoptotic process,BP,HCAR2
3551,GO:0007588,0.127663923625049,0.976845688230263,2,20,excretion,BP,EDN1;NEDD4L
2482,GO:0005719,0.127700101199768,0.976755066029096,2,21,nuclear euchromatin,CC,JUN;CREB1
14900,GO:0070723,0.127709099344951,0.977132029764031,2,17,response to cholesterol,BP,INHBA;HMGCS1
1175,GO:0002820,0.127797759712351,0.976896044305458,2,19,negative regulation of adaptive immune response,BP,RC3H1;IL7R
4898,GO:0014824,0.127812250068667,0.993538144979699,1,4,artery smooth muscle contraction,BP,EDN1
19875,GO:2000347,0.12808661321641,0.993509554003595,1,4,positive regulation of hepatocyte proliferation,BP,TNFAIP3
20240,GO:2001179,0.128092942565787,0.993091889608462,1,5,regulation of interleukin-10 secretion,BP,CD274
6455,GO:0021772,0.128100130732701,0.977020358887683,2,17,olfactory bulb development,BP,DLX2;WNT5A
1024,GO:0002523,0.128113454503951,0.9930896144701,1,5,leukocyte migration involved in inflammatory response,BP,ADAM8
1348,GO:0003209,0.128144939314392,0.97700754862933,2,17,cardiac atrium morphogenesis,BP,SOX4;WNT5A
15423,GO:0071695,0.128212344158699,0.944428017003806,6,98,anatomical structure maturation,BP,BMP2;CDKN1A;EREG;FERMT1;FEM1B;WNT5A
2086,GO:0004844,0.128261410421082,0.993073191802138,1,5,uracil DNA N-glycosylase activity,MF,TDG
16644,GO:0097506,0.128261410421082,0.993073191802138,1,5,deaminated base DNA N-glycosylase activity,MF,TDG
6234,GO:0019783,0.128321618218939,0.944381179278736,6,97,ubiquitin-like protein-specific protease activity,MF,TNFAIP3;ZC3H12A;CYLD;USP36;USP31;ATXN7
3298,GO:0006997,0.128322796905064,0.94008794282703,7,124,nucleus organization,BP,ETS1;ANKLE2;USP36;PML;NUP153;AGFG1;ATXN7
17846,GO:1902023,0.128487956227542,0.993467610198542,1,4,L-arginine transport,BP,SLC7A2
11114,GO:0045137,0.128490959798964,0.936447505068798,8,147,development of primary sexual characteristics,BP,INHBA;BCL2L2;CEBPB;HMGCS1;EREG;SOX9;ADAMTS1;WNT5A
10288,GO:0043034,0.128596237769314,0.976878369362235,2,17,costamere,CC,SDC4;VCL
15261,GO:0071438,0.12893517323153,0.993420703528522,1,4,invadopodium membrane,CC,PLAUR
11342,GO:0045666,0.12894946830457,0.926237743373784,12,233,positive regulation of neuron differentiation,BP,SEMA7A;KCTD11;BMP2;ENC1;DLX2;NEDD4L;NRG1;SPAG9;SKIL;ABL2;WNT5A;NFE2L2
6817,GO:0030274,0.128952599411196,0.993418872171808,1,4,LIM domain binding,MF,RIPK2
4857,GO:0014068,0.128997528999372,0.964558804242637,3,36,positive regulation of phosphatidylinositol 3-kinase signaling,BP,PPARD;SOX9;NRG1
10164,GO:0042749,0.12939255228871,0.992946957232418,1,5,regulation of circadian sleep/wake cycle,BP,CSF2
11141,GO:0045187,0.12939255228871,0.992946957232418,1,5,regulation of circadian sleep/wake cycle, sleep,BP,CSF2
9921,GO:0042268,0.129406923362474,0.992662651179267,1,6,regulation of cytolysis,BP,CSF2
13095,GO:0051602,0.129407567366979,0.97653189430885,2,18,response to electrical stimulus,BP,BTG2;SLC9A1
7029,GO:0030801,0.129491285080603,0.976315670771058,2,20,positive regulation of cyclic nucleotide metabolic process,BP,ADM;WNT5A
13757,GO:0060330,0.129517231171569,0.976308110966196,2,20,regulation of response to interferon-gamma,BP,IFNGR2;SOCS3
13761,GO:0060334,0.129517231171569,0.976308110966196,2,20,regulation of interferon-gamma-mediated signaling pathway,BP,IFNGR2;SOCS3
1127,GO:0002714,0.12958106708235,0.976380381071181,2,19,positive regulation of B cell mediated immunity,BP,TNF;TFRC
1223,GO:0002891,0.12958106708235,0.976380381071181,2,19,positive regulation of immunoglobulin mediated immune response,BP,TNF;TFRC
10511,GO:0043415,0.129633928726732,0.993347057965187,1,4,positive regulation of skeletal muscle tissue regeneration,BP,PPARD
10512,GO:0043416,0.129633928726732,0.993347057965187,1,4,regulation of skeletal muscle tissue regeneration,BP,PPARD
9241,GO:0035635,0.129785398619331,0.976422594603101,2,18,entry of bacterium into host cell,BP,CXCL8;ITGAV
655,GO:0001843,0.129863172992058,0.948802796448987,5,75,neural tube closure,BP,SDC4;BCL10;ADM;WNT5A;KDM6A
13944,GO:0060606,0.129863172992058,0.948802796448987,5,75,tube closure,BP,SDC4;BCL10;ADM;WNT5A;KDM6A
14487,GO:0061900,0.130017917168062,0.976469549280585,2,17,glial cell activation,BP,JUN;LDLR
7352,GO:0031392,0.130083202941778,0.993299477015744,1,4,regulation of prostaglandin biosynthetic process,BP,PTGS2
20302,GO:2001279,0.130083202941778,0.993299477015744,1,4,regulation of unsaturated fatty acid biosynthetic process,BP,PTGS2
13640,GO:0060136,0.130146354487285,0.993292774461736,1,4,embryonic process involved in female pregnancy,BP,JUNB
17638,GO:1901361,0.130242020152756,0.912659544915961,22,569,organic cyclic compound catabolic process,BP,ZC3H12A;BTG2;NOCT;AMPD3;ZFP36L1;HAL;RC3H1;ZFP36;CYP27B1;PNRC1;SAMD4A;QKI;NUP153;MAOA;NFE2L2;YWHAH;TDG;ERN1;UPP1;ISG20;PABPC4;AHCY
9471,GO:0036091,0.130310124166557,0.993275376304071,1,4,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,NFE2L2
8614,GO:0034127,0.130324446204218,0.993273853658581,1,4,regulation of MyD88-independent toll-like receptor signaling pathway,BP,TICAM1
11203,GO:0045334,0.130487382020999,0.963922462379283,3,37,clathrin-coated endocytic vesicle,CC,HBEGF;LDLR;WNT5A
8742,GO:0034392,0.130505072507897,0.993254634707512,1,4,negative regulation of smooth muscle cell apoptotic process,BP,EDN1
15212,GO:0071362,0.130538632373244,0.993251060676597,1,4,cellular response to ether,BP,ZC3H12A
776,GO:0002028,0.130596542000815,0.955082974086646,4,56,regulation of sodium ion transport,BP,ADRB2;NEDD4L;SLC9A1;YWHAH
2642,GO:0005977,0.131019585000524,0.954913418925582,4,55,glycogen metabolic process,BP,PHLDA2;IL6ST;STK40;PHKG2
18025,GO:1902525,0.131116603183023,0.992752233732069,1,5,regulation of protein monoubiquitination,BP,BIRC2
18804,GO:1904352,0.131286282637346,0.99317117763461,1,4,positive regulation of protein catabolic process in the vacuole,BP,LDLR
7881,GO:0032446,0.131345277835697,0.905528725560767,32,786,protein modification by small protein conjugation,BP,TNFAIP3;BIRC3;TICAM1;RNF19B;KCTD11;BIRC2;ENC1;ADRB2;N4BP1;PELI1;BCL10;DCUN1D3;NEDD4L;RC3H1;KLHL21;SOCS3;RIPK2;ZNF451;FEM1C;UHRF1;FEM1B;SOX4;TNFAIP1;PRPF19;NUP153;RNF19A;NFE2L2;RELA;RNF11;BACH1;SH3RF2;IFIH1
658,GO:0001846,0.131478408965029,0.992711013134823,1,5,opsonin binding,MF,ITGAV
13476,GO:0055008,0.13163353529923,0.963562082740867,3,35,cardiac muscle tissue morphogenesis,BP,BMP2;NRG1;WNT5A
13489,GO:0055023,0.131661330091206,0.975876933278068,2,18,positive regulation of cardiac muscle tissue growth,BP,EDN1;PIM1
17645,GO:1901379,0.131665610605283,0.963499742052851,3,36,regulation of potassium ion transmembrane transport,BP,CAB39;NEDD4L;OXSR1
3944,GO:0008631,0.131726064232934,0.963342627156013,3,39,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,SOD2;PML;NFE2L2
10208,GO:0042824,0.131855550671647,0.993110019475101,1,4,MHC class I peptide loading complex,CC,TAP1
18626,GO:1903912,0.131967329865376,0.993097976718171,1,4,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,PPP1R15B
10517,GO:0043426,0.132007665532934,0.993093628333561,1,4,MRF binding,MF,BHLHE40
12346,GO:0048709,0.132127287517585,0.954286966743959,4,59,oligodendrocyte differentiation,BP,DLX2;DUSP10;SOX9;NRG1
18462,GO:1903553,0.132149970799065,0.993078275512756,1,4,positive regulation of extracellular exosome assembly,BP,SDC4
1383,GO:0003279,0.132150432898793,0.947639826404493,5,74,cardiac septum development,BP,PRDM1;TBX3;JAG1;SOX4;WNT5A
18582,GO:1903826,0.132252071191269,0.993067249108958,1,4,arginine transmembrane transport,BP,SLC7A2
14780,GO:0070487,0.132414991262207,0.993049635149639,1,4,monocyte aggregation,BP,IL1B
2646,GO:0005981,0.132748813150227,0.993013470180689,1,4,regulation of glycogen catabolic process,BP,PHKG2
6644,GO:0023029,0.132812993462807,0.993006505715145,1,4,MHC class Ib protein binding,MF,TAP1
3614,GO:0008063,0.132987619907014,0.992987537644824,1,4,Toll signaling pathway,BP,PELI1
12207,GO:0048386,0.132997151639493,0.992986501515042,1,4,positive regulation of retinoic acid receptor signaling pathway,BP,TRIM16
18663,GO:1903978,0.133065777995468,0.99297903921176,1,4,regulation of microglial cell activation,BP,LDLR
16342,GO:0090596,0.133220605588216,0.933603841080471,8,142,sensory organ morphogenesis,BP,PRDM1;EDN1;EPHA2;ALDH1A3;JAG1;SOX9;WNT5A;INSIG1
19703,GO:2000020,0.133574277565862,0.992923614607789,1,4,positive regulation of male gonad development,BP,SOX9
9296,GO:0035739,0.133603631505724,0.99292040806934,1,4,CD4-positive, alpha-beta T cell proliferation,BP,CD55
19980,GO:2000561,0.133603631505724,0.99292040806934,1,4,regulation of CD4-positive, alpha-beta T cell proliferation,BP,CD55
7429,GO:0031529,0.133701646783365,0.962591737222477,3,38,ruffle organization,BP,TACSTD2;PIP5K1A;CORO1C
15209,GO:0071359,0.133757236846155,0.95354496412928,4,58,cellular response to dsRNA,BP,ZC3H12A;NFKB1;SMAD3;IFIH1
10793,GO:0044265,0.133775052553416,0.901363569659426,37,959,cellular macromolecule catabolic process,BP,TNFAIP3;ZC3H12A;BTG2;RNF19B;PMAIP1;NOCT;EFNA1;TRIB1;SQSTM1;BIRC2;ZFP36L1;ENC1;N4BP1;CYLD;LDLR;NEDD4L;RC3H1;PLK2;PLK3;USP36;ZFP36;PNRC1;PML;UHRF1;USP31;TNFAIP1;SAMD4A;PRPF19;QKI;ADAMTS9;RNF19A;CTSC;NFE2L2;RNF11;ERN1;ISG20;PABPC4
7643,GO:0032052,0.133798892334792,0.992443695278867,1,5,bile acid binding,MF,STARD5
6063,GO:0019209,0.134328187706598,0.953275228516621,4,58,kinase activator activity,MF,CAB39;CDKN1A;BCL10;NRG1
8927,GO:0034774,0.134356050448591,0.926886254607292,10,221,secretory granule lumen,CC,CXCL1;NFKB1;CAB39;AMPD3;VEGFC;SERPINB1;VCL;COTL1;CTSC;CREG1
10914,GO:0044464,0.134394650605784,0.904557551450533,371,11076,cell part,CC,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;BTG2;BIRC3;HBEGF;PLAU;NFKBID;CSF2;ITPKC;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;CXCL8;REL;SERPINB2;PPIF;IER3;KLF6;NUAK2;CCL20;SPRR2D;ZNF697;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;TRPV3;NOCT;PLEKHF1;EFNA1;TGFA;KDM6B;IRF6;LGALSL;EDN1;ODC1;SEMA7A;PHLDA1;HAS3;ERRFI1;IL1RN;IRAK2;CLDN1;KLF7;PANX1;CREB5;DAPP1;CPEB2;EHF;SPRR2A;HCAR2;TNFRSF10B;EFNB2;EPHA2;RELB;GADD45A;MAFF;LIF;TRIB1;KCTD11;CD83;SQSTM1;IFNGR2;RRAD;BMP2;PHLDA2;CAB39;ZNF267;N4BP3;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;TMCC3;NMNAT2;RGMB;PHLDB2;CLDN4;TJP2;SERTAD2;CD274;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;BCL2L2;ZFP36L1;ENC1;RELT;RND3;ADRB2;CEBPB;DUSP16;ARNTL2;UGCG;PPP1R15A;MAST4;RUNX1;N4BP1;CDKN2B;GJB4;NAB1;HMGCS1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;ALDH1A3;C3ORF52;EHD1;NEDD9;ZSWIM4;ANKLE2;DUSP8;B4GALT1;HAL;DUSP1;BCL10;FGD6;DCUN1D3;TMCC1;TRAF1;PPP1R10;PIM3;CDV3;SACS;IL6ST;G0S2;B3GNT5;SGMS2;VMP1;NABP1;DLX2;SLC6A14;TXNRD1;VGLL3;CYLD;ADAM8;LDLR;VEGFC;KLF3;HCAR3;ZNF217;TACSTD2;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;DIEXF;PIM1;WISP1;ITGA5;TFRC;LIPG;AKIRIN1;KLHL21;CREB1;SERPINB8;EFNB1;GJB3;F3;STK40;HIVEP2;PPARD;KRT34;SLC25A25;SERPINB1;SOCS3;CCDC85B;KRTAP2-3;RAET1L;USP36;IL16;BDKRB1;RAPH1;ZFP36;SLC9A1;MAFK;LARP4B;CYP27B1;IFFO2;CD55;TMEM217;PNRC1;IFNAR2;ELL2;ANTXR2;AZIN1;JAG1;PLAGL2;RIPK2;AMOTL2;PHKG2;NAV3;SAA1;PPP1R15B;STARD5;NDRG1;ITGAV;PIP5K1A;CLK4;TP53BP2;SOX9;STX1A;NRG1;ZNF451;FEM1C;PML;POU2F2;RASA2;PPTC7;FERMT1;NCOA7;ELK3;POLR3A;SLC7A2;ZNF460;CDC42EP1;SLC28A3;FOXN2;PTPN11;MAP3K8;UHRF1;PANK3;ARHGEF3;C15ORF39;MXD1;DCBLD2;RHOB;SPAG9;ABCA5;GCH1;FEM1B;SOX4;USP31;FOSL2;TRAF4;VCL;EIF1;OXCT1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;ADAMTS1;HIVEP1;NFKBIB;KLF10;AEN;TIFA;SKIL;COTL1;IL7R;HEXDC;RBM3;CDK6;IER5;YRDC;SAMD4A;EMP3;PTPN1;SQLE;TFE3;BTG3;TMEM65;CORO1C;STEAP4;PRPF19;TOB2;ADM;MAFG;ABL2;MTF1;ATP6V1C2;HLA-E;RAB3IP;OSMR;QKI;CELF1;PMM2;WNT5A;NUP153;MAOA;INSIG1;ADAM9;LCE1C;PDPK1;TNFRSF10A;ADAMTS9;RNF19A;CTSC;ERO1A;KDM6A;FRMD6;ZBTB21;SMTN;NFE2L2;YWHAH;SGK1;B3GNT2;TSC22D2;CYTH1;SAT1;RELA;AGFG1;RNF11;NOTCH2NL;BACH1;BTAF1;GINS3;POLR3D;ALAS1;YWHAG;TDG;ELF4;RAB22A;CREG1;SFN;ITM2B;ERN1;ETNK1;SH3RF2;UPP1;ISG20;TMEM132A;ATXN7;IFIH1;ATP13A3;MYO1B;BRD2;IPO4;CXCL16;PABPC4;TAP1;DSE;AHCY;STX12;PDLIM5;FUBP3;GPR156;RAB24;SMPD3
4710,GO:0010871,0.134429793419322,0.99282984403656,1,4,negative regulation of receptor biosynthetic process,BP,ITGAV
20304,GO:2001286,0.134632073131156,0.992807576883437,1,4,regulation of caveolin-mediated endocytosis,BP,NEDD4L
10880,GO:0044419,0.134644072623266,0.905049626457568,28,726,interspecies interaction between organisms,BP,NFKBIA;ZC3H12A;TNF;CXCL8;TNIP1;CLDN1;EFNB2;EPHA2;SQSTM1;JUN;IL6ST;LDLR;NEDD4L;SMAD3;ITGA5;TFRC;CREB1;RAET1L;IL16;ZFP36;CD55;ITGAV;PML;NUP153;RELA;ISG20;IFIH1;TAP1
14601,GO:0070164,0.134696627498841,0.992800462952011,1,4,negative regulation of adiponectin secretion,BP,IL1B
6727,GO:0030136,0.134720503634076,0.936337051703225,7,124,clathrin-coated vesicle,CC,HBEGF;EDN1;ADRB2;LDLR;TFRC;IL7R;WNT5A
8212,GO:0032965,0.134772754358701,0.974757128111794,2,20,regulation of collagen biosynthetic process,BP,ERRFI1;PPARD
17493,GO:1900451,0.135050762446888,0.992761370570906,1,4,positive regulation of glutamate receptor signaling pathway,BP,ADRB2
1374,GO:0003263,0.13505847222668,0.992296455317087,1,5,cardioblast proliferation,BP,PIM1
17389,GO:1900117,0.135266117334201,0.974609522188175,2,20,regulation of execution phase of apoptosis,BP,ZC3H12A;TP53BP2
8281,GO:0033085,0.13540715699096,0.99225542915155,1,5,negative regulation of T cell differentiation in thymus,BP,NFKBID
14321,GO:0061470,0.135448200760862,0.992717364001087,1,4,T follicular helper cell differentiation,BP,RC3H1
17464,GO:1900271,0.135548510594875,0.9746220702104,2,19,regulation of long-term synaptic potentiation,BP,SQSTM1;CREB1
6212,GO:0019725,0.135613730793916,0.907816202875988,23,549,cellular homeostasis,BP,EDN1;PIM3;TXNRD1;NEDD4L;SMAD3;TFRC;BDKRB1;SLC9A1;CD55;SAA1;ITGAV;PML;SOX4;OXCT1;ADM;MAFG;ABL2;ATP6V1C2;PDPK1;ERO1A;NFE2L2;ERN1;ATP13A3
540,GO:0001658,0.135614987708682,0.961913123857204,3,36,branching involved in ureteric bud morphogenesis,BP,BMP2;TACSTD2;SOX9
8286,GO:0033093,0.135791319447167,0.992679257950357,1,4,Weibel-Palade body,CC,EDN1
3836,GO:0008440,0.135904072819186,0.992666712713781,1,4,inositol-1,4,5-trisphosphate 3-kinase activity,MF,ITPKC
16277,GO:0090344,0.135913623704209,0.974512858827376,2,19,negative regulation of cell aging,BP,PLK2;CDK6
8054,GO:0032713,0.135952493118286,0.992661321838906,1,4,negative regulation of interleukin-4 production,BP,CD83
14968,GO:0070876,0.136030077963558,0.992652679537433,1,4,SOSS complex,CC,NABP1
721,GO:0001945,0.136310070419017,0.974503369202302,2,18,lymph vessel development,BP,EFNB2;VEGFC
15438,GO:0071715,0.136421277966657,0.974360699637857,2,19,icosanoid transport,BP,IL1B;EDN1
17694,GO:1901571,0.136421277966657,0.974360699637857,2,19,fatty acid derivative transport,BP,IL1B;EDN1
13955,GO:0060633,0.136498212557127,0.992600418479813,1,4,negative regulation of transcription initiation from RNA polymerase II promoter,BP,ZNF451
19758,GO:2000143,0.136498212557127,0.992600418479813,1,4,negative regulation of DNA-templated transcription, initiation,BP,ZNF451
9974,GO:0042363,0.136505448281786,0.992599609160604,1,4,fat-soluble vitamin catabolic process,BP,CYP27B1
3501,GO:0007406,0.136540256319645,0.992595715207286,1,4,negative regulation of neuroblast proliferation,BP,KCTD11
11225,GO:0045359,0.136590950913732,0.992590042086236,1,4,positive regulation of interferon-beta biosynthetic process,BP,TICAM1
6009,GO:0019049,0.136633942642085,0.992585229165163,1,4,evasion or tolerance of host defenses by virus,BP,SMAD3
10875,GO:0044413,0.136633942642085,0.992585229165163,1,4,avoidance of host defenses,BP,SMAD3
10877,GO:0044415,0.136633942642085,0.992585229165163,1,4,evasion or tolerance of host defenses,BP,SMAD3
13207,GO:0051832,0.136633942642085,0.992585229165163,1,4,avoidance of defenses of other organism involved in symbiotic interaction,BP,SMAD3
13209,GO:0051834,0.136633942642085,0.992585229165163,1,4,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP,SMAD3
18073,GO:1902652,0.136753277982803,0.939588303627068,6,104,secondary alcohol metabolic process,BP,HMGCS1;LDLR;PPARD;CYP27B1;SQLE;INSIG1
16426,GO:0097065,0.136777839772347,0.992569107798856,1,4,anterior head development,BP,SOX9
7064,GO:0030850,0.136794824685451,0.961434775175873,3,36,prostate gland development,BP,SOX9;FEM1B;WNT5A
3758,GO:0008299,0.136800558253518,0.974059402884499,2,21,isoprenoid biosynthetic process,BP,HMGCS1;ALDH1A3
18546,GO:1903753,0.136858719610216,0.992560038334126,1,4,negative regulation of p38MAPK cascade,BP,DUSP10
181,GO:0000393,0.13689612102741,0.992078936874034,1,5,spliceosomal conformational changes to generate catalytic conformation,BP,PRPF19
4437,GO:0010288,0.136939904379863,0.974106195906447,2,20,response to lead ion,BP,PTGS2;CLDN1
592,GO:0001754,0.136955943489728,0.974310133312924,2,18,eye photoreceptor cell differentiation,BP,PRDM1;SOX9
19876,GO:2000348,0.13701715449707,0.992542255175823,1,4,regulation of CD40 signaling pathway,BP,TNFAIP3
10866,GO:0044389,0.13709226339826,0.918714161470089,13,281,ubiquitin-like protein ligase binding,MF,NFKBIA;TRIB1;SQSTM1;JUN;CDKN1A;CEBPB;BCL10;TRAF1;SMAD3;PML;TRAF4;VCL;RELA
10993,GO:0044793,0.137215523702983,0.992519957839492,1,4,negative regulation by host of viral process,BP,ZC3H12A
11008,GO:0044828,0.137215523702983,0.992519957839492,1,4,negative regulation by host of viral genome replication,BP,ZC3H12A
12140,GO:0048243,0.137290852445051,0.99251148136936,1,4,norepinephrine secretion,BP,STX1A
4812,GO:0014002,0.137325466355314,0.97408879090165,2,19,astrocyte development,BP,LDLR;CDK6
9155,GO:0035509,0.137373335900978,0.992502193946861,1,4,negative regulation of myosin-light-chain-phosphatase activity,BP,TNF
18359,GO:1903347,0.137373335900978,0.992502193946861,1,4,negative regulation of bicellular tight junction assembly,BP,TNF
11256,GO:0045499,0.137408438901023,0.97429856705293,2,17,chemorepellent activity,MF,SEMA7A;NRG1
4622,GO:0010739,0.137437899556609,0.992014194154539,1,5,positive regulation of protein kinase A signaling,BP,ADRB2
9451,GO:0036041,0.137709772353409,0.991661162203385,1,6,long-chain fatty acid binding,MF,PPARD
8554,GO:0033962,0.138058137198863,0.973979025108674,2,18,cytoplasmic mRNA processing body assembly,BP,NOCT;RC3H1
7581,GO:0031944,0.138144619295416,0.992415052948319,1,4,negative regulation of glucocorticoid metabolic process,BP,BMP2
7584,GO:0031947,0.138144619295416,0.992415052948319,1,4,negative regulation of glucocorticoid biosynthetic process,BP,BMP2
16072,GO:0090032,0.138144619295416,0.992415052948319,1,4,negative regulation of steroid hormone biosynthetic process,BP,BMP2
1253,GO:0003002,0.138151662103821,0.924523285791608,10,196,regionalization,BP,BTG2;TBX3;EDN1;BMP2;ETS2;DLX2;SMAD3;NRARP;WNT5A;KDM6A
7335,GO:0031344,0.138173595840866,0.908621898694898,20,436,regulation of cell projection organization,BP,EFNA1;SEMA7A;EFNB2;EPHA2;ENC1;ZSWIM4;CYLD;TACSTD2;NEDD4L;PLK2;NAV3;NRG1;CDC42EP1;SKIL;CORO1C;ABL2;WNT5A;NFE2L2;YWHAH;PDLIM5
10099,GO:0042609,0.138210498719682,0.991921384237581,1,5,CD4 receptor binding,MF,IL16
17707,GO:1901615,0.138280339412695,0.914602992841954,15,328,organic hydroxy compound metabolic process,BP,IL1B;ITPKC;TNF;NFKB1;BMP2;HMGCS1;ALDH1A3;LDLR;PPARD;CYP27B1;GCH1;SQLE;WNT5A;MAOA;INSIG1
2708,GO:0006073,0.138286554116304,0.951449512714902,4,56,cellular glucan metabolic process,BP,PHLDA2;IL6ST;STK40;PHKG2
10720,GO:0044042,0.138286554116304,0.951449512714902,4,56,glucan metabolic process,BP,PHLDA2;IL6ST;STK40;PHKG2
1343,GO:0003203,0.138360678740023,0.973887842102291,2,18,endocardial cushion morphogenesis,BP,BMP2;SOX9
13933,GO:0060592,0.138460646561762,0.992379192807454,1,4,mammary gland formation,BP,TBX3
483,GO:0001533,0.138478753738974,0.960414381464032,3,44,cornified envelope,CC,SPRR2D;SPRR2A;LCE1C
3125,GO:0006705,0.138530283709851,0.992371278858031,1,4,mineralocorticoid biosynthetic process,BP,BMP2
3703,GO:0008212,0.138530283709851,0.992371278858031,1,4,mineralocorticoid metabolic process,BP,BMP2
7794,GO:0032341,0.138530283709851,0.992371278858031,1,4,aldosterone metabolic process,BP,BMP2
7795,GO:0032342,0.138530283709851,0.992371278858031,1,4,aldosterone biosynthetic process,BP,BMP2
7796,GO:0032344,0.138530283709851,0.992371278858031,1,4,regulation of aldosterone metabolic process,BP,BMP2
7799,GO:0032347,0.138530283709851,0.992371278858031,1,4,regulation of aldosterone biosynthetic process,BP,BMP2
7334,GO:0031343,0.138584626087968,0.973435097167039,2,22,positive regulation of cell killing,BP,IL23A;HLA-E
723,GO:0001947,0.138680651766642,0.960719080435904,3,35,heart looping,BP,TBX3;SMAD3;WNT5A
8005,GO:0032627,0.138770269507622,0.991853784905262,1,5,interleukin-23 production,BP,CSF2
8029,GO:0032667,0.138770269507622,0.991853784905262,1,5,regulation of interleukin-23 production,BP,CSF2
8404,GO:0033353,0.138781002266029,0.992342749602522,1,4,S-adenosylmethionine cycle,BP,AHCY
19712,GO:2000047,0.138791272190843,0.99185124274519,1,5,regulation of cell-cell adhesion mediated by cadherin,BP,WNT5A
3470,GO:0007296,0.138856040079637,0.992334200028267,1,4,vitellogenesis,BP,FOSL1
1346,GO:0003207,0.138875418467749,0.992331991289922,1,4,cardiac chamber formation,BP,SOX4
1349,GO:0003211,0.138875418467749,0.992331991289922,1,4,cardiac ventricle formation,BP,SOX4
17338,GO:1900019,0.138897819157053,0.992329437649126,1,4,regulation of protein kinase C activity,BP,WNT5A
17339,GO:1900020,0.138897819157053,0.992329437649126,1,4,positive regulation of protein kinase C activity,BP,WNT5A
17660,GO:1901490,0.139200112120589,0.992294932477559,1,4,regulation of lymphangiogenesis,BP,VEGFC
1414,GO:0003348,0.139222280661531,0.992292398808015,1,4,cardiac endothelial cell differentiation,BP,NRG1
14110,GO:0060956,0.139222280661531,0.992292398808015,1,4,endocardial cell differentiation,BP,NRG1
34,GO:0000064,0.139266132983974,0.992287385566004,1,4,L-ornithine transmembrane transporter activity,MF,SLC7A2
6750,GO:0030168,0.139316643939176,0.938152892269094,6,103,platelet activation,BP,RAP2B;SAA1;PTPN11;RHOB;VCL;PDPK1
4237,GO:0009416,0.13959290711188,0.921105546123495,11,224,response to light stimulus,BP,BHLHE40;PTGS2;CDKN1A;BCL3;N4BP1;HMGCS1;DUSP1;DCUN1D3;CREB1;PML;RELA
18837,GO:1904427,0.139767433562439,0.960122342188259,3,38,positive regulation of calcium ion transmembrane transport,BP,BDKRB1;SLC9A1;PDPK1
13181,GO:0051783,0.140009772809296,0.929318887052439,8,154,regulation of nuclear division,BP,IL1B;IL1A;TGFA;EDN1;LIF;EREG;DUSP1;WNT5A
19950,GO:2000481,0.140119711120657,0.992189457763492,1,4,positive regulation of cAMP-dependent protein kinase activity,BP,ADRB2
12591,GO:0050764,0.140156490471746,0.959916713183,3,39,regulation of phagocytosis,BP,IL1B;TNF;ITGAV
15316,GO:0071532,0.140323115287206,0.992166024841844,1,4,ankyrin repeat binding,MF,RELA
12381,GO:0048787,0.140351087489332,0.992162799413966,1,4,presynaptic active zone membrane,CC,STX1A
6967,GO:0030620,0.140504645549882,0.991308753846315,1,6,U2 snRNA binding,MF,ISG20
1262,GO:0003014,0.140537284043522,0.950312463357708,4,58,renal system process,BP,EDN1;CLDN4;ADM;SGK1
13748,GO:0060317,0.140600131492762,0.973094441921469,2,19,cardiac epithelial to mesenchymal transition,BP,EFNA1;BMP2
10786,GO:0044248,0.140778604409443,0.888078301616247,66,1799,cellular catabolic process,BP,TNFAIP3;IL1B;ZC3H12A;BTG2;TICAM1;TNF;RNF19B;PMAIP1;NOCT;PLEKHF1;EFNA1;TRIB1;SQSTM1;BIRC2;AMPD3;ZFP36L1;ENC1;ADRB2;N4BP1;HAL;VMP1;CYLD;ADAM8;LDLR;NEDD4L;RC3H1;PLK2;PLK3;LIPG;PPARD;USP36;ZFP36;SLC9A1;CYP27B1;PNRC1;RIPK2;PHKG2;PML;UHRF1;USP31;OXCT1;TNFAIP1;SAMD4A;PTPN1;PRPF19;ABL2;ATP6V1C2;QKI;NUP153;MAOA;ADAM9;ADAMTS9;RNF19A;CTSC;NFE2L2;SAT1;RNF11;TDG;ERN1;UPP1;ISG20;PABPC4;AHCY;STX12;RAB24;SMPD3
18091,GO:1902713,0.140780550525364,0.992113189922719,1,4,regulation of interferon-gamma secretion,BP,ZC3H12A
9382,GO:0035914,0.140899429096262,0.959655671507953,3,38,skeletal muscle cell differentiation,BP,BTG2;MAFF;FOXN2
5117,GO:0015440,0.140904855657612,0.992098799662132,1,4,peptide-transporting ATPase activity,MF,TAP1
8354,GO:0033220,0.140904855657612,0.992098799662132,1,4,amide-transporting ATPase activity,MF,TAP1
9668,GO:0038027,0.140912526817877,0.992097911147496,1,4,apolipoprotein A-I-mediated signaling pathway,BP,ITGAV
7458,GO:0031593,0.140944154214303,0.95968553702181,3,37,polyubiquitin modification-dependent protein binding,MF,TNFAIP3;TNIP1;SQSTM1
8626,GO:0034144,0.140948041289932,0.992093796978281,1,4,negative regulation of toll-like receptor 4 signaling pathway,BP,TNFAIP3
18638,GO:1903936,0.141016051510449,0.991579567634331,1,5,cellular response to sodium arsenite,BP,ZC3H12A
8261,GO:0033043,0.141031599688166,0.893974887290521,41,1018,regulation of organelle organization,BP,IL1B;IL1A;PLAUR;CSF2;SDC4;TNF;PPIF;PMAIP1;TGFA;EDN1;LIF;SQSTM1;PHLDB2;RND3;ADRB2;UGCG;EREG;DUSP1;PPP1R10;CYLD;TACSTD2;SMAD3;PLK2;BBC3;USP36;SLC9A1;PLAGL2;NAV3;TP53BP2;NRG1;ZNF451;PML;CDC42EP1;UHRF1;RHOB;ABL2;WNT5A;INSIG1;YWHAH;YWHAG;SFN
18647,GO:1903955,0.141118784425734,0.949903248949098,4,63,positive regulation of protein targeting to mitochondrion,BP,UGCG;USP36;PLAGL2;NRG1
7336,GO:0031345,0.141140471675312,0.932521995586013,7,124,negative regulation of cell projection organization,BP,EFNA1;SEMA7A;EFNB2;TACSTD2;PLK2;WNT5A;YWHAH
11849,GO:0046827,0.141275886802647,0.972784005086343,2,20,positive regulation of protein export from nucleus,BP,IL1B;SFN
3761,GO:0008305,0.141281694523445,0.973130333784508,2,17,integrin complex,CC,ITGA5;ITGAV
16795,GO:0098636,0.141281694523445,0.973130333784508,2,17,protein complex involved in cell adhesion,CC,ITGA5;ITGAV
17920,GO:1902231,0.141331143862888,0.991203056330464,1,6,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,SKIL
11208,GO:0045341,0.141471836517937,0.992032985405236,1,4,MHC class I biosynthetic process,BP,PML
11210,GO:0045343,0.141471836517937,0.992032985405236,1,4,regulation of MHC class I biosynthetic process,BP,PML
11211,GO:0045345,0.141471836517937,0.992032985405236,1,4,positive regulation of MHC class I biosynthetic process,BP,PML
18568,GO:1903793,0.141493668701319,0.972623472701129,2,21,positive regulation of anion transport,BP,IL1B;EDN1
12193,GO:0048341,0.14157441441962,0.992021047229347,1,4,paraxial mesoderm formation,BP,WNT5A
792,GO:0002053,0.141591022900037,0.972906290465776,2,18,positive regulation of mesenchymal cell proliferation,BP,SOX9;WNT5A
3196,GO:0006826,0.141645125458259,0.959176549815341,3,42,iron ion transport,BP,TFRC;STEAP4;ATP6V1C2
2331,GO:0005345,0.141666462089647,0.991499248747176,1,5,purine nucleobase transmembrane transporter activity,MF,SLC28A3
13987,GO:0060696,0.141671055349993,0.991498680085656,1,5,regulation of phospholipid catabolic process,BP,LDLR
9157,GO:0035511,0.141704160021416,0.991494581014472,1,5,oxidative DNA demethylation,BP,TDG
5514,GO:0016469,0.141885797466928,0.972268879992393,2,24,proton-transporting two-sector ATPase complex,CC,PPIF;ATP6V1C2
2435,GO:0005623,0.141909811580203,0.898685199779875,371,11082,cell,CC,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;BTG2;BIRC3;HBEGF;PLAU;NFKBID;CSF2;ITPKC;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;CXCL8;REL;SERPINB2;PPIF;IER3;KLF6;NUAK2;CCL20;SPRR2D;ZNF697;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;TRPV3;NOCT;PLEKHF1;EFNA1;TGFA;KDM6B;IRF6;LGALSL;EDN1;ODC1;SEMA7A;PHLDA1;HAS3;ERRFI1;IL1RN;IRAK2;CLDN1;KLF7;PANX1;CREB5;DAPP1;CPEB2;EHF;SPRR2A;HCAR2;TNFRSF10B;EFNB2;EPHA2;RELB;GADD45A;MAFF;LIF;TRIB1;KCTD11;CD83;SQSTM1;IFNGR2;RRAD;BMP2;PHLDA2;CAB39;ZNF267;N4BP3;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;TMCC3;NMNAT2;RGMB;PHLDB2;CLDN4;TJP2;SERTAD2;CD274;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;BCL2L2;ZFP36L1;ENC1;RELT;RND3;ADRB2;CEBPB;DUSP16;ARNTL2;UGCG;PPP1R15A;MAST4;RUNX1;N4BP1;CDKN2B;GJB4;NAB1;HMGCS1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;ALDH1A3;C3ORF52;EHD1;NEDD9;ZSWIM4;ANKLE2;DUSP8;B4GALT1;HAL;DUSP1;BCL10;FGD6;DCUN1D3;TMCC1;TRAF1;PPP1R10;PIM3;CDV3;SACS;IL6ST;G0S2;B3GNT5;SGMS2;VMP1;NABP1;DLX2;SLC6A14;TXNRD1;VGLL3;CYLD;ADAM8;LDLR;VEGFC;KLF3;HCAR3;ZNF217;TACSTD2;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;DIEXF;PIM1;WISP1;ITGA5;TFRC;LIPG;AKIRIN1;KLHL21;CREB1;SERPINB8;EFNB1;GJB3;F3;STK40;HIVEP2;PPARD;KRT34;SLC25A25;SERPINB1;SOCS3;CCDC85B;KRTAP2-3;RAET1L;USP36;IL16;BDKRB1;RAPH1;ZFP36;SLC9A1;MAFK;LARP4B;CYP27B1;IFFO2;CD55;TMEM217;PNRC1;IFNAR2;ELL2;ANTXR2;AZIN1;JAG1;PLAGL2;RIPK2;AMOTL2;PHKG2;NAV3;SAA1;PPP1R15B;STARD5;NDRG1;ITGAV;PIP5K1A;CLK4;TP53BP2;SOX9;STX1A;NRG1;ZNF451;FEM1C;PML;POU2F2;RASA2;PPTC7;FERMT1;NCOA7;ELK3;POLR3A;SLC7A2;ZNF460;CDC42EP1;SLC28A3;FOXN2;PTPN11;MAP3K8;UHRF1;PANK3;ARHGEF3;C15ORF39;MXD1;DCBLD2;RHOB;SPAG9;ABCA5;GCH1;FEM1B;SOX4;USP31;FOSL2;TRAF4;VCL;EIF1;OXCT1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;ADAMTS1;HIVEP1;NFKBIB;KLF10;AEN;TIFA;SKIL;COTL1;IL7R;HEXDC;RBM3;CDK6;IER5;YRDC;SAMD4A;EMP3;PTPN1;SQLE;TFE3;BTG3;TMEM65;CORO1C;STEAP4;PRPF19;TOB2;ADM;MAFG;ABL2;MTF1;ATP6V1C2;HLA-E;RAB3IP;OSMR;QKI;CELF1;PMM2;WNT5A;NUP153;MAOA;INSIG1;ADAM9;LCE1C;PDPK1;TNFRSF10A;ADAMTS9;RNF19A;CTSC;ERO1A;KDM6A;FRMD6;ZBTB21;SMTN;NFE2L2;YWHAH;SGK1;B3GNT2;TSC22D2;CYTH1;SAT1;RELA;AGFG1;RNF11;NOTCH2NL;BACH1;BTAF1;GINS3;POLR3D;ALAS1;YWHAG;TDG;ELF4;RAB22A;CREG1;SFN;ITM2B;ERN1;ETNK1;SH3RF2;UPP1;ISG20;TMEM132A;ATXN7;IFIH1;ATP13A3;MYO1B;BRD2;IPO4;CXCL16;PABPC4;TAP1;DSE;AHCY;STX12;PDLIM5;FUBP3;GPR156;RAB24;SMPD3
1075,GO:0002639,0.141968157251824,0.972476573829457,2,21,positive regulation of immunoglobulin production,BP,TFRC;HLA-E
7648,GO:0032058,0.142285982187835,0.991937971428607,1,4,positive regulation of translational initiation in response to stress,BP,PPP1R15A
4561,GO:0010641,0.142333285812643,0.991932432444283,1,4,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,F3
7277,GO:0031258,0.142653525039744,0.972463288205362,2,19,lamellipodium membrane,CC,EPHA2;ITGAV
13569,GO:0060029,0.142678484985401,0.991891950155038,1,4,convergent extension involved in organogenesis,BP,WNT5A
9067,GO:0035305,0.142722434278768,0.941979180676049,5,79,negative regulation of dephosphorylation,BP,TNF;PLEKHF1;PPP1R15A;PPP1R10;SH3RF2
5221,GO:0015822,0.142849885442905,0.991871809473822,1,4,ornithine transport,BP,SLC7A2
18364,GO:1903352,0.142849885442905,0.991871809473822,1,4,L-ornithine transmembrane transport,BP,SLC7A2
10031,GO:0042476,0.143037213650597,0.941792080346567,5,80,odontogenesis,BP,INHBA;EDN1;BMP2;DLX2;ADM
14032,GO:0060754,0.143039072592599,0.991328413958241,1,5,positive regulation of mast cell chemotaxis,BP,VEGFC
10379,GO:0043200,0.143141759020616,0.941699456780513,5,82,response to amino acid,BP,TNF;EDN1;CEBPB;CREB1;RELA
18051,GO:1902581,0.143201835262681,0.991308036576499,1,5,multi-organism cellular localization,BP,NUP153
18052,GO:1902583,0.143201835262681,0.991308036576499,1,5,multi-organism intracellular transport,BP,NUP153
1386,GO:0003284,0.143232996652008,0.991826694989115,1,4,septum primum development,BP,SOX4
9898,GO:0042182,0.143448969804686,0.991277047423597,1,5,ketone catabolic process,BP,OXCT1
14976,GO:0070888,0.143463169992926,0.972212812009956,2,19,E-box binding,MF,BHLHE40;ARNTL2
7632,GO:0032036,0.143513789513126,0.991268909712275,1,5,myosin heavy chain binding,MF,STX1A
15131,GO:0071225,0.14358919394654,0.991784630291167,1,4,cellular response to muramyl dipeptide,BP,RIPK2
3706,GO:0008215,0.143838988264388,0.99087818208851,1,6,spermine metabolic process,BP,SAT1
13582,GO:0060046,0.143886314187505,0.991222063229896,1,5,regulation of acrosome reaction,BP,B4GALT1
1438,GO:0003415,0.14401106873689,0.991734660388806,1,4,chondrocyte hypertrophy,BP,SOX9
8379,GO:0033278,0.144014795949127,0.99173421819001,1,4,cell proliferation in midbrain,BP,WNT5A
17910,GO:1902219,0.144810650609741,0.991639508166255,1,4,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,PTGS2
12600,GO:0050773,0.145160312661186,0.934892672080783,6,98,regulation of dendrite development,BP,EFNA1;NEDD4L;PLK2;NRG1;YWHAH;PDLIM5
16017,GO:0086036,0.145219030888079,0.991590685479135,1,4,regulation of cardiac muscle cell membrane potential,BP,SLC9A1
11507,GO:0045992,0.145546244638587,0.971564192143278,2,19,negative regulation of embryonic development,BP,NRARP;WNT5A
7932,GO:0032507,0.146009955168118,0.947573616288893,4,61,maintenance of protein location in cell,BP,BCL3;PML;SOX4;INSIG1
14323,GO:0061476,0.146153447500963,0.991478402666954,1,4,response to anticoagulant,BP,SOX9
15309,GO:0071503,0.146153447500963,0.991478402666954,1,4,response to heparin,BP,SOX9
15310,GO:0071504,0.146153447500963,0.991478402666954,1,4,cellular response to heparin,BP,SOX9
5632,GO:0016709,0.146191660485337,0.971253216586253,2,20,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,CYP27B1;SQLE
10368,GO:0043184,0.146283548454196,0.990917404970522,1,5,vascular endothelial growth factor receptor 2 binding,MF,ITGA5
11853,GO:0046834,0.146343380137581,0.940100781621943,5,76,lipid phosphorylation,BP,HBEGF;EREG;PIP5K1A;NRG1;PTPN11
3001,GO:0006547,0.146539766381169,0.990884515152401,1,5,histidine metabolic process,BP,HAL
13417,GO:0052803,0.146539766381169,0.990884515152401,1,5,imidazole-containing compound metabolic process,BP,HAL
12401,GO:0048843,0.146547322072114,0.971372115383415,2,18,negative regulation of axon extension involved in axon guidance,BP,SEMA7A;WNT5A
19853,GO:2000319,0.146547494291969,0.990883522162392,1,5,regulation of T-helper 17 cell differentiation,BP,IL23A
13523,GO:0055091,0.146587832499085,0.991425934409068,1,4,phospholipid homeostasis,BP,LIPG
9948,GO:0042310,0.146732905804291,0.957221991357412,3,38,vasoconstriction,BP,PTGS2;EDN1;ADM
3516,GO:0007442,0.146882086468035,0.991390294414599,1,4,hindgut morphogenesis,BP,WNT5A
8122,GO:0032808,0.146935628183309,0.991383800952454,1,4,lacrimal gland development,BP,SOX9
12637,GO:0050821,0.146944652389941,0.928927994377248,7,134,protein stabilization,BP,EFNA1;CDKN1A;SMAD3;CREB1;USP36;SOX4;STX12
16823,GO:0098706,0.147173012280632,0.99135497982562,1,4,ferric iron import across plasma membrane,BP,STEAP4
7835,GO:0032387,0.147256993230603,0.956821451946563,3,42,negative regulation of intracellular transport,BP,SOX4;NUP153;INSIG1
6784,GO:0030218,0.147308921332492,0.939460745377002,5,82,erythrocyte differentiation,BP,INHBA;ETS1;ZFP36L1;ZFP36;CDK6
11136,GO:0045182,0.147370174616982,0.956858714101592,3,40,translation regulator activity,MF,CPEB2;SAMD4A;CELF1
8466,GO:0033605,0.147460934839321,0.990765744180826,1,5,positive regulation of catecholamine secretion,BP,STX1A
6965,GO:0030618,0.14750372639819,0.991314741584462,1,4,transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,MF,SMAD3
6989,GO:0030666,0.14763734826897,0.933279454251753,6,112,endocytic vesicle membrane,CC,HBEGF;LDLR;HLA-E;WNT5A;RAB22A;TAP1
13777,GO:0060352,0.147647039217006,0.990741649216925,1,5,cell adhesion molecule production,BP,IL1B
10348,GO:0043153,0.148185638532873,0.970622699437159,2,20,entrainment of circadian clock by photoperiod,BP,BHLHE40;PML
20089,GO:2000739,0.148360065677235,0.991210085635371,1,4,regulation of mesenchymal stem cell differentiation,BP,SOX9
13631,GO:0060123,0.14842178750025,0.99120251650676,1,4,regulation of growth hormone secretion,BP,PTPN11
3418,GO:0007205,0.148652681213141,0.97047421837069,2,20,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,EDN1;BDKRB1
13420,GO:0052811,0.148675723349512,0.991171338936586,1,4,1-phosphatidylinositol-3-phosphate 4-kinase activity,MF,PIP5K1A
564,GO:0001702,0.148687210502417,0.970699231997819,2,18,gastrulation with mouth forming second,BP,ETS2;WNT5A
14801,GO:0070530,0.148767920868814,0.970549190365845,2,19,K63-linked polyubiquitin modification-dependent protein binding,MF,TNFAIP3;SQSTM1
13280,GO:0051964,0.148834750306329,0.99115178397757,1,4,negative regulation of synapse assembly,BP,WNT5A
9177,GO:0035546,0.148875050825916,0.991146824694504,1,4,interferon-beta secretion,BP,IFIH1
9178,GO:0035547,0.148875050825916,0.991146824694504,1,4,regulation of interferon-beta secretion,BP,IFIH1
9179,GO:0035549,0.148875050825916,0.991146824694504,1,4,positive regulation of interferon-beta secretion,BP,IFIH1
16652,GO:0097527,0.148931267622411,0.990574466529076,1,5,necroptotic signaling pathway,BP,TNF
9716,GO:0038132,0.148936635785428,0.991139243328273,1,4,neuregulin binding,MF,ITGAV
13844,GO:0060441,0.148955844358924,0.970377675721976,2,20,epithelial tube branching involved in lung morphogenesis,BP,TNF;SOX9
17782,GO:1901841,0.149064420884556,0.990557041081583,1,5,regulation of high voltage-gated calcium channel activity,BP,RRAD
8834,GO:0034620,0.149427937973399,0.927449088414275,7,131,cellular response to unfolded protein,BP,CXCL8;PPP1R15A;PPP1R15B;PTPN1;ERO1A;NFE2L2;ERN1
324,GO:0000904,0.149484727233874,0.898096949986453,22,482,cell morphogenesis involved in differentiation,BP,EFNA1;SEMA7A;KLF7;EFNB2;EPHA2;ZSWIM4;TACSTD2;NEDD4L;CREB1;EFNB1;RAPH1;ITGAV;NRG1;PTPN11;VCL;SKIL;CORO1C;WNT5A;FRMD6;YWHAH;B3GNT2;PDLIM5
1234,GO:0002920,0.149557996145363,0.969992114228149,2,22,regulation of humoral immune response,BP,TNF;CD55
17335,GO:1900015,0.150238456389064,0.969967818553262,2,20,regulation of cytokine production involved in inflammatory response,BP,ZC3H12A;TICAM1
12614,GO:0050792,0.1504445341464,0.92270338788013,8,163,regulation of viral process,BP,ZC3H12A;TNF;CXCL8;TNIP1;JUN;ZFP36;PML;ISG20
664,GO:0001865,0.150463754221269,0.990950137202947,1,4,NK T cell differentiation,BP,PRDM1
12833,GO:0051136,0.150463754221269,0.990950137202947,1,4,regulation of NK T cell differentiation,BP,PRDM1
17858,GO:1902047,0.150534085423452,0.990363567689368,1,5,polyamine transmembrane transport,BP,AZIN1
18618,GO:1903900,0.150639659257643,0.931551044468147,6,111,regulation of viral life cycle,BP,ZC3H12A;TNF;CXCL8;TNIP1;PML;ISG20
14400,GO:0061665,0.150730125143101,0.990337601686959,1,5,SUMO ligase activity,MF,ZNF451
12205,GO:0048384,0.15082012305116,0.969678449846367,2,21,retinoic acid receptor signaling pathway,BP,TRIM16;PML
9646,GO:0036515,0.150898939311851,0.990895855758944,1,4,serotonergic neuron axon guidance,BP,WNT5A
3451,GO:0007265,0.151088094762814,0.902452425534927,17,366,Ras protein signal transduction,BP,SQSTM1;JUN;RAP2B;CDKN1A;RND3;FGD6;PLK2;NRG1;RASA2;CDC42EP1;ARHGEF3;RHOB;TNFAIP1;CYTH1;AGFG1;RAB22A;RAB24
10484,GO:0043379,0.15112560355681,0.990285105868478,1,5,memory T cell differentiation,BP,IL23A
16375,GO:0090713,0.15112560355681,0.990285105868478,1,5,immunological memory process,BP,IL23A
16376,GO:0090715,0.15112560355681,0.990285105868478,1,5,immunological memory formation process,BP,IL23A
839,GO:0002138,0.151265236691838,0.990266534661054,1,5,retinoic acid biosynthetic process,BP,ALDH1A3
5352,GO:0016102,0.151265236691838,0.990266534661054,1,5,diterpenoid biosynthetic process,BP,ALDH1A3
17479,GO:1900376,0.151649200217375,0.990801865927749,1,4,regulation of secondary metabolite biosynthetic process,BP,WNT5A
1431,GO:0003402,0.15187286484864,0.990773745979046,1,4,planar cell polarity pathway involved in axis elongation,BP,WNT5A
13034,GO:0051481,0.151924493892267,0.990767248449513,1,4,negative regulation of cytosolic calcium ion concentration,BP,SMAD3
17650,GO:1901386,0.151964060743814,0.990173306234864,1,5,negative regulation of voltage-gated calcium channel activity,BP,RRAD
10055,GO:0042538,0.152017011449203,0.990166222850853,1,5,hyperosmotic salinity response,BP,CLDN1
5896,GO:0018076,0.152047808854801,0.990751719307187,1,4,N-terminal peptidyl-lysine acetylation,BP,SOX4
8164,GO:0032897,0.152154443542126,0.969247226821052,2,21,negative regulation of viral transcription,BP,JUN;ZFP36
17692,GO:1901569,0.152247506643963,0.990135356989946,1,5,fatty acid derivative catabolic process,BP,OXCT1
11795,GO:0046661,0.152273946087459,0.930691827379254,6,104,male sex differentiation,BP,INHBA;TBX3;BCL2L2;HMGCS1;SOX9;WNT5A
20144,GO:2000831,0.152384139771111,0.990117035889707,1,5,regulation of steroid hormone secretion,BP,PTPN11
18519,GO:1903690,0.152413445824182,0.99070559215046,1,4,negative regulation of wound healing, spreading of epidermal cells,BP,PHLDB2
405,GO:0001085,0.152443442739663,0.930551682126844,6,107,RNA polymerase II transcription factor binding,MF,BHLHE40;TBX3;JUN;SMAD3;CREB1;NFE2L2
2030,GO:0004767,0.152450496942028,0.990108131517833,1,5,sphingomyelin phosphodiesterase activity,MF,SMPD3
16087,GO:0090066,0.152499100442381,0.904339936303,15,326,regulation of anatomical structure size,BP,PTGS2;EDN1;SEMA7A;ADRB2;PPP1R15A;SOD2;CREB1;PPARD;NRG1;CDC42EP1;GCH1;IL7R;ADM;WNT5A;RAB22A
19621,GO:1990763,0.152548348156497,0.990094993184333,1,5,arrestin family protein binding,MF,CREB1
17954,GO:1902305,0.152670875834943,0.95464484590251,3,39,regulation of sodium ion transmembrane transport,BP,NEDD4L;SLC9A1;YWHAH
1406,GO:0003338,0.152674153583043,0.969183235200837,2,20,metanephros morphogenesis,BP,LIF;SOX9
8627,GO:0034145,0.15304473862902,0.990028199952449,1,5,positive regulation of toll-like receptor 4 signaling pathway,BP,PELI1
19688,GO:2000002,0.153080214733921,0.990023417173418,1,5,negative regulation of DNA damage checkpoint,BP,PPP1R10
10908,GO:0044454,0.153126929091992,0.898322675661054,19,464,nuclear chromosome part,CC,KDM6B;JUN;JUNB;IRF1;ENC1;CEBPB;PPP1R10;NABP1;SMAD3;CREB1;PPARD;PML;UHRF1;MXD1;PRPF19;KDM6A;RELA;POLR3D;IPO4
9372,GO:0035897,0.153163824439819,0.99001214031946,1,5,proteolysis in other organism,BP,MAP2K3
8275,GO:0033079,0.15321361326563,0.990005421818243,1,5,immature T cell proliferation,BP,RIPK2
8735,GO:0034384,0.153478648786038,0.98996961727472,1,5,high-density lipoprotein particle clearance,BP,LIPG
6106,GO:0019336,0.153601035754532,0.989953060492127,1,5,phenol-containing compound catabolic process,BP,MAOA
6188,GO:0019614,0.153601035754532,0.989953060492127,1,5,catechol-containing compound catabolic process,BP,MAOA
10006,GO:0042424,0.153601035754532,0.989953060492127,1,5,catecholamine catabolic process,BP,MAOA
884,GO:0002248,0.153641732250764,0.989947551743203,1,5,connective tissue replacement involved in inflammatory response wound healing,BP,IL1A
10803,GO:0044283,0.153822137530165,0.894652411791996,22,542,small molecule biosynthetic process,BP,IL1B;ITPKC;TNF;PTGS2;NFKB1;EDN1;HAS3;BMP2;AMPD3;HMGCS1;ALDH1A3;CYP27B1;GCH1;SQLE;ADM;QKI;NUP153;INSIG1;TDG;UPP1;DSE;AHCY
2751,GO:0006152,0.153869633748251,0.989515886071215,1,6,purine nucleoside catabolic process,BP,AHCY
11576,GO:0046130,0.153869633748251,0.989515886071215,1,6,purine ribonucleoside catabolic process,BP,AHCY
2191,GO:0005048,0.153986347174929,0.954077957900557,3,39,signal sequence binding,MF,NFKBIA;NUP153;IPO4
1236,GO:0002922,0.154083853918641,0.989485688188077,1,6,positive regulation of humoral immune response,BP,TNF
19599,GO:1990712,0.154171540210287,0.989875688590554,1,5,HFE-transferrin receptor complex,CC,TFRC
4789,GO:0010977,0.154207464109497,0.929577110640533,6,103,negative regulation of neuron projection development,BP,EFNA1;SEMA7A;EFNB2;PLK2;WNT5A;YWHAH
12390,GO:0048814,0.154234790316586,0.943621465967044,4,57,regulation of dendrite morphogenesis,BP,EFNA1;NEDD4L;YWHAH;PDLIM5
4604,GO:0010718,0.15433265846925,0.95397982097514,3,38,positive regulation of epithelial to mesenchymal transition,BP,IL1B;BMP2;SMAD3
14291,GO:0061371,0.1543977014006,0.954006143397524,3,37,determination of heart left/right asymmetry,BP,TBX3;SMAD3;WNT5A
15773,GO:0072376,0.154542081837206,0.968372898074855,2,22,protein activation cascade,BP,F3;CD55
13726,GO:0060291,0.15459332415658,0.953815579430911,3,39,long-term synaptic potentiation,BP,SQSTM1;PLK2;CREB1
6529,GO:0021915,0.154720198785285,0.924288513555863,7,124,neural tube development,BP,SDC4;ZFP36L1;BCL10;SOX4;ADM;WNT5A;KDM6A
11691,GO:0046476,0.154722793232783,0.989800625817619,1,5,glycosylceramide biosynthetic process,BP,UGCG
10035,GO:0042487,0.154812531614416,0.989788378276619,1,5,regulation of odontogenesis of dentin-containing tooth,BP,BMP2
1466,GO:0003714,0.155058271509112,0.916295399738487,9,178,transcription corepressor activity,MF,BHLHE40;RELB;JUNB;ZNF451;ELK3;MXD1;HDAC9;TOB2;CREG1
4824,GO:0014020,0.155147317416316,0.935229181557734,5,80,primary neural tube formation,BP,SDC4;BCL10;ADM;WNT5A;KDM6A
7812,GO:0032364,0.155207773270938,0.989734341851757,1,5,oxygen homeostasis,BP,SOD2
11593,GO:0046173,0.15530265813096,0.953367861937214,3,42,polyol biosynthetic process,BP,ITPKC;CYP27B1;GCH1
488,GO:0001540,0.155612448408912,0.953233085524606,3,42,amyloid-beta binding,MF,ADRB2;LDLR;ITM2B
15514,GO:0071895,0.155830400920338,0.989648908045406,1,5,odontoblast differentiation,BP,CEBPB
19450,GO:1990089,0.155860351756142,0.953266238758374,3,39,response to nerve growth factor,BP,EHD1;CREB1;PDPK1
19451,GO:1990090,0.155860351756142,0.953266238758374,3,39,cellular response to nerve growth factor stimulus,BP,EHD1;CREB1;PDPK1
1407,GO:0003339,0.156141125745566,0.989606130124758,1,5,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,LIF
11307,GO:0045625,0.156181875724239,0.989600513010343,1,5,regulation of T-helper 1 cell differentiation,BP,RIPK2
9336,GO:0035821,0.156200728674506,0.934448922446604,5,91,modification of morphology or physiology of other organism,BP,ZC3H12A;TNIP1;JUN;SMAD3;ITGAV
7245,GO:0031175,0.156413549856629,0.887889167988905,28,644,neuron projection development,BP,BTG2;SDC4;EFNA1;SEMA7A;KLF7;EFNB2;JUN;ENC1;EHD1;ZSWIM4;NEDD4L;PLK2;CREB1;EFNB1;RAPH1;NRG1;PTPN11;VCL;AREG;SKIL;ADM;ABL2;WNT5A;NFE2L2;YWHAH;SGK1;B3GNT2;PDLIM5
4195,GO:0009299,0.156448578262095,0.967951269751222,2,20,mRNA transcription,BP,EREG;PPARD
14696,GO:0070324,0.156469579428741,0.989560808711042,1,5,thyroid hormone binding,MF,ALDH1A3
6198,GO:0019673,0.156480920047503,0.988849416195068,1,7,GDP-mannose metabolic process,BP,PMM2
1885,GO:0004563,0.156495463874996,0.989557232577077,1,5,beta-N-acetylhexosaminidase activity,MF,HEXDC
8302,GO:0033135,0.156670928331173,0.934292063489005,5,85,regulation of peptidyl-serine phosphorylation,BP,TNF;PTGS2;LIF;RIPK2;WNT5A
13853,GO:0060453,0.156714087604588,0.989527001864638,1,5,regulation of gastric acid secretion,BP,SGK1
7088,GO:0030881,0.15680378445665,0.989098230628132,1,6,beta-2-microglobulin binding,MF,HLA-E
14098,GO:0060923,0.156913652720605,0.989499365654371,1,5,cardiac muscle cell fate commitment,BP,TBX3
7602,GO:0031981,0.156957434972773,0.868226378770436,124,3517,nuclear lumen,CC,NFKBIZ;ZC3H12A;BIRC3;ITPKC;ELF3;ETS1;REL;KLF6;BHLHE40;TNIP1;NFKB1;PRDM1;FOSL1;NFKB2;NOCT;KDM6B;PHLDA1;EHF;RELB;GADD45A;MAFF;SQSTM1;MAP2K3;JUN;NFKBIE;CDKN1A;TJP2;SERTAD2;JUNB;BCL3;ETS2;NAMPT;IRF1;TAF4B;ENC1;CEBPB;DUSP16;ARNTL2;RUNX1;N4BP1;GJB4;TRIM16;ELMSAN1;NEDD9;PPP1R10;VMP1;NABP1;TXNRD1;KLF3;ZNF217;NEDD4L;SMAD3;DUSP10;PLK3;DIEXF;PIM1;AKIRIN1;CREB1;STK40;HIVEP2;PPARD;USP36;IL16;RAPH1;SLC9A1;MAFK;LARP4B;TMEM217;ELL2;PIP5K1A;TP53BP2;SOX9;NRG1;ZNF451;FEM1C;PML;POU2F2;ELK3;POLR3A;PTPN11;UHRF1;MXD1;GCH1;FEM1B;SOX4;FOSL2;OXCT1;CCNL1;TNFAIP1;HDAC9;HIVEP1;AEN;SKIL;RBM3;CDK6;SAMD4A;TFE3;PRPF19;MAFG;MTF1;CELF1;NUP153;PDPK1;CTSC;KDM6A;ZBTB21;NFE2L2;SGK1;RELA;RNF11;BTAF1;GINS3;POLR3D;ALAS1;TDG;ELF4;ETNK1;SH3RF2;UPP1;ISG20;ATXN7;BRD2;IPO4;DSE
8405,GO:0033363,0.156982137773566,0.967666479571025,2,21,secretory granule organization,BP,CREB1;AGFG1
6555,GO:0021984,0.157412322965523,0.989430138116456,1,5,adenohypophysis development,BP,BMP2
20263,GO:2001214,0.157431996896926,0.989427401898784,1,5,positive regulation of vasculogenesis,BP,ADM
16264,GO:0090324,0.15772438803335,0.989386691886233,1,5,negative regulation of oxidative phosphorylation,BP,PPIF
8227,GO:0032989,0.158138560515043,0.884034310515007,32,747,cellular component morphogenesis,BP,EFNA1;EDN1;SEMA7A;KLF7;EFNB2;EPHA2;PHLDB2;RND3;ZSWIM4;FGD6;ADAM8;TACSTD2;NEDD4L;CREB1;EFNB1;RAPH1;ITGAV;NRG1;CDC42EP1;PTPN11;RHOB;VCL;SKIL;IL7R;CORO1C;WNT5A;FRMD6;YWHAH;SGK1;B3GNT2;AGFG1;PDLIM5
15879,GO:0072608,0.158140267341821,0.988905098303728,1,6,interleukin-10 secretion,BP,CD274
489,GO:0001541,0.158151672962626,0.952123384491983,3,42,ovarian follicle development,BP,INHBA;CEBPB;EREG
13481,GO:0055013,0.158329354687063,0.95224263736846,3,38,cardiac muscle cell development,BP,TBX3;EDN1;PDLIM5
3707,GO:0008216,0.158339022841982,0.98857392031835,1,7,spermidine metabolic process,BP,SAT1
12349,GO:0048712,0.158614906750512,0.989262186961489,1,5,negative regulation of astrocyte differentiation,BP,LDLR
4261,GO:0009597,0.158836955346977,0.989231020691039,1,5,detection of virus,BP,IFIH1
2045,GO:0004791,0.159120264786817,0.988762327280595,1,6,thioredoxin-disulfide reductase activity,MF,TXNRD1
6552,GO:0021978,0.159133488639364,0.989189324362087,1,5,telencephalon regionalization,BP,BMP2
13504,GO:0055067,0.159183781311737,0.932881576188421,5,86,monovalent inorganic cation homeostasis,BP,EDN1;NEDD4L;SLC9A1;MAFG;ATP6V1C2
1235,GO:0002921,0.159230006970734,0.989175734022497,1,5,negative regulation of humoral immune response,BP,CD55
5019,GO:0015181,0.159254801064369,0.989172241392279,1,5,arginine transmembrane transporter activity,MF,SLC7A2
5026,GO:0015189,0.159254801064369,0.989172241392279,1,5,L-lysine transmembrane transporter activity,MF,SLC7A2
7529,GO:0031748,0.159282749672276,0.98916830367554,1,5,D1 dopamine receptor binding,MF,PTPN11
16123,GO:0090114,0.159413961333083,0.94083288023451,4,63,COPII-coated vesicle budding,BP,TGFA;AREG;INSIG1;CTSC
7568,GO:0031915,0.159429313091952,0.989147641586086,1,5,positive regulation of synaptic plasticity,BP,PTGS2
2235,GO:0005138,0.159433434082374,0.989147060315422,1,5,interleukin-6 receptor binding,MF,IL6ST
3576,GO:0007622,0.15945440815524,0.966651308604941,2,23,rhythmic behavior,BP,CSF2;AHCY
12239,GO:0048512,0.15945440815524,0.966651308604941,2,23,circadian behavior,BP,CSF2;AHCY
16062,GO:0089720,0.159598381933846,0.98869231799623,1,6,caspase binding,MF,RIPK2
3107,GO:0006685,0.159948080389508,0.989074337536987,1,5,sphingomyelin catabolic process,BP,SMPD3
13234,GO:0051894,0.160089977637024,0.966744180898007,2,20,positive regulation of focal adhesion assembly,BP,SDC4;SMAD3
18256,GO:1903078,0.16010554487795,0.951409549400781,3,39,positive regulation of protein localization to plasma membrane,BP,EPHA2;SQSTM1;PDPK1
9609,GO:0036473,0.160114185353394,0.940449743849451,4,64,cell death in response to oxidative stress,BP,SOD2;PML;NCOA7;NFE2L2
17880,GO:1902117,0.160252914225914,0.940524233844925,4,59,positive regulation of organelle assembly,BP,CSF2;SDC4;TNF;EDN1
772,GO:0002024,0.160365309692986,0.989015189104247,1,5,diet induced thermogenesis,BP,ADRB2
10336,GO:0043130,0.160498729790264,0.940227553372179,4,65,ubiquitin binding,MF,TNFAIP3;SQSTM1;BIRC2;SMAD3
10653,GO:0043696,0.160553211310574,0.988988495294217,1,5,dedifferentiation,BP,CDK6
10654,GO:0043697,0.160553211310574,0.988988495294217,1,5,cell dedifferentiation,BP,CDK6
9330,GO:0035810,0.160713411659927,0.988965709339284,1,5,positive regulation of urine volume,BP,EDN1
18079,GO:1902668,0.160813307002321,0.96662762068508,2,19,negative regulation of axon guidance,BP,SEMA7A;WNT5A
5568,GO:0016578,0.161020158772293,0.966319667747624,2,21,histone deubiquitination,BP,USP36;ATXN7
2523,GO:0005776,0.161127186791777,0.931837399281277,5,84,autophagosome,CC,TICAM1;PLEKHF1;SQSTM1;VMP1;RAB24
17204,GO:0106049,0.161196879610377,0.988896790396923,1,5,regulation of cellular response to osmotic stress,BP,PTGS2
17909,GO:1902218,0.161196879610377,0.988896790396923,1,5,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,PTGS2
16683,GO:0097629,0.161201314525441,0.988896157128095,1,5,extrinsic component of omegasome membrane,CC,PLEKHF1
15167,GO:0071295,0.161230109078003,0.966362506044818,2,20,cellular response to vitamin,BP,PIM1;CYP27B1
16094,GO:0090074,0.161239582707242,0.988890691945869,1,5,negative regulation of protein homodimerization activity,BP,SPAG9
3215,GO:0006863,0.161261081590202,0.988447039910261,1,6,purine nucleobase transport,BP,SLC28A3
67,GO:0000138,0.16164649955811,0.988389781105164,1,6,Golgi trans cisterna,CC,B4GALT1
3545,GO:0007569,0.161668706024559,0.931478547249372,5,87,cell aging,BP,TBX3;CDKN1A;PLK2;PML;CDK6
13956,GO:0060638,0.16189058753702,0.988797498935711,1,5,mesenchymal-epithelial cell signaling,BP,WNT5A
12810,GO:0051101,0.161966945595765,0.9312257489535,5,92,regulation of DNA binding,BP,NFKBIA;PLAUR;LIF;JUN;BCL3
11315,GO:0045634,0.162062286886878,0.98877285005351,1,5,regulation of melanocyte differentiation,BP,ADAMTS9
1609,GO:0004030,0.162216818605211,0.988750640849293,1,5,aldehyde dehydrogenase [NAD(P)+] activity,MF,ALDH1A3
18865,GO:1904502,0.162398288701011,0.988724529978924,1,5,regulation of lipophagy,BP,ADRB2
18866,GO:1904504,0.162398288701011,0.988724529978924,1,5,positive regulation of lipophagy,BP,ADRB2
8352,GO:0033216,0.162458044737955,0.988715924849576,1,5,ferric iron import,BP,STEAP4
11332,GO:0045656,0.162507786187679,0.988708759174873,1,5,negative regulation of monocyte differentiation,BP,CDK6
17894,GO:1902175,0.162648443615712,0.965571233200747,2,23,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,SOD2;NFE2L2
6277,GO:0019870,0.16266125049283,0.988686635948503,1,5,potassium channel inhibitor activity,MF,NEDD4L
3458,GO:0007272,0.162674339746385,0.931013259587364,5,82,ensheathment of neurons,BP,NAB1;PPARD;NDRG1;NRG1;QKI
3796,GO:0008366,0.162674339746385,0.931013259587364,5,82,axon ensheathment,BP,NAB1;PPARD;NDRG1;NRG1;QKI
5801,GO:0017049,0.162685999702977,0.965757542245994,2,21,GTP-Rho binding,MF,CDC42EP1;TNFAIP1
615,GO:0001781,0.162693856633861,0.988681932490527,1,5,neutrophil apoptotic process,BP,HCAR2
8251,GO:0033029,0.162693856633861,0.988681932490527,1,5,regulation of neutrophil apoptotic process,BP,HCAR2
5588,GO:0016604,0.162838710258303,0.883411249666874,27,653,nuclear body,CC,NFKBIZ;ITPKC;BHLHE40;GADD45A;SQSTM1;CDKN1A;NAMPT;N4BP1;TRIM16;PPP1R10;ZNF217;DUSP10;USP36;IL16;RAPH1;PIP5K1A;ZNF451;PML;CCNL1;HIVEP1;PRPF19;SGK1;POLR3D;TDG;ELF4;ISG20;BRD2
14031,GO:0060753,0.162898181503973,0.9882027805944,1,6,regulation of mast cell chemotaxis,BP,VEGFC
2734,GO:0006112,0.162963412091356,0.939110192923363,4,60,energy reserve metabolic process,BP,PHLDA2;IL6ST;STK40;PHKG2
7588,GO:0031954,0.163090126126455,0.965736027517372,2,20,positive regulation of protein autophosphorylation,BP,RAP2B;VEGFC
7883,GO:0032449,0.163122908034433,0.988619943673954,1,5,CBM complex,CC,BCL10
638,GO:0001825,0.163207965367529,0.965475915831227,2,22,blastocyst formation,BP,JUNB;SKIL
16230,GO:0090280,0.163403971964858,0.988579237260909,1,5,positive regulation of calcium ion import,BP,TRPV3
10615,GO:0043604,0.163526411283898,0.883505604360192,26,734,amide biosynthetic process,BP,ZC3H12A;BTG2;TNF;TNIP1;CPEB2;BCL3;ZFP36L1;ENC1;UGCG;PPP1R15A;SGMS2;RC3H1;ZFP36;LARP4B;PPP1R15B;GCH1;SOX4;EIF1;RBM3;SAMD4A;QKI;CELF1;NUP153;NFE2L2;PABPC4;SMPD3
3985,GO:0008823,0.163559741727383,0.988556643523857,1,5,cupric reductase activity,MF,STEAP4
13448,GO:0052851,0.163559741727383,0.988556643523857,1,5,ferric-chelate reductase (NADPH) activity,MF,STEAP4
5387,GO:0016209,0.163590799467114,0.94931497827633,3,53,antioxidant activity,MF,PTGS2;SOD2;TXNRD1
5934,GO:0018210,0.163638107091435,0.923990057074717,6,104,peptidyl-threonine modification,BP,CAB39;OXSR1;RIPK2;PHKG2;WNT5A;PDPK1
8844,GO:0034638,0.163676044410141,0.988085760786378,1,6,phosphatidylcholine catabolic process,BP,LDLR
8715,GO:0034362,0.163918149883795,0.988049212573455,1,6,low-density lipoprotein particle,CC,LDLR
20031,GO:2000646,0.163944449825949,0.988500740413763,1,5,positive regulation of receptor catabolic process,BP,PTPN1
6703,GO:0030100,0.164291287201416,0.913869908963221,8,157,regulation of endocytosis,BP,IL1B;TNF;LDLR;NEDD4L;ITGAV;PTPN1;ABL2;WNT5A
4765,GO:0010944,0.164611374252159,0.987944231212402,1,6,negative regulation of transcription by competitive promoter binding,BP,CREB1
3157,GO:0006766,0.164815269838729,0.929642790796006,5,91,vitamin metabolic process,BP,IL1B;TNF;NFKB1;PPARD;CYP27B1
9863,GO:0042117,0.164940086535628,0.988355381109558,1,5,monocyte activation,BP,ADAM9
17586,GO:1901216,0.165268060399752,0.937808347129991,4,64,positive regulation of neuron death,BP,EFNB2;JUN;TP53BP2;WNT5A
8016,GO:0032647,0.165437578277174,0.964820733977731,2,21,regulation of interferon-alpha production,BP,RIPK2;IFIH1
18352,GO:1903321,0.165470835412066,0.937624389171397,4,67,negative regulation of protein modification by small protein conjugation or removal,BP,TNFAIP3;N4BP1;SOX4;RELA
343,GO:0000956,0.165527495239701,0.9127768367784,8,200,nuclear-transcribed mRNA catabolic process,BP,ZC3H12A;BTG2;NOCT;ZFP36L1;RC3H1;ZFP36;PNRC1;SAMD4A
19219,GO:1905332,0.165596429959351,0.964766335419502,2,21,positive regulation of morphogenesis of an epithelium,BP,LIF;SOX9
14690,GO:0070314,0.165637498213705,0.988252976509572,1,5,G1 to G0 transition,BP,CYP27B1
4598,GO:0010712,0.165647021518391,0.964544505239435,2,23,regulation of collagen metabolic process,BP,ERRFI1;PPARD
13882,GO:0060509,0.165797238961104,0.988229453036627,1,5,Type I pneumocyte differentiation,BP,CREB1
11283,GO:0045591,0.16599762742137,0.987732819162281,1,6,positive regulation of regulatory T cell differentiation,BP,DUSP10
16738,GO:0097756,0.166153088930686,0.948668276238114,3,40,negative regulation of blood vessel diameter,BP,PTGS2;EDN1;ADM
10481,GO:0043374,0.166198044227456,0.988170318837408,1,5,CD8-positive, alpha-beta T cell differentiation,BP,IRF1
12649,GO:0050850,0.166270543144963,0.964329461340435,2,23,positive regulation of calcium-mediated signaling,BP,SLC9A1;NRG1
16125,GO:0090118,0.166348461556896,0.988148085334853,1,5,receptor-mediated endocytosis involved in cholesterol transport,BP,LDLR
6507,GO:0021877,0.166723268488606,0.988092586567541,1,5,forebrain neuron fate commitment,BP,DLX2
19653,GO:1990868,0.166824724083859,0.988077539734513,1,5,response to chemokine,BP,ZC3H12A
19654,GO:1990869,0.166824724083859,0.988077539734513,1,5,cellular response to chemokine,BP,ZC3H12A
11667,GO:0046439,0.166986148943639,0.988053577799874,1,5,L-cysteine metabolic process,BP,AHCY
4958,GO:0015026,0.167047449272994,0.964387457237273,2,20,coreceptor activity,MF,RGMB;ITGAV
2553,GO:0005827,0.167159074951199,0.988027879895438,1,5,polar microtubule,CC,KLHL21
2555,GO:0005829,0.167169539974286,0.858179514519986,144,4101,cytosol,CC,NFKBIA;TNFAIP3;IL1B;IL1A;BTG2;BIRC3;ITPKC;TICAM1;ELF3;REL;IER3;KLF6;SPRR2D;RNF19B;PMAIP1;TNIP1;NFKB1;FOSL1;NFKB2;IRF6;ODC1;PHLDA1;ERRFI1;IRAK2;DAPP1;SPRR2A;RELB;LIF;SQSTM1;CAB39;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;PHLDB2;TJP2;SERTAD2;BCL3;ETS2;NAMPT;AMPD3;IRF1;BCL2L2;ZFP36L1;DUSP16;PPP1R15A;RUNX1;CDKN2B;HMGCS1;TRIM16;PELI1;ALDH1A3;NEDD9;HAL;BCL10;TMCC1;TRAF1;PIM3;CDV3;NABP1;TXNRD1;CYLD;TACSTD2;NEDD4L;OXSR1;SMAD3;DUSP10;PLK2;PIM1;WISP1;KLHL21;SERPINB8;STK40;KRT34;SOCS3;KRTAP2-3;IL16;RAPH1;ZFP36;LARP4B;AZIN1;RIPK2;AMOTL2;PHKG2;STARD5;NDRG1;ITGAV;PIP5K1A;TP53BP2;STX1A;FEM1C;PML;RASA2;FERMT1;POLR3A;PTPN11;MAP3K8;ARHGEF3;C15ORF39;MXD1;RHOB;SPAG9;GCH1;FEM1B;VCL;FAM83G;NFKBIB;CDK6;SAMD4A;PTPN1;TFE3;TOB2;ABL2;ATP6V1C2;RAB3IP;PMM2;NUP153;PDPK1;RNF19A;ZBTB21;NFE2L2;YWHAH;SGK1;CYTH1;SAT1;RELA;AGFG1;BACH1;POLR3D;ALAS1;YWHAG;SFN;ETNK1;UPP1;ATXN7;IFIH1;PABPC4;DSE;AHCY;STX12;PDLIM5;RAB24
19701,GO:2000018,0.167176814589823,0.988025241990908,1,5,regulation of male gonad development,BP,SOX9
20203,GO:2001054,0.167182273079741,0.988024430244267,1,5,negative regulation of mesenchymal cell apoptotic process,BP,SOX9
13172,GO:0051766,0.167368155907565,0.98799676942714,1,5,inositol trisphosphate kinase activity,MF,ITPKC
13828,GO:0060421,0.167451100408221,0.964128660523776,2,21,positive regulation of heart growth,BP,EDN1;PIM1
2436,GO:0005634,0.167547050524915,0.85681463626146,197,5696,nucleus,CC,NFKBIA;NFKBIZ;TNFAIP3;ZC3H12A;BTG2;BIRC3;NFKBID;ITPKC;ELF3;ETS1;REL;IER3;KLF6;NUAK2;ZNF697;BHLHE40;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;PLEKHF1;KDM6B;IRF6;PHLDA1;ERRFI1;IRAK2;KLF7;CREB5;CPEB2;EHF;RELB;GADD45A;MAFF;TRIB1;SQSTM1;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;TJP2;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;ZFP36L1;ENC1;RELT;ADRB2;CEBPB;DUSP16;ARNTL2;RUNX1;N4BP1;CDKN2B;GJB4;NAB1;TRIM16;ELMSAN1;PELI1;ALDH1A3;NEDD9;DUSP8;DUSP1;BCL10;PPP1R10;SACS;VMP1;NABP1;DLX2;TXNRD1;VGLL3;KLF3;ZNF217;TACSTD2;NEDD4L;SMAD3;DUSP10;PLK3;DIEXF;PIM1;AKIRIN1;CREB1;EFNB1;STK40;HIVEP2;PPARD;CCDC85B;USP36;IL16;RAPH1;ZFP36;SLC9A1;MAFK;LARP4B;TMEM217;PNRC1;ELL2;AZIN1;PLAGL2;NAV3;NDRG1;PIP5K1A;CLK4;TP53BP2;SOX9;STX1A;NRG1;ZNF451;FEM1C;PML;POU2F2;NCOA7;ELK3;POLR3A;ZNF460;FOXN2;PTPN11;UHRF1;MXD1;RHOB;GCH1;FEM1B;SOX4;USP31;FOSL2;TRAF4;EIF1;OXCT1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;HIVEP1;NFKBIB;KLF10;AEN;SKIL;COTL1;HEXDC;RBM3;CDK6;IER5;SAMD4A;TFE3;BTG3;PRPF19;TOB2;MAFG;MTF1;RAB3IP;QKI;CELF1;PMM2;NUP153;PDPK1;CTSC;KDM6A;ZBTB21;NFE2L2;SGK1;TSC22D2;RELA;AGFG1;RNF11;BACH1;BTAF1;GINS3;POLR3D;ALAS1;TDG;ELF4;SFN;ERN1;ETNK1;SH3RF2;UPP1;ISG20;ATXN7;IFIH1;BRD2;IPO4;PABPC4;DSE;AHCY;FUBP3
6578,GO:0022402,0.167585669824083,0.870768365653118,44,1141,cell cycle process,BP,IL1B;IL1A;BTG2;BIRC3;INHBA;CXCL8;TGFA;IRF6;EDN1;PHLDA1;GADD45A;LIF;CAB39;BIRC2;CDKN1A;OVOL1;IRF1;ZFP36L1;RND3;PPP1R15A;CDKN2B;EREG;ANKLE2;DUSP1;DCUN1D3;PPP1R10;NABP1;SMAD3;PLK2;PLK3;KLHL21;CYP27B1;SOX9;PML;RHOB;SOX4;SKIL;CDK6;WNT5A;NUP153;BACH1;YWHAG;SFN;ERN1
11291,GO:0045602,0.167805852918733,0.987931500941951,1,5,negative regulation of endothelial cell differentiation,BP,JAG1
3136,GO:0006729,0.167946456292658,0.987091881738965,1,7,tetrahydrobiopterin biosynthetic process,BP,GCH1
11584,GO:0046146,0.167946456292658,0.987091881738965,1,7,tetrahydrobiopterin metabolic process,BP,GCH1
5911,GO:0018146,0.16808226463367,0.963801194058589,2,22,keratan sulfate biosynthetic process,BP,B4GALT1;B3GNT2
4282,GO:0009648,0.168305799057917,0.963723613669509,2,22,photoperiodism,BP,BHLHE40;PML
5250,GO:0015874,0.168347082216034,0.987850530270309,1,5,norepinephrine transport,BP,STX1A
12370,GO:0048755,0.168348570225392,0.987850307254426,1,5,branching morphogenesis of a nerve,BP,DLX2
9431,GO:0036003,0.168764508561752,0.96346401188179,2,23,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,CEBPB;NFE2L2
14229,GO:0061179,0.16895020403984,0.986931445738868,1,7,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,PIM3
17863,GO:1902075,0.168962064240172,0.987274091960189,1,6,cellular response to salt,BP,ZC3H12A
14302,GO:0061419,0.169012102701419,0.987750640287218,1,5,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,NFE2L2
3259,GO:0006929,0.169022489125806,0.96358471834705,2,21,substrate-dependent cell migration,BP,ADAM8;VEGFC
13971,GO:0060675,0.169029065019544,0.947371563122214,3,40,ureteric bud morphogenesis,BP,BMP2;TACSTD2;SOX9
15653,GO:0072171,0.169029065019544,0.947371563122214,3,40,mesonephric tubule morphogenesis,BP,BMP2;TACSTD2;SOX9
18305,GO:1903214,0.169309412482166,0.935605892226427,4,68,regulation of protein targeting to mitochondrion,BP,UGCG;USP36;PLAGL2;NRG1
8186,GO:0032924,0.169472775399455,0.963317494332688,2,22,activin receptor signaling pathway,BP,INHBA;SMAD3
8305,GO:0033139,0.169586141406709,0.98717636573583,1,6,regulation of peptidyl-serine phosphorylation of STAT protein,BP,LIF
9945,GO:0042306,0.16959214125444,0.947014174116101,3,42,regulation of protein import into nucleus,BP,ZC3H12A;PTGS2;CDKN1A
15660,GO:0072178,0.169645522299828,0.987655086964382,1,5,nephric duct morphogenesis,BP,EFNB2
11706,GO:0046498,0.169654885785033,0.987165576243442,1,6,S-adenosylhomocysteine metabolic process,BP,AHCY
6920,GO:0030511,0.169806477585556,0.96320102158774,2,22,positive regulation of transforming growth factor beta receptor signaling pathway,BP,CDKN2B;FERMT1
18592,GO:1903846,0.169806477585556,0.96320102158774,2,22,positive regulation of cellular response to transforming growth factor beta stimulus,BP,CDKN2B;FERMT1
1375,GO:0003264,0.170094563481861,0.987096452946244,1,6,regulation of cardioblast proliferation,BP,PIM1
1975,GO:0004689,0.170343570864879,0.987549320411533,1,5,phosphorylase kinase activity,MF,PHKG2
2634,GO:0005964,0.170343570864879,0.987549320411533,1,5,phosphorylase kinase complex,CC,PHKG2
9183,GO:0035561,0.170583368081772,0.963041090215203,2,21,regulation of chromatin binding,BP,BTAF1;TDG
3570,GO:0007616,0.170591508605198,0.963038246330573,2,21,long-term memory,BP,LDLR;SGK1
15183,GO:0071322,0.170687765934907,0.926331388084182,5,90,cellular response to carbohydrate stimulus,BP,ZFP36L1;PIM3;SOX4;OXCT1;ERN1
495,GO:0001547,0.171034669390863,0.98744412742177,1,5,antral ovarian follicle growth,BP,EREG
5696,GO:0016814,0.171176006149794,0.962619105738781,2,23,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,AMPD3;GCH1
803,GO:0002069,0.171654515535993,0.986849594271925,1,6,columnar/cuboidal epithelial cell maturation,BP,CDKN1A
10250,GO:0042985,0.171712387601851,0.98684038769339,1,6,negative regulation of amyloid precursor protein biosynthetic process,BP,ITM2B
13707,GO:0060260,0.17201197471457,0.962324361034941,2,23,regulation of transcription initiation from RNA polymerase II promoter,BP,CREB1;ZNF451
6278,GO:0019871,0.172014394883493,0.987294183643919,1,5,sodium channel inhibitor activity,MF,NEDD4L
8883,GO:0034698,0.172073574064462,0.962518989148114,2,21,response to gonadotropin,BP,INHBA;HMGCS1
17343,GO:1900027,0.172073622069312,0.962302587818369,2,23,regulation of ruffle assembly,BP,TACSTD2;CORO1C
903,GO:0002281,0.1720744485563,0.987284961377238,1,5,macrophage activation involved in immune response,BP,TICAM1
17673,GO:1901533,0.172337826547575,0.986740668281555,1,6,negative regulation of hematopoietic progenitor cell differentiation,BP,NFE2L2
14488,GO:0061912,0.17238715979975,0.945789847525693,3,41,selective autophagy,BP,SQSTM1;ADRB2;RIPK2
4526,GO:0010587,0.172760879313994,0.987179291571054,1,5,miRNA catabolic process,BP,ZC3H12A
14263,GO:0061314,0.172788505977503,0.987175028811946,1,5,Notch signaling involved in heart development,BP,JAG1
19909,GO:2000394,0.172809335258274,0.987171814374479,1,5,positive regulation of lamellipodium morphogenesis,BP,CORO1C
7760,GO:0032275,0.17285406214161,0.987164910517147,1,5,luteinizing hormone secretion,BP,TBX3
3693,GO:0008200,0.172865991994097,0.961927355669315,2,24,ion channel inhibitor activity,MF,NEDD4L;STX1A
11793,GO:0046658,0.173066032336487,0.961856289282896,2,24,anchored component of plasma membrane,CC,EFNA1;RGMB
8854,GO:0034650,0.17310359324434,0.987126357114311,1,5,cortisol metabolic process,BP,BMP2
8855,GO:0034651,0.17310359324434,0.987126357114311,1,5,cortisol biosynthetic process,BP,BMP2
19724,GO:2000064,0.17310359324434,0.987126357114311,1,5,regulation of cortisol biosynthetic process,BP,BMP2
9897,GO:0042181,0.173203086585548,0.961720208581859,2,25,ketone biosynthetic process,BP,BMP2;ADM
10017,GO:0042447,0.173257715237151,0.986593264932036,1,6,hormone catabolic process,BP,YWHAH
15489,GO:0071855,0.173308457755558,0.986222468028257,1,7,neuropeptide receptor binding,MF,EDN1
15146,GO:0071257,0.173443834146114,0.987073688110552,1,5,cellular response to electrical stimulus,BP,SLC9A1
18637,GO:1903935,0.173462277607099,0.986560366395555,1,6,response to sodium arsenite,BP,ZC3H12A
20042,GO:2000659,0.173704348476802,0.986521379445575,1,6,regulation of interleukin-1-mediated signaling pathway,BP,IL1RN
7991,GO:0032607,0.173740830204771,0.961816387254864,2,22,interferon-alpha production,BP,RIPK2;IFIH1
19593,GO:1990668,0.17386010927249,0.986496261055737,1,6,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,TAP1
883,GO:0002246,0.173959208701339,0.986480266901922,1,6,wound healing involved in inflammatory response,BP,IL1A
3108,GO:0006686,0.17409505264862,0.986458325780017,1,6,sphingomyelin biosynthetic process,BP,SGMS2
10716,GO:0044033,0.174225028975283,0.986437314420958,1,6,multi-organism metabolic process,BP,MAP2K3
10422,GO:0043266,0.174339967161088,0.944893411675878,3,41,regulation of potassium ion transport,BP,CAB39;NEDD4L;OXSR1
12362,GO:0048742,0.174490934125732,0.986910868851098,1,5,regulation of skeletal muscle fiber development,BP,HDAC9
11487,GO:0045948,0.174598115420698,0.961406521918058,2,23,positive regulation of translational initiation,BP,TNF;PPP1R15A
2099,GO:0004864,0.174719958079093,0.961363054860616,2,23,protein phosphatase inhibitor activity,MF,PPP1R10;SH3RF2
15905,GO:0072677,0.174723797880097,0.986356522737153,1,6,eosinophil migration,BP,ADAM8
13568,GO:0060028,0.174860960023589,0.986853068120467,1,5,convergent extension involved in axis elongation,BP,WNT5A
9671,GO:0038031,0.174892522834847,0.986848131408957,1,5,non-canonical Wnt signaling pathway via JNK cascade,BP,WNT5A
16150,GO:0090166,0.174913516613035,0.986325723736857,1,6,Golgi disassembly,BP,PLK3
12718,GO:0050942,0.174979275075599,0.98683455740683,1,5,positive regulation of pigment cell differentiation,BP,ADAMTS9
4419,GO:0010212,0.175111949199654,0.911379465832976,7,136,response to ionizing radiation,BP,GADD45A;CDKN1A;DCUN1D3;NABP1;PML;RHOB;AEN
2326,GO:0005337,0.175146165489028,0.986287904308372,1,6,nucleoside transmembrane transporter activity,MF,SLC28A3
5239,GO:0015858,0.175146165489028,0.986287904308372,1,6,nucleoside transport,BP,SLC28A3
17723,GO:1901642,0.175146165489028,0.986287904308372,1,6,nucleoside transmembrane transport,BP,SLC28A3
479,GO:0001523,0.175163075613442,0.944412663053741,3,43,retinoid metabolic process,BP,SDC4;ALDH1A3;PPARD
4584,GO:0010668,0.175284120679453,0.986786798607942,1,5,ectodermal cell differentiation,BP,ETS2
9546,GO:0036302,0.175296665755701,0.98678483122418,1,5,atrioventricular canal development,BP,PTPN11
5211,GO:0015809,0.175392828449518,0.9862477452047,1,6,arginine transport,BP,SLC7A2
498,GO:0001553,0.175514445804388,0.986750652594055,1,5,luteinization,BP,INHBA
10156,GO:0042737,0.175880728158804,0.932026622204824,4,73,drug catabolic process,BP,AMPD3;OXCT1;MAOA;SAT1
3098,GO:0006672,0.175900402672538,0.932192639548647,4,66,ceramide metabolic process,BP,TNF;UGCG;SGMS2;SMPD3
18705,GO:1904064,0.17593152493017,0.932204563176984,4,65,positive regulation of cation transmembrane transport,BP,ADRB2;BDKRB1;SLC9A1;PDPK1
9784,GO:0039706,0.176047373338221,0.986140871770082,1,6,co-receptor binding,MF,BMP2
12808,GO:0051099,0.176190530793277,0.910647703103538,7,140,positive regulation of binding,BP,PLAUR;TICAM1;BMP2;PLK2;RIPK2;TRAF4;WNT5A
7468,GO:0031625,0.176318987035144,0.892995965475524,12,268,ubiquitin protein ligase binding,MF,NFKBIA;TRIB1;SQSTM1;JUN;CDKN1A;BCL10;TRAF1;SMAD3;PML;TRAF4;VCL;RELA
5035,GO:0015205,0.17643553081575,0.986077282879818,1,6,nucleobase transmembrane transporter activity,MF,SLC28A3
5232,GO:0015846,0.176470149793614,0.986071603884258,1,6,polyamine transport,BP,AZIN1
4895,GO:0014820,0.176483276945938,0.986069450141992,1,6,tonic smooth muscle contraction,BP,EDN1
7067,GO:0030853,0.176634960015491,0.98657404296426,1,5,negative regulation of granulocyte differentiation,BP,TRIB1
8617,GO:0034135,0.17664012240497,0.986043702956571,1,6,regulation of toll-like receptor 2 signaling pathway,BP,TNFAIP3
19832,GO:2000288,0.176926471069762,0.985996630785561,1,6,positive regulation of myoblast proliferation,BP,PPARD
10134,GO:0042693,0.177042791511467,0.985977484705341,1,6,muscle cell fate commitment,BP,TBX3
3442,GO:0007253,0.177229373634513,0.985567380465085,1,7,cytoplasmic sequestering of NF-kappaB,BP,NFKBIA
1347,GO:0003208,0.177307060595207,0.943577082710797,3,40,cardiac ventricle morphogenesis,BP,JAG1;NRG1;SOX4
4515,GO:0010564,0.177317336383167,0.873365293054945,25,623,regulation of cell cycle process,BP,IL1B;IL1A;BTG2;TGFA;EDN1;GADD45A;LIF;CDKN1A;OVOL1;ZFP36L1;CDKN2B;EREG;DUSP1;DCUN1D3;PPP1R10;PLK2;PLK3;KLHL21;SOX9;PML;SOX4;CDK6;WNT5A;YWHAG;SFN
13555,GO:0060013,0.177319998726724,0.986465447413591,1,5,righting reflex,BP,ALDH1A3
11216,GO:0045350,0.1775183727367,0.985899058164192,1,6,interferon-beta biosynthetic process,BP,TICAM1
11223,GO:0045357,0.1775183727367,0.985899058164192,1,6,regulation of interferon-beta biosynthetic process,BP,TICAM1
8256,GO:0033034,0.177702188315815,0.985868682441125,1,6,positive regulation of myeloid cell apoptotic process,BP,HCAR2
15300,GO:0071493,0.177767090128203,0.98585794891363,1,6,cellular response to UV-B,BP,CDKN1A
4591,GO:0010694,0.177914629920909,0.986370799776021,1,5,positive regulation of alkaline phosphatase activity,BP,SMAD3
6516,GO:0021891,0.177972962063546,0.986361495800854,1,5,olfactory bulb interneuron development,BP,WNT5A
13320,GO:0052173,0.178092164304857,0.985804121572243,1,6,response to defenses of other organism involved in symbiotic interaction,BP,SMAD3
13325,GO:0052200,0.178092164304857,0.985804121572243,1,6,response to host defenses,BP,SMAD3
15951,GO:0075136,0.178092164304857,0.985804121572243,1,6,response to host,BP,SMAD3
17864,GO:1902083,0.178165203659949,0.986330808942137,1,5,negative regulation of peptidyl-cysteine S-nitrosylation,BP,NCOA7
19768,GO:2000169,0.178165203659949,0.986330808942137,1,5,regulation of peptidyl-cysteine S-nitrosylation,BP,NCOA7
6084,GO:0019238,0.178321116553139,0.985766144257762,1,6,cyclohydrolase activity,MF,GCH1
15982,GO:0080154,0.178475648740284,0.985740480339142,1,6,regulation of fertilization,BP,B4GALT1
3169,GO:0006782,0.178568778093894,0.985339837764215,1,7,protoporphyrinogen IX biosynthetic process,BP,ALAS1
15230,GO:0071389,0.178571137703081,0.985724609532244,1,6,cellular response to mineralocorticoid stimulus,BP,EDN1
9828,GO:0042048,0.17867706501594,0.986248920196144,1,5,olfactory behavior,BP,GJB4
1203,GO:0002861,0.178796385857443,0.985012159495108,1,8,regulation of inflammatory response to antigenic stimulus,BP,TNF
6725,GO:0030134,0.178837563321073,0.930575289978372,4,68,COPII-coated ER to Golgi transport vesicle,CC,TGFA;AREG;HLA-E;CTSC
6872,GO:0030346,0.179067048622736,0.98564203288536,1,6,protein phosphatase 2B binding,MF,SLC9A1
14651,GO:0070244,0.179108481309813,0.985635122066614,1,6,negative regulation of thymocyte apoptotic process,BP,EFNA1
13584,GO:0060048,0.17913554067585,0.930530513527117,4,64,cardiac muscle contraction,BP,ZC3H12A;MAP2K3;NEDD4L;SLC9A1
16463,GO:0097136,0.179271943042054,0.985607839721237,1,6,Bcl-2 family protein complex,CC,BCL2L2
4353,GO:0009925,0.179314341399395,0.959939344151027,2,21,basal plasma membrane,CC,CLDN4;TACSTD2
11684,GO:0046467,0.179367846738303,0.914254029544851,6,118,membrane lipid biosynthetic process,BP,PLAUR;TNF;UGCG;B3GNT5;SGMS2;SMPD3
1305,GO:0003143,0.179627418127612,0.942497042289424,3,40,embryonic heart tube morphogenesis,BP,TBX3;SMAD3;WNT5A
1361,GO:0003230,0.180122404772146,0.959647064778199,2,21,cardiac atrium development,BP,SOX4;WNT5A
7748,GO:0032261,0.180336969702699,0.985036508076522,1,7,purine nucleotide salvage,BP,AMPD3
9645,GO:0036514,0.18048104191159,0.985958202472465,1,5,dopaminergic neuron axon guidance,BP,WNT5A
19068,GO:1904938,0.18048104191159,0.985958202472465,1,5,planar cell polarity pathway involved in axon guidance,BP,WNT5A
10057,GO:0042541,0.180684228358798,0.985370958336573,1,6,hemoglobin biosynthetic process,BP,INHBA
5558,GO:0016567,0.180703199306212,0.868187228479721,28,706,protein ubiquitination,BP,TNFAIP3;BIRC3;TICAM1;RNF19B;KCTD11;BIRC2;ENC1;ADRB2;N4BP1;PELI1;BCL10;DCUN1D3;NEDD4L;RC3H1;KLHL21;SOCS3;RIPK2;FEM1C;UHRF1;FEM1B;SOX4;TNFAIP1;PRPF19;RNF19A;NFE2L2;RNF11;BACH1;SH3RF2
9695,GO:0038092,0.181097661977894,0.985301217639774,1,6,nodal signaling pathway,BP,SMAD3
17821,GO:1901977,0.181241823614509,0.985276857314487,1,6,negative regulation of cell cycle checkpoint,BP,PPP1R10
14339,GO:0061525,0.181428082980477,0.985804263144755,1,5,hindgut development,BP,WNT5A
14965,GO:0070873,0.181578009940652,0.959118346681351,2,21,regulation of glycogen metabolic process,BP,PHLDA2;PHKG2
13641,GO:0060137,0.18166357476941,0.985205464780045,1,6,maternal process involved in parturition,BP,EDN1
17923,GO:1902235,0.181717733611328,0.958636840902535,2,25,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,PMAIP1;PTPN1
4888,GO:0014807,0.18196935902905,0.985153585830289,1,6,regulation of somitogenesis,BP,NRARP
9942,GO:0042301,0.181975978576737,0.985152461679824,1,6,phosphate ion binding,MF,RELA
3756,GO:0008297,0.182069006407487,0.985136658555492,1,6,single-stranded DNA exodeoxyribonuclease activity,MF,ISG20
15056,GO:0071012,0.182099708255245,0.985131441075033,1,6,catalytic step 1 spliceosome,CC,PRPF19
11848,GO:0046826,0.182109503417789,0.984729064292575,1,7,negative regulation of protein export from nucleus,BP,SOX4
15549,GO:0071971,0.182519953975661,0.985059924753175,1,6,extracellular exosome assembly,BP,SDC4
18461,GO:1903551,0.182519953975661,0.985059924753175,1,6,regulation of extracellular exosome assembly,BP,SDC4
10407,GO:0043243,0.182619753792663,0.958501868737274,2,23,positive regulation of protein complex disassembly,BP,TNF;ADRB2
2928,GO:0006446,0.183155728514021,0.928203841882906,4,70,regulation of translational initiation,BP,TNF;PPP1R15A;PPP1R15B;EIF1
5142,GO:0015662,0.183171400996314,0.958412041433351,2,22,ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,MF,ATP6V1C2;ATP13A3
8623,GO:0034141,0.183378404558307,0.984913258312219,1,6,positive regulation of toll-like receptor 3 signaling pathway,BP,PELI1
13860,GO:0060462,0.183570072143232,0.985452727207531,1,5,lung lobe development,BP,LIF
13861,GO:0060463,0.183570072143232,0.985452727207531,1,5,lung lobe morphogenesis,BP,LIF
3230,GO:0006885,0.183583251711461,0.927999371514239,4,69,regulation of pH,BP,EDN1;SLC9A1;MAFG;ATP6V1C2
12886,GO:0051220,0.183655519543449,0.958016649507513,2,24,cytoplasmic sequestering of protein,BP,NFKBIA;NFKBIE
14260,GO:0061309,0.183692949562331,0.984859323962933,1,6,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,JAG1
16432,GO:0097084,0.183732716242061,0.984852497833323,1,6,vascular smooth muscle cell development,BP,ADM
12289,GO:0048617,0.183907963106162,0.985396847402681,1,5,embryonic foregut morphogenesis,BP,SMAD3
9719,GO:0038155,0.183941676218112,0.984816601522413,1,6,interleukin-23-mediated signaling pathway,BP,IL23A
4672,GO:0010819,0.184029983985457,0.984801417684751,1,6,regulation of T cell chemotaxis,BP,WNT5A
4673,GO:0010820,0.184029983985457,0.984801417684751,1,6,positive regulation of T cell chemotaxis,BP,WNT5A
2344,GO:0005381,0.184268030114262,0.984760446535574,1,6,iron ion transmembrane transporter activity,MF,TFRC
1003,GO:0002475,0.184277187783362,0.984758869175806,1,6,antigen processing and presentation via MHC class Ib,BP,HLA-E
2986,GO:0006531,0.184392083018239,0.984739071566014,1,6,aspartate metabolic process,BP,NMNAT2
19639,GO:1990822,0.18443606230601,0.984731489805089,1,6,basic amino acid transmembrane transport,BP,SLC7A2
4413,GO:0010171,0.184446745295799,0.940117134084061,3,42,body morphogenesis,BP,PHLDB2;CSRNP1;PTPN11
15774,GO:0072378,0.184664261545595,0.984279992918774,1,7,blood coagulation, fibrin clot formation,BP,F3
14940,GO:0070830,0.184808626886156,0.940001090310777,3,41,bicellular tight junction assembly,BP,TNF;CLDN1;RUNX1
16559,GO:0097342,0.184972293872001,0.984638882599363,1,6,ripoptosome,CC,TICAM1
1029,GO:0002534,0.18521603023121,0.957543112372267,2,23,cytokine production involved in inflammatory response,BP,ZC3H12A;TICAM1
18953,GO:1904714,0.185270038162975,0.984587331084907,1,6,regulation of chaperone-mediated autophagy,BP,PLK3
8922,GO:0034765,0.18542108547505,0.892246127561911,10,209,regulation of ion transmembrane transport,BP,PPIF;RRAD;CAB39;ADRB2;NEDD4L;OXSR1;BDKRB1;SLC9A1;PDPK1;YWHAH
8069,GO:0032736,0.186035348769731,0.984454395274094,1,6,positive regulation of interleukin-13 production,BP,HLA-E
9665,GO:0038024,0.186061756716159,0.939349612292449,3,42,cargo receptor activity,MF,LDLR;TFRC;CXCL16
19415,GO:1905941,0.18614056741151,0.984436070197674,1,6,positive regulation of gonad development,BP,SOX9
11192,GO:0045296,0.186332254635227,0.883268998770912,13,298,cadherin binding,MF,EPHA2;PHLDB2;TJP2;EHD1;TACSTD2;NDRG1;CDC42EP1;EFHD2;VCL;PTPN1;SFN;MYO1B;PDLIM5
17730,GO:1901658,0.186351177800712,0.956745130839671,2,27,glycosyl compound catabolic process,BP,UPP1;AHCY
11135,GO:0045180,0.186664003074739,0.984936709153471,1,5,basal cortex,CC,PHLDB2
15718,GO:0072282,0.186705191642056,0.984337534146257,1,6,metanephric nephron tubule morphogenesis,BP,SOX9
17226,GO:0110011,0.18674529984115,0.984923018308274,1,5,regulation of basement membrane organization,BP,PHLDB2
18768,GO:1904259,0.18674529984115,0.984923018308274,1,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,PHLDB2
18769,GO:1904261,0.18674529984115,0.984923018308274,1,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,PHLDB2
20251,GO:2001197,0.18674529984115,0.984923018308274,1,5,basement membrane assembly involved in embryonic body morphogenesis,BP,PHLDB2
8071,GO:0032740,0.186796541430244,0.983899787358849,1,7,positive regulation of interleukin-17 production,BP,IL23A
14172,GO:0061051,0.18683340751721,0.984315111402737,1,6,positive regulation of cell growth involved in cardiac muscle cell development,BP,EDN1
5410,GO:0016248,0.186852092121037,0.956730029874282,2,25,channel inhibitor activity,MF,NEDD4L;STX1A
16076,GO:0090037,0.187196915289588,0.984251445545524,1,6,positive regulation of protein kinase C signaling,BP,WNT5A
7274,GO:0031253,0.187197554835306,0.891039622119805,10,202,cell projection membrane,CC,PLAUR;EPHA2;EHD1;B4GALT1;SLC6A14;ITGA5;ITGAV;PIP5K1A;NRG1;FERMT1
6276,GO:0019869,0.187509355687534,0.983771587975102,1,7,chloride channel inhibitor activity,MF,STX1A
11396,GO:0045779,0.187557505648327,0.984188152377031,1,6,negative regulation of bone resorption,BP,TNFAIP3
14163,GO:0061042,0.187601757727465,0.984180375472796,1,6,vascular wound healing,BP,TNFAIP3
14420,GO:0061724,0.187605170119025,0.984179775689537,1,6,lipophagy,BP,ADRB2
16716,GO:0097709,0.187610919881864,0.984178765047383,1,6,connective tissue replacement,BP,IL1A
6066,GO:0019212,0.188052987079231,0.956377566862056,2,24,phosphatase inhibitor activity,MF,PPP1R10;SH3RF2
15558,GO:0072006,0.188260454662707,0.916227546752269,5,85,nephron development,BP,LIF;BMP2;TACSTD2;JAG1;SOX9
18193,GO:1902961,0.188320845807035,0.98405371126357,1,6,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,EFNA1
19184,GO:1905247,0.188320845807035,0.98405371126357,1,6,positive regulation of aspartic-type peptidase activity,BP,EFNA1
14320,GO:0061469,0.188540946891111,0.98401483179854,1,6,regulation of type B pancreatic cell proliferation,BP,ERRFI1
18386,GO:1903393,0.188807782911103,0.956320081049159,2,22,positive regulation of adherens junction organization,BP,SDC4;SMAD3
13602,GO:0060068,0.189158947378927,0.983905391038249,1,6,vagina development,BP,WNT5A
775,GO:0002027,0.189245948244952,0.937719643802482,3,44,regulation of heart rate,BP,EDN1;GCH1;ADM
6966,GO:0030619,0.189285323207344,0.983449782843889,1,7,U1 snRNA binding,MF,ISG20
11324,GO:0045648,0.189849305002203,0.955809559698463,2,23,positive regulation of erythrocyte differentiation,BP,INHBA;ETS1
12433,GO:0048934,0.189852612399394,0.983782067733674,1,6,peripheral nervous system neuron differentiation,BP,RUNX1
12434,GO:0048935,0.189852612399394,0.983782067733674,1,6,peripheral nervous system neuron development,BP,RUNX1
13985,GO:0060693,0.189897160007148,0.983774130355748,1,6,regulation of branching involved in salivary gland morphogenesis,BP,TNF
562,GO:0001696,0.189911824899703,0.983771516941343,1,6,gastric acid secretion,BP,SGK1
15826,GO:0072529,0.189948620650314,0.955385370001071,2,27,pyrimidine-containing compound catabolic process,BP,TDG;UPP1
10102,GO:0042612,0.190027873719284,0.982734346389951,1,9,MHC class I protein complex,CC,HLA-E
15166,GO:0071294,0.190063194131483,0.982981134438619,1,8,cellular response to zinc ion,BP,CREB1
18361,GO:1903349,0.190177667598143,0.983724101754594,1,6,omegasome membrane,CC,PLEKHF1
13470,GO:0055001,0.190512393016944,0.914849094097485,5,87,muscle cell development,BP,TBX3;EDN1;HDAC9;ADM;PDLIM5
12350,GO:0048713,0.190583207673871,0.955422651605805,2,24,regulation of oligodendrocyte differentiation,BP,DLX2;DUSP10
17538,GO:1901033,0.19093211068885,0.983148321112848,1,7,positive regulation of response to reactive oxygen species,BP,TNF
13560,GO:0060020,0.191147033556399,0.983550570471931,1,6,Bergmann glial cell differentiation,BP,PTPN11
18833,GO:1904415,0.191166044986617,0.983547157132697,1,6,regulation of xenophagy,BP,RIPK2
18834,GO:1904417,0.191166044986617,0.983547157132697,1,6,positive regulation of xenophagy,BP,RIPK2
11422,GO:0045836,0.191167182187177,0.983546952945886,1,6,positive regulation of meiotic nuclear division,BP,WNT5A
12929,GO:0051281,0.191257453556126,0.955166734103486,2,24,positive regulation of release of sequestered calcium ion into cytosol,BP,BDKRB1;PDPK1
7646,GO:0032056,0.191346940022804,0.983514659718138,1,6,positive regulation of translation in response to stress,BP,PPP1R15A
12004,GO:0047484,0.191349576879304,0.98351418575458,1,6,regulation of response to osmotic stress,BP,PTGS2
4932,GO:0014888,0.191433899144222,0.955330810399433,2,22,striated muscle adaptation,BP,ERRFI1;SMAD3
11799,GO:0046676,0.191600655740578,0.95503623300627,2,24,negative regulation of insulin secretion,BP,PIM3;PTPN11
16228,GO:0090278,0.191600655740578,0.95503623300627,2,24,negative regulation of peptide hormone secretion,BP,PIM3;PTPN11
6646,GO:0023035,0.191747414106333,0.983442591334146,1,6,CD40 signaling pathway,BP,TNFAIP3
4810,GO:0012507,0.191753206888823,0.936410247662802,3,46,ER to Golgi transport vesicle membrane,CC,TGFA;AREG;HLA-E
16593,GO:0097413,0.191991283904273,0.982952867053034,1,7,Lewy body,CC,SQSTM1
20202,GO:2001053,0.192056108859731,0.983386922651183,1,6,regulation of mesenchymal cell apoptotic process,BP,SOX9
13999,GO:0060710,0.192076828154447,0.983383182583296,1,6,chorio-allantoic fusion,BP,ZFP36L1
14902,GO:0070727,0.192079267665235,0.846543275826249,54,1469,cellular macromolecule localization,BP,NFKBIA;TNFAIP3;IL1B;ZC3H12A;TNF;PTGS2;PMAIP1;PLEKHF1;EPHA2;LIF;SQSTM1;CDKN1A;BCL3;ZFP36L1;DUSP16;UGCG;PPP1R15A;EHD1;PPP1R10;CYLD;NEDD4L;BBC3;PLK3;KLHL21;USP36;ZFP36;PLAGL2;PIP5K1A;TP53BP2;SOX9;STX1A;NRG1;PML;PTPN11;RHOB;SOX4;VCL;PTPN1;PRPF19;RAB3IP;PMM2;WNT5A;NUP153;INSIG1;PDPK1;FRMD6;YWHAH;AGFG1;YWHAG;RAB22A;SFN;IPO4;STX12;RAB24
14934,GO:0070821,0.192091470792463,0.936345024006345,3,44,tertiary granule membrane,CC,PLAU;RAP2B;ADAM8
6864,GO:0030332,0.192364306425121,0.954745289834139,2,24,cyclin binding,MF,CDKN1A;CDK6
14567,GO:0070099,0.192610925121381,0.983286613940104,1,6,regulation of chemokine-mediated signaling pathway,BP,EDN1
14822,GO:0070562,0.19262793020478,0.983283534295763,1,6,regulation of vitamin D receptor signaling pathway,BP,CYP27B1
7626,GO:0032024,0.193119039191509,0.935795056089364,3,45,positive regulation of insulin secretion,BP,PPARD;SOX4;OXCT1
11674,GO:0046456,0.193280644776347,0.954110329461371,2,27,icosanoid biosynthetic process,BP,PTGS2;EDN1
13824,GO:0060415,0.19340956023098,0.935814348997096,3,42,muscle tissue morphogenesis,BP,BMP2;NRG1;WNT5A
16116,GO:0090102,0.193757144963227,0.954324990501278,2,23,cochlea development,BP,SOX9;WNT5A
2019,GO:0004745,0.194054981909367,0.98256852483076,1,7,retinol dehydrogenase activity,MF,BMP2
3400,GO:0007182,0.194193568652845,0.982998671436664,1,6,common-partner SMAD protein phosphorylation,BP,PML
12312,GO:0048663,0.194234421569949,0.954029484485469,2,24,neuron fate commitment,BP,DLX2;NRG1
19650,GO:1990845,0.194378748789877,0.982964805179244,1,6,adaptive thermogenesis,BP,ADRB2
20265,GO:2001223,0.194787629153885,0.982889898011147,1,6,negative regulation of neuron migration,BP,NRG1
16496,GO:0097194,0.194829812069455,0.921816372431524,4,70,execution phase of apoptosis,BP,ZC3H12A;BIRC2;BBC3;TP53BP2
1117,GO:0002704,0.194929187218314,0.953562488609392,2,26,negative regulation of leukocyte mediated immunity,BP,IL7R;HLA-E
9603,GO:0036462,0.195093317204613,0.982373383689955,1,7,TRAIL-activated apoptotic signaling pathway,BP,TNFRSF10A
5236,GO:0015851,0.195238367670083,0.98234602936134,1,7,nucleobase transport,BP,SLC28A3
12060,GO:0048009,0.195432338180896,0.953806823259015,2,22,insulin-like growth factor receptor signaling pathway,BP,BMP2;ATXN7
20086,GO:2000736,0.195553577041045,0.911295934236229,5,121,regulation of stem cell differentiation,BP,RUNX1;TACSTD2;JAG1;SOX9;NFE2L2
8734,GO:0034383,0.195584653780127,0.953405183411733,2,25,low-density lipoprotein particle clearance,BP,EHD1;LDLR
13885,GO:0060513,0.195638249442933,0.982733490022638,1,6,prostatic bud formation,BP,WNT5A
4661,GO:0010807,0.195849843191486,0.982694462723317,1,6,regulation of synaptic vesicle priming,BP,STX1A
12005,GO:0047485,0.196215610401884,0.911259756627634,5,96,protein N-terminus binding,MF,GADD45A;BIRC2;STX1A;RELA;PDLIM5
4475,GO:0010470,0.196310698576463,0.953343838293048,2,23,regulation of gastrulation,BP,IL1RN;PHLDB2
12071,GO:0048020,0.196428346080806,0.981771735580199,1,8,CCR chemokine receptor binding,MF,CCL20
6463,GO:0021782,0.196431626310015,0.920984860082473,4,68,glial cell development,BP,LDLR;NDRG1;SOX4;CDK6
11476,GO:0045933,0.196461808713578,0.953065541923858,2,25,positive regulation of muscle contraction,BP,PTGS2;EDN1
14641,GO:0070229,0.196483477885556,0.95296018670176,2,26,negative regulation of lymphocyte apoptotic process,BP,EFNA1;BCL10
7167,GO:0031045,0.196537664940715,0.982567265972566,1,6,dense core granule,CC,ADAM8
6515,GO:0021889,0.196617154917711,0.982552533405484,1,6,olfactory bulb interneuron differentiation,BP,WNT5A
399,GO:0001075,0.196686709799176,0.982539636630414,1,6,transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,MF,TAF4B
10243,GO:0042976,0.196742775567597,0.982060959426876,1,7,activation of Janus kinase activity,BP,IL23A
11453,GO:0045906,0.196940937602652,0.982492453844485,1,6,negative regulation of vasoconstriction,BP,ADM
6877,GO:0030368,0.196946595148733,0.982491403056469,1,6,interleukin-17 receptor activity,MF,IL6ST
11071,GO:0045072,0.197058333600871,0.982470642591068,1,6,regulation of interferon-gamma biosynthetic process,BP,INHBA
11356,GO:0045714,0.197085681083114,0.98246555951755,1,6,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,ITGAV
19871,GO:2000343,0.197544302764166,0.981555049677229,1,8,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,TNF
12809,GO:0051100,0.197686598231155,0.902709257469869,6,123,negative regulation of binding,BP,NFKBIA;JUN;ADRB2;SPAG9;BTAF1;TDG
6213,GO:0019730,0.197705567075406,0.951677390037279,2,39,antimicrobial humoral response,BP,BCL3;HLA-E
15676,GO:0072201,0.198145588027799,0.982267935332095,1,6,negative regulation of mesenchymal cell proliferation,BP,WNT5A
15282,GO:0071468,0.198186206034198,0.982260337891373,1,6,cellular response to acidic pH,BP,SLC9A1
8605,GO:0034115,0.198237800658613,0.981775203744029,1,7,negative regulation of heterotypic cell-cell adhesion,BP,IL1RN
14841,GO:0070587,0.198237800658613,0.981775203744029,1,7,regulation of cell-cell adhesion involved in gastrulation,BP,IL1RN
17655,GO:1901409,0.198341874103766,0.981755219812868,1,7,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,CCNL1
14387,GO:0061635,0.198493005305955,0.981726178725519,1,7,regulation of protein complex stability,BP,SQSTM1
20033,GO:2000648,0.198629923749517,0.95244515167133,2,23,positive regulation of stem cell proliferation,BP,TBX3;VEGFC
9537,GO:0036289,0.198879517811202,0.982130382723151,1,6,peptidyl-serine autophosphorylation,BP,ERN1
11421,GO:0045835,0.198924580797264,0.982121918148147,1,6,negative regulation of meiotic nuclear division,BP,LIF
3131,GO:0006720,0.199100306802068,0.919381878273715,4,72,isoprenoid metabolic process,BP,SDC4;HMGCS1;ALDH1A3;PPARD
17395,GO:1900125,0.199102339609795,0.98208850681782,1,6,regulation of hyaluronan biosynthetic process,BP,NFKB1
12088,GO:0048048,0.199130537705416,0.952378225332562,2,22,embryonic eye morphogenesis,BP,ALDH1A3;WNT5A
19156,GO:1905165,0.199264917644645,0.98205791903553,1,6,regulation of lysosomal protein catabolic process,BP,LDLR
18903,GO:1904589,0.199372069499589,0.932675968178916,3,46,regulation of protein import,BP,ZC3H12A;PTGS2;CDKN1A
15836,GO:0072542,0.19938821088225,0.98155364160627,1,7,protein phosphatase activator activity,MF,PPP1R15A
10108,GO:0042626,0.199685546048358,0.919232013769086,4,66,ATPase activity, coupled to transmembrane movement of substances,MF,ABCA5;ATP6V1C2;ATP13A3;TAP1
14294,GO:0061384,0.199936629995879,0.951935639662194,2,23,heart trabecula morphogenesis,BP,NRG1;ADAMTS1
8974,GO:0035065,0.199945923923451,0.932391641785353,3,46,regulation of histone acetylation,BP,IL1B;LIF;ZNF451
507,GO:0001569,0.199956580013818,0.951927843032623,2,23,branching involved in blood vessel morphogenesis,BP,EDN1;NRARP
15409,GO:0071674,0.199996501195941,0.951494940992875,2,27,mononuclear cell migration,BP,TNF;CCL20
19891,GO:2000371,0.200002103602292,0.981918865708948,1,6,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,UHRF1
19892,GO:2000373,0.200002103602292,0.981918865708948,1,6,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,UHRF1
19530,GO:1990416,0.200040538350427,0.981911599792028,1,6,cellular response to brain-derived neurotrophic factor stimulus,BP,PDPK1
6125,GO:0019371,0.200286346910117,0.981379651411261,1,7,cyclooxygenase pathway,BP,PTGS2
5345,GO:0016081,0.200288306144065,0.98186472213698,1,6,synaptic vesicle docking,BP,STX1A
3588,GO:0008013,0.20044505933994,0.918909226830634,4,63,beta-catenin binding,MF,KDM6B;SMAD3;SOX9;VCL
532,GO:0001650,0.200551623468106,0.900949773251582,6,118,fibrillar center,CC,KLF6;NFKBIE;TAF4B;TXNRD1;TMEM217;SAMD4A
9625,GO:0036492,0.200557883573716,0.981813642824639,1,6,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,PPP1R15B
11384,GO:0045760,0.200666468343916,0.98179304610052,1,6,positive regulation of action potential,BP,SLC9A1
8943,GO:0034983,0.200746687669873,0.981777821650047,1,6,peptidyl-lysine deacetylation,BP,HDAC9
5443,GO:0016308,0.200893796892256,0.981749884416463,1,6,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,PIP5K1A
20104,GO:2000766,0.200923341035158,0.981744270925016,1,6,negative regulation of cytoplasmic translation,BP,CPEB2
19850,GO:2000316,0.200992119768214,0.981242301476155,1,7,regulation of T-helper 17 type immune response,BP,IL23A
18007,GO:1902474,0.201315664245885,0.981669638699978,1,6,positive regulation of protein localization to synapse,BP,WNT5A
3114,GO:0006692,0.201351095676201,0.950960060922664,2,27,prostanoid metabolic process,BP,PTGS2;EDN1
3115,GO:0006693,0.201351095676201,0.950960060922664,2,27,prostaglandin metabolic process,BP,PTGS2;EDN1
15802,GO:0072497,0.201389353465767,0.981655602130956,1,6,mesenchymal stem cell differentiation,BP,SOX9
20121,GO:2000794,0.201397745121419,0.981654003287968,1,6,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,SOX9
6798,GO:0030238,0.201655582933846,0.981604840923878,1,6,male sex determination,BP,SOX9
22,GO:0000041,0.202036568474856,0.917678831351668,4,74,transition metal ion transport,BP,HEPHL1;TFRC;STEAP4;ATP6V1C2
8097,GO:0032780,0.202302997312266,0.98098573086389,1,7,negative regulation of ATPase activity,BP,PPIF
1865,GO:0004527,0.202491999384597,0.917561957774393,4,69,exonuclease activity,MF,ZC3H12A;NOCT;AEN;ISG20
6543,GO:0021953,0.202585685432829,0.907548696950724,5,89,central nervous system neuron differentiation,BP,BTG2;INHBA;DLX2;SOX4;WNT5A
12301,GO:0048640,0.20272431810668,0.917559229395017,4,65,negative regulation of developmental growth,BP,SEMA7A;ADRB2;DUSP10;WNT5A
16824,GO:0098711,0.202729631770817,0.98139927629069,1,6,iron ion import across plasma membrane,BP,STEAP4
16341,GO:0090594,0.202846854284451,0.98087872640535,1,7,inflammatory response to wounding,BP,IL1A
10166,GO:0042753,0.20300897822485,0.981345606833606,1,6,positive regulation of circadian rhythm,BP,ARNTL2
11035,GO:0045008,0.203230795302555,0.980429219132508,1,8,depyrimidination,BP,TDG
5413,GO:0016255,0.203391452268589,0.980771247615894,1,7,attachment of GPI anchor to protein,BP,PLAUR
6264,GO:0019855,0.203414681170562,0.980392205765001,1,8,calcium channel inhibitor activity,MF,STX1A
8328,GO:0033173,0.203527140693557,0.950403026483251,2,24,calcineurin-NFAT signaling cascade,BP,SLC9A1;NRG1
17561,GO:1901142,0.20370445935847,0.981211620007241,1,6,insulin metabolic process,BP,ERN1
9035,GO:0035251,0.203711532556398,0.980707924875742,1,7,UDP-glucosyltransferase activity,MF,UGCG
8975,GO:0035066,0.203876104889029,0.950051038803033,2,26,positive regulation of histone acetylation,BP,IL1B;LIF
323,GO:0000902,0.203964491707161,0.848275200860459,29,689,cell morphogenesis,BP,EFNA1;SEMA7A;KLF7;EFNB2;EPHA2;RND3;ZSWIM4;FGD6;ADAM8;TACSTD2;NEDD4L;CREB1;EFNB1;RAPH1;ITGAV;NRG1;CDC42EP1;PTPN11;RHOB;VCL;SKIL;IL7R;CORO1C;WNT5A;FRMD6;YWHAH;SGK1;B3GNT2;PDLIM5
15828,GO:0072531,0.204053955437099,0.980640056122585,1,7,pyrimidine-containing compound transmembrane transport,BP,SLC28A3
1328,GO:0003177,0.204319769192833,0.98109264096707,1,6,pulmonary valve development,BP,JAG1
1333,GO:0003184,0.204319769192833,0.98109264096707,1,6,pulmonary valve morphogenesis,BP,JAG1
6199,GO:0019674,0.204375011531777,0.930084886451395,3,48,NAD metabolic process,BP,PTGS2;NMNAT2;NAMPT
16836,GO:0098739,0.204720632426167,0.930174287939456,3,43,import across plasma membrane,BP,SLC9A1;SLC7A2;STEAP4
15204,GO:0071353,0.204731838113028,0.949709555651402,2,26,cellular response to interleukin-4,BP,IL24;PML
15305,GO:0071499,0.204735541502946,0.980504577127236,1,7,cellular response to laminar fluid shear stress,BP,NFE2L2
17445,GO:1900223,0.204762316527164,0.981006813894701,1,6,positive regulation of amyloid-beta clearance,BP,LDLR
7583,GO:0031946,0.204820849330903,0.980995446184971,1,6,regulation of glucocorticoid biosynthetic process,BP,BMP2
11579,GO:0046133,0.204838418080133,0.980104338114587,1,8,pyrimidine ribonucleoside catabolic process,BP,UPP1
6913,GO:0030502,0.205115420736088,0.980938180679523,1,6,negative regulation of bone mineralization,BP,SOX9
4469,GO:0010464,0.205118284193727,0.949892735806345,2,23,regulation of mesenchymal cell proliferation,BP,SOX9;WNT5A
9832,GO:0042058,0.205346616348428,0.915947992777416,4,69,regulation of epidermal growth factor receptor signaling pathway,BP,PLAUR;TGFA;ERRFI1;EREG
11621,GO:0046324,0.205371327332835,0.929848022658911,3,43,regulation of glucose import,BP,TNF;PTPN11;NFE2L2
16809,GO:0098657,0.205543300798795,0.854845379344632,21,499,import into cell,BP,IL1B;TNF;CXCL8;ADRB2;EHD1;LDLR;NEDD4L;TFRC;SLC9A1;SAA1;ITGAV;PIP5K1A;SLC7A2;PTPN1;CORO1C;STEAP4;ADM;ABL2;WNT5A;RAB22A;CXCL16
1008,GO:0002480,0.205554484005374,0.979661976961284,1,9,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,HLA-E
8768,GO:0034446,0.2055931348046,0.915871326137376,4,67,substrate adhesion-dependent cell spreading,BP,EFNA1;TACSTD2;ITGAV;CORO1C
13520,GO:0055088,0.205702933734105,0.915715625766283,4,70,lipid homeostasis,BP,EHD1;LDLR;LIPG;INSIG1
16879,GO:0098815,0.205821606818911,0.949489823257565,2,24,modulation of excitatory postsynaptic potential,BP,ADRB2;STX1A
9153,GO:0035507,0.205845049321746,0.980795932549444,1,6,regulation of myosin-light-chain-phosphatase activity,BP,TNF
11790,GO:0046654,0.206185663598385,0.980214617496939,1,7,tetrahydrofolate biosynthetic process,BP,GCH1
18251,GO:1903071,0.206520777795586,0.980147276632727,1,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,NFE2L2
16766,GO:0098562,0.206589879708253,0.890715638995652,7,139,cytoplasmic side of membrane,CC,ERRFI1;BIRC2;CYLD;RASA2;PTPN1;ABL2;CYTH1
17556,GO:1901098,0.206637158151636,0.980640847355308,1,6,positive regulation of autophagosome maturation,BP,ADRB2
9670,GO:0038030,0.206896458315719,0.98058993107499,1,6,non-canonical Wnt signaling pathway via MAPK cascade,BP,WNT5A
8509,GO:0033689,0.207014845278289,0.980566660198238,1,6,negative regulation of osteoblast proliferation,BP,SMAD3
18296,GO:1903201,0.207082063222527,0.928720721495666,3,48,regulation of oxidative stress-induced cell death,BP,SOD2;NCOA7;NFE2L2
13005,GO:0051427,0.207335382204554,0.890177932309088,7,142,hormone receptor binding,MF,ETS2;CEBPB;SMAD3;NCOA7;PTPN11;TOB2;YWHAH
490,GO:0001542,0.207402536181641,0.980490346302964,1,6,ovulation from ovarian follicle,BP,ADAMTS1
13781,GO:0060363,0.207448908195328,0.97996011629889,1,7,cranial suture morphogenesis,BP,INSIG1
5321,GO:0016042,0.207461102267196,0.88021819308913,9,201,lipid catabolic process,BP,IL1B;TNF;HCAR2;LDLR;LIPG;PPARD;CYP27B1;YWHAH;SMPD3
4494,GO:0010518,0.20787267946372,0.948553136936821,2,25,positive regulation of phospholipase activity,BP,ABL2;PDPK1
13709,GO:0060263,0.208065694311432,0.979443320699665,1,8,regulation of respiratory burst,BP,DUSP10
7276,GO:0031256,0.208262114091864,0.896097539439723,6,111,leading edge membrane,CC,EPHA2;ITGA5;ITGAV;PIP5K1A;NRG1;FERMT1
2612,GO:0005916,0.208342162895709,0.980304707789484,1,6,fascia adherens,CC,VCL
8170,GO:0032906,0.208521240030583,0.980269218819205,1,6,transforming growth factor beta2 production,BP,SMAD3
8173,GO:0032909,0.208521240030583,0.980269218819205,1,6,regulation of transforming growth factor beta2 production,BP,SMAD3
13688,GO:0060219,0.208740327315243,0.980225753100195,1,6,camera-type eye photoreceptor cell differentiation,BP,SOX9
11915,GO:0046950,0.208764389496363,0.979693198482129,1,7,cellular ketone body metabolic process,BP,OXCT1
17914,GO:1902224,0.208764389496363,0.979693198482129,1,7,ketone body metabolic process,BP,OXCT1
3034,GO:0006584,0.208922755259457,0.948022994149541,2,26,catecholamine metabolic process,BP,GCH1;MAOA
4291,GO:0009712,0.208922755259457,0.948022994149541,2,26,catechol-containing compound metabolic process,BP,GCH1;MAOA
15511,GO:0071889,0.209229864527829,0.948120347348112,2,24,14-3-3 protein binding,MF,ZFP36L1;ZFP36
1709,GO:0004252,0.209407132058989,0.913516980405803,4,73,serine-type endopeptidase activity,MF,PLAU;ADAM8;F3;CTSC
9794,GO:0040014,0.20947468991445,0.927662203384419,3,45,regulation of multicellular organism growth,BP,ADRB2;CREB1;PTPN11
3919,GO:0008585,0.209495133228702,0.91358480451968,4,69,female gonad development,BP,INHBA;CEBPB;EREG;ADAMTS1
13912,GO:0060560,0.209651615233476,0.883369331165481,8,156,developmental growth involved in morphogenesis,BP,SEMA7A;NEDD4L;RAPH1;SOX9;NRG1;VCL;AREG;WNT5A
12821,GO:0051123,0.209681513490595,0.947525191750699,2,28,RNA polymerase II transcriptional preinitiation complex assembly,BP,TAF4B;CREB1
1405,GO:0003337,0.209775912882656,0.97948663969744,1,7,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,LIF
7267,GO:0031234,0.210040018867136,0.913371540383925,4,66,extrinsic component of cytoplasmic side of plasma membrane,CC,ERRFI1;CYLD;ABL2;CYTH1
6751,GO:0030169,0.210138970264326,0.979947032773372,1,6,low-density lipoprotein particle binding,MF,LDLR
4641,GO:0010762,0.210276640243158,0.947696629355093,2,24,regulation of fibroblast migration,BP,SDC4;CORO1C
8291,GO:0033120,0.210338289039878,0.947555223950027,2,25,positive regulation of RNA splicing,BP,PRPF19;ERN1
4741,GO:0010907,0.210515174499806,0.947726882176894,2,23,positive regulation of glucose metabolic process,BP,PMAIP1;PHKG2
12683,GO:0050891,0.210724865122603,0.927026346408401,3,45,multicellular organismal water homeostasis,BP,CLDN1;CLDN4;SFN
6756,GO:0030176,0.21077552543696,0.894277398844116,6,123,integral component of endoplasmic reticulum membrane,CC,ANKLE2;SGMS2;HLA-E;INSIG1;ERN1;TAP1
4420,GO:0010216,0.210791966404176,0.979816170899456,1,6,maintenance of DNA methylation,BP,UHRF1
3918,GO:0008584,0.210942680008446,0.902337189140006,5,93,male gonad development,BP,INHBA;BCL2L2;HMGCS1;SOX9;WNT5A
3585,GO:0007635,0.211001043534543,0.9797741726025,1,6,chemosensory behavior,BP,GJB4
10623,GO:0043620,0.211112123626493,0.901958360598854,5,108,regulation of DNA-templated transcription in response to stress,BP,JUN;CEBPB;NFE2L2;RELA;BACH1
15360,GO:0071599,0.211750024755605,0.979623327695452,1,6,otic vesicle development,BP,SOX9
10974,GO:0044754,0.211795183863677,0.978664706677274,1,8,autolysosome,CC,SQSTM1
15885,GO:0072641,0.211888888268572,0.979595292910908,1,6,type I interferon secretion,BP,IFIH1
15886,GO:0072642,0.211888888268572,0.979595292910908,1,6,interferon-alpha secretion,BP,IFIH1
18103,GO:1902739,0.211888888268572,0.979595292910908,1,6,regulation of interferon-alpha secretion,BP,IFIH1
18104,GO:1902741,0.211888888268572,0.979595292910908,1,6,positive regulation of interferon-alpha secretion,BP,IFIH1
6589,GO:0022417,0.211937592444459,0.978319132592524,1,9,protein maturation by protein folding,BP,ERO1A
4703,GO:0010862,0.212073591991697,0.946848022284938,2,25,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,INHBA;BMP2
7641,GO:0032050,0.212203101749187,0.97898631843363,1,7,clathrin heavy chain binding,MF,LDLR
16720,GO:0097720,0.212278089092656,0.946764417229255,2,25,calcineurin-mediated signaling,BP,SLC9A1;NRG1
4748,GO:0010917,0.212351242982262,0.978547258980377,1,8,negative regulation of mitochondrial membrane potential,BP,PMAIP1
11423,GO:0045837,0.212351242982262,0.978547258980377,1,8,negative regulation of membrane potential,BP,PMAIP1
15571,GO:0072033,0.212396850646517,0.979492561312528,1,6,renal vesicle formation,BP,SOX9
18614,GO:1903896,0.212522582915493,0.978919970676646,1,7,positive regulation of IRE1-mediated unfolded protein response,BP,PTPN1
11251,GO:0045472,0.212530006151061,0.978918427703976,1,7,response to ether,BP,ZC3H12A
9849,GO:0042095,0.212906462767571,0.978840097261391,1,7,interferon-gamma biosynthetic process,BP,INHBA
8924,GO:0034767,0.213090903781972,0.911488150043633,4,70,positive regulation of ion transmembrane transport,BP,ADRB2;BDKRB1;SLC9A1;PDPK1
14089,GO:0060911,0.213275975581843,0.978763056624692,1,7,cardiac cell fate commitment,BP,TBX3
6023,GO:0019079,0.213399940400925,0.900732124528008,5,97,viral genome replication,BP,ZC3H12A;TNF;CXCL8;TNIP1;ISG20
6924,GO:0030515,0.213463812325499,0.945805641666174,2,30,snoRNA binding,MF,DIEXF;ISG20
13097,GO:0051604,0.213671311135328,0.875724403353976,9,209,protein maturation,BP,BIRC3;PLAU;BIRC2;ADAM8;F3;CD55;RIPK2;SOX4;ERO1A
3100,GO:0006678,0.213725681309266,0.9786690890726,1,7,glucosylceramide metabolic process,BP,UGCG
10545,GO:0043495,0.213738563927595,0.978666393850781,1,7,protein membrane anchor,MF,NUP153
14353,GO:0061564,0.213809080624148,0.858029222650641,15,331,axon development,BP,EFNA1;SEMA7A;KLF7;EFNB2;JUN;ZSWIM4;CREB1;EFNB1;RAPH1;NRG1;PTPN11;VCL;SKIL;WNT5A;B3GNT2
9838,GO:0042074,0.213858196781586,0.979195432975229,1,6,cell migration involved in gastrulation,BP,WNT5A
15834,GO:0072539,0.214178615403421,0.97857421675383,1,7,T-helper 17 cell differentiation,BP,IL23A
15286,GO:0071474,0.214293128340541,0.978550194082081,1,7,cellular hyperosmotic response,BP,ERRFI1
15285,GO:0071472,0.214424055300653,0.978522709947416,1,7,cellular response to salt stress,BP,ZFP36L1
15708,GO:0072257,0.214461440623972,0.979072092849273,1,6,metanephric nephron tubule epithelial cell differentiation,BP,LIF
15732,GO:0072307,0.214461440623972,0.979072092849273,1,6,regulation of metanephric nephron tubule epithelial cell differentiation,BP,LIF
1123,GO:0002710,0.214621505871308,0.978064078848153,1,8,negative regulation of T cell mediated immunity,BP,IL7R
3301,GO:0007000,0.21465732499997,0.978473694182111,1,7,nucleolus organization,BP,USP36
9987,GO:0042391,0.214886860459485,0.874962197398616,9,194,regulation of membrane potential,BP,PMAIP1;EDN1;JUN;ADRB2;NEDD4L;SLC9A1;USP53;STX1A;YWHAH
12148,GO:0048255,0.214987960866986,0.945651265597933,2,25,mRNA stabilization,BP,NOCT;ZFP36
11489,GO:0045953,0.215208788745205,0.977938126533021,1,8,negative regulation of natural killer cell mediated cytotoxicity,BP,HLA-E
6283,GO:0019885,0.215288522398321,0.978340756215382,1,7,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,TAP1
3065,GO:0006629,0.215350488769765,0.833291024487415,37,975,lipid metabolic process,BP,IL1B;PLAUR;HBEGF;SDC4;TNF;PTGS2;NFKB1;EDN1;IL1RN;HCAR2;BMP2;UGCG;HMGCS1;EREG;ALDH1A3;G0S2;B3GNT5;SGMS2;TXNRD1;LDLR;LIPG;CREB1;PPARD;CYP27B1;PLAGL2;PIP5K1A;NRG1;PTPN11;SQLE;PRPF19;ADM;QKI;INSIG1;YWHAH;ALAS1;ETNK1;SMPD3
4175,GO:0009247,0.215385977818857,0.924251102494939,3,53,glycolipid biosynthetic process,BP,PLAUR;UGCG;B3GNT5
18037,GO:1902555,0.215395920642585,0.945085903375359,2,29,endoribonuclease complex,CC,ZFP36;ERN1
19227,GO:1905348,0.215395920642585,0.945085903375359,2,29,endonuclease complex,CC,ZFP36;ERN1
8481,GO:0033629,0.215598886870756,0.978275224741645,1,7,negative regulation of cell adhesion mediated by integrin,BP,PTPN11
912,GO:0002295,0.215747851730399,0.978243733136827,1,7,T-helper cell lineage commitment,BP,IL23A
10480,GO:0043373,0.215747851730399,0.978243733136827,1,7,CD4-positive, alpha-beta T cell lineage commitment,BP,IL23A
11057,GO:0045055,0.216140668068304,0.847513032904521,20,512,regulated exocytosis,BP,CXCL1;PLAUR;PLAU;NFKB1;CAB39;RAP2B;AMPD3;B4GALT1;ADAM8;VEGFC;SERPINB1;CD55;ITGAV;STX1A;VCL;COTL1;PDPK1;CTSC;CREG1;RAB24
12124,GO:0048194,0.216208321884022,0.909653477070411,4,71,Golgi vesicle budding,BP,TGFA;AREG;INSIG1;CTSC
8333,GO:0033180,0.21638010292277,0.977685737558547,1,8,proton-transporting V-type ATPase, V1 domain,CC,ATP6V1C2
18813,GO:1904377,0.216426348954192,0.924101103587778,3,45,positive regulation of protein localization to cell periphery,BP,EPHA2;SQSTM1;PDPK1
5351,GO:0016101,0.216664637672743,0.923816083619819,3,48,diterpenoid metabolic process,BP,SDC4;ALDH1A3;PPARD
1607,GO:0004028,0.216824912267926,0.978015293384905,1,7,3-chloroallyl aldehyde dehydrogenase activity,MF,ALDH1A3
15684,GO:0072210,0.21683797815564,0.944885697676052,2,25,metanephric nephron development,BP,LIF;SOX9
3755,GO:0008296,0.2168590141785,0.977582090265786,1,8,3'-5'-exodeoxyribonuclease activity,MF,ISG20
746,GO:0001974,0.216861967230156,0.944875740639451,2,25,blood vessel remodeling,BP,LIF;JAG1
4973,GO:0015085,0.216915488439249,0.909444700774669,4,65,calcium ion transmembrane transporter activity,MF,TRPV3;PANX1;ITGAV;ATP13A3
3515,GO:0007440,0.216969973843679,0.978554888138698,1,6,foregut morphogenesis,BP,SMAD3
1412,GO:0003344,0.217093875043092,0.978529162197858,1,6,pericardium morphogenesis,BP,WNT5A
10791,GO:0044262,0.217503944247968,0.873103734128,9,191,cellular carbohydrate metabolic process,BP,PMAIP1;HAS3;PHLDA2;B4GALT1;IL6ST;B3GNT5;STK40;PHKG2;B3GNT2
9408,GO:0035967,0.217775091670023,0.883047631341856,7,146,cellular response to topologically incorrect protein,BP,CXCL8;PPP1R15A;PPP1R15B;PTPN1;ERO1A;NFE2L2;ERN1
5729,GO:0016868,0.218229131439296,0.977284108704698,1,8,intramolecular transferase activity, phosphotransferases,MF,PMM2
11735,GO:0046546,0.218230994014163,0.897779642871088,5,94,development of primary male sexual characteristics,BP,INHBA;BCL2L2;HMGCS1;SOX9;WNT5A
15655,GO:0072173,0.218252090140239,0.977710573557358,1,7,metanephric tubule morphogenesis,BP,SOX9
3502,GO:0007409,0.218664331765826,0.8564689520814,14,306,axonogenesis,BP,EFNA1;SEMA7A;KLF7;EFNB2;ZSWIM4;CREB1;EFNB1;RAPH1;NRG1;PTPN11;VCL;SKIL;WNT5A;B3GNT2
9298,GO:0035743,0.218681573412889,0.977185234057782,1,8,CD4-positive, alpha-beta T cell cytokine production,BP,CD55
11355,GO:0045713,0.218715930028513,0.977611041205976,1,7,low-density lipoprotein particle receptor biosynthetic process,BP,ITGAV
18225,GO:1903025,0.218790524423226,0.976825011537553,1,9,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,LIF
12717,GO:0050932,0.218958119979621,0.97755897428795,1,7,regulation of pigment cell differentiation,BP,ADAMTS9
4406,GO:0010155,0.219017643951724,0.976774557918467,1,9,regulation of proton transport,BP,PPIF
5992,GO:0018958,0.219070380833701,0.922618617836178,3,47,phenol-containing compound metabolic process,BP,GCH1;WNT5A;MAOA
14688,GO:0070307,0.219149852016357,0.977517707803534,1,7,lens fiber cell development,BP,EPHA2
2103,GO:0004869,0.219264313023557,0.943467272434295,2,29,cysteine-type endopeptidase inhibitor activity,MF,BIRC3;BIRC2
12323,GO:0048675,0.219338174065375,0.897249997298726,5,87,axon extension,BP,SEMA7A;RAPH1;NRG1;VCL;WNT5A
14881,GO:0070670,0.219695388004449,0.943474423308706,2,27,response to interleukin-4,BP,IL24;PML
18518,GO:1903689,0.219695406157085,0.977985071264529,1,6,regulation of wound healing, spreading of epidermal cells,BP,PHLDB2
468,GO:0001508,0.21982140830482,0.907680534335691,4,67,action potential,BP,NEDD4L;SLC9A1;USP53;YWHAH
16296,GO:0090400,0.219852584004521,0.977366101993084,1,7,stress-induced premature senescence,BP,CDKN1A
4009,GO:0008970,0.219948228878239,0.977345424416581,1,7,phosphatidylcholine 1-acylhydrolase activity,MF,LIPG
11862,GO:0046851,0.219989497632957,0.977336499266214,1,7,negative regulation of bone remodeling,BP,TNFAIP3
19551,GO:1990462,0.220189236128282,0.977293274675887,1,7,omegasome,CC,PLEKHF1
19401,GO:1905906,0.220228544413597,0.976845382194418,1,8,regulation of amyloid fibril formation,BP,LDLR
12096,GO:0048087,0.220315476876542,0.97726593204307,1,7,positive regulation of developmental pigmentation,BP,ADAMTS9
6657,GO:0030004,0.220352344777974,0.907176333316411,4,73,cellular monovalent inorganic cation homeostasis,BP,NEDD4L;SLC9A1;MAFG;ATP6V1C2
11217,GO:0045351,0.22036156172258,0.976816030805811,1,8,type I interferon biosynthetic process,BP,TICAM1
5856,GO:0017151,0.220385490425147,0.977250759914795,1,7,DEAD/H-box RNA helicase binding,MF,SMAD3
1473,GO:0003727,0.220731369070195,0.907015173206321,4,71,single-stranded RNA binding,MF,DLX2;ZFP36;IFIH1;PABPC4
9853,GO:0042101,0.220738554546118,0.977174165012604,1,7,T cell receptor complex,CC,BCL10
10739,GO:0044106,0.220989775065493,0.906455702518554,4,87,cellular amine metabolic process,BP,ODC1;AZIN1;MAOA;SAT1
19953,GO:2000484,0.221138166350298,0.976644258171346,1,8,positive regulation of interleukin-8 secretion,BP,WNT5A
14138,GO:0061001,0.221407412065244,0.943100781354988,2,24,regulation of dendritic spine morphogenesis,BP,EFNA1;PDLIM5
3942,GO:0008627,0.221475223072372,0.977013892962194,1,7,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,PTGS2
9200,GO:0035584,0.221530071909568,0.975937068290333,1,10,calcium-mediated signaling using intracellular calcium source,BP,CCL20
8447,GO:0033572,0.221584408369361,0.942486887512216,2,29,transferrin transport,BP,TFRC;ATP6V1C2
1147,GO:0002741,0.221707974908812,0.976963126242407,1,7,positive regulation of cytokine secretion involved in immune response,BP,WNT5A
6918,GO:0030509,0.221780296119896,0.895616940871716,5,91,BMP signaling pathway,BP,BMP2;RGMB;FAM83G;SKIL;WNT5A
1040,GO:0002551,0.221807478805849,0.976495657095776,1,8,mast cell chemotaxis,BP,VEGFC
4076,GO:0009128,0.222019354385517,0.97644850829987,1,8,purine nucleoside monophosphate catabolic process,BP,AMPD3
4105,GO:0009158,0.222019354385517,0.97644850829987,1,8,ribonucleoside monophosphate catabolic process,BP,AMPD3
4115,GO:0009169,0.222019354385517,0.97644850829987,1,8,purine ribonucleoside monophosphate catabolic process,BP,AMPD3
15417,GO:0071682,0.222359060558321,0.976372804756828,1,8,endocytic vesicle lumen,CC,SAA1
4278,GO:0009642,0.222397561313864,0.976812354548073,1,7,response to light intensity,BP,HMGCS1
8211,GO:0032964,0.22250951262263,0.942286290069157,2,27,collagen biosynthetic process,BP,ERRFI1;PPARD
7649,GO:0032059,0.2227369051911,0.976737961077003,1,7,bleb,CC,PANX1
4063,GO:0009111,0.223361864484697,0.976148549466201,1,8,vitamin catabolic process,BP,CYP27B1
16325,GO:0090533,0.223367738197085,0.976599315988731,1,7,cation-transporting ATPase complex,CC,SLC9A1
11734,GO:0046545,0.223630726869791,0.905311112248081,4,71,development of primary female sexual characteristics,BP,INHBA;CEBPB;EREG;ADAMTS1
5648,GO:0016740,0.223671712550145,0.814732287827099,70,1894,transferase activity,MF,TNFAIP3;BIRC3;HBEGF;CSF2;ITPKC;NUAK2;RNF19B;PRDM1;HAS3;IRAK2;EPHA2;KCTD11;SQSTM1;CAB39;MAP2K3;BIRC2;CDKN1A;NMNAT2;TJP2;NAMPT;UGCG;MAST4;HMGCS1;EREG;PELI1;B4GALT1;PIM3;B3GNT5;SGMS2;NEDD4L;OXSR1;RC3H1;PLK2;PLK3;PIM1;KLHL21;STK40;RIPK2;PHKG2;PIP5K1A;CLK4;SOX9;NRG1;ZNF451;POLR3A;PTPN11;MAP3K8;UHRF1;PANK3;FEM1B;OXCT1;TNFAIP1;CDK6;YRDC;PRPF19;ABL2;PDPK1;RNF19A;SGK1;B3GNT2;SAT1;RNF11;BACH1;ANKK1;POLR3D;ALAS1;ERN1;ETNK1;SH3RF2;UPP1
6593,GO:0022604,0.223677478213638,0.850270562299004,15,337,regulation of cell morphogenesis,BP,EFNA1;SEMA7A;RND3;ZSWIM4;FGD6;TACSTD2;NEDD4L;NRG1;CDC42EP1;RHOB;SKIL;CORO1C;WNT5A;YWHAH;PDLIM5
9896,GO:0042180,0.223712643167408,0.878795143764485,7,162,cellular ketone metabolic process,BP,PTGS2;ODC1;BMP2;AZIN1;OXCT1;ADM;INSIG1
5705,GO:0016831,0.223850509727817,0.941615830529815,2,28,carboxy-lyase activity,MF,ODC1;AZIN1
9411,GO:0035973,0.223979457929757,0.976464437588207,1,7,aggrephagy,BP,SQSTM1
10523,GO:0043455,0.224052163307015,0.976448378307688,1,7,regulation of secondary metabolic process,BP,WNT5A
5999,GO:0019003,0.224095983726857,0.919737656962758,3,52,GDP binding,MF,RAP2B;RHOB;RAB22A
10018,GO:0042448,0.22416642886065,0.975967782367718,1,8,progesterone metabolic process,BP,ADM
17588,GO:1901223,0.224228707190113,0.975953758506757,1,8,negative regulation of NIK/NF-kappaB signaling,BP,RELA
20261,GO:2001212,0.224270582694084,0.976400097131909,1,7,regulation of vasculogenesis,BP,ADM
5469,GO:0016363,0.224289317337214,0.893963131699414,5,94,nuclear matrix,CC,ENC1;CEBPB;PML;UHRF1;ATXN7
8161,GO:0032890,0.224603918310524,0.941504237038266,2,26,regulation of organic acid transport,BP,IL1B;EDN1
19873,GO:2000345,0.224733455543622,0.976297599656524,1,7,regulation of hepatocyte proliferation,BP,TNFAIP3
16469,GO:0097152,0.224788858357942,0.976285314960773,1,7,mesenchymal cell apoptotic process,BP,SOX9
14840,GO:0070586,0.225018373633325,0.975775550044024,1,8,cell-cell adhesion involved in gastrulation,BP,IL1RN
4500,GO:0010524,0.225050297364776,0.941204490458715,2,27,positive regulation of calcium ion transport into cytosol,BP,BDKRB1;PDPK1
13895,GO:0060534,0.225215495515864,0.97619059722696,1,7,trachea cartilage development,BP,SOX9
10283,GO:0043029,0.225375980684348,0.940963623240183,2,28,T cell homeostasis,BP,PMAIP1;RC3H1
8954,GO:0035019,0.225378618806966,0.919202249586207,3,49,somatic stem cell population maintenance,BP,SOX9;SOX4;KLF10
13825,GO:0060416,0.225407778886618,0.941408788456686,2,24,response to growth hormone,BP,TRIM16;PTPN1
13153,GO:0051721,0.225433173223826,0.941269080523749,2,25,protein phosphatase 2A binding,MF,ANKLE2;PTPN1
9574,GO:0036376,0.225592985019355,0.97610661695534,1,7,sodium ion export across plasma membrane,BP,SLC9A1
12844,GO:0051151,0.225751223134103,0.976071365082447,1,7,negative regulation of smooth muscle cell differentiation,BP,EREG
17964,GO:1902337,0.225775221066111,0.976066016379987,1,7,regulation of apoptotic process involved in morphogenesis,BP,B4GALT1
18971,GO:1904748,0.225775221066111,0.976066016379987,1,7,regulation of apoptotic process involved in development,BP,B4GALT1
16163,GO:0090184,0.225850532532497,0.940861989539293,2,27,positive regulation of kidney development,BP,LIF;SOX9
3284,GO:0006974,0.226077956547483,0.830445653709807,28,740,cellular response to DNA damage stimulus,BP,ZC3H12A;BTG2;TNF;IER3;PMAIP1;EPHA2;GADD45A;CDKN1A;BCL3;BCL2L2;PPP1R15A;PPP1R10;NABP1;PLK2;PLK3;NDRG1;PML;PTPN11;UHRF1;FEM1B;SOX4;AEN;SKIL;PRPF19;SGK1;BACH1;TDG;SFN
15827,GO:0072530,0.226692469250416,0.975395347151938,1,8,purine-containing compound transmembrane transport,BP,SLC28A3
3711,GO:0008227,0.226692999180183,0.975395226282827,1,8,G-protein coupled amine receptor activity,MF,ADRB2
686,GO:0001894,0.226806045845953,0.88371449940795,6,122,tissue homeostasis,BP,TNFAIP3;ADRB2;ADAM8;TFRC;SOX9;PTPN11
6939,GO:0030546,0.227338489331665,0.975716169239828,1,7,receptor activator activity,MF,NRG1
19457,GO:1990124,0.227346444341823,0.975714381797027,1,7,messenger ribonucleoprotein complex,CC,CPEB2
3069,GO:0006636,0.22743760951749,0.939981593011984,2,29,unsaturated fatty acid biosynthetic process,BP,PTGS2;EDN1
19045,GO:1904888,0.227502929783747,0.918239695761225,3,46,cranial skeletal system development,BP,DLX2;SMAD3;INSIG1
16093,GO:0090073,0.227543245584226,0.975200875709693,1,8,positive regulation of protein homodimerization activity,BP,TRAF4
13795,GO:0060379,0.227614560417576,0.975654095208614,1,7,cardiac muscle cell myoblast differentiation,BP,NRG1
2000,GO:0004721,0.227655436354173,0.8762660805962,7,144,phosphoprotein phosphatase activity,MF,DUSP16;DUSP8;DUSP1;DUSP10;PPTC7;PTPN11;PTPN1
9961,GO:0042339,0.227810524051837,0.940019508532708,2,27,keratan sulfate metabolic process,BP,B4GALT1;B3GNT2
1437,GO:0003413,0.227915666054125,0.975586292339088,1,7,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,SOX9
19833,GO:2000291,0.228044341844191,0.975085939099372,1,8,regulation of myoblast proliferation,BP,PPARD
10325,GO:0043116,0.228248931675953,0.97551112614995,1,7,negative regulation of vascular permeability,BP,ADM
7790,GO:0032329,0.228312422128377,0.975024328972781,1,8,serine transport,BP,NFKBIE
8659,GO:0034214,0.228409917052584,0.975474771040314,1,7,protein hexamerization,BP,PANX1
1125,GO:0002712,0.228772301111079,0.939604227610818,2,27,regulation of B cell mediated immunity,BP,TNF;TFRC
1221,GO:0002889,0.228772301111079,0.939604227610818,2,27,regulation of immunoglobulin mediated immune response,BP,TNF;TFRC
18006,GO:1902473,0.228909599508522,0.975361738467334,1,7,regulation of protein localization to synapse,BP,WNT5A
7426,GO:0031526,0.228932611552868,0.939768463270718,2,25,brush border membrane,CC,B4GALT1;SLC6A14
6585,GO:0022410,0.228987593852821,0.974500147180952,1,9,circadian sleep/wake cycle process,BP,CSF2
12621,GO:0050802,0.228987593852821,0.974500147180952,1,9,circadian sleep/wake cycle, sleep,BP,CSF2
17033,GO:0099503,0.229004325402514,0.833074565442423,23,608,secretory vesicle,CC,IL1B;CXCL1;PLAUR;PLAU;NFKB1;EDN1;CAB39;RAP2B;AMPD3;B4GALT1;ADAM8;VEGFC;SERPINB1;CD55;ITGAV;STX1A;SPAG9;VCL;SKIL;COTL1;CTSC;CREG1;RAB24
7261,GO:0031227,0.229050375103771,0.882151175675959,6,126,intrinsic component of endoplasmic reticulum membrane,CC,ANKLE2;SGMS2;HLA-E;INSIG1;ERN1;TAP1
11655,GO:0046394,0.229100307010363,0.85357890910953,12,286,carboxylic acid biosynthetic process,BP,IL1B;PTGS2;NFKB1;EDN1;HAS3;ALDH1A3;GCH1;QKI;NUP153;INSIG1;DSE;AHCY
12407,GO:0048853,0.229189478727859,0.975298301716875,1,7,forebrain morphogenesis,BP,WNT5A
15761,GO:0072357,0.229366188945294,0.975258202533218,1,7,PTW/PP1 phosphatase complex,CC,PPP1R10
15596,GO:0072078,0.229377167712243,0.917184099988767,3,47,nephron tubule morphogenesis,BP,BMP2;TACSTD2;SOX9
8416,GO:0033483,0.229838420438637,0.974672023292927,1,8,gas homeostasis,BP,SOD2
18240,GO:1903047,0.230153311847265,0.826140164275414,29,761,mitotic cell cycle process,BP,IL1B;IL1A;BTG2;BIRC3;INHBA;TGFA;EDN1;PHLDA1;GADD45A;BIRC2;CDKN1A;ZFP36L1;CDKN2B;EREG;ANKLE2;DUSP1;DCUN1D3;PPP1R10;NABP1;PLK2;PLK3;PML;RHOB;SOX4;CDK6;NUP153;BACH1;YWHAG;SFN
20258,GO:2001204,0.230334631965733,0.975037803686419,1,7,regulation of osteoclast development,BP,TJP2
10531,GO:0043471,0.230336192175844,0.97455651339716,1,8,regulation of cellular carbohydrate catabolic process,BP,PHKG2
16070,GO:0090030,0.230368029758701,0.975030183700383,1,7,regulation of steroid hormone biosynthetic process,BP,BMP2
14605,GO:0070168,0.230642165970006,0.974967588578329,1,7,negative regulation of biomineral tissue development,BP,SOX9
10000,GO:0042416,0.230810314822102,0.974446221230309,1,8,dopamine biosynthetic process,BP,GCH1
16160,GO:0090181,0.230985734079789,0.916214272638945,3,49,regulation of cholesterol metabolic process,BP,HMGCS1;LDLR;SQLE
4908,GO:0014841,0.231183117143474,0.974843815486946,1,7,skeletal muscle satellite cell proliferation,BP,PPARD
4909,GO:0014842,0.231183117143474,0.974843815486946,1,7,regulation of skeletal muscle satellite cell proliferation,BP,PPARD
4919,GO:0014856,0.231183117143474,0.974843815486946,1,7,skeletal muscle cell proliferation,BP,PPARD
4920,GO:0014857,0.231183117143474,0.974843815486946,1,7,regulation of skeletal muscle cell proliferation,BP,PPARD
7052,GO:0030825,0.231259984321981,0.974341373752655,1,8,positive regulation of cGMP metabolic process,BP,WNT5A
3232,GO:0006887,0.23133753159127,0.831145986198871,23,600,exocytosis,BP,CXCL1;PLAUR;PLAU;SDC4;NFKB1;CAB39;RAP2B;AMPD3;B4GALT1;VMP1;ADAM8;VEGFC;SERPINB1;CD55;ITGAV;STX1A;VCL;COTL1;PDPK1;CTSC;CREG1;RAB24;SMPD3
19026,GO:1904861,0.231377504209855,0.974799255918969,1,7,excitatory synapse assembly,BP,WNT5A
15666,GO:0072189,0.23153778118677,0.974762482597347,1,7,ureter development,BP,SOX9
11249,GO:0045454,0.231738100455746,0.915449528180245,3,57,cell redox homeostasis,BP,TXNRD1;ERO1A;NFE2L2
12316,GO:0048667,0.231803000952997,0.839797306479587,17,385,cell morphogenesis involved in neuron differentiation,BP,EFNA1;SEMA7A;KLF7;EFNB2;ZSWIM4;NEDD4L;CREB1;EFNB1;RAPH1;NRG1;PTPN11;VCL;SKIL;WNT5A;YWHAH;B3GNT2;PDLIM5
14805,GO:0070536,0.231932054475855,0.938469299854293,2,25,protein K63-linked deubiquitination,BP,TNFAIP3;CYLD
4744,GO:0010911,0.231967123679505,0.974663829596283,1,7,regulation of isomerase activity,BP,UHRF1
4745,GO:0010912,0.231967123679505,0.974663829596283,1,7,positive regulation of isomerase activity,BP,UHRF1
14508,GO:0065003,0.232322480071685,0.812556949570731,50,1421,protein-containing complex assembly,BP,TNFAIP3;ZC3H12A;BIRC3;CSF2;TNF;PMAIP1;FOSL1;NOCT;TGFA;CLDN1;PANX1;KCTD11;SQSTM1;CAB39;JUN;BIRC2;TAF4B;ADRB2;SOD2;ALDH1A3;EHD1;B4GALT1;BCL10;TMCC1;TRAF1;CYLD;SMAD3;RC3H1;CREB1;SLC9A1;PLAGL2;NAV3;SOX9;STX1A;NRG1;ZNF451;PML;CDC42EP1;PTPN11;SPAG9;GCH1;AREG;TNFAIP1;PRPF19;CELF1;NUP153;INSIG1;CTSC;BRD2;IPO4
11059,GO:0045058,0.232366964921894,0.938155841908017,2,26,T cell selection,BP,CYLD;IL23A
5304,GO:0016004,0.232401011428776,0.974074259584891,1,8,phospholipase activator activity,MF,PDPK1
13691,GO:0060229,0.232401011428776,0.974074259584891,1,8,lipase activator activity,MF,PDPK1
5329,GO:0016053,0.232660468682111,0.850835451370968,12,287,organic acid biosynthetic process,BP,IL1B;PTGS2;NFKB1;EDN1;HAS3;ALDH1A3;GCH1;QKI;NUP153;INSIG1;DSE;AHCY
16199,GO:0090232,0.232762303097415,0.973989362251474,1,8,positive regulation of spindle checkpoint,BP,NDRG1
2405,GO:0005575,0.232807080612906,0.854288600918188,387,11685,cellular_component,CC,NFKBIA;NFKBIZ;TNFAIP3;CXCL2;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;CXCL3;BTG2;IL36G;BIRC3;HBEGF;PLAU;NFKBID;CSF2;ITPKC;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;CXCL8;REL;SERPINB2;PPIF;IER3;KLF6;NUAK2;CCL20;ZC3H12C;SPRR2D;ZNF697;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;TRPV3;NOCT;PLEKHF1;EFNA1;TGFA;KDM6B;IRF6;LGALSL;EDN1;ODC1;SEMA7A;PHLDA1;HAS3;ERRFI1;IL1RN;IRAK2;CLDN1;KLF7;PANX1;CREB5;DAPP1;CPEB2;EHF;SPRR2A;HCAR2;TNFRSF10B;EFNB2;EPHA2;RELB;GADD45A;CXCL5;MAFF;LIF;TRIB1;KCTD11;CD83;SQSTM1;IFNGR2;RRAD;BMP2;PHLDA2;IL24;CAB39;ZNF267;N4BP3;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;TMCC3;NMNAT2;RGMB;PHLDB2;CLDN4;TJP2;SERTAD2;CD274;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;BCL2L2;ZFP36L1;ENC1;RELT;RND3;ADRB2;CEBPB;DUSP16;ARNTL2;UGCG;TRAF3IP3;PPP1R15A;MAST4;RUNX1;N4BP1;CDKN2B;GJB4;NAB1;HMGCS1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;ALDH1A3;C3ORF52;EHD1;NEDD9;ZSWIM4;ANKLE2;DUSP8;B4GALT1;HAL;TFPI2;DUSP1;BCL10;FGD6;DCUN1D3;HEPHL1;TMCC1;TRAF1;PPP1R10;PIM3;TMEM265;CDV3;SACS;IL6ST;G0S2;B3GNT5;SGMS2;VMP1;NABP1;DLX2;SLC6A14;TXNRD1;VGLL3;CYLD;ADAM8;LDLR;VEGFC;KLF3;HCAR3;ZNF217;TACSTD2;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;SLC43A3;DUSP10;PLK2;BBC3;PLK3;DIEXF;PIM1;WISP1;ITGA5;TFRC;LIPG;AKIRIN1;KLHL21;CREB1;SERPINB8;EFNB1;GJB3;F3;STK40;HIVEP2;PPARD;KRT34;SLC25A25;SERPINB1;SOCS3;CCDC85B;KRTAP2-3;RAET1L;USP36;IL16;BDKRB1;RAPH1;ZFP36;SLC9A1;MAFK;LARP4B;CYP27B1;IFFO2;CD55;TMEM217;PNRC1;IFNAR2;ELL2;ANTXR2;AZIN1;JAG1;PLAGL2;RIPK2;AMOTL2;PHKG2;NAV3;SAA1;PPP1R15B;STARD5;USP53;NDRG1;ITGAV;PIP5K1A;CLK4;TP53BP2;SOX9;STX1A;NRG1;ZNF451;FEM1C;PML;POU2F2;RASA2;PPTC7;FERMT1;NCOA7;ELK3;POLR3A;SLC7A2;ZNF460;CDC42EP1;SLC28A3;FOXN2;PTPN11;MAP3K8;UHRF1;PANK3;EFHD2;ARHGEF3;C15ORF39;MXD1;DCBLD2;RHOB;SPAG9;ABCA5;GCH1;FEM1B;SOX4;USP31;FOSL2;TRAF4;VCL;EIF1;OXCT1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;ADAMTS1;HIVEP1;NFKBIB;KLF10;AEN;TIFA;SKIL;COTL1;IL7R;HEXDC;RBM3;CDK6;IER5;YRDC;SAMD4A;EMP3;PTPN1;SQLE;TFE3;BTG3;TMEM65;CORO1C;STEAP4;PRPF19;TOB2;ADM;MAFG;ABL2;MTF1;ATP6V1C2;HLA-E;RAB3IP;OSMR;QKI;CELF1;PMM2;WNT5A;NUP153;MAOA;INSIG1;ADAM9;LCE1C;PDPK1;TNFRSF10A;ADAMTS9;RNF19A;CTSC;ERO1A;KDM6A;FRMD6;ZBTB21;SMTN;NFE2L2;YWHAH;SGK1;B3GNT2;TSC22D2;CYTH1;SAT1;RELA;AGFG1;TMEM154;RNF11;NOTCH2NL;BACH1;BTAF1;GINS3;POLR3D;ALAS1;YWHAG;TDG;ELF4;RAB22A;CREG1;SFN;ITM2B;ERN1;ETNK1;SH3RF2;UPP1;ISG20;TMEM132A;ATXN7;IFIH1;LAMB3;ATP13A3;ADAMTS6;MYO1B;BRD2;IPO4;CXCL16;PABPC4;TAP1;DSE;AHCY;STX12;PDLIM5;FUBP3;GPR156;RAB24;SMPD3
13119,GO:0051651,0.233078816050356,0.899592779742077,4,74,maintenance of location in cell,BP,BCL3;PML;SOX4;INSIG1
8717,GO:0034364,0.233092326870648,0.973224669217318,1,10,high-density lipoprotein particle,CC,SAA1
17829,GO:1901987,0.23313321704204,0.84263513901655,15,380,regulation of cell cycle phase transition,BP,BTG2;GADD45A;CDKN1A;OVOL1;ZFP36L1;CDKN2B;DUSP1;DCUN1D3;PLK2;PLK3;PML;SOX4;CDK6;YWHAG;SFN
16843,GO:0098751,0.233158945195454,0.937934446676148,2,25,bone cell development,BP,TJP2;PTPN11
2649,GO:0005984,0.233316516360866,0.974352381417333,1,7,disaccharide metabolic process,BP,B4GALT1
14739,GO:0070410,0.233402126925201,0.974332550816271,1,7,co-SMAD binding,MF,SMAD3
15330,GO:0071550,0.233617809477887,0.973403938161982,1,9,death-inducing signaling complex assembly,BP,TNF
5108,GO:0015399,0.233725849038333,0.899234795316924,4,73,primary active transmembrane transporter activity,MF,ABCA5;ATP6V1C2;ATP13A3;TAP1
5109,GO:0015405,0.233725849038333,0.899234795316924,4,73,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,ABCA5;ATP6V1C2;ATP13A3;TAP1
19464,GO:1990138,0.233738383401152,0.879231238095033,6,112,neuron projection extension,BP,SEMA7A;NEDD4L;RAPH1;NRG1;VCL;WNT5A
5322,GO:0016043,0.233747019957871,0.797005964343489,160,4594,cellular component organization,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;BTG2;BIRC3;HBEGF;CSF2;INHBA;ELF3;SDC4;ETS1;TNF;PPIF;NUAK2;PMAIP1;FOSL1;NFKB2;NOCT;PLEKHF1;EFNA1;TGFA;KDM6B;EDN1;SEMA7A;HAS3;CLDN1;KLF7;PANX1;EFNB2;EPHA2;GADD45A;LIF;KCTD11;SQSTM1;CAB39;JUN;BIRC2;CDKN1A;PHLDB2;SERTAD2;BCL3;TAF4B;ENC1;RND3;ADRB2;UGCG;PPP1R15A;MAST4;RUNX1;TRIM16;EREG;SOD2;ALDH1A3;EHD1;NEDD9;ZSWIM4;ANKLE2;B4GALT1;DUSP1;BCL10;FGD6;DCUN1D3;TMCC1;TRAF1;PPP1R10;SACS;VMP1;CYLD;ADAM8;LDLR;TACSTD2;NEDD4L;SMAD3;RC3H1;PLK2;BBC3;PLK3;WISP1;ITGA5;TFRC;LIPG;CREB1;EFNB1;PPARD;CCDC85B;USP36;BDKRB1;RAPH1;SLC9A1;CYP27B1;PLAGL2;AMOTL2;NAV3;NDRG1;ITGAV;PIP5K1A;TP53BP2;SOX9;STX1A;NRG1;ZNF451;PML;FERMT1;CDC42EP1;PTPN11;UHRF1;DCBLD2;RHOB;SPAG9;ABCA5;GCH1;VCL;AREG;AKAP2;TNFAIP1;HDAC9;SKIL;IL7R;EMP3;PTPN1;CORO1C;PRPF19;ADM;ABL2;ATP6V1C2;RAB3IP;CELF1;WNT5A;NUP153;INSIG1;ADAM9;PDPK1;ADAMTS9;RNF19A;CTSC;ERO1A;KDM6A;FRMD6;NFE2L2;YWHAH;SGK1;B3GNT2;AGFG1;ALAS1;YWHAG;TDG;RAB22A;SFN;ATXN7;LAMB3;MYO1B;BRD2;IPO4;CXCL16;TAP1;STX12;PDLIM5
4442,GO:0010332,0.234006260037954,0.91453596664464,3,50,response to gamma radiation,BP,CDKN1A;DCUN1D3;PML
2333,GO:0005347,0.234112331259542,0.973670768928722,1,8,ATP transmembrane transporter activity,MF,SLC25A25
505,GO:0001562,0.234130016066992,0.973281105354111,1,9,response to protozoan,BP,BCL3
10212,GO:0042832,0.234130016066992,0.973281105354111,1,9,defense response to protozoan,BP,BCL3
12399,GO:0048841,0.234133999700822,0.937644220270399,2,24,regulation of axon extension involved in axon guidance,BP,SEMA7A;WNT5A
5521,GO:0016485,0.234145740561428,0.871632337759575,7,153,protein processing,BP,BIRC3;PLAU;BIRC2;ADAM8;F3;CD55;RIPK2
16261,GO:0090317,0.234735825605742,0.936793767198523,2,29,negative regulation of intracellular protein transport,BP,SOX4;INSIG1
18168,GO:1902916,0.234878135605954,0.973489091753452,1,8,positive regulation of protein polyubiquitination,BP,BIRC2
8297,GO:0033129,0.23492408147239,0.973478169687469,1,8,positive regulation of histone phosphorylation,BP,IL1B
11765,GO:0046622,0.234997267686426,0.937003147820006,2,26,positive regulation of organ growth,BP,EDN1;PIM1
111,GO:0000228,0.235087719201331,0.833539350065366,19,495,nuclear chromosome,CC,KDM6B;JUN;JUNB;IRF1;ENC1;CEBPB;PPP1R10;NABP1;SMAD3;CREB1;PPARD;PML;UHRF1;MXD1;PRPF19;KDM6A;RELA;POLR3D;IPO4
14210,GO:0061136,0.235261062753058,0.870850243274598,7,153,regulation of proteasomal protein catabolic process,BP,RNF19B;TRIB1;N4BP1;PLK2;PLK3;RNF19A;NFE2L2
3563,GO:0007606,0.235324178433118,0.936533684424607,2,29,sensory perception of chemical stimulus,BP,GJB4;B3GNT2
15658,GO:0072176,0.23548634506193,0.973847144246151,1,7,nephric duct development,BP,EFNB2
13567,GO:0060027,0.236085021423269,0.973706781579297,1,7,convergent extension involved in gastrulation,BP,WNT5A
13754,GO:0060325,0.236112003537237,0.936511855585761,2,26,face morphogenesis,BP,CSRNP1;PTPN11
3948,GO:0008643,0.236145233456326,0.886375848108749,5,94,carbohydrate transport,BP,IL1B;TNF;PPARD;PTPN11;NFE2L2
17336,GO:1900016,0.236154745404069,0.973184693418844,1,8,negative regulation of cytokine production involved in inflammatory response,BP,ZC3H12A
14258,GO:0061307,0.236180103899327,0.973178627360109,1,8,cardiac neural crest cell differentiation involved in heart development,BP,JAG1
14259,GO:0061308,0.236180103899327,0.973178627360109,1,8,cardiac neural crest cell development involved in heart development,BP,JAG1
16553,GO:0097327,0.236240432461766,0.897686344932081,4,74,response to antineoplastic agent,BP,ZC3H12A;EDN1;ERRFI1;CLDN1
7580,GO:0031943,0.236371950097346,0.973132710787893,1,8,regulation of glucocorticoid metabolic process,BP,BMP2
14896,GO:0070700,0.23642858835866,0.973119146632321,1,8,BMP receptor binding,MF,BMP2
6755,GO:0030175,0.236503717296567,0.897731308441642,4,68,filopodium,CC,B4GALT1;RAPH1;ITGAV;MYO1B
3519,GO:0007494,0.236507343825928,0.973607515069793,1,7,midgut development,BP,WNT5A
12691,GO:0050905,0.236531518556378,0.913393018367021,3,46,neuromuscular process,BP,ALDH1A3;NRG1;GCH1
12993,GO:0051400,0.236550740610507,0.973089879775952,1,8,BH domain binding,MF,BCL2L2
14335,GO:0061515,0.23682519691233,0.913115587708289,3,48,myeloid cell development,BP,TJP2;PTPN11;PABPC4
6332,GO:0020027,0.236841825848232,0.973020066543387,1,8,hemoglobin metabolic process,BP,INHBA
6126,GO:0019372,0.236986672201383,0.97259029902017,1,9,lipoxygenase pathway,BP,PTGS2
13772,GO:0060347,0.237128182245595,0.972951289595451,1,8,heart trabecula formation,BP,ADAMTS1
1007,GO:0002479,0.237570345433237,0.911973892331314,3,66,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,ITGAV;HLA-E;TAP1
4962,GO:0015036,0.237605065706692,0.935103116023499,2,34,disulfide oxidoreductase activity,MF,TXNRD1;ERO1A
6807,GO:0030252,0.237642146036356,0.973339751463311,1,7,growth hormone secretion,BP,PTPN11
5104,GO:0015386,0.237695464528764,0.97332713370272,1,7,potassium:proton antiporter activity,MF,SLC9A1
13096,GO:0051603,0.238018731028788,0.825584803211725,23,590,proteolysis involved in cellular protein catabolic process,BP,TNFAIP3;RNF19B;PMAIP1;EFNA1;TRIB1;SQSTM1;BIRC2;ENC1;N4BP1;CYLD;NEDD4L;PLK2;PLK3;USP36;PML;UHRF1;USP31;TNFAIP1;PRPF19;RNF19A;CTSC;NFE2L2;RNF11
17558,GO:1901135,0.238228603116954,0.816093240273025,33,908,carbohydrate derivative metabolic process,BP,IL1B;PLAUR;HBEGF;SDC4;PPIF;TNIP1;NFKB1;PHLDA1;HAS3;EPHA2;BMP2;TJP2;AMPD3;UGCG;B4GALT1;B3GNT5;PIM1;PPARD;SLC25A25;SLC9A1;PANK3;ADM;PMM2;WNT5A;NUP153;ADAMTS9;B3GNT2;TDG;ITM2B;UPP1;DSE;AHCY;SMPD3
17311,GO:0140131,0.238352970602134,0.972656024045523,1,8,positive regulation of lymphocyte chemotaxis,BP,WNT5A
11458,GO:0045913,0.238385135133949,0.912385269524111,3,46,positive regulation of carbohydrate metabolic process,BP,PMAIP1;NFKB1;PHKG2
736,GO:0001964,0.238616882908388,0.973108556923224,1,7,startle response,BP,NRG1
9944,GO:0042304,0.238644717537918,0.935159823978273,2,28,regulation of fatty acid biosynthetic process,BP,PTGS2;INSIG1
3231,GO:0006886,0.238866366223295,0.815532124847799,33,920,intracellular protein transport,BP,NFKBIA;IL1B;ZC3H12A;TNF;PTGS2;CDKN1A;BCL3;DUSP16;UGCG;EHD1;PPP1R10;PLK3;USP36;PLAGL2;STX1A;NRG1;PML;PTPN11;RHOB;SOX4;PTPN1;RAB3IP;PMM2;NUP153;INSIG1;YWHAH;AGFG1;YWHAG;RAB22A;SFN;IPO4;STX12;RAB24
6252,GO:0019827,0.239267834472135,0.875338000459996,6,120,stem cell population maintenance,BP,TBX3;LIF;JAG1;SOX9;SOX4;KLF10
10313,GO:0043094,0.239369003537053,0.93446346882488,2,32,cellular metabolic compound salvage,BP,AMPD3;UPP1
2820,GO:0006285,0.23938237861922,0.971681713872296,1,10,base-excision repair, AP site formation,BP,TDG
4510,GO:0010559,0.239437182660288,0.934805776667964,2,28,regulation of glycoprotein biosynthetic process,BP,HBEGF;ITM2B
13484,GO:0055017,0.239874346900792,0.911511206158633,3,47,cardiac muscle tissue growth,BP,EDN1;PIM1;PDLIM5
15863,GO:0072584,0.239967339085832,0.972264121108932,1,8,caveolin-mediated endocytosis,BP,NEDD4L
15093,GO:0071108,0.240027959175887,0.934903036718278,2,25,protein K48-linked deubiquitination,BP,TNFAIP3;CYLD
7651,GO:0032069,0.240061859535553,0.934422570611248,2,29,regulation of nuclease activity,BP,PTPN1;ERN1
9343,GO:0035850,0.240227763087866,0.93468363342268,2,26,epithelial cell differentiation involved in kidney development,BP,LIF;JAG1
15099,GO:0071141,0.240319476854927,0.972702060569618,1,7,SMAD protein complex,CC,SMAD3
10101,GO:0042611,0.241026317915775,0.970782567238578,1,12,MHC protein complex,CC,HLA-E
17323,GO:0150011,0.241203766985012,0.972489596034629,1,7,regulation of neuron projection arborization,BP,WNT5A
17324,GO:0150012,0.241203766985012,0.972489596034629,1,7,positive regulation of neuron projection arborization,BP,WNT5A
13751,GO:0060322,0.241514177437622,0.826791398156048,20,482,head development,BP,BTG2;INHBA;ETS1;TBX3;KDM6B;SEMA7A;BMP2;CSRNP1;HMGCS1;ALDH1A3;B3GNT5;DLX2;CREB1;SOX9;NRG1;PTPN11;OXCT1;CDK6;WNT5A;YWHAH
2667,GO:0006013,0.241554623406008,0.971875771284553,1,8,mannose metabolic process,BP,PMM2
6820,GO:0030277,0.241559903784438,0.971874474362751,1,8,maintenance of gastrointestinal epithelium,BP,SOX9
6415,GO:0021670,0.241633887426973,0.971856299632017,1,8,lateral ventricle development,BP,CDK6
13006,GO:0051428,0.241766764825886,0.97141246865666,1,9,peptide hormone receptor binding,MF,PTPN11
2788,GO:0006222,0.241773759412476,0.971410725012274,1,9,UMP biosynthetic process,BP,UPP1
4117,GO:0009173,0.241773759412476,0.971410725012274,1,9,pyrimidine ribonucleoside monophosphate metabolic process,BP,UPP1
4118,GO:0009174,0.241773759412476,0.971410725012274,1,9,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,UPP1
11528,GO:0046049,0.241773759412476,0.971410725012274,1,9,UMP metabolic process,BP,UPP1
4787,GO:0010975,0.242225506190878,0.837912227413431,14,317,regulation of neuron projection development,BP,EFNA1;SEMA7A;EFNB2;ENC1;ZSWIM4;NEDD4L;PLK2;NRG1;SKIL;ABL2;WNT5A;NFE2L2;YWHAH;PDLIM5
1494,GO:0003831,0.242813230188653,0.971565702156403,1,8,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,B4GALT1
14133,GO:0060996,0.243075630776185,0.893697663514858,4,69,dendritic spine development,BP,EFNA1;PLK2;NRG1;PDLIM5
6294,GO:0019902,0.243149000382809,0.865425653486838,7,142,phosphatase binding,MF,PPP1R15A;ANKLE2;SMAD3;SLC9A1;PTPN1;CTSC;SH3RF2
11709,GO:0046501,0.243318344372101,0.971024236331178,1,9,protoporphyrinogen IX metabolic process,BP,ALAS1
19540,GO:1990440,0.24343856000037,0.970994034827955,1,9,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,CEBPB
12157,GO:0048265,0.243566085436706,0.971379325419291,1,8,response to pain,BP,GCH1
3495,GO:0007389,0.243619358580082,0.845748900984451,11,249,pattern specification process,BP,BTG2;TBX3;EDN1;BMP2;ETS2;DLX2;SMAD3;EFNB1;NRARP;WNT5A;KDM6A
14018,GO:0060736,0.243701151561145,0.971884603513409,1,7,prostate gland growth,BP,SOX9
2200,GO:0005078,0.243735449186503,0.971876243847217,1,7,MAP-kinase scaffold activity,MF,SPAG9
3124,GO:0006704,0.243876012973936,0.971302402933014,1,8,glucocorticoid biosynthetic process,BP,BMP2
7207,GO:0031095,0.244123172376952,0.9717816442704,1,7,platelet dense tubular network membrane,CC,EHD1
4223,GO:0009396,0.244453705214457,0.970738304749369,1,9,folic acid-containing compound biosynthetic process,BP,GCH1
18802,GO:1904350,0.244479578781675,0.971152271066126,1,8,regulation of protein catabolic process in the vacuole,BP,LDLR
18686,GO:1904031,0.244495510807072,0.932320784453997,2,30,positive regulation of cyclin-dependent protein kinase activity,BP,CDKN1A;CCNL1
7189,GO:0031076,0.245031038997313,0.932655678988533,2,25,embryonic camera-type eye development,BP,ALDH1A3;WNT5A
18191,GO:1902959,0.245170627180343,0.970979843061877,1,8,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,EFNA1
19182,GO:1905245,0.245170627180343,0.970979843061877,1,8,regulation of aspartic-type peptidase activity,BP,EFNA1
19503,GO:1990314,0.245462141200242,0.970906933882644,1,8,cellular response to insulin-like growth factor stimulus,BP,CREB1
2814,GO:0006275,0.245497757925482,0.880164808352817,5,99,regulation of DNA replication,BP,CSF2;JUN;EREG;AREG;TNFAIP1
13837,GO:0060433,0.2455752759049,0.970878610858828,1,8,bronchus development,BP,SOX9
1311,GO:0003157,0.245683010456566,0.970851625483459,1,8,endocardium development,BP,NRG1
16474,GO:0097157,0.245743898720006,0.970836368019995,1,8,pre-mRNA intronic binding,MF,SOX9
3689,GO:0008194,0.246097946707117,0.879748225981979,5,100,UDP-glycosyltransferase activity,MF,HAS3;UGCG;B4GALT1;B3GNT5;B3GNT2
9946,GO:0042307,0.246179128594056,0.931875491140935,2,27,positive regulation of protein import into nucleus,BP,ZC3H12A;PTGS2
10248,GO:0042983,0.246385751118041,0.970248143101631,1,9,amyloid precursor protein biosynthetic process,BP,ITM2B
10249,GO:0042984,0.246385751118041,0.970248143101631,1,9,regulation of amyloid precursor protein biosynthetic process,BP,ITM2B
3714,GO:0008234,0.246431897318893,0.862986360285642,7,150,cysteine-type peptidase activity,MF,TNFAIP3;ZC3H12A;CYLD;USP36;USP31;CTSC;ATXN7
3696,GO:0008203,0.246479634963555,0.879496977552992,5,100,cholesterol metabolic process,BP,HMGCS1;LDLR;PPARD;SQLE;INSIG1
8968,GO:0035050,0.246535304357819,0.907839715728509,3,47,embryonic heart tube development,BP,TBX3;SMAD3;WNT5A
1129,GO:0002716,0.246540214084245,0.97020876010796,1,9,negative regulation of natural killer cell mediated immunity,BP,HLA-E
19074,GO:1904953,0.246565831354805,0.97062997166097,1,8,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT5A
17256,GO:0120039,0.246660866907273,0.824148731681294,19,442,plasma membrane bounded cell projection morphogenesis,BP,EFNA1;SEMA7A;KLF7;EFNB2;ZSWIM4;NEDD4L;CREB1;EFNB1;RAPH1;NRG1;PTPN11;VCL;SKIL;CORO1C;WNT5A;YWHAH;SGK1;B3GNT2;PDLIM5
14941,GO:0070831,0.247004906964469,0.971072980472875,1,7,basement membrane assembly,BP,PHLDB2
6685,GO:0030048,0.24712219787263,0.891211408893763,4,69,actin filament-based movement,BP,NEDD4L;SLC9A1;FRMD6;MYO1B
11270,GO:0045576,0.24725740063141,0.931159050546489,2,29,mast cell activation,BP,NDRG1;PDPK1
11518,GO:0046033,0.24741110735758,0.969986168091523,1,9,AMP metabolic process,BP,AMPD3
4517,GO:0010566,0.247548881174647,0.970382051385351,1,8,regulation of ketone biosynthetic process,BP,BMP2
13880,GO:0060502,0.247785084933285,0.970322308841409,1,8,epithelial cell proliferation involved in lung morphogenesis,BP,SOX9
1979,GO:0004693,0.248282005044115,0.930587422129243,2,30,cyclin-dependent protein serine/threonine kinase activity,MF,CDKN1A;CDK6
15482,GO:0071837,0.248485087643759,0.97014486420746,1,8,HMG box domain binding,MF,JUN
15499,GO:0071872,0.248747294117657,0.970078245224936,1,8,cellular response to epinephrine stimulus,BP,SLC9A1
10732,GO:0044089,0.248799713069786,0.827944854726926,16,383,positive regulation of cellular component biogenesis,BP,CSF2;SDC4;TNF;PMAIP1;FOSL1;EDN1;HAS3;CLDN1;JUN;PHLDB2;SMAD3;CREB1;NAV3;SOX9;CDC42EP1;SMPD3
4073,GO:0009125,0.248899788243189,0.969603537710573,1,9,nucleoside monophosphate catabolic process,BP,AMPD3
13517,GO:0055085,0.249081835935421,0.806728856200327,33,874,transmembrane transport,BP,IL1B;TNF;PPIF;TRPV3;PANX1;RRAD;CAB39;CLDN4;ADRB2;SLC6A14;NEDD4L;OXSR1;SLC43A3;GJB3;PPARD;SLC25A25;BDKRB1;SLC9A1;AZIN1;ITGAV;SLC7A2;SLC28A3;PTPN11;ABCA5;STEAP4;ATP6V1C2;PDPK1;ERO1A;NFE2L2;YWHAH;SGK1;ATP13A3;TAP1
12412,GO:0048858,0.249132394125068,0.822101171822036,19,443,cell projection morphogenesis,BP,EFNA1;SEMA7A;KLF7;EFNB2;ZSWIM4;NEDD4L;CREB1;EFNB1;RAPH1;NRG1;PTPN11;VCL;SKIL;CORO1C;WNT5A;YWHAH;SGK1;B3GNT2;PDLIM5
17766,GO:1901741,0.249159358957919,0.969536544638857,1,9,positive regulation of myoblast fusion,BP,EHD1
6436,GO:0021700,0.249266536197457,0.860988282298712,7,148,developmental maturation,BP,BMP2;CDKN1A;EREG;POU2F2;FERMT1;FEM1B;WNT5A
5590,GO:0016607,0.249280996253434,0.832188123681208,14,340,nuclear speck,CC,NFKBIZ;ITPKC;GADD45A;NAMPT;ZNF217;DUSP10;USP36;IL16;PIP5K1A;CCNL1;PRPF19;SGK1;POLR3D;BRD2
10547,GO:0043497,0.24938887292615,0.969477240496988,1,9,regulation of protein heterodimerization activity,BP,NRG1
361,GO:0000979,0.249394946726094,0.9301762901574,2,29,RNA polymerase II core promoter sequence-specific DNA binding,MF,GADD45A;CEBPB
19869,GO:2000341,0.249527450393245,0.969091733542008,1,10,regulation of chemokine (C-X-C motif) ligand 2 production,BP,TNF
15566,GO:0072017,0.249823512606855,0.970370335613635,1,7,distal tubule development,BP,JAG1
10075,GO:0042574,0.249840583739558,0.969799579161786,1,8,retinal metabolic process,BP,ALDH1A3
6775,GO:0030208,0.249957594511507,0.969769669137468,1,8,dermatan sulfate biosynthetic process,BP,DSE
17832,GO:1901990,0.250005232366321,0.831539855261014,14,358,regulation of mitotic cell cycle phase transition,BP,BTG2;GADD45A;CDKN1A;ZFP36L1;CDKN2B;DUSP1;DCUN1D3;PLK2;PLK3;PML;SOX4;CDK6;YWHAG;SFN
922,GO:0002315,0.250731552411272,0.969571415459515,1,8,marginal zone B cell differentiation,BP,BCL3
3189,GO:0006814,0.250814793575764,0.867421267973331,6,119,sodium ion transport,BP,ADRB2;NEDD4L;SLC9A1;SLC28A3;YWHAH;SGK1
8661,GO:0034220,0.250826316447737,0.81482949856486,23,582,ion transmembrane transport,BP,PPIF;TRPV3;PANX1;RRAD;CAB39;CLDN4;ADRB2;SLC6A14;NEDD4L;OXSR1;SLC25A25;BDKRB1;SLC9A1;ITGAV;SLC7A2;SLC28A3;STEAP4;ATP6V1C2;PDPK1;ERO1A;YWHAH;SGK1;ATP13A3
270,GO:0000768,0.250893067138679,0.92959431038286,2,28,syncytium formation by plasma membrane fusion,BP,EHD1;ADAM9
12261,GO:0048546,0.251016269361718,0.929784582796941,2,26,digestive tract morphogenesis,BP,SMAD3;WNT5A
14271,GO:0061333,0.251106461029061,0.905166336801519,3,49,renal tubule morphogenesis,BP,BMP2;TACSTD2;SOX9
849,GO:0002162,0.251301651636288,0.969998081967725,1,7,dystroglycan binding,MF,VCL
5205,GO:0015802,0.251307732555189,0.968978908585553,1,9,basic amino acid transport,BP,SLC7A2
9047,GO:0035265,0.251395442159254,0.876414070153938,5,93,organ growth,BP,EDN1;PIM1;SOX9;PTPN11;PDLIM5
13773,GO:0060348,0.251499848002227,0.866964599582527,6,118,bone development,BP,BMP2;TJP2;NAB1;SOX9;PTPN11;INSIG1
16830,GO:0098727,0.251506792489381,0.866888293767333,6,122,maintenance of cell number,BP,TBX3;LIF;JAG1;SOX9;SOX4;KLF10
13621,GO:0060090,0.25161503527032,0.859332591036943,7,146,molecular adaptor activity,MF,TJP2;BCL3;SLC9A1;TP53BP2;STX1A;PTPN11;SPAG9
9992,GO:0042402,0.251754796098697,0.968215523710293,1,11,cellular biogenic amine catabolic process,BP,SAT1
7286,GO:0031272,0.251773501683653,0.968857268187787,1,9,regulation of pseudopodium assembly,BP,CDC42EP1
7287,GO:0031274,0.251773501683653,0.968857268187787,1,9,positive regulation of pseudopodium assembly,BP,CDC42EP1
8193,GO:0032933,0.2521280108085,0.969211872717212,1,8,SREBP signaling pathway,BP,INSIG1
15307,GO:0071501,0.2521280108085,0.969211872717212,1,8,cellular response to sterol depletion,BP,INSIG1
5842,GO:0017127,0.252961646644752,0.968186371107638,1,10,cholesterol transporter activity,MF,STARD5
4162,GO:0009223,0.253086218285429,0.967859493731016,1,11,pyrimidine deoxyribonucleotide catabolic process,BP,TDG
16338,GO:0090575,0.253134385774722,0.865612077478168,6,131,RNA polymerase II transcription factor complex,CC,JUN;JUNB;TAF4B;CEBPB;CREB1;PPARD
14551,GO:0070076,0.253184248519006,0.928922141859939,2,25,histone lysine demethylation,BP,KDM6B;KDM6A
10089,GO:0042590,0.253230981130136,0.903170628304501,3,68,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,ITGAV;HLA-E;TAP1
6923,GO:0030514,0.25324867632863,0.928621533318273,2,27,negative regulation of BMP signaling pathway,BP,SKIL;WNT5A
9042,GO:0035258,0.253257117074464,0.887191105399751,4,75,steroid hormone receptor binding,MF,ETS2;CEBPB;SMAD3;YWHAH
16655,GO:0097531,0.253275437154456,0.968463211645325,1,9,mast cell migration,BP,VEGFC
87,GO:0000175,0.253582230420124,0.928129028032383,2,30,3'-5'-exoribonuclease activity,MF,NOCT;ISG20
6757,GO:0030177,0.25376403185211,0.865115144623355,6,135,positive regulation of Wnt signaling pathway,BP,NFKB1;BMP2;NRARP;SOX4;ATP6V1C2;WNT5A
18242,GO:1903051,0.253837635076519,0.903360377343878,3,54,negative regulation of proteolysis involved in cellular protein catabolic process,BP,EFNA1;N4BP1;PML
10171,GO:0042759,0.254010508613681,0.968269345218508,1,9,long-chain fatty acid biosynthetic process,BP,QKI
14933,GO:0070820,0.254039999209138,0.874341358447179,5,107,tertiary granule,CC,CXCL1;PLAU;RAP2B;ADAM8;CD55
10011,GO:0042438,0.254729625713468,0.968535738914265,1,8,melanin biosynthetic process,BP,WNT5A
18249,GO:1903069,0.25473378674741,0.968077941086329,1,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,NFE2L2
8331,GO:0033178,0.254953989912798,0.967654438014333,1,10,proton-transporting two-sector ATPase complex, catalytic domain,CC,ATP6V1C2
2709,GO:0006081,0.255137670233943,0.902529195416092,3,56,cellular aldehyde metabolic process,BP,BMP2;ALDH1A3;RELA
12841,GO:0051148,0.255147190392028,0.927614585255513,2,28,negative regulation of muscle cell differentiation,BP,BMP2;EREG
4347,GO:0009898,0.255147355827891,0.864390784931866,6,120,cytoplasmic side of plasma membrane,CC,ERRFI1;BIRC2;CYLD;RASA2;ABL2;CYTH1
11015,GO:0044849,0.255149514933374,0.967967633992703,1,9,estrous cycle,BP,ETS1
4201,GO:0009308,0.2552014482823,0.885517633930333,4,92,amine metabolic process,BP,ODC1;AZIN1;MAOA;SAT1
17654,GO:1901407,0.255225587301218,0.96794742633617,1,9,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,CCNL1
3717,GO:0008237,0.255417695777793,0.873614148802607,5,98,metallopeptidase activity,MF,ADAM8;ADAMTS1;ADAM9;ADAMTS9;ADAMTS6
19846,GO:2000311,0.255579423626375,0.96831310341937,1,8,regulation of AMPA receptor activity,BP,ADRB2
3050,GO:0006610,0.255596414047187,0.968308643199442,1,8,ribosomal protein import into nucleus,BP,IPO4
7126,GO:0030948,0.255684994416871,0.9682853839373,1,8,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,PTPN1
11190,GO:0045294,0.255701438315757,0.968281065078759,1,8,alpha-catenin binding,MF,VCL
12070,GO:0048019,0.255713939594304,0.967450242133473,1,10,receptor antagonist activity,MF,IL1RN
6834,GO:0030295,0.255866435587027,0.902310265708319,3,52,protein kinase activator activity,MF,CAB39;CDKN1A;NRG1
4301,GO:0009746,0.256000592116965,0.863659093710827,6,128,response to hexose,BP,PTGS2;PIM3;PPARD;SOX4;OXCT1;ERN1
18573,GO:1903799,0.256213027497288,0.968146535765347,1,8,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,ZC3H12A
20215,GO:2001135,0.256267215959531,0.968132267498479,1,8,regulation of endocytic recycling,BP,EHD1
7187,GO:0031072,0.256341955693999,0.872905779179608,5,102,heat shock protein binding,MF,NFKBIA;SACS;CREB1;ZFP36;ERN1
3908,GO:0008553,0.256358920993968,0.967645526558774,1,9,proton-exporting ATPase activity, phosphorylative mechanism,MF,ATP6V1C2
4069,GO:0009119,0.256461952304546,0.884942589240569,4,83,ribonucleoside metabolic process,BP,TJP2;AMPD3;UPP1;AHCY
2396,GO:0005539,0.256650369395773,0.872699289022255,5,102,glycosaminoglycan binding,MF,HBEGF;WISP1;LIPG;SAA1;ADAMTS1
7768,GO:0032287,0.256728351085903,0.968010702004111,1,8,peripheral nervous system myelin maintenance,BP,NDRG1
7475,GO:0031638,0.256822504553934,0.926508268676832,2,31,zymogen activation,BP,PLAU;RIPK2
17310,GO:0140115,0.256881364647276,0.967970306926713,1,8,export across plasma membrane,BP,SLC9A1
12403,GO:0048845,0.256912263455405,0.967962146277179,1,8,venous blood vessel morphogenesis,BP,EFNB2
5286,GO:0015937,0.257130282854913,0.967067758869622,1,10,coenzyme A biosynthetic process,BP,PANK3
11363,GO:0045723,0.257337180284272,0.967383662307521,1,9,positive regulation of fatty acid biosynthetic process,BP,PTGS2
12103,GO:0048143,0.257397270382171,0.967833898988797,1,8,astrocyte activation,BP,LDLR
13603,GO:0060070,0.257619432859287,0.838745968739743,10,238,canonical Wnt signaling pathway,BP,NFKB1;BMP2;CYLD;SMAD3;NRARP;SOX9;FERMT1;SOX4;WNT5A;KDM6A
829,GO:0002102,0.257633710061565,0.92656981534621,2,27,podosome,CC,ADAM8;VCL
11623,GO:0046326,0.257898402871602,0.92657865933994,2,26,positive regulation of glucose import,BP,PTPN11;NFE2L2
7886,GO:0032452,0.258025276324091,0.926663596813714,2,25,histone demethylase activity,MF,KDM6B;KDM6A
3351,GO:0007084,0.258084537048991,0.966808653859991,1,10,mitotic nuclear envelope reassembly,BP,ANKLE2
5311,GO:0016018,0.258356593246496,0.966734575429194,1,10,cyclosporin A binding,MF,PPIF
12782,GO:0051054,0.258700985975033,0.847806360691844,8,181,positive regulation of DNA metabolic process,BP,CSF2;JUN;EREG;PPP1R10;TFRC;PML;AREG;TNFAIP1
14836,GO:0070578,0.258715262583719,0.967012766435096,1,9,RISC-loading complex,CC,ZFP36
4377,GO:0010002,0.258869907212282,0.967442738448601,1,8,cardioblast differentiation,BP,NRG1
5040,GO:0015217,0.25891501336829,0.966958810787053,1,9,ADP transmembrane transporter activity,MF,SLC25A25
5244,GO:0015866,0.25891501336829,0.966958810787053,1,9,ADP transport,BP,SLC25A25
2610,GO:0005913,0.258989772855921,0.883624108797786,4,74,cell-cell adherens junction,CC,NDRG1;CDC42EP1;VCL;PDLIM5
14041,GO:0060767,0.259046409884665,0.96692329171059,1,9,epithelial cell proliferation involved in prostate gland development,BP,SOX9
17013,GO:0099132,0.259156521419967,0.92550313311208,2,30,ATP hydrolysis coupled cation transmembrane transport,BP,ATP6V1C2;ATP13A3
554,GO:0001675,0.259180270234633,0.967359961753013,1,8,acrosome assembly,BP,AGFG1
17822,GO:1901978,0.259272450264009,0.96686213850812,1,9,positive regulation of cell cycle checkpoint,BP,NDRG1
11448,GO:0045899,0.259288550452131,0.966480111472338,1,10,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,CREB1
6926,GO:0030517,0.259410886067607,0.925731011080046,2,27,negative regulation of axon extension,BP,SEMA7A;WNT5A
16352,GO:0090630,0.259515047994046,0.883439257530219,4,70,activation of GTPase activity,BP,EPHA2;PIP5K1A;CORO1C;WNT5A
140,GO:0000290,0.259665902674651,0.966755542526871,1,9,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,NOCT
5584,GO:0016600,0.259745704873441,0.967208851963253,1,8,flotillin complex,CC,CORO1C
14022,GO:0060742,0.260123910023401,0.967107559786873,1,8,epithelial cell differentiation involved in prostate gland development,BP,FEM1B
2434,GO:0005622,0.260265439145084,0.787998426763491,350,10506,intracellular,CC,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;BTG2;BIRC3;HBEGF;PLAU;NFKBID;CSF2;ITPKC;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;CXCL8;REL;SERPINB2;PPIF;IER3;KLF6;NUAK2;CCL20;SPRR2D;ZNF697;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;PLEKHF1;TGFA;KDM6B;IRF6;LGALSL;EDN1;ODC1;PHLDA1;HAS3;ERRFI1;IL1RN;IRAK2;CLDN1;KLF7;PANX1;CREB5;DAPP1;CPEB2;EHF;SPRR2A;TNFRSF10B;EPHA2;RELB;GADD45A;MAFF;LIF;TRIB1;KCTD11;SQSTM1;IFNGR2;RRAD;BMP2;PHLDA2;CAB39;ZNF267;N4BP3;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;NMNAT2;RGMB;PHLDB2;TJP2;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;BCL2L2;ZFP36L1;ENC1;RELT;RND3;ADRB2;CEBPB;DUSP16;ARNTL2;UGCG;PPP1R15A;MAST4;RUNX1;N4BP1;CDKN2B;GJB4;NAB1;HMGCS1;TRIM16;EREG;ELMSAN1;SOD2;PELI1;ALDH1A3;C3ORF52;EHD1;NEDD9;ZSWIM4;ANKLE2;DUSP8;B4GALT1;HAL;DUSP1;BCL10;FGD6;DCUN1D3;TMCC1;TRAF1;PPP1R10;PIM3;CDV3;SACS;G0S2;B3GNT5;SGMS2;VMP1;NABP1;DLX2;TXNRD1;VGLL3;CYLD;ADAM8;LDLR;VEGFC;KLF3;ZNF217;TACSTD2;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;DIEXF;PIM1;WISP1;ITGA5;TFRC;LIPG;AKIRIN1;KLHL21;CREB1;SERPINB8;EFNB1;GJB3;STK40;HIVEP2;PPARD;KRT34;SLC25A25;SERPINB1;SOCS3;CCDC85B;KRTAP2-3;RAET1L;USP36;IL16;BDKRB1;RAPH1;ZFP36;SLC9A1;MAFK;LARP4B;CYP27B1;IFFO2;CD55;TMEM217;PNRC1;IFNAR2;ELL2;ANTXR2;AZIN1;PLAGL2;RIPK2;AMOTL2;PHKG2;NAV3;SAA1;PPP1R15B;STARD5;NDRG1;ITGAV;PIP5K1A;CLK4;TP53BP2;SOX9;STX1A;NRG1;ZNF451;FEM1C;PML;POU2F2;RASA2;PPTC7;FERMT1;NCOA7;ELK3;POLR3A;ZNF460;CDC42EP1;SLC28A3;FOXN2;PTPN11;MAP3K8;UHRF1;PANK3;ARHGEF3;C15ORF39;MXD1;RHOB;SPAG9;ABCA5;GCH1;FEM1B;SOX4;USP31;FOSL2;TRAF4;VCL;EIF1;OXCT1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;ADAMTS1;HIVEP1;NFKBIB;KLF10;AEN;TIFA;SKIL;COTL1;IL7R;HEXDC;RBM3;CDK6;IER5;YRDC;SAMD4A;PTPN1;SQLE;TFE3;BTG3;TMEM65;CORO1C;STEAP4;PRPF19;TOB2;ADM;MAFG;ABL2;MTF1;ATP6V1C2;HLA-E;RAB3IP;QKI;CELF1;PMM2;WNT5A;NUP153;MAOA;INSIG1;LCE1C;PDPK1;TNFRSF10A;ADAMTS9;RNF19A;CTSC;ERO1A;KDM6A;FRMD6;ZBTB21;SMTN;NFE2L2;YWHAH;SGK1;B3GNT2;TSC22D2;CYTH1;SAT1;RELA;AGFG1;RNF11;NOTCH2NL;BACH1;BTAF1;GINS3;POLR3D;ALAS1;YWHAG;TDG;ELF4;RAB22A;CREG1;SFN;ITM2B;ERN1;ETNK1;SH3RF2;UPP1;ISG20;TMEM132A;ATXN7;IFIH1;ATP13A3;MYO1B;BRD2;IPO4;PABPC4;TAP1;DSE;AHCY;STX12;PDLIM5;FUBP3;RAB24;SMPD3
8131,GO:0032823,0.260610361461344,0.966498882125352,1,9,regulation of natural killer cell differentiation,BP,PRDM1
11622,GO:0046325,0.260731548759945,0.966465868897943,1,9,negative regulation of glucose import,BP,TNF
5147,GO:0015677,0.260956480801284,0.966883959869498,1,8,copper ion import,BP,STEAP4
16621,GO:0097472,0.261000599303731,0.924523569649372,2,31,cyclin-dependent protein kinase activity,MF,CDKN1A;CDK6
16515,GO:0097225,0.261041632291729,0.9659985027918,1,10,sperm midpiece,CC,SQSTM1
3292,GO:0006986,0.261099596386572,0.852340848903873,7,157,response to unfolded protein,BP,CXCL8;PPP1R15A;PPP1R15B;PTPN1;ERO1A;NFE2L2;ERN1
9765,GO:0039530,0.261102224309915,0.966364778183666,1,9,MDA-5 signaling pathway,BP,IFIH1
5245,GO:0015867,0.261530741269725,0.966247700280632,1,9,ATP transport,BP,SLC25A25
3747,GO:0008286,0.261546423575886,0.86942992717688,5,101,insulin receptor signaling pathway,BP,IL1B;SOCS3;PTPN1;ATP6V1C2;RELA
4706,GO:0010867,0.261795222199414,0.966175325849335,1,9,positive regulation of triglyceride biosynthetic process,BP,LDLR
7432,GO:0031532,0.261987513917317,0.881625350913896,4,77,actin cytoskeleton reorganization,BP,NEDD9;PIP5K1A;PTPN1;ABL2
7103,GO:0030898,0.262173356707978,0.966555617955788,1,8,actin-dependent ATPase activity,MF,MYO1B
14653,GO:0070252,0.262243700340724,0.898773286330102,3,50,actin-mediated cell contraction,BP,NEDD4L;SLC9A1;FRMD6
3319,GO:0007028,0.262446848489442,0.966481572907753,1,8,cytoplasm organization,BP,FOSL1
5015,GO:0015174,0.262520350854996,0.965976450346102,1,9,basic amino acid transmembrane transporter activity,MF,SLC7A2
11089,GO:0045091,0.26263742208169,0.965944280775988,1,9,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,CXCL8
16227,GO:0090277,0.262665897262393,0.898362977756476,3,53,positive regulation of peptide hormone secretion,BP,PPARD;SOX4;OXCT1
2588,GO:0005881,0.262855242944098,0.898307216251418,3,52,cytoplasmic microtubule,CC,BCL10;CYLD;SAA1
7361,GO:0031402,0.263191259861103,0.966279565089838,1,8,sodium ion binding,MF,TDG
2199,GO:0005072,0.263336109035589,0.966240178674832,1,8,transforming growth factor beta receptor, cytoplasmic mediator activity,MF,SMAD3
12739,GO:0050999,0.263598789972172,0.923380855118962,2,30,regulation of nitric-oxide synthase activity,BP,IL1B;GCH1
17049,GO:0099528,0.263797607291582,0.96562455496451,1,9,G-protein coupled neurotransmitter receptor activity,MF,GPR156
3740,GO:0008277,0.263998741333535,0.880313259269355,4,78,regulation of G-protein coupled receptor protein signaling pathway,BP,CXCL8;EDN1;ADRB2;ADM
6595,GO:0022607,0.264024078282866,0.776559686954179,78,2214,cellular component assembly,BP,TNFAIP3;ZC3H12A;BIRC3;CSF2;SDC4;TNF;PMAIP1;FOSL1;NOCT;TGFA;EDN1;HAS3;CLDN1;PANX1;EPHA2;KCTD11;SQSTM1;CAB39;JUN;BIRC2;PHLDB2;TAF4B;RND3;ADRB2;RUNX1;SOD2;ALDH1A3;EHD1;NEDD9;B4GALT1;BCL10;FGD6;TMCC1;TRAF1;SACS;VMP1;CYLD;TACSTD2;SMAD3;RC3H1;PLK2;ITGA5;CREB1;SLC9A1;PLAGL2;NAV3;PIP5K1A;SOX9;STX1A;NRG1;ZNF451;PML;CDC42EP1;PTPN11;RHOB;SPAG9;GCH1;VCL;AREG;TNFAIP1;EMP3;CORO1C;PRPF19;RAB3IP;CELF1;WNT5A;NUP153;INSIG1;PDPK1;CTSC;AGFG1;YWHAG;LAMB3;MYO1B;BRD2;IPO4;STX12;PDLIM5
5103,GO:0015385,0.26403553560121,0.966049631476222,1,8,sodium:proton antiporter activity,MF,SLC9A1
10541,GO:0043489,0.264317641984731,0.923145934441613,2,29,RNA stabilization,BP,NOCT;ZFP36
15833,GO:0072538,0.264318906649399,0.965480348044564,1,9,T-helper 17 type immune response,BP,IL23A
15506,GO:0071880,0.264460495022549,0.965933563727984,1,8,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,ADRB2
14970,GO:0070878,0.264553045901239,0.965908256068352,1,8,primary miRNA binding,MF,SMAD3
3270,GO:0006949,0.264633929377916,0.922993716141274,2,29,syncytium formation,BP,EHD1;ADAM9
17714,GO:1901623,0.264670414308886,0.965382919139273,1,9,regulation of lymphocyte chemotaxis,BP,WNT5A
5234,GO:0015849,0.264779135831102,0.843325002193448,8,176,organic acid transport,BP,IL1B;EDN1;NFKBIE;SLC6A14;PPARD;STARD5;STX1A;SLC7A2
11910,GO:0046942,0.264779135831102,0.843325002193448,8,176,carboxylic acid transport,BP,IL1B;EDN1;NFKBIE;SLC6A14;PPARD;STARD5;STX1A;SLC7A2
6935,GO:0030539,0.265557785590074,0.965632833448859,1,8,male genitalia development,BP,TBX3
15565,GO:0072015,0.265585286694918,0.965625277217458,1,8,glomerular visceral epithelial cell development,BP,JAG1
15735,GO:0072310,0.265585286694918,0.965625277217458,1,8,glomerular epithelial cell development,BP,JAG1
12679,GO:0050884,0.265766981897962,0.965575330964875,1,8,neuromuscular process controlling posture,BP,GCH1
8448,GO:0033574,0.265832032596902,0.922101681022757,2,32,response to testosterone,BP,EDN1;DUSP1
618,GO:0001784,0.265896129602358,0.922634430605608,2,27,phosphotyrosine residue binding,MF,SOCS3;ABL2
6638,GO:0023019,0.266088868783,0.964988191669188,1,9,signal transduction involved in regulation of gene expression,BP,SMAD3
17925,GO:1902237,0.266184681109894,0.964563338580746,1,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,PMAIP1
9990,GO:0042398,0.266366576986451,0.921750338706663,2,33,cellular modified amino acid biosynthetic process,BP,GCH1;NFE2L2
6734,GO:0030148,0.266401258673982,0.878777883674446,4,78,sphingolipid biosynthetic process,BP,TNF;UGCG;SGMS2;SMPD3
20035,GO:2000650,0.266638917592534,0.965335076102426,1,8,negative regulation of sodium ion transmembrane transporter activity,BP,NEDD4L
948,GO:0002363,0.266774201674417,0.964796575500749,1,9,alpha-beta T cell lineage commitment,BP,IL23A
9910,GO:0042246,0.267059277794452,0.92170939186382,2,30,tissue regeneration,BP,DUSP10;PPARD
778,GO:0002031,0.267086631408091,0.964308214672026,1,10,G-protein coupled receptor internalization,BP,ADM
19148,GO:1905146,0.267104267559282,0.964704080607495,1,9,lysosomal protein catabolic process,BP,LDLR
8024,GO:0032656,0.267395848685894,0.96462225677809,1,9,regulation of interleukin-13 production,BP,HLA-E
9795,GO:0040015,0.267543160583228,0.9645808774154,1,9,negative regulation of multicellular organism growth,BP,ADRB2
7609,GO:0031994,0.267692198691239,0.964538985471221,1,9,insulin-like growth factor I binding,MF,ITGAV
4724,GO:0010885,0.267750034534399,0.964522721347196,1,9,regulation of cholesterol storage,BP,EHD1
18222,GO:1903018,0.267757462996328,0.92126461925349,2,31,regulation of glycoprotein metabolic process,BP,HBEGF;ITM2B
14779,GO:0070486,0.267794809375754,0.964107179959784,1,10,leukocyte aggregation,BP,IL1B
9386,GO:0035924,0.268123234038244,0.9213055864052,2,29,cellular response to vascular endothelial growth factor stimulus,BP,MAP2K3;ERN1
17859,GO:1902065,0.268388583304817,0.964342874866193,1,9,response to L-glutamate,BP,CREB1
16252,GO:0090308,0.26851677983663,0.964814447894948,1,8,regulation of methylation-dependent chromatin silencing,BP,UHRF1
17337,GO:1900017,0.268631097029698,0.964274437044281,1,9,positive regulation of cytokine production involved in inflammatory response,BP,TICAM1
14398,GO:0061659,0.269005842031183,0.834672734183511,9,203,ubiquitin-like protein ligase activity,MF,RNF19B;PELI1;NEDD4L;RC3H1;ZNF451;UHRF1;PRPF19;RNF19A;RNF11
3558,GO:0007600,0.269277981248124,0.834403421006868,9,210,sensory perception,BP,PTGS2;EDN1;GJB4;TACSTD2;BDKRB1;SLC9A1;USP53;B3GNT2;ATXN7
3073,GO:0006641,0.269459963725856,0.894413207033437,3,53,triglyceride metabolic process,BP,LDLR;PTPN11;INSIG1
8829,GO:0034613,0.269504750058286,0.778609782471517,52,1459,cellular protein localization,BP,NFKBIA;TNFAIP3;IL1B;ZC3H12A;TNF;PTGS2;PMAIP1;PLEKHF1;EPHA2;LIF;SQSTM1;CDKN1A;BCL3;DUSP16;UGCG;PPP1R15A;EHD1;PPP1R10;CYLD;NEDD4L;BBC3;PLK3;KLHL21;USP36;PLAGL2;PIP5K1A;TP53BP2;SOX9;STX1A;NRG1;PML;PTPN11;RHOB;SOX4;VCL;PTPN1;PRPF19;RAB3IP;PMM2;WNT5A;NUP153;INSIG1;PDPK1;FRMD6;YWHAH;AGFG1;YWHAG;RAB22A;SFN;IPO4;STX12;RAB24
17840,GO:1902004,0.269667447093476,0.963981144361864,1,9,positive regulation of amyloid-beta formation,BP,EFNA1
15589,GO:0072070,0.270065272185735,0.963868198897528,1,9,loop of Henle development,BP,JAG1
17764,GO:1901739,0.270071912828077,0.963456459045351,1,10,regulation of myoblast fusion,BP,EHD1
18281,GO:1903169,0.270167308112699,0.876390786779752,4,77,regulation of calcium ion transmembrane transport,BP,RRAD;BDKRB1;SLC9A1;PDPK1
17354,GO:1900044,0.270336110587419,0.96430587118448,1,8,regulation of protein K63-linked ubiquitination,BP,BIRC2
10316,GO:0043097,0.270430782779846,0.963017793344523,1,11,pyrimidine nucleoside salvage,BP,UPP1
7807,GO:0032355,0.270497181080913,0.876021080567063,4,82,response to estradiol,BP,ETS1;PTGS2;DUSP1;AREG
10568,GO:0043531,0.270850952844466,0.919974611652659,2,29,ADP binding,MF,ERN1;TAP1
13253,GO:0051926,0.270892337822846,0.919731927477957,2,31,negative regulation of calcium ion transport,BP,PTGS2;RRAD
7445,GO:0031577,0.27151784105472,0.919323678244557,2,32,spindle checkpoint,BP,DUSP1;NDRG1
11040,GO:0045019,0.271705608232304,0.962985546436321,1,10,negative regulation of nitric oxide biosynthetic process,BP,ZC3H12A
18828,GO:1904406,0.271705608232304,0.962985546436321,1,10,negative regulation of nitric oxide metabolic process,BP,ZC3H12A
15498,GO:0071871,0.271743073785351,0.963389665168212,1,9,response to epinephrine,BP,SLC9A1
20107,GO:2000772,0.271803665029302,0.919283903452626,2,31,regulation of cellular senescence,BP,PLK2;CDK6
5787,GO:0017014,0.271841171298117,0.962946317799694,1,10,protein nitrosylation,BP,NCOA7
5907,GO:0018119,0.271841171298117,0.962946317799694,1,10,peptidyl-cysteine S-nitrosylation,BP,NCOA7
14913,GO:0070757,0.271883195222499,0.963870156114449,1,8,interleukin-35-mediated signaling pathway,BP,IL6ST
5265,GO:0015908,0.271942651928667,0.89301146182751,3,52,fatty acid transport,BP,IL1B;EDN1;PPARD
16164,GO:0090185,0.271986315823086,0.963319994280824,1,9,negative regulation of kidney development,BP,TACSTD2
6295,GO:0019903,0.272129187197958,0.862275939110007,5,99,protein phosphatase binding,MF,PPP1R15A;ANKLE2;SLC9A1;PTPN1;SH3RF2
14573,GO:0070106,0.272221653209995,0.963774436045951,1,8,interleukin-27-mediated signaling pathway,BP,IL6ST
11402,GO:0045793,0.272243093375629,0.963246365409985,1,9,positive regulation of cell size,BP,EDN1
6772,GO:0030205,0.272305696894712,0.963228401734529,1,9,dermatan sulfate metabolic process,BP,DSE
11065,GO:0045064,0.272500101977088,0.962755305902341,1,10,T-helper 2 cell differentiation,BP,BCL3
15719,GO:0072283,0.272515097052793,0.963168279733105,1,9,metanephric renal vesicle morphogenesis,BP,LIF
5711,GO:0016840,0.272637292872301,0.962374445872338,1,11,carbon-nitrogen lyase activity,MF,HAL
10688,GO:0043966,0.27271105510164,0.892397117028868,3,55,histone H3 acetylation,BP,LIF;TRIM16;ZNF451
8859,GO:0034656,0.272984863653823,0.91833058948616,2,35,nucleobase-containing small molecule catabolic process,BP,UPP1;AHCY
13018,GO:0051450,0.273048770409137,0.962595834672233,1,10,myoblast proliferation,BP,PPARD
7206,GO:0031094,0.273236985416094,0.963486429040561,1,8,platelet dense tubular network,CC,EHD1
12597,GO:0050770,0.273374096835899,0.85148948876643,6,121,regulation of axonogenesis,BP,EFNA1;SEMA7A;ZSWIM4;NRG1;SKIL;WNT5A
13673,GO:0060193,0.273389528242052,0.918501622015425,2,31,positive regulation of lipase activity,BP,ABL2;PDPK1
11708,GO:0046500,0.273768079303249,0.962386184627692,1,10,S-adenosylmethionine metabolic process,BP,AHCY
10898,GO:0044444,0.274088461753992,0.759534354020881,240,7167,cytoplasmic part,CC,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;BTG2;BIRC3;HBEGF;PLAU;ITPKC;INHBA;TICAM1;ELF3;SDC4;TNF;REL;PPIF;IER3;KLF6;SPRR2D;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;FOSL1;NFKB2;NOCT;PLEKHF1;TGFA;IRF6;EDN1;ODC1;PHLDA1;ERRFI1;IRAK2;PANX1;DAPP1;EHF;SPRR2A;RELB;MAFF;LIF;SQSTM1;IFNGR2;CAB39;N4BP3;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;NMNAT2;RGMB;PHLDB2;TJP2;SERTAD2;BCL3;ETS2;NAMPT;AMPD3;IRF1;BCL2L2;ZFP36L1;RND3;ADRB2;DUSP16;UGCG;PPP1R15A;RUNX1;CDKN2B;HMGCS1;TRIM16;SOD2;PELI1;ALDH1A3;C3ORF52;EHD1;NEDD9;ANKLE2;B4GALT1;HAL;BCL10;FGD6;DCUN1D3;TMCC1;TRAF1;PIM3;CDV3;SACS;G0S2;B3GNT5;SGMS2;VMP1;NABP1;TXNRD1;CYLD;ADAM8;LDLR;VEGFC;ZNF217;TACSTD2;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;PIM1;WISP1;ITGA5;TFRC;LIPG;KLHL21;CREB1;SERPINB8;STK40;KRT34;SLC25A25;SERPINB1;SOCS3;KRTAP2-3;RAET1L;IL16;BDKRB1;RAPH1;ZFP36;SLC9A1;LARP4B;CYP27B1;CD55;PNRC1;ANTXR2;AZIN1;RIPK2;AMOTL2;PHKG2;SAA1;PPP1R15B;STARD5;NDRG1;ITGAV;PIP5K1A;TP53BP2;STX1A;FEM1C;PML;RASA2;PPTC7;FERMT1;ELK3;POLR3A;SLC28A3;PTPN11;MAP3K8;ARHGEF3;C15ORF39;MXD1;RHOB;SPAG9;ABCA5;GCH1;FEM1B;SOX4;TRAF4;VCL;OXCT1;AREG;FAM83G;TNFAIP1;ADAMTS1;HIVEP1;NFKBIB;SKIL;COTL1;IL7R;RBM3;CDK6;YRDC;SAMD4A;PTPN1;SQLE;TFE3;TMEM65;STEAP4;TOB2;ABL2;ATP6V1C2;HLA-E;RAB3IP;PMM2;WNT5A;NUP153;MAOA;INSIG1;PDPK1;ADAMTS9;RNF19A;CTSC;ERO1A;ZBTB21;NFE2L2;YWHAH;SGK1;B3GNT2;CYTH1;SAT1;RELA;AGFG1;RNF11;BACH1;POLR3D;ALAS1;YWHAG;RAB22A;CREG1;SFN;ITM2B;ERN1;ETNK1;UPP1;TMEM132A;ATXN7;IFIH1;MYO1B;PABPC4;TAP1;DSE;AHCY;STX12;PDLIM5;RAB24;SMPD3
2347,GO:0005388,0.274335486001312,0.963173378362948,1,8,calcium-transporting ATPase activity,MF,ATP13A3
18599,GO:1903861,0.274791954852049,0.963042849351647,1,8,positive regulation of dendrite extension,BP,NEDD4L
20029,GO:2000644,0.275106717020278,0.962419593702021,1,9,regulation of receptor catabolic process,BP,PTPN1
10789,GO:0044257,0.275388493312747,0.792559924363917,24,633,cellular protein catabolic process,BP,TNFAIP3;RNF19B;PMAIP1;EFNA1;TRIB1;SQSTM1;BIRC2;ENC1;N4BP1;CYLD;LDLR;NEDD4L;PLK2;PLK3;USP36;PML;UHRF1;USP31;TNFAIP1;PRPF19;RNF19A;CTSC;NFE2L2;RNF11
11813,GO:0046700,0.275466675239933,0.799813557209025,19,544,heterocycle catabolic process,BP,ZC3H12A;BTG2;NOCT;AMPD3;ZFP36L1;HAL;RC3H1;ZFP36;PNRC1;SAMD4A;QKI;NUP153;NFE2L2;TDG;ERN1;UPP1;ISG20;PABPC4;AHCY
13767,GO:0060340,0.275558896444487,0.962288092699925,1,9,positive regulation of type I interferon-mediated signaling pathway,BP,WNT5A
4709,GO:0010870,0.276115517423248,0.961697397789749,1,10,positive regulation of receptor biosynthetic process,BP,EDN1
13826,GO:0060419,0.276471701535948,0.890393253883415,3,51,heart growth,BP,EDN1;PIM1;PDLIM5
137,GO:0000287,0.276962868800463,0.84069916544086,7,156,magnesium ion binding,MF,NUAK2;MAST4;OXSR1;MAP3K8;ABL2;TDG;ERN1
15412,GO:0071677,0.27703250602697,0.961074289513392,1,11,positive regulation of mononuclear cell migration,BP,TNF
11903,GO:0046930,0.277224379826189,0.96101696321349,1,11,pore complex,CC,PPIF
8684,GO:0034284,0.277254141378715,0.84850896423424,6,132,response to monosaccharide,BP,PTGS2;PIM3;PPARD;SOX4;OXCT1;ERN1
8387,GO:0033293,0.277321432651193,0.916254373192677,2,34,monocarboxylic acid binding,MF,PPARD;STARD5
17443,GO:1900221,0.277333633116684,0.961769460423187,1,9,regulation of amyloid-beta clearance,BP,LDLR
17955,GO:1902306,0.277433340605423,0.961740203987584,1,9,negative regulation of sodium ion transmembrane transport,BP,NEDD4L
6008,GO:0019048,0.277453446868879,0.916592812316816,2,30,modulation by virus of host morphology or physiology,BP,ZC3H12A;SMAD3
932,GO:0002328,0.277852592346732,0.96161704749554,1,9,pro-B cell differentiation,BP,SOX4
7356,GO:0031397,0.278328169750121,0.888914709688674,3,58,negative regulation of protein ubiquitination,BP,TNFAIP3;N4BP1;SOX4
9430,GO:0036002,0.278338348191312,0.915934296928537,2,32,pre-mRNA binding,MF,SOX9;CELF1
3295,GO:0006991,0.278668943573094,0.961376599109477,1,9,response to sterol depletion,BP,INSIG1
7472,GO:0031629,0.278871405875703,0.960879746694156,1,10,synaptic vesicle fusion to presynaptic active zone membrane,BP,STX1A
17031,GO:0099500,0.278871405875703,0.960879746694156,1,10,vesicle fusion to plasma membrane,BP,STX1A
19740,GO:2000107,0.278883874731922,0.915660516872458,2,32,negative regulation of leukocyte apoptotic process,BP,EFNA1;BCL10
2797,GO:0006244,0.279060437210735,0.960168776886155,1,12,pyrimidine nucleotide catabolic process,BP,TDG
6214,GO:0019731,0.27927259581511,0.959144712935267,1,17,antibacterial humoral response,BP,HLA-E
11305,GO:0045623,0.279343877516707,0.961177161875582,1,9,negative regulation of T-helper cell differentiation,BP,RC3H1
6661,GO:0030011,0.279529319443215,0.961122263518366,1,9,maintenance of cell polarity,BP,SLC9A1
18905,GO:1904591,0.279564872686806,0.91553582648029,2,30,positive regulation of protein import,BP,ZC3H12A;PTGS2
15001,GO:0070933,0.279647519476414,0.96108724857628,1,9,histone H4 deacetylation,BP,HDAC9
14092,GO:0060914,0.27966955869329,0.960282240853065,1,11,heart formation,BP,PIM1
729,GO:0001956,0.279871870336775,0.96102073898873,1,9,positive regulation of neurotransmitter secretion,BP,STX1A
5618,GO:0016668,0.279944640277832,0.96019909977676,1,11,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,TXNRD1
12129,GO:0048207,0.279980703551393,0.888023159185786,3,56,vesicle targeting, rough ER to cis-Golgi,BP,TGFA;AREG;CTSC
12130,GO:0048208,0.279980703551393,0.888023159185786,3,56,COPII vesicle coating,BP,TGFA;AREG;CTSC
3310,GO:0007015,0.279988310196879,0.813501861110376,12,281,actin filament organization,BP,SDC4;PHLDB2;RND3;NEDD9;TACSTD2;SMAD3;SLC9A1;CDC42EP1;RHOB;AKAP2;TNFAIP1;MYO1B
1874,GO:0004540,0.280139610911804,0.869625509800499,4,86,ribonuclease activity,MF,ZC3H12A;NOCT;ERN1;ISG20
9920,GO:0042267,0.280155281297826,0.914828882175546,2,34,natural killer cell mediated cytotoxicity,BP,RAET1L;HLA-E
5721,GO:0016857,0.280552688949425,0.960376123629602,1,10,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,DSE
10417,GO:0043256,0.280620642122275,0.961353082766557,1,8,laminin complex,CC,LAMB3
788,GO:0002043,0.280737453855994,0.960320555557994,1,10,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,NRARP
8026,GO:0032660,0.281180151728168,0.959824464526199,1,11,regulation of interleukin-17 production,BP,IL23A
11466,GO:0045921,0.281203797592488,0.887289248372499,3,56,positive regulation of exocytosis,BP,SDC4;STX1A;SMPD3
4683,GO:0010830,0.281215095077837,0.914592192630507,2,31,regulation of myotube differentiation,BP,EHD1;HDAC9
12994,GO:0051402,0.281264055913184,0.837459393685037,7,159,neuron apoptotic process,BP,BTG2;JUN;CEBPB;SOD2;ADAM8;USP53;PDPK1
9780,GO:0039692,0.281374222760284,0.960128709461819,1,10,single stranded viral RNA replication via double stranded DNA intermediate,BP,CXCL8
3795,GO:0008361,0.281621098374581,0.845511762617577,6,123,regulation of cell size,BP,EDN1;SEMA7A;CREB1;NRG1;IL7R;WNT5A
7999,GO:0032616,0.281859042657041,0.959982291328138,1,10,interleukin-13 production,BP,HLA-E
4203,GO:0009310,0.282074785416666,0.95924827529098,1,12,amine catabolic process,BP,SAT1
5567,GO:0016577,0.28262843131694,0.914386495951028,2,27,histone demethylation,BP,KDM6B;KDM6A
5282,GO:0015932,0.282995193925674,0.913483944977752,2,33,nucleobase-containing compound transmembrane transporter activity,MF,SLC25A25;SLC28A3
2403,GO:0005547,0.283226734388104,0.913811235457088,2,29,phosphatidylinositol-3,4,5-trisphosphate binding,MF,DAPP1;MYO1B
10282,GO:0043028,0.283237014451265,0.913461567536479,2,32,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,BIRC3;BIRC2
9041,GO:0035257,0.28330859466322,0.844161438302356,6,130,nuclear hormone receptor binding,MF,ETS2;CEBPB;SMAD3;NCOA7;TOB2;YWHAH
614,GO:0001780,0.283487076665032,0.959940112919222,1,9,neutrophil homeostasis,BP,HCAR2
3033,GO:0006582,0.283525250779615,0.959928612788423,1,9,melanin metabolic process,BP,WNT5A
9320,GO:0035791,0.283914093799461,0.959811365280684,1,9,platelet-derived growth factor receptor-beta signaling pathway,BP,PTPN1
5751,GO:0016896,0.283927136736832,0.913110629172643,2,32,exoribonuclease activity, producing 5'-phosphomonoesters,MF,NOCT;ISG20
1130,GO:0002717,0.283953614723904,0.959346223286606,1,10,positive regulation of natural killer cell mediated immunity,BP,HLA-E
14963,GO:0070862,0.284212223550102,0.959267295992684,1,10,negative regulation of protein exit from endoplasmic reticulum,BP,INSIG1
4292,GO:0009713,0.284371371301316,0.959218681028791,1,10,catechol-containing compound biosynthetic process,BP,GCH1
10005,GO:0042423,0.284371371301316,0.959218681028791,1,10,catecholamine biosynthetic process,BP,GCH1
15688,GO:0072216,0.284380302329563,0.959215951887635,1,10,positive regulation of metanephros development,BP,LIF
13774,GO:0060349,0.284441889787234,0.885560522032293,3,52,bone morphogenesis,BP,NAB1;SOX9;INSIG1
2368,GO:0005484,0.284749617912976,0.912494969286914,2,34,SNAP receptor activity,MF,STX1A;STX12
5515,GO:0016471,0.285173148230969,0.958600096927311,1,11,vacuolar proton-transporting V-type ATPase complex,CC,ATP6V1C2
2378,GO:0005507,0.285239699509261,0.912069652387764,2,36,copper ion binding,MF,IL1A;HEPHL1
15887,GO:0072643,0.285642442226589,0.959287863160452,1,9,interferon-gamma secretion,BP,ZC3H12A
2893,GO:0006401,0.286341279433045,0.808040901012087,12,346,RNA catabolic process,BP,ZC3H12A;BTG2;NOCT;ZFP36L1;RC3H1;ZFP36;PNRC1;SAMD4A;QKI;ERN1;ISG20;PABPC4
8357,GO:0033234,0.286736022147393,0.958492471366474,1,10,negative regulation of protein sumoylation,BP,RELA
10293,GO:0043043,0.286833244418872,0.785225923369769,22,673,peptide biosynthetic process,BP,ZC3H12A;BTG2;TNF;TNIP1;CPEB2;BCL3;ZFP36L1;ENC1;PPP1R15A;RC3H1;ZFP36;LARP4B;PPP1R15B;SOX4;EIF1;RBM3;SAMD4A;QKI;CELF1;NUP153;NFE2L2;PABPC4
10544,GO:0043492,0.28707385722815,0.865365233240341,4,76,ATPase activity, coupled to movement of substances,MF,ABCA5;ATP6V1C2;ATP13A3;TAP1
642,GO:0001829,0.287111076462973,0.958376619410722,1,10,trophectodermal cell differentiation,BP,JUNB
2769,GO:0006188,0.287780694084559,0.958169322600678,1,10,IMP biosynthetic process,BP,AMPD3
17664,GO:1901505,0.287876379549329,0.910987152987701,2,33,carbohydrate derivative transmembrane transporter activity,MF,SLC25A25;SLC28A3
7603,GO:0031982,0.288017290698792,0.750690495121053,102,3052,vesicle,CC,TNFAIP3;IL1B;CXCL1;PLAUR;BTG2;HBEGF;PLAU;TICAM1;SDC4;TNF;NFKB1;PLEKHF1;EFNA1;TGFA;IRF6;EDN1;PHLDA1;IL1RN;IRAK2;CREB5;SQSTM1;IFNGR2;CAB39;N4BP3;RAP2B;NMNAT2;CD274;NAMPT;AMPD3;BCL2L2;RELT;RND3;ADRB2;DUSP16;SOD2;ALDH1A3;EHD1;B4GALT1;IL6ST;SLC6A14;TXNRD1;ADAM8;LDLR;VEGFC;TACSTD2;NEDD4L;OXSR1;ITGA5;TFRC;LIPG;SERPINB8;EFNB1;F3;KRT34;SLC25A25;SERPINB1;SLC9A1;CD55;ANTXR2;RIPK2;AMOTL2;SAA1;NDRG1;ITGAV;STX1A;PML;RHOB;SPAG9;ABCA5;GCH1;VCL;AREG;TNFAIP1;ADAMTS1;SKIL;COTL1;IL7R;PTPN1;CORO1C;STEAP4;ATP6V1C2;HLA-E;PMM2;WNT5A;ADAM9;PDPK1;CTSC;YWHAH;B3GNT2;AGFG1;RNF11;YWHAG;RAB22A;CREG1;SFN;ITM2B;TMEM132A;MYO1B;TAP1;AHCY;STX12;RAB24
10676,GO:0043922,0.288018808159937,0.958095467446469,1,10,negative regulation by host of viral transcription,BP,JUN
4498,GO:0010522,0.288134976473677,0.883148865542514,3,55,regulation of calcium ion transport into cytosol,BP,BDKRB1;PML;PDPK1
16102,GO:0090084,0.288260614406558,0.958020391347548,1,10,negative regulation of inclusion body assembly,BP,SACS
3954,GO:0008655,0.288428847824429,0.957268847062847,1,12,pyrimidine-containing compound salvage,BP,UPP1
7480,GO:0031643,0.288554182073116,0.958397205052954,1,9,positive regulation of myelination,BP,NRG1
13940,GO:0060601,0.288568742183471,0.958392723775139,1,9,lateral sprouting from an epithelium,BP,WNT5A
17837,GO:1901998,0.288668881434661,0.910578763767747,2,33,toxin transport,BP,CD274;ANTXR2
3217,GO:0006865,0.288712731103398,0.864203763517213,4,78,amino acid transport,BP,NFKBIE;SLC6A14;STX1A;SLC7A2
13035,GO:0051482,0.288856365142307,0.957452215172498,1,11,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,EDN1
19907,GO:2000392,0.289292126610641,0.958169736256659,1,9,regulation of lamellipodium morphogenesis,BP,CORO1C
13845,GO:0060442,0.28930410653986,0.958166037662205,1,9,branching involved in prostate gland morphogenesis,BP,FEM1B
14520,GO:0070011,0.290144574990723,0.79880112250205,14,357,peptidase activity, acting on L-amino acid peptides,MF,TNFAIP3;ZC3H12A;PLAU;CYLD;ADAM8;F3;USP36;USP31;ADAMTS1;ADAM9;ADAMTS9;CTSC;ATXN7;ADAMTS6
6995,GO:0030674,0.290209115705907,0.839159956277246,6,128,protein binding, bridging,MF,TJP2;BCL3;SLC9A1;TP53BP2;STX1A;PTPN11
20009,GO:2000615,0.290251015704704,0.957399506729127,1,10,regulation of histone H3-K9 acetylation,BP,ZNF451
13775,GO:0060350,0.29055130704243,0.90993977455454,2,30,endochondral bone morphogenesis,BP,NAB1;SOX9
14498,GO:0061971,0.29055130704243,0.90993977455454,2,30,replacement bone morphogenesis,BP,NAB1;SOX9
722,GO:0001946,0.290630644419653,0.957755339981002,1,9,lymphangiogenesis,BP,VEGFC
11620,GO:0046323,0.290660609110195,0.881781637522989,3,52,glucose import,BP,TNF;PTPN11;NFE2L2
5718,GO:0016853,0.290735325225861,0.848873237670289,5,120,isomerase activity,MF,PPIF;HMGCS1;PMM2;ERO1A;DSE
17108,GO:0101002,0.290888916907797,0.838376880851708,6,146,ficolin-1-rich granule,CC,CAB39;AMPD3;ADAM8;CD55;VCL;COTL1
11273,GO:0045579,0.290897621753918,0.957196688659982,1,10,positive regulation of B cell differentiation,BP,PRDM1
19695,GO:2000009,0.290921131791504,0.957189304043105,1,10,negative regulation of protein localization to cell surface,BP,NEDD4L
2356,GO:0005451,0.290961946513452,0.957652411736683,1,9,monovalent cation:proton antiporter activity,MF,SLC9A1
12388,GO:0048812,0.291280145829537,0.78848887528799,18,430,neuron projection morphogenesis,BP,EFNA1;SEMA7A;KLF7;EFNB2;ZSWIM4;NEDD4L;CREB1;EFNB1;RAPH1;NRG1;PTPN11;VCL;SKIL;WNT5A;YWHAH;SGK1;B3GNT2;PDLIM5
15189,GO:0071333,0.291593123412364,0.862083656474318,4,84,cellular response to glucose stimulus,BP,PIM3;SOX4;OXCT1;ERN1
10278,GO:0043023,0.291889179059004,0.956493630844055,1,11,ribosomal large subunit binding,MF,CPEB2
14171,GO:0061050,0.291974179035699,0.956857793013738,1,10,regulation of cell growth involved in cardiac muscle cell development,BP,EDN1
8344,GO:0033197,0.292131925035015,0.956416380851405,1,11,response to vitamin E,BP,HMGCS1
15662,GO:0072182,0.292138812655127,0.957285630921159,1,9,regulation of nephron tubule epithelial cell differentiation,BP,LIF
5326,GO:0016050,0.292600130390647,0.799821968192882,13,319,vesicle organization,BP,SDC4;PLEKHF1;TGFA;SQSTM1;CREB1;STX1A;AREG;INSIG1;CTSC;AGFG1;RAB22A;TAP1;STX12
3268,GO:0006941,0.292613289553141,0.8615624910592,4,79,striated muscle contraction,BP,ZC3H12A;MAP2K3;NEDD4L;SLC9A1
7650,GO:0032060,0.292631388667149,0.956650157983222,1,10,bleb assembly,BP,EMP3
11414,GO:0045822,0.292700815549028,0.956628190494892,1,10,negative regulation of heart contraction,BP,ZC3H12A
6992,GO:0030670,0.292701455229973,0.880010415769455,3,62,phagocytic vesicle membrane,CC,HLA-E;RAB22A;TAP1
4440,GO:0010314,0.292718624716852,0.956622554441553,1,10,phosphatidylinositol-5-phosphate binding,MF,PLEKHF1
5620,GO:0016671,0.292762051758592,0.955888355698702,1,12,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,ERO1A
9286,GO:0035725,0.292912719424053,0.861470122928681,4,76,sodium ion transmembrane transport,BP,NEDD4L;SLC9A1;SLC28A3;YWHAH
6520,GO:0021895,0.293013987046322,0.956529020523812,1,10,cerebral cortex neuron differentiation,BP,DLX2
13471,GO:0055002,0.293151196308085,0.861236894917673,4,78,striated muscle cell development,BP,TBX3;EDN1;HDAC9;PDLIM5
16323,GO:0090527,0.293383172463748,0.95689585254294,1,9,actin filament reorganization,BP,NEDD9
13752,GO:0060323,0.29344753429134,0.908317063820346,2,31,head morphogenesis,BP,CSRNP1;PTPN11
14405,GO:0061684,0.293458100612423,0.956388164711662,1,10,chaperone-mediated autophagy,BP,PLK3
2205,GO:0005088,0.293897118369537,0.82119631484878,8,172,Ras guanyl-nucleotide exchange factor activity,MF,HBEGF;CSF2;EREG;FGD6;NRG1;ARHGEF3;DENND2C;RAB3IP
10610,GO:0043589,0.293947501535942,0.956718418406782,1,9,skin morphogenesis,BP,ERRFI1
14047,GO:0060788,0.294031014014095,0.956206074910642,1,10,ectodermal placode formation,BP,TBX3
15425,GO:0071697,0.294031014014095,0.956206074910642,1,10,ectodermal placode morphogenesis,BP,TBX3
2666,GO:0006012,0.294083685808868,0.955792428556943,1,11,galactose metabolic process,BP,B4GALT1
10679,GO:0043931,0.294160765886786,0.956651256358589,1,9,ossification involved in bone maturation,BP,BMP2
13551,GO:0060009,0.294357791015524,0.956102021260789,1,10,Sertoli cell development,BP,SOX9
12404,GO:0048846,0.29474577384779,0.908030083706116,2,28,axon extension involved in axon guidance,BP,SEMA7A;WNT5A
17945,GO:1902284,0.29474577384779,0.908030083706116,2,28,neuron projection extension involved in neuron projection guidance,BP,SEMA7A;WNT5A
11663,GO:0046426,0.294793802278565,0.90750059942576,2,32,negative regulation of JAK-STAT cascade,BP,BCL3;SOCS3
19049,GO:1904893,0.294793802278565,0.90750059942576,2,32,negative regulation of STAT cascade,BP,BCL3;SOCS3
14058,GO:0060828,0.294797158918549,0.820246357492929,8,195,regulation of canonical Wnt signaling pathway,BP,NFKB1;BMP2;CYLD;NRARP;SOX9;FERMT1;SOX4;WNT5A
10831,GO:0044325,0.294845112180919,0.859995055628606,4,81,ion channel binding,MF,PANX1;NEDD4L;STX1A;YWHAH
10949,GO:0044615,0.295127001570557,0.956346220605211,1,9,nuclear pore nuclear basket,CC,NUP153
12511,GO:0050651,0.295177720978803,0.955840315851822,1,10,dermatan sulfate proteoglycan biosynthetic process,BP,DSE
18345,GO:1903311,0.295267262896752,0.809064410389048,10,251,regulation of mRNA metabolic process,BP,ZC3H12A;BTG2;NOCT;ZFP36L1;RC3H1;ZFP36;SAMD4A;PRPF19;QKI;PABPC4
12689,GO:0050901,0.295372299479606,0.955778079984422,1,10,leukocyte tethering or rolling,BP,TNF
10622,GO:0043619,0.295507563221378,0.955734786463565,1,10,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,NFE2L2
15597,GO:0072079,0.295571818569487,0.955313296273057,1,11,nephron tubule formation,BP,SOX9
4827,GO:0014029,0.296172670794648,0.955521555505827,1,10,neural crest formation,BP,SOX9
6151,GO:0019439,0.296174910310836,0.782142088702098,19,553,aromatic compound catabolic process,BP,ZC3H12A;BTG2;NOCT;AMPD3;ZFP36L1;HAL;RC3H1;ZFP36;PNRC1;SAMD4A;QKI;NUP153;MAOA;TDG;ERN1;UPP1;ISG20;PABPC4;AHCY
8228,GO:0032990,0.296292373514628,0.782271054752502,19,461,cell part morphogenesis,BP,EFNA1;SEMA7A;KLF7;EFNB2;ZSWIM4;NEDD4L;CREB1;EFNB1;RAPH1;NRG1;PTPN11;VCL;SKIL;CORO1C;WNT5A;YWHAH;SGK1;B3GNT2;PDLIM5
9359,GO:0035871,0.296474806860467,0.955918683702234,1,9,protein K11-linked deubiquitination,BP,TNFAIP3
11597,GO:0046184,0.296627604370974,0.955375368693081,1,10,aldehyde biosynthetic process,BP,BMP2
16762,GO:0098554,0.296661862966067,0.954340798721371,1,13,cytoplasmic side of endoplasmic reticulum membrane,CC,PTPN1
7852,GO:0032411,0.296735610214359,0.877808951522165,3,56,positive regulation of transporter activity,BP,ADRB2;SLC9A1;SGK1
7731,GO:0032225,0.296784125990925,0.954920794208315,1,11,regulation of synaptic transmission, dopaminergic,BP,PTGS2
10848,GO:0044344,0.297163544074638,0.844569673982979,5,107,cellular response to fibroblast growth factor stimulus,BP,CXCL8;ZFP36L1;ZFP36;PTPN11;WNT5A
16827,GO:0098719,0.297273986830039,0.955664051084973,1,9,sodium ion import across plasma membrane,BP,SLC9A1
3240,GO:0006897,0.297459552671231,0.78314611037474,18,452,endocytosis,BP,IL1B;TNF;CXCL8;ADRB2;EHD1;LDLR;NEDD4L;TFRC;SAA1;ITGAV;PIP5K1A;PTPN1;CORO1C;ADM;ABL2;WNT5A;RAB22A;CXCL16
3679,GO:0008179,0.297694009948931,0.955031619836065,1,10,adenylate cyclase binding,MF,ADRB2
6611,GO:0022821,0.297750984309168,0.955511671734584,1,9,potassium ion antiporter activity,MF,SLC9A1
6496,GO:0021854,0.298047436879617,0.954509695108112,1,11,hypothalamus development,BP,ETS1
14028,GO:0060749,0.298356296411801,0.954408863856842,1,11,mammary gland alveolus development,BP,AREG
14292,GO:0061377,0.298356296411801,0.954408863856842,1,11,mammary gland lobule development,BP,AREG
13951,GO:0060627,0.298548183104868,0.791851610060782,14,345,regulation of vesicle-mediated transport,BP,IL1B;SDC4;TNF;EHD1;LDLR;NEDD4L;ITGAV;STX1A;PTPN1;ABL2;WNT5A;INSIG1;PDPK1;SMPD3
10074,GO:0042573,0.298678309481197,0.954303602767479,1,11,retinoic acid metabolic process,BP,ALDH1A3
15185,GO:0071326,0.299065093040427,0.857015240265763,4,85,cellular response to monosaccharide stimulus,BP,PIM3;SOX4;OXCT1;ERN1
15187,GO:0071331,0.299065093040427,0.857015240265763,4,85,cellular response to hexose stimulus,BP,PIM3;SOX4;OXCT1;ERN1
597,GO:0001759,0.299325277499018,0.954091699919641,1,11,organ induction,BP,BMP2
4645,GO:0010766,0.299345992619876,0.954496137066092,1,10,negative regulation of sodium ion transport,BP,NEDD4L
13939,GO:0060600,0.299350560440824,0.954494651404109,1,10,dichotomous subdivision of an epithelial terminal unit,BP,AREG
16988,GO:0099068,0.299734935833439,0.954874676878127,1,9,postsynapse assembly,BP,WNT5A
15992,GO:0086003,0.299955792868892,0.905154305159772,2,29,cardiac muscle cell contraction,BP,NEDD4L;SLC9A1
4681,GO:0010828,0.299972748965431,0.905145340395139,2,29,positive regulation of glucose transmembrane transport,BP,PTPN11;NFE2L2
2860,GO:0006352,0.300105128263788,0.816012572485407,8,206,DNA-templated transcription, initiation,BP,FOSL1;JUN;CDKN1A;TAF4B;CREB1;PPARD;SOX9;ZNF451
14281,GO:0061351,0.300154697789075,0.85647386521386,4,79,neural precursor cell proliferation,BP,BTG2;KCTD11;VEGFC;WNT5A
8216,GO:0032970,0.300313647944696,0.800721358489566,11,264,regulation of actin filament-based process,BP,SDC4;EDN1;PHLDB2;RND3;TACSTD2;SMAD3;SLC9A1;CDC42EP1;RHOB;ABL2;FRMD6
19510,GO:1990380,0.300412358776265,0.954655986409028,1,9,Lys48-specific deubiquitinase activity,MF,CYLD
144,GO:0000295,0.300773514670336,0.953615324947448,1,11,adenine nucleotide transmembrane transporter activity,MF,SLC25A25
2332,GO:0005346,0.300773514670336,0.953615324947448,1,11,purine ribonucleotide transmembrane transporter activity,MF,SLC25A25
5039,GO:0015216,0.300773514670336,0.953615324947448,1,11,purine nucleotide transmembrane transporter activity,MF,SLC25A25
19413,GO:1905939,0.300783348515421,0.953612080651598,1,11,regulation of gonad development,BP,SOX9
2536,GO:0005791,0.301248211606128,0.874698946389935,3,62,rough endoplasmic reticulum,CC,ZC3H12A;EDN1;TMCC1
1313,GO:0003159,0.301277061743396,0.953449032388734,1,11,morphogenesis of an endothelium,BP,RHOB
14221,GO:0061154,0.301277061743396,0.953449032388734,1,11,endothelial tube morphogenesis,BP,RHOB
11147,GO:0045198,0.301488323737557,0.953796307680366,1,10,establishment of epithelial cell apical/basal polarity,BP,WNT5A
3509,GO:0007420,0.302006986378179,0.779259112947053,18,449,brain development,BP,BTG2;INHBA;ETS1;TBX3;KDM6B;SEMA7A;BMP2;HMGCS1;ALDH1A3;B3GNT5;DLX2;CREB1;NRG1;PTPN11;OXCT1;CDK6;WNT5A;YWHAH
10564,GO:0043523,0.302018744883218,0.830290722848616,6,136,regulation of neuron apoptotic process,BP,BTG2;JUN;CEBPB;SOD2;ADAM8;PDPK1
2211,GO:0005095,0.302191061999435,0.953146321258407,1,11,GTPase inhibitor activity,MF,CPEB2
12607,GO:0050780,0.30225885559358,0.953543104910624,1,10,dopamine receptor binding,MF,PTPN11
4805,GO:0010998,0.302404708309026,0.953495087386285,1,10,regulation of translational initiation by eIF2 alpha phosphorylation,BP,PPP1R15B
10286,GO:0043032,0.302442863362108,0.95306272904696,1,11,positive regulation of macrophage activation,BP,WNT5A
15851,GO:0072567,0.302724105028645,0.952619489025647,1,12,chemokine (C-X-C motif) ligand 2 production,BP,TNF
12206,GO:0048385,0.30276045740574,0.952957173624774,1,11,regulation of retinoic acid receptor signaling pathway,BP,TRIM16
5640,GO:0016723,0.302851286869885,0.953347888453543,1,10,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,STEAP4
12642,GO:0050832,0.303118242504977,0.951937634253196,1,14,defense response to fungus,BP,COTL1
645,GO:0001833,0.303320765080319,0.953192854115363,1,10,inner cell mass cell proliferation,BP,PRPF19
13816,GO:0060402,0.303472936869669,0.854178806594622,4,80,calcium ion transport into cytosol,BP,BDKRB1;PML;PDPK1;ERO1A
6254,GO:0019829,0.303625317564472,0.902608826046572,2,34,cation-transporting ATPase activity,MF,ATP6V1C2;ATP13A3
2894,GO:0006402,0.303659327324256,0.797673349286544,11,322,mRNA catabolic process,BP,ZC3H12A;BTG2;NOCT;ZFP36L1;RC3H1;ZFP36;PNRC1;SAMD4A;QKI;ERN1;PABPC4
3290,GO:0006983,0.304111693996007,0.952931001453631,1,10,ER overload response,BP,PPP1R15B
16861,GO:0098792,0.304357936725283,0.95284930700101,1,10,xenophagy,BP,RIPK2
2376,GO:0005504,0.304412774302891,0.951497658257749,1,14,fatty acid binding,MF,PPARD
3462,GO:0007281,0.304429498453553,0.828542250842349,6,133,germ cell development,BP,PRDM1;TAF4B;EREG;QKI;CELF1;AGFG1
66,GO:0000137,0.304448547144947,0.952819225293557,1,10,Golgi cis cisterna,CC,SMPD3
10514,GO:0043422,0.304464551015787,0.952388483049378,1,11,protein kinase B binding,MF,BCL10
8341,GO:0033189,0.304579296108096,0.952350049662608,1,11,response to vitamin A,BP,PPARD
5356,GO:0016125,0.304631360450462,0.839145314737927,5,110,sterol metabolic process,BP,HMGCS1;LDLR;PPARD;SQLE;INSIG1
2298,GO:0005262,0.304641802664917,0.873047598100175,3,53,calcium channel activity,MF,TRPV3;PANX1;ITGAV
56,GO:0000118,0.304839666617343,0.872801754923678,3,55,histone deacetylase complex,CC,ELMSAN1;ZNF217;HDAC9
12938,GO:0051292,0.304933863126878,0.952657918230404,1,10,nuclear pore complex assembly,BP,NUP153
12551,GO:0050700,0.304963788177128,0.952221136171801,1,11,CARD domain binding,MF,RIPK2
2533,GO:0005788,0.304984483790871,0.812399407142267,8,185,endoplasmic reticulum lumen,CC,PLAUR;PTGS2;EDN1;IL23A;WNT5A;CTSC;ERO1A;TMEM132A
8047,GO:0032695,0.305044044142717,0.952194202576452,1,11,negative regulation of interleukin-12 production,BP,NFKB1
2056,GO:0004806,0.305083416520023,0.952608146736817,1,10,triglyceride lipase activity,MF,LIPG
2953,GO:0006482,0.305279965211547,0.902320403623668,2,29,protein demethylation,BP,KDM6B;KDM6A
3705,GO:0008214,0.305279965211547,0.902320403623668,2,29,protein dealkylation,BP,KDM6B;KDM6A
5604,GO:0016641,0.305461247382269,0.95248227069319,1,10,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,MAOA
10846,GO:0044342,0.305516302210429,0.952035538416568,1,11,type B pancreatic cell proliferation,BP,ERRFI1
13918,GO:0060572,0.305517732331711,0.952463436023728,1,10,morphogenesis of an epithelial bud,BP,WNT5A
7173,GO:0031053,0.305608889525922,0.952433031009462,1,10,primary miRNA processing,BP,SMAD3
5380,GO:0016192,0.305940182736692,0.745479507554846,52,1437,vesicle-mediated transport,BP,IL1B;CXCL1;PLAUR;PLAU;SDC4;TNF;CXCL8;NFKB1;TGFA;SQSTM1;CAB39;RAP2B;AMPD3;ADRB2;EHD1;B4GALT1;VMP1;ADAM8;LDLR;VEGFC;NEDD4L;TFRC;SERPINB1;CD55;SAA1;ITGAV;PIP5K1A;STX1A;RHOB;SPAG9;VCL;AREG;COTL1;PTPN1;CORO1C;ADM;ABL2;WNT5A;INSIG1;PDPK1;ADAMTS9;CTSC;CYTH1;AGFG1;RAB22A;CREG1;MYO1B;CXCL16;TAP1;STX12;RAB24;SMPD3
7409,GO:0031490,0.305983815672446,0.852091230906208,4,92,chromatin DNA binding,MF,KDM6B;SMAD3;KDM6A;RELA
10478,GO:0043371,0.306124376826493,0.952260882971328,1,10,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,RC3H1
20279,GO:2001241,0.306418257000881,0.951373313623321,1,12,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,INHBA
2786,GO:0006220,0.306424214043362,0.90050863358053,2,41,pyrimidine nucleotide metabolic process,BP,TDG;UPP1
8204,GO:0032956,0.306476411717994,0.800108460598463,10,240,regulation of actin cytoskeleton organization,BP,SDC4;EDN1;PHLDB2;RND3;TACSTD2;SMAD3;SLC9A1;CDC42EP1;RHOB;ABL2
17426,GO:1900182,0.306567855710303,0.871598280846618,3,57,positive regulation of protein localization to nucleus,BP,ZC3H12A;PTGS2;LIF
6587,GO:0022412,0.306741479504882,0.811008160537324,8,186,cellular process involved in reproduction in multicellular organism,BP,INHBA;PRDM1;FOSL1;TAF4B;EREG;QKI;CELF1;AGFG1
19717,GO:2000052,0.306800101583811,0.952034682672952,1,10,positive regulation of non-canonical Wnt signaling pathway,BP,WNT5A
7285,GO:0031269,0.306902389335295,0.951568115099923,1,11,pseudopodium assembly,BP,CDC42EP1
7560,GO:0031901,0.307519275704456,0.837127250231808,5,107,early endosome membrane,CC,EHD1;PML;STEAP4;HLA-E;STX12
3303,GO:0007005,0.30781567054913,0.776207056845166,17,487,mitochondrion organization,BP,PLAUR;PPIF;PMAIP1;SQSTM1;JUN;UGCG;SOD2;BBC3;USP36;SLC9A1;PLAGL2;TP53BP2;NRG1;YWHAH;ALAS1;YWHAG;SFN
4493,GO:0010517,0.307898908155029,0.900410530460656,2,33,regulation of phospholipase activity,BP,ABL2;PDPK1
16870,GO:0098801,0.308008990498884,0.951193074406695,1,11,regulation of renal system process,BP,EDN1
5146,GO:0015672,0.308239217909924,0.79861173124127,10,249,monovalent inorganic cation transport,BP,PPIF;CAB39;ADRB2;NEDD4L;OXSR1;SLC9A1;SLC28A3;ATP6V1C2;YWHAH;SGK1
8597,GO:0034104,0.308454778485561,0.95104152226224,1,11,negative regulation of tissue remodeling,BP,TNFAIP3
878,GO:0002228,0.30853488695922,0.899763289937294,2,36,natural killer cell mediated immunity,BP,RAET1L;HLA-E
12063,GO:0048012,0.308897571451079,0.950890721312572,1,11,hepatocyte growth factor receptor signaling pathway,BP,PTPN1
20036,GO:2000651,0.308946954288694,0.9513119419739,1,10,positive regulation of sodium ion transmembrane transporter activity,BP,SLC9A1
589,GO:0001741,0.308994241953183,0.95085776306067,1,11,XY body,CC,BIRC2
10049,GO:0042532,0.309189141636969,0.950791276551487,1,11,negative regulation of tyrosine phosphorylation of STAT protein,BP,SOCS3
10560,GO:0043517,0.309441527235997,0.950705103060649,1,11,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,PMAIP1
12527,GO:0050667,0.309644832827093,0.950635624277109,1,11,homocysteine metabolic process,BP,AHCY
10030,GO:0042475,0.309766478765502,0.869625945856353,3,56,odontogenesis of dentin-containing tooth,BP,BMP2;DLX2;ADM
11574,GO:0046128,0.309999000560527,0.869167489846683,3,62,purine ribonucleoside metabolic process,BP,TJP2;AMPD3;AHCY
7337,GO:0031346,0.310356775695116,0.792537981343539,11,258,positive regulation of cell projection organization,BP,SEMA7A;ENC1;NEDD4L;NAV3;NRG1;CDC42EP1;SKIL;CORO1C;ABL2;WNT5A;NFE2L2
2563,GO:0005845,0.310391809915928,0.950379865415992,1,11,mRNA cap binding complex,CC,ZFP36
12343,GO:0048705,0.310728722665344,0.82385001105451,6,131,skeletal system morphogenesis,BP,CSRNP1;NAB1;DLX2;SMAD3;SOX9;INSIG1
9124,GO:0035437,0.310906102900049,0.95020333420259,1,11,maintenance of protein localization in endoplasmic reticulum,BP,INSIG1
3463,GO:0007283,0.311070269132459,0.791843109624808,11,274,spermatogenesis,BP,BIRC3;OVOL1;TAF4B;BCL2L2;GJB3;SOX9;SPAG9;SKIL;QKI;AGFG1;BRD2
12389,GO:0048813,0.311181276561058,0.834621918767329,5,101,dendrite morphogenesis,BP,EFNA1;KLF7;NEDD4L;YWHAH;PDLIM5
10062,GO:0042552,0.31132330089364,0.848782943656532,4,80,myelination,BP,NAB1;NDRG1;NRG1;QKI
17554,GO:1901096,0.311394401016224,0.950480419049138,1,10,regulation of autophagosome maturation,BP,ADRB2
17976,GO:1902373,0.311690290040458,0.898462386930301,2,32,negative regulation of mRNA catabolic process,BP,NOCT;ZFP36
6237,GO:0019787,0.311844923642476,0.775264970340369,16,401,ubiquitin-like protein transferase activity,MF,TNFAIP3;BIRC3;RNF19B;BIRC2;PELI1;NEDD4L;RC3H1;KLHL21;ZNF451;UHRF1;FEM1B;TNFAIP1;PRPF19;RNF19A;RNF11;BACH1
6333,GO:0020037,0.312033286272899,0.868016440995289,3,59,heme binding,MF,PTGS2;CYP27B1;BACH1
8665,GO:0034236,0.312093125620266,0.94979451202571,1,11,protein kinase A catalytic subunit binding,MF,SOX9
16186,GO:0090208,0.312123199850973,0.949784129199982,1,11,positive regulation of triglyceride metabolic process,BP,LDLR
3478,GO:0007340,0.312226178490541,0.94937650551468,1,12,acrosome reaction,BP,B4GALT1
3117,GO:0006695,0.312291692669135,0.867851169628703,3,59,cholesterol biosynthetic process,BP,HMGCS1;SQLE;INSIG1
8913,GO:0034754,0.312295542683835,0.86765393267526,3,63,cellular hormone metabolic process,BP,BMP2;ALDH1A3;ADM
16504,GO:0097202,0.312562560930265,0.94925943998455,1,12,activation of cysteine-type endopeptidase activity,BP,RIPK2
11101,GO:0045116,0.312832456812908,0.94857989560495,1,14,protein neddylation,BP,DCUN1D3
12736,GO:0050996,0.312935262238528,0.94995274954731,1,10,positive regulation of lipid catabolic process,BP,IL1B
6602,GO:0022617,0.312997288590768,0.867507678853519,3,57,extracellular matrix disassembly,BP,ETS1;ADAM8;LAMB3
8057,GO:0032717,0.313017587877009,0.949100837262743,1,12,negative regulation of interleukin-8 production,BP,BCL3
4459,GO:0010447,0.313328298567526,0.949367064335643,1,11,response to acidic pH,BP,SLC9A1
16169,GO:0090190,0.313597114299504,0.949273760799015,1,11,positive regulation of branching involved in ureteric bud morphogenesis,BP,SOX9
1996,GO:0004715,0.313648884496851,0.89751397023719,2,31,non-membrane spanning protein tyrosine kinase activity,MF,RIPK2;ABL2
7044,GO:0030816,0.313860505440924,0.948806280558284,1,12,positive regulation of cAMP metabolic process,BP,ADM
19722,GO:2000059,0.314006007314107,0.896766874659668,2,36,negative regulation of ubiquitin-dependent protein catabolic process,BP,N4BP1;PML
6219,GO:0019748,0.314022717780773,0.89675766063839,2,36,secondary metabolic process,BP,WNT5A;NFE2L2
18206,GO:1902993,0.314031091056542,0.949122922657792,1,11,positive regulation of amyloid precursor protein catabolic process,BP,EFNA1
1434,GO:0003407,0.314071754917203,0.897281952854344,2,31,neural retina development,BP,DLX2;SOX9
13487,GO:0055021,0.314189016755607,0.897093097359251,2,32,regulation of cardiac muscle tissue growth,BP,EDN1;PIM1
15041,GO:0070989,0.314214718468689,0.949059021287382,1,11,oxidative demethylation,BP,TDG
4275,GO:0009635,0.314319879222328,0.948645341222707,1,12,response to herbicide,BP,ZC3H12A
2989,GO:0006534,0.3143236635774,0.949021087136114,1,11,cysteine metabolic process,BP,AHCY
1228,GO:0002903,0.314434713881305,0.948605064063085,1,12,negative regulation of B cell apoptotic process,BP,BCL10
17424,GO:1900180,0.314494863886464,0.846444007080306,4,84,regulation of protein localization to nucleus,BP,ZC3H12A;PTGS2;LIF;CDKN1A
12180,GO:0048306,0.314541049979856,0.896292261294687,2,38,calcium-dependent protein binding,MF,SLC9A1;STX1A
9238,GO:0035631,0.314870466214815,0.948830447482087,1,11,CD40 receptor complex,CC,BIRC2
13807,GO:0060393,0.314986381098341,0.896427099803706,2,34,regulation of pathway-restricted SMAD protein phosphorylation,BP,INHBA;BMP2
13822,GO:0060413,0.315105362884062,0.949204126901079,1,10,atrial septum morphogenesis,BP,SOX4
2902,GO:0006412,0.315114129046598,0.762139294850711,21,654,translation,BP,ZC3H12A;BTG2;TNF;TNIP1;CPEB2;BCL3;ZFP36L1;ENC1;PPP1R15A;RC3H1;ZFP36;LARP4B;PPP1R15B;SOX4;EIF1;RBM3;SAMD4A;QKI;CELF1;NUP153;PABPC4
14733,GO:0070403,0.315206035375993,0.948334059433599,1,12,NAD+ binding,MF,ALDH1A3
19306,GO:1905564,0.315220587369727,0.949164198540238,1,10,positive regulation of vascular endothelial cell proliferation,BP,PDPK1
16810,GO:0098659,0.315425492881957,0.896537568202974,2,31,inorganic cation import across plasma membrane,BP,SLC9A1;STEAP4
17076,GO:0099587,0.315425492881957,0.896537568202974,2,31,inorganic ion import across plasma membrane,BP,SLC9A1;STEAP4
15040,GO:0070988,0.315700952395719,0.865889859901426,3,55,demethylation,BP,KDM6B;KDM6A;TDG
3243,GO:0006901,0.315915653510093,0.865472790451689,3,60,vesicle coating,BP,TGFA;AREG;CTSC
12515,GO:0050655,0.316181712743367,0.948371617804684,1,11,dermatan sulfate proteoglycan metabolic process,BP,DSE
4717,GO:0010878,0.316300005184457,0.948330108966158,1,11,cholesterol storage,BP,EHD1
12339,GO:0048701,0.316518070756615,0.895809183966879,2,32,embryonic cranial skeleton morphogenesis,BP,DLX2;SMAD3
12707,GO:0050922,0.316521758681091,0.895689162620522,2,33,negative regulation of chemotaxis,BP,SEMA7A;WNT5A
15424,GO:0071696,0.316601009537237,0.948224399753308,1,11,ectodermal placode development,BP,TBX3
19217,GO:1905330,0.317113653676076,0.818797177679961,6,144,regulation of morphogenesis of an epithelium,BP,TNF;LIF;PHLDB2;TACSTD2;SOX9;WNT5A
2321,GO:0005328,0.317407981192916,0.94840277212685,1,10,neurotransmitter:sodium symporter activity,MF,SLC6A14
16295,GO:0090399,0.317454782614262,0.947923886633951,1,11,replicative senescence,BP,CDKN1A
15451,GO:0071774,0.317511630002474,0.829767889404035,5,110,response to fibroblast growth factor,BP,CXCL8;ZFP36L1;ZFP36;PTPN11;WNT5A
5097,GO:0015370,0.317721547684362,0.895269360205284,2,31,solute:sodium symporter activity,MF,SLC6A14;SLC28A3
11027,GO:0044877,0.31778719868558,0.754144823223742,25,667,protein-containing complex binding,MF,IL1B;ZC3H12A;SEMA7A;PANX1;CPEB2;CDKN1A;ADRB2;SACS;LDLR;SMAD3;PIM1;WISP1;ITGA5;ITGAV;NRG1;PTPN11;UHRF1;PTPN1;CORO1C;ABL2;HLA-E;ADAM9;PDPK1;IFIH1;MYO1B
13626,GO:0060113,0.317797344765104,0.894982184738621,2,33,inner ear receptor cell differentiation,BP,SDC4;JAG1
12306,GO:0048645,0.318325623022947,0.894471733265939,2,35,animal organ formation,BP,PIM1;WNT5A
6627,GO:0022853,0.318479120754968,0.894386251036307,2,35,active ion transmembrane transporter activity,MF,ATP6V1C2;ATP13A3
10107,GO:0042625,0.318479120754968,0.894386251036307,2,35,ATPase coupled ion transmembrane transporter activity,MF,ATP6V1C2;ATP13A3
4021,GO:0009048,0.318504774579971,0.948018519219369,1,10,dosage compensation by inactivation of X chromosome,BP,EIF1
11581,GO:0046135,0.318737516385827,0.946755289260856,1,13,pyrimidine nucleoside catabolic process,BP,UPP1
10593,GO:0043560,0.318795794730349,0.947916286043027,1,10,insulin receptor substrate binding,MF,PTPN11
13547,GO:0060004,0.318826949630835,0.947905334683816,1,10,reflex,BP,ALDH1A3
19801,GO:2000232,0.319062216348427,0.947355373608752,1,11,regulation of rRNA processing,BP,USP36
10317,GO:0043101,0.319119980270526,0.946617952549237,1,13,purine-containing compound salvage,BP,AMPD3
14228,GO:0061178,0.319251153404652,0.893856156606386,2,36,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,PIM3;OXCT1
10605,GO:0043584,0.319734341804566,0.947585790345232,1,10,nose development,BP,ALDH1A3
17254,GO:0120036,0.319845145031926,0.739528489667102,39,1024,plasma membrane bounded cell projection organization,BP,BTG2;SDC4;EFNA1;SEMA7A;KLF7;EFNB2;EPHA2;JUN;ENC1;EHD1;ZSWIM4;FGD6;CYLD;TACSTD2;NEDD4L;PLK2;CREB1;EFNB1;RAPH1;NAV3;PIP5K1A;NRG1;CDC42EP1;PTPN11;VCL;AREG;SKIL;EMP3;CORO1C;ADM;ABL2;RAB3IP;WNT5A;NFE2L2;YWHAH;SGK1;B3GNT2;YWHAG;PDLIM5
3077,GO:0006646,0.320019393966714,0.947015147820634,1,11,phosphatidylethanolamine biosynthetic process,BP,ETNK1
443,GO:0001191,0.320091252943486,0.893486530458696,2,35,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,BHLHE40;ZNF451
17487,GO:1900409,0.320096801028161,0.94659654369526,1,12,positive regulation of cellular response to oxidative stress,BP,TNF
18148,GO:1902884,0.320096801028161,0.94659654369526,1,12,positive regulation of response to oxidative stress,BP,TNF
7284,GO:0031268,0.32010050985528,0.94659521349589,1,12,pseudopodium organization,BP,CDC42EP1
4414,GO:0010172,0.320105887283756,0.947454621988301,1,10,embryonic body morphogenesis,BP,PHLDB2
15465,GO:0071804,0.320289048482071,0.842535433136747,4,80,cellular potassium ion transport,BP,CAB39;NEDD4L;OXSR1;SLC9A1
15466,GO:0071805,0.320289048482071,0.842535433136747,4,80,potassium ion transmembrane transport,BP,CAB39;NEDD4L;OXSR1;SLC9A1
13811,GO:0060397,0.320352467930672,0.94736746584358,1,10,JAK-STAT cascade involved in growth hormone signaling pathway,BP,PTPN1
18074,GO:1902653,0.320387643480219,0.862578747897774,3,60,secondary alcohol biosynthetic process,BP,HMGCS1;SQLE;INSIG1
7195,GO:0031083,0.32053754633794,0.946107147318331,1,13,BLOC-1 complex,CC,STX12
15646,GO:0072160,0.32074324055589,0.94722917260254,1,10,nephron tubule epithelial cell differentiation,BP,LIF
8001,GO:0032620,0.321060385628091,0.945918039117196,1,13,interleukin-17 production,BP,IL23A
3242,GO:0006900,0.321072611827188,0.841776533742966,4,86,vesicle budding from membrane,BP,TGFA;AREG;INSIG1;CTSC
856,GO:0002182,0.321184147522255,0.946599431185352,1,11,cytoplasmic translational elongation,BP,CPEB2
17458,GO:1900247,0.321184147522255,0.946599431185352,1,11,regulation of cytoplasmic translational elongation,BP,CPEB2
16437,GO:0097094,0.321697132158021,0.946415744048109,1,11,craniofacial suture morphogenesis,BP,INSIG1
6994,GO:0030673,0.321939305949686,0.946804583191116,1,10,axolemma,CC,NRG1
6985,GO:0030660,0.322026673761907,0.841041629175269,4,88,Golgi-associated vesicle membrane,CC,TGFA;AREG;HLA-E;ITM2B
15031,GO:0070977,0.322168913231394,0.946722849870039,1,10,bone maturation,BP,BMP2
19070,GO:1904948,0.32225224685396,0.946216560204675,1,11,midbrain dopaminergic neuron differentiation,BP,WNT5A
3352,GO:0007088,0.322363747396151,0.814839031456112,6,141,regulation of mitotic nuclear division,BP,IL1B;IL1A;TGFA;EDN1;EREG;DUSP1
4601,GO:0010715,0.322721709724291,0.946047775903136,1,11,regulation of extracellular matrix disassembly,BP,ETS1
14798,GO:0070525,0.322777645198387,0.945294223801061,1,13,tRNA threonylcarbamoyladenosine metabolic process,BP,YRDC
6037,GO:0019104,0.323432652835226,0.94451688290065,1,15,DNA N-glycosylase activity,MF,TDG
9133,GO:0035458,0.323722540564376,0.94528699876212,1,12,cellular response to interferon-beta,BP,IRF1
3467,GO:0007289,0.323727634618723,0.94568508865753,1,11,spermatid nucleus differentiation,BP,AGFG1
8612,GO:0034123,0.323886397869302,0.945227383456249,1,12,positive regulation of toll-like receptor signaling pathway,BP,PELI1
12077,GO:0048026,0.323890123400477,0.945226027580093,1,12,positive regulation of mRNA splicing, via spliceosome,BP,PRPF19
10947,GO:0044613,0.323959386231654,0.945200816412087,1,12,nuclear pore central transport channel,CC,NUP153
7466,GO:0031623,0.323972175058156,0.860294770604026,3,59,receptor internalization,BP,CXCL8;TFRC;ADM
15210,GO:0071360,0.32437443481946,0.945049601128862,1,12,cellular response to exogenous dsRNA,BP,IFIH1
9207,GO:0035591,0.324465444292131,0.860206492633635,3,55,signaling adaptor activity,MF,TP53BP2;PTPN11;SPAG9
4485,GO:0010506,0.324574135613456,0.780657915240254,11,273,regulation of autophagy,BP,ZC3H12A;TICAM1;PLEKHF1;ADRB2;PLK2;PLK3;USP36;RIPK2;ABL2;ATP6V1C2;ERN1
16061,GO:0089718,0.324637618393178,0.945355780760063,1,11,amino acid import across plasma membrane,BP,SLC7A2
18597,GO:1903859,0.325110734578034,0.945669210458158,1,10,regulation of dendrite extension,BP,NEDD4L
3536,GO:0007530,0.325194598428502,0.945153650092815,1,11,sex determination,BP,SOX9
12827,GO:0051129,0.325314927304295,0.757000288416559,19,493,negative regulation of cellular component organization,BP,TNF;PPIF;EFNA1;SEMA7A;EFNB2;LIF;BIRC2;PHLDB2;DUSP1;SACS;LDLR;TACSTD2;PLK2;NAV3;ZNF451;CORO1C;WNT5A;INSIG1;YWHAH
9931,GO:0042278,0.325322542328331,0.859158629729604,3,64,purine nucleoside metabolic process,BP,TJP2;AMPD3;AHCY
9884,GO:0042159,0.325422497336009,0.944666685399415,1,12,lipoprotein catabolic process,BP,LDLR
3278,GO:0006958,0.325672606220059,0.944575079153093,1,12,complement activation, classical pathway,BP,CD55
5243,GO:0015865,0.325811141431341,0.944524300733292,1,12,purine nucleotide transport,BP,SLC25A25
5246,GO:0015868,0.325811141431341,0.944524300733292,1,12,purine ribonucleotide transport,BP,SLC25A25
13047,GO:0051503,0.325811141431341,0.944524300733292,1,12,adenine nucleotide transport,BP,SLC25A25
15003,GO:0070935,0.326348407904638,0.944733550857616,1,11,3'-UTR-mediated mRNA stabilization,BP,ZFP36
6156,GO:0019471,0.326802137783942,0.944160277363425,1,12,4-hydroxyproline metabolic process,BP,ERO1A
6835,GO:0030296,0.326850914918377,0.944550008228624,1,11,protein tyrosine kinase activator activity,MF,NRG1
6290,GO:0019898,0.327003462961164,0.794884349608606,8,187,extrinsic component of membrane,CC,ZC3H12A;PLAUR;PLEKHF1;ERRFI1;CYLD;PML;ABL2;CYTH1
5280,GO:0015929,0.327086106898532,0.94405571252093,1,12,hexosaminidase activity,MF,HEXDC
464,GO:0001502,0.327187435239388,0.944426895557517,1,11,cartilage condensation,BP,SOX9
16838,GO:0098743,0.327187435239388,0.944426895557517,1,11,cell aggregation,BP,SOX9
13270,GO:0051954,0.327247802342912,0.943996121387306,1,12,positive regulation of amine transport,BP,STX1A
10066,GO:0042559,0.327316802098989,0.94332987072825,1,14,pteridine-containing compound biosynthetic process,BP,GCH1
14129,GO:0060992,0.327349633067989,0.94436750050462,1,11,response to fungicide,BP,KDM6B
7400,GO:0031462,0.32754654240566,0.943885927202526,1,12,Cul2-RING ubiquitin ligase complex,CC,ZSWIM4
3401,GO:0007183,0.327549779930481,0.944294158205193,1,11,SMAD protein complex assembly,BP,SMAD3
3051,GO:0006611,0.327673245037651,0.801668069427971,7,170,protein export from nucleus,BP,IL1B;DUSP16;PTPN11;SOX4;NUP153;AGFG1;SFN
8295,GO:0033127,0.32778685831685,0.943797192409924,1,12,regulation of histone phosphorylation,BP,IL1B
10554,GO:0043508,0.328090112459241,0.943685102160629,1,12,negative regulation of JUN kinase activity,BP,DUSP10
11492,GO:0045956,0.328355179638674,0.943587020702474,1,12,positive regulation of calcium ion-dependent exocytosis,BP,STX1A
15485,GO:0071840,0.328519057298856,0.708149447717629,163,4803,cellular component organization or biogenesis,BP,TNFAIP3;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;BTG2;BIRC3;HBEGF;CSF2;INHBA;ELF3;SDC4;ETS1;TNF;PPIF;NUAK2;PMAIP1;FOSL1;NFKB2;NOCT;PLEKHF1;EFNA1;TGFA;KDM6B;EDN1;SEMA7A;HAS3;CLDN1;KLF7;PANX1;EFNB2;EPHA2;GADD45A;LIF;KCTD11;SQSTM1;CAB39;JUN;BIRC2;CDKN1A;PHLDB2;SERTAD2;BCL3;TAF4B;ENC1;RND3;ADRB2;UGCG;PPP1R15A;MAST4;RUNX1;TRIM16;EREG;SOD2;ALDH1A3;EHD1;NEDD9;ZSWIM4;ANKLE2;B4GALT1;DUSP1;BCL10;FGD6;DCUN1D3;TMCC1;TRAF1;PPP1R10;SACS;VMP1;CYLD;ADAM8;LDLR;TACSTD2;NEDD4L;SMAD3;RC3H1;PLK2;BBC3;PLK3;DIEXF;WISP1;ITGA5;TFRC;LIPG;CREB1;EFNB1;PPARD;CCDC85B;USP36;BDKRB1;RAPH1;SLC9A1;CYP27B1;PLAGL2;AMOTL2;NAV3;NDRG1;ITGAV;PIP5K1A;TP53BP2;SOX9;STX1A;NRG1;ZNF451;PML;FERMT1;CDC42EP1;PTPN11;UHRF1;DCBLD2;RHOB;SPAG9;ABCA5;GCH1;VCL;AREG;AKAP2;TNFAIP1;HDAC9;SKIL;IL7R;EMP3;PTPN1;CORO1C;PRPF19;ADM;ABL2;ATP6V1C2;RAB3IP;CELF1;WNT5A;NUP153;INSIG1;ADAM9;PDPK1;ADAMTS9;RNF19A;CTSC;ERO1A;KDM6A;FRMD6;NFE2L2;YWHAH;SGK1;B3GNT2;AGFG1;ALAS1;YWHAG;TDG;RAB22A;SFN;ISG20;ATXN7;LAMB3;MYO1B;BRD2;IPO4;CXCL16;TAP1;STX12;PDLIM5;SMPD3
15180,GO:0071318,0.328557275160992,0.943512173829933,1,12,cellular response to ATP,BP,PTGS2
4516,GO:0010565,0.328564301340693,0.821304441546324,5,123,regulation of cellular ketone metabolic process,BP,PTGS2;ODC1;BMP2;AZIN1;INSIG1
16503,GO:0097201,0.328650807138953,0.943477514412792,1,12,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,JUN
7191,GO:0031078,0.329009782422797,0.94375745421567,1,11,histone deacetylase activity (H3-K14 specific),MF,HDAC9
7635,GO:0032041,0.329009782422797,0.94375745421567,1,11,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,HDAC9
12485,GO:0050433,0.329045066358915,0.943331281298508,1,12,regulation of catecholamine secretion,BP,STX1A
19951,GO:2000482,0.329107311826243,0.942959094110442,1,13,regulation of interleukin-8 secretion,BP,WNT5A
9284,GO:0035722,0.329269035225681,0.887829576959462,2,40,interleukin-12-mediated signaling pathway,BP,SERPINB2;SOD2
15200,GO:0071349,0.329269035225681,0.887829576959462,2,40,cellular response to interleukin-12,BP,SERPINB2;SOD2
15502,GO:0071875,0.329506323237671,0.943574242366315,1,11,adrenergic receptor signaling pathway,BP,ADRB2
14266,GO:0061318,0.33050825019431,0.943203500782453,1,11,renal filtration cell differentiation,BP,JAG1
15623,GO:0072112,0.33050825019431,0.943203500782453,1,11,glomerular visceral epithelial cell differentiation,BP,JAG1
15736,GO:0072311,0.33050825019431,0.943203500782453,1,11,glomerular epithelial cell differentiation,BP,JAG1
20066,GO:2000696,0.330565736422715,0.943182186438462,1,11,regulation of epithelial cell differentiation involved in kidney development,BP,LIF
3327,GO:0007039,0.331066884755641,0.942577929203056,1,12,protein catabolic process in the vacuole,BP,LDLR
11359,GO:0045717,0.331087638840384,0.942570166042094,1,12,negative regulation of fatty acid biosynthetic process,BP,INSIG1
17022,GO:0099175,0.331092489255908,0.887482012299625,2,33,regulation of postsynapse organization,BP,EFNA1;PDLIM5
3241,GO:0006898,0.331196519574713,0.798959714165828,7,164,receptor-mediated endocytosis,BP,CXCL8;ADRB2;LDLR;TFRC;SAA1;ADM;CXCL16
2084,GO:0004842,0.331314376899323,0.761127387976111,15,377,ubiquitin-protein transferase activity,MF,TNFAIP3;BIRC3;RNF19B;BIRC2;PELI1;NEDD4L;RC3H1;KLHL21;UHRF1;FEM1B;TNFAIP1;PRPF19;RNF19A;RNF11;BACH1
20082,GO:2000726,0.331427760788636,0.942862013436475,1,11,negative regulation of cardiac muscle cell differentiation,BP,BMP2
9808,GO:0040037,0.331468689600412,0.942846785649613,1,11,negative regulation of fibroblast growth factor receptor signaling pathway,BP,WNT5A
19948,GO:2000479,0.331514338988183,0.942410421781068,1,12,regulation of cAMP-dependent protein kinase activity,BP,ADRB2
7476,GO:0031639,0.33153472005392,0.942402785246833,1,12,plasminogen activation,BP,PLAU
2169,GO:0005003,0.331619705770809,0.942790578848771,1,11,ephrin receptor activity,MF,EPHA2
2171,GO:0005005,0.331619705770809,0.942790578848771,1,11,transmembrane-ephrin receptor activity,MF,EPHA2
5346,GO:0016082,0.33186334821639,0.942699829684554,1,11,synaptic vesicle priming,BP,STX1A
7792,GO:0032331,0.333041636058652,0.941836531642912,1,12,negative regulation of chondrocyte differentiation,BP,SOX9
4621,GO:0010738,0.33305203425324,0.941832613126466,1,12,regulation of protein kinase A signaling,BP,ADRB2
6504,GO:0021871,0.333173492742345,0.942210406666482,1,11,forebrain regionalization,BP,BMP2
14967,GO:0070875,0.333262022354429,0.942686961164555,1,10,positive regulation of glycogen metabolic process,BP,PHKG2
4714,GO:0010875,0.333563455917557,0.941639696538463,1,12,positive regulation of cholesterol efflux,BP,NFKBIA
17537,GO:1901032,0.333603415888231,0.941265956206891,1,13,negative regulation of response to reactive oxygen species,BP,NFE2L2
18301,GO:1903206,0.333603415888231,0.941265956206891,1,13,negative regulation of hydrogen peroxide-induced cell death,BP,NFE2L2
20197,GO:2001039,0.333603415888231,0.941265956206891,1,13,negative regulation of cellular response to drug,BP,NFE2L2
17113,GO:0101023,0.333675644110965,0.942022178552579,1,11,vascular endothelial cell proliferation,BP,PDPK1
19304,GO:1905562,0.333675644110965,0.942022178552579,1,11,regulation of vascular endothelial cell proliferation,BP,PDPK1
808,GO:0002076,0.333839516690936,0.94196067487834,1,11,osteoblast development,BP,SMAD3
3716,GO:0008236,0.333854558879104,0.832534234790288,4,91,serine-type peptidase activity,MF,PLAU;ADAM8;F3;CTSC
16075,GO:0090036,0.334087668003773,0.941867467930871,1,11,regulation of protein kinase C signaling,BP,WNT5A
10723,GO:0044058,0.334152995595948,0.941416851499483,1,12,regulation of digestive system process,BP,SGK1
8809,GO:0034518,0.33422594347306,0.941389242969432,1,12,RNA cap binding complex,CC,ZFP36
5719,GO:0016854,0.334243382958162,0.94102261784373,1,13,racemase and epimerase activity,MF,DSE
11781,GO:0046639,0.334246336462675,0.941807825567947,1,11,negative regulation of alpha-beta T cell differentiation,BP,RC3H1
13805,GO:0060391,0.334454081535864,0.941729681798708,1,11,positive regulation of SMAD protein signal transduction,BP,SMAD3
5763,GO:0016925,0.334931913068618,0.831953289444299,4,85,protein sumoylation,BP,ZNF451;NUP153;RELA;IFIH1
357,GO:0000974,0.33523900840448,0.940642882167602,1,13,Prp19 complex,CC,PRPF19
16837,GO:0098742,0.335347223815833,0.816599231340467,5,106,cell-cell adhesion via plasma-membrane adhesion molecules,BP,IL1RN;CLDN1;BMP2;CLDN4;ITGA5
4231,GO:0009408,0.335467674783244,0.804741846571825,6,140,response to heat,BP,IL1A;PTGS2;TRPV3;CDKN1A;IER5;NUP153
4129,GO:0009187,0.335719790437682,0.852583362606845,3,58,cyclic nucleotide metabolic process,BP,EPHA2;ADM;WNT5A
1779,GO:0004385,0.335827335127729,0.941211592028662,1,11,guanylate kinase activity,MF,TJP2
14142,GO:0061005,0.335872059024503,0.884726892606048,2,33,cell differentiation involved in kidney development,BP,LIF;JAG1
7448,GO:0031581,0.336139886004074,0.941093301924494,1,11,hemidesmosome assembly,BP,LAMB3
5687,GO:0016801,0.336488569468164,0.940164287143448,1,13,hydrolase activity, acting on ether bonds,MF,AHCY
10037,GO:0042490,0.336723080940014,0.883997968553203,2,35,mechanoreceptor differentiation,BP,SDC4;JAG1
1527,GO:0003899,0.336810416798996,0.883382123608171,2,41,DNA-directed 5'-3' RNA polymerase activity,MF,POLR3A;POLR3D
9873,GO:0042135,0.336926001858616,0.94036202207265,1,12,neurotransmitter catabolic process,BP,MAOA
11392,GO:0045773,0.336940507421813,0.884106730880593,2,33,positive regulation of axon extension,BP,SEMA7A;NRG1
11447,GO:0045898,0.337033484772242,0.939954878181311,1,13,regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,CREB1
12645,GO:0050840,0.337195239029881,0.883837316053715,2,34,extracellular matrix binding,MF,ITGAV;ADAM9
14113,GO:0060965,0.337844064326341,0.940010380605052,1,12,negative regulation of gene silencing by miRNA,BP,ZC3H12A
10887,GO:0044428,0.337942403281166,0.70112864532749,128,3795,nuclear part,CC,NFKBIZ;ZC3H12A;BIRC3;ITPKC;ELF3;ETS1;REL;KLF6;BHLHE40;TNIP1;NFKB1;PRDM1;FOSL1;NFKB2;NOCT;KDM6B;PHLDA1;EHF;RELB;GADD45A;MAFF;SQSTM1;MAP2K3;JUN;NFKBIE;CDKN1A;TJP2;SERTAD2;JUNB;BCL3;ETS2;NAMPT;IRF1;TAF4B;ENC1;CEBPB;DUSP16;ARNTL2;RUNX1;N4BP1;GJB4;TRIM16;ELMSAN1;NEDD9;PPP1R10;VMP1;NABP1;TXNRD1;KLF3;ZNF217;NEDD4L;SMAD3;DUSP10;PLK3;DIEXF;PIM1;AKIRIN1;CREB1;STK40;HIVEP2;PPARD;USP36;IL16;RAPH1;SLC9A1;MAFK;LARP4B;TMEM217;ELL2;NAV3;PIP5K1A;TP53BP2;SOX9;STX1A;NRG1;ZNF451;FEM1C;PML;POU2F2;ELK3;POLR3A;PTPN11;UHRF1;MXD1;GCH1;FEM1B;SOX4;FOSL2;OXCT1;CCNL1;TNFAIP1;HDAC9;HIVEP1;AEN;SKIL;RBM3;CDK6;SAMD4A;TFE3;PRPF19;MAFG;MTF1;CELF1;NUP153;PDPK1;CTSC;KDM6A;ZBTB21;NFE2L2;SGK1;RELA;AGFG1;RNF11;BTAF1;GINS3;POLR3D;ALAS1;TDG;ELF4;ERN1;ETNK1;SH3RF2;UPP1;ISG20;ATXN7;BRD2;IPO4;DSE
18219,GO:1903010,0.337944849487164,0.940407468880812,1,11,regulation of bone development,BP,TJP2
6785,GO:0030219,0.33812939112212,0.850092389725371,3,78,megakaryocyte differentiation,BP,RUNX1;CDKN2B;PTPN11
16546,GO:0097305,0.338163312442061,0.814299548764201,5,113,response to alcohol,BP,INHBA;CLDN1;BIRC2;HMGCS1;OXCT1
18106,GO:1902743,0.33821822893047,0.883241197066222,2,34,regulation of lamellipodium organization,BP,EPHA2;CORO1C
8890,GO:0034707,0.33831165634047,0.939830817521185,1,12,chloride channel complex,CC,CLDN4
7600,GO:0031974,0.338838509549903,0.699246995861737,143,4305,membrane-enclosed lumen,CC,NFKBIZ;ZC3H12A;CXCL1;PLAUR;BIRC3;ITPKC;ELF3;SDC4;ETS1;REL;PPIF;KLF6;BHLHE40;PTGS2;TNIP1;NFKB1;PRDM1;FOSL1;NFKB2;NOCT;KDM6B;EDN1;PHLDA1;EHF;RELB;GADD45A;MAFF;SQSTM1;CAB39;MAP2K3;JUN;NFKBIE;CDKN1A;TJP2;SERTAD2;JUNB;BCL3;ETS2;NAMPT;AMPD3;IRF1;TAF4B;ENC1;CEBPB;DUSP16;ARNTL2;RUNX1;N4BP1;GJB4;TRIM16;ELMSAN1;SOD2;NEDD9;PPP1R10;VMP1;NABP1;TXNRD1;VEGFC;KLF3;ZNF217;NEDD4L;SMAD3;IL23A;DUSP10;PLK3;DIEXF;PIM1;AKIRIN1;CREB1;STK40;HIVEP2;PPARD;SERPINB1;USP36;IL16;RAPH1;SLC9A1;MAFK;LARP4B;TMEM217;ELL2;SAA1;PIP5K1A;TP53BP2;SOX9;NRG1;ZNF451;FEM1C;PML;POU2F2;ELK3;POLR3A;PTPN11;UHRF1;MXD1;GCH1;FEM1B;SOX4;FOSL2;VCL;OXCT1;CCNL1;TNFAIP1;HDAC9;HIVEP1;AEN;SKIL;COTL1;RBM3;CDK6;SAMD4A;TFE3;PRPF19;MAFG;MTF1;CELF1;WNT5A;NUP153;PDPK1;CTSC;ERO1A;KDM6A;ZBTB21;NFE2L2;SGK1;RELA;RNF11;BTAF1;GINS3;POLR3D;ALAS1;TDG;ELF4;CREG1;ETNK1;SH3RF2;UPP1;ISG20;TMEM132A;ATXN7;BRD2;IPO4;DSE
10401,GO:0043233,0.338838509549903,0.699246995861737,143,4305,organelle lumen,CC,NFKBIZ;ZC3H12A;CXCL1;PLAUR;BIRC3;ITPKC;ELF3;SDC4;ETS1;REL;PPIF;KLF6;BHLHE40;PTGS2;TNIP1;NFKB1;PRDM1;FOSL1;NFKB2;NOCT;KDM6B;EDN1;PHLDA1;EHF;RELB;GADD45A;MAFF;SQSTM1;CAB39;MAP2K3;JUN;NFKBIE;CDKN1A;TJP2;SERTAD2;JUNB;BCL3;ETS2;NAMPT;AMPD3;IRF1;TAF4B;ENC1;CEBPB;DUSP16;ARNTL2;RUNX1;N4BP1;GJB4;TRIM16;ELMSAN1;SOD2;NEDD9;PPP1R10;VMP1;NABP1;TXNRD1;VEGFC;KLF3;ZNF217;NEDD4L;SMAD3;IL23A;DUSP10;PLK3;DIEXF;PIM1;AKIRIN1;CREB1;STK40;HIVEP2;PPARD;SERPINB1;USP36;IL16;RAPH1;SLC9A1;MAFK;LARP4B;TMEM217;ELL2;SAA1;PIP5K1A;TP53BP2;SOX9;NRG1;ZNF451;FEM1C;PML;POU2F2;ELK3;POLR3A;PTPN11;UHRF1;MXD1;GCH1;FEM1B;SOX4;FOSL2;VCL;OXCT1;CCNL1;TNFAIP1;HDAC9;HIVEP1;AEN;SKIL;COTL1;RBM3;CDK6;SAMD4A;TFE3;PRPF19;MAFG;MTF1;CELF1;WNT5A;NUP153;PDPK1;CTSC;ERO1A;KDM6A;ZBTB21;NFE2L2;SGK1;RELA;RNF11;BTAF1;GINS3;POLR3D;ALAS1;TDG;ELF4;CREG1;ETNK1;SH3RF2;UPP1;ISG20;TMEM132A;ATXN7;BRD2;IPO4;DSE
14522,GO:0070013,0.338838509549903,0.699246995861737,143,4305,intracellular organelle lumen,CC,NFKBIZ;ZC3H12A;CXCL1;PLAUR;BIRC3;ITPKC;ELF3;SDC4;ETS1;REL;PPIF;KLF6;BHLHE40;PTGS2;TNIP1;NFKB1;PRDM1;FOSL1;NFKB2;NOCT;KDM6B;EDN1;PHLDA1;EHF;RELB;GADD45A;MAFF;SQSTM1;CAB39;MAP2K3;JUN;NFKBIE;CDKN1A;TJP2;SERTAD2;JUNB;BCL3;ETS2;NAMPT;AMPD3;IRF1;TAF4B;ENC1;CEBPB;DUSP16;ARNTL2;RUNX1;N4BP1;GJB4;TRIM16;ELMSAN1;SOD2;NEDD9;PPP1R10;VMP1;NABP1;TXNRD1;VEGFC;KLF3;ZNF217;NEDD4L;SMAD3;IL23A;DUSP10;PLK3;DIEXF;PIM1;AKIRIN1;CREB1;STK40;HIVEP2;PPARD;SERPINB1;USP36;IL16;RAPH1;SLC9A1;MAFK;LARP4B;TMEM217;ELL2;SAA1;PIP5K1A;TP53BP2;SOX9;NRG1;ZNF451;FEM1C;PML;POU2F2;ELK3;POLR3A;PTPN11;UHRF1;MXD1;GCH1;FEM1B;SOX4;FOSL2;VCL;OXCT1;CCNL1;TNFAIP1;HDAC9;HIVEP1;AEN;SKIL;COTL1;RBM3;CDK6;SAMD4A;TFE3;PRPF19;MAFG;MTF1;CELF1;WNT5A;NUP153;PDPK1;CTSC;ERO1A;KDM6A;ZBTB21;NFE2L2;SGK1;RELA;RNF11;BTAF1;GINS3;POLR3D;ALAS1;TDG;ELF4;CREG1;ETNK1;SH3RF2;UPP1;ISG20;TMEM132A;ATXN7;BRD2;IPO4;DSE
6990,GO:0030667,0.338956322204365,0.785109679855539,8,196,secretory granule membrane,CC,PLAUR;PLAU;RAP2B;B4GALT1;ADAM8;CD55;ITGAV;RAB24
6708,GO:0030111,0.33916590479933,0.773063401946465,10,256,regulation of Wnt signaling pathway,BP,NFKB1;BMP2;RUNX1;CYLD;NRARP;SOX9;FERMT1;SOX4;ATP6V1C2;WNT5A
7326,GO:0031334,0.339468426609217,0.784670977077887,8,198,positive regulation of protein complex assembly,BP,CSF2;TNF;PMAIP1;FOSL1;JUN;CREB1;NAV3;CDC42EP1
961,GO:0002381,0.339512722873115,0.882369469105756,2,35,immunoglobulin production involved in immunoglobulin mediated immune response,BP,TFRC;POU2F2
4077,GO:0009129,0.33969612330217,0.938607324083392,1,14,pyrimidine nucleoside monophosphate metabolic process,BP,UPP1
4078,GO:0009130,0.33969612330217,0.938607324083392,1,14,pyrimidine nucleoside monophosphate biosynthetic process,BP,UPP1
11525,GO:0046040,0.339724747616576,0.939286263607721,1,12,IMP metabolic process,BP,AMPD3
1990,GO:0004708,0.340317582299806,0.939056953826679,1,12,MAP kinase kinase activity,MF,MAP2K3
9081,GO:0035333,0.340563610898273,0.938961641212431,1,12,Notch receptor processing, ligand-dependent,BP,JAG1
2606,GO:0005903,0.340820345544983,0.849158226733761,3,58,brush border,CC,B4GALT1;SLC6A14;MYO1B
17924,GO:1902236,0.340915884252272,0.938450531651101,1,13,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,PTPN1
10692,GO:0043970,0.341133161358588,0.938740660916359,1,12,histone H3-K9 acetylation,BP,ZNF451
735,GO:0001963,0.341194943294161,0.938020588433741,1,14,synaptic transmission, dopaminergic,BP,PTGS2
11894,GO:0046914,0.341443015572874,0.73043969577508,27,730,transition metal ion binding,MF,TNFAIP3;IL1A;KLF7;SQSTM1;BIRC2;TRIM16;SOD2;ZSWIM4;B4GALT1;HEPHL1;TRAF1;CYLD;ADAM8;SMAD3;PIM1;PPARD;CYP27B1;PML;UHRF1;GCH1;TRAF4;ADAMTS1;PTPN1;ABL2;ADAMTS9;RNF11;IFIH1
16220,GO:0090266,0.341512517450328,0.938217423035981,1,13,regulation of mitotic cell cycle spindle assembly checkpoint,BP,DUSP1
18426,GO:1903504,0.341512517450328,0.938217423035981,1,13,regulation of mitotic spindle checkpoint,BP,DUSP1
9054,GO:0035278,0.341583774414168,0.938565496640454,1,12,miRNA mediated inhibition of translation,BP,ZFP36
9805,GO:0040033,0.341583774414168,0.938565496640454,1,12,negative regulation of translation, ncRNA-mediated,BP,ZFP36
11496,GO:0045974,0.341583774414168,0.938565496640454,1,12,regulation of translation, ncRNA-mediated,BP,ZFP36
3800,GO:0008376,0.341625585172721,0.881245313212585,2,34,acetylgalactosaminyltransferase activity,MF,B3GNT5;B3GNT2
3331,GO:0007043,0.342031826095716,0.826969423751724,4,81,cell-cell junction assembly,BP,TNF;CLDN1;RUNX1;VCL
7258,GO:0031224,0.342052632655151,0.700789863020512,96,2765,intrinsic component of membrane,CC,PLAUR;HBEGF;SDC4;TNF;PPIF;IER3;RNF19B;TRPV3;EFNA1;TGFA;SEMA7A;HAS3;CLDN1;PANX1;HCAR2;TNFRSF10B;EFNB2;EPHA2;CD83;IFNGR2;BMP2;BIRC2;TMCC3;RGMB;CLDN4;CD274;RELT;ADRB2;UGCG;TRAF3IP3;GJB4;EREG;C3ORF52;ANKLE2;B4GALT1;BCL10;HEPHL1;TMCC1;TMEM265;IL6ST;B3GNT5;SGMS2;VMP1;SLC6A14;ADAM8;LDLR;HCAR3;TACSTD2;SLC43A3;ITGA5;TFRC;EFNB1;GJB3;F3;SLC25A25;RAET1L;BDKRB1;SLC9A1;CD55;TMEM217;IFNAR2;ANTXR2;JAG1;ITGAV;STX1A;NRG1;RASA2;SLC7A2;SLC28A3;DCBLD2;SPAG9;ABCA5;AREG;IL7R;EMP3;SQLE;TMEM65;STEAP4;HLA-E;OSMR;MAOA;INSIG1;ADAM9;TNFRSF10A;RNF19A;B3GNT2;TMEM154;ITM2B;ERN1;TMEM132A;ATP13A3;CXCL16;TAP1;DSE;STX12;GPR156
12093,GO:0048070,0.342163443613772,0.938339735229327,1,12,regulation of developmental pigmentation,BP,ADAMTS9
3257,GO:0006925,0.342392316452425,0.937872740683021,1,13,inflammatory cell apoptotic process,BP,HCAR2
4770,GO:0010954,0.342670688439902,0.938141783473888,1,12,positive regulation of protein processing,BP,ADAM8
13566,GO:0060026,0.342722810804202,0.938569560903788,1,11,convergent extension,BP,WNT5A
8827,GO:0034605,0.343049258607252,0.810591176129006,5,113,cellular response to heat,BP,IL1A;PTGS2;CDKN1A;IER5;NUP153
13952,GO:0060628,0.343219371667228,0.937927242680607,1,12,regulation of ER to Golgi vesicle-mediated transport,BP,INSIG1
10779,GO:0044233,0.343226754881788,0.937924352805685,1,12,ER-mitochondrion membrane contact site,CC,PLEKHF1
14066,GO:0060841,0.343605984744348,0.938226256882248,1,11,venous blood vessel development,BP,EFNB2
18368,GO:1903363,0.343839502659285,0.846787135503629,3,64,negative regulation of cellular protein catabolic process,BP,EFNA1;N4BP1;PML
3067,GO:0006633,0.344102300001763,0.825053297070163,4,93,fatty acid biosynthetic process,BP,PTGS2;EDN1;QKI;INSIG1
6977,GO:0030641,0.344234687283303,0.846518497500974,3,64,regulation of cellular pH,BP,SLC9A1;MAFG;ATP6V1C2
3151,GO:0006750,0.34436532672122,0.936768752200163,1,14,glutathione biosynthetic process,BP,NFE2L2
10312,GO:0043090,0.344396731005431,0.937465415981928,1,12,amino acid import,BP,SLC7A2
6898,GO:0030431,0.344544424416361,0.936697598434907,1,14,sleep,BP,CSF2
9561,GO:0036342,0.344572170904064,0.93784940084878,1,11,post-anal tail morphogenesis,BP,WNT5A
16984,GO:0099054,0.345223864265719,0.93759445254152,1,11,presynapse assembly,BP,WNT5A
15820,GO:0072523,0.345618763150202,0.878451034973263,2,38,purine-containing compound catabolic process,BP,AMPD3;AHCY
9442,GO:0036020,0.346100006151226,0.93679374662515,1,12,endolysosome membrane,CC,LDLR
12470,GO:0050321,0.346379119469187,0.936683280202389,1,12,tau-protein kinase activity,MF,PHKG2
7427,GO:0031527,0.346640928635008,0.937037971414633,1,11,filopodium membrane,CC,ITGAV
17109,GO:0101003,0.346959259524606,0.877751989854056,2,37,ficolin-1-rich granule membrane,CC,ADAM8;CD55
12740,GO:0051000,0.347056312549065,0.936414793348058,1,12,positive regulation of nitric-oxide synthase activity,BP,GCH1
16180,GO:0090201,0.347253840301453,0.935615461016932,1,14,negative regulation of release of cytochrome c from mitochondria,BP,PPIF
16275,GO:0090342,0.347261651508099,0.877571460436457,2,37,regulation of cell aging,BP,PLK2;CDK6
68,GO:0000139,0.347472629833283,0.731966289443807,22,583,Golgi membrane,CC,TGFA;IFNGR2;NMNAT2;RND3;UGCG;B4GALT1;B3GNT5;SGMS2;CD55;ABCA5;AREG;STEAP4;HLA-E;CTSC;B3GNT2;CYTH1;ITM2B;TMEM132A;MYO1B;DSE;STX12;SMPD3
10024,GO:0042462,0.347553907345879,0.936217087337999,1,12,eye photoreceptor cell development,BP,PRDM1
11381,GO:0045747,0.347930376381087,0.877390789910017,2,35,positive regulation of Notch signaling pathway,BP,ELF3;JAG1
1356,GO:0003222,0.348080557114199,0.936469659601631,1,11,ventricular trabecula myocardium morphogenesis,BP,NRG1
17708,GO:1901616,0.348232335532034,0.876991106131097,2,37,organic hydroxy compound catabolic process,BP,CYP27B1;MAOA
3500,GO:0007405,0.348287779685215,0.87742385070821,2,33,neuroblast proliferation,BP,KCTD11;VEGFC
1017,GO:0002507,0.348498189966119,0.935840911923029,1,12,tolerance induction,BP,TNFAIP3
2198,GO:0005070,0.348894574246363,0.87681428647089,2,35,SH3/SH2 adaptor activity,MF,TP53BP2;PTPN11
11007,GO:0044827,0.348916430033036,0.935673882190198,1,12,modulation by host of viral genome replication,BP,ZC3H12A
4196,GO:0009301,0.348995853862947,0.84312258474644,3,67,snRNA transcription,BP,NABP1;ELL2;POU2F2
10192,GO:0042795,0.348995853862947,0.84312258474644,3,67,snRNA transcription by RNA polymerase II,BP,NABP1;ELL2;POU2F2
8914,GO:0034755,0.349757980436918,0.935337025289544,1,12,iron ion transmembrane transport,BP,STEAP4
3477,GO:0007339,0.349764555998897,0.934311270360615,1,15,binding of sperm to zona pellucida,BP,B4GALT1
10621,GO:0043618,0.350023565805269,0.820439147048333,4,103,regulation of transcription from RNA polymerase II promoter in response to stress,BP,JUN;CEBPB;NFE2L2;BACH1
11665,GO:0046434,0.350093470094615,0.78370446375754,7,172,organophosphate catabolic process,BP,AMPD3;LDLR;LIPG;NUP153;TDG;UPP1;SMPD3
16776,GO:0098588,0.350303888338744,0.703543599822277,54,1518,bounding membrane of organelle,CC,ZC3H12A;PLAUR;HBEGF;PLAU;TICAM1;PMAIP1;PLEKHF1;TGFA;IRAK2;IFNGR2;RAP2B;NMNAT2;BCL2L2;RND3;ADRB2;UGCG;PPP1R15A;EHD1;B4GALT1;B3GNT5;SGMS2;VMP1;ADAM8;LDLR;TFRC;CYP27B1;CD55;ANTXR2;NAV3;NDRG1;ITGAV;STX1A;PML;RHOB;ABCA5;AREG;IL7R;STEAP4;ATP6V1C2;HLA-E;WNT5A;MAOA;CTSC;B3GNT2;CYTH1;RAB22A;ITM2B;TMEM132A;MYO1B;TAP1;DSE;STX12;RAB24;SMPD3
12654,GO:0050855,0.35034242884407,0.935102473571841,1,12,regulation of B cell receptor signaling pathway,BP,RUNX1
7268,GO:0031235,0.350439211231646,0.935532062418773,1,11,intrinsic component of the cytoplasmic side of the plasma membrane,CC,RASA2
18612,GO:1903894,0.35046059914208,0.934659337133409,1,13,regulation of IRE1-mediated unfolded protein response,BP,PTPN1
5627,GO:0016701,0.350620910063782,0.934255670802677,1,14,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,PTGS2
5628,GO:0016702,0.350620910063782,0.934255670802677,1,14,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,PTGS2
15878,GO:0072606,0.350758399118647,0.934199791738396,1,14,interleukin-8 secretion,BP,WNT5A
15291,GO:0071479,0.351242613936112,0.841774210560758,3,63,cellular response to ionizing radiation,BP,GADD45A;CDKN1A;RHOB
3395,GO:0007175,0.351298684092869,0.93432009482244,1,13,negative regulation of epidermal growth factor-activated receptor activity,BP,ERRFI1
8581,GO:0034062,0.351391353219437,0.874553555787411,2,43,5'-3' RNA polymerase activity,MF,POLR3A;POLR3D
16733,GO:0097747,0.351391353219437,0.874553555787411,2,43,RNA polymerase activity,MF,POLR3A;POLR3D
19963,GO:2000515,0.351457713503646,0.93465350107642,1,12,negative regulation of CD4-positive, alpha-beta T cell activation,BP,RC3H1
14982,GO:0070897,0.351487132367821,0.874836753418177,2,39,DNA-templated transcriptional preinitiation complex assembly,BP,TAF4B;CREB1
11817,GO:0046710,0.351573699854582,0.93460670481997,1,12,GDP metabolic process,BP,TJP2
10415,GO:0043254,0.351621680961724,0.749769577274274,13,337,regulation of protein complex assembly,BP,CSF2;TNF;PMAIP1;FOSL1;JUN;BIRC2;CREB1;NAV3;STX1A;ZNF451;CDC42EP1;PTPN11;INSIG1
2873,GO:0006367,0.351623327557677,0.791860430385522,6,151,transcription initiation from RNA polymerase II promoter,BP,CDKN1A;TAF4B;CREB1;PPARD;SOX9;ZNF451
4788,GO:0010976,0.351752182515869,0.774719936703542,8,187,positive regulation of neuron projection development,BP,SEMA7A;ENC1;NEDD4L;NRG1;SKIL;ABL2;WNT5A;NFE2L2
3713,GO:0008233,0.351753775950467,0.746252094823562,14,374,peptidase activity,MF,TNFAIP3;ZC3H12A;PLAU;CYLD;ADAM8;F3;USP36;USP31;ADAMTS1;ADAM9;ADAMTS9;CTSC;ATXN7;ADAMTS6
6433,GO:0021697,0.351960953266288,0.934450319581045,1,12,cerebellar cortex formation,BP,PTPN11
9407,GO:0035966,0.351978898418148,0.782148903360115,7,174,response to topologically incorrect protein,BP,CXCL8;PPP1R15A;PPP1R15B;PTPN1;ERO1A;NFE2L2;ERN1
116,GO:0000244,0.352192768019826,0.934356600338428,1,12,spliceosomal tri-snRNP complex assembly,BP,PRPF19
3384,GO:0007163,0.352618441617115,0.781842550266611,7,159,establishment or maintenance of cell polarity,BP,RND3;SLC9A1;AMOTL2;FERMT1;RHOB;WNT5A;CYTH1
5357,GO:0016126,0.352762179544893,0.840674693543618,3,64,sterol biosynthetic process,BP,HMGCS1;SQLE;INSIG1
17702,GO:1901605,0.352850430578054,0.790885059369714,6,151,alpha-amino acid metabolic process,BP,ODC1;NMNAT2;HAL;AZIN1;ERO1A;AHCY
10614,GO:0043603,0.353650421601701,0.716905882803249,29,907,cellular amide metabolic process,BP,ZC3H12A;BTG2;TNF;TNIP1;EFNA1;CPEB2;BCL3;ZFP36L1;ENC1;UGCG;PPP1R15A;HAL;SGMS2;RC3H1;PLK3;ZFP36;LARP4B;PPP1R15B;GCH1;SOX4;EIF1;RBM3;SAMD4A;QKI;CELF1;NUP153;NFE2L2;PABPC4;SMPD3
14293,GO:0061383,0.353665635864992,0.874064945801333,2,34,trabecula morphogenesis,BP,NRG1;ADAMTS1
12125,GO:0048199,0.353677391587956,0.840042165863154,3,64,vesicle targeting, to, from or within Golgi,BP,TGFA;AREG;CTSC
11132,GO:0045177,0.353738899472462,0.766481379110958,9,217,apical part of cell,CC,CLDN1;CLDN4;ADRB2;LDLR;SLC9A1;JAG1;AMOTL2;OSMR;MYO1B
6306,GO:0019933,0.353911950150473,0.83998572827833,3,62,cAMP-mediated signaling,BP,ADRB2;SOX9;ADM
5169,GO:0015718,0.354044271520871,0.817935949660505,4,87,monocarboxylic acid transport,BP,IL1B;EDN1;PPARD;STARD5
8690,GO:0034312,0.35404996183904,0.932554727762664,1,15,diol biosynthetic process,BP,GCH1
12136,GO:0048232,0.354132480630129,0.755601817118147,11,284,male gamete generation,BP,BIRC3;OVOL1;TAF4B;BCL2L2;GJB3;SOX9;SPAG9;SKIL;QKI;AGFG1;BRD2
3110,GO:0006688,0.354362053552684,0.933071306354666,1,13,glycosphingolipid biosynthetic process,BP,UGCG
4902,GO:0014829,0.354925953867374,0.933245669420915,1,12,vascular smooth muscle contraction,BP,EDN1
6780,GO:0030214,0.355001848741729,0.93280874580399,1,13,hyaluronan catabolic process,BP,SLC9A1
2545,GO:0005811,0.355268706624986,0.838992191990594,3,63,lipid droplet,CC,EHD1;G0S2;PRPF19
15562,GO:0072010,0.355443893619453,0.933033909946448,1,12,glomerular epithelium development,BP,JAG1
325,GO:0000910,0.355863175298024,0.788669672846874,6,140,cytokinesis,BP,BIRC3;BIRC2;RND3;PLK3;KLHL21;RHOB
4056,GO:0009100,0.356193426642389,0.749588748120061,12,308,glycoprotein metabolic process,BP,HBEGF;TNIP1;PHLDA1;BMP2;B4GALT1;B3GNT5;PPARD;PMM2;ADAMTS9;B3GNT2;ITM2B;DSE
15281,GO:0071467,0.356608296283845,0.93214682001525,1,13,cellular response to pH,BP,SLC9A1
15469,GO:0071813,0.356698003219176,0.932519530163793,1,12,lipoprotein particle binding,MF,LDLR
15470,GO:0071814,0.356698003219176,0.932519530163793,1,12,protein-lipid complex binding,MF,LDLR
13581,GO:0060045,0.356894345680413,0.932438789172467,1,12,positive regulation of cardiac muscle cell proliferation,BP,PIM1
3540,GO:0007549,0.356953381532065,0.932414501004629,1,12,dosage compensation,BP,EIF1
5602,GO:0016638,0.357241611821823,0.93229584514689,1,12,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,MAOA
13533,GO:0055106,0.357248985438819,0.930959755751921,1,16,ubiquitin-protein transferase regulator activity,MF,TRIB1
20301,GO:2001275,0.357566773869072,0.93264949010719,1,11,positive regulation of glucose import in response to insulin stimulus,BP,PTPN11
4705,GO:0010866,0.357692925684711,0.931697743465041,1,13,regulation of triglyceride biosynthetic process,BP,LDLR
3700,GO:0008209,0.357973758129103,0.931581183922318,1,13,androgen metabolic process,BP,ADM
5455,GO:0016327,0.358020613262895,0.931561725290239,1,13,apicolateral plasma membrane,CC,CLDN4
4803,GO:0010996,0.358100964863651,0.931941346189617,1,12,response to auditory stimulus,BP,USP53
4461,GO:0010453,0.358563888202088,0.93133586852906,1,13,regulation of cell fate commitment,BP,IL23A
6256,GO:0019835,0.358660688069537,0.930130095865243,1,17,cytolysis,BP,CSF2
9368,GO:0035886,0.358917286414323,0.931188714018223,1,13,vascular smooth muscle cell differentiation,BP,ADM
14664,GO:0070268,0.358954907511017,0.836005122104058,3,72,cornification,BP,SPRR2D;SPRR2A;KRT34
13803,GO:0060389,0.359475598582235,0.870174103231159,2,37,pathway-restricted SMAD protein phosphorylation,BP,INHBA;BMP2
5077,GO:0015299,0.359665951485416,0.931292952194177,1,12,solute:proton antiporter activity,MF,SLC9A1
5868,GO:0017171,0.359925052909242,0.81333075357403,4,94,serine hydrolase activity,MF,PLAU;ADAM8;F3;CTSC
5170,GO:0015721,0.360021673804861,0.930727650471381,1,13,bile acid and bile salt transport,BP,STARD5
12184,GO:0048313,0.360260079313912,0.930270263589832,1,14,Golgi inheritance,BP,PLK3
747,GO:0001975,0.360484399013375,0.930533930046824,1,13,response to amphetamine,BP,HDAC9
10795,GO:0044270,0.360897391405379,0.727362857891949,18,544,cellular nitrogen compound catabolic process,BP,ZC3H12A;BTG2;NOCT;AMPD3;ZFP36L1;HAL;RC3H1;ZFP36;PNRC1;SAMD4A;QKI;NUP153;TDG;ERN1;UPP1;ISG20;PABPC4;AHCY
16108,GO:0090090,0.361147693075532,0.796309573998979,5,128,negative regulation of canonical Wnt signaling pathway,BP,BMP2;CYLD;SOX9;FERMT1;WNT5A
791,GO:0002052,0.361256408204708,0.930630282641503,1,12,positive regulation of neuroblast proliferation,BP,VEGFC
13692,GO:0060231,0.361302859624383,0.930190498285928,1,13,mesenchymal to epithelial transition,BP,LIF
4067,GO:0009116,0.361373837148899,0.812101290148884,4,99,nucleoside metabolic process,BP,TJP2;AMPD3;UPP1;AHCY
10387,GO:0043217,0.361654134723455,0.930463980658362,1,12,myelin maintenance,BP,NDRG1
1872,GO:0004535,0.362607704906672,0.930064303516553,1,12,poly(A)-specific ribonuclease activity,MF,NOCT
12219,GO:0048469,0.363233605837088,0.810945318412745,4,91,cell maturation,BP,CDKN1A;EREG;POU2F2;FEM1B
7144,GO:0030983,0.36338561451571,0.929312043250806,1,13,mismatched DNA binding,MF,TDG
10360,GO:0043174,0.363430664057021,0.928339034041925,1,16,nucleoside salvage,BP,UPP1
45,GO:0000097,0.363625235031406,0.928846278217246,1,14,sulfur amino acid biosynthetic process,BP,AHCY
556,GO:0001678,0.363641127656146,0.810606561106252,4,92,cellular glucose homeostasis,BP,PIM3;SOX4;OXCT1;ERN1
13827,GO:0060420,0.363760878903366,0.867642993571726,2,36,regulation of heart growth,BP,EDN1;PIM1
9346,GO:0035855,0.363963776894839,0.929493587120035,1,12,megakaryocyte development,BP,PTPN11
11805,GO:0046686,0.364064188680622,0.866694986723777,2,44,response to cadmium ion,BP,JUN;MTF1
4585,GO:0010669,0.364301097680659,0.928923858750559,1,13,epithelial structure maintenance,BP,SOX9
2677,GO:0006029,0.364551585536739,0.832735661855827,3,59,proteoglycan metabolic process,BP,BMP2;PPARD;DSE
18965,GO:1904738,0.364687357345994,0.929187937001061,1,12,vascular associated smooth muscle cell migration,BP,NFE2L2
18975,GO:1904752,0.364687357345994,0.929187937001061,1,12,regulation of vascular associated smooth muscle cell migration,BP,NFE2L2
18784,GO:1904294,0.364696665940519,0.928755740095181,1,13,positive regulation of ERAD pathway,BP,NFE2L2
10063,GO:0042554,0.364888734655785,0.927989827814493,1,15,superoxide anion generation,BP,EDN1
10210,GO:0042826,0.364901375662935,0.809758126912381,4,89,histone deacetylase binding,MF,PRDM1;CEBPB;HDAC9;RELA
19424,GO:1990000,0.365137249468692,0.928200917223839,1,14,amyloid fibril formation,BP,LDLR
6672,GO:0030030,0.365336296070059,0.697584251615575,39,1045,cell projection organization,BP,BTG2;SDC4;EFNA1;SEMA7A;KLF7;EFNB2;EPHA2;JUN;ENC1;EHD1;ZSWIM4;FGD6;CYLD;TACSTD2;NEDD4L;PLK2;CREB1;EFNB1;RAPH1;NAV3;PIP5K1A;NRG1;CDC42EP1;PTPN11;VCL;AREG;SKIL;EMP3;CORO1C;ADM;ABL2;RAB3IP;WNT5A;NFE2L2;YWHAH;SGK1;B3GNT2;YWHAG;PDLIM5
3450,GO:0007264,0.365760359018655,0.723252399630696,18,457,small GTPase mediated signal transduction,BP,SQSTM1;RRAD;JUN;RAP2B;CDKN1A;RND3;FGD6;PLK2;NRG1;RASA2;CDC42EP1;ARHGEF3;RHOB;TNFAIP1;CYTH1;AGFG1;RAB22A;RAB24
17560,GO:1901137,0.365995241386714,0.718759186336562,20,553,carbohydrate derivative biosynthetic process,BP,IL1B;PLAUR;HBEGF;SDC4;TNIP1;NFKB1;PHLDA1;HAS3;AMPD3;UGCG;B4GALT1;B3GNT5;PANK3;ADM;PMM2;NUP153;B3GNT2;ITM2B;UPP1;DSE
812,GO:0002082,0.36615391132323,0.927765044733263,1,14,regulation of oxidative phosphorylation,BP,PPIF
2451,GO:0005662,0.366217008543744,0.927737941662984,1,14,DNA replication factor A complex,CC,PRPF19
16391,GO:0097009,0.366362316609594,0.928045248439916,1,13,energy homeostasis,BP,AMPD3
5704,GO:0016830,0.366369216227842,0.865507025831235,2,41,carbon-carbon lyase activity,MF,ODC1;AZIN1
4587,GO:0010676,0.367103346220908,0.865685574346467,2,35,positive regulation of cellular carbohydrate metabolic process,BP,PMAIP1;PHKG2
11890,GO:0046906,0.367164006178157,0.830548237902733,3,65,tetrapyrrole binding,MF,PTGS2;CYP27B1;BACH1
6100,GO:0019318,0.367275031947349,0.769634647771342,7,173,hexose metabolic process,BP,TNF;PMAIP1;PHLDA2;B4GALT1;PPARD;PHKG2;PMM2
9547,GO:0036303,0.367526579409323,0.927981033840586,1,12,lymph vessel morphogenesis,BP,VEGFC
2288,GO:0005245,0.367560362664522,0.927531631843924,1,13,voltage-gated calcium channel activity,MF,ITGAV
7051,GO:0030823,0.368168039253938,0.927270285569783,1,13,regulation of cGMP metabolic process,BP,WNT5A
10837,GO:0044331,0.368482437923574,0.927134851642462,1,13,cell-cell adhesion mediated by cadherin,BP,WNT5A
13408,GO:0052742,0.368518892258935,0.865068129957715,2,33,phosphatidylinositol kinase activity,MF,PIP5K1A;PTPN11
18449,GO:1903533,0.368958281885462,0.806467859689254,4,96,regulation of protein targeting,BP,UGCG;USP36;PLAGL2;NRG1
6940,GO:0030547,0.369225009499119,0.926113957569446,1,15,receptor inhibitor activity,MF,IL1RN
16090,GO:0090069,0.369242555872579,0.92680679692049,1,13,regulation of ribosome biogenesis,BP,USP36
16101,GO:0090083,0.369496341417532,0.926321022831072,1,14,regulation of inclusion body assembly,BP,SACS
7676,GO:0032104,0.369756578314673,0.926207882029643,1,14,regulation of response to extracellular stimulus,BP,CYP27B1
7679,GO:0032107,0.369756578314673,0.926207882029643,1,14,regulation of response to nutrient levels,BP,CYP27B1
16159,GO:0090179,0.369849844011805,0.926984440271709,1,12,planar cell polarity pathway involved in neural tube closure,BP,WNT5A
11585,GO:0046148,0.369958975423371,0.863347346085489,2,40,pigment biosynthetic process,BP,WNT5A;ALAS1
6901,GO:0030449,0.370211211271641,0.926009978302782,1,14,regulation of complement activation,BP,CD55
19814,GO:2000257,0.370211211271641,0.926009978302782,1,14,regulation of protein activation cascade,BP,CD55
9696,GO:0038093,0.37039153678909,0.776736161118334,6,154,Fc receptor signaling pathway,BP,NFKBIA;NFKB1;JUN;BCL10;PDPK1;RELA
13647,GO:0060149,0.370564640434993,0.92585591173036,1,14,negative regulation of posttranscriptional gene silencing,BP,ZC3H12A
14115,GO:0060967,0.370564640434993,0.92585591173036,1,14,negative regulation of gene silencing by RNA,BP,ZC3H12A
9994,GO:0042405,0.371061218201034,0.926461576035694,1,12,nuclear inclusion body,CC,NUP153
9314,GO:0035773,0.371147007081872,0.862598023928793,2,40,insulin secretion involved in cellular response to glucose stimulus,BP,PIM3;OXCT1
426,GO:0001133,0.371343540766983,0.925895491045368,1,13,RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding,MF,PPARD
819,GO:0002089,0.371445506573985,0.926295242408986,1,12,lens morphogenesis in camera-type eye,BP,EPHA2
13043,GO:0051496,0.371549557835878,0.862657933326604,2,37,positive regulation of stress fiber assembly,BP,SDC4;SMAD3
14134,GO:0060997,0.37167078826595,0.86282173252763,2,35,dendritic spine morphogenesis,BP,EFNA1;PDLIM5
14149,GO:0061024,0.371678085676809,0.706860412123002,24,662,membrane organization,BP,PPIF;PMAIP1;TGFA;ADRB2;ANKLE2;LDLR;BBC3;TFRC;SLC9A1;NDRG1;TP53BP2;STX1A;AREG;IL7R;WNT5A;NUP153;INSIG1;CTSC;YWHAH;AGFG1;YWHAG;SFN;TAP1;STX12
1608,GO:0004029,0.37222290496721,0.925512075316397,1,13,aldehyde dehydrogenase (NAD) activity,MF,ALDH1A3
11350,GO:0045683,0.372283099023214,0.92548578680508,1,13,negative regulation of epidermis development,BP,FERMT1
17956,GO:1902307,0.372887880929473,0.925221354628064,1,13,positive regulation of sodium ion transmembrane transport,BP,SLC9A1
5540,GO:0016525,0.373252833837424,0.826436300083543,3,61,negative regulation of angiogenesis,BP,PLK2;PML;ADAMTS9
926,GO:0002320,0.373428503017249,0.924984503667162,1,13,lymphoid progenitor cell differentiation,BP,SOX4
3406,GO:0007189,0.373637349604362,0.861226348632812,2,38,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,ADRB2;ADM
4754,GO:0010927,0.373715171260249,0.82616669024295,3,60,cellular component assembly involved in morphogenesis,BP,EDN1;PHLDB2;AGFG1
2978,GO:0006521,0.374671575124917,0.859464609231661,2,52,regulation of cellular amino acid metabolic process,BP,ODC1;AZIN1
3531,GO:0007519,0.374851496259546,0.802174643378129,4,90,skeletal muscle tissue development,BP,BTG2;MAFF;FOXN2;HDAC9
14159,GO:0061037,0.375027593082082,0.923894020231168,1,14,negative regulation of cartilage development,BP,SOX9
1132,GO:0002719,0.375425592010618,0.923381759310783,1,15,negative regulation of cytokine production involved in immune response,BP,TNF
3099,GO:0006677,0.375832931524623,0.923536749151208,1,14,glycosylceramide metabolic process,BP,UGCG
12581,GO:0050732,0.375895096712664,0.85968440986638,2,39,negative regulation of peptidyl-tyrosine phosphorylation,BP,ERRFI1;SOCS3
7885,GO:0032451,0.376110950118673,0.860009705684746,2,35,demethylase activity,MF,KDM6B;KDM6A
2222,GO:0005123,0.376559024533552,0.92321377933433,1,14,death receptor binding,MF,FEM1B
11195,GO:0045309,0.376749212344792,0.859477276104216,2,36,protein phosphorylated amino acid binding,MF,SOCS3;ABL2
5285,GO:0015936,0.376881844698031,0.922731520196293,1,15,coenzyme A metabolic process,BP,PANK3
12361,GO:0048741,0.377192732222548,0.923322984325075,1,13,skeletal muscle fiber development,BP,HDAC9
9052,GO:0035272,0.377655072505839,0.858666651615694,2,38,exocrine system development,BP,TNF;SOX9
14243,GO:0061213,0.378060289344288,0.922543435800228,1,14,positive regulation of mesonephros development,BP,SOX9
11723,GO:0046527,0.378142748148941,0.922506515726106,1,14,glucosyltransferase activity,MF,UGCG
10491,GO:0043392,0.378305175890855,0.857944572872307,2,41,negative regulation of DNA binding,BP,NFKBIA;JUN
14385,GO:0061630,0.378536060804872,0.752168155146072,8,198,ubiquitin protein ligase activity,MF,RNF19B;PELI1;NEDD4L;RC3H1;UHRF1;PRPF19;RNF19A;RNF11
8981,GO:0035089,0.378599407592663,0.92269650680822,1,13,establishment of apical/basal cell polarity,BP,WNT5A
5661,GO:0016763,0.378636845614664,0.857828405540896,2,40,transferase activity, transferring pentosyl groups,MF,NAMPT;UPP1
18159,GO:1902904,0.378683938972694,0.799237139298923,4,90,negative regulation of supramolecular fiber organization,BP,PHLDB2;LDLR;TACSTD2;NAV3
19171,GO:1905208,0.378780498482102,0.922615635025058,1,13,negative regulation of cardiocyte differentiation,BP,BMP2
920,GO:0002313,0.379824049771922,0.921407783023909,1,15,mature B cell differentiation involved in immune response,BP,BCL3
14645,GO:0070233,0.380067165995334,0.921297801952143,1,15,negative regulation of T cell apoptotic process,BP,EFNA1
17878,GO:1902115,0.380174852224776,0.768930281441913,6,143,regulation of organelle assembly,BP,CSF2;SDC4;TNF;EDN1;CYLD;PLK2
4482,GO:0010498,0.380448230382622,0.717716354805161,15,415,proteasomal protein catabolic process,BP,RNF19B;PMAIP1;TRIB1;BIRC2;ENC1;N4BP1;NEDD4L;PLK2;PLK3;PML;TNFAIP1;PRPF19;RNF19A;NFE2L2;RNF11
5466,GO:0016358,0.380476950651133,0.758800974748511,7,163,dendrite development,BP,EFNA1;KLF7;NEDD4L;PLK2;NRG1;YWHAH;PDLIM5
13776,GO:0060351,0.380627174923578,0.921788059244046,1,13,cartilage development involved in endochondral bone morphogenesis,BP,SOX9
14799,GO:0070527,0.38113625443935,0.856219193257395,2,40,platelet aggregation,BP,RAP2B;VCL
9144,GO:0035493,0.381175228756428,0.921141455387191,1,14,SNARE complex assembly,BP,STX1A
4158,GO:0009219,0.381253206963229,0.919954150245299,1,18,pyrimidine deoxyribonucleotide metabolic process,BP,TDG
19141,GO:1905114,0.381328828595554,0.714114552631647,16,430,cell surface receptor signaling pathway involved in cell-cell signaling,BP,NFKB1;BMP2;ADRB2;RUNX1;CYLD;SMAD3;WISP1;AMOTL2;NRARP;SOX9;STX1A;FERMT1;SOX4;ATP6V1C2;WNT5A;KDM6A
11789,GO:0046653,0.381404285049746,0.920691274230693,1,15,tetrahydrofolate metabolic process,BP,GCH1
8858,GO:0034655,0.381411414810042,0.711248741649886,17,518,nucleobase-containing compound catabolic process,BP,ZC3H12A;BTG2;NOCT;AMPD3;ZFP36L1;RC3H1;ZFP36;PNRC1;SAMD4A;QKI;NUP153;TDG;ERN1;UPP1;ISG20;PABPC4;AHCY
1471,GO:0003725,0.381714719394749,0.820218080721589,3,63,double-stranded RNA binding,MF,TFRC;YRDC;IFIH1
17340,GO:1900024,0.381715150593031,0.855948285241508,2,39,regulation of substrate adhesion-dependent cell spreading,BP,TACSTD2;CORO1C
7211,GO:0031102,0.381999048584328,0.855873545953815,2,38,neuron projection regeneration,BP,JUN;ADM
4713,GO:0010874,0.382154733835127,0.920697491080274,1,14,regulation of cholesterol efflux,BP,NFKBIA
12484,GO:0050432,0.382311271428872,0.920626401772123,1,14,catecholamine secretion,BP,STX1A
17280,GO:0140030,0.382324809319166,0.779857202913214,5,114,modification-dependent protein binding,MF,TNFAIP3;TNIP1;SQSTM1;UHRF1;BRD2
12181,GO:0048308,0.382374811612688,0.920249293864982,1,15,organelle inheritance,BP,PLK3
7428,GO:0031528,0.38240541667242,0.920583628721239,1,14,microvillus membrane,CC,ITGAV
17392,GO:1900120,0.382526869102889,0.91987540199077,1,16,regulation of receptor binding,BP,PHLDA2
9448,GO:0036035,0.382755636005711,0.920827669560144,1,13,osteoclast development,BP,TJP2
14409,GO:0061695,0.382801373134979,0.741547715467793,9,240,transferase complex, transferring phosphorus-containing groups,CC,CAB39;CDKN1A;TAF4B;PHKG2;POLR3A;CCNL1;CDK6;POLR3D;ERN1
15260,GO:0071437,0.382804150353907,0.920805697494696,1,13,invadopodium,CC,PLAUR
5038,GO:0015215,0.383297781372987,0.91982760922534,1,15,nucleotide transmembrane transporter activity,MF,SLC25A25
17019,GO:0099172,0.383376569035876,0.920546174482069,1,13,presynapse organization,BP,WNT5A
16753,GO:0098533,0.383614551034545,0.920438128673284,1,13,ATPase dependent transmembrane transport complex,CC,SLC9A1
18299,GO:1903204,0.384214316538467,0.919759112753988,1,14,negative regulation of oxidative stress-induced neuron death,BP,NCOA7
15622,GO:0072111,0.38428357923082,0.919727440772194,1,14,cell proliferation involved in kidney development,BP,BMP2
17772,GO:1901798,0.384403916767289,0.91901301562756,1,16,positive regulation of signal transduction by p53 class mediator,BP,PMAIP1
13815,GO:0060401,0.384982438923382,0.794373459966797,4,90,cytosolic calcium ion transport,BP,BDKRB1;PML;PDPK1;ERO1A
6851,GO:0030318,0.385796366725876,0.919443463709377,1,13,melanocyte differentiation,BP,ADAMTS9
13599,GO:0060065,0.385857222434032,0.919415614078831,1,13,uterus development,BP,WNT5A
12227,GO:0048485,0.38595983125544,0.919368643741109,1,13,sympathetic nervous system development,BP,SOX4
4188,GO:0009264,0.386106071010288,0.917710195183786,1,18,deoxyribonucleotide catabolic process,BP,TDG
12753,GO:0051018,0.386383020396372,0.853144298646906,2,37,protein kinase A binding,MF,SOX9;AKAP2
182,GO:0000394,0.386680598800391,0.917685475496045,1,17,RNA splicing, via endonucleolytic cleavage and ligation,BP,ERN1
12220,GO:0048471,0.386728726212856,0.701983358245731,19,513,perinuclear region of cytoplasm,CC,INHBA;NOCT;PLEKHF1;TGFA;ODC1;NFKBIE;CDKN1A;BCL3;BCL10;DCUN1D3;CYLD;TFRC;SLC9A1;NDRG1;TP53BP2;RASA2;SPAG9;TRAF4;MYO1B
18254,GO:1903076,0.38675825411593,0.816424993169541,3,65,regulation of protein localization to plasma membrane,BP,EPHA2;SQSTM1;PDPK1
18572,GO:1903798,0.386975234180994,0.918490816202952,1,14,regulation of production of miRNAs involved in gene silencing by miRNA,BP,ZC3H12A
4035,GO:0009066,0.387184307483745,0.852188847328164,2,41,aspartate family amino acid metabolic process,BP,NMNAT2;AHCY
10978,GO:0044770,0.387293735639501,0.703608753315667,18,512,cell cycle phase transition,BP,BTG2;INHBA;PHLDA1;GADD45A;CDKN1A;OVOL1;ZFP36L1;CDKN2B;DUSP1;DCUN1D3;PLK2;PLK3;PML;SOX4;CDK6;BACH1;YWHAG;SFN
17975,GO:1902369,0.387452677537036,0.852329229708021,2,38,negative regulation of RNA catabolic process,BP,NOCT;ZFP36
10931,GO:0044550,0.387566386529298,0.918217705383632,1,14,secondary metabolite biosynthetic process,BP,WNT5A
6786,GO:0030220,0.387769125532537,0.918123914325133,1,14,platelet formation,BP,PTPN11
14803,GO:0070534,0.388317830158304,0.851546318100228,2,40,protein K63-linked ubiquitination,BP,BIRC2;PRPF19
20183,GO:2001023,0.388409289769882,0.851290579962921,2,42,regulation of response to drug,BP,PTPN11;NFE2L2
12411,GO:0048857,0.388498595678502,0.851327406269384,2,41,neural nucleus development,BP,ALDH1A3;YWHAH
11044,GO:0045026,0.388575809622846,0.917076483197966,1,16,plasma membrane fusion,BP,STX1A
17530,GO:1901020,0.388601183836297,0.917064620964887,1,16,negative regulation of calcium ion transmembrane transporter activity,BP,RRAD
16121,GO:0090110,0.388643610047446,0.918134276939855,1,13,cargo loading into COPII-coated vesicle,BP,INSIG1
17649,GO:1901385,0.388770921537014,0.917659516787149,1,14,regulation of voltage-gated calcium channel activity,BP,RRAD
8740,GO:0034390,0.389442968041013,0.917347095826081,1,14,smooth muscle cell apoptotic process,BP,EDN1
8741,GO:0034391,0.389442968041013,0.917347095826081,1,14,regulation of smooth muscle cell apoptotic process,BP,EDN1
9017,GO:0035196,0.389597104495123,0.850924026519112,2,38,production of miRNAs involved in gene silencing by miRNA,BP,ZC3H12A;SMAD3
2972,GO:0006513,0.3897011769224,0.81426234570466,3,65,protein monoubiquitination,BP,BIRC2;NEDD4L;UHRF1
13550,GO:0060008,0.389750935552673,0.917203690512682,1,14,Sertoli cell differentiation,BP,SOX9
7374,GO:0031420,0.38975483300512,0.917619886167255,1,13,alkali metal ion binding,MF,TDG
2974,GO:0006516,0.389805322680859,0.916816594618538,1,15,glycoprotein catabolic process,BP,ADAMTS9
8689,GO:0034311,0.390382178216794,0.915950141873145,1,17,diol metabolic process,BP,GCH1
5408,GO:0016246,0.39042688548033,0.916525513965994,1,15,RNA interference,BP,CELF1
9015,GO:0035194,0.390454352540677,0.77274435162232,5,140,posttranscriptional gene silencing by RNA,BP,ZC3H12A;SMAD3;ZFP36;CELF1;NUP153
8976,GO:0035067,0.39084677815553,0.916692199107646,1,14,negative regulation of histone acetylation,BP,ZNF451
6050,GO:0019184,0.391026642164938,0.915926039142868,1,16,nonribosomal peptide biosynthetic process,BP,NFE2L2
2945,GO:0006474,0.391260487658932,0.916498605278666,1,14,N-terminal protein amino acid acetylation,BP,SOX4
4721,GO:0010882,0.391662595796112,0.915945010986361,1,15,regulation of cardiac muscle contraction by calcium ion signaling,BP,SLC9A1
8966,GO:0035036,0.392043164547856,0.914914296962035,1,18,sperm-egg recognition,BP,B4GALT1
14931,GO:0070816,0.392063798281871,0.915756017160877,1,15,phosphorylation of RNA polymerase II C-terminal domain,BP,CCNL1
3072,GO:0006639,0.392376338096519,0.812231925835241,3,66,acylglycerol metabolic process,BP,LDLR;PTPN11;INSIG1
17290,GO:0140058,0.392520939626154,0.916331018137259,1,13,neuron projection arborization,BP,WNT5A
14995,GO:0070920,0.392650473158576,0.915479193786964,1,15,regulation of production of small RNA involved in gene silencing by RNA,BP,ZC3H12A
3090,GO:0006664,0.392731489875478,0.788001579602547,4,100,glycolipid metabolic process,BP,PLAUR;UGCG;B3GNT5;SMPD3
18430,GO:1903509,0.392731489875478,0.788001579602547,4,100,liposaccharide metabolic process,BP,PLAUR;UGCG;B3GNT5;SMPD3
11690,GO:0046475,0.392818302399561,0.915399902888199,1,15,glycerophospholipid catabolic process,BP,LDLR
3606,GO:0008047,0.39298154905425,0.706518284188158,15,393,enzyme activator activity,MF,CXCL1;ERRFI1;BMP2;CAB39;JUN;CDKN1A;PPP1R15A;BCL10;AZIN1;NRG1;RASA2;CDC42EP1;PDPK1;CTSC;AGFG1
13804,GO:0060390,0.39313073993209,0.915620053539949,1,14,regulation of SMAD protein signal transduction,BP,SMAD3
10827,GO:0044321,0.39314540224745,0.915613144051395,1,14,response to leptin,BP,EDN1
378,GO:0001010,0.393211047725348,0.915582205016383,1,14,transcription factor activity, sequence-specific DNA binding transcription factor recruiting,MF,PPARD
11250,GO:0045471,0.393536140234782,0.811167518239246,3,70,response to ethanol,BP,CLDN1;BIRC2;OXCT1
6191,GO:0019637,0.393598285318535,0.680032878671748,29,849,organophosphate metabolic process,BP,PLAUR;HBEGF;ITPKC;PPIF;PTGS2;EPHA2;NMNAT2;TJP2;NAMPT;AMPD3;HMGCS1;EREG;SGMS2;LDLR;LIPG;PPARD;SLC25A25;PIP5K1A;NRG1;PTPN11;PANK3;GCH1;ADM;WNT5A;NUP153;TDG;ETNK1;UPP1;SMPD3
8939,GO:0034975,0.394096865350773,0.915164047040454,1,14,protein folding in endoplasmic reticulum,BP,ERO1A
7484,GO:0031647,0.394127322304632,0.738665133838324,8,213,regulation of protein stability,BP,EFNA1;BMP2;CDKN1A;SMAD3;CREB1;USP36;SOX4;STX12
4159,GO:0009220,0.394153100148782,0.913907174872618,1,18,pyrimidine ribonucleotide biosynthetic process,BP,UPP1
11578,GO:0046132,0.394153100148782,0.913907174872618,1,18,pyrimidine ribonucleoside biosynthetic process,BP,UPP1
4918,GO:0014855,0.394572691257577,0.847758459547221,2,37,striated muscle cell proliferation,BP,PIM1;PPARD
16229,GO:0090279,0.394818288470132,0.914822573316998,1,14,regulation of calcium ion import,BP,TRPV3
9855,GO:0042104,0.394870625899212,0.913816726110802,1,17,positive regulation of activated T cell proliferation,BP,IL23A
19777,GO:2000181,0.394916814323794,0.810519353662671,3,63,negative regulation of blood vessel morphogenesis,BP,PLK2;PML;ADAMTS9
10980,GO:0044772,0.395020230326689,0.698977180737365,17,485,mitotic cell cycle phase transition,BP,BTG2;INHBA;PHLDA1;GADD45A;CDKN1A;ZFP36L1;CDKN2B;DUSP1;DCUN1D3;PLK2;PLK3;PML;SOX4;CDK6;BACH1;YWHAG;SFN
16157,GO:0090177,0.395131780689956,0.915103428438536,1,13,establishment of planar polarity involved in neural tube closure,BP,WNT5A
16158,GO:0090178,0.395131780689956,0.915103428438536,1,13,regulation of establishment of planar polarity involved in neural tube closure,BP,WNT5A
16858,GO:0098787,0.395195795511007,0.914643557179206,1,14,mRNA cleavage involved in mRNA processing,BP,ERN1
12385,GO:0048799,0.395540985012026,0.914910047266742,1,13,animal organ maturation,BP,BMP2
3659,GO:0008143,0.395734284700842,0.9143878102808,1,14,poly(A) binding,MF,PABPC4
13284,GO:0051968,0.395990503079676,0.914697308681505,1,13,positive regulation of synaptic transmission, glutamatergic,BP,PTGS2
1002,GO:0002474,0.396176996263392,0.808671597475074,3,83,antigen processing and presentation of peptide antigen via MHC class I,BP,ITGAV;HLA-E;TAP1
7894,GO:0032461,0.396318372764322,0.913409507729985,1,16,positive regulation of protein oligomerization,BP,PMAIP1
18479,GO:1903579,0.396897129435827,0.913459084391023,1,15,negative regulation of ATP metabolic process,BP,PPIF
3407,GO:0007190,0.397136974096021,0.913719458053111,1,14,activation of adenylate cyclase activity,BP,ADRB2
2589,GO:0005882,0.39735756381785,0.808321759573073,3,70,intermediate filament,CC,KRT34;KRTAP2-3;IFFO2
8539,GO:0033866,0.39765078414832,0.912768819476899,1,16,nucleoside bisphosphate biosynthetic process,BP,PANK3
8563,GO:0034030,0.39765078414832,0.912768819476899,1,16,ribonucleoside bisphosphate biosynthetic process,BP,PANK3
8566,GO:0034033,0.39765078414832,0.912768819476899,1,16,purine nucleoside bisphosphate biosynthetic process,BP,PANK3
5821,GO:0017085,0.397920326983879,0.912968053586184,1,15,response to insecticide,BP,ZC3H12A
3076,GO:0006644,0.398193760465476,0.70856686164953,13,345,phospholipid metabolic process,BP,PLAUR;HBEGF;HMGCS1;EREG;SGMS2;LDLR;LIPG;PPARD;PIP5K1A;NRG1;PTPN11;ETNK1;SMPD3
7248,GO:0031201,0.398482459707034,0.844510254010224,2,43,SNARE complex,CC,STX1A;STX12
5501,GO:0016441,0.398526402686992,0.766138314079108,5,141,posttranscriptional gene silencing,BP,ZC3H12A;SMAD3;ZFP36;CELF1;NUP153
8635,GO:0034162,0.398966391933097,0.912843061985548,1,14,toll-like receptor 9 signaling pathway,BP,IRAK2
613,GO:0001779,0.39913720610898,0.912381891990138,1,15,natural killer cell differentiation,BP,PRDM1
11533,GO:0046058,0.399324597901872,0.844351993031086,2,39,cAMP metabolic process,BP,EPHA2;ADM
12364,GO:0048745,0.399638757251324,0.912958855330687,1,13,smooth muscle tissue development,BP,SOX9
11904,GO:0046931,0.399767029680209,0.912077577770886,1,15,pore complex assembly,BP,NUP153
11467,GO:0045922,0.399970716318161,0.911979025372119,1,15,negative regulation of fatty acid metabolic process,BP,INSIG1
7483,GO:0031646,0.400329441021478,0.912186602372543,1,14,positive regulation of neurological system process,BP,NRG1
10229,GO:0042921,0.400624141882978,0.912044279635406,1,14,glucocorticoid receptor signaling pathway,BP,YWHAH
12640,GO:0050829,0.400633210716099,0.910136731957354,1,21,defense response to Gram-negative bacterium,BP,IL23A
10529,GO:0043467,0.400805199860128,0.781849584759391,4,93,regulation of generation of precursor metabolites and energy,BP,PPIF;PHLDA2;PHKG2;NUP153
3071,GO:0006638,0.40214956694928,0.804882485332681,3,67,neutral lipid metabolic process,BP,LDLR;PTPN11;INSIG1
20131,GO:2000811,0.40251696019537,0.91112683671125,1,14,negative regulation of anoikis,BP,ITGA5
5531,GO:0016505,0.40261103474019,0.910358594709517,1,16,peptidase activator activity involved in apoptotic process,MF,CTSC
4704,GO:0010863,0.402742550996791,0.910631253317228,1,15,positive regulation of phospholipase C activity,BP,ABL2
6308,GO:0019935,0.402924000111942,0.804299201580915,3,67,cyclic-nucleotide-mediated signaling,BP,ADRB2;SOX9;ADM
12143,GO:0048246,0.403097016422973,0.909558580524636,1,18,macrophage chemotaxis,BP,SAA1
11500,GO:0045981,0.403471204806901,0.841239411520553,2,42,positive regulation of nucleotide metabolic process,BP,ADM;WNT5A
17502,GO:1900544,0.403471204806901,0.841239411520553,2,42,positive regulation of purine nucleotide metabolic process,BP,ADM;WNT5A
15677,GO:0072202,0.403559722048638,0.910618949847252,1,14,cell differentiation involved in metanephros development,BP,LIF
17899,GO:1902187,0.403813445627178,0.910495106175133,1,14,negative regulation of viral release from host cell,BP,PML
16673,GO:0097581,0.403972473515827,0.803620547334468,3,65,lamellipodium organization,BP,EPHA2;VCL;CORO1C
9563,GO:0036344,0.404000212465467,0.910015640811682,1,15,platelet morphogenesis,BP,PTPN11
3323,GO:0007032,0.404663560759916,0.802880467306925,3,69,endosome organization,BP,PLEKHF1;SQSTM1;RAB22A
13841,GO:0060438,0.404860694206045,0.909592968691019,1,15,trachea development,BP,SOX9
15332,GO:0071556,0.404861248060325,0.908685502248513,1,18,integral component of lumenal side of endoplasmic reticulum membrane,CC,HLA-E
16761,GO:0098553,0.404861248060325,0.908685502248513,1,18,lumenal side of endoplasmic reticulum membrane,CC,HLA-E
3214,GO:0006862,0.405387288593834,0.908992230159681,1,16,nucleotide transport,BP,SLC25A25
12882,GO:0051209,0.405497992868713,0.802410576291933,3,66,release of sequestered calcium ion into cytosol,BP,BDKRB1;PDPK1;ERO1A
12931,GO:0051283,0.405497992868713,0.802410576291933,3,66,negative regulation of sequestering of calcium ion,BP,BDKRB1;PDPK1;ERO1A
7027,GO:0030799,0.405921082690099,0.839675244886571,2,41,regulation of cyclic nucleotide metabolic process,BP,ADM;WNT5A
10247,GO:0042982,0.405949437962462,0.839554495317948,2,42,amyloid precursor protein metabolic process,BP,EFNA1;ITM2B
13899,GO:0060538,0.406138286454406,0.777564495158018,4,94,skeletal muscle organ development,BP,BTG2;MAFF;FOXN2;HDAC9
11742,GO:0046578,0.406287638130718,0.728388132773708,8,190,regulation of Ras protein signal transduction,BP,SQSTM1;FGD6;NRG1;RASA2;ARHGEF3;TNFAIP1;CYTH1;AGFG1
5454,GO:0016324,0.406331484268868,0.736702465069723,7,172,apical plasma membrane,CC,CLDN1;CLDN4;ADRB2;SLC9A1;JAG1;AMOTL2;OSMR
10977,GO:0044769,0.40707102223038,0.907584770172074,1,18,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,ATP6V1C2
11919,GO:0046961,0.40707102223038,0.907584770172074,1,18,proton-transporting ATPase activity, rotational mechanism,MF,ATP6V1C2
4423,GO:0010226,0.407239610657305,0.908418181765825,1,15,response to lithium ion,BP,PTGS2
4228,GO:0009404,0.407704439671419,0.907537930485981,1,17,toxin metabolic process,BP,NFE2L2
3308,GO:0007010,0.407832636767547,0.659927368784583,36,980,cytoskeleton organization,BP,CXCL1;BIRC3;SDC4;TNF;NUAK2;EDN1;GADD45A;BIRC2;PHLDB2;RND3;MAST4;NEDD9;FGD6;CYLD;TACSTD2;SMAD3;PLK2;PLK3;SLC9A1;AMOTL2;NAV3;PIP5K1A;SOX9;CDC42EP1;RHOB;AKAP2;TNFAIP1;PTPN1;CORO1C;ABL2;PDPK1;RNF19A;FRMD6;AGFG1;ATXN7;MYO1B
8849,GO:0034644,0.407893954062267,0.80043117780576,3,69,cellular response to UV,BP,PTGS2;CDKN1A;N4BP1
9882,GO:0042157,0.407940251479083,0.758540239857813,5,132,lipoprotein metabolic process,BP,PLAUR;LDLR;LIPG;RAET1L;ITGAV
12885,GO:0051219,0.408000166313377,0.800630195637921,3,64,phosphoprotein binding,MF,SOCS3;ABL2;SFN
13917,GO:0060571,0.408079435793398,0.90800124961614,1,15,morphogenesis of an epithelial fold,BP,WNT5A
5442,GO:0016307,0.408172802608885,0.908351012870924,1,14,phosphatidylinositol phosphate kinase activity,MF,PIP5K1A
11652,GO:0046386,0.408453118856394,0.906649933244677,1,19,deoxyribose phosphate catabolic process,BP,TDG
3430,GO:0007220,0.409166564807782,0.907459834650434,1,15,Notch receptor processing,BP,JAG1
753,GO:0001990,0.410135714879452,0.906626142226194,1,16,regulation of systemic arterial blood pressure by hormone,BP,EDN1
19005,GO:1904813,0.410205530929929,0.773852639550259,4,109,ficolin-1-rich granule lumen,CC,CAB39;AMPD3;VCL;COTL1
11264,GO:0045540,0.410377127106947,0.836625080762772,2,41,regulation of cholesterol biosynthetic process,BP,HMGCS1;SQLE
14856,GO:0070628,0.4105384707714,0.905841433257698,1,18,proteasome binding,MF,SACS
1385,GO:0003283,0.410640200800899,0.907123768241249,1,14,atrial septum development,BP,SOX4
4302,GO:0009749,0.410880254438226,0.756225099358858,5,126,response to glucose,BP,PIM3;PPARD;SOX4;OXCT1;ERN1
7085,GO:0030878,0.411235563208255,0.906424087779152,1,15,thyroid gland development,BP,SMAD3
13537,GO:0055117,0.411460393948776,0.835879248866863,2,41,regulation of cardiac muscle contraction,BP,ZC3H12A;SLC9A1
2676,GO:0006027,0.411966167731554,0.835530440636784,2,41,glycosaminoglycan catabolic process,BP,SDC4;SLC9A1
3762,GO:0008306,0.412021172367785,0.835601294004413,2,40,associative learning,BP,BTG2;CREB1
9922,GO:0042269,0.412231815412597,0.905569927993351,1,16,regulation of natural killer cell mediated cytotoxicity,BP,HLA-E
16527,GO:0097242,0.412317197404421,0.906283980356324,1,14,amyloid-beta clearance,BP,LDLR
12874,GO:0051194,0.41276442085038,0.906059246656393,1,14,positive regulation of cofactor metabolic process,BP,NFE2L2
10201,GO:0042809,0.412905373603462,0.905583056665813,1,15,vitamin D receptor binding,MF,TOB2
18055,GO:1902600,0.413125466644919,0.795864059333567,3,82,proton transmembrane transport,BP,PPIF;SLC9A1;ATP6V1C2
6239,GO:0019789,0.413293093176442,0.905032398023141,1,16,SUMO transferase activity,MF,ZNF451
8728,GO:0034377,0.414098902513948,0.904623019964003,1,16,plasma lipoprotein particle assembly,BP,PLAGL2
11631,GO:0046337,0.414135228453386,0.904960684499758,1,15,phosphatidylethanolamine metabolic process,BP,ETNK1
13630,GO:0060122,0.414539526043954,0.904398714805861,1,16,inner ear receptor cell stereocilium organization,BP,SDC4
3300,GO:0006999,0.414989018473724,0.904527154793417,1,15,nuclear pore organization,BP,NUP153
1860,GO:0004521,0.415159741346942,0.832759923468609,2,47,endoribonuclease activity,MF,ZC3H12A;ERN1
12930,GO:0051282,0.41556754984125,0.794669056257726,3,67,regulation of sequestering of calcium ion,BP,BDKRB1;PDPK1;ERO1A
14004,GO:0060716,0.415569215852808,0.903873285392736,1,16,labyrinthine layer blood vessel development,BP,JUNB
1227,GO:0002902,0.415833525453818,0.903421791654628,1,17,regulation of B cell apoptotic process,BP,BCL10
13727,GO:0060292,0.416255794265651,0.903881704145559,1,15,long term synaptic depression,BP,PLK2
12599,GO:0050772,0.416315757050116,0.794149983453992,3,66,positive regulation of axonogenesis,BP,SEMA7A;NRG1;SKIL
2932,GO:0006450,0.416866311663895,0.902608808735678,1,18,regulation of translational fidelity,BP,YRDC
18172,GO:1902936,0.417540353769093,0.793092513072276,3,68,phosphatidylinositol bisphosphate binding,MF,DAPP1;SLC9A1;MYO1B
13770,GO:0060343,0.417579007966957,0.903204660466499,1,15,trabecula formation,BP,ADAMTS1
11418,GO:0045830,0.417664204363453,0.90279882924651,1,16,positive regulation of isotype switching,BP,TFRC
7171,GO:0031050,0.41771737324964,0.831538000296477,2,41,dsRNA fragmentation,BP,ZC3H12A;SMAD3
14994,GO:0070918,0.41771737324964,0.831538000296477,2,41,production of small RNA involved in gene silencing by RNA,BP,ZC3H12A;SMAD3
12780,GO:0051052,0.418149877822511,0.694533203010276,12,323,regulation of DNA metabolic process,BP,CSF2;JUN;CDKN1A;EREG;DUSP1;PPP1R10;TFRC;PML;UHRF1;AREG;TNFAIP1;IL7R
6662,GO:0030014,0.418172861801884,0.902899861404974,1,15,CCR4-NOT complex,CC,ZFP36
2849,GO:0006335,0.418268329526225,0.899781287917208,1,32,DNA replication-dependent nucleosome assembly,BP,IPO4
8902,GO:0034723,0.418268329526225,0.899781287917208,1,32,DNA replication-dependent nucleosome organization,BP,IPO4
17250,GO:0120032,0.418662159868933,0.749784861446098,5,123,regulation of plasma membrane bounded cell projection assembly,BP,EPHA2;CYLD;TACSTD2;CDC42EP1;CORO1C
18166,GO:1902914,0.419449083199635,0.902242849920189,1,15,regulation of protein polyubiquitination,BP,BIRC2
9077,GO:0035329,0.419472147968162,0.830662822285781,2,38,hippo signaling,BP,TJP2;AMOTL2
11778,GO:0046636,0.419537839432399,0.90219705653756,1,15,negative regulation of alpha-beta T cell activation,BP,RC3H1
9912,GO:0042249,0.419653941839565,0.902555574569477,1,14,establishment of planar polarity of embryonic epithelium,BP,WNT5A
2976,GO:0006518,0.419828557357821,0.661945246320502,24,784,peptide metabolic process,BP,ZC3H12A;BTG2;TNF;TNIP1;EFNA1;CPEB2;BCL3;ZFP36L1;ENC1;PPP1R15A;RC3H1;PLK3;ZFP36;LARP4B;PPP1R15B;SOX4;EIF1;RBM3;SAMD4A;QKI;CELF1;NUP153;NFE2L2;PABPC4
17020,GO:0099173,0.419934369364917,0.791353568388333,3,66,postsynapse organization,BP,EFNA1;WNT5A;PDLIM5
9900,GO:0042219,0.419998650890982,0.90127036733602,1,17,cellular modified amino acid catabolic process,BP,AHCY
13708,GO:0060261,0.420128067095697,0.901203055664807,1,17,positive regulation of transcription initiation from RNA polymerase II promoter,BP,CREB1
6116,GO:0019359,0.420459141453511,0.765920083144053,4,96,nicotinamide nucleotide biosynthetic process,BP,PTGS2;NMNAT2;NAMPT;NUP153
6118,GO:0019363,0.420459141453511,0.765920083144053,4,96,pyridine nucleotide biosynthetic process,BP,PTGS2;NMNAT2;NAMPT;NUP153
16675,GO:0097602,0.421449215649378,0.900514297572315,1,17,cullin family protein binding,MF,DCUN1D3
10729,GO:0044085,0.421935461307577,0.62679632110511,82,2477,cellular component biogenesis,BP,TNFAIP3;ZC3H12A;BIRC3;CSF2;SDC4;TNF;PMAIP1;FOSL1;NOCT;TGFA;EDN1;HAS3;CLDN1;PANX1;EPHA2;KCTD11;SQSTM1;CAB39;JUN;BIRC2;PHLDB2;TAF4B;RND3;ADRB2;RUNX1;SOD2;ALDH1A3;EHD1;NEDD9;B4GALT1;BCL10;FGD6;TMCC1;TRAF1;SACS;VMP1;CYLD;TACSTD2;SMAD3;RC3H1;PLK2;DIEXF;ITGA5;CREB1;USP36;SLC9A1;PLAGL2;NAV3;PIP5K1A;SOX9;STX1A;NRG1;ZNF451;PML;CDC42EP1;PTPN11;RHOB;SPAG9;GCH1;VCL;AREG;TNFAIP1;EMP3;CORO1C;PRPF19;RAB3IP;CELF1;WNT5A;NUP153;INSIG1;PDPK1;CTSC;AGFG1;YWHAG;ISG20;LAMB3;MYO1B;BRD2;IPO4;STX12;PDLIM5;SMPD3
4740,GO:0010906,0.422477129894748,0.789320445712509,3,67,regulation of glucose metabolic process,BP,PMAIP1;PHLDA2;PHKG2
10906,GO:0044452,0.423018502412958,0.732496085575878,6,163,nucleolar part,CC,KLF6;NFKBIE;TAF4B;TXNRD1;TMEM217;SAMD4A
5799,GO:0017046,0.423526484086002,0.900125558348924,1,15,peptide hormone binding,MF,INHBA
644,GO:0001832,0.423588004650518,0.90009339920319,1,15,blastocyst growth,BP,PRPF19
683,GO:0001891,0.423950051496355,0.899531084251973,1,16,phagocytic cup,CC,TNF
10174,GO:0042762,0.424253016955659,0.89974536641537,1,15,regulation of sulfur metabolic process,BP,NFE2L2
15901,GO:0072673,0.424413054008494,0.89966150048626,1,15,lamellipodium morphogenesis,BP,CORO1C
5847,GO:0017136,0.424528139336376,0.899227234301078,1,16,NAD-dependent histone deacetylase activity,MF,HDAC9
1843,GO:0004497,0.424973383979658,0.826221354711042,2,43,monooxygenase activity,MF,CYP27B1;SQLE
7073,GO:0030859,0.425553893828558,0.899062406253594,1,15,polarized epithelial cell differentiation,BP,WNT5A
9441,GO:0036019,0.42576492135069,0.898575275528415,1,16,endolysosome,CC,LDLR
2402,GO:0005546,0.425928429205882,0.825542936963569,2,43,phosphatidylinositol-4,5-bisphosphate binding,MF,SLC9A1;MYO1B
2856,GO:0006346,0.426180083496068,0.898732641132119,1,15,methylation-dependent chromatin silencing,BP,UHRF1
10863,GO:0044381,0.426309830593439,0.899095826052173,1,14,glucose import in response to insulin stimulus,BP,PTPN11
20299,GO:2001273,0.426309830593439,0.899095826052173,1,14,regulation of glucose import in response to insulin stimulus,BP,PTPN11
12853,GO:0051168,0.426403104977118,0.71902003494965,7,187,nuclear export,BP,IL1B;DUSP16;PTPN11;SOX4;NUP153;AGFG1;SFN
17539,GO:1901068,0.426641844693799,0.824752630303866,2,46,guanosine-containing compound metabolic process,BP,TJP2;AMPD3
3276,GO:0006956,0.427132879921883,0.897517722730899,1,17,complement activation,BP,CD55
2203,GO:0005086,0.427189074723798,0.898199893193003,1,15,ARF guanyl-nucleotide exchange factor activity,MF,CYTH1
5314,GO:0016021,0.427389853773204,0.619558613292923,92,2700,integral component of membrane,CC,PLAUR;HBEGF;SDC4;TNF;PPIF;IER3;RNF19B;TRPV3;EFNA1;TGFA;HAS3;CLDN1;PANX1;HCAR2;TNFRSF10B;EFNB2;EPHA2;CD83;IFNGR2;BMP2;BIRC2;TMCC3;CLDN4;CD274;RELT;ADRB2;UGCG;TRAF3IP3;GJB4;EREG;C3ORF52;ANKLE2;B4GALT1;BCL10;HEPHL1;TMCC1;TMEM265;IL6ST;B3GNT5;SGMS2;VMP1;SLC6A14;ADAM8;LDLR;HCAR3;TACSTD2;SLC43A3;ITGA5;TFRC;EFNB1;GJB3;F3;SLC25A25;BDKRB1;SLC9A1;CD55;TMEM217;IFNAR2;ANTXR2;JAG1;ITGAV;STX1A;NRG1;SLC7A2;SLC28A3;DCBLD2;SPAG9;ABCA5;AREG;IL7R;EMP3;SQLE;TMEM65;STEAP4;HLA-E;OSMR;MAOA;INSIG1;ADAM9;TNFRSF10A;RNF19A;B3GNT2;TMEM154;ITM2B;ERN1;TMEM132A;ATP13A3;CXCL16;TAP1;DSE;STX12;GPR156
7406,GO:0031468,0.427421284235662,0.897067816249985,1,18,nuclear envelope reassembly,BP,ANKLE2
5617,GO:0016667,0.427775262073108,0.823619267001427,2,50,oxidoreductase activity, acting on a sulfur group of donors,MF,TXNRD1;ERO1A
14226,GO:0061162,0.427963556169415,0.897789800125945,1,15,establishment of monopolar cell polarity,BP,WNT5A
14273,GO:0061339,0.427963556169415,0.897789800125945,1,15,establishment or maintenance of monopolar cell polarity,BP,WNT5A
3009,GO:0006555,0.428224722474514,0.896935820389299,1,17,methionine metabolic process,BP,AHCY
3730,GO:0008266,0.428424281699891,0.897164662930037,1,16,poly(U) RNA binding,MF,PABPC4
2217,GO:0005112,0.428918448041822,0.897282781647735,1,15,Notch binding,MF,JAG1
15687,GO:0072215,0.429697689795272,0.896484960378317,1,16,regulation of metanephros development,BP,LIF
18400,GO:1903427,0.430003485808163,0.895683565644951,1,18,negative regulation of reactive oxygen species biosynthetic process,BP,ZC3H12A
570,GO:0001709,0.430267024414569,0.89584192514936,1,17,cell fate determination,BP,JAG1
5327,GO:0016051,0.430408768113907,0.726169228302602,6,158,carbohydrate biosynthetic process,BP,NFKB1;HAS3;B4GALT1;B3GNT5;PHKG2;B3GNT2
3188,GO:0006813,0.430678735686092,0.757586634261913,4,94,potassium ion transport,BP,CAB39;NEDD4L;OXSR1;SLC9A1
501,GO:0001556,0.430702634097779,0.895607684803669,1,17,oocyte maturation,BP,EREG
3170,GO:0006783,0.430764998734457,0.895273166956615,1,18,heme biosynthetic process,BP,ALAS1
10068,GO:0042562,0.430995407389181,0.821821213228079,2,44,hormone binding,MF,INHBA;ALDH1A3
2268,GO:0005198,0.431108829780025,0.668221400277262,16,509,structural molecule activity,MF,SPRR2D;CLDN1;SPRR2A;CLDN4;TFPI2;KRT34;SLC9A1;IFFO2;JAG1;SPAG9;VCL;NUP153;LCE1C;FRMD6;SMTN;LAMB3
13612,GO:0060079,0.431282636100753,0.821819648670039,2,42,excitatory postsynaptic potential,BP,ADRB2;STX1A
11869,GO:0046873,0.431560914846272,0.705937513035812,8,200,metal ion transmembrane transporter activity,MF,TRPV3;PANX1;SLC6A14;TFRC;SLC9A1;ITGAV;SLC28A3;ATP13A3
1867,GO:0004529,0.431738446296866,0.895049396278884,1,17,exodeoxyribonuclease activity,MF,ISG20
5750,GO:0016895,0.431738446296866,0.895049396278884,1,17,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,ISG20
11454,GO:0045907,0.432204527089607,0.895138830147379,1,16,positive regulation of vasoconstriction,BP,PTGS2
6511,GO:0021884,0.432227862215785,0.895126249205691,1,16,forebrain neuron development,BP,WNT5A
10677,GO:0043923,0.432289456820823,0.895093036510499,1,16,positive regulation by host of viral transcription,BP,JUN
6394,GO:0021591,0.432693158988869,0.89453319420604,1,17,ventricular system development,BP,CDK6
13525,GO:0055093,0.432722879333598,0.894517099710018,1,17,response to hyperoxia,BP,CDKN1A
5420,GO:0016266,0.4329927378476,0.820588599231282,2,42,O-glycan processing,BP,B3GNT5;B3GNT2
2565,GO:0005847,0.433522087465474,0.89442702021066,1,16,mRNA cleavage and polyadenylation specificity factor complex,CC,PIP5K1A
3496,GO:0007398,0.43398148071077,0.894568582202163,1,15,ectoderm development,BP,ETS2
11096,GO:0045109,0.434116077641211,0.894105145917323,1,16,intermediate filament organization,BP,AGFG1
13877,GO:0060491,0.434130391756071,0.736608529397273,5,125,regulation of cell projection assembly,BP,EPHA2;CYLD;TACSTD2;CDC42EP1;CORO1C
4860,GO:0014072,0.434420130686258,0.893595471202371,1,17,response to isoquinoline alkaloid,BP,RELA
10432,GO:0043278,0.434420130686258,0.893595471202371,1,17,response to morphine,BP,RELA
2930,GO:0006448,0.434504790475043,0.893549370361912,1,17,regulation of translational elongation,BP,CPEB2
4157,GO:0009218,0.434555855400105,0.892695794798625,1,20,pyrimidine ribonucleotide metabolic process,BP,UPP1
731,GO:0001958,0.43457334193548,0.89385694918203,1,16,endochondral ossification,BP,NAB1
9466,GO:0036075,0.43457334193548,0.89385694918203,1,16,replacement ossification,BP,NAB1
5686,GO:0016799,0.434632958884383,0.892653504679193,1,20,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,TDG
4605,GO:0010719,0.43470268260025,0.893135196737647,1,18,negative regulation of epithelial to mesenchymal transition,BP,EFNA1
8329,GO:0033176,0.435137877481754,0.892376310472314,1,20,proton-transporting V-type ATPase complex,CC,ATP6V1C2
11850,GO:0046831,0.435157032366704,0.893932132186475,1,15,regulation of RNA export from nucleus,BP,NUP153
1485,GO:0003785,0.435380228880528,0.892764634286912,1,18,actin monomer binding,MF,ABL2
10155,GO:0042734,0.43552437637265,0.819110648920651,2,39,presynaptic membrane,CC,FOSL1;STX1A
5331,GO:0016055,0.43561625483842,0.670598430156055,14,389,Wnt signaling pathway,BP,NFKB1;BMP2;RUNX1;CYLD;SMAD3;WISP1;AMOTL2;NRARP;SOX9;FERMT1;SOX4;ATP6V1C2;WNT5A;KDM6A
6348,GO:0021522,0.436104689141108,0.893023140007463,1,16,spinal cord motor neuron differentiation,BP,SOX4
10905,GO:0044451,0.436992470375451,0.633819572699954,34,976,nucleoplasm part,CC,NFKBIZ;ITPKC;BHLHE40;KDM6B;GADD45A;SQSTM1;CDKN1A;NAMPT;TAF4B;N4BP1;TRIM16;ELMSAN1;PPP1R10;ZNF217;DUSP10;USP36;IL16;RAPH1;ELL2;PIP5K1A;ZNF451;PML;POLR3A;CCNL1;HDAC9;HIVEP1;PRPF19;KDM6A;SGK1;POLR3D;TDG;ELF4;ISG20;BRD2
8988,GO:0035097,0.437162391153363,0.777579301422818,3,70,histone methyltransferase complex,CC,KDM6B;HDAC9;KDM6A
2675,GO:0006026,0.437217313792489,0.817422034618835,2,43,aminoglycan catabolic process,BP,SDC4;SLC9A1
4943,GO:0014904,0.437852060407396,0.892066775622385,1,16,myotube cell development,BP,HDAC9
70,GO:0000146,0.437985009047239,0.892846447241825,1,14,microfilament motor activity,MF,MYO1B
7194,GO:0031082,0.437985110085873,0.891332594400934,1,18,BLOC complex,CC,STX12
3287,GO:0006978,0.438097407457993,0.891270594618529,1,18,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,CDKN1A
16219,GO:0090263,0.43837092827895,0.750676588090254,4,110,positive regulation of canonical Wnt signaling pathway,BP,NFKB1;NRARP;SOX4;WNT5A
8997,GO:0035116,0.438376336037705,0.891427952186291,1,17,embryonic hindlimb morphogenesis,BP,TBX3
2971,GO:0006511,0.438574758324121,0.656106271997261,18,513,ubiquitin-dependent protein catabolic process,BP,TNFAIP3;RNF19B;TRIB1;SQSTM1;BIRC2;N4BP1;CYLD;NEDD4L;PLK2;PLK3;USP36;PML;UHRF1;USP31;TNFAIP1;RNF19A;NFE2L2;RNF11
20180,GO:2001020,0.438651942277575,0.718893702757966,6,162,regulation of response to DNA damage stimulus,BP,IER3;PMAIP1;PPP1R10;PML;FEM1B;SKIL
1039,GO:0002548,0.438703556892509,0.890656821445998,1,19,monocyte chemotaxis,BP,CCL20
11098,GO:0045111,0.438975788939576,0.750402344673247,4,102,intermediate filament cytoskeleton,CC,PHLDB2;KRT34;KRTAP2-3;IFFO2
3320,GO:0007029,0.439121655416672,0.816033506854783,2,43,endoplasmic reticulum organization,BP,TMCC1;VMP1
5167,GO:0015711,0.440010773824668,0.684617542269663,10,267,organic anion transport,BP,IL1B;EDN1;NFKBIE;SLC6A14;LDLR;PPARD;SLC25A25;STARD5;STX1A;SLC7A2
7814,GO:0032366,0.440133046477134,0.890456810518733,1,17,intracellular sterol transport,BP,LDLR
7815,GO:0032367,0.440133046477134,0.890456810518733,1,17,intracellular cholesterol transport,BP,LDLR
6544,GO:0021954,0.440313021573774,0.815269981456917,2,42,central nervous system neuron development,BP,BTG2;WNT5A
20099,GO:2000757,0.44047538469422,0.890266935950367,1,17,negative regulation of peptidyl-lysine acetylation,BP,ZNF451
7739,GO:0032233,0.4407826125999,0.814818033598828,2,43,positive regulation of actin filament bundle assembly,BP,SDC4;SMAD3
17633,GO:1901343,0.441381257536449,0.774315233298057,3,68,negative regulation of vasculature development,BP,PLK2;PML;ADAMTS9
450,GO:0001223,0.441395813500161,0.890111013224798,1,16,transcription coactivator binding,MF,CREB1
15994,GO:0086005,0.441589110625209,0.890407678688394,1,15,ventricular cardiac muscle cell action potential,BP,NEDD4L
13085,GO:0051590,0.441613511368132,0.889634219484909,1,17,positive regulation of neurotransmitter transport,BP,STX1A
882,GO:0002244,0.441836907606574,0.729338291131392,5,158,hematopoietic progenitor cell differentiation,BP,INHBA;RUNX1;SOX4;NFE2L2;SMPD3
3269,GO:0006942,0.441845545591632,0.813934670738392,2,44,regulation of striated muscle contraction,BP,ZC3H12A;SLC9A1
12483,GO:0050431,0.442441597943605,0.88993518822955,1,15,transforming growth factor beta binding,MF,ITGAV
12881,GO:0051208,0.442780012772168,0.773077264763513,3,70,sequestering of calcium ion,BP,BDKRB1;PDPK1;ERO1A
2383,GO:0005518,0.442963544219507,0.81332456217513,2,42,collagen binding,MF,SMAD3;ADAM9
17331,GO:0198738,0.443290015668517,0.663437170493263,14,391,cell-cell signaling by wnt,BP,NFKB1;BMP2;RUNX1;CYLD;SMAD3;WISP1;AMOTL2;NRARP;SOX9;FERMT1;SOX4;ATP6V1C2;WNT5A;KDM6A
4560,GO:0010640,0.443374361256807,0.889009583197549,1,16,regulation of platelet-derived growth factor receptor signaling pathway,BP,F3
5839,GO:0017124,0.443536816739897,0.746769652807423,4,96,SH3 domain binding,MF,ERRFI1;TP53BP2;QKI;ADAM9
11744,GO:0046580,0.443603001223555,0.812968056813206,2,41,negative regulation of Ras protein signal transduction,BP,RASA2;TNFAIP1
6925,GO:0030516,0.443906746704525,0.772342805804399,3,67,regulation of axon extension,BP,SEMA7A;NRG1;WNT5A
7598,GO:0031968,0.444015553634972,0.714150516282946,6,163,organelle outer membrane,CC,PMAIP1;BCL2L2;PPP1R15A;CYP27B1;NAV3;MAOA
2130,GO:0004930,0.444220230732793,0.727681970632273,5,135,G-protein coupled receptor activity,MF,HCAR2;ADRB2;HCAR3;BDKRB1;GPR156
3488,GO:0007368,0.444391069802615,0.771834766031994,3,69,determination of left/right symmetry,BP,TBX3;SMAD3;WNT5A
15822,GO:0072525,0.44448929220581,0.745861286832214,4,99,pyridine-containing compound biosynthetic process,BP,PTGS2;NMNAT2;NAMPT;NUP153
7591,GO:0031958,0.444792934641362,0.888215679389617,1,16,corticosteroid receptor signaling pathway,BP,YWHAH
14049,GO:0060795,0.445010703416212,0.887732182714027,1,17,cell fate commitment involved in formation of primary germ layer,BP,ETS2
8941,GO:0034979,0.445215710922596,0.887616755839863,1,17,NAD-dependent protein deacetylase activity,MF,HDAC9
7663,GO:0032091,0.445604483339208,0.770400743089637,3,78,negative regulation of protein binding,BP,ADRB2;SPAG9;TDG
2441,GO:0005640,0.445763370224923,0.887308041541077,1,17,nuclear outer membrane,CC,NAV3
16856,GO:0098780,0.446015133957957,0.887165946189835,1,17,response to mitochondrial depolarisation,BP,SQSTM1
5672,GO:0016780,0.446385147988081,0.88663424592226,1,18,phosphotransferase activity, for other substituted phosphate groups,MF,SGMS2
12647,GO:0050848,0.446486386642613,0.810407823617481,2,45,regulation of calcium-mediated signaling,BP,SLC9A1;NRG1
1128,GO:0002715,0.446616731894553,0.886502964244226,1,18,regulation of natural killer cell mediated immunity,BP,HLA-E
13182,GO:0051784,0.446621186135015,0.81012060089007,2,47,negative regulation of nuclear division,BP,LIF;DUSP1
1481,GO:0003756,0.447172341710764,0.886511385261487,1,17,protein disulfide isomerase activity,MF,ERO1A
5727,GO:0016864,0.447172341710764,0.886511385261487,1,17,intramolecular oxidoreductase activity, transposing S-S bonds,MF,ERO1A
3452,GO:0007266,0.447277895764361,0.711511063746046,6,149,Rho protein signal transduction,BP,RND3;FGD6;CDC42EP1;ARHGEF3;RHOB;TNFAIP1
8320,GO:0033158,0.447407230434279,0.886378235469415,1,17,regulation of protein import into nucleus, translocation,BP,CDKN1A
10013,GO:0042440,0.447485980717316,0.809389709543256,2,48,pigment metabolic process,BP,WNT5A;ALAS1
10527,GO:0043462,0.447515590048942,0.809125164649192,2,51,regulation of ATPase activity,BP,PPIF;UHRF1
12796,GO:0051087,0.447671180485982,0.768680454642242,3,79,chaperone binding,MF,BIRC2;SACS;CTSC
7622,GO:0032011,0.447779440878931,0.81000056521686,2,40,ARF protein signal transduction,BP,CYTH1;AGFG1
7623,GO:0032012,0.447779440878931,0.81000056521686,2,40,regulation of ARF protein signal transduction,BP,CYTH1;AGFG1
8254,GO:0033032,0.448088691985354,0.885666319900448,1,18,regulation of myeloid cell apoptotic process,BP,HCAR2
19194,GO:1905276,0.448302851963478,0.886236199565806,1,16,regulation of epithelial tube formation,BP,WNT5A
17467,GO:1900274,0.448302924290938,0.885869607055937,1,17,regulation of phospholipase C activity,BP,ABL2
10180,GO:0042772,0.449151272273237,0.884768145624134,1,19,DNA damage response, signal transduction resulting in transcription,BP,CDKN1A
2518,GO:0005770,0.449158598504137,0.698710572216842,7,191,late endosome,CC,SQSTM1;NMNAT2;LDLR;NEDD4L;RHOB;ABCA5;RAB22A
17827,GO:1901984,0.450180255283901,0.884470913470033,1,18,negative regulation of protein acetylation,BP,ZNF451
10536,GO:0043484,0.450219082463566,0.740936536767248,4,101,regulation of RNA splicing,BP,CLK4;PRPF19;CELF1;ERN1
10465,GO:0043325,0.450504565825639,0.88461336096891,1,17,phosphatidylinositol-3,4-bisphosphate binding,MF,DAPP1
4620,GO:0010737,0.450517912294563,0.884277203169562,1,18,protein kinase A signaling,BP,ADRB2
3817,GO:0008408,0.450866753668883,0.807045546876857,2,46,3'-5' exonuclease activity,MF,NOCT;ISG20
13671,GO:0060191,0.450963122660048,0.806973355087219,2,46,regulation of lipase activity,BP,ABL2;PDPK1
13012,GO:0051438,0.451027232477058,0.806743836428539,2,48,regulation of ubiquitin-protein transferase activity,BP,DCUN1D3;FEM1B
5303,GO:0015991,0.451383151625688,0.883220323025097,1,20,ATP hydrolysis coupled proton transport,BP,ATP6V1C2
11468,GO:0045923,0.452111360519296,0.883691110698911,1,17,positive regulation of fatty acid metabolic process,BP,PTGS2
3371,GO:0007143,0.452535040277187,0.883115777530834,1,18,female meiotic nuclear division,BP,EREG
13738,GO:0060306,0.452782949902357,0.883678015544478,1,16,regulation of membrane repolarization,BP,NEDD4L
17839,GO:1902003,0.453317707372335,0.882995689036723,1,17,regulation of amyloid-beta formation,BP,EFNA1
18282,GO:1903170,0.453318487695402,0.882365593556715,1,19,negative regulation of calcium ion transmembrane transport,BP,RRAD
19715,GO:2000050,0.453589871723282,0.883213472515194,1,16,regulation of non-canonical Wnt signaling pathway,BP,WNT5A
16288,GO:0090383,0.454193264885871,0.881346850787605,1,21,phagosome acidification,BP,ATP6V1C2
5159,GO:0015696,0.454339553471115,0.804341538987322,2,47,ammonium transport,BP,CSF2;EDN1
2202,GO:0005085,0.454343114595019,0.677857585558081,9,229,guanyl-nucleotide exchange factor activity,MF,HBEGF;CSF2;EREG;FGD6;NRG1;ARHGEF3;DENND2C;RAB3IP;CYTH1
14510,GO:0065005,0.454597171763202,0.881920944209079,1,18,protein-lipid complex assembly,BP,PLAGL2
5846,GO:0017134,0.454956786277125,0.881711799336234,1,18,fibroblast growth factor binding,MF,ITGAV
10188,GO:0042788,0.455011386507131,0.879530938158332,1,29,polysomal ribosome,CC,LARP4B
4972,GO:0015081,0.455235239278722,0.763127622909617,3,67,sodium ion transmembrane transporter activity,MF,SLC6A14;SLC9A1;SLC28A3
9130,GO:0035455,0.455560101024535,0.881060400397514,1,19,response to interferon-alpha,BP,IFNAR2
15322,GO:0071542,0.455937978679196,0.881476241156205,1,17,dopaminergic neuron differentiation,BP,WNT5A
10073,GO:0042572,0.455940860665665,0.881138296423511,1,18,retinol metabolic process,BP,ALDH1A3
4684,GO:0010831,0.456372086784275,0.880886437485155,1,18,positive regulation of myotube differentiation,BP,EHD1
3252,GO:0006914,0.456547240260458,0.647547236733371,15,428,autophagy,BP,ZC3H12A;TICAM1;PLEKHF1;SQSTM1;ADRB2;VMP1;PLK2;PLK3;USP36;RIPK2;ABL2;ATP6V1C2;ERN1;STX12;RAB24
14489,GO:0061919,0.456547240260458,0.647547236733371,15,428,process utilizing autophagic mechanism,BP,ZC3H12A;TICAM1;PLEKHF1;SQSTM1;ADRB2;VMP1;PLK2;PLK3;USP36;RIPK2;ABL2;ATP6V1C2;ERN1;STX12;RAB24
7741,GO:0032239,0.457029539946822,0.881220240914736,1,16,regulation of nucleobase-containing compound transport,BP,NUP153
7154,GO:0031012,0.457423139342778,0.674905579218147,9,240,extracellular matrix,CC,TFPI2;WISP1;F3;SERPINB1;ADAMTS1;WNT5A;ADAMTS9;LAMB3;ADAMTS6
6345,GO:0021517,0.457470515241976,0.880581855089106,1,17,ventral spinal cord development,BP,SOX4
6735,GO:0030149,0.457565793864776,0.879884929456711,1,19,sphingolipid catabolic process,BP,SMPD3
9315,GO:0035774,0.45785733245111,0.879713465513177,1,19,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,OXCT1
6275,GO:0019867,0.45838012648003,0.7013194254981,6,165,outer membrane,CC,PMAIP1;BCL2L2;PPP1R15A;CYP27B1;NAV3;MAOA
10277,GO:0043022,0.458766828920321,0.800986015328916,2,47,ribosome binding,MF,ZC3H12A;CPEB2
6343,GO:0021515,0.458970386202837,0.879702447109746,1,17,cell differentiation in spinal cord,BP,SOX4
12843,GO:0051150,0.459282866622396,0.879177641028352,1,18,regulation of smooth muscle cell differentiation,BP,EREG
1699,GO:0004175,0.459826896478839,0.679997979617595,8,228,endopeptidase activity,MF,PLAU;ADAM8;F3;ADAMTS1;ADAM9;ADAMTS9;CTSC;ADAMTS6
12883,GO:0051213,0.45990889829233,0.758931580447928,3,73,dioxygenase activity,MF,PTGS2;KDM6B;KDM6A
2542,GO:0005798,0.459951381170912,0.713875677075434,5,136,Golgi-associated vesicle,CC,TGFA;AREG;HLA-E;CTSC;ITM2B
5301,GO:0015988,0.459971441576576,0.877942331415756,1,21,energy coupled proton transmembrane transport, against electrochemical gradient,BP,ATP6V1C2
952,GO:0002369,0.460125146004031,0.878374446927059,1,19,T cell cytokine production,BP,CD55
11753,GO:0046599,0.46015313913629,0.879006114597054,1,17,regulation of centriole replication,BP,PLK2
13702,GO:0060251,0.461952066166536,0.877942170886635,1,17,regulation of glial cell proliferation,BP,CREB1
13810,GO:0060396,0.462221275781049,0.878171516019413,1,16,growth hormone receptor signaling pathway,BP,PTPN1
6309,GO:0019941,0.463097746721707,0.632811854046105,18,521,modification-dependent protein catabolic process,BP,TNFAIP3;RNF19B;TRIB1;SQSTM1;BIRC2;N4BP1;CYLD;NEDD4L;PLK2;PLK3;USP36;PML;UHRF1;USP31;TNFAIP1;RNF19A;NFE2L2;RNF11
14946,GO:0070841,0.46331442850815,0.876785594106902,1,18,inclusion body assembly,BP,SACS
3405,GO:0007188,0.463694596126034,0.755788392095116,3,73,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,EDN1;ADRB2;ADM
5338,GO:0016073,0.46426414354401,0.754806369232307,3,84,snRNA metabolic process,BP,NABP1;ELL2;POU2F2
16667,GO:0097553,0.464281058100852,0.755353790128686,3,72,calcium ion transmembrane import into cytosol,BP,BDKRB1;PDPK1;ERO1A
2438,GO:0005637,0.464438081481501,0.796841225551185,2,45,nuclear inner membrane,CC,SMAD3;ERN1
10990,GO:0044788,0.464463045144735,0.876098681171193,1,18,modulation by host of viral process,BP,ZC3H12A
18811,GO:1904375,0.46506510400454,0.754645832188414,3,73,regulation of protein localization to cell periphery,BP,EPHA2;SQSTM1;PDPK1
14835,GO:0070577,0.465130572028221,0.876441797271291,1,16,lysine-acetylated histone binding,MF,BRD2
17282,GO:0140033,0.465130572028221,0.876441797271291,1,16,acetylation-dependent protein binding,MF,BRD2
13212,GO:0051851,0.465439562923236,0.795779682936382,2,48,modification by host of symbiont morphology or physiology,BP,ZC3H12A;JUN
11807,GO:0046688,0.466011040498224,0.874087668088829,1,22,response to copper ion,BP,IL1A
2881,GO:0006383,0.466721955754029,0.794614346477734,2,50,transcription by RNA polymerase III,BP,POLR3A;POLR3D
1484,GO:0003779,0.467077575110712,0.65404710332794,11,291,actin binding,MF,PANX1;ENC1;KLHL21;VCL;COTL1;CORO1C;ABL2;SMTN;YWHAH;MYO1B;PDLIM5
18933,GO:1904680,0.467277807476107,0.873550585528996,1,21,peptide transmembrane transporter activity,MF,TAP1
8959,GO:0035024,0.467528606875619,0.874606658189877,1,17,negative regulation of Rho protein signal transduction,BP,TNFAIP1
19290,GO:1905517,0.467704939467355,0.873290816889478,1,21,macrophage migration,BP,SAA1
8113,GO:0032799,0.468572459691637,0.873304486436392,1,19,low-density lipoprotein receptor particle metabolic process,BP,ITGAV
16603,GO:0097435,0.469343190113566,0.629504983599877,17,468,supramolecular fiber organization,BP,SDC4;EDN1;PHLDB2;RND3;NEDD9;LDLR;TACSTD2;SMAD3;PLK3;SLC9A1;NAV3;CDC42EP1;RHOB;AKAP2;TNFAIP1;AGFG1;MYO1B
20291,GO:2001258,0.469514276294975,0.872445156807597,1,20,negative regulation of cation channel activity,BP,RRAD
16185,GO:0090207,0.469998670459536,0.872435590050505,1,19,regulation of triglyceride metabolic process,BP,LDLR
2566,GO:0005849,0.47059481779165,0.872390817371476,1,18,mRNA cleavage factor complex,CC,PIP5K1A
17729,GO:1901657,0.470785692089429,0.722761783449498,4,115,glycosyl compound metabolic process,BP,TJP2;AMPD3;UPP1;AHCY
12223,GO:0048477,0.470860902132201,0.791765396044006,2,46,oogenesis,BP,TAF4B;EREG
9706,GO:0038111,0.471595137383856,0.869909283749806,1,26,interleukin-7-mediated signaling pathway,BP,IL7R
16849,GO:0098760,0.471595137383856,0.869909283749806,1,26,response to interleukin-7,BP,IL7R
16850,GO:0098761,0.471595137383856,0.869909283749806,1,26,cellular response to interleukin-7,BP,IL7R
15410,GO:0071675,0.471894455712456,0.870986018576646,1,20,regulation of mononuclear cell migration,BP,TNF
2811,GO:0006271,0.472062222970881,0.870882775024205,1,20,DNA strand elongation involved in DNA replication,BP,GINS3
7383,GO:0031434,0.472280956864889,0.791098999777154,2,42,mitogen-activated protein kinase kinase binding,MF,EPHA2;TRIB1
4165,GO:0009226,0.47238026969626,0.870425390951043,1,21,nucleotide-sugar biosynthetic process,BP,PMM2
8237,GO:0033006,0.47242534709036,0.870948537714068,1,19,regulation of mast cell activation involved in immune response,BP,PDPK1
10447,GO:0043304,0.47242534709036,0.870948537714068,1,19,regulation of mast cell degranulation,BP,PDPK1
6289,GO:0019897,0.472812615777076,0.721440265717134,4,100,extrinsic component of plasma membrane,CC,ERRFI1;CYLD;ABL2;CYTH1
18924,GO:1904646,0.472924227252489,0.870964080313925,1,18,cellular response to amyloid-beta,BP,ADRB2
15972,GO:0080111,0.47307484156074,0.870548680158286,1,19,DNA demethylation,BP,TDG
17529,GO:1901019,0.473098802060485,0.790017008089548,2,46,regulation of calcium ion transmembrane transporter activity,BP,RRAD;SLC9A1
14544,GO:0070062,0.473267908165508,0.581933467227389,63,2036,extracellular exosome,CC,TNFAIP3;IL1B;PLAUR;BTG2;PLAU;SDC4;EFNA1;IRF6;IL1RN;CREB5;SQSTM1;CAB39;RAP2B;CD274;NAMPT;BCL2L2;RELT;RND3;SOD2;ALDH1A3;EHD1;B4GALT1;IL6ST;SLC6A14;TXNRD1;TACSTD2;NEDD4L;OXSR1;TFRC;SERPINB8;EFNB1;F3;KRT34;SLC25A25;SERPINB1;SLC9A1;CD55;SAA1;NDRG1;ITGAV;RHOB;SPAG9;VCL;COTL1;STEAP4;ATP6V1C2;HLA-E;PMM2;WNT5A;ADAM9;CTSC;YWHAH;B3GNT2;RNF11;YWHAG;RAB22A;CREG1;SFN;ITM2B;TMEM132A;MYO1B;AHCY;STX12
16361,GO:0090662,0.473311018493094,0.869850113340033,1,21,ATP hydrolysis coupled transmembrane transport,BP,ATP6V1C2
17012,GO:0099131,0.473311018493094,0.869850113340033,1,21,ATP hydrolysis coupled ion transmembrane transport,BP,ATP6V1C2
8206,GO:0032958,0.474335833839728,0.870457722781279,1,17,inositol phosphate biosynthetic process,BP,ITPKC
18300,GO:1903205,0.474501092650942,0.86937599177214,1,20,regulation of hydrogen peroxide-induced cell death,BP,NFE2L2
10778,GO:0044232,0.474859072935102,0.869771358342191,1,18,organelle membrane contact site,CC,PLEKHF1
4111,GO:0009165,0.475013326303246,0.66589147547863,8,233,nucleotide biosynthetic process,BP,PTGS2;NMNAT2;NAMPT;AMPD3;PANK3;ADM;NUP153;UPP1
18298,GO:1903203,0.475181680003321,0.869571812094584,1,18,regulation of oxidative stress-induced neuron death,BP,NCOA7
16467,GO:0097150,0.475530976481635,0.869720444851969,1,17,neuronal stem cell population maintenance,BP,JAG1
5684,GO:0016796,0.475600014345554,0.787859081878533,2,48,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,NOCT;ISG20
13848,GO:0060445,0.476112449146528,0.869360775543289,1,17,branching involved in salivary gland morphogenesis,BP,TNF
3244,GO:0006903,0.476374665065625,0.744915073654838,3,77,vesicle targeting,BP,TGFA;AREG;CTSC
10324,GO:0043114,0.476771492600855,0.868952362701538,1,17,regulation of vascular permeability,BP,ADM
10023,GO:0042461,0.477194162044947,0.868322622407872,1,18,photoreceptor cell development,BP,PRDM1
16626,GO:0097484,0.478429222024024,0.867921471105501,1,17,dendrite extension,BP,NEDD4L
5054,GO:0015248,0.47954084056598,0.866227121221501,1,20,sterol transporter activity,MF,STARD5
15222,GO:0071378,0.480094266744857,0.866880848273309,1,17,cellular response to growth hormone stimulus,BP,PTPN1
11456,GO:0045911,0.480364666066537,0.866006737609172,1,19,positive regulation of DNA recombination,BP,TFRC
8356,GO:0033233,0.480533258514014,0.865601426774525,1,20,regulation of protein sumoylation,BP,RELA
17251,GO:0120033,0.480594979084133,0.865861615537546,1,19,negative regulation of plasma membrane bounded cell projection assembly,BP,TACSTD2
12934,GO:0051287,0.480600352788129,0.783554103725957,2,52,NAD binding,MF,ALDH1A3;AHCY
2731,GO:0006109,0.480644977769762,0.69550331836041,5,129,regulation of carbohydrate metabolic process,BP,PMAIP1;NFKB1;PHLDA2;PHKG2;NUP153
1114,GO:0002701,0.480809396877195,0.865426997987039,1,20,negative regulation of production of molecular mediator of immune response,BP,TNF
8359,GO:0033238,0.481122040972794,0.782523799922784,2,61,regulation of cellular amine metabolic process,BP,ODC1;AZIN1
8880,GO:0034694,0.481579033175431,0.865574555255567,1,18,response to prostaglandin,BP,EDN1
13913,GO:0060561,0.48179218344058,0.865440048159301,1,18,apoptotic process involved in morphogenesis,BP,B4GALT1
12598,GO:0050771,0.48194255301624,0.783248144443329,2,44,negative regulation of axonogenesis,BP,SEMA7A;WNT5A
11522,GO:0046037,0.481999806064755,0.864974254633976,1,19,GMP metabolic process,BP,TJP2
12927,GO:0051279,0.482035925100512,0.78285609276764,2,47,regulation of release of sequestered calcium ion into cytosol,BP,BDKRB1;PDPK1
7022,GO:0030742,0.48224042666788,0.864520747650914,1,20,GTP-dependent protein binding,MF,GCH1
797,GO:0002063,0.482287146059058,0.865502384591302,1,17,chondrocyte development,BP,SOX9
18584,GO:1903828,0.482526827935131,0.739660167180713,3,77,negative regulation of cellular protein localization,BP,NEDD4L;SOX4;INSIG1
3318,GO:0007026,0.483507681359487,0.864354366664746,1,18,negative regulation of microtubule depolymerization,BP,NAV3
16547,GO:0097306,0.483544344360438,0.782087296368675,2,43,cellular response to alcohol,BP,INHBA;HMGCS1
3166,GO:0006779,0.484130376288109,0.863043698742969,1,21,porphyrin-containing compound biosynthetic process,BP,ALAS1
7942,GO:0032528,0.484245080688067,0.863885978244604,1,18,microvillus organization,BP,PTPN11
18158,GO:1902903,0.484441293800623,0.649557207994122,9,250,regulation of supramolecular fiber organization,BP,SDC4;EDN1;PHLDB2;LDLR;TACSTD2;SMAD3;SLC9A1;NAV3;CDC42EP1
4331,GO:0009855,0.484592383337296,0.738040609508909,3,74,determination of bilateral symmetry,BP,TBX3;SMAD3;WNT5A
13261,GO:0051937,0.484760523290505,0.862915367786575,1,20,catecholamine transport,BP,STX1A
3799,GO:0008375,0.484836338968155,0.78042635673086,2,49,acetylglucosaminyltransferase activity,MF,B3GNT5;B3GNT2
17747,GO:1901681,0.484846912949011,0.691454702184771,5,139,sulfur compound binding,MF,HBEGF;WISP1;LIPG;SAA1;ADAMTS1
9611,GO:0036475,0.48552816610099,0.862729073943934,1,19,neuron death in response to oxidative stress,BP,NCOA7
10276,GO:0043021,0.48567285404334,0.709728786362655,4,110,ribonucleoprotein complex binding,MF,ZC3H12A;CPEB2;PIM1;IFIH1
9590,GO:0036442,0.485734392440604,0.861765133711448,1,22,proton-exporting ATPase activity,MF,ATP6V1C2
7595,GO:0031965,0.485966427386268,0.648104358804459,9,251,nuclear membrane,CC,SMAD3;AKIRIN1;NAV3;STX1A;GCH1;AEN;NUP153;ERN1;IPO4
2427,GO:0005605,0.486326112805827,0.862939661537301,1,17,basal lamina,CC,LAMB3
17608,GO:1901293,0.486769627304299,0.654841786454806,8,236,nucleoside phosphate biosynthetic process,BP,PTGS2;NMNAT2;NAMPT;AMPD3;PANK3;ADM;NUP153;UPP1
4808,GO:0012505,0.487204596782985,0.558656324372352,106,3161,endomembrane system,CC,IL1B;ZC3H12A;CXCL1;PLAUR;PLAU;TICAM1;ELF3;SDC4;TNF;PTGS2;RNF19B;NFKB1;PLEKHF1;TGFA;EDN1;IRAK2;PANX1;EHF;SQSTM1;IFNGR2;CAB39;RAP2B;NFKBIE;TMCC3;NMNAT2;CD274;AMPD3;RND3;ADRB2;UGCG;PPP1R15A;C3ORF52;EHD1;NEDD9;ANKLE2;B4GALT1;FGD6;TMCC1;B3GNT5;SGMS2;VMP1;ADAM8;LDLR;VEGFC;NEDD4L;SMAD3;IL23A;DUSP10;PLK3;ITGA5;TFRC;LIPG;AKIRIN1;SERPINB1;RAET1L;BDKRB1;SLC9A1;CD55;ANTXR2;AMOTL2;NAV3;PPP1R15B;NDRG1;ITGAV;STX1A;PML;CDC42EP1;SLC28A3;RHOB;SPAG9;ABCA5;GCH1;VCL;AREG;TNFAIP1;AEN;SKIL;COTL1;PTPN1;SQLE;STEAP4;HLA-E;WNT5A;NUP153;INSIG1;ADAMTS9;CTSC;ERO1A;NFE2L2;SGK1;B3GNT2;CYTH1;AGFG1;RNF11;RAB22A;CREG1;ITM2B;ERN1;TMEM132A;MYO1B;IPO4;TAP1;DSE;STX12;RAB24;SMPD3
6781,GO:0030215,0.487411910925075,0.862245436724537,1,17,semaphorin receptor binding,MF,SEMA7A
3063,GO:0006626,0.487990246960132,0.707358061467704,4,121,protein targeting to mitochondrion,BP,UGCG;USP36;PLAGL2;NRG1
2654,GO:0005996,0.488094868623849,0.662852471117409,7,198,monosaccharide metabolic process,BP,TNF;PMAIP1;PHLDA2;B4GALT1;PPARD;PHKG2;PMM2
2444,GO:0005643,0.488096816901045,0.734909767242867,3,76,nuclear pore,CC,NUP153;AGFG1;IPO4
2663,GO:0006006,0.488261482947577,0.688401756766787,5,136,glucose metabolic process,BP,TNF;PMAIP1;PHLDA2;PPARD;PHKG2
3733,GO:0008270,0.488869092615784,0.603347785079454,20,571,zinc ion binding,MF,TNFAIP3;KLF7;SQSTM1;BIRC2;TRIM16;ZSWIM4;TRAF1;CYLD;ADAM8;SMAD3;PPARD;PML;UHRF1;GCH1;TRAF4;ADAMTS1;PTPN1;ADAMTS9;RNF11;IFIH1
16860,GO:0098791,0.489739988430892,0.59670303560129,23,660,Golgi subcompartment,CC,TGFA;IFNGR2;NMNAT2;RND3;UGCG;B4GALT1;B3GNT5;SGMS2;PLK3;CD55;ABCA5;AREG;STEAP4;HLA-E;CTSC;B3GNT2;CYTH1;ITM2B;TMEM132A;MYO1B;DSE;STX12;SMPD3
12762,GO:0051028,0.489751787636115,0.687059430362539,5,135,mRNA transport,BP,ZFP36L1;ZFP36;QKI;NUP153;AGFG1
10634,GO:0043632,0.489893304743037,0.606945326594833,18,530,modification-dependent macromolecule catabolic process,BP,TNFAIP3;RNF19B;TRIB1;SQSTM1;BIRC2;N4BP1;CYLD;NEDD4L;PLK2;PLK3;USP36;PML;UHRF1;USP31;TNFAIP1;RNF19A;NFE2L2;RNF11
20023,GO:2000637,0.489894714716746,0.859917671999637,1,19,positive regulation of gene silencing by miRNA,BP,ZFP36
14962,GO:0070861,0.48996925994021,0.859869358753608,1,19,regulation of protein exit from endoplasmic reticulum,BP,INSIG1
6958,GO:0030594,0.490092947208852,0.85919773490274,1,21,neurotransmitter receptor activity,MF,GPR156
10398,GO:0043230,0.491174968853285,0.564270659113203,63,2045,extracellular organelle,CC,TNFAIP3;IL1B;PLAUR;BTG2;PLAU;SDC4;EFNA1;IRF6;IL1RN;CREB5;SQSTM1;CAB39;RAP2B;CD274;NAMPT;BCL2L2;RELT;RND3;SOD2;ALDH1A3;EHD1;B4GALT1;IL6ST;SLC6A14;TXNRD1;TACSTD2;NEDD4L;OXSR1;TFRC;SERPINB8;EFNB1;F3;KRT34;SLC25A25;SERPINB1;SLC9A1;CD55;SAA1;NDRG1;ITGAV;RHOB;SPAG9;VCL;COTL1;STEAP4;ATP6V1C2;HLA-E;PMM2;WNT5A;ADAM9;CTSC;YWHAH;B3GNT2;RNF11;YWHAG;RAB22A;CREG1;SFN;ITM2B;TMEM132A;MYO1B;AHCY;STX12
18466,GO:1903561,0.491174968853285,0.564270659113203,63,2045,extracellular vesicle,CC,TNFAIP3;IL1B;PLAUR;BTG2;PLAU;SDC4;EFNA1;IRF6;IL1RN;CREB5;SQSTM1;CAB39;RAP2B;CD274;NAMPT;BCL2L2;RELT;RND3;SOD2;ALDH1A3;EHD1;B4GALT1;IL6ST;SLC6A14;TXNRD1;TACSTD2;NEDD4L;OXSR1;TFRC;SERPINB8;EFNB1;F3;KRT34;SLC25A25;SERPINB1;SLC9A1;CD55;SAA1;NDRG1;ITGAV;RHOB;SPAG9;VCL;COTL1;STEAP4;ATP6V1C2;HLA-E;PMM2;WNT5A;ADAM9;CTSC;YWHAH;B3GNT2;RNF11;YWHAG;RAB22A;CREG1;SFN;ITM2B;TMEM132A;MYO1B;AHCY;STX12
4318,GO:0009799,0.491287487146783,0.732193637029394,3,75,specification of symmetry,BP,TBX3;SMAD3;WNT5A
9736,GO:0038191,0.491530824545553,0.859591438033857,1,17,neuropilin binding,MF,SEMA7A
10728,GO:0044070,0.491844002078178,0.774862364423284,2,48,regulation of anion transport,BP,IL1B;EDN1
7902,GO:0032469,0.492127377455498,0.858152870128749,1,20,endoplasmic reticulum calcium ion homeostasis,BP,PML
18108,GO:1902745,0.492572908310619,0.858175201315242,1,19,positive regulation of lamellipodium organization,BP,CORO1C
16299,GO:0090407,0.492680545921322,0.606864660742748,17,499,organophosphate biosynthetic process,BP,PLAUR;ITPKC;PTGS2;NMNAT2;NAMPT;AMPD3;HMGCS1;SGMS2;PPARD;PIP5K1A;PTPN11;PANK3;GCH1;ADM;NUP153;ETNK1;UPP1
14800,GO:0070528,0.492763180902723,0.858050880591851,1,19,protein kinase C signaling,BP,WNT5A
11580,GO:0046134,0.492865470165563,0.856677894333143,1,24,pyrimidine nucleoside biosynthetic process,BP,UPP1
10801,GO:0044281,0.492994629301936,0.569143491553158,48,1503,small molecule metabolic process,BP,IL1B;ITPKC;TNF;PPIF;PTGS2;PMAIP1;NFKB1;EDN1;ODC1;HAS3;EPHA2;BMP2;PHLDA2;NMNAT2;TJP2;NAMPT;AMPD3;HMGCS1;ALDH1A3;B4GALT1;HAL;SLC6A14;TXNRD1;LDLR;PIM1;PPARD;SLC25A25;SLC9A1;CYP27B1;AZIN1;PHKG2;SLC7A2;PANK3;GCH1;OXCT1;SQLE;ADM;QKI;PMM2;WNT5A;NUP153;INSIG1;ERO1A;B3GNT2;TDG;UPP1;DSE;AHCY
202,GO:0000423,0.493044530830101,0.857866923235105,1,19,mitophagy,BP,SQSTM1
6773,GO:0030206,0.493194640972912,0.85811856343389,1,18,chondroitin sulfate biosynthetic process,BP,DSE
11699,GO:0046488,0.494440739397462,0.668379797555081,6,160,phosphatidylinositol metabolic process,BP,PLAUR;HBEGF;EREG;PIP5K1A;NRG1;PTPN11
7718,GO:0032206,0.494858350506878,0.772308808564033,2,49,positive regulation of telomere maintenance,BP,PPP1R10;PML
10890,GO:0044431,0.494959345660942,0.588325594249323,25,719,Golgi apparatus part,CC,SDC4;TGFA;IFNGR2;NMNAT2;RND3;UGCG;B4GALT1;B3GNT5;SGMS2;PLK3;CD55;ABCA5;AREG;STEAP4;HLA-E;WNT5A;CTSC;B3GNT2;CYTH1;ITM2B;TMEM132A;MYO1B;DSE;STX12;SMPD3
12344,GO:0048706,0.495107769537527,0.728807456640821,3,76,embryonic skeletal system development,BP,DLX2;SMAD3;WNT5A
5124,GO:0015491,0.495108912141221,0.856864929972894,1,18,cation:cation antiporter activity,MF,SLC9A1
10501,GO:0043403,0.495192829462019,0.856140303501218,1,20,skeletal muscle tissue regeneration,BP,PPARD
9798,GO:0040018,0.495462125509558,0.856279884344147,1,19,positive regulation of multicellular organism growth,BP,CREB1
10154,GO:0042733,0.496506543100627,0.771155723336532,2,47,embryonic digit morphogenesis,BP,TBX3;WNT5A
7168,GO:0031047,0.496593423580393,0.68036262131729,5,155,gene silencing by RNA,BP,ZC3H12A;SMAD3;ZFP36;CELF1;NUP153
17069,GO:0099565,0.496889992071252,0.770841169077987,2,47,chemical synaptic transmission, postsynaptic,BP,ADRB2;STX1A
7605,GO:0031984,0.497546009847147,0.567719572415567,43,1277,organelle subcompartment,CC,ZC3H12A;PLAUR;PTGS2;RNF19B;TGFA;PANX1;IFNGR2;NMNAT2;RND3;UGCG;PPP1R15A;C3ORF52;ANKLE2;B4GALT1;TMCC1;B3GNT5;SGMS2;PLK3;SLC9A1;CD55;ANTXR2;PML;SLC28A3;ABCA5;AREG;PTPN1;SQLE;STEAP4;HLA-E;INSIG1;CTSC;ERO1A;SGK1;B3GNT2;CYTH1;ITM2B;ERN1;TMEM132A;MYO1B;TAP1;DSE;STX12;SMPD3
3532,GO:0007520,0.497749836771969,0.854447564922465,1,20,myoblast fusion,BP,EHD1
15225,GO:0071383,0.497982471558429,0.653611882828418,7,193,cellular response to steroid hormone stimulus,BP,EDN1;ERRFI1;ZFP36L1;RUNX1;PPARD;ZFP36;YWHAH
3779,GO:0008333,0.498475440699669,0.769436906290123,2,48,endosome to lysosome transport,BP,ADRB2;RHOB
9892,GO:0042175,0.499293796138077,0.581113820011398,27,812,nuclear outer membrane-endoplasmic reticulum membrane network,CC,ZC3H12A;PLAUR;PTGS2;RNF19B;TGFA;PANX1;IFNGR2;PPP1R15A;C3ORF52;ANKLE2;TMCC1;SGMS2;SLC9A1;ANTXR2;NAV3;PML;SLC28A3;AREG;PTPN1;SQLE;HLA-E;INSIG1;ERO1A;SGK1;ERN1;TMEM132A;TAP1
6432,GO:0021696,0.499494426620664,0.85360754435342,1,19,cerebellar cortex morphogenesis,BP,PTPN11
14546,GO:0070064,0.499814050204887,0.853394358509227,1,19,proline-rich region binding,MF,CYLD
14296,GO:0061387,0.499906758523563,0.724700887855497,3,74,regulation of extent of cell growth,BP,SEMA7A;NRG1;WNT5A
79,GO:0000159,0.500041500945053,0.852919617217868,1,20,protein phosphatase type 2A complex,CC,IER5
3404,GO:0007187,0.500316395011551,0.724127364996987,3,78,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,EDN1;ADRB2;ADM
8250,GO:0033028,0.500553947963459,0.852284144756473,1,21,myeloid cell apoptotic process,BP,HCAR2
6011,GO:0019054,0.500704796984224,0.85247544604289,1,20,modulation by virus of host process,BP,ZC3H12A
9610,GO:0036474,0.500849817091347,0.851819664205933,1,22,cell death in response to hydrogen peroxide,BP,NFE2L2
12539,GO:0050685,0.501142061233841,0.851889110457922,1,21,positive regulation of mRNA processing,BP,PRPF19
96,GO:0000186,0.501229730506866,0.767482465623445,2,45,activation of MAPKK activity,BP,MAP3K8;ADAM9
7080,GO:0030867,0.501266488950542,0.850869417331309,1,25,rough endoplasmic reticulum membrane,CC,ZC3H12A
13279,GO:0051963,0.501775048128046,0.767147834509432,2,44,regulation of synapse assembly,BP,WNT5A;PDLIM5
2382,GO:0005516,0.502565428979392,0.675370498234119,5,129,calmodulin binding,MF,ITPKC;RRAD;SLC9A1;PHKG2;MYO1B
13518,GO:0055086,0.502639867365937,0.597006642949281,17,545,nucleobase-containing small molecule metabolic process,BP,PPIF;PTGS2;EPHA2;NMNAT2;TJP2;NAMPT;AMPD3;TXNRD1;SLC25A25;PANK3;ADM;PMM2;WNT5A;NUP153;TDG;UPP1;AHCY
11683,GO:0046466,0.50270211232901,0.85057020402459,1,22,membrane lipid catabolic process,BP,SMPD3
6056,GO:0019201,0.503148116950804,0.850831815431571,1,20,nucleotide kinase activity,MF,TJP2
18923,GO:1904645,0.503268556965724,0.850750490003392,1,20,response to amyloid-beta,BP,ADRB2
12847,GO:0051154,0.503957456704774,0.850284768185625,1,20,negative regulation of striated muscle cell differentiation,BP,BMP2
15156,GO:0071276,0.503965188668148,0.849244201806153,1,24,cellular response to cadmium ion,BP,JUN
7855,GO:0032414,0.504041435362632,0.764730539425472,2,49,positive regulation of ion transmembrane transporter activity,BP,ADRB2;SLC9A1
2408,GO:0005578,0.504600780676889,0.647417063022282,7,187,proteinaceous extracellular matrix,CC,TFPI2;WISP1;ADAMTS1;WNT5A;ADAMTS9;LAMB3;ADAMTS6
1913,GO:0004601,0.50462519164921,0.84805563616231,1,28,peroxidase activity,MF,PTGS2
6743,GO:0030159,0.504995012625208,0.849910641632363,1,19,receptor signaling complex scaffold activity,MF,SPAG9
8234,GO:0033003,0.505137550805026,0.849187249935085,1,21,regulation of mast cell activation,BP,PDPK1
4842,GO:0014047,0.505392713420975,0.849641030689491,1,19,glutamate secretion,BP,STX1A
1401,GO:0003333,0.505613553778435,0.763518334426004,2,48,amino acid transmembrane transport,BP,SLC6A14;SLC7A2
14116,GO:0060968,0.505632849843362,0.691204343253037,4,127,regulation of gene silencing,BP,ZC3H12A;ZFP36;UHRF1;NUP153
17491,GO:1900449,0.505693454482867,0.849436942496809,1,19,regulation of glutamate receptor signaling pathway,BP,ADRB2
10797,GO:0044272,0.505899315648877,0.671918725300416,5,144,sulfur compound biosynthetic process,BP,B4GALT1;NFE2L2;B3GNT2;DSE;AHCY
19838,GO:2000300,0.505980955092334,0.849241671448903,1,19,regulation of synaptic vesicle exocytosis,BP,STX1A
8996,GO:0035115,0.506010687761425,0.848592593127249,1,21,embryonic forelimb morphogenesis,BP,TBX3
5968,GO:0018394,0.507467428914824,0.670536310348029,5,140,peptidyl-lysine acetylation,BP,IL1B;LIF;TRIM16;ZNF451;SOX4
13140,GO:0051702,0.507535943775623,0.761536816387203,2,52,interaction with symbiont,BP,ZC3H12A;JUN
5012,GO:0015171,0.50757305583941,0.761780026159123,2,49,amino acid transmembrane transporter activity,MF,SLC6A14;SLC7A2
5834,GO:0017112,0.507632823475137,0.761729919488638,2,49,Rab guanyl-nucleotide exchange factor activity,MF,DENND2C;RAB3IP
15744,GO:0072330,0.507967135620697,0.643988785201186,7,203,monocarboxylic acid biosynthetic process,BP,PTGS2;EDN1;ALDH1A3;QKI;NUP153;INSIG1;DSE
3683,GO:0008187,0.508153812671371,0.847427509427083,1,20,poly-pyrimidine tract binding,MF,PABPC4
919,GO:0002312,0.508184119987548,0.76117213691394,2,50,B cell activation involved in immune response,BP,BCL3;TFRC
15890,GO:0072657,0.508279654145279,0.601022424144013,14,451,protein localization to membrane,BP,TNF;PMAIP1;PLEKHF1;EPHA2;SQSTM1;BBC3;PIP5K1A;TP53BP2;STX1A;RAB3IP;PDPK1;YWHAH;YWHAG;SFN
11157,GO:0045214,0.508767046525431,0.847007022761,1,20,sarcomere organization,BP,EDN1
2540,GO:0005796,0.509339387416869,0.760296766338263,2,49,Golgi lumen,CC,SDC4;WNT5A
13611,GO:0060078,0.50980476661209,0.760004910517105,2,48,regulation of postsynaptic membrane potential,BP,ADRB2;STX1A
10038,GO:0042491,0.509890490554052,0.846234737329535,1,20,inner ear auditory receptor cell differentiation,BP,JAG1
19820,GO:2000272,0.510104525036942,0.845784150908565,1,21,negative regulation of signaling receptor activity,BP,ERRFI1
15000,GO:0070932,0.510124201134069,0.84607376030675,1,20,histone H3 deacetylation,BP,HDAC9
19791,GO:2000209,0.510276219321481,0.845968993140312,1,20,regulation of anoikis,BP,ITGA5
3378,GO:0007157,0.510572839895439,0.845460737491194,1,21,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,ITGA5
13646,GO:0060148,0.510576308515376,0.845762042815339,1,20,positive regulation of posttranscriptional gene silencing,BP,ZFP36
4221,GO:0009394,0.511233588749227,0.843654767457653,1,27,2'-deoxyribonucleotide metabolic process,BP,TDG
8992,GO:0035107,0.511391381340602,0.686547934115036,4,104,appendage morphogenesis,BP,TBX3;SOX9;SOX4;WNT5A
8993,GO:0035108,0.511391381340602,0.686547934115036,4,104,limb morphogenesis,BP,TBX3;SOX9;SOX4;WNT5A
617,GO:0001783,0.512042783008993,0.844165435028611,1,22,B cell apoptotic process,BP,BCL10
714,GO:0001937,0.512260429357819,0.844597261561791,1,20,negative regulation of endothelial cell proliferation,BP,TNF
549,GO:0001669,0.513435076586892,0.756559589726372,2,52,acrosomal vesicle,CC,SPAG9;SKIL
12062,GO:0048011,0.513498081696346,0.84373762276171,1,20,neurotrophin TRK receptor signaling pathway,BP,PTPN11
606,GO:0001772,0.513549176879242,0.843702066926226,1,20,immunological synapse,CC,BCL10
3137,GO:0006730,0.513557343042372,0.843389285896456,1,21,one-carbon metabolic process,BP,AHCY
2188,GO:0005044,0.513870772829634,0.843170699482305,1,21,scavenger receptor activity,MF,CXCL16
18204,GO:1902991,0.513952433457958,0.843113716555423,1,21,regulation of amyloid precursor protein catabolic process,BP,EFNA1
1857,GO:0004518,0.515927219433066,0.64779610384148,6,177,nuclease activity,MF,ZC3H12A;ZC3H12C;NOCT;AEN;ERN1;ISG20
3156,GO:0006760,0.516721124055396,0.840891550152571,1,22,folic acid-containing compound metabolic process,BP,GCH1
10406,GO:0043242,0.517189775184098,0.753744659057043,2,48,negative regulation of protein complex disassembly,BP,TNF;NAV3
9846,GO:0042092,0.517599805733761,0.840013489019169,1,23,type 2 immune response,BP,BCL3
117,GO:0000245,0.518014608299273,0.75248665576171,2,54,spliceosomal complex assembly,BP,PRPF19;CELF1
12786,GO:0051058,0.518290652100628,0.752910119319187,2,47,negative regulation of small GTPase mediated signal transduction,BP,RASA2;TNFAIP1
6758,GO:0030178,0.518442608018484,0.659969844082204,5,151,negative regulation of Wnt signaling pathway,BP,BMP2;CYLD;SOX9;FERMT1;WNT5A
4359,GO:0009954,0.518759018832755,0.839735784572151,1,21,proximal/distal pattern formation,BP,DLX2
15998,GO:0086009,0.519118892466487,0.839794448505854,1,20,membrane repolarization,BP,NEDD4L
2645,GO:0005980,0.51960706595865,0.839448937390083,1,20,glycogen catabolic process,BP,PHKG2
6674,GO:0030032,0.51973555831343,0.751463666967321,2,49,lamellipodium assembly,BP,EPHA2;VCL
4057,GO:0009101,0.52012154490603,0.615209079577848,9,257,glycoprotein biosynthetic process,BP,HBEGF;TNIP1;PHLDA1;B4GALT1;B3GNT5;PMM2;B3GNT2;ITM2B;DSE
10397,GO:0043229,0.520531532360751,0.527869100051096,305,9289,intracellular organelle,CC,NFKBIA;NFKBIZ;TNFAIP3;IL1B;ZC3H12A;CXCL1;PLAUR;BTG2;BIRC3;HBEGF;PLAU;NFKBID;CSF2;ITPKC;TICAM1;ELF3;SDC4;ETS1;TNF;REL;PPIF;IER3;KLF6;NUAK2;ZNF697;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;PLEKHF1;TGFA;KDM6B;IRF6;EDN1;PHLDA1;ERRFI1;IRAK2;KLF7;PANX1;CREB5;CPEB2;EHF;RELB;GADD45A;MAFF;TRIB1;SQSTM1;IFNGR2;BMP2;CAB39;ZNF267;N4BP3;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;NMNAT2;RGMB;PHLDB2;TJP2;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;BCL2L2;ZFP36L1;ENC1;RELT;RND3;ADRB2;CEBPB;DUSP16;ARNTL2;UGCG;PPP1R15A;RUNX1;N4BP1;CDKN2B;GJB4;NAB1;TRIM16;ELMSAN1;SOD2;PELI1;ALDH1A3;C3ORF52;EHD1;NEDD9;ANKLE2;DUSP8;B4GALT1;DUSP1;BCL10;FGD6;TMCC1;PPP1R10;SACS;G0S2;B3GNT5;SGMS2;VMP1;NABP1;DLX2;TXNRD1;VGLL3;CYLD;ADAM8;LDLR;VEGFC;KLF3;ZNF217;TACSTD2;NEDD4L;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;DIEXF;PIM1;ITGA5;TFRC;LIPG;AKIRIN1;KLHL21;CREB1;EFNB1;GJB3;STK40;HIVEP2;PPARD;KRT34;SLC25A25;SERPINB1;CCDC85B;KRTAP2-3;RAET1L;USP36;IL16;BDKRB1;RAPH1;ZFP36;SLC9A1;MAFK;LARP4B;CYP27B1;IFFO2;CD55;TMEM217;PNRC1;ELL2;ANTXR2;AZIN1;PLAGL2;RIPK2;AMOTL2;NAV3;SAA1;PPP1R15B;STARD5;NDRG1;ITGAV;PIP5K1A;CLK4;TP53BP2;SOX9;STX1A;NRG1;ZNF451;FEM1C;PML;POU2F2;PPTC7;FERMT1;NCOA7;ELK3;POLR3A;ZNF460;CDC42EP1;SLC28A3;FOXN2;PTPN11;UHRF1;MXD1;RHOB;SPAG9;ABCA5;GCH1;FEM1B;SOX4;USP31;FOSL2;TRAF4;VCL;EIF1;OXCT1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;ADAMTS1;HIVEP1;NFKBIB;KLF10;AEN;SKIL;COTL1;IL7R;HEXDC;RBM3;CDK6;IER5;YRDC;SAMD4A;PTPN1;SQLE;TFE3;BTG3;TMEM65;CORO1C;STEAP4;PRPF19;TOB2;MAFG;ABL2;MTF1;ATP6V1C2;HLA-E;RAB3IP;QKI;CELF1;PMM2;WNT5A;NUP153;MAOA;INSIG1;PDPK1;ADAMTS9;RNF19A;CTSC;ERO1A;KDM6A;FRMD6;ZBTB21;SMTN;NFE2L2;YWHAH;SGK1;B3GNT2;TSC22D2;CYTH1;RELA;AGFG1;RNF11;BACH1;BTAF1;GINS3;POLR3D;ALAS1;YWHAG;TDG;ELF4;RAB22A;CREG1;SFN;ITM2B;ERN1;ETNK1;SH3RF2;UPP1;ISG20;TMEM132A;ATXN7;IFIH1;ATP13A3;MYO1B;BRD2;IPO4;PABPC4;TAP1;DSE;AHCY;STX12;PDLIM5;FUBP3;RAB24;SMPD3
11577,GO:0046131,0.521614994119605,0.836493055499023,1,26,pyrimidine ribonucleoside metabolic process,BP,UPP1
9799,GO:0040019,0.52175729157574,0.837921265283553,1,20,positive regulation of embryonic development,BP,PHLDB2
4314,GO:0009791,0.521853327706503,0.704910337936165,3,76,post-embryonic development,BP,PRDM1;CSRNP1;PLAGL2
4192,GO:0009268,0.521896650260273,0.83721769575879,1,22,response to pH,BP,SLC9A1
12510,GO:0050650,0.521942305569936,0.83778937396879,1,20,chondroitin sulfate proteoglycan biosynthetic process,BP,DSE
19807,GO:2000249,0.522257104437499,0.836697145262269,1,23,regulation of actin cytoskeleton reorganization,BP,ABL2
15027,GO:0070972,0.522286540322446,0.702880327960877,3,125,protein localization to endoplasmic reticulum,BP,PPP1R15A;PMM2;INSIG1
12380,GO:0048786,0.522313755588143,0.837875337305787,1,19,presynaptic active zone,CC,STX1A
18120,GO:1902803,0.522376100631917,0.837479856958873,1,20,regulation of synaptic vesicle transport,BP,STX1A
419,GO:0001106,0.522647337919681,0.836968590887265,1,21,RNA polymerase II transcription corepressor activity,MF,ZNF451
9002,GO:0035137,0.52279897640347,0.836860043694446,1,21,hindlimb morphogenesis,BP,TBX3
3075,GO:0006643,0.522909000157027,0.641066952473441,6,179,membrane lipid metabolic process,BP,PLAUR;TNF;UGCG;B3GNT5;SGMS2;SMPD3
12550,GO:0050699,0.5236424619151,0.835965994468832,1,22,WW domain binding,MF,TRAF4
15290,GO:0071478,0.524409136167972,0.654472695756806,5,142,cellular response to radiation,BP,PTGS2;GADD45A;CDKN1A;N4BP1;RHOB
19776,GO:2000179,0.524719960492112,0.83548082983027,1,21,positive regulation of neural precursor cell proliferation,BP,VEGFC
5076,GO:0015298,0.524797876769378,0.835744753902814,1,20,solute:cation antiporter activity,MF,SLC9A1
5728,GO:0016866,0.52570912856678,0.833966609753453,1,24,intramolecular transferase activity,MF,PMM2
5132,GO:0015605,0.525828581105515,0.834389699696551,1,22,organophosphate ester transmembrane transporter activity,MF,SLC25A25
9134,GO:0035459,0.525957391307187,0.834909708070515,1,20,cargo loading into vesicle,BP,INSIG1
8862,GO:0034661,0.526217429824714,0.833841858603686,1,23,ncRNA catabolic process,BP,ZC3H12A
9807,GO:0040036,0.526270163117293,0.834362246275045,1,21,regulation of fibroblast growth factor receptor signaling pathway,BP,WNT5A
9039,GO:0035255,0.526515455391128,0.834506812005242,1,20,ionotropic glutamate receptor binding,MF,SQSTM1
9889,GO:0042168,0.526904036250504,0.832874095398553,1,25,heme metabolic process,BP,ALAS1
10403,GO:0043236,0.527129193009229,0.833740240724342,1,21,laminin binding,MF,ADAM9
5659,GO:0016757,0.527743541613321,0.624857563204876,7,207,transferase activity, transferring glycosyl groups,MF,HAS3;NAMPT;UGCG;B4GALT1;B3GNT5;B3GNT2;UPP1
417,GO:0001104,0.527817852692107,0.699183343748371,3,81,RNA polymerase II transcription cofactor activity,MF,ZNF451;SOX4;TDG
9019,GO:0035198,0.528686683870318,0.832608566939194,1,21,miRNA binding,MF,ZC3H12A
17602,GO:1901264,0.52880020059903,0.742991809721724,2,56,carbohydrate derivative transport,BP,SLC25A25;SLC28A3
5290,GO:0015949,0.528961156358905,0.830969474425787,1,27,nucleobase-containing small molecule interconversion,BP,TXNRD1
2848,GO:0006334,0.529051896744892,0.696850677437057,3,116,nucleosome assembly,BP,SOX9;BRD2;IPO4
3552,GO:0007589,0.529388560765928,0.742813429475734,2,52,body fluid secretion,BP,EDN1;CREB1
4430,GO:0010259,0.529410779582111,0.832080710660237,1,21,multicellular organism aging,BP,EDN1
7574,GO:0031935,0.529592521355214,0.83227365173782,1,20,regulation of chromatin silencing,BP,UHRF1
20196,GO:2001038,0.529907661089257,0.831151886889749,1,23,regulation of cellular response to drug,BP,NFE2L2
18160,GO:1902905,0.530005312896539,0.649067426327881,5,144,positive regulation of supramolecular fiber organization,BP,SDC4;EDN1;SMAD3;NAV3;CDC42EP1
8840,GO:0034629,0.53017063600866,0.831229330296418,1,22,cellular protein-containing complex localization,BP,KLHL21
12870,GO:0051188,0.530538516433767,0.612679859847021,8,242,cofactor biosynthetic process,BP,PTGS2;NMNAT2;NAMPT;PANK3;GCH1;NUP153;NFE2L2;ALAS1
4951,GO:0015012,0.530820499343019,0.831376922646696,1,20,heparan sulfate proteoglycan biosynthetic process,BP,DSE
6660,GO:0030010,0.531097505669949,0.668096000492017,4,104,establishment of cell polarity,BP,AMOTL2;FERMT1;WNT5A;CYTH1
6085,GO:0019239,0.531252535412528,0.829916020004542,1,24,deaminase activity,MF,AMPD3
2494,GO:0005741,0.531275199582795,0.64776306128951,5,148,mitochondrial outer membrane,CC,PMAIP1;BCL2L2;PPP1R15A;CYP27B1;MAOA
3049,GO:0006607,0.532497102923437,0.830147466435158,1,20,NLS-bearing protein import into nucleus,BP,IPO4
11442,GO:0045879,0.533061838020233,0.829732011269079,1,20,negative regulation of smoothened signaling pathway,BP,KCTD11
2787,GO:0006221,0.533674876427186,0.827304033082706,1,28,pyrimidine nucleotide biosynthetic process,BP,UPP1
18511,GO:1903671,0.533833035234931,0.828833022214645,1,21,negative regulation of sprouting angiogenesis,BP,ADAMTS9
15999,GO:0086010,0.534001839279447,0.829038992130355,1,20,membrane depolarization during action potential,BP,YWHAH
8656,GO:0034205,0.534786534981384,0.827826189236324,1,22,amyloid-beta formation,BP,EFNA1
13492,GO:0055026,0.534794188687691,0.828121690902205,1,21,negative regulation of cardiac muscle tissue development,BP,BMP2
14899,GO:0070717,0.534819863787569,0.828102662388314,1,21,poly-purine tract binding,MF,PABPC4
14117,GO:0060969,0.534926463525663,0.827722320699613,1,22,negative regulation of gene silencing,BP,ZC3H12A
4644,GO:0010765,0.534967487880896,0.827993227016071,1,21,positive regulation of sodium ion transport,BP,SLC9A1
4101,GO:0009154,0.535206553908915,0.827239184809578,1,23,purine ribonucleotide catabolic process,BP,AMPD3
2519,GO:0005771,0.53569733839295,0.826389442537021,1,25,multivesicular body,CC,NEDD4L
10408,GO:0043244,0.535817164501573,0.691873728849629,3,79,regulation of protein complex disassembly,BP,TNF;ADRB2;NAV3
4371,GO:0009988,0.53591792389398,0.826010550089377,1,26,cell-cell recognition,BP,B4GALT1
16316,GO:0090501,0.536197412100905,0.662663334803039,4,123,RNA phosphodiester bond hydrolysis,BP,ZC3H12A;NOCT;ERN1;ISG20
15135,GO:0071230,0.536608697678459,0.736547203401017,2,51,cellular response to amino acid stimulus,BP,TNF;CEBPB
16904,GO:0098862,0.536838605232102,0.690818481634207,3,81,cluster of actin-based cell projections,CC,B4GALT1;SLC6A14;MYO1B
17825,GO:1901981,0.537224277458556,0.662088278786145,4,109,phosphatidylinositol phosphate binding,MF,PLEKHF1;DAPP1;SLC9A1;MYO1B
2534,GO:0005789,0.537251634628267,0.544765335795558,26,797,endoplasmic reticulum membrane,CC,ZC3H12A;PLAUR;PTGS2;RNF19B;TGFA;PANX1;IFNGR2;PPP1R15A;C3ORF52;ANKLE2;TMCC1;SGMS2;SLC9A1;ANTXR2;PML;SLC28A3;AREG;PTPN1;SQLE;HLA-E;INSIG1;ERO1A;SGK1;ERN1;TMEM132A;TAP1
3109,GO:0006687,0.537509588655856,0.735562653785985,2,53,glycosphingolipid metabolic process,BP,UGCG;SMPD3
5281,GO:0015931,0.538794916748539,0.614018653614397,7,208,nucleobase-containing compound transport,BP,ZFP36L1;SLC25A25;ZFP36;SLC28A3;QKI;NUP153;AGFG1
4178,GO:0009251,0.539094458282347,0.824915077831514,1,21,glucan catabolic process,BP,PHKG2
9119,GO:0035418,0.539169594941877,0.824552846055893,1,22,protein localization to synapse,BP,WNT5A
16317,GO:0090502,0.539521267812066,0.733290864457558,2,59,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,ZC3H12A;ERN1
10612,GO:0043601,0.539582552441589,0.823707136944276,1,24,nuclear replisome,CC,PRPF19
14112,GO:0060964,0.539837030017809,0.687148057992796,3,103,regulation of gene silencing by miRNA,BP,ZC3H12A;ZFP36;NUP153
7223,GO:0031116,0.539918521038033,0.823989425767272,1,22,positive regulation of microtubule polymerization,BP,NAV3
17531,GO:1901021,0.539954715388356,0.823962166099764,1,22,positive regulation of calcium ion transmembrane transporter activity,BP,SLC9A1
2640,GO:0005975,0.54012615571028,0.566091871876437,15,449,carbohydrate metabolic process,BP,TNF;PMAIP1;NFKB1;HAS3;PHLDA2;B4GALT1;IL6ST;B3GNT5;STK40;PPARD;PHKG2;HEXDC;PMM2;NUP153;B3GNT2
17364,GO:1900078,0.54025707637515,0.824379470951504,1,20,positive regulation of cellular response to insulin stimulus,BP,PTPN11
9543,GO:0036296,0.54057997721817,0.822953754130775,1,24,response to increased oxygen levels,BP,CDKN1A
4391,GO:0010043,0.54084196833563,0.822301493522003,1,26,response to zinc ion,BP,CREB1
8242,GO:0033014,0.540880203424413,0.822726565625721,1,24,tetrapyrrole biosynthetic process,BP,ALAS1
6203,GO:0019692,0.541171662970426,0.821488092239808,1,29,deoxyribose phosphate metabolic process,BP,TDG
12935,GO:0051289,0.541605095981283,0.731575294728199,2,57,protein homotetramerization,BP,SOD2;ALDH1A3
7911,GO:0032482,0.541872034513434,0.731259870329296,2,58,Rab protein signal transduction,BP,RAB22A;RAB24
6567,GO:0022011,0.542359187311038,0.822454203906681,1,21,myelination in peripheral nervous system,BP,NDRG1
7773,GO:0032292,0.542359187311038,0.822454203906681,1,21,peripheral nervous system axon ensheathment,BP,NDRG1
4862,GO:0014075,0.542582741078616,0.821693047956357,1,23,response to amine,BP,HDAC9
16423,GO:0097061,0.544717513849355,0.729400465366486,2,50,dendritic spine organization,BP,EFNA1;PDLIM5
8422,GO:0033500,0.544841471616109,0.634616032301356,5,147,carbohydrate homeostasis,BP,PIM3;PTPN11;SOX4;OXCT1;ERN1
10091,GO:0042593,0.544841471616109,0.634616032301356,5,147,glucose homeostasis,BP,PIM3;PTPN11;SOX4;OXCT1;ERN1
16249,GO:0090305,0.545215064429002,0.598118894219729,8,248,nucleic acid phosphodiester bond hydrolysis,BP,ZC3H12A;ZC3H12C;NOCT;ZFP36;PNRC1;AEN;ERN1;ISG20
7389,GO:0031440,0.545332366240788,0.819880605456476,1,22,regulation of mRNA 3'-end processing,BP,ZFP36L1
2991,GO:0006536,0.545503153182142,0.819464796469306,1,23,glutamate metabolic process,BP,HAL
10351,GO:0043161,0.54563518755453,0.572430684826336,12,370,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,RNF19B;TRIB1;BIRC2;N4BP1;NEDD4L;PLK2;PLK3;PML;TNFAIP1;RNF19A;NFE2L2;RNF11
11144,GO:0045191,0.546434748442189,0.818750096787192,1,23,regulation of isotype switching,BP,TFRC
1972,GO:0004683,0.547025501065924,0.818582558355438,1,22,calmodulin-dependent protein kinase activity,MF,PHKG2
4586,GO:0010675,0.54731010249987,0.680962679455206,3,81,regulation of cellular carbohydrate metabolic process,BP,PMAIP1;PHLDA2;PHKG2
13216,GO:0051865,0.547755202331543,0.726460653640216,2,52,protein autoubiquitination,BP,UHRF1;RNF11
2390,GO:0005525,0.547903394295365,0.587593456738923,9,277,GTP binding,MF,RRAD;RAP2B;RND3;EHD1;IRGQ;RHOB;GCH1;RAB22A;RAB24
16884,GO:0098827,0.548131003936578,0.533807589259748,26,801,endoplasmic reticulum subcompartment,CC,ZC3H12A;PLAUR;PTGS2;RNF19B;TGFA;PANX1;IFNGR2;PPP1R15A;C3ORF52;ANKLE2;TMCC1;SGMS2;SLC9A1;ANTXR2;PML;SLC28A3;AREG;PTPN1;SQLE;HLA-E;INSIG1;ERO1A;SGK1;ERN1;TMEM132A;TAP1
10884,GO:0044424,0.54907609213011,0.509750780426711,341,10384,intracellular part,CC,NFKBIA;NFKBIZ;TNFAIP3;IL1B;IL1A;ZC3H12A;CXCL1;PLAUR;BTG2;BIRC3;HBEGF;PLAU;NFKBID;CSF2;ITPKC;INHBA;TICAM1;ELF3;SDC4;ETS1;TNF;REL;SERPINB2;PPIF;IER3;KLF6;NUAK2;SPRR2D;ZNF697;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;PLEKHF1;TGFA;KDM6B;IRF6;EDN1;ODC1;PHLDA1;HAS3;ERRFI1;IL1RN;IRAK2;CLDN1;KLF7;PANX1;CREB5;DAPP1;CPEB2;EHF;SPRR2A;EPHA2;RELB;GADD45A;MAFF;LIF;TRIB1;KCTD11;SQSTM1;IFNGR2;BMP2;PHLDA2;CAB39;ZNF267;N4BP3;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;NMNAT2;RGMB;PHLDB2;TJP2;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;BCL2L2;ZFP36L1;ENC1;RELT;RND3;ADRB2;CEBPB;DUSP16;ARNTL2;UGCG;PPP1R15A;MAST4;RUNX1;N4BP1;CDKN2B;GJB4;NAB1;HMGCS1;TRIM16;ELMSAN1;SOD2;PELI1;ALDH1A3;C3ORF52;EHD1;NEDD9;ZSWIM4;ANKLE2;DUSP8;B4GALT1;HAL;DUSP1;BCL10;FGD6;DCUN1D3;TMCC1;TRAF1;PPP1R10;PIM3;CDV3;SACS;G0S2;B3GNT5;SGMS2;VMP1;NABP1;DLX2;TXNRD1;VGLL3;CYLD;ADAM8;LDLR;VEGFC;KLF3;ZNF217;TACSTD2;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;DIEXF;PIM1;WISP1;ITGA5;TFRC;LIPG;AKIRIN1;KLHL21;CREB1;SERPINB8;EFNB1;GJB3;STK40;HIVEP2;PPARD;KRT34;SLC25A25;SERPINB1;SOCS3;CCDC85B;KRTAP2-3;RAET1L;USP36;IL16;BDKRB1;RAPH1;ZFP36;SLC9A1;MAFK;LARP4B;CYP27B1;IFFO2;CD55;TMEM217;PNRC1;ELL2;ANTXR2;AZIN1;PLAGL2;RIPK2;AMOTL2;PHKG2;NAV3;SAA1;PPP1R15B;STARD5;NDRG1;ITGAV;PIP5K1A;CLK4;TP53BP2;SOX9;STX1A;NRG1;ZNF451;FEM1C;PML;POU2F2;RASA2;PPTC7;FERMT1;NCOA7;ELK3;POLR3A;ZNF460;CDC42EP1;SLC28A3;FOXN2;PTPN11;MAP3K8;UHRF1;PANK3;ARHGEF3;C15ORF39;MXD1;RHOB;SPAG9;ABCA5;GCH1;FEM1B;SOX4;USP31;FOSL2;TRAF4;VCL;EIF1;OXCT1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;ADAMTS1;HIVEP1;NFKBIB;KLF10;AEN;SKIL;COTL1;IL7R;HEXDC;RBM3;CDK6;IER5;YRDC;SAMD4A;PTPN1;SQLE;TFE3;BTG3;TMEM65;CORO1C;STEAP4;PRPF19;TOB2;ADM;MAFG;ABL2;MTF1;ATP6V1C2;HLA-E;RAB3IP;QKI;CELF1;PMM2;WNT5A;NUP153;MAOA;INSIG1;LCE1C;PDPK1;ADAMTS9;RNF19A;CTSC;ERO1A;KDM6A;FRMD6;ZBTB21;SMTN;NFE2L2;YWHAH;SGK1;B3GNT2;TSC22D2;CYTH1;SAT1;RELA;AGFG1;RNF11;NOTCH2NL;BACH1;BTAF1;GINS3;POLR3D;ALAS1;YWHAG;TDG;ELF4;RAB22A;CREG1;SFN;ITM2B;ERN1;ETNK1;SH3RF2;UPP1;ISG20;TMEM132A;ATXN7;IFIH1;ATP13A3;MYO1B;BRD2;IPO4;PABPC4;TAP1;DSE;AHCY;STX12;PDLIM5;FUBP3;RAB24;SMPD3
14197,GO:0061099,0.549137688161405,0.816401322521587,1,24,negative regulation of protein tyrosine kinase activity,BP,ERRFI1
14666,GO:0070273,0.549274234202552,0.816560008080331,1,23,phosphatidylinositol-4-phosphate binding,MF,PLEKHF1
1427,GO:0003382,0.551388297879372,0.815208903653121,1,22,epithelial cell morphogenesis,BP,FRMD6
4185,GO:0009261,0.551388896484494,0.814651036011708,1,24,ribonucleotide catabolic process,BP,AMPD3
3506,GO:0007416,0.551843234496836,0.676920581233898,3,76,synapse assembly,BP,NRG1;WNT5A;PDLIM5
17500,GO:1900542,0.551876647995511,0.647746912852715,4,115,regulation of purine nucleotide metabolic process,BP,PPIF;ADM;WNT5A;NUP153
11091,GO:0045095,0.551900722503856,0.81377995797753,1,26,keratin filament,CC,KRTAP2-3
20103,GO:2000765,0.552579824456563,0.813988103419509,1,23,regulation of cytoplasmic translation,BP,CPEB2
74,GO:0000151,0.55279251482695,0.582786686836147,9,266,ubiquitin ligase complex,CC,RNF19B;ENC1;ZSWIM4;DCUN1D3;KLHL21;TNFAIP1;RNF19A;RNF11;BACH1
9016,GO:0035195,0.553714418382905,0.645461543600628,4,134,gene silencing by miRNA,BP,ZC3H12A;SMAD3;ZFP36;NUP153
6919,GO:0030510,0.553988948824235,0.72077939660608,2,52,regulation of BMP signaling pathway,BP,SKIL;WNT5A
10681,GO:0043933,0.554132603290703,0.505897952623327,52,1671,protein-containing complex subunit organization,BP,TNFAIP3;ZC3H12A;BIRC3;CSF2;TNF;PMAIP1;FOSL1;NOCT;TGFA;CLDN1;PANX1;KCTD11;SQSTM1;CAB39;JUN;BIRC2;TAF4B;ADRB2;SOD2;ALDH1A3;EHD1;B4GALT1;BCL10;TMCC1;TRAF1;CYLD;SMAD3;RC3H1;LIPG;CREB1;SLC9A1;PLAGL2;NAV3;SOX9;STX1A;NRG1;ZNF451;PML;CDC42EP1;PTPN11;SPAG9;ABCA5;GCH1;AREG;TNFAIP1;PRPF19;CELF1;NUP153;INSIG1;CTSC;BRD2;IPO4
12716,GO:0050931,0.55428890314785,0.812648889032689,1,23,pigment cell differentiation,BP,ADAMTS9
8599,GO:0034109,0.55490577228628,0.71966589855425,2,55,homotypic cell-cell adhesion,BP,RAP2B;VCL
13579,GO:0060043,0.555099026301461,0.812306456585437,1,22,regulation of cardiac muscle cell proliferation,BP,PIM1
5231,GO:0015844,0.555440075373929,0.811473071936624,1,24,monoamine transport,BP,STX1A
132,GO:0000272,0.556040676320183,0.811565056420118,1,22,polysaccharide catabolic process,BP,PHKG2
10785,GO:0044247,0.556040676320183,0.811565056420118,1,22,cellular polysaccharide catabolic process,BP,PHKG2
2216,GO:0005109,0.556665293258002,0.810775986481546,1,23,frizzled binding,MF,WNT5A
11539,GO:0046068,0.55767542914011,0.810273249237522,1,22,cGMP metabolic process,BP,WNT5A
18105,GO:1902742,0.558094058732011,0.809941480414068,1,22,apoptotic process involved in development,BP,B4GALT1
7946,GO:0032535,0.558387476265255,0.577172961369026,9,264,regulation of cellular component size,BP,EDN1;SEMA7A;PPP1R15A;CREB1;NRG1;CDC42EP1;IL7R;WNT5A;RAB22A
7221,GO:0031114,0.558432451668772,0.809673013088749,1,22,regulation of microtubule depolymerization,BP,NAV3
12617,GO:0050795,0.559092870981663,0.808576272017852,1,24,regulation of behavior,BP,CSF2
17278,GO:0140014,0.559481330113711,0.583909894203331,8,240,mitotic nuclear division,BP,IL1B;IL1A;BIRC3;TGFA;EDN1;BIRC2;EREG;DUSP1
10559,GO:0043516,0.559814370355779,0.807748626752633,1,25,regulation of DNA damage response, signal transduction by p53 class mediator,BP,PMAIP1
15495,GO:0071868,0.559817286467104,0.808272330713882,1,23,cellular response to monoamine stimulus,BP,SLC9A1
15497,GO:0071870,0.559817286467104,0.808272330713882,1,23,cellular response to catecholamine stimulus,BP,SLC9A1
5626,GO:0016684,0.560050695137699,0.806239707911335,1,32,oxidoreductase activity, acting on peroxide as acceptor,MF,PTGS2
18239,GO:1903046,0.560060507327751,0.639691921529819,4,116,meiotic cell cycle process,BP,LIF;OVOL1;EREG;WNT5A
8891,GO:0034708,0.560480204472704,0.667921241160124,3,90,methyltransferase complex,CC,KDM6B;HDAC9;KDM6A
6610,GO:0022804,0.560796823566919,0.59218849304169,7,202,active transmembrane transporter activity,MF,SLC6A14;SLC9A1;SLC28A3;ABCA5;ATP6V1C2;ATP13A3;TAP1
7953,GO:0032550,0.561191869450755,0.574205420633992,9,280,purine ribonucleoside binding,MF,RRAD;RAP2B;RND3;EHD1;IRGQ;RHOB;GCH1;RAB22A;RAB24
12163,GO:0048278,0.561271144128633,0.713695766555154,2,56,vesicle docking,BP,STX1A;STX12
13645,GO:0060147,0.561288770604651,0.666569028880563,3,106,regulation of posttranscriptional gene silencing,BP,ZC3H12A;ZFP36;NUP153
14114,GO:0060966,0.561288770604651,0.666569028880563,3,106,regulation of gene silencing by RNA,BP,ZC3H12A;ZFP36;NUP153
16513,GO:0097223,0.561379525634029,0.667091984398682,3,89,sperm part,CC,SQSTM1;SPAG9;SKIL
17693,GO:1901570,0.561523935740132,0.713222192175488,2,59,fatty acid derivative biosynthetic process,BP,PTGS2;EDN1
9156,GO:0035510,0.561561618860435,0.806348097774994,1,25,DNA dealkylation,BP,TDG
16573,GO:0097366,0.562258380120573,0.806041657778508,1,24,response to bronchodilator,BP,HDAC9
5671,GO:0016779,0.562447503157971,0.637059082045165,4,126,nucleotidyltransferase activity,MF,NMNAT2;POLR3A;YRDC;POLR3D
7283,GO:0031267,0.562840649054512,0.540084236783061,16,446,small GTPase binding,MF,HBEGF;CSF2;ERRFI1;EREG;EHD1;FGD6;NDRG1;NRG1;CDC42EP1;ARHGEF3;TNFAIP1;DENND2C;CORO1C;RAB3IP;AGFG1;IPO4
7099,GO:0030894,0.563005103687847,0.804951030797761,1,26,replisome,CC,PRPF19
10675,GO:0043921,0.563005817672689,0.805439880871274,1,24,modulation by host of viral transcription,BP,JUN
13340,GO:0052312,0.563005817672689,0.805439880871274,1,24,modulation of transcription in other organism involved in symbiotic interaction,BP,JUN
13358,GO:0052472,0.563005817672689,0.805439880871274,1,24,modulation by host of symbiont transcription,BP,JUN
6220,GO:0019751,0.563405812661263,0.665257540948602,3,86,polyol metabolic process,BP,ITPKC;CYP27B1;GCH1
11524,GO:0046039,0.563470380194388,0.804357459279907,1,27,GTP metabolic process,BP,AMPD3
6364,GO:0021543,0.563556868165727,0.636329732026283,4,113,pallium development,BP,BTG2;KDM6B;DLX2;CDK6
16476,GO:0097159,0.565092454432537,0.476521044584735,152,4609,organic cyclic compound binding,MF,TNFAIP3;ZC3H12A;ITPKC;ELF3;ETS1;TNF;REL;KLF6;NUAK2;ZNF697;BHLHE40;PTGS2;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;KDM6B;IRF6;IRAK2;KLF7;CREB5;CPEB2;EHF;EPHA2;RELB;GADD45A;MAFF;RRAD;ZNF267;MAP2K3;JUN;RAP2B;NMNAT2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;IRF1;TAF4B;ZFP36L1;RND3;ADRB2;CEBPB;ARNTL2;MAST4;RUNX1;TRIM16;ELMSAN1;ALDH1A3;EHD1;PPP1R10;PIM3;NABP1;DLX2;TXNRD1;KLF3;ZNF217;OXSR1;SMAD3;RC3H1;PLK2;PLK3;DIEXF;PIM1;TFRC;CREB1;STK40;HIVEP2;PPARD;USP36;ZFP36;MAFK;LARP4B;CYP27B1;PLAGL2;RIPK2;PHKG2;NAV3;STARD5;PIP5K1A;CLK4;SOX9;ZNF451;PML;POU2F2;ELK3;POLR3A;ZNF460;FOXN2;MAP3K8;UHRF1;PANK3;MXD1;IRGQ;RHOB;ABCA5;GCH1;SOX4;FOSL2;TRAF4;EIF1;HIVEP1;KLF10;AEN;C11ORF68;SKIL;RBM3;CDK6;YRDC;SAMD4A;PTPN1;SQLE;TFE3;MAFG;ABL2;MTF1;QKI;CELF1;WNT5A;NUP153;PDPK1;KDM6A;ZBTB21;NFE2L2;SGK1;RELA;AGFG1;RNF11;BACH1;BTAF1;ANKK1;POLR3D;ALAS1;YWHAG;TDG;ELF4;RAB22A;ITM2B;ERN1;ETNK1;ISG20;IFIH1;ATP13A3;MYO1B;PABPC4;TAP1;AHCY;FUBP3;RAB24
17079,GO:0099601,0.565335021522365,0.803835604776693,1,23,regulation of neurotransmitter receptor activity,BP,ADRB2
13268,GO:0051952,0.5660288202796,0.802735890362569,1,25,regulation of amine transport,BP,STX1A
427,GO:0001134,0.566107801739682,0.803208701330165,1,23,transcription factor activity, transcription factor recruiting,MF,PPARD
195,GO:0000413,0.566182716345976,0.801583889983238,1,30,protein peptidyl-prolyl isomerization,BP,PPIF
1480,GO:0003755,0.566182716345976,0.801583889983238,1,30,peptidyl-prolyl cis-trans isomerase activity,MF,PPIF
9781,GO:0039694,0.56711192954984,0.802111297855257,1,24,viral RNA genome replication,BP,CXCL8
15052,GO:0071007,0.567193915660013,0.800933494588634,1,29,U2-type catalytic step 2 spliceosome,CC,PRPF19
17198,GO:0106027,0.56771087440447,0.708034703469377,2,52,neuron projection organization,BP,EFNA1;PDLIM5
15329,GO:0071549,0.568058634597612,0.800840782047374,1,26,cellular response to dexamethasone stimulus,BP,ERRFI1
6601,GO:0022616,0.568932960238901,0.800363142992873,1,25,DNA strand elongation,BP,GINS3
675,GO:0001883,0.568973726224837,0.566291492756998,9,282,purine nucleoside binding,MF,RRAD;RAP2B;RND3;EHD1;IRGQ;RHOB;GCH1;RAB22A;RAB24
3454,GO:0007268,0.569097332519254,0.559613428121345,10,293,chemical synaptic transmission,BP,IL1B;PTGS2;EDN1;SQSTM1;ADRB2;PLK2;CREB1;STX1A;YWHAH;YWHAG
16936,GO:0098916,0.569097332519254,0.559613428121345,10,293,anterograde trans-synaptic signaling,BP,IL1B;PTGS2;EDN1;SQSTM1;ADRB2;PLK2;CREB1;STX1A;YWHAH;YWHAG
6632,GO:0022890,0.570134878414153,0.565215586678419,9,269,inorganic cation transmembrane transporter activity,MF,TRPV3;PANX1;SLC6A14;TFRC;SLC9A1;ITGAV;SLC28A3;ATP6V1C2;ATP13A3
17501,GO:1900543,0.570650125753142,0.798951053847664,1,25,negative regulation of purine nucleotide metabolic process,BP,PPIF
41,GO:0000083,0.570716489242638,0.798896344039497,1,25,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,BACH1
7342,GO:0031365,0.571177383355228,0.798777612148428,1,24,N-terminal protein amino acid modification,BP,SOX4
7219,GO:0031112,0.571202054444455,0.798757265396017,1,24,positive regulation of microtubule polymerization or depolymerization,BP,NAV3
2761,GO:0006171,0.571208824781145,0.798490146364762,1,25,cAMP biosynthetic process,BP,ADM
15294,GO:0071482,0.571371301386956,0.657416289236179,3,87,cellular response to light stimulus,BP,PTGS2;CDKN1A;N4BP1
7875,GO:0032435,0.571753932236517,0.797798131512101,1,26,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,N4BP1
17703,GO:1901606,0.571824112777737,0.70338790808864,2,61,alpha-amino acid catabolic process,BP,HAL;AHCY
15292,GO:0071480,0.571907969637935,0.797670614010354,1,26,cellular response to gamma radiation,BP,CDKN1A
16857,GO:0098781,0.572363943698329,0.656142023040892,3,94,ncRNA transcription,BP,NABP1;ELL2;POU2F2
14735,GO:0070405,0.572560608745507,0.796905605791301,1,27,ammonium ion binding,MF,SAT1
5681,GO:0016791,0.572804797239997,0.579964684544458,7,207,phosphatase activity,MF,DUSP16;DUSP8;DUSP1;DUSP10;PPTC7;PTPN11;PTPN1
5660,GO:0016758,0.572849883169212,0.606659292562934,5,152,transferase activity, transferring hexosyl groups,MF,HAS3;UGCG;B4GALT1;B3GNT5;B3GNT2
11835,GO:0046782,0.572932757063794,0.702407127586081,2,60,regulation of viral transcription,BP,JUN;ZFP36
15824,GO:0072527,0.573043740688167,0.701957852826876,2,65,pyrimidine-containing compound metabolic process,BP,TDG;UPP1
15494,GO:0071867,0.573309166183563,0.797014280613868,1,24,response to monoamine,BP,SLC9A1
15496,GO:0071869,0.573309166183563,0.797014280613868,1,24,response to catecholamine,BP,SLC9A1
42,GO:0000086,0.573911953281645,0.578623162298121,7,225,G2/M transition of mitotic cell cycle,BP,PHLDA1;CDKN1A;CDKN2B;PLK3;CDK6;BACH1;YWHAG
3112,GO:0006690,0.57441981852952,0.700916491721926,2,61,icosanoid metabolic process,BP,PTGS2;EDN1
7579,GO:0031941,0.574728101216316,0.795326261885251,1,26,filamentous actin,CC,FERMT1
5722,GO:0016859,0.575663792170995,0.79355989607495,1,31,cis-trans isomerase activity,MF,PPIF
4186,GO:0009262,0.575877677901404,0.79338019696432,1,31,deoxyribonucleotide metabolic process,BP,TDG
2746,GO:0006140,0.576399417082434,0.623321123235934,4,119,regulation of nucleotide metabolic process,BP,PPIF;ADM;WNT5A;NUP153
14783,GO:0070491,0.576438794043914,0.699381800057113,2,56,repressing transcription factor binding,MF,HDAC9;RELA
200,GO:0000421,0.577949699666298,0.79262543471688,1,26,autophagosome membrane,CC,VMP1
11499,GO:0045980,0.578215896724856,0.792401178141344,1,26,negative regulation of nucleotide metabolic process,BP,PPIF
17054,GO:0099537,0.578395330065525,0.550083316368059,10,295,trans-synaptic signaling,BP,IL1B;PTGS2;EDN1;SQSTM1;ADRB2;PLK2;CREB1;STX1A;YWHAH;YWHAG
2604,GO:0005901,0.578680332767885,0.697506883943772,2,53,caveola,CC,PTGS2;CORO1C
3763,GO:0008307,0.578847180894756,0.792115869649707,1,25,structural constituent of muscle,MF,SMTN
5072,GO:0015294,0.579250081571834,0.696959177654361,2,53,solute:cation symporter activity,MF,SLC6A14;SLC28A3
7964,GO:0032561,0.580262073538493,0.55472327086424,9,284,guanyl ribonucleotide binding,MF,RRAD;RAP2B;RND3;EHD1;IRGQ;RHOB;GCH1;RAB22A;RAB24
12794,GO:0051085,0.580337248251409,0.790608079528294,1,26,chaperone cofactor-dependent protein refolding,BP,ERO1A
902,GO:0002279,0.581307626945161,0.789784305782129,1,26,mast cell activation involved in immune response,BP,PDPK1
10446,GO:0043303,0.581307626945161,0.789784305782129,1,26,mast cell degranulation,BP,PDPK1
9001,GO:0035136,0.581411244228428,0.78994540996699,1,25,forelimb morphogenesis,BP,TBX3
1188,GO:0002833,0.581639379335356,0.789502162105593,1,26,positive regulation of response to biotic stimulus,BP,RIPK2
8439,GO:0033559,0.582095598118761,0.693464942149934,2,62,unsaturated fatty acid metabolic process,BP,PTGS2;EDN1
7952,GO:0032549,0.5822274387147,0.552700261598644,9,284,ribonucleoside binding,MF,RRAD;RAP2B;RND3;EHD1;IRGQ;RHOB;GCH1;RAB22A;RAB24
4942,GO:0014902,0.583158585252332,0.69290808138151,2,56,myotube differentiation,BP,EHD1;HDAC9
2879,GO:0006379,0.583207289930148,0.78793331870705,1,27,mRNA cleavage,BP,ERN1
13628,GO:0060119,0.583367862837645,0.788278653725066,1,25,inner ear receptor cell development,BP,SDC4
17053,GO:0099536,0.583447133696848,0.544875297297968,10,296,synaptic signaling,BP,IL1B;PTGS2;EDN1;SQSTM1;ADRB2;PLK2;CREB1;STX1A;YWHAH;YWHAG
298,GO:0000803,0.583516485389164,0.78815167615006,1,25,sex chromosome,CC,BIRC2
3895,GO:0008528,0.584049358891307,0.787212233709401,1,27,G-protein coupled peptide receptor activity,MF,BDKRB1
13282,GO:0051966,0.584085419666295,0.787937618492828,1,24,regulation of synaptic transmission, glutamatergic,BP,PTGS2
6123,GO:0019369,0.584150355014488,0.78735817107843,1,26,arachidonic acid metabolic process,BP,PTGS2
6391,GO:0021587,0.584521064220361,0.787564897146818,1,24,cerebellum morphogenesis,BP,PTPN11
10272,GO:0043015,0.584700099440367,0.787138557201135,1,25,gamma-tubulin binding,MF,NDRG1
5997,GO:0019001,0.584991591610917,0.549841374000859,9,285,guanyl nucleotide binding,MF,RRAD;RAP2B;RND3;EHD1;IRGQ;RHOB;GCH1;RAB22A;RAB24
7977,GO:0032589,0.585063786790173,0.787099928754908,1,24,neuron projection membrane,CC,NRG1
4527,GO:0010591,0.5851309968663,0.786768896854501,1,25,regulation of lamellipodium assembly,BP,EPHA2
7106,GO:0030901,0.585174514007849,0.690699842384635,2,59,midbrain development,BP,WNT5A;YWHAH
2320,GO:0005326,0.585632266712917,0.78661213668856,1,24,neurotransmitter transporter activity,MF,SLC6A14
14825,GO:0070566,0.587046027059729,0.785120632538523,1,25,adenylyltransferase activity,MF,NMNAT2
4839,GO:0014044,0.587085581760537,0.785361573195208,1,24,Schwann cell development,BP,NDRG1
12225,GO:0048483,0.587209389296933,0.785254803247966,1,24,autonomic nervous system development,BP,SOX4
10065,GO:0042558,0.587237553785245,0.784248868212395,1,28,pteridine-containing compound metabolic process,BP,GCH1
12408,GO:0048854,0.587627684582188,0.785193611215965,1,23,brain morphogenesis,BP,WNT5A
6148,GO:0019432,0.58834957447862,0.783993622465662,1,25,triglyceride biosynthetic process,BP,LDLR
14301,GO:0061418,0.588521787049018,0.686639555065378,2,71,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,NFE2L2;BACH1
1991,GO:0004709,0.589191752698443,0.687512926460226,2,51,MAP kinase kinase kinase activity,MF,EPHA2;MAP3K8
16139,GO:0090150,0.589563523643024,0.562164904792047,7,265,establishment of protein localization to membrane,BP,PMAIP1;BBC3;TP53BP2;RAB3IP;YWHAH;YWHAG;SFN
2877,GO:0006376,0.589929734245275,0.782366026906022,1,26,mRNA splice site selection,BP,CELF1
3248,GO:0006909,0.589990228424118,0.58917759907495,5,151,phagocytosis,BP,IL1B;TNF;ITGAV;PIP5K1A;CORO1C
13021,GO:0051453,0.590913096831676,0.684927492960532,2,61,regulation of intracellular pH,BP,SLC9A1;ATP6V1C2
4205,GO:0009312,0.591016396533385,0.781418369403254,1,26,oligosaccharide biosynthetic process,BP,B4GALT1
10576,GO:0043539,0.591751410570939,0.780537652102423,1,27,protein serine/threonine kinase activator activity,MF,CAB39
5207,GO:0015804,0.592086177903987,0.780482627508997,1,26,neutral amino acid transport,BP,NFKBIE
4068,GO:0009117,0.592235964478115,0.516309339249544,14,475,nucleotide metabolic process,BP,PPIF;PTGS2;EPHA2;NMNAT2;TJP2;NAMPT;AMPD3;SLC25A25;PANK3;ADM;WNT5A;NUP153;TDG;UPP1
6768,GO:0030201,0.592239374967681,0.78088566868325,1,24,heparan sulfate proteoglycan metabolic process,BP,DSE
18782,GO:1904292,0.592646111082282,0.779991739318577,1,26,regulation of ERAD pathway,BP,NFE2L2
12342,GO:0048704,0.593249012650242,0.682859477602995,2,58,embryonic skeletal system morphogenesis,BP,DLX2;SMAD3
1541,GO:0003924,0.594002736944371,0.557918769494285,7,226,GTPase activity,MF,RRAD;RAP2B;RND3;RHOB;GCH1;RAB22A;RAB24
11371,GO:0045737,0.594248246950032,0.778120388976888,1,28,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,CCNL1
555,GO:0001676,0.595038955115319,0.680849539861313,2,61,long-chain fatty acid metabolic process,BP,PTGS2;QKI
7343,GO:0031369,0.595621807453655,0.776905613425585,1,28,translation initiation factor binding,MF,GCH1
9,GO:0000018,0.596168501352355,0.679965768311978,2,58,regulation of DNA recombination,BP,TFRC;IL7R
4112,GO:0009166,0.5964542231185,0.602682888795095,4,125,nucleotide catabolic process,BP,AMPD3;NUP153;TDG;UPP1
17640,GO:1901363,0.596990617882248,0.444199203791156,150,4571,heterocyclic compound binding,MF,TNFAIP3;ZC3H12A;ITPKC;ELF3;ETS1;TNF;REL;KLF6;NUAK2;ZNF697;BHLHE40;PTGS2;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;KDM6B;IRF6;IRAK2;KLF7;CREB5;CPEB2;EHF;EPHA2;RELB;GADD45A;MAFF;RRAD;ZNF267;MAP2K3;JUN;RAP2B;NMNAT2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;IRF1;TAF4B;ZFP36L1;RND3;CEBPB;ARNTL2;MAST4;RUNX1;TRIM16;ELMSAN1;ALDH1A3;EHD1;PPP1R10;PIM3;NABP1;DLX2;TXNRD1;KLF3;ZNF217;OXSR1;SMAD3;RC3H1;PLK2;PLK3;DIEXF;PIM1;TFRC;CREB1;STK40;HIVEP2;PPARD;USP36;ZFP36;MAFK;LARP4B;CYP27B1;PLAGL2;RIPK2;PHKG2;NAV3;PIP5K1A;CLK4;SOX9;ZNF451;PML;POU2F2;ELK3;POLR3A;ZNF460;FOXN2;MAP3K8;UHRF1;PANK3;MXD1;IRGQ;RHOB;ABCA5;GCH1;SOX4;FOSL2;TRAF4;EIF1;HIVEP1;KLF10;AEN;C11ORF68;SKIL;RBM3;CDK6;YRDC;SAMD4A;PTPN1;SQLE;TFE3;MAFG;ABL2;MTF1;QKI;CELF1;WNT5A;NUP153;PDPK1;KDM6A;ZBTB21;NFE2L2;SGK1;RELA;AGFG1;RNF11;BACH1;BTAF1;ANKK1;POLR3D;ALAS1;YWHAG;TDG;ELF4;RAB22A;ITM2B;ERN1;ETNK1;ISG20;IFIH1;ATP13A3;MYO1B;PABPC4;TAP1;AHCY;FUBP3;RAB24
5860,GO:0017157,0.59702538093529,0.602174585704577,4,122,regulation of exocytosis,BP,SDC4;STX1A;PDPK1;SMPD3
5805,GO:0017056,0.597118218538238,0.776305146825919,1,25,structural constituent of nuclear pore,MF,NUP153
6070,GO:0019217,0.597192512987094,0.679032263673303,2,57,regulation of fatty acid metabolic process,BP,PTGS2;INSIG1
993,GO:0002448,0.597819728508263,0.775177146092364,1,27,mast cell mediated immunity,BP,PDPK1
538,GO:0001656,0.59905332152842,0.677176277931732,2,57,metanephros development,BP,LIF;SOX9
5800,GO:0017048,0.599174634584218,0.579925755514932,5,139,Rho GTPase binding,MF,FGD6;CDC42EP1;ARHGEF3;TNFAIP1;CORO1C
535,GO:0001653,0.599565049727439,0.773392344263354,1,28,peptide receptor activity,MF,BDKRB1
13040,GO:0051493,0.599689925227123,0.512702281165121,13,394,regulation of cytoskeleton organization,BP,SDC4;EDN1;PHLDB2;RND3;CYLD;TACSTD2;SMAD3;PLK2;SLC9A1;NAV3;CDC42EP1;RHOB;ABL2
1371,GO:0003254,0.599746663106417,0.773455965066102,1,27,regulation of membrane depolarization,BP,NEDD4L
5595,GO:0016620,0.600053150146022,0.773425556963491,1,26,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,ALDH1A3
6880,GO:0030374,0.600746218256104,0.675482102505991,2,57,ligand-dependent nuclear receptor transcription coactivator activity,MF,PPARD;NCOA7
10221,GO:0042887,0.600883160915135,0.771998048260585,1,29,amide transmembrane transporter activity,MF,TAP1
9073,GO:0035315,0.600930880801674,0.77263846526859,1,26,hair cell differentiation,BP,JAG1
13578,GO:0060042,0.601544953862085,0.772639383765737,1,24,retina morphogenesis in camera-type eye,BP,SOX9
3772,GO:0008324,0.601680669767736,0.525834572755542,10,308,cation transmembrane transporter activity,MF,TRPV3;PANX1;SLC6A14;TFRC;SLC9A1;ITGAV;SLC7A2;SLC28A3;ATP6V1C2;ATP13A3
1218,GO:0002886,0.601986307664452,0.771443851171825,1,27,regulation of myeloid leukocyte mediated immunity,BP,PDPK1
2607,GO:0005905,0.602515412448123,0.673795005461839,2,56,clathrin-coated pit,CC,LDLR;TFRC
10399,GO:0043231,0.603939817771688,0.438827582025329,269,8291,intracellular membrane-bounded organelle,CC,NFKBIA;NFKBIZ;TNFAIP3;IL1B;ZC3H12A;PLAUR;BTG2;BIRC3;NFKBID;CSF2;ITPKC;TICAM1;ELF3;SDC4;ETS1;REL;PPIF;IER3;KLF6;NUAK2;ZNF697;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;PLEKHF1;TGFA;KDM6B;IRF6;EDN1;PHLDA1;ERRFI1;IRAK2;KLF7;PANX1;CREB5;CPEB2;EHF;RELB;GADD45A;MAFF;TRIB1;SQSTM1;IFNGR2;BMP2;ZNF267;MAP2K3;JUN;BIRC2;NFKBIE;CDKN1A;NMNAT2;RGMB;TJP2;SERTAD2;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;IRF1;TAF4B;BCL2L2;ZFP36L1;ENC1;RELT;RND3;ADRB2;CEBPB;DUSP16;ARNTL2;UGCG;PPP1R15A;RUNX1;N4BP1;CDKN2B;GJB4;NAB1;TRIM16;ELMSAN1;SOD2;PELI1;ALDH1A3;C3ORF52;EHD1;NEDD9;ANKLE2;DUSP8;B4GALT1;DUSP1;BCL10;FGD6;TMCC1;PPP1R10;SACS;G0S2;B3GNT5;SGMS2;VMP1;NABP1;DLX2;TXNRD1;VGLL3;ADAM8;LDLR;KLF3;ZNF217;TACSTD2;NEDD4L;SMAD3;IL23A;DUSP10;BBC3;PLK3;DIEXF;PIM1;ITGA5;LIPG;AKIRIN1;CREB1;EFNB1;GJB3;STK40;HIVEP2;PPARD;SLC25A25;CCDC85B;RAET1L;USP36;IL16;BDKRB1;RAPH1;ZFP36;SLC9A1;MAFK;LARP4B;CYP27B1;CD55;TMEM217;PNRC1;ELL2;ANTXR2;AZIN1;PLAGL2;NAV3;PPP1R15B;STARD5;NDRG1;PIP5K1A;CLK4;TP53BP2;SOX9;STX1A;NRG1;ZNF451;FEM1C;PML;POU2F2;PPTC7;NCOA7;ELK3;POLR3A;ZNF460;SLC28A3;FOXN2;PTPN11;UHRF1;MXD1;RHOB;ABCA5;GCH1;FEM1B;SOX4;USP31;FOSL2;TRAF4;EIF1;OXCT1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;HIVEP1;NFKBIB;KLF10;AEN;SKIL;COTL1;HEXDC;RBM3;CDK6;IER5;YRDC;SAMD4A;PTPN1;SQLE;TFE3;BTG3;TMEM65;STEAP4;PRPF19;TOB2;MAFG;MTF1;ATP6V1C2;HLA-E;RAB3IP;QKI;CELF1;PMM2;WNT5A;NUP153;MAOA;INSIG1;PDPK1;ADAMTS9;CTSC;ERO1A;KDM6A;ZBTB21;NFE2L2;YWHAH;SGK1;B3GNT2;TSC22D2;CYTH1;RELA;AGFG1;RNF11;BACH1;BTAF1;GINS3;POLR3D;ALAS1;YWHAG;TDG;ELF4;CREG1;SFN;ITM2B;ERN1;ETNK1;SH3RF2;UPP1;ISG20;TMEM132A;ATXN7;IFIH1;ATP13A3;MYO1B;BRD2;IPO4;PABPC4;TAP1;DSE;AHCY;STX12;FUBP3;RAB24;SMPD3
10395,GO:0043227,0.603983605056797,0.4426719119197,300,9232,membrane-bounded organelle,CC,NFKBIA;NFKBIZ;TNFAIP3;IL1B;ZC3H12A;CXCL1;PLAUR;BTG2;BIRC3;HBEGF;PLAU;NFKBID;CSF2;ITPKC;TICAM1;ELF3;SDC4;ETS1;TNF;REL;PPIF;IER3;KLF6;NUAK2;ZNF697;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;PLEKHF1;EFNA1;TGFA;KDM6B;IRF6;EDN1;PHLDA1;ERRFI1;IL1RN;IRAK2;KLF7;PANX1;CREB5;CPEB2;EHF;RELB;GADD45A;MAFF;TRIB1;SQSTM1;IFNGR2;BMP2;CAB39;ZNF267;N4BP3;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;NMNAT2;RGMB;TJP2;SERTAD2;CD274;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;BCL2L2;ZFP36L1;ENC1;RELT;RND3;ADRB2;CEBPB;DUSP16;ARNTL2;UGCG;PPP1R15A;RUNX1;N4BP1;CDKN2B;GJB4;NAB1;TRIM16;ELMSAN1;SOD2;PELI1;ALDH1A3;C3ORF52;EHD1;NEDD9;ANKLE2;DUSP8;B4GALT1;DUSP1;BCL10;FGD6;TMCC1;PPP1R10;SACS;IL6ST;G0S2;B3GNT5;SGMS2;VMP1;NABP1;DLX2;SLC6A14;TXNRD1;VGLL3;ADAM8;LDLR;VEGFC;KLF3;ZNF217;TACSTD2;NEDD4L;OXSR1;SMAD3;IL23A;DUSP10;BBC3;PLK3;DIEXF;PIM1;ITGA5;TFRC;LIPG;AKIRIN1;CREB1;SERPINB8;EFNB1;GJB3;F3;STK40;HIVEP2;PPARD;KRT34;SLC25A25;SERPINB1;CCDC85B;RAET1L;USP36;IL16;BDKRB1;RAPH1;ZFP36;SLC9A1;MAFK;LARP4B;CYP27B1;CD55;TMEM217;PNRC1;ELL2;ANTXR2;AZIN1;PLAGL2;RIPK2;AMOTL2;NAV3;SAA1;PPP1R15B;STARD5;NDRG1;ITGAV;PIP5K1A;CLK4;TP53BP2;SOX9;STX1A;NRG1;ZNF451;FEM1C;PML;POU2F2;PPTC7;NCOA7;ELK3;POLR3A;ZNF460;SLC28A3;FOXN2;PTPN11;UHRF1;MXD1;RHOB;SPAG9;ABCA5;GCH1;FEM1B;SOX4;USP31;FOSL2;TRAF4;VCL;EIF1;OXCT1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;ADAMTS1;HIVEP1;NFKBIB;KLF10;AEN;SKIL;COTL1;IL7R;HEXDC;RBM3;CDK6;IER5;YRDC;SAMD4A;PTPN1;SQLE;TFE3;BTG3;TMEM65;CORO1C;STEAP4;PRPF19;TOB2;MAFG;MTF1;ATP6V1C2;HLA-E;RAB3IP;QKI;CELF1;PMM2;WNT5A;NUP153;MAOA;INSIG1;ADAM9;PDPK1;ADAMTS9;CTSC;ERO1A;KDM6A;ZBTB21;NFE2L2;YWHAH;SGK1;B3GNT2;TSC22D2;CYTH1;RELA;AGFG1;RNF11;BACH1;BTAF1;GINS3;POLR3D;ALAS1;YWHAG;TDG;ELF4;RAB22A;CREG1;SFN;ITM2B;ERN1;ETNK1;SH3RF2;UPP1;ISG20;TMEM132A;ATXN7;IFIH1;ATP13A3;MYO1B;BRD2;IPO4;PABPC4;TAP1;DSE;AHCY;STX12;FUBP3;RAB24;SMPD3
3028,GO:0006575,0.604020623196333,0.594590812315165,4,134,cellular modified amino acid metabolic process,BP,GCH1;ERO1A;NFE2L2;AHCY
12520,GO:0050660,0.605902419630819,0.670037520244406,2,60,flavin adenine dinucleotide binding,MF,TXNRD1;SQLE
5403,GO:0016239,0.606044287396747,0.670058301246001,2,58,positive regulation of macroautophagy,BP,ADRB2;RIPK2
674,GO:0001882,0.606355398457153,0.527533000900889,9,290,nucleoside binding,MF,RRAD;RAP2B;RND3;EHD1;IRGQ;RHOB;GCH1;RAB22A;RAB24
17770,GO:1901796,0.606512541189794,0.571756668236785,5,162,regulation of signal transduction by p53 class mediator,BP,PMAIP1;TAF4B;PLK3;TP53BP2;PML
10443,GO:0043300,0.606528267465305,0.767324694844427,1,27,regulation of leukocyte degranulation,BP,PDPK1
13042,GO:0051495,0.606778515534122,0.571570529839443,5,157,positive regulation of cytoskeleton organization,BP,SDC4;EDN1;SMAD3;NAV3;CDC42EP1
3153,GO:0006753,0.606830013840721,0.5010663736258,14,480,nucleoside phosphate metabolic process,BP,PPIF;PTGS2;EPHA2;NMNAT2;TJP2;NAMPT;AMPD3;SLC25A25;PANK3;ADM;WNT5A;NUP153;TDG;UPP1
12957,GO:0051321,0.606903812730428,0.571518139246009,5,153,meiotic cell cycle,BP,LIF;OVOL1;EREG;DUSP1;WNT5A
18344,GO:1903307,0.607179871175738,0.766498025583986,1,28,positive regulation of regulated secretory pathway,BP,STX1A
7478,GO:0031641,0.607369310586823,0.766805837362254,1,26,regulation of myelination,BP,NRG1
4060,GO:0009108,0.607599433452169,0.55551521306961,6,192,coenzyme biosynthetic process,BP,PTGS2;NMNAT2;NAMPT;PANK3;GCH1;NUP153
20264,GO:2001222,0.607758697250269,0.767012819174875,1,24,regulation of neuron migration,BP,NRG1
6983,GO:0030658,0.608707710836504,0.589879443480872,4,126,transport vesicle membrane,CC,TGFA;STX1A;AREG;HLA-E
10530,GO:0043470,0.609025357079324,0.667031233663304,2,58,regulation of carbohydrate catabolic process,BP,PHKG2;NUP153
10431,GO:0043277,0.610151296011291,0.764001492948915,1,27,apoptotic cell clearance,BP,ITGAV
15892,GO:0072659,0.61026813072276,0.552832032621887,6,183,protein localization to plasma membrane,BP,TNF;PLEKHF1;EPHA2;SQSTM1;PIP5K1A;PDPK1
6387,GO:0021575,0.610570840223984,0.763866487558161,1,26,hindbrain morphogenesis,BP,PTPN11
15991,GO:0086002,0.610733360534675,0.764284638987223,1,24,cardiac muscle cell action potential involved in contraction,BP,NEDD4L
18218,GO:1903008,0.610754370789745,0.617061090428809,3,96,organelle disassembly,BP,SQSTM1;PLK3;USP36
3356,GO:0007094,0.610892790469888,0.76286554486077,1,29,mitotic spindle assembly checkpoint,BP,DUSP1
15112,GO:0071173,0.610892790469888,0.76286554486077,1,29,spindle assembly checkpoint,BP,DUSP1
15113,GO:0071174,0.610892790469888,0.76286554486077,1,29,mitotic spindle checkpoint,BP,DUSP1
17918,GO:1902229,0.611243960886156,0.761802208459388,1,33,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,SKIL
11677,GO:0046460,0.612110933520995,0.762190058307565,1,27,neutral lipid biosynthetic process,BP,LDLR
11680,GO:0046463,0.612110933520995,0.762190058307565,1,27,acylglycerol biosynthetic process,BP,LDLR
19826,GO:2000279,0.6124497008352,0.761875911769251,1,27,negative regulation of DNA biosynthetic process,BP,DUSP1
9890,GO:0042169,0.612779120024007,0.762097938468017,1,25,SH2 domain binding,MF,SQSTM1
11763,GO:0046620,0.612876709907711,0.66318286432535,2,57,regulation of organ growth,BP,EDN1;PIM1
6691,GO:0030057,0.6129264473871,0.762258775195424,1,24,desmosome,CC,B4GALT1
7325,GO:0031333,0.614103649007422,0.613672071501259,3,93,negative regulation of protein complex assembly,BP,BIRC2;ZNF451;INSIG1
7042,GO:0030814,0.614200960990768,0.760010936276375,1,28,regulation of cAMP metabolic process,BP,ADM
2839,GO:0006308,0.614861251037109,0.759174119684081,1,29,DNA catabolic process,BP,ISG20
5227,GO:0015837,0.614981717290332,0.759061427279683,1,29,amine transport,BP,STX1A
9728,GO:0038179,0.615920641319119,0.758640169920379,1,27,neurotrophin signaling pathway,BP,PTPN11
1928,GO:0004620,0.616093872488549,0.659617799431071,2,60,phospholipase activity,MF,LIPG;SMPD3
11895,GO:0046915,0.616100911837566,0.758233676471514,1,28,transition metal ion transmembrane transporter activity,MF,TFRC
3165,GO:0006778,0.616223872003195,0.75749827374528,1,31,porphyrin-containing compound metabolic process,BP,ALAS1
8156,GO:0032885,0.616609115073677,0.758528350567345,1,25,regulation of polysaccharide biosynthetic process,BP,NFKB1
10022,GO:0042455,0.616630828435144,0.75660531183891,1,34,ribonucleoside biosynthetic process,BP,UPP1
17691,GO:1901568,0.617775166099259,0.609562240337693,3,99,fatty acid derivative metabolic process,BP,PTGS2;EDN1;OXCT1
2967,GO:0006506,0.617917713520053,0.755720843652715,1,32,GPI anchor biosynthetic process,BP,PLAUR
7892,GO:0032459,0.618349945628618,0.755687814808511,1,30,regulation of protein oligomerization,BP,PMAIP1
7399,GO:0031461,0.619883378115907,0.557677463404955,5,157,cullin-RING ubiquitin ligase complex,CC,ENC1;ZSWIM4;KLHL21;TNFAIP1;BACH1
13507,GO:0055072,0.620719286692532,0.654446598461617,2,65,iron ion homeostasis,BP,TFRC;STEAP4
12365,GO:0048747,0.620832437589051,0.754007664943712,1,27,muscle fiber development,BP,HDAC9
12285,GO:0048599,0.62174540917557,0.752898152583757,1,28,oocyte development,BP,EREG
19616,GO:1990752,0.621911555299705,0.753523355757078,1,25,microtubule end,CC,NAV3
4082,GO:0009135,0.62231839252627,0.604982765064737,3,93,purine nucleoside diphosphate metabolic process,BP,TJP2;AMPD3;NUP153
4121,GO:0009179,0.62231839252627,0.604982765064737,3,93,purine ribonucleoside diphosphate metabolic process,BP,TJP2;AMPD3;NUP153
3192,GO:0006820,0.622621394899777,0.497962710624399,11,338,anion transport,BP,IL1B;EDN1;NFKBIE;CLDN4;SLC6A14;LDLR;PPARD;SLC25A25;STARD5;STX1A;SLC7A2
6799,GO:0030239,0.623144512027224,0.751805127012148,1,27,myofibril assembly,BP,EDN1
17236,GO:0110053,0.623320626698408,0.538874049722485,6,187,regulation of actin filament organization,BP,SDC4;PHLDB2;TACSTD2;SMAD3;SLC9A1;CDC42EP1
7218,GO:0031111,0.623323669266871,0.75163386747203,1,27,negative regulation of microtubule polymerization or depolymerization,BP,NAV3
5789,GO:0017016,0.623413980755736,0.48387156681369,14,406,Ras GTPase binding,MF,HBEGF;CSF2;EREG;EHD1;FGD6;NDRG1;NRG1;CDC42EP1;ARHGEF3;TNFAIP1;DENND2C;CORO1C;RAB3IP;IPO4
3513,GO:0007435,0.623821645577667,0.751157396211893,1,27,salivary gland morphogenesis,BP,TNF
10885,GO:0044425,0.624069278905114,0.418596199699481,121,3698,membrane part,CC,ZC3H12A;PLAUR;BIRC3;HBEGF;SDC4;TNF;PPIF;IER3;PTGS2;RNF19B;FOSL1;TRPV3;PLEKHF1;EFNA1;TGFA;SEMA7A;HAS3;ERRFI1;CLDN1;PANX1;HCAR2;TNFRSF10B;EFNB2;EPHA2;CD83;IFNGR2;BMP2;RAP2B;BIRC2;TMCC3;RGMB;CLDN4;CD274;RELT;ADRB2;UGCG;TRAF3IP3;PPP1R15A;GJB4;EREG;C3ORF52;EHD1;ANKLE2;B4GALT1;BCL10;HEPHL1;TMCC1;TMEM265;IL6ST;B3GNT5;SGMS2;VMP1;SLC6A14;CYLD;ADAM8;LDLR;HCAR3;TACSTD2;SLC43A3;ITGA5;TFRC;EFNB1;GJB3;F3;SLC25A25;RAET1L;BDKRB1;SLC9A1;CD55;TMEM217;IFNAR2;ANTXR2;JAG1;AMOTL2;NAV3;ITGAV;PIP5K1A;STX1A;NRG1;PML;RASA2;FERMT1;SLC7A2;SLC28A3;EFHD2;DCBLD2;RHOB;SPAG9;ABCA5;AREG;IL7R;EMP3;PTPN1;SQLE;TMEM65;CORO1C;STEAP4;ABL2;ATP6V1C2;HLA-E;OSMR;MAOA;INSIG1;ADAM9;TNFRSF10A;RNF19A;ERO1A;SGK1;B3GNT2;CYTH1;TMEM154;ITM2B;ERN1;TMEM132A;ATP13A3;CXCL16;TAP1;DSE;STX12;PDLIM5;GPR156
17607,GO:1901292,0.625262012883969,0.572181957435512,4,130,nucleoside phosphate catabolic process,BP,AMPD3;NUP153;TDG;UPP1
11626,GO:0046329,0.625591949966149,0.749214069780609,1,28,negative regulation of JNK cascade,BP,DUSP10
11427,GO:0045841,0.625846851424746,0.74852931579382,1,30,negative regulation of mitotic metaphase/anaphase transition,BP,DUSP1
17868,GO:1902100,0.625846851424746,0.74852931579382,1,30,negative regulation of metaphase/anaphase transition of cell cycle,BP,DUSP1
2944,GO:0006473,0.626367860056386,0.550627943342019,5,162,protein acetylation,BP,IL1B;LIF;TRIM16;ZNF451;SOX4
5562,GO:0016572,0.626483292707956,0.748127073691088,1,29,histone phosphorylation,BP,IL1B
6448,GO:0021762,0.626581691916642,0.747621074626438,1,31,substantia nigra development,BP,YWHAH
12750,GO:0051015,0.626915198642675,0.570651392094592,4,121,actin filament binding,MF,PANX1;CORO1C;ABL2;MYO1B
6771,GO:0030204,0.62698430556911,0.748115913778681,1,27,chondroitin sulfate metabolic process,BP,DSE
13013,GO:0051443,0.627980437547946,0.746464746641248,1,30,positive regulation of ubiquitin-protein transferase activity,BP,DCUN1D3
6117,GO:0019362,0.628943174689416,0.568242891900892,4,129,pyridine nucleotide metabolic process,BP,PTGS2;NMNAT2;NAMPT;NUP153
11704,GO:0046496,0.628943174689416,0.568242891900892,4,129,nicotinamide nucleotide metabolic process,BP,PTGS2;NMNAT2;NAMPT;NUP153
2520,GO:0005773,0.629216740636687,0.462901695276367,19,601,vacuole,CC,TNFAIP3;IL1B;TICAM1;SDC4;RNF19B;PLEKHF1;SQSTM1;ADRB2;B4GALT1;BCL10;VMP1;ADAM8;LDLR;BBC3;ABCA5;ATP6V1C2;CTSC;CREG1;RAB24
2966,GO:0006505,0.62960535003333,0.744320256504541,1,33,GPI anchor metabolic process,BP,PLAUR
2977,GO:0006520,0.629729673260663,0.510391466976035,8,279,cellular amino acid metabolic process,BP,ODC1;NMNAT2;HAL;SLC6A14;AZIN1;SLC7A2;ERO1A;AHCY
7202,GO:0031090,0.629852343766738,0.421468906576044,70,2223,organelle membrane,CC,ZC3H12A;PLAUR;HBEGF;PLAU;TICAM1;PPIF;PTGS2;PMAIP1;PLEKHF1;TGFA;IRAK2;IFNGR2;RAP2B;NMNAT2;BCL2L2;RND3;ADRB2;UGCG;PPP1R15A;SOD2;EHD1;B4GALT1;B3GNT5;SGMS2;VMP1;ADAM8;LDLR;SMAD3;TFRC;AKIRIN1;SLC25A25;CYP27B1;CD55;ANTXR2;NAV3;NDRG1;ITGAV;STX1A;PML;RHOB;ABCA5;GCH1;AREG;AEN;IL7R;SQLE;TMEM65;STEAP4;ATP6V1C2;HLA-E;WNT5A;NUP153;MAOA;CTSC;YWHAH;B3GNT2;CYTH1;YWHAG;RAB22A;SFN;ITM2B;ERN1;TMEM132A;MYO1B;IPO4;TAP1;DSE;STX12;RAB24;SMPD3
12652,GO:0050853,0.630050570425194,0.744894344243807,1,28,B cell receptor signaling pathway,BP,RUNX1
3091,GO:0006665,0.630331483495812,0.566742580454808,4,129,sphingolipid metabolic process,BP,TNF;UGCG;SGMS2;SMPD3
4038,GO:0009069,0.630620456576417,0.743692389563933,1,31,serine family amino acid metabolic process,BP,AHCY
18346,GO:1903312,0.630946794692648,0.643986950947077,2,61,negative regulation of mRNA metabolic process,BP,NOCT;ZFP36
19375,GO:1905819,0.631372479868731,0.742956004603734,1,31,negative regulation of chromosome separation,BP,DUSP1
20133,GO:2000816,0.631372479868731,0.742956004603734,1,31,negative regulation of mitotic sister chromatid separation,BP,DUSP1
12869,GO:0051187,0.631419224530223,0.742221261552167,1,35,cofactor catabolic process,BP,AHCY
16903,GO:0098858,0.631810511224153,0.565305541245486,4,123,actin-based cell projection,CC,B4GALT1;RAPH1;ITGAV;MYO1B
5122,GO:0015485,0.632127519742607,0.742416775018525,1,30,cholesterol binding,MF,STARD5
10798,GO:0044273,0.632184993895492,0.742158663514927,1,31,sulfur compound catabolic process,BP,AHCY
134,GO:0000280,0.632437721414841,0.493132738355593,10,318,nuclear division,BP,IL1B;IL1A;BIRC3;TGFA;EDN1;LIF;BIRC2;EREG;DUSP1;WNT5A
13478,GO:0055010,0.632444874984817,0.742801391636411,1,27,ventricular cardiac muscle tissue morphogenesis,BP,NRG1
10430,GO:0043276,0.632563132538492,0.74243644380495,1,28,anoikis,BP,ITGA5
4127,GO:0009185,0.633928022048177,0.592429552262746,3,95,ribonucleoside diphosphate metabolic process,BP,TJP2;AMPD3;NUP153
16251,GO:0090307,0.634663674767365,0.640026432235557,2,61,mitotic spindle assembly,BP,BIRC3;BIRC2
4374,GO:0009994,0.634838050479678,0.739963152305968,1,29,oocyte differentiation,BP,EREG
5051,GO:0015238,0.634880036233717,0.639715668382826,2,62,drug transmembrane transporter activity,MF,SLC25A25;SLC7A2
44,GO:0000096,0.63506865283532,0.739517644339868,1,30,sulfur amino acid metabolic process,BP,AHCY
5629,GO:0016705,0.635108157182211,0.591149531065892,3,95,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,PTGS2;CYP27B1;SQLE
11711,GO:0046503,0.635505860621456,0.739084661959019,1,30,glycerolipid catabolic process,BP,LDLR
14499,GO:0061980,0.635751713118615,0.739292494032596,1,28,regulatory RNA binding,MF,ZC3H12A
784,GO:0002039,0.635936276762499,0.638663985165433,2,61,p53 binding,MF,PLK3;TP53BP2
1984,GO:0004702,0.636134924725098,0.590398663336239,3,87,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,EPHA2;OXSR1;MAP3K8
16287,GO:0090382,0.636995677460101,0.737029704833979,1,33,phagosome maturation,BP,ATP6V1C2
16865,GO:0098796,0.637126932080207,0.448235934725835,22,728,membrane protein complex,CC,PPIF;BMP2;BIRC2;CLDN4;GJB4;BCL10;IL6ST;ADAM8;ITGA5;TFRC;GJB3;SLC9A1;ITGAV;STX1A;CORO1C;ATP6V1C2;HLA-E;OSMR;INSIG1;ERN1;TAP1;STX12
17104,GO:0099738,0.637595610255241,0.737461688039032,1,28,cell cortex region,CC,PHLDB2
3794,GO:0008360,0.637615303507244,0.558990807911055,4,123,regulation of cell shape,BP,RND3;FGD6;CDC42EP1;RHOB
3415,GO:0007200,0.637710095475304,0.736688951325835,1,31,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,EDN1
10252,GO:0042987,0.638730365440501,0.735875084674473,1,30,amyloid precursor protein catabolic process,BP,EFNA1
5530,GO:0016504,0.638761973358049,0.73544571343963,1,32,peptidase activator activity,MF,CTSC
7813,GO:0032365,0.638830554130013,0.735994641323376,1,29,intracellular lipid transport,BP,LDLR
3201,GO:0006836,0.639199794155017,0.557146589588658,4,127,neurotransmitter transport,BP,CSF2;EDN1;SLC6A14;STX1A
12487,GO:0050435,0.639409474541315,0.735415547761955,1,29,amyloid-beta metabolic process,BP,EFNA1
12514,GO:0050654,0.639896032587906,0.735164439953142,1,28,chondroitin sulfate proteoglycan metabolic process,BP,DSE
2712,GO:0006084,0.640138345111382,0.734685137097062,1,29,acetyl-CoA metabolic process,BP,HMGCS1
12680,GO:0050885,0.640214385296632,0.735099632931525,1,27,neuromuscular process controlling balance,BP,ALDH1A3
17898,GO:1902186,0.640227655476874,0.73459553653355,1,29,regulation of viral release from host cell,BP,PML
14333,GO:0061512,0.640564406817234,0.734036709491362,1,30,protein localization to cilium,BP,EHD1
11012,GO:0044839,0.640673224139817,0.508085455888946,7,239,cell cycle G2/M phase transition,BP,PHLDA1;CDKN1A;CDKN2B;PLK3;CDK6;BACH1;YWHAG
5669,GO:0016776,0.640733169835209,0.733467170555117,1,32,phosphotransferase activity, phosphate group as acceptor,MF,TJP2
15825,GO:0072528,0.640741347606762,0.732793680472735,1,36,pyrimidine-containing compound biosynthetic process,BP,UPP1
17850,GO:1902036,0.640886272322262,0.63156689276329,2,95,regulation of hematopoietic stem cell differentiation,BP,RUNX1;NFE2L2
4233,GO:0009410,0.641394314267627,0.534162555431237,5,170,response to xenobiotic stimulus,BP,EDN1;ERRFI1;CLDN1;HDAC9;RELA
11743,GO:0046579,0.641876441679399,0.732937403339636,1,29,positive regulation of Ras protein signal transduction,BP,NRG1
9194,GO:0035578,0.643058474298193,0.630401111181862,2,69,azurophil granule lumen,CC,CTSC;CREG1
2196,GO:0005057,0.643468124712838,0.552694319370036,4,119,signal transducer activity, downstream of receptor,MF,EPHA2;OXSR1;SMAD3;MAP3K8
2296,GO:0005254,0.643478929064672,0.731318554746697,1,29,chloride channel activity,MF,CLDN4
8538,GO:0033865,0.643817438095205,0.730166571041754,1,33,nucleoside bisphosphate metabolic process,BP,PANK3
8544,GO:0033875,0.643817438095205,0.730166571041754,1,33,ribonucleoside bisphosphate metabolic process,BP,PANK3
8565,GO:0034032,0.643817438095205,0.730166571041754,1,33,purine nucleoside bisphosphate metabolic process,BP,PANK3
12793,GO:0051084,0.643885407670796,0.730475762756247,1,31,'de novo' posttranslational protein folding,BP,ERO1A
18962,GO:1904724,0.645686972151357,0.727627282629783,1,37,tertiary granule lumen,CC,CXCL1
3620,GO:0008076,0.645931135487985,0.728827347946929,1,29,voltage-gated potassium channel complex,CC,STX1A
12091,GO:0048066,0.647216756771124,0.72728972017202,1,30,developmental pigmentation,BP,ADAMTS9
4164,GO:0009225,0.647256472555767,0.726657274466161,1,33,nucleotide-sugar metabolic process,BP,PMM2
2782,GO:0006213,0.647547890355589,0.725865779946572,1,36,pyrimidine nucleoside metabolic process,BP,UPP1
4453,GO:0010390,0.648539697193861,0.726158638836146,1,29,histone monoubiquitination,BP,UHRF1
12784,GO:0051056,0.648689226195018,0.482344620564657,9,266,regulation of small GTPase mediated signal transduction,BP,SQSTM1;FGD6;NRG1;RASA2;ARHGEF3;RHOB;TNFAIP1;CYTH1;AGFG1
5563,GO:0016573,0.649068815826202,0.546167960710781,4,131,histone acetylation,BP,IL1B;LIF;TRIM16;ZNF451
11146,GO:0045197,0.649332493959518,0.725343728442627,1,29,establishment or maintenance of epithelial cell apical/basal polarity,BP,WNT5A
5441,GO:0016303,0.649436887006355,0.726020384808489,1,26,1-phosphatidylinositol-3-kinase activity,MF,PTPN11
7634,GO:0032040,0.649730099462877,0.724112378544547,1,33,small-subunit processome,CC,DIEXF
2831,GO:0006298,0.650300192834504,0.723908137976306,1,31,mismatch repair,BP,TDG
8524,GO:0033762,0.65084814220515,0.723553849902482,1,30,response to glucagon,BP,CREB1
4970,GO:0015078,0.652692427739573,0.6194730230028,2,75,proton transmembrane transporter activity,MF,SLC9A1;ATP6V1C2
20182,GO:2001022,0.65352936117561,0.619034253670193,2,67,positive regulation of response to DNA damage stimulus,BP,PMAIP1;SKIL
3361,GO:0007099,0.653603790468142,0.720922307941521,1,29,centriole replication,BP,PLK2
160,GO:0000323,0.653930105871546,0.444319678670866,16,518,lytic vacuole,CC,TNFAIP3;IL1B;SDC4;RNF19B;PLEKHF1;SQSTM1;ADRB2;B4GALT1;BCL10;ADAM8;LDLR;BBC3;ABCA5;ATP6V1C2;CTSC;CREG1
2512,GO:0005764,0.653930105871546,0.444319678670866,16,518,lysosome,CC,TNFAIP3;IL1B;SDC4;RNF19B;PLEKHF1;SQSTM1;ADRB2;B4GALT1;BCL10;ADAM8;LDLR;BBC3;ABCA5;ATP6V1C2;CTSC;CREG1
16719,GO:0097718,0.654192891433427,0.720079414081807,1,30,disordered domain specific binding,MF,BCL2L2
2458,GO:0005669,0.654667632156498,0.718635902372541,1,35,transcription factor TFIID complex,CC,TAF4B
11017,GO:0044853,0.654925081664621,0.617938025335344,2,61,plasma membrane raft,CC,PTGS2;CORO1C
2717,GO:0006091,0.6551746790953,0.468188143060536,10,364,generation of precursor metabolites and energy,BP,PPIF;PHLDA2;IL6ST;TXNRD1;STK40;PPARD;SLC25A25;PHKG2;OXCT1;NUP153
9630,GO:0036498,0.65571550457739,0.616604599664818,2,67,IRE1-mediated unfolded protein response,BP,PTPN1;ERN1
12302,GO:0048641,0.655844641283747,0.718581642178997,1,29,regulation of skeletal muscle tissue development,BP,HDAC9
223,GO:0000462,0.656313748810741,0.716599735866221,1,37,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,DIEXF
2487,GO:0005730,0.656740362616933,0.422329200226712,25,834,nucleolus,CC,KLF6;PHLDA1;NFKBIE;CDKN1A;TAF4B;ENC1;ARNTL2;N4BP1;GJB4;VMP1;TXNRD1;PLK3;DIEXF;PIM1;USP36;LARP4B;TMEM217;PML;TNFAIP1;AEN;RBM3;SAMD4A;NUP153;ISG20;ATXN7
9038,GO:0035254,0.656820735075786,0.717557505284488,1,29,glutamate receptor binding,MF,SQSTM1
10311,GO:0043087,0.656920245325786,0.456034522580281,12,362,regulation of GTPase activity,BP,CCL20;ERRFI1;CPEB2;EPHA2;JUN;FGD6;PIP5K1A;RASA2;CDC42EP1;CORO1C;WNT5A;AGFG1
288,GO:0000792,0.656961489287007,0.615285288416801,2,66,heterochromatin,CC,PML;UHRF1
12626,GO:0050807,0.657684957363146,0.566294586024668,3,93,regulation of synapse organization,BP,EFNA1;WNT5A;PDLIM5
8888,GO:0034705,0.65854453577738,0.715510487123662,1,30,potassium channel complex,CC,STX1A
2965,GO:0006501,0.659383981425919,0.713832411923809,1,34,C-terminal protein lipidation,BP,RAET1L
15821,GO:0072524,0.660070884358291,0.533799431954867,4,134,pyridine-containing compound metabolic process,BP,PTGS2;NMNAT2;NAMPT;NUP153
18008,GO:1902475,0.660289808971719,0.713445060408297,1,31,L-alpha-amino acid transmembrane transport,BP,SLC7A2
5313,GO:0016020,0.660357674356796,0.377858492265276,186,5733,membrane,CC,NFKBIA;ZC3H12A;PLAUR;BIRC3;HBEGF;PLAU;TICAM1;SDC4;TNF;SERPINB2;PPIF;IER3;SPRR2D;PTGS2;RNF19B;PMAIP1;FOSL1;TRPV3;PLEKHF1;EFNA1;TGFA;SEMA7A;HAS3;ERRFI1;IL1RN;IRAK2;CLDN1;PANX1;DAPP1;SPRR2A;HCAR2;TNFRSF10B;EFNB2;EPHA2;CD83;IFNGR2;RRAD;BMP2;PHLDA2;MAP2K3;RAP2B;BIRC2;TMCC3;NMNAT2;RGMB;PHLDB2;CLDN4;TJP2;CD274;BCL3;ETS2;BCL2L2;RELT;RND3;ADRB2;UGCG;TRAF3IP3;PPP1R15A;GJB4;TRIM16;EREG;SOD2;ALDH1A3;C3ORF52;EHD1;NEDD9;ANKLE2;B4GALT1;BCL10;DCUN1D3;HEPHL1;TMCC1;TMEM265;CDV3;IL6ST;B3GNT5;SGMS2;VMP1;SLC6A14;CYLD;ADAM8;LDLR;VEGFC;HCAR3;TACSTD2;NEDD4L;SMAD3;SLC43A3;PIM1;ITGA5;TFRC;AKIRIN1;EFNB1;GJB3;F3;SLC25A25;SERPINB1;RAET1L;IL16;BDKRB1;RAPH1;SLC9A1;LARP4B;CYP27B1;CD55;TMEM217;IFNAR2;ANTXR2;JAG1;AMOTL2;NAV3;NDRG1;ITGAV;PIP5K1A;STX1A;NRG1;PML;RASA2;FERMT1;POLR3A;SLC7A2;CDC42EP1;SLC28A3;EFHD2;DCBLD2;RHOB;SPAG9;ABCA5;GCH1;TRAF4;VCL;AREG;AEN;IL7R;YRDC;EMP3;PTPN1;SQLE;TMEM65;CORO1C;STEAP4;PRPF19;ABL2;ATP6V1C2;HLA-E;OSMR;CELF1;WNT5A;NUP153;MAOA;INSIG1;ADAM9;LCE1C;PDPK1;TNFRSF10A;RNF19A;CTSC;ERO1A;FRMD6;NFE2L2;YWHAH;SGK1;B3GNT2;CYTH1;AGFG1;TMEM154;YWHAG;TDG;RAB22A;SFN;ITM2B;ERN1;ETNK1;TMEM132A;ATP13A3;MYO1B;IPO4;CXCL16;TAP1;DSE;STX12;PDLIM5;FUBP3;GPR156;RAB24;SMPD3
10583,GO:0043547,0.660567941193781,0.462645859184666,10,302,positive regulation of GTPase activity,BP,CCL20;ERRFI1;EPHA2;JUN;PIP5K1A;RASA2;CDC42EP1;CORO1C;WNT5A;AGFG1
10891,GO:0044432,0.661666320771717,0.410629594205524,30,964,endoplasmic reticulum part,CC,ZC3H12A;PLAUR;PTGS2;RNF19B;TGFA;EDN1;PANX1;IFNGR2;PPP1R15A;C3ORF52;ANKLE2;TMCC1;SGMS2;IL23A;SLC9A1;ANTXR2;PML;SLC28A3;AREG;PTPN1;SQLE;HLA-E;WNT5A;INSIG1;CTSC;ERO1A;SGK1;ERN1;TMEM132A;TAP1
2449,GO:0005657,0.661694580570971,0.60983907117605,2,68,replication fork,CC,UHRF1;PRPF19
13222,GO:0051879,0.662201035659804,0.711409969135689,1,31,Hsp90 protein binding,MF,ERN1
12358,GO:0048736,0.662797767234666,0.530934809060708,4,126,appendage development,BP,TBX3;SOX9;SOX4;WNT5A
13663,GO:0060173,0.662797767234666,0.530934809060708,4,126,limb development,BP,TBX3;SOX9;SOX4;WNT5A
20292,GO:2001259,0.662941948497695,0.710837046711228,1,30,positive regulation of cation channel activity,BP,ADRB2
7413,GO:0031497,0.66338674016648,0.558591478832365,3,134,chromatin assembly,BP,SOX9;BRD2;IPO4
16754,GO:0098534,0.663692717418434,0.710033424692075,1,30,centriole assembly,BP,PLK2
6808,GO:0030258,0.664277378014084,0.493847171639095,6,195,lipid modification,BP,HBEGF;EREG;PPARD;PIP5K1A;NRG1;PTPN11
16921,GO:0098900,0.665083975162551,0.708775269280767,1,29,regulation of action potential,BP,SLC9A1
16565,GO:0097352,0.66551828401425,0.707269492216338,1,34,autophagosome maturation,BP,ADRB2
2206,GO:0005089,0.665686205796515,0.606121289836547,2,58,Rho guanyl-nucleotide exchange factor activity,MF,FGD6;ARHGEF3
5186,GO:0015748,0.666204206993814,0.604805237915027,2,67,organophosphate ester transport,BP,LDLR;SLC25A25
8266,GO:0033048,0.666397269658598,0.706319900319523,1,34,negative regulation of mitotic sister chromatid segregation,BP,DUSP1
7752,GO:0032266,0.66644888130387,0.707068792482805,1,30,phosphatidylinositol-3-phosphate binding,MF,PLEKHF1
6431,GO:0021695,0.666555507953498,0.706732703184335,1,31,cerebellar cortex development,BP,PTPN11
5967,GO:0018393,0.66655826822734,0.52646470914605,4,134,internal peptidyl-lysine acetylation,BP,IL1B;LIF;TRIM16;ZNF451
3512,GO:0007431,0.666620442704114,0.706662525214793,1,31,salivary gland development,BP,TNF
2772,GO:0006195,0.666732371795591,0.705957269377765,1,34,purine nucleotide catabolic process,BP,AMPD3
5401,GO:0016236,0.667108087209877,0.469518053695294,8,270,macroautophagy,BP,PLEKHF1;SQSTM1;ADRB2;VMP1;RIPK2;ATP6V1C2;ERN1;STX12
13041,GO:0051494,0.668529054779009,0.553787619863455,3,98,negative regulation of cytoskeleton organization,BP,PHLDB2;TACSTD2;NAV3
10363,GO:0043177,0.66895286876451,0.552970234069606,3,107,organic acid binding,MF,HMGCS1;PPARD;STARD5
5134,GO:0015629,0.668956306077669,0.447651268831274,11,346,actin cytoskeleton,CC,ADAM8;KLHL21;STX1A;FERMT1;VCL;CORO1C;ABL2;SMTN;RAB22A;MYO1B;PDLIM5
2483,GO:0005720,0.669294107917221,0.703357894051237,1,33,nuclear heterochromatin,CC,UHRF1
13020,GO:0051452,0.669555449873372,0.702396783286483,1,37,intracellular pH reduction,BP,ATP6V1C2
178,GO:0000387,0.669797907318243,0.702131830102395,1,37,spliceosomal snRNP assembly,BP,PRPF19
1858,GO:0004519,0.669943409534722,0.551802104499719,3,108,endonuclease activity,MF,ZC3H12A;ZC3H12C;ERN1
2106,GO:0004879,0.669981214615326,0.703013008084368,1,31,nuclear receptor activity,MF,PPARD
16751,GO:0098531,0.669981214615326,0.703013008084368,1,31,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,PPARD
8194,GO:0032934,0.670263145853367,0.70230028275088,1,33,sterol binding,MF,STARD5
3233,GO:0006888,0.671125432262223,0.500983130065421,5,170,ER to Golgi vesicle-mediated transport,BP,TGFA;CD55;AREG;INSIG1;CTSC
6752,GO:0030170,0.672034477627745,0.700359655430269,1,33,pyridoxal phosphate binding,MF,ALAS1
14669,GO:0070279,0.672034477627745,0.700359655430269,1,33,vitamin B6 binding,MF,ALAS1
8436,GO:0033555,0.672205175607651,0.700369193141125,1,32,multicellular organismal response to stress,BP,GCH1
3150,GO:0006749,0.673260316738441,0.697660026824897,1,42,glutathione metabolic process,BP,NFE2L2
11901,GO:0046928,0.673794581723758,0.698830406709944,1,31,regulation of neurotransmitter secretion,BP,STX1A
11429,GO:0045843,0.673908126495574,0.698494373786514,1,32,negative regulation of striated muscle tissue development,BP,BMP2
17792,GO:1901862,0.673908126495574,0.698494373786514,1,32,negative regulation of muscle tissue development,BP,BMP2
15181,GO:0071320,0.673931710245832,0.698904224211004,1,30,cellular response to cAMP,BP,ZFP36L1
8980,GO:0035088,0.674768903257751,0.697754590487847,1,31,establishment or maintenance of apical/basal cell polarity,BP,WNT5A
14248,GO:0061245,0.674768903257751,0.697754590487847,1,31,establishment or maintenance of bipolar cell polarity,BP,WNT5A
6848,GO:0030315,0.67513626565353,0.697573924252029,1,30,T-tubule,CC,SLC9A1
14121,GO:0060976,0.675240439054569,0.69745866569723,1,30,coronary vasculature development,BP,PRDM1
14136,GO:0060999,0.675833889588331,0.696801425512799,1,30,positive regulation of dendritic spine development,BP,NRG1
10177,GO:0042769,0.676010077435384,0.695282012053739,1,37,DNA damage response, detection of DNA damage,BP,SOX4
20059,GO:2000677,0.676556718529786,0.695174203701273,1,34,regulation of transcription regulatory region DNA binding,BP,LIF
3409,GO:0007193,0.677467006987277,0.694760107889878,1,31,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,EDN1
5813,GO:0017069,0.677566198894209,0.69339803176367,1,38,snRNA binding,MF,ISG20
2901,GO:0006409,0.678043813220028,0.693904044147428,1,32,tRNA export from nucleus,BP,NUP153
15258,GO:0071431,0.678043813220028,0.693904044147428,1,32,tRNA-containing ribonucleoprotein complex export from nucleus,BP,NUP153
15314,GO:0071526,0.678100812043931,0.694524032372331,1,29,semaphorin-plexin signaling pathway,BP,SEMA7A
2538,GO:0005794,0.678137353471084,0.386432012626089,37,1147,Golgi apparatus,CC,ELF3;SDC4;TGFA;EHF;IFNGR2;NFKBIE;NMNAT2;RND3;UGCG;PPP1R15A;NEDD9;B4GALT1;FGD6;B3GNT5;SGMS2;LDLR;NEDD4L;DUSP10;PLK3;ITGA5;LIPG;CD55;ABCA5;AREG;STEAP4;HLA-E;WNT5A;CTSC;NFE2L2;B3GNT2;CYTH1;ITM2B;TMEM132A;MYO1B;DSE;STX12;SMPD3
5203,GO:0015800,0.678617724811612,0.693476104781503,1,31,acidic amino acid transport,BP,STX1A
2528,GO:0005783,0.678698519334502,0.382863046076855,41,1324,endoplasmic reticulum,CC,ZC3H12A;PLAUR;PTGS2;RNF19B;PLEKHF1;TGFA;EDN1;PANX1;SQSTM1;IFNGR2;PPP1R15A;C3ORF52;ANKLE2;TMCC1;B3GNT5;SGMS2;VMP1;IL23A;ITGA5;RAET1L;BDKRB1;SLC9A1;ANTXR2;PPP1R15B;PML;SLC28A3;AREG;PTPN1;SQLE;HLA-E;WNT5A;INSIG1;ADAMTS9;CTSC;ERO1A;SGK1;B3GNT2;ERN1;TMEM132A;TAP1;DSE
3904,GO:0008542,0.678813342256875,0.693257418339788,1,31,visual learning,BP,CREB1
3465,GO:0007286,0.678936008128515,0.590021309227197,2,69,spermatid development,BP,QKI;AGFG1
4109,GO:0009163,0.679160602453324,0.69133504768474,1,40,nucleoside biosynthetic process,BP,UPP1
11431,GO:0045851,0.679180998088423,0.69158959571548,1,38,pH reduction,BP,ATP6V1C2
8115,GO:0032801,0.680627822627772,0.691008940528247,1,32,receptor catabolic process,BP,PTPN1
7212,GO:0031103,0.68208039280092,0.68937228471302,1,32,axon regeneration,BP,JUN
6022,GO:0019076,0.682186590218787,0.689050442120229,1,33,viral release from host cell,BP,PML
9370,GO:0035890,0.682186590218787,0.689050442120229,1,33,exit from host,BP,PML
9371,GO:0035891,0.682186590218787,0.689050442120229,1,33,exit from host cell,BP,PML
13314,GO:0052126,0.682186590218787,0.689050442120229,1,33,movement in host environment,BP,PML
13323,GO:0052192,0.682186590218787,0.689050442120229,1,33,movement in environment of other organism involved in symbiotic interaction,BP,PML
9801,GO:0040029,0.682201711674991,0.452398505258905,8,291,regulation of gene expression, epigenetic,BP,ZC3H12A;SMAD3;ZFP36;UHRF1;EIF1;CELF1;NUP153;TDG
3953,GO:0008654,0.682452020168606,0.461644175554736,7,231,phospholipid biosynthetic process,BP,PLAUR;HMGCS1;SGMS2;PPARD;PIP5K1A;PTPN11;ETNK1
3553,GO:0007595,0.682547784065913,0.688844244421992,1,32,lactation,BP,CREB1
9349,GO:0035861,0.682582333767417,0.688805184102545,1,32,site of double-strand break,CC,PRPF19
17277,GO:0140013,0.68270727717358,0.537198045324974,3,103,meiotic nuclear division,BP,LIF;EREG;WNT5A
9033,GO:0035249,0.682967333920571,0.688585183876486,1,31,synaptic transmission, glutamatergic,BP,PTGS2
11094,GO:0045104,0.683394175934552,0.687683751614441,1,33,intermediate filament cytoskeleton organization,BP,AGFG1
14272,GO:0061337,0.683675334474491,0.584762081652562,2,65,cardiac conduction,BP,SLC9A1;TMEM65
3660,GO:0008144,0.684375541869233,0.376193806842719,42,1266,drug binding,MF,ITPKC;PPIF;NUAK2;IRAK2;EPHA2;MAP2K3;NMNAT2;NAMPT;MAST4;RUNX1;HMGCS1;EHD1;PIM3;OXSR1;PLK2;PLK3;PIM1;STK40;PPARD;RIPK2;PHKG2;NAV3;PIP5K1A;CLK4;MAP3K8;PANK3;ABCA5;CDK6;ABL2;PDPK1;SGK1;BTAF1;ANKK1;ALAS1;TDG;ITM2B;ERN1;ETNK1;IFIH1;ATP13A3;MYO1B;TAP1
8312,GO:0033146,0.684391910359818,0.686754068771498,1,32,regulation of intracellular estrogen receptor signaling pathway,BP,RUNX1
13687,GO:0060218,0.685493226211696,0.580899806806212,2,100,hematopoietic stem cell differentiation,BP,RUNX1;NFE2L2
2946,GO:0006475,0.686143042332768,0.503827765677141,4,138,internal protein amino acid acetylation,BP,IL1B;LIF;TRIM16;ZNF451
3425,GO:0007215,0.686185724021318,0.684710532279454,1,32,glutamate receptor signaling pathway,BP,ADRB2
13574,GO:0060038,0.68627758502514,0.68482283857564,1,31,cardiac muscle cell proliferation,BP,PIM1
12297,GO:0048635,0.686306458191419,0.684368694923119,1,33,negative regulation of muscle organ development,BP,BMP2
7941,GO:0032527,0.68647957219391,0.683978913813061,1,34,protein exit from endoplasmic reticulum,BP,INSIG1
5059,GO:0015267,0.687035029944281,0.482836750704778,5,164,channel activity,MF,TRPV3;PANX1;CLDN4;GJB3;ITGAV
6609,GO:0022803,0.687035029944281,0.482836750704778,5,164,passive transmembrane transporter activity,MF,TRPV3;PANX1;CLDN4;GJB3;ITGAV
12083,GO:0048037,0.687059435286845,0.432804888592768,10,355,cofactor binding,MF,PTGS2;ALDH1A3;TXNRD1;CYP27B1;GCH1;SQLE;BACH1;ALAS1;CREG1;AHCY
14792,GO:0070509,0.687276463884125,0.683462913276739,1,32,calcium ion import,BP,TRPV3
3900,GO:0008536,0.687539434354805,0.683161548746509,1,32,Ran GTPase binding,MF,IPO4
868,GO:0002204,0.687580888072776,0.682909478960628,1,33,somatic recombination of immunoglobulin genes involved in immune response,BP,TFRC
869,GO:0002208,0.687580888072776,0.682909478960628,1,33,somatic diversification of immunoglobulins involved in immune response,BP,TFRC
11143,GO:0045190,0.687580888072776,0.682909478960628,1,33,isotype switching,BP,TFRC
8958,GO:0035023,0.688939984586199,0.530195125394753,3,95,regulation of Rho protein signal transduction,BP,FGD6;ARHGEF3;TNFAIP1
282,GO:0000784,0.689207504863729,0.52918846275236,3,114,nuclear chromosome, telomeric region,CC,PPP1R10;NABP1;PML
18009,GO:1902476,0.689596997336732,0.68079588463815,1,32,chloride transmembrane transport,BP,CLDN4
12765,GO:0051031,0.689976795648514,0.680152016232517,1,33,tRNA transport,BP,NUP153
7898,GO:0032465,0.690549166538794,0.576410543536089,2,68,regulation of cytokinesis,BP,PLK3;KLHL21
8264,GO:0033046,0.691025147734793,0.678390477142578,1,36,negative regulation of sister chromatid segregation,BP,DUSP1
13294,GO:0051985,0.691025147734793,0.678390477142578,1,36,negative regulation of chromosome segregation,BP,DUSP1
12517,GO:0050657,0.691224068367211,0.477812818035407,5,173,nucleic acid transport,BP,ZFP36L1;ZFP36;QKI;NUP153;AGFG1
12518,GO:0050658,0.691224068367211,0.477812818035407,5,173,RNA transport,BP,ZFP36L1;ZFP36;QKI;NUP153;AGFG1
8098,GO:0032781,0.691355031824999,0.677404550696712,1,40,positive regulation of ATPase activity,BP,UHRF1
4032,GO:0009063,0.691523889353147,0.574804637000337,2,75,cellular amino acid catabolic process,BP,HAL;AHCY
3314,GO:0007019,0.691902793919527,0.678128520160691,1,32,microtubule depolymerization,BP,NAV3
9689,GO:0038083,0.69259730192009,0.67754220404222,1,31,peptidyl-tyrosine autophosphorylation,BP,ABL2
7177,GO:0031057,0.692763517330314,0.677128387938269,1,32,negative regulation of histone modification,BP,ZNF451
5925,GO:0018198,0.693206504126562,0.675534468957141,1,38,peptidyl-cysteine modification,BP,NCOA7
8905,GO:0034728,0.6934176633147,0.52357706620564,3,139,nucleosome organization,BP,SOX9;BRD2;IPO4
5756,GO:0016903,0.694010506539672,0.675272184509277,1,34,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,ALDH1A3
10783,GO:0044242,0.694791813348267,0.493500132854618,4,146,cellular lipid catabolic process,BP,LDLR;LIPG;PPARD;SMPD3
6221,GO:0019752,0.694967108512347,0.385722405780588,22,753,carboxylic acid metabolic process,BP,IL1B;PTGS2;NFKB1;EDN1;ODC1;HAS3;NMNAT2;ALDH1A3;HAL;SLC6A14;PIM1;PPARD;SLC9A1;AZIN1;SLC7A2;GCH1;QKI;NUP153;INSIG1;ERO1A;DSE;AHCY
4411,GO:0010165,0.695161451176733,0.674121055550022,1,33,response to X-ray,BP,CDKN1A
11093,GO:0045103,0.695220393782819,0.673856146145641,1,34,intermediate filament-based process,BP,AGFG1
13238,GO:0051898,0.695360070087114,0.67369235998287,1,34,negative regulation of protein kinase B signaling,BP,EPHA2
4132,GO:0009190,0.695437428017609,0.673417008516282,1,35,cyclic nucleotide biosynthetic process,BP,ADM
13386,GO:0052652,0.695437428017609,0.673417008516282,1,35,cyclic purine nucleotide metabolic process,BP,ADM
13514,GO:0055081,0.695483808443819,0.673951523956773,1,32,anion homeostasis,BP,LIPG
418,GO:0001105,0.695840753898197,0.673324330615174,1,33,RNA polymerase II transcription coactivator activity,MF,SOX4
12785,GO:0051057,0.69615848015756,0.67295115960524,1,33,positive regulation of small GTPase mediated signal transduction,BP,NRG1
2903,GO:0006413,0.69672539854901,0.490554160957891,4,186,translational initiation,BP,TNF;PPP1R15A;PPP1R15B;EIF1
4183,GO:0009259,0.698594796722098,0.419663215491962,10,370,ribonucleotide metabolic process,BP,PPIF;EPHA2;TJP2;AMPD3;SLC25A25;PANK3;ADM;WNT5A;NUP153;UPP1
1448,GO:0003676,0.698645072334806,0.343025885709209,102,3231,nucleic acid binding,MF,TNFAIP3;ZC3H12A;ELF3;ETS1;TNF;REL;KLF6;ZNF697;BHLHE40;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;KDM6B;IRF6;KLF7;CREB5;CPEB2;EHF;RELB;GADD45A;MAFF;ZNF267;JUN;JUNB;BCL3;OVOL1;CSRNP1;ETS2;IRF1;TAF4B;ZFP36L1;CEBPB;ARNTL2;RUNX1;TRIM16;ELMSAN1;PPP1R10;NABP1;DLX2;KLF3;ZNF217;SMAD3;RC3H1;DIEXF;TFRC;CREB1;HIVEP2;PPARD;USP36;ZFP36;MAFK;LARP4B;PLAGL2;SOX9;ZNF451;PML;POU2F2;ELK3;POLR3A;ZNF460;FOXN2;UHRF1;MXD1;SOX4;FOSL2;TRAF4;EIF1;HIVEP1;KLF10;AEN;C11ORF68;SKIL;RBM3;YRDC;SAMD4A;PTPN1;TFE3;MAFG;MTF1;QKI;CELF1;WNT5A;NUP153;KDM6A;ZBTB21;NFE2L2;RELA;AGFG1;RNF11;BACH1;BTAF1;POLR3D;YWHAG;TDG;ELF4;ISG20;IFIH1;PABPC4;FUBP3
5723,GO:0016860,0.699082227954904,0.668327952366529,1,40,intramolecular oxidoreductase activity,MF,ERO1A
4428,GO:0010256,0.699253038520823,0.413656843895572,11,358,endomembrane system organization,BP,PLEKHF1;SQSTM1;ANKLE2;TMCC1;VMP1;PLK3;CREB1;NDRG1;NUP153;AGFG1;RAB22A
3139,GO:0006733,0.699683142634942,0.487748824282136,4,144,oxidoreduction coenzyme metabolic process,BP,PTGS2;NMNAT2;NAMPT;NUP153
569,GO:0001708,0.69975043027545,0.668511185351215,1,34,cell fate specification,BP,SOX9
14509,GO:0065004,0.699833253441674,0.467193398184247,5,213,protein-DNA complex assembly,BP,TAF4B;CREB1;SOX9;BRD2;IPO4
19895,GO:2000378,0.700621641153223,0.666945587526562,1,37,negative regulation of reactive oxygen species metabolic process,BP,ZC3H12A
733,GO:0001960,0.700709787535024,0.666682694548189,1,38,negative regulation of cytokine-mediated signaling pathway,BP,IL1RN
17731,GO:1901659,0.701030224076031,0.665744587629396,1,42,glycosyl compound biosynthetic process,BP,UPP1
6753,GO:0030173,0.701394668719819,0.666190442862559,1,36,integral component of Golgi membrane,CC,SGMS2
7890,GO:0032456,0.701817231962231,0.666248609508055,1,33,endocytic recycling,BP,EHD1
5399,GO:0016234,0.701901314302604,0.562736135775804,2,68,inclusion body,CC,SQSTM1;NUP153
4532,GO:0010596,0.70222845270093,0.665558355477639,1,34,negative regulation of endothelial cell migration,BP,ADAMTS9
4079,GO:0009132,0.702388289296299,0.513604367655619,3,109,nucleoside diphosphate metabolic process,BP,TJP2;AMPD3;NUP153
17672,GO:1901532,0.702411675632959,0.560485923564828,2,103,regulation of hematopoietic progenitor cell differentiation,BP,RUNX1;NFE2L2
13536,GO:0055114,0.702520030196655,0.381107782292086,20,719,oxidation-reduction process,BP,PTGS2;KDM6B;BMP2;PHLDA2;SOD2;ALDH1A3;HEPHL1;IL6ST;TXNRD1;STK40;PPARD;SLC25A25;CYP27B1;PHKG2;SQLE;STEAP4;MAOA;ERO1A;KDM6A;TDG
5692,GO:0016810,0.703115088708687,0.512693545065409,3,110,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,AMPD3;GCH1;HDAC9
3432,GO:0007223,0.705116873794832,0.662503536765121,1,32,Wnt signaling pathway, calcium modulating pathway,BP,WNT5A
5930,GO:0018205,0.705337113478572,0.412141382147278,10,337,peptidyl-lysine modification,BP,IL1B;LIF;TRIM16;ZNF451;SOX4;HDAC9;NUP153;KDM6A;RELA;IFIH1
4184,GO:0009260,0.706200557793475,0.460048952760846,5,183,ribonucleotide biosynthetic process,BP,AMPD3;PANK3;ADM;NUP153;UPP1
8686,GO:0034308,0.706233790690383,0.660205093152889,1,37,primary alcohol metabolic process,BP,ALDH1A3
10521,GO:0043436,0.707164619501839,0.369013784043509,24,820,oxoacid metabolic process,BP,IL1B;PTGS2;NFKB1;EDN1;ODC1;HAS3;NMNAT2;ALDH1A3;B4GALT1;HAL;SLC6A14;PIM1;PPARD;SLC9A1;AZIN1;SLC7A2;GCH1;QKI;NUP153;INSIG1;ERO1A;B3GNT2;DSE;AHCY
10078,GO:0042578,0.70717727484171,0.42396978688635,8,267,phosphoric ester hydrolase activity,MF,DUSP16;DUSP8;DUSP1;DUSP10;PPTC7;PTPN11;PTPN1;SMPD3
2955,GO:0006487,0.70729260289595,0.555514194208587,2,78,protein N-linked glycosylation,BP,B4GALT1;PMM2
3337,GO:0007052,0.707349698969869,0.507731041339655,3,105,mitotic spindle organization,BP,BIRC3;BIRC2;PLK2
12242,GO:0048515,0.707741240588413,0.555249876020812,2,73,spermatid differentiation,BP,QKI;AGFG1
12898,GO:0051236,0.707755140213993,0.45831054511876,5,176,establishment of RNA localization,BP,ZFP36L1;ZFP36;QKI;NUP153;AGFG1
16818,GO:0098693,0.708113081167092,0.658664324079145,1,33,regulation of synaptic vesicle cycle,BP,STX1A
12755,GO:0051020,0.708220019841506,0.38186382565328,17,522,GTPase binding,MF,HBEGF;CSF2;ERRFI1;EREG;EHD1;FGD6;NDRG1;NRG1;CDC42EP1;ARHGEF3;TNFAIP1;DENND2C;CORO1C;RAB3IP;CYTH1;AGFG1;IPO4
7205,GO:0031093,0.709800660739081,0.655865145163865,1,37,platelet alpha granule lumen,CC,VEGFC
13701,GO:0060249,0.709810559812435,0.420758951692086,8,286,anatomical structure homeostasis,BP,TNFAIP3;ADRB2;PPP1R10;ADAM8;TFRC;SOX9;PML;PTPN11
17346,GO:1900034,0.709843838091762,0.552715668665003,2,72,regulation of cellular response to heat,BP,IER5;NUP153
8136,GO:0032835,0.709939338285376,0.656236435196761,1,34,glomerulus development,BP,JAG1
19649,GO:1990841,0.710000555974089,0.656364069531642,1,33,promoter-specific chromatin binding,MF,PRDM1
7697,GO:0032153,0.710523080830444,0.552005503792738,2,70,cell division site,CC,RND3;RHOB
10799,GO:0044275,0.710945587611904,0.654813691801525,1,35,cellular carbohydrate catabolic process,BP,PHKG2
5400,GO:0016235,0.711376996836964,0.654475739774087,1,34,aggresome,CC,SQSTM1
3245,GO:0006904,0.711804772214804,0.653407336456874,1,37,vesicle docking involved in exocytosis,BP,STX1A
12622,GO:0050803,0.712237772275266,0.501911201450917,3,101,regulation of synapse structure or activity,BP,EFNA1;WNT5A;PDLIM5
17842,GO:1902017,0.713664545021959,0.651113991628107,1,37,regulation of cilium assembly,BP,CYLD
10566,GO:0043525,0.714147339619658,0.650354062236322,1,38,positive regulation of neuron apoptotic process,BP,JUN
5973,GO:0018410,0.715597662228021,0.64839956066165,1,39,C-terminal protein amino acid modification,BP,RAET1L
5932,GO:0018208,0.715699824113238,0.647853059124655,1,42,peptidyl-proline modification,BP,PPIF
3583,GO:0007632,0.715704450235368,0.648939107915944,1,35,visual behavior,BP,CREB1
8678,GO:0034260,0.716199503570849,0.648140937301412,1,36,negative regulation of GTPase activity,BP,CPEB2
9490,GO:0036126,0.716512945816475,0.647414506535806,1,38,sperm flagellum,CC,SQSTM1
16724,GO:0097729,0.716512945816475,0.647414506535806,1,38,9+2 motile cilium,CC,SQSTM1
16382,GO:0090734,0.716576862909587,0.647853491391474,1,35,site of DNA damage,CC,PRPF19
2426,GO:0005604,0.716832944388493,0.544350156365276,2,67,basement membrane,CC,ADAMTS1;LAMB3
6572,GO:0022029,0.717179075875923,0.647296266036579,1,34,telencephalon cell migration,BP,NRG1
15847,GO:0072562,0.717314826208509,0.646258354664745,1,39,blood microparticle,CC,TFRC
2591,GO:0005884,0.717431685424171,0.54319031054243,2,73,actin filament,CC,FERMT1;MYO1B
10355,GO:0043168,0.718523331020937,0.329386038999481,65,1997,anion binding,MF,HBEGF;ITPKC;NUAK2;PLEKHF1;IRAK2;DAPP1;EPHA2;RRAD;MAP2K3;RAP2B;NMNAT2;RND3;MAST4;RUNX1;ALDH1A3;EHD1;PIM3;TXNRD1;OXSR1;PLK2;PLK3;PIM1;WISP1;LIPG;F3;STK40;PPARD;SLC9A1;JAG1;RIPK2;PHKG2;NAV3;SAA1;STARD5;PIP5K1A;CLK4;RASA2;MAP3K8;PANK3;IRGQ;RHOB;ABCA5;GCH1;ADAMTS1;CDK6;SQLE;ABL2;WNT5A;PDPK1;CTSC;SGK1;RELA;BTAF1;ANKK1;ALAS1;TDG;RAB22A;ITM2B;ERN1;ETNK1;IFIH1;ATP13A3;MYO1B;TAP1;RAB24
7220,GO:0031113,0.719088972310518,0.644528726673129,1,36,regulation of microtubule polymerization,BP,NAV3
12522,GO:0050662,0.719228528124411,0.429945402540697,6,221,coenzyme binding,MF,ALDH1A3;TXNRD1;GCH1;SQLE;ALAS1;AHCY
11653,GO:0046390,0.719245836406758,0.444395196719921,5,186,ribose phosphate biosynthetic process,BP,AMPD3;PANK3;ADM;NUP153;UPP1
201,GO:0000422,0.719497947332441,0.540351936858029,2,77,autophagy of mitochondrion,BP,SQSTM1;USP36
14421,GO:0061726,0.719497947332441,0.540351936858029,2,77,mitochondrion disassembly,BP,SQSTM1;USP36
16425,GO:0097064,0.719931031346997,0.643296560252283,1,37,ncRNA export from nucleus,BP,NUP153
7079,GO:0030866,0.720349159587596,0.64332308924641,1,34,cortical actin cytoskeleton organization,BP,TNF
6287,GO:0019894,0.720970429880784,0.642540196125348,1,34,kinesin binding,MF,SPAG9
2710,GO:0006082,0.72162699078575,0.352971158746159,24,827,organic acid metabolic process,BP,IL1B;PTGS2;NFKB1;EDN1;ODC1;HAS3;NMNAT2;ALDH1A3;B4GALT1;HAL;SLC6A14;PIM1;PPARD;SLC9A1;AZIN1;SLC7A2;GCH1;QKI;NUP153;INSIG1;ERO1A;B3GNT2;DSE;AHCY
5509,GO:0016458,0.721971967386508,0.426500762763547,6,237,gene silencing,BP,ZC3H12A;SMAD3;ZFP36;UHRF1;CELF1;NUP153
2850,GO:0006336,0.722318707344693,0.638650881817907,1,50,DNA replication-independent nucleosome assembly,BP,IPO4
1050,GO:0002576,0.722536957906375,0.536562060625617,2,76,platelet degranulation,BP,VEGFC;VCL
18342,GO:1903305,0.722623984238058,0.53663197422049,2,73,regulation of regulated secretory pathway,BP,STX1A;PDPK1
18478,GO:1903578,0.722940511278758,0.536168147871598,2,74,regulation of ATP metabolic process,BP,PPIF;NUP153
5510,GO:0016459,0.723979593218061,0.638531873309694,1,35,myosin complex,CC,MYO1B
12486,GO:0050434,0.724182800576516,0.637439178715716,1,40,positive regulation of viral transcription,BP,JUN
2819,GO:0006284,0.724383717608277,0.637040723979504,1,41,base-excision repair,BP,TDG
8210,GO:0032963,0.724886467889481,0.533752793303406,2,73,collagen metabolic process,BP,ERRFI1;PPARD
6059,GO:0019205,0.725150164452619,0.636061578067114,1,41,nucleobase-containing compound kinase activity,MF,TJP2
8147,GO:0032873,0.726321296856969,0.635179172791979,1,37,negative regulation of stress-activated MAPK cascade,BP,DUSP10
14684,GO:0070303,0.726321296856969,0.635179172791979,1,37,negative regulation of stress-activated protein kinase signaling cascade,BP,DUSP10
3078,GO:0006650,0.726383755295869,0.401424992640287,8,272,glycerophospholipid metabolic process,BP,PLAUR;HBEGF;EREG;LDLR;PIP5K1A;NRG1;PTPN11;ETNK1
10638,GO:0043648,0.726670446572787,0.53117933214923,2,78,dicarboxylic acid metabolic process,BP,NMNAT2;HAL
19629,GO:1990778,0.727030406362231,0.42075184561281,6,207,protein localization to cell periphery,BP,TNF;PLEKHF1;EPHA2;SQSTM1;PIP5K1A;PDPK1
4677,GO:0010824,0.729318450716572,0.631320349079847,1,37,regulation of centrosome duplication,BP,PLK2
5506,GO:0016447,0.729587644615519,0.630972130262297,1,37,somatic recombination of immunoglobulin gene segments,BP,TFRC
9833,GO:0042059,0.729693884017202,0.630507423447267,1,39,negative regulation of epidermal growth factor receptor signaling pathway,BP,ERRFI1
12945,GO:0051301,0.729956147694141,0.362743642722336,15,506,cell division,BP,IL1B;IL1A;BIRC3;TGFA;BIRC2;RND3;EREG;NEDD9;ANKLE2;VEGFC;PLK3;KLHL21;RHOB;CDK6;SFN
4676,GO:0010823,0.730026467049078,0.629781341935686,1,41,negative regulation of mitochondrion organization,BP,PPIF
7322,GO:0031330,0.73082688635251,0.430406111785072,5,180,negative regulation of cellular catabolic process,BP,NOCT;EFNA1;N4BP1;ZFP36;PML
4985,GO:0015108,0.731249671031532,0.628994159578401,1,36,chloride transmembrane transporter activity,MF,CLDN4
7485,GO:0031648,0.732357576420556,0.627204442009237,1,38,protein destabilization,BP,BMP2
2643,GO:0005978,0.733500195652986,0.625880345959814,1,37,glycogen biosynthetic process,BP,PHKG2
4177,GO:0009250,0.733500195652986,0.625880345959814,1,37,glucan biosynthetic process,BP,PHKG2
8903,GO:0034724,0.733507958756277,0.624109934417098,1,51,DNA replication-independent nucleosome organization,BP,IPO4
7178,GO:0031058,0.733558783215413,0.522470785529696,2,75,positive regulation of histone modification,BP,IL1B;LIF
3138,GO:0006732,0.733950402525175,0.392263686125958,8,295,coenzyme metabolic process,BP,PTGS2;NMNAT2;NAMPT;HMGCS1;PANK3;GCH1;NUP153;AHCY
3653,GO:0008135,0.734299819537559,0.521175634362095,2,81,translation factor activity, RNA binding,MF,CPEB2;EIF1
5017,GO:0015179,0.73601152545059,0.622411527958357,1,38,L-amino acid transmembrane transporter activity,MF,SLC7A2
9472,GO:0036092,0.736078521853765,0.623278219945795,1,33,phosphatidylinositol-3-phosphate biosynthetic process,BP,PTPN11
14394,GO:0061647,0.73608842590879,0.622659907023111,1,36,histone H3-K9 modification,BP,ZNF451
1462,GO:0003707,0.736115151376494,0.622444983021735,1,37,steroid hormone receptor activity,MF,PPARD
17039,GO:0099516,0.736434039595167,0.622204067886716,1,36,ion antiporter activity,MF,SLC9A1
5438,GO:0016298,0.736526224534999,0.518606814424384,2,75,lipase activity,MF,LIPG;SMPD3
2297,GO:0005261,0.736567586506065,0.471319393620424,3,105,cation channel activity,MF,TRPV3;PANX1;ITGAV
14035,GO:0060761,0.736687848370952,0.620919519521819,1,42,negative regulation of response to cytokine stimulus,BP,IL1RN
15990,GO:0086001,0.736931218327523,0.621737918577159,1,35,cardiac muscle cell action potential,BP,NEDD4L
10490,GO:0043388,0.737813885576468,0.619427990991411,1,42,positive regulation of DNA binding,BP,PLAUR
2271,GO:0005201,0.738197011194323,0.620062571795871,1,35,extracellular matrix structural constituent,MF,TFPI2
7459,GO:0031594,0.7388243500027,0.618858216145259,1,37,neuromuscular junction,CC,NRG1
19486,GO:1990234,0.739061021460743,0.338317940464035,21,713,transferase complex,CC,RNF19B;KDM6B;CAB39;CDKN1A;TAF4B;ENC1;ZSWIM4;DCUN1D3;KLHL21;PHKG2;POLR3A;CCNL1;TNFAIP1;HDAC9;CDK6;RNF19A;KDM6A;RNF11;BACH1;POLR3D;ERN1
6204,GO:0019693,0.739407543631681,0.372257472061803,10,384,ribose phosphate metabolic process,BP,PPIF;EPHA2;TJP2;AMPD3;SLC25A25;PANK3;ADM;WNT5A;NUP153;UPP1
7262,GO:0031228,0.739488483184501,0.617486871516313,1,40,intrinsic component of Golgi membrane,CC,SGMS2
11425,GO:0045839,0.739513103953391,0.617167995547781,1,42,negative regulation of mitotic nuclear division,BP,DUSP1
8651,GO:0034198,0.741992625321125,0.61413752531499,1,40,cellular response to amino acid starvation,BP,CDKN1A
7716,GO:0032204,0.742306013514988,0.510953658939866,2,76,regulation of telomere maintenance,BP,PPP1R10;PML
8241,GO:0033013,0.742984869265017,0.612381795793734,1,43,tetrapyrrole metabolic process,BP,ALAS1
17942,GO:1902275,0.74445794705498,0.432843897624114,4,142,regulation of chromatin organization,BP,IL1B;LIF;ZNF451;UHRF1
8202,GO:0032947,0.745320794585684,0.507205243227875,2,72,protein-containing complex scaffold activity,MF,SLC9A1;SPAG9
4559,GO:0010639,0.74642327009579,0.377384612799382,8,282,negative regulation of organelle organization,BP,PPIF;LIF;PHLDB2;DUSP1;TACSTD2;NAV3;ZNF451;INSIG1
10611,GO:0043596,0.746596369578933,0.607767171795089,1,41,nuclear replication fork,CC,PRPF19
20287,GO:2001252,0.746774328628783,0.429794150404836,4,147,positive regulation of chromosome organization,BP,IL1B;LIF;PPP1R10;PML
15754,GO:0072347,0.747901845724437,0.606292736396215,1,39,response to anesthetic,BP,RELA
6512,GO:0021885,0.748076331219312,0.606393506887855,1,37,forebrain cell migration,BP,NRG1
2514,GO:0005766,0.748937088342691,0.454826158770929,3,122,primary lysosome,CC,B4GALT1;CTSC;CREG1
10081,GO:0042582,0.748937088342691,0.454826158770929,3,122,azurophil granule,CC,B4GALT1;CTSC;CREG1
6623,GO:0022843,0.75136668302558,0.601703326279001,1,38,voltage-gated cation channel activity,MF,ITGAV
5405,GO:0016241,0.751845899483209,0.423237868788421,4,151,regulation of macroautophagy,BP,ADRB2;RIPK2;ATP6V1C2;ERN1
5298,GO:0015980,0.752164684205538,0.403443851678619,5,216,energy derivation by oxidation of organic compounds,BP,PHLDA2;IL6ST;STK40;SLC25A25;PHKG2
6261,GO:0019843,0.752361336375935,0.598251923055985,1,56,rRNA binding,MF,DIEXF
4649,GO:0010770,0.752782349419807,0.450156906002429,3,110,positive regulation of cell morphogenesis involved in differentiation,BP,SEMA7A;NRG1;SKIL
2295,GO:0005253,0.753117513296039,0.598957643278894,1,40,anion channel activity,MF,CLDN4
15897,GO:0072666,0.753211645095806,0.598827071300421,1,40,establishment of protein localization to vacuole,BP,TNFAIP3
5479,GO:0016410,0.753433285652154,0.495851687966584,2,80,N-acyltransferase activity,MF,SAT1;ALAS1
12873,GO:0051193,0.754063331213945,0.495165122461866,2,77,regulation of cofactor metabolic process,BP,NUP153;NFE2L2
13224,GO:0051881,0.754281531532589,0.596312721705019,1,48,regulation of mitochondrial membrane potential,BP,PMAIP1
5071,GO:0015293,0.755196719228005,0.493746709623894,2,75,symporter activity,MF,SLC6A14;SLC28A3
9244,GO:0035639,0.755215660563462,0.297339608526766,45,1403,purine ribonucleoside triphosphate binding,MF,ITPKC;NUAK2;IRAK2;EPHA2;RRAD;MAP2K3;RAP2B;NMNAT2;RND3;MAST4;RUNX1;EHD1;PIM3;OXSR1;PLK2;PLK3;PIM1;STK40;RIPK2;PHKG2;NAV3;PIP5K1A;CLK4;MAP3K8;PANK3;IRGQ;RHOB;ABCA5;GCH1;CDK6;ABL2;PDPK1;SGK1;BTAF1;ANKK1;TDG;RAB22A;ITM2B;ERN1;ETNK1;IFIH1;ATP13A3;MYO1B;TAP1;RAB24
17773,GO:1901799,0.755395439079762,0.595493036600492,1,42,negative regulation of proteasomal protein catabolic process,BP,N4BP1
9986,GO:0042383,0.755723499243732,0.492912714034697,2,77,sarcolemma,CC,SLC9A1;VCL
11516,GO:0046031,0.755992801796365,0.492434201403822,2,79,ADP metabolic process,BP,AMPD3;NUP153
3299,GO:0006998,0.756504987960458,0.491683213096283,2,80,nuclear envelope organization,BP,ANKLE2;NUP153
18562,GO:1903779,0.75707747080615,0.593592462587556,1,39,regulation of cardiac conduction,BP,TMEM65
16663,GO:0097542,0.757709643782914,0.592393680896844,1,41,ciliary tip,CC,CYLD
5703,GO:0016829,0.758863157814786,0.441594741151231,3,129,lyase activity,MF,ODC1;HAL;AZIN1
9613,GO:0036477,0.759070805822146,0.332106490815119,14,472,somatodendritic compartment,CC,N4BP3;ENC1;SACS;IL6ST;LDLR;PLK2;PLK3;NRG1;RBM3;SAMD4A;PMM2;PDPK1;ERO1A;AGFG1
5816,GO:0017076,0.759320732752659,0.292287484863441,46,1436,purine nucleotide binding,MF,ITPKC;NUAK2;IRAK2;EPHA2;RRAD;MAP2K3;RAP2B;NMNAT2;RND3;MAST4;RUNX1;EHD1;PIM3;OXSR1;PLK2;PLK3;PIM1;STK40;RIPK2;PHKG2;NAV3;PIP5K1A;CLK4;MAP3K8;PANK3;IRGQ;RHOB;ABCA5;GCH1;CDK6;ABL2;PDPK1;SGK1;BTAF1;ANKK1;TDG;RAB22A;ITM2B;ERN1;ETNK1;IFIH1;ATP13A3;MYO1B;TAP1;AHCY;RAB24
5685,GO:0016798,0.760209949505945,0.486415806224636,2,84,hydrolase activity, acting on glycosyl bonds,MF,HEXDC;TDG
5674,GO:0016782,0.761533713809129,0.586323299805998,1,46,transferase activity, transferring sulfur-containing groups,MF,OXCT1
12166,GO:0048285,0.762214171732027,0.34513505171638,10,355,organelle fission,BP,IL1B;IL1A;BIRC3;TGFA;EDN1;LIF;BIRC2;EREG;DUSP1;WNT5A
2539,GO:0005795,0.762443191597846,0.437212184569646,3,115,Golgi stack,CC,B4GALT1;PLK3;SMPD3
18014,GO:1902495,0.763264590723141,0.436209326670291,3,112,transmembrane transporter complex,CC,CLDN4;SLC9A1;STX1A
4097,GO:0009150,0.763581354428008,0.34920632794889,9,356,purine ribonucleotide metabolic process,BP,PPIF;EPHA2;TJP2;AMPD3;SLC25A25;PANK3;ADM;WNT5A;NUP153
6280,GO:0019882,0.763911229739019,0.40728592922304,4,171,antigen processing and presentation,BP,RELB;ITGAV;HLA-E;TAP1
6947,GO:0030554,0.764278640738902,0.291416922059259,38,1181,adenyl nucleotide binding,MF,ITPKC;NUAK2;IRAK2;EPHA2;MAP2K3;NMNAT2;MAST4;RUNX1;EHD1;PIM3;OXSR1;PLK2;PLK3;PIM1;STK40;RIPK2;PHKG2;NAV3;PIP5K1A;CLK4;MAP3K8;PANK3;ABCA5;CDK6;ABL2;PDPK1;SGK1;BTAF1;ANKK1;TDG;ITM2B;ERN1;ETNK1;IFIH1;ATP13A3;MYO1B;TAP1;AHCY
15818,GO:0072521,0.764790383600727,0.341846386816498,10,392,purine-containing compound metabolic process,BP,PPIF;EPHA2;TJP2;AMPD3;SLC25A25;PANK3;ADM;WNT5A;NUP153;AHCY
2389,GO:0005524,0.765011865927959,0.29128441101863,37,1150,ATP binding,MF,ITPKC;NUAK2;IRAK2;EPHA2;MAP2K3;NMNAT2;MAST4;RUNX1;EHD1;PIM3;OXSR1;PLK2;PLK3;PIM1;STK40;RIPK2;PHKG2;NAV3;PIP5K1A;CLK4;MAP3K8;PANK3;ABCA5;CDK6;ABL2;PDPK1;SGK1;BTAF1;ANKK1;TDG;ITM2B;ERN1;ETNK1;IFIH1;ATP13A3;MYO1B;TAP1
3348,GO:0007077,0.765770972448452,0.580774599139448,1,42,mitotic nuclear envelope disassembly,BP,NUP153
20290,GO:2001257,0.766560610545726,0.477957048729599,2,78,regulation of cation channel activity,BP,RRAD;ADRB2
13494,GO:0055029,0.766843416239073,0.430986061088578,3,127,nuclear DNA-directed RNA polymerase complex,CC,TAF4B;POLR3A;POLR3D
1995,GO:0004714,0.766848030418208,0.579853533147385,1,38,transmembrane receptor protein tyrosine kinase activity,MF,EPHA2
10815,GO:0044304,0.766987391977563,0.579481575340558,1,39,main axon,CC,NRG1
14790,GO:0070507,0.76740147987573,0.403128188820548,4,148,regulation of microtubule cytoskeleton organization,BP,PHLDB2;CYLD;PLK2;NAV3
3225,GO:0006879,0.76936367596096,0.575046754143411,1,46,cellular iron ion homeostasis,BP,TFRC
2318,GO:0005319,0.769422108704816,0.473855167425525,2,80,lipid transporter activity,MF,STARD5;ABCA5
5793,GO:0017022,0.770034166282987,0.574452948532038,1,43,myosin binding,MF,STX1A
11697,GO:0046486,0.770429662602917,0.341027985966003,9,318,glycerolipid metabolic process,BP,PLAUR;HBEGF;EREG;LDLR;PIP5K1A;NRG1;PTPN11;INSIG1;ETNK1
1787,GO:0004407,0.772379548292191,0.571158741279904,1,42,histone deacetylase activity,MF,HDAC9
203,GO:0000428,0.772480329938617,0.42334264229739,3,128,DNA-directed RNA polymerase complex,CC,TAF4B;POLR3A;POLR3D
17289,GO:0140056,0.772994859233218,0.395619867724812,4,155,organelle localization by membrane tethering,BP,STX1A;RAB3IP;YWHAG;STX12
19189,GO:1905268,0.773114885805102,0.570380513070935,1,40,negative regulation of chromatin organization,BP,ZNF451
11891,GO:0046907,0.773375418029863,0.278151776486228,43,1459,intracellular transport,BP,NFKBIA;IL1B;ZC3H12A;TNF;PTGS2;TGFA;SQSTM1;CDKN1A;BCL3;ADRB2;DUSP16;UGCG;EHD1;PPP1R10;LDLR;PLK3;USP36;CD55;PLAGL2;STX1A;NRG1;PML;PTPN11;RHOB;SPAG9;SOX4;AREG;PTPN1;RAB3IP;PMM2;NUP153;INSIG1;PDPK1;CTSC;YWHAH;AGFG1;YWHAG;RAB22A;SFN;IPO4;TAP1;STX12;RAB24
19190,GO:1905269,0.774171860294479,0.467121833899504,2,81,positive regulation of chromatin organization,BP,IL1B;LIF
3193,GO:0006821,0.774836405118167,0.567534644429057,1,42,chloride transport,BP,CLDN4
13577,GO:0060041,0.775459969436972,0.465519674726787,2,77,retina development in camera-type eye,BP,DLX2;SOX9
5209,GO:0015807,0.775557284641269,0.56632448755403,1,43,L-amino acid transport,BP,SLC7A2
13117,GO:0051649,0.775636688113705,0.27230140448028,50,1673,establishment of localization in cell,BP,NFKBIA;IL1B;ZC3H12A;TNF;PTGS2;PMAIP1;TGFA;SQSTM1;CDKN1A;BCL3;ADRB2;DUSP16;UGCG;EHD1;PPP1R10;PIM3;LDLR;BBC3;PLK3;USP36;BDKRB1;CD55;PLAGL2;TP53BP2;STX1A;NRG1;PML;PTPN11;RHOB;SPAG9;SOX4;OXCT1;AREG;PTPN1;RAB3IP;PMM2;NUP153;INSIG1;PDPK1;CTSC;ERO1A;YWHAH;AGFG1;YWHAG;RAB22A;SFN;IPO4;TAP1;STX12;RAB24
10903,GO:0044449,0.775659931565248,0.419221096686794,3,120,contractile fiber part,CC,SDC4;SQSTM1;VCL
19825,GO:2000278,0.777583355285553,0.462129242469782,2,84,regulation of DNA biosynthetic process,BP,CDKN1A;DUSP1
6696,GO:0030071,0.778127818763747,0.562105506054602,1,46,regulation of mitotic metaphase/anaphase transition,BP,DUSP1
17867,GO:1902099,0.778127818763747,0.562105506054602,1,46,regulation of metaphase/anaphase transition of cell cycle,BP,DUSP1
2936,GO:0006458,0.778160812088293,0.562056134399976,1,46,'de novo' protein folding,BP,ERO1A
10256,GO:0042995,0.77832340758022,0.273774991017123,41,1309,cell projection,CC,PLAUR;PTGS2;FOSL1;PANX1;CPEB2;EPHA2;SQSTM1;N4BP3;EHD1;NEDD9;B4GALT1;FGD6;SACS;IL6ST;SLC6A14;CYLD;PLK2;PLK3;ITGA5;CREB1;BDKRB1;RAPH1;SLC9A1;ITGAV;PIP5K1A;STX1A;NRG1;FERMT1;GCH1;RBM3;CDK6;SAMD4A;CORO1C;RAB3IP;PDPK1;ERO1A;AGFG1;RAB22A;MYO1B;AHCY;PDLIM5
2522,GO:0005775,0.778348182647272,0.415380229698083,3,126,vacuolar lumen,CC,SDC4;CTSC;CREG1
18276,GO:1903146,0.778591770866613,0.561664445720394,1,44,regulation of autophagy of mitochondrion,BP,USP36
7087,GO:0030880,0.779043413678207,0.414327216653917,3,130,RNA polymerase complex,CC,TAF4B;POLR3A;POLR3D
10788,GO:0044255,0.779305253195503,0.290444423485829,22,758,cellular lipid metabolic process,BP,PLAUR;HBEGF;SDC4;TNF;PTGS2;EDN1;UGCG;HMGCS1;EREG;ALDH1A3;B3GNT5;SGMS2;LDLR;LIPG;PPARD;PIP5K1A;NRG1;PTPN11;QKI;INSIG1;ETNK1;SMPD3
8750,GO:0034404,0.780131030973511,0.385931102779918,4,166,nucleobase-containing small molecule biosynthetic process,BP,AMPD3;NUP153;TDG;UPP1
8438,GO:0033558,0.780581044263534,0.558811503528605,1,43,protein deacetylase activity,MF,HDAC9
18581,GO:1903825,0.781382421588877,0.456901709905029,2,80,organic acid transmembrane transport,BP,SLC6A14;SLC7A2
19111,GO:1905039,0.781382421588877,0.456901709905029,2,80,carboxylic acid transmembrane transport,BP,SLC6A14;SLC7A2
11858,GO:0046847,0.782197415069755,0.556820662877266,1,40,filopodium assembly,BP,FGD6
4103,GO:0009156,0.782653152592374,0.409448079082028,3,126,ribonucleoside monophosphate biosynthetic process,BP,AMPD3;NUP153;UPP1
4107,GO:0009161,0.783029625072177,0.350401678854363,6,258,ribonucleoside monophosphate metabolic process,BP,PPIF;TJP2;AMPD3;SLC25A25;NUP153;UPP1
3905,GO:0008543,0.783037027071357,0.454315701350185,2,84,fibroblast growth factor receptor signaling pathway,BP,PTPN11;WNT5A
3559,GO:0007601,0.784353143251326,0.452516391610229,2,82,visual perception,BP,TACSTD2;ATXN7
5861,GO:0017158,0.784455791736878,0.552937391273588,1,43,regulation of calcium ion-dependent exocytosis,BP,STX1A
1477,GO:0003743,0.784754160836301,0.551744630972965,1,49,translation initiation factor activity,MF,EIF1
9193,GO:0035577,0.785026393677936,0.55155338810482,1,47,azurophil granule membrane,CC,B4GALT1
7176,GO:0031056,0.785905811337733,0.405151456002175,3,118,regulation of histone modification,BP,IL1B;LIF;ZNF451
17797,GO:1901880,0.786316927094923,0.550234879502925,1,42,negative regulation of protein depolymerization,BP,NAV3
2274,GO:0005216,0.78679551868186,0.377251911515886,4,150,ion channel activity,MF,TRPV3;PANX1;CLDN4;ITGAV
7958,GO:0032555,0.786887551193589,0.262034749620694,45,1422,purine ribonucleotide binding,MF,ITPKC;NUAK2;IRAK2;EPHA2;RRAD;MAP2K3;RAP2B;NMNAT2;RND3;MAST4;RUNX1;EHD1;PIM3;OXSR1;PLK2;PLK3;PIM1;STK40;RIPK2;PHKG2;NAV3;PIP5K1A;CLK4;MAP3K8;PANK3;IRGQ;RHOB;ABCA5;GCH1;CDK6;ABL2;PDPK1;SGK1;BTAF1;ANKK1;TDG;RAB22A;ITM2B;ERN1;ETNK1;IFIH1;ATP13A3;MYO1B;TAP1;RAB24
7078,GO:0030865,0.788453841890772,0.546946760013235,1,42,cortical cytoskeleton organization,BP,TNF
16574,GO:0097367,0.788637378950361,0.257837960558094,50,1581,carbohydrate derivative binding,MF,HBEGF;ITPKC;NUAK2;IRAK2;EPHA2;RRAD;MAP2K3;RAP2B;NMNAT2;RND3;MAST4;RUNX1;EHD1;PIM3;OXSR1;PLK2;PLK3;PIM1;WISP1;LIPG;STK40;RIPK2;PHKG2;NAV3;SAA1;PIP5K1A;CLK4;MAP3K8;PANK3;IRGQ;RHOB;ABCA5;GCH1;ADAMTS1;CDK6;ABL2;PDPK1;SGK1;BTAF1;ANKK1;TDG;RAB22A;ITM2B;ERN1;ETNK1;IFIH1;ATP13A3;MYO1B;TAP1;RAB24
16447,GO:0097110,0.790258409145456,0.543738103418714,1,45,scaffold protein binding,MF,PANX1
12720,GO:0050953,0.790461734845435,0.443576063962364,2,83,sensory perception of light stimulus,BP,TACSTD2;ATXN7
2847,GO:0006333,0.791160669541413,0.396977958164577,3,156,chromatin assembly or disassembly,BP,SOX9;BRD2;IPO4
13068,GO:0051568,0.791457857555567,0.541871750551866,1,45,histone H3-K4 methylation,BP,KDM6A
10579,GO:0043543,0.79221470354994,0.351772827317792,5,198,protein acylation,BP,IL1B;LIF;TRIM16;ZNF451;SOX4
1006,GO:0002478,0.792353834168797,0.395571618198017,3,141,antigen processing and presentation of exogenous peptide antigen,BP,ITGAV;HLA-E;TAP1
19506,GO:1990351,0.793558723379881,0.394369681946821,3,120,transporter complex,CC,CLDN4;SLC9A1;STX1A
3246,GO:0006906,0.79410646362721,0.393568617441507,3,121,vesicle fusion,BP,STX1A;TAP1;STX12
5504,GO:0016445,0.79500124452897,0.536317196229569,1,45,somatic diversification of immunoglobulins,BP,TFRC
6908,GO:0030490,0.795312775679072,0.534945330303218,1,53,maturation of SSU-rRNA,BP,DIEXF
6664,GO:0030016,0.795558670131192,0.391434112107184,3,124,myofibril,CC,SDC4;SQSTM1;VCL
5523,GO:0016491,0.796631296762425,0.29009588185713,13,529,oxidoreductase activity,MF,PTGS2;KDM6B;BMP2;SOD2;ALDH1A3;HEPHL1;TXNRD1;CYP27B1;SQLE;STEAP4;MAOA;ERO1A;KDM6A
83,GO:0000166,0.796750912421451,0.248336737688293,51,1627,nucleotide binding,MF,ITPKC;NUAK2;IRAK2;EPHA2;RRAD;MAP2K3;RAP2B;NMNAT2;RND3;MAST4;RUNX1;ALDH1A3;EHD1;PIM3;TXNRD1;OXSR1;PLK2;PLK3;PIM1;STK40;RIPK2;PHKG2;NAV3;PIP5K1A;CLK4;MAP3K8;UHRF1;PANK3;IRGQ;RHOB;ABCA5;GCH1;CDK6;SQLE;ABL2;PDPK1;ZBTB21;SGK1;BTAF1;ANKK1;TDG;RAB22A;ITM2B;ERN1;ETNK1;IFIH1;ATP13A3;MYO1B;TAP1;AHCY;RAB24
18136,GO:1902850,0.796813531970059,0.389707342761189,3,122,microtubule cytoskeleton organization involved in mitosis,BP,BIRC3;BIRC2;PLK2
6618,GO:0022838,0.796914824360885,0.363393462205849,4,153,substrate-specific channel activity,MF,TRPV3;PANX1;CLDN4;ITGAV
15477,GO:0071824,0.797057400661565,0.344899839227595,5,237,protein-DNA complex subunit organization,BP,TAF4B;CREB1;SOX9;BRD2;IPO4
6888,GO:0030397,0.79712990489388,0.532823221039722,1,46,membrane disassembly,BP,NUP153
12790,GO:0051081,0.79712990489388,0.532823221039722,1,46,nuclear envelope disassembly,BP,NUP153
17248,GO:0120025,0.797151991129888,0.253657662976349,39,1260,plasma membrane bounded cell projection,CC,PLAUR;PTGS2;FOSL1;PANX1;CPEB2;EPHA2;SQSTM1;N4BP3;EHD1;NEDD9;B4GALT1;FGD6;SACS;IL6ST;SLC6A14;CYLD;PLK2;PLK3;ITGA5;CREB1;BDKRB1;RAPH1;SLC9A1;ITGAV;PIP5K1A;STX1A;NRG1;FERMT1;GCH1;RBM3;CDK6;SAMD4A;CORO1C;RAB3IP;ERO1A;RAB22A;MYO1B;AHCY;PDLIM5
7962,GO:0032559,0.797245929454637,0.254821708911117,37,1169,adenyl ribonucleotide binding,MF,ITPKC;NUAK2;IRAK2;EPHA2;MAP2K3;NMNAT2;MAST4;RUNX1;EHD1;PIM3;OXSR1;PLK2;PLK3;PIM1;STK40;RIPK2;PHKG2;NAV3;PIP5K1A;CLK4;MAP3K8;PANK3;ABCA5;CDK6;ABL2;PDPK1;SGK1;BTAF1;ANKK1;TDG;ITM2B;ERN1;ETNK1;IFIH1;ATP13A3;MYO1B;TAP1
17603,GO:1901265,0.797498764161193,0.247496275288197,51,1628,nucleoside phosphate binding,MF,ITPKC;NUAK2;IRAK2;EPHA2;RRAD;MAP2K3;RAP2B;NMNAT2;RND3;MAST4;RUNX1;ALDH1A3;EHD1;PIM3;TXNRD1;OXSR1;PLK2;PLK3;PIM1;STK40;RIPK2;PHKG2;NAV3;PIP5K1A;CLK4;MAP3K8;UHRF1;PANK3;IRGQ;RHOB;ABCA5;GCH1;CDK6;SQLE;ABL2;PDPK1;ZBTB21;SGK1;BTAF1;ANKK1;TDG;RAB22A;ITM2B;ERN1;ETNK1;IFIH1;ATP13A3;MYO1B;TAP1;AHCY;RAB24
11328,GO:0045652,0.797780653377114,0.530119300848142,1,65,regulation of megakaryocyte differentiation,BP,RUNX1
7859,GO:0032418,0.798361816168073,0.530625370227953,1,48,lysosome localization,BP,PDPK1
3087,GO:0006661,0.799059779022193,0.386593824893967,3,119,phosphatidylinositol biosynthetic process,BP,PLAUR;PIP5K1A;PTPN11
1045,GO:0002562,0.79935559569284,0.529406189136813,1,45,somatic diversification of immune receptors via germline recombination within a single locus,BP,TFRC
5503,GO:0016444,0.79935559569284,0.529406189136813,1,45,somatic cell DNA recombination,BP,TFRC
10025,GO:0042470,0.800431379925915,0.42839660573701,2,92,melanosome,CC,TFRC;AHCY
12378,GO:0048770,0.800431379925915,0.42839660573701,2,92,pigment granule,CC,TFRC;AHCY
2754,GO:0006163,0.800530526886743,0.303161184360576,9,371,purine nucleotide metabolic process,BP,PPIF;EPHA2;TJP2;AMPD3;SLC25A25;PANK3;ADM;WNT5A;NUP153
7606,GO:0031985,0.801046169185965,0.427736883785843,2,86,Golgi cisterna,CC,B4GALT1;SMPD3
4959,GO:0015030,0.801240086519772,0.525693688959271,1,51,Cajal body,CC,ISG20
5269,GO:0015914,0.802069432007633,0.524922409485832,1,46,phospholipid transport,BP,LDLR
3595,GO:0008023,0.802144580623143,0.524801250550438,1,46,transcription elongation factor complex,CC,ELL2
3354,GO:0007091,0.802750969466651,0.523469550406663,1,49,metaphase/anaphase transition of mitotic cell cycle,BP,DUSP1
10987,GO:0044784,0.802750969466651,0.523469550406663,1,49,metaphase/anaphase transition of cell cycle,BP,DUSP1
7956,GO:0032553,0.802819584808816,0.244049043229246,45,1433,ribonucleotide binding,MF,ITPKC;NUAK2;IRAK2;EPHA2;RRAD;MAP2K3;RAP2B;NMNAT2;RND3;MAST4;RUNX1;EHD1;PIM3;OXSR1;PLK2;PLK3;PIM1;STK40;RIPK2;PHKG2;NAV3;PIP5K1A;CLK4;MAP3K8;PANK3;IRGQ;RHOB;ABCA5;GCH1;CDK6;ABL2;PDPK1;SGK1;BTAF1;ANKK1;TDG;RAB22A;ITM2B;ERN1;ETNK1;IFIH1;ATP13A3;MYO1B;TAP1;RAB24
5564,GO:0016574,0.803048019801504,0.523470697166554,1,45,histone ubiquitination,BP,UHRF1
12325,GO:0048678,0.80315612001548,0.522814402245471,1,49,response to axon injury,BP,JUN
5082,GO:0015318,0.804584779964769,0.288082116484635,11,399,inorganic molecular entity transmembrane transporter activity,MF,TRPV3;PANX1;CLDN4;SLC6A14;TFRC;SLC9A1;ITGAV;SLC7A2;SLC28A3;ATP6V1C2;ATP13A3
10364,GO:0043178,0.80463389433481,0.520530552885177,1,48,alcohol binding,MF,STARD5
6581,GO:0022406,0.805033910668377,0.351978090031672,4,163,membrane docking,BP,STX1A;RAB3IP;YWHAG;STX12
3476,GO:0007338,0.805623590108562,0.518493128208107,1,52,single fertilization,BP,B4GALT1
4780,GO:0010965,0.805668789957577,0.518623801970389,1,50,regulation of mitotic sister chromatid separation,BP,DUSP1
4099,GO:0009152,0.80609428155697,0.350373190717399,4,171,purine ribonucleotide biosynthetic process,BP,AMPD3;PANK3;ADM;NUP153
3211,GO:0006855,0.806235040166259,0.518162367538452,1,46,drug transmembrane transport,BP,SLC7A2
99,GO:0000209,0.807484912008952,0.308654167142497,7,276,protein polyubiquitination,BP,TNFAIP3;RNF19B;BIRC2;PELI1;NEDD4L;PRPF19;RNF19A
10886,GO:0044427,0.807678795765374,0.258552988514047,21,773,chromosomal part,CC,KDM6B;JUN;JUNB;IRF1;ENC1;CEBPB;PPP1R10;NABP1;SMAD3;PLK2;CREB1;PPARD;PML;UHRF1;MXD1;PRPF19;KDM6A;NFE2L2;RELA;POLR3D;IPO4
6282,GO:0019884,0.807680916344579,0.37362002346677,3,144,antigen processing and presentation of exogenous antigen,BP,ITGAV;HLA-E;TAP1
2399,GO:0005543,0.80792854163253,0.300360653638957,8,295,phospholipid binding,MF,PLEKHF1;DAPP1;F3;SLC9A1;JAG1;RASA2;WNT5A;MYO1B
4969,GO:0015077,0.807939744294242,0.347870472418284,4,166,monovalent inorganic cation transmembrane transporter activity,MF,SLC6A14;SLC9A1;SLC28A3;ATP6V1C2
4033,GO:0009064,0.808093336910619,0.514762190235419,1,49,glutamine family amino acid metabolic process,BP,HAL
16812,GO:0098661,0.808147459233458,0.515157603374927,1,45,inorganic anion transmembrane transport,BP,CLDN4
2960,GO:0006493,0.809432158517437,0.414939916869371,2,88,protein O-linked glycosylation,BP,B3GNT5;B3GNT2
13661,GO:0060170,0.809670024770528,0.512648991807895,1,45,ciliary membrane,CC,EHD1
10629,GO:0043627,0.810243412573425,0.511215491765293,1,49,response to estrogen,BP,CYP27B1
6027,GO:0019083,0.810631724927999,0.368899496182962,3,171,viral transcription,BP,JUN;ZFP36;NUP153
6928,GO:0030520,0.810784640840431,0.510675199487096,1,46,intracellular estrogen receptor signaling pathway,BP,RUNX1
3200,GO:0006835,0.810890013106331,0.510500484415417,1,46,dicarboxylic acid transport,BP,STX1A
6628,GO:0022857,0.811031643533615,0.266641507680247,15,537,transmembrane transporter activity,MF,TRPV3;PANX1;CLDN4;SLC6A14;TFRC;GJB3;SLC25A25;SLC9A1;ITGAV;SLC7A2;SLC28A3;ABCA5;ATP6V1C2;ATP13A3;TAP1
2437,GO:0005635,0.811462153620338,0.283977440943595,10,375,nuclear envelope,CC,SMAD3;AKIRIN1;NAV3;STX1A;GCH1;AEN;NUP153;AGFG1;ERN1;IPO4
6748,GO:0030166,0.811677980208048,0.509457283887125,1,44,proteoglycan biosynthetic process,BP,DSE
13083,GO:0051588,0.812208090003353,0.508066975299806,1,48,regulation of neurotransmitter transport,BP,STX1A
17249,GO:0120031,0.812515138145171,0.274162674449608,12,428,plasma membrane bounded cell projection assembly,BP,EPHA2;EHD1;FGD6;CYLD;TACSTD2;PIP5K1A;CDC42EP1;VCL;EMP3;CORO1C;RAB3IP;YWHAG
2874,GO:0006368,0.813082075108288,0.408968521036666,2,97,transcription elongation from RNA polymerase II promoter,BP,TAF4B;ELL2
10394,GO:0043226,0.813878999963045,0.222176554136888,314,9767,organelle,CC,NFKBIA;NFKBIZ;TNFAIP3;IL1B;ZC3H12A;CXCL1;PLAUR;BTG2;BIRC3;HBEGF;PLAU;NFKBID;CSF2;ITPKC;TICAM1;ELF3;SDC4;ETS1;TNF;REL;PPIF;IER3;KLF6;NUAK2;ZNF697;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;TBX3;NFKB2;NOCT;PLEKHF1;EFNA1;TGFA;KDM6B;IRF6;EDN1;PHLDA1;ERRFI1;IL1RN;IRAK2;KLF7;PANX1;CREB5;CPEB2;EHF;RELB;GADD45A;MAFF;TRIB1;SQSTM1;IFNGR2;BMP2;CAB39;ZNF267;N4BP3;MAP2K3;JUN;RAP2B;BIRC2;NFKBIE;CDKN1A;NMNAT2;RGMB;PHLDB2;TJP2;SERTAD2;CD274;JUNB;BCL3;OVOL1;CSRNP1;ETS2;NAMPT;AMPD3;IRF1;TAF4B;BCL2L2;ZFP36L1;ENC1;RELT;RND3;ADRB2;CEBPB;DUSP16;ARNTL2;UGCG;PPP1R15A;RUNX1;N4BP1;CDKN2B;GJB4;NAB1;TRIM16;ELMSAN1;SOD2;PELI1;ALDH1A3;C3ORF52;EHD1;NEDD9;ANKLE2;DUSP8;B4GALT1;DUSP1;BCL10;FGD6;TMCC1;PPP1R10;SACS;IL6ST;G0S2;B3GNT5;SGMS2;VMP1;NABP1;DLX2;SLC6A14;TXNRD1;VGLL3;CYLD;ADAM8;LDLR;VEGFC;KLF3;ZNF217;TACSTD2;NEDD4L;OXSR1;SMAD3;RC3H1;IL23A;DUSP10;PLK2;BBC3;PLK3;DIEXF;PIM1;ITGA5;TFRC;LIPG;AKIRIN1;KLHL21;CREB1;SERPINB8;EFNB1;GJB3;F3;STK40;HIVEP2;PPARD;KRT34;SLC25A25;SERPINB1;CCDC85B;KRTAP2-3;RAET1L;USP36;IL16;BDKRB1;RAPH1;ZFP36;SLC9A1;MAFK;LARP4B;CYP27B1;IFFO2;CD55;TMEM217;PNRC1;ELL2;ANTXR2;AZIN1;PLAGL2;RIPK2;AMOTL2;NAV3;SAA1;PPP1R15B;STARD5;NDRG1;ITGAV;PIP5K1A;CLK4;TP53BP2;SOX9;STX1A;NRG1;ZNF451;FEM1C;PML;POU2F2;PPTC7;FERMT1;NCOA7;ELK3;POLR3A;ZNF460;CDC42EP1;SLC28A3;FOXN2;PTPN11;UHRF1;MXD1;RHOB;SPAG9;ABCA5;GCH1;FEM1B;SOX4;USP31;FOSL2;TRAF4;VCL;EIF1;OXCT1;AREG;CCNL1;FAM83G;TNFAIP1;HDAC9;ADAMTS1;HIVEP1;NFKBIB;KLF10;AEN;SKIL;COTL1;IL7R;HEXDC;RBM3;CDK6;IER5;YRDC;SAMD4A;PTPN1;SQLE;TFE3;BTG3;TMEM65;CORO1C;STEAP4;PRPF19;TOB2;MAFG;ABL2;MTF1;ATP6V1C2;HLA-E;RAB3IP;QKI;CELF1;PMM2;WNT5A;NUP153;MAOA;INSIG1;ADAM9;PDPK1;ADAMTS9;RNF19A;CTSC;ERO1A;KDM6A;FRMD6;ZBTB21;SMTN;NFE2L2;YWHAH;SGK1;B3GNT2;TSC22D2;CYTH1;RELA;AGFG1;RNF11;BACH1;BTAF1;GINS3;POLR3D;ALAS1;YWHAG;TDG;ELF4;RAB22A;CREG1;SFN;ITM2B;ERN1;ETNK1;SH3RF2;UPP1;ISG20;TMEM132A;ATXN7;IFIH1;ATP13A3;MYO1B;BRD2;IPO4;PABPC4;TAP1;DSE;AHCY;STX12;PDLIM5;FUBP3;RAB24;SMPD3
4305,GO:0009755,0.813907524765757,0.339570521854217,4,160,hormone-mediated signaling pathway,BP,RUNX1;PPARD;PTPN11;YWHAH
4358,GO:0009953,0.81526120849947,0.50295593765128,1,48,dorsal/ventral pattern formation,BP,EDN1
16154,GO:0090174,0.815345655554886,0.362821562136536,3,126,organelle membrane fusion,BP,STX1A;TAP1;STX12
4072,GO:0009124,0.815485070127459,0.362407360226059,3,135,nucleoside monophosphate biosynthetic process,BP,AMPD3;NUP153;UPP1
2605,GO:0005902,0.815574019435927,0.502315008979644,1,49,microvillus,CC,ITGAV
18537,GO:1903725,0.815847974371878,0.502087174262934,1,47,regulation of phospholipid metabolic process,BP,LDLR
7698,GO:0032154,0.815988064276869,0.501731630250883,1,48,cleavage furrow,CC,RHOB
4071,GO:0009123,0.816298839126704,0.306358803013225,6,270,nucleoside monophosphate metabolic process,BP,PPIF;TJP2;AMPD3;SLC25A25;NUP153;UPP1
13110,GO:0051641,0.816971289039834,0.221066603059191,66,2184,cellular localization,BP,NFKBIA;TNFAIP3;IL1B;ZC3H12A;TNF;PTGS2;PMAIP1;PLEKHF1;TGFA;EPHA2;LIF;SQSTM1;CDKN1A;BCL3;ZFP36L1;ADRB2;DUSP16;UGCG;PPP1R15A;EHD1;PPP1R10;PIM3;CYLD;LDLR;NEDD4L;BBC3;PLK3;KLHL21;USP36;BDKRB1;ZFP36;CD55;PLAGL2;PIP5K1A;TP53BP2;SOX9;STX1A;NRG1;PML;PTPN11;RHOB;SPAG9;SOX4;VCL;OXCT1;AREG;PTPN1;PRPF19;RAB3IP;PMM2;WNT5A;NUP153;INSIG1;PDPK1;CTSC;ERO1A;FRMD6;YWHAH;AGFG1;YWHAG;RAB22A;SFN;IPO4;TAP1;STX12;RAB24
13510,GO:0055076,0.818723874936746,0.400134265499935,2,99,transition metal ion homeostasis,BP,TFRC;STEAP4
12950,GO:0051306,0.818836704096832,0.496472839679945,1,52,mitotic sister chromatid separation,BP,DUSP1
20113,GO:2000779,0.819251361484565,0.496084021004368,1,49,regulation of double-strand break repair,BP,PML
2755,GO:0006164,0.819425522706404,0.331495729607354,4,175,purine nucleotide biosynthetic process,BP,AMPD3;PANK3;ADM;NUP153
6819,GO:0030276,0.819896674925362,0.495217543353188,1,47,clathrin binding,MF,LDLR
6338,GO:0021510,0.82001177595284,0.495020902707882,1,47,spinal cord development,BP,SOX4
7758,GO:0032273,0.820691052776483,0.397236186981662,2,94,positive regulation of protein polymerization,BP,NAV3;CDC42EP1
6993,GO:0030672,0.821071688365911,0.492653302968171,1,52,synaptic vesicle membrane,CC,STX1A
17032,GO:0099501,0.821071688365911,0.492653302968171,1,52,exocytic vesicle membrane,CC,STX1A
2469,GO:0005684,0.82142504622381,0.491509863141741,1,58,U2-type spliceosomal complex,CC,PRPF19
17704,GO:1901607,0.821974867527795,0.491003684230796,1,53,alpha-amino acid biosynthetic process,BP,AHCY
6858,GO:0030326,0.822178529737713,0.395145247834043,2,88,embryonic limb morphogenesis,BP,TBX3;WNT5A
8995,GO:0035113,0.822178529737713,0.395145247834043,2,88,embryonic appendage morphogenesis,BP,TBX3;WNT5A
12055,GO:0048002,0.822226516943809,0.352149244460529,3,149,antigen processing and presentation of peptide antigen,BP,ITGAV;HLA-E;TAP1
5848,GO:0017137,0.822823323458218,0.326895161804665,4,158,Rab GTPase binding,MF,EHD1;NDRG1;DENND2C;RAB3IP
2895,GO:0006403,0.822978943248689,0.309695047025414,5,209,RNA localization,BP,ZFP36L1;ZFP36;QKI;NUP153;AGFG1
19374,GO:1905818,0.824387781844264,0.486835516705972,1,53,regulation of chromosome separation,BP,DUSP1
2328,GO:0005342,0.82660452579415,0.388000800608869,2,91,organic acid transmembrane transporter activity,MF,SLC6A14;SLC7A2
11911,GO:0046943,0.82660452579415,0.388000800608869,2,91,carboxylic acid transmembrane transporter activity,MF,SLC6A14;SLC7A2
12816,GO:0051117,0.8267251168576,0.482670974791807,1,54,ATPase binding,MF,BBC3
10437,GO:0043292,0.828213969202181,0.343483677761392,3,133,contractile fiber,CC,SDC4;SQSTM1;VCL
6067,GO:0019213,0.828377154556537,0.480071241158849,1,51,deacetylase activity,MF,HDAC9
15962,GO:0075733,0.82839120127591,0.479943980418901,1,52,intracellular transport of virus,BP,NUP153
11758,GO:0046605,0.828804205614449,0.479426893675896,1,50,regulation of centrosome cycle,BP,PLK2
10862,GO:0044380,0.829562665261315,0.478438401420685,1,47,protein localization to cytoskeleton,BP,KLHL21
10881,GO:0044420,0.829943580392486,0.382925003822981,2,85,extracellular matrix component,CC,ADAMTS1;LAMB3
72,GO:0000149,0.831041247123655,0.38081115866393,2,93,SNARE binding,MF,STX1A;STX12
3329,GO:0007041,0.831174558443629,0.380719431110742,2,90,lysosomal transport,BP,ADRB2;RHOB
25,GO:0000049,0.83223146252506,0.472955575507222,1,54,tRNA binding,MF,YRDC
16717,GO:0097711,0.832780993489018,0.377963362332004,2,94,ciliary basal body-plasma membrane docking,BP,RAB3IP;YWHAG
4968,GO:0015075,0.833642052373982,0.247344699361148,12,445,ion transmembrane transporter activity,MF,TRPV3;PANX1;CLDN4;SLC6A14;TFRC;SLC25A25;SLC9A1;ITGAV;SLC7A2;SLC28A3;ATP6V1C2;ATP13A3
5069,GO:0015291,0.834263304326796,0.334435087396243,3,127,secondary active transmembrane transporter activity,MF,SLC6A14;SLC9A1;SLC28A3
10671,GO:0043902,0.834928232427703,0.333095708075599,3,142,positive regulation of multi-organism process,BP,INHBA;JUN;RIPK2
12919,GO:0051262,0.835525181740858,0.372795130664372,2,117,protein tetramerization,BP,SOD2;ALDH1A3
2845,GO:0006323,0.83573109133297,0.33147366449016,3,166,DNA packaging,BP,SOX9;BRD2;IPO4
8157,GO:0032886,0.835920047394439,0.307729136554577,4,166,regulation of microtubule-based process,BP,PHLDB2;CYLD;PLK2;NAV3
6673,GO:0030031,0.836025951722356,0.244308280812217,12,438,cell projection assembly,BP,EPHA2;EHD1;FGD6;CYLD;TACSTD2;PIP5K1A;CDC42EP1;VCL;EMP3;CORO1C;RAB3IP;YWHAG
5679,GO:0016788,0.836452334705188,0.235045724295769,15,553,hydrolase activity, acting on ester bonds,MF,ZC3H12A;ZC3H12C;NOCT;DUSP16;DUSP8;DUSP1;DUSP10;LIPG;PPTC7;PTPN11;AEN;PTPN1;ERN1;ISG20;SMPD3
15896,GO:0072665,0.836725426087033,0.465085432982309,1,52,protein localization to vacuole,BP,TNFAIP3
279,GO:0000781,0.837039635825722,0.32978375584472,3,146,chromosome, telomeric region,CC,PPP1R10;NABP1;PML
7203,GO:0031091,0.837527918757913,0.463532857640917,1,53,platelet alpha granule,CC,VEGFC
5343,GO:0016079,0.837647099918265,0.463626870328986,1,50,synaptic vesicle exocytosis,BP,STX1A
9242,GO:0035637,0.839087130923993,0.367842193675732,2,90,multicellular organismal signaling,BP,SLC9A1;TMEM65
14545,GO:0070063,0.840450179398503,0.458206578646268,1,53,RNA polymerase binding,MF,ZFP36
2370,GO:0005496,0.84147518869533,0.456137227873576,1,55,steroid binding,MF,STARD5
6724,GO:0030133,0.843555215366155,0.268880554797061,6,253,transport vesicle,CC,TGFA;EDN1;CD55;STX1A;AREG;HLA-E
11686,GO:0046470,0.844291963375418,0.450843517312636,1,56,phosphatidylcholine metabolic process,BP,LDLR
10802,GO:0044282,0.844737999411112,0.258315903390489,7,302,small molecule catabolic process,BP,HAL;PPARD;SLC9A1;CYP27B1;OXCT1;UPP1;AHCY
5075,GO:0015297,0.84483105142209,0.450219190786352,1,52,antiporter activity,MF,SLC9A1
7228,GO:0031122,0.845645493840738,0.448805802640551,1,51,cytoplasmic microtubule organization,BP,PLK3
10637,GO:0043647,0.845794544801565,0.448635714905934,1,50,inositol phosphate metabolic process,BP,ITPKC
4204,GO:0009311,0.846475924506085,0.446954389802713,1,54,oligosaccharide metabolic process,BP,B4GALT1
11840,GO:0046794,0.846599093578888,0.446631234496708,1,55,transport of virus,BP,NUP153
2732,GO:0006110,0.846705577577482,0.44672059152395,1,52,regulation of glycolytic process,BP,NUP153
3884,GO:0008514,0.848217942156454,0.312635800052769,3,134,organic anion transmembrane transporter activity,MF,SLC6A14;SLC25A25;SLC7A2
17279,GO:0140029,0.849232667852079,0.441588529330839,1,56,exocytic process,BP,STX1A
6603,GO:0022618,0.849990065049056,0.286405455791099,4,194,ribonucleoprotein complex assembly,BP,NOCT;RC3H1;PRPF19;CELF1
15819,GO:0072522,0.851619168494553,0.284045848713587,4,185,purine-containing compound biosynthetic process,BP,AMPD3;PANK3;ADM;NUP153
2562,GO:0005844,0.851741267810108,0.435901381581501,1,69,polysome,CC,LARP4B
3952,GO:0008652,0.852927582212381,0.434389997576797,1,58,cellular amino acid biosynthetic process,BP,AHCY
867,GO:0002200,0.854110366482626,0.432472363680877,1,54,somatic diversification of immune receptors,BP,TFRC
8262,GO:0033044,0.854518125880353,0.244823598590307,7,280,regulation of chromosome organization,BP,IL1B;LIF;DUSP1;PPP1R10;ZNF451;PML;UHRF1
6054,GO:0019199,0.854890033036715,0.431380339980047,1,50,transmembrane receptor protein kinase activity,MF,EPHA2
3749,GO:0008289,0.855415534907069,0.219071490234068,12,455,lipid binding,MF,PLEKHF1;DAPP1;F3;PPARD;SLC9A1;CD55;JAG1;STARD5;RASA2;WNT5A;CYTH1;MYO1B
7410,GO:0031491,0.855434309421456,0.428992119753957,1,66,nucleosome binding,MF,UHRF1
7561,GO:0031902,0.855629153770033,0.339531689192258,2,105,late endosome membrane,CC,RHOB;ABCA5
11519,GO:0046034,0.855734531332211,0.277555441503932,4,207,ATP metabolic process,BP,PPIF;AMPD3;SLC25A25;NUP153
7365,GO:0031406,0.856300091238075,0.338349663292112,2,106,carboxylic acid binding,MF,PPARD;STARD5
9927,GO:0042274,0.856356723562489,0.426968313113742,1,70,ribosomal small subunit biogenesis,BP,DIEXF
9474,GO:0036094,0.856502897783608,0.178887157612836,55,1809,small molecule binding,MF,ITPKC;NUAK2;IRAK2;EPHA2;RRAD;MAP2K3;RAP2B;NMNAT2;RND3;MAST4;RUNX1;HMGCS1;ALDH1A3;EHD1;PIM3;TXNRD1;OXSR1;PLK2;PLK3;PIM1;STK40;PPARD;RIPK2;PHKG2;NAV3;STARD5;PIP5K1A;CLK4;MAP3K8;UHRF1;PANK3;IRGQ;RHOB;ABCA5;GCH1;CDK6;SQLE;ABL2;PDPK1;ZBTB21;SGK1;BTAF1;ANKK1;ALAS1;TDG;RAB22A;ITM2B;ERN1;ETNK1;IFIH1;ATP13A3;MYO1B;TAP1;AHCY;RAB24
5330,GO:0016054,0.85661164160922,0.276391419623126,4,190,organic acid catabolic process,BP,HAL;PPARD;SLC9A1;AHCY
11656,GO:0046395,0.85661164160922,0.276391419623126,4,190,carboxylic acid catabolic process,BP,HAL;PPARD;SLC9A1;AHCY
4971,GO:0015079,0.856823024999479,0.427326225411026,1,53,potassium ion transmembrane transporter activity,MF,SLC9A1
11053,GO:0045047,0.857241241001261,0.424048560769509,1,101,protein targeting to ER,BP,PMM2
12868,GO:0051186,0.859091446360237,0.221433854889232,10,429,cofactor metabolic process,BP,PTGS2;NMNAT2;NAMPT;HMGCS1;PANK3;GCH1;NUP153;NFE2L2;ALAS1;AHCY
3068,GO:0006635,0.859095915744071,0.4222098155646,1,61,fatty acid beta-oxidation,BP,PPARD
12196,GO:0048365,0.85933186484179,0.422531257257677,1,52,Rac GTPase binding,MF,CORO1C
3175,GO:0006790,0.859976016370589,0.245317058609052,6,273,sulfur compound metabolic process,BP,HMGCS1;B4GALT1;NFE2L2;B3GNT2;DSE;AHCY
6024,GO:0019080,0.860856215233904,0.291699383498406,3,185,viral gene expression,BP,JUN;ZFP36;NUP153
17334,GO:1900006,0.861127738057846,0.418999105541033,1,52,positive regulation of dendrite development,BP,NRG1
4074,GO:0009126,0.861431566765036,0.253944734184176,5,247,purine nucleoside monophosphate metabolic process,BP,PPIF;TJP2;AMPD3;SLC25A25;NUP153
4113,GO:0009167,0.861431566765036,0.253944734184176,5,247,purine ribonucleoside monophosphate metabolic process,BP,PPIF;TJP2;AMPD3;SLC25A25;NUP153
2961,GO:0006497,0.862387446517113,0.32771667729049,2,109,protein lipidation,BP,PLAUR;RAET1L
10120,GO:0042641,0.862931009139618,0.415231375320277,1,54,actomyosin,CC,STX1A
12890,GO:0051225,0.863484709575037,0.326105454495876,2,99,spindle assembly,BP,BIRC3;BIRC2
1873,GO:0004536,0.86358070214691,0.413351816246649,1,61,deoxyribonuclease activity,MF,ISG20
11039,GO:0045017,0.863713366665679,0.250824221505834,5,212,glycerolipid biosynthetic process,BP,PLAUR;LDLR;PIP5K1A;PTPN11;ETNK1
12538,GO:0050684,0.863739657861163,0.325624861537437,2,100,regulation of mRNA processing,BP,ZFP36L1;PRPF19
7039,GO:0030811,0.863821933998732,0.413365203298582,1,55,regulation of nucleotide catabolic process,BP,NUP153
17796,GO:1901879,0.864271199588212,0.412468864619037,1,55,regulation of protein depolymerization,BP,NAV3
2852,GO:0006338,0.86432051453258,0.286459028600588,3,155,chromatin remodeling,BP,KDM6B;SOX9;KDM6A
2585,GO:0005876,0.864365661173333,0.4121904208722,1,56,spindle microtubule,CC,KLHL21
2898,GO:0006406,0.865284756172359,0.322812724345831,2,103,mRNA export from nucleus,BP,NUP153;AGFG1
15256,GO:0071427,0.865284756172359,0.322812724345831,2,103,mRNA-containing ribonucleoprotein complex export from nucleus,BP,NUP153;AGFG1
8973,GO:0035064,0.865677482568942,0.409563528463974,1,56,methylated histone binding,MF,UHRF1
17283,GO:0140034,0.865677482568942,0.409563528463974,1,56,methylation-dependent protein binding,MF,UHRF1
10689,GO:0043967,0.86626399256769,0.408133904151593,1,59,histone H4 acetylation,BP,TRIM16
3920,GO:0008589,0.866449564709687,0.408194318195587,1,54,regulation of smoothened signaling pathway,BP,KCTD11
9883,GO:0042158,0.866909323721538,0.319713726579889,2,111,lipoprotein biosynthetic process,BP,PLAUR;RAET1L
20181,GO:2001021,0.867090186078803,0.406242672772934,1,62,negative regulation of response to DNA damage stimulus,BP,PPP1R10
2834,GO:0006303,0.867308130500426,0.405470819499741,1,67,double-strand break repair via nonhomologous end joining,BP,PRPF19
10416,GO:0043255,0.868009475788328,0.405044375877848,1,54,regulation of carbohydrate biosynthetic process,BP,NFKB1
10383,GO:0043204,0.868322993582423,0.404055835299653,1,58,perikaryon,CC,PDPK1
6370,GO:0021549,0.868759653922133,0.403339866900137,1,56,cerebellum development,BP,PTPN11
3624,GO:0008081,0.86877999512569,0.403211934652107,1,57,phosphoric diester hydrolase activity,MF,SMPD3
8885,GO:0034702,0.868811200285938,0.316701554701661,2,99,ion channel complex,CC,CLDN4;STX1A
7217,GO:0031110,0.868872082261227,0.403024845346787,1,57,regulation of microtubule polymerization or depolymerization,BP,NAV3
8265,GO:0033047,0.869050499243118,0.402344434199152,1,61,regulation of mitotic sister chromatid segregation,BP,DUSP1
5610,GO:0016651,0.870053369079967,0.399105700679832,1,83,oxidoreductase activity, acting on NAD(P)H,MF,TXNRD1
5560,GO:0016570,0.872201587761365,0.203724574895191,10,389,histone modification,BP,IL1B;KDM6B;LIF;TRIM16;USP36;ZNF451;UHRF1;HDAC9;KDM6A;ATXN7
7699,GO:0032155,0.873145506178212,0.394185749471634,1,58,cell division site part,CC,RHOB
15874,GO:0072599,0.873676838183581,0.390992021577681,1,104,establishment of protein localization to endoplasmic reticulum,BP,PMM2
3580,GO:0007626,0.876250680696622,0.303230661612193,2,102,locomotory behavior,BP,ALDH1A3;NRG1
12165,GO:0048284,0.876455332229409,0.266524271703447,3,146,organelle fusion,BP,STX1A;TAP1;STX12
1489,GO:0003824,0.877134661358671,0.146099967949611,133,4344,catalytic activity,MF,TNFAIP3;ZC3H12A;BIRC3;HBEGF;PLAU;CSF2;ITPKC;PPIF;NUAK2;ZC3H12C;PTGS2;RNF19B;PRDM1;NOCT;KDM6B;ODC1;HAS3;IRAK2;EPHA2;KCTD11;SQSTM1;RRAD;BMP2;CAB39;MAP2K3;RAP2B;BIRC2;CDKN1A;NMNAT2;TJP2;NAMPT;AMPD3;RND3;DUSP16;UGCG;MAST4;HMGCS1;EREG;SOD2;PELI1;ALDH1A3;DUSP8;B4GALT1;HAL;DUSP1;HEPHL1;PIM3;B3GNT5;SGMS2;TXNRD1;CYLD;ADAM8;NEDD4L;OXSR1;RC3H1;DUSP10;PLK2;PLK3;PIM1;LIPG;KLHL21;F3;STK40;USP36;CYP27B1;AZIN1;RIPK2;PHKG2;PIP5K1A;CLK4;SOX9;NRG1;ZNF451;PPTC7;POLR3A;PTPN11;MAP3K8;UHRF1;PANK3;RHOB;ABCA5;GCH1;FEM1B;USP31;OXCT1;TNFAIP1;HDAC9;ADAMTS1;AEN;HEXDC;CDK6;YRDC;PTPN1;SQLE;STEAP4;PRPF19;ABL2;ATP6V1C2;PMM2;MAOA;ADAM9;PDPK1;ADAMTS9;RNF19A;CTSC;ERO1A;KDM6A;SGK1;B3GNT2;SAT1;RNF11;BACH1;BTAF1;ANKK1;POLR3D;ALAS1;TDG;RAB22A;ERN1;ETNK1;SH3RF2;UPP1;ISG20;ATXN7;IFIH1;ATP13A3;ADAMTS6;MYO1B;TAP1;DSE;AHCY;RAB24;SMPD3
2802,GO:0006260,0.877923820711822,0.219042344683355,6,260,DNA replication,BP,CSF2;JUN;EREG;AREG;TNFAIP1;GINS3
15479,GO:0071826,0.878282939374109,0.242367718221467,4,205,ribonucleoprotein complex subunit organization,BP,NOCT;RC3H1;PRPF19;CELF1
5996,GO:0018995,0.878666133556633,0.382422803694515,1,61,host,CC,NUP153
10646,GO:0043657,0.878666133556633,0.382422803694515,1,61,host cell,CC,NUP153
10769,GO:0044215,0.878666133556633,0.382422803694515,1,61,other organism,CC,NUP153
10770,GO:0044216,0.878666133556633,0.382422803694515,1,61,other organism cell,CC,NUP153
10771,GO:0044217,0.878666133556633,0.382422803694515,1,61,other organism part,CC,NUP153
11837,GO:0046785,0.879776007038897,0.380227524691226,1,59,microtubule polymerization,BP,NAV3
20234,GO:2001169,0.880659025044698,0.378273820933765,1,60,regulation of ATP biosynthetic process,BP,NUP153
3601,GO:0008037,0.880703359394013,0.37803145931462,1,62,cell recognition,BP,B4GALT1
135,GO:0000281,0.881608439440695,0.37624945516378,1,60,mitotic cytokinesis,BP,RHOB
14183,GO:0061077,0.882017575401444,0.374896019152974,1,67,chaperone-mediated protein folding,BP,ERO1A
6894,GO:0030425,0.884623179089815,0.190606316125212,9,360,dendrite,CC,N4BP3;SACS;IL6ST;PLK2;PLK3;NRG1;RBM3;SAMD4A;ERO1A
16609,GO:0097447,0.884623179089815,0.190606316125212,9,360,dendritic tree,CC,N4BP3;SACS;IL6ST;PLK2;PLK3;NRG1;RBM3;SAMD4A;ERO1A
12627,GO:0050808,0.885107011627743,0.231692787923287,4,175,synapse organization,BP,EFNA1;NRG1;WNT5A;PDLIM5
1878,GO:0004553,0.885477868389054,0.367770147524749,1,62,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,HEXDC
4254,GO:0009566,0.886155896313941,0.365966616115448,1,67,fertilization,BP,B4GALT1
10966,GO:0044728,0.88663796486078,0.365319043027716,1,61,DNA methylation or demethylation,BP,TDG
855,GO:0002181,0.886779617007249,0.363744099715671,1,85,cytoplasmic translation,BP,CPEB2
3307,GO:0007009,0.887037556293051,0.364521938350032,1,60,plasma membrane organization,BP,NDRG1
2818,GO:0006283,0.887183893748856,0.363389339824817,1,73,transcription-coupled nucleotide-excision repair,BP,PRPF19
5559,GO:0016569,0.88740927840963,0.182587635089373,10,397,covalent chromatin modification,BP,IL1B;KDM6B;LIF;TRIM16;USP36;ZNF451;UHRF1;HDAC9;KDM6A;ATXN7
2492,GO:0005739,0.887652449949231,0.148793842720524,36,1425,mitochondrion,CC,PPIF;PMAIP1;NFKB1;MAFF;BCL2L2;PPP1R15A;SOD2;SACS;G0S2;TXNRD1;ZNF217;BBC3;CREB1;SLC25A25;SLC9A1;CYP27B1;STARD5;TP53BP2;PPTC7;ELK3;PTPN11;MXD1;SOX4;OXCT1;HIVEP1;YRDC;TMEM65;MAOA;YWHAH;SGK1;ALAS1;YWHAG;SFN;ERN1;TAP1;RAB24
8309,GO:0033143,0.888005982183002,0.362254922784931,1,62,regulation of intracellular steroid hormone receptor signaling pathway,BP,RUNX1
10651,GO:0043687,0.889146605603902,0.194672778698796,7,318,post-translational protein modification,BP,DCUN1D3;KLHL21;SOCS3;RAET1L;FEM1C;FEM1B;TMEM132A
7010,GO:0030695,0.889728947198543,0.20131142981208,6,248,GTPase regulator activity,MF,ERRFI1;CPEB2;JUN;RASA2;CDC42EP1;AGFG1
2287,GO:0005244,0.891062883388312,0.355508063439064,1,62,voltage-gated ion channel activity,MF,ITGAV
6614,GO:0022832,0.891062883388312,0.355508063439064,1,62,voltage-gated channel activity,MF,ITGAV
6574,GO:0022037,0.891358185471196,0.354924006077358,1,61,metencephalon development,BP,PTPN11
12075,GO:0048024,0.892001578746113,0.353281097210417,1,64,regulation of mRNA splicing, via spliceosome,BP,PRPF19
12942,GO:0051298,0.892130393218976,0.353203691554381,1,61,centrosome duplication,BP,PLK2
6747,GO:0030165,0.892487298452466,0.352481352495716,1,60,PDZ domain binding,MF,DAPP1
7976,GO:0032588,0.89281005241935,0.351409479942322,1,65,trans-Golgi network membrane,CC,MYO1B
13118,GO:0051650,0.893111820196608,0.218428064313862,4,188,establishment of vesicle localization,BP,TGFA;STX1A;AREG;CTSC
4075,GO:0009127,0.894754534847546,0.268312004727738,2,115,purine nucleoside monophosphate biosynthetic process,BP,AMPD3;NUP153
4114,GO:0009168,0.894754534847546,0.268312004727738,2,115,purine ribonucleoside monophosphate biosynthetic process,BP,AMPD3;NUP153
3360,GO:0007098,0.89565836835414,0.266748983153796,2,108,centrosome cycle,BP,GADD45A;PLK2
260,GO:0000726,0.895870038077859,0.344008955048077,1,74,non-recombinational repair,BP,PRPF19
17727,GO:1901655,0.896097030570951,0.344002250519172,1,65,cellular response to ketone,BP,ERRFI1
2739,GO:0006119,0.89629053689198,0.342217323688739,1,96,oxidative phosphorylation,BP,PPIF
10976,GO:0044766,0.896696971753115,0.342454542935281,1,68,multi-organism transport,BP,NUP153
18050,GO:1902579,0.896696971753115,0.342454542935281,1,68,multi-organism localization,BP,NUP153
2862,GO:0006354,0.897045331598655,0.263759661116248,2,121,DNA-templated transcription, elongation,BP,TAF4B;ELL2
1453,GO:0003684,0.89707058794662,0.34172475736202,1,66,damaged DNA binding,MF,TDG
10499,GO:0043401,0.89717695923703,0.230754414443348,3,149,steroid hormone mediated signaling pathway,BP,RUNX1;PPARD;YWHAH
10280,GO:0043025,0.897586000148382,0.189120400369117,6,266,neuronal cell body,CC,ENC1;IL6ST;PLK3;PMM2;PDPK1;AGFG1
4024,GO:0009055,0.897925662417107,0.338747645462457,1,88,electron transfer activity,MF,TXNRD1
10433,GO:0043279,0.89825471844478,0.339019041509073,1,66,response to alkaloid,BP,RELA
3912,GO:0008565,0.899147300952356,0.336681356446175,1,71,protein transporter activity,MF,IPO4
3880,GO:0008509,0.899154153870099,0.208353308716822,4,189,anion transmembrane transporter activity,MF,CLDN4;SLC6A14;SLC25A25;SLC7A2
10354,GO:0043167,0.899722825382042,0.120313356569414,138,4367,ion binding,MF,TNFAIP3;IL1A;ZC3H12A;BIRC3;HBEGF;ITPKC;KLF6;NUAK2;ZC3H12C;ZNF697;PTGS2;RNF19B;PRDM1;NOCT;PLEKHF1;KDM6B;IRAK2;KLF7;CREB5;DAPP1;EPHA2;SQSTM1;RRAD;ZNF267;MAP2K3;RAP2B;BIRC2;CDKN1A;NMNAT2;OVOL1;AMPD3;ZFP36L1;RND3;MAST4;RUNX1;TRIM16;SOD2;ALDH1A3;EHD1;ZSWIM4;B4GALT1;FGD6;HEPHL1;TRAF1;PPP1R10;PIM3;TXNRD1;CYLD;ADAM8;LDLR;KLF3;ZNF217;OXSR1;SMAD3;RC3H1;PLK2;PLK3;PIM1;WISP1;ITGA5;LIPG;F3;STK40;HIVEP2;PPARD;SLC25A25;ZFP36;SLC9A1;CYP27B1;ANTXR2;JAG1;PLAGL2;RIPK2;PHKG2;NAV3;SAA1;STARD5;ITGAV;PIP5K1A;CLK4;ZNF451;PML;RASA2;PPTC7;POLR3A;ZNF460;MAP3K8;UHRF1;PANK3;EFHD2;IRGQ;RHOB;ABCA5;GCH1;TRAF4;HDAC9;ADAMTS1;HIVEP1;KLF10;CDK6;PTPN1;SQLE;STEAP4;ABL2;MTF1;WNT5A;NUP153;ADAM9;PDPK1;ADAMTS9;RNF19A;CTSC;KDM6A;ZBTB21;SGK1;SAT1;RELA;AGFG1;RNF11;NOTCH2NL;BTAF1;ANKK1;ALAS1;TDG;RAB22A;ITM2B;ERN1;ETNK1;SH3RF2;ISG20;IFIH1;ATP13A3;ADAMTS6;MYO1B;TAP1;PDLIM5;RAB24;SMPD3
16869,GO:0098800,0.899724273397238,0.334279454490153,1,99,inner mitochondrial membrane protein complex,CC,PPIF
6900,GO:0030433,0.900025549840546,0.33482580471747,1,68,ubiquitin-dependent ERAD pathway,BP,NFE2L2
13780,GO:0060359,0.900723218826429,0.333271905024442,1,67,response to ammonium ion,BP,RELA
6933,GO:0030534,0.901117358761078,0.33248241328088,1,65,adult behavior,BP,MAFG
8983,GO:0035091,0.901593926805518,0.204267574823083,4,187,phosphatidylinositol binding,MF,PLEKHF1;DAPP1;SLC9A1;MYO1B
19235,GO:1905368,0.901825722216702,0.329861188070139,1,85,peptidase complex,CC,F3
5693,GO:0016811,0.901827513957427,0.330535514526397,1,70,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,HDAC9
12948,GO:0051304,0.902524751310542,0.328966169407959,1,69,chromosome separation,BP,DUSP1
20286,GO:2001251,0.902696123159354,0.252948942906965,2,111,negative regulation of chromosome organization,BP,DUSP1;ZNF451
3047,GO:0006605,0.902982696795968,0.173683984261056,7,368,protein targeting,BP,UGCG;USP36;PLAGL2;NRG1;RAB3IP;PMM2;YWHAG
7061,GO:0030838,0.903225531024741,0.327217704530221,1,71,positive regulation of actin filament polymerization,BP,CDC42EP1
2892,GO:0006400,0.903499972661439,0.326421116389183,1,74,tRNA modification,BP,YRDC
7002,GO:0030684,0.904288089214211,0.324570113975553,1,74,preribosome,CC,DIEXF
8263,GO:0033045,0.904543613972149,0.324175885702285,1,70,regulation of sister chromatid segregation,BP,DUSP1
10809,GO:0044297,0.906296134406135,0.168821260185402,7,310,cell body,CC,ENC1;IL6ST;PLK3;NRG1;PMM2;PDPK1;AGFG1
10381,GO:0043202,0.906706777787048,0.319000620562681,1,71,lysosomal lumen,CC,SDC4
7971,GO:0032580,0.906766614748705,0.319083453403856,1,67,Golgi cisterna membrane,CC,B4GALT1
3630,GO:0008092,0.907274543866692,0.137867656576175,18,671,cytoskeletal protein binding,MF,NFKB1;PANX1;ENC1;B4GALT1;KLHL21;NAV3;NDRG1;STX1A;SPAG9;VCL;COTL1;CORO1C;ABL2;SMTN;YWHAH;RELA;MYO1B;PDLIM5
13116,GO:0051648,0.907318409335367,0.194466997433565,4,194,vesicle localization,BP,TGFA;STX1A;AREG;CTSC
3336,GO:0007051,0.907905175969785,0.211379340389422,3,155,spindle organization,BP,BIRC3;BIRC2;PLK2
5859,GO:0017156,0.908306625197199,0.315404749924773,1,67,calcium ion regulated exocytosis,BP,STX1A
3562,GO:0007605,0.908444946291996,0.314902158334293,1,70,sensory perception of sound,BP,USP53
5283,GO:0015934,0.90863736189478,0.312954959798266,1,115,large ribosomal subunit,CC,RBM3
9879,GO:0042147,0.908801299423402,0.314158872793651,1,68,retrograde transport, endosome to Golgi,BP,SPAG9
4145,GO:0009205,0.909081616992923,0.19115046302672,4,232,purine ribonucleoside triphosphate metabolic process,BP,PPIF;AMPD3;SLC25A25;NUP153
4858,GO:0014069,0.909318981992269,0.20890691288452,3,147,postsynaptic density,CC,STX1A;PDPK1;PDLIM5
11896,GO:0046916,0.910227466737017,0.310263445852254,1,77,cellular transition metal ion homeostasis,BP,TFRC
11689,GO:0046474,0.910275271563848,0.189383816162715,4,194,glycerophospholipid biosynthetic process,BP,PLAUR;PIP5K1A;PTPN11;ETNK1
8230,GO:0032993,0.910465203289207,0.236563024066647,2,163,protein-DNA complex,CC,PRPF19;NFE2L2
6927,GO:0030518,0.910987727777929,0.236288191407987,2,114,intracellular steroid hormone receptor signaling pathway,BP,RUNX1;YWHAH
15255,GO:0071426,0.911029513273859,0.236052081505647,2,121,ribonucleoprotein complex export from nucleus,BP,NUP153;AGFG1
14388,GO:0061640,0.911039708452903,0.308695488476958,1,69,cytoskeleton-dependent cytokinesis,BP,RHOB
2954,GO:0006486,0.911286595714513,0.187574937921555,4,201,protein glycosylation,BP,B4GALT1;B3GNT5;PMM2;B3GNT2
10509,GO:0043413,0.911286595714513,0.187574937921555,4,201,macromolecule glycosylation,BP,B4GALT1;B3GNT5;PMM2;B3GNT2
17073,GO:0099572,0.91186945362318,0.204197637971196,3,148,postsynaptic specialization,CC,STX1A;PDPK1;PDLIM5
18013,GO:1902494,0.911872742879596,0.120737797565033,32,1230,catalytic complex,CC,TICAM1;RNF19B;KDM6B;CAB39;CDKN1A;TAF4B;ENC1;PPP1R15A;ELMSAN1;ZSWIM4;DCUN1D3;PPP1R10;ZNF217;KLHL21;F3;ZFP36;SLC9A1;PHKG2;PPP1R15B;POLR3A;CCNL1;TNFAIP1;HDAC9;CDK6;IER5;PRPF19;RNF19A;KDM6A;RNF11;BACH1;POLR3D;ERN1
16808,GO:0098656,0.912840210762035,0.202317260561916,3,154,anion transmembrane transport,BP,CLDN4;SLC6A14;SLC7A2
3623,GO:0008080,0.912920887006954,0.303947365707257,1,72,N-acetyltransferase activity,MF,SAT1
15109,GO:0071166,0.91317919171584,0.231652700136494,2,122,ribonucleoprotein complex localization,BP,NUP153;AGFG1
19662,GO:1990904,0.913378737072742,0.13380087001459,15,701,ribonucleoprotein complex,CC,NFKBIZ;ZC3H12A;NOCT;CPEB2;SQSTM1;ZFP36L1;RC3H1;DIEXF;ZFP36;LARP4B;PNRC1;RBM3;SAMD4A;PRPF19;PABPC4
12876,GO:0051196,0.913843687401488,0.301897757667295,1,68,regulation of coenzyme metabolic process,BP,NUP153
7764,GO:0032279,0.914038157975089,0.200162990980359,3,149,asymmetric synapse,CC,STX1A;PDPK1;PDLIM5
5593,GO:0016616,0.914606348266344,0.299316912542339,1,83,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,BMP2
10532,GO:0043473,0.915202179937758,0.298277932826531,1,73,pigmentation,BP,ADAMTS9
7162,GO:0031023,0.915953709167613,0.226096119997214,2,115,microtubule organizing center organization,BP,GADD45A;PLK2
3321,GO:0007030,0.916270469311484,0.225463515389711,2,114,Golgi organization,BP,VMP1;PLK3
2212,GO:0005096,0.917605137578948,0.165507813566762,5,225,GTPase activator activity,MF,ERRFI1;JUN;RASA2;CDC42EP1;AGFG1
3325,GO:0007034,0.918231689756683,0.221284247882266,2,119,vacuolar transport,BP,ADRB2;RHOB
16968,GO:0098984,0.918849771441857,0.19111925801153,3,151,neuron to neuron synapse,CC,STX1A;PDPK1;PDLIM5
3297,GO:0006996,0.919531658560898,0.0998745104767782,91,3094,organelle organization,BP,IL1B;IL1A;CXCL1;PLAUR;BIRC3;CSF2;SDC4;ETS1;TNF;PPIF;NUAK2;PMAIP1;NOCT;PLEKHF1;TGFA;KDM6B;EDN1;GADD45A;LIF;SQSTM1;JUN;BIRC2;PHLDB2;RND3;ADRB2;UGCG;MAST4;TRIM16;EREG;SOD2;EHD1;NEDD9;ANKLE2;DUSP1;FGD6;TMCC1;PPP1R10;VMP1;CYLD;TACSTD2;SMAD3;RC3H1;PLK2;BBC3;PLK3;CREB1;USP36;SLC9A1;PLAGL2;AMOTL2;NAV3;PIP5K1A;TP53BP2;SOX9;STX1A;NRG1;ZNF451;PML;CDC42EP1;UHRF1;RHOB;AREG;AKAP2;TNFAIP1;HDAC9;PTPN1;CORO1C;ABL2;ATP6V1C2;RAB3IP;WNT5A;NUP153;INSIG1;PDPK1;RNF19A;CTSC;KDM6A;FRMD6;YWHAH;AGFG1;ALAS1;YWHAG;TDG;RAB22A;SFN;ATXN7;MYO1B;BRD2;IPO4;TAP1;STX12
4091,GO:0009144,0.919721564701767,0.172555155454533,4,239,purine nucleoside triphosphate metabolic process,BP,PPIF;AMPD3;SLC25A25;NUP153
4139,GO:0009199,0.919745264495011,0.172518920223082,4,238,ribonucleoside triphosphate metabolic process,BP,PPIF;AMPD3;SLC25A25;NUP153
1706,GO:0004197,0.92008541810603,0.285941335035329,1,75,cysteine-type endopeptidase activity,MF,CTSC
3070,GO:0006637,0.920209253225675,0.285536954956247,1,77,acyl-CoA metabolic process,BP,HMGCS1
9106,GO:0035383,0.920209253225675,0.285536954956247,1,77,thioester metabolic process,BP,HMGCS1
12721,GO:0050954,0.92059355465613,0.284697226063975,1,74,sensory perception of mechanical stimulus,BP,USP53
2477,GO:0005694,0.920852224441364,0.115532949858603,22,883,chromosome,CC,KDM6B;JUN;BIRC2;JUNB;IRF1;ENC1;CEBPB;PPP1R10;NABP1;SMAD3;PLK2;CREB1;PPARD;PML;UHRF1;MXD1;PRPF19;KDM6A;NFE2L2;RELA;POLR3D;IPO4
6135,GO:0019395,0.921658790971606,0.281800390603863,1,78,fatty acid oxidation,BP,PPARD
14557,GO:0070085,0.922247946452606,0.168276099696016,4,207,glycosylation,BP,B4GALT1;B3GNT5;PMM2;B3GNT2
11868,GO:0046872,0.923449385624163,0.0954210672340144,89,2926,metal ion binding,MF,TNFAIP3;IL1A;ZC3H12A;BIRC3;KLF6;NUAK2;ZC3H12C;ZNF697;PTGS2;RNF19B;PRDM1;NOCT;PLEKHF1;KDM6B;KLF7;CREB5;SQSTM1;ZNF267;BIRC2;CDKN1A;OVOL1;AMPD3;ZFP36L1;MAST4;TRIM16;SOD2;EHD1;ZSWIM4;B4GALT1;FGD6;HEPHL1;TRAF1;PPP1R10;CYLD;ADAM8;LDLR;KLF3;ZNF217;OXSR1;SMAD3;RC3H1;PIM1;ITGA5;HIVEP2;PPARD;SLC25A25;ZFP36;CYP27B1;ANTXR2;JAG1;PLAGL2;ITGAV;ZNF451;PML;RASA2;PPTC7;POLR3A;ZNF460;MAP3K8;UHRF1;EFHD2;GCH1;TRAF4;HDAC9;ADAMTS1;HIVEP1;KLF10;PTPN1;STEAP4;ABL2;MTF1;NUP153;ADAM9;ADAMTS9;RNF19A;KDM6A;ZBTB21;AGFG1;RNF11;NOTCH2NL;TDG;ERN1;SH3RF2;ISG20;IFIH1;ATP13A3;ADAMTS6;PDLIM5;SMPD3
17252,GO:0120034,0.923607349733289,0.277067769715655,1,72,positive regulation of plasma membrane bounded cell projection assembly,BP,CDC42EP1
8766,GO:0034440,0.923739917770653,0.276407948276,1,79,lipid oxidation,BP,PPARD
7422,GO:0031514,0.924012819324413,0.275830652512201,1,76,motile cilium,CC,SQSTM1
8886,GO:0034703,0.926081458309483,0.270584663309636,1,73,cation channel complex,CC,STX1A
8861,GO:0034660,0.926154142887775,0.123555787169617,11,545,ncRNA metabolic process,BP,ZC3H12A;NFKB1;NABP1;SMAD3;DIEXF;USP36;ELL2;POU2F2;YRDC;RELA;ISG20
3066,GO:0006631,0.926357089121216,0.150451549210205,5,259,fatty acid metabolic process,BP,PTGS2;EDN1;PPARD;QKI;INSIG1
10356,GO:0043169,0.927689233088156,0.0903315648555711,90,2968,cation binding,MF,TNFAIP3;IL1A;ZC3H12A;BIRC3;KLF6;NUAK2;ZC3H12C;ZNF697;PTGS2;RNF19B;PRDM1;NOCT;PLEKHF1;KDM6B;KLF7;CREB5;SQSTM1;ZNF267;BIRC2;CDKN1A;OVOL1;AMPD3;ZFP36L1;MAST4;TRIM16;SOD2;EHD1;ZSWIM4;B4GALT1;FGD6;HEPHL1;TRAF1;PPP1R10;CYLD;ADAM8;LDLR;KLF3;ZNF217;OXSR1;SMAD3;RC3H1;PIM1;ITGA5;HIVEP2;PPARD;SLC25A25;ZFP36;CYP27B1;ANTXR2;JAG1;PLAGL2;ITGAV;ZNF451;PML;RASA2;PPTC7;POLR3A;ZNF460;MAP3K8;UHRF1;EFHD2;GCH1;TRAF4;HDAC9;ADAMTS1;HIVEP1;KLF10;PTPN1;STEAP4;ABL2;MTF1;NUP153;ADAM9;ADAMTS9;RNF19A;KDM6A;ZBTB21;SAT1;AGFG1;RNF11;NOTCH2NL;TDG;ERN1;SH3RF2;ISG20;IFIH1;ATP13A3;ADAMTS6;PDLIM5;SMPD3
2719,GO:0006096,0.928001965110014,0.265438878776772,1,75,glycolytic process,BP,NUP153
3155,GO:0006757,0.928001965110014,0.265438878776772,1,75,ATP generation from ADP,BP,NUP153
2273,GO:0005215,0.929554747461145,0.108676258535147,17,683,transporter activity,MF,TRPV3;PANX1;CLDN4;SLC6A14;TFRC;GJB3;SLC25A25;SLC9A1;STARD5;ITGAV;SLC7A2;SLC28A3;ABCA5;ATP6V1C2;ATP13A3;IPO4;TAP1
16422,GO:0097060,0.929802239264568,0.16999022954938,3,157,synaptic membrane,CC,FOSL1;STX1A;PDLIM5
5803,GO:0017053,0.930487841859119,0.258913272104892,1,73,transcriptional repressor complex,CC,JUN
3455,GO:0007269,0.930872075774297,0.25779009553185,1,75,neurotransmitter secretion,BP,STX1A
17102,GO:0099643,0.930872075774297,0.25779009553185,1,75,signal release from synapse,BP,STX1A
2835,GO:0006304,0.931318993997072,0.256418412309063,1,79,DNA modification,BP,TDG
2270,GO:0005200,0.932517394510667,0.253181463521315,1,79,structural constituent of cytoskeleton,MF,FRMD6
10219,GO:0042866,0.932736496789345,0.252669537066516,1,77,pyruvate biosynthetic process,BP,NUP153
8104,GO:0032787,0.933388073037679,0.118203786534763,9,417,monocarboxylic acid metabolic process,BP,PTGS2;EDN1;ALDH1A3;HAL;PPARD;QKI;NUP153;INSIG1;DSE
17036,GO:0099513,0.933802876018537,0.112272180925869,11,471,polymeric cytoskeletal fiber,CC,BCL10;CYLD;KLHL21;KRT34;KRTAP2-3;IFFO2;NAV3;SAA1;NDRG1;FERMT1;MYO1B
10900,GO:0044446,0.93406327352624,0.0801810787826545,216,7071,intracellular organelle part,CC,NFKBIZ;ZC3H12A;CXCL1;PLAUR;BIRC3;HBEGF;PLAU;ITPKC;TICAM1;ELF3;SDC4;ETS1;REL;PPIF;KLF6;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;NFKB2;NOCT;PLEKHF1;TGFA;KDM6B;EDN1;PHLDA1;IRAK2;PANX1;EHF;RELB;GADD45A;MAFF;SQSTM1;IFNGR2;CAB39;MAP2K3;JUN;RAP2B;NFKBIE;CDKN1A;NMNAT2;TJP2;SERTAD2;JUNB;BCL3;ETS2;NAMPT;AMPD3;IRF1;TAF4B;BCL2L2;ENC1;RND3;ADRB2;CEBPB;DUSP16;ARNTL2;UGCG;PPP1R15A;RUNX1;N4BP1;GJB4;TRIM16;ELMSAN1;SOD2;C3ORF52;EHD1;NEDD9;ANKLE2;B4GALT1;BCL10;TMCC1;PPP1R10;B3GNT5;SGMS2;VMP1;NABP1;TXNRD1;CYLD;ADAM8;LDLR;VEGFC;KLF3;ZNF217;NEDD4L;SMAD3;IL23A;DUSP10;PLK2;PLK3;DIEXF;PIM1;TFRC;AKIRIN1;KLHL21;CREB1;STK40;HIVEP2;PPARD;KRT34;SLC25A25;SERPINB1;CCDC85B;KRTAP2-3;USP36;IL16;RAPH1;SLC9A1;MAFK;LARP4B;CYP27B1;IFFO2;CD55;TMEM217;ELL2;ANTXR2;NAV3;SAA1;NDRG1;ITGAV;PIP5K1A;TP53BP2;SOX9;STX1A;NRG1;ZNF451;FEM1C;PML;POU2F2;FERMT1;ELK3;POLR3A;SLC28A3;PTPN11;UHRF1;MXD1;RHOB;SPAG9;ABCA5;GCH1;FEM1B;SOX4;FOSL2;VCL;OXCT1;AREG;CCNL1;TNFAIP1;HDAC9;HIVEP1;AEN;SKIL;COTL1;IL7R;RBM3;CDK6;SAMD4A;PTPN1;SQLE;TFE3;TMEM65;STEAP4;PRPF19;MAFG;MTF1;ATP6V1C2;HLA-E;CELF1;WNT5A;NUP153;MAOA;INSIG1;PDPK1;RNF19A;CTSC;ERO1A;KDM6A;ZBTB21;NFE2L2;YWHAH;SGK1;B3GNT2;CYTH1;RELA;AGFG1;RNF11;BTAF1;GINS3;POLR3D;ALAS1;YWHAG;TDG;ELF4;RAB22A;CREG1;SFN;ITM2B;ERN1;ETNK1;SH3RF2;UPP1;ISG20;TMEM132A;ATXN7;MYO1B;BRD2;IPO4;TAP1;DSE;STX12;RAB24;SMPD3
12231,GO:0048489,0.93428287771117,0.248497150228111,1,76,synaptic vesicle transport,BP,STX1A
16625,GO:0097480,0.93428287771117,0.248497150228111,1,76,establishment of synaptic vesicle localization,BP,STX1A
110,GO:0000226,0.934405596328246,0.113814521540568,10,427,microtubule cytoskeleton organization,BP,BIRC3;GADD45A;BIRC2;PHLDB2;CYLD;PLK2;PLK3;NAV3;RNF19A;ATXN7
94,GO:0000184,0.934559693176844,0.246562231012591,1,119,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,PNRC1
12918,GO:0051261,0.934912593902572,0.246813546934616,1,75,protein depolymerization,BP,NAV3
16616,GO:0097458,0.935198704528039,0.0943161352434565,25,940,neuron part,CC,PTGS2;FOSL1;CPEB2;EPHA2;SQSTM1;N4BP3;ENC1;SACS;IL6ST;LDLR;PLK2;PLK3;CREB1;BDKRB1;STX1A;NRG1;GCH1;RBM3;SAMD4A;PMM2;PDPK1;ERO1A;AGFG1;AHCY;PDLIM5
10817,GO:0044306,0.935488907796056,0.245060178214936,1,79,neuron projection terminus,CC,GCH1
2853,GO:0006342,0.936619248239219,0.241121278511166,1,107,chromatin silencing,BP,UHRF1
2897,GO:0006405,0.936960861308344,0.180543656709333,2,133,RNA export from nucleus,BP,NUP153;AGFG1
6260,GO:0019842,0.938055943033981,0.237747174563568,1,84,vitamin binding,MF,ALAS1
6586,GO:0022411,0.938827468673682,0.106935232445805,10,476,cellular component disassembly,BP,ETS1;TNF;SQSTM1;ADRB2;ADAM8;PLK3;USP36;NAV3;NUP153;LAMB3
17051,GO:0099531,0.93913734365325,0.23485734024733,1,80,presynaptic process involved in chemical synaptic transmission,BP,STX1A
2546,GO:0005813,0.939401119199171,0.106107989772786,10,440,centrosome,CC,RELB;CYLD;PLK2;PLK3;CCDC85B;NDRG1;CDK6;RNF19A;CTSC;NFE2L2
4982,GO:0015103,0.939488712895478,0.233985281088493,1,77,inorganic anion transmembrane transporter activity,MF,CLDN4
5381,GO:0016197,0.940253722637527,0.148953399462404,3,175,endosomal transport,BP,SQSTM1;EHD1;SPAG9
13394,GO:0052689,0.940364542129804,0.231210943429102,1,85,carboxylic ester hydrolase activity,MF,LIPG
5591,GO:0016614,0.940369682269719,0.230951974584354,1,93,oxidoreductase activity, acting on CH-OH group of donors,MF,BMP2
7303,GO:0031301,0.940827319171937,0.171681477469984,2,140,integral component of organelle membrane,CC,SGMS2;ITM2B
5565,GO:0016575,0.940853636861568,0.229999235077336,1,80,histone deacetylation,BP,HDAC9
10386,GO:0043209,0.940915288798275,0.171493418377603,2,139,myelin sheath,CC,NDRG1;YWHAG
13930,GO:0060589,0.940999462302899,0.118345220699954,6,283,nucleoside-triphosphatase regulator activity,MF,ERRFI1;CPEB2;JUN;RASA2;CDC42EP1;AGFG1
19071,GO:1904949,0.941243512132436,0.228851388410394,1,81,ATPase complex,CC,SLC9A1
16624,GO:0097479,0.94197377613652,0.226839086831305,1,79,synaptic vesicle localization,BP,STX1A
14150,GO:0061025,0.942055468339105,0.145257984718567,3,177,membrane fusion,BP,STX1A;TAP1;STX12
2817,GO:0006282,0.942505132213972,0.225168055900418,1,83,regulation of DNA repair,BP,PML
4088,GO:0009141,0.942524177889973,0.13069427574132,4,256,nucleoside triphosphate metabolic process,BP,PPIF;AMPD3;SLC25A25;NUP153
4031,GO:0009062,0.94270421900855,0.224431982055123,1,88,fatty acid catabolic process,BP,PPARD
2379,GO:0005509,0.944416258260813,0.103914670977742,8,367,calcium ion binding,MF,EHD1;ADAM8;LDLR;SLC25A25;JAG1;EFHD2;GCH1;NOTCH2NL
9635,GO:0036503,0.945530958921899,0.216289870591557,1,86,ERAD pathway,BP,NFE2L2
2756,GO:0006165,0.946012704660704,0.214876681008672,1,86,nucleoside diphosphate phosphorylation,BP,NUP153
23,GO:0000045,0.946066475563363,0.214783639542335,1,84,autophagosome assembly,BP,STX12
14997,GO:0070925,0.946391011052981,0.0869920043578753,15,636,organelle assembly,BP,BIRC3;CSF2;SDC4;TNF;NOCT;EDN1;BIRC2;EHD1;CYLD;RC3H1;PLK2;RAB3IP;AGFG1;YWHAG;STX12
17034,GO:0099504,0.94640579413806,0.213961778627329,1,79,synaptic vesicle cycle,BP,STX1A
5328,GO:0016052,0.946577464101813,0.158416463060209,2,135,carbohydrate catabolic process,BP,PHKG2;NUP153
10265,GO:0043005,0.946926626235287,0.0823396065898231,19,755,neuron projection,CC,PTGS2;FOSL1;CPEB2;EPHA2;N4BP3;SACS;IL6ST;PLK2;PLK3;CREB1;BDKRB1;STX1A;NRG1;GCH1;RBM3;SAMD4A;ERO1A;AHCY;PDLIM5
13129,GO:0051668,0.946935081667205,0.212256697037597,1,83,localization within membrane,BP,INSIG1
5476,GO:0016407,0.94839870885548,0.207750357646735,1,88,acetyltransferase activity,MF,SAT1
7036,GO:0030808,0.949292708206766,0.205135334708311,1,86,regulation of nucleotide biosynthetic process,BP,NUP153
17476,GO:1900371,0.949292708206766,0.205135334708311,1,86,regulation of purine nucleotide biosynthetic process,BP,NUP153
10396,GO:0043228,0.949420868326537,0.0641594843204893,93,3274,non-membrane-bounded organelle,CC,NFKBIZ;ZC3H12A;SDC4;KLF6;NOCT;KDM6B;PHLDA1;RELB;SQSTM1;JUN;BIRC2;NFKBIE;CDKN1A;PHLDB2;JUNB;IRF1;TAF4B;ZFP36L1;ENC1;CEBPB;ARNTL2;N4BP1;GJB4;EHD1;NEDD9;BCL10;FGD6;PPP1R10;G0S2;VMP1;NABP1;TXNRD1;CYLD;ADAM8;SMAD3;RC3H1;PLK2;PLK3;DIEXF;PIM1;KLHL21;CREB1;PPARD;KRT34;CCDC85B;KRTAP2-3;USP36;RAPH1;ZFP36;LARP4B;IFFO2;TMEM217;PNRC1;RIPK2;NAV3;SAA1;NDRG1;STX1A;PML;FERMT1;CDC42EP1;UHRF1;MXD1;SPAG9;TRAF4;VCL;TNFAIP1;AEN;COTL1;RBM3;CDK6;SAMD4A;CORO1C;PRPF19;ABL2;RAB3IP;NUP153;RNF19A;CTSC;KDM6A;FRMD6;SMTN;NFE2L2;RELA;POLR3D;RAB22A;ISG20;ATXN7;MYO1B;IPO4;PABPC4;TAP1;PDLIM5
10400,GO:0043232,0.949420868326537,0.0641594843204893,93,3274,intracellular non-membrane-bounded organelle,CC,NFKBIZ;ZC3H12A;SDC4;KLF6;NOCT;KDM6B;PHLDA1;RELB;SQSTM1;JUN;BIRC2;NFKBIE;CDKN1A;PHLDB2;JUNB;IRF1;TAF4B;ZFP36L1;ENC1;CEBPB;ARNTL2;N4BP1;GJB4;EHD1;NEDD9;BCL10;FGD6;PPP1R10;G0S2;VMP1;NABP1;TXNRD1;CYLD;ADAM8;SMAD3;RC3H1;PLK2;PLK3;DIEXF;PIM1;KLHL21;CREB1;PPARD;KRT34;CCDC85B;KRTAP2-3;USP36;RAPH1;ZFP36;LARP4B;IFFO2;TMEM217;PNRC1;RIPK2;NAV3;SAA1;NDRG1;STX1A;PML;FERMT1;CDC42EP1;UHRF1;MXD1;SPAG9;TRAF4;VCL;TNFAIP1;AEN;COTL1;RBM3;CDK6;SAMD4A;CORO1C;PRPF19;ABL2;RAB3IP;NUP153;RNF19A;CTSC;KDM6A;FRMD6;SMTN;NFE2L2;RELA;POLR3D;RAB22A;ISG20;ATXN7;MYO1B;IPO4;PABPC4;TAP1;PDLIM5
7230,GO:0031124,0.950340103739655,0.201918972053605,1,88,mRNA 3'-end processing,BP,ZFP36L1
2377,GO:0005506,0.950697836545858,0.200806930145904,1,89,iron ion binding,MF,CYP27B1
5779,GO:0016999,0.950772502252285,0.200369760426886,1,97,antibiotic metabolic process,BP,HAL
15057,GO:0071013,0.950977756766347,0.199771584071404,1,96,catalytic step 2 spliceosome,CC,PRPF19
2801,GO:0006259,0.951676425251746,0.0748380126946134,20,843,DNA metabolic process,BP,BTG2;CSF2;GADD45A;JUN;CDKN1A;EREG;DUSP1;PPP1R10;NABP1;TFRC;PML;UHRF1;AREG;TNFAIP1;IL7R;PRPF19;BACH1;GINS3;TDG;ISG20
19109,GO:1905037,0.951870934385752,0.197295453559167,1,87,autophagosome organization,BP,STX12
17035,GO:0099512,0.952032401521183,0.079830611500556,14,598,supramolecular fiber,CC,SDC4;SQSTM1;BCL10;CYLD;KLHL21;KRT34;KRTAP2-3;IFFO2;NAV3;SAA1;NDRG1;FERMT1;VCL;MYO1B
13292,GO:0051983,0.952058611363272,0.196663226461185,1,89,regulation of chromosome segregation,BP,DUSP1
5653,GO:0016746,0.953248561978513,0.121684798168936,3,190,transferase activity, transferring acyl groups,MF,HMGCS1;SAT1;ALAS1
5161,GO:0015698,0.953481102418201,0.192407310910517,1,85,inorganic anion transport,BP,CLDN4
257,GO:0000723,0.953567322285828,0.141481142666267,2,153,telomere maintenance,BP,PPP1R10;PML
2833,GO:0006302,0.953584139554661,0.120937081083827,3,194,double-strand break repair,BP,NABP1;PML;PRPF19
7107,GO:0030902,0.954088870091595,0.19052434523944,1,85,hindbrain development,BP,PTPN11
7216,GO:0031109,0.954133388831286,0.190355646313578,1,86,microtubule polymerization or depolymerization,BP,NAV3
13604,GO:0060071,0.954540709817249,0.18875052742936,1,99,Wnt signaling pathway, planar cell polarity pathway,BP,WNT5A
11908,GO:0046939,0.954577820628796,0.188805071165613,1,92,nucleotide phosphorylation,BP,NUP153
12249,GO:0048524,0.954585623295082,0.188704788273356,1,95,positive regulation of viral process,BP,JUN
12123,GO:0048193,0.955090996440394,0.0934584229637078,6,309,Golgi vesicle transport,BP,TGFA;CD55;AREG;INSIG1;CTSC;MYO1B
1483,GO:0003777,0.955947271949087,0.184809328158311,1,82,microtubule motor activity,MF,MYO1B
332,GO:0000922,0.956752090404024,0.133763125627314,2,142,spindle pole,CC,NEDD9;KLHL21
17303,GO:0140098,0.956810162565303,0.0902959556351645,6,331,catalytic activity, acting on RNA,MF,ZC3H12A;NOCT;POLR3A;POLR3D;ERN1;ISG20
16996,GO:0099081,0.956912348724101,0.072451252065462,14,604,supramolecular polymer,CC,SDC4;SQSTM1;BCL10;CYLD;KLHL21;KRT34;KRTAP2-3;IFFO2;NAV3;SAA1;NDRG1;FERMT1;VCL;MYO1B
2572,GO:0005856,0.957358551264204,0.0591113746147258,43,1565,cytoskeleton,CC,ZC3H12A;RELB;PHLDB2;ENC1;NEDD9;BCL10;FGD6;CYLD;ADAM8;PLK2;PLK3;KLHL21;KRT34;CCDC85B;KRTAP2-3;RAPH1;IFFO2;RIPK2;NAV3;SAA1;NDRG1;STX1A;FERMT1;CDC42EP1;SPAG9;TRAF4;VCL;COTL1;CDK6;CORO1C;PRPF19;ABL2;RAB3IP;RNF19A;CTSC;FRMD6;SMTN;NFE2L2;RAB22A;ATXN7;MYO1B;TAP1;PDLIM5
16995,GO:0099080,0.957706952157022,0.0712408540654877,14,605,supramolecular complex,CC,SDC4;SQSTM1;BCL10;CYLD;KLHL21;KRT34;KRTAP2-3;IFFO2;NAV3;SAA1;NDRG1;FERMT1;VCL;MYO1B
16155,GO:0090175,0.957894526300059,0.178138957249719,1,101,regulation of establishment of planar polarity,BP,WNT5A
2904,GO:0006414,0.95796268095492,0.177513515235347,1,125,translational elongation,BP,CPEB2
3236,GO:0006892,0.958010335411265,0.178056617369245,1,89,post-Golgi vesicle-mediated transport,BP,MYO1B
2935,GO:0006457,0.958683200255291,0.109737430842686,3,210,protein folding,BP,PPIF;SACS;ERO1A
8935,GO:0034968,0.958745642202272,0.175699902443301,1,89,histone lysine methylation,BP,KDM6A
7302,GO:0031300,0.959618422236794,0.126469156950553,2,154,intrinsic component of organelle membrane,CC,SGMS2;ITM2B
3154,GO:0006754,0.960038428972306,0.171373428366732,1,95,ATP biosynthetic process,BP,NUP153
15743,GO:0072329,0.960094597159975,0.171101289194024,1,99,monocarboxylic acid catabolic process,BP,PPARD
2947,GO:0006476,0.960312117461208,0.170581757659233,1,91,protein deacetylation,BP,HDAC9
7712,GO:0032200,0.961335966467253,0.122012963936108,2,166,telomere organization,BP,PPP1R10;PML
599,GO:0001764,0.961411189713229,0.167095519361969,1,87,neuron migration,BP,NRG1
1459,GO:0003697,0.961654180858131,0.166072395529545,1,96,single-stranded DNA binding,MF,NABP1
2621,GO:0005938,0.96208924338497,0.0921378275227529,4,225,cell cortex,CC,PHLDB2;RND3;NEDD9;RHOB
9461,GO:0036064,0.962296304795326,0.164025075421909,1,93,ciliary basal body,CC,CYLD
11409,GO:0045814,0.962563686315144,0.162628231997736,1,121,negative regulation of gene expression, epigenetic,BP,UHRF1
16973,GO:0099003,0.962598771801034,0.163097812297367,1,90,vesicle-mediated transport in synapse,BP,STX1A
5576,GO:0016591,0.962842955195711,0.161999254415913,1,103,DNA-directed RNA polymerase II, holoenzyme,CC,TAF4B
1780,GO:0004386,0.96394295623823,0.115561071797375,2,138,helicase activity,MF,BTAF1;IFIH1
2561,GO:0005840,0.964558212631865,0.113395843930893,2,225,ribosome,CC,LARP4B;RBM3
2950,GO:0006479,0.965260026283796,0.112019970587936,2,149,protein methylation,BP,BTG2;KDM6A
3704,GO:0008213,0.965260026283796,0.112019970587936,2,149,protein alkylation,BP,BTG2;KDM6A
2871,GO:0006364,0.965733086576155,0.0937204678990463,3,255,rRNA processing,BP,DIEXF;USP36;ISG20
3593,GO:0008021,0.966416192661792,0.149939206015127,1,104,synaptic vesicle,CC,STX1A
7756,GO:0032271,0.966426237117025,0.108921025649667,2,153,regulation of protein polymerization,BP,NAV3;CDC42EP1
5886,GO:0018022,0.96644053756963,0.150035594204644,1,95,peptidyl-lysine methylation,BP,KDM6A
5336,GO:0016071,0.966593976049611,0.0565864735733726,15,738,mRNA metabolic process,BP,ZC3H12A;BTG2;NOCT;ZFP36L1;EREG;RC3H1;PPARD;ZFP36;PNRC1;SAMD4A;PRPF19;QKI;CELF1;ERN1;PABPC4
15280,GO:0071466,0.966969483391304,0.147987996586006,1,107,cellular response to xenobiotic stimulus,BP,ERRFI1
10883,GO:0044422,0.967298402694329,0.0409726485672404,216,7166,organelle part,CC,NFKBIZ;ZC3H12A;CXCL1;PLAUR;BIRC3;HBEGF;PLAU;ITPKC;TICAM1;ELF3;SDC4;ETS1;REL;PPIF;KLF6;BHLHE40;PTGS2;RNF19B;PMAIP1;TNIP1;NFKB1;PRDM1;FOSL1;NFKB2;NOCT;PLEKHF1;TGFA;KDM6B;EDN1;PHLDA1;IRAK2;PANX1;EHF;RELB;GADD45A;MAFF;SQSTM1;IFNGR2;CAB39;MAP2K3;JUN;RAP2B;NFKBIE;CDKN1A;NMNAT2;TJP2;SERTAD2;JUNB;BCL3;ETS2;NAMPT;AMPD3;IRF1;TAF4B;BCL2L2;ENC1;RND3;ADRB2;CEBPB;DUSP16;ARNTL2;UGCG;PPP1R15A;RUNX1;N4BP1;GJB4;TRIM16;ELMSAN1;SOD2;C3ORF52;EHD1;NEDD9;ANKLE2;B4GALT1;BCL10;TMCC1;PPP1R10;B3GNT5;SGMS2;VMP1;NABP1;TXNRD1;CYLD;ADAM8;LDLR;VEGFC;KLF3;ZNF217;NEDD4L;SMAD3;IL23A;DUSP10;PLK2;PLK3;DIEXF;PIM1;TFRC;AKIRIN1;KLHL21;CREB1;STK40;HIVEP2;PPARD;KRT34;SLC25A25;SERPINB1;CCDC85B;KRTAP2-3;USP36;IL16;RAPH1;SLC9A1;MAFK;LARP4B;CYP27B1;IFFO2;CD55;TMEM217;ELL2;ANTXR2;NAV3;SAA1;NDRG1;ITGAV;PIP5K1A;TP53BP2;SOX9;STX1A;NRG1;ZNF451;FEM1C;PML;POU2F2;FERMT1;ELK3;POLR3A;SLC28A3;PTPN11;UHRF1;MXD1;RHOB;SPAG9;ABCA5;GCH1;FEM1B;SOX4;FOSL2;VCL;OXCT1;AREG;CCNL1;TNFAIP1;HDAC9;HIVEP1;AEN;SKIL;COTL1;IL7R;RBM3;CDK6;SAMD4A;PTPN1;SQLE;TFE3;TMEM65;STEAP4;PRPF19;MAFG;MTF1;ATP6V1C2;HLA-E;CELF1;WNT5A;NUP153;MAOA;INSIG1;PDPK1;RNF19A;CTSC;ERO1A;KDM6A;ZBTB21;NFE2L2;YWHAH;SGK1;B3GNT2;CYTH1;RELA;AGFG1;RNF11;BTAF1;GINS3;POLR3D;ALAS1;YWHAG;TDG;ELF4;RAB22A;CREG1;SFN;ITM2B;ERN1;ETNK1;SH3RF2;UPP1;ISG20;TMEM132A;ATXN7;MYO1B;BRD2;IPO4;TAP1;DSE;STX12;RAB24;SMPD3
10893,GO:0044437,0.967312725157738,0.0629422678837572,9,453,vacuolar part,CC,SDC4;PLEKHF1;B4GALT1;VMP1;LDLR;ABCA5;ATP6V1C2;CTSC;CREG1
4146,GO:0009206,0.967591588549689,0.145894818713903,1,104,purine ribonucleoside triphosphate biosynthetic process,BP,NUP153
277,GO:0000779,0.96775655866777,0.145323700441689,1,104,condensed chromosome, centromeric region,CC,CEBPB
585,GO:0001736,0.968399224289226,0.143005720165941,1,109,establishment of planar polarity,BP,WNT5A
3385,GO:0007164,0.968399224289226,0.143005720165941,1,109,establishment of tissue polarity,BP,WNT5A
4092,GO:0009145,0.968527819621556,0.142624449217323,1,105,purine nucleoside triphosphate biosynthetic process,BP,NUP153
10899,GO:0044445,0.968720281378898,0.102515921130271,2,203,cytosolic part,CC,TICAM1;STX12
3433,GO:0007224,0.96884552005346,0.141664499809404,1,97,smoothened signaling pathway,BP,KCTD11
1482,GO:0003774,0.968999259013789,0.141188644033977,1,94,motor activity,MF,MYO1B
2824,GO:0006289,0.969807869547121,0.138003722108329,1,113,nucleotide-excision repair,BP,PRPF19
9213,GO:0035601,0.970393271258463,0.136146359786579,1,100,protein deacylation,BP,HDAC9
2846,GO:0006325,0.970429756657173,0.0514527801548317,14,661,chromatin organization,BP,IL1B;KDM6B;LIF;TRIM16;USP36;SOX9;ZNF451;UHRF1;HDAC9;KDM6A;TDG;ATXN7;BRD2;IPO4
16832,GO:0098732,0.971170177645321,0.133356657475996,1,101,macromolecule deacylation,BP,HDAC9
258,GO:0000724,0.971218449872883,0.133183767316096,1,101,double-strand break repair via homologous recombination,BP,NABP1
6634,GO:0022900,0.971253154987758,0.132532684571259,1,142,electron transport chain,BP,TXNRD1
2716,GO:0006090,0.97151415944958,0.132104960916991,1,102,pyruvate metabolic process,BP,NUP153
6909,GO:0030496,0.972112240561986,0.0935858982313684,2,156,midbody,CC,BCL3;CYLD
259,GO:0000725,0.972221051567206,0.129556096638744,1,102,recombinational repair,BP,NABP1
4141,GO:0009201,0.973352957447639,0.125308468156332,1,110,ribonucleoside triphosphate biosynthetic process,BP,NUP153
3594,GO:0008022,0.973937220379534,0.0884929401985142,2,161,protein C-terminus binding,MF,TJP2;BCL10
2513,GO:0005765,0.974434126018875,0.0606865752492377,5,298,lysosomal membrane,CC,PLEKHF1;B4GALT1;LDLR;ABCA5;ATP6V1C2
16900,GO:0098852,0.974434126018875,0.0606865752492377,5,298,lytic vacuole membrane,CC,PLEKHF1;B4GALT1;LDLR;ABCA5;ATP6V1C2
6665,GO:0030017,0.974735137569858,0.120257072420322,1,107,sarcomere,CC,SQSTM1
2521,GO:0005774,0.974824716503116,0.0563315238275001,6,343,vacuolar membrane,CC,PLEKHF1;B4GALT1;VMP1;LDLR;ABCA5;ATP6V1C2
3599,GO:0008033,0.975599823311616,0.116855408046146,1,120,tRNA processing,BP,YRDC
10868,GO:0044391,0.976294590160729,0.113763004810446,1,182,ribosomal subunit,CC,RBM3
6598,GO:0022613,0.976420852833451,0.0505595734978473,7,448,ribonucleoprotein complex biogenesis,BP,NOCT;RC3H1;DIEXF;USP36;PRPF19;CELF1;ISG20
2583,GO:0005874,0.976515433503525,0.05300278842294,6,333,microtubule,CC,BCL10;CYLD;KLHL21;NAV3;SAA1;NDRG1
13098,GO:0051606,0.976831306628505,0.112280600926051,1,114,detection of stimulus,BP,SOX4
14726,GO:0070382,0.976948694883173,0.111833883773751,1,114,exocytic vesicle,CC,STX1A
2841,GO:0006310,0.977432313894542,0.0660088942105515,3,215,DNA recombination,BP,NABP1;TFRC;IL7R
4452,GO:0010389,0.978057759031677,0.0766746812016239,2,180,regulation of G2/M transition of mitotic cell cycle,BP,CDK6;YWHAG
10105,GO:0042623,0.978274249464818,0.0526658544758894,5,290,ATPase activity, coupled,MF,ABCA5;ATP6V1C2;ATP13A3;MYO1B;TAP1
15088,GO:0071103,0.978336699265382,0.0636663134706442,3,245,DNA conformation change,BP,SOX9;BRD2;IPO4
5678,GO:0016787,0.978604191561117,0.0304769584006956,47,1813,hydrolase activity,MF,TNFAIP3;ZC3H12A;PLAU;ZC3H12C;NOCT;RRAD;RAP2B;AMPD3;RND3;DUSP16;DUSP8;DUSP1;CYLD;ADAM8;DUSP10;LIPG;F3;USP36;PPTC7;PTPN11;RHOB;ABCA5;GCH1;USP31;HDAC9;ADAMTS1;AEN;HEXDC;PTPN1;ATP6V1C2;ADAM9;ADAMTS9;CTSC;BTAF1;TDG;RAB22A;ERN1;ISG20;ATXN7;IFIH1;ATP13A3;ADAMTS6;MYO1B;TAP1;AHCY;RAB24;SMPD3
6619,GO:0022839,0.9789737660914,0.104119482201723,1,107,ion gated channel activity,MF,ITGAV
5833,GO:0017111,0.979173060750143,0.0373696259216443,14,646,nucleoside-triphosphatase activity,MF,RRAD;RAP2B;RND3;RHOB;ABCA5;GCH1;ATP6V1C2;BTAF1;RAB22A;IFIH1;ATP13A3;MYO1B;TAP1;RAB24
4089,GO:0009142,0.979406720960421,0.102274796689762,1,119,nucleoside triphosphate biosynthetic process,BP,NUP153
5654,GO:0016747,0.979430497066517,0.0727135112937253,2,172,transferase activity, transferring acyl groups other than amino-acyl groups,MF,SAT1;ALAS1
7056,GO:0030833,0.979669907507298,0.101286519930593,1,115,regulation of actin filament polymerization,BP,CDC42EP1
2544,GO:0005802,0.979701968919587,0.0719364405355099,2,168,trans-Golgi network,CC,NMNAT2;MYO1B
6617,GO:0022836,0.979706779223953,0.10122999481415,1,108,gated channel activity,MF,ITGAV
7416,GO:0031503,0.979757071436548,0.0601673764175204,3,219,protein-containing complex localization,BP,KLHL21;NUP153;AGFG1
12781,GO:0051053,0.979889744826788,0.100494665084618,1,109,negative regulation of DNA metabolic process,BP,DUSP1
586,GO:0001738,0.980037755032034,0.0997674288679667,1,121,morphogenesis of a polarized epithelium,BP,WNT5A
9989,GO:0042393,0.98016190556291,0.0705588928184545,2,172,histone binding,MF,UHRF1;BRD2
10913,GO:0044463,0.980537264316362,0.0320413968493967,21,890,cell projection part,CC,PLAUR;EPHA2;SQSTM1;N4BP3;EHD1;B4GALT1;SACS;IL6ST;SLC6A14;CYLD;PLK2;PLK3;ITGA5;ITGAV;PIP5K1A;NRG1;FERMT1;GCH1;RBM3;SAMD4A;ERO1A
17255,GO:0120038,0.980537264316362,0.0320413968493967,21,890,plasma membrane bounded cell projection part,CC,PLAUR;EPHA2;SQSTM1;N4BP3;EHD1;B4GALT1;SACS;IL6ST;SLC6A14;CYLD;PLK2;PLK3;ITGA5;ITGAV;PIP5K1A;NRG1;FERMT1;GCH1;RBM3;SAMD4A;ERO1A
7229,GO:0031123,0.98057394993908,0.0976607816631935,1,119,RNA 3'-end processing,BP,ZFP36L1
5561,GO:0016571,0.980955887760558,0.096227825129497,1,111,histone methylation,BP,KDM6A
2547,GO:0005814,0.981059586693788,0.0958120878147725,1,111,centriole,CC,PLK2
8229,GO:0032991,0.981092553441339,0.0248120021632902,105,3843,protein-containing complex,CC,NFKBIA;NFKBIZ;ZC3H12A;INHBA;TICAM1;ETS1;REL;PPIF;RNF19B;NFKB1;NFKB2;TRPV3;NOCT;KDM6B;CPEB2;EPHA2;RELB;SQSTM1;BMP2;CAB39;JUN;BIRC2;CDKN1A;CLDN4;JUNB;BCL3;TAF4B;BCL2L2;ZFP36L1;ENC1;ADRB2;CEBPB;ARNTL2;PPP1R15A;GJB4;ELMSAN1;ZSWIM4;BCL10;DCUN1D3;PPP1R10;IL6ST;NABP1;ADAM8;LDLR;ZNF217;SMAD3;RC3H1;IL23A;DIEXF;ITGA5;TFRC;KLHL21;CREB1;GJB3;F3;PPARD;ZFP36;SLC9A1;LARP4B;PNRC1;ELL2;RIPK2;PHKG2;SAA1;PPP1R15B;ITGAV;PIP5K1A;SOX9;STX1A;FERMT1;POLR3A;PTPN11;GCH1;SOX4;VCL;CCNL1;TNFAIP1;HDAC9;RBM3;CDK6;IER5;SAMD4A;CORO1C;PRPF19;ATP6V1C2;HLA-E;OSMR;NUP153;INSIG1;RNF19A;KDM6A;NFE2L2;RELA;AGFG1;RNF11;BACH1;POLR3D;CREG1;ERN1;LAMB3;MYO1B;IPO4;PABPC4;TAP1;STX12
15516,GO:0071897,0.982945694023179,0.0621764345150656,2,178,DNA biosynthetic process,BP,CDKN1A;DUSP1
17302,GO:0140097,0.983491693255056,0.0605070586916228,2,178,catalytic activity, acting on DNA,MF,TDG;ISG20
11202,GO:0045333,0.983803342473195,0.0842350763971829,1,154,cellular respiration,BP,SLC25A25
3052,GO:0006612,0.984032899598286,0.0832177457543785,1,165,protein targeting to membrane,BP,RAB3IP
5337,GO:0016072,0.984108838597593,0.0487873660673222,3,284,rRNA metabolic process,BP,DIEXF;USP36;ISG20
3591,GO:0008017,0.984189168660879,0.0487258217844206,3,213,microtubule binding,MF,NAV3;NDRG1;MYO1B
4252,GO:0009451,0.984341521063536,0.0821422693233582,1,131,RNA modification,BP,YRDC
7596,GO:0031966,0.985577581737109,0.0301094556208117,9,578,mitochondrial membrane,CC,PPIF;PMAIP1;BCL2L2;PPP1R15A;SOD2;SLC25A25;CYP27B1;TMEM65;MAOA
6274,GO:0019866,0.985847556614646,0.0337502711367599,6,451,organelle inner membrane,CC,PPIF;SOD2;SMAD3;SLC25A25;TMEM65;ERN1
18110,GO:1902749,0.985939618754887,0.0528236820353711,2,195,regulation of cell cycle G2/M phase transition,BP,CDK6;YWHAG
11155,GO:0045211,0.986009824235343,0.0751836788963011,1,114,postsynaptic membrane,CC,PDLIM5
6803,GO:0030246,0.986090113074666,0.0747528452383203,1,123,carbohydrate binding,MF,LGALSL
11150,GO:0045202,0.986354374946917,0.0277987512544498,10,510,synapse,CC,FOSL1;CPEB2;NMNAT2;ITGA5;EFNB1;STX1A;NRG1;SAMD4A;PDPK1;PDLIM5
6680,GO:0030041,0.986414658004516,0.0733196007040974,1,126,actin filament polymerization,BP,CDC42EP1
7747,GO:0032259,0.986766767682858,0.0370588818176828,4,285,methylation,BP,BTG2;PRDM1;KDM6A;AHCY
9186,GO:0035567,0.987053324137331,0.0704799232493582,1,132,non-canonical Wnt signaling pathway,BP,WNT5A
10909,GO:0044455,0.987566568188647,0.0680225534357181,1,166,mitochondrial membrane part,CC,PPIF
7597,GO:0031967,0.98768163462118,0.0213868612262369,19,972,organelle envelope,CC,PPIF;PMAIP1;BCL2L2;PPP1R15A;SOD2;SMAD3;AKIRIN1;SLC25A25;CYP27B1;NAV3;STX1A;GCH1;AEN;TMEM65;NUP153;MAOA;AGFG1;ERN1;IPO4
7601,GO:0031975,0.98768163462118,0.0213868612262369,19,972,envelope,CC,PPIF;PMAIP1;BCL2L2;PPP1R15A;SOD2;SMAD3;AKIRIN1;SLC25A25;CYP27B1;NAV3;STX1A;GCH1;AEN;TMEM65;NUP153;MAOA;AGFG1;ERN1;IPO4
8835,GO:0034622,0.988011374460893,0.0214076126911078,17,883,cellular protein-containing complex assembly,BP,NOCT;TAF4B;ADRB2;SMAD3;RC3H1;CREB1;NAV3;SOX9;STX1A;NRG1;CDC42EP1;PRPF19;CELF1;NUP153;INSIG1;BRD2;IPO4
5513,GO:0016462,0.988223214775187,0.0221252008197014,14,684,pyrophosphatase activity,MF,RRAD;RAP2B;RND3;RHOB;ABCA5;GCH1;ATP6V1C2;BTAF1;RAB22A;IFIH1;ATP13A3;MYO1B;TAP1;RAB24
2507,GO:0005759,0.988259679096151,0.030539299169944,5,393,mitochondrial matrix,CC,PPIF;SOD2;CREB1;OXCT1;ALAS1
5698,GO:0016817,0.988434127390525,0.0217591504055739,14,686,hydrolase activity, acting on acid anhydrides,MF,RRAD;RAP2B;RND3;RHOB;ABCA5;GCH1;ATP6V1C2;BTAF1;RAB22A;IFIH1;ATP13A3;MYO1B;TAP1;RAB24
5699,GO:0016818,0.988434127390525,0.0217591504055739,14,686,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,RRAD;RAP2B;RND3;RHOB;ABCA5;GCH1;ATP6V1C2;BTAF1;RAB22A;IFIH1;ATP13A3;MYO1B;TAP1;RAB24
8785,GO:0034470,0.98845128199532,0.0300949760485828,5,396,ncRNA processing,BP,SMAD3;DIEXF;USP36;YRDC;ISG20
3615,GO:0008064,0.988494210680193,0.064061924413873,1,131,regulation of actin polymerization or depolymerization,BP,CDC42EP1
7055,GO:0030832,0.988965263273124,0.0619153237683632,1,132,regulation of actin filament length,BP,CDC42EP1
2816,GO:0006281,0.989254723293603,0.0239520645580918,8,484,DNA repair,BP,BTG2;GADD45A;NABP1;PML;UHRF1;PRPF19;BACH1;TDG
13715,GO:0060271,0.98948363433168,0.0302949314457017,4,285,cilium assembly,BP,EHD1;CYLD;RAB3IP;YWHAG
2548,GO:0005815,0.989835983398004,0.0201455864626256,12,611,microtubule organizing center,CC,RELB;CYLD;PLK2;PLK3;CCDC85B;NDRG1;SPAG9;CDK6;RNF19A;CTSC;NFE2L2;TAP1
10902,GO:0044448,0.990447030265333,0.0550752570583071,1,127,cell cortex part,CC,PHLDB2
8224,GO:0032984,0.990461777308289,0.0313980953391436,3,275,protein-containing complex disassembly,BP,TNF;ADRB2;NAV3
2803,GO:0006261,0.990462458106139,0.0549419048760658,1,137,DNA-dependent DNA replication,BP,GINS3
5520,GO:0016482,0.99082064277779,0.0532808626303423,1,131,cytosolic transport,BP,SPAG9
10985,GO:0044782,0.991103528255075,0.0261393765357255,4,291,cilium organization,BP,EHD1;CYLD;RAB3IP;YWHAG
35,GO:0000070,0.991794839418988,0.0485350005093817,1,142,mitotic sister chromatid segregation,BP,DUSP1
16817,GO:0098687,0.991999051800714,0.0237832361086562,4,312,chromosomal region,CC,CEBPB;PPP1R10;NABP1;PML
2551,GO:0005819,0.992360115932216,0.0228425544084409,4,299,spindle,CC,NEDD9;CYLD;KLHL21;PRPF19
9914,GO:0042254,0.992395722234684,0.025733690303467,3,317,ribosome biogenesis,BP,DIEXF;USP36;ISG20
3324,GO:0007033,0.992466333665889,0.0452366899140247,1,142,vacuole organization,BP,STX12
2493,GO:0005740,0.992498665283554,0.0166065020755046,9,617,mitochondrial envelope,CC,PPIF;PMAIP1;BCL2L2;PPP1R15A;SOD2;SLC25A25;CYP27B1;TMEM65;MAOA
2888,GO:0006396,0.992793492270902,0.0135435826469508,16,877,RNA processing,BP,ZC3H12A;NOCT;ZFP36L1;SMAD3;DIEXF;USP36;CLK4;CCNL1;RBM3;YRDC;PRPF19;QKI;CELF1;ERN1;ISG20;PABPC4
13122,GO:0051656,0.992804761811948,0.0197733539552164,5,348,establishment of organelle localization,BP,TGFA;STX1A;AREG;PDPK1;CTSC
12915,GO:0051258,0.993049447169483,0.0289980930519333,2,205,protein polymerization,BP,NAV3;CDC42EP1
16862,GO:0098793,0.993676145504894,0.0267294125694323,2,209,presynapse,CC,FOSL1;STX1A
3664,GO:0008154,0.993900320955455,0.0379538517023646,1,148,actin polymerization or depolymerization,BP,CDC42EP1
16867,GO:0098798,0.994786130862163,0.0331414364582856,1,218,mitochondrial protein complex,CC,PPIF
10626,GO:0043624,0.994815359237317,0.033058740870663,1,179,cellular protein complex disassembly,BP,NAV3
10904,GO:0044450,0.994931884195568,0.0325237216255045,1,147,microtubule organizing center part,CC,PLK2
3803,GO:0008380,0.995125678741145,0.0139278814187016,5,392,RNA splicing,BP,CLK4;PRPF19;QKI;CELF1;ERN1
2496,GO:0005743,0.995231514447192,0.0149790340723852,4,407,mitochondrial inner membrane,CC,PPIF;SOD2;SLC25A25;TMEM65
5742,GO:0016887,0.995381440193573,0.0132857745204205,5,349,ATPase activity,MF,ABCA5;ATP6V1C2;ATP13A3;MYO1B;TAP1
3312,GO:0007017,0.995412580041861,0.00992842922527664,11,605,microtubule-based process,BP,BIRC3;GADD45A;BIRC2;PHLDB2;CYLD;PLK2;PLK3;NAV3;RNF19A;ATXN7;MYO1B
16863,GO:0098794,0.995557377743166,0.0160889384780631,3,257,postsynapse,CC,STX1A;PDPK1;PDLIM5
10897,GO:0044441,0.995662201180552,0.0157440962654575,3,269,ciliary part,CC,SQSTM1;EHD1;CYLD
2889,GO:0006397,0.995869484191125,0.011151656216762,6,440,mRNA processing,BP,NOCT;ZFP36L1;PRPF19;QKI;CELF1;ERN1
6893,GO:0030424,0.996097568503634,0.0114103755873139,5,361,axon,CC,N4BP3;SACS;CREB1;STX1A;NRG1
10889,GO:0044430,0.996653021883176,0.00585806748699739,26,1191,cytoskeletal part,CC,RELB;NEDD9;BCL10;CYLD;ADAM8;PLK2;PLK3;KLHL21;KRT34;CCDC85B;KRTAP2-3;IFFO2;NAV3;SAA1;NDRG1;STX1A;FERMT1;SPAG9;VCL;CDK6;PRPF19;RNF19A;CTSC;NFE2L2;MYO1B;TAP1
2891,GO:0006399,0.996746760481446,0.0223221704057679,1,183,tRNA metabolic process,BP,YRDC
2466,GO:0005681,0.996759477418427,0.0222514728150033,1,181,spliceosomal complex,CC,PRPF19
10510,GO:0043414,0.997194523619667,0.0131781207368415,2,234,macromolecule methylation,BP,BTG2;KDM6A
5136,GO:0015631,0.99720121622235,0.010674127214139,3,276,tubulin binding,MF,NAV3;NDRG1;MYO1B
273,GO:0000775,0.997376158718094,0.0186095218214306,1,173,chromosome, centromeric region,CC,CEBPB
3669,GO:0008168,0.997385526628513,0.0185467429614534,1,177,methyltransferase activity,MF,PRDM1
289,GO:0000793,0.997432989182362,0.0182624293634574,1,175,condensed chromosome,CC,CEBPB
13109,GO:0051640,0.997482014839994,0.00636072751075478,8,522,organelle localization,BP,TGFA;STX1A;AREG;RAB3IP;PDPK1;CTSC;YWHAG;STX12
1469,GO:0003723,0.997771525328598,0.00385392592595114,30,1484,RNA binding,MF,ZC3H12A;NOCT;CPEB2;JUN;ZFP36L1;PPP1R10;NABP1;DLX2;SMAD3;RC3H1;DIEXF;TFRC;USP36;ZFP36;LARP4B;SOX9;EIF1;C11ORF68;RBM3;YRDC;SAMD4A;PTPN1;QKI;CELF1;AGFG1;YWHAG;ISG20;IFIH1;PABPC4;FUBP3
17070,GO:0099568,0.997915572208719,0.00714218191417774,4,338,cytoplasmic region,CC,PHLDB2;RND3;NEDD9;RHOB
5649,GO:0016741,0.998049466496039,0.0144279262680848,1,185,transferase activity, transferring one-carbon groups,MF,PRDM1
5135,GO:0015630,0.998165787916958,0.00358824504381913,19,968,microtubule cytoskeleton,CC,RELB;NEDD9;BCL10;CYLD;PLK2;PLK3;KLHL21;CCDC85B;NAV3;SAA1;NDRG1;SPAG9;CDK6;PRPF19;RNF19A;CTSC;NFE2L2;ATXN7;TAP1
10888,GO:0044429,0.998905197678327,0.00253717706466955,12,851,mitochondrial part,CC,PPIF;PMAIP1;BCL2L2;PPP1R15A;SOD2;CREB1;SLC25A25;CYP27B1;OXCT1;TMEM65;MAOA;ALAS1
172,GO:0000377,0.999310896428839,0.0037874603639959,2,299,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,PRPF19;CELF1
184,GO:0000398,0.999310896428839,0.0037874603639959,2,299,mRNA splicing, via spliceosome,BP,PRPF19;CELF1
308,GO:0000819,0.999321106872901,0.00576329467538014,1,216,sister chromatid segregation,BP,DUSP1
171,GO:0000375,0.999364269611331,0.0035232387815242,2,302,RNA splicing, via transesterification reactions,BP,PRPF19;CELF1
2619,GO:0005929,0.999456361268359,0.00243864531239595,3,340,cilium,CC,SQSTM1;EHD1;CYLD
3313,GO:0007018,0.999725057742802,0.00259440475560457,1,228,microtubule-based movement,BP,MYO1B
10910,GO:0044456,0.999784528469987,0.000896861225352708,4,419,synapse part,CC,FOSL1;STX1A;PDPK1;PDLIM5
12926,GO:0051276,0.999797378202097,0.000459403206491402,17,1049,chromosome organization,BP,IL1B;KDM6B;LIF;TRIM16;DUSP1;PPP1R10;USP36;SOX9;ZNF451;PML;UHRF1;HDAC9;KDM6A;TDG;ATXN7;BRD2;IPO4
16877,GO:0098813,0.999816844147506,0.00180412861196794,1,253,nuclear chromosome segregation,BP,DUSP1
8370,GO:0033267,0.999827906974966,0.00170768033343817,1,242,axon part,CC,NRG1
3340,GO:0007059,0.9999662807585,0.000391645088750694,1,301,chromosome segregation,BP,DUSP1
1,GO:0000002,1,0.435610150535414,0,24,mitochondrial genome maintenance,BP,
3,GO:0000009,1,0.968837711911951,0,1,alpha-1,6-mannosyltransferase activity,MF,
4,GO:0000010,1,0.938565338361051,0,2,trans-hexaprenyltranstransferase activity,MF,
5,GO:0000011,1,0.965469978279355,0,1,vacuole inheritance,BP,
6,GO:0000012,1,0.74765308756054,0,8,single strand break repair,BP,
7,GO:0000014,1,0.774389079014339,0,7,single-stranded DNA endodeoxyribonuclease activity,MF,
8,GO:0000015,1,0.9734248695555,0,1,phosphopyruvate hydratase complex,CC,
10,GO:0000019,1,0.896848259931636,0,3,regulation of mitotic recombination,BP,
11,GO:0000022,1,0.69811294618667,0,10,mitotic spindle elongation,BP,
12,GO:0000023,1,0.886210625470691,0,3,maltose metabolic process,BP,
13,GO:0000026,1,0.897544062522436,0,3,alpha-1,2-mannosyltransferase activity,MF,
14,GO:0000027,1,0.521399034016406,0,26,ribosomal large subunit assembly,BP,
15,GO:0000028,1,0.705284155885968,0,18,ribosomal small subunit assembly,BP,
16,GO:0000030,1,0.497311323436925,0,22,mannosyltransferase activity,MF,
17,GO:0000032,1,0.973839944555444,0,1,cell wall mannoprotein biosynthetic process,BP,
18,GO:0000033,1,0.918405743809246,0,3,alpha-1,3-mannosyltransferase activity,MF,
19,GO:0000035,1,0.972106481842648,0,2,acyl binding,MF,
20,GO:0000036,1,0.972106481842648,0,2,acyl carrier activity,MF,
21,GO:0000038,1,0.46651701756425,0,23,very long-chain fatty acid metabolic process,BP,
24,GO:0000048,1,0.968914883799795,0,1,peptidyltransferase activity,MF,
26,GO:0000050,1,0.730137192608997,0,10,urea cycle,BP,
27,GO:0000052,1,0.778090378715973,0,7,citrulline metabolic process,BP,
28,GO:0000053,1,0.973356344779232,0,1,argininosuccinate metabolic process,BP,
29,GO:0000054,1,0.697946860140434,0,13,ribosomal subunit export from nucleus,BP,
30,GO:0000055,1,0.799185145941486,0,8,ribosomal large subunit export from nucleus,BP,
31,GO:0000056,1,0.826934992028169,0,7,ribosomal small subunit export from nucleus,BP,
33,GO:0000062,1,0.595647344104509,0,17,fatty-acyl-CoA binding,MF,
37,GO:0000076,1,0.591022041446637,0,16,DNA replication checkpoint,BP,
43,GO:0000095,1,0.969958160463322,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
46,GO:0000098,1,0.785002066211024,0,7,sulfur amino acid catabolic process,BP,
47,GO:0000099,1,0.855028197531585,0,4,sulfur amino acid transmembrane transporter activity,MF,
48,GO:0000101,1,0.891122072247922,0,3,sulfur amino acid transport,BP,
49,GO:0000103,1,0.911053056105758,0,3,sulfate assimilation,BP,
50,GO:0000104,1,0.866506498156601,0,5,succinate dehydrogenase activity,MF,
51,GO:0000105,1,0.932782478650145,0,2,histidine biosynthetic process,BP,
52,GO:0000109,1,0.716703624142715,0,10,nucleotide-excision repair complex,CC,
53,GO:0000110,1,0.901820479053904,0,3,nucleotide-excision repair factor 1 complex,CC,
54,GO:0000111,1,0.962126452482903,0,1,nucleotide-excision repair factor 2 complex,CC,
57,GO:0000120,1,0.855823912599744,0,5,RNA polymerase I transcription factor complex,CC,
58,GO:0000121,1,0.964189244898402,0,1,glycerol-1-phosphatase activity,MF,
60,GO:0000123,1,0.0701025452764211,0,79,histone acetyltransferase complex,CC,
61,GO:0000124,1,0.677058347115864,0,13,SAGA complex,CC,
62,GO:0000125,1,0.866178122514901,0,5,PCAF complex,CC,
63,GO:0000126,1,0.923138528939391,0,2,transcription factor TFIIIB complex,CC,
64,GO:0000127,1,0.814214246190887,0,6,transcription factor TFIIIC complex,CC,
65,GO:0000132,1,0.534956074260006,0,18,establishment of mitotic spindle orientation,BP,
69,GO:0000145,1,0.560061542418172,0,16,exocyst,CC,
71,GO:0000147,1,0.884344160867303,0,3,actin cortical patch assembly,BP,
73,GO:0000150,1,0.778561151567327,0,8,recombinase activity,MF,
75,GO:0000152,1,0.281986819096802,0,40,nuclear ubiquitin ligase complex,CC,
76,GO:0000153,1,0.695328678142981,0,11,cytoplasmic ubiquitin ligase complex,CC,
77,GO:0000154,1,0.37288589488524,0,34,rRNA modification,BP,
78,GO:0000155,1,0.95950763690405,0,1,phosphorelay sensor kinase activity,MF,
80,GO:0000160,1,0.92286244997048,0,2,phosphorelay signal transduction system,BP,
84,GO:0000171,1,0.92918873049377,0,2,ribonuclease MRP activity,MF,
85,GO:0000172,1,0.839854992951938,0,6,ribonuclease MRP complex,CC,
86,GO:0000173,1,0.975013508696357,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
88,GO:0000176,1,0.729975318615172,0,13,nuclear exosome (RNase complex),CC,
89,GO:0000177,1,0.639401961416438,0,15,cytoplasmic exosome (RNase complex),CC,
90,GO:0000178,1,0.519491443372393,0,22,exosome (RNase complex),CC,
91,GO:0000179,1,0.888358049044867,0,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,
92,GO:0000182,1,0.692059383057262,0,10,rDNA binding,MF,
93,GO:0000183,1,0.486091928647585,0,39,chromatin silencing at rDNA,BP,
100,GO:0000210,1,0.962607920802641,0,1,NAD+ diphosphatase activity,MF,
101,GO:0000212,1,0.702360303868199,0,10,meiotic spindle organization,BP,
102,GO:0000213,1,0.889737420331692,0,4,tRNA-intron endonuclease activity,MF,
103,GO:0000214,1,0.891459244765437,0,4,tRNA-intron endonuclease complex,CC,
104,GO:0000215,1,0.947934951500506,0,2,tRNA 2'-phosphotransferase activity,MF,
105,GO:0000217,1,0.44121812155805,0,23,DNA secondary structure binding,MF,
106,GO:0000220,1,0.858807951921387,0,5,vacuolar proton-transporting V-type ATPase, V0 domain,CC,
108,GO:0000224,1,0.967691660411353,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
109,GO:0000225,1,0.980195887653006,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
112,GO:0000229,1,0.97555681749682,0,1,cytoplasmic chromosome,CC,
113,GO:0000235,1,0.740547055547236,0,8,astral microtubule,CC,
114,GO:0000242,1,0.493260011249591,0,19,pericentriolar material,CC,
115,GO:0000243,1,0.802284272030448,0,8,commitment complex,CC,
118,GO:0000246,1,0.960370615281752,0,1,delta24(24-1) sterol reductase activity,MF,
119,GO:0000247,1,0.980173776056391,0,1,C-8 sterol isomerase activity,MF,
120,GO:0000248,1,0.927005009590946,0,2,C-5 sterol desaturase activity,MF,
121,GO:0000250,1,0.960426409753782,0,1,lanosterol synthase activity,MF,
122,GO:0000252,1,0.975507479019621,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
123,GO:0000253,1,0.91421997986084,0,4,3-keto sterol reductase activity,MF,
124,GO:0000254,1,0.932129376517163,0,2,C-4 methylsterol oxidase activity,MF,
125,GO:0000255,1,0.884879288698469,0,3,allantoin metabolic process,BP,
126,GO:0000257,1,0.977916236444337,0,1,nitrilase activity,MF,
127,GO:0000262,1,0.97555681749682,0,1,mitochondrial chromosome,CC,
128,GO:0000266,1,0.309560569028848,0,33,mitochondrial fission,BP,
129,GO:0000268,1,0.87157558137105,0,4,peroxisome targeting sequence binding,MF,
130,GO:0000270,1,0.953757494730048,0,2,peptidoglycan metabolic process,BP,
141,GO:0000291,1,0.366121499638299,0,35,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
142,GO:0000293,1,0.895894370650367,0,3,ferric-chelate reductase activity,MF,
145,GO:0000296,1,0.969480203691181,0,1,spermine transport,BP,
146,GO:0000298,1,0.883830410916759,0,4,endopolyphosphatase activity,MF,
147,GO:0000301,1,0.899966727595267,0,3,retrograde transport, vesicle recycling within Golgi,BP,
151,GO:0000306,1,0.861445775505087,0,4,extrinsic component of vacuolar membrane,CC,
153,GO:0000308,1,0.922324202682527,0,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,
155,GO:0000313,1,0.160206857246089,0,84,organellar ribosome,CC,
156,GO:0000314,1,0.54677534483676,0,28,organellar small ribosomal subunit,CC,
157,GO:0000315,1,0.328041303189327,0,51,organellar large ribosomal subunit,CC,
158,GO:0000320,1,0.922296365864541,0,2,re-entry into mitotic cell cycle,BP,
159,GO:0000322,1,0.910319017113514,0,3,storage vacuole,CC,
161,GO:0000332,1,0.988466016036463,0,1,template for synthesis of G-rich strand of telomere DNA activity,MF,
162,GO:0000333,1,0.948439510376411,0,2,telomerase catalytic core complex,CC,
163,GO:0000338,1,0.752471576063627,0,10,protein deneddylation,BP,
164,GO:0000339,1,0.566923841515699,0,17,RNA cap binding,MF,
165,GO:0000340,1,0.720468627584002,0,9,RNA 7-methylguanosine cap binding,MF,
166,GO:0000346,1,0.661460976695098,0,13,transcription export complex,CC,
167,GO:0000347,1,0.842136044445684,0,6,THO complex,CC,
169,GO:0000350,1,0.921259637803254,0,3,generation of catalytic spliceosome for second transesterification step,BP,
170,GO:0000354,1,0.924481909406043,0,2,cis assembly of pre-catalytic spliceosome,BP,
173,GO:0000379,1,0.915174657030781,0,3,tRNA-type intron splice site recognition and cleavage,BP,
174,GO:0000380,1,0.198763824155607,0,46,alternative mRNA splicing, via spliceosome,BP,
175,GO:0000381,1,0.302085654001909,0,34,regulation of alternative mRNA splicing, via spliceosome,BP,
176,GO:0000384,1,0.950776553332212,0,2,first spliceosomal transesterification activity,MF,
177,GO:0000386,1,0.899736004726511,0,3,second spliceosomal transesterification activity,MF,
179,GO:0000389,1,0.817134370143641,0,6,mRNA 3'-splice site recognition,BP,
180,GO:0000390,1,0.945831310341906,0,2,spliceosomal complex disassembly,BP,
183,GO:0000395,1,0.81985245706935,0,6,mRNA 5'-splice site recognition,BP,
185,GO:0000400,1,0.579516512610997,0,16,four-way junction DNA binding,MF,
186,GO:0000403,1,0.790198454404104,0,6,Y-form DNA binding,MF,
187,GO:0000404,1,0.890354526094593,0,3,heteroduplex DNA loop binding,MF,
188,GO:0000405,1,0.763401109307238,0,7,bubble DNA binding,MF,
189,GO:0000406,1,0.925409777784344,0,2,double-strand/single-strand DNA junction binding,MF,
191,GO:0000408,1,0.873396839051439,0,5,EKC/KEOPS complex,CC,
192,GO:0000409,1,0.95950763690405,0,1,regulation of transcription by galactose,BP,
193,GO:0000411,1,0.95950763690405,0,1,positive regulation of transcription by galactose,BP,
194,GO:0000412,1,0.965498537683264,0,1,histone peptidyl-prolyl isomerization,BP,
196,GO:0000414,1,0.854284153022055,0,4,regulation of histone H3-K36 methylation,BP,
197,GO:0000415,1,0.95950763690405,0,1,negative regulation of histone H3-K36 methylation,BP,
198,GO:0000416,1,0.961756802661115,0,1,positive regulation of histone H3-K36 methylation,BP,
199,GO:0000417,1,0.960897596709916,0,1,HIR complex,CC,
204,GO:0000429,1,0.91128636004538,0,3,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
205,GO:0000430,1,0.949748849082676,0,2,regulation of transcription from RNA polymerase II promoter by glucose,BP,
206,GO:0000431,1,0.95950763690405,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
207,GO:0000432,1,0.949748849082676,0,2,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
208,GO:0000435,1,0.95950763690405,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
209,GO:0000436,1,0.91128636004538,0,3,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
210,GO:0000438,1,0.924811298808414,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
211,GO:0000439,1,0.750947962900118,0,9,core TFIIH complex,CC,
212,GO:0000444,1,0.883571021200532,0,4,MIS12/MIND type complex,CC,
213,GO:0000445,1,0.842136044445684,0,6,THO complex part of transcription export complex,CC,
214,GO:0000447,1,0.769786505201826,0,9,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
215,GO:0000448,1,0.929547923003204,0,2,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
216,GO:0000451,1,0.933954959882258,0,2,rRNA 2'-O-methylation,BP,
217,GO:0000453,1,0.933954959882258,0,2,enzyme-directed rRNA 2'-O-methylation,BP,
218,GO:0000454,1,0.942736677344505,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
219,GO:0000455,1,0.945423171018118,0,2,enzyme-directed rRNA pseudouridine synthesis,BP,
220,GO:0000459,1,0.825750430265255,0,7,exonucleolytic trimming involved in rRNA processing,BP,
221,GO:0000460,1,0.37523086367209,0,33,maturation of 5.8S rRNA,BP,
222,GO:0000461,1,0.969863998137535,0,2,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
224,GO:0000463,1,0.760828954808047,0,10,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
225,GO:0000466,1,0.512632160780754,0,22,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
226,GO:0000467,1,0.825750430265255,0,7,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
227,GO:0000469,1,0.458584320466376,0,26,cleavage involved in rRNA processing,BP,
228,GO:0000470,1,0.509507325979793,0,24,maturation of LSU-rRNA,BP,
229,GO:0000472,1,0.898179096516643,0,3,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
230,GO:0000478,1,0.613607575651446,0,15,endonucleolytic cleavage involved in rRNA processing,BP,
231,GO:0000479,1,0.63369350410048,0,14,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
232,GO:0000480,1,0.812031072902567,0,6,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
233,GO:0000481,1,0.962137105657478,0,1,maturation of 5S rRNA,BP,
234,GO:0000491,1,0.764945534977572,0,9,small nucleolar ribonucleoprotein complex assembly,BP,
235,GO:0000492,1,0.813400584386632,0,7,box C/D snoRNP assembly,BP,
236,GO:0000493,1,0.940459278215442,0,2,box H/ACA snoRNP assembly,BP,
237,GO:0000494,1,0.980030274204034,0,1,box C/D snoRNA 3'-end processing,BP,
238,GO:0000495,1,0.967418178557372,0,1,box H/ACA snoRNA 3'-end processing,BP,
239,GO:0000496,1,0.988466016036463,0,1,base pairing,MF,
240,GO:0000497,1,0.988466016036463,0,1,base pairing with DNA,MF,
241,GO:0000502,1,0.189623350288768,0,63,proteasome complex,CC,
242,GO:0000506,1,0.7880836806712,0,9,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,
245,GO:0000701,1,0.951980943479876,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
246,GO:0000702,1,0.89146701351888,0,5,oxidized base lesion DNA N-glycosylase activity,MF,
247,GO:0000703,1,0.957413389951641,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
248,GO:0000706,1,0.926810506632953,0,2,meiotic DNA double-strand break processing,BP,
249,GO:0000707,1,0.775750160317181,0,8,meiotic DNA recombinase assembly,BP,
250,GO:0000710,1,0.856084776018709,0,4,meiotic mismatch repair,BP,
251,GO:0000712,1,0.727449575033556,0,9,resolution of meiotic recombination intermediates,BP,
252,GO:0000715,1,0.507193288131461,0,23,nucleotide-excision repair, DNA damage recognition,BP,
253,GO:0000717,1,0.505819979286842,0,22,nucleotide-excision repair, DNA duplex unwinding,BP,
254,GO:0000718,1,0.974280666574357,0,1,nucleotide-excision repair, DNA damage removal,BP,
255,GO:0000720,1,0.906331821457572,0,3,pyrimidine dimer repair by nucleotide-excision repair,BP,
256,GO:0000722,1,0.620325529097465,0,14,telomere maintenance via recombination,BP,
261,GO:0000727,1,0.85520800700542,0,5,double-strand break repair via break-induced replication,BP,
262,GO:0000729,1,0.451475958534578,0,22,DNA double-strand break processing,BP,
263,GO:0000730,1,0.724030393939032,0,10,DNA recombinase assembly,BP,
264,GO:0000731,1,0.0974416380670275,0,68,DNA synthesis involved in DNA repair,BP,
265,GO:0000732,1,0.398030779564406,0,25,strand displacement,BP,
266,GO:0000733,1,0.721974045648033,0,9,DNA strand renaturation,BP,
267,GO:0000737,1,0.501571714960535,0,21,DNA catabolic process, endonucleolytic,BP,
269,GO:0000741,1,0.974092226169022,0,1,karyogamy,BP,
271,GO:0000773,1,0.981993172542882,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
272,GO:0000774,1,0.706892408208993,0,11,adenyl-nucleotide exchange factor activity,MF,
274,GO:0000776,1,0.0173001316742974,0,121,kinetochore,CC,
275,GO:0000777,1,0.0488461509927613,0,92,condensed chromosome kinetochore,CC,
276,GO:0000778,1,0.682408929608101,0,12,condensed nuclear chromosome kinetochore,CC,
278,GO:0000780,1,0.517984610754035,0,20,condensed nuclear chromosome, centromeric region,CC,
280,GO:0000782,1,0.714542801556634,0,10,telomere cap complex,CC,
281,GO:0000783,1,0.714542801556634,0,10,nuclear telomere cap complex,CC,
284,GO:0000786,1,0.238396158457734,0,84,nucleosome,CC,
285,GO:0000788,1,0.63930851729476,0,31,nuclear nucleosome,CC,
290,GO:0000794,1,0.100104149602923,0,66,condensed nuclear chromosome,CC,
291,GO:0000795,1,0.55470176474251,0,17,synaptonemal complex,CC,
292,GO:0000796,1,0.750829502594678,0,7,condensin complex,CC,
293,GO:0000797,1,0.959729991544901,0,1,condensin core heterodimer,CC,
294,GO:0000798,1,0.895603809113009,0,3,nuclear cohesin complex,CC,
295,GO:0000799,1,0.884064593634511,0,3,nuclear condensin complex,CC,
296,GO:0000800,1,0.766833853765818,0,7,lateral element,CC,
297,GO:0000801,1,0.960629688403153,0,1,central element,CC,
299,GO:0000805,1,0.775714477432956,0,7,X chromosome,CC,
300,GO:0000806,1,0.930636638844483,0,2,Y chromosome,CC,
301,GO:0000808,1,0.729569816831089,0,9,origin recognition complex,CC,
302,GO:0000811,1,0.90763924194799,0,3,GINS complex,CC,
303,GO:0000812,1,0.735818597534501,0,10,Swr1 complex,CC,
304,GO:0000813,1,0.773844367936004,0,8,ESCRT I complex,CC,
305,GO:0000814,1,0.922404724644116,0,3,ESCRT II complex,CC,
306,GO:0000815,1,0.694716488620913,0,12,ESCRT III complex,CC,
307,GO:0000818,1,0.938696249958601,0,2,nuclear MIS12/MIND complex,CC,
309,GO:0000820,1,0.892793123290669,0,3,regulation of glutamine family amino acid metabolic process,BP,
310,GO:0000821,1,0.930374671040359,0,2,regulation of arginine metabolic process,BP,
311,GO:0000822,1,0.889311143310511,0,3,inositol hexakisphosphate binding,MF,
312,GO:0000823,1,0.973654635197688,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
313,GO:0000824,1,0.973654635197688,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
314,GO:0000825,1,0.973654635197688,0,1,inositol tetrakisphosphate 6-kinase activity,MF,
315,GO:0000827,1,0.8649344388281,0,4,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,
316,GO:0000828,1,0.8649344388281,0,4,inositol hexakisphosphate kinase activity,MF,
317,GO:0000829,1,0.8649344388281,0,4,inositol heptakisphosphate kinase activity,MF,
318,GO:0000832,1,0.8649344388281,0,4,inositol hexakisphosphate 5-kinase activity,MF,
319,GO:0000835,1,0.803370338856195,0,6,ER ubiquitin ligase complex,CC,
320,GO:0000836,1,0.836943967351613,0,5,Hrd1p ubiquitin ligase complex,CC,
321,GO:0000839,1,0.902752492977423,0,3,Hrd1p ubiquitin ligase ERAD-L complex,CC,
326,GO:0000912,1,0.794901972726079,0,6,assembly of actomyosin apparatus involved in cytokinesis,BP,
327,GO:0000915,1,0.794901972726079,0,6,actomyosin contractile ring assembly,BP,
328,GO:0000916,1,0.970328760383685,0,1,actomyosin contractile ring contraction,BP,
329,GO:0000917,1,0.973151890372272,0,1,division septum assembly,BP,
330,GO:0000920,1,0.597770307123381,0,17,cell separation after cytokinesis,BP,
331,GO:0000921,1,0.681613071281822,0,10,septin ring assembly,BP,
333,GO:0000923,1,0.796204435701933,0,6,equatorial microtubule organizing center,CC,
334,GO:0000928,1,0.965469978279355,0,1,gamma-tubulin small complex, spindle pole body,CC,
335,GO:0000930,1,0.504369611466844,0,19,gamma-tubulin complex,CC,
336,GO:0000931,1,0.737503275223946,0,8,gamma-tubulin large complex,CC,
338,GO:0000938,1,0.859125406373184,0,4,GARP complex,CC,
339,GO:0000939,1,0.915361935417857,0,3,condensed chromosome inner kinetochore,CC,
340,GO:0000940,1,0.632577425688658,0,13,condensed chromosome outer kinetochore,CC,
341,GO:0000941,1,0.969756216940315,0,1,condensed nuclear chromosome inner kinetochore,CC,
342,GO:0000942,1,0.880013980215921,0,4,condensed nuclear chromosome outer kinetochore,CC,
344,GO:0000957,1,0.827260103288955,0,5,mitochondrial RNA catabolic process,BP,
345,GO:0000958,1,0.8930297189695,0,3,mitochondrial mRNA catabolic process,BP,
346,GO:0000959,1,0.253546792544583,0,41,mitochondrial RNA metabolic process,BP,
347,GO:0000960,1,0.86084310978326,0,4,regulation of mitochondrial RNA catabolic process,BP,
348,GO:0000961,1,0.926372432346771,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
349,GO:0000962,1,0.929275563973652,0,2,positive regulation of mitochondrial RNA catabolic process,BP,
350,GO:0000963,1,0.600902303676581,0,16,mitochondrial RNA processing,BP,
351,GO:0000964,1,0.880673401560619,0,4,mitochondrial RNA 5'-end processing,BP,
352,GO:0000965,1,0.854642211221043,0,5,mitochondrial RNA 3'-end processing,BP,
353,GO:0000966,1,0.533864681178469,0,21,RNA 5'-end processing,BP,
354,GO:0000967,1,0.898179096516643,0,3,rRNA 5'-end processing,BP,
355,GO:0000972,1,0.785158848836965,0,7,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
356,GO:0000973,1,0.901446262564934,0,3,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
369,GO:0000990,1,0.727062093801138,0,9,transcription factor activity, core RNA polymerase binding,MF,
370,GO:0000991,1,0.937416437364575,0,2,transcription factor activity, core RNA polymerase II binding,MF,
371,GO:0000992,1,0.929194296712773,0,2,polymerase III regulatory region sequence-specific DNA binding,MF,
372,GO:0000993,1,0.397013928422362,0,27,RNA polymerase II core binding,MF,
373,GO:0000994,1,0.973802776143225,0,1,RNA polymerase III core binding,MF,
374,GO:0000995,1,0.854892916436103,0,4,transcription factor activity, core RNA polymerase III binding,MF,
375,GO:0001002,1,0.929194296712773,0,2,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
376,GO:0001003,1,0.929194296712773,0,2,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
377,GO:0001007,1,0.860976155303711,0,4,transcription factor activity, RNA polymerase III transcription factor binding,MF,
379,GO:0001011,1,0.95950763690405,0,1,transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting,MF,
381,GO:0001013,1,0.755859303863818,0,8,RNA polymerase I regulatory region DNA binding,MF,
382,GO:0001016,1,0.797417996376767,0,7,RNA polymerase III regulatory region DNA binding,MF,
383,GO:0001018,1,0.9375931621039,0,2,mitochondrial promoter sequence-specific DNA binding,MF,
384,GO:0001025,1,0.883364048004276,0,3,RNA polymerase III transcription factor binding,MF,
385,GO:0001026,1,0.923138528939391,0,2,TFIIIB-type transcription factor activity,MF,
386,GO:0001030,1,0.833031392691457,0,5,RNA polymerase III type 1 promoter DNA binding,MF,
387,GO:0001031,1,0.833031392691457,0,5,RNA polymerase III type 2 promoter DNA binding,MF,
388,GO:0001032,1,0.871451845823884,0,4,RNA polymerase III type 3 promoter DNA binding,MF,
389,GO:0001034,1,0.973557880585802,0,1,RNA polymerase III transcription factor activity, sequence-specific DNA binding,MF,
390,GO:0001042,1,0.796679502856821,0,6,RNA polymerase I core binding,MF,
393,GO:0001054,1,0.739820804363044,0,11,RNA polymerase I activity,MF,
394,GO:0001055,1,0.746612146169696,0,11,RNA polymerase II activity,MF,
397,GO:0001069,1,0.921072209584177,0,2,regulatory region RNA binding,MF,
398,GO:0001074,1,0.96734812294771,0,1,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding involved in preinitiation complex assembly,MF,
403,GO:0001083,1,0.832000014526456,0,5,transcription factor activity, RNA polymerase II basal transcription factor binding,MF,
404,GO:0001084,1,0.96734812294771,0,1,transcription factor activity, TFIID-class binding,MF,
406,GO:0001087,1,0.95950763690405,0,1,transcription factor activity, TFIIB-class binding,MF,
407,GO:0001091,1,0.580780709619371,0,16,RNA polymerase II basal transcription factor binding,MF,
408,GO:0001093,1,0.896301974599914,0,3,TFIIB-class transcription factor binding,MF,
409,GO:0001094,1,0.74571435149869,0,9,TFIID-class transcription factor binding,MF,
410,GO:0001096,1,0.961925547325922,0,1,TFIIF-class transcription factor binding,MF,
411,GO:0001097,1,0.903535828936516,0,3,TFIIH-class transcription factor binding,MF,
412,GO:0001098,1,0.243739671852018,0,42,basal transcription machinery binding,MF,
413,GO:0001099,1,0.243739671852018,0,42,basal RNA polymerase II transcription machinery binding,MF,
416,GO:0001103,1,0.373053770074572,0,29,RNA polymerase II repressing transcription factor binding,MF,
420,GO:0001112,1,0.964706812155929,0,1,DNA-templated transcriptional open complex formation,BP,
421,GO:0001113,1,0.964706812155929,0,1,transcriptional open complex formation at RNA polymerase II promoter,BP,
422,GO:0001120,1,0.964706812155929,0,1,protein-DNA complex remodeling,BP,
423,GO:0001128,1,0.978106327090634,0,1,RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly,MF,
424,GO:0001129,1,0.896401388660157,0,3,RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,MF,
425,GO:0001132,1,0.896401388660157,0,3,RNA polymerase II transcription factor activity, TBP-class protein binding,MF,
428,GO:0001135,1,0.768295671322617,0,7,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,
429,GO:0001147,1,0.923736219776388,0,2,transcription termination site sequence-specific DNA binding,MF,
430,GO:0001156,1,0.883364048004276,0,3,TFIIIC-class transcription factor binding,MF,
432,GO:0001160,1,0.923736219776388,0,2,transcription termination site DNA binding,MF,
433,GO:0001161,1,0.706057569370904,0,10,intronic transcription regulatory region sequence-specific DNA binding,MF,
434,GO:0001162,1,0.764586407027657,0,8,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,
435,GO:0001163,1,0.755859303863818,0,8,RNA polymerase I regulatory region sequence-specific DNA binding,MF,
436,GO:0001164,1,0.755859303863818,0,8,RNA polymerase I CORE element sequence-specific DNA binding,MF,
437,GO:0001165,1,0.959952365304941,0,1,RNA polymerase I upstream control element sequence-specific DNA binding,MF,
438,GO:0001172,1,0.950635164900056,0,2,transcription, RNA-templated,BP,
439,GO:0001179,1,0.973043534260665,0,1,RNA polymerase I transcription factor binding,MF,
440,GO:0001181,1,0.937953830677835,0,2,transcription factor activity, core RNA polymerase I binding,MF,
441,GO:0001188,1,0.755859303863818,0,8,RNA polymerase I transcriptional preinitiation complex assembly,BP,
444,GO:0001192,1,0.983386685254278,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation,BP,
445,GO:0001193,1,0.983386685254278,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter,BP,
449,GO:0001222,1,0.643956025574104,0,13,transcription corepressor binding,MF,
453,GO:0001226,1,0.963445624205636,0,1,RNA polymerase II transcription corepressor binding,MF,
456,GO:0001300,1,0.929503219273477,0,2,chronological cell aging,BP,
457,GO:0001302,1,0.820582855310319,0,6,replicative cell aging,BP,
460,GO:0001325,1,0.569441693165265,0,15,formation of extrachromosomal circular DNA,BP,
461,GO:0001401,1,0.938259142995484,0,2,mitochondrial sorting and assembly machinery complex,CC,
462,GO:0001405,1,0.855267022957822,0,5,presequence translocase-associated import motor,CC,
466,GO:0001504,1,0.57890101372809,0,16,neurotransmitter uptake,BP,
469,GO:0001510,1,0.138198122712155,0,61,RNA methylation,BP,
470,GO:0001512,1,0.980328748456309,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
471,GO:0001514,1,0.793485413432396,0,7,selenocysteine incorporation,BP,
472,GO:0001515,1,0.972020621072151,0,1,opioid peptide activity,MF,
474,GO:0001517,1,0.829586671306351,0,5,N-acetylglucosamine 6-O-sulfotransferase activity,MF,
475,GO:0001518,1,0.780952811892852,0,6,voltage-gated sodium channel complex,CC,
476,GO:0001519,1,0.961748720514894,0,1,peptide amidation,BP,
477,GO:0001520,1,0.925752222912225,0,2,outer dense fiber,CC,
478,GO:0001522,1,0.611810394175355,0,18,pseudouridine synthesis,BP,
481,GO:0001527,1,0.752819703434179,0,8,microfibril,CC,
482,GO:0001530,1,0.737726278835259,0,10,lipopolysaccharide binding,MF,
484,GO:0001534,1,0.961623367319171,0,1,radial spoke,CC,
485,GO:0001536,1,0.961623367319171,0,1,radial spoke stalk,CC,
486,GO:0001537,1,0.930951094393178,0,2,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,
487,GO:0001539,1,0.590374324160719,0,15,cilium or flagellum-dependent cell motility,BP,
491,GO:0001543,1,0.95950763690405,0,1,ovarian follicle rupture,BP,
492,GO:0001544,1,0.95950763690405,0,1,initiation of primordial ovarian follicle growth,BP,
493,GO:0001545,1,0.960844645506627,0,1,primary ovarian follicle growth,BP,
494,GO:0001546,1,0.975008657882268,0,1,preantral ovarian follicle growth,BP,
497,GO:0001552,1,0.972333328804803,0,1,ovarian follicle atresia,BP,
499,GO:0001554,1,0.818045672883395,0,5,luteolysis,BP,
500,GO:0001555,1,0.932025269400477,0,2,oocyte growth,BP,
503,GO:0001560,1,0.921941771025202,0,2,regulation of cell growth by extracellular stimulus,BP,
504,GO:0001561,1,0.824819872742784,0,6,fatty acid alpha-oxidation,BP,
509,GO:0001572,1,0.959741413083679,0,1,lactosylceramide biosynthetic process,BP,
510,GO:0001573,1,0.718680197302633,0,10,ganglioside metabolic process,BP,
511,GO:0001574,1,0.879303550683529,0,4,ganglioside biosynthetic process,BP,
512,GO:0001575,1,0.944518691981026,0,2,globoside metabolic process,BP,
513,GO:0001576,1,0.971074942959089,0,1,globoside biosynthetic process,BP,
514,GO:0001578,1,0.198893983600524,0,45,microtubule bundle formation,BP,
515,GO:0001579,1,0.928791208221416,0,2,medium-chain fatty acid transport,BP,
516,GO:0001580,1,0.885661675142013,0,5,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
517,GO:0001582,1,0.967549206826007,0,1,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
518,GO:0001588,1,0.958667927388671,0,2,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
519,GO:0001595,1,0.979876170311414,0,1,angiotensin receptor activity,MF,
520,GO:0001605,1,0.959630263764256,0,1,adrenomedullin receptor activity,MF,
521,GO:0001608,1,0.850507304250595,0,5,G-protein coupled nucleotide receptor activity,MF,
522,GO:0001609,1,0.911960513995914,0,3,G-protein coupled adenosine receptor activity,MF,
523,GO:0001614,1,0.826294330538462,0,6,purinergic nucleotide receptor activity,MF,
525,GO:0001631,1,0.939918295195159,0,2,cysteinyl leukotriene receptor activity,MF,
526,GO:0001632,1,0.939918295195159,0,2,leukotriene B4 receptor activity,MF,
527,GO:0001635,1,0.911834361469733,0,3,calcitonin gene-related peptide receptor activity,MF,
528,GO:0001637,1,0.81493749736054,0,6,G-protein coupled chemoattractant receptor activity,MF,
529,GO:0001640,1,0.95950763690405,0,1,adenylate cyclase inhibiting G-protein coupled glutamate receptor activity,MF,
530,GO:0001642,1,0.95950763690405,0,1,group III metabotropic glutamate receptor activity,MF,
533,GO:0001651,1,0.946188096531211,0,2,dense fibrillar component,CC,
534,GO:0001652,1,0.883150561858637,0,4,granular component,CC,
543,GO:0001661,1,0.931234688054712,0,2,conditioned taste aversion,BP,
544,GO:0001662,1,0.543234239055156,0,18,behavioral fear response,BP,
546,GO:0001665,1,0.890940764842104,0,4,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,
550,GO:0001671,1,0.504476867177554,0,22,ATPase activator activity,MF,
551,GO:0001672,1,0.766454544602132,0,7,regulation of chromatin assembly or disassembly,BP,
552,GO:0001673,1,0.726380072179448,0,10,male germ cell nucleus,CC,
553,GO:0001674,1,0.931463261198114,0,2,female germ cell nucleus,CC,
557,GO:0001680,1,0.969587045794927,0,1,tRNA 3'-terminal CCA addition,BP,
558,GO:0001681,1,0.965759055880773,0,1,sialate O-acetylesterase activity,MF,
559,GO:0001682,1,0.72247628578252,0,12,tRNA 5'-leader removal,BP,
560,GO:0001692,1,0.983015491524096,0,1,histamine metabolic process,BP,
561,GO:0001695,1,0.983015491524096,0,1,histamine catabolic process,BP,
571,GO:0001710,1,0.815214832583759,0,6,mesodermal cell fate commitment,BP,
572,GO:0001711,1,0.716872373571076,0,10,endodermal cell fate commitment,BP,
574,GO:0001714,1,0.893882334247781,0,4,endodermal cell fate specification,BP,
575,GO:0001715,1,0.961388733148346,0,1,ectodermal cell fate specification,BP,
576,GO:0001725,1,0.210050329896343,0,43,stress fiber,CC,
578,GO:0001727,1,0.834959322128676,0,5,lipid kinase activity,MF,
579,GO:0001729,1,0.92673001020278,0,2,ceramide kinase activity,MF,
580,GO:0001730,1,0.878175544994544,0,4,2'-5'-oligoadenylate synthetase activity,MF,
581,GO:0001731,1,0.757195603717879,0,8,formation of translation preinitiation complex,BP,
582,GO:0001732,1,0.932841204888526,0,2,formation of cytoplasmic translation initiation complex,BP,
583,GO:0001733,1,0.967691660411353,0,1,galactosylceramide sulfotransferase activity,MF,
584,GO:0001735,1,0.928429904171287,0,2,prenylcysteine oxidase activity,MF,
587,GO:0001739,1,0.821306960955686,0,6,sex chromatin,CC,
588,GO:0001740,1,0.905419559256169,0,3,Barr body,CC,
590,GO:0001743,1,0.923973743000541,0,2,optic placode formation,BP,
591,GO:0001750,1,0.282742288796959,0,35,photoreceptor outer segment,CC,
595,GO:0001757,1,0.924352297366207,0,2,somite specification,BP,
600,GO:0001765,1,0.754327680083487,0,9,membrane raft assembly,BP,
601,GO:0001766,1,0.830446826982294,0,6,membrane raft polarization,BP,
602,GO:0001767,1,0.792504193569205,0,6,establishment of lymphocyte polarity,BP,
603,GO:0001768,1,0.825965216744501,0,5,establishment of T cell polarity,BP,
604,GO:0001770,1,0.95950763690405,0,1,establishment of natural killer cell polarity,BP,
605,GO:0001771,1,0.812656420729399,0,6,immunological synapse formation,BP,
611,GO:0001777,1,0.984110997931916,0,1,T cell homeostatic proliferation,BP,
612,GO:0001778,1,0.848066298493675,0,4,plasma membrane repair,BP,
619,GO:0001786,1,0.376679143548202,0,27,phosphatidylserine binding,MF,
621,GO:0001792,1,0.960389834323899,0,1,polymeric immunoglobulin receptor activity,MF,
622,GO:0001794,1,0.959577913492681,0,1,type IIa hypersensitivity,BP,
623,GO:0001796,1,0.959577913492681,0,1,regulation of type IIa hypersensitivity,BP,
624,GO:0001798,1,0.959577913492681,0,1,positive regulation of type IIa hypersensitivity,BP,
625,GO:0001806,1,0.916036469736505,0,3,type IV hypersensitivity,BP,
626,GO:0001807,1,0.949736131783899,0,2,regulation of type IV hypersensitivity,BP,
627,GO:0001808,1,0.971466789900701,0,1,negative regulation of type IV hypersensitivity,BP,
628,GO:0001809,1,0.977632718767071,0,1,positive regulation of type IV hypersensitivity,BP,
633,GO:0001820,1,0.902821410879017,0,3,serotonin secretion,BP,
639,GO:0001826,1,0.820484937881786,0,5,inner cell mass cell differentiation,BP,
640,GO:0001827,1,0.920922396433451,0,2,inner cell mass cell fate commitment,BP,
641,GO:0001828,1,0.920922396433451,0,2,inner cell mass cellular morphogenesis,BP,
643,GO:0001831,1,0.95950763690405,0,1,trophectodermal cellular morphogenesis,BP,
646,GO:0001834,1,0.926372432346771,0,2,trophectodermal cell proliferation,BP,
647,GO:0001835,1,0.963623477545562,0,1,blastocyst hatching,BP,
651,GO:0001839,1,0.833994680277118,0,5,neural plate morphogenesis,BP,
652,GO:0001840,1,0.739255169855409,0,8,neural plate development,BP,
654,GO:0001842,1,0.846600069320254,0,5,neural fold formation,BP,
657,GO:0001845,1,0.757421769592495,0,9,phagolysosome assembly,BP,
659,GO:0001848,1,0.868521591034896,0,5,complement binding,MF,
660,GO:0001849,1,0.953181570035937,0,2,complement component C1q binding,MF,
661,GO:0001850,1,0.973342662232965,0,1,complement component C3a binding,MF,
662,GO:0001851,1,0.973342662232965,0,1,complement component C3b binding,MF,
663,GO:0001855,1,0.975660677638797,0,1,complement component C4b binding,MF,
666,GO:0001867,1,0.887883070088548,0,4,complement activation, lectin pathway,BP,
667,GO:0001868,1,0.97276136741588,0,1,regulation of complement activation, lectin pathway,BP,
668,GO:0001869,1,0.97276136741588,0,1,negative regulation of complement activation, lectin pathway,BP,
669,GO:0001871,1,0.800691267313552,0,6,pattern binding,MF,
670,GO:0001875,1,0.894301017580593,0,3,lipopolysaccharide receptor activity,MF,
671,GO:0001878,1,0.969343762500031,0,1,response to yeast,BP,
672,GO:0001880,1,0.923146994715143,0,2,Mullerian duct regression,BP,
673,GO:0001881,1,0.371233497859262,0,28,receptor recycling,BP,
676,GO:0001884,1,0.928459682999359,0,2,pyrimidine nucleoside binding,MF,
678,GO:0001886,1,0.774934132259229,0,7,endothelial cell morphogenesis,BP,
680,GO:0001888,1,0.926504656429739,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
687,GO:0001895,1,0.334465962284449,0,33,retina homeostasis,BP,
688,GO:0001905,1,0.920718395014415,0,2,activation of membrane attack complex,BP,
690,GO:0001907,1,0.921000638001773,0,3,killing by symbiont of host cells,BP,
699,GO:0001917,1,0.438002770782119,0,23,photoreceptor inner segment,CC,
700,GO:0001918,1,0.966073958881589,0,1,farnesylated protein binding,MF,
701,GO:0001919,1,0.481339860698548,0,20,regulation of receptor recycling,BP,
702,GO:0001920,1,0.893979439588119,0,3,negative regulation of receptor recycling,BP,
703,GO:0001921,1,0.61803354426679,0,13,positive regulation of receptor recycling,BP,
705,GO:0001923,1,0.902300161420998,0,3,B-1 B cell differentiation,BP,
706,GO:0001927,1,0.893406301554946,0,3,exocyst assembly,BP,
707,GO:0001928,1,0.969725342433419,0,1,regulation of exocyst assembly,BP,
708,GO:0001931,1,0.749596647815651,0,8,uropod,CC,
716,GO:0001939,1,0.809663656367237,0,6,female pronucleus,CC,
717,GO:0001940,1,0.839161948095681,0,5,male pronucleus,CC,
718,GO:0001941,1,0.515011222669076,0,19,postsynaptic membrane organization,BP,
724,GO:0001951,1,0.889870737679391,0,3,intestinal D-glucose absorption,BP,
728,GO:0001955,1,0.840969436021272,0,5,blood vessel maturation,BP,
730,GO:0001957,1,0.8637126255612,0,4,intramembranous ossification,BP,
737,GO:0001965,1,0.605105726904682,0,16,G-protein alpha-subunit binding,MF,
738,GO:0001966,1,0.977958404736081,0,1,thigmotaxis,BP,
739,GO:0001967,1,0.772600715097247,0,7,suckling behavior,BP,
741,GO:0001969,1,0.920718395014415,0,2,regulation of activation of membrane attack complex,BP,
742,GO:0001970,1,0.959577913492681,0,1,positive regulation of activation of membrane attack complex,BP,
743,GO:0001971,1,0.95950763690405,0,1,negative regulation of activation of membrane attack complex,BP,
744,GO:0001972,1,0.72452539004596,0,9,retinoic acid binding,MF,
745,GO:0001973,1,0.863800633065812,0,5,adenosine receptor signaling pathway,BP,
749,GO:0001977,1,0.741955159020879,0,9,renal system process involved in regulation of blood volume,BP,
750,GO:0001978,1,0.970316822191537,0,1,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
751,GO:0001983,1,0.970316822191537,0,1,baroreceptor response to increased systemic arterial blood pressure,BP,
752,GO:0001985,1,0.970316822191537,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
754,GO:0001991,1,0.757760938326008,0,8,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,
755,GO:0001992,1,0.960259554778064,0,1,regulation of systemic arterial blood pressure by vasopressin,BP,
757,GO:0001994,1,0.970316822191537,0,1,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
758,GO:0001996,1,0.906525352859438,0,3,positive regulation of heart rate by epinephrine-norepinephrine,BP,
759,GO:0001997,1,0.970316822191537,0,1,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
760,GO:0001998,1,0.972526528927923,0,1,angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
761,GO:0001999,1,0.861967633986623,0,4,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,
762,GO:0002001,1,0.861967633986623,0,4,renin secretion into blood stream,BP,
763,GO:0002002,1,0.879148470681614,0,4,regulation of angiotensin levels in blood,BP,
764,GO:0002003,1,0.879148470681614,0,4,angiotensin maturation,BP,
767,GO:0002016,1,0.985554531774291,0,1,regulation of blood volume by renin-angiotensin,BP,
768,GO:0002017,1,0.972872945563909,0,1,regulation of blood volume by renal aldosterone,BP,
769,GO:0002019,1,0.985554531774291,0,1,regulation of renal output by angiotensin,BP,
780,GO:0002034,1,0.972526528927923,0,1,regulation of blood vessel diameter by renin-angiotensin,BP,
781,GO:0002036,1,0.869574797870154,0,4,regulation of L-glutamate import across plasma membrane,BP,
782,GO:0002037,1,0.970787824273876,0,1,negative regulation of L-glutamate import across plasma membrane,BP,
783,GO:0002038,1,0.969671436256047,0,1,positive regulation of L-glutamate import across plasma membrane,BP,
786,GO:0002041,1,0.969472596267671,0,1,intussusceptive angiogenesis,BP,
789,GO:0002046,1,0.982198699800016,0,1,opsin binding,MF,
790,GO:0002051,1,0.852498980176814,0,4,osteoblast fate commitment,BP,
793,GO:0002054,1,0.921518307864417,0,3,nucleobase binding,MF,
794,GO:0002055,1,0.984960135159515,0,1,adenine binding,MF,
795,GO:0002060,1,0.921518307864417,0,3,purine nucleobase binding,MF,
805,GO:0002071,1,0.930921617962836,0,2,glandular epithelial cell maturation,BP,
807,GO:0002074,1,0.898386275270741,0,3,extraocular skeletal muscle development,BP,
809,GO:0002079,1,0.924636071401952,0,2,inner acrosomal membrane,CC,
810,GO:0002080,1,0.700875285302958,0,10,acrosomal membrane,CC,
811,GO:0002081,1,0.95950763690405,0,1,outer acrosomal membrane,CC,
813,GO:0002083,1,0.975105824257611,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
814,GO:0002084,1,0.747765521487458,0,9,protein depalmitoylation,BP,
815,GO:0002085,1,0.903062800579698,0,3,inhibition of neuroepithelial cell differentiation,BP,
816,GO:0002086,1,0.962172802487713,0,1,diaphragm contraction,BP,
817,GO:0002087,1,0.820352373312558,0,5,regulation of respiratory gaseous exchange by neurological system process,BP,
820,GO:0002090,1,0.414887369775347,0,25,regulation of receptor internalization,BP,
821,GO:0002091,1,0.774695160566645,0,7,negative regulation of receptor internalization,BP,
822,GO:0002092,1,0.581771805092095,0,15,positive regulation of receptor internalization,BP,
823,GO:0002093,1,0.782641531683845,0,7,auditory receptor cell morphogenesis,BP,
824,GO:0002094,1,0.939417623086894,0,2,polyprenyltransferase activity,MF,
825,GO:0002097,1,0.598103910883699,0,16,tRNA wobble base modification,BP,
826,GO:0002098,1,0.686228598886072,0,12,tRNA wobble uridine modification,BP,
827,GO:0002100,1,0.95950763690405,0,1,tRNA wobble adenosine to inosine editing,BP,
828,GO:0002101,1,0.908490767829457,0,3,tRNA wobble cytosine modification,BP,
830,GO:0002114,1,0.961499406568799,0,1,interleukin-33 receptor activity,MF,
831,GO:0002115,1,0.63572250898422,0,13,store-operated calcium entry,BP,
832,GO:0002116,1,0.667259895120179,0,10,semaphorin receptor complex,CC,
833,GO:0002118,1,0.962840098217462,0,1,aggressive behavior,BP,
834,GO:0002121,1,0.962840098217462,0,1,inter-male aggressive behavior,BP,
835,GO:0002127,1,0.977164591004212,0,1,tRNA wobble base cytosine methylation,BP,
836,GO:0002133,1,0.920743106004502,0,2,polycystin complex,CC,
837,GO:0002134,1,0.928459682999359,0,2,UTP binding,MF,
838,GO:0002135,1,0.967644020655307,0,1,CTP binding,MF,
840,GO:0002143,1,0.890617854539544,0,4,tRNA wobble position uridine thiolation,BP,
841,GO:0002144,1,0.970951403324723,0,1,cytosolic tRNA wobble base thiouridylase complex,CC,
842,GO:0002151,1,0.804676011393088,0,6,G-quadruplex RNA binding,MF,
843,GO:0002153,1,0.968514565991004,0,1,steroid receptor RNA activator RNA binding,MF,
844,GO:0002154,1,0.830167995296844,0,5,thyroid hormone mediated signaling pathway,BP,
845,GO:0002155,1,0.901737900711345,0,3,regulation of thyroid hormone mediated signaling pathway,BP,
847,GO:0002159,1,0.857083109240365,0,4,desmosome assembly,BP,
848,GO:0002161,1,0.674133067418445,0,11,aminoacyl-tRNA editing activity,MF,
850,GO:0002169,1,0.930762605419215,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
851,GO:0002175,1,0.853340329707827,0,4,protein localization to paranode region of axon,BP,
852,GO:0002176,1,0.933724747409783,0,3,male germ cell proliferation,BP,
853,GO:0002177,1,0.919630472941533,0,3,manchette,CC,
854,GO:0002178,1,0.699067622206629,0,11,palmitoyltransferase complex,CC,
857,GO:0002183,1,0.557587820989826,0,18,cytoplasmic translational initiation,BP,
858,GO:0002184,1,0.926666712488667,0,2,cytoplasmic translational termination,BP,
859,GO:0002188,1,0.88802600725366,0,3,translation reinitiation,BP,
860,GO:0002189,1,0.967695069193562,0,1,ribose phosphate diphosphokinase complex,CC,
861,GO:0002190,1,0.87584253773274,0,5,cap-independent translational initiation,BP,
862,GO:0002191,1,0.907282436496213,0,3,cap-dependent translational initiation,BP,
863,GO:0002192,1,0.959067556193121,0,2,IRES-dependent translational initiation of linear mRNA,BP,
864,GO:0002193,1,0.89207416036795,0,3,MAML1-RBP-Jkappa- ICN1 complex,CC,
865,GO:0002196,1,0.972707993343804,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
866,GO:0002199,1,0.807557872296417,0,7,zona pellucida receptor complex,CC,
870,GO:0002209,1,0.543234239055156,0,18,behavioral defense response,BP,
876,GO:0002225,1,0.950328631621162,0,2,positive regulation of antimicrobial peptide production,BP,
877,GO:0002227,1,0.870791028323152,0,10,innate immune response in mucosa,BP,
881,GO:0002238,1,0.959616422844776,0,1,response to molecule of fungal origin,BP,
885,GO:0002249,1,0.920650957478618,0,2,lymphocyte anergy,BP,
887,GO:0002251,1,0.74419921777653,0,14,organ or tissue specific immune response,BP,
890,GO:0002254,1,0.942533063323143,0,2,kinin cascade,BP,
894,GO:0002265,1,0.886266024171693,0,3,astrocyte activation involved in immune response,BP,
899,GO:0002276,1,0.932601057301533,0,2,basophil activation involved in immune response,BP,
900,GO:0002277,1,0.983131290533574,0,1,myeloid dendritic cell activation involved in immune response,BP,
901,GO:0002278,1,0.886179093475453,0,4,eosinophil activation involved in immune response,BP,
908,GO:0002291,1,0.912950769664044,0,3,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
913,GO:0002296,1,0.922080771540824,0,2,T-helper 1 cell lineage commitment,BP,
914,GO:0002299,1,0.975889352523486,0,1,alpha-beta intraepithelial T cell differentiation,BP,
915,GO:0002300,1,0.975889352523486,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
916,GO:0002304,1,0.975889352523486,0,1,gamma-delta intraepithelial T cell differentiation,BP,
917,GO:0002305,1,0.975889352523486,0,1,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
918,GO:0002309,1,0.983876628796848,0,1,T cell proliferation involved in immune response,BP,
921,GO:0002314,1,0.945761890089089,0,2,germinal center B cell differentiation,BP,
923,GO:0002316,1,0.960409336878159,0,1,follicular B cell differentiation,BP,
924,GO:0002317,1,0.935955101942011,0,3,plasma cell differentiation,BP,
925,GO:0002318,1,0.900323310880593,0,3,myeloid progenitor cell differentiation,BP,
927,GO:0002322,1,0.921941425200017,0,2,B cell proliferation involved in immune response,BP,
928,GO:0002323,1,0.7623776235632,0,9,natural killer cell activation involved in immune response,BP,
929,GO:0002325,1,0.979953165374025,0,1,natural killer cell differentiation involved in immune response,BP,
930,GO:0002326,1,0.885920465638126,0,3,B cell lineage commitment,BP,
931,GO:0002327,1,0.780922122031649,0,6,immature B cell differentiation,BP,
933,GO:0002329,1,0.848256480203055,0,4,pre-B cell differentiation,BP,
934,GO:0002331,1,0.920650957478618,0,2,pre-B cell allelic exclusion,BP,
935,GO:0002332,1,0.959508441249815,0,1,transitional stage B cell differentiation,BP,
936,GO:0002333,1,0.959508441249815,0,1,transitional one stage B cell differentiation,BP,
938,GO:0002337,1,0.940273167127053,0,2,B-1a B cell differentiation,BP,
939,GO:0002339,1,0.954816227394226,0,2,B cell selection,BP,
940,GO:0002347,1,0.711303112427076,0,10,response to tumor cell,BP,
941,GO:0002349,1,0.862559511995293,0,5,histamine production involved in inflammatory response,BP,
942,GO:0002351,1,0.959616422844776,0,1,serotonin production involved in inflammatory response,BP,
943,GO:0002352,1,0.954816227394226,0,2,B cell negative selection,BP,
944,GO:0002353,1,0.942533063323143,0,2,plasma kallikrein-kinin cascade,BP,
945,GO:0002357,1,0.966225539049244,0,1,defense response to tumor cell,BP,
946,GO:0002358,1,0.984110997931916,0,1,B cell homeostatic proliferation,BP,
951,GO:0002368,1,0.969283456517294,0,1,B cell cytokine production,BP,
953,GO:0002370,1,0.910529238377625,0,3,natural killer cell cytokine production,BP,
954,GO:0002371,1,0.873196568611743,0,4,dendritic cell cytokine production,BP,
955,GO:0002373,1,0.982623158049942,0,1,plasmacytoid dendritic cell cytokine production,BP,
959,GO:0002378,1,0.960094585722157,0,1,immunoglobulin biosynthetic process,BP,
962,GO:0002384,1,0.960671527649304,0,1,hepatic immune response,BP,
963,GO:0002385,1,0.774685859463465,0,13,mucosal immune response,BP,
964,GO:0002386,1,0.960389834323899,0,1,immune response in mucosal-associated lymphoid tissue,BP,
965,GO:0002396,1,0.972561827696324,0,1,MHC protein complex assembly,BP,
966,GO:0002397,1,0.972561827696324,0,1,MHC class I protein complex assembly,BP,
967,GO:0002407,1,0.698905586459477,0,11,dendritic cell chemotaxis,BP,
968,GO:0002408,1,0.959513721015153,0,1,myeloid dendritic cell chemotaxis,BP,
969,GO:0002414,1,0.935366370259888,0,2,immunoglobulin transcytosis in epithelial cells,BP,
970,GO:0002415,1,0.960389834323899,0,1,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
971,GO:0002416,1,0.973947100683964,0,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,
972,GO:0002418,1,0.762690645122141,0,8,immune response to tumor cell,BP,
973,GO:0002420,1,0.865743829016186,0,4,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
974,GO:0002423,1,0.865743829016186,0,4,natural killer cell mediated immune response to tumor cell,BP,
975,GO:0002424,1,0.933290001508291,0,2,T cell mediated immune response to tumor cell,BP,
978,GO:0002430,1,0.969484008610393,0,1,complement receptor mediated signaling pathway,BP,
979,GO:0002431,1,0.113035546387911,0,61,Fc receptor mediated stimulatory signaling pathway,BP,
980,GO:0002432,1,0.96017002565021,0,1,granuloma formation,BP,
981,GO:0002433,1,0.124538615163056,0,58,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,
983,GO:0002438,1,0.784469299231205,0,8,acute inflammatory response to antigenic stimulus,BP,
986,GO:0002441,1,0.862559511995293,0,5,histamine secretion involved in inflammatory response,BP,
987,GO:0002442,1,0.959616422844776,0,1,serotonin secretion involved in inflammatory response,BP,
990,GO:0002445,1,0.959577913492681,0,1,type II hypersensitivity,BP,
992,GO:0002447,1,0.886179093475453,0,4,eosinophil mediated immunity,BP,
997,GO:0002457,1,0.867380160791,0,4,T cell antigen processing and presentation,BP,
999,GO:0002461,1,0.969238362043476,0,1,tolerance induction dependent upon immune response,BP,
1001,GO:0002468,1,0.865319670824849,0,4,dendritic cell antigen processing and presentation,BP,
1005,GO:0002477,1,0.982084438804893,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1009,GO:0002481,1,0.982084438804893,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
1011,GO:0002488,1,0.960909550686142,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1012,GO:0002489,1,0.960909550686142,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
1013,GO:0002495,1,0.07753284269824,0,76,antigen processing and presentation of peptide antigen via MHC class II,BP,
1014,GO:0002501,1,0.972561827696324,0,1,peptide antigen assembly with MHC protein complex,BP,
1015,GO:0002502,1,0.972561827696324,0,1,peptide antigen assembly with MHC class I protein complex,BP,
1016,GO:0002504,1,0.0743734988419217,0,77,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1018,GO:0002513,1,0.898203151535159,0,3,tolerance induction to self antigen,BP,
1019,GO:0002514,1,0.959869033700348,0,1,B cell tolerance induction,BP,
1020,GO:0002517,1,0.841325831599226,0,5,T cell tolerance induction,BP,
1021,GO:0002519,1,0.969238362043476,0,1,natural killer cell tolerance induction,BP,
1025,GO:0002524,1,0.879000336240275,0,4,hypersensitivity,BP,
1027,GO:0002528,1,0.925915236941815,0,2,regulation of vascular permeability involved in acute inflammatory response,BP,
1032,GO:0002538,1,0.964046331367156,0,1,arachidonic acid metabolite production involved in inflammatory response,BP,
1033,GO:0002540,1,0.964046331367156,0,1,leukotriene production involved in inflammatory response,BP,
1035,GO:0002542,1,0.971332584835709,0,1,Factor XII activation,BP,
1038,GO:0002545,1,0.972855058342775,0,1,chronic inflammatory response to non-antigenic stimulus,BP,
1041,GO:0002553,1,0.862559511995293,0,5,histamine secretion by mast cell,BP,
1042,GO:0002554,1,0.959616422844776,0,1,serotonin secretion by platelet,BP,
1043,GO:0002560,1,0.960557918077305,0,1,basophil mediated immunity,BP,
1044,GO:0002561,1,0.960557918077305,0,1,basophil degranulation,BP,
1046,GO:0002566,1,0.593906798229087,0,15,somatic diversification of immune receptors via somatic mutation,BP,
1047,GO:0002568,1,0.822304647887759,0,5,somatic diversification of T cell receptor genes,BP,
1048,GO:0002572,1,0.926940737218332,0,2,pro-T cell differentiation,BP,
1051,GO:0002577,1,0.787291885930328,0,8,regulation of antigen processing and presentation,BP,
1052,GO:0002578,1,0.88799219879415,0,4,negative regulation of antigen processing and presentation,BP,
1053,GO:0002579,1,0.886629891804567,0,4,positive regulation of antigen processing and presentation,BP,
1054,GO:0002580,1,0.922405706861371,0,3,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1055,GO:0002581,1,0.938235091382619,0,2,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1056,GO:0002582,1,0.983131290533574,0,1,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1057,GO:0002583,1,0.909859378080039,0,4,regulation of antigen processing and presentation of peptide antigen,BP,
1058,GO:0002584,1,0.925474021685248,0,3,negative regulation of antigen processing and presentation of peptide antigen,BP,
1059,GO:0002585,1,0.983131290533574,0,1,positive regulation of antigen processing and presentation of peptide antigen,BP,
1060,GO:0002586,1,0.961336314902207,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1061,GO:0002587,1,0.977832027584077,0,1,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1062,GO:0002588,1,0.983131290533574,0,1,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1063,GO:0002589,1,0.946457993631581,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1064,GO:0002590,1,0.946457993631581,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1065,GO:0002604,1,0.865319670824849,0,4,regulation of dendritic cell antigen processing and presentation,BP,
1066,GO:0002605,1,0.95950763690405,0,1,negative regulation of dendritic cell antigen processing and presentation,BP,
1067,GO:0002606,1,0.901846881959032,0,3,positive regulation of dendritic cell antigen processing and presentation,BP,
1068,GO:0002625,1,0.972289642118233,0,1,regulation of T cell antigen processing and presentation,BP,
1069,GO:0002626,1,0.972289642118233,0,1,negative regulation of T cell antigen processing and presentation,BP,
1072,GO:0002636,1,0.976124642047473,0,1,positive regulation of germinal center formation,BP,
1074,GO:0002638,1,0.831867156366159,0,5,negative regulation of immunoglobulin production,BP,
1076,GO:0002643,1,0.72519189374949,0,9,regulation of tolerance induction,BP,
1077,GO:0002645,1,0.841325831599226,0,5,positive regulation of tolerance induction,BP,
1078,GO:0002649,1,0.959869033700348,0,1,regulation of tolerance induction to self antigen,BP,
1079,GO:0002651,1,0.959869033700348,0,1,positive regulation of tolerance induction to self antigen,BP,
1080,GO:0002652,1,0.969238362043476,0,1,regulation of tolerance induction dependent upon immune response,BP,
1081,GO:0002661,1,0.959869033700348,0,1,regulation of B cell tolerance induction,BP,
1082,GO:0002663,1,0.959869033700348,0,1,positive regulation of B cell tolerance induction,BP,
1083,GO:0002664,1,0.841325831599226,0,5,regulation of T cell tolerance induction,BP,
1084,GO:0002666,1,0.876842779890175,0,4,positive regulation of T cell tolerance induction,BP,
1085,GO:0002667,1,0.920650957478618,0,2,regulation of T cell anergy,BP,
1086,GO:0002669,1,0.95950763690405,0,1,positive regulation of T cell anergy,BP,
1088,GO:0002674,1,0.891041144716674,0,4,negative regulation of acute inflammatory response,BP,
1094,GO:0002681,1,0.822304647887759,0,5,somatic recombination of T cell receptor gene segments,BP,
1099,GO:0002686,1,0.594483519714612,0,17,negative regulation of leukocyte migration,BP,
1102,GO:0002689,1,0.827736808543564,0,7,negative regulation of leukocyte chemotaxis,BP,
1105,GO:0002692,1,0.872415728221214,0,4,negative regulation of cellular extravasation,BP,
1126,GO:0002713,1,0.871702030532727,0,4,negative regulation of B cell mediated immunity,BP,
1134,GO:0002724,1,0.649789278273,0,13,regulation of T cell cytokine production,BP,
1135,GO:0002725,1,0.91615236932134,0,3,negative regulation of T cell cytokine production,BP,
1136,GO:0002726,1,0.738271652979327,0,9,positive regulation of T cell cytokine production,BP,
1137,GO:0002727,1,0.910529238377625,0,3,regulation of natural killer cell cytokine production,BP,
1138,GO:0002728,1,0.96010064133299,0,1,negative regulation of natural killer cell cytokine production,BP,
1139,GO:0002729,1,0.948373711584599,0,2,positive regulation of natural killer cell cytokine production,BP,
1140,GO:0002730,1,0.873196568611743,0,4,regulation of dendritic cell cytokine production,BP,
1141,GO:0002731,1,0.942842025354087,0,2,negative regulation of dendritic cell cytokine production,BP,
1142,GO:0002732,1,0.960065573690081,0,1,positive regulation of dendritic cell cytokine production,BP,
1143,GO:0002736,1,0.982623158049942,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1144,GO:0002737,1,0.982623158049942,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
1153,GO:0002759,1,0.889686884462241,0,4,regulation of antimicrobial humoral response,BP,
1154,GO:0002760,1,0.950328631621162,0,2,positive regulation of antimicrobial humoral response,BP,
1159,GO:0002765,1,0.914235609079723,0,3,immune response-inhibiting signal transduction,BP,
1160,GO:0002767,1,0.941092062283634,0,2,immune response-inhibiting cell surface receptor signaling pathway,BP,
1162,GO:0002774,1,0.964536893806967,0,1,Fc receptor mediated inhibitory signaling pathway,BP,
1163,GO:0002775,1,0.914169841862721,0,3,antimicrobial peptide production,BP,
1164,GO:0002778,1,0.914169841862721,0,3,antibacterial peptide production,BP,
1165,GO:0002784,1,0.914169841862721,0,3,regulation of antimicrobial peptide production,BP,
1166,GO:0002785,1,0.961956093172106,0,1,negative regulation of antimicrobial peptide production,BP,
1167,GO:0002786,1,0.914169841862721,0,3,regulation of antibacterial peptide production,BP,
1168,GO:0002787,1,0.961956093172106,0,1,negative regulation of antibacterial peptide production,BP,
1173,GO:0002803,1,0.950328631621162,0,2,positive regulation of antibacterial peptide production,BP,
1181,GO:0002826,1,0.900923298417725,0,3,negative regulation of T-helper 1 type immune response,BP,
1183,GO:0002828,1,0.542440873504351,0,19,regulation of type 2 immune response,BP,
1184,GO:0002829,1,0.764158980422809,0,8,negative regulation of type 2 immune response,BP,
1185,GO:0002830,1,0.730362504508122,0,10,positive regulation of type 2 immune response,BP,
1189,GO:0002834,1,0.807969779492494,0,6,regulation of response to tumor cell,BP,
1190,GO:0002835,1,0.933054856515872,0,2,negative regulation of response to tumor cell,BP,
1191,GO:0002836,1,0.899365334260005,0,3,positive regulation of response to tumor cell,BP,
1192,GO:0002837,1,0.807969779492494,0,6,regulation of immune response to tumor cell,BP,
1193,GO:0002838,1,0.933054856515872,0,2,negative regulation of immune response to tumor cell,BP,
1194,GO:0002839,1,0.899365334260005,0,3,positive regulation of immune response to tumor cell,BP,
1195,GO:0002840,1,0.933290001508291,0,2,regulation of T cell mediated immune response to tumor cell,BP,
1196,GO:0002842,1,0.969283456517294,0,1,positive regulation of T cell mediated immune response to tumor cell,BP,
1197,GO:0002855,1,0.865743829016186,0,4,regulation of natural killer cell mediated immune response to tumor cell,BP,
1198,GO:0002856,1,0.933054856515872,0,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,
1199,GO:0002857,1,0.92787164640472,0,2,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1200,GO:0002858,1,0.865743829016186,0,4,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1201,GO:0002859,1,0.933054856515872,0,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1202,GO:0002860,1,0.92787164640472,0,2,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1204,GO:0002862,1,0.913805761798545,0,4,negative regulation of inflammatory response to antigenic stimulus,BP,
1206,GO:0002864,1,0.895553409782316,0,4,regulation of acute inflammatory response to antigenic stimulus,BP,
1207,GO:0002865,1,0.971466789900701,0,1,negative regulation of acute inflammatory response to antigenic stimulus,BP,
1208,GO:0002866,1,0.921862466919563,0,3,positive regulation of acute inflammatory response to antigenic stimulus,BP,
1209,GO:0002870,1,0.920650957478618,0,2,T cell anergy,BP,
1211,GO:0002875,1,0.975222839342954,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
1213,GO:0002880,1,0.972855058342775,0,1,regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1214,GO:0002882,1,0.972855058342775,0,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1215,GO:0002883,1,0.911340908965595,0,3,regulation of hypersensitivity,BP,
1216,GO:0002884,1,0.971466789900701,0,1,negative regulation of hypersensitivity,BP,
1217,GO:0002885,1,0.938112542352137,0,2,positive regulation of hypersensitivity,BP,
1219,GO:0002887,1,0.865829810890382,0,4,negative regulation of myeloid leukocyte mediated immunity,BP,
1220,GO:0002888,1,0.653665381804922,0,13,positive regulation of myeloid leukocyte mediated immunity,BP,
1222,GO:0002890,1,0.871702030532727,0,4,negative regulation of immunoglobulin mediated immune response,BP,
1224,GO:0002892,1,0.959577913492681,0,1,regulation of type II hypersensitivity,BP,
1225,GO:0002894,1,0.959577913492681,0,1,positive regulation of type II hypersensitivity,BP,
1229,GO:0002904,1,0.920860949332376,0,3,positive regulation of B cell apoptotic process,BP,
1232,GO:0002911,1,0.920650957478618,0,2,regulation of lymphocyte anergy,BP,
1233,GO:0002913,1,0.95950763690405,0,1,positive regulation of lymphocyte anergy,BP,
1238,GO:0002924,1,0.969733056219969,0,1,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1240,GO:0002930,1,0.95957314079426,0,1,trabecular meshwork development,BP,
1242,GO:0002933,1,0.942456594248565,0,2,lipid hydroxylation,BP,
1243,GO:0002934,1,0.707891756212609,0,9,desmosome organization,BP,
1244,GO:0002940,1,0.936767048180285,0,2,tRNA N2-guanine methylation,BP,
1245,GO:0002943,1,0.887292632693373,0,4,tRNA dihydrouridine synthesis,BP,
1246,GO:0002944,1,0.930341552763522,0,2,cyclin K-CDK12 complex,CC,
1247,GO:0002945,1,0.930341552763522,0,2,cyclin K-CDK13 complex,CC,
1248,GO:0002946,1,0.977164591004212,0,1,tRNA C5-cytosine methylation,BP,
1249,GO:0002947,1,0.960687481883758,0,1,tumor necrosis factor receptor superfamily complex,CC,
1252,GO:0002951,1,0.968914883799795,0,1,leukotriene-C(4) hydrolase,MF,
1257,GO:0003009,1,0.551818872963451,0,18,skeletal muscle contraction,BP,
1258,GO:0003010,1,0.942064261301531,0,2,voluntary skeletal muscle contraction,BP,
1259,GO:0003011,1,0.92331209088055,0,2,involuntary skeletal muscle contraction,BP,
1265,GO:0003017,1,0.95950763690405,0,1,lymph circulation,BP,
1267,GO:0003025,1,0.931023476247554,0,2,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,
1268,GO:0003032,1,0.934764197438139,0,2,detection of oxygen,BP,
1270,GO:0003050,1,0.963901148558739,0,1,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,
1271,GO:0003056,1,0.835337912983676,0,5,regulation of vascular smooth muscle contraction,BP,
1272,GO:0003057,1,0.908270650175515,0,3,regulation of the force of heart contraction by chemical signal,BP,
1273,GO:0003062,1,0.872527412196556,0,4,regulation of heart rate by chemical signal,BP,
1274,GO:0003064,1,0.973206247380663,0,1,regulation of heart rate by hormone,BP,
1275,GO:0003065,1,0.973691590557428,0,1,positive regulation of heart rate by epinephrine,BP,
1279,GO:0003071,1,0.694917588566202,0,11,renal system process involved in regulation of systemic arterial blood pressure,BP,
1280,GO:0003072,1,0.972526528927923,0,1,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
1282,GO:0003081,1,0.726274592243318,0,10,regulation of systemic arterial blood pressure by renin-angiotensin,BP,
1283,GO:0003083,1,0.985554531774291,0,1,negative regulation of renal output by angiotensin,BP,
1284,GO:0003084,1,0.834454472162708,0,6,positive regulation of systemic arterial blood pressure,BP,
1286,GO:0003091,1,0.480866695629098,0,20,renal water homeostasis,BP,
1287,GO:0003093,1,0.762657834384399,0,8,regulation of glomerular filtration,BP,
1288,GO:0003094,1,0.662691828718589,0,11,glomerular filtration,BP,
1290,GO:0003097,1,0.87688179692558,0,4,renal water transport,BP,
1291,GO:0003099,1,0.970316822191537,0,1,positive regulation of the force of heart contraction by chemical signal,BP,
1293,GO:0003104,1,0.870068617025558,0,4,positive regulation of glomerular filtration,BP,
1294,GO:0003105,1,0.913537202622593,0,3,negative regulation of glomerular filtration,BP,
1295,GO:0003106,1,0.985554531774291,0,1,negative regulation of glomerular filtration by angiotensin,BP,
1296,GO:0003127,1,0.959603664790612,0,1,detection of nodal flow,BP,
1297,GO:0003128,1,0.865335786706314,0,5,heart field specification,BP,
1300,GO:0003131,1,0.965844339410484,0,1,mesodermal-endodermal cell signaling,BP,
1303,GO:0003139,1,0.888833094837005,0,4,secondary heart field specification,BP,
1304,GO:0003140,1,0.875358471724142,0,4,determination of left/right asymmetry in lateral mesoderm,BP,
1306,GO:0003148,1,0.557469772603637,0,16,outflow tract septum morphogenesis,BP,
1307,GO:0003149,1,0.734117340053132,0,9,membranous septum morphogenesis,BP,
1308,GO:0003150,1,0.859334532174455,0,4,muscular septum morphogenesis,BP,
1314,GO:0003160,1,0.907376958955055,0,3,endocardium morphogenesis,BP,
1316,GO:0003162,1,0.920651017862595,0,2,atrioventricular node development,BP,
1319,GO:0003165,1,0.959508100279369,0,1,Purkinje myocyte development,BP,
1322,GO:0003169,1,0.923508923734726,0,2,coronary vein morphogenesis,BP,
1326,GO:0003175,1,0.853874932337066,0,4,tricuspid valve development,BP,
1334,GO:0003186,1,0.853874932337066,0,4,tricuspid valve morphogenesis,BP,
1336,GO:0003190,1,0.851245034705719,0,4,atrioventricular valve formation,BP,
1337,GO:0003192,1,0.887179610924174,0,3,mitral valve formation,BP,
1338,GO:0003193,1,0.964039008079129,0,1,pulmonary valve formation,BP,
1339,GO:0003195,1,0.963651240948405,0,1,tricuspid valve formation,BP,
1341,GO:0003198,1,0.672158041533887,0,11,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
1351,GO:0003214,1,0.804587354351846,0,6,cardiac left ventricle morphogenesis,BP,
1353,GO:0003219,1,0.935165054087287,0,2,cardiac right ventricle formation,BP,
1354,GO:0003220,1,0.95950763690405,0,1,left ventricular cardiac muscle tissue morphogenesis,BP,
1355,GO:0003221,1,0.95950763690405,0,1,right ventricular cardiac muscle tissue morphogenesis,BP,
1357,GO:0003223,1,0.793264117582788,0,6,ventricular compact myocardium morphogenesis,BP,
1358,GO:0003226,1,0.95950763690405,0,1,right ventricular compact myocardium morphogenesis,BP,
1359,GO:0003228,1,0.909712111043764,0,3,atrial cardiac muscle tissue development,BP,
1363,GO:0003241,1,0.902545876388185,0,3,growth involved in heart morphogenesis,BP,
1364,GO:0003245,1,0.940640385261361,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
1365,GO:0003247,1,0.975135035644344,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1366,GO:0003249,1,0.920650957478618,0,2,cell proliferation involved in heart valve morphogenesis,BP,
1367,GO:0003250,1,0.920650957478618,0,2,regulation of cell proliferation involved in heart valve morphogenesis,BP,
1368,GO:0003251,1,0.95950763690405,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
1369,GO:0003252,1,0.95950763690405,0,1,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
1370,GO:0003253,1,0.870806448113261,0,4,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
1372,GO:0003256,1,0.892830709152377,0,3,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1373,GO:0003257,1,0.960321290422278,0,1,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1376,GO:0003266,1,0.858612472314529,0,5,regulation of secondary heart field cardioblast proliferation,BP,
1377,GO:0003270,1,0.95950763690405,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
1378,GO:0003272,1,0.596161371221228,0,14,endocardial cushion formation,BP,
1379,GO:0003273,1,0.861924544241363,0,4,cell migration involved in endocardial cushion formation,BP,
1380,GO:0003274,1,0.888889264144574,0,3,endocardial cushion fusion,BP,
1381,GO:0003275,1,0.923852082752787,0,2,apoptotic process involved in outflow tract morphogenesis,BP,
1382,GO:0003278,1,0.89564372937316,0,3,apoptotic process involved in heart morphogenesis,BP,
1388,GO:0003292,1,0.959507699830069,0,1,cardiac septum cell differentiation,BP,
1389,GO:0003294,1,0.929546541190834,0,2,atrial ventricular junction remodeling,BP,
1398,GO:0003310,1,0.976999496905179,0,1,pancreatic A cell differentiation,BP,
1399,GO:0003321,1,0.906525352859438,0,3,positive regulation of blood pressure by epinephrine-norepinephrine,BP,
1403,GO:0003335,1,0.967657616169375,0,1,corneocyte development,BP,
1404,GO:0003336,1,0.967657616169375,0,1,corneocyte desquamation,BP,
1408,GO:0003340,1,0.926550250423139,0,2,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1409,GO:0003341,1,0.439667574422933,0,25,cilium movement,BP,
1413,GO:0003345,1,0.961315721656026,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,
1415,GO:0003350,1,0.930680484819668,0,2,pulmonary myocardium development,BP,
1416,GO:0003351,1,0.742097332120711,0,10,epithelial cilium movement,BP,
1417,GO:0003352,1,0.842906792883965,0,5,regulation of cilium movement,BP,
1418,GO:0003356,1,0.842906792883965,0,5,regulation of cilium beat frequency,BP,
1420,GO:0003360,1,0.896993862357994,0,3,brainstem development,BP,
1421,GO:0003363,1,0.95950763690405,0,1,lamellipodium assembly involved in ameboidal cell migration,BP,
1423,GO:0003366,1,0.95950763690405,0,1,cell-matrix adhesion involved in ameboidal cell migration,BP,
1424,GO:0003373,1,0.735771310173645,0,8,dynamin family protein polymerization involved in membrane fission,BP,
1425,GO:0003374,1,0.735771310173645,0,8,dynamin family protein polymerization involved in mitochondrial fission,BP,
1426,GO:0003376,1,0.729239586288199,0,9,sphingosine-1-phosphate signaling pathway,BP,
1429,GO:0003400,1,0.970432530399028,0,1,regulation of COPII vesicle coating,BP,
1432,GO:0003404,1,0.963396276407058,0,1,optic vesicle morphogenesis,BP,
1433,GO:0003406,1,0.894695535851731,0,3,retinal pigment epithelium development,BP,
1436,GO:0003409,1,0.963396276407058,0,1,optic cup structural organization,BP,
1439,GO:0003416,1,0.616700064389084,0,13,endochondral bone growth,BP,
1440,GO:0003417,1,0.748473969585578,0,8,growth plate cartilage development,BP,
1441,GO:0003418,1,0.862963441141092,0,4,growth plate cartilage chondrocyte differentiation,BP,
1442,GO:0003419,1,0.934008142005168,0,2,growth plate cartilage chondrocyte proliferation,BP,
1443,GO:0003420,1,0.934008142005168,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
1444,GO:0003430,1,0.927049624428317,0,2,growth plate cartilage chondrocyte growth,BP,
1445,GO:0003431,1,0.862963441141092,0,4,growth plate cartilage chondrocyte development,BP,
1446,GO:0003433,1,0.837205144321875,0,5,chondrocyte development involved in endochondral bone morphogenesis,BP,
1450,GO:0003678,1,0.182170485371723,0,46,DNA helicase activity,MF,
1451,GO:0003680,1,0.818041106685687,0,6,AT DNA binding,MF,
1454,GO:0003688,1,0.609726643200036,0,14,DNA replication origin binding,MF,
1455,GO:0003689,1,0.778756876774389,0,8,DNA clamp loader activity,MF,
1457,GO:0003691,1,0.737144337434153,0,9,double-stranded telomeric DNA binding,MF,
1458,GO:0003696,1,0.872112932406826,0,4,satellite DNA binding,MF,
1463,GO:0003708,1,0.861939294429311,0,4,retinoic acid receptor activity,MF,
1467,GO:0003720,1,0.781580071143877,0,8,telomerase activity,MF,
1468,GO:0003721,1,0.988466016036463,0,1,telomerase RNA reverse transcriptase activity,MF,
1470,GO:0003724,1,0.106556754664566,0,61,RNA helicase activity,MF,
1472,GO:0003726,1,0.920797429950406,0,2,double-stranded RNA adenosine deaminase activity,MF,
1476,GO:0003735,1,0.0526618945690429,0,154,structural constituent of ribosome,MF,
1478,GO:0003746,1,0.600032834824632,0,16,translation elongation factor activity,MF,
1479,GO:0003747,1,0.811053149270468,0,6,translation release factor activity,MF,
1486,GO:0003796,1,0.976356512012925,0,1,lysozyme activity,MF,
1487,GO:0003810,1,0.899884576391308,0,3,protein-glutamine gamma-glutamyltransferase activity,MF,
1490,GO:0003826,1,0.941722241907971,0,2,alpha-ketoacid dehydrogenase activity,MF,
1491,GO:0003827,1,0.932201804625012,0,2,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
1492,GO:0003828,1,0.921877947715586,0,2,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,
1493,GO:0003829,1,0.923850515021155,0,2,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
1495,GO:0003835,1,0.921494142300365,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
1496,GO:0003836,1,0.81924047533433,0,6,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,
1497,GO:0003839,1,0.904591110815551,0,4,gamma-glutamylcyclotransferase activity,MF,
1498,GO:0003841,1,0.50303712638704,0,19,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,
1499,GO:0003842,1,0.963623477545562,0,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,
1500,GO:0003844,1,0.964304391831253,0,1,1,4-alpha-glucan branching enzyme activity,MF,
1501,GO:0003845,1,0.950912881571594,0,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,
1502,GO:0003846,1,0.931267234838056,0,2,2-acylglycerol O-acyltransferase activity,MF,
1503,GO:0003847,1,0.900490222032807,0,4,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
1504,GO:0003854,1,0.914501859124944,0,3,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
1505,GO:0003857,1,0.770953124802374,0,9,3-hydroxyacyl-CoA dehydrogenase activity,MF,
1506,GO:0003858,1,0.929565135599461,0,2,3-hydroxybutyrate dehydrogenase activity,MF,
1507,GO:0003860,1,0.972434120752001,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
1508,GO:0003863,1,0.941722241907971,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
1509,GO:0003865,1,0.937579216348392,0,2,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,
1510,GO:0003867,1,0.959675503888475,0,1,4-aminobutyrate transaminase activity,MF,
1511,GO:0003868,1,0.973636177478892,0,1,4-hydroxyphenylpyruvate dioxygenase activity,MF,
1513,GO:0003872,1,0.898481958936468,0,3,6-phosphofructokinase activity,MF,
1514,GO:0003873,1,0.886882618387179,0,3,6-phosphofructo-2-kinase activity,MF,
1515,GO:0003874,1,0.98268071838369,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
1516,GO:0003875,1,0.962811556658615,0,1,ADP-ribosylarginine hydrolase activity,MF,
1518,GO:0003877,1,0.970898097235127,0,1,ATP adenylyltransferase activity,MF,
1519,GO:0003878,1,0.960255606590893,0,1,ATP citrate synthase activity,MF,
1520,GO:0003880,1,0.906737331117646,0,3,protein C-terminal carboxyl O-methyltransferase activity,MF,
1521,GO:0003881,1,0.972926686614341,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
1522,GO:0003882,1,0.968296737259694,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
1523,GO:0003883,1,0.927919751257868,0,2,CTP synthase activity,MF,
1524,GO:0003886,1,0.885635370802844,0,3,DNA (cytosine-5-)-methyltransferase activity,MF,
1525,GO:0003887,1,0.413912903489767,0,26,DNA-directed DNA polymerase activity,MF,
1526,GO:0003896,1,0.914346721307405,0,3,DNA primase activity,MF,
1528,GO:0003905,1,0.980941812318171,0,1,alkylbase DNA N-glycosylase activity,MF,
1529,GO:0003906,1,0.696519829469327,0,13,DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
1530,GO:0003908,1,0.978972116435553,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
1531,GO:0003909,1,0.784710763423421,0,7,DNA ligase activity,MF,
1532,GO:0003910,1,0.808268560295115,0,6,DNA ligase (ATP) activity,MF,
1533,GO:0003916,1,0.797664416621553,0,6,DNA topoisomerase activity,MF,
1534,GO:0003917,1,0.866397449613728,0,4,DNA topoisomerase type I activity,MF,
1535,GO:0003918,1,0.920695452576305,0,2,DNA topoisomerase type II (ATP-hydrolyzing) activity,MF,
1536,GO:0003919,1,0.972059476421804,0,1,FMN adenylyltransferase activity,MF,
1537,GO:0003920,1,0.972855058342775,0,1,GMP reductase activity,MF,
1538,GO:0003921,1,0.968197743416709,0,1,GMP synthase activity,MF,
1539,GO:0003922,1,0.968197743416709,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
1540,GO:0003923,1,0.849679566571803,0,5,GPI-anchor transamidase activity,MF,
1544,GO:0003937,1,0.971000731150142,0,1,IMP cyclohydrolase activity,MF,
1545,GO:0003938,1,0.943262730457125,0,2,IMP dehydrogenase activity,MF,
1546,GO:0003939,1,0.967753139758002,0,1,L-iditol 2-dehydrogenase activity,MF,
1547,GO:0003940,1,0.97022553835382,0,1,L-iduronidase activity,MF,
1548,GO:0003941,1,0.946345933773731,0,2,L-serine ammonia-lyase activity,MF,
1549,GO:0003943,1,0.930788770364437,0,2,N-acetylgalactosamine-4-sulfatase activity,MF,
1550,GO:0003944,1,0.970122863847962,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
1552,GO:0003948,1,0.971074942959089,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
1553,GO:0003950,1,0.539220546105784,0,17,NAD+ ADP-ribosyltransferase activity,MF,
1554,GO:0003951,1,0.613000139190373,0,13,NAD+ kinase activity,MF,
1555,GO:0003952,1,0.96834646839626,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1556,GO:0003953,1,0.976569571756151,0,1,NAD+ nucleosidase activity,MF,
1557,GO:0003954,1,0.471918298704989,0,40,NADH dehydrogenase activity,MF,
1558,GO:0003955,1,0.913638678715001,0,3,NAD(P)H dehydrogenase (quinone) activity,MF,
1559,GO:0003956,1,0.975135035644344,0,1,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
1560,GO:0003957,1,0.959858463421999,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
1561,GO:0003958,1,0.831360891257857,0,5,NADPH-hemoprotein reductase activity,MF,
1562,GO:0003960,1,0.923604427691264,0,3,NADPH:quinone reductase activity,MF,
1563,GO:0003962,1,0.97411570855655,0,1,cystathionine gamma-synthase activity,MF,
1564,GO:0003963,1,0.936882376316022,0,2,RNA-3'-phosphate cyclase activity,MF,
1565,GO:0003964,1,0.781580071143877,0,8,RNA-directed DNA polymerase activity,MF,
1566,GO:0003968,1,0.950635164900056,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
1567,GO:0003972,1,0.965469978279355,0,1,RNA ligase (ATP) activity,MF,
1568,GO:0003973,1,0.95950763690405,0,1,(S)-2-hydroxy-acid oxidase activity,MF,
1569,GO:0003974,1,0.975379559437511,0,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,
1570,GO:0003975,1,0.970617467329383,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
1571,GO:0003976,1,0.911876868259338,0,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,
1572,GO:0003977,1,0.93340907558475,0,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,
1573,GO:0003978,1,0.975379559437511,0,1,UDP-glucose 4-epimerase activity,MF,
1574,GO:0003979,1,0.963881994690651,0,1,UDP-glucose 6-dehydrogenase activity,MF,
1575,GO:0003980,1,0.920789202522597,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
1576,GO:0003983,1,0.970625547048195,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
1577,GO:0003985,1,0.913809534236436,0,3,acetyl-CoA C-acetyltransferase activity,MF,
1578,GO:0003986,1,0.937574234975072,0,3,acetyl-CoA hydrolase activity,MF,
1579,GO:0003987,1,0.926397307532552,0,2,acetate-CoA ligase activity,MF,
1580,GO:0003988,1,0.839088838220567,0,6,acetyl-CoA C-acyltransferase activity,MF,
1581,GO:0003989,1,0.920650957478618,0,2,acetyl-CoA carboxylase activity,MF,
1582,GO:0003990,1,0.96834646839626,0,1,acetylcholinesterase activity,MF,
1583,GO:0003991,1,0.971207527567196,0,1,acetylglutamate kinase activity,MF,
1584,GO:0003993,1,0.844289601342381,0,6,acid phosphatase activity,MF,
1585,GO:0003994,1,0.929895009355511,0,2,aconitate hydratase activity,MF,
1586,GO:0003995,1,0.644814239416541,0,13,acyl-CoA dehydrogenase activity,MF,
1587,GO:0003996,1,0.969787143083465,0,1,acyl-CoA ligase activity,MF,
1588,GO:0003997,1,0.901922070015872,0,3,acyl-CoA oxidase activity,MF,
1589,GO:0003998,1,0.965848461248826,0,2,acylphosphatase activity,MF,
1590,GO:0003999,1,0.984960135159515,0,1,adenine phosphoribosyltransferase activity,MF,
1591,GO:0004000,1,0.806316360493282,0,6,adenosine deaminase activity,MF,
1592,GO:0004001,1,0.971357684520004,0,1,adenosine kinase activity,MF,
1593,GO:0004003,1,0.292023400262648,0,33,ATP-dependent DNA helicase activity,MF,
1594,GO:0004004,1,0.110488034911216,0,60,ATP-dependent RNA helicase activity,MF,
1595,GO:0004008,1,0.920650957478618,0,2,copper-exporting ATPase activity,MF,
1596,GO:0004012,1,0.586023202521835,0,13,phospholipid-translocating ATPase activity,MF,
1598,GO:0004014,1,0.963561401555438,0,1,adenosylmethionine decarboxylase activity,MF,
1599,GO:0004016,1,0.783511684251023,0,6,adenylate cyclase activity,MF,
1600,GO:0004017,1,0.840794790780659,0,5,adenylate kinase activity,MF,
1601,GO:0004018,1,0.976712320382908,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
1602,GO:0004019,1,0.966231642871698,0,1,adenylosuccinate synthase activity,MF,
1603,GO:0004020,1,0.930234301013966,0,2,adenylylsulfate kinase activity,MF,
1604,GO:0004021,1,0.961179164310998,0,1,L-alanine:2-oxoglutarate aminotransferase activity,MF,
1605,GO:0004022,1,0.966980370923912,0,1,alcohol dehydrogenase (NAD) activity,MF,
1606,GO:0004027,1,0.979383959654329,0,1,alcohol sulfotransferase activity,MF,
1610,GO:0004031,1,0.959651701925598,0,1,aldehyde oxidase activity,MF,
1611,GO:0004032,1,0.891514236663534,0,5,alditol:NADP+ 1-oxidoreductase activity,MF,
1612,GO:0004033,1,0.64948042036869,0,16,aldo-keto reductase (NADP) activity,MF,
1613,GO:0004034,1,0.968064392792103,0,1,aldose 1-epimerase activity,MF,
1614,GO:0004040,1,0.93277850686723,0,2,amidase activity,MF,
1615,GO:0004042,1,0.971207527567196,0,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,
1616,GO:0004043,1,0.962322160905979,0,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,
1617,GO:0004044,1,0.961686286518876,0,1,amidophosphoribosyltransferase activity,MF,
1618,GO:0004045,1,0.912080600840327,0,4,aminoacyl-tRNA hydrolase activity,MF,
1619,GO:0004046,1,0.918110988339175,0,3,aminoacylase activity,MF,
1620,GO:0004047,1,0.948344685253324,0,2,aminomethyltransferase activity,MF,
1621,GO:0004052,1,0.937777607268669,0,2,arachidonate 12-lipoxygenase activity,MF,
1622,GO:0004053,1,0.94964838868482,0,2,arginase activity,MF,
1623,GO:0004055,1,0.973356344779232,0,1,argininosuccinate synthase activity,MF,
1624,GO:0004056,1,0.971883007514942,0,1,argininosuccinate lyase activity,MF,
1625,GO:0004057,1,0.970059951479277,0,1,arginyltransferase activity,MF,
1626,GO:0004060,1,0.971678162598109,0,1,arylamine N-acetyltransferase activity,MF,
1627,GO:0004061,1,0.974565797611057,0,1,arylformamidase activity,MF,
1628,GO:0004062,1,0.909228372297523,0,4,aryl sulfotransferase activity,MF,
1629,GO:0004064,1,0.917765517555514,0,3,arylesterase activity,MF,
1630,GO:0004065,1,0.769324089219535,0,7,arylsulfatase activity,MF,
1631,GO:0004066,1,0.938327508934156,0,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,
1632,GO:0004069,1,0.939954248592068,0,2,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
1633,GO:0004070,1,0.92065096379418,0,2,aspartate carbamoyltransferase activity,MF,
1634,GO:0004074,1,0.964904266066433,0,2,biliverdin reductase activity,MF,
1635,GO:0004075,1,0.890843785618285,0,3,biotin carboxylase activity,MF,
1636,GO:0004077,1,0.95950763690405,0,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,
1637,GO:0004078,1,0.95950763690405,0,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,
1638,GO:0004079,1,0.95950763690405,0,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,
1639,GO:0004080,1,0.95950763690405,0,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,
1640,GO:0004081,1,0.948916484520426,0,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
1641,GO:0004082,1,0.947406678157987,0,2,bisphosphoglycerate mutase activity,MF,
1642,GO:0004083,1,0.965469978279355,0,1,bisphosphoglycerate 2-phosphatase activity,MF,
1643,GO:0004084,1,0.935811104363509,0,2,branched-chain-amino-acid transaminase activity,MF,
1644,GO:0004085,1,0.972508899337928,0,1,butyryl-CoA dehydrogenase activity,MF,
1645,GO:0004087,1,0.92065096379418,0,2,carbamoyl-phosphate synthase (ammonia) activity,MF,
1646,GO:0004088,1,0.92065096379418,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1647,GO:0004089,1,0.8343527859875,0,5,carbonate dehydratase activity,MF,
1648,GO:0004090,1,0.924797232922175,0,4,carbonyl reductase (NADPH) activity,MF,
1649,GO:0004092,1,0.965876859418042,0,1,carnitine O-acetyltransferase activity,MF,
1650,GO:0004095,1,0.865621869304936,0,4,carnitine O-palmitoyltransferase activity,MF,
1651,GO:0004096,1,0.923031999586088,0,3,catalase activity,MF,
1652,GO:0004098,1,0.972659171582353,0,1,cerebroside-sulfatase activity,MF,
1653,GO:0004103,1,0.942653697572856,0,2,choline kinase activity,MF,
1654,GO:0004104,1,0.936062633599681,0,2,cholinesterase activity,MF,
1655,GO:0004105,1,0.936171845595031,0,2,choline-phosphate cytidylyltransferase activity,MF,
1656,GO:0004108,1,0.964974510611066,0,1,citrate (Si)-synthase activity,MF,
1657,GO:0004109,1,0.935573701059971,0,2,coproporphyrinogen oxidase activity,MF,
1658,GO:0004111,1,0.889038119662485,0,4,creatine kinase activity,MF,
1659,GO:0004112,1,0.63646994777675,0,12,cyclic-nucleotide phosphodiesterase activity,MF,
1660,GO:0004113,1,0.959553707418115,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
1661,GO:0004114,1,0.663326156245007,0,11,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,
1662,GO:0004115,1,0.789547855123357,0,6,3',5'-cyclic-AMP phosphodiesterase activity,MF,
1663,GO:0004117,1,0.966591019336054,0,1,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
1664,GO:0004118,1,0.960526598640712,0,1,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
1665,GO:0004122,1,0.967261870054133,0,1,cystathionine beta-synthase activity,MF,
1666,GO:0004123,1,0.97411570855655,0,1,cystathionine gamma-lyase activity,MF,
1667,GO:0004126,1,0.819084729578533,0,7,cytidine deaminase activity,MF,
1668,GO:0004127,1,0.931830514758852,0,2,cytidylate kinase activity,MF,
1669,GO:0004128,1,0.804664248680444,0,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,
1670,GO:0004129,1,0.727006130892384,0,18,cytochrome-c oxidase activity,MF,
1671,GO:0004132,1,0.971563767141032,0,1,dCMP deaminase activity,MF,
1672,GO:0004133,1,0.95950763690405,0,1,glycogen debranching enzyme activity,MF,
1673,GO:0004134,1,0.95950763690405,0,1,4-alpha-glucanotransferase activity,MF,
1674,GO:0004135,1,0.95950763690405,0,1,amylo-alpha-1,6-glucosidase activity,MF,
1675,GO:0004137,1,0.928170731798632,0,2,deoxycytidine kinase activity,MF,
1676,GO:0004138,1,0.981788291745788,0,1,deoxyguanosine kinase activity,MF,
1677,GO:0004139,1,0.974280666574357,0,1,deoxyribose-phosphate aldolase activity,MF,
1678,GO:0004140,1,0.941748483668886,0,2,dephospho-CoA kinase activity,MF,
1679,GO:0004142,1,0.908564445909018,0,3,diacylglycerol cholinephosphotransferase activity,MF,
1680,GO:0004143,1,0.730892262882817,0,8,diacylglycerol kinase activity,MF,
1681,GO:0004144,1,0.931267234838056,0,2,diacylglycerol O-acyltransferase activity,MF,
1683,GO:0004146,1,0.943020602715542,0,2,dihydrofolate reductase activity,MF,
1684,GO:0004148,1,0.962237779638328,0,1,dihydrolipoyl dehydrogenase activity,MF,
1685,GO:0004149,1,0.965706449886715,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
1686,GO:0004151,1,0.92065096379418,0,2,dihydroorotase activity,MF,
1687,GO:0004152,1,0.971240804302592,0,1,dihydroorotate dehydrogenase activity,MF,
1688,GO:0004155,1,0.975008657882268,0,1,6,7-dihydropteridine reductase activity,MF,
1689,GO:0004157,1,0.959994889811302,0,1,dihydropyrimidinase activity,MF,
1690,GO:0004161,1,0.943382473024233,0,2,dimethylallyltranstransferase activity,MF,
1691,GO:0004163,1,0.973599301954395,0,1,diphosphomevalonate decarboxylase activity,MF,
1692,GO:0004164,1,0.973673106223246,0,1,diphthine synthase activity,MF,
1693,GO:0004165,1,0.895963533705364,0,3,dodecenoyl-CoA delta-isomerase activity,MF,
1694,GO:0004167,1,0.973375629788393,0,2,dopachrome isomerase activity,MF,
1695,GO:0004168,1,0.970185983388655,0,1,dolichol kinase activity,MF,
1696,GO:0004169,1,0.87626392269377,0,5,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,
1697,GO:0004170,1,0.97293565503566,0,1,dUTP diphosphatase activity,MF,
1698,GO:0004174,1,0.933779616104715,0,2,electron-transferring-flavoprotein dehydrogenase activity,MF,
1700,GO:0004176,1,0.862265893229641,0,4,ATP-dependent peptidase activity,MF,
1701,GO:0004177,1,0.317240283597435,0,33,aminopeptidase activity,MF,
1702,GO:0004180,1,0.562635593384727,0,17,carboxypeptidase activity,MF,
1703,GO:0004181,1,0.746442821274138,0,8,metallocarboxypeptidase activity,MF,
1704,GO:0004185,1,0.763414557035465,0,8,serine-type carboxypeptidase activity,MF,
1705,GO:0004190,1,0.622469635847014,0,14,aspartic-type endopeptidase activity,MF,
1707,GO:0004198,1,0.600390067305244,0,16,calcium-dependent cysteine-type endopeptidase activity,MF,
1710,GO:0004298,1,0.705385869401805,0,18,threonine-type endopeptidase activity,MF,
1711,GO:0004300,1,0.788504362899923,0,8,enoyl-CoA hydratase activity,MF,
1712,GO:0004301,1,0.817408198666997,0,7,epoxide hydrolase activity,MF,
1713,GO:0004303,1,0.836301985865986,0,7,estradiol 17-beta-dehydrogenase activity,MF,
1714,GO:0004304,1,0.973765661015785,0,1,estrone sulfotransferase activity,MF,
1716,GO:0004306,1,0.973070578565454,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
1717,GO:0004307,1,0.951464280898454,0,2,ethanolaminephosphotransferase activity,MF,
1718,GO:0004308,1,0.880953021567115,0,4,exo-alpha-sialidase activity,MF,
1719,GO:0004309,1,0.863900537728847,0,4,exopolyphosphatase activity,MF,
1720,GO:0004310,1,0.970918583286906,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
1721,GO:0004311,1,0.904909308922657,0,3,farnesyltranstransferase activity,MF,
1722,GO:0004312,1,0.748888425681649,0,9,fatty acid synthase activity,MF,
1723,GO:0004313,1,0.95950763690405,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1724,GO:0004314,1,0.932895668697753,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
1725,GO:0004315,1,0.939215360809059,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
1726,GO:0004316,1,0.95950763690405,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1727,GO:0004317,1,0.95950763690405,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1728,GO:0004319,1,0.95950763690405,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
1729,GO:0004320,1,0.934547454336808,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
1731,GO:0004324,1,0.972712436640328,0,1,ferredoxin-NADP+ reductase activity,MF,
1732,GO:0004325,1,0.95950763690405,0,1,ferrochelatase activity,MF,
1733,GO:0004326,1,0.968015553109921,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
1734,GO:0004329,1,0.926207804745498,0,2,formate-tetrahydrofolate ligase activity,MF,
1735,GO:0004331,1,0.856249450919771,0,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
1736,GO:0004332,1,0.951709892506856,0,2,fructose-bisphosphate aldolase activity,MF,
1737,GO:0004333,1,0.973673106223246,0,1,fumarate hydratase activity,MF,
1738,GO:0004334,1,0.97695833568072,0,1,fumarylacetoacetase activity,MF,
1739,GO:0004335,1,0.942729016031012,0,2,galactokinase activity,MF,
1740,GO:0004336,1,0.965373453992635,0,1,galactosylceramidase activity,MF,
1741,GO:0004337,1,0.943382473024233,0,2,geranyltranstransferase activity,MF,
1742,GO:0004339,1,0.95950763690405,0,1,glucan 1,4-alpha-glucosidase activity,MF,
1743,GO:0004340,1,0.887295757004347,0,3,glucokinase activity,MF,
1744,GO:0004342,1,0.942806188438993,0,2,glucosamine-6-phosphate deaminase activity,MF,
1745,GO:0004343,1,0.961163074394959,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
1746,GO:0004344,1,0.95950763690405,0,1,glucose dehydrogenase activity,MF,
1747,GO:0004345,1,0.929855857100311,0,2,glucose-6-phosphate dehydrogenase activity,MF,
1748,GO:0004346,1,0.975144779061842,0,1,glucose-6-phosphatase activity,MF,
1749,GO:0004347,1,0.971083205022903,0,1,glucose-6-phosphate isomerase activity,MF,
1750,GO:0004348,1,0.931931440147491,0,2,glucosylceramidase activity,MF,
1751,GO:0004349,1,0.962674958488356,0,1,glutamate 5-kinase activity,MF,
1752,GO:0004350,1,0.962674958488356,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
1753,GO:0004351,1,0.930362772896416,0,2,glutamate decarboxylase activity,MF,
1754,GO:0004352,1,0.962627550615603,0,1,glutamate dehydrogenase (NAD+) activity,MF,
1755,GO:0004353,1,0.962627550615603,0,1,glutamate dehydrogenase [NAD(P)+] activity,MF,
1756,GO:0004356,1,0.96024696931705,0,1,glutamate-ammonia ligase activity,MF,
1757,GO:0004357,1,0.927589540336195,0,2,glutamate-cysteine ligase activity,MF,
1758,GO:0004359,1,0.899221020810171,0,3,glutaminase activity,MF,
1759,GO:0004360,1,0.95950763690405,0,1,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
1760,GO:0004361,1,0.974422863836396,0,1,glutaryl-CoA dehydrogenase activity,MF,
1761,GO:0004362,1,0.969633028597371,0,1,glutathione-disulfide reductase activity,MF,
1762,GO:0004363,1,0.972632583635904,0,1,glutathione synthase activity,MF,
1763,GO:0004364,1,0.672102677588141,0,18,glutathione transferase activity,MF,
1764,GO:0004365,1,0.978446360623188,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
1765,GO:0004366,1,0.834981011372505,0,5,glycerol-3-phosphate O-acyltransferase activity,MF,
1766,GO:0004367,1,0.961203486413657,0,1,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,
1767,GO:0004368,1,0.95950763690405,0,1,glycerol-3-phosphate dehydrogenase activity,MF,
1768,GO:0004370,1,0.923049845939004,0,2,glycerol kinase activity,MF,
1769,GO:0004371,1,0.965469978279355,0,1,glycerone kinase activity,MF,
1770,GO:0004372,1,0.939052002373933,0,2,glycine hydroxymethyltransferase activity,MF,
1771,GO:0004373,1,0.962783158105344,0,1,glycogen (starch) synthase activity,MF,
1772,GO:0004375,1,0.961447268770442,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
1773,GO:0004376,1,0.878171863197621,0,4,glycolipid mannosyltransferase activity,MF,
1774,GO:0004377,1,0.967712124992046,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
1775,GO:0004378,1,0.96539608532011,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
1776,GO:0004379,1,0.920943340100716,0,2,glycylpeptide N-tetradecanoyltransferase activity,MF,
1777,GO:0004382,1,0.935056080082887,0,2,guanosine-diphosphatase activity,MF,
1778,GO:0004383,1,0.783511684251023,0,6,guanylate cyclase activity,MF,
1781,GO:0004392,1,0.950762503219111,0,2,heme oxygenase (decyclizing) activity,MF,
1782,GO:0004394,1,0.96059999101814,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
1783,GO:0004395,1,0.97896132643455,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
1784,GO:0004396,1,0.887295757004347,0,3,hexokinase activity,MF,
1786,GO:0004402,1,0.167592187281958,0,51,histone acetyltransferase activity,MF,
1788,GO:0004408,1,0.969495428197879,0,1,holocytochrome-c synthase activity,MF,
1789,GO:0004415,1,0.849343505751543,0,5,hyalurononglucosaminidase activity,MF,
1790,GO:0004416,1,0.94163509654683,0,2,hydroxyacylglutathione hydrolase activity,MF,
1791,GO:0004418,1,0.976824874083371,0,1,hydroxymethylbilane synthase activity,MF,
1792,GO:0004419,1,0.976473028796796,0,1,hydroxymethylglutaryl-CoA lyase activity,MF,
1793,GO:0004420,1,0.960036282648594,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
1795,GO:0004422,1,0.950413889877113,0,2,hypoxanthine phosphoribosyltransferase activity,MF,
1796,GO:0004423,1,0.95950763690405,0,1,iduronate-2-sulfatase activity,MF,
1797,GO:0004427,1,0.930876297178543,0,3,inorganic diphosphatase activity,MF,
1798,GO:0004430,1,0.802019437107279,0,6,1-phosphatidylinositol 4-kinase activity,MF,
1799,GO:0004435,1,0.589056316560616,0,14,phosphatidylinositol phospholipase C activity,MF,
1800,GO:0004438,1,0.576380448075463,0,14,phosphatidylinositol-3-phosphatase activity,MF,
1801,GO:0004439,1,0.738524510018925,0,8,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,
1802,GO:0004441,1,0.971054302070478,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
1803,GO:0004445,1,0.833798243341554,0,5,inositol-polyphosphate 5-phosphatase activity,MF,
1804,GO:0004446,1,0.965735644384804,0,1,inositol-hexakisphosphate phosphatase activity,MF,
1805,GO:0004448,1,0.869287957341861,0,5,isocitrate dehydrogenase activity,MF,
1806,GO:0004449,1,0.920716040710217,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
1807,GO:0004450,1,0.944154774103706,0,2,isocitrate dehydrogenase (NADP+) activity,MF,
1808,GO:0004452,1,0.949319237974671,0,2,isopentenyl-diphosphate delta-isomerase activity,MF,
1809,GO:0004454,1,0.96853255244706,0,1,ketohexokinase activity,MF,
1810,GO:0004457,1,0.89490355677403,0,4,lactate dehydrogenase activity,MF,
1811,GO:0004458,1,0.967334818525518,0,1,D-lactate dehydrogenase (cytochrome) activity,MF,
1812,GO:0004459,1,0.925128931763705,0,3,L-lactate dehydrogenase activity,MF,
1814,GO:0004462,1,0.971441562671629,0,1,lactoylglutathione lyase activity,MF,
1815,GO:0004463,1,0.971199216547478,0,1,leukotriene-A4 hydrolase activity,MF,
1816,GO:0004464,1,0.970362569282251,0,2,leukotriene-C4 synthase activity,MF,
1818,GO:0004466,1,0.884579950996091,0,4,long-chain-acyl-CoA dehydrogenase activity,MF,
1819,GO:0004467,1,0.719734812471164,0,9,long-chain fatty acid-CoA ligase activity,MF,
1820,GO:0004468,1,0.856269172868613,0,4,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,
1821,GO:0004470,1,0.877741362608107,0,4,malic enzyme activity,MF,
1822,GO:0004471,1,0.896669298066246,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
1823,GO:0004473,1,0.896669298066246,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
1824,GO:0004475,1,0.975458217445957,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
1825,GO:0004476,1,0.973839944555444,0,1,mannose-6-phosphate isomerase activity,MF,
1826,GO:0004477,1,0.870413893223982,0,4,methenyltetrahydrofolate cyclohydrolase activity,MF,
1827,GO:0004478,1,0.965888708222766,0,1,methionine adenosyltransferase activity,MF,
1828,GO:0004479,1,0.966323575434221,0,1,methionyl-tRNA formyltransferase activity,MF,
1829,GO:0004482,1,0.95950763690405,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
1830,GO:0004483,1,0.932129376517163,0,2,mRNA (nucleoside-2'-O-)-methyltransferase activity,MF,
1831,GO:0004484,1,0.960089237709914,0,1,mRNA guanylyltransferase activity,MF,
1832,GO:0004485,1,0.930762605419215,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
1833,GO:0004486,1,0.962670991845225,0,1,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
1834,GO:0004487,1,0.904686047303147,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
1835,GO:0004488,1,0.870413893223982,0,4,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
1836,GO:0004489,1,0.95950763690405,0,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,
1837,GO:0004490,1,0.975596343500866,0,1,methylglutaconyl-CoA hydratase activity,MF,
1838,GO:0004491,1,0.970296941415236,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
1839,GO:0004492,1,0.970853099580044,0,1,methylmalonyl-CoA decarboxylase activity,MF,
1840,GO:0004493,1,0.983433213616715,0,1,methylmalonyl-CoA epimerase activity,MF,
1841,GO:0004494,1,0.965078240821728,0,1,methylmalonyl-CoA mutase activity,MF,
1842,GO:0004496,1,0.971203371649147,0,1,mevalonate kinase activity,MF,
1845,GO:0004499,1,0.970633630017325,0,1,N,N-dimethylaniline monooxygenase activity,MF,
1846,GO:0004500,1,0.964638459389207,0,1,dopamine beta-monooxygenase activity,MF,
1847,GO:0004504,1,0.961748720514894,0,1,peptidylglycine monooxygenase activity,MF,
1848,GO:0004505,1,0.95125820435887,0,2,phenylalanine 4-monooxygenase activity,MF,
1850,GO:0004511,1,0.972641442982888,0,1,tyrosine 3-monooxygenase activity,MF,
1851,GO:0004512,1,0.969686821893012,0,1,inositol-3-phosphate synthase activity,MF,
1852,GO:0004513,1,0.969328666711818,0,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,
1855,GO:0004516,1,0.965469978279355,0,1,nicotinate phosphoribosyltransferase activity,MF,
1856,GO:0004517,1,0.928990002505218,0,2,nitric-oxide synthase activity,MF,
1859,GO:0004520,1,0.228270522326307,0,45,endodeoxyribonuclease activity,MF,
1861,GO:0004522,1,0.975854450984385,0,1,ribonuclease A activity,MF,
1862,GO:0004523,1,0.851500846689398,0,6,RNA-DNA hybrid ribonuclease activity,MF,
1863,GO:0004525,1,0.866392911663149,0,4,ribonuclease III activity,MF,
1864,GO:0004526,1,0.740957370981149,0,11,ribonuclease P activity,MF,
1866,GO:0004528,1,0.879372232817632,0,4,phosphodiesterase I activity,MF,
1868,GO:0004530,1,0.92529758743886,0,2,deoxyribonuclease I activity,MF,
1869,GO:0004531,1,0.97174623432934,0,1,deoxyribonuclease II activity,MF,
1871,GO:0004534,1,0.886324658860314,0,3,5'-3' exoribonuclease activity,MF,
1875,GO:0004549,1,0.633774275780935,0,16,tRNA-specific ribonuclease activity,MF,
1876,GO:0004550,1,0.751281310984899,0,11,nucleoside diphosphate kinase activity,MF,
1877,GO:0004551,1,0.71004447866661,0,12,nucleotide diphosphatase activity,MF,
1879,GO:0004556,1,0.970304891294337,0,1,alpha-amylase activity,MF,
1880,GO:0004557,1,0.939945704442731,0,2,alpha-galactosidase activity,MF,
1881,GO:0004558,1,0.886210625470691,0,3,alpha-1,4-glucosidase activity,MF,
1882,GO:0004559,1,0.606784746759092,0,13,alpha-mannosidase activity,MF,
1883,GO:0004560,1,0.942697111703923,0,2,alpha-L-fucosidase activity,MF,
1884,GO:0004561,1,0.966128302870444,0,1,alpha-N-acetylglucosaminidase activity,MF,
1886,GO:0004565,1,0.872209789112551,0,4,beta-galactosidase activity,MF,
1887,GO:0004566,1,0.944101769975079,0,2,beta-glucuronidase activity,MF,
1888,GO:0004567,1,0.963303061456278,0,1,beta-mannosidase activity,MF,
1889,GO:0004568,1,0.928597192699348,0,2,chitinase activity,MF,
1890,GO:0004569,1,0.959965873789812,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
1891,GO:0004571,1,0.769998674630168,0,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,
1892,GO:0004572,1,0.920715621333305,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
1893,GO:0004573,1,0.966437928547837,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
1894,GO:0004574,1,0.962172802487713,0,1,oligo-1,6-glucosidase activity,MF,
1895,GO:0004576,1,0.756416900102331,0,10,oligosaccharyl transferase activity,MF,
1896,GO:0004577,1,0.946562397290955,0,2,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
1897,GO:0004578,1,0.961131193844183,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
1898,GO:0004579,1,0.771862173656079,0,9,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,
1899,GO:0004581,1,0.980002722314715,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
1900,GO:0004582,1,0.946804217850518,0,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
1901,GO:0004583,1,0.868188337855326,0,4,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
1902,GO:0004584,1,0.968933310120561,0,1,dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,MF,
1904,GO:0004587,1,0.971973221568393,0,1,ornithine-oxo-acid transaminase activity,MF,
1905,GO:0004588,1,0.966902852799295,0,1,orotate phosphoribosyltransferase activity,MF,
1906,GO:0004590,1,0.966902852799295,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
1907,GO:0004591,1,0.867398204318182,0,4,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,
1909,GO:0004595,1,0.969419434440591,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
1910,GO:0004596,1,0.717992509452937,0,10,peptide alpha-N-acetyltransferase activity,MF,
1911,GO:0004597,1,0.962075325331281,0,1,peptide-aspartate beta-dioxygenase activity,MF,
1912,GO:0004598,1,0.961748720514894,0,1,peptidylamidoglycolate lyase activity,MF,
1914,GO:0004602,1,0.731116887147666,0,15,glutathione peroxidase activity,MF,
1915,GO:0004605,1,0.895853342184651,0,3,phosphatidate cytidylyltransferase activity,MF,
1916,GO:0004607,1,0.97801117474444,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
1917,GO:0004608,1,0.981993172542882,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
1918,GO:0004609,1,0.938446394129076,0,2,phosphatidylserine decarboxylase activity,MF,
1919,GO:0004610,1,0.971823065893586,0,1,phosphoacetylglucosamine mutase activity,MF,
1920,GO:0004611,1,0.972102727103467,0,1,phosphoenolpyruvate carboxykinase activity,MF,
1921,GO:0004613,1,0.972102727103467,0,1,phosphoenolpyruvate carboxykinase (GTP) activity,MF,
1922,GO:0004614,1,0.869906929015185,0,4,phosphoglucomutase activity,MF,
1924,GO:0004616,1,0.908890198770322,0,3,phosphogluconate dehydrogenase (decarboxylating) activity,MF,
1925,GO:0004617,1,0.971644205399406,0,1,phosphoglycerate dehydrogenase activity,MF,
1926,GO:0004618,1,0.96846789459855,0,1,phosphoglycerate kinase activity,MF,
1927,GO:0004619,1,0.947406678157987,0,2,phosphoglycerate mutase activity,MF,
1929,GO:0004621,1,0.969484008610393,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
1930,GO:0004622,1,0.57594232204026,0,16,lysophospholipase activity,MF,
1931,GO:0004623,1,0.512767601218454,0,20,phospholipase A2 activity,MF,
1932,GO:0004629,1,0.568149899618629,0,15,phospholipase C activity,MF,
1933,GO:0004630,1,0.847190528770638,0,5,phospholipase D activity,MF,
1934,GO:0004631,1,0.978617367780443,0,1,phosphomevalonate kinase activity,MF,
1935,GO:0004632,1,0.978988306091013,0,1,phosphopantothenate--cysteine ligase activity,MF,
1936,GO:0004633,1,0.970028572950931,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
1937,GO:0004634,1,0.9734248695555,0,1,phosphopyruvate hydratase activity,MF,
1938,GO:0004637,1,0.96277709129628,0,1,phosphoribosylamine-glycine ligase activity,MF,
1939,GO:0004638,1,0.963206805024532,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
1940,GO:0004639,1,0.963206805024532,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
1941,GO:0004641,1,0.96277709129628,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
1942,GO:0004642,1,0.959521448017182,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
1943,GO:0004643,1,0.971000731150142,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
1944,GO:0004644,1,0.96277709129628,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
1945,GO:0004645,1,0.868170588198917,0,4,phosphorylase activity,MF,
1946,GO:0004647,1,0.943454998136414,0,2,phosphoserine phosphatase activity,MF,
1947,GO:0004648,1,0.970816356584251,0,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,
1948,GO:0004649,1,0.936041719413493,0,2,poly(ADP-ribose) glycohydrolase activity,MF,
1949,GO:0004651,1,0.936176830461394,0,2,polynucleotide 5'-phosphatase activity,MF,
1950,GO:0004652,1,0.736179150815183,0,8,polynucleotide adenylyltransferase activity,MF,
1951,GO:0004653,1,0.633742472553647,0,12,polypeptide N-acetylgalactosaminyltransferase activity,MF,
1952,GO:0004654,1,0.959934770795553,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
1953,GO:0004655,1,0.963915545405274,0,1,porphobilinogen synthase activity,MF,
1954,GO:0004656,1,0.906006515337939,0,3,procollagen-proline 4-dioxygenase activity,MF,
1955,GO:0004657,1,0.970028572950931,0,1,proline dehydrogenase activity,MF,
1956,GO:0004658,1,0.942383735296497,0,2,propionyl-CoA carboxylase activity,MF,
1957,GO:0004659,1,0.609943554324522,0,15,prenyltransferase activity,MF,
1958,GO:0004660,1,0.942177934346024,0,2,protein farnesyltransferase activity,MF,
1959,GO:0004661,1,0.858808529431793,0,5,protein geranylgeranyltransferase activity,MF,
1960,GO:0004662,1,0.942739853967568,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
1961,GO:0004663,1,0.88863909745034,0,4,Rab geranylgeranyltransferase activity,MF,
1963,GO:0004668,1,0.963877213708537,0,1,protein-arginine deiminase activity,MF,
1964,GO:0004671,1,0.959744328323857,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
1966,GO:0004673,1,0.945166271578868,0,2,protein histidine kinase activity,MF,
1968,GO:0004675,1,0.623463504555814,0,12,transmembrane receptor protein serine/threonine kinase activity,MF,
1970,GO:0004677,1,0.889199087376065,0,3,DNA-dependent protein kinase activity,MF,
1971,GO:0004679,1,0.778333448842526,0,7,AMP-activated protein kinase activity,MF,
1973,GO:0004686,1,0.95950763690405,0,1,elongation factor-2 kinase activity,MF,
1974,GO:0004687,1,0.920650957478618,0,2,myosin light chain kinase activity,MF,
1976,GO:0004690,1,0.768616804978464,0,7,cyclic nucleotide-dependent protein kinase activity,MF,
1977,GO:0004691,1,0.799440203904496,0,6,cAMP-dependent protein kinase activity,MF,
1978,GO:0004692,1,0.961465047858816,0,1,cGMP-dependent protein kinase activity,MF,
1980,GO:0004694,1,0.85468419483733,0,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,
1981,GO:0004697,1,0.609028313086569,0,13,protein kinase C activity,MF,
1982,GO:0004698,1,0.95950763690405,0,1,calcium-dependent protein kinase C activity,MF,
1983,GO:0004699,1,0.892203195130756,0,3,calcium-independent protein kinase C activity,MF,
1985,GO:0004703,1,0.933720677196498,0,2,G-protein coupled receptor kinase activity,MF,
1986,GO:0004704,1,0.847112678645692,0,5,NF-kappaB-inducing kinase activity,MF,
1987,GO:0004705,1,0.901975409642305,0,3,JUN kinase activity,MF,
1988,GO:0004706,1,0.88895660162835,0,3,JUN kinase kinase kinase activity,MF,
1989,GO:0004707,1,0.66374170093429,0,12,MAP kinase activity,MF,
1992,GO:0004711,1,0.767120979143646,0,7,ribosomal protein S6 kinase activity,MF,
1997,GO:0004716,1,0.792575388403865,0,6,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,
1998,GO:0004719,1,0.899571639379674,0,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,
1999,GO:0004720,1,0.833580098487413,0,5,protein-lysine 6-oxidase activity,MF,
2001,GO:0004722,1,0.120373441744281,0,62,protein serine/threonine phosphatase activity,MF,
2002,GO:0004723,1,0.767047075124067,0,7,calcium-dependent protein serine/threonine phosphatase activity,MF,
2005,GO:0004727,1,0.971357684520004,0,1,prenylated protein tyrosine phosphatase activity,MF,
2006,GO:0004728,1,0.967334818525518,0,1,signal transducer, downstream of receptor, with protein tyrosine phosphatase activity,MF,
2007,GO:0004729,1,0.974106313102107,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
2008,GO:0004730,1,0.974853850947444,0,1,pseudouridylate synthase activity,MF,
2009,GO:0004731,1,0.92949929908719,0,2,purine-nucleoside phosphorylase activity,MF,
2010,GO:0004733,1,0.96269881942736,0,1,pyridoxamine-phosphate oxidase activity,MF,
2011,GO:0004735,1,0.948067845229967,0,2,pyrroline-5-carboxylate reductase activity,MF,
2012,GO:0004736,1,0.96092640127301,0,1,pyruvate carboxylase activity,MF,
2013,GO:0004738,1,0.839841620216904,0,5,pyruvate dehydrogenase activity,MF,
2014,GO:0004739,1,0.940097963751501,0,2,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
2015,GO:0004740,1,0.89293211833887,0,3,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,
2016,GO:0004741,1,0.886046314629068,0,3,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
2017,GO:0004742,1,0.96026590075859,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
2018,GO:0004743,1,0.965469978279355,0,1,pyruvate kinase activity,MF,
2020,GO:0004747,1,0.979689659713573,0,1,ribokinase activity,MF,
2021,GO:0004748,1,0.89088303670792,0,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,
2022,GO:0004749,1,0.885148720178782,0,4,ribose phosphate diphosphokinase activity,MF,
2023,GO:0004750,1,0.969411852768212,0,1,ribulose-phosphate 3-epimerase activity,MF,
2024,GO:0004751,1,0.973260723755022,0,1,ribose-5-phosphate isomerase activity,MF,
2025,GO:0004753,1,0.95950763690405,0,1,saccharopine dehydrogenase activity,MF,
2026,GO:0004756,1,0.937952519968535,0,2,selenide, water dikinase activity,MF,
2027,GO:0004757,1,0.976948052424378,0,1,sepiapterin reductase activity,MF,
2028,GO:0004758,1,0.836493768075057,0,5,serine C-palmitoyltransferase activity,MF,
2029,GO:0004766,1,0.978853563349783,0,1,spermidine synthase activity,MF,
2031,GO:0004768,1,0.894822872855362,0,3,stearoyl-CoA 9-desaturase activity,MF,
2032,GO:0004769,1,0.980173776056391,0,1,steroid delta-isomerase activity,MF,
2033,GO:0004771,1,0.828382735691209,0,5,sterol esterase activity,MF,
2034,GO:0004772,1,0.96295569661504,0,1,sterol O-acyltransferase activity,MF,
2035,GO:0004773,1,0.95950763690405,0,1,steryl-sulfatase activity,MF,
2036,GO:0004774,1,0.918606240580552,0,3,succinate-CoA ligase activity,MF,
2037,GO:0004775,1,0.948012769605661,0,2,succinate-CoA ligase (ADP-forming) activity,MF,
2038,GO:0004776,1,0.946606414613643,0,2,succinate-CoA ligase (GDP-forming) activity,MF,
2039,GO:0004777,1,0.959571905640215,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
2040,GO:0004779,1,0.930234301013966,0,2,sulfate adenylyltransferase activity,MF,
2041,GO:0004781,1,0.930234301013966,0,2,sulfate adenylyltransferase (ATP) activity,MF,
2042,GO:0004782,1,0.966591019336054,0,1,sulfinoalanine decarboxylase activity,MF,
2044,GO:0004790,1,0.96756271365883,0,1,thioether S-methyltransferase activity,MF,
2046,GO:0004792,1,0.927339960386098,0,3,thiosulfate sulfurtransferase activity,MF,
2047,GO:0004793,1,0.939052002373933,0,2,threonine aldolase activity,MF,
2048,GO:0004794,1,0.977538649595907,0,1,L-threonine ammonia-lyase activity,MF,
2049,GO:0004795,1,0.970861273644229,0,1,threonine synthase activity,MF,
2050,GO:0004797,1,0.936131505337534,0,2,thymidine kinase activity,MF,
2051,GO:0004798,1,0.94600677119047,0,2,thymidylate kinase activity,MF,
2052,GO:0004799,1,0.975655724279616,0,1,thymidylate synthase activity,MF,
2053,GO:0004801,1,0.979188435392656,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
2054,GO:0004802,1,0.970902192816698,0,1,transketolase activity,MF,
2055,GO:0004803,1,0.922491051972439,0,2,transposase activity,MF,
2057,GO:0004807,1,0.976917219603082,0,1,triose-phosphate isomerase activity,MF,
2058,GO:0004809,1,0.910714884261158,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
2059,GO:0004810,1,0.969587045794927,0,1,tRNA adenylyltransferase activity,MF,
2060,GO:0004812,1,0.230645101127663,0,44,aminoacyl-tRNA ligase activity,MF,
2061,GO:0004813,1,0.89913944469425,0,3,alanine-tRNA ligase activity,MF,
2062,GO:0004814,1,0.916062889693917,0,3,arginine-tRNA ligase activity,MF,
2063,GO:0004815,1,0.933427894933381,0,2,aspartate-tRNA ligase activity,MF,
2064,GO:0004816,1,0.936199165043618,0,2,asparagine-tRNA ligase activity,MF,
2065,GO:0004817,1,0.940778391914611,0,2,cysteine-tRNA ligase activity,MF,
2066,GO:0004818,1,0.922364176944032,0,2,glutamate-tRNA ligase activity,MF,
2067,GO:0004819,1,0.929292830579161,0,2,glutamine-tRNA ligase activity,MF,
2068,GO:0004820,1,0.942641652448435,0,2,glycine-tRNA ligase activity,MF,
2069,GO:0004821,1,0.940938472028834,0,2,histidine-tRNA ligase activity,MF,
2070,GO:0004822,1,0.923909246551073,0,2,isoleucine-tRNA ligase activity,MF,
2071,GO:0004823,1,0.921787017360986,0,2,leucine-tRNA ligase activity,MF,
2072,GO:0004824,1,0.970898097235127,0,1,lysine-tRNA ligase activity,MF,
2073,GO:0004825,1,0.931905580753366,0,2,methionine-tRNA ligase activity,MF,
2074,GO:0004826,1,0.856661813610069,0,5,phenylalanine-tRNA ligase activity,MF,
2075,GO:0004827,1,0.911764394669496,0,3,proline-tRNA ligase activity,MF,
2076,GO:0004828,1,0.944673776150464,0,2,serine-tRNA ligase activity,MF,
2077,GO:0004829,1,0.901223935073089,0,3,threonine-tRNA ligase activity,MF,
2078,GO:0004830,1,0.933713549778709,0,2,tryptophan-tRNA ligase activity,MF,
2079,GO:0004831,1,0.935786301673142,0,2,tyrosine-tRNA ligase activity,MF,
2080,GO:0004832,1,0.886672780895546,0,3,valine-tRNA ligase activity,MF,
2081,GO:0004833,1,0.975784758760467,0,1,tryptophan 2,3-dioxygenase activity,MF,
2082,GO:0004835,1,0.959570082177354,0,1,tubulin-tyrosine ligase activity,MF,
2083,GO:0004839,1,0.826311912858539,0,5,ubiquitin activating enzyme activity,MF,
2087,GO:0004849,1,0.864437267169697,0,5,uridine kinase activity,MF,
2089,GO:0004852,1,0.977979504797558,0,1,uroporphyrinogen-III synthase activity,MF,
2090,GO:0004853,1,0.977664123937547,0,1,uroporphyrinogen decarboxylase activity,MF,
2091,GO:0004854,1,0.920789213549214,0,2,xanthine dehydrogenase activity,MF,
2092,GO:0004855,1,0.95950764839315,0,1,xanthine oxidase activity,MF,
2093,GO:0004856,1,0.96185516989919,0,1,xylulokinase activity,MF,
2095,GO:0004859,1,0.839762350064949,0,7,phospholipase inhibitor activity,MF,
2098,GO:0004862,1,0.803572434022099,0,7,cAMP-dependent protein kinase inhibitor activity,MF,
2100,GO:0004865,1,0.852216681455727,0,6,protein serine/threonine phosphatase inhibitor activity,MF,
2105,GO:0004874,1,0.920890963653339,0,2,aryl hydrocarbon receptor activity,MF,
2107,GO:0004882,1,0.963504406783783,0,1,androgen receptor activity,MF,
2108,GO:0004883,1,0.95950763690405,0,1,glucocorticoid receptor activity,MF,
2109,GO:0004886,1,0.926453570626044,0,2,9-cis retinoic acid receptor activity,MF,
2110,GO:0004887,1,0.871869354861309,0,4,thyroid hormone receptor activity,MF,
2112,GO:0004890,1,0.964080596108445,0,1,GABA-A receptor activity,MF,
2115,GO:0004900,1,0.973133797886935,0,1,erythropoietin receptor activity,MF,
2119,GO:0004908,1,0.843605554118928,0,5,interleukin-1 receptor activity,MF,
2120,GO:0004909,1,0.932883083762822,0,2,interleukin-1, Type I, activating receptor activity,MF,
2121,GO:0004910,1,0.977205976262402,0,1,interleukin-1, Type II, blocking receptor activity,MF,
2122,GO:0004913,1,0.968742654876565,0,1,interleukin-4 receptor activity,MF,
2125,GO:0004918,1,0.968085371787524,0,1,interleukin-8 receptor activity,MF,
2131,GO:0004931,1,0.971542648304535,0,1,extracellularly ATP-gated cation channel activity,MF,
2133,GO:0004936,1,0.970316822191537,0,1,alpha-adrenergic receptor activity,MF,
2134,GO:0004937,1,0.970316822191537,0,1,alpha1-adrenergic receptor activity,MF,
2137,GO:0004945,1,0.979876170311414,0,1,angiotensin type II receptor activity,MF,
2139,GO:0004948,1,0.959630263764256,0,1,calcitonin receptor activity,MF,
2140,GO:0004950,1,0.81493749736054,0,6,chemokine receptor activity,MF,
2141,GO:0004952,1,0.958667927388671,0,2,dopamine neurotransmitter receptor activity,MF,
2142,GO:0004953,1,0.853935641204974,0,5,icosanoid receptor activity,MF,
2143,GO:0004954,1,0.908534808215675,0,3,prostanoid receptor activity,MF,
2144,GO:0004955,1,0.936989355319717,0,2,prostaglandin receptor activity,MF,
2145,GO:0004957,1,0.962918289861815,0,1,prostaglandin E receptor activity,MF,
2146,GO:0004960,1,0.969636865735874,0,1,thromboxane receptor activity,MF,
2147,GO:0004961,1,0.969636865735874,0,1,thromboxane A2 receptor activity,MF,
2148,GO:0004962,1,0.961456145704303,0,1,endothelin receptor activity,MF,
2150,GO:0004966,1,0.925335378216051,0,3,galanin receptor activity,MF,
2151,GO:0004968,1,0.95950763690405,0,1,gonadotropin-releasing hormone receptor activity,MF,
2152,GO:0004969,1,0.926801636986132,0,2,histamine receptor activity,MF,
2153,GO:0004970,1,0.921462566618038,0,2,ionotropic glutamate receptor activity,MF,
2154,GO:0004972,1,0.921462566618038,0,2,NMDA glutamate receptor activity,MF,
2155,GO:0004974,1,0.939918295195159,0,2,leukotriene receptor activity,MF,
2156,GO:0004977,1,0.938351925871959,0,2,melanocortin receptor activity,MF,
2157,GO:0004979,1,0.973007521550594,0,1,beta-endorphin receptor activity,MF,
2158,GO:0004980,1,0.964385436313833,0,1,melanocyte-stimulating hormone receptor activity,MF,
2159,GO:0004984,1,0.930778948106928,0,3,olfactory receptor activity,MF,
2160,GO:0004985,1,0.919217013493765,0,3,opioid receptor activity,MF,
2161,GO:0004990,1,0.960259554778064,0,1,oxytocin receptor activity,MF,
2162,GO:0004992,1,0.960654669220098,0,1,platelet activating factor receptor activity,MF,
2163,GO:0004993,1,0.915994570052804,0,3,G-protein coupled serotonin receptor activity,MF,
2164,GO:0004996,1,0.961319966218223,0,1,thyroid-stimulating hormone receptor activity,MF,
2166,GO:0004999,1,0.966025865350803,0,1,vasoactive intestinal polypeptide receptor activity,MF,
2167,GO:0005000,1,0.925464021736979,0,2,vasopressin receptor activity,MF,
2168,GO:0005001,1,0.671020564479414,0,10,transmembrane receptor protein tyrosine phosphatase activity,MF,
2170,GO:0005004,1,0.95950763690405,0,1,GPI-linked ephrin receptor activity,MF,
2172,GO:0005006,1,0.935063049877165,0,2,epidermal growth factor-activated receptor activity,MF,
2173,GO:0005007,1,0.823565400370607,0,5,fibroblast growth factor-activated receptor activity,MF,
2174,GO:0005008,1,0.95950763690405,0,1,hepatocyte growth factor-activated receptor activity,MF,
2175,GO:0005009,1,0.95950763690405,0,1,insulin-activated receptor activity,MF,
2176,GO:0005010,1,0.883365642781354,0,3,insulin-like growth factor-activated receptor activity,MF,
2177,GO:0005011,1,0.959766192011667,0,1,macrophage colony-stimulating factor receptor activity,MF,
2178,GO:0005021,1,0.928871916954526,0,2,vascular endothelial growth factor-activated receptor activity,MF,
2179,GO:0005024,1,0.753452172079392,0,7,transforming growth factor beta-activated receptor activity,MF,
2180,GO:0005025,1,0.888508993254402,0,3,transforming growth factor beta receptor activity, type I,MF,
2181,GO:0005026,1,0.959869033700348,0,1,transforming growth factor beta receptor activity, type II,MF,
2182,GO:0005030,1,0.95950763690405,0,1,neurotrophin receptor activity,MF,
2184,GO:0005034,1,0.964068341794451,0,1,osmosensor activity,MF,
2187,GO:0005042,1,0.959627453305779,0,1,netrin receptor activity,MF,
2189,GO:0005046,1,0.94316882325732,0,2,KDEL sequence binding,MF,
2190,GO:0005047,1,0.846618157731171,0,5,signal recognition particle binding,MF,
2192,GO:0005049,1,0.731789947131102,0,8,nuclear export signal receptor activity,MF,
2193,GO:0005052,1,0.927549724355735,0,2,peroxisome matrix targeting signal-1 binding,MF,
2194,GO:0005053,1,0.976651073377099,0,1,peroxisome matrix targeting signal-2 binding,MF,
2195,GO:0005055,1,0.949543199194247,0,2,laminin receptor activity,MF,
2197,GO:0005068,1,0.762725401719546,0,7,transmembrane receptor protein tyrosine kinase adaptor activity,MF,
2204,GO:0005087,1,0.896518024312773,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
2207,GO:0005090,1,0.970432530399028,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
2208,GO:0005092,1,0.659750941425851,0,13,GDP-dissociation inhibitor activity,MF,
2209,GO:0005093,1,0.938080893764485,0,2,Rab GDP-dissociation inhibitor activity,MF,
2210,GO:0005094,1,0.953079049845308,0,2,Rho GDP-dissociation inhibitor activity,MF,
2214,GO:0005104,1,0.681486653445925,0,10,fibroblast growth factor receptor binding,MF,
2215,GO:0005105,1,0.969583219132283,0,1,type 1 fibroblast growth factor receptor binding,MF,
2218,GO:0005113,1,0.834276660122989,0,5,patched binding,MF,
2219,GO:0005114,1,0.776057806601067,0,7,type II transforming growth factor beta receptor binding,MF,
2221,GO:0005119,1,0.924044364327204,0,2,smoothened binding,MF,
2223,GO:0005124,1,0.940430423579966,0,2,scavenger receptor binding,MF,
2227,GO:0005128,1,0.963536266677396,0,1,erythropoietin receptor binding,MF,
2229,GO:0005131,1,0.857872270841083,0,4,growth hormone receptor binding,MF,
2230,GO:0005132,1,0.957683421785851,0,2,type I interferon receptor binding,MF,
2231,GO:0005134,1,0.90712127556899,0,3,interleukin-2 receptor binding,MF,
2232,GO:0005135,1,0.963536266677396,0,1,interleukin-3 receptor binding,MF,
2233,GO:0005136,1,0.964234112328043,0,1,interleukin-4 receptor binding,MF,
2234,GO:0005137,1,0.970440535418824,0,1,interleukin-5 receptor binding,MF,
2236,GO:0005141,1,0.975222839342954,0,1,interleukin-10 receptor binding,MF,
2237,GO:0005142,1,0.968999810749328,0,1,interleukin-11 receptor binding,MF,
2238,GO:0005143,1,0.932607678127853,0,2,interleukin-12 receptor binding,MF,
2246,GO:0005157,1,0.968453561303749,0,1,macrophage colony-stimulating factor receptor binding,MF,
2252,GO:0005165,1,0.772628926245659,0,7,neurotrophin receptor binding,MF,
2253,GO:0005166,1,0.981981773219839,0,1,neurotrophin p75 receptor binding,MF,
2254,GO:0005167,1,0.772628926245659,0,7,neurotrophin TRK receptor binding,MF,
2255,GO:0005168,1,0.786814533394166,0,6,neurotrophin TRKA receptor binding,MF,
2256,GO:0005169,1,0.942240286606435,0,2,neurotrophin TRKB receptor binding,MF,
2257,GO:0005170,1,0.959531143039369,0,1,neurotrophin TRKC receptor binding,MF,
2258,GO:0005171,1,0.97144996847628,0,1,hepatocyte growth factor receptor binding,MF,
2260,GO:0005173,1,0.884212520470168,0,3,stem cell factor receptor binding,MF,
2261,GO:0005174,1,0.96954117901,0,1,CD40 receptor binding,MF,
2262,GO:0005175,1,0.985757459502051,0,1,CD27 receptor binding,MF,
2266,GO:0005183,1,0.974422863836396,0,1,gonadotropin hormone-releasing hormone activity,MF,
2267,GO:0005184,1,0.934118152121204,0,3,neuropeptide hormone activity,MF,
2269,GO:0005199,1,0.963099154166237,0,1,structural constituent of cell wall,MF,
2272,GO:0005212,1,0.924634534028194,0,3,structural constituent of eye lens,MF,
2275,GO:0005217,1,0.545035646178443,0,16,intracellular ligand-gated ion channel activity,MF,
2276,GO:0005219,1,0.942474768554657,0,2,ryanodine-sensitive calcium-release channel activity,MF,
2277,GO:0005220,1,0.883364048004276,0,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,
2278,GO:0005225,1,0.726502032044014,0,8,volume-sensitive anion channel activity,MF,
2279,GO:0005227,1,0.640744728224455,0,13,calcium activated cation channel activity,MF,
2280,GO:0005229,1,0.682199769133258,0,10,intracellular calcium activated chloride channel activity,MF,
2281,GO:0005230,1,0.724002603008566,0,9,extracellular ligand-gated ion channel activity,MF,
2282,GO:0005231,1,0.782087729353764,0,7,excitatory extracellular ligand-gated ion channel activity,MF,
2283,GO:0005234,1,0.959590301644531,0,1,extracellularly glutamate-gated ion channel activity,MF,
2284,GO:0005237,1,0.964080596108445,0,1,inhibitory extracellular ligand-gated ion channel activity,MF,
2285,GO:0005242,1,0.783720795060831,0,7,inward rectifier potassium channel activity,MF,
2290,GO:0005247,1,0.771514597300808,0,7,voltage-gated chloride channel activity,MF,
2291,GO:0005248,1,0.700805345108336,0,9,voltage-gated sodium channel activity,MF,
2292,GO:0005249,1,0.40988345622689,0,24,voltage-gated potassium channel activity,MF,
2293,GO:0005250,1,0.959818243747726,0,1,A-type (transient outward) potassium channel activity,MF,
2294,GO:0005251,1,0.74232062959022,0,8,delayed rectifier potassium channel activity,MF,
2299,GO:0005267,1,0.309281757762229,0,33,potassium channel activity,MF,
2300,GO:0005272,1,0.562143681026526,0,15,sodium channel activity,MF,
2301,GO:0005275,1,0.964759741425514,0,1,amine transmembrane transporter activity,MF,
2302,GO:0005280,1,0.892702514120268,0,3,amino acid:proton symporter activity,MF,
2303,GO:0005283,1,0.771970206789135,0,7,amino acid:sodium symporter activity,MF,
2306,GO:0005290,1,0.933342807207576,0,2,L-histidine transmembrane transporter activity,MF,
2308,GO:0005294,1,0.95950763690405,0,1,neutral L-amino acid secondary active transmembrane transporter activity,MF,
2309,GO:0005295,1,0.963768076646009,0,1,neutral amino acid:sodium symporter activity,MF,
2310,GO:0005298,1,0.960259554778064,0,1,proline:sodium symporter activity,MF,
2311,GO:0005308,1,0.962400535170761,0,1,creatine transmembrane transporter activity,MF,
2312,GO:0005309,1,0.962400535170761,0,1,creatine:sodium symporter activity,MF,
2313,GO:0005310,1,0.477991557783929,0,20,dicarboxylic acid transmembrane transporter activity,MF,
2314,GO:0005313,1,0.798086131162148,0,6,L-glutamate transmembrane transporter activity,MF,
2315,GO:0005314,1,0.929544297211519,0,2,high-affinity glutamate transmembrane transporter activity,MF,
2316,GO:0005315,1,0.889284554178795,0,3,inorganic phosphate transmembrane transporter activity,MF,
2317,GO:0005316,1,0.963454635055526,0,1,high-affinity inorganic phosphate:sodium symporter activity,MF,
2319,GO:0005324,1,0.932503982283131,0,2,long-chain fatty acid transporter activity,MF,
2322,GO:0005329,1,0.921128593637169,0,2,dopamine transmembrane transporter activity,MF,
2323,GO:0005330,1,0.960004427287314,0,1,dopamine:sodium symporter activity,MF,
2324,GO:0005332,1,0.971840175661916,0,1,gamma-aminobutyric acid:sodium symporter activity,MF,
2325,GO:0005335,1,0.960004427287314,0,1,serotonin:sodium symporter activity,MF,
2327,GO:0005338,1,0.703132224892991,0,11,nucleotide-sugar transmembrane transporter activity,MF,
2329,GO:0005343,1,0.625055228169912,0,13,organic acid:sodium symporter activity,MF,
2330,GO:0005344,1,0.972254752043476,0,1,oxygen carrier activity,MF,
2335,GO:0005351,1,0.75226478735404,0,8,carbohydrate:proton symporter activity,MF,
2336,GO:0005355,1,0.725203251273828,0,9,glucose transmembrane transporter activity,MF,
2337,GO:0005365,1,0.920650957478618,0,2,myo-inositol transmembrane transporter activity,MF,
2338,GO:0005366,1,0.95950763690405,0,1,myo-inositol:proton symporter activity,MF,
2339,GO:0005367,1,0.95950763690405,0,1,myo-inositol:sodium symporter activity,MF,
2340,GO:0005368,1,0.95950763690405,0,1,taurine transmembrane transporter activity,MF,
2341,GO:0005369,1,0.95950763690405,0,1,taurine:sodium symporter activity,MF,
2342,GO:0005372,1,0.887251571663773,0,4,water transmembrane transporter activity,MF,
2343,GO:0005375,1,0.816634322345999,0,6,copper ion transmembrane transporter activity,MF,
2345,GO:0005384,1,0.855877335173842,0,4,manganese ion transmembrane transporter activity,MF,
2346,GO:0005385,1,0.596769504262792,0,15,zinc ion transmembrane transporter activity,MF,
2348,GO:0005391,1,0.84078416295074,0,5,sodium:potassium-exchanging ATPase activity,MF,
2349,GO:0005402,1,0.672393644864664,0,11,carbohydrate:cation symporter activity,MF,
2350,GO:0005412,1,0.931628079469697,0,2,glucose:sodium symporter activity,MF,
2352,GO:0005416,1,0.713165179494926,0,9,amino acid:cation symporter activity,MF,
2353,GO:0005427,1,0.964139678475021,0,1,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
2354,GO:0005432,1,0.898278672725134,0,3,calcium:sodium antiporter activity,MF,
2355,GO:0005436,1,0.926820735358338,0,2,sodium:phosphate symporter activity,MF,
2357,GO:0005452,1,0.614174789542371,0,13,inorganic anion exchanger activity,MF,
2358,GO:0005456,1,0.973470656517695,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
2359,GO:0005457,1,0.924780083578031,0,2,GDP-fucose transmembrane transporter activity,MF,
2360,GO:0005459,1,0.954615319455284,0,2,UDP-galactose transmembrane transporter activity,MF,
2361,GO:0005461,1,0.95950763690405,0,1,UDP-glucuronic acid transmembrane transporter activity,MF,
2362,GO:0005462,1,0.931257790241445,0,2,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
2363,GO:0005464,1,0.95950763690405,0,1,UDP-xylose transmembrane transporter activity,MF,
2364,GO:0005471,1,0.917220839970861,0,3,ATP:ADP antiporter activity,MF,
2365,GO:0005476,1,0.934931869852453,0,2,carnitine:acyl carnitine antiporter activity,MF,
2366,GO:0005477,1,0.962411835340502,0,1,pyruvate secondary active transmembrane transporter activity,MF,
2367,GO:0005483,1,0.899747608222622,0,3,soluble NSF attachment protein activity,MF,
2371,GO:0005497,1,0.956125571723065,0,2,androgen binding,MF,
2372,GO:0005499,1,0.932302920828198,0,2,vitamin D binding,MF,
2373,GO:0005501,1,0.674321942950521,0,12,retinoid binding,MF,
2374,GO:0005502,1,0.959848101363135,0,1,11-cis retinal binding,MF,
2375,GO:0005503,1,0.959848101363135,0,1,all-trans retinal binding,MF,
2380,GO:0005513,1,0.79907809475967,0,7,detection of calcium ion,BP,
2384,GO:0005519,1,0.961032866151144,0,1,cytoskeletal regulatory protein binding,MF,
2386,GO:0005521,1,0.614954559019702,0,14,lamin binding,MF,
2387,GO:0005522,1,0.69548281259806,0,10,profilin binding,MF,
2388,GO:0005523,1,0.816375057876218,0,7,tropomyosin binding,MF,
2391,GO:0005527,1,0.711717633602768,0,12,macrolide binding,MF,
2392,GO:0005528,1,0.711717633602768,0,12,FK506 binding,MF,
2393,GO:0005534,1,0.908947846959084,0,3,galactose binding,MF,
2394,GO:0005536,1,0.724206711625717,0,9,glucose binding,MF,
2395,GO:0005537,1,0.762933515518286,0,8,mannose binding,MF,
2397,GO:0005540,1,0.769944143420486,0,8,hyaluronic acid binding,MF,
2398,GO:0005542,1,0.84053598339913,0,6,folic acid binding,MF,
2400,GO:0005544,1,0.324462500698374,0,33,calcium-dependent phospholipid binding,MF,
2401,GO:0005545,1,0.623201426860893,0,12,1-phosphatidylinositol binding,MF,
2404,GO:0005548,1,0.215224965479918,0,42,phospholipid transporter activity,MF,
2407,GO:0005577,1,0.890617571430228,0,3,fibrinogen complex,CC,
2409,GO:0005579,1,0.959513657507019,0,1,membrane attack complex,CC,
2410,GO:0005581,1,0.261423777492487,0,35,collagen trimer,CC,
2411,GO:0005583,1,0.692612947172662,0,9,fibrillar collagen trimer,CC,
2412,GO:0005584,1,0.920659520408784,0,2,collagen type I trimer,CC,
2413,GO:0005586,1,0.959511558625026,0,1,collagen type III trimer,CC,
2414,GO:0005587,1,0.813249026366698,0,5,collagen type IV trimer,CC,
2415,GO:0005588,1,0.883364048004276,0,3,collagen type V trimer,CC,
2416,GO:0005589,1,0.937922239736655,0,2,collagen type VI trimer,CC,
2417,GO:0005590,1,0.95950763690405,0,1,collagen type VII trimer,CC,
2418,GO:0005591,1,0.96710076651168,0,1,collagen type VIII trimer,CC,
2419,GO:0005592,1,0.95950763690405,0,1,collagen type XI trimer,CC,
2420,GO:0005593,1,0.860473424178694,0,4,FACIT collagen trimer,CC,
2421,GO:0005594,1,0.934648434981819,0,2,collagen type IX trimer,CC,
2422,GO:0005595,1,0.95950763690405,0,1,collagen type XII trimer,CC,
2423,GO:0005597,1,0.959508251718916,0,1,collagen type XVI trimer,CC,
2424,GO:0005598,1,0.96710076651168,0,1,short-chain collagen trimer,CC,
2425,GO:0005600,1,0.964560229490338,0,1,collagen type XIII trimer,CC,
2428,GO:0005606,1,0.883364048004276,0,3,laminin-1 complex,CC,
2429,GO:0005607,1,0.920735258610205,0,2,laminin-2 complex,CC,
2430,GO:0005608,1,0.920650957478618,0,2,laminin-3 complex,CC,
2432,GO:0005614,1,0.728987434298939,0,8,interstitial matrix,CC,
2439,GO:0005638,1,0.87082974812127,0,4,lamin filament,CC,
2440,GO:0005639,1,0.7424055505512,0,8,integral component of nuclear inner membrane,CC,
2442,GO:0005641,1,0.780698696673458,0,7,nuclear envelope lumen,CC,
2443,GO:0005642,1,0.832817147216689,0,5,annulate lamellae,CC,
2445,GO:0005652,1,0.733449157010705,0,9,nuclear lamina,CC,
2447,GO:0005655,1,0.820821560373676,0,8,nucleolar ribonuclease P complex,CC,
2448,GO:0005656,1,0.91631909499239,0,3,nuclear pre-replicative complex,CC,
2450,GO:0005658,1,0.8168517723953,0,6,alpha DNA polymerase:primase complex,CC,
2452,GO:0005663,1,0.843903460146229,0,6,DNA replication factor C complex,CC,
2453,GO:0005664,1,0.729569816831089,0,9,nuclear origin of replication recognition complex,CC,
2454,GO:0005665,1,0.628538607857267,0,17,DNA-directed RNA polymerase II, core complex,CC,
2457,GO:0005668,1,0.948903581698045,0,2,RNA polymerase transcription factor SL1 complex,CC,
2459,GO:0005671,1,0.614826250006359,0,14,Ada2/Gcn5/Ada3 transcription activator complex,CC,
2460,GO:0005672,1,0.907062296687471,0,4,transcription factor TFIIA complex,CC,
2461,GO:0005673,1,0.941672015919739,0,2,transcription factor TFIIE complex,CC,
2462,GO:0005674,1,0.945273322154545,0,2,transcription factor TFIIF complex,CC,
2463,GO:0005675,1,0.674943516367137,0,13,holo TFIIH complex,CC,
2464,GO:0005677,1,0.717841795544604,0,9,chromatin silencing complex,CC,
2465,GO:0005680,1,0.532872377465094,0,21,anaphase-promoting complex,CC,
2467,GO:0005682,1,0.504143912421333,0,22,U5 snRNP,CC,
2468,GO:0005683,1,0.865544761603559,0,7,U7 snRNP,CC,
2470,GO:0005685,1,0.582173124346898,0,20,U1 snRNP,CC,
2471,GO:0005686,1,0.590723326662513,0,20,U2 snRNP,CC,
2472,GO:0005687,1,0.765291940815635,0,11,U4 snRNP,CC,
2473,GO:0005688,1,0.834454607064927,0,8,U6 snRNP,CC,
2474,GO:0005689,1,0.517170080209657,0,26,U12-type spliceosomal complex,CC,
2475,GO:0005690,1,0.936736412956346,0,2,U4atac snRNP,CC,
2476,GO:0005691,1,0.960217643807024,0,1,U6atac snRNP,CC,
2478,GO:0005697,1,0.512283397126253,0,22,telomerase holoenzyme complex,CC,
2479,GO:0005712,1,0.928962971173858,0,2,chiasma,CC,
2480,GO:0005713,1,0.968169574119123,0,1,recombination nodule,CC,
2481,GO:0005715,1,0.968169574119123,0,1,late recombination nodule,CC,
2484,GO:0005721,1,0.523845020289304,0,18,pericentric heterochromatin,CC,
2485,GO:0005724,1,0.975135035644344,0,1,nuclear telomeric heterochromatin,CC,
2486,GO:0005726,1,0.852050834155867,0,4,perichromatin fibrils,CC,
2488,GO:0005731,1,0.974365896217661,0,1,nucleolus organizer region,CC,
2489,GO:0005732,1,0.571884908128797,0,24,small nucleolar ribonucleoprotein complex,CC,
2490,GO:0005736,1,0.710339335558466,0,12,DNA-directed RNA polymerase I complex,CC,
2495,GO:0005742,1,0.817581883014143,0,8,mitochondrial outer membrane translocase complex,CC,
2497,GO:0005744,1,0.696329755398192,0,13,mitochondrial inner membrane presequence translocase complex,CC,
2498,GO:0005745,1,0.932809166867866,0,2,m-AAA complex,CC,
2499,GO:0005746,1,0.225567069608321,0,72,mitochondrial respiratory chain,CC,
2500,GO:0005747,1,0.456668736736086,0,42,mitochondrial respiratory chain complex I,CC,
2501,GO:0005749,1,0.866506498156601,0,5,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,
2502,GO:0005750,1,0.750737934986019,0,11,mitochondrial respiratory chain complex III,CC,
2503,GO:0005751,1,0.849806615282399,0,10,mitochondrial respiratory chain complex IV,CC,
2506,GO:0005758,1,0.139307781736854,0,71,mitochondrial intermembrane space,CC,
2508,GO:0005760,1,0.921843787497642,0,2,gamma DNA polymerase complex,CC,
2509,GO:0005761,1,0.160206857246089,0,84,mitochondrial ribosome,CC,
2510,GO:0005762,1,0.328041303189327,0,51,mitochondrial large ribosomal subunit,CC,
2511,GO:0005763,1,0.54677534483676,0,28,mitochondrial small ribosomal subunit,CC,
2524,GO:0005777,1,0.0351878117122921,0,104,peroxisome,CC,
2525,GO:0005778,1,0.18053987007189,0,51,peroxisomal membrane,CC,
2526,GO:0005779,1,0.63286150622337,0,15,integral component of peroxisomal membrane,CC,
2527,GO:0005782,1,0.390766893641842,0,30,peroxisomal matrix,CC,
2529,GO:0005784,1,0.921436795127022,0,4,Sec61 translocon complex,CC,
2530,GO:0005785,1,0.813548218131038,0,7,signal recognition particle receptor complex,CC,
2531,GO:0005786,1,0.848877523163909,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2532,GO:0005787,1,0.876095383523598,0,5,signal peptidase complex,CC,
2535,GO:0005790,1,0.465552720346797,0,23,smooth endoplasmic reticulum,CC,
2541,GO:0005797,1,0.807337858996181,0,7,Golgi medial cisterna,CC,
2543,GO:0005801,1,0.208718714851762,0,46,cis-Golgi network,CC,
2549,GO:0005816,1,0.768695970510774,0,7,spindle pole body,CC,
2550,GO:0005818,1,0.740547055547236,0,8,aster,CC,
2552,GO:0005826,1,0.832147900815625,0,5,actomyosin contractile ring,CC,
2554,GO:0005828,1,0.763082140960225,0,7,kinetochore microtubule,CC,
2556,GO:0005832,1,0.722199023203402,0,10,chaperonin-containing T-complex,CC,
2557,GO:0005833,1,0.964947396982097,0,1,hemoglobin complex,CC,
2558,GO:0005834,1,0.531292409087409,0,19,heterotrimeric G-protein complex,CC,
2559,GO:0005838,1,0.572207061983557,0,21,proteasome regulatory particle,CC,
2560,GO:0005839,1,0.647575991018552,0,20,proteasome core complex,CC,
2564,GO:0005846,1,0.931761631255154,0,2,nuclear cap binding complex,CC,
2567,GO:0005850,1,0.859870315371781,0,4,eukaryotic translation initiation factor 2 complex,CC,
2568,GO:0005851,1,0.835139597264088,0,6,eukaryotic translation initiation factor 2B complex,CC,
2569,GO:0005852,1,0.61133023930521,0,17,eukaryotic translation initiation factor 3 complex,CC,
2570,GO:0005853,1,0.924882046668301,0,3,eukaryotic translation elongation factor 1 complex,CC,
2571,GO:0005854,1,0.941360283034411,0,2,nascent polypeptide-associated complex,CC,
2573,GO:0005858,1,0.742898691812901,0,8,axonemal dynein complex,CC,
2574,GO:0005859,1,0.78619752720156,0,7,muscle myosin complex,CC,
2575,GO:0005861,1,0.927949421126534,0,3,troponin complex,CC,
2576,GO:0005862,1,0.885664382283449,0,4,muscle thin filament tropomyosin,CC,
2577,GO:0005863,1,0.96179747889877,0,1,striated muscle myosin thick filament,CC,
2578,GO:0005865,1,0.704839048028411,0,11,striated muscle thin filament,CC,
2579,GO:0005868,1,0.533879872371434,0,20,cytoplasmic dynein complex,CC,
2580,GO:0005869,1,0.786918379941833,0,8,dynactin complex,CC,
2581,GO:0005871,1,0.185762267865991,0,44,kinesin complex,CC,
2582,GO:0005873,1,0.889040264574047,0,3,plus-end kinesin complex,CC,
2584,GO:0005875,1,0.0143129080581657,0,119,microtubule associated complex,CC,
2586,GO:0005879,1,0.839104377223323,0,5,axonemal microtubule,CC,
2587,GO:0005880,1,0.97693263283438,0,1,nuclear microtubule,CC,
2590,GO:0005883,1,0.771998303436506,0,7,neurofilament,CC,
2592,GO:0005885,1,0.768699071657267,0,10,Arp2/3 protein complex,CC,
2595,GO:0005889,1,0.925940181840502,0,2,potassium:proton exchanging ATPase complex,CC,
2596,GO:0005890,1,0.873774929462321,0,4,sodium:potassium-exchanging ATPase complex,CC,
2597,GO:0005891,1,0.718896145029779,0,10,voltage-gated calcium channel complex,CC,
2598,GO:0005892,1,0.837914506342213,0,5,acetylcholine-gated channel complex,CC,
2599,GO:0005895,1,0.970440535418824,0,1,interleukin-5 receptor complex,CC,
2601,GO:0005898,1,0.96095070683969,0,1,interleukin-13 receptor complex,CC,
2602,GO:0005899,1,0.920650957478618,0,2,insulin receptor complex,CC,
2611,GO:0005915,1,0.792939004260115,0,6,zonula adherens,CC,
2618,GO:0005927,1,0.976024317261928,0,1,muscle tendon junction,CC,
2620,GO:0005930,1,0.112621847396849,0,62,axoneme,CC,
2622,GO:0005940,1,0.710213389119023,0,9,septin ring,CC,
2623,GO:0005942,1,0.542499721067568,0,16,phosphatidylinositol 3-kinase complex,CC,
2624,GO:0005943,1,0.922821705420813,0,2,phosphatidylinositol 3-kinase complex, class IA,CC,
2625,GO:0005945,1,0.929087155423035,0,2,6-phosphofructokinase complex,CC,
2626,GO:0005947,1,0.858099296455835,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
2627,GO:0005952,1,0.83778746040987,0,5,cAMP-dependent protein kinase complex,CC,
2628,GO:0005953,1,0.942739853967568,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
2629,GO:0005954,1,0.968113388317252,0,1,calcium- and calmodulin-dependent protein kinase complex,CC,
2630,GO:0005955,1,0.856667782722141,0,4,calcineurin complex,CC,
2631,GO:0005956,1,0.94756456276961,0,2,protein kinase CK2 complex,CC,
2632,GO:0005958,1,0.898827446433608,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
2633,GO:0005960,1,0.938805586709968,0,2,glycine cleavage complex,CC,
2635,GO:0005965,1,0.942177934346024,0,2,protein farnesyltransferase complex,CC,
2636,GO:0005967,1,0.893637895929928,0,3,mitochondrial pyruvate dehydrogenase complex,CC,
2637,GO:0005968,1,0.874087178601318,0,4,Rab-protein geranylgeranyltransferase complex,CC,
2638,GO:0005969,1,0.95950763690405,0,1,serine-pyruvate aminotransferase complex,CC,
2639,GO:0005971,1,0.89088303670792,0,3,ribonucleoside-diphosphate reductase complex,CC,
2644,GO:0005979,1,0.47889860286885,0,19,regulation of glycogen biosynthetic process,BP,
2647,GO:0005982,1,0.95950763690405,0,1,starch metabolic process,BP,
2648,GO:0005983,1,0.95950763690405,0,1,starch catabolic process,BP,
2650,GO:0005985,1,0.962172802487713,0,1,sucrose metabolic process,BP,
2653,GO:0005991,1,0.965111227715674,0,1,trehalose metabolic process,BP,
2655,GO:0005997,1,0.899668346031347,0,4,xylulose metabolic process,BP,
2656,GO:0005998,1,0.96185516989919,0,1,xylulose catabolic process,BP,
2657,GO:0005999,1,0.950694690099748,0,2,xylulose biosynthetic process,BP,
2658,GO:0006000,1,0.69853148029073,0,11,fructose metabolic process,BP,
2659,GO:0006001,1,0.874946270057428,0,4,fructose catabolic process,BP,
2660,GO:0006002,1,0.822050360296562,0,6,fructose 6-phosphate metabolic process,BP,
2661,GO:0006003,1,0.856249450919771,0,4,fructose 2,6-bisphosphate metabolic process,BP,
2662,GO:0006004,1,0.624513163119041,0,13,fucose metabolic process,BP,
2664,GO:0006007,1,0.510822318937845,0,21,glucose catabolic process,BP,
2665,GO:0006011,1,0.817612736956096,0,6,UDP-glucose metabolic process,BP,
2668,GO:0006014,1,0.934030118291985,0,3,D-ribose metabolic process,BP,
2669,GO:0006015,1,0.907194495020286,0,3,5-phosphoribose 1-diphosphate biosynthetic process,BP,
2670,GO:0006020,1,0.686027683962548,0,10,inositol metabolic process,BP,
2671,GO:0006021,1,0.874877282082208,0,4,inositol biosynthetic process,BP,
2678,GO:0006030,1,0.928597192699348,0,2,chitin metabolic process,BP,
2679,GO:0006032,1,0.928597192699348,0,2,chitin catabolic process,BP,
2680,GO:0006040,1,0.403279632761275,0,27,amino sugar metabolic process,BP,
2681,GO:0006041,1,0.880645354964554,0,4,glucosamine metabolic process,BP,
2682,GO:0006043,1,0.942806188438993,0,2,glucosamine catabolic process,BP,
2683,GO:0006044,1,0.635954609875389,0,13,N-acetylglucosamine metabolic process,BP,
2684,GO:0006045,1,0.922635224286999,0,2,N-acetylglucosamine biosynthetic process,BP,
2685,GO:0006046,1,0.917605370885463,0,3,N-acetylglucosamine catabolic process,BP,
2686,GO:0006047,1,0.653439097507545,0,13,UDP-N-acetylglucosamine metabolic process,BP,
2687,GO:0006048,1,0.748955423031218,0,9,UDP-N-acetylglucosamine biosynthetic process,BP,
2688,GO:0006049,1,0.965311472293097,0,1,UDP-N-acetylglucosamine catabolic process,BP,
2689,GO:0006050,1,0.97573506936744,0,1,mannosamine metabolic process,BP,
2690,GO:0006051,1,0.97573506936744,0,1,N-acetylmannosamine metabolic process,BP,
2691,GO:0006054,1,0.723592138247174,0,10,N-acetylneuraminate metabolic process,BP,
2692,GO:0006055,1,0.97924266861207,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
2693,GO:0006056,1,0.973839944555444,0,1,mannoprotein metabolic process,BP,
2694,GO:0006057,1,0.973839944555444,0,1,mannoprotein biosynthetic process,BP,
2695,GO:0006059,1,0.92510015556955,0,3,hexitol metabolic process,BP,
2696,GO:0006060,1,0.945984003450146,0,2,sorbitol metabolic process,BP,
2697,GO:0006061,1,0.977507342145317,0,1,sorbitol biosynthetic process,BP,
2698,GO:0006062,1,0.967753139758002,0,1,sorbitol catabolic process,BP,
2699,GO:0006063,1,0.693779266617031,0,12,uronic acid metabolic process,BP,
2700,GO:0006064,1,0.873504287721904,0,5,glucuronate catabolic process,BP,
2701,GO:0006065,1,0.897676398778916,0,3,UDP-glucuronate biosynthetic process,BP,
2703,GO:0006067,1,0.706982558152224,0,11,ethanol metabolic process,BP,
2704,GO:0006068,1,0.81288801294522,0,7,ethanol catabolic process,BP,
2705,GO:0006069,1,0.812788464977099,0,6,ethanol oxidation,BP,
2706,GO:0006071,1,0.702424801311082,0,11,glycerol metabolic process,BP,
2707,GO:0006072,1,0.762552221922074,0,7,glycerol-3-phosphate metabolic process,BP,
2711,GO:0006083,1,0.888937782773414,0,3,acetate metabolic process,BP,
2713,GO:0006085,1,0.518659724322327,0,18,acetyl-CoA biosynthetic process,BP,
2714,GO:0006086,1,0.619237576050045,0,13,acetyl-CoA biosynthetic process from pyruvate,BP,
2715,GO:0006089,1,0.698750407386286,0,11,lactate metabolic process,BP,
2718,GO:0006094,1,0.190698707567631,0,51,gluconeogenesis,BP,
2720,GO:0006097,1,0.944154774103706,0,2,glyoxylate cycle,BP,
2721,GO:0006098,1,0.628827868923741,0,16,pentose-phosphate shunt,BP,
2722,GO:0006099,1,0.419101386894258,0,28,tricarboxylic acid cycle,BP,
2723,GO:0006101,1,0.355983017065077,0,32,citrate metabolic process,BP,
2724,GO:0006102,1,0.868819935127749,0,5,isocitrate metabolic process,BP,
2725,GO:0006103,1,0.578181216731014,0,16,2-oxoglutarate metabolic process,BP,
2726,GO:0006104,1,0.851905916614585,0,5,succinyl-CoA metabolic process,BP,
2727,GO:0006105,1,0.692741479923088,0,11,succinate metabolic process,BP,
2728,GO:0006106,1,0.915204332906594,0,3,fumarate metabolic process,BP,
2729,GO:0006107,1,0.72790762873582,0,10,oxaloacetate metabolic process,BP,
2730,GO:0006108,1,0.836261914597237,0,6,malate metabolic process,BP,
2733,GO:0006111,1,0.452177360787166,0,22,regulation of gluconeogenesis,BP,
2735,GO:0006113,1,0.965469978279355,0,1,fermentation,BP,
2736,GO:0006114,1,0.909858120299714,0,3,glycerol biosynthetic process,BP,
2737,GO:0006116,1,0.932737235799141,0,2,NADH oxidation,BP,
2740,GO:0006120,1,0.411421403758198,0,45,mitochondrial electron transport, NADH to ubiquinone,BP,
2741,GO:0006121,1,0.896901060595657,0,4,mitochondrial electron transport, succinate to ubiquinone,BP,
2742,GO:0006122,1,0.692795783783431,0,13,mitochondrial electron transport, ubiquinol to cytochrome c,BP,
2743,GO:0006123,1,0.763128064420005,0,14,mitochondrial electron transport, cytochrome c to oxygen,BP,
2744,GO:0006127,1,0.95950763690405,0,1,glycerophosphate shuttle,BP,
2747,GO:0006144,1,0.530787372044558,0,19,purine nucleobase metabolic process,BP,
2748,GO:0006145,1,0.851888657307525,0,4,purine nucleobase catabolic process,BP,
2749,GO:0006147,1,0.959518308911787,0,1,guanine catabolic process,BP,
2750,GO:0006148,1,0.968561372296152,0,1,inosine catabolic process,BP,
2752,GO:0006154,1,0.944374411880084,0,2,adenosine catabolic process,BP,
2753,GO:0006157,1,0.976124642047473,0,1,deoxyadenosine catabolic process,BP,
2757,GO:0006166,1,0.872623020847747,0,5,purine ribonucleoside salvage,BP,
2758,GO:0006167,1,0.873728207884192,0,5,AMP biosynthetic process,BP,
2759,GO:0006168,1,0.936117925323936,0,3,adenine salvage,BP,
2760,GO:0006169,1,0.971357684520004,0,1,adenosine salvage,BP,
2762,GO:0006172,1,0.969518289110119,0,1,ADP biosynthetic process,BP,
2763,GO:0006175,1,0.971357684520004,0,1,dATP biosynthetic process,BP,
2764,GO:0006177,1,0.867965257622682,0,5,GMP biosynthetic process,BP,
2765,GO:0006178,1,0.950413889877113,0,2,guanine salvage,BP,
2766,GO:0006182,1,0.601424355088602,0,14,cGMP biosynthetic process,BP,
2767,GO:0006183,1,0.812376945594565,0,9,GTP biosynthetic process,BP,
2768,GO:0006185,1,0.982027382476281,0,1,dGDP biosynthetic process,BP,
2770,GO:0006189,1,0.811521149172634,0,6,'de novo' IMP biosynthetic process,BP,
2771,GO:0006193,1,0.980779539261051,0,1,ITP catabolic process,BP,
2774,GO:0006198,1,0.701731500037623,0,9,cAMP catabolic process,BP,
2775,GO:0006203,1,0.922727649535946,0,3,dGTP catabolic process,BP,
2776,GO:0006206,1,0.581013237535411,0,17,pyrimidine nucleobase metabolic process,BP,
2777,GO:0006207,1,0.801064313660848,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
2778,GO:0006208,1,0.935581118230264,0,2,pyrimidine nucleobase catabolic process,BP,
2779,GO:0006210,1,0.935581118230264,0,2,thymine catabolic process,BP,
2780,GO:0006211,1,0.883364048004276,0,3,5-methylcytosine catabolic process,BP,
2781,GO:0006212,1,0.96422412068149,0,1,uracil catabolic process,BP,
2783,GO:0006214,1,0.96422412068149,0,1,thymidine catabolic process,BP,
2784,GO:0006216,1,0.846238923550477,0,6,cytidine catabolic process,BP,
2789,GO:0006226,1,0.921963101530694,0,3,dUMP biosynthetic process,BP,
2790,GO:0006227,1,0.94600677119047,0,2,dUDP biosynthetic process,BP,
2791,GO:0006228,1,0.826373190904062,0,8,UTP biosynthetic process,BP,
2792,GO:0006231,1,0.917800478247105,0,3,dTMP biosynthetic process,BP,
2793,GO:0006233,1,0.94600677119047,0,2,dTDP biosynthetic process,BP,
2794,GO:0006235,1,0.903027016080252,0,4,dTTP biosynthetic process,BP,
2795,GO:0006238,1,0.979177596081991,0,1,CMP salvage,BP,
2796,GO:0006241,1,0.739252690118812,0,12,CTP biosynthetic process,BP,
2798,GO:0006253,1,0.98060658390074,0,1,dCTP catabolic process,BP,
2799,GO:0006256,1,0.96524986344849,0,1,UDP catabolic process,BP,
2800,GO:0006258,1,0.949134208150965,0,2,UDP-glucose catabolic process,BP,
2804,GO:0006264,1,0.697019512737769,0,10,mitochondrial DNA replication,BP,
2805,GO:0006265,1,0.724900533279167,0,9,DNA topological change,BP,
2806,GO:0006266,1,0.487435141749965,0,23,DNA ligation,BP,
2807,GO:0006267,1,0.91631909499239,0,3,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,
2808,GO:0006268,1,0.78468477910861,0,7,DNA unwinding involved in DNA replication,BP,
2809,GO:0006269,1,0.844918724013806,0,5,DNA replication, synthesis of RNA primer,BP,
2810,GO:0006270,1,0.254194756408639,0,41,DNA replication initiation,BP,
2812,GO:0006272,1,0.900580829276661,0,3,leading strand elongation,BP,
2813,GO:0006273,1,0.690279263418495,0,11,lagging strand elongation,BP,
2815,GO:0006278,1,0.108664877883833,0,66,RNA-dependent DNA biosynthetic process,BP,
2821,GO:0006286,1,0.956031437787469,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
2822,GO:0006287,1,0.839764895982357,0,5,base-excision repair, gap-filling,BP,
2823,GO:0006288,1,0.915244813337058,0,3,base-excision repair, DNA ligation,BP,
2825,GO:0006290,1,0.794846858330731,0,7,pyrimidine dimer repair,BP,
2826,GO:0006293,1,0.499892954411545,0,21,nucleotide-excision repair, preincision complex stabilization,BP,
2827,GO:0006294,1,0.413826796506899,0,29,nucleotide-excision repair, preincision complex assembly,BP,
2828,GO:0006295,1,0.499892954411545,0,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,
2829,GO:0006296,1,0.318655845279939,0,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,
2830,GO:0006297,1,0.493111305746671,0,23,nucleotide-excision repair, DNA gap filling,BP,
2832,GO:0006301,1,0.203130411516619,0,49,postreplication repair,BP,
2836,GO:0006305,1,0.199644971961822,0,44,DNA alkylation,BP,
2837,GO:0006306,1,0.199644971961822,0,44,DNA methylation,BP,
2838,GO:0006307,1,0.741299333716865,0,10,DNA dealkylation involved in DNA repair,BP,
2840,GO:0006309,1,0.594271390030717,0,16,apoptotic DNA fragmentation,BP,
2842,GO:0006311,1,0.964075692128143,0,1,meiotic gene conversion,BP,
2843,GO:0006312,1,0.468251647156058,0,22,mitotic recombination,BP,
2844,GO:0006313,1,0.960885710978881,0,1,transposition, DNA-mediated,BP,
2851,GO:0006337,1,0.575498578528225,0,16,nucleosome disassembly,BP,
2854,GO:0006343,1,0.961398896095493,0,1,establishment of chromatin silencing,BP,
2855,GO:0006344,1,0.855951466615193,0,4,maintenance of chromatin silencing,BP,
2857,GO:0006348,1,0.802304447265069,0,8,chromatin silencing at telomere,BP,
2858,GO:0006349,1,0.608036807944996,0,13,regulation of gene expression by genetic imprinting,BP,
2861,GO:0006353,1,0.0344593926398392,0,107,DNA-templated transcription, termination,BP,
2864,GO:0006356,1,0.353940671549853,0,30,regulation of transcription by RNA polymerase I,BP,
2866,GO:0006359,1,0.437427430095818,0,24,regulation of transcription by RNA polymerase III,BP,
2867,GO:0006360,1,0.145334271592792,0,59,transcription by RNA polymerase I,BP,
2868,GO:0006361,1,0.349128005033359,0,35,transcription initiation from RNA polymerase I promoter,BP,
2869,GO:0006362,1,0.424269005867158,0,29,transcription elongation from RNA polymerase I promoter,BP,
2870,GO:0006363,1,0.409675689107866,0,30,termination of RNA polymerase I transcription,BP,
2875,GO:0006369,1,0.110208476338068,0,69,termination of RNA polymerase II transcription,BP,
2876,GO:0006370,1,0.386755611641258,0,32,7-methylguanosine mRNA capping,BP,
2878,GO:0006378,1,0.250637550274544,0,39,mRNA polyadenylation,BP,
2880,GO:0006382,1,0.824114905275485,0,5,adenosine to inosine editing,BP,
2882,GO:0006384,1,0.777988194809794,0,7,transcription initiation from RNA polymerase III promoter,BP,
2883,GO:0006386,1,0.984298973294839,0,1,termination of RNA polymerase III transcription,BP,
2884,GO:0006388,1,0.683364347728775,0,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,
2885,GO:0006390,1,0.647020865331838,0,13,mitochondrial transcription,BP,
2886,GO:0006391,1,0.910361838296091,0,3,transcription initiation from mitochondrial promoter,BP,
2887,GO:0006393,1,0.932129376517163,0,2,termination of mitochondrial transcription,BP,
2890,GO:0006398,1,0.842498922332916,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
2896,GO:0006404,1,0.917406928566232,0,3,RNA import into nucleus,BP,
2899,GO:0006407,1,0.920054182653315,0,3,rRNA export from nucleus,BP,
2900,GO:0006408,1,0.945874231275546,0,2,snRNA export from nucleus,BP,
2905,GO:0006415,1,0.0923140818103114,0,100,translational termination,BP,
2907,GO:0006418,1,0.205136992463027,0,49,tRNA aminoacylation for protein translation,BP,
2908,GO:0006419,1,0.89913944469425,0,3,alanyl-tRNA aminoacylation,BP,
2909,GO:0006420,1,0.916062889693917,0,3,arginyl-tRNA aminoacylation,BP,
2910,GO:0006421,1,0.901683076964364,0,3,asparaginyl-tRNA aminoacylation,BP,
2911,GO:0006422,1,0.969155989246758,0,1,aspartyl-tRNA aminoacylation,BP,
2912,GO:0006423,1,0.940778391914611,0,2,cysteinyl-tRNA aminoacylation,BP,
2913,GO:0006424,1,0.922364176944032,0,2,glutamyl-tRNA aminoacylation,BP,
2914,GO:0006425,1,0.929292830579161,0,2,glutaminyl-tRNA aminoacylation,BP,
2915,GO:0006426,1,0.942641652448435,0,2,glycyl-tRNA aminoacylation,BP,
2916,GO:0006427,1,0.940938472028834,0,2,histidyl-tRNA aminoacylation,BP,
2917,GO:0006428,1,0.923909246551073,0,2,isoleucyl-tRNA aminoacylation,BP,
2918,GO:0006429,1,0.921787017360986,0,2,leucyl-tRNA aminoacylation,BP,
2919,GO:0006430,1,0.970898097235127,0,1,lysyl-tRNA aminoacylation,BP,
2920,GO:0006431,1,0.931905580753366,0,2,methionyl-tRNA aminoacylation,BP,
2921,GO:0006432,1,0.856661813610069,0,5,phenylalanyl-tRNA aminoacylation,BP,
2922,GO:0006433,1,0.911764394669496,0,3,prolyl-tRNA aminoacylation,BP,
2923,GO:0006434,1,0.944673776150464,0,2,seryl-tRNA aminoacylation,BP,
2924,GO:0006435,1,0.901223935073089,0,3,threonyl-tRNA aminoacylation,BP,
2925,GO:0006436,1,0.933713549778709,0,2,tryptophanyl-tRNA aminoacylation,BP,
2926,GO:0006437,1,0.935786301673142,0,2,tyrosyl-tRNA aminoacylation,BP,
2927,GO:0006438,1,0.886672780895546,0,3,valyl-tRNA aminoacylation,BP,
2931,GO:0006449,1,0.783516613959871,0,7,regulation of translational termination,BP,
2933,GO:0006451,1,0.793485413432396,0,7,translational readthrough,BP,
2934,GO:0006452,1,0.938859165808801,0,2,translational frameshifting,BP,
2937,GO:0006463,1,0.961702192758632,0,1,steroid hormone receptor complex assembly,BP,
2939,GO:0006465,1,0.613795943533052,0,16,signal peptide processing,BP,
2943,GO:0006471,1,0.437064416433335,0,24,protein ADP-ribosylation,BP,
2948,GO:0006477,1,0.838490753563984,0,5,protein sulfation,BP,
2949,GO:0006478,1,0.944454688585882,0,2,peptidyl-tyrosine sulfation,BP,
2951,GO:0006480,1,0.965469978279355,0,1,N-terminal protein amino acid methylation,BP,
2952,GO:0006481,1,0.906737331117646,0,3,C-terminal protein methylation,BP,
2956,GO:0006488,1,0.522784231837856,0,20,dolichol-linked oligosaccharide biosynthetic process,BP,
2957,GO:0006489,1,0.795726370462371,0,7,dolichyl diphosphate biosynthetic process,BP,
2958,GO:0006490,1,0.505877397426599,0,21,oligosaccharide-lipid intermediate biosynthetic process,BP,
2959,GO:0006491,1,0.554328823096726,0,16,N-glycan processing,BP,
2962,GO:0006498,1,0.829532931621301,0,5,N-terminal protein lipidation,BP,
2963,GO:0006499,1,0.854590512407345,0,4,N-terminal protein myristoylation,BP,
2964,GO:0006500,1,0.970690301828148,0,1,N-terminal protein palmitoylation,BP,
2968,GO:0006507,1,0.969484008610393,0,1,GPI anchor release,BP,
2973,GO:0006515,1,0.432716031037581,0,24,protein quality control for misfolded or incompletely synthesized proteins,BP,
2975,GO:0006517,1,0.321935506452221,0,32,protein deglycosylation,BP,
2979,GO:0006522,1,0.961179164310998,0,1,alanine metabolic process,BP,
2980,GO:0006524,1,0.961179164310998,0,1,alanine catabolic process,BP,
2981,GO:0006525,1,0.601102485862997,0,16,arginine metabolic process,BP,
2982,GO:0006526,1,0.845829016614699,0,5,arginine biosynthetic process,BP,
2983,GO:0006527,1,0.755577914891492,0,9,arginine catabolic process,BP,
2984,GO:0006528,1,0.918492140080107,0,3,asparagine metabolic process,BP,
2985,GO:0006529,1,0.938327508934156,0,2,asparagine biosynthetic process,BP,
2987,GO:0006532,1,0.939954248592068,0,2,aspartate biosynthetic process,BP,
2988,GO:0006533,1,0.939954248592068,0,2,aspartate catabolic process,BP,
2990,GO:0006535,1,0.967261870054133,0,1,cysteine biosynthetic process from serine,BP,
2992,GO:0006537,1,0.85992889835693,0,4,glutamate biosynthetic process,BP,
2993,GO:0006538,1,0.807749292366305,0,6,glutamate catabolic process,BP,
2994,GO:0006540,1,0.929708666731478,0,2,glutamate decarboxylation to succinate,BP,
2995,GO:0006541,1,0.5313603421716,0,17,glutamine metabolic process,BP,
2996,GO:0006542,1,0.96024696931705,0,1,glutamine biosynthetic process,BP,
2997,GO:0006543,1,0.893035144305684,0,3,glutamine catabolic process,BP,
2998,GO:0006544,1,0.775873863050094,0,8,glycine metabolic process,BP,
2999,GO:0006545,1,0.939052002373933,0,2,glycine biosynthetic process,BP,
3000,GO:0006546,1,0.911778596622869,0,3,glycine catabolic process,BP,
3003,GO:0006549,1,0.837696233599032,0,5,isoleucine metabolic process,BP,
3004,GO:0006550,1,0.946694572556772,0,2,isoleucine catabolic process,BP,
3005,GO:0006551,1,0.796463460860888,0,7,leucine metabolic process,BP,
3006,GO:0006552,1,0.851117272624453,0,5,leucine catabolic process,BP,
3007,GO:0006553,1,0.72601040001832,0,9,lysine metabolic process,BP,
3008,GO:0006554,1,0.751856198413543,0,8,lysine catabolic process,BP,
3010,GO:0006556,1,0.937975851870164,0,2,S-adenosylmethionine biosynthetic process,BP,
3011,GO:0006557,1,0.963561401555438,0,1,S-adenosylmethioninamine biosynthetic process,BP,
3012,GO:0006558,1,0.914856427280232,0,4,L-phenylalanine metabolic process,BP,
3013,GO:0006559,1,0.914856427280232,0,4,L-phenylalanine catabolic process,BP,
3014,GO:0006560,1,0.829182402432969,0,6,proline metabolic process,BP,
3015,GO:0006561,1,0.887091258798581,0,4,proline biosynthetic process,BP,
3016,GO:0006562,1,0.934739644750603,0,2,proline catabolic process,BP,
3017,GO:0006563,1,0.742707488740772,0,10,L-serine metabolic process,BP,
3018,GO:0006564,1,0.83804899489148,0,6,L-serine biosynthetic process,BP,
3019,GO:0006565,1,0.915499773272944,0,3,L-serine catabolic process,BP,
3020,GO:0006566,1,0.925955147511133,0,3,threonine metabolic process,BP,
3021,GO:0006567,1,0.953749497534718,0,2,threonine catabolic process,BP,
3022,GO:0006568,1,0.862415979450591,0,5,tryptophan metabolic process,BP,
3023,GO:0006569,1,0.922418598255783,0,3,tryptophan catabolic process,BP,
3024,GO:0006570,1,0.904992715160747,0,4,tyrosine metabolic process,BP,
3025,GO:0006572,1,0.930453187589765,0,3,tyrosine catabolic process,BP,
3026,GO:0006573,1,0.736715711778424,0,9,valine metabolic process,BP,
3027,GO:0006574,1,0.889735216681438,0,4,valine catabolic process,BP,
3030,GO:0006577,1,0.640569054208659,0,13,amino-acid betaine metabolic process,BP,
3031,GO:0006578,1,0.819360961202583,0,6,amino-acid betaine biosynthetic process,BP,
3032,GO:0006580,1,0.966663527476837,0,1,ethanolamine metabolic process,BP,
3035,GO:0006585,1,0.972641442982888,0,1,dopamine biosynthetic process from tyrosine,BP,
3036,GO:0006586,1,0.862415979450591,0,5,indolalkylamine metabolic process,BP,
3037,GO:0006589,1,0.964638459389207,0,1,octopamine biosynthetic process,BP,
3038,GO:0006590,1,0.712632057823536,0,9,thyroid hormone generation,BP,
3040,GO:0006592,1,0.962674958488356,0,1,ornithine biosynthetic process,BP,
3043,GO:0006597,1,0.939088559532639,0,2,spermine biosynthetic process,BP,
3045,GO:0006600,1,0.774702351688489,0,8,creatine metabolic process,BP,
3046,GO:0006601,1,0.981845137628092,0,1,creatine biosynthetic process,BP,
3053,GO:0006613,1,0.161118304770517,0,96,cotranslational protein targeting to membrane,BP,
3054,GO:0006614,1,0.191013082431901,0,91,SRP-dependent cotranslational protein targeting to membrane,BP,
3055,GO:0006616,1,0.864235598934806,0,6,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3056,GO:0006617,1,0.953577558252978,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
3057,GO:0006620,1,0.799045807732462,0,7,posttranslational protein targeting to endoplasmic reticulum membrane,BP,
3058,GO:0006621,1,0.772861001994609,0,8,protein retention in ER lumen,BP,
3059,GO:0006622,1,0.46880072151271,0,21,protein targeting to lysosome,BP,
3060,GO:0006623,1,0.290536845430176,0,34,protein targeting to vacuole,BP,
3061,GO:0006624,1,0.955843981329501,0,2,vacuolar protein processing,BP,
3062,GO:0006625,1,0.553788752410809,0,17,protein targeting to peroxisome,BP,
3064,GO:0006627,1,0.846741979786465,0,6,protein processing involved in protein targeting to mitochondrion,BP,
3074,GO:0006642,1,0.893771729088789,0,3,triglyceride mobilization,BP,
3079,GO:0006651,1,0.942403422426089,0,2,diacylglycerol biosynthetic process,BP,
3080,GO:0006654,1,0.34375068419108,0,29,phosphatidic acid biosynthetic process,BP,
3081,GO:0006655,1,0.709185377815747,0,10,phosphatidylglycerol biosynthetic process,BP,
3082,GO:0006656,1,0.384892478870236,0,29,phosphatidylcholine biosynthetic process,BP,
3083,GO:0006657,1,0.801763033633121,0,7,CDP-choline pathway,BP,
3084,GO:0006658,1,0.486405426286948,0,21,phosphatidylserine metabolic process,BP,
3085,GO:0006659,1,0.874905250384695,0,4,phosphatidylserine biosynthetic process,BP,
3086,GO:0006660,1,0.973765661015785,0,1,phosphatidylserine catabolic process,BP,
3088,GO:0006662,1,0.769687569326867,0,9,glycerol ether metabolic process,BP,
3089,GO:0006663,1,0.903757072089068,0,3,platelet activating factor biosynthetic process,BP,
3092,GO:0006666,1,0.959558536378073,0,1,3-keto-sphinganine metabolic process,BP,
3093,GO:0006667,1,0.933480632916514,0,2,sphinganine metabolic process,BP,
3094,GO:0006668,1,0.929731463176053,0,2,sphinganine-1-phosphate metabolic process,BP,
3095,GO:0006669,1,0.96507275374546,0,1,sphinganine-1-phosphate biosynthetic process,BP,
3096,GO:0006670,1,0.732773036136062,0,10,sphingosine metabolic process,BP,
3097,GO:0006671,1,0.960204027932764,0,1,phytosphingosine metabolic process,BP,
3102,GO:0006680,1,0.90030636322989,0,3,glucosylceramide catabolic process,BP,
3103,GO:0006681,1,0.813866559494111,0,6,galactosylceramide metabolic process,BP,
3104,GO:0006682,1,0.903310710048148,0,3,galactosylceramide biosynthetic process,BP,
3105,GO:0006683,1,0.965373453992635,0,1,galactosylceramide catabolic process,BP,
3111,GO:0006689,1,0.878390830546999,0,4,ganglioside catabolic process,BP,
3113,GO:0006691,1,0.692014406163918,0,12,leukotriene metabolic process,BP,
3118,GO:0006696,1,0.942435551799044,0,2,ergosterol biosynthetic process,BP,
3119,GO:0006699,1,0.523403863826881,0,19,bile acid biosynthetic process,BP,
3122,GO:0006702,1,0.835942559627985,0,5,androgen biosynthetic process,BP,
3123,GO:0006703,1,0.808537913571646,0,8,estrogen biosynthetic process,BP,
3127,GO:0006707,1,0.882926931557998,0,4,cholesterol catabolic process,BP,
3128,GO:0006710,1,0.972917721501784,0,1,androgen catabolic process,BP,
3129,GO:0006711,1,0.973765661015785,0,1,estrogen catabolic process,BP,
3133,GO:0006722,1,0.968615547286787,0,1,triterpenoid metabolic process,BP,
3135,GO:0006726,1,0.959734229948343,0,1,eye pigment biosynthetic process,BP,
3140,GO:0006734,1,0.43153692337919,0,26,NADH metabolic process,BP,
3141,GO:0006735,1,0.585973219166511,0,17,NADH regeneration,BP,
3142,GO:0006738,1,0.968561372296152,0,1,nicotinamide riboside catabolic process,BP,
3143,GO:0006739,1,0.437120906566824,0,27,NADP metabolic process,BP,
3144,GO:0006740,1,0.901499735918405,0,3,NADPH regeneration,BP,
3145,GO:0006741,1,0.872973787731407,0,4,NADP biosynthetic process,BP,
3146,GO:0006742,1,0.962607920802641,0,1,NADP catabolic process,BP,
3147,GO:0006743,1,0.655671809269321,0,15,ubiquinone metabolic process,BP,
3148,GO:0006744,1,0.682992512164167,0,14,ubiquinone biosynthetic process,BP,
3149,GO:0006747,1,0.972059476421804,0,1,FAD biosynthetic process,BP,
3152,GO:0006751,1,0.866454448157668,0,5,glutathione catabolic process,BP,
3158,GO:0006767,1,0.113308085321989,0,65,water-soluble vitamin metabolic process,BP,
3159,GO:0006768,1,0.682073122507281,0,11,biotin metabolic process,BP,
3160,GO:0006771,1,0.819886003537562,0,6,riboflavin metabolic process,BP,
3161,GO:0006772,1,0.97364540467502,0,1,thiamine metabolic process,BP,
3164,GO:0006777,1,0.817345851954138,0,6,Mo-molybdopterin cofactor biosynthetic process,BP,
3167,GO:0006780,1,0.949053681313646,0,2,uroporphyrinogen III biosynthetic process,BP,
3168,GO:0006781,1,0.970424528624568,0,1,succinyl-CoA pathway,BP,
3171,GO:0006784,1,0.925803658026204,0,2,heme a biosynthetic process,BP,
3172,GO:0006787,1,0.861228672876724,0,6,porphyrin-containing compound catabolic process,BP,
3173,GO:0006788,1,0.950762503219111,0,2,heme oxidation,BP,
3174,GO:0006789,1,0.938793903442157,0,2,bilirubin conjugation,BP,
3178,GO:0006797,1,0.834288815671213,0,5,polyphosphate metabolic process,BP,
3179,GO:0006798,1,0.863900537728847,0,4,polyphosphate catabolic process,BP,
3181,GO:0006805,1,0.126415118722189,0,67,xenobiotic metabolic process,BP,
3183,GO:0006808,1,0.946113121958907,0,2,regulation of nitrogen utilization,BP,
3191,GO:0006817,1,0.645743028806109,0,12,phosphate ion transport,BP,
3194,GO:0006824,1,0.932483151374965,0,2,cobalt ion transport,BP,
3197,GO:0006828,1,0.887197852554654,0,3,manganese ion transport,BP,
3198,GO:0006829,1,0.55166762790024,0,17,zinc ion transport,BP,
3199,GO:0006833,1,0.817981185793765,0,6,water transport,BP,
3202,GO:0006837,1,0.812222045512771,0,6,serotonin transport,BP,
3204,GO:0006842,1,0.867745889173515,0,4,tricarboxylic acid transport,BP,
3205,GO:0006843,1,0.975477912832917,0,1,mitochondrial citrate transmembrane transport,BP,
3206,GO:0006844,1,0.942696406882776,0,2,acyl carnitine transport,BP,
3207,GO:0006848,1,0.897086260392901,0,3,pyruvate transport,BP,
3208,GO:0006850,1,0.932129376517163,0,2,mitochondrial pyruvate transmembrane transport,BP,
3209,GO:0006851,1,0.513880917355728,0,20,mitochondrial calcium ion transmembrane transport,BP,
3210,GO:0006853,1,0.692186297425917,0,10,carnitine shuttle,BP,
3212,GO:0006857,1,0.755908733336901,0,8,oligopeptide transport,BP,
3213,GO:0006858,1,0.915968587433228,0,3,extracellular transport,BP,
3216,GO:0006864,1,0.937694877882284,0,2,pyrimidine nucleotide transport,BP,
3218,GO:0006867,1,0.966134356702796,0,1,asparagine transport,BP,
3219,GO:0006868,1,0.865879756194469,0,4,glutamine transport,BP,
3224,GO:0006878,1,0.674231342587432,0,13,cellular copper ion homeostasis,BP,
3226,GO:0006880,1,0.93598283976286,0,3,intracellular sequestering of iron ion,BP,
3227,GO:0006882,1,0.528434202967232,0,21,cellular zinc ion homeostasis,BP,
3229,GO:0006884,1,0.536188898480757,0,17,cell volume homeostasis,BP,
3234,GO:0006890,1,0.0716566023192809,0,77,retrograde vesicle-mediated transport, Golgi to ER,BP,
3235,GO:0006891,1,0.356934998164357,0,30,intra-Golgi vesicle-mediated transport,BP,
3237,GO:0006893,1,0.20547673933471,0,45,Golgi to plasma membrane transport,BP,
3238,GO:0006895,1,0.482442465887433,0,19,Golgi to endosome transport,BP,
3239,GO:0006896,1,0.606835306994072,0,14,Golgi to vacuole transport,BP,
3247,GO:0006907,1,0.577836558033873,0,16,pinocytosis,BP,
3249,GO:0006910,1,0.806708281916481,0,6,phagocytosis, recognition,BP,
3250,GO:0006911,1,0.422252397699298,0,25,phagocytosis, engulfment,BP,
3255,GO:0006921,1,0.445238576252656,0,25,cellular component disassembly involved in execution phase of apoptosis,BP,
3256,GO:0006924,1,0.785703155454037,0,8,activation-induced cell death of T cells,BP,
3260,GO:0006930,1,0.750965630781096,0,8,substrate-dependent cell migration, cell extension,BP,
3261,GO:0006931,1,0.903692769071016,0,3,substrate-dependent cell migration, cell attachment to substrate,BP,
3262,GO:0006933,1,0.944967281577775,0,2,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,
3277,GO:0006957,1,0.920724172817557,0,2,complement activation, alternative pathway,BP,
3285,GO:0006975,1,0.790602295558484,0,7,DNA damage induced protein phosphorylation,BP,
3289,GO:0006982,1,0.95730306499771,0,2,response to lipid hydroperoxide,BP,
3294,GO:0006990,1,0.90899020435685,0,3,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,
3296,GO:0006995,1,0.75964527467528,0,10,cellular response to nitrogen starvation,BP,
3302,GO:0007004,1,0.116848255468797,0,64,telomere maintenance via telomerase,BP,
3305,GO:0007007,1,0.540694884525377,0,22,inner mitochondrial membrane organization,BP,
3306,GO:0007008,1,0.963039672539869,0,1,outer mitochondrial membrane organization,BP,
3309,GO:0007014,1,0.96179747889877,0,1,actin ubiquitination,BP,
3311,GO:0007016,1,0.724985551477118,0,8,cytoskeletal anchoring at plasma membrane,BP,
3315,GO:0007020,1,0.389609514904548,0,26,microtubule nucleation,BP,
3316,GO:0007021,1,0.843659231545624,0,7,tubulin complex assembly,BP,
3317,GO:0007023,1,0.897164273934675,0,4,post-chaperonin tubulin folding pathway,BP,
3322,GO:0007031,1,0.399822326300826,0,28,peroxisome organization,BP,
3326,GO:0007035,1,0.563902107447999,0,19,vacuolar acidification,BP,
3328,GO:0007040,1,0.184856228509007,0,51,lysosome organization,BP,
3330,GO:0007042,1,0.809906360666825,0,8,lysosomal lumen acidification,BP,
3338,GO:0007056,1,0.941192963803122,0,2,spindle assembly involved in female meiosis,BP,
3339,GO:0007057,1,0.941192963803122,0,2,spindle assembly involved in female meiosis I,BP,
3341,GO:0007060,1,0.934735974768799,0,2,male meiosis chromosome segregation,BP,
3342,GO:0007062,1,0.017826020526688,0,120,sister chromatid cohesion,BP,
3343,GO:0007063,1,0.476743092674578,0,21,regulation of sister chromatid cohesion,BP,
3344,GO:0007064,1,0.463620979340609,0,22,mitotic sister chromatid cohesion,BP,
3345,GO:0007066,1,0.982646176507809,0,1,female meiosis sister chromatid cohesion,BP,
3346,GO:0007072,1,0.974365896217661,0,1,positive regulation of transcription involved in exit from mitosis,BP,
3347,GO:0007076,1,0.548003163537879,0,16,mitotic chromosome condensation,BP,
3349,GO:0007079,1,0.888979923858958,0,3,mitotic chromosome movement towards spindle pole,BP,
3350,GO:0007080,1,0.248952066809513,0,43,mitotic metaphase plate congression,BP,
3353,GO:0007089,1,0.869543589646552,0,4,traversing start control point of mitotic cell cycle,BP,
3357,GO:0007095,1,0.498508977435474,0,19,mitotic G2 DNA damage checkpoint,BP,
3358,GO:0007096,1,0.613404715721602,0,15,regulation of exit from mitosis,BP,
3359,GO:0007097,1,0.534101774908694,0,16,nuclear migration,BP,
3362,GO:0007100,1,0.633203871754939,0,13,mitotic centrosome separation,BP,
3364,GO:0007127,1,0.105525161802749,0,67,meiosis I,BP,
3365,GO:0007129,1,0.541293500655348,0,18,synapsis,BP,
3366,GO:0007130,1,0.785801568619647,0,7,synaptonemal complex assembly,BP,
3367,GO:0007131,1,0.295625362390431,0,36,reciprocal meiotic recombination,BP,
3368,GO:0007135,1,0.822101718240396,0,6,meiosis II,BP,
3369,GO:0007140,1,0.46076835409571,0,23,male meiotic nuclear division,BP,
3370,GO:0007141,1,0.691492619631711,0,12,male meiosis I,BP,
3372,GO:0007144,1,0.829772666921851,0,6,female meiosis I,BP,
3373,GO:0007146,1,0.965469978279355,0,1,meiotic recombination nodule assembly,BP,
3374,GO:0007147,1,0.962084097441063,0,1,female meiosis II,BP,
3377,GO:0007156,1,0.0751005110651394,0,66,homophilic cell adhesion via plasma membrane adhesion molecules,BP,
3379,GO:0007158,1,0.786580578340985,0,6,neuron cell-cell adhesion,BP,
3382,GO:0007161,1,0.854446154743683,0,4,calcium-independent cell-matrix adhesion,BP,
3389,GO:0007168,1,0.933554453941842,0,2,receptor guanylyl cyclase signaling pathway,BP,
3392,GO:0007172,1,0.773778977764776,0,7,signal complex assembly,BP,
3394,GO:0007174,1,0.969919155567986,0,1,epidermal growth factor catabolic process,BP,
3399,GO:0007181,1,0.938094074416336,0,2,transforming growth factor beta receptor complex assembly,BP,
3402,GO:0007185,1,0.84758490062702,0,4,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,
3408,GO:0007191,1,0.819704470021964,0,6,adenylate cyclase-activating dopamine receptor signaling pathway,BP,
3410,GO:0007194,1,0.796004070687044,0,7,negative regulation of adenylate cyclase activity,BP,
3411,GO:0007195,1,0.929163477060555,0,2,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
3412,GO:0007196,1,0.95950763690405,0,1,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,BP,
3413,GO:0007197,1,0.927943055563232,0,2,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,BP,
3414,GO:0007198,1,0.944376817438466,0,2,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,
3416,GO:0007202,1,0.733649041797957,0,10,activation of phospholipase C activity,BP,
3419,GO:0007206,1,0.96050352256103,0,1,phospholipase C-activating G-protein coupled glutamate receptor signaling pathway,BP,
3420,GO:0007207,1,0.938050070823441,0,2,phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,BP,
3421,GO:0007210,1,0.915994570052804,0,3,serotonin receptor signaling pathway,BP,
3422,GO:0007212,1,0.427536570170095,0,26,dopamine receptor signaling pathway,BP,
3423,GO:0007213,1,0.723634793822154,0,10,G-protein coupled acetylcholine receptor signaling pathway,BP,
3424,GO:0007214,1,0.80694043478422,0,6,gamma-aminobutyric acid signaling pathway,BP,
3426,GO:0007216,1,0.845418775032111,0,5,G-protein coupled glutamate receptor signaling pathway,BP,
3427,GO:0007217,1,0.967488582753513,0,1,tachykinin receptor signaling pathway,BP,
3428,GO:0007218,1,0.616595600373626,0,17,neuropeptide signaling pathway,BP,
3431,GO:0007221,1,0.533403265832884,0,16,positive regulation of transcription of Notch receptor target,BP,
3434,GO:0007225,1,0.959796825212613,0,1,patched ligand maturation,BP,
3435,GO:0007227,1,0.887007069866377,0,3,signal transduction downstream of smoothened,BP,
3436,GO:0007228,1,0.922910842634119,0,2,positive regulation of hh target transcription factor activity,BP,
3438,GO:0007231,1,0.93997744975211,0,2,osmosensory signaling pathway,BP,
3441,GO:0007252,1,0.636527335328822,0,13,I-kappaB phosphorylation,BP,
3444,GO:0007256,1,0.785243832716169,0,6,activation of JNKK activity,BP,
3446,GO:0007258,1,0.870020201975335,0,4,JUN phosphorylation,BP,
3449,GO:0007263,1,0.762239575217597,0,8,nitric oxide mediated signal transduction,BP,
3456,GO:0007270,1,0.806284180617662,0,6,neuron-neuron synaptic transmission,BP,
3457,GO:0007271,1,0.707414531498611,0,10,synaptic transmission, cholinergic,BP,
3459,GO:0007274,1,0.70531862516975,0,9,neuromuscular synaptic transmission,BP,
3464,GO:0007284,1,0.92236436650772,0,2,spermatogonial cell division,BP,
3466,GO:0007288,1,0.714069592196994,0,10,sperm axoneme assembly,BP,
3468,GO:0007290,1,0.959772846310539,0,1,spermatid nucleus elongation,BP,
3471,GO:0007308,1,0.967461720989723,0,1,oocyte construction,BP,
3472,GO:0007309,1,0.967461720989723,0,1,oocyte axis specification,BP,
3473,GO:0007314,1,0.967461720989723,0,1,oocyte anterior/posterior axis specification,BP,
3474,GO:0007315,1,0.967461720989723,0,1,pole plasm assembly,BP,
3475,GO:0007320,1,0.857739206159447,0,4,insemination,BP,
3480,GO:0007342,1,0.909183416798754,0,4,fusion of sperm to egg plasma membrane involved in single fertilization,BP,
3481,GO:0007344,1,0.974092226169022,0,1,pronuclear fusion,BP,
3485,GO:0007352,1,0.95950763690405,0,1,zygotic specification of dorsal/ventral axis,BP,
3486,GO:0007354,1,0.905104811055867,0,3,zygotic determination of anterior/posterior axis, embryo,BP,
3487,GO:0007356,1,0.939508014069785,0,2,thorax and anterior abdomen determination,BP,
3490,GO:0007371,1,0.961708575034571,0,1,ventral midline determination,BP,
3491,GO:0007379,1,0.682278769397819,0,11,segment specification,BP,
3492,GO:0007386,1,0.841011661823945,0,5,compartment pattern specification,BP,
3493,GO:0007387,1,0.966556488205042,0,1,anterior compartment pattern formation,BP,
3494,GO:0007388,1,0.966556488205042,0,1,posterior compartment specification,BP,
3498,GO:0007402,1,0.981981773219839,0,1,ganglion mother cell fate determination,BP,
3499,GO:0007403,1,0.962860572657923,0,1,glial cell fate determination,BP,
3504,GO:0007412,1,0.942428323581686,0,2,axon target recognition,BP,
3505,GO:0007413,1,0.587052659688486,0,14,axonal fasciculation,BP,
3508,GO:0007418,1,0.92276298174806,0,2,ventral midline development,BP,
3514,GO:0007439,1,0.965067269736794,0,1,ectodermal digestive tract development,BP,
3517,GO:0007468,1,0.971391196536963,0,1,regulation of rhodopsin gene expression,BP,
3520,GO:0007495,1,0.963934783144147,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
3521,GO:0007497,1,0.959685895923181,0,1,posterior midgut development,BP,
3523,GO:0007499,1,0.959896383980452,0,1,ectoderm and mesoderm interaction,BP,
3524,GO:0007500,1,0.939921421848248,0,2,mesodermal cell fate determination,BP,
3525,GO:0007501,1,0.898745587864151,0,3,mesodermal cell fate specification,BP,
3527,GO:0007509,1,0.95950763690405,0,1,mesoderm migration involved in gastrulation,BP,
3528,GO:0007512,1,0.842238772800766,0,5,adult heart development,BP,
3530,GO:0007518,1,0.968885443341724,0,1,myoblast fate determination,BP,
3533,GO:0007525,1,0.928161937568297,0,2,somatic muscle development,BP,
3534,GO:0007528,1,0.329228105272229,0,29,neuromuscular junction development,BP,
3535,GO:0007529,1,0.923439442826244,0,2,establishment of synaptic specificity at neuromuscular junction,BP,
3547,GO:0007576,1,0.967637227650905,0,1,nucleolar fragmentation,BP,
3555,GO:0007597,1,0.869797140976732,0,5,blood coagulation, intrinsic pathway,BP,
3560,GO:0007602,1,0.450553651463838,0,23,phototransduction,BP,
3561,GO:0007603,1,0.571716090979791,0,16,phototransduction, visible light,BP,
3569,GO:0007614,1,0.836831412825124,0,6,short-term memory,BP,
3571,GO:0007617,1,0.684236545817604,0,11,mating behavior,BP,
3572,GO:0007618,1,0.539606651676011,0,18,mating,BP,
3573,GO:0007619,1,0.903848764045058,0,3,courtship behavior,BP,
3574,GO:0007620,1,0.76488899436672,0,8,copulation,BP,
3575,GO:0007621,1,0.95950763690405,0,1,negative regulation of female receptivity,BP,
3578,GO:0007624,1,0.960645258376781,0,1,ultradian rhythm,BP,
3579,GO:0007625,1,0.839705665008444,0,6,grooming behavior,BP,
3581,GO:0007628,1,0.650130485648009,0,12,adult walking behavior,BP,
3582,GO:0007631,1,0.306905125448448,0,35,feeding behavior,BP,
3584,GO:0007634,1,0.968367829563511,0,1,optokinetic behavior,BP,
3586,GO:0007638,1,0.722917314943374,0,8,mechanosensory behavior,BP,
3592,GO:0008020,1,0.932832229741185,0,2,G-protein coupled photoreceptor activity,MF,
3596,GO:0008024,1,0.747642270310577,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3597,GO:0008026,1,0.0389803174621326,0,88,ATP-dependent helicase activity,MF,
3598,GO:0008028,1,0.415020163034466,0,26,monocarboxylic acid transmembrane transporter activity,MF,
3600,GO:0008035,1,0.870453151215581,0,4,high-density lipoprotein particle binding,MF,
3602,GO:0008038,1,0.42691053553748,0,22,neuron recognition,BP,
3603,GO:0008043,1,0.963157155759383,0,2,intracellular ferritin complex,CC,
3604,GO:0008045,1,0.596162314181622,0,14,motor neuron axon guidance,BP,
3605,GO:0008046,1,0.848612214083179,0,4,axon guidance receptor activity,MF,
3607,GO:0008048,1,0.969648381987573,0,1,calcium sensitive guanylate cyclase activator activity,MF,
3608,GO:0008049,1,0.972623727590411,0,1,male courtship behavior,BP,
3609,GO:0008050,1,0.929294026278309,0,2,female courtship behavior,BP,
3610,GO:0008052,1,0.981981773219839,0,1,sensory organ boundary specification,BP,
3611,GO:0008053,1,0.540547134815447,0,20,mitochondrial fusion,BP,
3612,GO:0008057,1,0.95950763690405,0,1,eye pigment granule organization,BP,
3613,GO:0008061,1,0.928597192699348,0,2,chitin binding,MF,
3617,GO:0008066,1,0.884142866235775,0,3,glutamate receptor activity,MF,
3618,GO:0008073,1,0.953377202828455,0,2,ornithine decarboxylase inhibitor activity,MF,
3619,GO:0008074,1,0.783511684251023,0,6,guanylate cyclase complex, soluble,CC,
3621,GO:0008078,1,0.95950763690405,0,1,mesodermal cell migration,BP,
3622,GO:0008079,1,0.811053149270468,0,6,translation termination factor activity,MF,
3626,GO:0008088,1,0.18732151499623,0,48,axo-dendritic transport,BP,
3627,GO:0008089,1,0.313604313281873,0,34,anterograde axonal transport,BP,
3628,GO:0008090,1,0.795400844794802,0,7,retrograde axonal transport,BP,
3629,GO:0008091,1,0.782885463325608,0,6,spectrin,CC,
3631,GO:0008093,1,0.677570709661463,0,11,cytoskeletal adaptor activity,MF,
3632,GO:0008094,1,0.0577451243250706,0,79,DNA-dependent ATPase activity,MF,
3633,GO:0008097,1,0.790182975256882,0,10,5S rRNA binding,MF,
3635,GO:0008106,1,0.729022854554115,0,12,alcohol dehydrogenase (NADP+) activity,MF,
3636,GO:0008107,1,0.926264719375324,0,2,galactoside 2-alpha-L-fucosyltransferase activity,MF,
3637,GO:0008108,1,0.978191085599748,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
3638,GO:0008109,1,0.92435184289798,0,2,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
3639,GO:0008111,1,0.972042199160794,0,1,alpha-methylacyl-CoA racemase activity,MF,
3640,GO:0008112,1,0.975745001181979,0,1,nicotinamide N-methyltransferase activity,MF,
3641,GO:0008113,1,0.955411129192,0,2,peptide-methionine (S)-S-oxide reductase activity,MF,
3642,GO:0008116,1,0.959509082802852,0,1,prostaglandin-I synthase activity,MF,
3643,GO:0008117,1,0.959507636971929,0,1,sphinganine-1-phosphate aldolase activity,MF,
3644,GO:0008118,1,0.969985511974525,0,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,
3645,GO:0008119,1,0.963628097336532,0,1,thiopurine S-methyltransferase activity,MF,
3647,GO:0008121,1,0.849401889425016,0,7,ubiquinol-cytochrome-c reductase activity,MF,
3648,GO:0008124,1,0.95125820435887,0,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
3649,GO:0008126,1,0.965759055880773,0,1,acetylesterase activity,MF,
3650,GO:0008127,1,0.97860666069852,0,1,quercetin 2,3-dioxygenase activity,MF,
3654,GO:0008137,1,0.498721485595465,0,38,NADH dehydrogenase (ubiquinone) activity,MF,
3657,GO:0008140,1,0.769793308790057,0,8,cAMP response element binding protein binding,MF,
3658,GO:0008142,1,0.862366711502661,0,4,oxysterol binding,MF,
3661,GO:0008146,1,0.390986420726474,0,28,sulfotransferase activity,MF,
3665,GO:0008156,1,0.314056729360803,0,33,negative regulation of DNA replication,BP,
3667,GO:0008158,1,0.942932134299992,0,2,hedgehog receptor activity,MF,
3668,GO:0008160,1,0.967169579017997,0,1,protein tyrosine phosphatase activator activity,MF,
3670,GO:0008169,1,0.908530626419002,0,3,C-methyltransferase activity,MF,
3671,GO:0008170,1,0.0758132326303511,0,76,N-methyltransferase activity,MF,
3672,GO:0008171,1,0.503288442830276,0,21,O-methyltransferase activity,MF,
3673,GO:0008172,1,0.851150215655491,0,5,S-methyltransferase activity,MF,
3674,GO:0008173,1,0.165420347013194,0,55,RNA methyltransferase activity,MF,
3675,GO:0008174,1,0.737923059384222,0,9,mRNA methyltransferase activity,MF,
3676,GO:0008175,1,0.387799626089862,0,28,tRNA methyltransferase activity,MF,
3677,GO:0008176,1,0.953421682087677,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
3678,GO:0008177,1,0.866506498156601,0,5,succinate dehydrogenase (ubiquinone) activity,MF,
3680,GO:0008180,1,0.414121838150028,0,27,COP9 signalosome,CC,
3681,GO:0008184,1,0.927946587710174,0,2,glycogen phosphorylase activity,MF,
3682,GO:0008186,1,0.106168937162557,0,61,RNA-dependent ATPase activity,MF,
3684,GO:0008188,1,0.864941359861066,0,5,neuropeptide receptor activity,MF,
3685,GO:0008190,1,0.762077517435002,0,8,eukaryotic initiation factor 4E binding,MF,
3686,GO:0008191,1,0.805529069057089,0,7,metalloendopeptidase inhibitor activity,MF,
3687,GO:0008192,1,0.90257099874191,0,3,RNA guanylyltransferase activity,MF,
3688,GO:0008193,1,0.940096701089026,0,2,tRNA guanylyltransferase activity,MF,
3690,GO:0008195,1,0.715909567668523,0,9,phosphatidate phosphatase activity,MF,
3691,GO:0008198,1,0.591034558430451,0,17,ferrous iron binding,MF,
3692,GO:0008199,1,0.877003136971232,0,5,ferric iron binding,MF,
3697,GO:0008204,1,0.942435551799044,0,2,ergosterol metabolic process,BP,
3698,GO:0008206,1,0.419821052491755,0,26,bile acid metabolic process,BP,
3701,GO:0008210,1,0.595893036042843,0,17,estrogen metabolic process,BP,
3709,GO:0008218,1,0.962623618845412,0,1,bioluminescence,BP,
3712,GO:0008228,1,0.920676010076768,0,2,opsonization,BP,
3715,GO:0008235,1,0.326639442935847,0,31,metalloexopeptidase activity,MF,
3718,GO:0008238,1,0.10692780399873,0,64,exopeptidase activity,MF,
3719,GO:0008239,1,0.819767677024096,0,6,dipeptidyl-peptidase activity,MF,
3720,GO:0008240,1,0.923723980372391,0,2,tripeptidyl-peptidase activity,MF,
3721,GO:0008242,1,0.771929301256345,0,8,omega peptidase activity,MF,
3722,GO:0008250,1,0.72689507990864,0,12,oligosaccharyltransferase complex,CC,
3723,GO:0008251,1,0.927286390781422,0,2,tRNA-specific adenosine deaminase activity,MF,
3724,GO:0008252,1,0.70545947994644,0,10,nucleotidase activity,MF,
3725,GO:0008253,1,0.759411030827119,0,8,5'-nucleotidase activity,MF,
3726,GO:0008254,1,0.95950763690405,0,1,3'-nucleotidase activity,MF,
3729,GO:0008265,1,0.966403819748522,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
3731,GO:0008267,1,0.95950763690405,0,1,poly-glutamine tract binding,MF,
3732,GO:0008269,1,0.970114988474346,0,1,JAK pathway signal transduction adaptor activity,MF,
3734,GO:0008271,1,0.827711056435569,0,5,secondary active sulfate transmembrane transporter activity,MF,
3735,GO:0008272,1,0.775585131803389,0,7,sulfate transport,BP,
3736,GO:0008273,1,0.921269993688515,0,2,calcium, potassium:sodium antiporter activity,MF,
3737,GO:0008274,1,0.737503275223946,0,8,gamma-tubulin ring complex,CC,
3738,GO:0008275,1,0.858257167389014,0,4,gamma-tubulin small complex,CC,
3739,GO:0008276,1,0.0842766024294192,0,72,protein methyltransferase activity,MF,
3741,GO:0008278,1,0.738930108728561,0,8,cohesin complex,CC,
3742,GO:0008281,1,0.959834303092691,0,1,sulfonylurea receptor activity,MF,
3743,GO:0008282,1,0.925725303156033,0,2,inward rectifying potassium channel,CC,
3750,GO:0008290,1,0.823437587783911,0,6,F-actin capping protein complex,CC,
3751,GO:0008291,1,0.966967419757367,0,1,acetylcholine metabolic process,BP,
3752,GO:0008292,1,0.966967419757367,0,1,acetylcholine biosynthetic process,BP,
3753,GO:0008294,1,0.95950763690405,0,1,calcium- and calmodulin-responsive adenylate cyclase activity,MF,
3754,GO:0008295,1,0.891787679931622,0,4,spermidine biosynthetic process,BP,
3759,GO:0008300,1,0.928223328530971,0,2,isoprenoid catabolic process,BP,
3760,GO:0008301,1,0.62773621990655,0,13,DNA binding, bending,MF,
3764,GO:0008308,1,0.676159115212669,0,12,voltage-gated anion channel activity,MF,
3765,GO:0008309,1,0.887360767411566,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
3767,GO:0008311,1,0.949273821890397,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
3768,GO:0008312,1,0.823565414262872,0,7,7S RNA binding,MF,
3769,GO:0008318,1,0.795878837949441,0,7,protein prenyltransferase activity,MF,
3770,GO:0008320,1,0.723367648097192,0,13,protein transmembrane transporter activity,MF,
3771,GO:0008321,1,0.920721568656077,0,2,Ral guanyl-nucleotide exchange factor activity,MF,
3774,GO:0008328,1,0.538920813554879,0,17,ionotropic glutamate receptor complex,CC,
3775,GO:0008329,1,0.795436331253948,0,7,signaling pattern recognition receptor activity,MF,
3777,GO:0008331,1,0.903585714952712,0,3,high voltage-gated calcium channel activity,MF,
3778,GO:0008332,1,0.972385861534772,0,1,low voltage-gated calcium channel activity,MF,
3780,GO:0008334,1,0.480324400719131,0,24,histone mRNA metabolic process,BP,
3781,GO:0008336,1,0.972783641722553,0,1,gamma-butyrobetaine dioxygenase activity,MF,
3782,GO:0008340,1,0.703440803795513,0,9,determination of adult lifespan,BP,
3783,GO:0008343,1,0.95950763690405,0,1,adult feeding behavior,BP,
3784,GO:0008344,1,0.258995655615139,0,39,adult locomotory behavior,BP,
3785,GO:0008347,1,0.312261910001199,0,33,glial cell migration,BP,
3786,GO:0008348,1,0.961956093172106,0,1,negative regulation of antimicrobial humoral response,BP,
3787,GO:0008349,1,0.678665036199732,0,10,MAP kinase kinase kinase kinase activity,MF,
3788,GO:0008352,1,0.966877114128716,0,1,katanin complex,CC,
3789,GO:0008353,1,0.614370606781385,0,16,RNA polymerase II carboxy-terminal domain kinase activity,MF,
3790,GO:0008354,1,0.777730409701159,0,7,germ cell migration,BP,
3791,GO:0008355,1,0.9601787864867,0,1,olfactory learning,BP,
3792,GO:0008356,1,0.627191613841523,0,13,asymmetric cell division,BP,
3793,GO:0008358,1,0.967461720989723,0,1,maternal determination of anterior/posterior axis, embryo,BP,
3797,GO:0008373,1,0.619922486834258,0,14,sialyltransferase activity,MF,
3798,GO:0008374,1,0.258578971056416,0,38,O-acyltransferase activity,MF,
3802,GO:0008379,1,0.910000198779158,0,5,thioredoxin peroxidase activity,MF,
3804,GO:0008381,1,0.894414366663201,0,3,mechanosensitive ion channel activity,MF,
3805,GO:0008384,1,0.891243669326606,0,3,IkappaB kinase activity,MF,
3806,GO:0008385,1,0.738231451160367,0,9,IkappaB kinase complex,CC,
3807,GO:0008391,1,0.941053595651254,0,2,arachidonic acid monooxygenase activity,MF,
3808,GO:0008392,1,0.941053595651254,0,2,arachidonic acid epoxygenase activity,MF,
3809,GO:0008395,1,0.776443208996304,0,8,steroid hydroxylase activity,MF,
3810,GO:0008396,1,0.96869169431729,0,1,oxysterol 7-alpha-hydroxylase activity,MF,
3811,GO:0008398,1,0.964482682859472,0,1,sterol 14-demethylase activity,MF,
3812,GO:0008401,1,0.92844758668372,0,2,retinoic acid 4-hydroxylase activity,MF,
3813,GO:0008403,1,0.963990358831639,0,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,
3814,GO:0008404,1,0.973052545716935,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
3815,GO:0008405,1,0.973052545716935,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
3818,GO:0008409,1,0.557602336088507,0,16,5'-3' exonuclease activity,MF,
3820,GO:0008413,1,0.95732642948702,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
3821,GO:0008417,1,0.695620650435708,0,10,fucosyltransferase activity,MF,
3822,GO:0008418,1,0.980628870944044,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
3823,GO:0008419,1,0.966935096935043,0,1,RNA lariat debranching enzyme activity,MF,
3824,GO:0008420,1,0.765063813159485,0,8,CTD phosphatase activity,MF,
3825,GO:0008422,1,0.923150385831744,0,2,beta-glucosidase activity,MF,
3826,GO:0008424,1,0.963445624205636,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
3827,GO:0008425,1,0.97896132643455,0,1,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
3829,GO:0008427,1,0.951766714349224,0,2,calcium-dependent protein kinase inhibitor activity,MF,
3830,GO:0008428,1,0.901137600071028,0,3,ribonuclease inhibitor activity,MF,
3831,GO:0008429,1,0.795768364909503,0,8,phosphatidylethanolamine binding,MF,
3832,GO:0008430,1,0.973970453824071,0,1,selenium binding,MF,
3833,GO:0008431,1,0.964604475807153,0,1,vitamin E binding,MF,
3835,GO:0008434,1,0.959821324189641,0,1,calcitriol receptor activity,MF,
3837,GO:0008441,1,0.929003536503953,0,2,3'(2'),5'-bisphosphate nucleotidase activity,MF,
3838,GO:0008442,1,0.972003373389247,0,1,3-hydroxyisobutyrate dehydrogenase activity,MF,
3839,GO:0008443,1,0.79682226272529,0,6,phosphofructokinase activity,MF,
3840,GO:0008444,1,0.97022553835382,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
3841,GO:0008446,1,0.974757511401424,0,1,GDP-mannose 4,6-dehydratase activity,MF,
3842,GO:0008448,1,0.973274361505117,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
3843,GO:0008449,1,0.921625833558827,0,2,N-acetylglucosamine-6-sulfatase activity,MF,
3844,GO:0008452,1,0.965469978279355,0,1,RNA ligase activity,MF,
3845,GO:0008453,1,0.965469978279355,0,1,alanine-glyoxylate transaminase activity,MF,
3846,GO:0008454,1,0.927542059769076,0,2,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
3847,GO:0008455,1,0.966591019336054,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
3848,GO:0008456,1,0.961750335528858,0,1,alpha-N-acetylgalactosaminidase activity,MF,
3850,GO:0008458,1,0.963618860731002,0,1,carnitine O-octanoyltransferase activity,MF,
3851,GO:0008459,1,0.930096973079821,0,2,chondroitin 6-sulfotransferase activity,MF,
3852,GO:0008460,1,0.972623727590411,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
3853,GO:0008465,1,0.979253522576618,0,1,glycerate dehydrogenase activity,MF,
3854,GO:0008466,1,0.973534897803609,0,1,glycogenin glucosyltransferase activity,MF,
3855,GO:0008467,1,0.918339798721767,0,3,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,
3856,GO:0008469,1,0.775021010976311,0,8,histone-arginine N-methyltransferase activity,MF,
3857,GO:0008470,1,0.959908738805963,0,1,isovaleryl-CoA dehydrogenase activity,MF,
3858,GO:0008474,1,0.728301338936843,0,10,palmitoyl-(protein) hydrolase activity,MF,
3859,GO:0008475,1,0.894520728907075,0,3,procollagen-lysine 5-dioxygenase activity,MF,
3860,GO:0008476,1,0.944454688585882,0,2,protein-tyrosine sulfotransferase activity,MF,
3861,GO:0008478,1,0.95950763690405,0,1,pyridoxal kinase activity,MF,
3862,GO:0008479,1,0.90532511657119,0,4,queuine tRNA-ribosyltransferase activity,MF,
3863,GO:0008481,1,0.939020734863484,0,2,sphinganine kinase activity,MF,
3864,GO:0008482,1,0.969148520080678,0,1,sulfite oxidase activity,MF,
3865,GO:0008483,1,0.668042183220483,0,12,transaminase activity,MF,
3866,GO:0008484,1,0.636138157129034,0,12,sulfuric ester hydrolase activity,MF,
3867,GO:0008486,1,0.883830410916759,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
3868,GO:0008488,1,0.964002492999255,0,1,gamma-glutamyl carboxylase activity,MF,
3869,GO:0008489,1,0.965415928238747,0,1,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,
3870,GO:0008493,1,0.973021020108301,0,1,tetracycline transmembrane transporter activity,MF,
3871,GO:0008494,1,0.813252278590965,0,7,translation activator activity,MF,
3872,GO:0008495,1,0.964877259482504,0,1,protoheme IX farnesyltransferase activity,MF,
3873,GO:0008496,1,0.96043093818927,0,1,mannan endo-1,6-alpha-mannosidase activity,MF,
3875,GO:0008503,1,0.949351383873444,0,2,benzodiazepine receptor activity,MF,
3876,GO:0008504,1,0.864983365385437,0,4,monoamine transmembrane transporter activity,MF,
3877,GO:0008506,1,0.927462486132584,0,2,sucrose:proton symporter activity,MF,
3878,GO:0008507,1,0.962245056751667,0,1,sodium:iodide symporter activity,MF,
3879,GO:0008508,1,0.949900333744676,0,2,bile acid:sodium symporter activity,MF,
3881,GO:0008510,1,0.815469139140083,0,5,sodium:bicarbonate symporter activity,MF,
3882,GO:0008511,1,0.95950763690405,0,1,sodium:potassium:chloride symporter activity,MF,
3883,GO:0008513,1,0.970217620882069,0,1,secondary active organic cation transmembrane transporter activity,MF,
3885,GO:0008515,1,0.927462486132584,0,2,sucrose transmembrane transporter activity,MF,
3886,GO:0008517,1,0.860073592551443,0,4,folic acid transmembrane transporter activity,MF,
3887,GO:0008518,1,0.965782517085911,0,1,reduced folate carrier activity,MF,
3888,GO:0008519,1,0.536257009352389,0,18,ammonium transmembrane transporter activity,MF,
3889,GO:0008520,1,0.95950763690405,0,1,L-ascorbate:sodium symporter activity,MF,
3890,GO:0008521,1,0.966883544077274,0,1,acetyl-CoA transmembrane transporter activity,MF,
3891,GO:0008523,1,0.963380649984966,0,1,sodium-dependent multivitamin transmembrane transporter activity,MF,
3892,GO:0008525,1,0.808730833517463,0,6,phosphatidylcholine transporter activity,MF,
3893,GO:0008526,1,0.744943870562066,0,8,phosphatidylinositol transporter activity,MF,
3894,GO:0008527,1,0.892265323136168,0,5,taste receptor activity,MF,
3896,GO:0008531,1,0.966591019336054,0,1,riboflavin kinase activity,MF,
3898,GO:0008534,1,0.91356704312085,0,4,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
3899,GO:0008535,1,0.48588775164154,0,24,respiratory chain complex IV assembly,BP,
3901,GO:0008537,1,0.930206257807261,0,3,proteasome activator complex,CC,
3902,GO:0008540,1,0.718675648445265,0,12,proteasome regulatory particle, base subcomplex,CC,
3903,GO:0008541,1,0.834836439615478,0,7,proteasome regulatory particle, lid subcomplex,CC,
3907,GO:0008545,1,0.926166128013714,0,2,JUN kinase kinase activity,MF,
3909,GO:0008555,1,0.959525020585039,0,1,chloride-transporting ATPase activity,MF,
3910,GO:0008556,1,0.84078416295074,0,5,potassium-transporting ATPase activity,MF,
3911,GO:0008559,1,0.854087305977153,0,4,xenobiotic transmembrane transporting ATPase activity,MF,
3913,GO:0008568,1,0.698989659947276,0,10,microtubule-severing ATPase activity,MF,
3914,GO:0008569,1,0.657153195765562,0,11,ATP-dependent microtubule motor activity, minus-end-directed,MF,
3915,GO:0008574,1,0.432099929840431,0,23,ATP-dependent microtubule motor activity, plus-end-directed,MF,
3916,GO:0008579,1,0.959539700930704,0,1,JUN kinase phosphatase activity,MF,
3917,GO:0008582,1,0.920650957478618,0,2,regulation of synaptic growth at neuromuscular junction,BP,
3921,GO:0008591,1,0.973571680227903,0,1,regulation of Wnt signaling pathway, calcium modulating pathway,BP,
3922,GO:0008592,1,0.963679111569354,0,1,regulation of Toll signaling pathway,BP,
3924,GO:0008594,1,0.923274241721745,0,2,photoreceptor cell morphogenesis,BP,
3926,GO:0008597,1,0.944002313691233,0,2,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,
3927,GO:0008603,1,0.847315180090845,0,5,cAMP-dependent protein kinase regulator activity,MF,
3928,GO:0008607,1,0.906667816810984,0,3,phosphorylase kinase regulator activity,MF,
3929,GO:0008608,1,0.389872561068466,0,28,attachment of spindle microtubules to kinetochore,BP,
3930,GO:0008609,1,0.95950763690405,0,1,alkylglycerone-phosphate synthase activity,MF,
3932,GO:0008611,1,0.849911174943155,0,5,ether lipid biosynthetic process,BP,
3933,GO:0008612,1,0.894897984025284,0,4,peptidyl-lysine modification to peptidyl-hypusine,BP,
3934,GO:0008614,1,0.934601102288259,0,2,pyridoxine metabolic process,BP,
3935,GO:0008615,1,0.934601102288259,0,2,pyridoxine biosynthetic process,BP,
3936,GO:0008616,1,0.925513517074796,0,3,queuosine biosynthetic process,BP,
3937,GO:0008617,1,0.981788291745788,0,1,guanosine metabolic process,BP,
3938,GO:0008622,1,0.864875955978964,0,5,epsilon DNA polymerase complex,CC,
3939,GO:0008623,1,0.929249240287132,0,2,CHRAC,CC,
3941,GO:0008626,1,0.906321645476638,0,3,granzyme-mediated apoptotic signaling pathway,BP,
3945,GO:0008635,1,0.751784894132316,0,9,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,
3947,GO:0008641,1,0.70546250678571,0,10,ubiquitin-like modifier activating enzyme activity,MF,
3950,GO:0008649,1,0.615290427841473,0,16,rRNA methyltransferase activity,MF,
3951,GO:0008650,1,0.962288960908254,0,1,rRNA (uridine-2'-O-)-methyltransferase activity,MF,
3955,GO:0008656,1,0.638024419044447,0,14,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
3956,GO:0008670,1,0.955223629170929,0,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
3957,GO:0008689,1,0.97896132643455,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
3958,GO:0008700,1,0.965469978279355,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
3959,GO:0008705,1,0.95950763690405,0,1,methionine synthase activity,MF,
3960,GO:0008709,1,0.982479465094501,0,1,cholate 7-alpha-dehydrogenase activity,MF,
3961,GO:0008721,1,0.968092371147854,0,1,D-serine ammonia-lyase activity,MF,
3962,GO:0008725,1,0.980941812318171,0,1,DNA-3-methyladenine glycosylase activity,MF,
3963,GO:0008732,1,0.939052002373933,0,2,L-allo-threonine aldolase activity,MF,
3964,GO:0008745,1,0.953757494730048,0,2,N-acetylmuramoyl-L-alanine amidase activity,MF,
3965,GO:0008746,1,0.959858463421999,0,1,NAD(P)+ transhydrogenase activity,MF,
3966,GO:0008747,1,0.975914304760254,0,1,N-acetylneuraminate lyase activity,MF,
3967,GO:0008750,1,0.959858463421999,0,1,NAD(P)+ transhydrogenase (AB-specific) activity,MF,
3968,GO:0008753,1,0.962750877589798,0,1,NADPH dehydrogenase (quinone) activity,MF,
3969,GO:0008757,1,0.012021329607708,0,132,S-adenosylmethionine-dependent methyltransferase activity,MF,
3970,GO:0008761,1,0.959536710930568,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
3971,GO:0008768,1,0.983479770292255,0,1,UDP-sugar diphosphatase activity,MF,
3972,GO:0008775,1,0.973370034794152,0,1,acetate CoA-transferase activity,MF,
3973,GO:0008781,1,0.953908129116228,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
3974,GO:0008783,1,0.970193887903363,0,1,agmatinase activity,MF,
3975,GO:0008785,1,0.975854450984385,0,1,alkyl hydroperoxide reductase activity,MF,
3976,GO:0008792,1,0.965469978279355,0,1,arginine decarboxylase activity,MF,
3977,GO:0008794,1,0.982946100067738,0,1,arsenate reductase (glutaredoxin) activity,MF,
3978,GO:0008796,1,0.948916484520426,0,2,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
3979,GO:0008798,1,0.959507671057142,0,1,beta-aspartyl-peptidase activity,MF,
3980,GO:0008802,1,0.962322160905979,0,1,betaine-aldehyde dehydrogenase activity,MF,
3981,GO:0008803,1,0.982050199050839,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
3982,GO:0008808,1,0.961523527165928,0,1,cardiolipin synthase activity,MF,
3983,GO:0008817,1,0.960657817676271,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
3984,GO:0008821,1,0.753532993849882,0,9,crossover junction endodeoxyribonuclease activity,MF,
3986,GO:0008832,1,0.96386288872104,0,1,dGTPase activity,MF,
3987,GO:0008841,1,0.968015553109921,0,1,dihydrofolate synthase activity,MF,
3988,GO:0008852,1,0.965817802144373,0,1,exodeoxyribonuclease I activity,MF,
3989,GO:0008853,1,0.908568939120349,0,3,exodeoxyribonuclease III activity,MF,
3991,GO:0008865,1,0.887295757004347,0,3,fructokinase activity,MF,
3992,GO:0008887,1,0.963683767101609,0,1,glycerate kinase activity,MF,
3993,GO:0008889,1,0.892739242822694,0,3,glycerophosphodiester phosphodiesterase activity,MF,
3994,GO:0008890,1,0.975665631760242,0,1,glycine C-acetyltransferase activity,MF,
3995,GO:0008892,1,0.959518308911787,0,1,guanine deaminase activity,MF,
3996,GO:0008893,1,0.981436987402546,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
3997,GO:0008894,1,0.9663976283264,0,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,
3998,GO:0008897,1,0.965648293641464,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
3999,GO:0008900,1,0.962255993975266,0,1,potassium:proton exchanging ATPase activity,MF,
4000,GO:0008903,1,0.98068462724151,0,1,hydroxypyruvate isomerase activity,MF,
4001,GO:0008905,1,0.975458217445957,0,1,mannose-phosphate guanylyltransferase activity,MF,
4002,GO:0008934,1,0.869857860184935,0,4,inositol monophosphate 1-phosphatase activity,MF,
4003,GO:0008940,1,0.895219360129896,0,3,nitrate reductase activity,MF,
4004,GO:0008941,1,0.941034123342604,0,2,nitric oxide dioxygenase activity,MF,
4005,GO:0008948,1,0.874003088056527,0,4,oxaloacetate decarboxylase activity,MF,
4006,GO:0008962,1,0.940088599528209,0,2,phosphatidylglycerophosphatase activity,MF,
4007,GO:0008963,1,0.970617467329383,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
4008,GO:0008967,1,0.93684640733786,0,2,phosphoglycolate phosphatase activity,MF,
4010,GO:0008973,1,0.963641974571025,0,1,phosphopentomutase activity,MF,
4011,GO:0008988,1,0.932129376517163,0,2,rRNA (adenine-N6-)-methyltransferase activity,MF,
4012,GO:0008995,1,0.967334818525518,0,1,ribonuclease E activity,MF,
4013,GO:0009000,1,0.968190696316451,0,1,selenocysteine lyase activity,MF,
4014,GO:0009007,1,0.961922167578605,0,1,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
4015,GO:0009008,1,0.833981277436765,0,5,DNA-methyltransferase activity,MF,
4016,GO:0009013,1,0.959571905640215,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
4017,GO:0009019,1,0.863517185577173,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
4018,GO:0009020,1,0.972176441940517,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
4019,GO:0009032,1,0.974911808109321,0,1,thymidine phosphorylase activity,MF,
4020,GO:0009041,1,0.913538314678608,0,3,uridylate kinase activity,MF,
4022,GO:0009051,1,0.924873510277573,0,3,pentose-phosphate shunt, oxidative branch,BP,
4023,GO:0009052,1,0.862338817851367,0,5,pentose-phosphate shunt, non-oxidative branch,BP,
4029,GO:0009060,1,0.151436930202872,0,68,aerobic respiration,BP,
4030,GO:0009061,1,0.968684427031627,0,1,anaerobic respiration,BP,
4034,GO:0009065,1,0.509264220122689,0,20,glutamine family amino acid catabolic process,BP,
4036,GO:0009067,1,0.496915835442369,0,21,aspartate family amino acid biosynthetic process,BP,
4037,GO:0009068,1,0.673966459403282,0,12,aspartate family amino acid catabolic process,BP,
4039,GO:0009070,1,0.647421760143685,0,14,serine family amino acid biosynthetic process,BP,
4040,GO:0009071,1,0.810382305399597,0,7,serine family amino acid catabolic process,BP,
4041,GO:0009072,1,0.747118532330185,0,11,aromatic amino acid family metabolic process,BP,
4042,GO:0009074,1,0.821608054626989,0,8,aromatic amino acid family catabolic process,BP,
4043,GO:0009078,1,0.961179164310998,0,1,pyruvate family amino acid metabolic process,BP,
4044,GO:0009080,1,0.961179164310998,0,1,pyruvate family amino acid catabolic process,BP,
4045,GO:0009081,1,0.465480117960676,0,23,branched-chain amino acid metabolic process,BP,
4046,GO:0009082,1,0.935811104363509,0,2,branched-chain amino acid biosynthetic process,BP,
4047,GO:0009083,1,0.526142198199058,0,20,branched-chain amino acid catabolic process,BP,
4048,GO:0009084,1,0.619451542423236,0,14,glutamine family amino acid biosynthetic process,BP,
4049,GO:0009085,1,0.926543544185302,0,2,lysine biosynthetic process,BP,
4050,GO:0009086,1,0.700473962259929,0,11,methionine biosynthetic process,BP,
4051,GO:0009088,1,0.970861273644229,0,1,threonine biosynthetic process,BP,
4052,GO:0009092,1,0.885968313810123,0,4,homoserine metabolic process,BP,
4053,GO:0009093,1,0.967261870054133,0,1,cysteine catabolic process,BP,
4054,GO:0009098,1,0.935811104363509,0,2,leucine biosynthetic process,BP,
4055,GO:0009099,1,0.935811104363509,0,2,valine biosynthetic process,BP,
4058,GO:0009106,1,0.937960052134655,0,2,lipoate metabolic process,BP,
4059,GO:0009107,1,0.974771941901092,0,1,lipoate biosynthetic process,BP,
4061,GO:0009109,1,0.716063105720666,0,11,coenzyme catabolic process,BP,
4064,GO:0009112,1,0.31959217231103,0,35,nucleobase metabolic process,BP,
4065,GO:0009113,1,0.664252833336169,0,13,purine nucleobase biosynthetic process,BP,
4066,GO:0009115,1,0.920789213549214,0,2,xanthine catabolic process,BP,
4070,GO:0009120,1,0.84277167812134,0,6,deoxyribonucleoside metabolic process,BP,
4080,GO:0009133,1,0.900679351167713,0,4,nucleoside diphosphate biosynthetic process,BP,
4081,GO:0009134,1,0.811218350852731,0,7,nucleoside diphosphate catabolic process,BP,
4083,GO:0009136,1,0.952092137070829,0,2,purine nucleoside diphosphate biosynthetic process,BP,
4084,GO:0009137,1,0.888135353129763,0,4,purine nucleoside diphosphate catabolic process,BP,
4085,GO:0009138,1,0.913128367831506,0,3,pyrimidine nucleoside diphosphate metabolic process,BP,
4086,GO:0009139,1,0.94600677119047,0,2,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4087,GO:0009140,1,0.96524986344849,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4090,GO:0009143,1,0.727169649837659,0,11,nucleoside triphosphate catabolic process,BP,
4093,GO:0009146,1,0.847595395175865,0,6,purine nucleoside triphosphate catabolic process,BP,
4094,GO:0009147,1,0.59081671036691,0,20,pyrimidine nucleoside triphosphate metabolic process,BP,
4095,GO:0009148,1,0.640456358731222,0,17,pyrimidine nucleoside triphosphate biosynthetic process,BP,
4096,GO:0009149,1,0.954065794439129,0,2,pyrimidine nucleoside triphosphate catabolic process,BP,
4098,GO:0009151,1,0.790157397654576,0,9,purine deoxyribonucleotide metabolic process,BP,
4100,GO:0009153,1,0.953898553734929,0,2,purine deoxyribonucleotide biosynthetic process,BP,
4102,GO:0009155,1,0.843736644688296,0,6,purine deoxyribonucleotide catabolic process,BP,
4104,GO:0009157,1,0.774202733700956,0,9,deoxyribonucleoside monophosphate biosynthetic process,BP,
4106,GO:0009159,1,0.965469978279355,0,1,deoxyribonucleoside monophosphate catabolic process,BP,
4108,GO:0009162,1,0.734008849795801,0,11,deoxyribonucleoside monophosphate metabolic process,BP,
4116,GO:0009170,1,0.982027382476281,0,1,purine deoxyribonucleoside monophosphate metabolic process,BP,
4119,GO:0009176,1,0.870937946525829,0,5,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4120,GO:0009177,1,0.870937946525829,0,5,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
4122,GO:0009180,1,0.952092137070829,0,2,purine ribonucleoside diphosphate biosynthetic process,BP,
4123,GO:0009181,1,0.888135353129763,0,4,purine ribonucleoside diphosphate catabolic process,BP,
4124,GO:0009182,1,0.958768045406562,0,2,purine deoxyribonucleoside diphosphate metabolic process,BP,
4125,GO:0009183,1,0.982027382476281,0,1,purine deoxyribonucleoside diphosphate biosynthetic process,BP,
4126,GO:0009184,1,0.976316075006814,0,1,purine deoxyribonucleoside diphosphate catabolic process,BP,
4128,GO:0009186,1,0.90699563860546,0,4,deoxyribonucleoside diphosphate metabolic process,BP,
4130,GO:0009188,1,0.952092137070829,0,2,ribonucleoside diphosphate biosynthetic process,BP,
4131,GO:0009189,1,0.929002150320465,0,3,deoxyribonucleoside diphosphate biosynthetic process,BP,
4133,GO:0009191,1,0.839760894223422,0,6,ribonucleoside diphosphate catabolic process,BP,
4134,GO:0009192,1,0.976316075006814,0,1,deoxyribonucleoside diphosphate catabolic process,BP,
4135,GO:0009193,1,0.96524986344849,0,1,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4136,GO:0009195,1,0.96524986344849,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4137,GO:0009196,1,0.94600677119047,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4138,GO:0009197,1,0.94600677119047,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
4140,GO:0009200,1,0.669076760694777,0,15,deoxyribonucleoside triphosphate metabolic process,BP,
4142,GO:0009202,1,0.877155613600322,0,5,deoxyribonucleoside triphosphate biosynthetic process,BP,
4143,GO:0009203,1,0.980779539261051,0,1,ribonucleoside triphosphate catabolic process,BP,
4144,GO:0009204,1,0.824500777762721,0,7,deoxyribonucleoside triphosphate catabolic process,BP,
4147,GO:0009207,1,0.980779539261051,0,1,purine ribonucleoside triphosphate catabolic process,BP,
4148,GO:0009208,1,0.68586920925479,0,14,pyrimidine ribonucleoside triphosphate metabolic process,BP,
4149,GO:0009209,1,0.709296171219081,0,13,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,
4150,GO:0009211,1,0.861536622690952,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,
4151,GO:0009212,1,0.903027016080252,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,
4152,GO:0009213,1,0.954065794439129,0,2,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
4153,GO:0009214,1,0.646033293450401,0,11,cyclic nucleotide catabolic process,BP,
4154,GO:0009215,1,0.809335879673655,0,8,purine deoxyribonucleoside triphosphate metabolic process,BP,
4155,GO:0009216,1,0.971357684520004,0,1,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
4156,GO:0009217,1,0.864212101152944,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,
4160,GO:0009221,1,0.806086500637473,0,8,pyrimidine deoxyribonucleotide biosynthetic process,BP,
4161,GO:0009222,1,0.96524986344849,0,1,pyrimidine ribonucleotide catabolic process,BP,
4163,GO:0009224,1,0.979177596081991,0,1,CMP biosynthetic process,BP,
4166,GO:0009227,1,0.916205858742127,0,3,nucleotide-sugar catabolic process,BP,
4167,GO:0009231,1,0.966591019336054,0,1,riboflavin biosynthetic process,BP,
4168,GO:0009233,1,0.927285789720998,0,2,menaquinone metabolic process,BP,
4169,GO:0009234,1,0.962014420692069,0,1,menaquinone biosynthetic process,BP,
4170,GO:0009235,1,0.670350863540624,0,12,cobalamin metabolic process,BP,
4171,GO:0009236,1,0.890164979434136,0,3,cobalamin biosynthetic process,BP,
4172,GO:0009237,1,0.965294632921743,0,1,siderophore metabolic process,BP,
4173,GO:0009240,1,0.878433642698884,0,5,isopentenyl diphosphate biosynthetic process,BP,
4174,GO:0009245,1,0.972106481842648,0,2,lipid A biosynthetic process,BP,
4176,GO:0009249,1,0.866908085240491,0,7,protein lipoylation,BP,
4179,GO:0009253,1,0.953757494730048,0,2,peptidoglycan catabolic process,BP,
4180,GO:0009256,1,0.861099123876499,0,4,10-formyltetrahydrofolate metabolic process,BP,
4181,GO:0009257,1,0.926207804745498,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
4182,GO:0009258,1,0.95950763690405,0,1,10-formyltetrahydrofolate catabolic process,BP,
4187,GO:0009263,1,0.684951542688875,0,13,deoxyribonucleotide biosynthetic process,BP,
4189,GO:0009265,1,0.768904768231073,0,10,2'-deoxyribonucleotide biosynthetic process,BP,
4193,GO:0009295,1,0.268620884553281,0,40,nucleoid,CC,
4197,GO:0009303,1,0.413512089174229,0,27,rRNA transcription,BP,
4198,GO:0009304,1,0.783339797649198,0,7,tRNA transcription,BP,
4199,GO:0009305,1,0.95950763690405,0,1,protein biotinylation,BP,
4206,GO:0009313,1,0.72760188892728,0,9,oligosaccharide catabolic process,BP,
4208,GO:0009328,1,0.880254669905109,0,4,phenylalanine-tRNA ligase complex,CC,
4209,GO:0009330,1,0.922747740587805,0,2,DNA topoisomerase complex (ATP-hydrolyzing),CC,
4210,GO:0009331,1,0.922278297736811,0,2,glycerol-3-phosphate dehydrogenase complex,CC,
4211,GO:0009346,1,0.960255606590893,0,1,citrate lyase complex,CC,
4212,GO:0009353,1,0.978318536559371,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
4213,GO:0009360,1,0.966628797890458,0,1,DNA polymerase III complex,CC,
4214,GO:0009368,1,0.949782570711193,0,2,endopeptidase Clp complex,CC,
4215,GO:0009372,1,0.963486266439358,0,1,quorum sensing,BP,
4216,GO:0009374,1,0.828758203017834,0,5,biotin binding,MF,
4217,GO:0009378,1,0.819311673926603,0,5,four-way junction helicase activity,MF,
4218,GO:0009383,1,0.928059437076038,0,2,rRNA (cytosine-C5-)-methyltransferase activity,MF,
4219,GO:0009384,1,0.959536710930568,0,1,N-acylmannosamine kinase activity,MF,
4220,GO:0009386,1,0.969343762500031,0,1,translational attenuation,BP,
4224,GO:0009397,1,0.905548815761081,0,3,folic acid-containing compound catabolic process,BP,
4225,GO:0009398,1,0.966591019336054,0,1,FMN biosynthetic process,BP,
4226,GO:0009400,1,0.965741492599732,0,1,signal transducer, downstream of receptor, with serine/threonine phosphatase activity,MF,
4227,GO:0009403,1,0.8514413220838,0,5,toxin biosynthetic process,BP,
4229,GO:0009405,1,0.920664105295261,0,2,pathogenesis,BP,
4235,GO:0009414,1,0.836859393114657,0,6,response to water deprivation,BP,
4236,GO:0009415,1,0.719758760700929,0,10,response to water,BP,
4239,GO:0009436,1,0.965469978279355,0,1,glyoxylate catabolic process,BP,
4240,GO:0009437,1,0.665675507586501,0,12,carnitine metabolic process,BP,
4241,GO:0009438,1,0.872893149197985,0,5,methylglyoxal metabolic process,BP,
4242,GO:0009439,1,0.957726680592048,0,2,cyanate metabolic process,BP,
4243,GO:0009440,1,0.957726680592048,0,2,cyanate catabolic process,BP,
4244,GO:0009441,1,0.942887913590307,0,2,glycolate metabolic process,BP,
4245,GO:0009443,1,0.95950763690405,0,1,pyridoxal 5'-phosphate salvage,BP,
4249,GO:0009448,1,0.858295795559116,0,4,gamma-aminobutyric acid metabolic process,BP,
4250,GO:0009449,1,0.894467335623171,0,3,gamma-aminobutyric acid biosynthetic process,BP,
4251,GO:0009450,1,0.920873726082149,0,2,gamma-aminobutyric acid catabolic process,BP,
4253,GO:0009452,1,0.371966853951754,0,33,7-methylguanosine RNA capping,BP,
4255,GO:0009581,1,0.187759992190137,0,47,detection of external stimulus,BP,
4256,GO:0009582,1,0.18013747128183,0,48,detection of abiotic stimulus,BP,
4257,GO:0009583,1,0.375300162749394,0,28,detection of light stimulus,BP,
4258,GO:0009584,1,0.460568821980877,0,22,detection of visible light,BP,
4259,GO:0009593,1,0.47333288597168,0,24,detection of chemical stimulus,BP,
4260,GO:0009595,1,0.726076014541359,0,9,detection of biotic stimulus,BP,
4264,GO:0009608,1,0.942863658534019,0,2,response to symbiont,BP,
4265,GO:0009609,1,0.942863658534019,0,2,response to symbiotic bacterium,BP,
4271,GO:0009624,1,0.967215647218539,0,1,response to nematode,BP,
4274,GO:0009631,1,0.959586373676917,0,1,cold acclimation,BP,
4277,GO:0009637,1,0.925646114640367,0,2,response to blue light,BP,
4279,GO:0009644,1,0.931808603511645,0,2,response to high light intensity,BP,
4281,GO:0009646,1,0.963432130161792,0,1,response to absence of light,BP,
4284,GO:0009650,1,0.678673240115558,0,12,UV protection,BP,
4287,GO:0009669,1,0.927462486132584,0,2,sucrose:cation symporter activity,MF,
4288,GO:0009674,1,0.95950763690405,0,1,potassium:sodium symporter activity,MF,
4289,GO:0009692,1,0.967215647218539,0,1,ethylene metabolic process,BP,
4290,GO:0009698,1,0.967215647218539,0,1,phenylpropanoid metabolic process,BP,
4294,GO:0009720,1,0.964955523036117,0,1,detection of hormone stimulus,BP,
4296,GO:0009726,1,0.925971430408726,0,2,detection of endogenous stimulus,BP,
4297,GO:0009737,1,0.960262723320359,0,1,response to abscisic acid,BP,
4298,GO:0009738,1,0.960262723320359,0,1,abscisic acid-activated signaling pathway,BP,
4300,GO:0009744,1,0.895349524875021,0,3,response to sucrose,BP,
4304,GO:0009753,1,0.954817137752606,0,2,response to jasmonic acid,BP,
4306,GO:0009756,1,0.835819149195887,0,6,carbohydrate mediated signaling,BP,
4307,GO:0009757,1,0.863023509679527,0,5,hexose mediated signaling,BP,
4308,GO:0009758,1,0.95950763690405,0,1,carbohydrate utilization,BP,
4309,GO:0009785,1,0.925646114640367,0,2,blue light signaling pathway,BP,
4310,GO:0009786,1,0.937953564820301,0,2,regulation of asymmetric cell division,BP,
4311,GO:0009787,1,0.960262723320359,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4312,GO:0009789,1,0.960262723320359,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
4316,GO:0009794,1,0.874727016864788,0,4,regulation of mitotic cell cycle, embryonic,BP,
4319,GO:0009804,1,0.967215647218539,0,1,coumarin metabolic process,BP,
4320,GO:0009810,1,0.970114988474346,0,1,stilbene metabolic process,BP,
4321,GO:0009812,1,0.766150083236419,0,9,flavonoid metabolic process,BP,
4322,GO:0009814,1,0.97017018407529,0,1,defense response, incompatible interaction,BP,
4323,GO:0009817,1,0.97017018407529,0,1,defense response to fungus, incompatible interaction,BP,
4324,GO:0009820,1,0.884886676222458,0,4,alkaloid metabolic process,BP,
4325,GO:0009822,1,0.974403861517845,0,1,alkaloid catabolic process,BP,
4326,GO:0009826,1,0.933744016075488,0,2,unidimensional cell growth,BP,
4327,GO:0009838,1,0.865615667044196,0,5,abscission,BP,
4328,GO:0009841,1,0.968962833898243,0,1,mitochondrial endopeptidase Clp complex,CC,
4329,GO:0009850,1,0.973370034794152,0,1,auxin metabolic process,BP,
4330,GO:0009852,1,0.973370034794152,0,1,auxin catabolic process,BP,
4333,GO:0009881,1,0.863460845838186,0,4,photoreceptor activity,MF,
4334,GO:0009882,1,0.925646114640367,0,2,blue light photoreceptor activity,MF,
4335,GO:0009886,1,0.730369471777908,0,10,post-embryonic animal morphogenesis,BP,
4348,GO:0009912,1,0.852955722492822,0,5,auditory receptor cell fate commitment,BP,
4351,GO:0009918,1,0.966912517779355,0,1,sterol delta7 reductase activity,MF,
4352,GO:0009922,1,0.842051452556028,0,5,fatty acid elongase activity,MF,
4354,GO:0009931,1,0.788015660554288,0,7,calcium-dependent protein serine/threonine kinase activity,MF,
4356,GO:0009950,1,0.663981575746989,0,11,dorsal/ventral axis specification,BP,
4360,GO:0009955,1,0.970146509392019,0,1,adaxial/abaxial pattern specification,BP,
4361,GO:0009956,1,0.961207561953446,0,1,radial pattern formation,BP,
4362,GO:0009957,1,0.929727730202435,0,2,epidermal cell fate specification,BP,
4366,GO:0009972,1,0.846238923550477,0,6,cytidine deamination,BP,
4367,GO:0009975,1,0.708663436457527,0,9,cyclase activity,MF,
4368,GO:0009982,1,0.674321713764347,0,13,pseudouridine synthase activity,MF,
4373,GO:0009992,1,0.97034070587156,0,1,cellular water homeostasis,BP,
4375,GO:0009996,1,0.935978347109055,0,2,negative regulation of cell fate specification,BP,
4379,GO:0010009,1,0.84413327513087,0,5,cytoplasmic side of endosome membrane,CC,
4380,GO:0010015,1,0.984487367317405,0,1,root morphogenesis,BP,
4381,GO:0010025,1,0.931688157704,0,2,wax biosynthetic process,BP,
4382,GO:0010032,1,0.813933823711801,0,5,meiotic chromosome condensation,BP,
4384,GO:0010034,1,0.962415607838045,0,1,response to acetate,BP,
4387,GO:0010039,1,0.442163357383308,0,24,response to iron ion,BP,
4388,GO:0010040,1,0.884657674010483,0,4,response to iron(II) ion,BP,
4389,GO:0010041,1,0.857678129246711,0,5,response to iron(III) ion,BP,
4392,GO:0010044,1,0.879539830750284,0,4,response to aluminum ion,BP,
4393,GO:0010046,1,0.879328609583175,0,4,response to mycotoxin,BP,
4394,GO:0010053,1,0.984487367317405,0,1,root epidermal cell differentiation,BP,
4395,GO:0010054,1,0.984487367317405,0,1,trichoblast differentiation,BP,
4396,GO:0010070,1,0.96855416254264,0,1,zygote asymmetric cell division,BP,
4397,GO:0010092,1,0.587769886279082,0,16,specification of animal organ identity,BP,
4398,GO:0010106,1,0.972289642118233,0,1,cellular response to iron ion starvation,BP,
4399,GO:0010107,1,0.508277349458458,0,18,potassium ion import,BP,
4400,GO:0010121,1,0.971973221568393,0,1,arginine catabolic process to proline via ornithine,BP,
4401,GO:0010124,1,0.973370034794152,0,1,phenylacetate catabolic process,BP,
4402,GO:0010133,1,0.934739644750603,0,2,proline catabolic process to glutamate,BP,
4404,GO:0010139,1,0.97535011377032,0,1,pyrimidine deoxyribonucleotide salvage,BP,
4407,GO:0010157,1,0.95950763690405,0,1,response to chlorate,BP,
4409,GO:0010160,1,0.981981773219839,0,1,formation of animal organ boundary,BP,
4410,GO:0010164,1,0.97535011377032,0,1,response to cesium ion,BP,
4412,GO:0010166,1,0.931688157704,0,2,wax metabolic process,BP,
4415,GO:0010181,1,0.707350158245915,0,10,FMN binding,MF,
4416,GO:0010182,1,0.863023509679527,0,5,sugar mediated signaling pathway,BP,
4417,GO:0010189,1,0.974752702840451,0,1,vitamin E biosynthetic process,BP,
4424,GO:0010232,1,0.96422412068149,0,1,vascular transport,BP,
4426,GO:0010248,1,0.83643665981805,0,6,establishment or maintenance of transmembrane electrochemical gradient,BP,
4427,GO:0010255,1,0.863023509679527,0,5,glucose mediated signaling pathway,BP,
4429,GO:0010257,1,0.306942191151907,0,55,NADH dehydrogenase complex assembly,BP,
4432,GO:0010265,1,0.815632428000839,0,6,SCF complex assembly,BP,
4433,GO:0010266,1,0.910748983106517,0,3,response to vitamin B1,BP,
4434,GO:0010269,1,0.924320785674829,0,3,response to selenium ion,BP,
4435,GO:0010273,1,0.910881296603993,0,5,detoxification of copper ion,BP,
4436,GO:0010286,1,0.872519913180007,0,5,heat acclimation,BP,
4438,GO:0010309,1,0.974786379621363,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
4439,GO:0010310,1,0.721243944187712,0,10,regulation of hydrogen peroxide metabolic process,BP,
4441,GO:0010324,1,0.239259122175878,0,42,membrane invagination,BP,
4444,GO:0010340,1,0.78747507321037,0,7,carboxyl-O-methyltransferase activity,MF,
4445,GO:0010348,1,0.965469978279355,0,1,lithium:proton antiporter activity,MF,
4446,GO:0010359,1,0.802011248991094,0,6,regulation of anion channel activity,BP,
4447,GO:0010360,1,0.89478661521431,0,3,negative regulation of anion channel activity,BP,
4448,GO:0010369,1,0.637157517928116,0,13,chromocenter,CC,
4449,GO:0010370,1,0.934217712488892,0,2,perinucleolar chromocenter,CC,
4450,GO:0010385,1,0.837110019022404,0,5,double-stranded methylated DNA binding,MF,
4451,GO:0010387,1,0.969464992063792,0,1,COP9 signalosome assembly,BP,
4454,GO:0010412,1,0.963303061456278,0,1,mannan metabolic process,BP,
4455,GO:0010420,1,0.97896132643455,0,1,polyprenyldihydroxybenzoate methyltransferase activity,MF,
4456,GO:0010421,1,0.709349184973543,0,11,hydrogen peroxide-mediated programmed cell death,BP,
4457,GO:0010428,1,0.95950763690405,0,1,methyl-CpNpG binding,MF,
4458,GO:0010430,1,0.959828889936689,0,1,fatty acid omega-oxidation,BP,
4460,GO:0010452,1,0.72190839569412,0,9,histone H3-K36 methylation,BP,
4462,GO:0010454,1,0.902468737722401,0,3,negative regulation of cell fate commitment,BP,
4464,GO:0010457,1,0.648326620493477,0,11,centriole-centriole cohesion,BP,
4465,GO:0010458,1,0.429182028074251,0,26,exit from mitosis,BP,
4466,GO:0010459,1,0.897865282096387,0,4,negative regulation of heart rate,BP,
4470,GO:0010465,1,0.95950763690405,0,1,nerve growth factor receptor activity,MF,
4476,GO:0010477,1,0.963637345848928,0,1,response to sulfur dioxide,BP,
4479,GO:0010484,1,0.855782683636801,0,4,H3 histone acetyltransferase activity,MF,
4480,GO:0010485,1,0.518887552979324,0,18,H4 histone acetyltransferase activity,MF,
4484,GO:0010501,1,0.225583872855866,0,42,RNA secondary structure unwinding,BP,
4486,GO:0010507,1,0.118649338253435,0,60,negative regulation of autophagy,BP,
4488,GO:0010509,1,0.959511558625026,0,1,polyamine homeostasis,BP,
4489,GO:0010510,1,0.664373909906076,0,11,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,
4490,GO:0010511,1,0.884615521038112,0,4,regulation of phosphatidylinositol biosynthetic process,BP,
4491,GO:0010512,1,0.932897972628058,0,2,negative regulation of phosphatidylinositol biosynthetic process,BP,
4492,GO:0010513,1,0.948253532046082,0,2,positive regulation of phosphatidylinositol biosynthetic process,BP,
4495,GO:0010519,1,0.823286937321625,0,6,negative regulation of phospholipase activity,BP,
4496,GO:0010520,1,0.932327131431848,0,2,regulation of reciprocal meiotic recombination,BP,
4497,GO:0010521,1,0.911590289033222,0,3,telomerase inhibitor activity,MF,
4499,GO:0010523,1,0.666468532063968,0,13,negative regulation of calcium ion transport into cytosol,BP,
4501,GO:0010528,1,0.685267179586499,0,11,regulation of transposition,BP,
4502,GO:0010529,1,0.685267179586499,0,11,negative regulation of transposition,BP,
4505,GO:0010543,1,0.480506542011945,0,21,regulation of platelet activation,BP,
4506,GO:0010544,1,0.622605843460165,0,14,negative regulation of platelet activation,BP,
4511,GO:0010560,1,0.607182006558051,0,14,positive regulation of glycoprotein biosynthetic process,BP,
4518,GO:0010569,1,0.418159985820533,0,25,regulation of double-strand break repair via homologous recombination,BP,
4519,GO:0010571,1,0.789906206755114,0,6,positive regulation of nuclear cell cycle DNA replication,BP,
4520,GO:0010572,1,0.933127109765006,0,2,positive regulation of platelet activation,BP,
4524,GO:0010585,1,0.972456089723406,0,1,glutamine secretion,BP,
4528,GO:0010592,1,0.613577577834754,0,14,positive regulation of lamellipodium assembly,BP,
4529,GO:0010593,1,0.920778879658604,0,2,negative regulation of lamellipodium assembly,BP,
4533,GO:0010603,1,0.753579998522604,0,7,regulation of cytoplasmic mRNA processing body assembly,BP,
4536,GO:0010606,1,0.816588684299174,0,5,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4538,GO:0010609,1,0.936448650909905,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,
4543,GO:0010615,1,0.959880804825942,0,1,positive regulation of cardiac muscle adaptation,BP,
4545,GO:0010621,1,0.980796304885343,0,1,negative regulation of transcription by transcription factor localization,BP,
4547,GO:0010624,1,0.854496504442668,0,4,regulation of Schwann cell proliferation,BP,
4548,GO:0010626,1,0.854496504442668,0,4,negative regulation of Schwann cell proliferation,BP,
4555,GO:0010635,1,0.765025819586308,0,8,regulation of mitochondrial fusion,BP,
4556,GO:0010636,1,0.928283713493399,0,2,positive regulation of mitochondrial fusion,BP,
4557,GO:0010637,1,0.852701222220858,0,5,negative regulation of mitochondrial fusion,BP,
4562,GO:0010642,1,0.67554118025296,0,11,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,
4563,GO:0010643,1,0.896845068479848,0,3,cell communication by chemical coupling,BP,
4564,GO:0010644,1,0.517483873551161,0,19,cell communication by electrical coupling,BP,
4565,GO:0010645,1,0.929546541190834,0,2,regulation of cell communication by chemical coupling,BP,
4569,GO:0010649,1,0.726588430917164,0,9,regulation of cell communication by electrical coupling,BP,
4570,GO:0010650,1,0.95950763690405,0,1,positive regulation of cell communication by electrical coupling,BP,
4571,GO:0010652,1,0.929546541190834,0,2,positive regulation of cell communication by chemical coupling,BP,
4577,GO:0010661,1,0.584462843915568,0,15,positive regulation of muscle cell apoptotic process,BP,
4579,GO:0010663,1,0.800221652411925,0,6,positive regulation of striated muscle cell apoptotic process,BP,
4582,GO:0010666,1,0.800221652411925,0,6,positive regulation of cardiac muscle cell apoptotic process,BP,
4588,GO:0010677,1,0.494462977579141,0,20,negative regulation of cellular carbohydrate metabolic process,BP,
4592,GO:0010698,1,0.94976355874121,0,2,acetyltransferase activator activity,MF,
4593,GO:0010700,1,0.96434481732467,0,1,negative regulation of norepinephrine secretion,BP,
4595,GO:0010705,1,0.959961340990031,0,1,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
4596,GO:0010710,1,0.914592022806265,0,3,regulation of collagen catabolic process,BP,
4597,GO:0010711,1,0.984546325131077,0,1,negative regulation of collagen catabolic process,BP,
4600,GO:0010714,1,0.607470133067386,0,15,positive regulation of collagen metabolic process,BP,
4602,GO:0010716,1,0.922709862829226,0,3,negative regulation of extracellular matrix disassembly,BP,
4608,GO:0010722,1,0.95950763690405,0,1,regulation of ferrochelatase activity,BP,
4609,GO:0010724,1,0.89296895661137,0,3,regulation of definitive erythrocyte differentiation,BP,
4610,GO:0010726,1,0.936635895974475,0,2,positive regulation of hydrogen peroxide metabolic process,BP,
4611,GO:0010727,1,0.858549212798265,0,4,negative regulation of hydrogen peroxide metabolic process,BP,
4612,GO:0010728,1,0.868300100390483,0,4,regulation of hydrogen peroxide biosynthetic process,BP,
4613,GO:0010729,1,0.97160183262359,0,1,positive regulation of hydrogen peroxide biosynthetic process,BP,
4614,GO:0010730,1,0.893686260716246,0,3,negative regulation of hydrogen peroxide biosynthetic process,BP,
4615,GO:0010731,1,0.969100048754566,0,1,protein glutathionylation,BP,
4616,GO:0010732,1,0.969100048754566,0,1,regulation of protein glutathionylation,BP,
4617,GO:0010734,1,0.969100048754566,0,1,negative regulation of protein glutathionylation,BP,
4618,GO:0010735,1,0.886149459950615,0,3,positive regulation of transcription via serum response element binding,BP,
4619,GO:0010736,1,0.960321290422278,0,1,serum response element binding,MF,
4627,GO:0010746,1,0.85302530204627,0,4,regulation of plasma membrane long-chain fatty acid transport,BP,
4628,GO:0010748,1,0.85302530204627,0,4,negative regulation of plasma membrane long-chain fatty acid transport,BP,
4629,GO:0010749,1,0.890750350988928,0,3,regulation of nitric oxide mediated signal transduction,BP,
4630,GO:0010750,1,0.967528970318412,0,1,positive regulation of nitric oxide mediated signal transduction,BP,
4631,GO:0010751,1,0.920650957478618,0,2,negative regulation of nitric oxide mediated signal transduction,BP,
4632,GO:0010752,1,0.921383178454736,0,2,regulation of cGMP-mediated signaling,BP,
4633,GO:0010754,1,0.95950763690405,0,1,negative regulation of cGMP-mediated signaling,BP,
4634,GO:0010755,1,0.799540146638374,0,7,regulation of plasminogen activation,BP,
4635,GO:0010756,1,0.912864124998061,0,3,positive regulation of plasminogen activation,BP,
4636,GO:0010757,1,0.875885656332103,0,4,negative regulation of plasminogen activation,BP,
4637,GO:0010758,1,0.647376486064618,0,14,regulation of macrophage chemotaxis,BP,
4638,GO:0010759,1,0.795836168834703,0,7,positive regulation of macrophage chemotaxis,BP,
4639,GO:0010760,1,0.909802908513651,0,4,negative regulation of macrophage chemotaxis,BP,
4642,GO:0010763,1,0.716070966311951,0,9,positive regulation of fibroblast migration,BP,
4643,GO:0010764,1,0.820073755186427,0,6,negative regulation of fibroblast migration,BP,
4646,GO:0010767,1,0.890008867070811,0,3,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4647,GO:0010768,1,0.920650957478618,0,2,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4651,GO:0010792,1,0.807895536746785,0,6,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4652,GO:0010793,1,0.830806000826141,0,5,regulation of mRNA export from nucleus,BP,
4653,GO:0010795,1,0.97896132643455,0,1,regulation of ubiquinone biosynthetic process,BP,
4654,GO:0010796,1,0.923900785357215,0,3,regulation of multivesicular body size,BP,
4655,GO:0010797,1,0.979525658773862,0,1,regulation of multivesicular body size involved in endosome transport,BP,
4658,GO:0010801,1,0.590343244000177,0,15,negative regulation of peptidyl-threonine phosphorylation,BP,
4660,GO:0010804,1,0.673063054445726,0,14,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,
4662,GO:0010808,1,0.95950763690405,0,1,positive regulation of synaptic vesicle priming,BP,
4666,GO:0010813,1,0.937285152739077,0,2,neuropeptide catabolic process,BP,
4667,GO:0010814,1,0.959579885668155,0,1,substance P catabolic process,BP,
4668,GO:0010815,1,0.870656633516257,0,4,bradykinin catabolic process,BP,
4669,GO:0010816,1,0.959579885668155,0,1,calcitonin catabolic process,BP,
4678,GO:0010825,1,0.796936172079152,0,6,positive regulation of centrosome duplication,BP,
4679,GO:0010826,1,0.658974243951336,0,12,negative regulation of centrosome duplication,BP,
4685,GO:0010832,1,0.786316878054625,0,7,negative regulation of myotube differentiation,BP,
4686,GO:0010833,1,0.0807782894031038,0,74,telomere maintenance via telomere lengthening,BP,
4687,GO:0010835,1,0.790231882852302,0,7,regulation of protein ADP-ribosylation,BP,
4688,GO:0010836,1,0.919128321952552,0,3,negative regulation of protein ADP-ribosylation,BP,
4690,GO:0010838,1,0.823343987450758,0,5,positive regulation of keratinocyte proliferation,BP,
4692,GO:0010842,1,0.561781662867592,0,15,retina layer formation,BP,
4693,GO:0010845,1,0.967071381844478,0,1,positive regulation of reciprocal meiotic recombination,BP,
4694,GO:0010847,1,0.864058319775558,0,4,regulation of chromatin assembly,BP,
4695,GO:0010848,1,0.963499867245998,0,1,regulation of chromatin disassembly,BP,
4697,GO:0010851,1,0.969648381987573,0,1,cyclase regulator activity,MF,
4698,GO:0010853,1,0.969648381987573,0,1,cyclase activator activity,MF,
4699,GO:0010856,1,0.963468173567511,0,1,adenylate cyclase activator activity,MF,
4700,GO:0010857,1,0.761893800665357,0,8,calcium-dependent protein kinase activity,MF,
4701,GO:0010858,1,0.951766714349224,0,2,calcium-dependent protein kinase regulator activity,MF,
4702,GO:0010859,1,0.960226819021511,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
4707,GO:0010868,1,0.923075518049426,0,2,negative regulation of triglyceride biosynthetic process,BP,
4711,GO:0010872,1,0.874874322054879,0,5,regulation of cholesterol esterification,BP,
4712,GO:0010873,1,0.939087151116331,0,3,positive regulation of cholesterol esterification,BP,
4716,GO:0010877,1,0.950199065254335,0,2,lipid transport involved in lipid storage,BP,
4718,GO:0010879,1,0.969671436256047,0,1,cholesterol transport involved in cholesterol storage,BP,
4719,GO:0010880,1,0.607368431739566,0,15,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
4720,GO:0010881,1,0.707623648570773,0,11,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,
4726,GO:0010887,1,0.819330710866425,0,6,negative regulation of cholesterol storage,BP,
4728,GO:0010889,1,0.787226230319519,0,7,regulation of sequestering of triglyceride,BP,
4729,GO:0010890,1,0.943025653348473,0,2,positive regulation of sequestering of triglyceride,BP,
4730,GO:0010891,1,0.8348100753994,0,5,negative regulation of sequestering of triglyceride,BP,
4733,GO:0010896,1,0.903432142177137,0,3,regulation of triglyceride catabolic process,BP,
4734,GO:0010897,1,0.969484008610393,0,1,negative regulation of triglyceride catabolic process,BP,
4735,GO:0010898,1,0.931874199083446,0,2,positive regulation of triglyceride catabolic process,BP,
4737,GO:0010900,1,0.988307251928198,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
4738,GO:0010904,1,0.970296941415236,0,1,regulation of UDP-glucose catabolic process,BP,
4739,GO:0010905,1,0.970296941415236,0,1,negative regulation of UDP-glucose catabolic process,BP,
4742,GO:0010908,1,0.893365013816634,0,3,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
4743,GO:0010909,1,0.893365013816634,0,3,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
4746,GO:0010915,1,0.964364597559996,0,2,regulation of very-low-density lipoprotein particle clearance,BP,
4747,GO:0010916,1,0.964364597559996,0,2,negative regulation of very-low-density lipoprotein particle clearance,BP,
4749,GO:0010918,1,0.79682049327977,0,7,positive regulation of mitochondrial membrane potential,BP,
4750,GO:0010919,1,0.763736732472119,0,7,regulation of inositol phosphate biosynthetic process,BP,
4755,GO:0010931,1,0.95950763690405,0,1,macrophage tolerance induction,BP,
4756,GO:0010932,1,0.95950763690405,0,1,regulation of macrophage tolerance induction,BP,
4757,GO:0010933,1,0.95950763690405,0,1,positive regulation of macrophage tolerance induction,BP,
4760,GO:0010936,1,0.843504024244212,0,5,negative regulation of macrophage cytokine production,BP,
4762,GO:0010940,1,0.879570486134093,0,5,positive regulation of necrotic cell death,BP,
4774,GO:0010958,1,0.869574797870154,0,4,regulation of amino acid import across plasma membrane,BP,
4776,GO:0010960,1,0.756483169565791,0,7,magnesium ion homeostasis,BP,
4777,GO:0010961,1,0.920846654129018,0,2,cellular magnesium ion homeostasis,BP,
4778,GO:0010962,1,0.47889860286885,0,19,regulation of glucan biosynthetic process,BP,
4779,GO:0010963,1,0.97702009441203,0,1,regulation of L-arginine import,BP,
4781,GO:0010966,1,0.884422878893238,0,3,regulation of phosphate transport,BP,
4782,GO:0010967,1,0.974565797611057,0,1,regulation of polyamine biosynthetic process,BP,
4783,GO:0010968,1,0.824035358276658,0,6,regulation of microtubule nucleation,BP,
4784,GO:0010970,1,0.0103320296621042,0,131,transport along microtubule,BP,
4785,GO:0010971,1,0.521936650837477,0,19,positive regulation of G2/M transition of mitotic cell cycle,BP,
4786,GO:0010972,1,0.0827816649173959,0,87,negative regulation of G2/M transition of mitotic cell cycle,BP,
4795,GO:0010985,1,0.8661987937233,0,5,negative regulation of lipoprotein particle clearance,BP,
4797,GO:0010988,1,0.828048144629933,0,6,regulation of low-density lipoprotein particle clearance,BP,
4798,GO:0010989,1,0.898215703845399,0,3,negative regulation of low-density lipoprotein particle clearance,BP,
4799,GO:0010990,1,0.885166977156149,0,3,regulation of SMAD protein complex assembly,BP,
4800,GO:0010991,1,0.921123087517597,0,2,negative regulation of SMAD protein complex assembly,BP,
4801,GO:0010992,1,0.793799249713682,0,7,ubiquitin recycling,BP,
4802,GO:0010994,1,0.862067351608143,0,5,free ubiquitin chain polymerization,BP,
4804,GO:0010997,1,0.838968460292741,0,5,anaphase-promoting complex binding,MF,
4806,GO:0010999,1,0.960092576390416,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
4811,GO:0012510,1,0.655022492495594,0,13,trans-Golgi network transport vesicle membrane,CC,
4813,GO:0014003,1,0.41255955429818,0,27,oligodendrocyte development,BP,
4814,GO:0014004,1,0.927014829081721,0,2,microglia differentiation,BP,
4815,GO:0014005,1,0.927014829081721,0,2,microglia development,BP,
4817,GO:0014010,1,0.819882536291219,0,5,Schwann cell proliferation,BP,
4818,GO:0014011,1,0.965469978279355,0,1,Schwann cell proliferation involved in axon regeneration,BP,
4819,GO:0014012,1,0.877765995808494,0,4,peripheral nervous system axon regeneration,BP,
4823,GO:0014016,1,0.96834646839626,0,1,neuroblast differentiation,BP,
4825,GO:0014022,1,0.893511954104448,0,3,neural plate elongation,BP,
4836,GO:0014041,1,0.779822687628241,0,7,regulation of neuron maturation,BP,
4837,GO:0014042,1,0.849404930050371,0,4,positive regulation of neuron maturation,BP,
4838,GO:0014043,1,0.935675445575243,0,2,negative regulation of neuron maturation,BP,
4840,GO:0014045,1,0.869502650789532,0,4,establishment of endothelial blood-brain barrier,BP,
4841,GO:0014046,1,0.74631834217024,0,9,dopamine secretion,BP,
4843,GO:0014048,1,0.837653366897429,0,5,regulation of glutamate secretion,BP,
4844,GO:0014049,1,0.868933102164461,0,4,positive regulation of glutamate secretion,BP,
4845,GO:0014051,1,0.814944684169939,0,5,gamma-aminobutyric acid secretion,BP,
4846,GO:0014052,1,0.885205521083641,0,3,regulation of gamma-aminobutyric acid secretion,BP,
4847,GO:0014053,1,0.959675503888475,0,1,negative regulation of gamma-aminobutyric acid secretion,BP,
4848,GO:0014054,1,0.960678954917327,0,1,positive regulation of gamma-aminobutyric acid secretion,BP,
4849,GO:0014059,1,0.74631834217024,0,9,regulation of dopamine secretion,BP,
4851,GO:0014062,1,0.940820847510375,0,2,regulation of serotonin secretion,BP,
4852,GO:0014063,1,0.980019251714782,0,1,negative regulation of serotonin secretion,BP,
4853,GO:0014064,1,0.960004427287314,0,1,positive regulation of serotonin secretion,BP,
4856,GO:0014067,1,0.725359619328355,0,9,negative regulation of phosphatidylinositol 3-kinase signaling,BP,
4863,GO:0014701,1,0.851932800055919,0,4,junctional sarcoplasmic reticulum membrane,CC,
4866,GO:0014717,1,0.942094977151389,0,2,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
4867,GO:0014718,1,0.942094977151389,0,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
4868,GO:0014719,1,0.917986323975557,0,3,skeletal muscle satellite cell activation,BP,
4869,GO:0014721,1,0.942064261301531,0,2,twitch skeletal muscle contraction,BP,
4870,GO:0014722,1,0.892158768550935,0,4,regulation of skeletal muscle contraction by calcium ion signaling,BP,
4871,GO:0014731,1,0.796279273237441,0,6,spectrin-associated cytoskeleton,CC,
4872,GO:0014732,1,0.908987237404757,0,3,skeletal muscle atrophy,BP,
4873,GO:0014733,1,0.74066067138256,0,8,regulation of skeletal muscle adaptation,BP,
4874,GO:0014734,1,0.95950763690405,0,1,skeletal muscle hypertrophy,BP,
4875,GO:0014735,1,0.938144379617227,0,2,regulation of muscle atrophy,BP,
4876,GO:0014736,1,0.938144379617227,0,2,negative regulation of muscle atrophy,BP,
4877,GO:0014738,1,0.901875259850442,0,3,regulation of muscle hyperplasia,BP,
4878,GO:0014739,1,0.965037162506956,0,1,positive regulation of muscle hyperplasia,BP,
4879,GO:0014740,1,0.934555450684521,0,2,negative regulation of muscle hyperplasia,BP,
4883,GO:0014744,1,0.888801413123958,0,3,positive regulation of muscle adaptation,BP,
4885,GO:0014802,1,0.950837126888075,0,2,terminal cisterna,CC,
4887,GO:0014806,1,0.944963263076758,0,2,smooth muscle hyperplasia,BP,
4889,GO:0014808,1,0.593829906282191,0,16,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
4890,GO:0014809,1,0.923933140112341,0,3,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
4891,GO:0014810,1,0.984440229969269,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
4893,GO:0014816,1,0.920650957478618,0,2,skeletal muscle satellite cell differentiation,BP,
4894,GO:0014819,1,0.880855535757155,0,5,regulation of skeletal muscle contraction,BP,
4899,GO:0014825,1,0.98406407037836,0,1,stomach fundus smooth muscle contraction,BP,
4901,GO:0014827,1,0.969950353019707,0,1,intestine smooth muscle contraction,BP,
4903,GO:0014831,1,0.880663095279808,0,4,gastro-intestinal system smooth muscle contraction,BP,
4904,GO:0014832,1,0.888650788072826,0,3,urinary bladder smooth muscle contraction,BP,
4905,GO:0014834,1,0.869228419928841,0,4,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,
4906,GO:0014835,1,0.960321290422278,0,1,myoblast differentiation involved in skeletal muscle regeneration,BP,
4907,GO:0014839,1,0.951221025134851,0,2,myoblast migration involved in skeletal muscle regeneration,BP,
4910,GO:0014843,1,0.95950763690405,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
4911,GO:0014846,1,0.960452882098195,0,1,esophagus smooth muscle contraction,BP,
4912,GO:0014847,1,0.98406407037836,0,1,proximal stomach smooth muscle contraction,BP,
4913,GO:0014848,1,0.888650788072826,0,3,urinary tract smooth muscle contraction,BP,
4914,GO:0014850,1,0.623403990277271,0,14,response to muscle activity,BP,
4915,GO:0014852,1,0.965616439891596,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
4916,GO:0014853,1,0.965616439891596,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
4917,GO:0014854,1,0.756506518232902,0,8,response to inactivity,BP,
4921,GO:0014858,1,0.920813584741226,0,2,positive regulation of skeletal muscle cell proliferation,BP,
4922,GO:0014859,1,0.963276668035714,0,1,negative regulation of skeletal muscle cell proliferation,BP,
4923,GO:0014866,1,0.895021901612252,0,3,skeletal myofibril assembly,BP,
4924,GO:0014870,1,0.800280494892586,0,6,response to muscle inactivity,BP,
4925,GO:0014874,1,0.777639740380173,0,7,response to stimulus involved in regulation of muscle adaptation,BP,
4926,GO:0014876,1,0.977737497125709,0,1,response to injury involved in regulation of muscle adaptation,BP,
4927,GO:0014877,1,0.828916287400823,0,5,response to muscle inactivity involved in regulation of muscle adaptation,BP,
4928,GO:0014878,1,0.959532420869656,0,1,response to electrical stimulus involved in regulation of muscle adaptation,BP,
4929,GO:0014883,1,0.867638959628176,0,4,transition between fast and slow fiber,BP,
4930,GO:0014886,1,0.925079561471814,0,2,transition between slow and fast fiber,BP,
4933,GO:0014889,1,0.801243462690593,0,7,muscle atrophy,BP,
4934,GO:0014891,1,0.878444314919528,0,4,striated muscle atrophy,BP,
4935,GO:0014894,1,0.828916287400823,0,5,response to denervation involved in regulation of muscle adaptation,BP,
4936,GO:0014895,1,0.985554531774291,0,1,smooth muscle hypertrophy,BP,
4940,GO:0014900,1,0.880228511606467,0,4,muscle hyperplasia,BP,
4941,GO:0014901,1,0.942094977151389,0,2,satellite cell activation involved in skeletal muscle regeneration,BP,
4944,GO:0014908,1,0.95950763690405,0,1,myotube differentiation involved in skeletal muscle regeneration,BP,
4947,GO:0014911,1,0.435712484858846,0,22,positive regulation of smooth muscle cell migration,BP,
4950,GO:0015002,1,0.727006130892384,0,18,heme-copper terminal oxidase activity,MF,
4952,GO:0015014,1,0.853744762867546,0,4,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
4953,GO:0015015,1,0.861144079418417,0,4,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
4954,GO:0015016,1,0.922047490667268,0,2,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,
4955,GO:0015018,1,0.977112922135342,0,1,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,
4956,GO:0015019,1,0.959552489516168,0,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,
4957,GO:0015020,1,0.618776392191981,0,14,glucuronosyltransferase activity,MF,
4963,GO:0015037,1,0.733605807446392,0,12,peptide disulfide oxidoreductase activity,MF,
4964,GO:0015038,1,0.896066427247134,0,5,glutathione disulfide oxidoreductase activity,MF,
4965,GO:0015039,1,0.972712436640328,0,1,NADPH-adrenodoxin reductase activity,MF,
4966,GO:0015057,1,0.898644793293917,0,3,thrombin-activated receptor activity,MF,
4967,GO:0015074,1,0.700527043238881,0,10,DNA integration,BP,
4974,GO:0015086,1,0.960589873502901,0,1,cadmium ion transmembrane transporter activity,MF,
4975,GO:0015087,1,0.960589873502901,0,1,cobalt ion transmembrane transporter activity,MF,
4977,GO:0015093,1,0.922011205362417,0,2,ferrous iron transmembrane transporter activity,MF,
4978,GO:0015094,1,0.960589873502901,0,1,lead ion transmembrane transporter activity,MF,
4979,GO:0015095,1,0.543376876320202,0,17,magnesium ion transmembrane transporter activity,MF,
4980,GO:0015098,1,0.972707993343804,0,1,molybdate ion transmembrane transporter activity,MF,
4981,GO:0015101,1,0.537256869171339,0,18,organic cation transmembrane transporter activity,MF,
4983,GO:0015105,1,0.978778277954407,0,1,arsenite transmembrane transporter activity,MF,
4984,GO:0015106,1,0.650772327369744,0,11,bicarbonate transmembrane transporter activity,MF,
4986,GO:0015111,1,0.886943505018025,0,3,iodide transmembrane transporter activity,MF,
4987,GO:0015112,1,0.966928641813719,0,1,nitrate transmembrane transporter activity,MF,
4988,GO:0015114,1,0.767354350657839,0,7,phosphate ion transmembrane transporter activity,MF,
4989,GO:0015116,1,0.80517314617927,0,6,sulfate transmembrane transporter activity,MF,
4990,GO:0015117,1,0.972783641722553,0,1,thiosulfate transmembrane transporter activity,MF,
4991,GO:0015119,1,0.899353583913465,0,3,hexose phosphate transmembrane transporter activity,MF,
4992,GO:0015125,1,0.880055618256245,0,4,bile acid transmembrane transporter activity,MF,
4993,GO:0015127,1,0.959598545219491,0,1,bilirubin transmembrane transporter activity,MF,
4994,GO:0015129,1,0.898218891160975,0,3,lactate transmembrane transporter activity,MF,
4995,GO:0015130,1,0.960654669220098,0,1,mevalonate transmembrane transporter activity,MF,
4996,GO:0015131,1,0.972783641722553,0,1,oxaloacetate transmembrane transporter activity,MF,
4997,GO:0015136,1,0.963316298045155,0,1,sialic acid transmembrane transporter activity,MF,
4998,GO:0015137,1,0.867745889173515,0,4,citrate transmembrane transporter activity,MF,
4999,GO:0015140,1,0.947279584492557,0,2,malate transmembrane transporter activity,MF,
5000,GO:0015141,1,0.900812617306245,0,3,succinate transmembrane transporter activity,MF,
5001,GO:0015142,1,0.867745889173515,0,4,tricarboxylic acid transmembrane transporter activity,MF,
5002,GO:0015143,1,0.972980546782408,0,1,urate transmembrane transporter activity,MF,
5003,GO:0015144,1,0.509289317298967,0,19,carbohydrate transmembrane transporter activity,MF,
5004,GO:0015145,1,0.67371558847086,0,11,monosaccharide transmembrane transporter activity,MF,
5005,GO:0015149,1,0.702173011163916,0,10,hexose transmembrane transporter activity,MF,
5006,GO:0015152,1,0.970926783408878,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
5007,GO:0015154,1,0.927462486132584,0,2,disaccharide transmembrane transporter activity,MF,
5008,GO:0015157,1,0.927462486132584,0,2,oligosaccharide transmembrane transporter activity,MF,
5009,GO:0015165,1,0.755666354489351,0,9,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,
5010,GO:0015166,1,0.864573078761489,0,4,polyol transmembrane transporter activity,MF,
5011,GO:0015168,1,0.939101178431822,0,2,glycerol transmembrane transporter activity,MF,
5013,GO:0015172,1,0.798086131162148,0,6,acidic amino acid transmembrane transporter activity,MF,
5014,GO:0015173,1,0.968169574119123,0,1,aromatic amino acid transmembrane transporter activity,MF,
5016,GO:0015175,1,0.43874752407301,0,24,neutral amino acid transmembrane transporter activity,MF,
5018,GO:0015180,1,0.829879578262208,0,5,L-alanine transmembrane transporter activity,MF,
5020,GO:0015182,1,0.966134356702796,0,1,L-asparagine transmembrane transporter activity,MF,
5021,GO:0015183,1,0.894846263051042,0,3,L-aspartate transmembrane transporter activity,MF,
5022,GO:0015184,1,0.922364795228684,0,2,L-cystine transmembrane transporter activity,MF,
5023,GO:0015185,1,0.971840175661916,0,1,gamma-aminobutyric acid transmembrane transporter activity,MF,
5024,GO:0015186,1,0.865879756194469,0,4,L-glutamine transmembrane transporter activity,MF,
5025,GO:0015187,1,0.839995986434349,0,5,glycine transmembrane transporter activity,MF,
5027,GO:0015190,1,0.966134356702796,0,1,L-leucine transmembrane transporter activity,MF,
5028,GO:0015191,1,0.966134356702796,0,1,L-methionine transmembrane transporter activity,MF,
5029,GO:0015193,1,0.824199793632776,0,5,L-proline transmembrane transporter activity,MF,
5030,GO:0015194,1,0.797711754948691,0,7,L-serine transmembrane transporter activity,MF,
5031,GO:0015195,1,0.960345710738993,0,1,L-threonine transmembrane transporter activity,MF,
5032,GO:0015196,1,0.968169574119123,0,1,L-tryptophan transmembrane transporter activity,MF,
5033,GO:0015203,1,0.965469978279355,0,1,polyamine transmembrane transporter activity,MF,
5034,GO:0015204,1,0.902094838759755,0,3,urea transmembrane transporter activity,MF,
5036,GO:0015207,1,0.917220839970861,0,3,adenine transmembrane transporter activity,MF,
5037,GO:0015211,1,0.968120400403909,0,1,purine nucleoside transmembrane transporter activity,MF,
5041,GO:0015218,1,0.937694877882284,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
5042,GO:0015220,1,0.834582055548474,0,5,choline transmembrane transporter activity,MF,
5043,GO:0015222,1,0.933745929139426,0,2,serotonin transmembrane transporter activity,MF,
5044,GO:0015226,1,0.873953731762148,0,4,carnitine transmembrane transporter activity,MF,
5045,GO:0015227,1,0.942696406882776,0,2,acyl carnitine transmembrane transporter activity,MF,
5046,GO:0015228,1,0.904672350912616,0,3,coenzyme A transmembrane transporter activity,MF,
5047,GO:0015229,1,0.95950763690405,0,1,L-ascorbic acid transmembrane transporter activity,MF,
5048,GO:0015230,1,0.935481923354222,0,2,FAD transmembrane transporter activity,MF,
5049,GO:0015232,1,0.769396537286455,0,7,heme transporter activity,MF,
5050,GO:0015234,1,0.938086320998008,0,2,thiamine transmembrane transporter activity,MF,
5052,GO:0015245,1,0.843796240225471,0,5,fatty acid transmembrane transporter activity,MF,
5053,GO:0015247,1,0.884462315421108,0,3,aminophospholipid transmembrane transporter activity,MF,
5055,GO:0015250,1,0.887251571663773,0,4,water channel activity,MF,
5056,GO:0015252,1,0.964274199594967,0,1,proton channel activity,MF,
5057,GO:0015254,1,0.939101178431822,0,2,glycerol channel activity,MF,
5058,GO:0015265,1,0.964759741425514,0,1,urea channel activity,MF,
5060,GO:0015269,1,0.802468370120292,0,7,calcium-activated potassium channel activity,MF,
5061,GO:0015271,1,0.850125529528362,0,4,outward rectifier potassium channel activity,MF,
5062,GO:0015272,1,0.964467255430663,0,1,ATP-activated inward rectifier potassium channel activity,MF,
5063,GO:0015275,1,0.926409352446473,0,2,stretch-activated, cation-selective, calcium channel activity,MF,
5064,GO:0015276,1,0.226049365324212,0,40,ligand-gated ion channel activity,MF,
5065,GO:0015278,1,0.545035646178443,0,16,calcium-release channel activity,MF,
5066,GO:0015279,1,0.838170041597088,0,5,store-operated calcium channel activity,MF,
5067,GO:0015280,1,0.892318119509319,0,3,ligand-gated sodium channel activity,MF,
5068,GO:0015288,1,0.844236448738394,0,6,porin activity,MF,
5070,GO:0015292,1,0.965469978279355,0,1,uniporter activity,MF,
5073,GO:0015295,1,0.530658070090633,0,18,solute:proton symporter activity,MF,
5074,GO:0015296,1,0.756505504734195,0,7,anion:cation symporter activity,MF,
5078,GO:0015301,1,0.522609491979948,0,18,anion:anion antiporter activity,MF,
5079,GO:0015307,1,0.940363947714873,0,2,drug:proton antiporter activity,MF,
5080,GO:0015315,1,0.899353583913465,0,3,organophosphate:inorganic phosphate antiporter activity,MF,
5081,GO:0015317,1,0.974699861727813,0,1,phosphate:proton symporter activity,MF,
5083,GO:0015319,1,0.926820735358338,0,2,sodium:inorganic phosphate symporter activity,MF,
5084,GO:0015321,1,0.926820735358338,0,2,sodium-dependent phosphate transmembrane transporter activity,MF,
5085,GO:0015322,1,0.964139678475021,0,1,secondary active oligopeptide transmembrane transporter activity,MF,
5086,GO:0015327,1,0.95950763690405,0,1,cystine:glutamate antiporter activity,MF,
5087,GO:0015328,1,0.95950763690405,0,1,cystine secondary active transmembrane transporter activity,MF,
5088,GO:0015333,1,0.893699750741102,0,3,peptide:proton symporter activity,MF,
5089,GO:0015347,1,0.719721069790185,0,9,sodium-independent organic anion transmembrane transporter activity,MF,
5090,GO:0015349,1,0.927694868781138,0,2,thyroid hormone transmembrane transporter activity,MF,
5091,GO:0015350,1,0.926672345318717,0,2,methotrexate transmembrane transporter activity,MF,
5092,GO:0015355,1,0.888441534089749,0,4,secondary active monocarboxylate transmembrane transporter activity,MF,
5093,GO:0015362,1,0.960824997668048,0,1,high-affinity sodium:dicarboxylate symporter activity,MF,
5094,GO:0015367,1,0.973784211919837,0,1,oxoglutarate:malate antiporter activity,MF,
5095,GO:0015368,1,0.794020918272592,0,6,calcium:cation antiporter activity,MF,
5096,GO:0015369,1,0.959515685611627,0,1,calcium:proton antiporter activity,MF,
5098,GO:0015373,1,0.923277790663248,0,2,anion:sodium symporter activity,MF,
5099,GO:0015375,1,0.963768076646009,0,1,glycine:sodium symporter activity,MF,
5100,GO:0015377,1,0.786206283827449,0,6,cation:chloride symporter activity,MF,
5101,GO:0015378,1,0.95950763690405,0,1,sodium:chloride symporter activity,MF,
5102,GO:0015379,1,0.786206283827449,0,6,potassium:chloride symporter activity,MF,
5110,GO:0015410,1,0.891001811463119,0,3,manganese-transporting ATPase activity,MF,
5111,GO:0015420,1,0.95950763690405,0,1,cobalamin-transporting ATPase activity,MF,
5112,GO:0015421,1,0.962426942657735,0,1,oligopeptide-transporting ATPase activity,MF,
5113,GO:0015431,1,0.95950763690405,0,1,glutathione S-conjugate-exporting ATPase activity,MF,
5114,GO:0015432,1,0.962409950174483,0,1,bile acid-exporting ATPase activity,MF,
5115,GO:0015433,1,0.924919436789486,0,2,peptide antigen-transporting ATPase activity,MF,
5116,GO:0015439,1,0.964952813586371,0,1,heme-transporting ATPase activity,MF,
5118,GO:0015450,1,0.850682526773856,0,7,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
5120,GO:0015464,1,0.788690839579116,0,7,acetylcholine receptor activity,MF,
5121,GO:0015467,1,0.932290537761644,0,2,G-protein activated inward rectifier potassium channel activity,MF,
5123,GO:0015489,1,0.965469978279355,0,1,putrescine transmembrane transporter activity,MF,
5125,GO:0015499,1,0.966912517779355,0,1,formate transmembrane transporter activity,MF,
5126,GO:0015501,1,0.929544297211519,0,2,glutamate:sodium symporter activity,MF,
5127,GO:0015526,1,0.899353583913465,0,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,
5128,GO:0015538,1,0.963316298045155,0,1,sialic acid:proton symporter activity,MF,
5129,GO:0015556,1,0.784922198535361,0,7,C4-dicarboxylate transmembrane transporter activity,MF,
5130,GO:0015562,1,0.862391809592036,0,4,efflux transmembrane transporter activity,MF,
5131,GO:0015578,1,0.968268389587276,0,1,mannose transmembrane transporter activity,MF,
5133,GO:0015616,1,0.853001138132885,0,4,DNA translocase activity,MF,
5137,GO:0015643,1,0.795648450636428,0,7,toxic substance binding,MF,
5138,GO:0015645,1,0.697756165782059,0,10,fatty acid ligase activity,MF,
5139,GO:0015651,1,0.812467116109677,0,6,quaternary ammonium group transmembrane transporter activity,MF,
5140,GO:0015658,1,0.966134356702796,0,1,branched-chain amino acid transmembrane transporter activity,MF,
5141,GO:0015660,1,0.966912517779355,0,1,formate efflux transmembrane transporter activity,MF,
5143,GO:0015669,1,0.91835336652812,0,3,gas transport,BP,
5144,GO:0015670,1,0.97484420258987,0,1,carbon dioxide transport,BP,
5145,GO:0015671,1,0.9420550656842,0,2,oxygen transport,BP,
5148,GO:0015679,1,0.920904318167174,0,2,plasma membrane copper ion transport,BP,
5149,GO:0015680,1,0.930457452126757,0,3,intracellular copper ion transport,BP,
5151,GO:0015684,1,0.922011205362417,0,2,ferrous iron transport,BP,
5152,GO:0015688,1,0.95477818478089,0,2,iron chelate transport,BP,
5153,GO:0015689,1,0.972707993343804,0,1,molybdate ion transport,BP,
5154,GO:0015691,1,0.899509770962486,0,3,cadmium ion transport,BP,
5155,GO:0015692,1,0.960589873502901,0,1,lead ion transport,BP,
5156,GO:0015693,1,0.543376876320202,0,17,magnesium ion transport,BP,
5157,GO:0015694,1,0.959598545219491,0,1,mercury ion transport,BP,
5158,GO:0015695,1,0.377185300798267,0,28,organic cation transport,BP,
5160,GO:0015697,1,0.726324909483978,0,9,quaternary ammonium group transport,BP,
5162,GO:0015700,1,0.978778277954407,0,1,arsenite transport,BP,
5163,GO:0015701,1,0.500395167737282,0,19,bicarbonate transport,BP,
5164,GO:0015705,1,0.851018468913665,0,4,iodide transport,BP,
5165,GO:0015706,1,0.966928641813719,0,1,nitrate transport,BP,
5166,GO:0015709,1,0.972783641722553,0,1,thiosulfate transport,BP,
5168,GO:0015712,1,0.87699401066705,0,4,hexose phosphate transport,BP,
5171,GO:0015722,1,0.890971914914611,0,3,canalicular bile acid transport,BP,
5172,GO:0015723,1,0.959598545219491,0,1,bilirubin transport,BP,
5173,GO:0015724,1,0.966912517779355,0,1,formate transport,BP,
5174,GO:0015727,1,0.862581344805807,0,4,lactate transport,BP,
5175,GO:0015728,1,0.960654669220098,0,1,mevalonate transport,BP,
5176,GO:0015729,1,0.972783641722553,0,1,oxaloacetate transport,BP,
5178,GO:0015734,1,0.95950763690405,0,1,taurine transport,BP,
5179,GO:0015739,1,0.963316298045155,0,1,sialic acid transport,BP,
5180,GO:0015740,1,0.714847084279012,0,9,C4-dicarboxylate transport,BP,
5181,GO:0015742,1,0.973784211919837,0,1,alpha-ketoglutarate transport,BP,
5182,GO:0015743,1,0.972783641722553,0,1,malate transport,BP,
5183,GO:0015744,1,0.900812617306245,0,3,succinate transport,BP,
5184,GO:0015746,1,0.867745889173515,0,4,citrate transport,BP,
5185,GO:0015747,1,0.941365045167428,0,2,urate transport,BP,
5188,GO:0015760,1,0.87699401066705,0,4,glucose-6-phosphate transport,BP,
5189,GO:0015761,1,0.968268389587276,0,1,mannose transmembrane transport,BP,
5190,GO:0015766,1,0.927462486132584,0,2,disaccharide transport,BP,
5191,GO:0015770,1,0.927462486132584,0,2,sucrose transport,BP,
5192,GO:0015772,1,0.927462486132584,0,2,oligosaccharide transport,BP,
5193,GO:0015780,1,0.681761478990639,0,12,nucleotide-sugar transmembrane transport,BP,
5194,GO:0015782,1,0.973470656517695,0,1,CMP-N-acetylneuraminate transmembrane transport,BP,
5195,GO:0015783,1,0.924780083578031,0,2,GDP-fucose transmembrane transport,BP,
5196,GO:0015786,1,0.969633028597371,0,1,UDP-glucose transmembrane transport,BP,
5197,GO:0015787,1,0.95950763690405,0,1,UDP-glucuronic acid transmembrane transport,BP,
5198,GO:0015790,1,0.95950763690405,0,1,UDP-xylose transmembrane transport,BP,
5199,GO:0015791,1,0.802091422962234,0,6,polyol transport,BP,
5200,GO:0015793,1,0.939101178431822,0,2,glycerol transport,BP,
5201,GO:0015797,1,0.966912517779355,0,1,mannitol transport,BP,
5202,GO:0015798,1,0.883364048004276,0,3,myo-inositol transport,BP,
5204,GO:0015801,1,0.93881146157925,0,2,aromatic amino acid transport,BP,
5206,GO:0015803,1,0.899601459351411,0,3,branched-chain amino acid transport,BP,
5208,GO:0015805,1,0.969958160463322,0,1,S-adenosyl-L-methionine transport,BP,
5210,GO:0015808,1,0.829879578262208,0,5,L-alanine transport,BP,
5212,GO:0015810,1,0.926219225679772,0,2,aspartate transmembrane transport,BP,
5213,GO:0015811,1,0.922364795228684,0,2,L-cystine transport,BP,
5214,GO:0015812,1,0.791984292919656,0,6,gamma-aminobutyric acid transport,BP,
5215,GO:0015813,1,0.626185764376622,0,13,L-glutamate transmembrane transport,BP,
5216,GO:0015816,1,0.805982127958718,0,6,glycine transport,BP,
5217,GO:0015817,1,0.966061916776235,0,1,histidine transport,BP,
5218,GO:0015819,1,0.972801476041507,0,1,lysine transport,BP,
5219,GO:0015820,1,0.931140715201483,0,2,leucine transport,BP,
5220,GO:0015821,1,0.966134356702796,0,1,methionine transport,BP,
5222,GO:0015824,1,0.791430132243269,0,6,proline transport,BP,
5223,GO:0015825,1,0.797711754948691,0,7,L-serine transport,BP,
5224,GO:0015826,1,0.960345710738993,0,1,threonine transport,BP,
5225,GO:0015827,1,0.93881146157925,0,2,tryptophan transport,BP,
5228,GO:0015838,1,0.7813084614528,0,7,amino-acid betaine transport,BP,
5229,GO:0015840,1,0.902094838759755,0,3,urea transport,BP,
5230,GO:0015842,1,0.946038146298464,0,2,aminergic neurotransmitter loading into synaptic vesicle,BP,
5233,GO:0015847,1,0.965469978279355,0,1,putrescine transport,BP,
5237,GO:0015853,1,0.896285395813966,0,4,adenine transport,BP,
5241,GO:0015862,1,0.969170937212095,0,1,uridine transport,BP,
5247,GO:0015870,1,0.966967419757367,0,1,acetylcholine transport,BP,
5248,GO:0015871,1,0.768334552072914,0,7,choline transport,BP,
5249,GO:0015872,1,0.622588638176831,0,15,dopamine transport,BP,
5251,GO:0015876,1,0.966883544077274,0,1,acetyl-CoA transport,BP,
5252,GO:0015878,1,0.963380649984966,0,1,biotin transport,BP,
5253,GO:0015879,1,0.848500732023024,0,5,carnitine transport,BP,
5254,GO:0015880,1,0.904672350912616,0,3,coenzyme A transport,BP,
5255,GO:0015881,1,0.962400535170761,0,1,creatine transmembrane transport,BP,
5256,GO:0015882,1,0.95950763690405,0,1,L-ascorbic acid transmembrane transport,BP,
5257,GO:0015884,1,0.846050134400318,0,5,folic acid transport,BP,
5258,GO:0015886,1,0.769396537286455,0,7,heme transport,BP,
5259,GO:0015887,1,0.963380649984966,0,1,pantothenate transmembrane transport,BP,
5260,GO:0015888,1,0.928837726418441,0,2,thiamine transport,BP,
5261,GO:0015889,1,0.940138682928088,0,2,cobalamin transport,BP,
5262,GO:0015891,1,0.95477818478089,0,2,siderophore transport,BP,
5264,GO:0015904,1,0.973021020108301,0,1,tetracycline transport,BP,
5266,GO:0015909,1,0.268378535039358,0,37,long-chain fatty acid transport,BP,
5267,GO:0015910,1,0.932503982283131,0,2,peroxisomal long-chain fatty acid import,BP,
5268,GO:0015911,1,0.826470187914499,0,5,plasma membrane long-chain fatty acid transport,BP,
5270,GO:0015916,1,0.966883544077274,0,1,fatty-acyl-CoA transport,BP,
5271,GO:0015917,1,0.848637534834021,0,4,aminophospholipid transport,BP,
5273,GO:0015919,1,0.569163810915444,0,16,peroxisomal membrane transport,BP,
5274,GO:0015920,1,0.966730093139671,0,1,lipopolysaccharide transport,BP,
5275,GO:0015923,1,0.584490122105995,0,14,mannosidase activity,MF,
5276,GO:0015924,1,0.708911326546771,0,9,mannosyl-oligosaccharide mannosidase activity,MF,
5277,GO:0015925,1,0.819812291522472,0,6,galactosidase activity,MF,
5278,GO:0015926,1,0.729147187359899,0,8,glucosidase activity,MF,
5279,GO:0015928,1,0.942697111703923,0,2,fucosidase activity,MF,
5284,GO:0015935,1,0.254186225752643,0,68,small ribosomal subunit,CC,
5287,GO:0015938,1,0.981788291745788,0,1,coenzyme A catabolic process,BP,
5288,GO:0015939,1,0.851206752049409,0,5,pantothenate metabolic process,BP,
5291,GO:0015950,1,0.972855058342775,0,1,purine nucleotide interconversion,BP,
5292,GO:0015951,1,0.972855058342775,0,1,purine ribonucleotide interconversion,BP,
5293,GO:0015959,1,0.797467647085977,0,7,diadenosine polyphosphate metabolic process,BP,
5294,GO:0015960,1,0.902314781953993,0,3,diadenosine polyphosphate biosynthetic process,BP,
5295,GO:0015961,1,0.883830410916759,0,4,diadenosine polyphosphate catabolic process,BP,
5296,GO:0015965,1,0.902314781953993,0,3,diadenosine tetraphosphate metabolic process,BP,
5297,GO:0015966,1,0.902314781953993,0,3,diadenosine tetraphosphate biosynthetic process,BP,
5299,GO:0015985,1,0.797041094458063,0,8,energy coupled proton transport, down electrochemical gradient,BP,
5300,GO:0015986,1,0.797041094458063,0,8,ATP synthesis coupled proton transport,BP,
5302,GO:0015990,1,0.984369572391226,0,1,electron transport coupled proton transport,BP,
5305,GO:0016005,1,0.928307182788818,0,2,phospholipase A2 activator activity,MF,
5306,GO:0016010,1,0.649510805847439,0,12,dystrophin-associated glycoprotein complex,CC,
5307,GO:0016011,1,0.897904417324934,0,3,dystroglycan complex,CC,
5308,GO:0016012,1,0.935803367501395,0,2,sarcoglycan complex,CC,
5309,GO:0016013,1,0.929838002052688,0,2,syntrophin complex,CC,
5310,GO:0016015,1,0.946506266815006,0,2,morphogen activity,MF,
5312,GO:0016019,1,0.953757494730048,0,2,peptidoglycan receptor activity,MF,
5315,GO:0016024,1,0.621770999545133,0,13,CDP-diacylglycerol biosynthetic process,BP,
5316,GO:0016031,1,0.963039672539869,0,1,tRNA import into mitochondrion,BP,
5318,GO:0016034,1,0.978191085599748,0,1,maleylacetoacetate isomerase activity,MF,
5319,GO:0016035,1,0.940657554590655,0,2,zeta DNA polymerase complex,CC,
5320,GO:0016036,1,0.969636865735874,0,1,cellular response to phosphate starvation,BP,
5323,GO:0016045,1,0.781006289376684,0,7,detection of bacterium,BP,
5324,GO:0016048,1,0.790401175481308,0,7,detection of temperature stimulus,BP,
5332,GO:0016056,1,0.625168586727761,0,13,rhodopsin mediated signaling pathway,BP,
5333,GO:0016062,1,0.967502032617667,0,1,adaptation of rhodopsin mediated signaling,BP,
5339,GO:0016074,1,0.751047417574666,0,12,snoRNA metabolic process,BP,
5340,GO:0016075,1,0.648383306442346,0,15,rRNA catabolic process,BP,
5341,GO:0016077,1,0.95950763690405,0,1,snoRNA catabolic process,BP,
5342,GO:0016078,1,0.853004523138501,0,6,tRNA catabolic process,BP,
5344,GO:0016080,1,0.886110819916734,0,3,synaptic vesicle targeting,BP,
5347,GO:0016093,1,0.831121380532359,0,6,polyprenol metabolic process,BP,
5348,GO:0016094,1,0.89399650688757,0,3,polyprenol biosynthetic process,BP,
5349,GO:0016095,1,0.966883544077274,0,1,polyprenol catabolic process,BP,
5350,GO:0016098,1,0.964209155829131,0,1,monoterpenoid metabolic process,BP,
5353,GO:0016103,1,0.960018965720951,0,1,diterpenoid catabolic process,BP,
5355,GO:0016115,1,0.960018965720951,0,1,terpenoid catabolic process,BP,
5358,GO:0016127,1,0.882926931557998,0,4,sterol catabolic process,BP,
5359,GO:0016128,1,0.911248131636689,0,3,phytosteroid metabolic process,BP,
5360,GO:0016129,1,0.911248131636689,0,3,phytosteroid biosynthetic process,BP,
5361,GO:0016131,1,0.966912517779355,0,1,brassinosteroid metabolic process,BP,
5362,GO:0016132,1,0.966912517779355,0,1,brassinosteroid biosynthetic process,BP,
5363,GO:0016137,1,0.68237605886555,0,13,glycoside metabolic process,BP,
5364,GO:0016139,1,0.798481505377646,0,7,glycoside catabolic process,BP,
5365,GO:0016149,1,0.961875149812614,0,1,translation release factor activity, codon specific,MF,
5366,GO:0016150,1,0.975320696042382,0,1,translation release factor activity, codon nonspecific,MF,
5367,GO:0016154,1,0.974911808109321,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
5368,GO:0016155,1,0.95950763690405,0,1,formyltetrahydrofolate dehydrogenase activity,MF,
5369,GO:0016160,1,0.931012027324941,0,2,amylase activity,MF,
5370,GO:0016165,1,0.937029095596679,0,2,linoleate 13S-lipoxygenase activity,MF,
5371,GO:0016174,1,0.866078702702589,0,4,NAD(P)H oxidase activity,MF,
5372,GO:0016175,1,0.955140232713679,0,2,superoxide-generating NADPH oxidase activity,MF,
5373,GO:0016176,1,0.844452443217751,0,5,superoxide-generating NADPH oxidase activator activity,MF,
5374,GO:0016180,1,0.502831225323418,0,22,snRNA processing,BP,
5375,GO:0016182,1,0.959734229948343,0,1,synaptic vesicle budding from endosome,BP,
5376,GO:0016185,1,0.85877718473312,0,4,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,
5377,GO:0016188,1,0.836656606143985,0,5,synaptic vesicle maturation,BP,
5378,GO:0016189,1,0.95950763690405,0,1,synaptic vesicle to endosome fusion,BP,
5379,GO:0016191,1,0.855805295680235,0,4,synaptic vesicle uncoating,BP,
5382,GO:0016198,1,0.819946232169456,0,5,axon choice point recognition,BP,
5383,GO:0016199,1,0.850771582321912,0,4,axon midline choice point recognition,BP,
5385,GO:0016206,1,0.935295742239704,0,2,catechol O-methyltransferase activity,MF,
5386,GO:0016208,1,0.76105841593815,0,9,AMP binding,MF,
5388,GO:0016211,1,0.96024696931705,0,1,ammonia ligase activity,MF,
5389,GO:0016212,1,0.939224592945848,0,2,kynurenine-oxoglutarate transaminase activity,MF,
5390,GO:0016213,1,0.964075692128143,0,1,linoleoyl-CoA desaturase activity,MF,
5391,GO:0016215,1,0.894822872855362,0,3,acyl-CoA desaturase activity,MF,
5392,GO:0016222,1,0.934192489769845,0,2,procollagen-proline 4-dioxygenase complex,CC,
5393,GO:0016226,1,0.583065839756935,0,20,iron-sulfur cluster assembly,BP,
5394,GO:0016229,1,0.599060378973244,0,19,steroid dehydrogenase activity,MF,
5395,GO:0016230,1,0.940799174885389,0,2,sphingomyelin phosphodiesterase activator activity,MF,
5396,GO:0016231,1,0.95957889503157,0,1,beta-N-acetylglucosaminidase activity,MF,
5397,GO:0016232,1,0.965918384735841,0,1,HNK-1 sulfotransferase activity,MF,
5398,GO:0016233,1,0.228983196038602,0,51,telomere capping,BP,
5402,GO:0016237,1,0.959643961346915,0,1,lysosomal microautophagy,BP,
5404,GO:0016240,1,0.876309231544966,0,4,autophagosome membrane docking,BP,
5406,GO:0016242,1,0.366417038359976,0,29,negative regulation of macroautophagy,BP,
5407,GO:0016243,1,0.960965422041728,0,1,regulation of autophagosome size,BP,
5411,GO:0016250,1,0.966201155015601,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5412,GO:0016254,1,0.604483939569302,0,17,preassembly of GPI anchor in ER membrane,BP,
5414,GO:0016256,1,0.939485636971985,0,2,N-glycan processing to lysosome,BP,
5415,GO:0016259,1,0.875378814607621,0,4,selenocysteine metabolic process,BP,
5416,GO:0016260,1,0.937952519968535,0,2,selenocysteine biosynthetic process,BP,
5417,GO:0016262,1,0.901319143699615,0,3,protein N-acetylglucosaminyltransferase activity,MF,
5418,GO:0016263,1,0.946636361412639,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5419,GO:0016264,1,0.772180686167752,0,7,gap junction assembly,BP,
5421,GO:0016267,1,0.946636361412639,0,2,O-glycan processing, core 1,BP,
5422,GO:0016269,1,0.968001627529609,0,1,O-glycan processing, core 3,BP,
5423,GO:0016272,1,0.875833196259402,0,7,prefoldin complex,CC,
5424,GO:0016273,1,0.70108374454766,0,11,arginine N-methyltransferase activity,MF,
5425,GO:0016274,1,0.70108374454766,0,11,protein-arginine N-methyltransferase activity,MF,
5426,GO:0016277,1,0.968633645563109,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
5427,GO:0016278,1,0.181981147508646,0,48,lysine N-methyltransferase activity,MF,
5428,GO:0016279,1,0.188517625138284,0,47,protein-lysine N-methyltransferase activity,MF,
5429,GO:0016281,1,0.736838183974161,0,9,eukaryotic translation initiation factor 4F complex,CC,
5430,GO:0016282,1,0.960062984714058,0,1,eukaryotic 43S preinitiation complex,CC,
5431,GO:0016286,1,0.967894135268979,0,1,small conductance calcium-activated potassium channel activity,MF,
5432,GO:0016287,1,0.96669201322498,0,1,glycerone-phosphate O-acyltransferase activity,MF,
5433,GO:0016289,1,0.68927084505411,0,13,CoA hydrolase activity,MF,
5434,GO:0016290,1,0.826065946214967,0,7,palmitoyl-CoA hydrolase activity,MF,
5435,GO:0016295,1,0.934547454336808,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5436,GO:0016296,1,0.934547454336808,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5437,GO:0016297,1,0.934547454336808,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
5439,GO:0016300,1,0.894264564169252,0,3,tRNA (uracil) methyltransferase activity,MF,
5444,GO:0016309,1,0.889486310018623,0,3,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
5447,GO:0016312,1,0.862720751888055,0,4,inositol bisphosphate phosphatase activity,MF,
5448,GO:0016314,1,0.920855269422982,0,2,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,
5449,GO:0016316,1,0.921852166729382,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5450,GO:0016320,1,0.939272206625786,0,2,endoplasmic reticulum membrane fusion,BP,
5451,GO:0016321,1,0.906334091443513,0,3,female meiosis chromosome segregation,BP,
5452,GO:0016322,1,0.796470576911212,0,6,neuron remodeling,BP,
5458,GO:0016332,1,0.96120892185491,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
5459,GO:0016333,1,0.965202511716011,0,1,morphogenesis of follicular epithelium,BP,
5460,GO:0016334,1,0.965202511716011,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
5462,GO:0016339,1,0.531218788375743,0,17,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
5463,GO:0016340,1,0.920651101645653,0,2,calcium-dependent cell-matrix adhesion,BP,
5464,GO:0016342,1,0.608155652519722,0,13,catenin complex,CC,
5465,GO:0016344,1,0.928967554152274,0,2,meiotic chromosome movement towards spindle pole,BP,
5467,GO:0016361,1,0.939744339386141,0,2,activin receptor activity, type I,MF,
5468,GO:0016362,1,0.920650957478618,0,2,activin receptor activity, type II,MF,
5470,GO:0016401,1,0.933953348142699,0,2,palmitoyl-CoA oxidase activity,MF,
5471,GO:0016402,1,0.965709365843982,0,1,pristanoyl-CoA oxidase activity,MF,
5472,GO:0016403,1,0.940072938490657,0,2,dimethylargininase activity,MF,
5473,GO:0016404,1,0.960089904426351,0,1,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
5474,GO:0016405,1,0.603741009076001,0,14,CoA-ligase activity,MF,
5475,GO:0016406,1,0.805642794792231,0,6,carnitine O-acyltransferase activity,MF,
5477,GO:0016408,1,0.669198239102317,0,13,C-acyltransferase activity,MF,
5478,GO:0016409,1,0.32687693739147,0,33,palmitoyltransferase activity,MF,
5480,GO:0016411,1,0.439366111792212,0,23,acylglycerol O-acyltransferase activity,MF,
5481,GO:0016413,1,0.804948657463862,0,6,O-acetyltransferase activity,MF,
5482,GO:0016414,1,0.963618860731002,0,1,O-octanoyltransferase activity,MF,
5483,GO:0016415,1,0.963618860731002,0,1,octanoyltransferase activity,MF,
5484,GO:0016416,1,0.865621869304936,0,4,O-palmitoyltransferase activity,MF,
5485,GO:0016417,1,0.406002657005683,0,27,S-acyltransferase activity,MF,
5486,GO:0016418,1,0.921378588809331,0,2,S-acetyltransferase activity,MF,
5487,GO:0016419,1,0.932895668697753,0,2,S-malonyltransferase activity,MF,
5488,GO:0016420,1,0.932895668697753,0,2,malonyltransferase activity,MF,
5489,GO:0016421,1,0.807504934495005,0,6,CoA carboxylase activity,MF,
5490,GO:0016422,1,0.911273319954913,0,3,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
5491,GO:0016423,1,0.651742555214827,0,13,tRNA (guanine) methyltransferase activity,MF,
5492,GO:0016426,1,0.874197533291159,0,4,tRNA (adenine) methyltransferase activity,MF,
5493,GO:0016427,1,0.767089414863893,0,8,tRNA (cytosine) methyltransferase activity,MF,
5494,GO:0016428,1,0.875772293004421,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
5495,GO:0016429,1,0.905471172712226,0,3,tRNA (adenine-N1-)-methyltransferase activity,MF,
5496,GO:0016430,1,0.965469978279355,0,1,tRNA (adenine-N6-)-methyltransferase activity,MF,
5497,GO:0016433,1,0.834684858546183,0,6,rRNA (adenine) methyltransferase activity,MF,
5498,GO:0016434,1,0.896007602136318,0,3,rRNA (cytosine) methyltransferase activity,MF,
5499,GO:0016435,1,0.88694002233548,0,4,rRNA (guanine) methyltransferase activity,MF,
5500,GO:0016436,1,0.928303195036878,0,2,rRNA (uridine) methyltransferase activity,MF,
5502,GO:0016442,1,0.664563458200762,0,11,RISC complex,CC,
5505,GO:0016446,1,0.619001273818846,0,14,somatic hypermutation of immunoglobulin genes,BP,
5507,GO:0016453,1,0.891567517251669,0,4,C-acetyltransferase activity,MF,
5508,GO:0016454,1,0.836493768075057,0,5,C-palmitoyltransferase activity,MF,
5511,GO:0016460,1,0.629431256204602,0,13,myosin II complex,CC,
5512,GO:0016461,1,0.801782773541603,0,7,unconventional myosin complex,CC,
5516,GO:0016476,1,0.896522874771423,0,3,regulation of embryonic cell shape,BP,
5518,GO:0016479,1,0.905419559256169,0,3,negative regulation of transcription by RNA polymerase I,BP,
5519,GO:0016480,1,0.926927113466099,0,3,negative regulation of transcription by RNA polymerase III,BP,
5522,GO:0016486,1,0.557496485776727,0,17,peptide hormone processing,BP,
5524,GO:0016492,1,0.960678954917327,0,1,G-protein coupled neurotensin receptor activity,MF,
5525,GO:0016493,1,0.935163315904475,0,2,C-C chemokine receptor activity,MF,
5526,GO:0016494,1,0.902634902828901,0,3,C-X-C chemokine receptor activity,MF,
5527,GO:0016500,1,0.792227593488393,0,6,protein-hormone receptor activity,MF,
5528,GO:0016502,1,0.826294330538462,0,6,nucleotide receptor activity,MF,
5529,GO:0016503,1,0.978521095739886,0,1,pheromone receptor activity,MF,
5532,GO:0016507,1,0.964607085368538,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
5533,GO:0016508,1,0.896289995348276,0,3,long-chain-enoyl-CoA hydratase activity,MF,
5534,GO:0016509,1,0.905586972137202,0,3,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
5535,GO:0016514,1,0.623778493494698,0,13,SWI/SNF complex,CC,
5536,GO:0016517,1,0.97193881161879,0,1,interleukin-12 receptor activity,MF,
5537,GO:0016519,1,0.971542648304535,0,1,gastric inhibitory peptide receptor activity,MF,
5538,GO:0016520,1,0.95994021823879,0,1,growth hormone-releasing hormone receptor activity,MF,
5539,GO:0016524,1,0.932129376517163,0,2,latrotoxin receptor activity,MF,
5541,GO:0016528,1,0.216487085270612,0,43,sarcoplasm,CC,
5542,GO:0016529,1,0.268613800621906,0,37,sarcoplasmic reticulum,CC,
5543,GO:0016530,1,0.867464414395943,0,6,metallochaperone activity,MF,
5544,GO:0016531,1,0.90408203583273,0,5,copper chaperone activity,MF,
5545,GO:0016532,1,0.925467773634657,0,3,superoxide dismutase copper chaperone activity,MF,
5546,GO:0016533,1,0.942376105176288,0,2,cyclin-dependent protein kinase 5 holoenzyme complex,CC,
5547,GO:0016534,1,0.961380049307401,0,1,cyclin-dependent protein kinase 5 activator activity,MF,
5549,GO:0016540,1,0.734588003832282,0,9,protein autoprocessing,BP,
5550,GO:0016553,1,0.684755654318974,0,11,base conversion or substitution editing,BP,
5551,GO:0016554,1,0.830973410411828,0,6,cytidine to uridine editing,BP,
5552,GO:0016556,1,0.62271321431622,0,15,mRNA modification,BP,
5553,GO:0016557,1,0.921586817310683,0,3,peroxisome membrane biogenesis,BP,
5554,GO:0016558,1,0.663356748647901,0,12,protein import into peroxisome matrix,BP,
5555,GO:0016559,1,0.828360076184918,0,7,peroxisome fission,BP,
5556,GO:0016560,1,0.865934710132189,0,4,protein import into peroxisome matrix, docking,BP,
5557,GO:0016561,1,0.936011053287883,0,2,protein import into peroxisome matrix, translocation,BP,
5566,GO:0016576,1,0.905258672535863,0,3,histone dephosphorylation,BP,
5570,GO:0016580,1,0.672009459282692,0,11,Sin3 complex,CC,
5571,GO:0016581,1,0.571978614857689,0,15,NuRD complex,CC,
5572,GO:0016584,1,0.822035529319309,0,7,nucleosome positioning,BP,
5573,GO:0016586,1,0.921191346521139,0,2,RSC-type complex,CC,
5574,GO:0016589,1,0.781997908278885,0,7,NURF complex,CC,
5575,GO:0016590,1,0.95950763690405,0,1,ACF complex,CC,
5577,GO:0016592,1,0.328946940287001,0,35,mediator complex,CC,
5578,GO:0016593,1,0.751894275880674,0,8,Cdc73/Paf1 complex,CC,
5579,GO:0016594,1,0.874022149442664,0,4,glycine binding,MF,
5580,GO:0016595,1,0.797364140869424,0,6,glutamate binding,MF,
5581,GO:0016596,1,0.965469978279355,0,1,thienylcyclohexylpiperidine binding,MF,
5582,GO:0016597,1,0.327166050336237,0,33,amino acid binding,MF,
5583,GO:0016598,1,0.944145743156373,0,2,protein arginylation,BP,
5585,GO:0016601,1,0.292340772371861,0,34,Rac protein signal transduction,BP,
5586,GO:0016602,1,0.879527853062464,0,4,CCAAT-binding factor complex,CC,
5587,GO:0016603,1,0.945718801031391,0,2,glutaminyl-peptide cyclotransferase activity,MF,
5592,GO:0016615,1,0.834518686735253,0,6,malate dehydrogenase activity,MF,
5594,GO:0016618,1,0.913322210871206,0,3,hydroxypyruvate reductase activity,MF,
5596,GO:0016623,1,0.959651701925598,0,1,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
5597,GO:0016624,1,0.767876453645988,0,8,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,
5598,GO:0016627,1,0.216576978107071,0,49,oxidoreductase activity, acting on the CH-CH group of donors,MF,
5599,GO:0016628,1,0.538766417443202,0,21,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,
5600,GO:0016634,1,0.821941540426407,0,6,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,
5601,GO:0016635,1,0.841577533637829,0,6,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,
5603,GO:0016639,1,0.962627550615603,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,
5605,GO:0016642,1,0.961447268770442,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
5606,GO:0016645,1,0.544406675759063,0,19,oxidoreductase activity, acting on the CH-NH group of donors,MF,
5607,GO:0016646,1,0.63512490948008,0,14,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,
5608,GO:0016647,1,0.946499775823608,0,2,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,
5609,GO:0016649,1,0.933779616104715,0,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
5611,GO:0016652,1,0.959858463421999,0,1,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
5612,GO:0016653,1,0.663099839279146,0,12,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,
5613,GO:0016655,1,0.378710633013849,0,49,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,
5614,GO:0016657,1,0.972855058342775,0,1,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
5615,GO:0016661,1,0.848863904571809,0,5,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,
5616,GO:0016662,1,0.967261870054133,0,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,
5619,GO:0016670,1,0.77500151607378,0,7,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,
5621,GO:0016672,1,0.961363431180354,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
5622,GO:0016675,1,0.703643680037302,0,19,oxidoreductase activity, acting on a heme group of donors,MF,
5623,GO:0016676,1,0.727006130892384,0,18,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,
5624,GO:0016679,1,0.821543425082518,0,8,oxidoreductase activity, acting on diphenols and related substances as donors,MF,
5625,GO:0016681,1,0.849401889425016,0,7,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
5630,GO:0016706,1,0.24803436687683,0,39,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,
5631,GO:0016708,1,0.941034123342604,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,
5633,GO:0016711,1,0.967215647218539,0,1,flavonoid 3'-monooxygenase activity,MF,
5634,GO:0016712,1,0.719674185923346,0,10,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,
5635,GO:0016714,1,0.925229884148622,0,3,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
5636,GO:0016715,1,0.927736525589044,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,
5637,GO:0016717,1,0.829487699286582,0,5,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
5642,GO:0016725,1,0.790922389123897,0,6,oxidoreductase activity, acting on CH or CH2 groups,MF,
5643,GO:0016726,1,0.920789213549214,0,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,
5644,GO:0016727,1,0.95950764839315,0,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,
5645,GO:0016728,1,0.89088303670792,0,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,
5646,GO:0016730,1,0.972712436640328,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
5647,GO:0016731,1,0.972712436640328,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
5650,GO:0016742,1,0.813931297095421,0,6,hydroxymethyl-, formyl- and related transferase activity,MF,
5651,GO:0016743,1,0.92065096379418,0,2,carboxyl- or carbamoyltransferase activity,MF,
5652,GO:0016744,1,0.950694690099748,0,2,transferase activity, transferring aldehyde or ketonic groups,MF,
5657,GO:0016751,1,0.965706449886715,0,1,S-succinyltransferase activity,MF,
5658,GO:0016755,1,0.748199137366935,0,9,transferase activity, transferring amino-acyl groups,MF,
5662,GO:0016765,1,0.272237606574132,0,47,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,
5663,GO:0016768,1,0.974604036915511,0,1,spermine synthase activity,MF,
5664,GO:0016769,1,0.653628798021985,0,13,transferase activity, transferring nitrogenous groups,MF,
5667,GO:0016774,1,0.905468524486121,0,3,phosphotransferase activity, carboxyl group as acceptor,MF,
5668,GO:0016775,1,0.840274690969614,0,6,phosphotransferase activity, nitrogenous group as acceptor,MF,
5670,GO:0016778,1,0.885148720178782,0,4,diphosphotransferase activity,MF,
5673,GO:0016781,1,0.937952519968535,0,2,phosphotransferase activity, paired acceptors,MF,
5675,GO:0016783,1,0.73574720742072,0,12,sulfurtransferase activity,MF,
5676,GO:0016784,1,0.976768554059973,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
5677,GO:0016785,1,0.959508251718916,0,1,transferase activity, transferring selenium-containing groups,MF,
5680,GO:0016790,1,0.432480749096614,0,28,thiolester hydrolase activity,MF,
5682,GO:0016793,1,0.96386288872104,0,1,triphosphoric monoester hydrolase activity,MF,
5683,GO:0016794,1,0.981436987402546,0,1,diphosphoric monoester hydrolase activity,MF,
5689,GO:0016803,1,0.742314674698037,0,10,ether hydrolase activity,MF,
5690,GO:0016805,1,0.783091564581043,0,7,dipeptidase activity,MF,
5691,GO:0016807,1,0.965469978279355,0,1,cysteine-type carboxypeptidase activity,MF,
5694,GO:0016812,1,0.817273583504223,0,5,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,
5695,GO:0016813,1,0.834817449006314,0,6,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,
5697,GO:0016815,1,0.977916236444337,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
5700,GO:0016822,1,0.952267848579748,0,2,hydrolase activity, acting on acid carbon-carbon bonds,MF,
5701,GO:0016823,1,0.952267848579748,0,2,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
5702,GO:0016826,1,0.966201155015601,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
5706,GO:0016832,1,0.806576614902702,0,7,aldehyde-lyase activity,MF,
5707,GO:0016833,1,0.858499317040978,0,5,oxo-acid-lyase activity,MF,
5708,GO:0016835,1,0.1969221928641,0,53,carbon-oxygen lyase activity,MF,
5709,GO:0016836,1,0.325618264334337,0,36,hydro-lyase activity,MF,
5710,GO:0016838,1,0.954045387420846,0,2,carbon-oxygen lyase activity, acting on phosphates,MF,
5713,GO:0016842,1,0.825812623660308,0,7,amidine-lyase activity,MF,
5714,GO:0016843,1,0.965469978279355,0,1,amine-lyase activity,MF,
5715,GO:0016844,1,0.965469978279355,0,1,strictosidine synthase activity,MF,
5716,GO:0016846,1,0.844731596163574,0,7,carbon-sulfur lyase activity,MF,
5717,GO:0016849,1,0.709583883605589,0,9,phosphorus-oxygen lyase activity,MF,
5720,GO:0016855,1,0.968092371147854,0,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,
5724,GO:0016861,1,0.801645413490867,0,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,
5725,GO:0016862,1,0.973375629788393,0,2,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,
5726,GO:0016863,1,0.78022707276513,0,10,intramolecular oxidoreductase activity, transposing C=C bonds,MF,
5730,GO:0016872,1,0.969686821893012,0,1,intramolecular lyase activity,MF,
5731,GO:0016874,1,0.00937217740539955,0,135,ligase activity,MF,
5732,GO:0016875,1,0.230645101127663,0,44,ligase activity, forming carbon-oxygen bonds,MF,
5733,GO:0016877,1,0.376230436323703,0,28,ligase activity, forming carbon-sulfur bonds,MF,
5734,GO:0016878,1,0.533605516109221,0,18,acid-thiol ligase activity,MF,
5735,GO:0016879,1,0.224469638711969,0,43,ligase activity, forming carbon-nitrogen bonds,MF,
5736,GO:0016880,1,0.927086295266028,0,2,acid-ammonia (or amide) ligase activity,MF,
5737,GO:0016881,1,0.574894442035991,0,16,acid-amino acid ligase activity,MF,
5738,GO:0016882,1,0.94666874932589,0,2,cyclo-ligase activity,MF,
5739,GO:0016884,1,0.712748950526834,0,10,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,
5740,GO:0016885,1,0.753160469561422,0,8,ligase activity, forming carbon-carbon bonds,MF,
5741,GO:0016886,1,0.709748139423545,0,10,ligase activity, forming phosphoric ester bonds,MF,
5743,GO:0016888,1,0.680654656482142,0,11,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
5744,GO:0016889,1,0.554845846059172,0,20,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,
5745,GO:0016890,1,0.93767880358649,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
5746,GO:0016891,1,0.441413561647979,0,27,endoribonuclease activity, producing 5'-phosphomonoesters,MF,
5747,GO:0016892,1,0.8501247952788,0,6,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
5748,GO:0016893,1,0.334250252057967,0,35,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
5749,GO:0016894,1,0.471573475288294,0,26,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,
5752,GO:0016898,1,0.967334818525518,0,1,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
5753,GO:0016899,1,0.922685707006507,0,2,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
5754,GO:0016900,1,0.963254159397223,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
5755,GO:0016901,1,0.95950763690405,0,1,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
5757,GO:0016907,1,0.927943055563232,0,2,G-protein coupled acetylcholine receptor activity,MF,
5758,GO:0016909,1,0.901975409642305,0,3,SAP kinase activity,MF,
5760,GO:0016918,1,0.877619881109996,0,5,retinal binding,MF,
5761,GO:0016920,1,0.95950763690405,0,1,pyroglutamyl-peptidase activity,MF,
5762,GO:0016922,1,0.520187530781415,0,18,ligand-dependent nuclear receptor binding,MF,
5764,GO:0016926,1,0.772441737360549,0,7,protein desumoylation,BP,
5765,GO:0016929,1,0.79244913694268,0,6,SUMO-specific protease activity,MF,
5766,GO:0016936,1,0.945933683279097,0,2,galactoside binding,MF,
5767,GO:0016938,1,0.9651360404064,0,1,kinesin I complex,CC,
5768,GO:0016939,1,0.888259211542427,0,3,kinesin II complex,CC,
5769,GO:0016941,1,0.962779112836945,0,1,natriuretic peptide receptor activity,MF,
5770,GO:0016942,1,0.911586814307684,0,3,insulin-like growth factor binding protein complex,CC,
5771,GO:0016964,1,0.95950763690405,0,1,alpha-2 macroglobulin receptor activity,MF,
5772,GO:0016971,1,0.897452433701029,0,3,flavin-linked sulfhydryl oxidase activity,MF,
5773,GO:0016972,1,0.86135641798637,0,4,thiol oxidase activity,MF,
5774,GO:0016973,1,0.712728243084072,0,10,poly(A)+ mRNA export from nucleus,BP,
5775,GO:0016979,1,0.977403161549352,0,1,lipoate-protein ligase activity,MF,
5776,GO:0016992,1,0.974771941901092,0,1,lipoate synthase activity,MF,
5777,GO:0016997,1,0.880953021567115,0,4,alpha-sialidase activity,MF,
5778,GO:0016998,1,0.940525081817062,0,2,cell wall macromolecule catabolic process,BP,
5780,GO:0017000,1,0.616921908980167,0,14,antibiotic biosynthetic process,BP,
5781,GO:0017001,1,0.451134770140687,0,28,antibiotic catabolic process,BP,
5782,GO:0017002,1,0.830154441166756,0,5,activin-activated receptor activity,MF,
5783,GO:0017003,1,0.969495428197879,0,1,protein-heme linkage,BP,
5784,GO:0017004,1,0.356707079279654,0,34,cytochrome complex assembly,BP,
5785,GO:0017005,1,0.962031732755762,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
5786,GO:0017006,1,0.969495428197879,0,1,protein-tetrapyrrole linkage,BP,
5791,GO:0017018,1,0.920830583063995,0,2,myosin phosphatase activity,MF,
5792,GO:0017020,1,0.965616439891596,0,1,myosin phosphatase regulator activity,MF,
5794,GO:0017024,1,0.983131290533574,0,1,myosin I binding,MF,
5795,GO:0017025,1,0.492203631552712,0,23,TBP-class protein binding,MF,
5796,GO:0017034,1,0.824722546310394,0,5,Rap guanyl-nucleotide exchange factor activity,MF,
5798,GO:0017040,1,0.884812371549088,0,4,N-acylsphingosine amidohydrolase activity,MF,
5802,GO:0017050,1,0.939020734863484,0,2,D-erythro-sphingosine kinase activity,MF,
5804,GO:0017055,1,0.932549593610605,0,2,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
5806,GO:0017057,1,0.941802963062751,0,2,6-phosphogluconolactonase activity,MF,
5807,GO:0017059,1,0.771246636353146,0,8,serine C-palmitoyltransferase complex,CC,
5808,GO:0017060,1,0.935641077885814,0,2,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
5809,GO:0017061,1,0.95967318671744,0,1,S-methyl-5-thioadenosine phosphorylase activity,MF,
5810,GO:0017062,1,0.750246799413677,0,9,respiratory chain complex III assembly,BP,
5811,GO:0017064,1,0.970943193427557,0,1,fatty acid amide hydrolase activity,MF,
5812,GO:0017065,1,0.975814608731305,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
5814,GO:0017070,1,0.723352893102939,0,11,U6 snRNA binding,MF,
5815,GO:0017075,1,0.595985303217032,0,14,syntaxin-1 binding,MF,
5819,GO:0017082,1,0.965469978279355,0,1,mineralocorticoid receptor activity,MF,
5820,GO:0017084,1,0.962674958488356,0,1,delta1-pyrroline-5-carboxylate synthetase activity,MF,
5822,GO:0017087,1,0.961168426610387,0,1,mitochondrial processing peptidase complex,CC,
5823,GO:0017089,1,0.941836706874682,0,2,glycolipid transporter activity,MF,
5825,GO:0017095,1,0.922706555882102,0,2,heparan sulfate 6-O-sulfotransferase activity,MF,
5826,GO:0017098,1,0.967644020655307,0,1,sulfonylurea receptor binding,MF,
5827,GO:0017099,1,0.884579950996091,0,4,very-long-chain-acyl-CoA dehydrogenase activity,MF,
5828,GO:0017101,1,0.678714505058426,0,12,aminoacyl-tRNA synthetase multienzyme complex,CC,
5829,GO:0017102,1,0.932774506704826,0,2,methionyl glutamyl tRNA synthetase complex,CC,
5830,GO:0017108,1,0.809046984614441,0,6,5'-flap endonuclease activity,MF,
5831,GO:0017109,1,0.927589540336195,0,2,glutamate-cysteine ligase complex,CC,
5832,GO:0017110,1,0.658843581616184,0,13,nucleoside-diphosphatase activity,MF,
5835,GO:0017113,1,0.96422412068149,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
5836,GO:0017116,1,0.893819079939175,0,3,single-stranded DNA-dependent ATP-dependent DNA helicase activity,MF,
5837,GO:0017119,1,0.653249106543703,0,12,Golgi transport complex,CC,
5838,GO:0017121,1,0.790030614604304,0,7,phospholipid scrambling,BP,
5840,GO:0017125,1,0.959793907635471,0,1,deoxycytidyl transferase activity,MF,
5841,GO:0017126,1,0.959531064667319,0,1,nucleologenesis,BP,
5843,GO:0017128,1,0.814033456302346,0,6,phospholipid scramblase activity,MF,
5844,GO:0017130,1,0.95950763690405,0,1,poly(C) RNA binding,MF,
5845,GO:0017133,1,0.968999810749328,0,1,mitochondrial electron transfer flavoprotein complex,CC,
5849,GO:0017143,1,0.935117087024613,0,2,insecticide metabolic process,BP,
5851,GO:0017145,1,0.379904423868713,0,26,stem cell division,BP,
5852,GO:0017146,1,0.885288381755832,0,3,NMDA selective glutamate receptor complex,CC,
5853,GO:0017147,1,0.456161060513364,0,21,Wnt-protein binding,MF,
5855,GO:0017150,1,0.887292632693373,0,4,tRNA dihydrouridine synthase activity,MF,
5857,GO:0017153,1,0.860764770512806,0,4,sodium:dicarboxylate symporter activity,MF,
5858,GO:0017154,1,0.667259895120179,0,10,semaphorin receptor activity,MF,
5862,GO:0017160,1,0.595128008742917,0,14,Ral GTPase binding,MF,
5863,GO:0017161,1,0.921852166729382,0,2,inositol-1,3,4-trisphosphate 4-phosphatase activity,MF,
5864,GO:0017162,1,0.755651610254319,0,8,aryl hydrocarbon receptor binding,MF,
5865,GO:0017166,1,0.675330216279375,0,10,vinculin binding,MF,
5866,GO:0017168,1,0.960897596709916,0,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,
5867,GO:0017169,1,0.8146455410478,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
5869,GO:0017176,1,0.836319479400883,0,7,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,
5870,GO:0017177,1,0.961222559055262,0,1,glucosidase II complex,CC,
5871,GO:0017178,1,0.965469978279355,0,1,diphthine-ammonia ligase activity,MF,
5872,GO:0017182,1,0.737366887843953,0,9,peptidyl-diphthamide metabolic process,BP,
5873,GO:0017183,1,0.737366887843953,0,9,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
5874,GO:0017185,1,0.748821378353721,0,8,peptidyl-lysine hydroxylation,BP,
5875,GO:0017186,1,0.945718801031391,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
5876,GO:0017187,1,0.893497848306476,0,4,peptidyl-glutamic acid carboxylation,BP,
5877,GO:0017196,1,0.814947254976662,0,6,N-terminal peptidyl-methionine acetylation,BP,
5878,GO:0017198,1,0.983235665013756,0,1,N-terminal peptidyl-serine acetylation,BP,
5879,GO:0018002,1,0.983235665013756,0,1,N-terminal peptidyl-glutamic acid acetylation,BP,
5880,GO:0018008,1,0.920943340100716,0,2,N-terminal peptidyl-glycine N-myristoylation,BP,
5881,GO:0018009,1,0.970690301828148,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
5882,GO:0018011,1,0.965469978279355,0,1,N-terminal peptidyl-alanine methylation,BP,
5883,GO:0018012,1,0.965469978279355,0,1,N-terminal peptidyl-alanine trimethylation,BP,
5884,GO:0018013,1,0.965469978279355,0,1,N-terminal peptidyl-glycine methylation,BP,
5885,GO:0018016,1,0.965469978279355,0,1,N-terminal peptidyl-proline dimethylation,BP,
5887,GO:0018023,1,0.276862036613525,0,37,peptidyl-lysine trimethylation,BP,
5888,GO:0018024,1,0.239920335582186,0,40,histone-lysine N-methyltransferase activity,MF,
5889,GO:0018025,1,0.965469978279355,0,1,calmodulin-lysine N-methyltransferase activity,MF,
5890,GO:0018026,1,0.731368280153537,0,9,peptidyl-lysine monomethylation,BP,
5891,GO:0018027,1,0.61738969836409,0,14,peptidyl-lysine dimethylation,BP,
5892,GO:0018032,1,0.961748720514894,0,1,protein amidation,BP,
5893,GO:0018057,1,0.895033914844124,0,3,peptidyl-lysine oxidation,BP,
5894,GO:0018063,1,0.969495428197879,0,1,cytochrome c-heme linkage,BP,
5895,GO:0018065,1,0.782897961731622,0,11,protein-cofactor linkage,BP,
5897,GO:0018094,1,0.962930732430284,0,1,protein polyglycylation,BP,
5898,GO:0018095,1,0.75044792442483,0,8,protein polyglutamylation,BP,
5899,GO:0018101,1,0.963877213708537,0,1,protein citrullination,BP,
5900,GO:0018103,1,0.80626962628764,0,6,protein C-linked glycosylation,BP,
5902,GO:0018106,1,0.985054986897857,0,1,peptidyl-histidine phosphorylation,BP,
5905,GO:0018114,1,0.968092371147854,0,1,threonine racemase activity,MF,
5906,GO:0018117,1,0.975028065885525,0,1,protein adenylylation,BP,
5908,GO:0018125,1,0.914388494285652,0,3,peptidyl-cysteine methylation,BP,
5909,GO:0018126,1,0.486267904293182,0,20,protein hydroxylation,BP,
5913,GO:0018153,1,0.937145562833651,0,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,
5914,GO:0018158,1,0.762087574854132,0,9,protein oxidation,BP,
5915,GO:0018160,1,0.976824874083371,0,1,peptidyl-pyrromethane cofactor linkage,BP,
5916,GO:0018166,1,0.959570082177354,0,1,C-terminal protein-tyrosinylation,BP,
5917,GO:0018171,1,0.8986092558096,0,4,peptidyl-cysteine oxidation,BP,
5918,GO:0018175,1,0.975028065885525,0,1,protein nucleotidylation,BP,
5919,GO:0018192,1,0.96827547172546,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
5921,GO:0018194,1,0.965469978279355,0,1,peptidyl-alanine modification,BP,
5922,GO:0018195,1,0.586881240051251,0,17,peptidyl-arginine modification,BP,
5923,GO:0018196,1,0.293723354994484,0,39,peptidyl-asparagine modification,BP,
5924,GO:0018197,1,0.887074416031773,0,3,peptidyl-aspartic acid modification,BP,
5926,GO:0018199,1,0.886268037062033,0,4,peptidyl-glutamine modification,BP,
5927,GO:0018200,1,0.588529150698513,0,16,peptidyl-glutamic acid modification,BP,
5928,GO:0018201,1,0.889136672601007,0,3,peptidyl-glycine modification,BP,
5929,GO:0018202,1,0.696903971004237,0,11,peptidyl-histidine modification,BP,
5931,GO:0018206,1,0.717138857522098,0,10,peptidyl-methionine modification,BP,
5935,GO:0018211,1,0.80626962628764,0,6,peptidyl-tryptophan modification,BP,
5937,GO:0018214,1,0.893497848306476,0,4,protein carboxylation,BP,
5938,GO:0018216,1,0.650126353504231,0,13,peptidyl-arginine methylation,BP,
5939,GO:0018217,1,0.960965422041728,0,1,peptidyl-aspartic acid phosphorylation,BP,
5940,GO:0018230,1,0.559159948860094,0,18,peptidyl-L-cysteine S-palmitoylation,BP,
5941,GO:0018231,1,0.559159948860094,0,18,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,
5942,GO:0018242,1,0.611834619046789,0,13,protein O-linked glycosylation via serine,BP,
5943,GO:0018243,1,0.633742472553647,0,12,protein O-linked glycosylation via threonine,BP,
5944,GO:0018262,1,0.937145562833651,0,2,isopeptide cross-linking,BP,
5945,GO:0018271,1,0.95950763690405,0,1,biotin-protein ligase activity,MF,
5946,GO:0018272,1,0.97411570855655,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
5947,GO:0018277,1,0.968933310120561,0,1,protein deamination,BP,
5948,GO:0018279,1,0.306156642011563,0,38,protein N-linked glycosylation via asparagine,BP,
5949,GO:0018282,1,0.929583021811392,0,2,metal incorporation into metallo-sulfur cluster,BP,
5950,GO:0018283,1,0.929583021811392,0,2,iron incorporation into metallo-sulfur cluster,BP,
5951,GO:0018293,1,0.979613059364224,0,1,protein-FAD linkage,BP,
5952,GO:0018298,1,0.89516607156651,0,3,protein-chromophore linkage,BP,
5953,GO:0018307,1,0.951504261290537,0,2,enzyme active site formation,BP,
5954,GO:0018312,1,0.934923373676735,0,2,peptidyl-serine ADP-ribosylation,BP,
5955,GO:0018315,1,0.960409336878159,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
5956,GO:0018317,1,0.80626962628764,0,6,protein C-linked glycosylation via tryptophan,BP,
5957,GO:0018322,1,0.959570082177354,0,1,protein tyrosinylation,BP,
5958,GO:0018323,1,0.98268071838369,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
5959,GO:0018335,1,0.860447170767109,0,4,protein succinylation,BP,
5960,GO:0018342,1,0.737709263976794,0,9,protein prenylation,BP,
5961,GO:0018343,1,0.910208833775037,0,3,protein farnesylation,BP,
5962,GO:0018344,1,0.824020266588116,0,6,protein geranylgeranylation,BP,
5963,GO:0018345,1,0.405934825286434,0,27,protein palmitoylation,BP,
5964,GO:0018352,1,0.943800961779598,0,2,protein-pyridoxal-5-phosphate linkage,BP,
5965,GO:0018364,1,0.967178119003345,0,2,peptidyl-glutamine methylation,BP,
5966,GO:0018377,1,0.854590512407345,0,4,protein myristoylation,BP,
5969,GO:0018395,1,0.962108754463036,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
5970,GO:0018400,1,0.95950763690405,0,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,
5971,GO:0018401,1,0.841058487509075,0,5,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,
5972,GO:0018406,1,0.80626962628764,0,6,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,
5974,GO:0018423,1,0.944775237772646,0,2,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
5975,GO:0018444,1,0.891331046870547,0,3,translation release factor complex,CC,
5976,GO:0018455,1,0.978821283132607,0,1,alcohol dehydrogenase [NAD(P)+] activity,MF,
5977,GO:0018467,1,0.966980370923912,0,1,formaldehyde dehydrogenase activity,MF,
5978,GO:0018478,1,0.970296941415236,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
5979,GO:0018479,1,0.970959616480647,0,1,benzaldehyde dehydrogenase (NAD+) activity,MF,
5980,GO:0018585,1,0.970476598173301,0,1,fluorene oxygenase activity,MF,
5981,GO:0018636,1,0.954817137752606,0,2,phenanthrene 9,10-monooxygenase activity,MF,
5982,GO:0018738,1,0.979722523940509,0,1,S-formylglutathione hydrolase activity,MF,
5983,GO:0018773,1,0.974728672087704,0,1,acetylpyruvate hydrolase activity,MF,
5984,GO:0018812,1,0.868854350931026,0,4,3-hydroxyacyl-CoA dehydratase activity,MF,
5985,GO:0018872,1,0.968162539753859,0,1,arsonoacetate metabolic process,BP,
5986,GO:0018879,1,0.909158087820093,0,3,biphenyl metabolic process,BP,
5987,GO:0018894,1,0.901642896888254,0,3,dibenzo-p-dioxin metabolic process,BP,
5988,GO:0018904,1,0.686100854518451,0,13,ether metabolic process,BP,
5989,GO:0018916,1,0.900921176287448,0,4,nitrobenzene metabolic process,BP,
5990,GO:0018917,1,0.970476598173301,0,1,fluorene metabolic process,BP,
5991,GO:0018931,1,0.977507342145317,0,1,naphthalene metabolic process,BP,
5993,GO:0018963,1,0.940363260171789,0,2,phthalate metabolic process,BP,
5995,GO:0018993,1,0.965362156840262,0,1,somatic sex determination,BP,
5998,GO:0019002,1,0.93576930234647,0,2,GMP binding,MF,
6000,GO:0019005,1,0.180008249358225,0,52,SCF ubiquitin ligase complex,CC,
6001,GO:0019008,1,0.938789444373182,0,2,molybdopterin synthase complex,CC,
6002,GO:0019034,1,0.921510099823807,0,2,viral replication complex,CC,
6003,GO:0019035,1,0.959507688488047,0,1,viral integration complex,CC,
6004,GO:0019042,1,0.697135151425558,0,11,viral latency,BP,
6005,GO:0019043,1,0.757263719668893,0,9,establishment of viral latency,BP,
6006,GO:0019045,1,0.920650957478618,0,2,latent virus replication,BP,
6007,GO:0019046,1,0.920650957478618,0,2,release from viral latency,BP,
6010,GO:0019050,1,0.917627164374237,0,3,suppression by virus of host apoptotic process,BP,
6013,GO:0019060,1,0.958958617476767,0,2,intracellular transport of viral protein in host cell,BP,
6014,GO:0019061,1,0.969594701537399,0,1,uncoating of virus,BP,
6015,GO:0019062,1,0.881315241637329,0,4,virion attachment to host cell,BP,
6016,GO:0019064,1,0.910418283630571,0,3,fusion of virus membrane with host plasma membrane,BP,
6017,GO:0019065,1,0.89434347333198,0,3,receptor-mediated endocytosis of virus by host cell,BP,
6018,GO:0019068,1,0.324921969085581,0,36,virion assembly,BP,
6019,GO:0019072,1,0.92201240631435,0,2,viral genome packaging,BP,
6020,GO:0019074,1,0.92201240631435,0,2,viral RNA genome packaging,BP,
6021,GO:0019075,1,0.932129376517163,0,2,virus maturation,BP,
6025,GO:0019081,1,0.625845163055787,0,14,viral translation,BP,
6026,GO:0019082,1,0.960553968499037,0,1,viral protein processing,BP,
6028,GO:0019085,1,0.924813769537602,0,2,early viral transcription,BP,
6029,GO:0019086,1,0.878331850108969,0,4,late viral transcription,BP,
6030,GO:0019087,1,0.908161661563602,0,3,transformation of host cell by virus,BP,
6031,GO:0019088,1,0.975655724279616,0,1,immortalization of host cell by virus,BP,
6032,GO:0019089,1,0.95950763690405,0,1,transmission of virus,BP,
6033,GO:0019098,1,0.55431608864571,0,17,reproductive behavior,BP,
6035,GO:0019101,1,0.965362156840262,0,1,female somatic sex determination,BP,
6036,GO:0019103,1,0.84481016377286,0,6,pyrimidine nucleotide binding,MF,
6038,GO:0019107,1,0.920943340100716,0,2,myristoyltransferase activity,MF,
6039,GO:0019118,1,0.977916236444337,0,1,phenanthrene-epoxide hydrolase activity,MF,
6040,GO:0019119,1,0.977916236444337,0,1,phenanthrene-9,10-epoxide hydrolase activity,MF,
6041,GO:0019135,1,0.972814860458125,0,1,deoxyhypusine monooxygenase activity,MF,
6042,GO:0019136,1,0.888966578252667,0,4,deoxynucleoside kinase activity,MF,
6043,GO:0019144,1,0.956236348656328,0,2,ADP-sugar diphosphatase activity,MF,
6044,GO:0019145,1,0.967911421107606,0,1,aminobutyraldehyde dehydrogenase activity,MF,
6045,GO:0019150,1,0.971320046025628,0,1,D-ribulokinase activity,MF,
6046,GO:0019153,1,0.97552720519445,0,1,protein-disulfide reductase (glutathione) activity,MF,
6047,GO:0019158,1,0.887295757004347,0,3,mannokinase activity,MF,
6048,GO:0019166,1,0.919624242946793,0,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
6049,GO:0019171,1,0.95950763690405,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
6051,GO:0019185,1,0.928077412545855,0,2,snRNA-activating protein complex,CC,
6052,GO:0019187,1,0.961131193844183,0,1,beta-1,4-mannosyltransferase activity,MF,
6053,GO:0019198,1,0.671020564479414,0,10,transmembrane receptor protein phosphatase activity,MF,
6055,GO:0019200,1,0.51857224479135,0,19,carbohydrate kinase activity,MF,
6057,GO:0019202,1,0.962674958488356,0,1,amino acid kinase activity,MF,
6058,GO:0019203,1,0.834958917170355,0,5,carbohydrate phosphatase activity,MF,
6060,GO:0019206,1,0.74639849631431,0,10,nucleoside kinase activity,MF,
6068,GO:0019215,1,0.672326188838904,0,11,intermediate filament binding,MF,
6076,GO:0019226,1,0.385394951134589,0,27,transmission of nerve impulse,BP,
6077,GO:0019227,1,0.904313521923425,0,3,neuronal action potential propagation,BP,
6078,GO:0019228,1,0.629273542244645,0,13,neuronal action potential,BP,
6080,GO:0019230,1,0.920650957478618,0,2,proprioception,BP,
6082,GO:0019236,1,0.940526774633141,0,2,response to pheromone,BP,
6083,GO:0019237,1,0.80397807521354,0,6,centromeric DNA binding,MF,
6086,GO:0019240,1,0.850382372963854,0,4,citrulline biosynthetic process,BP,
6087,GO:0019242,1,0.971083205022903,0,1,methylglyoxal biosynthetic process,BP,
6088,GO:0019243,1,0.94163509654683,0,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,
6089,GO:0019249,1,0.910325215024504,0,3,lactate biosynthetic process,BP,
6090,GO:0019254,1,0.934176681687772,0,2,carnitine metabolic process, CoA-linked,BP,
6091,GO:0019255,1,0.943274255057829,0,2,glucose 1-phosphate metabolic process,BP,
6092,GO:0019262,1,0.873764151526221,0,5,N-acetylneuraminate catabolic process,BP,
6093,GO:0019264,1,0.939052002373933,0,2,glycine biosynthetic process from serine,BP,
6094,GO:0019276,1,0.965607768776367,0,1,UDP-N-acetylgalactosamine metabolic process,BP,
6095,GO:0019285,1,0.962322160905979,0,1,glycine betaine biosynthetic process from choline,BP,
6096,GO:0019287,1,0.925339598990189,0,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,
6097,GO:0019290,1,0.965294632921743,0,1,siderophore biosynthetic process,BP,
6098,GO:0019303,1,0.959694317632096,0,2,D-ribose catabolic process,BP,
6099,GO:0019317,1,0.794777768467148,0,6,fucose catabolic process,BP,
6101,GO:0019319,1,0.173084813156468,0,54,hexose biosynthetic process,BP,
6102,GO:0019320,1,0.289345349886145,0,38,hexose catabolic process,BP,
6103,GO:0019321,1,0.745502557428525,0,11,pentose metabolic process,BP,
6104,GO:0019322,1,0.895795445146782,0,4,pentose biosynthetic process,BP,
6105,GO:0019323,1,0.894842126026221,0,4,pentose catabolic process,BP,
6107,GO:0019341,1,0.967215647218539,0,1,dibenzo-p-dioxin catabolic process,BP,
6108,GO:0019343,1,0.942222894970286,0,2,cysteine biosynthetic process via cystathionine,BP,
6109,GO:0019344,1,0.912929440267712,0,3,cysteine biosynthetic process,BP,
6110,GO:0019346,1,0.885968313810123,0,4,transsulfuration,BP,
6111,GO:0019348,1,0.862705388294931,0,5,dolichol metabolic process,BP,
6112,GO:0019353,1,0.966572172411756,0,1,protoporphyrinogen IX biosynthetic process from glutamate,BP,
6114,GO:0019357,1,0.965469978279355,0,1,nicotinate nucleotide biosynthetic process,BP,
6115,GO:0019358,1,0.965469978279355,0,1,nicotinate nucleotide salvage,BP,
6119,GO:0019364,1,0.962607920802641,0,1,pyridine nucleotide catabolic process,BP,
6120,GO:0019365,1,0.965469978279355,0,1,pyridine nucleotide salvage,BP,
6121,GO:0019367,1,0.842051452556028,0,5,fatty acid elongation, saturated fatty acid,BP,
6122,GO:0019368,1,0.842051452556028,0,5,fatty acid elongation, unsaturated fatty acid,BP,
6124,GO:0019370,1,0.819648786656886,0,7,leukotriene biosynthetic process,BP,
6127,GO:0019373,1,0.816944614887955,0,6,epoxygenase P450 pathway,BP,
6128,GO:0019374,1,0.813866559494111,0,6,galactolipid metabolic process,BP,
6129,GO:0019375,1,0.903310710048148,0,3,galactolipid biosynthetic process,BP,
6130,GO:0019376,1,0.965373453992635,0,1,galactolipid catabolic process,BP,
6131,GO:0019377,1,0.696577222045992,0,11,glycolipid catabolic process,BP,
6132,GO:0019388,1,0.782515232216146,0,8,galactose catabolic process,BP,
6133,GO:0019389,1,0.966999821290441,0,1,glucuronoside metabolic process,BP,
6134,GO:0019391,1,0.966999821290441,0,1,glucuronoside catabolic process,BP,
6136,GO:0019400,1,0.649767894965497,0,14,alditol metabolic process,BP,
6137,GO:0019401,1,0.889388122646105,0,4,alditol biosynthetic process,BP,
6138,GO:0019402,1,0.97792677453395,0,1,galactitol metabolic process,BP,
6139,GO:0019405,1,0.808380725475867,0,6,alditol catabolic process,BP,
6140,GO:0019406,1,0.977507342145317,0,1,hexitol biosynthetic process,BP,
6141,GO:0019407,1,0.967753139758002,0,1,hexitol catabolic process,BP,
6142,GO:0019408,1,0.927963472838217,0,2,dolichol biosynthetic process,BP,
6143,GO:0019413,1,0.926397307532552,0,2,acetate biosynthetic process,BP,
6144,GO:0019417,1,0.925063606238736,0,2,sulfur oxidation,BP,
6145,GO:0019418,1,0.913889628446296,0,4,sulfide oxidation,BP,
6146,GO:0019427,1,0.926397307532552,0,2,acetyl-CoA biosynthetic process from acetate,BP,
6149,GO:0019433,1,0.692707560718139,0,11,triglyceride catabolic process,BP,
6152,GO:0019441,1,0.922418598255783,0,3,tryptophan catabolic process to kynurenine,BP,
6153,GO:0019448,1,0.967261870054133,0,1,L-cysteine catabolic process,BP,
6154,GO:0019464,1,0.911778596622869,0,3,glycine decarboxylation via glycine cleavage system,BP,
6155,GO:0019470,1,0.873833110042727,0,4,4-hydroxyproline catabolic process,BP,
6157,GO:0019474,1,0.898782674274902,0,3,L-lysine catabolic process to acetyl-CoA,BP,
6158,GO:0019477,1,0.898782674274902,0,3,L-lysine catabolic process,BP,
6159,GO:0019482,1,0.92787315795244,0,2,beta-alanine metabolic process,BP,
6160,GO:0019483,1,0.96422412068149,0,1,beta-alanine biosynthetic process,BP,
6161,GO:0019493,1,0.971973221568393,0,1,arginine catabolic process to proline,BP,
6162,GO:0019509,1,0.858169092181886,0,5,L-methionine salvage from methylthioadenosine,BP,
6164,GO:0019511,1,0.67941362605624,0,11,peptidyl-proline hydroxylation,BP,
6165,GO:0019516,1,0.967334818525518,0,1,lactate oxidation,BP,
6166,GO:0019518,1,0.975665631760242,0,1,L-threonine catabolic process to glycine,BP,
6167,GO:0019519,1,0.967753139758002,0,1,pentitol metabolic process,BP,
6168,GO:0019520,1,0.938730976130804,0,2,aldonic acid metabolic process,BP,
6169,GO:0019521,1,0.938730976130804,0,2,D-gluconate metabolic process,BP,
6170,GO:0019527,1,0.967753139758002,0,1,pentitol catabolic process,BP,
6171,GO:0019530,1,0.855307424189856,0,4,taurine metabolic process,BP,
6172,GO:0019531,1,0.827711056435569,0,5,oxalate transmembrane transporter activity,MF,
6173,GO:0019532,1,0.827711056435569,0,5,oxalate transport,BP,
6174,GO:0019534,1,0.854554529181322,0,4,toxin transmembrane transporter activity,MF,
6176,GO:0019541,1,0.900548424235039,0,3,propionate metabolic process,BP,
6177,GO:0019542,1,0.926397307532552,0,2,propionate biosynthetic process,BP,
6178,GO:0019543,1,0.972102727103467,0,1,propionate catabolic process,BP,
6179,GO:0019544,1,0.971973221568393,0,1,arginine catabolic process to glutamate,BP,
6180,GO:0019547,1,0.94964838868482,0,2,arginine catabolic process to ornithine,BP,
6181,GO:0019550,1,0.939954248592068,0,2,glutamate catabolic process to aspartate,BP,
6182,GO:0019551,1,0.939954248592068,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
6185,GO:0019563,1,0.835329513106664,0,5,glycerol catabolic process,BP,
6186,GO:0019585,1,0.693779266617031,0,12,glucuronate metabolic process,BP,
6187,GO:0019605,1,0.972508899337928,0,1,butyrate metabolic process,BP,
6189,GO:0019626,1,0.811278322057698,0,7,short-chain fatty acid catabolic process,BP,
6190,GO:0019627,1,0.730137192608997,0,10,urea metabolic process,BP,
6192,GO:0019640,1,0.873504287721904,0,5,glucuronate catabolic process to xylulose 5-phosphate,BP,
6193,GO:0019646,1,0.763128064420005,0,14,aerobic electron transport chain,BP,
6194,GO:0019659,1,0.965469978279355,0,1,glucose catabolic process to lactate,BP,
6195,GO:0019660,1,0.965469978279355,0,1,glycolytic fermentation,BP,
6196,GO:0019661,1,0.965469978279355,0,1,glucose catabolic process to lactate via pyruvate,BP,
6197,GO:0019666,1,0.965469978279355,0,1,nitrogenous compound fermentation,BP,
6200,GO:0019676,1,0.96024696931705,0,1,ammonia assimilation cycle,BP,
6201,GO:0019677,1,0.962607920802641,0,1,NAD catabolic process,BP,
6202,GO:0019682,1,0.550104207943202,0,20,glyceraldehyde-3-phosphate metabolic process,BP,
6205,GO:0019694,1,0.855307424189856,0,4,alkanesulfonate metabolic process,BP,
6206,GO:0019695,1,0.864742645017835,0,4,choline metabolic process,BP,
6207,GO:0019706,1,0.469447092145355,0,23,protein-cysteine S-palmitoyltransferase activity,MF,
6208,GO:0019707,1,0.469447092145355,0,23,protein-cysteine S-acyltransferase activity,MF,
6209,GO:0019720,1,0.817345851954138,0,6,Mo-molybdopterin cofactor metabolic process,BP,
6215,GO:0019732,1,0.931938434209234,0,2,antifungal humoral response,BP,
6216,GO:0019740,1,0.90849709923075,0,3,nitrogen utilization,BP,
6217,GO:0019742,1,0.968615547286787,0,1,pentacyclic triterpenoid metabolic process,BP,
6218,GO:0019747,1,0.983108116140981,0,1,regulation of isoprenoid metabolic process,BP,
6222,GO:0019755,1,0.879396065178989,0,4,one-carbon compound transport,BP,
6223,GO:0019763,1,0.935366370259888,0,2,immunoglobulin receptor activity,MF,
6224,GO:0019770,1,0.973947100683964,0,1,IgG receptor activity,MF,
6225,GO:0019773,1,0.87258773146969,0,7,proteasome core complex, alpha-subunit complex,CC,
6226,GO:0019774,1,0.834352279329353,0,10,proteasome core complex, beta-subunit complex,CC,
6227,GO:0019776,1,0.905937828719029,0,3,Atg8 ligase activity,MF,
6228,GO:0019777,1,0.948778565001997,0,2,Atg12 transferase activity,MF,
6229,GO:0019778,1,0.959643961346915,0,1,Atg12 activating enzyme activity,MF,
6230,GO:0019779,1,0.959643961346915,0,1,Atg8 activating enzyme activity,MF,
6231,GO:0019780,1,0.95950763690405,0,1,FAT10 activating enzyme activity,MF,
6232,GO:0019781,1,0.945031452755777,0,2,NEDD8 activating enzyme activity,MF,
6233,GO:0019782,1,0.963263511187272,0,1,ISG15 activating enzyme activity,MF,
6235,GO:0019784,1,0.823432162055746,0,7,NEDD8-specific protease activity,MF,
6236,GO:0019785,1,0.933404489773265,0,2,ISG15-specific protease activity,MF,
6238,GO:0019788,1,0.8570089354991,0,6,NEDD8 transferase activity,MF,
6240,GO:0019797,1,0.899937323989477,0,3,procollagen-proline 3-dioxygenase activity,MF,
6241,GO:0019798,1,0.815327656199988,0,6,procollagen-proline dioxygenase activity,MF,
6242,GO:0019799,1,0.965469978279355,0,1,tubulin N-acetyltransferase activity,MF,
6243,GO:0019800,1,0.976564484034383,0,1,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP,
6246,GO:0019810,1,0.963561401555438,0,1,putrescine binding,MF,
6247,GO:0019811,1,0.960004427287314,0,1,cocaine binding,MF,
6248,GO:0019814,1,0.959616422844776,0,1,immunoglobulin complex,CC,
6249,GO:0019815,1,0.959616422844776,0,1,B cell receptor complex,CC,
6250,GO:0019825,1,0.69196213133323,0,11,oxygen binding,MF,
6251,GO:0019826,1,0.931530248825867,0,2,oxygen sensor activity,MF,
6253,GO:0019828,1,0.978446360623188,0,1,aspartic-type endopeptidase inhibitor activity,MF,
6255,GO:0019834,1,0.929600720204285,0,3,phospholipase A2 inhibitor activity,MF,
6258,GO:0019840,1,0.651670247431403,0,13,isoprenoid binding,MF,
6259,GO:0019841,1,0.910861779162309,0,4,retinol binding,MF,
6262,GO:0019852,1,0.760639875500031,0,9,L-ascorbic acid metabolic process,BP,
6263,GO:0019853,1,0.976768554059973,0,1,L-ascorbic acid biosynthetic process,BP,
6265,GO:0019856,1,0.801064313660848,0,6,pyrimidine nucleobase biosynthetic process,BP,
6266,GO:0019857,1,0.883364048004276,0,3,5-methylcytosine metabolic process,BP,
6267,GO:0019858,1,0.944904837431011,0,2,cytosine metabolic process,BP,
6268,GO:0019859,1,0.935581118230264,0,2,thymine metabolic process,BP,
6269,GO:0019860,1,0.94074863979868,0,2,uracil metabolic process,BP,
6270,GO:0019862,1,0.975824564766843,0,1,IgA binding,MF,
6271,GO:0019863,1,0.977476059244459,0,1,IgE binding,MF,
6272,GO:0019864,1,0.973947100683964,0,1,IgG binding,MF,
6273,GO:0019865,1,0.928990432257369,0,3,immunoglobulin binding,MF,
6279,GO:0019878,1,0.926543544185302,0,2,lysine biosynthetic process via aminoadipic acid,BP,
6284,GO:0019886,1,0.0822210085446735,0,74,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,
6288,GO:0019896,1,0.666934267815004,0,11,axonal transport of mitochondrion,BP,
6297,GO:0019905,1,0.104701283063859,0,63,syntaxin binding,MF,
6298,GO:0019907,1,0.815130311615544,0,7,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6299,GO:0019908,1,0.595339486156608,0,16,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6300,GO:0019911,1,0.776746773811934,0,8,structural constituent of myelin sheath,MF,
6303,GO:0019918,1,0.874328900961881,0,4,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
6304,GO:0019919,1,0.800343075577587,0,7,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
6307,GO:0019934,1,0.83379907740564,0,5,cGMP-mediated signaling,BP,
6310,GO:0019948,1,0.936039457903662,0,2,SUMO activating enzyme activity,MF,
6315,GO:0019958,1,0.899944007416529,0,3,C-X-C chemokine binding,MF,
6316,GO:0019959,1,0.968085371787524,0,1,interleukin-8 binding,MF,
6318,GO:0019961,1,0.923701761181295,0,2,interferon binding,MF,
6319,GO:0019962,1,0.95950763690405,0,1,type I interferon binding,MF,
6320,GO:0019964,1,0.962686875867438,0,1,interferon-gamma binding,MF,
6324,GO:0019985,1,0.281473504379627,0,39,translesion synthesis,BP,
6325,GO:0019988,1,0.966323575434221,0,1,charged-tRNA amino acid modification,BP,
6326,GO:0019992,1,0.756782524982663,0,8,diacylglycerol binding,MF,
6327,GO:0020003,1,0.965469978279355,0,1,symbiont-containing vacuole,CC,
6328,GO:0020012,1,0.927482832823174,0,2,evasion or tolerance of host immune response,BP,
6331,GO:0020021,1,0.975655724279616,0,1,immortalization of host cell,BP,
6334,GO:0021501,1,0.97109973893736,0,1,prechordal plate formation,BP,
6335,GO:0021502,1,0.92338568035334,0,2,neural fold elevation formation,BP,
6336,GO:0021503,1,0.95950763690405,0,1,neural fold bending,BP,
6337,GO:0021508,1,0.95950763690405,0,1,floor plate formation,BP,
6339,GO:0021511,1,0.731205046390543,0,8,spinal cord patterning,BP,
6340,GO:0021512,1,0.960429125032102,0,1,spinal cord anterior/posterior patterning,BP,
6341,GO:0021513,1,0.761352669015273,0,7,spinal cord dorsal/ventral patterning,BP,
6342,GO:0021514,1,0.847751460969733,0,4,ventral spinal cord interneuron differentiation,BP,
6344,GO:0021516,1,0.927428939292639,0,2,dorsal spinal cord development,BP,
6346,GO:0021520,1,0.808311828537767,0,6,spinal cord motor neuron cell fate specification,BP,
6347,GO:0021521,1,0.883525697189267,0,3,ventral spinal cord interneuron specification,BP,
6349,GO:0021523,1,0.945553516862889,0,2,somatic motor neuron differentiation,BP,
6350,GO:0021524,1,0.941042405348094,0,2,visceral motor neuron differentiation,BP,
6351,GO:0021526,1,0.972953601805667,0,1,medial motor column neuron differentiation,BP,
6352,GO:0021527,1,0.959522005754726,0,1,spinal cord association neuron differentiation,BP,
6353,GO:0021532,1,0.380129339780561,0,27,neural tube patterning,BP,
6354,GO:0021533,1,0.719337512243618,0,9,cell differentiation in hindbrain,BP,
6355,GO:0021534,1,0.840657991993513,0,5,cell proliferation in hindbrain,BP,
6356,GO:0021535,1,0.681289923416883,0,10,cell migration in hindbrain,BP,
6359,GO:0021538,1,0.962442096191974,0,1,epithalamus development,BP,
6360,GO:0021539,1,0.946309385730879,0,2,subthalamus development,BP,
6361,GO:0021540,1,0.88407407293639,0,4,corpus callosum morphogenesis,BP,
6362,GO:0021541,1,0.960487389780408,0,1,ammon gyrus development,BP,
6366,GO:0021545,1,0.389995009662746,0,26,cranial nerve development,BP,
6367,GO:0021546,1,0.939599510081914,0,2,rhombomere development,BP,
6368,GO:0021547,1,0.97109973893736,0,1,midbrain-hindbrain boundary initiation,BP,
6369,GO:0021548,1,0.830601849242999,0,5,pons development,BP,
6371,GO:0021553,1,0.95950763690405,0,1,olfactory nerve development,BP,
6372,GO:0021554,1,0.804348593375002,0,6,optic nerve development,BP,
6373,GO:0021555,1,0.937468280661562,0,2,midbrain-hindbrain boundary morphogenesis,BP,
6374,GO:0021557,1,0.941235603223433,0,2,oculomotor nerve development,BP,
6375,GO:0021558,1,0.976999496905179,0,1,trochlear nerve development,BP,
6376,GO:0021559,1,0.798703816276807,0,6,trigeminal nerve development,BP,
6377,GO:0021560,1,0.932693732503927,0,2,abducens nerve development,BP,
6378,GO:0021561,1,0.803003455180695,0,6,facial nerve development,BP,
6379,GO:0021562,1,0.856094332896392,0,4,vestibulocochlear nerve development,BP,
6380,GO:0021563,1,0.924587243765377,0,2,glossopharyngeal nerve development,BP,
6381,GO:0021564,1,0.936606321148025,0,2,vagus nerve development,BP,
6382,GO:0021566,1,0.959660275719761,0,1,hypoglossal nerve development,BP,
6383,GO:0021569,1,0.975537072891635,0,1,rhombomere 3 development,BP,
6384,GO:0021570,1,0.975537072891635,0,1,rhombomere 4 development,BP,
6385,GO:0021571,1,0.963163523892684,0,1,rhombomere 5 development,BP,
6386,GO:0021572,1,0.963163523892684,0,1,rhombomere 6 development,BP,
6388,GO:0021577,1,0.961058355211294,0,1,hindbrain structural organization,BP,
6389,GO:0021578,1,0.886722710690787,0,3,hindbrain maturation,BP,
6390,GO:0021586,1,0.961380049307401,0,1,pons maturation,BP,
6392,GO:0021589,1,0.961058355211294,0,1,cerebellum structural organization,BP,
6393,GO:0021590,1,0.922350950826665,0,2,cerebellum maturation,BP,
6395,GO:0021592,1,0.959540479163537,0,1,fourth ventricle development,BP,
6396,GO:0021598,1,0.932693732503927,0,2,abducens nerve morphogenesis,BP,
6397,GO:0021599,1,0.932693732503927,0,2,abducens nerve formation,BP,
6398,GO:0021602,1,0.575202330103839,0,15,cranial nerve morphogenesis,BP,
6399,GO:0021603,1,0.862153873574666,0,4,cranial nerve formation,BP,
6400,GO:0021604,1,0.836773489946995,0,5,cranial nerve structural organization,BP,
6401,GO:0021610,1,0.803003455180695,0,6,facial nerve morphogenesis,BP,
6402,GO:0021612,1,0.836773489946995,0,5,facial nerve structural organization,BP,
6403,GO:0021615,1,0.963609636029821,0,1,glossopharyngeal nerve morphogenesis,BP,
6404,GO:0021618,1,0.959660275719761,0,1,hypoglossal nerve morphogenesis,BP,
6405,GO:0021622,1,0.963396276407058,0,1,oculomotor nerve morphogenesis,BP,
6406,GO:0021623,1,0.963396276407058,0,1,oculomotor nerve formation,BP,
6407,GO:0021626,1,0.886722710690787,0,3,central nervous system maturation,BP,
6408,GO:0021631,1,0.883541431071938,0,3,optic nerve morphogenesis,BP,
6409,GO:0021636,1,0.857764993843085,0,4,trigeminal nerve morphogenesis,BP,
6410,GO:0021637,1,0.857764993843085,0,4,trigeminal nerve structural organization,BP,
6411,GO:0021644,1,0.976134690872091,0,1,vagus nerve morphogenesis,BP,
6412,GO:0021648,1,0.928855334503976,0,2,vestibulocochlear nerve morphogenesis,BP,
6413,GO:0021649,1,0.968057406154827,0,1,vestibulocochlear nerve structural organization,BP,
6414,GO:0021650,1,0.95950763690405,0,1,vestibulocochlear nerve formation,BP,
6416,GO:0021675,1,0.205333910233684,0,43,nerve development,BP,
6417,GO:0021678,1,0.932453154352056,0,3,third ventricle development,BP,
6418,GO:0021679,1,0.929209793147726,0,2,cerebellar molecular layer development,BP,
6419,GO:0021680,1,0.570041624736854,0,15,cerebellar Purkinje cell layer development,BP,
6420,GO:0021681,1,0.788780103532677,0,7,cerebellar granular layer development,BP,
6421,GO:0021682,1,0.959507787140328,0,1,nerve maturation,BP,
6422,GO:0021683,1,0.836215280675949,0,5,cerebellar granular layer morphogenesis,BP,
6423,GO:0021684,1,0.898758097396893,0,3,cerebellar granular layer formation,BP,
6424,GO:0021685,1,0.95950763690405,0,1,cerebellar granular layer structural organization,BP,
6425,GO:0021687,1,0.929209793147726,0,2,cerebellar molecular layer morphogenesis,BP,
6426,GO:0021688,1,0.96333841813498,0,1,cerebellar molecular layer formation,BP,
6427,GO:0021691,1,0.922350950826665,0,2,cerebellar Purkinje cell layer maturation,BP,
6428,GO:0021692,1,0.729696976751611,0,8,cerebellar Purkinje cell layer morphogenesis,BP,
6429,GO:0021693,1,0.924326982496576,0,2,cerebellar Purkinje cell layer structural organization,BP,
6430,GO:0021694,1,0.822806253574554,0,5,cerebellar Purkinje cell layer formation,BP,
6434,GO:0021698,1,0.924326982496576,0,2,cerebellar cortex structural organization,BP,
6435,GO:0021699,1,0.922350950826665,0,2,cerebellar cortex maturation,BP,
6437,GO:0021702,1,0.822806253574554,0,5,cerebellar Purkinje cell differentiation,BP,
6438,GO:0021707,1,0.898758097396893,0,3,cerebellar granule cell differentiation,BP,
6439,GO:0021718,1,0.961380049307401,0,1,superior olivary nucleus development,BP,
6440,GO:0021722,1,0.961380049307401,0,1,superior olivary nucleus maturation,BP,
6441,GO:0021730,1,0.95950763690405,0,1,trigeminal sensory nucleus development,BP,
6442,GO:0021740,1,0.95950763690405,0,1,principal sensory nucleus of trigeminal nerve development,BP,
6443,GO:0021747,1,0.885527303421492,0,3,cochlear nucleus development,BP,
6445,GO:0021757,1,0.962031732755762,0,1,caudate nucleus development,BP,
6446,GO:0021758,1,0.962031732755762,0,1,putamen development,BP,
6449,GO:0021763,1,0.969903576232698,0,1,subthalamic nucleus development,BP,
6450,GO:0021764,1,0.920650957478618,0,2,amygdala development,BP,
6453,GO:0021769,1,0.896020586172848,0,3,orbitofrontal cortex development,BP,
6454,GO:0021771,1,0.959507712723564,0,1,lateral geniculate nucleus development,BP,
6457,GO:0021775,1,0.883525697189267,0,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,
6458,GO:0021776,1,0.883525697189267,0,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,
6459,GO:0021778,1,0.95950763690405,0,1,oligodendrocyte cell fate specification,BP,
6460,GO:0021779,1,0.95950763690405,0,1,oligodendrocyte cell fate commitment,BP,
6461,GO:0021780,1,0.95950763690405,0,1,glial cell fate specification,BP,
6464,GO:0021783,1,0.70784496829237,0,10,preganglionic parasympathetic fiber development,BP,
6465,GO:0021784,1,0.985673851116461,0,1,postganglionic parasympathetic fiber development,BP,
6466,GO:0021785,1,0.789676992768407,0,6,branchiomotor neuron axon guidance,BP,
6467,GO:0021794,1,0.771833435600471,0,7,thalamus development,BP,
6468,GO:0021795,1,0.328794713513841,0,30,cerebral cortex cell migration,BP,
6469,GO:0021796,1,0.895687654132969,0,3,cerebral cortex regionalization,BP,
6470,GO:0021797,1,0.962970307750424,0,1,forebrain anterior/posterior pattern specification,BP,
6471,GO:0021798,1,0.920811485104472,0,2,forebrain dorsal/ventral pattern formation,BP,
6472,GO:0021799,1,0.462604332951917,0,21,cerebral cortex radially oriented cell migration,BP,
6473,GO:0021800,1,0.82061296951221,0,5,cerebral cortex tangential migration,BP,
6474,GO:0021801,1,0.539085963952396,0,17,cerebral cortex radial glia guided migration,BP,
6475,GO:0021812,1,0.95950763690405,0,1,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,
6476,GO:0021814,1,0.765665985802076,0,7,cell motility involved in cerebral cortex radial glia guided migration,BP,
6477,GO:0021815,1,0.821649745191302,0,5,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,
6478,GO:0021816,1,0.926372432346771,0,2,extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration,BP,
6479,GO:0021817,1,0.886974465133433,0,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,
6480,GO:0021819,1,0.706331972430969,0,10,layer formation in cerebral cortex,BP,
6481,GO:0021822,1,0.970653851661716,0,1,negative regulation of cell motility involved in cerebral cortex radial glia guided migration,BP,
6482,GO:0021823,1,0.920778879658604,0,2,cerebral cortex tangential migration using cell-cell interactions,BP,
6483,GO:0021824,1,0.928855750669955,0,2,cerebral cortex tangential migration using cell-axon interactions,BP,
6484,GO:0021825,1,0.85525766010646,0,4,substrate-dependent cerebral cortex tangential migration,BP,
6486,GO:0021827,1,0.920778879658604,0,2,postnatal olfactory bulb interneuron migration,BP,
6487,GO:0021828,1,0.928855750669955,0,2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6489,GO:0021836,1,0.920778879658604,0,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,
6493,GO:0021846,1,0.579939621355156,0,14,cell proliferation in forebrain,BP,
6494,GO:0021847,1,0.92184223579625,0,2,ventricular zone neuroblast division,BP,
6495,GO:0021849,1,0.926072984312114,0,2,neuroblast division in subventricular zone,BP,
6497,GO:0021855,1,0.90089538255199,0,3,hypothalamus cell migration,BP,
6498,GO:0021856,1,0.928855750669955,0,2,hypothalamic tangential migration using cell-axon interactions,BP,
6499,GO:0021859,1,0.82874763311724,0,5,pyramidal neuron differentiation,BP,
6500,GO:0021860,1,0.82874763311724,0,5,pyramidal neuron development,BP,
6501,GO:0021861,1,0.810495456287261,0,7,forebrain radial glial cell differentiation,BP,
6502,GO:0021869,1,0.884507517225189,0,3,forebrain ventricular zone progenitor cell division,BP,
6503,GO:0021870,1,0.95950763690405,0,1,Cajal-Retzius cell differentiation,BP,
6506,GO:0021873,1,0.78841120765723,0,6,forebrain neuroblast division,BP,
6509,GO:0021881,1,0.962970307750424,0,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,
6513,GO:0021886,1,0.912402869428187,0,3,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
6514,GO:0021888,1,0.912402869428187,0,3,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
6519,GO:0021894,1,0.981233919576313,0,1,cerebral cortex GABAergic interneuron development,BP,
6521,GO:0021896,1,0.920669887994288,0,2,forebrain astrocyte differentiation,BP,
6522,GO:0021897,1,0.920669887994288,0,2,forebrain astrocyte development,BP,
6524,GO:0021902,1,0.92067381650789,0,2,commitment of neuronal cell to specific neuron type in forebrain,BP,
6525,GO:0021903,1,0.848596504772252,0,5,rostrocaudal neural tube patterning,BP,
6526,GO:0021904,1,0.518975583281943,0,18,dorsal/ventral neural tube patterning,BP,
6527,GO:0021910,1,0.79010329506943,0,6,smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6528,GO:0021914,1,0.929906760666254,0,2,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6530,GO:0021924,1,0.840657991993513,0,5,cell proliferation in external granule layer,BP,
6531,GO:0021930,1,0.840657991993513,0,5,cerebellar granule cell precursor proliferation,BP,
6532,GO:0021932,1,0.769040585697596,0,7,hindbrain radial glia guided cell migration,BP,
6533,GO:0021934,1,0.920651769691047,0,2,hindbrain tangential cell migration,BP,
6534,GO:0021935,1,0.920651769691047,0,2,cerebellar granule cell precursor tangential migration,BP,
6535,GO:0021936,1,0.885849248950208,0,3,regulation of cerebellar granule cell precursor proliferation,BP,
6536,GO:0021937,1,0.92276298174806,0,2,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,
6537,GO:0021938,1,0.92276298174806,0,2,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,
6538,GO:0021940,1,0.92276298174806,0,2,positive regulation of cerebellar granule cell precursor proliferation,BP,
6539,GO:0021941,1,0.960004427287314,0,1,negative regulation of cerebellar granule cell precursor proliferation,BP,
6540,GO:0021942,1,0.899065935067522,0,3,radial glia guided migration of Purkinje cell,BP,
6541,GO:0021943,1,0.855413080900614,0,4,formation of radial glial scaffolds,BP,
6542,GO:0021952,1,0.564898960884547,0,15,central nervous system projection neuron axonogenesis,BP,
6545,GO:0021955,1,0.472886021469486,0,20,central nervous system neuron axonogenesis,BP,
6546,GO:0021956,1,0.971840175661916,0,1,central nervous system interneuron axonogenesis,BP,
6547,GO:0021957,1,0.849904643192053,0,4,corticospinal tract morphogenesis,BP,
6548,GO:0021960,1,0.889886693446609,0,3,anterior commissure morphogenesis,BP,
6549,GO:0021965,1,0.920797429950406,0,2,spinal cord ventral commissure morphogenesis,BP,
6550,GO:0021966,1,0.959640944479446,0,1,corticospinal neuron axon guidance,BP,
6551,GO:0021972,1,0.959640944479446,0,1,corticospinal neuron axon guidance through spinal cord,BP,
6553,GO:0021979,1,0.877059525799109,0,4,hypothalamus cell differentiation,BP,
6556,GO:0021986,1,0.962442096191974,0,1,habenula development,BP,
6557,GO:0021987,1,0.0513586795739806,0,82,cerebral cortex development,BP,
6559,GO:0021993,1,0.959540479163537,0,1,initiation of neural tube closure,BP,
6560,GO:0021997,1,0.920650957478618,0,2,neural plate axis specification,BP,
6561,GO:0021998,1,0.962108754463036,0,1,neural plate mediolateral regionalization,BP,
6562,GO:0021999,1,0.850931821991579,0,5,neural plate anterior/posterior regionalization,BP,
6563,GO:0022007,1,0.893511954104448,0,3,convergent extension involved in neural plate elongation,BP,
6565,GO:0022009,1,0.869502650789532,0,4,central nervous system vasculogenesis,BP,
6566,GO:0022010,1,0.757864960425104,0,8,central nervous system myelination,BP,
6568,GO:0022012,1,0.95950763690405,0,1,subpallium cell proliferation in forebrain,BP,
6569,GO:0022018,1,0.95950763690405,0,1,lateral ganglionic eminence cell proliferation,BP,
6570,GO:0022027,1,0.847886966043643,0,4,interkinetic nuclear migration,BP,
6571,GO:0022028,1,0.849158018849168,0,4,tangential migration from the subventricular zone to the olfactory bulb,BP,
6573,GO:0022030,1,0.539085963952396,0,17,telencephalon glial cell migration,BP,
6575,GO:0022038,1,0.641585277351207,0,13,corpus callosum development,BP,
6576,GO:0022400,1,0.67021941393107,0,11,regulation of rhodopsin mediated signaling pathway,BP,
6599,GO:0022614,1,0.856721009588632,0,4,membrane to membrane docking,BP,
6600,GO:0022615,1,0.892947390923279,0,4,protein to membrane docking,BP,
6604,GO:0022622,1,0.984487367317405,0,1,root system development,BP,
6605,GO:0022624,1,0.532215675457889,0,24,proteasome accessory complex,CC,
6606,GO:0022625,1,0.286546329944147,0,63,cytosolic large ribosomal subunit,CC,
6607,GO:0022626,1,0.110322744670937,0,110,cytosolic ribosome,CC,
6608,GO:0022627,1,0.435426198580618,0,43,cytosolic small ribosomal subunit,CC,
6612,GO:0022824,1,0.775760422359161,0,7,transmitter-gated ion channel activity,MF,
6615,GO:0022834,1,0.226049365324212,0,40,ligand-gated channel activity,MF,
6616,GO:0022835,1,0.775760422359161,0,7,transmitter-gated channel activity,MF,
6621,GO:0022841,1,0.913872925645141,0,3,potassium ion leak channel activity,MF,
6624,GO:0022848,1,0.873287807182264,0,4,acetylcholine-gated cation-selective channel activity,MF,
6625,GO:0022849,1,0.959590301644531,0,1,glutamate-gated calcium ion channel activity,MF,
6626,GO:0022851,1,0.964080596108445,0,1,GABA-gated chloride ion channel activity,MF,
6629,GO:0022858,1,0.829879578262208,0,5,alanine transmembrane transporter activity,MF,
6630,GO:0022884,1,0.695228589821004,0,14,macromolecule transmembrane transporter activity,MF,
6631,GO:0022889,1,0.797711754948691,0,7,serine transmembrane transporter activity,MF,
6635,GO:0022904,1,0.112004011407375,0,94,respiratory electron transport chain,BP,
6637,GO:0023016,1,0.92444716271081,0,2,signal transduction by trans-phosphorylation,BP,
6639,GO:0023021,1,0.906947686826613,0,3,termination of signal transduction,BP,
6640,GO:0023023,1,0.698850699881998,0,12,MHC protein complex binding,MF,
6641,GO:0023024,1,0.963881994690651,0,1,MHC class I protein complex binding,MF,
6642,GO:0023025,1,0.935104118904593,0,2,MHC class Ib protein complex binding,MF,
6643,GO:0023026,1,0.747387660939126,0,10,MHC class II protein complex binding,MF,
6645,GO:0023030,1,0.935104118904593,0,2,MHC class Ib protein binding, via antigen binding groove,MF,
6647,GO:0023041,1,0.913014479932662,0,3,neuronal signal transduction,BP,
6655,GO:0030002,1,0.804944532044761,0,6,cellular anion homeostasis,BP,
6658,GO:0030007,1,0.774737355215394,0,7,cellular potassium ion homeostasis,BP,
6659,GO:0030008,1,0.696300083386707,0,13,TRAPP complex,CC,
6663,GO:0030015,1,0.837702408479543,0,5,CCR4-NOT core complex,CC,
6666,GO:0030018,1,0.0858325358961094,0,70,Z disc,CC,
6667,GO:0030020,1,0.896796004439674,0,3,extracellular matrix structural constituent conferring tensile strength,MF,
6668,GO:0030021,1,0.964456985633728,0,1,extracellular matrix structural constituent conferring compression resistance,MF,
6669,GO:0030023,1,0.883364048004276,0,3,extracellular matrix constituent conferring elasticity,MF,
6675,GO:0030033,1,0.573184009022543,0,15,microvillus assembly,BP,
6676,GO:0030035,1,0.889597745766689,0,3,microspike assembly,BP,
6678,GO:0030037,1,0.959644468541833,0,1,actin filament reorganization involved in cell cycle,BP,
6681,GO:0030042,1,0.284208581975538,0,35,actin filament depolymerization,BP,
6682,GO:0030043,1,0.888199819151487,0,4,actin filament fragmentation,BP,
6683,GO:0030046,1,0.889846272063074,0,3,parallel actin filament bundle assembly,BP,
6684,GO:0030047,1,0.890466392188071,0,3,actin modification,BP,
6686,GO:0030049,1,0.654848990376807,0,14,muscle filament sliding,BP,
6687,GO:0030050,1,0.788178844019074,0,6,vesicle transport along actin filament,BP,
6690,GO:0030056,1,0.780302336404996,0,6,hemidesmosome,CC,
6692,GO:0030060,1,0.930705764220484,0,3,L-malate dehydrogenase activity,MF,
6693,GO:0030061,1,0.842208620919033,0,5,mitochondrial crista,CC,
6694,GO:0030062,1,0.83147520296445,0,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,
6695,GO:0030070,1,0.89712986510204,0,3,insulin processing,BP,
6699,GO:0030091,1,0.833592181263014,0,7,protein repair,BP,
6705,GO:0030103,1,0.964068341794451,0,1,vasopressin secretion,BP,
6707,GO:0030108,1,0.976768554059973,0,1,HLA-A specific activating MHC class I receptor activity,MF,
6709,GO:0030117,1,0.0413527841491189,0,92,membrane coat,CC,
6710,GO:0030118,1,0.200556727389493,0,45,clathrin coat,CC,
6711,GO:0030119,1,0.213587579212355,0,43,AP-type membrane coat adaptor complex,CC,
6712,GO:0030120,1,0.166598241340315,0,52,vesicle coat,CC,
6713,GO:0030121,1,0.806801368447879,0,6,AP-1 adaptor complex,CC,
6714,GO:0030122,1,0.645928941565984,0,12,AP-2 adaptor complex,CC,
6715,GO:0030123,1,0.717027010284544,0,9,AP-3 adaptor complex,CC,
6716,GO:0030124,1,0.882444773341641,0,4,AP-4 adaptor complex,CC,
6717,GO:0030125,1,0.430740267300396,0,24,clathrin vesicle coat,CC,
6718,GO:0030126,1,0.616131384554338,0,15,COPI vesicle coat,CC,
6719,GO:0030127,1,0.604688520032188,0,14,COPII vesicle coat,CC,
6720,GO:0030128,1,0.619978013285274,0,13,clathrin coat of endocytic vesicle,CC,
6721,GO:0030130,1,0.686845217430885,0,11,clathrin coat of trans-Golgi network vesicle,CC,
6722,GO:0030131,1,0.363213429748144,0,28,clathrin adaptor complex,CC,
6723,GO:0030132,1,0.551797485237037,0,17,clathrin coat of coated pit,CC,
6728,GO:0030137,1,0.481207599422671,0,23,COPI-coated vesicle,CC,
6730,GO:0030140,1,0.385065016050853,0,28,trans-Golgi network transport vesicle,CC,
6732,GO:0030144,1,0.900659711115477,0,3,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
6736,GO:0030150,1,0.605029767512501,0,18,protein import into mitochondrial matrix,BP,
6737,GO:0030151,1,0.873009451798586,0,4,molybdenum ion binding,MF,
6740,GO:0030156,1,0.98497198627848,0,1,benzodiazepine receptor binding,MF,
6741,GO:0030157,1,0.806652692339832,0,6,pancreatic juice secretion,BP,
6742,GO:0030158,1,0.891434781211834,0,3,protein xylosyltransferase activity,MF,
6744,GO:0030160,1,0.89563010794061,0,3,GKAP/Homer scaffold activity,MF,
6749,GO:0030167,1,0.905129351228818,0,3,proteoglycan catabolic process,BP,
6754,GO:0030174,1,0.820161466351275,0,6,regulation of DNA-dependent DNA replication initiation,BP,
6766,GO:0030199,1,0.347686401019449,0,28,collagen fibril organization,BP,
6767,GO:0030200,1,0.905129351228818,0,3,heparan sulfate proteoglycan catabolic process,BP,
6769,GO:0030202,1,0.851427524702709,0,4,heparin metabolic process,BP,
6774,GO:0030207,1,0.735986376386062,0,9,chondroitin sulfate catabolic process,BP,
6776,GO:0030209,1,0.97022553835382,0,1,dermatan sulfate catabolic process,BP,
6777,GO:0030210,1,0.851427524702709,0,4,heparin biosynthetic process,BP,
6791,GO:0030226,1,0.883364048004276,0,3,apolipoprotein receptor activity,MF,
6794,GO:0030233,1,0.975076641206544,0,1,deoxynucleotide transmembrane transporter activity,MF,
6796,GO:0030235,1,0.788716323050154,0,7,nitric-oxide synthase regulator activity,MF,
6797,GO:0030237,1,0.927932558238785,0,2,female sex determination,BP,
6800,GO:0030240,1,0.95950763690405,0,1,skeletal muscle thin filament assembly,BP,
6801,GO:0030241,1,0.920650957478618,0,2,skeletal muscle myosin thick filament assembly,BP,
6802,GO:0030242,1,0.824155993338545,0,5,autophagy of peroxisome,BP,
6804,GO:0030247,1,0.800691267313552,0,6,polysaccharide binding,MF,
6805,GO:0030249,1,0.969648381987573,0,1,guanylate cyclase regulator activity,MF,
6806,GO:0030250,1,0.969648381987573,0,1,guanylate cyclase activator activity,MF,
6809,GO:0030259,1,0.876382595266638,0,4,lipid glycosylation,BP,
6811,GO:0030261,1,0.361955353563081,0,28,chromosome condensation,BP,
6812,GO:0030262,1,0.472538560307006,0,23,apoptotic nuclear changes,BP,
6813,GO:0030263,1,0.857690781092989,0,4,apoptotic chromosome condensation,BP,
6814,GO:0030264,1,0.965469978279355,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
6815,GO:0030267,1,0.913322210871206,0,3,glyoxylate reductase (NADP) activity,MF,
6816,GO:0030272,1,0.983270488978234,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
6818,GO:0030275,1,0.592576027518084,0,16,LRR domain binding,MF,
6823,GO:0030280,1,0.712364971738085,0,11,structural constituent of epidermis,MF,
6825,GO:0030283,1,0.982479465094501,0,1,testosterone dehydrogenase [NAD(P)] activity,MF,
6826,GO:0030284,1,0.831834929337983,0,5,estrogen receptor activity,MF,
6827,GO:0030285,1,0.773600610185278,0,7,integral component of synaptic vesicle membrane,CC,
6828,GO:0030286,1,0.317467706937777,0,34,dynein complex,CC,
6829,GO:0030289,1,0.886744467612959,0,4,protein phosphatase 4 complex,CC,
6830,GO:0030290,1,0.962263299830291,0,1,sphingolipid activator protein activity,MF,
6832,GO:0030292,1,0.90572555253279,0,3,protein tyrosine kinase inhibitor activity,MF,
6833,GO:0030294,1,0.97011105200139,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
6837,GO:0030298,1,0.979405733055773,0,1,receptor signaling protein tyrosine kinase activator activity,MF,
6840,GO:0030302,1,0.975076641206544,0,1,deoxynucleotide transport,BP,
6841,GO:0030305,1,0.973923768380021,0,1,heparanase activity,MF,
6842,GO:0030306,1,0.787267619842746,0,6,ADP-ribosylation factor binding,MF,
6847,GO:0030314,1,0.887896336299282,0,3,junctional membrane complex,CC,
6850,GO:0030317,1,0.393433548038822,0,28,flagellated sperm motility,BP,
6852,GO:0030320,1,0.804944532044761,0,6,cellular monovalent inorganic anion homeostasis,BP,
6853,GO:0030321,1,0.927756696717505,0,2,transepithelial chloride transport,BP,
6854,GO:0030322,1,0.938444030268073,0,2,stabilization of membrane potential,BP,
6857,GO:0030325,1,0.692959377338457,0,11,adrenal gland development,BP,
6859,GO:0030327,1,0.89506147992588,0,3,prenylated protein catabolic process,BP,
6860,GO:0030328,1,0.928429904171287,0,2,prenylcysteine catabolic process,BP,
6861,GO:0030329,1,0.928429904171287,0,2,prenylcysteine metabolic process,BP,
6863,GO:0030331,1,0.315396230052023,0,33,estrogen receptor binding,MF,
6868,GO:0030337,1,0.944417383938316,0,2,DNA polymerase processivity factor activity,MF,
6869,GO:0030342,1,0.963990358831639,0,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,
6870,GO:0030343,1,0.97535011377032,0,1,vitamin D3 25-hydroxylase activity,MF,
6871,GO:0030345,1,0.964456985633728,0,1,structural constituent of tooth enamel,MF,
6873,GO:0030348,1,0.933546877108994,0,2,syntaxin-3 binding,MF,
6874,GO:0030350,1,0.923358890087776,0,2,iron-responsive element binding,MF,
6875,GO:0030351,1,0.965735644384804,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
6876,GO:0030366,1,0.952868443009731,0,2,molybdopterin synthase activity,MF,
6879,GO:0030372,1,0.959753219292847,0,1,high molecular weight B cell growth factor receptor binding,MF,
6881,GO:0030375,1,0.888636261792297,0,3,thyroid hormone receptor coactivator activity,MF,
6883,GO:0030378,1,0.968092371147854,0,1,serine racemase activity,MF,
6884,GO:0030379,1,0.95950763690405,0,1,neurotensin receptor activity, non-G-protein coupled,MF,
6885,GO:0030388,1,0.88574464449695,0,4,fructose 1,6-bisphosphate metabolic process,BP,
6886,GO:0030389,1,0.98562610618749,0,1,fructosamine metabolic process,BP,
6887,GO:0030395,1,0.987152564600386,0,1,lactose binding,MF,
6890,GO:0030421,1,0.983108116140981,0,1,defecation,BP,
6891,GO:0030422,1,0.764273482178544,0,9,production of siRNA involved in RNA interference,BP,
6892,GO:0030423,1,0.87655621131907,0,4,targeting of mRNA for destruction involved in RNA interference,BP,
6895,GO:0030426,1,0.0123714239645269,0,121,growth cone,CC,
6896,GO:0030427,1,0.0104781604919156,0,125,site of polarized growth,CC,
6897,GO:0030430,1,0.868939008157368,0,4,host cell cytoplasm,CC,
6899,GO:0030432,1,0.945873272089563,0,2,peristalsis,BP,
6902,GO:0030473,1,0.818143776657618,0,5,nuclear migration along microtubule,BP,
6903,GO:0030474,1,0.965469978279355,0,1,spindle pole body duplication,BP,
6904,GO:0030478,1,0.856248786422505,0,4,actin cap,CC,
6905,GO:0030479,1,0.814616387428769,0,5,actin cortical patch,CC,
6906,GO:0030485,1,0.936700174031878,0,2,smooth muscle contractile fiber,CC,
6907,GO:0030488,1,0.352802071664327,0,32,tRNA methylation,BP,
6910,GO:0030497,1,0.716938417240267,0,10,fatty acid elongation,BP,
6914,GO:0030504,1,0.95950763690405,0,1,inorganic diphosphate transmembrane transporter activity,MF,
6915,GO:0030505,1,0.920650957478618,0,2,inorganic diphosphate transport,BP,
6916,GO:0030506,1,0.614439119644995,0,13,ankyrin binding,MF,
6917,GO:0030507,1,0.528336310514202,0,17,spectrin binding,MF,
6922,GO:0030513,1,0.466055707329239,0,22,positive regulation of BMP signaling pathway,BP,
6929,GO:0030521,1,0.129544613581876,0,58,androgen receptor signaling pathway,BP,
6931,GO:0030523,1,0.96026590075859,0,1,dihydrolipoamide S-acyltransferase activity,MF,
6932,GO:0030532,1,0.124493619309265,0,69,small nuclear ribonucleoprotein complex,CC,
6934,GO:0030538,1,0.927865825206982,0,2,embryonic genitalia morphogenesis,BP,
6941,GO:0030548,1,0.844887456413189,0,6,acetylcholine receptor regulator activity,MF,
6942,GO:0030549,1,0.980234604906956,0,1,acetylcholine receptor activator activity,MF,
6943,GO:0030550,1,0.905565802138715,0,3,acetylcholine receptor inhibitor activity,MF,
6944,GO:0030551,1,0.554819626411658,0,16,cyclic nucleotide binding,MF,
6945,GO:0030552,1,0.65482617966584,0,11,cAMP binding,MF,
6946,GO:0030553,1,0.886106696133162,0,3,cGMP binding,MF,
6948,GO:0030572,1,0.961523527165928,0,1,phosphatidyltransferase activity,MF,
6949,GO:0030574,1,0.234680187055441,0,39,collagen catabolic process,BP,
6951,GO:0030576,1,0.901136591606873,0,3,Cajal body organization,BP,
6953,GO:0030579,1,0.840432222312758,0,5,ubiquitin-dependent SMAD protein catabolic process,BP,
6954,GO:0030580,1,0.97896132643455,0,1,quinone cofactor methyltransferase activity,MF,
6955,GO:0030581,1,0.958958617476767,0,2,symbiont intracellular protein transport in host,BP,
6956,GO:0030586,1,0.963432130161792,0,1,[methionine synthase] reductase activity,MF,
6960,GO:0030611,1,0.982946100067738,0,1,arsenate reductase activity,MF,
6961,GO:0030613,1,0.944966773870591,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
6962,GO:0030614,1,0.944966773870591,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
6963,GO:0030616,1,0.95950763690405,0,1,transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,MF,
6964,GO:0030617,1,0.964431364167245,0,1,transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,MF,
6968,GO:0030621,1,0.805195572185714,0,6,U4 snRNA binding,MF,
6969,GO:0030622,1,0.898810610872076,0,3,U4atac snRNA binding,MF,
6970,GO:0030623,1,0.95950763690405,0,1,U5 snRNA binding,MF,
6971,GO:0030624,1,0.960217643807024,0,1,U6atac snRNA binding,MF,
6972,GO:0030626,1,0.935243300287478,0,2,U12 snRNA binding,MF,
6973,GO:0030627,1,0.946002619191743,0,2,pre-mRNA 5'-splice site binding,MF,
6974,GO:0030628,1,0.846111166992901,0,6,pre-mRNA 3'-splice site binding,MF,
6975,GO:0030629,1,0.965469978279355,0,1,U6 snRNA 3'-end binding,MF,
6976,GO:0030638,1,0.878717147081427,0,5,polyketide metabolic process,BP,
6978,GO:0030643,1,0.85844260279313,0,4,cellular phosphate ion homeostasis,BP,
6979,GO:0030644,1,0.937703307438728,0,2,cellular chloride ion homeostasis,BP,
6980,GO:0030647,1,0.878717147081427,0,5,aminoglycoside antibiotic metabolic process,BP,
6981,GO:0030653,1,0.959598545219491,0,1,beta-lactam antibiotic metabolic process,BP,
6987,GO:0030663,1,0.570301798735429,0,18,COPI-coated vesicle membrane,CC,
6996,GO:0030676,1,0.651486217158532,0,11,Rac guanyl-nucleotide exchange factor activity,MF,
6997,GO:0030677,1,0.70280892768946,0,13,ribonuclease P complex,CC,
6998,GO:0030678,1,0.9174386258161,0,3,mitochondrial ribonuclease P complex,CC,
6999,GO:0030681,1,0.7661002722592,0,10,multimeric ribonuclease P complex,CC,
7000,GO:0030682,1,0.927482832823174,0,2,evasion or tolerance of host defense response,BP,
7001,GO:0030683,1,0.927482832823174,0,2,evasion or tolerance by virus of host immune response,BP,
7003,GO:0030686,1,0.347379125586305,0,32,90S preribosome,CC,
7004,GO:0030687,1,0.484114538434117,0,24,preribosome, large subunit precursor,CC,
7005,GO:0030688,1,0.671166004680944,0,12,preribosome, small subunit precursor,CC,
7006,GO:0030689,1,0.909148538366672,0,3,Noc complex,CC,
7007,GO:0030690,1,0.965936228029112,0,1,Noc1p-Noc2p complex,CC,
7008,GO:0030691,1,0.965936228029112,0,1,Noc2p-Noc3p complex,CC,
7009,GO:0030692,1,0.941214687816075,0,2,Noc4p-Nop14p complex,CC,
7011,GO:0030696,1,0.964043889520126,0,1,tRNA (m5U54) methyltransferase activity,MF,
7012,GO:0030697,1,0.964043889520126,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
7013,GO:0030702,1,0.960897596709916,0,1,chromatin silencing at centromere,BP,
7014,GO:0030705,1,0.00463827467099244,0,152,cytoskeleton-dependent intracellular transport,BP,
7015,GO:0030718,1,0.961425186723365,0,1,germ-line stem cell population maintenance,BP,
7016,GO:0030719,1,0.967461720989723,0,1,P granule organization,BP,
7018,GO:0030729,1,0.963246010042085,0,1,acetoacetate-CoA ligase activity,MF,
7020,GO:0030731,1,0.981845137628092,0,1,guanidinoacetate N-methyltransferase activity,MF,
7021,GO:0030735,1,0.965469978279355,0,1,carnosine N-methyltransferase activity,MF,
7023,GO:0030748,1,0.96756271365883,0,1,amine N-methyltransferase activity,MF,
7024,GO:0030760,1,0.975745001181979,0,1,pyridine N-methyltransferase activity,MF,
7025,GO:0030791,1,0.968162539753859,0,1,arsenite methyltransferase activity,MF,
7026,GO:0030792,1,0.968162539753859,0,1,methylarsonite methyltransferase activity,MF,
7028,GO:0030800,1,0.712210383104532,0,10,negative regulation of cyclic nucleotide metabolic process,BP,
7030,GO:0030802,1,0.426846918693701,0,26,regulation of cyclic nucleotide biosynthetic process,BP,
7031,GO:0030803,1,0.768869073480015,0,8,negative regulation of cyclic nucleotide biosynthetic process,BP,
7032,GO:0030804,1,0.620599713351435,0,15,positive regulation of cyclic nucleotide biosynthetic process,BP,
7033,GO:0030805,1,0.888838618487412,0,3,regulation of cyclic nucleotide catabolic process,BP,
7034,GO:0030806,1,0.926356024535169,0,2,negative regulation of cyclic nucleotide catabolic process,BP,
7035,GO:0030807,1,0.95950763690405,0,1,positive regulation of cyclic nucleotide catabolic process,BP,
7037,GO:0030809,1,0.559051503512687,0,17,negative regulation of nucleotide biosynthetic process,BP,
7038,GO:0030810,1,0.323956611962242,0,33,positive regulation of nucleotide biosynthetic process,BP,
7040,GO:0030812,1,0.750482214366403,0,8,negative regulation of nucleotide catabolic process,BP,
7041,GO:0030813,1,0.622543707781456,0,12,positive regulation of nucleotide catabolic process,BP,
7043,GO:0030815,1,0.712210383104532,0,10,negative regulation of cAMP metabolic process,BP,
7045,GO:0030817,1,0.539468651924404,0,19,regulation of cAMP biosynthetic process,BP,
7046,GO:0030818,1,0.768869073480015,0,8,negative regulation of cAMP biosynthetic process,BP,
7047,GO:0030819,1,0.752995673105434,0,9,positive regulation of cAMP biosynthetic process,BP,
7048,GO:0030820,1,0.888838618487412,0,3,regulation of cAMP catabolic process,BP,
7049,GO:0030821,1,0.926356024535169,0,2,negative regulation of cAMP catabolic process,BP,
7050,GO:0030822,1,0.95950763690405,0,1,positive regulation of cAMP catabolic process,BP,
7053,GO:0030826,1,0.791524653592254,0,7,regulation of cGMP biosynthetic process,BP,
7054,GO:0030828,1,0.824288708963626,0,6,positive regulation of cGMP biosynthetic process,BP,
7057,GO:0030834,1,0.3203090805602,0,32,regulation of actin filament depolymerization,BP,
7058,GO:0030835,1,0.414327820545792,0,24,negative regulation of actin filament depolymerization,BP,
7059,GO:0030836,1,0.79964246901649,0,7,positive regulation of actin filament depolymerization,BP,
7060,GO:0030837,1,0.271342245625694,0,38,negative regulation of actin filament polymerization,BP,
7062,GO:0030846,1,0.95950763690405,0,1,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7063,GO:0030849,1,0.959575340213997,0,1,autosome,CC,
7074,GO:0030860,1,0.928778206106253,0,2,regulation of polarized epithelial cell differentiation,BP,
7075,GO:0030862,1,0.959510825131099,0,1,positive regulation of polarized epithelial cell differentiation,BP,
7076,GO:0030863,1,0.0526164944581597,0,79,cortical cytoskeleton,CC,
7077,GO:0030864,1,0.11119243780145,0,59,cortical actin cytoskeleton,CC,
7081,GO:0030868,1,0.912366951617592,0,3,smooth endoplasmic reticulum membrane,CC,
7082,GO:0030870,1,0.82869767741537,0,5,Mre11 complex,CC,
7083,GO:0030874,1,0.974365896217661,0,1,nucleolar chromatin,CC,
7084,GO:0030877,1,0.692354600467785,0,10,beta-catenin destruction complex,CC,
7089,GO:0030882,1,0.961579994842804,0,1,lipid antigen binding,MF,
7090,GO:0030883,1,0.961579994842804,0,1,endogenous lipid antigen binding,MF,
7091,GO:0030884,1,0.961579994842804,0,1,exogenous lipid antigen binding,MF,
7092,GO:0030885,1,0.927704889191805,0,3,regulation of myeloid dendritic cell activation,BP,
7093,GO:0030886,1,0.945221503547106,0,2,negative regulation of myeloid dendritic cell activation,BP,
7097,GO:0030891,1,0.884015937458388,0,4,VCB complex,CC,
7098,GO:0030893,1,0.893600951568033,0,3,meiotic cohesin complex,CC,
7100,GO:0030895,1,0.966342046405042,0,1,apolipoprotein B mRNA editing enzyme complex,CC,
7101,GO:0030896,1,0.851493255946848,0,5,checkpoint clamp complex,CC,
7102,GO:0030897,1,0.592728031127843,0,14,HOPS complex,CC,
7104,GO:0030899,1,0.981822393206615,0,1,calcium-dependent ATPase activity,MF,
7109,GO:0030904,1,0.50232507357487,0,20,retromer complex,CC,
7110,GO:0030905,1,0.872765580672399,0,4,retromer, tubulation complex,CC,
7111,GO:0030906,1,0.87908053985073,0,4,retromer, cargo-selective complex,CC,
7112,GO:0030910,1,0.923973743000541,0,2,olfactory placode formation,BP,
7113,GO:0030911,1,0.740935759313973,0,8,TPR domain binding,MF,
7114,GO:0030913,1,0.775100646587417,0,7,paranodal junction assembly,BP,
7115,GO:0030914,1,0.689037321144298,0,12,STAGA complex,CC,
7116,GO:0030915,1,0.816049330874271,0,7,Smc5-Smc6 complex,CC,
7118,GO:0030917,1,0.873499222784822,0,4,midbrain-hindbrain boundary development,BP,
7119,GO:0030920,1,0.983235665013756,0,1,peptidyl-serine acetylation,BP,
7120,GO:0030934,1,0.920650957478618,0,2,anchoring collagen complex,CC,
7121,GO:0030935,1,0.96710076651168,0,1,sheet-forming collagen trimer,CC,
7122,GO:0030936,1,0.964560229490338,0,1,transmembrane collagen trimer,CC,
7123,GO:0030942,1,0.920271148458778,0,3,endoplasmic reticulum signal peptide binding,MF,
7124,GO:0030943,1,0.907572249122022,0,3,mitochondrion targeting sequence binding,MF,
7129,GO:0030951,1,0.862300910853497,0,4,establishment or maintenance of microtubule cytoskeleton polarity,BP,
7131,GO:0030953,1,0.760694998384398,0,7,astral microtubule organization,BP,
7132,GO:0030955,1,0.711339738876387,0,9,potassium ion binding,MF,
7133,GO:0030956,1,0.91725123304458,0,3,glutamyl-tRNA(Gln) amidotransferase complex,CC,
7134,GO:0030957,1,0.723010566895652,0,10,Tat protein binding,MF,
7135,GO:0030961,1,0.965469978279355,0,1,peptidyl-arginine hydroxylation,BP,
7136,GO:0030964,1,0.456668736736086,0,42,NADH dehydrogenase complex,CC,
7139,GO:0030970,1,0.43448340799962,0,25,retrograde protein transport, ER to cytosol,BP,
7141,GO:0030974,1,0.942865314225329,0,2,thiamine pyrophosphate transmembrane transport,BP,
7142,GO:0030976,1,0.834935042126958,0,5,thiamine pyrophosphate binding,MF,
7143,GO:0030981,1,0.890371104598603,0,3,cortical microtubule cytoskeleton,CC,
7145,GO:0030984,1,0.946230689976432,0,2,kininogen binding,MF,
7146,GO:0030990,1,0.351463668522664,0,30,intraciliary transport particle,CC,
7147,GO:0030991,1,0.731381051513544,0,8,intraciliary transport particle A,CC,
7148,GO:0030992,1,0.531416359140542,0,19,intraciliary transport particle B,CC,
7149,GO:0030997,1,0.896807291146999,0,3,regulation of centriole-centriole cohesion,BP,
7150,GO:0031000,1,0.663884483326238,0,12,response to caffeine,BP,
7151,GO:0031005,1,0.689605987468017,0,10,filamin binding,MF,
7152,GO:0031010,1,0.697240702512281,0,10,ISWI-type complex,CC,
7153,GO:0031011,1,0.649514090220295,0,15,Ino80 complex,CC,
7155,GO:0031013,1,0.974565797611057,0,1,troponin I binding,MF,
7156,GO:0031014,1,0.967113411459424,0,2,troponin T binding,MF,
7158,GO:0031017,1,0.890680847260615,0,4,exocrine pancreas development,BP,
7160,GO:0031021,1,0.915102947075679,0,3,interphase microtubule organizing center,CC,
7161,GO:0031022,1,0.922257540833332,0,2,nuclear migration along microfilament,BP,
7164,GO:0031033,1,0.824948700880041,0,5,myosin filament organization,BP,
7165,GO:0031034,1,0.849668269271878,0,4,myosin filament assembly,BP,
7166,GO:0031038,1,0.970918583286906,0,1,myosin II filament organization,BP,
7169,GO:0031048,1,0.926882866603706,0,2,chromatin silencing by small RNA,BP,
7170,GO:0031049,1,0.965844339410484,0,1,programmed DNA elimination,BP,
7172,GO:0031052,1,0.965844339410484,0,1,chromosome breakage,BP,
7174,GO:0031054,1,0.638526024564229,0,13,pre-miRNA processing,BP,
7175,GO:0031055,1,0.368674122878673,0,42,chromatin remodeling at centromere,BP,
7179,GO:0031060,1,0.15229305268666,0,51,regulation of histone methylation,BP,
7180,GO:0031061,1,0.551052239495588,0,16,negative regulation of histone methylation,BP,
7181,GO:0031062,1,0.333464323884556,0,30,positive regulation of histone methylation,BP,
7182,GO:0031063,1,0.464488633923497,0,22,regulation of histone deacetylation,BP,
7183,GO:0031064,1,0.920651064011069,0,2,negative regulation of histone deacetylation,BP,
7184,GO:0031065,1,0.566341255205376,0,16,positive regulation of histone deacetylation,BP,
7185,GO:0031069,1,0.5418891430972,0,17,hair follicle morphogenesis,BP,
7186,GO:0031071,1,0.968815727656145,0,1,cysteine desulfurase activity,MF,
7188,GO:0031074,1,0.903979177843179,0,3,nucleocytoplasmic transport complex,CC,
7190,GO:0031077,1,0.799169087374887,0,7,post-embryonic camera-type eye development,BP,
7192,GO:0031080,1,0.705091675587389,0,10,nuclear pore outer ring,CC,
7193,GO:0031081,1,0.92738462411158,0,2,nuclear pore distribution,BP,
7196,GO:0031084,1,0.891089765068986,0,3,BLOC-2 complex,CC,
7197,GO:0031085,1,0.928433254421499,0,2,BLOC-3 complex,CC,
7200,GO:0031088,1,0.850011085687157,0,5,platelet dense granule membrane,CC,
7201,GO:0031089,1,0.853106261951185,0,5,platelet dense granule lumen,CC,
7204,GO:0031092,1,0.668105895947236,0,11,platelet alpha granule membrane,CC,
7213,GO:0031104,1,0.96076275326809,0,1,dendrite regeneration,BP,
7214,GO:0031105,1,0.710213389119023,0,9,septin complex,CC,
7215,GO:0031106,1,0.634463157174614,0,12,septin ring organization,BP,
7222,GO:0031115,1,0.729680279393335,0,9,negative regulation of microtubule polymerization,BP,
7224,GO:0031117,1,0.932132718792457,0,2,positive regulation of microtubule depolymerization,BP,
7225,GO:0031118,1,0.82989108793271,0,8,rRNA pseudouridine synthesis,BP,
7226,GO:0031119,1,0.822901251612351,0,7,tRNA pseudouridine synthesis,BP,
7227,GO:0031120,1,0.919439361396973,0,4,snRNA pseudouridine synthesis,BP,
7231,GO:0031125,1,0.753507041322181,0,12,rRNA 3'-end processing,BP,
7232,GO:0031126,1,0.848417612011957,0,7,snoRNA 3'-end processing,BP,
7233,GO:0031127,1,0.926264719375324,0,2,alpha-(1,2)-fucosyltransferase activity,MF,
7235,GO:0031133,1,0.937618524309517,0,2,regulation of axon diameter,BP,
7236,GO:0031134,1,0.901859659109869,0,3,sister chromatid biorientation,BP,
7237,GO:0031143,1,0.657730018619986,0,12,pseudopodium,CC,
7238,GO:0031145,1,0.132573393083996,0,77,anaphase-promoting complex-dependent catabolic process,BP,
7239,GO:0031146,1,0.144982260785865,0,70,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,
7240,GO:0031151,1,0.95950763690405,0,1,histone methyltransferase activity (H3-K79 specific),MF,
7241,GO:0031161,1,0.964124867264658,0,1,phosphatidylinositol catabolic process,BP,
7242,GO:0031163,1,0.583065839756935,0,20,metallo-sulfur cluster assembly,BP,
7243,GO:0031166,1,0.891196694566004,0,3,integral component of vacuolar membrane,CC,
7244,GO:0031167,1,0.534372405306276,0,21,rRNA methylation,BP,
7246,GO:0031177,1,0.932740784915525,0,3,phosphopantetheine binding,MF,
7247,GO:0031179,1,0.961748720514894,0,1,peptide modification,BP,
7249,GO:0031204,1,0.9092129584553,0,3,posttranslational protein targeting to membrane, translocation,BP,
7250,GO:0031205,1,0.947123009456618,0,2,endoplasmic reticulum Sec complex,CC,
7251,GO:0031208,1,0.928315941853759,0,2,POZ domain binding,MF,
7252,GO:0031209,1,0.730820285863963,0,8,SCAR complex,CC,
7253,GO:0031210,1,0.68207753924804,0,12,phosphatidylcholine binding,MF,
7254,GO:0031211,1,0.771246636353146,0,8,endoplasmic reticulum palmitoyltransferase complex,CC,
7255,GO:0031213,1,0.922460603152258,0,2,RSF complex,CC,
7257,GO:0031223,1,0.785263506600654,0,6,auditory behavior,BP,
7263,GO:0031229,1,0.7424055505512,0,8,intrinsic component of nuclear inner membrane,CC,
7264,GO:0031231,1,0.63286150622337,0,15,intrinsic component of peroxisomal membrane,CC,
7265,GO:0031232,1,0.911858902161759,0,3,extrinsic component of external side of plasma membrane,CC,
7269,GO:0031247,1,0.938816543532895,0,2,actin rod assembly,BP,
7270,GO:0031248,1,0.0518277772687426,0,88,protein acetyltransferase complex,CC,
7271,GO:0031249,1,0.968496599492446,0,1,denatured protein binding,MF,
7272,GO:0031251,1,0.920676493604076,0,2,PAN complex,CC,
7275,GO:0031254,1,0.749596647815651,0,8,cell trailing edge,CC,
7278,GO:0031260,1,0.980975442997535,0,1,pseudopodium membrane,CC,
7279,GO:0031261,1,0.852177307857018,0,5,DNA replication preinitiation complex,CC,
7280,GO:0031262,1,0.909969888630257,0,4,Ndc80 complex,CC,
7281,GO:0031264,1,0.745395754466801,0,9,death-inducing signaling complex,CC,
7282,GO:0031265,1,0.820730622781947,0,6,CD95 death-inducing signaling complex,CC,
7288,GO:0031279,1,0.547801343650986,0,18,regulation of cyclase activity,BP,
7289,GO:0031280,1,0.796004070687044,0,7,negative regulation of cyclase activity,BP,
7290,GO:0031281,1,0.738548847646973,0,9,positive regulation of cyclase activity,BP,
7291,GO:0031282,1,0.876330254005447,0,4,regulation of guanylate cyclase activity,BP,
7292,GO:0031284,1,0.876330254005447,0,4,positive regulation of guanylate cyclase activity,BP,
7293,GO:0031289,1,0.964627989219559,0,1,actin phosphorylation,BP,
7294,GO:0031290,1,0.581254387583943,0,14,retinal ganglion cell axon guidance,BP,
7295,GO:0031291,1,0.91162823139405,0,3,Ran protein signal transduction,BP,
7299,GO:0031296,1,0.97981575440144,0,1,B cell costimulation,BP,
7300,GO:0031297,1,0.396583925363023,0,26,replication fork processing,BP,
7301,GO:0031298,1,0.741515710330684,0,9,replication fork protection complex,CC,
7304,GO:0031302,1,0.959579885668155,0,1,intrinsic component of endosome membrane,CC,
7305,GO:0031304,1,0.342320109702287,0,36,intrinsic component of mitochondrial inner membrane,CC,
7306,GO:0031305,1,0.342320109702287,0,36,integral component of mitochondrial inner membrane,CC,
7307,GO:0031306,1,0.492355456690625,0,22,intrinsic component of mitochondrial outer membrane,CC,
7308,GO:0031307,1,0.512949032969495,0,21,integral component of mitochondrial outer membrane,CC,
7309,GO:0031310,1,0.891196694566004,0,3,intrinsic component of vacuolar membrane,CC,
7311,GO:0031313,1,0.784258542053372,0,7,extrinsic component of endosome membrane,CC,
7312,GO:0031314,1,0.833660196826482,0,5,extrinsic component of mitochondrial inner membrane,CC,
7313,GO:0031315,1,0.95950763690405,0,1,extrinsic component of mitochondrial outer membrane,CC,
7314,GO:0031320,1,0.967753139758002,0,1,hexitol dehydrogenase activity,MF,
7324,GO:0031332,1,0.664563458200762,0,11,RNAi effector complex,CC,
7327,GO:0031335,1,0.969636865735874,0,1,regulation of sulfur amino acid metabolic process,BP,
7328,GO:0031337,1,0.969636865735874,0,1,positive regulation of sulfur amino acid metabolic process,BP,
7329,GO:0031338,1,0.162740055948279,0,49,regulation of vesicle fusion,BP,
7330,GO:0031339,1,0.898411731395017,0,3,negative regulation of vesicle fusion,BP,
7331,GO:0031340,1,0.813121402665682,0,6,positive regulation of vesicle fusion,BP,
7341,GO:0031362,1,0.751338171907776,0,9,anchored component of external side of plasma membrane,CC,
7344,GO:0031370,1,0.959792663278372,0,1,eukaryotic initiation factor 4G binding,MF,
7345,GO:0031371,1,0.776276391212666,0,8,ubiquitin conjugating enzyme complex,CC,
7346,GO:0031372,1,0.944678458627299,0,2,UBC13-MMS2 complex,CC,
7347,GO:0031379,1,0.95452346258719,0,2,RNA-directed RNA polymerase complex,CC,
7348,GO:0031380,1,0.963432130161792,0,1,nuclear RNA-directed RNA polymerase complex,CC,
7349,GO:0031386,1,0.743111670917444,0,12,protein tag,MF,
7350,GO:0031389,1,0.96544149613875,0,1,Rad17 RFC-like complex,CC,
7351,GO:0031390,1,0.779973705030169,0,8,Ctf18 RFC-like complex,CC,
7353,GO:0031393,1,0.927010267217462,0,2,negative regulation of prostaglandin biosynthetic process,BP,
7362,GO:0031403,1,0.923971737909566,0,2,lithium ion binding,MF,
7364,GO:0031405,1,0.95950763690405,0,1,lipoic acid binding,MF,
7366,GO:0031407,1,0.968911200939047,0,1,oxylipin metabolic process,BP,
7368,GO:0031414,1,0.740809635673528,0,9,N-terminal protein acetyltransferase complex,CC,
7369,GO:0031415,1,0.883598948240517,0,4,NatA complex,CC,
7370,GO:0031416,1,0.941445546916457,0,2,NatB complex,CC,
7371,GO:0031417,1,0.890610536472624,0,3,NatC complex,CC,
7372,GO:0031418,1,0.544769981137445,0,18,L-ascorbic acid binding,MF,
7373,GO:0031419,1,0.815844992794085,0,6,cobalamin binding,MF,
7376,GO:0031427,1,0.893932426354942,0,3,response to methotrexate,BP,
7377,GO:0031428,1,0.872089783699481,0,5,box C/D snoRNP complex,CC,
7378,GO:0031429,1,0.901384652359411,0,5,box H/ACA snoRNP complex,CC,
7379,GO:0031430,1,0.64222155198239,0,13,M band,CC,
7380,GO:0031431,1,0.928464029413962,0,2,Dbf4-dependent protein kinase complex,CC,
7381,GO:0031432,1,0.765470872438451,0,8,titin binding,MF,
7382,GO:0031433,1,0.95950763690405,0,1,telethonin binding,MF,
7384,GO:0031435,1,0.553204742661865,0,16,mitogen-activated protein kinase kinase kinase binding,MF,
7385,GO:0031436,1,0.928104636309614,0,2,BRCA1-BARD1 complex,CC,
7386,GO:0031437,1,0.896899931144207,0,3,regulation of mRNA cleavage,BP,
7387,GO:0031438,1,0.964487831399215,0,1,negative regulation of mRNA cleavage,BP,
7388,GO:0031439,1,0.929929686285785,0,2,positive regulation of mRNA cleavage,BP,
7390,GO:0031441,1,0.716600825017067,0,9,negative regulation of mRNA 3'-end processing,BP,
7391,GO:0031442,1,0.731214117574684,0,9,positive regulation of mRNA 3'-end processing,BP,
7392,GO:0031443,1,0.95950763690405,0,1,fast-twitch skeletal muscle fiber contraction,BP,
7393,GO:0031444,1,0.981822393206615,0,1,slow-twitch skeletal muscle fiber contraction,BP,
7394,GO:0031445,1,0.935647048636663,0,2,regulation of heterochromatin assembly,BP,
7395,GO:0031453,1,0.935647048636663,0,2,positive regulation of heterochromatin assembly,BP,
7396,GO:0031455,1,0.962322160905979,0,1,glycine betaine metabolic process,BP,
7397,GO:0031456,1,0.962322160905979,0,1,glycine betaine biosynthetic process,BP,
7398,GO:0031460,1,0.959689862438527,0,1,glycine betaine transport,BP,
7402,GO:0031464,1,0.673905971382336,0,12,Cul4A-RING E3 ubiquitin ligase complex,CC,
7403,GO:0031465,1,0.850207616843058,0,5,Cul4B-RING E3 ubiquitin ligase complex,CC,
7404,GO:0031466,1,0.888218383562579,0,4,Cul5-RING ubiquitin ligase complex,CC,
7405,GO:0031467,1,0.859757384791905,0,5,Cul7-RING ubiquitin ligase complex,CC,
7407,GO:0031475,1,0.976305973083661,0,1,myosin V complex,CC,
7408,GO:0031489,1,0.660506009059066,0,13,myosin V binding,MF,
7411,GO:0031492,1,0.342178071440303,0,42,nucleosomal DNA binding,MF,
7414,GO:0031498,1,0.554464077462333,0,17,chromatin disassembly,BP,
7415,GO:0031501,1,0.917386088350193,0,4,mannosyltransferase complex,CC,
7417,GO:0031506,1,0.973839944555444,0,1,cell wall glycoprotein biosynthetic process,BP,
7418,GO:0031507,1,0.719087414391643,0,10,heterochromatin assembly,BP,
7419,GO:0031508,1,0.945074246253031,0,2,pericentric heterochromatin assembly,BP,
7420,GO:0031509,1,0.975135035644344,0,1,telomeric heterochromatin assembly,BP,
7421,GO:0031510,1,0.914516140772823,0,3,SUMO activating enzyme complex,CC,
7423,GO:0031515,1,0.909041177762865,0,3,tRNA (m1A) methyltransferase complex,CC,
7424,GO:0031519,1,0.19059655305314,0,47,PcG protein complex,CC,
7425,GO:0031523,1,0.927352042682747,0,2,Myb complex,CC,
7430,GO:0031530,1,0.974422863836396,0,1,gonadotropin-releasing hormone receptor binding,MF,
7431,GO:0031531,1,0.978318536559371,0,1,thyrotropin-releasing hormone receptor binding,MF,
7433,GO:0031533,1,0.95950763690405,0,1,mRNA cap methyltransferase complex,CC,
7434,GO:0031536,1,0.902891577091841,0,4,positive regulation of exit from mitosis,BP,
7435,GO:0031543,1,0.708111120352157,0,10,peptidyl-proline dioxygenase activity,MF,
7436,GO:0031544,1,0.868191164241965,0,4,peptidyl-proline 3-dioxygenase activity,MF,
7437,GO:0031545,1,0.81567587017443,0,6,peptidyl-proline 4-dioxygenase activity,MF,
7438,GO:0031547,1,0.920977667766087,0,2,brain-derived neurotrophic factor receptor signaling pathway,BP,
7439,GO:0031554,1,0.95950763690405,0,1,regulation of DNA-templated transcription, termination,BP,
7440,GO:0031559,1,0.960426409753782,0,1,oxidosqualene cyclase activity,MF,
7443,GO:0031572,1,0.296670459935532,0,33,G2 DNA damage checkpoint,BP,
7444,GO:0031573,1,0.647337001789152,0,14,intra-S DNA damage checkpoint,BP,
7446,GO:0031579,1,0.538919845836205,0,19,membrane raft organization,BP,
7447,GO:0031580,1,0.830446826982294,0,6,membrane raft distribution,BP,
7450,GO:0031584,1,0.856644382870939,0,5,activation of phospholipase D activity,BP,
7451,GO:0031585,1,0.849227888426299,0,4,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7452,GO:0031587,1,0.885077527476683,0,3,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7453,GO:0031588,1,0.721075404017315,0,9,nucleotide-activated protein kinase complex,CC,
7455,GO:0031590,1,0.932025269400477,0,2,wybutosine metabolic process,BP,
7456,GO:0031591,1,0.932025269400477,0,2,wybutosine biosynthetic process,BP,
7457,GO:0031592,1,0.95950763690405,0,1,centrosomal corona,CC,
7460,GO:0031595,1,0.81255270273545,0,8,nuclear proteasome complex,CC,
7461,GO:0031597,1,0.706960652989267,0,12,cytosolic proteasome complex,CC,
7462,GO:0031616,1,0.763757178956402,0,9,spindle pole centrosome,CC,
7463,GO:0031618,1,0.7548763075781,0,8,nuclear pericentric heterochromatin,CC,
7469,GO:0031626,1,0.959558274183475,0,1,beta-endorphin binding,MF,
7470,GO:0031627,1,0.896473032244769,0,3,telomeric loop formation,BP,
7471,GO:0031628,1,0.867591422232696,0,4,opioid receptor binding,MF,
7473,GO:0031630,1,0.961188596200167,0,1,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
7474,GO:0031635,1,0.973007521550594,0,1,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
7477,GO:0031640,1,0.691031182606779,0,16,killing of cells of other organism,BP,
7479,GO:0031642,1,0.807062328170995,0,6,negative regulation of myelination,BP,
7482,GO:0031645,1,0.787054874662056,0,7,negative regulation of neurological system process,BP,
7488,GO:0031651,1,0.960608130332783,0,1,negative regulation of heat generation,BP,
7492,GO:0031659,1,0.827787198942705,0,5,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7496,GO:0031666,1,0.879457519228572,0,4,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,
7501,GO:0031672,1,0.507600418416384,0,19,A band,CC,
7502,GO:0031673,1,0.95950763690405,0,1,H zone,CC,
7503,GO:0031674,1,0.0702853129783541,0,76,I band,CC,
7504,GO:0031681,1,0.836209442835315,0,5,G-protein beta-subunit binding,MF,
7505,GO:0031682,1,0.964672571476155,0,1,G-protein gamma-subunit binding,MF,
7506,GO:0031683,1,0.668849138510522,0,12,G-protein beta/gamma-subunit complex binding,MF,
7507,GO:0031685,1,0.926558793674959,0,2,adenosine receptor binding,MF,
7508,GO:0031686,1,0.96434481732467,0,1,A1 adenosine receptor binding,MF,
7509,GO:0031690,1,0.649499882518952,0,13,adrenergic receptor binding,MF,
7510,GO:0031691,1,0.943622796434369,0,2,alpha-1A adrenergic receptor binding,MF,
7511,GO:0031692,1,0.943622796434369,0,2,alpha-1B adrenergic receptor binding,MF,
7512,GO:0031694,1,0.980484164003837,0,1,alpha-2A adrenergic receptor binding,MF,
7513,GO:0031697,1,0.856925066333751,0,4,beta-1 adrenergic receptor binding,MF,
7514,GO:0031698,1,0.870296584832722,0,4,beta-2 adrenergic receptor binding,MF,
7515,GO:0031699,1,0.960608130332783,0,1,beta-3 adrenergic receptor binding,MF,
7517,GO:0031701,1,0.741501932026118,0,8,angiotensin receptor binding,MF,
7518,GO:0031702,1,0.76432593128578,0,7,type 1 angiotensin receptor binding,MF,
7519,GO:0031704,1,0.963768076646009,0,1,apelin receptor binding,MF,
7523,GO:0031714,1,0.959577913492681,0,1,C5a anaphylatoxin chemotactic receptor binding,MF,
7524,GO:0031715,1,0.959577913492681,0,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,
7525,GO:0031726,1,0.979405733055773,0,1,CCR1 chemokine receptor binding,MF,
7526,GO:0031729,1,0.979405733055773,0,1,CCR4 chemokine receptor binding,MF,
7527,GO:0031730,1,0.856065065523411,0,5,CCR5 chemokine receptor binding,MF,
7530,GO:0031749,1,0.927045831094539,0,2,D2 dopamine receptor binding,MF,
7531,GO:0031752,1,0.921336674200201,0,2,D5 dopamine receptor binding,MF,
7532,GO:0031753,1,0.966061916776235,0,1,endothelial differentiation G-protein coupled receptor binding,MF,
7533,GO:0031755,1,0.966061916776235,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
7534,GO:0031762,1,0.943622796434369,0,2,follicle-stimulating hormone receptor binding,MF,
7535,GO:0031763,1,0.984487367317405,0,1,galanin receptor binding,MF,
7536,GO:0031764,1,0.984487367317405,0,1,type 1 galanin receptor binding,MF,
7537,GO:0031765,1,0.984487367317405,0,1,type 2 galanin receptor binding,MF,
7538,GO:0031766,1,0.984487367317405,0,1,type 3 galanin receptor binding,MF,
7539,GO:0031775,1,0.95950763690405,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
7540,GO:0031798,1,0.95950763690405,0,1,type 1 metabotropic glutamate receptor binding,MF,
7541,GO:0031802,1,0.900563256480909,0,3,type 5 metabotropic glutamate receptor binding,MF,
7542,GO:0031811,1,0.961245901711997,0,1,G-protein coupled nucleotide receptor binding,MF,
7543,GO:0031812,1,0.961245901711997,0,1,P2Y1 nucleotide receptor binding,MF,
7544,GO:0031821,1,0.817105069435701,0,6,G-protein coupled serotonin receptor binding,MF,
7545,GO:0031826,1,0.920822845332916,0,3,type 2A serotonin receptor binding,MF,
7546,GO:0031839,1,0.98406407037836,0,1,type 1 neuromedin U receptor binding,MF,
7547,GO:0031840,1,0.98406407037836,0,1,type 2 neuromedin U receptor binding,MF,
7548,GO:0031848,1,0.700510829024678,0,10,protection from non-homologous end joining at telomere,BP,
7549,GO:0031849,1,0.96165783320734,0,1,olfactory receptor binding,MF,
7550,GO:0031852,1,0.867591422232696,0,4,mu-type opioid receptor binding,MF,
7551,GO:0031859,1,0.972650305631637,0,1,platelet activating factor receptor binding,MF,
7552,GO:0031860,1,0.88604379810568,0,3,telomeric 3' overhang formation,BP,
7553,GO:0031862,1,0.922481204836713,0,2,prostanoid receptor binding,MF,
7554,GO:0031867,1,0.961414935659947,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
7555,GO:0031870,1,0.95950763690405,0,1,thromboxane A2 receptor binding,MF,
7556,GO:0031871,1,0.899181477253737,0,3,proteinase activated receptor binding,MF,
7557,GO:0031883,1,0.970976052569857,0,1,taste receptor binding,MF,
7558,GO:0031893,1,0.970158343090863,0,1,vasopressin receptor binding,MF,
7559,GO:0031896,1,0.970158343090863,0,1,V2 vasopressin receptor binding,MF,
7562,GO:0031903,1,0.18053987007189,0,51,microbody membrane,CC,
7563,GO:0031904,1,0.590204794949589,0,17,endosome lumen,CC,
7564,GO:0031905,1,0.914631167464882,0,3,early endosome lumen,CC,
7565,GO:0031906,1,0.941196788371582,0,2,late endosome lumen,CC,
7566,GO:0031907,1,0.390766893641842,0,30,microbody lumen,CC,
7567,GO:0031914,1,0.910960009503764,0,3,negative regulation of synaptic plasticity,BP,
7569,GO:0031929,1,0.0402463934066433,0,92,TOR signaling,BP,
7570,GO:0031930,1,0.976896678529752,0,1,mitochondria-nucleus signaling pathway,BP,
7571,GO:0031931,1,0.778297402950941,0,7,TORC1 complex,CC,
7572,GO:0031932,1,0.646294742168377,0,13,TORC2 complex,CC,
7573,GO:0031933,1,0.907695333296886,0,3,telomeric heterochromatin,CC,
7575,GO:0031936,1,0.739135145188341,0,8,negative regulation of chromatin silencing,BP,
7576,GO:0031937,1,0.736986528090932,0,8,positive regulation of chromatin silencing,BP,
7577,GO:0031938,1,0.948308624998706,0,2,regulation of chromatin silencing at telomere,BP,
7578,GO:0031940,1,0.975135035644344,0,1,positive regulation of chromatin silencing at telomere,BP,
7582,GO:0031945,1,0.96123077471094,0,1,positive regulation of glucocorticoid metabolic process,BP,
7585,GO:0031948,1,0.96123077471094,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
7589,GO:0031956,1,0.854546936061764,0,4,medium-chain fatty acid-CoA ligase activity,MF,
7590,GO:0031957,1,0.783549320521309,0,7,very long-chain fatty acid-CoA ligase activity,MF,
7592,GO:0031959,1,0.926399984295143,0,2,mineralocorticoid receptor signaling pathway,BP,
7599,GO:0031970,1,0.108622740002827,0,78,organelle envelope lumen,CC,
7607,GO:0031987,1,0.742263155099811,0,8,locomotion involved in locomotory behavior,BP,
7608,GO:0031990,1,0.929981381569634,0,2,mRNA export from nucleus in response to heat stress,BP,
7610,GO:0031995,1,0.829047457155726,0,6,insulin-like growth factor II binding,MF,
7612,GO:0031997,1,0.911398478344311,0,3,N-terminal myristoylation domain binding,MF,
7613,GO:0031998,1,0.649014790322897,0,11,regulation of fatty acid beta-oxidation,BP,
7614,GO:0031999,1,0.926526860158372,0,2,negative regulation of fatty acid beta-oxidation,BP,
7615,GO:0032000,1,0.814618642038631,0,5,positive regulation of fatty acid beta-oxidation,BP,
7616,GO:0032002,1,0.938790097380498,0,2,interleukin-28 receptor complex,CC,
7617,GO:0032006,1,0.0703457183181717,0,76,regulation of TOR signaling,BP,
7618,GO:0032007,1,0.292659159133984,0,35,negative regulation of TOR signaling,BP,
7619,GO:0032008,1,0.362653732795308,0,30,positive regulation of TOR signaling,BP,
7620,GO:0032009,1,0.771029912917304,0,7,early phagosome,CC,
7624,GO:0032020,1,0.851619080353327,0,6,ISG15-protein conjugation,BP,
7625,GO:0032021,1,0.868854350931026,0,4,NELF complex,CC,
7627,GO:0032025,1,0.725423121994979,0,10,response to cobalt ion,BP,
7628,GO:0032026,1,0.727723190040631,0,8,response to magnesium ion,BP,
7629,GO:0032027,1,0.898632145215805,0,3,myosin light chain binding,MF,
7631,GO:0032029,1,0.95950763690405,0,1,myosin tail binding,MF,
7633,GO:0032039,1,0.613052571824741,0,13,integrator complex,CC,
7636,GO:0032042,1,0.606428928391634,0,14,mitochondrial DNA metabolic process,BP,
7637,GO:0032044,1,0.93926446215824,0,2,DSIF complex,CC,
7638,GO:0032045,1,0.760269973697746,0,8,guanyl-nucleotide exchange factor complex,CC,
7639,GO:0032048,1,0.62218324310046,0,14,cardiolipin metabolic process,BP,
7640,GO:0032049,1,0.764329774613258,0,8,cardiolipin biosynthetic process,BP,
7642,GO:0032051,1,0.818779723555488,0,5,clathrin light chain binding,MF,
7644,GO:0032053,1,0.926372432346771,0,2,ciliary basal body organization,BP,
7645,GO:0032055,1,0.809105976922979,0,6,negative regulation of translation in response to stress,BP,
7647,GO:0032057,1,0.862033734638759,0,4,negative regulation of translational initiation in response to stress,BP,
7652,GO:0032070,1,0.754845513184895,0,9,regulation of deoxyribonuclease activity,BP,
7653,GO:0032071,1,0.798411080937524,0,7,regulation of endodeoxyribonuclease activity,BP,
7654,GO:0032072,1,0.962868782887146,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
7655,GO:0032074,1,0.811633959149637,0,6,negative regulation of nuclease activity,BP,
7657,GO:0032076,1,0.966540823598339,0,1,negative regulation of deoxyribonuclease activity,BP,
7658,GO:0032077,1,0.862787371580056,0,5,positive regulation of deoxyribonuclease activity,BP,
7659,GO:0032079,1,0.882024786560821,0,4,positive regulation of endodeoxyribonuclease activity,BP,
7662,GO:0032090,1,0.946205362105096,0,2,Pyrin domain binding,MF,
7665,GO:0032093,1,0.965469978279355,0,1,SAM domain binding,MF,
7667,GO:0032095,1,0.780715398231485,0,8,regulation of response to food,BP,
7668,GO:0032096,1,0.836262942790419,0,6,negative regulation of response to food,BP,
7669,GO:0032097,1,0.973007521550594,0,1,positive regulation of response to food,BP,
7670,GO:0032098,1,0.780716174274966,0,8,regulation of appetite,BP,
7671,GO:0032099,1,0.836262942790419,0,6,negative regulation of appetite,BP,
7672,GO:0032100,1,0.973007521550594,0,1,positive regulation of appetite,BP,
7677,GO:0032105,1,0.779189221881859,0,8,negative regulation of response to extracellular stimulus,BP,
7680,GO:0032108,1,0.779189221881859,0,8,negative regulation of response to nutrient levels,BP,
7682,GO:0032116,1,0.926372432346771,0,2,SMC loading complex,CC,
7683,GO:0032119,1,0.78832345661872,0,8,sequestering of zinc ion,BP,
7685,GO:0032129,1,0.937491392972958,0,2,histone deacetylase activity (H3-K9 specific),MF,
7686,GO:0032133,1,0.890349024411095,0,4,chromosome passenger complex,CC,
7687,GO:0032135,1,0.807709928232894,0,6,DNA insertion or deletion binding,MF,
7688,GO:0032137,1,0.896334814416154,0,3,guanine/thymine mispair binding,MF,
7689,GO:0032138,1,0.858239145545409,0,4,single base insertion or deletion binding,MF,
7690,GO:0032139,1,0.905228570840293,0,3,dinucleotide insertion or deletion binding,MF,
7691,GO:0032142,1,0.888674480521648,0,3,single guanine insertion binding,MF,
7692,GO:0032143,1,0.925809356702358,0,2,single thymine insertion binding,MF,
7693,GO:0032144,1,0.959675503888475,0,1,4-aminobutyrate transaminase complex,CC,
7694,GO:0032145,1,0.959675503888475,0,1,succinate-semialdehyde dehydrogenase binding,MF,
7700,GO:0032156,1,0.682128013628828,0,10,septin cytoskeleton,CC,
7701,GO:0032160,1,0.710213389119023,0,9,septin filament array,CC,
7702,GO:0032173,1,0.964874572204777,0,1,septin collar,CC,
7703,GO:0032181,1,0.925409777784344,0,2,dinucleotide repeat insertion binding,MF,
7706,GO:0032184,1,0.85788656848225,0,4,SUMO polymer binding,MF,
7707,GO:0032185,1,0.612530451089004,0,13,septin cytoskeleton organization,BP,
7708,GO:0032190,1,0.955296687036376,0,2,acrosin binding,MF,
7709,GO:0032194,1,0.962014420692069,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
7710,GO:0032196,1,0.609251154254607,0,14,transposition,BP,
7711,GO:0032197,1,0.961155066858964,0,1,transposition, RNA-mediated,BP,
7713,GO:0032201,1,0.428891781404975,0,27,telomere maintenance via semi-conservative replication,BP,
7714,GO:0032202,1,0.88233948843979,0,4,telomere assembly,BP,
7715,GO:0032203,1,0.973075088847771,0,1,telomere formation via telomerase,BP,
7717,GO:0032205,1,0.275928225337368,0,35,negative regulation of telomere maintenance,BP,
7719,GO:0032207,1,0.965435808978647,0,1,regulation of telomere maintenance via recombination,BP,
7720,GO:0032208,1,0.965435808978647,0,1,negative regulation of telomere maintenance via recombination,BP,
7721,GO:0032210,1,0.171419513119713,0,51,regulation of telomere maintenance via telomerase,BP,
7722,GO:0032211,1,0.508286523169557,0,19,negative regulation of telomere maintenance via telomerase,BP,
7723,GO:0032212,1,0.333100005606135,0,33,positive regulation of telomere maintenance via telomerase,BP,
7724,GO:0032213,1,0.931870390664989,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
7725,GO:0032214,1,0.931870390664989,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
7726,GO:0032216,1,0.969771673556553,0,1,glucosaminyl-phosphotidylinositol O-acyltransferase activity,MF,
7727,GO:0032217,1,0.932129376517163,0,2,riboflavin transmembrane transporter activity,MF,
7728,GO:0032218,1,0.932129376517163,0,2,riboflavin transport,BP,
7729,GO:0032222,1,0.95950763690405,0,1,regulation of synaptic transmission, cholinergic,BP,
7730,GO:0032224,1,0.95950763690405,0,1,positive regulation of synaptic transmission, cholinergic,BP,
7732,GO:0032226,1,0.85715939463526,0,5,positive regulation of synaptic transmission, dopaminergic,BP,
7734,GO:0032228,1,0.567820486987106,0,15,regulation of synaptic transmission, GABAergic,BP,
7735,GO:0032229,1,0.941981412267899,0,2,negative regulation of synaptic transmission, GABAergic,BP,
7736,GO:0032230,1,0.77156597630498,0,7,positive regulation of synaptic transmission, GABAergic,BP,
7740,GO:0032237,1,0.854914724140468,0,4,activation of store-operated calcium channel activity,BP,
7743,GO:0032241,1,0.769650516717637,0,7,positive regulation of nucleobase-containing compound transport,BP,
7744,GO:0032252,1,0.888977416462397,0,3,secretory granule localization,BP,
7745,GO:0032253,1,0.965469978279355,0,1,dense core granule localization,BP,
7746,GO:0032258,1,0.93706058190814,0,2,protein localization by the Cvt pathway,BP,
7750,GO:0032263,1,0.950413889877113,0,2,GMP salvage,BP,
7757,GO:0032272,1,0.193110113981366,0,48,negative regulation of protein polymerization,BP,
7765,GO:0032280,1,0.848993414484724,0,4,symmetric synapse,CC,
7766,GO:0032281,1,0.718306331576595,0,10,AMPA glutamate receptor complex,CC,
7767,GO:0032286,1,0.894633358709309,0,3,central nervous system myelin maintenance,BP,
7769,GO:0032288,1,0.475676886681312,0,20,myelin assembly,BP,
7770,GO:0032289,1,0.90226461289167,0,3,central nervous system myelin formation,BP,
7771,GO:0032290,1,0.852902204951488,0,4,peripheral nervous system myelin formation,BP,
7772,GO:0032291,1,0.757864960425104,0,8,axon ensheathment in central nervous system,BP,
7774,GO:0032296,1,0.866392911663149,0,4,double-stranded RNA-specific ribonuclease activity,MF,
7775,GO:0032298,1,0.969845268824029,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
7776,GO:0032299,1,0.924107947772589,0,3,ribonuclease H2 complex,CC,
7777,GO:0032300,1,0.641007474142471,0,12,mismatch repair complex,CC,
7778,GO:0032301,1,0.925809356702358,0,2,MutSalpha complex,CC,
7779,GO:0032302,1,0.925409777784344,0,2,MutSbeta complex,CC,
7781,GO:0032304,1,0.959613614615176,0,1,negative regulation of icosanoid secretion,BP,
7787,GO:0032311,1,0.955382155768287,0,2,angiogenin-PRI complex,CC,
7788,GO:0032324,1,0.796912918752052,0,7,molybdopterin cofactor biosynthetic process,BP,
7789,GO:0032328,1,0.796411656446272,0,6,alanine transport,BP,
7798,GO:0032346,1,0.96123077471094,0,1,positive regulation of aldosterone metabolic process,BP,
7801,GO:0032349,1,0.96123077471094,0,1,positive regulation of aldosterone biosynthetic process,BP,
7808,GO:0032356,1,0.712015181631303,0,10,oxidized DNA binding,MF,
7809,GO:0032357,1,0.733395925737467,0,9,oxidized purine DNA binding,MF,
7810,GO:0032358,1,0.983759698430541,0,1,oxidized pyrimidine DNA binding,MF,
7811,GO:0032361,1,0.971805969249971,0,1,pyridoxal phosphate catabolic process,BP,
7825,GO:0032377,1,0.796277545040868,0,7,regulation of intracellular lipid transport,BP,
7826,GO:0032378,1,0.962038677568488,0,1,negative regulation of intracellular lipid transport,BP,
7827,GO:0032379,1,0.91987413341333,0,3,positive regulation of intracellular lipid transport,BP,
7828,GO:0032380,1,0.796277545040868,0,7,regulation of intracellular sterol transport,BP,
7829,GO:0032381,1,0.962038677568488,0,1,negative regulation of intracellular sterol transport,BP,
7830,GO:0032382,1,0.91987413341333,0,3,positive regulation of intracellular sterol transport,BP,
7831,GO:0032383,1,0.796277545040868,0,7,regulation of intracellular cholesterol transport,BP,
7832,GO:0032384,1,0.962038677568488,0,1,negative regulation of intracellular cholesterol transport,BP,
7833,GO:0032385,1,0.91987413341333,0,3,positive regulation of intracellular cholesterol transport,BP,
7837,GO:0032389,1,0.777409367598646,0,7,MutLalpha complex,CC,
7838,GO:0032391,1,0.431966085462579,0,24,photoreceptor connecting cilium,CC,
7839,GO:0032392,1,0.057717400975615,0,81,DNA geometric change,BP,
7840,GO:0032393,1,0.956238494688268,0,2,MHC class I receptor activity,MF,
7841,GO:0032395,1,0.934462635097523,0,3,MHC class II receptor activity,MF,
7842,GO:0032397,1,0.976768554059973,0,1,activating MHC class I receptor activity,MF,
7844,GO:0032400,1,0.477050866319332,0,22,melanosome localization,BP,
7845,GO:0032401,1,0.510163350880516,0,20,establishment of melanosome localization,BP,
7846,GO:0032402,1,0.531727831278239,0,19,melanosome transport,BP,
7847,GO:0032404,1,0.770896480799446,0,8,mismatch repair complex binding,MF,
7848,GO:0032405,1,0.84721198682277,0,5,MutLalpha complex binding,MF,
7849,GO:0032407,1,0.851271016246591,0,5,MutSalpha complex binding,MF,
7856,GO:0032415,1,0.901835005059888,0,3,regulation of sodium:proton antiporter activity,BP,
7857,GO:0032416,1,0.971788885729268,0,1,negative regulation of sodium:proton antiporter activity,BP,
7858,GO:0032417,1,0.928020368190077,0,2,positive regulation of sodium:proton antiporter activity,BP,
7860,GO:0032419,1,0.969919155567986,0,1,extrinsic component of lysosome membrane,CC,
7861,GO:0032420,1,0.441958669489364,0,24,stereocilium,CC,
7862,GO:0032421,1,0.387310737450451,0,28,stereocilium bundle,CC,
7864,GO:0032423,1,0.962868782887146,0,1,regulation of mismatch repair,BP,
7865,GO:0032425,1,0.962868782887146,0,1,positive regulation of mismatch repair,BP,
7866,GO:0032426,1,0.783365036089484,0,7,stereocilium tip,CC,
7867,GO:0032427,1,0.93161781167414,0,2,GBD domain binding,MF,
7868,GO:0032428,1,0.962263299830291,0,1,beta-N-acetylgalactosaminidase activity,MF,
7869,GO:0032429,1,0.79726375025468,0,7,regulation of phospholipase A2 activity,BP,
7870,GO:0032430,1,0.911934512995217,0,3,positive regulation of phospholipase A2 activity,BP,
7871,GO:0032431,1,0.950282125815646,0,2,activation of phospholipase A2 activity,BP,
7872,GO:0032432,1,0.184080911758279,0,47,actin filament bundle,CC,
7873,GO:0032433,1,0.635890815965638,0,12,filopodium tip,CC,
7877,GO:0032437,1,0.898843239186462,0,3,cuticular plate,CC,
7878,GO:0032438,1,0.494438886845164,0,22,melanosome organization,BP,
7879,GO:0032440,1,0.979112611699708,0,1,2-alkenal reductase [NAD(P)] activity,MF,
7880,GO:0032444,1,0.920650957478618,0,2,activin responsive factor complex,CC,
7882,GO:0032447,1,0.96827547172546,0,1,protein urmylation,BP,
7884,GO:0032450,1,0.886210625470691,0,3,maltose alpha-glucosidase activity,MF,
7887,GO:0032453,1,0.785751472862228,0,6,histone demethylase activity (H3-K4 specific),MF,
7888,GO:0032454,1,0.620417771196245,0,12,histone demethylase activity (H3-K9 specific),MF,
7889,GO:0032455,1,0.89123999237024,0,3,nerve growth factor processing,BP,
7891,GO:0032458,1,0.961308661325201,0,1,slow endocytic recycling,BP,
7893,GO:0032460,1,0.649418537054823,0,13,negative regulation of protein oligomerization,BP,
7895,GO:0032462,1,0.597166243253062,0,17,regulation of protein homooligomerization,BP,
7896,GO:0032463,1,0.705441909359337,0,11,negative regulation of protein homooligomerization,BP,
7897,GO:0032464,1,0.834383906561796,0,6,positive regulation of protein homooligomerization,BP,
7899,GO:0032466,1,0.82737361982104,0,6,negative regulation of cytokinesis,BP,
7900,GO:0032467,1,0.409103579830022,0,25,positive regulation of cytokinesis,BP,
7901,GO:0032468,1,0.962564990613363,0,1,Golgi calcium ion homeostasis,BP,
7903,GO:0032470,1,0.95950763690405,0,1,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
7904,GO:0032471,1,0.817965189414274,0,7,negative regulation of endoplasmic reticulum calcium ion concentration,BP,
7905,GO:0032472,1,0.935722004803807,0,2,Golgi calcium ion transport,BP,
7906,GO:0032474,1,0.892204379526397,0,3,otolith morphogenesis,BP,
7907,GO:0032475,1,0.966967419757367,0,1,otolith formation,BP,
7912,GO:0032483,1,0.854674464541195,0,4,regulation of Rab protein signal transduction,BP,
7913,GO:0032484,1,0.887088457963602,0,3,Ral protein signal transduction,BP,
7914,GO:0032485,1,0.887088457963602,0,3,regulation of Ral protein signal transduction,BP,
7916,GO:0032487,1,0.886178335306371,0,3,regulation of Rap protein signal transduction,BP,
7917,GO:0032488,1,0.676707238875081,0,11,Cdc42 protein signal transduction,BP,
7918,GO:0032489,1,0.873336586740714,0,4,regulation of Cdc42 protein signal transduction,BP,
7919,GO:0032490,1,0.857552355271125,0,4,detection of molecule of bacterial origin,BP,
7920,GO:0032493,1,0.899717847709813,0,3,response to bacterial lipoprotein,BP,
7924,GO:0032497,1,0.966730093139671,0,1,detection of lipopolysaccharide,BP,
7925,GO:0032498,1,0.960065573690081,0,1,detection of muramyl dipeptide,BP,
7926,GO:0032499,1,0.960065573690081,0,1,detection of peptidoglycan,BP,
7927,GO:0032500,1,0.960065573690081,0,1,muramyl dipeptide binding,MF,
7931,GO:0032506,1,0.438628822462014,0,23,cytokinetic process,BP,
7933,GO:0032508,1,0.0827174807522263,0,71,DNA duplex unwinding,BP,
7934,GO:0032509,1,0.521415968978101,0,20,endosome transport via multivesicular body sorting pathway,BP,
7935,GO:0032510,1,0.806952216364031,0,6,endosome to lysosome transport via multivesicular body sorting pathway,BP,
7936,GO:0032511,1,0.795516567925797,0,8,late endosome to vacuole transport via multivesicular body sorting pathway,BP,
7943,GO:0032530,1,0.715931672897833,0,9,regulation of microvillus organization,BP,
7944,GO:0032532,1,0.904301431440748,0,3,regulation of microvillus length,BP,
7945,GO:0032534,1,0.791742705922355,0,6,regulation of microvillus assembly,BP,
7947,GO:0032536,1,0.814972459291029,0,6,regulation of cell projection size,BP,
7948,GO:0032541,1,0.851036592602517,0,5,cortical endoplasmic reticulum,CC,
7949,GO:0032542,1,0.931361081390797,0,2,sulfiredoxin activity,MF,
7950,GO:0032543,1,0.0380542039213561,0,129,mitochondrial translation,BP,
7951,GO:0032545,1,0.908501138590578,0,3,CURI complex,CC,
7954,GO:0032551,1,0.928459682999359,0,2,pyrimidine ribonucleoside binding,MF,
7955,GO:0032552,1,0.844333476178554,0,6,deoxyribonucleotide binding,MF,
7957,GO:0032554,1,0.884997490157486,0,4,purine deoxyribonucleotide binding,MF,
7959,GO:0032556,1,0.954065794439129,0,2,pyrimidine deoxyribonucleotide binding,MF,
7960,GO:0032557,1,0.901181648478815,0,3,pyrimidine ribonucleotide binding,MF,
7961,GO:0032558,1,0.918185078966956,0,3,adenyl deoxyribonucleotide binding,MF,
7963,GO:0032560,1,0.96386288872104,0,1,guanyl deoxyribonucleotide binding,MF,
7965,GO:0032564,1,0.918185078966956,0,3,dATP binding,MF,
7966,GO:0032567,1,0.96386288872104,0,1,dGTP binding,MF,
7968,GO:0032571,1,0.932800781023109,0,2,response to vitamin K,BP,
7969,GO:0032574,1,0.96106862809971,0,1,5'-3' RNA helicase activity,MF,
7970,GO:0032575,1,0.96106862809971,0,1,ATP-dependent 5'-3' RNA helicase activity,MF,
7972,GO:0032581,1,0.973183584123691,0,1,ER-dependent peroxisome organization,BP,
7973,GO:0032584,1,0.894677580795153,0,3,growth cone membrane,CC,
7974,GO:0032585,1,0.730359987781856,0,10,multivesicular body membrane,CC,
7978,GO:0032590,1,0.617932494836812,0,14,dendrite membrane,CC,
7979,GO:0032591,1,0.82118126920835,0,5,dendritic spine membrane,CC,
7980,GO:0032592,1,0.134340921006557,0,65,integral component of mitochondrial membrane,CC,
7981,GO:0032593,1,0.827790313060996,0,6,insulin-responsive compartment,CC,
7982,GO:0032594,1,0.494515264080898,0,21,protein transport within lipid bilayer,BP,
7983,GO:0032595,1,0.970368607052476,0,1,B cell receptor transport within lipid bilayer,BP,
7984,GO:0032596,1,0.848589456068595,0,5,protein transport into membrane raft,BP,
7985,GO:0032597,1,0.970368607052476,0,1,B cell receptor transport into membrane raft,BP,
7986,GO:0032599,1,0.970368607052476,0,1,protein transport out of membrane raft,BP,
7987,GO:0032600,1,0.970368607052476,0,1,chemokine receptor transport out of membrane raft,BP,
8000,GO:0032618,1,0.949137593004916,0,2,interleukin-15 production,BP,
8002,GO:0032621,1,0.804356658724294,0,6,interleukin-18 production,BP,
8004,GO:0032625,1,0.962320310343519,0,1,interleukin-21 production,BP,
8006,GO:0032632,1,0.930094030263467,0,2,interleukin-3 production,BP,
8008,GO:0032634,1,0.741949225199574,0,8,interleukin-5 production,BP,
8025,GO:0032658,1,0.973747123429304,0,1,regulation of interleukin-15 production,BP,
8027,GO:0032661,1,0.837037164083133,0,5,regulation of interleukin-18 production,BP,
8030,GO:0032672,1,0.930094030263467,0,2,regulation of interleukin-3 production,BP,
8032,GO:0032674,1,0.741949225199574,0,8,regulation of interleukin-5 production,BP,
8037,GO:0032681,1,0.966531434241085,0,1,regulation of lymphotoxin A production,BP,
8038,GO:0032682,1,0.733408378538718,0,10,negative regulation of chemokine production,BP,
8039,GO:0032685,1,0.963554537674313,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
8040,GO:0032687,1,0.849918841523776,0,5,negative regulation of interferon-alpha production,BP,
8043,GO:0032690,1,0.977205976262402,0,1,negative regulation of interleukin-1 alpha production,BP,
8048,GO:0032696,1,0.900093393638742,0,3,negative regulation of interleukin-13 production,BP,
8049,GO:0032700,1,0.857615722208413,0,5,negative regulation of interleukin-17 production,BP,
8050,GO:0032701,1,0.939678172906436,0,2,negative regulation of interleukin-18 production,BP,
8052,GO:0032707,1,0.96888176688872,0,1,negative regulation of interleukin-23 production,BP,
8053,GO:0032712,1,0.969238362043476,0,1,negative regulation of interleukin-3 production,BP,
8055,GO:0032714,1,0.926040326082464,0,2,negative regulation of interleukin-5 production,BP,
8070,GO:0032738,1,0.973747123429304,0,1,positive regulation of interleukin-15 production,BP,
8072,GO:0032741,1,0.924366550017628,0,2,positive regulation of interleukin-18 production,BP,
8075,GO:0032752,1,0.959616422844776,0,1,positive regulation of interleukin-3 production,BP,
8077,GO:0032754,1,0.801240509933108,0,6,positive regulation of interleukin-5 production,BP,
8082,GO:0032761,1,0.966531434241085,0,1,positive regulation of lymphotoxin A production,BP,
8085,GO:0032764,1,0.939337996851725,0,2,negative regulation of mast cell cytokine production,BP,
8087,GO:0032767,1,0.911661239772599,0,3,copper-dependent protein binding,MF,
8091,GO:0032771,1,0.960375828840977,0,1,regulation of monophenol monooxygenase activity,BP,
8092,GO:0032773,1,0.960375828840977,0,1,positive regulation of monophenol monooxygenase activity,BP,
8094,GO:0032775,1,0.961922167578605,0,1,DNA methylation on adenine,BP,
8095,GO:0032776,1,0.885635370802844,0,3,DNA methylation on cytosine,BP,
8096,GO:0032777,1,0.877721169433882,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
8099,GO:0032782,1,0.944496505692627,0,2,bile acid secretion,BP,
8100,GO:0032783,1,0.867690212068,0,4,ELL-EAF complex,CC,
8101,GO:0032784,1,0.256907225964562,0,40,regulation of DNA-templated transcription, elongation,BP,
8102,GO:0032785,1,0.684366760757192,0,11,negative regulation of DNA-templated transcription, elongation,BP,
8103,GO:0032786,1,0.44822582094936,0,24,positive regulation of DNA-templated transcription, elongation,BP,
8105,GO:0032790,1,0.768158530718085,0,8,ribosome disassembly,BP,
8106,GO:0032792,1,0.878239810783849,0,4,negative regulation of CREB transcription factor activity,BP,
8107,GO:0032793,1,0.651769649023956,0,12,positive regulation of CREB transcription factor activity,BP,
8108,GO:0032794,1,0.595037505352677,0,14,GTPase activating protein binding,MF,
8109,GO:0032795,1,0.981031537246148,0,1,heterotrimeric G-protein binding,MF,
8110,GO:0032796,1,0.935768830885315,0,2,uropod organization,BP,
8111,GO:0032797,1,0.699461898590609,0,11,SMN complex,CC,
8112,GO:0032798,1,0.932129376517163,0,2,Swi5-Sfr1 complex,CC,
8116,GO:0032802,1,0.653497919775984,0,13,low-density lipoprotein particle receptor catabolic process,BP,
8117,GO:0032803,1,0.851656526796868,0,5,regulation of low-density lipoprotein particle receptor catabolic process,BP,
8118,GO:0032804,1,0.936672104363512,0,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,
8119,GO:0032805,1,0.942719203679428,0,2,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,
8120,GO:0032806,1,0.443814510803317,0,25,carboxy-terminal domain protein kinase complex,CC,
8121,GO:0032807,1,0.875904208699977,0,4,DNA ligase IV complex,CC,
8123,GO:0032809,1,0.76411909579337,0,7,neuronal cell body membrane,CC,
8124,GO:0032810,1,0.936522047889293,0,2,sterol response element binding,MF,
8127,GO:0032815,1,0.872395221614787,0,5,negative regulation of natural killer cell activation,BP,
8132,GO:0032824,1,0.979953165374025,0,1,negative regulation of natural killer cell differentiation,BP,
8133,GO:0032825,1,0.786250445582935,0,7,positive regulation of natural killer cell differentiation,BP,
8134,GO:0032826,1,0.979953165374025,0,1,regulation of natural killer cell differentiation involved in immune response,BP,
8135,GO:0032827,1,0.979953165374025,0,1,negative regulation of natural killer cell differentiation involved in immune response,BP,
8137,GO:0032836,1,0.771381692307229,0,7,glomerular basement membrane development,BP,
8138,GO:0032838,1,0.0143532154335202,0,122,plasma membrane bounded cell projection cytoplasm,CC,
8139,GO:0032839,1,0.458298599732219,0,22,dendrite cytoplasm,CC,
8140,GO:0032847,1,0.937203265305085,0,2,regulation of cellular pH reduction,BP,
8141,GO:0032848,1,0.961390182901005,0,1,negative regulation of cellular pH reduction,BP,
8142,GO:0032849,1,0.97484420258987,0,1,positive regulation of cellular pH reduction,BP,
8149,GO:0032875,1,0.756502674148405,0,7,regulation of DNA endoreduplication,BP,
8150,GO:0032876,1,0.850563961710505,0,4,negative regulation of DNA endoreduplication,BP,
8151,GO:0032877,1,0.922827954951874,0,2,positive regulation of DNA endoreduplication,BP,
8152,GO:0032878,1,0.46305899743172,0,20,regulation of establishment or maintenance of cell polarity,BP,
8158,GO:0032887,1,0.95950763690405,0,1,regulation of spindle elongation,BP,
8159,GO:0032888,1,0.95950763690405,0,1,regulation of mitotic spindle elongation,BP,
8160,GO:0032889,1,0.967773689954041,0,1,regulation of vacuole fusion, non-autophagic,BP,
8162,GO:0032891,1,0.734695489383865,0,8,negative regulation of organic acid transport,BP,
8165,GO:0032898,1,0.889537209275305,0,3,neurotrophin production,BP,
8166,GO:0032899,1,0.961272228317104,0,1,regulation of neurotrophin production,BP,
8167,GO:0032901,1,0.961272228317104,0,1,positive regulation of neurotrophin production,BP,
8168,GO:0032902,1,0.925382042490954,0,2,nerve growth factor production,BP,
8169,GO:0032905,1,0.809002449814002,0,6,transforming growth factor beta1 production,BP,
8172,GO:0032908,1,0.809002449814002,0,6,regulation of transforming growth factor beta1 production,BP,
8175,GO:0032911,1,0.893893771597741,0,3,negative regulation of transforming growth factor beta1 production,BP,
8176,GO:0032912,1,0.960375828840977,0,1,negative regulation of transforming growth factor beta2 production,BP,
8177,GO:0032913,1,0.970368607052476,0,1,negative regulation of transforming growth factor beta3 production,BP,
8178,GO:0032914,1,0.905057519394747,0,3,positive regulation of transforming growth factor beta1 production,BP,
8179,GO:0032915,1,0.970836761220147,0,1,positive regulation of transforming growth factor beta2 production,BP,
8183,GO:0032919,1,0.982324613531412,0,1,spermine acetylation,BP,
8184,GO:0032920,1,0.982324613531412,0,1,putrescine acetylation,BP,
8187,GO:0032925,1,0.583538422645216,0,16,regulation of activin receptor signaling pathway,BP,
8188,GO:0032926,1,0.787432030069674,0,7,negative regulation of activin receptor signaling pathway,BP,
8189,GO:0032927,1,0.812551765949132,0,6,positive regulation of activin receptor signaling pathway,BP,
8190,GO:0032928,1,0.726043773247605,0,11,regulation of superoxide anion generation,BP,
8191,GO:0032929,1,0.946999818385994,0,2,negative regulation of superoxide anion generation,BP,
8192,GO:0032930,1,0.798990021100642,0,8,positive regulation of superoxide anion generation,BP,
8197,GO:0032941,1,0.568336740188099,0,17,secretion by tissue,BP,
8203,GO:0032954,1,0.924307875469249,0,2,regulation of cytokinetic process,BP,
8205,GO:0032957,1,0.732269918050727,0,8,inositol trisphosphate metabolic process,BP,
8207,GO:0032959,1,0.792040543813962,0,6,inositol trisphosphate biosynthetic process,BP,
8208,GO:0032960,1,0.858497285593897,0,4,regulation of inositol trisphosphate biosynthetic process,BP,
8209,GO:0032962,1,0.894026134991057,0,3,positive regulation of inositol trisphosphate biosynthetic process,BP,
8214,GO:0032967,1,0.607470133067386,0,15,positive regulation of collagen biosynthetic process,BP,
8215,GO:0032968,1,0.598274596042615,0,15,positive regulation of transcription elongation from RNA polymerase II promoter,BP,
8217,GO:0032976,1,0.984110997931916,0,1,release of matrix enzymes from mitochondria,BP,
8218,GO:0032977,1,0.960025106199272,0,1,membrane insertase activity,MF,
8219,GO:0032978,1,0.960025106199272,0,1,protein insertion into membrane from inner side,BP,
8220,GO:0032979,1,0.960025106199272,0,1,protein insertion into mitochondrial membrane from inner side,BP,
8221,GO:0032980,1,0.968539752618285,0,1,keratinocyte activation,BP,
8222,GO:0032981,1,0.306942191151907,0,55,mitochondrial respiratory chain complex I assembly,BP,
8223,GO:0032982,1,0.750474194671955,0,7,myosin filament,CC,
8225,GO:0032986,1,0.550276420421301,0,18,protein-DNA complex disassembly,BP,
8226,GO:0032988,1,0.654410359921839,0,13,ribonucleoprotein complex disassembly,BP,
8235,GO:0033004,1,0.907574370759727,0,3,negative regulation of mast cell activation,BP,
8236,GO:0033005,1,0.743606963893706,0,9,positive regulation of mast cell activation,BP,
8238,GO:0033007,1,0.907574370759727,0,3,negative regulation of mast cell activation involved in immune response,BP,
8239,GO:0033008,1,0.768974843370277,0,8,positive regulation of mast cell activation involved in immune response,BP,
8240,GO:0033010,1,0.807592286780969,0,6,paranodal junction,CC,
8243,GO:0033015,1,0.861228672876724,0,6,tetrapyrrole catabolic process,BP,
8244,GO:0033017,1,0.47045003616121,0,21,sarcoplasmic reticulum membrane,CC,
8245,GO:0033018,1,0.936499112918747,0,2,sarcoplasmic reticulum lumen,CC,
8246,GO:0033023,1,0.923362889671194,0,2,mast cell homeostasis,BP,
8247,GO:0033024,1,0.923362889671194,0,2,mast cell apoptotic process,BP,
8248,GO:0033025,1,0.923362889671194,0,2,regulation of mast cell apoptotic process,BP,
8249,GO:0033026,1,0.95952287020388,0,1,negative regulation of mast cell apoptotic process,BP,
8252,GO:0033030,1,0.95950763690405,0,1,negative regulation of neutrophil apoptotic process,BP,
8255,GO:0033033,1,0.775134708710786,0,8,negative regulation of myeloid cell apoptotic process,BP,
8258,GO:0033037,1,0.959507646993656,0,1,polysaccharide localization,BP,
8259,GO:0033038,1,0.92219745001264,0,4,bitter taste receptor activity,MF,
8260,GO:0033041,1,0.967549206826007,0,1,sweet taste receptor activity,MF,
8267,GO:0033058,1,0.965469978279355,0,1,directional locomotion,BP,
8268,GO:0033059,1,0.236741627124289,0,44,cellular pigmentation,BP,
8269,GO:0033061,1,0.74894660553227,0,9,DNA recombinase mediator complex,CC,
8270,GO:0033063,1,0.803510465079551,0,7,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
8271,GO:0033065,1,0.950448783893347,0,2,Rad51C-XRCC3 complex,CC,
8272,GO:0033076,1,0.972641442982888,0,1,isoquinoline alkaloid metabolic process,BP,
8276,GO:0033080,1,0.898368472310423,0,3,immature T cell proliferation in thymus,BP,
8280,GO:0033084,1,0.934608573650904,0,2,regulation of immature T cell proliferation in thymus,BP,
8282,GO:0033087,1,0.910699913804725,0,3,negative regulation of immature T cell proliferation,BP,
8283,GO:0033088,1,0.934608573650904,0,2,negative regulation of immature T cell proliferation in thymus,BP,
8287,GO:0033106,1,0.946992357745868,0,2,cis-Golgi network membrane,CC,
8288,GO:0033108,1,0.112043425550725,0,89,mitochondrial respiratory chain complex assembly,BP,
8290,GO:0033119,1,0.473897170009383,0,23,negative regulation of RNA splicing,BP,
8292,GO:0033121,1,0.888838618487412,0,3,regulation of purine nucleotide catabolic process,BP,
8293,GO:0033122,1,0.926356024535169,0,2,negative regulation of purine nucleotide catabolic process,BP,
8294,GO:0033123,1,0.95950763690405,0,1,positive regulation of purine nucleotide catabolic process,BP,
8296,GO:0033128,1,0.940474780368726,0,2,negative regulation of histone phosphorylation,BP,
8298,GO:0033130,1,0.796905859160094,0,6,acetylcholine receptor binding,MF,
8299,GO:0033131,1,0.833717458102125,0,6,regulation of glucokinase activity,BP,
8300,GO:0033132,1,0.942921212134301,0,2,negative regulation of glucokinase activity,BP,
8301,GO:0033133,1,0.88420192174364,0,4,positive regulation of glucokinase activity,BP,
8303,GO:0033137,1,0.473927262574357,0,22,negative regulation of peptidyl-serine phosphorylation,BP,
8306,GO:0033140,1,0.94004171787667,0,2,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8308,GO:0033142,1,0.970249310208654,0,1,progesterone receptor binding,MF,
8310,GO:0033144,1,0.402697913646611,0,25,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,
8311,GO:0033145,1,0.663603456062809,0,13,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,
8313,GO:0033147,1,0.689441103467668,0,10,negative regulation of intracellular estrogen receptor signaling pathway,BP,
8314,GO:0033148,1,0.753572987693898,0,8,positive regulation of intracellular estrogen receptor signaling pathway,BP,
8315,GO:0033149,1,0.92297768340245,0,2,FFAT motif binding,MF,
8316,GO:0033151,1,0.643698049461239,0,12,V(D)J recombination,BP,
8317,GO:0033152,1,0.866765877921655,0,4,immunoglobulin V(D)J recombination,BP,
8318,GO:0033153,1,0.822304647887759,0,5,T cell receptor V(D)J recombination,BP,
8321,GO:0033159,1,0.894803126625975,0,3,negative regulation of protein import into nucleus, translocation,BP,
8322,GO:0033160,1,0.689422844897088,0,10,positive regulation of protein import into nucleus, translocation,BP,
8323,GO:0033162,1,0.852664968812708,0,6,melanosome membrane,CC,
8324,GO:0033167,1,0.95950763690405,0,1,ARC complex,CC,
8325,GO:0033168,1,0.95950763690405,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
8326,GO:0033169,1,0.600219062643259,0,13,histone H3-K9 demethylation,BP,
8327,GO:0033170,1,0.778756876774389,0,8,protein-DNA loading ATPase activity,MF,
8330,GO:0033177,1,0.778125639160626,0,9,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,
8332,GO:0033179,1,0.795964449015022,0,8,proton-transporting V-type ATPase, V0 domain,CC,
8334,GO:0033181,1,0.974796008776728,0,1,plasma membrane proton-transporting V-type ATPase complex,CC,
8335,GO:0033182,1,0.693193414055704,0,10,regulation of histone ubiquitination,BP,
8336,GO:0033183,1,0.891797616883243,0,3,negative regulation of histone ubiquitination,BP,
8337,GO:0033184,1,0.827634763849122,0,5,positive regulation of histone ubiquitination,BP,
8338,GO:0033185,1,0.946804217850518,0,3,dolichol-phosphate-mannose synthase complex,CC,
8339,GO:0033186,1,0.895977624190984,0,3,CAF-1 complex,CC,
8342,GO:0033192,1,0.826628008632427,0,5,calmodulin-dependent protein phosphatase activity,MF,
8343,GO:0033194,1,0.635965607741601,0,14,response to hydroperoxide,BP,
8346,GO:0033202,1,0.649514090220295,0,15,DNA helicase complex,CC,
8347,GO:0033204,1,0.96806788730341,0,1,ribonuclease P RNA binding,MF,
8348,GO:0033206,1,0.858910946426269,0,4,meiotic cytokinesis,BP,
8350,GO:0033210,1,0.777776670339369,0,7,leptin-mediated signaling pathway,BP,
8351,GO:0033211,1,0.846308747203858,0,5,adiponectin-activated signaling pathway,BP,
8355,GO:0033227,1,0.902546754253111,0,3,dsRNA transport,BP,
8358,GO:0033235,1,0.729383509626668,0,10,positive regulation of protein sumoylation,BP,
8360,GO:0033239,1,0.860653234518605,0,4,negative regulation of cellular amine metabolic process,BP,
8361,GO:0033240,1,0.809833985238907,0,7,positive regulation of cellular amine metabolic process,BP,
8362,GO:0033241,1,0.95950763690405,0,1,regulation of cellular amine catabolic process,BP,
8363,GO:0033242,1,0.95950763690405,0,1,negative regulation of cellular amine catabolic process,BP,
8366,GO:0033260,1,0.209982445052534,0,49,nuclear DNA replication,BP,
8367,GO:0033262,1,0.652146897204028,0,12,regulation of nuclear cell cycle DNA replication,BP,
8368,GO:0033263,1,0.85427188767338,0,4,CORVET complex,CC,
8369,GO:0033265,1,0.936062633599681,0,2,choline binding,MF,
8371,GO:0033268,1,0.699983135802044,0,9,node of Ranvier,CC,
8372,GO:0033269,1,0.931639327659007,0,2,internode region of axon,CC,
8373,GO:0033270,1,0.740833642647029,0,8,paranode region of axon,CC,
8375,GO:0033274,1,0.95950763690405,0,1,response to vitamin B2,BP,
8376,GO:0033275,1,0.654848990376807,0,14,actin-myosin filament sliding,BP,
8377,GO:0033276,1,0.637915913798143,0,14,transcription factor TFTC complex,CC,
8381,GO:0033283,1,0.962409950174483,0,1,organic acid-transporting ATPase activity,MF,
8382,GO:0033284,1,0.962409950174483,0,1,carboxylic acid-transporting ATPase activity,MF,
8383,GO:0033285,1,0.962409950174483,0,1,monocarboxylic acid-transporting ATPase activity,MF,
8384,GO:0033290,1,0.960602022066878,0,1,eukaryotic 48S preinitiation complex,CC,
8385,GO:0033291,1,0.989378992727946,0,1,eukaryotic 80S initiation complex,CC,
8386,GO:0033292,1,0.920650957478618,0,2,T-tubule organization,BP,
8388,GO:0033299,1,0.854254441257026,0,5,secretion of lysosomal enzymes,BP,
8389,GO:0033300,1,0.92453125086049,0,2,dehydroascorbic acid transmembrane transporter activity,MF,
8390,GO:0033301,1,0.96177627201327,0,1,cell cycle comprising mitosis without cytokinesis,BP,
8391,GO:0033306,1,0.935565192742095,0,2,phytol metabolic process,BP,
8392,GO:0033313,1,0.838994174117315,0,5,meiotic cell cycle checkpoint,BP,
8393,GO:0033314,1,0.765504822830007,0,8,mitotic DNA replication checkpoint,BP,
8394,GO:0033316,1,0.964709451383227,0,1,meiotic spindle assembly checkpoint,BP,
8395,GO:0033319,1,0.971041927321966,0,1,UDP-D-xylose metabolic process,BP,
8396,GO:0033320,1,0.971041927321966,0,1,UDP-D-xylose biosynthetic process,BP,
8397,GO:0033326,1,0.959673475190026,0,1,cerebrospinal fluid secretion,BP,
8398,GO:0033327,1,0.806486495383316,0,6,Leydig cell differentiation,BP,
8399,GO:0033328,1,0.962131775847945,0,1,peroxisome membrane targeting sequence binding,MF,
8400,GO:0033341,1,0.928589659134272,0,2,regulation of collagen binding,BP,
8401,GO:0033342,1,0.967780546363309,0,1,negative regulation of collagen binding,BP,
8402,GO:0033343,1,0.95950763690405,0,1,positive regulation of collagen binding,BP,
8406,GO:0033364,1,0.95950763690405,0,1,mast cell secretory granule organization,BP,
8408,GO:0033383,1,0.943382473024233,0,2,geranyl diphosphate metabolic process,BP,
8409,GO:0033384,1,0.943382473024233,0,2,geranyl diphosphate biosynthetic process,BP,
8410,GO:0033385,1,0.965948139140535,0,1,geranylgeranyl diphosphate metabolic process,BP,
8411,GO:0033386,1,0.965948139140535,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
8413,GO:0033388,1,0.970193887903363,0,1,putrescine biosynthetic process from arginine,BP,
8414,GO:0033391,1,0.79321811782123,0,6,chromatoid body,CC,
8415,GO:0033477,1,0.971874434579777,0,1,S-methylmethionine metabolic process,BP,
8417,GO:0033484,1,0.911693944262853,0,3,nitric oxide homeostasis,BP,
8418,GO:0033488,1,0.964482682859472,0,1,cholesterol biosynthetic process via 24,25-dihydrolanosterol,BP,
8419,GO:0033489,1,0.878741503965353,0,4,cholesterol biosynthetic process via desmosterol,BP,
8420,GO:0033490,1,0.878741503965353,0,4,cholesterol biosynthetic process via lathosterol,BP,
8421,GO:0033499,1,0.94695023218408,0,2,galactose catabolic process via UDP-galactose,BP,
8423,GO:0033503,1,0.869145853781326,0,4,HULC complex,CC,
8424,GO:0033504,1,0.883490439991927,0,3,floor plate development,BP,
8425,GO:0033505,1,0.95950763690405,0,1,floor plate morphogenesis,BP,
8426,GO:0033512,1,0.898782674274902,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
8427,GO:0033522,1,0.406375866916094,0,25,histone H2A ubiquitination,BP,
8428,GO:0033523,1,0.652169048260075,0,12,histone H2B ubiquitination,BP,
8429,GO:0033526,1,0.966572172411756,0,1,tetrapyrrole biosynthetic process from glutamate,BP,
8430,GO:0033539,1,0.679640962793306,0,12,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,
8431,GO:0033540,1,0.657971860702574,0,13,fatty acid beta-oxidation using acyl-CoA oxidase,BP,
8433,GO:0033552,1,0.96734812294771,0,1,response to vitamin B3,BP,
8434,GO:0033553,1,0.869029344491632,0,4,rDNA heterochromatin,CC,
8437,GO:0033557,1,0.899937323989477,0,3,Slx1-Slx4 complex,CC,
8440,GO:0033560,1,0.961189946387075,0,1,folate reductase activity,MF,
8442,GO:0033564,1,0.920765933504962,0,2,anterior/posterior axon guidance,BP,
8443,GO:0033565,1,0.89378745563803,0,3,ESCRT-0 complex,CC,
8444,GO:0033566,1,0.935079499958678,0,2,gamma-tubulin complex localization,BP,
8445,GO:0033567,1,0.858376397493427,0,5,DNA replication, Okazaki fragment processing,BP,
8449,GO:0033577,1,0.934222771392905,0,2,protein glycosylation in endoplasmic reticulum,BP,
8450,GO:0033578,1,0.841460491397722,0,5,protein glycosylation in Golgi,BP,
8451,GO:0033588,1,0.84841130076058,0,5,Elongator holoenzyme complex,CC,
8453,GO:0033591,1,0.880970480540416,0,4,response to L-ascorbic acid,BP,
8454,GO:0033592,1,0.827862481858691,0,5,RNA strand annealing activity,MF,
8455,GO:0033593,1,0.95950763690405,0,1,BRCA2-MAGE-D1 complex,CC,
8456,GO:0033594,1,0.967528970318412,0,1,response to hydroxyisoflavone,BP,
8457,GO:0033596,1,0.885882923534408,0,3,TSC1-TSC2 complex,CC,
8458,GO:0033597,1,0.970548920921222,0,1,mitotic checkpoint complex,CC,
8460,GO:0033599,1,0.566059095671693,0,17,regulation of mammary gland epithelial cell proliferation,BP,
8461,GO:0033600,1,0.867729567408764,0,4,negative regulation of mammary gland epithelial cell proliferation,BP,
8462,GO:0033601,1,0.741208262654383,0,8,positive regulation of mammary gland epithelial cell proliferation,BP,
8463,GO:0033602,1,0.959675503888475,0,1,negative regulation of dopamine secretion,BP,
8464,GO:0033603,1,0.914423472341906,0,3,positive regulation of dopamine secretion,BP,
8465,GO:0033604,1,0.925454620963887,0,2,negative regulation of catecholamine secretion,BP,
8467,GO:0033606,1,0.970368607052476,0,1,chemokine receptor transport within lipid bilayer,BP,
8468,GO:0033608,1,0.965469978279355,0,1,formyl-CoA transferase activity,MF,
8469,GO:0033609,1,0.965469978279355,0,1,oxalate metabolic process,BP,
8472,GO:0033615,1,0.909127994206169,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
8473,GO:0033617,1,0.5544527665787,0,20,mitochondrial respiratory chain complex IV assembly,BP,
8475,GO:0033622,1,0.658767031230508,0,11,integrin activation,BP,
8476,GO:0033623,1,0.795680342933632,0,6,regulation of integrin activation,BP,
8477,GO:0033624,1,0.923923826526747,0,2,negative regulation of integrin activation,BP,
8478,GO:0033625,1,0.927663381956361,0,2,positive regulation of integrin activation,BP,
8484,GO:0033632,1,0.849937253117172,0,5,regulation of cell-cell adhesion mediated by integrin,BP,
8485,GO:0033633,1,0.959716919283985,0,1,negative regulation of cell-cell adhesion mediated by integrin,BP,
8486,GO:0033634,1,0.907290795110181,0,3,positive regulation of cell-cell adhesion mediated by integrin,BP,
8487,GO:0033643,1,0.715601931179411,0,9,host cell part,CC,
8488,GO:0033644,1,0.960557918077305,0,1,host cell membrane,CC,
8489,GO:0033646,1,0.776228343768706,0,7,host intracellular part,CC,
8490,GO:0033647,1,0.837761132521043,0,5,host intracellular organelle,CC,
8491,GO:0033648,1,0.837761132521043,0,5,host intracellular membrane-bounded organelle,CC,
8492,GO:0033650,1,0.974035953495293,0,1,host cell mitochondrion,CC,
8493,GO:0033655,1,0.868939008157368,0,4,host cell cytoplasm part,CC,
8494,GO:0033668,1,0.881508414903699,0,4,negative regulation by symbiont of host apoptotic process,BP,
8497,GO:0033676,1,0.97746563707461,0,1,double-stranded DNA-dependent ATPase activity,MF,
8498,GO:0033677,1,0.896964075409084,0,3,DNA/RNA helicase activity,MF,
8499,GO:0033678,1,0.966857843156553,0,1,5'-3' DNA/RNA helicase activity,MF,
8500,GO:0033679,1,0.959909259195392,0,1,3'-5' DNA/RNA helicase activity,MF,
8501,GO:0033680,1,0.928092573626195,0,2,ATP-dependent DNA/RNA helicase activity,MF,
8502,GO:0033681,1,0.959909259195392,0,1,ATP-dependent 3'-5' DNA/RNA helicase activity,MF,
8503,GO:0033682,1,0.966857843156553,0,1,ATP-dependent 5'-3' DNA/RNA helicase activity,MF,
8504,GO:0033683,1,0.299157224799772,0,39,nucleotide-excision repair, DNA incision,BP,
8505,GO:0033684,1,0.926268966643181,0,2,regulation of luteinizing hormone secretion,BP,
8506,GO:0033686,1,0.926268966643181,0,2,positive regulation of luteinizing hormone secretion,BP,
8511,GO:0033691,1,0.921877947715586,0,2,sialic acid binding,MF,
8513,GO:0033693,1,0.893528926243893,0,3,neurofilament bundle assembly,BP,
8514,GO:0033695,1,0.964209155829131,0,1,oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor,MF,
8515,GO:0033699,1,0.971644205399406,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
8516,GO:0033700,1,0.825503429829021,0,6,phospholipid efflux,BP,
8517,GO:0033737,1,0.967911421107606,0,1,1-pyrroline dehydrogenase activity,MF,
8518,GO:0033743,1,0.882986248930356,0,4,peptide-methionine (R)-S-oxide reductase activity,MF,
8519,GO:0033745,1,0.902648371896363,0,3,L-methionine-(R)-S-oxide reductase activity,MF,
8520,GO:0033746,1,0.962108754463036,0,1,histone demethylase activity (H3-R2 specific),MF,
8521,GO:0033749,1,0.962108754463036,0,1,histone demethylase activity (H4-R3 specific),MF,
8522,GO:0033750,1,0.697946860140434,0,13,ribosome localization,BP,
8523,GO:0033754,1,0.975784758760467,0,1,indoleamine 2,3-dioxygenase activity,MF,
8525,GO:0033764,1,0.659396986935523,0,16,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
8526,GO:0033765,1,0.937579216348392,0,2,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,
8527,GO:0033768,1,0.930938147493841,0,2,SUMO-targeted ubiquitin ligase complex,CC,
8528,GO:0033787,1,0.965735644384804,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
8529,GO:0033814,1,0.977320014662109,0,1,propanoyl-CoA C-acyltransferase activity,MF,
8530,GO:0033823,1,0.964931165528966,0,1,procollagen glucosyltransferase activity,MF,
8531,GO:0033829,1,0.917288699369305,0,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,
8532,GO:0033842,1,0.926828099345063,0,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,
8533,GO:0033857,1,0.920679357056224,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
8534,GO:0033858,1,0.964009782504063,0,1,N-acetylgalactosamine kinase activity,MF,
8535,GO:0033860,1,0.93612608268593,0,3,regulation of NAD(P)H oxidase activity,BP,
8536,GO:0033862,1,0.964947396982097,0,1,UMP kinase activity,MF,
8537,GO:0033864,1,0.93612608268593,0,3,positive regulation of NAD(P)H oxidase activity,BP,
8540,GO:0033867,1,0.975066919827892,0,1,Fas-activated serine/threonine kinase activity,MF,
8541,GO:0033869,1,0.981788291745788,0,1,nucleoside bisphosphate catabolic process,BP,
8542,GO:0033871,1,0.972280914660677,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
8543,GO:0033872,1,0.971576448266443,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
8545,GO:0033878,1,0.961497904997032,0,1,hormone-sensitive lipase activity,MF,
8546,GO:0033882,1,0.980140625810969,0,1,choloyl-CoA hydrolase activity,MF,
8547,GO:0033883,1,0.952893035317697,0,2,pyridoxal phosphatase activity,MF,
8548,GO:0033885,1,0.970114988474346,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
8549,GO:0033897,1,0.97913426334244,0,1,ribonuclease T2 activity,MF,
8550,GO:0033906,1,0.943269270381327,0,2,hyaluronoglucuronidase activity,MF,
8551,GO:0033919,1,0.961222559055262,0,1,glucan 1,3-alpha-glucosidase activity,MF,
8552,GO:0033925,1,0.960059116294967,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
8553,GO:0033961,1,0.974078146739534,0,1,cis-stilbene-oxide hydrolase activity,MF,
8555,GO:0033967,1,0.980030274204034,0,1,box C/D snoRNA metabolic process,BP,
8556,GO:0033979,1,0.967418178557372,0,1,box H/ACA snoRNA metabolic process,BP,
8557,GO:0033981,1,0.986092578351853,0,1,D-dopachrome decarboxylase activity,MF,
8558,GO:0033989,1,0.966685677564125,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
8560,GO:0034012,1,0.965469978279355,0,1,FAD-AMP lyase (cyclizing) activity,MF,
8561,GO:0034014,1,0.969484008610393,0,1,response to triglyceride,BP,
8564,GO:0034031,1,0.981788291745788,0,1,ribonucleoside bisphosphate catabolic process,BP,
8567,GO:0034034,1,0.981788291745788,0,1,purine nucleoside bisphosphate catabolic process,BP,
8568,GO:0034035,1,0.571996156462107,0,18,purine ribonucleoside bisphosphate metabolic process,BP,
8569,GO:0034036,1,0.810968784245712,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
8570,GO:0034038,1,0.979821243831223,0,1,deoxyhypusine synthase activity,MF,
8571,GO:0034039,1,0.946501315234507,0,2,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
8572,GO:0034040,1,0.891068318637396,0,3,lipid-transporting ATPase activity,MF,
8573,GO:0034041,1,0.964955523036117,0,1,sterol-transporting ATPase activity,MF,
8574,GO:0034045,1,0.560623450352796,0,16,phagophore assembly site membrane,CC,
8575,GO:0034046,1,0.769390167229239,0,7,poly(G) binding,MF,
8576,GO:0034056,1,0.892859768849191,0,3,estrogen response element binding,MF,
8577,GO:0034057,1,0.929975245659327,0,2,RNA strand-exchange activity,MF,
8578,GO:0034058,1,0.680235528397465,0,10,endosomal vesicle fusion,BP,
8579,GO:0034059,1,0.892892917492039,0,3,response to anoxia,BP,
8580,GO:0034061,1,0.323328058235748,0,34,DNA polymerase activity,MF,
8582,GO:0034063,1,0.60852057511018,0,13,stress granule assembly,BP,
8583,GO:0034066,1,0.944803187342964,0,2,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
8584,GO:0034067,1,0.455485425003036,0,21,protein localization to Golgi apparatus,BP,
8585,GO:0034080,1,0.390153679695796,0,40,CENP-A containing nucleosome assembly,BP,
8586,GO:0034085,1,0.777371116373287,0,7,establishment of sister chromatid cohesion,BP,
8587,GO:0034086,1,0.664734411424422,0,12,maintenance of sister chromatid cohesion,BP,
8588,GO:0034087,1,0.92330935129542,0,2,establishment of mitotic sister chromatid cohesion,BP,
8589,GO:0034088,1,0.664734411424422,0,12,maintenance of mitotic sister chromatid cohesion,BP,
8590,GO:0034091,1,0.771168044570569,0,8,regulation of maintenance of sister chromatid cohesion,BP,
8591,GO:0034092,1,0.90521361908307,0,3,negative regulation of maintenance of sister chromatid cohesion,BP,
8592,GO:0034093,1,0.851952666117576,0,5,positive regulation of maintenance of sister chromatid cohesion,BP,
8594,GO:0034098,1,0.720117309130637,0,9,VCP-NPL4-UFD1 AAA ATPase complex,CC,
8600,GO:0034110,1,0.488298806662805,0,21,regulation of homotypic cell-cell adhesion,BP,
8601,GO:0034111,1,0.682076747572456,0,11,negative regulation of homotypic cell-cell adhesion,BP,
8602,GO:0034112,1,0.865622582762744,0,5,positive regulation of homotypic cell-cell adhesion,BP,
8607,GO:0034117,1,0.987152564600386,0,1,erythrocyte aggregation,BP,
8608,GO:0034118,1,0.987152564600386,0,1,regulation of erythrocyte aggregation,BP,
8609,GO:0034120,1,0.987152564600386,0,1,positive regulation of erythrocyte aggregation,BP,
8619,GO:0034137,1,0.926615679193412,0,3,positive regulation of toll-like receptor 2 signaling pathway,BP,
8631,GO:0034150,1,0.95950763690405,0,1,toll-like receptor 6 signaling pathway,BP,
8632,GO:0034154,1,0.867702611943451,0,4,toll-like receptor 7 signaling pathway,BP,
8633,GO:0034155,1,0.962514707228382,0,1,regulation of toll-like receptor 7 signaling pathway,BP,
8634,GO:0034157,1,0.962514707228382,0,1,positive regulation of toll-like receptor 7 signaling pathway,BP,
8636,GO:0034163,1,0.889237782364966,0,3,regulation of toll-like receptor 9 signaling pathway,BP,
8637,GO:0034164,1,0.95950763690405,0,1,negative regulation of toll-like receptor 9 signaling pathway,BP,
8638,GO:0034165,1,0.926771994322269,0,2,positive regulation of toll-like receptor 9 signaling pathway,BP,
8639,GO:0034166,1,0.963356167426761,0,1,toll-like receptor 10 signaling pathway,BP,
8640,GO:0034182,1,0.771168044570569,0,8,regulation of maintenance of mitotic sister chromatid cohesion,BP,
8641,GO:0034183,1,0.90521361908307,0,3,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
8642,GO:0034184,1,0.851952666117576,0,5,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
8643,GO:0034185,1,0.635760699236521,0,12,apolipoprotein binding,MF,
8644,GO:0034186,1,0.87930911938755,0,4,apolipoprotein A-I binding,MF,
8645,GO:0034188,1,0.920650957478618,0,2,apolipoprotein A-I receptor activity,MF,
8646,GO:0034189,1,0.925635365034715,0,2,very-low-density lipoprotein particle binding,MF,
8647,GO:0034190,1,0.869997260699242,0,4,apolipoprotein receptor binding,MF,
8648,GO:0034191,1,0.9043355668448,0,3,apolipoprotein A-I receptor binding,MF,
8649,GO:0034196,1,0.967308247591653,0,1,acylglycerol transport,BP,
8650,GO:0034197,1,0.967308247591653,0,1,triglyceride transport,BP,
8652,GO:0034199,1,0.681744044958627,0,10,activation of protein kinase A activity,BP,
8653,GO:0034201,1,0.843924425459685,0,5,response to oleic acid,BP,
8654,GO:0034203,1,0.95958885853108,0,1,glycolipid translocation,BP,
8655,GO:0034204,1,0.539823216187082,0,15,lipid translocation,BP,
8657,GO:0034212,1,0.1244694116142,0,60,peptide N-acetyltransferase activity,MF,
8658,GO:0034213,1,0.976024317261928,0,1,quinolinate catabolic process,BP,
8662,GO:0034224,1,0.969798753702356,0,1,cellular response to zinc ion starvation,BP,
8663,GO:0034227,1,0.869262919095145,0,5,tRNA thio-modification,BP,
8664,GO:0034235,1,0.816869579138393,0,6,GPI anchor binding,MF,
8666,GO:0034237,1,0.56549176074735,0,15,protein kinase A regulatory subunit binding,MF,
8670,GO:0034242,1,0.932799638943622,0,2,negative regulation of syncytium formation by plasma membrane fusion,BP,
8671,GO:0034243,1,0.417817299893583,0,25,regulation of transcription elongation from RNA polymerase II promoter,BP,
8672,GO:0034244,1,0.711607231805187,0,10,negative regulation of transcription elongation from RNA polymerase II promoter,BP,
8673,GO:0034245,1,0.961479940850368,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
8674,GO:0034247,1,0.978692388407155,0,1,snoRNA splicing,BP,
8679,GO:0034271,1,0.898237782768828,0,3,phosphatidylinositol 3-kinase complex, class III, type I,CC,
8680,GO:0034272,1,0.898237782768828,0,3,phosphatidylinositol 3-kinase complex, class III, type II,CC,
8681,GO:0034274,1,0.888097893763914,0,3,Atg12-Atg5-Atg16 complex,CC,
8682,GO:0034275,1,0.975784758760467,0,1,kynurenic acid metabolic process,BP,
8683,GO:0034276,1,0.975784758760467,0,1,kynurenic acid biosynthetic process,BP,
8685,GO:0034285,1,0.895349524875021,0,3,response to disaccharide,BP,
8687,GO:0034309,1,0.98268071838369,0,1,primary alcohol biosynthetic process,BP,
8688,GO:0034310,1,0.81288801294522,0,7,primary alcohol catabolic process,BP,
8691,GO:0034314,1,0.385233430268292,0,29,Arp2/3 complex-mediated actin nucleation,BP,
8692,GO:0034315,1,0.603701790769341,0,14,regulation of Arp2/3 complex-mediated actin nucleation,BP,
8693,GO:0034316,1,0.870859815060443,0,4,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,
8696,GO:0034331,1,0.762976489583058,0,7,cell junction maintenance,BP,
8699,GO:0034334,1,0.856219437699218,0,4,adherens junction maintenance,BP,
8700,GO:0034338,1,0.900002790742845,0,3,short-chain carboxylesterase activity,MF,
8703,GO:0034342,1,0.937248304952159,0,2,response to type III interferon,BP,
8706,GO:0034346,1,0.964669942905159,0,1,positive regulation of type III interferon production,BP,
8707,GO:0034349,1,0.624845056813921,0,13,glial cell apoptotic process,BP,
8708,GO:0034350,1,0.774004690384522,0,7,regulation of glial cell apoptotic process,BP,
8709,GO:0034351,1,0.774004690384522,0,7,negative regulation of glial cell apoptotic process,BP,
8710,GO:0034353,1,0.965469978279355,0,1,RNA pyrophosphohydrolase activity,MF,
8711,GO:0034355,1,0.965469978279355,0,1,NAD salvage,BP,
8714,GO:0034361,1,0.821701218208465,0,7,very-low-density lipoprotein particle,CC,
8716,GO:0034363,1,0.979920153523586,0,1,intermediate-density lipoprotein particle,CC,
8718,GO:0034365,1,0.979920153523586,0,1,discoidal high-density lipoprotein particle,CC,
8719,GO:0034366,1,0.965741492599732,0,1,spherical high-density lipoprotein particle,CC,
8723,GO:0034370,1,0.958371748043892,0,2,triglyceride-rich lipoprotein particle remodeling,BP,
8724,GO:0034371,1,0.979920153523586,0,1,chylomicron remodeling,BP,
8725,GO:0034372,1,0.958371748043892,0,2,very-low-density lipoprotein particle remodeling,BP,
8726,GO:0034374,1,0.920614559676206,0,3,low-density lipoprotein particle remodeling,BP,
8730,GO:0034379,1,0.826510942388358,0,6,very-low-density lipoprotein particle assembly,BP,
8731,GO:0034380,1,0.738945890986219,0,9,high-density lipoprotein particle assembly,BP,
8736,GO:0034385,1,0.821701218208465,0,7,triglyceride-rich plasma lipoprotein particle,CC,
8737,GO:0034386,1,0.959675503888475,0,1,4-aminobutyrate:2-oxoglutarate transaminase activity,MF,
8738,GO:0034388,1,0.811974334976158,0,6,Pwp2p-containing subcomplex of 90S preribosome,CC,
8739,GO:0034389,1,0.622197680289562,0,14,lipid particle organization,BP,
8743,GO:0034393,1,0.730505076975381,0,9,positive regulation of smooth muscle cell apoptotic process,BP,
8745,GO:0034395,1,0.976004288060724,0,1,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
8746,GO:0034397,1,0.715638833124685,0,9,telomere localization,BP,
8747,GO:0034398,1,0.825354031365607,0,5,telomere tethering at nuclear periphery,BP,
8749,GO:0034402,1,0.929981381569634,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
8752,GO:0034414,1,0.932561306171818,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
8753,GO:0034416,1,0.93238589074051,0,2,bisphosphoglycerate phosphatase activity,MF,
8754,GO:0034417,1,0.965735644384804,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
8755,GO:0034418,1,0.940006647755898,0,2,urate biosynthetic process,BP,
8756,GO:0034421,1,0.896547891036012,0,3,post-translational protein acetylation,BP,
8757,GO:0034423,1,0.967051827522193,0,1,autophagosome lumen,CC,
8758,GO:0034427,1,0.773039434672912,0,10,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
8759,GO:0034431,1,0.883830410916759,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
8760,GO:0034432,1,0.883830410916759,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
8761,GO:0034433,1,0.82392184432652,0,7,steroid esterification,BP,
8762,GO:0034434,1,0.82392184432652,0,7,sterol esterification,BP,
8763,GO:0034435,1,0.82392184432652,0,7,cholesterol esterification,BP,
8764,GO:0034436,1,0.9117524324395,0,3,glycoprotein transport,BP,
8765,GO:0034437,1,0.92844210645447,0,2,glycoprotein transporter activity,MF,
8767,GO:0034441,1,0.973603908484958,0,1,plasma lipoprotein particle oxidation,BP,
8769,GO:0034447,1,0.909238336430512,0,4,very-low-density lipoprotein particle clearance,BP,
8770,GO:0034448,1,0.900072676323516,0,4,EGO complex,CC,
8772,GO:0034451,1,0.440281477566071,0,22,centriolar satellite,CC,
8773,GO:0034452,1,0.681022377507388,0,10,dynactin binding,MF,
8774,GO:0034453,1,0.423131321826891,0,23,microtubule anchoring,BP,
8775,GO:0034454,1,0.70265714313238,0,9,microtubule anchoring at centrosome,BP,
8776,GO:0034455,1,0.896893051663024,0,3,t-UTP complex,CC,
8777,GO:0034456,1,0.908501138590578,0,3,UTP-C complex,CC,
8778,GO:0034457,1,0.930269080790448,0,3,Mpp10 complex,CC,
8779,GO:0034458,1,0.929250865192459,0,2,3'-5' RNA helicase activity,MF,
8780,GO:0034459,1,0.959909259195392,0,1,ATP-dependent 3'-5' RNA helicase activity,MF,
8781,GO:0034462,1,0.969787143083465,0,1,small-subunit processome assembly,BP,
8782,GO:0034463,1,0.989378992727946,0,1,90S preribosome assembly,BP,
8783,GO:0034464,1,0.736548800550075,0,9,BBSome,CC,
8784,GO:0034465,1,0.884300093685305,0,4,response to carbon monoxide,BP,
8786,GO:0034471,1,0.578527382417749,0,19,ncRNA 5'-end processing,BP,
8787,GO:0034472,1,0.664930465906501,0,14,snRNA 3'-end processing,BP,
8788,GO:0034473,1,0.934423036766212,0,3,U1 snRNA 3'-end processing,BP,
8789,GO:0034474,1,0.95950763690405,0,1,U2 snRNA 3'-end processing,BP,
8790,GO:0034475,1,0.836177339828433,0,8,U4 snRNA 3'-end processing,BP,
8791,GO:0034476,1,0.934423036766212,0,3,U5 snRNA 3'-end processing,BP,
8792,GO:0034477,1,0.965469978279355,0,1,U6 snRNA 3'-end processing,BP,
8793,GO:0034481,1,0.866792835123321,0,4,chondroitin sulfotransferase activity,MF,
8794,GO:0034483,1,0.750463900579865,0,8,heparan sulfate sulfotransferase activity,MF,
8795,GO:0034485,1,0.860981892243804,0,4,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,
8796,GO:0034497,1,0.645779508954021,0,12,protein localization to phagophore assembly site,BP,
8797,GO:0034498,1,0.759631298827465,0,8,early endosome to Golgi transport,BP,
8798,GO:0034499,1,0.920875986706953,0,2,late endosome to Golgi transport,BP,
8799,GO:0034501,1,0.593710445282412,0,16,protein localization to kinetochore,BP,
8800,GO:0034502,1,0.0913801451934615,0,72,protein localization to chromosome,BP,
8802,GO:0034505,1,0.635242296016228,0,12,tooth mineralization,BP,
8803,GO:0034506,1,0.960909550686142,0,1,chromosome, centromeric core domain,CC,
8804,GO:0034508,1,0.270281864487855,0,50,centromere complex assembly,BP,
8806,GO:0034512,1,0.965469978279355,0,1,box C/D snoRNA binding,MF,
8807,GO:0034513,1,0.901384652359411,0,5,box H/ACA snoRNA binding,MF,
8808,GO:0034515,1,0.930119980279178,0,2,proteasome storage granule,CC,
8810,GO:0034545,1,0.974728672087704,0,1,fumarylpyruvate hydrolase activity,MF,
8811,GO:0034551,1,0.750246799413677,0,9,mitochondrial respiratory chain complex III assembly,BP,
8812,GO:0034552,1,0.895288129505721,0,4,respiratory chain complex II assembly,BP,
8813,GO:0034553,1,0.895288129505721,0,4,mitochondrial respiratory chain complex II assembly,BP,
8814,GO:0034584,1,0.961425186723365,0,1,piRNA binding,MF,
8815,GO:0034587,1,0.748651339186616,0,8,piRNA metabolic process,BP,
8816,GO:0034589,1,0.960345710738993,0,1,hydroxyproline transport,BP,
8817,GO:0034590,1,0.960345710738993,0,1,L-hydroxyproline transmembrane transporter activity,MF,
8818,GO:0034593,1,0.408760460183796,0,23,phosphatidylinositol bisphosphate phosphatase activity,MF,
8819,GO:0034594,1,0.826108689417895,0,5,phosphatidylinositol trisphosphate phosphatase activity,MF,
8820,GO:0034595,1,0.606702678080887,0,13,phosphatidylinositol phosphate 5-phosphatase activity,MF,
8821,GO:0034596,1,0.728080785791641,0,8,phosphatidylinositol phosphate 4-phosphatase activity,MF,
8822,GO:0034597,1,0.921852166729382,0,2,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
8824,GO:0034602,1,0.960341465926368,0,1,oxoglutarate dehydrogenase (NAD+) activity,MF,
8825,GO:0034603,1,0.839841620216904,0,5,pyruvate dehydrogenase [NAD(P)+] activity,MF,
8826,GO:0034604,1,0.839841620216904,0,5,pyruvate dehydrogenase (NAD+) activity,MF,
8832,GO:0034617,1,0.903569504719786,0,3,tetrahydrobiopterin binding,MF,
8833,GO:0034618,1,0.875713076033471,0,4,arginine binding,MF,
8836,GO:0034625,1,0.842051452556028,0,5,fatty acid elongation, monounsaturated fatty acid,BP,
8837,GO:0034626,1,0.842051452556028,0,5,fatty acid elongation, polyunsaturated fatty acid,BP,
8841,GO:0034634,1,0.95950763690405,0,1,glutathione transmembrane transporter activity,MF,
8842,GO:0034635,1,0.932436072679674,0,2,glutathione transport,BP,
8845,GO:0034640,1,0.96373517473614,0,1,establishment of mitochondrion localization by microtubule attachment,BP,
8847,GO:0034642,1,0.961473975241871,0,1,mitochondrion migration along actin filament,BP,
8848,GO:0034643,1,0.512733039032895,0,19,establishment of mitochondrion localization, microtubule-mediated,BP,
8851,GO:0034647,1,0.920650957478618,0,2,histone demethylase activity (H3-trimethyl-K4 specific),MF,
8852,GO:0034648,1,0.853497062828216,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
8853,GO:0034649,1,0.961272228317104,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
8856,GO:0034653,1,0.960018965720951,0,1,retinoic acid catabolic process,BP,
8860,GO:0034657,1,0.873845229639353,0,4,GID complex,CC,
8863,GO:0034663,1,0.750666192846836,0,9,endoplasmic reticulum chaperone complex,CC,
8864,GO:0034665,1,0.922916640397666,0,2,integrin alpha1-beta1 complex,CC,
8865,GO:0034666,1,0.889965133858059,0,3,integrin alpha2-beta1 complex,CC,
8866,GO:0034667,1,0.922824555501241,0,2,integrin alpha3-beta1 complex,CC,
8867,GO:0034669,1,0.95950763690405,0,1,integrin alpha4-beta7 complex,CC,
8869,GO:0034673,1,0.920688886882152,0,2,inhibin-betaglycan-ActRII complex,CC,
8870,GO:0034676,1,0.959507638389447,0,1,integrin alpha6-beta4 complex,CC,
8871,GO:0034677,1,0.961635860888525,0,1,integrin alpha7-beta1 complex,CC,
8872,GO:0034678,1,0.923116638591964,0,2,integrin alpha8-beta1 complex,CC,
8873,GO:0034680,1,0.922744205099906,0,2,integrin alpha10-beta1 complex,CC,
8874,GO:0034681,1,0.961635860888525,0,1,integrin alpha11-beta1 complex,CC,
8879,GO:0034693,1,0.968211847170313,0,1,U11/U12 snRNP,CC,
8881,GO:0034695,1,0.589137156597733,0,14,response to prostaglandin E,BP,
8884,GO:0034699,1,0.896130679308801,0,3,response to luteinizing hormone,BP,
8887,GO:0034704,1,0.44517987005066,0,24,calcium channel complex,CC,
8889,GO:0034706,1,0.722727315060601,0,8,sodium channel complex,CC,
8892,GO:0034709,1,0.770152663321184,0,12,methylosome,CC,
8894,GO:0034713,1,0.755615740538997,0,8,type I transforming growth factor beta receptor binding,MF,
8895,GO:0034714,1,0.897353047922928,0,3,type III transforming growth factor beta receptor binding,MF,
8896,GO:0034715,1,0.881793989965923,0,6,pICln-Sm protein complex,CC,
8897,GO:0034718,1,0.959519361353407,0,1,SMN-Gemin2 complex,CC,
8898,GO:0034719,1,0.658701834288289,0,16,SMN-Sm protein complex,CC,
8899,GO:0034720,1,0.785751472862228,0,6,histone H3-K4 demethylation,BP,
8900,GO:0034721,1,0.920650957478618,0,2,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
8901,GO:0034722,1,0.976589929863148,0,1,gamma-glutamyl-peptidase activity,MF,
8904,GO:0034727,1,0.959643961346915,0,1,piecemeal microautophagy of the nucleus,BP,
8906,GO:0034729,1,0.902746666000768,0,3,histone H3-K79 methylation,BP,
8907,GO:0034736,1,0.96295569661504,0,1,cholesterol O-acyltransferase activity,MF,
8908,GO:0034739,1,0.947355604388174,0,2,histone deacetylase activity (H4-K16 specific),MF,
8909,GO:0034750,1,0.92391496859245,0,2,Scrib-APC-beta-catenin complex,CC,
8910,GO:0034751,1,0.909253322415632,0,3,aryl hydrocarbon receptor complex,CC,
8911,GO:0034752,1,0.95950763690405,0,1,cytosolic aryl hydrocarbon receptor complex,CC,
8912,GO:0034753,1,0.95950763690405,0,1,nuclear aryl hydrocarbon receptor complex,CC,
8915,GO:0034756,1,0.916199931561619,0,3,regulation of iron ion transport,BP,
8916,GO:0034757,1,0.95950763690405,0,1,negative regulation of iron ion transport,BP,
8917,GO:0034759,1,0.95950763690405,0,1,regulation of iron ion transmembrane transport,BP,
8918,GO:0034760,1,0.95950763690405,0,1,negative regulation of iron ion transmembrane transport,BP,
8925,GO:0034770,1,0.712077571927398,0,9,histone H4-K20 methylation,BP,
8926,GO:0034773,1,0.80117103881759,0,6,histone H4-K20 trimethylation,BP,
8928,GO:0034775,1,0.95950763690405,0,1,glutathione transmembrane transport,BP,
8929,GO:0034776,1,0.921361924360193,0,2,response to histamine,BP,
8930,GO:0034777,1,0.969899683418484,0,1,recycling endosome lumen,CC,
8931,GO:0034875,1,0.964209155829131,0,1,caffeine oxidase activity,MF,
8932,GO:0034959,1,0.959579885668155,0,1,endothelin maturation,BP,
8933,GO:0034963,1,0.980030274204034,0,1,box C/D snoRNA processing,BP,
8934,GO:0034964,1,0.967418178557372,0,1,box H/ACA snoRNA processing,BP,
8936,GO:0034969,1,0.718703289014419,0,10,histone arginine methylation,BP,
8937,GO:0034970,1,0.933179738784981,0,2,histone H3-R2 methylation,BP,
8938,GO:0034971,1,0.964996256623698,0,1,histone H3-R17 methylation,BP,
8942,GO:0034982,1,0.747581054919624,0,10,mitochondrial protein processing,BP,
8944,GO:0034986,1,0.95950763690405,0,1,iron chaperone activity,MF,
8945,GO:0034987,1,0.95950763690405,0,1,immunoglobulin receptor binding,MF,
8946,GO:0034988,1,0.95950763690405,0,1,Fc-gamma receptor I complex binding,MF,
8947,GO:0034991,1,0.931318863844098,0,2,nuclear meiotic cohesin complex,CC,
8948,GO:0034992,1,0.821649745191302,0,5,microtubule organizing center attachment site,CC,
8949,GO:0034993,1,0.821649745191302,0,5,meiotic nuclear membrane microtubule tethering complex,CC,
8950,GO:0034998,1,0.965469978279355,0,1,oligosaccharyltransferase I complex,CC,
8952,GO:0035005,1,0.785757626003034,0,6,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
8953,GO:0035014,1,0.788896540021207,0,6,phosphatidylinositol 3-kinase regulator activity,MF,
8955,GO:0035020,1,0.576815654013474,0,15,regulation of Rac protein signal transduction,BP,
8956,GO:0035021,1,0.861985431240678,0,4,negative regulation of Rac protein signal transduction,BP,
8957,GO:0035022,1,0.870696177409787,0,4,positive regulation of Rac protein signal transduction,BP,
8960,GO:0035025,1,0.641963375604413,0,13,positive regulation of Rho protein signal transduction,BP,
8962,GO:0035032,1,0.813455695437922,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
8963,GO:0035033,1,0.937758817846943,0,2,histone deacetylase regulator activity,MF,
8964,GO:0035034,1,0.936103801918811,0,2,histone acetyltransferase regulator activity,MF,
8967,GO:0035037,1,0.960028813989422,0,1,sperm entry,BP,
8971,GO:0035061,1,0.852889681047734,0,4,interchromatin granule,CC,
8972,GO:0035063,1,0.96187014524559,0,1,nuclear speck organization,BP,
8977,GO:0035068,1,0.719769421913012,0,9,micro-ribonucleoprotein complex,CC,
8978,GO:0035082,1,0.4588177650944,0,23,axoneme assembly,BP,
8979,GO:0035087,1,0.881635220302397,0,4,siRNA loading onto RISC involved in RNA interference,BP,
8982,GO:0035090,1,0.838765200549755,0,5,maintenance of apical/basal cell polarity,BP,
8984,GO:0035092,1,0.88404012563736,0,3,sperm chromatin condensation,BP,
8985,GO:0035093,1,0.92065500126795,0,2,spermatogenesis, exchange of chromosomal proteins,BP,
8987,GO:0035095,1,0.863396912122855,0,4,behavioral response to nicotine,BP,
8989,GO:0035098,1,0.558879245133666,0,16,ESC/E(Z) complex,CC,
8990,GO:0035101,1,0.894681576147437,0,3,FACT complex,CC,
8991,GO:0035102,1,0.659235359210687,0,12,PRC1 complex,CC,
8994,GO:0035112,1,0.789488758759995,0,6,genitalia morphogenesis,BP,
8998,GO:0035120,1,0.95950763690405,0,1,post-embryonic appendage morphogenesis,BP,
8999,GO:0035127,1,0.95950763690405,0,1,post-embryonic limb morphogenesis,BP,
9000,GO:0035128,1,0.95950763690405,0,1,post-embryonic forelimb morphogenesis,BP,
9003,GO:0035145,1,0.490010216872581,0,21,exon-exon junction complex,CC,
9006,GO:0035162,1,0.594054587308969,0,14,embryonic hemopoiesis,BP,
9007,GO:0035166,1,0.892481421174581,0,3,post-embryonic hemopoiesis,BP,
9008,GO:0035173,1,0.623467257102968,0,14,histone kinase activity,MF,
9009,GO:0035174,1,0.825088237399879,0,6,histone serine kinase activity,MF,
9010,GO:0035175,1,0.974441879248554,0,1,histone kinase activity (H3-S10 specific),MF,
9011,GO:0035176,1,0.317576829998141,0,31,social behavior,BP,
9012,GO:0035184,1,0.871967705759967,0,4,histone threonine kinase activity,MF,
9013,GO:0035188,1,0.963623477545562,0,1,hatching,BP,
9014,GO:0035189,1,0.900116847052656,0,3,Rb-E2F complex,CC,
9018,GO:0035197,1,0.716789386730954,0,9,siRNA binding,MF,
9020,GO:0035226,1,0.964477537351657,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9021,GO:0035227,1,0.964477537351657,0,1,regulation of glutamate-cysteine ligase activity,BP,
9022,GO:0035229,1,0.964477537351657,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
9024,GO:0035235,1,0.745604292059639,0,8,ionotropic glutamate receptor signaling pathway,BP,
9026,GO:0035240,1,0.972641442982888,0,1,dopamine binding,MF,
9027,GO:0035241,1,0.904348062637955,0,3,protein-arginine omega-N monomethyltransferase activity,MF,
9028,GO:0035242,1,0.800343075577587,0,7,protein-arginine omega-N asymmetric methyltransferase activity,MF,
9029,GO:0035243,1,0.874328900961881,0,4,protein-arginine omega-N symmetric methyltransferase activity,MF,
9030,GO:0035246,1,0.70108374454766,0,11,peptidyl-arginine N-methylation,BP,
9031,GO:0035247,1,0.748242588204696,0,9,peptidyl-arginine omega-N-methylation,BP,
9032,GO:0035248,1,0.965607768776367,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
9036,GO:0035252,1,0.806007280480499,0,6,UDP-xylosyltransferase activity,MF,
9037,GO:0035253,1,0.721065745137209,0,9,ciliary rootlet,CC,
9040,GO:0035256,1,0.821004425934541,0,6,G-protein coupled glutamate receptor binding,MF,
9044,GO:0035261,1,0.920650957478618,0,2,external genitalia morphogenesis,BP,
9045,GO:0035262,1,0.95950763690405,0,1,gonad morphogenesis,BP,
9048,GO:0035267,1,0.554676135422987,0,19,NuA4 histone acetyltransferase complex,CC,
9049,GO:0035268,1,0.569723410543731,0,17,protein mannosylation,BP,
9050,GO:0035269,1,0.727925797971449,0,11,protein O-linked mannosylation,BP,
9053,GO:0035276,1,0.959511901020005,0,1,ethanol binding,MF,
9055,GO:0035279,1,0.928985764524472,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
9056,GO:0035280,1,0.781504783572297,0,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,
9057,GO:0035281,1,0.941396269994024,0,2,pre-miRNA export from nucleus,BP,
9059,GO:0035283,1,0.963163523892684,0,1,central nervous system segmentation,BP,
9060,GO:0035284,1,0.963163523892684,0,1,brain segmentation,BP,
9061,GO:0035290,1,0.893974106353757,0,3,trunk segmentation,BP,
9064,GO:0035299,1,0.960180254099541,0,1,inositol pentakisphosphate 2-kinase activity,MF,
9071,GO:0035312,1,0.803094758464402,0,6,5'-3' exodeoxyribonuclease activity,MF,
9074,GO:0035325,1,0.785850659692556,0,8,Toll-like receptor binding,MF,
9076,GO:0035327,1,0.525984095162374,0,20,transcriptionally active chromatin,CC,
9078,GO:0035330,1,0.65180019179108,0,11,regulation of hippo signaling,BP,
9079,GO:0035331,1,0.73325317475216,0,8,negative regulation of hippo signaling,BP,
9080,GO:0035332,1,0.920650957478618,0,2,positive regulation of hippo signaling,BP,
9083,GO:0035336,1,0.525081442916773,0,19,long-chain fatty-acyl-CoA metabolic process,BP,
9084,GO:0035337,1,0.342589721577817,0,32,fatty-acyl-CoA metabolic process,BP,
9085,GO:0035338,1,0.63918636623914,0,13,long-chain fatty-acyl-CoA biosynthetic process,BP,
9086,GO:0035339,1,0.897020102225329,0,4,SPOTS complex,CC,
9087,GO:0035349,1,0.904672350912616,0,3,coenzyme A transmembrane transport,BP,
9088,GO:0035350,1,0.935481923354222,0,2,FAD transmembrane transport,BP,
9089,GO:0035352,1,0.969671436256047,0,1,NAD transmembrane transport,BP,
9090,GO:0035354,1,0.962976580653528,0,1,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9091,GO:0035355,1,0.95950763690405,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
9092,GO:0035356,1,0.859233259599645,0,5,cellular triglyceride homeostasis,BP,
9093,GO:0035357,1,0.596810961600678,0,14,peroxisome proliferator activated receptor signaling pathway,BP,
9094,GO:0035358,1,0.778304586590608,0,7,regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9095,GO:0035359,1,0.960843484372208,0,1,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9096,GO:0035360,1,0.842577577367224,0,5,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9097,GO:0035363,1,0.873662762116487,0,4,histone locus body,CC,
9098,GO:0035368,1,0.872828756893332,0,4,selenocysteine insertion sequence binding,MF,
9099,GO:0035370,1,0.93787802744088,0,2,UBC13-UEV1A complex,CC,
9100,GO:0035371,1,0.499022340764268,0,18,microtubule plus-end,CC,
9101,GO:0035372,1,0.615393625087396,0,13,protein localization to microtubule,BP,
9102,GO:0035373,1,0.920650957478618,0,2,chondroitin sulfate proteoglycan binding,MF,
9103,GO:0035374,1,0.799708377250462,0,6,chondroitin sulfate binding,MF,
9105,GO:0035381,1,0.971542648304535,0,1,ATP-gated ion channel activity,MF,
9107,GO:0035384,1,0.221795998613808,0,43,thioester biosynthetic process,BP,
9108,GO:0035385,1,0.759327205696613,0,7,Roundabout signaling pathway,BP,
9109,GO:0035400,1,0.959536171863029,0,1,histone tyrosine kinase activity,MF,
9110,GO:0035401,1,0.959536171863029,0,1,histone kinase activity (H3-Y41 specific),MF,
9111,GO:0035402,1,0.932614881207992,0,2,histone kinase activity (H3-T11 specific),MF,
9112,GO:0035403,1,0.95950763690405,0,1,histone kinase activity (H3-T6 specific),MF,
9113,GO:0035404,1,0.743045796541704,0,9,histone-serine phosphorylation,BP,
9114,GO:0035405,1,0.871967705759967,0,4,histone-threonine phosphorylation,BP,
9115,GO:0035406,1,0.959536171863029,0,1,histone-tyrosine phosphorylation,BP,
9116,GO:0035407,1,0.932614881207992,0,2,histone H3-T11 phosphorylation,BP,
9117,GO:0035408,1,0.95950763690405,0,1,histone H3-T6 phosphorylation,BP,
9118,GO:0035409,1,0.959536171863029,0,1,histone H3-Y41 phosphorylation,BP,
9120,GO:0035425,1,0.902824450894955,0,3,autocrine signaling,BP,
9121,GO:0035426,1,0.854881453099327,0,4,extracellular matrix-cell signaling,BP,
9122,GO:0035434,1,0.816634322345999,0,6,copper ion transmembrane transport,BP,
9123,GO:0035435,1,0.746455958091254,0,8,phosphate ion transmembrane transport,BP,
9125,GO:0035438,1,0.974632750419636,0,1,cyclic-di-GMP binding,MF,
9126,GO:0035441,1,0.95950763690405,0,1,cell migration involved in vasculogenesis,BP,
9127,GO:0035442,1,0.942587011227302,0,2,dipeptide transmembrane transport,BP,
9128,GO:0035443,1,0.95950763690405,0,1,tripeptide transmembrane transport,BP,
9129,GO:0035445,1,0.964274199594967,0,1,borate transmembrane transport,BP,
9132,GO:0035457,1,0.714095557986407,0,9,cellular response to interferon-alpha,BP,
9135,GO:0035461,1,0.749368636797529,0,8,vitamin transmembrane transport,BP,
9136,GO:0035469,1,0.959523165875488,0,1,determination of pancreatic left/right asymmetry,BP,
9137,GO:0035470,1,0.973539492698059,0,1,positive regulation of vascular wound healing,BP,
9138,GO:0035473,1,0.936770774106798,0,2,lipase binding,MF,
9139,GO:0035482,1,0.959374670283556,0,2,gastric motility,BP,
9140,GO:0035483,1,0.98406407037836,0,1,gastric emptying,BP,
9141,GO:0035485,1,0.97320171307153,0,1,adenine/guanine mispair binding,MF,
9142,GO:0035490,1,0.964046331367156,0,1,regulation of leukotriene production involved in inflammatory response,BP,
9143,GO:0035491,1,0.964046331367156,0,1,positive regulation of leukotriene production involved in inflammatory response,BP,
9145,GO:0035494,1,0.903753968066628,0,3,SNARE complex disassembly,BP,
9147,GO:0035498,1,0.965469978279355,0,1,carnosine metabolic process,BP,
9148,GO:0035500,1,0.928781333983463,0,2,MH2 domain binding,MF,
9149,GO:0035501,1,0.965844339410484,0,1,MH1 domain binding,MF,
9150,GO:0035502,1,0.901549485758439,0,3,metanephric part of ureteric bud development,BP,
9154,GO:0035508,1,0.959509182830801,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
9158,GO:0035513,1,0.872811344744445,0,4,oxidative RNA demethylation,BP,
9159,GO:0035514,1,0.920744949819415,0,3,DNA demethylase activity,MF,
9160,GO:0035515,1,0.872811344744445,0,4,oxidative RNA demethylase activity,MF,
9161,GO:0035516,1,0.960361972512003,0,1,oxidative DNA demethylase activity,MF,
9162,GO:0035517,1,0.887088230438232,0,3,PR-DUB complex,CC,
9163,GO:0035518,1,0.548121672270606,0,17,histone H2A monoubiquitination,BP,
9164,GO:0035519,1,0.903327710079246,0,4,protein K29-linked ubiquitination,BP,
9165,GO:0035520,1,0.704212565284496,0,9,monoubiquitinated protein deubiquitination,BP,
9166,GO:0035521,1,0.86290659205335,0,4,monoubiquitinated histone deubiquitination,BP,
9167,GO:0035522,1,0.86290659205335,0,4,monoubiquitinated histone H2A deubiquitination,BP,
9168,GO:0035523,1,0.861127936726571,0,4,protein K29-linked deubiquitination,BP,
9169,GO:0035524,1,0.824199793632776,0,5,proline transmembrane transport,BP,
9171,GO:0035526,1,0.921623702076818,0,2,retrograde transport, plasma membrane to Golgi,BP,
9172,GO:0035529,1,0.863168191536762,0,5,NADH pyrophosphatase activity,MF,
9173,GO:0035538,1,0.96358892396452,0,1,carbohydrate response element binding,MF,
9174,GO:0035539,1,0.95732642948702,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
9175,GO:0035542,1,0.771864215134127,0,7,regulation of SNARE complex assembly,BP,
9176,GO:0035544,1,0.960085248102864,0,1,negative regulation of SNARE complex assembly,BP,
9180,GO:0035552,1,0.906501319243224,0,3,oxidative single-stranded DNA demethylation,BP,
9181,GO:0035553,1,0.902261364930347,0,3,oxidative single-stranded RNA demethylation,BP,
9185,GO:0035563,1,0.659870088333444,0,12,positive regulation of chromatin binding,BP,
9187,GO:0035568,1,0.965469978279355,0,1,N-terminal peptidyl-proline methylation,BP,
9188,GO:0035570,1,0.965469978279355,0,1,N-terminal peptidyl-serine methylation,BP,
9189,GO:0035572,1,0.965469978279355,0,1,N-terminal peptidyl-serine dimethylation,BP,
9190,GO:0035573,1,0.965469978279355,0,1,N-terminal peptidyl-serine trimethylation,BP,
9191,GO:0035574,1,0.926372432346771,0,2,histone H4-K20 demethylation,BP,
9192,GO:0035575,1,0.926372432346771,0,2,histone demethylase activity (H4-K20 specific),MF,
9197,GO:0035581,1,0.805744408120331,0,6,sequestering of extracellular ligand from receptor,BP,
9198,GO:0035582,1,0.908174776484364,0,3,sequestering of BMP in extracellular matrix,BP,
9199,GO:0035583,1,0.883414385978739,0,3,sequestering of TGFbeta in extracellular matrix,BP,
9201,GO:0035585,1,0.965469978279355,0,1,calcium-mediated signaling using extracellular calcium source,BP,
9202,GO:0035586,1,0.803853909130286,0,7,purinergic receptor activity,MF,
9203,GO:0035587,1,0.730734386072927,0,10,purinergic receptor signaling pathway,BP,
9204,GO:0035588,1,0.78370559573176,0,8,G-protein coupled purinergic receptor signaling pathway,BP,
9205,GO:0035589,1,0.850507304250595,0,5,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,
9206,GO:0035590,1,0.793032419875001,0,7,purinergic nucleotide receptor signaling pathway,BP,
9208,GO:0035594,1,0.904684285997711,0,3,ganglioside binding,MF,
9209,GO:0035596,1,0.936135047891476,0,2,methylthiotransferase activity,MF,
9210,GO:0035597,1,0.971610300626781,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
9211,GO:0035598,1,0.963490797074121,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
9212,GO:0035600,1,0.936135047891476,0,2,tRNA methylthiolation,BP,
9214,GO:0035602,1,0.960748333633886,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP,
9215,GO:0035603,1,0.960748333633886,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9216,GO:0035604,1,0.960748333633886,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
9217,GO:0035605,1,0.978446360623188,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
9218,GO:0035606,1,0.965650371859546,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
9219,GO:0035607,1,0.92184223579625,0,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,
9220,GO:0035608,1,0.927255026953292,0,2,protein deglutamylation,BP,
9221,GO:0035609,1,0.960137149337174,0,1,C-terminal protein deglutamylation,BP,
9222,GO:0035610,1,0.960137149337174,0,1,protein side chain deglutamylation,BP,
9223,GO:0035611,1,0.96575612672569,0,1,protein branching point deglutamylation,BP,
9224,GO:0035612,1,0.73842846488197,0,8,AP-2 adaptor complex binding,MF,
9226,GO:0035614,1,0.921750341081392,0,3,snRNA stem-loop binding,MF,
9227,GO:0035615,1,0.675170014212906,0,11,clathrin adaptor activity,MF,
9228,GO:0035616,1,0.887852269228746,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
9229,GO:0035617,1,0.900820830084806,0,3,stress granule disassembly,BP,
9230,GO:0035620,1,0.902992557885879,0,3,ceramide transporter activity,MF,
9231,GO:0035621,1,0.932630517934615,0,2,ER to Golgi ceramide transport,BP,
9233,GO:0035623,1,0.963669809445115,0,1,renal glucose absorption,BP,
9234,GO:0035624,1,0.923348229048427,0,2,receptor transactivation,BP,
9235,GO:0035625,1,0.962318460501103,0,1,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,
9236,GO:0035627,1,0.813318132404141,0,6,ceramide transport,BP,
9240,GO:0035634,1,0.984228433072579,0,1,response to stilbenoid,BP,
9243,GO:0035638,1,0.959796825212613,0,1,signal maturation,BP,
9245,GO:0035640,1,0.634717415166032,0,13,exploration behavior,BP,
9246,GO:0035641,1,0.789945116249763,0,7,locomotory exploration behavior,BP,
9247,GO:0035642,1,0.964996256623698,0,1,histone methyltransferase activity (H3-R17 specific),MF,
9248,GO:0035646,1,0.725959300026941,0,10,endosome to melanosome transport,BP,
9249,GO:0035650,1,0.888758151698844,0,4,AP-1 adaptor complex binding,MF,
9250,GO:0035651,1,0.919826793087003,0,3,AP-3 adaptor complex binding,MF,
9251,GO:0035655,1,0.859723770688772,0,5,interleukin-18-mediated signaling pathway,BP,
9252,GO:0035658,1,0.903980112558358,0,3,Mon1-Ccz1 complex,CC,
9253,GO:0035659,1,0.974413361039542,0,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,
9254,GO:0035662,1,0.950421050910507,0,3,Toll-like receptor 4 binding,MF,
9255,GO:0035663,1,0.934315203583832,0,2,Toll-like receptor 2 binding,MF,
9256,GO:0035664,1,0.973747123429304,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9257,GO:0035665,1,0.973747123429304,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
9259,GO:0035668,1,0.959511901020005,0,1,TRAM-dependent toll-like receptor signaling pathway,BP,
9260,GO:0035669,1,0.959511901020005,0,1,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
9261,GO:0035671,1,0.937579216348392,0,2,enone reductase activity,MF,
9262,GO:0035672,1,0.80520889897573,0,6,oligopeptide transmembrane transport,BP,
9263,GO:0035673,1,0.854274274912104,0,4,oligopeptide transmembrane transporter activity,MF,
9264,GO:0035674,1,0.940143784962707,0,2,tricarboxylic acid transmembrane transport,BP,
9265,GO:0035675,1,0.966967419757367,0,1,neuromast hair cell development,BP,
9266,GO:0035686,1,0.923584494941029,0,3,sperm fibrous sheath,CC,
9268,GO:0035691,1,0.978457029373676,0,1,macrophage migration inhibitory factor signaling pathway,BP,
9269,GO:0035692,1,0.938961899316266,0,2,macrophage migration inhibitory factor receptor complex,CC,
9270,GO:0035693,1,0.978457029373676,0,1,NOS2-CD74 complex,CC,
9271,GO:0035694,1,0.86722250934326,0,4,mitochondrial protein catabolic process,BP,
9272,GO:0035695,1,0.960341465926368,0,1,mitophagy by induced vacuole formation,BP,
9273,GO:0035697,1,0.946353971866504,0,2,CD8-positive, alpha-beta T cell extravasation,BP,
9274,GO:0035698,1,0.946353971866504,0,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
9275,GO:0035700,1,0.973774934802996,0,1,astrocyte chemotaxis,BP,
9276,GO:0035701,1,0.900362934546663,0,3,hematopoietic stem cell migration,BP,
9277,GO:0035709,1,0.970146509392019,0,1,memory T cell activation,BP,
9279,GO:0035711,1,0.962868782887146,0,1,T-helper 1 cell activation,BP,
9280,GO:0035712,1,0.963522594620731,0,1,T-helper 2 cell activation,BP,
9281,GO:0035718,1,0.955579919200807,0,2,macrophage migration inhibitory factor binding,MF,
9282,GO:0035720,1,0.898847625073622,0,3,intraciliary anterograde transport,BP,
9283,GO:0035721,1,0.660488342908773,0,12,intraciliary retrograde transport,BP,
9285,GO:0035723,1,0.717503981135131,0,9,interleukin-15-mediated signaling pathway,BP,
9287,GO:0035726,1,0.885050027781584,0,4,common myeloid progenitor cell proliferation,BP,
9288,GO:0035727,1,0.93139661848462,0,2,lysophosphatidic acid binding,MF,
9291,GO:0035730,1,0.982381924909768,0,1,S-nitrosoglutathione binding,MF,
9292,GO:0035731,1,0.982381924909768,0,1,dinitrosyl-iron complex binding,MF,
9293,GO:0035732,1,0.982381924909768,0,1,nitric oxide storage,BP,
9294,GO:0035733,1,0.869371535159089,0,4,hepatic stellate cell activation,BP,
9295,GO:0035735,1,0.262624146824143,0,39,intraciliary transport involved in cilium assembly,BP,
9299,GO:0035744,1,0.980273350044032,0,1,T-helper 1 cell cytokine production,BP,
9300,GO:0035745,1,0.825401258034093,0,6,T-helper 2 cell cytokine production,BP,
9301,GO:0035747,1,0.913515463279271,0,3,natural killer cell chemotaxis,BP,
9302,GO:0035748,1,0.796279409467314,0,6,myelin sheath abaxonal region,CC,
9303,GO:0035749,1,0.842182274675538,0,5,myelin sheath adaxonal region,CC,
9304,GO:0035750,1,0.95952647071939,0,1,protein localization to myelin sheath abaxonal region,BP,
9305,GO:0035751,1,0.741535612465046,0,11,regulation of lysosomal lumen pH,BP,
9306,GO:0035752,1,0.972654738194275,0,1,lysosomal lumen pH elevation,BP,
9307,GO:0035754,1,0.83820332274416,0,5,B cell chemotaxis,BP,
9308,GO:0035755,1,0.967461720989723,0,1,cardiolipin hydrolase activity,MF,
9309,GO:0035766,1,0.885176762684944,0,3,cell chemotaxis to fibroblast growth factor,BP,
9310,GO:0035767,1,0.518512677877695,0,19,endothelial cell chemotaxis,BP,
9311,GO:0035768,1,0.885176762684944,0,3,endothelial cell chemotaxis to fibroblast growth factor,BP,
9313,GO:0035771,1,0.835216825583073,0,5,interleukin-4-mediated signaling pathway,BP,
9316,GO:0035787,1,0.895136208366016,0,3,cell migration involved in kidney development,BP,
9317,GO:0035788,1,0.932897972628058,0,2,cell migration involved in metanephros development,BP,
9318,GO:0035789,1,0.932897972628058,0,2,metanephric mesenchymal cell migration,BP,
9319,GO:0035790,1,0.961394536352661,0,1,platelet-derived growth factor receptor-alpha signaling pathway,BP,
9321,GO:0035793,1,0.932897972628058,0,2,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
9323,GO:0035795,1,0.877511530285005,0,5,negative regulation of mitochondrial membrane permeability,BP,
9324,GO:0035799,1,0.89185449756389,0,3,ureter maturation,BP,
9325,GO:0035800,1,0.939916457758224,0,2,deubiquitinase activator activity,MF,
9326,GO:0035801,1,0.939481225893779,0,2,adrenal cortex development,BP,
9327,GO:0035802,1,0.939481225893779,0,2,adrenal cortex formation,BP,
9328,GO:0035803,1,0.955296687036376,0,2,egg coat formation,BP,
9331,GO:0035811,1,0.95950763690405,0,1,negative regulation of urine volume,BP,
9334,GO:0035814,1,0.969636865735874,0,1,negative regulation of renal sodium excretion,BP,
9337,GO:0035822,1,0.925034472206229,0,2,gene conversion,BP,
9338,GO:0035825,1,0.295625362390431,0,36,homologous recombination,BP,
9339,GO:0035838,1,0.921658809158459,0,2,growing cell tip,CC,
9340,GO:0035841,1,0.95950763690405,0,1,new growing cell tip,CC,
9341,GO:0035844,1,0.896851024391596,0,3,cloaca development,BP,
9342,GO:0035845,1,0.7752337888127,0,7,photoreceptor cell outer segment organization,BP,
9344,GO:0035851,1,0.965034430085033,0,1,Krueppel-associated box domain binding,MF,
9347,GO:0035859,1,0.641948018225438,0,13,Seh1-associated complex,CC,
9348,GO:0035860,1,0.926373933988985,0,2,glial cell-derived neurotrophic factor receptor signaling pathway,BP,
9350,GO:0035862,1,0.95950763690405,0,1,dITP metabolic process,BP,
9351,GO:0035863,1,0.95950763690405,0,1,dITP catabolic process,BP,
9352,GO:0035864,1,0.831089651978908,0,6,response to potassium ion,BP,
9353,GO:0035865,1,0.920436979509122,0,3,cellular response to potassium ion,BP,
9357,GO:0035869,1,0.185749617481425,0,50,ciliary transition zone,CC,
9358,GO:0035870,1,0.941063534563974,0,2,dITP diphosphatase activity,MF,
9361,GO:0035873,1,0.862581344805807,0,4,lactate transmembrane transport,BP,
9362,GO:0035877,1,0.88212558542884,0,4,death effector domain binding,MF,
9363,GO:0035878,1,0.779007276875708,0,7,nail development,BP,
9364,GO:0035879,1,0.896279972893717,0,3,plasma membrane lactate transport,BP,
9365,GO:0035880,1,0.932915786827036,0,2,embryonic nail plate morphogenesis,BP,
9369,GO:0035887,1,0.97411570855655,0,1,aortic smooth muscle cell differentiation,BP,
9373,GO:0035898,1,0.900249639973941,0,3,parathyroid hormone secretion,BP,
9374,GO:0035900,1,0.83730694316081,0,6,response to isolation stress,BP,
9375,GO:0035902,1,0.555138261159582,0,17,response to immobilization stress,BP,
9378,GO:0035907,1,0.831654268104412,0,5,dorsal aorta development,BP,
9381,GO:0035912,1,0.86316753555182,0,4,dorsal aorta morphogenesis,BP,
9383,GO:0035915,1,0.971454172605426,0,1,pore formation in membrane of other organism,BP,
9384,GO:0035921,1,0.971017199837092,0,1,desmosome disassembly,BP,
9385,GO:0035922,1,0.964039008079129,0,1,foramen ovale closure,BP,
9388,GO:0035926,1,0.837564082633629,0,5,chemokine (C-C motif) ligand 2 secretion,BP,
9389,GO:0035927,1,0.890287617787645,0,4,RNA import into mitochondrion,BP,
9390,GO:0035928,1,0.92446273289216,0,3,rRNA import into mitochondrion,BP,
9393,GO:0035931,1,0.966540823598339,0,1,mineralocorticoid secretion,BP,
9394,GO:0035932,1,0.966540823598339,0,1,aldosterone secretion,BP,
9396,GO:0035935,1,0.963504406783783,0,1,androgen secretion,BP,
9397,GO:0035936,1,0.95950763690405,0,1,testosterone secretion,BP,
9398,GO:0035938,1,0.95950763690405,0,1,estradiol secretion,BP,
9399,GO:0035945,1,0.968064392792103,0,1,mitochondrial ncRNA surveillance,BP,
9400,GO:0035946,1,0.968064392792103,0,1,mitochondrial mRNA surveillance,BP,
9401,GO:0035947,1,0.827218966107988,0,5,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,BP,
9402,GO:0035948,1,0.892309388407893,0,3,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,BP,
9403,GO:0035962,1,0.961409093300116,0,1,response to interleukin-13,BP,
9404,GO:0035963,1,0.961409093300116,0,1,cellular response to interleukin-13,BP,
9405,GO:0035964,1,0.816625817919288,0,6,COPI-coated vesicle budding,BP,
9406,GO:0035965,1,0.843467324587678,0,5,cardiolipin acyl-chain remodeling,BP,
9410,GO:0035971,1,0.979460208722271,0,1,peptidyl-histidine dephosphorylation,BP,
9413,GO:0035977,1,0.865246987631419,0,4,protein deglycosylation involved in glycoprotein catabolic process,BP,
9414,GO:0035978,1,0.965844339410484,0,1,histone H2A-S139 phosphorylation,BP,
9415,GO:0035981,1,0.937105475830558,0,2,tongue muscle cell differentiation,BP,
9416,GO:0035983,1,0.904260492873401,0,3,response to trichostatin A,BP,
9417,GO:0035984,1,0.904260492873401,0,3,cellular response to trichostatin A,BP,
9418,GO:0035985,1,0.895633811926047,0,4,senescence-associated heterochromatin focus,CC,
9419,GO:0035986,1,0.920185406732068,0,3,senescence-associated heterochromatin focus assembly,BP,
9421,GO:0035988,1,0.776597194867217,0,7,chondrocyte proliferation,BP,
9422,GO:0035989,1,0.865520754050465,0,4,tendon development,BP,
9423,GO:0035990,1,0.940130334607286,0,2,tendon cell differentiation,BP,
9424,GO:0035992,1,0.940130334607286,0,2,tendon formation,BP,
9425,GO:0035993,1,0.911831415988637,0,3,deltoid tuberosity development,BP,
9427,GO:0035995,1,0.95950763690405,0,1,detection of muscle stretch,BP,
9429,GO:0035999,1,0.775696532043711,0,8,tetrahydrofolate interconversion,BP,
9432,GO:0036004,1,0.979318697458905,0,1,GAF domain binding,MF,
9433,GO:0036005,1,0.839613334639943,0,5,response to macrophage colony-stimulating factor,BP,
9434,GO:0036006,1,0.839613334639943,0,5,cellular response to macrophage colony-stimulating factor stimulus,BP,
9435,GO:0036009,1,0.980030274204034,0,1,protein-glutamine N-methyltransferase activity,MF,
9436,GO:0036010,1,0.504035471317372,0,18,protein localization to endosome,BP,
9437,GO:0036015,1,0.920617383079832,0,3,response to interleukin-3,BP,
9438,GO:0036016,1,0.920617383079832,0,3,cellular response to interleukin-3,BP,
9439,GO:0036017,1,0.928515057820576,0,4,response to erythropoietin,BP,
9440,GO:0036018,1,0.928515057820576,0,4,cellular response to erythropoietin,BP,
9443,GO:0036021,1,0.878291881274632,0,4,endolysosome lumen,CC,
9444,GO:0036022,1,0.937199630760939,0,2,limb joint morphogenesis,BP,
9445,GO:0036023,1,0.937199630760939,0,2,embryonic skeletal limb joint morphogenesis,BP,
9446,GO:0036033,1,0.848611151133265,0,4,mediator complex binding,MF,
9447,GO:0036034,1,0.93684695220444,0,2,mediator complex assembly,BP,
9450,GO:0036038,1,0.675420067244644,0,13,MKS complex,CC,
9452,GO:0036042,1,0.90772621999914,0,4,long-chain fatty acyl-CoA binding,MF,
9453,GO:0036046,1,0.964100242098344,0,1,protein demalonylation,BP,
9454,GO:0036047,1,0.964100242098344,0,1,peptidyl-lysine demalonylation,BP,
9455,GO:0036048,1,0.964100242098344,0,1,protein desuccinylation,BP,
9456,GO:0036049,1,0.964100242098344,0,1,peptidyl-lysine desuccinylation,BP,
9457,GO:0036054,1,0.964100242098344,0,1,protein-malonyllysine demalonylase activity,MF,
9458,GO:0036055,1,0.964100242098344,0,1,protein-succinyllysine desuccinylase activity,MF,
9459,GO:0036056,1,0.847779502760951,0,4,filtration diaphragm,CC,
9460,GO:0036057,1,0.847779502760951,0,4,slit diaphragm,CC,
9462,GO:0036065,1,0.434983039488537,0,23,fucosylation,BP,
9463,GO:0036066,1,0.601859989126068,0,14,protein O-linked fucosylation,BP,
9464,GO:0036071,1,0.963445624205636,0,1,N-glycan fucosylation,BP,
9465,GO:0036072,1,0.8637126255612,0,4,direct ossification,BP,
9467,GO:0036080,1,0.924780083578031,0,2,purine nucleotide-sugar transmembrane transporter activity,MF,
9468,GO:0036085,1,0.963810594116868,0,1,GDP-fucose import into Golgi lumen,BP,
9469,GO:0036089,1,0.78208147682986,0,7,cleavage furrow formation,BP,
9470,GO:0036090,1,0.944161207348161,0,2,cleavage furrow ingression,BP,
9473,GO:0036093,1,0.933724747409783,0,3,germ cell proliferation,BP,
9475,GO:0036105,1,0.962131775847945,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
9476,GO:0036109,1,0.697763810403476,0,11,alpha-linolenic acid metabolic process,BP,
9477,GO:0036111,1,0.966685677564125,0,1,very long-chain fatty-acyl-CoA metabolic process,BP,
9478,GO:0036112,1,0.943676678942426,0,2,medium-chain fatty-acyl-CoA metabolic process,BP,
9479,GO:0036114,1,0.976200080423216,0,1,medium-chain fatty-acyl-CoA catabolic process,BP,
9480,GO:0036115,1,0.976200080423216,0,1,fatty-acyl-CoA catabolic process,BP,
9481,GO:0036116,1,0.976200080423216,0,1,long-chain fatty-acyl-CoA catabolic process,BP,
9486,GO:0036122,1,0.898767671870706,0,3,BMP binding,MF,
9487,GO:0036123,1,0.853700564552265,0,5,histone H3-K9 dimethylation,BP,
9488,GO:0036124,1,0.594856402293663,0,14,histone H3-K9 trimethylation,BP,
9489,GO:0036125,1,0.964607085368538,0,1,fatty acid beta-oxidation multienzyme complex,CC,
9491,GO:0036128,1,0.939553638245654,0,2,CatSper complex,CC,
9492,GO:0036132,1,0.909004386938343,0,3,13-prostaglandin reductase activity,MF,
9493,GO:0036135,1,0.926372432346771,0,2,Schwann cell migration,BP,
9494,GO:0036137,1,0.939224592945848,0,2,kynurenine aminotransferase activity,MF,
9495,GO:0036138,1,0.95950763690405,0,1,peptidyl-histidine hydroxylation,BP,
9496,GO:0036139,1,0.95950763690405,0,1,peptidyl-histidine dioxygenase activity,MF,
9497,GO:0036140,1,0.95950763690405,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
9498,GO:0036145,1,0.973774934802996,0,1,dendritic cell homeostasis,BP,
9499,GO:0036146,1,0.906313029638411,0,3,cellular response to mycotoxin,BP,
9500,GO:0036148,1,0.664565958519461,0,11,phosphatidylglycerol acyl-chain remodeling,BP,
9501,GO:0036149,1,0.781747738885129,0,7,phosphatidylinositol acyl-chain remodeling,BP,
9502,GO:0036150,1,0.645975219279413,0,12,phosphatidylserine acyl-chain remodeling,BP,
9503,GO:0036151,1,0.53867297860687,0,18,phosphatidylcholine acyl-chain remodeling,BP,
9504,GO:0036152,1,0.591769066645708,0,15,phosphatidylethanolamine acyl-chain remodeling,BP,
9505,GO:0036153,1,0.965960062720483,0,1,triglyceride acyl-chain remodeling,BP,
9506,GO:0036155,1,0.838840508124723,0,5,acylglycerol acyl-chain remodeling,BP,
9507,GO:0036156,1,0.920650957478618,0,2,inner dynein arm,CC,
9508,GO:0036157,1,0.907403836177733,0,3,outer dynein arm,CC,
9509,GO:0036158,1,0.826394369088101,0,6,outer dynein arm assembly,BP,
9510,GO:0036159,1,0.840212481387548,0,5,inner dynein arm assembly,BP,
9511,GO:0036164,1,0.980796304885343,0,1,cell-abiotic substrate adhesion,BP,
9512,GO:0036166,1,0.901473477577445,0,3,phenotypic switching,BP,
9513,GO:0036179,1,0.966280586003115,0,1,osteoclast maturation,BP,
9514,GO:0036194,1,0.929857828204956,0,3,muscle cell projection,CC,
9515,GO:0036195,1,0.929857828204956,0,3,muscle cell projection membrane,CC,
9517,GO:0036213,1,0.970328760383685,0,1,contractile ring contraction,BP,
9518,GO:0036215,1,0.965067269736794,0,1,response to stem cell factor,BP,
9519,GO:0036216,1,0.965067269736794,0,1,cellular response to stem cell factor stimulus,BP,
9520,GO:0036219,1,0.985256868465025,0,1,GTP diphosphatase activity,MF,
9521,GO:0036220,1,0.980779539261051,0,1,ITP diphosphatase activity,MF,
9522,GO:0036222,1,0.980779539261051,0,1,XTP diphosphatase activity,MF,
9523,GO:0036228,1,0.930524280872078,0,2,protein localization to nuclear inner membrane,BP,
9525,GO:0036245,1,0.937377821498808,0,2,cellular response to menadione,BP,
9526,GO:0036250,1,0.9724472996622,0,1,peroxisome transport along microtubule,BP,
9527,GO:0036255,1,0.961447268770442,0,1,response to methylamine,BP,
9528,GO:0036257,1,0.388663084652452,0,30,multivesicular body organization,BP,
9529,GO:0036258,1,0.402375251559268,0,29,multivesicular body assembly,BP,
9530,GO:0036260,1,0.371966853951754,0,33,RNA capping,BP,
9531,GO:0036261,1,0.961851849855523,0,1,7-methylguanosine cap hypermethylation,BP,
9532,GO:0036265,1,0.902811824488533,0,4,RNA (guanine-N7)-methylation,BP,
9533,GO:0036266,1,0.967606698334485,0,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,
9534,GO:0036269,1,0.975784758760467,0,1,swimming behavior,BP,
9535,GO:0036270,1,0.663884483326238,0,12,response to diuretic,BP,
9536,GO:0036284,1,0.936935861062736,0,2,tubulobulbar complex,CC,
9539,GO:0036292,1,0.940139498452747,0,2,DNA rewinding,BP,
9542,GO:0036295,1,0.651882945494769,0,13,cellular response to increased oxygen levels,BP,
9544,GO:0036297,1,0.191481130105439,0,48,interstrand cross-link repair,BP,
9545,GO:0036301,1,0.901513360054308,0,3,macrophage colony-stimulating factor production,BP,
9548,GO:0036309,1,0.920650957478618,0,2,protein localization to M-band,BP,
9549,GO:0036310,1,0.74636185271857,0,8,annealing helicase activity,MF,
9550,GO:0036312,1,0.705273167680396,0,9,phosphatidylinositol 3-kinase regulatory subunit binding,MF,
9551,GO:0036313,1,0.933594280452904,0,2,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
9555,GO:0036317,1,0.965469978279355,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
9556,GO:0036324,1,0.941239491257523,0,2,vascular endothelial growth factor receptor-2 signaling pathway,BP,
9557,GO:0036333,1,0.967055084606421,0,1,hepatocyte homeostasis,BP,
9558,GO:0036335,1,0.959545199483396,0,1,intestinal stem cell homeostasis,BP,
9559,GO:0036336,1,0.602432110782671,0,15,dendritic cell migration,BP,
9560,GO:0036337,1,0.863399685737672,0,4,Fas signaling pathway,BP,
9562,GO:0036343,1,0.987334204736486,0,1,psychomotor behavior,BP,
9564,GO:0036351,1,0.969283456517294,0,1,histone H2A-K13 ubiquitination,BP,
9565,GO:0036352,1,0.969283456517294,0,1,histone H2A-K15 ubiquitination,BP,
9566,GO:0036353,1,0.756066833993841,0,8,histone H2A-K119 monoubiquitination,BP,
9567,GO:0036361,1,0.968092371147854,0,1,racemase activity, acting on amino acids and derivatives,MF,
9568,GO:0036363,1,0.928893349701134,0,2,transforming growth factor beta activation,BP,
9569,GO:0036367,1,0.967502032617667,0,1,light adaption,BP,
9570,GO:0036369,1,0.920650957478618,0,2,transcription factor catabolic process,BP,
9571,GO:0036371,1,0.95950763690405,0,1,protein localization to T-tubule,BP,
9572,GO:0036372,1,0.982198699800016,0,1,opsin transport,BP,
9573,GO:0036374,1,0.906363414185936,0,3,glutathione hydrolase activity,MF,
9576,GO:0036379,1,0.677889117352349,0,12,myofilament,CC,
9577,GO:0036387,1,0.91631909499239,0,3,pre-replicative complex,CC,
9578,GO:0036388,1,0.91631909499239,0,3,pre-replicative complex assembly,BP,
9579,GO:0036392,1,0.96179747889877,0,1,chemokine (C-C motif) ligand 20 production,BP,
9580,GO:0036396,1,0.919599549378459,0,3,RNA N6-methyladenosine methyltransferase complex,CC,
9581,GO:0036398,1,0.963486266439358,0,1,TCR signalosome,CC,
9582,GO:0036399,1,0.963486266439358,0,1,TCR signalosome assembly,BP,
9583,GO:0036402,1,0.86687363822209,0,6,proteasome-activating ATPase activity,MF,
9584,GO:0036403,1,0.967097498396583,0,1,arachidonate 8(S)-lipoxygenase activity,MF,
9585,GO:0036404,1,0.95950763690405,0,1,conversion of ds siRNA to ss siRNA,BP,
9586,GO:0036414,1,0.963877213708537,0,1,histone citrullination,BP,
9587,GO:0036435,1,0.9064801907968,0,3,K48-linked polyubiquitin modification-dependent protein binding,MF,
9588,GO:0036438,1,0.868300316134166,0,4,maintenance of lens transparency,BP,
9589,GO:0036440,1,0.964974510611066,0,1,citrate synthase activity,MF,
9591,GO:0036444,1,0.747699506334386,0,8,calcium import into the mitochondrion,BP,
9592,GO:0036445,1,0.674108613728404,0,10,neuronal stem cell division,BP,
9593,GO:0036446,1,0.887124330698938,0,3,myofibroblast differentiation,BP,
9594,GO:0036449,1,0.758025594876638,0,7,microtubule minus-end,CC,
9595,GO:0036451,1,0.932129376517163,0,2,cap mRNA methylation,BP,
9596,GO:0036452,1,0.442968054078443,0,26,ESCRT complex,CC,
9597,GO:0036454,1,0.911586814307684,0,3,growth factor complex,CC,
9598,GO:0036455,1,0.980523086556783,0,1,iron-sulfur transferase activity,MF,
9599,GO:0036457,1,0.850060824761444,0,4,keratohyalin granule,CC,
9600,GO:0036458,1,0.97022553835382,0,1,hepatocyte growth factor binding,MF,
9602,GO:0036461,1,0.957600631091333,0,2,BLOC-2 complex binding,MF,
9605,GO:0036465,1,0.244901622096695,0,37,synaptic vesicle recycling,BP,
9606,GO:0036466,1,0.921337213283097,0,2,synaptic vesicle recycling via endosome,BP,
9607,GO:0036470,1,0.98268071838369,0,1,tyrosine 3-monooxygenase activator activity,MF,
9608,GO:0036471,1,0.98268071838369,0,1,cellular response to glyoxal,BP,
9612,GO:0036476,1,0.926579343327073,0,3,neuron death in response to hydrogen peroxide,BP,
9614,GO:0036478,1,0.98268071838369,0,1,L-dopa decarboxylase activator activity,MF,
9615,GO:0036480,1,0.782293016818279,0,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
9616,GO:0036481,1,0.841550455793127,0,6,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
9617,GO:0036482,1,0.950123747958847,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
9618,GO:0036483,1,0.959980813817654,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
9619,GO:0036484,1,0.893974106353757,0,3,trunk neural crest cell migration,BP,
9620,GO:0036486,1,0.893974106353757,0,3,ventral trunk neural crest cell migration,BP,
9621,GO:0036487,1,0.95950763690405,0,1,nitric-oxide synthase inhibitor activity,MF,
9626,GO:0036493,1,0.904641065711959,0,3,positive regulation of translation in response to endoplasmic reticulum stress,BP,
9627,GO:0036494,1,0.959509598915843,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,
9632,GO:0036500,1,0.71732187686092,0,10,ATF6-mediated unfolded protein response,BP,
9633,GO:0036501,1,0.960207038491092,0,1,UFD1-NPL4 complex,CC,
9634,GO:0036502,1,0.964184274700373,0,1,Derlin-1-VIMP complex,CC,
9636,GO:0036505,1,0.965133280370021,0,1,prosaposin receptor activity,MF,
9637,GO:0036506,1,0.8995490080058,0,3,maintenance of unfolded protein,BP,
9638,GO:0036507,1,0.461288946471471,0,22,protein demannosylation,BP,
9639,GO:0036508,1,0.461288946471471,0,22,protein alpha-1,2-demannosylation,BP,
9640,GO:0036509,1,0.939833029843011,0,2,trimming of terminal mannose on B branch,BP,
9641,GO:0036510,1,0.90177113838715,0,3,trimming of terminal mannose on C branch,BP,
9642,GO:0036511,1,0.939833029843011,0,2,trimming of first mannose on A branch,BP,
9643,GO:0036512,1,0.939833029843011,0,2,trimming of second mannose on A branch,BP,
9644,GO:0036513,1,0.700420424807468,0,10,Derlin-1 retrotranslocation complex,CC,
9649,GO:0036524,1,0.98268071838369,0,1,protein deglycase activity,MF,
9650,GO:0036525,1,0.98268071838369,0,1,protein deglycation,BP,
9651,GO:0036526,1,0.98268071838369,0,1,peptidyl-cysteine deglycation,BP,
9652,GO:0036527,1,0.98268071838369,0,1,peptidyl-arginine deglycation,BP,
9653,GO:0036528,1,0.98268071838369,0,1,peptidyl-lysine deglycation,BP,
9654,GO:0036529,1,0.98268071838369,0,1,protein deglycation, glyoxal removal,BP,
9655,GO:0036530,1,0.98268071838369,0,1,protein deglycation, methylglyoxal removal,BP,
9656,GO:0036531,1,0.98268071838369,0,1,glutathione deglycation,BP,
9657,GO:0038001,1,0.940255987444809,0,2,paracrine signaling,BP,
9658,GO:0038002,1,0.959527364375557,0,1,endocrine signaling,BP,
9659,GO:0038003,1,0.883224726471291,0,4,opioid receptor signaling pathway,BP,
9660,GO:0038007,1,0.889504939968982,0,3,netrin-activated signaling pathway,BP,
9661,GO:0038016,1,0.933083787542659,0,2,insulin receptor internalization,BP,
9662,GO:0038018,1,0.921106134410709,0,2,Wnt receptor catabolic process,BP,
9663,GO:0038021,1,0.960418295963196,0,1,leptin receptor activity,MF,
9666,GO:0038025,1,0.924142635038021,0,2,reelin receptor activity,MF,
9667,GO:0038026,1,0.887238192607636,0,3,reelin-mediated signaling pathway,BP,
9669,GO:0038028,1,0.859880517234558,0,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,
9672,GO:0038033,1,0.876993680982629,0,4,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,
9674,GO:0038036,1,0.810978381709706,0,6,sphingosine-1-phosphate receptor activity,MF,
9675,GO:0038037,1,0.905810474593211,0,3,G-protein coupled receptor dimeric complex,CC,
9676,GO:0038039,1,0.96024384506624,0,1,G-protein coupled receptor heterodimeric complex,CC,
9679,GO:0038047,1,0.973007521550594,0,1,morphine receptor activity,MF,
9680,GO:0038049,1,0.920650957478618,0,2,transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,MF,
9681,GO:0038051,1,0.95950763690405,0,1,glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity,MF,
9682,GO:0038052,1,0.929037424984411,0,2,RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding,MF,
9684,GO:0038062,1,0.961420789212395,0,1,protein tyrosine kinase collagen receptor activity,MF,
9685,GO:0038063,1,0.750265194467265,0,7,collagen-activated tyrosine kinase receptor signaling pathway,BP,
9686,GO:0038064,1,0.922486821916896,0,2,collagen receptor activity,MF,
9687,GO:0038065,1,0.719863717730287,0,8,collagen-activated signaling pathway,BP,
9690,GO:0038084,1,0.52398561032972,0,18,vascular endothelial growth factor signaling pathway,BP,
9691,GO:0038085,1,0.968057406154827,0,1,vascular endothelial growth factor binding,MF,
9692,GO:0038086,1,0.962485920222195,0,1,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,
9693,GO:0038089,1,0.807616036721441,0,6,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,
9694,GO:0038091,1,0.962485920222195,0,1,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,
9697,GO:0038094,1,0.121277078344176,0,59,Fc-gamma receptor signaling pathway,BP,
9699,GO:0038096,1,0.124538615163056,0,58,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
9700,GO:0038098,1,0.971513116310183,0,1,sequestering of BMP from receptor via BMP binding,BP,
9701,GO:0038101,1,0.974261762905889,0,1,sequestering of nodal from receptor via nodal binding,BP,
9702,GO:0038107,1,0.910220210967349,0,3,nodal signaling pathway involved in determination of left/right asymmetry,BP,
9703,GO:0038108,1,0.904297037957222,0,3,negative regulation of appetite by leptin-mediated signaling pathway,BP,
9704,GO:0038109,1,0.965067269736794,0,1,Kit signaling pathway,BP,
9705,GO:0038110,1,0.733876912057017,0,8,interleukin-2-mediated signaling pathway,BP,
9707,GO:0038112,1,0.968085371787524,0,1,interleukin-8-mediated signaling pathway,BP,
9708,GO:0038113,1,0.920749189957228,0,2,interleukin-9-mediated signaling pathway,BP,
9709,GO:0038114,1,0.850260163439648,0,4,interleukin-21-mediated signaling pathway,BP,
9710,GO:0038123,1,0.962976580653528,0,1,toll-like receptor TLR1:TLR2 signaling pathway,BP,
9711,GO:0038124,1,0.923979762491369,0,2,toll-like receptor TLR6:TLR2 signaling pathway,BP,
9715,GO:0038131,1,0.93701649205807,0,2,neuregulin receptor activity,MF,
9717,GO:0038145,1,0.905778750980983,0,3,macrophage colony-stimulating factor signaling pathway,BP,
9720,GO:0038158,1,0.938591588627547,0,2,granulocyte colony-stimulating factor signaling pathway,BP,
9721,GO:0038161,1,0.965469978279355,0,1,prolactin signaling pathway,BP,
9722,GO:0038162,1,0.973133797886935,0,1,erythropoietin-mediated signaling pathway,BP,
9723,GO:0038163,1,0.982164400809838,0,1,thrombopoietin-mediated signaling pathway,BP,
9725,GO:0038166,1,0.852642009934768,0,5,angiotensin-activated signaling pathway,BP,
9726,GO:0038171,1,0.898943839867351,0,3,cannabinoid signaling pathway,BP,
9727,GO:0038172,1,0.961499406568799,0,1,interleukin-33-mediated signaling pathway,BP,
9729,GO:0038180,1,0.757810519693738,0,8,nerve growth factor signaling pathway,BP,
9730,GO:0038181,1,0.959821324189641,0,1,bile acid receptor activity,MF,
9731,GO:0038183,1,0.959821324189641,0,1,bile acid signaling pathway,BP,
9732,GO:0038186,1,0.959821324189641,0,1,lithocholic acid receptor activity,MF,
9733,GO:0038187,1,0.795436331253948,0,7,pattern recognition receptor activity,MF,
9734,GO:0038189,1,0.867563758379769,0,4,neuropilin signaling pathway,BP,
9735,GO:0038190,1,0.931738706952722,0,2,VEGF-activated neuropilin signaling pathway,BP,
9737,GO:0038192,1,0.971542648304535,0,1,gastric inhibitory peptide signaling pathway,BP,
9738,GO:0038193,1,0.969636865735874,0,1,thromboxane A2 signaling pathway,BP,
9739,GO:0038194,1,0.961319966218223,0,1,thyroid-stimulating hormone signaling pathway,BP,
9741,GO:0038201,1,0.578090709749289,0,16,TOR complex,CC,
9742,GO:0038202,1,0.349774513786601,0,31,TORC1 signaling,BP,
9743,GO:0038203,1,0.785722527762221,0,7,TORC2 signaling,BP,
9744,GO:0039003,1,0.961319966218223,0,1,pronephric field specification,BP,
9745,GO:0039007,1,0.959510825131099,0,1,pronephric nephron morphogenesis,BP,
9746,GO:0039008,1,0.959510825131099,0,1,pronephric nephron tubule morphogenesis,BP,
9747,GO:0039017,1,0.961319966218223,0,1,pattern specification involved in pronephros development,BP,
9748,GO:0039019,1,0.923086152517853,0,2,pronephric nephron development,BP,
9749,GO:0039020,1,0.959510825131099,0,1,pronephric nephron tubule development,BP,
9750,GO:0039022,1,0.959510825131099,0,1,pronephric duct development,BP,
9751,GO:0039023,1,0.959510825131099,0,1,pronephric duct morphogenesis,BP,
9752,GO:0039502,1,0.959555954835982,0,1,suppression by virus of host type I interferon-mediated signaling pathway,BP,
9753,GO:0039503,1,0.959555954835982,0,1,suppression by virus of host innate immune response,BP,
9754,GO:0039506,1,0.927167608234395,0,2,modulation by virus of host molecular function,BP,
9755,GO:0039507,1,0.927167608234395,0,2,suppression by virus of host molecular function,BP,
9756,GO:0039513,1,0.966249973095834,0,1,suppression by virus of host catalytic activity,BP,
9757,GO:0039514,1,0.959555954835982,0,1,suppression by virus of host JAK-STAT cascade,BP,
9758,GO:0039516,1,0.966249973095834,0,1,modulation by virus of host catalytic activity,BP,
9759,GO:0039519,1,0.920785100266776,0,2,modulation by virus of host autophagy,BP,
9760,GO:0039520,1,0.959511102034941,0,1,induction by virus of host autophagy,BP,
9761,GO:0039521,1,0.959643961346915,0,1,suppression by virus of host autophagy,BP,
9762,GO:0039526,1,0.917627164374237,0,3,modulation by virus of host apoptotic process,BP,
9767,GO:0039532,1,0.705643074012848,0,10,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
9768,GO:0039533,1,0.809502780251756,0,6,regulation of MDA-5 signaling pathway,BP,
9769,GO:0039534,1,0.879295748645112,0,4,negative regulation of MDA-5 signaling pathway,BP,
9771,GO:0039536,1,0.783234373817811,0,7,negative regulation of RIG-I signaling pathway,BP,
9772,GO:0039552,1,0.959513469637306,0,1,RIG-I binding,MF,
9773,GO:0039562,1,0.959555954835982,0,1,suppression by virus of host STAT activity,BP,
9774,GO:0039563,1,0.959555954835982,0,1,suppression by virus of host STAT1 activity,BP,
9775,GO:0039564,1,0.959555954835982,0,1,suppression by virus of host STAT2 activity,BP,
9776,GO:0039650,1,0.966249973095834,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
9777,GO:0039656,1,0.939100825315449,0,2,modulation by virus of host gene expression,BP,
9778,GO:0039663,1,0.910418283630571,0,3,membrane fusion involved in viral entry into host cell,BP,
9779,GO:0039689,1,0.900656107781788,0,3,negative stranded viral RNA replication,BP,
9782,GO:0039695,1,0.959909259195392,0,1,DNA-templated viral transcription,BP,
9783,GO:0039702,1,0.543608661250455,0,20,viral budding via host ESCRT complex,BP,
9785,GO:0039713,1,0.962801397907159,0,1,viral factory,CC,
9786,GO:0039714,1,0.962801397907159,0,1,cytoplasmic viral factory,CC,
9787,GO:0040001,1,0.458034795951282,0,22,establishment of mitotic spindle localization,BP,
9790,GO:0040009,1,0.856388935412231,0,4,regulation of growth rate,BP,
9796,GO:0040016,1,0.782193006361009,0,7,embryonic cleavage,BP,
9802,GO:0040030,1,0.961549352280868,0,1,regulation of molecular function, epigenetic,BP,
9803,GO:0040031,1,0.857803360648262,0,6,snRNA modification,BP,
9804,GO:0040032,1,0.97276136741588,0,1,post-embryonic body morphogenesis,BP,
9806,GO:0040034,1,0.800386485180163,0,7,regulation of development, heterochronic,BP,
9809,GO:0040038,1,0.92460003006269,0,2,polar body extrusion after meiotic divisions,BP,
9810,GO:0042000,1,0.968550558863716,0,1,translocation of peptides or proteins into host,BP,
9811,GO:0042007,1,0.977340784861397,0,1,interleukin-18 binding,MF,
9812,GO:0042008,1,0.962472541989273,0,1,interleukin-18 receptor activity,MF,
9813,GO:0042015,1,0.902689360496748,0,3,interleukin-20 binding,MF,
9814,GO:0042019,1,0.97193881161879,0,1,interleukin-23 binding,MF,
9815,GO:0042020,1,0.97193881161879,0,1,interleukin-23 receptor activity,MF,
9816,GO:0042022,1,0.97193881161879,0,1,interleukin-12 receptor complex,CC,
9817,GO:0042023,1,0.730362589077275,0,8,DNA endoreduplication,BP,
9818,GO:0042025,1,0.893341564397414,0,3,host cell nucleus,CC,
9819,GO:0042026,1,0.450806543350585,0,24,protein refolding,BP,
9820,GO:0042030,1,0.920650957478618,0,2,ATPase inhibitor activity,MF,
9824,GO:0042040,1,0.960409336878159,0,1,metal incorporation into metallo-molybdopterin complex,BP,
9825,GO:0042043,1,0.715152781072337,0,9,neurexin family protein binding,MF,
9829,GO:0042053,1,0.713761031908571,0,10,regulation of dopamine metabolic process,BP,
9830,GO:0042054,1,0.175733924322825,0,50,histone methyltransferase activity,MF,
9836,GO:0042069,1,0.713761031908571,0,10,regulation of catecholamine metabolic process,BP,
9837,GO:0042073,1,0.186680272750622,0,49,intraciliary transport,BP,
9839,GO:0042078,1,0.942124840234752,0,2,germ-line stem cell division,BP,
9840,GO:0042083,1,0.975655724279616,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
9841,GO:0042084,1,0.95950763690405,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
9850,GO:0042097,1,0.931396256666983,0,2,interleukin-4 biosynthetic process,BP,
9856,GO:0042105,1,0.969733056219969,0,1,alpha-beta T cell receptor complex,CC,
9864,GO:0042118,1,0.748290722808079,0,8,endothelial cell activation,BP,
9866,GO:0042126,1,0.874352959888855,0,4,nitrate metabolic process,BP,
9868,GO:0042128,1,0.969148520080678,0,1,nitrate assimilation,BP,
9872,GO:0042134,1,0.953846511946471,0,2,rRNA primary transcript binding,MF,
9875,GO:0042137,1,0.972650305631637,0,1,sequestering of neurotransmitter,BP,
9876,GO:0042138,1,0.969141054125381,0,1,meiotic DNA double-strand break formation,BP,
9877,GO:0042140,1,0.965469978279355,0,1,late meiotic recombination nodule assembly,BP,
9878,GO:0042144,1,0.928768522224828,0,2,vacuole fusion, non-autophagic,BP,
9880,GO:0042148,1,0.770956850954814,0,8,strand invasion,BP,
9885,GO:0042162,1,0.287694241629159,0,35,telomeric DNA binding,MF,
9886,GO:0042165,1,0.553907339979312,0,18,neurotransmitter binding,MF,
9887,GO:0042166,1,0.843901004589341,0,5,acetylcholine binding,MF,
9888,GO:0042167,1,0.861228672876724,0,6,heme catabolic process,BP,
9891,GO:0042171,1,0.485884600431105,0,20,lysophosphatidic acid acyltransferase activity,MF,
9895,GO:0042178,1,0.754560122313021,0,10,xenobiotic catabolic process,BP,
9899,GO:0042214,1,0.972641442982888,0,1,terpene metabolic process,BP,
9901,GO:0042220,1,0.388902572005629,0,26,response to cocaine,BP,
9904,GO:0042223,1,0.959616422844776,0,1,interleukin-3 biosynthetic process,BP,
9907,GO:0042231,1,0.980273350044032,0,1,interleukin-13 biosynthetic process,BP,
9908,GO:0042241,1,0.963679111569354,0,1,interleukin-18 biosynthetic process,BP,
9909,GO:0042245,1,0.929020400010767,0,2,RNA repair,BP,
9911,GO:0042247,1,0.965202511716011,0,1,establishment of planar polarity of follicular epithelium,BP,
9913,GO:0042253,1,0.940684438517572,0,2,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
9915,GO:0042255,1,0.266614756892504,0,54,ribosome assembly,BP,
9916,GO:0042256,1,0.86395489565028,0,5,mature ribosome assembly,BP,
9917,GO:0042262,1,0.892531348401004,0,5,DNA protection,BP,
9918,GO:0042264,1,0.923114916053883,0,2,peptidyl-aspartic acid hydroxylation,BP,
9919,GO:0042265,1,0.95950763690405,0,1,peptidyl-asparagine hydroxylation,BP,
9924,GO:0042271,1,0.921515378613067,0,2,susceptibility to natural killer cell mediated cytotoxicity,BP,
9925,GO:0042272,1,0.920666088713302,0,2,nuclear RNA export factor complex,CC,
9926,GO:0042273,1,0.172563758677656,0,67,ribosomal large subunit biogenesis,BP,
9928,GO:0042275,1,0.976295874095453,0,1,error-free postreplication DNA repair,BP,
9929,GO:0042276,1,0.564398591917466,0,19,error-prone translesion synthesis,BP,
9932,GO:0042281,1,0.938399627900086,0,2,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
9933,GO:0042282,1,0.960036282648594,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
9934,GO:0042284,1,0.973115718657294,0,1,sphingolipid delta-4 desaturase activity,MF,
9935,GO:0042285,1,0.806007280480499,0,6,xylosyltransferase activity,MF,
9938,GO:0042289,1,0.954713528350512,0,2,MHC class II protein binding,MF,
9939,GO:0042292,1,0.96827547172546,0,1,URM1 activating enzyme activity,MF,
9940,GO:0042296,1,0.896755005825412,0,4,ISG15 transferase activity,MF,
9941,GO:0042297,1,0.849813996945739,0,4,vocal learning,BP,
9947,GO:0042308,1,0.787281738367502,0,7,negative regulation of protein import into nucleus,BP,
9951,GO:0042316,1,0.959598545219491,0,1,penicillin metabolic process,BP,
9952,GO:0042320,1,0.959507712723564,0,1,regulation of circadian sleep/wake cycle, REM sleep,BP,
9953,GO:0042321,1,0.976124642047473,0,1,negative regulation of circadian sleep/wake cycle, sleep,BP,
9954,GO:0042323,1,0.976124642047473,0,1,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
9958,GO:0042328,1,0.888772578159718,0,3,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
9960,GO:0042335,1,0.893093056707908,0,3,cuticle development,BP,
9962,GO:0042340,1,0.791596023366881,0,7,keratan sulfate catabolic process,BP,
9963,GO:0042350,1,0.916212538768218,0,3,GDP-L-fucose biosynthetic process,BP,
9964,GO:0042351,1,0.953229804160221,0,2,'de novo' GDP-L-fucose biosynthetic process,BP,
9965,GO:0042352,1,0.961171106876367,0,1,GDP-L-fucose salvage,BP,
9966,GO:0042354,1,0.794777768467148,0,6,L-fucose metabolic process,BP,
9967,GO:0042355,1,0.794777768467148,0,6,L-fucose catabolic process,BP,
9968,GO:0042356,1,0.977916236444337,0,1,GDP-4-dehydro-D-rhamnose reductase activity,MF,
9969,GO:0042357,1,0.97364540467502,0,1,thiamine diphosphate metabolic process,BP,
9971,GO:0042360,1,0.974752702840451,0,1,vitamin E metabolic process,BP,
9972,GO:0042361,1,0.963903546161097,0,1,menaquinone catabolic process,BP,
9975,GO:0042364,1,0.753611693766836,0,8,water-soluble vitamin biosynthetic process,BP,
9976,GO:0042365,1,0.917157223324306,0,3,water-soluble vitamin catabolic process,BP,
9979,GO:0042371,1,0.962014420692069,0,1,vitamin K biosynthetic process,BP,
9980,GO:0042373,1,0.874630504449892,0,5,vitamin K metabolic process,BP,
9981,GO:0042374,1,0.945294416329213,0,2,phylloquinone metabolic process,BP,
9982,GO:0042376,1,0.945294416329213,0,2,phylloquinone catabolic process,BP,
9983,GO:0042377,1,0.963903546161097,0,1,vitamin K catabolic process,BP,
9985,GO:0042382,1,0.807158165885504,0,6,paraspeckles,CC,
9988,GO:0042392,1,0.849360706987064,0,5,sphingosine-1-phosphate phosphatase activity,MF,
9993,GO:0042403,1,0.686128563646496,0,10,thyroid hormone metabolic process,BP,
9996,GO:0042407,1,0.645329876550738,0,15,cristae formation,BP,
9997,GO:0042412,1,0.966591019336054,0,1,taurine biosynthetic process,BP,
9998,GO:0042414,1,0.933254189188156,0,2,epinephrine metabolic process,BP,
9999,GO:0042415,1,0.784988618241354,0,7,norepinephrine metabolic process,BP,
10002,GO:0042418,1,0.972641442982888,0,1,epinephrine biosynthetic process,BP,
10004,GO:0042421,1,0.904952064937092,0,3,norepinephrine biosynthetic process,BP,
10007,GO:0042426,1,0.923820717010909,0,2,choline catabolic process,BP,
10008,GO:0042428,1,0.860480602917807,0,4,serotonin metabolic process,BP,
10009,GO:0042430,1,0.773386626593351,0,8,indole-containing compound metabolic process,BP,
10010,GO:0042436,1,0.922418598255783,0,3,indole-containing compound catabolic process,BP,
10012,GO:0042439,1,0.811904618247121,0,6,ethanolamine-containing compound metabolic process,BP,
10014,GO:0042441,1,0.959734229948343,0,1,eye pigment metabolic process,BP,
10019,GO:0042450,1,0.971883007514942,0,1,arginine biosynthetic process via ornithine,BP,
10020,GO:0042451,1,0.589153853819988,0,20,purine nucleoside biosynthetic process,BP,
10028,GO:0042473,1,0.826040657071463,0,6,outer ear morphogenesis,BP,
10034,GO:0042483,1,0.95950763690405,0,1,negative regulation of odontogenesis,BP,
10036,GO:0042488,1,0.968453561303749,0,1,positive regulation of odontogenesis of dentin-containing tooth,BP,
10039,GO:0042492,1,0.828499242088961,0,5,gamma-delta T cell differentiation,BP,
10041,GO:0042494,1,0.923979762491369,0,2,detection of bacterial lipoprotein,BP,
10042,GO:0042495,1,0.962976580653528,0,1,detection of triacyl bacterial lipopeptide,BP,
10043,GO:0042496,1,0.923979762491369,0,2,detection of diacyl bacterial lipopeptide,BP,
10044,GO:0042497,1,0.962976580653528,0,1,triacyl lipopeptide binding,MF,
10045,GO:0042500,1,0.814910746774877,0,6,aspartic endopeptidase activity, intramembrane cleaving,MF,
10052,GO:0042535,1,0.871880320600926,0,4,positive regulation of tumor necrosis factor biosynthetic process,BP,
10054,GO:0042537,1,0.69251922529934,0,13,benzene-containing compound metabolic process,BP,
10056,GO:0042539,1,0.925027418809873,0,2,hypotonic salinity response,BP,
10059,GO:0042543,1,0.987261516707437,0,1,protein N-linked glycosylation via arginine,BP,
10060,GO:0042546,1,0.973839944555444,0,1,cell wall biogenesis,BP,
10061,GO:0042551,1,0.399858489636594,0,25,neuron maturation,BP,
10064,GO:0042555,1,0.672771276252074,0,11,MCM complex,CC,
10067,GO:0042560,1,0.905548815761081,0,3,pteridine-containing compound catabolic process,BP,
10069,GO:0042564,1,0.960259554778064,0,1,NLS-dependent protein nuclear import complex,CC,
10070,GO:0042565,1,0.941396269994024,0,2,RNA nuclear export complex,CC,
10071,GO:0042567,1,0.928003373322001,0,2,insulin-like growth factor ternary complex,CC,
10072,GO:0042568,1,0.982313157077529,0,1,insulin-like growth factor binary complex,CC,
10076,GO:0042575,1,0.610072552212946,0,16,DNA polymerase complex,CC,
10077,GO:0042577,1,0.784263336557541,0,7,lipid phosphatase activity,MF,
10079,GO:0042579,1,0.0351878117122921,0,104,microbody,CC,
10082,GO:0042583,1,0.83858463654143,0,5,chromaffin granule,CC,
10083,GO:0042584,1,0.868343185911865,0,4,chromaffin granule membrane,CC,
10084,GO:0042585,1,0.931463261198114,0,2,germinal vesicle,CC,
10085,GO:0042586,1,0.980173776056391,0,1,peptide deformylase activity,MF,
10086,GO:0042587,1,0.844704490411395,0,5,glycogen granule,CC,
10087,GO:0042588,1,0.744764803878759,0,9,zymogen granule,CC,
10088,GO:0042589,1,0.797607745890341,0,7,zymogen granule membrane,CC,
10093,GO:0042595,1,0.961398896095493,0,1,behavioral response to starvation,BP,
10094,GO:0042596,1,0.543234239055156,0,18,fear response,BP,
10095,GO:0042599,1,0.689965287316168,0,12,lamellar body,CC,
10096,GO:0042602,1,0.983572968119121,0,1,riboflavin reductase (NADPH) activity,MF,
10100,GO:0042610,1,0.971174303078888,0,1,CD8 receptor binding,MF,
10103,GO:0042613,1,0.937069742233067,0,3,MHC class II protein complex,CC,
10104,GO:0042622,1,0.796708503308677,0,6,photoreceptor outer segment membrane,CC,
10106,GO:0042624,1,0.985554531774291,0,1,ATPase activity, uncoupled,MF,
10109,GO:0042627,1,0.939402710286453,0,3,chylomicron,CC,
10110,GO:0042628,1,0.969698369587268,0,1,mating plug formation,BP,
10111,GO:0042629,1,0.731628149434026,0,10,mast cell granule,CC,
10112,GO:0042631,1,0.962276112752038,0,1,cellular response to water deprivation,BP,
10118,GO:0042637,1,0.880144986442102,0,4,catagen,BP,
10121,GO:0042643,1,0.965202511716011,0,1,actomyosin, actin portion,CC,
10122,GO:0042645,1,0.268620884553281,0,40,mitochondrial nucleoid,CC,
10123,GO:0042658,1,0.978457029373676,0,1,MHC class II protein binding, via antigen binding groove,MF,
10124,GO:0042659,1,0.769434432284588,0,7,regulation of cell fate specification,BP,
10125,GO:0042660,1,0.95950763690405,0,1,positive regulation of cell fate specification,BP,
10126,GO:0042661,1,0.898745587864151,0,3,regulation of mesodermal cell fate specification,BP,
10127,GO:0042662,1,0.973571680227903,0,1,negative regulation of mesodermal cell fate specification,BP,
10128,GO:0042663,1,0.941732100845278,0,2,regulation of endodermal cell fate specification,BP,
10129,GO:0042665,1,0.961388733148346,0,1,regulation of ectodermal cell fate specification,BP,
10130,GO:0042666,1,0.961388733148346,0,1,negative regulation of ectodermal cell fate specification,BP,
10131,GO:0042668,1,0.956055159515671,0,2,auditory receptor cell fate determination,BP,
10132,GO:0042670,1,0.894212227534622,0,3,retinal cone cell differentiation,BP,
10137,GO:0042699,1,0.943622796434369,0,2,follicle-stimulating hormone signaling pathway,BP,
10140,GO:0042704,1,0.924949471917468,0,2,uterine wall breakdown,BP,
10141,GO:0042709,1,0.96898501039023,0,1,succinate-CoA ligase complex,CC,
10142,GO:0042711,1,0.810183504426614,0,6,maternal behavior,BP,
10143,GO:0042713,1,0.884550699942391,0,3,sperm ejaculation,BP,
10144,GO:0042719,1,0.891610274585486,0,5,mitochondrial intermembrane space protein transporter complex,CC,
10145,GO:0042720,1,0.960941579257563,0,2,mitochondrial inner membrane peptidase complex,CC,
10146,GO:0042721,1,0.878487600534735,0,5,mitochondrial inner membrane protein insertion complex,CC,
10147,GO:0042723,1,0.913359478285639,0,3,thiamine-containing compound metabolic process,BP,
10148,GO:0042726,1,0.78815722403406,0,7,flavin-containing compound metabolic process,BP,
10149,GO:0042727,1,0.939581668893093,0,2,flavin-containing compound biosynthetic process,BP,
10150,GO:0042728,1,0.961319966218223,0,1,flavin-containing compound catabolic process,BP,
10152,GO:0042731,1,0.873909346925157,0,4,PH domain binding,MF,
10153,GO:0042732,1,0.946334032589879,0,2,D-xylose metabolic process,BP,
10157,GO:0042738,1,0.741933530318946,0,9,exogenous drug catabolic process,BP,
10159,GO:0042743,1,0.444735578260446,0,28,hydrogen peroxide metabolic process,BP,
10160,GO:0042744,1,0.712171985578529,0,12,hydrogen peroxide catabolic process,BP,
10162,GO:0042747,1,0.885640726015939,0,4,circadian sleep/wake cycle, REM sleep,BP,
10163,GO:0042748,1,0.898665608151781,0,3,circadian sleep/wake cycle, non-REM sleep,BP,
10167,GO:0042754,1,0.721944053877865,0,9,negative regulation of circadian rhythm,BP,
10168,GO:0042755,1,0.632776191175983,0,14,eating behavior,BP,
10169,GO:0042756,1,0.914817978933331,0,3,drinking behavior,BP,
10170,GO:0042758,1,0.873051995154821,0,4,long-chain fatty acid catabolic process,BP,
10172,GO:0042760,1,0.844156776263513,0,5,very long-chain fatty acid catabolic process,BP,
10173,GO:0042761,1,0.716938417240267,0,10,very long-chain fatty acid biosynthetic process,BP,
10175,GO:0042765,1,0.849679566571803,0,5,GPI-anchor transamidase complex,CC,
10176,GO:0042766,1,0.95950763690405,0,1,nucleosome mobilization,BP,
10181,GO:0042773,1,0.171867477079687,0,80,ATP synthesis coupled electron transport,BP,
10182,GO:0042774,1,0.965469978279355,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
10183,GO:0042775,1,0.178041863098375,0,79,mitochondrial ATP synthesis coupled electron transport,BP,
10184,GO:0042776,1,0.925890332602585,0,4,mitochondrial ATP synthesis coupled proton transport,BP,
10185,GO:0042779,1,0.932561306171818,0,2,tRNA 3'-trailer cleavage,BP,
10186,GO:0042780,1,0.806560637039592,0,7,tRNA 3'-end processing,BP,
10187,GO:0042781,1,0.932561306171818,0,2,3'-tRNA processing endoribonuclease activity,MF,
10189,GO:0042789,1,0.6075495280543,0,14,mRNA transcription by RNA polymerase II,BP,
10190,GO:0042790,1,0.670222945736535,0,12,nucleolar large rRNA transcription by RNA polymerase I,BP,
10191,GO:0042791,1,0.814214246190887,0,6,5S class rRNA transcription by RNA polymerase III,BP,
10193,GO:0042796,1,0.810806066710294,0,6,snRNA transcription by RNA polymerase III,BP,
10194,GO:0042797,1,0.814214246190887,0,6,tRNA transcription by RNA polymerase III,BP,
10195,GO:0042799,1,0.863487267712028,0,4,histone methyltransferase activity (H4-K20 specific),MF,
10196,GO:0042800,1,0.582320464863103,0,16,histone methyltransferase activity (H3-K4 specific),MF,
10200,GO:0042806,1,0.965469978279355,0,1,fucose binding,MF,
10202,GO:0042813,1,0.539122216204132,0,16,Wnt-activated receptor activity,MF,
10203,GO:0042816,1,0.836286816474692,0,5,vitamin B6 metabolic process,BP,
10204,GO:0042819,1,0.896750584029808,0,3,vitamin B6 biosynthetic process,BP,
10205,GO:0042820,1,0.971805969249971,0,1,vitamin B6 catabolic process,BP,
10206,GO:0042822,1,0.897664876711299,0,3,pyridoxal phosphate metabolic process,BP,
10207,GO:0042823,1,0.923713222245862,0,2,pyridoxal phosphate biosynthetic process,BP,
10211,GO:0042827,1,0.696318178182504,0,11,platelet dense granule,CC,
10213,GO:0042834,1,0.794792474942006,0,7,peptidoglycan binding,MF,
10215,GO:0042839,1,0.976768554059973,0,1,D-glucuronate metabolic process,BP,
10216,GO:0042840,1,0.976768554059973,0,1,D-glucuronate catabolic process,BP,
10217,GO:0042851,1,0.961179164310998,0,1,L-alanine metabolic process,BP,
10218,GO:0042853,1,0.961179164310998,0,1,L-alanine catabolic process,BP,
10222,GO:0042891,1,0.783917539479302,0,7,antibiotic transport,BP,
10223,GO:0042895,1,0.816378310438325,0,6,antibiotic transmembrane transporter activity,MF,
10224,GO:0042903,1,0.934061687651233,0,2,tubulin deacetylase activity,MF,
10225,GO:0042904,1,0.931922416937515,0,2,9-cis-retinoic acid biosynthetic process,BP,
10226,GO:0042905,1,0.931922416937515,0,2,9-cis-retinoic acid metabolic process,BP,
10227,GO:0042908,1,0.788275706065711,0,6,xenobiotic transport,BP,
10228,GO:0042910,1,0.788275706065711,0,6,xenobiotic transmembrane transporter activity,MF,
10230,GO:0042922,1,0.98406407037836,0,1,neuromedin U receptor binding,MF,
10231,GO:0042923,1,0.943162043120069,0,2,neuropeptide binding,MF,
10232,GO:0042937,1,0.95950763690405,0,1,tripeptide transmembrane transporter activity,MF,
10233,GO:0042938,1,0.942587011227302,0,2,dipeptide transport,BP,
10234,GO:0042939,1,0.932436072679674,0,2,tripeptide transport,BP,
10237,GO:0042946,1,0.965469978279355,0,1,glucoside transport,BP,
10238,GO:0042947,1,0.965469978279355,0,1,glucoside transmembrane transporter activity,MF,
10239,GO:0042953,1,0.805645325592112,0,6,lipoprotein transport,BP,
10240,GO:0042954,1,0.829946501666808,0,5,lipoprotein transporter activity,MF,
10241,GO:0042974,1,0.485902725037714,0,20,retinoic acid receptor binding,MF,
10242,GO:0042975,1,0.725610258386851,0,9,peroxisome proliferator activated receptor binding,MF,
10251,GO:0042986,1,0.936227345213108,0,2,positive regulation of amyloid precursor protein biosynthetic process,BP,
10253,GO:0042988,1,0.959561890552078,0,1,X11-like protein binding,MF,
10254,GO:0042989,1,0.873422588044033,0,6,sequestering of actin monomers,BP,
10257,GO:0042996,1,0.829843166625058,0,5,regulation of Golgi to plasma membrane protein transport,BP,
10258,GO:0042997,1,0.898979205827955,0,3,negative regulation of Golgi to plasma membrane protein transport,BP,
10259,GO:0042998,1,0.923114745051928,0,2,positive regulation of Golgi to plasma membrane protein transport,BP,
10260,GO:0042999,1,0.95994516038268,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
10261,GO:0043000,1,0.93792798241908,0,2,Golgi to plasma membrane CFTR protein transport,BP,
10262,GO:0043001,1,0.362487416765243,0,29,Golgi to plasma membrane protein transport,BP,
10263,GO:0043002,1,0.95994516038268,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
10264,GO:0043004,1,0.95994516038268,0,1,cytoplasmic sequestering of CFTR protein,BP,
10266,GO:0043006,1,0.967528970318412,0,1,activation of phospholipase A2 activity by calcium-mediated signaling,BP,
10271,GO:0043014,1,0.440194289865887,0,23,alpha-tubulin binding,MF,
10273,GO:0043016,1,0.966531434241085,0,1,regulation of lymphotoxin A biosynthetic process,BP,
10274,GO:0043017,1,0.966531434241085,0,1,positive regulation of lymphotoxin A biosynthetic process,BP,
10275,GO:0043020,1,0.936254016224719,0,3,NADPH oxidase complex,CC,
10287,GO:0043033,1,0.95950763690405,0,1,isoamylase complex,CC,
10289,GO:0043035,1,0.961549352280868,0,1,chromatin insulator sequence binding,MF,
10290,GO:0043038,1,0.180976879956017,0,53,amino acid activation,BP,
10291,GO:0043039,1,0.188096801699446,0,52,tRNA aminoacylation,BP,
10292,GO:0043041,1,0.962303687676253,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
10294,GO:0043044,1,0.141227110680514,0,69,ATP-dependent chromatin remodeling,BP,
10295,GO:0043045,1,0.806578632461426,0,6,DNA methylation involved in embryo development,BP,
10296,GO:0043046,1,0.780762269904725,0,7,DNA methylation involved in gamete generation,BP,
10297,GO:0043047,1,0.68071258101648,0,11,single-stranded telomeric DNA binding,MF,
10298,GO:0043048,1,0.970185983388655,0,1,dolichyl monophosphate biosynthetic process,BP,
10299,GO:0043060,1,0.968169574119123,0,1,meiotic metaphase I plate congression,BP,
10306,GO:0043073,1,0.676557558158644,0,12,germ cell nucleus,CC,
10307,GO:0043083,1,0.850802653153975,0,4,synaptic cleft,CC,
10308,GO:0043084,1,0.867330012461055,0,4,penile erection,BP,
10314,GO:0043095,1,0.985280647683003,0,1,regulation of GTP cyclohydrolase I activity,BP,
10315,GO:0043096,1,0.884037282628396,0,5,purine nucleobase salvage,BP,
10318,GO:0043102,1,0.834023367793489,0,6,amino acid salvage,BP,
10319,GO:0043103,1,0.922992167202461,0,3,hypoxanthine salvage,BP,
10320,GO:0043105,1,0.985280647683003,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
10321,GO:0043111,1,0.939203945740166,0,2,replication fork arrest,BP,
10323,GO:0043113,1,0.357567767959715,0,29,receptor clustering,BP,
10326,GO:0043117,1,0.898381869504604,0,3,positive regulation of vascular permeability,BP,
10327,GO:0043120,1,0.916470155810407,0,3,tumor necrosis factor binding,MF,
10328,GO:0043121,1,0.821873868974165,0,5,neurotrophin binding,MF,
10333,GO:0043126,1,0.976508566825836,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
10334,GO:0043128,1,0.976508566825836,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
10335,GO:0043129,1,0.8318818300419,0,5,surfactant homeostasis,BP,
10337,GO:0043131,1,0.959571905640215,0,1,erythrocyte enucleation,BP,
10338,GO:0043132,1,0.969671436256047,0,1,NAD transport,BP,
10339,GO:0043136,1,0.964189244898402,0,1,glycerol-3-phosphatase activity,MF,
10340,GO:0043137,1,0.890141754959229,0,4,DNA replication, removal of RNA primer,BP,
10341,GO:0043138,1,0.64349329745666,0,12,3'-5' DNA helicase activity,MF,
10342,GO:0043139,1,0.79296085106765,0,7,5'-3' DNA helicase activity,MF,
10343,GO:0043140,1,0.75458742551708,0,7,ATP-dependent 3'-5' DNA helicase activity,MF,
10344,GO:0043141,1,0.851028136583547,0,5,ATP-dependent 5'-3' DNA helicase activity,MF,
10345,GO:0043142,1,0.643989225446755,0,13,single-stranded DNA-dependent ATPase activity,MF,
10346,GO:0043144,1,0.830332312922208,0,8,snoRNA processing,BP,
10350,GO:0043159,1,0.962237779638328,0,1,acrosomal matrix,CC,
10352,GO:0043162,1,0.558030801237957,0,18,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
10353,GO:0043163,1,0.926980955056578,0,2,cell envelope organization,BP,
10358,GO:0043171,1,0.448816953260852,0,23,peptide catabolic process,BP,
10361,GO:0043175,1,0.297159722882262,0,35,RNA polymerase core enzyme binding,MF,
10362,GO:0043176,1,0.915994570052804,0,3,amine binding,MF,
10366,GO:0043181,1,0.962172802487713,0,1,vacuolar sequestering,BP,
10367,GO:0043183,1,0.943786064691256,0,2,vascular endothelial growth factor receptor 1 binding,MF,
10370,GO:0043186,1,0.791567253296226,0,7,P granule,CC,
10371,GO:0043189,1,0.554676135422987,0,19,H4/H2A histone acetyltransferase complex,CC,
10372,GO:0043190,1,0.793781188097189,0,6,ATP-binding cassette (ABC) transporter complex,CC,
10373,GO:0043194,1,0.718567319763425,0,9,axon initial segment,CC,
10374,GO:0043195,1,0.241400779636226,0,41,terminal bouton,CC,
10375,GO:0043196,1,0.940133696953673,0,2,varicosity,CC,
10376,GO:0043197,1,0.0276764418156662,0,99,dendritic spine,CC,
10377,GO:0043198,1,0.466561279714162,0,21,dendritic shaft,CC,
10378,GO:0043199,1,0.90689804473338,0,3,sulfate binding,MF,
10380,GO:0043201,1,0.680384742584206,0,10,response to leucine,BP,
10382,GO:0043203,1,0.839786910142655,0,6,axon hillock,CC,
10385,GO:0043208,1,0.87259340893013,0,4,glycosphingolipid binding,MF,
10388,GO:0043218,1,0.672659047881211,0,12,compact myelin,CC,
10389,GO:0043219,1,0.875220874703972,0,4,lateral loop,CC,
10390,GO:0043220,1,0.729637193362835,0,9,Schmidt-Lanterman incisure,CC,
10391,GO:0043221,1,0.961334160076387,0,1,SMC family protein binding,MF,
10392,GO:0043224,1,0.963472740522715,0,2,nuclear SCF ubiquitin ligase complex,CC,
10393,GO:0043225,1,0.722610718076486,0,8,ATPase-coupled anion transmembrane transporter activity,MF,
10404,GO:0043237,1,0.850012808171643,0,4,laminin-1 binding,MF,
10405,GO:0043240,1,0.675895001123548,0,11,Fanconi anaemia nuclear complex,CC,
10409,GO:0043247,1,0.630069242718874,0,13,telomere maintenance in response to DNA damage,BP,
10410,GO:0043248,1,0.748525643400204,0,12,proteasome assembly,BP,
10411,GO:0043249,1,0.7363357246083,0,9,erythrocyte maturation,BP,
10412,GO:0043250,1,0.976478103480537,0,1,sodium-dependent organic anion transmembrane transporter activity,MF,
10413,GO:0043251,1,0.976478103480537,0,1,sodium-dependent organic anion transport,BP,
10414,GO:0043252,1,0.672416036623061,0,11,sodium-independent organic anion transport,BP,
10418,GO:0043257,1,0.95950763690405,0,1,laminin-8 complex,CC,
10419,GO:0043259,1,0.883364048004276,0,3,laminin-10 complex,CC,
10420,GO:0043260,1,0.883364048004276,0,3,laminin-11 complex,CC,
10421,GO:0043262,1,0.906029654453475,0,3,adenosine-diphosphatase activity,MF,
10424,GO:0043268,1,0.577604191157261,0,15,positive regulation of potassium ion transport,BP,
10428,GO:0043273,1,0.959521558388638,0,1,CTPase activity,MF,
10436,GO:0043291,1,0.920650957478618,0,2,RAVE complex,CC,
10438,GO:0043293,1,0.934493666141562,0,2,apoptosome,CC,
10439,GO:0043295,1,0.745170681033763,0,11,glutathione binding,MF,
10444,GO:0043301,1,0.83349774010142,0,5,negative regulation of leukocyte degranulation,BP,
10445,GO:0043302,1,0.64734327242341,0,13,positive regulation of leukocyte degranulation,BP,
10448,GO:0043305,1,0.940431208933793,0,2,negative regulation of mast cell degranulation,BP,
10449,GO:0043306,1,0.768974843370277,0,8,positive regulation of mast cell degranulation,BP,
10450,GO:0043307,1,0.886179093475453,0,4,eosinophil activation,BP,
10451,GO:0043308,1,0.886179093475453,0,4,eosinophil degranulation,BP,
10452,GO:0043309,1,0.943951503751533,0,2,regulation of eosinophil degranulation,BP,
10453,GO:0043311,1,0.943951503751533,0,2,positive regulation of eosinophil degranulation,BP,
10455,GO:0043313,1,0.848724803165524,0,4,regulation of neutrophil degranulation,BP,
10456,GO:0043314,1,0.920684983329116,0,2,negative regulation of neutrophil degranulation,BP,
10457,GO:0043315,1,0.960654669220098,0,1,positive regulation of neutrophil degranulation,BP,
10458,GO:0043316,1,0.929936036597969,0,2,cytotoxic T cell degranulation,BP,
10459,GO:0043317,1,0.962670991845225,0,1,regulation of cytotoxic T cell degranulation,BP,
10460,GO:0043318,1,0.962670991845225,0,1,negative regulation of cytotoxic T cell degranulation,BP,
10461,GO:0043320,1,0.81237852822516,0,6,natural killer cell degranulation,BP,
10462,GO:0043321,1,0.928465170340372,0,2,regulation of natural killer cell degranulation,BP,
10463,GO:0043323,1,0.928465170340372,0,2,positive regulation of natural killer cell degranulation,BP,
10464,GO:0043324,1,0.959734229948343,0,1,pigment metabolic process involved in developmental pigmentation,BP,
10466,GO:0043328,1,0.905639410355651,0,4,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
10469,GO:0043335,1,0.94047572712524,0,2,protein unfolding,BP,
10470,GO:0043337,1,0.961523527165928,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
10471,GO:0043353,1,0.774082673107025,0,7,enucleate erythrocyte differentiation,BP,
10472,GO:0043354,1,0.959571905640215,0,1,enucleate erythrocyte maturation,BP,
10473,GO:0043366,1,0.933249721562159,0,2,beta selection,BP,
10482,GO:0043375,1,0.961390182901005,0,1,CD8-positive, alpha-beta T cell lineage commitment,BP,
10483,GO:0043376,1,0.96214066244454,0,1,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
10487,GO:0043383,1,0.90470402708056,0,3,negative T cell selection,BP,
10493,GO:0043394,1,0.422815963181558,0,23,proteoglycan binding,MF,
10494,GO:0043395,1,0.684041559027189,0,10,heparan sulfate proteoglycan binding,MF,
10495,GO:0043396,1,0.963768076646009,0,1,corticotropin-releasing hormone secretion,BP,
10496,GO:0043397,1,0.963768076646009,0,1,regulation of corticotropin-releasing hormone secretion,BP,
10497,GO:0043398,1,0.903796662899747,0,3,HLH domain binding,MF,
10500,GO:0043402,1,0.888854363394305,0,3,glucocorticoid mediated signaling pathway,BP,
10513,GO:0043418,1,0.902518761458837,0,3,homocysteine catabolic process,BP,
10515,GO:0043423,1,0.960270683623153,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
10520,GO:0043435,1,0.930971998123976,0,2,response to corticotropin-releasing hormone,BP,
10522,GO:0043449,1,0.967215647218539,0,1,cellular alkene metabolic process,BP,
10524,GO:0043456,1,0.914688305171808,0,3,regulation of pentose-phosphate shunt,BP,
10525,GO:0043457,1,0.595997517097293,0,16,regulation of cellular respiration,BP,
10526,GO:0043461,1,0.887262112174997,0,4,proton-transporting ATP synthase complex assembly,BP,
10528,GO:0043465,1,0.965469978279355,0,1,regulation of fermentation,BP,
10533,GO:0043474,1,0.959734229948343,0,1,pigment metabolic process involved in pigmentation,BP,
10534,GO:0043476,1,0.668310521307393,0,12,pigment accumulation,BP,
10535,GO:0043482,1,0.668310521307393,0,12,cellular pigment accumulation,BP,
10537,GO:0043485,1,0.725959300026941,0,10,endosome to pigment granule transport,BP,
10538,GO:0043486,1,0.303878305278178,0,48,histone exchange,BP,
10542,GO:0043490,1,0.926219225679772,0,2,malate-aspartate shuttle,BP,
10549,GO:0043501,1,0.67320241333393,0,11,skeletal muscle adaptation,BP,
10551,GO:0043504,1,0.890806563871144,0,3,mitochondrial DNA repair,BP,
10558,GO:0043515,1,0.839867734725252,0,5,kinetochore binding,MF,
10561,GO:0043518,1,0.677757255170344,0,12,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,
10562,GO:0043519,1,0.970918583286906,0,1,regulation of myosin II filament organization,BP,
10563,GO:0043522,1,0.734515856363277,0,10,leucine zipper domain binding,MF,
10567,GO:0043527,1,0.866689535940706,0,5,tRNA methyltransferase complex,CC,
10569,GO:0043532,1,0.95950763690405,0,1,angiostatin binding,MF,
10570,GO:0043533,1,0.827585610889761,0,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,
10574,GO:0043537,1,0.449378782586129,0,23,negative regulation of blood vessel endothelial cell migration,BP,
10575,GO:0043538,1,0.964627989219559,0,1,regulation of actin phosphorylation,BP,
10577,GO:0043541,1,0.92775271406309,0,2,UDP-N-acetylglucosamine transferase complex,CC,
10580,GO:0043544,1,0.962237779638328,0,1,lipoamide binding,MF,
10581,GO:0043545,1,0.796912918752052,0,7,molybdopterin cofactor metabolic process,BP,
10582,GO:0043546,1,0.798846646038546,0,6,molybdopterin cofactor binding,MF,
10584,GO:0043548,1,0.452709912636852,0,21,phosphatidylinositol 3-kinase binding,MF,
10586,GO:0043550,1,0.289202083697109,0,33,regulation of lipid kinase activity,BP,
10587,GO:0043551,1,0.356723674543583,0,27,regulation of phosphatidylinositol 3-kinase activity,BP,
10588,GO:0043552,1,0.504072770157579,0,18,positive regulation of phosphatidylinositol 3-kinase activity,BP,
10589,GO:0043553,1,0.89764627332686,0,3,negative regulation of phosphatidylinositol 3-kinase activity,BP,
10592,GO:0043559,1,0.816399334132784,0,5,insulin binding,MF,
10594,GO:0043562,1,0.75964527467528,0,10,cellular response to nitrogen levels,BP,
10595,GO:0043564,1,0.934526548111222,0,2,Ku70:Ku80 complex,CC,
10598,GO:0043568,1,0.829387577004775,0,5,positive regulation of insulin-like growth factor receptor signaling pathway,BP,
10600,GO:0043570,1,0.854021837999091,0,4,maintenance of DNA repeat elements,BP,
10601,GO:0043574,1,0.532685917692004,0,18,peroxisomal transport,BP,
10602,GO:0043576,1,0.608780480768592,0,13,regulation of respiratory gaseous exchange,BP,
10603,GO:0043578,1,0.886974465133433,0,3,nuclear matrix organization,BP,
10606,GO:0043585,1,0.920651064011069,0,2,nose morphogenesis,BP,
10607,GO:0043586,1,0.620971284726416,0,14,tongue development,BP,
10608,GO:0043587,1,0.761385299015078,0,8,tongue morphogenesis,BP,
10613,GO:0043602,1,0.96789068048304,0,1,nitrate catabolic process,BP,
10617,GO:0043610,1,0.95950763690405,0,1,regulation of carbohydrate utilization,BP,
10618,GO:0043614,1,0.921725730623018,0,2,multi-eIF complex,CC,
10619,GO:0043615,1,0.846225624968113,0,5,astrocyte cell migration,BP,
10625,GO:0043622,1,0.855844785318445,0,4,cortical microtubule organization,BP,
10627,GO:0043625,1,0.887516320624203,0,4,delta DNA polymerase complex,CC,
10628,GO:0043626,1,0.978196388567245,0,1,PCNA complex,CC,
10630,GO:0043628,1,0.457999128096863,0,27,ncRNA 3'-end processing,BP,
10631,GO:0043629,1,0.95950763690405,0,1,ncRNA polyadenylation,BP,
10632,GO:0043630,1,0.95950763690405,0,1,ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process,BP,
10633,GO:0043631,1,0.231630064454483,0,41,RNA polyadenylation,BP,
10635,GO:0043633,1,0.79076170014672,0,8,polyadenylation-dependent RNA catabolic process,BP,
10636,GO:0043634,1,0.823782578783287,0,7,polyadenylation-dependent ncRNA catabolic process,BP,
10639,GO:0043649,1,0.678310551302134,0,12,dicarboxylic acid catabolic process,BP,
10640,GO:0043650,1,0.748599619119523,0,8,dicarboxylic acid biosynthetic process,BP,
10641,GO:0043651,1,0.63422941408889,0,14,linoleic acid metabolic process,BP,
10642,GO:0043652,1,0.787953171124868,0,8,engulfment of apoptotic cell,BP,
10643,GO:0043653,1,0.803842884005108,0,8,mitochondrial fragmentation involved in apoptotic process,BP,
10644,GO:0043654,1,0.892603198390193,0,3,recognition of apoptotic cell,BP,
10645,GO:0043656,1,0.776228343768706,0,7,intracellular region of host,CC,
10648,GO:0043679,1,0.101748337369193,0,66,axon terminus,CC,
10649,GO:0043682,1,0.920650957478618,0,2,copper-transporting ATPase activity,MF,
10650,GO:0043686,1,0.916486863835976,0,3,co-translational protein modification,BP,
10655,GO:0043733,1,0.980941812318171,0,1,DNA-3-methylbase glycosylase activity,MF,
10656,GO:0043734,1,0.890693110000107,0,4,DNA-N1-methyladenine dioxygenase activity,MF,
10658,GO:0043754,1,0.95950763690405,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
10659,GO:0043783,1,0.968999810749328,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
10660,GO:0043795,1,0.977507342145317,0,1,glyceraldehyde oxidoreductase activity,MF,
10661,GO:0043812,1,0.889817242426596,0,3,phosphatidylinositol-4-phosphate phosphatase activity,MF,
10662,GO:0043813,1,0.817314777993999,0,5,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,
10663,GO:0043843,1,0.967549206826007,0,1,ADP-specific glucokinase activity,MF,
10664,GO:0043849,1,0.965325526287144,0,1,Ras palmitoyltransferase activity,MF,
10665,GO:0043865,1,0.966134356702796,0,1,methionine transmembrane transporter activity,MF,
10666,GO:0043874,1,0.97170366491018,0,1,acireductone synthase activity,MF,
10667,GO:0043890,1,0.968874416385186,0,1,N-acetylgalactosamine-6-sulfatase activity,MF,
10668,GO:0043891,1,0.978446360623188,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
10673,GO:0043914,1,0.961168426610387,0,1,NADPH:sulfur oxidoreductase activity,MF,
10674,GO:0043916,1,0.980941812318171,0,1,DNA-7-methylguanine glycosylase activity,MF,
10678,GO:0043928,1,0.386708264125685,0,33,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,BP,
10680,GO:0043932,1,0.935178158022006,0,2,ossification involved in bone remodeling,BP,
10682,GO:0043946,1,0.974096920979988,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
10683,GO:0043947,1,0.974096920979988,0,1,positive regulation by host of symbiont catalytic activity,BP,
10684,GO:0043949,1,0.56774859695933,0,16,regulation of cAMP-mediated signaling,BP,
10685,GO:0043950,1,0.832716691993957,0,5,positive regulation of cAMP-mediated signaling,BP,
10686,GO:0043951,1,0.735724629426044,0,9,negative regulation of cAMP-mediated signaling,BP,
10687,GO:0043954,1,0.407707299260304,0,24,cellular component maintenance,BP,
10690,GO:0043968,1,0.609244064447173,0,16,histone H2A acetylation,BP,
10691,GO:0043969,1,0.95950763690405,0,1,histone H2B acetylation,BP,
10693,GO:0043972,1,0.959813878209401,0,1,histone H3-K23 acetylation,BP,
10694,GO:0043973,1,0.970142566444605,0,1,histone H3-K4 acetylation,BP,
10696,GO:0043981,1,0.593273858780511,0,15,histone H4-K5 acetylation,BP,
10697,GO:0043982,1,0.593273858780511,0,15,histone H4-K8 acetylation,BP,
10698,GO:0043983,1,0.794496910797296,0,7,histone H4-K12 acetylation,BP,
10699,GO:0043984,1,0.501478040096626,0,19,histone H4-K16 acetylation,BP,
10700,GO:0043985,1,0.82205904529601,0,6,histone H4-R3 methylation,BP,
10701,GO:0043987,1,0.879815921194796,0,4,histone H3-S10 phosphorylation,BP,
10702,GO:0043988,1,0.910519454084979,0,3,histone H3-S28 phosphorylation,BP,
10703,GO:0043990,1,0.964380348352828,0,1,histone H2A-S1 phosphorylation,BP,
10704,GO:0043994,1,0.959813878209401,0,1,histone acetyltransferase activity (H3-K23 specific),MF,
10705,GO:0043995,1,0.695234573635408,0,10,histone acetyltransferase activity (H4-K5 specific),MF,
10706,GO:0043996,1,0.695234573635408,0,10,histone acetyltransferase activity (H4-K8 specific),MF,
10707,GO:0043997,1,0.964229114996754,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
10708,GO:0043998,1,0.963237277172199,0,1,H2A histone acetyltransferase activity,MF,
10710,GO:0044004,1,0.921000638001773,0,3,disruption by symbiont of host cell,BP,
10711,GO:0044007,1,0.95950763690405,0,1,dissemination or transmission of symbiont from host,BP,
10712,GO:0044020,1,0.886453100404677,0,4,histone methyltransferase activity (H4-R3 specific),MF,
10713,GO:0044028,1,0.924588159588525,0,2,DNA hypomethylation,BP,
10714,GO:0044029,1,0.924588159588525,0,2,hypomethylation of CpG island,BP,
10715,GO:0044030,1,0.590095799628979,0,14,regulation of DNA methylation,BP,
10717,GO:0044035,1,0.975139906960328,0,1,multi-organism catabolic process,BP,
10718,GO:0044036,1,0.915917111459479,0,3,cell wall macromolecule metabolic process,BP,
10719,GO:0044038,1,0.973839944555444,0,1,cell wall macromolecule biosynthetic process,BP,
10721,GO:0044053,1,0.968550558863716,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
10726,GO:0044065,1,0.741815969816792,0,8,regulation of respiratory system process,BP,
10731,GO:0044088,1,0.268358975062863,0,38,regulation of vacuole organization,BP,
10733,GO:0044090,1,0.64013453045528,0,12,positive regulation of vacuole organization,BP,
10734,GO:0044091,1,0.454626375775372,0,23,membrane biogenesis,BP,
10737,GO:0044094,1,0.893341564397414,0,3,host cell nuclear part,CC,
10738,GO:0044105,1,0.983864928077052,0,1,L-xylulose reductase (NAD+) activity,MF,
10743,GO:0044111,1,0.935651723167617,0,2,development involved in symbiotic interaction,BP,
10744,GO:0044115,1,0.975139906960328,0,1,development of symbiont involved in interaction with host,BP,
10748,GO:0044128,1,0.959593238955368,0,1,positive regulation of growth of symbiont in host,BP,
10751,GO:0044145,1,0.975139906960328,0,1,modulation of development of symbiont involved in interaction with host,BP,
10753,GO:0044147,1,0.975139906960328,0,1,negative regulation of development of symbiont involved in interaction with host,BP,
10754,GO:0044148,1,0.959593238955368,0,1,positive regulation of growth of symbiont involved in interaction with host,BP,
10755,GO:0044154,1,0.783154978523641,0,7,histone H3-K14 acetylation,BP,
10756,GO:0044183,1,0.3487942329949,0,33,protein binding involved in protein folding,MF,
10757,GO:0044190,1,0.974035953495293,0,1,host cell mitochondrial envelope,CC,
10759,GO:0044205,1,0.901061168789769,0,3,'de novo' UMP biosynthetic process,BP,
10761,GO:0044207,1,0.960602022066878,0,1,translation initiation ternary complex,CC,
10762,GO:0044208,1,0.943728408112596,0,2,'de novo' AMP biosynthetic process,BP,
10763,GO:0044209,1,0.956747508189071,0,2,AMP salvage,BP,
10764,GO:0044210,1,0.927919751257868,0,2,'de novo' CTP biosynthetic process,BP,
10765,GO:0044211,1,0.925080666272494,0,3,CTP salvage,BP,
10767,GO:0044213,1,0.706057569370904,0,10,intronic transcription regulatory region DNA binding,MF,
10768,GO:0044214,1,0.892364595982206,0,3,spanning component of plasma membrane,CC,
10772,GO:0044218,1,0.960557918077305,0,1,other organism cell membrane,CC,
10773,GO:0044220,1,0.959725113952427,0,1,host cell perinuclear region of cytoplasm,CC,
10774,GO:0044221,1,0.960557918077305,0,1,host cell synapse,CC,
10775,GO:0044224,1,0.797945842135056,0,6,juxtaparanode region of axon,CC,
10776,GO:0044228,1,0.959804418459679,0,1,host cell surface,CC,
10777,GO:0044231,1,0.960557918077305,0,1,host cell presynaptic membrane,CC,
10784,GO:0044245,1,0.95950763690405,0,1,polysaccharide digestion,BP,
10800,GO:0044279,1,0.960557918077305,0,1,other organism membrane,CC,
10804,GO:0044284,1,0.983073368208227,0,1,mitochondrial crista junction,CC,
10806,GO:0044292,1,0.704726572843359,0,10,dendrite terminus,CC,
10807,GO:0044294,1,0.763797793675652,0,7,dendritic growth cone,CC,
10808,GO:0044295,1,0.468741998418078,0,20,axonal growth cone,CC,
10810,GO:0044298,1,0.76411909579337,0,7,cell body membrane,CC,
10811,GO:0044299,1,0.95950763690405,0,1,C-fiber,CC,
10812,GO:0044300,1,0.885487205129275,0,3,cerebellar mossy fiber,CC,
10813,GO:0044301,1,0.960074043443202,0,1,climbing fiber,CC,
10814,GO:0044302,1,0.890750428402635,0,3,dentate gyrus mossy fiber,CC,
10816,GO:0044305,1,0.95950763690405,0,1,calyx of Held,CC,
10818,GO:0044307,1,0.95950763690405,0,1,dendritic branch,CC,
10819,GO:0044308,1,0.920977667766087,0,2,axonal spine,CC,
10820,GO:0044309,1,0.025470378261093,0,101,neuron spine,CC,
10821,GO:0044313,1,0.885364377139672,0,3,protein K6-linked deubiquitination,BP,
10822,GO:0044314,1,0.906570451385859,0,4,protein K27-linked ubiquitination,BP,
10823,GO:0044316,1,0.961779526818629,0,1,cone cell pedicle,CC,
10824,GO:0044317,1,0.977832027584077,0,1,rod spherule,CC,
10826,GO:0044320,1,0.696744858479075,0,10,cellular response to leptin stimulus,BP,
10828,GO:0044322,1,0.404783591510371,0,26,endoplasmic reticulum quality control compartment,CC,
10829,GO:0044323,1,0.924307842962587,0,2,retinoic acid-responsive element binding,MF,
10830,GO:0044324,1,0.982969223190326,0,1,regulation of transcription involved in anterior/posterior axis specification,BP,
10832,GO:0044326,1,0.933139500795503,0,2,dendritic spine neck,CC,
10833,GO:0044327,1,0.747701429861107,0,8,dendritic spine head,CC,
10834,GO:0044328,1,0.965469978279355,0,1,canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration,BP,
10835,GO:0044329,1,0.965469978279355,0,1,canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion,BP,
10836,GO:0044330,1,0.965469978279355,0,1,canonical Wnt signaling pathway involved in positive regulation of wound healing,BP,
10838,GO:0044332,1,0.813810400086432,0,5,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
10839,GO:0044334,1,0.925322556894392,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
10840,GO:0044335,1,0.95950763690405,0,1,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
10841,GO:0044336,1,0.892645360613264,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
10842,GO:0044338,1,0.937757133345818,0,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,
10843,GO:0044339,1,0.900056265200181,0,3,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
10844,GO:0044340,1,0.835638935046757,0,5,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,
10845,GO:0044341,1,0.8903497846517,0,3,sodium-dependent phosphate transport,BP,
10847,GO:0044343,1,0.960101316739859,0,1,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,
10849,GO:0044345,1,0.960101316739859,0,1,stromal-epithelial cell signaling involved in prostate gland development,BP,
10850,GO:0044346,1,0.542443104888906,0,17,fibroblast apoptotic process,BP,
10851,GO:0044349,1,0.974280666574357,0,1,DNA excision,BP,
10852,GO:0044351,1,0.815834828677156,0,6,macropinocytosis,BP,
10853,GO:0044352,1,0.864135379560407,0,4,pinosome,CC,
10854,GO:0044354,1,0.864135379560407,0,4,macropinosome,CC,
10855,GO:0044355,1,0.977081954341158,0,1,clearance of foreign intracellular DNA,BP,
10856,GO:0044356,1,0.977081954341158,0,1,clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine,BP,
10857,GO:0044359,1,0.828990182865049,0,6,modulation of molecular function in other organism,BP,
10858,GO:0044362,1,0.863987732474028,0,5,negative regulation of molecular function in other organism,BP,
10859,GO:0044364,1,0.691031182606779,0,16,disruption of cells of other organism,BP,
10860,GO:0044375,1,0.956067985870595,0,2,regulation of peroxisome size,BP,
10861,GO:0044378,1,0.937288296507875,0,2,non-sequence-specific DNA binding, bending,MF,
10865,GO:0044388,1,0.880396773250616,0,5,small protein activating enzyme binding,MF,
10869,GO:0044393,1,0.895570910995539,0,3,microspike,CC,
10870,GO:0044395,1,0.967308247591653,0,1,protein targeting to vacuolar membrane,BP,
10871,GO:0044396,1,0.884344160867303,0,3,actin cortical patch organization,BP,
10873,GO:0044406,1,0.851984758708148,0,5,adhesion of symbiont to host,BP,
10876,GO:0044414,1,0.959555954835982,0,1,suppression of host defenses,BP,
10878,GO:0044416,1,0.947545724389011,0,2,induction by symbiont of host defense response,BP,
10879,GO:0044417,1,0.760254435299189,0,9,translocation of molecules into host,BP,
10894,GO:0044438,1,0.0934486736372679,0,73,microbody part,CC,
10895,GO:0044439,1,0.0934486736372679,0,73,peroxisomal part,CC,
10901,GO:0044447,1,0.563776873699156,0,16,axoneme part,CC,
10907,GO:0044453,1,0.7424055505512,0,8,nuclear membrane part,CC,
10911,GO:0044458,1,0.680185405064826,0,12,motile cilium assembly,BP,
10915,GO:0044495,1,0.98406407037836,0,1,modulation of blood pressure in other organism,BP,
10916,GO:0044497,1,0.98406407037836,0,1,positive regulation of blood pressure in other organism,BP,
10918,GO:0044524,1,0.97411570855655,0,1,protein sulfhydration,BP,
10919,GO:0044528,1,0.873414800740345,0,4,regulation of mitochondrial mRNA stability,BP,
10920,GO:0044530,1,0.894186267498197,0,3,supraspliceosomal complex,CC,
10921,GO:0044531,1,0.827709450336774,0,6,modulation of programmed cell death in other organism,BP,
10922,GO:0044532,1,0.827709450336774,0,6,modulation of apoptotic process in other organism,BP,
10923,GO:0044533,1,0.921000638001773,0,3,positive regulation of apoptotic process in other organism,BP,
10924,GO:0044539,1,0.891103826290874,0,3,long-chain fatty acid import,BP,
10925,GO:0044540,1,0.97411570855655,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
10926,GO:0044545,1,0.845483693270708,0,5,NSL complex,CC,
10927,GO:0044546,1,0.716685260614442,0,9,NLRP3 inflammasome complex assembly,BP,
10928,GO:0044547,1,0.835186379218312,0,5,DNA topoisomerase binding,MF,
10929,GO:0044548,1,0.709290935885044,0,11,S100 protein binding,MF,
10930,GO:0044549,1,0.985280647683003,0,1,GTP cyclohydrolase binding,MF,
10932,GO:0044557,1,0.862288712253536,0,5,relaxation of smooth muscle,BP,
10933,GO:0044565,1,0.942742824354714,0,2,dendritic cell proliferation,BP,
10934,GO:0044571,1,0.914399444449216,0,4,[2Fe-2S] cluster assembly,BP,
10935,GO:0044594,1,0.966685677564125,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
10936,GO:0044595,1,0.97896132643455,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
10937,GO:0044596,1,0.97896132643455,0,1,3-demethylubiquinone-10 3-O-methyltransferase activity,MF,
10938,GO:0044597,1,0.878717147081427,0,5,daunorubicin metabolic process,BP,
10939,GO:0044598,1,0.878717147081427,0,5,doxorubicin metabolic process,BP,
10940,GO:0044599,1,0.965469978279355,0,1,AP-5 adaptor complex,CC,
10941,GO:0044601,1,0.975028065885525,0,1,protein denucleotidylation,BP,
10942,GO:0044602,1,0.975028065885525,0,1,protein deadenylylation,BP,
10943,GO:0044603,1,0.975028065885525,0,1,protein adenylylhydrolase activity,MF,
10944,GO:0044609,1,0.937169867236577,0,2,DBIRD complex,CC,
10945,GO:0044610,1,0.969671436256047,0,1,FMN transmembrane transporter activity,MF,
10946,GO:0044611,1,0.88413112454601,0,3,nuclear pore inner ring,CC,
10948,GO:0044614,1,0.85795717765176,0,4,nuclear pore cytoplasmic filaments,CC,
10950,GO:0044620,1,0.972106481842648,0,2,ACP phosphopantetheine attachment site binding,MF,
10951,GO:0044648,1,0.965469978279355,0,1,histone H3-K4 dimethylation,BP,
10952,GO:0044650,1,0.881315241637329,0,4,adhesion of symbiont to host cell,BP,
10953,GO:0044665,1,0.378893552738991,0,29,MLL1/2 complex,CC,
10955,GO:0044691,1,0.922077180979395,0,2,tooth eruption,BP,
10958,GO:0044713,1,0.985256868465025,0,1,2-hydroxy-adenosine triphosphate pyrophosphatase activity,MF,
10959,GO:0044714,1,0.985256868465025,0,1,2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity,MF,
10960,GO:0044715,1,0.956389416630664,0,2,8-oxo-dGDP phosphatase activity,MF,
10961,GO:0044716,1,0.976316075006814,0,1,8-oxo-GDP phosphatase activity,MF,
10962,GO:0044717,1,0.976316075006814,0,1,8-hydroxy-dADP phosphatase activity,MF,
10963,GO:0044721,1,0.9724472996622,0,1,protein import into peroxisome matrix, substrate release,BP,
10964,GO:0044725,1,0.95950763690405,0,1,chromatin reprogramming in the zygote,BP,
10965,GO:0044727,1,0.95950763690405,0,1,DNA demethylation of male pronucleus,BP,
10968,GO:0044730,1,0.975139906960328,0,1,bone sialoprotein binding,MF,
10969,GO:0044732,1,0.965469978279355,0,1,mitotic spindle pole body,CC,
10970,GO:0044736,1,0.965469978279355,0,1,acid-sensing ion channel activity,MF,
10971,GO:0044743,1,0.331406665011177,0,38,protein transmembrane import into intracellular organelle,BP,
10972,GO:0044752,1,0.899015255259875,0,3,response to human chorionic gonadotropin,BP,
10983,GO:0044778,1,0.93933456336933,0,2,meiotic DNA integrity checkpoint,BP,
10984,GO:0044779,1,0.964709451383227,0,1,meiotic spindle checkpoint,BP,
10988,GO:0044785,1,0.964709451383227,0,1,metaphase/anaphase transition of meiotic cell cycle,BP,
10989,GO:0044786,1,0.153173357382526,0,57,cell cycle DNA replication,BP,
10991,GO:0044789,1,0.822772681322497,0,5,modulation by host of viral release from host cell,BP,
10992,GO:0044791,1,0.822772681322497,0,5,positive regulation by host of viral release from host cell,BP,
10994,GO:0044794,1,0.64260685991395,0,13,positive regulation by host of viral process,BP,
10995,GO:0044795,1,0.980162723686165,0,1,trans-Golgi network to recycling endosome transport,BP,
10996,GO:0044796,1,0.978196388567245,0,1,DNA polymerase processivity factor complex,CC,
10998,GO:0044800,1,0.910418283630571,0,3,multi-organism membrane fusion,BP,
10999,GO:0044803,1,0.873700818852976,0,4,multi-organism membrane organization,BP,
11000,GO:0044804,1,0.542177645189843,0,18,autophagy of nucleus,BP,
11001,GO:0044805,1,0.922846910768389,0,2,late nucleophagy,BP,
11002,GO:0044806,1,0.758778559269705,0,7,G-quadruplex DNA unwinding,BP,
11003,GO:0044815,1,0.178806391553185,0,91,DNA packaging complex,CC,
11004,GO:0044818,1,0.397272689861613,0,26,mitotic G2/M transition checkpoint,BP,
11006,GO:0044821,1,0.860161248911839,0,4,meiotic telomere tethering at nuclear periphery,BP,
11009,GO:0044829,1,0.781184553274134,0,7,positive regulation by host of viral genome replication,BP,
11010,GO:0044830,1,0.927005776745509,0,2,modulation by host of viral RNA genome replication,BP,
11011,GO:0044837,1,0.771302777752456,0,7,actomyosin contractile ring organization,BP,
11018,GO:0044854,1,0.880521354232825,0,4,plasma membrane raft assembly,BP,
11019,GO:0044855,1,0.966406916633823,0,1,plasma membrane raft distribution,BP,
11020,GO:0044856,1,0.966406916633823,0,1,plasma membrane raft localization,BP,
11021,GO:0044857,1,0.880521354232825,0,4,plasma membrane raft organization,BP,
11022,GO:0044858,1,0.966406916633823,0,1,plasma membrane raft polarization,BP,
11023,GO:0044860,1,0.872732228325872,0,4,protein localization to plasma membrane raft,BP,
11024,GO:0044861,1,0.933480632916514,0,2,protein transport into plasma membrane raft,BP,
11025,GO:0044868,1,0.95950763690405,0,1,modulation by host of viral molecular function,BP,
11026,GO:0044872,1,0.805645325592112,0,6,lipoprotein localization,BP,
11028,GO:0044878,1,0.896583113420177,0,4,mitotic cytokinesis checkpoint,BP,
11029,GO:0045002,1,0.785720121234729,0,7,double-strand break repair via single-strand annealing,BP,
11030,GO:0045003,1,0.724030393939032,0,10,double-strand break repair via synthesis-dependent strand annealing,BP,
11031,GO:0045004,1,0.923705578744297,0,2,DNA replication proofreading,BP,
11032,GO:0045005,1,0.325361018102971,0,32,DNA-dependent DNA replication maintenance of fidelity,BP,
11033,GO:0045006,1,0.769002881718704,0,10,DNA deamination,BP,
11034,GO:0045007,1,0.928460195344258,0,3,depurination,BP,
11036,GO:0045009,1,0.852664968812708,0,6,chitosome,CC,
11037,GO:0045010,1,0.278495952518127,0,38,actin nucleation,BP,
11038,GO:0045016,1,0.963193789750755,0,1,mitochondrial magnesium ion transmembrane transport,BP,
11041,GO:0045022,1,0.265490065829449,0,38,early endosome to late endosome transport,BP,
11042,GO:0045023,1,0.229332486997626,0,42,G0 to G1 transition,BP,
11043,GO:0045025,1,0.929275563973652,0,2,mitochondrial degradosome,CC,
11045,GO:0045027,1,0.970976052569857,0,1,DNA end binding,MF,
11046,GO:0045028,1,0.850507304250595,0,5,G-protein coupled purinergic nucleotide receptor activity,MF,
11047,GO:0045031,1,0.937410583631203,0,2,ATP-activated adenosine receptor activity,MF,
11048,GO:0045032,1,0.96434481732467,0,1,ADP-activated adenosine receptor activity,MF,
11049,GO:0045039,1,0.873401309447179,0,6,protein import into mitochondrial inner membrane,BP,
11050,GO:0045040,1,0.857926129461972,0,6,protein import into mitochondrial outer membrane,BP,
11051,GO:0045041,1,0.946349712125595,0,2,protein import into mitochondrial intermembrane space,BP,
11052,GO:0045046,1,0.809372043190957,0,6,protein import into peroxisome membrane,BP,
11054,GO:0045048,1,0.851363784862755,0,5,protein insertion into ER membrane,BP,
11055,GO:0045053,1,0.81942168612584,0,5,protein retention in Golgi apparatus,BP,
11056,GO:0045054,1,0.905677182096387,0,3,constitutive secretory pathway,BP,
11058,GO:0045056,1,0.610833436438061,0,14,transcytosis,BP,
11060,GO:0045059,1,0.818240288833395,0,6,positive thymic T cell selection,BP,
11061,GO:0045060,1,0.90470402708056,0,3,negative thymic T cell selection,BP,
11062,GO:0045061,1,0.672298277074465,0,11,thymic T cell selection,BP,
11063,GO:0045062,1,0.974451391860301,0,1,extrathymic T cell selection,BP,
11066,GO:0045065,1,0.93797789337099,0,2,cytotoxic T cell differentiation,BP,
11069,GO:0045070,1,0.343332779356666,0,31,positive regulation of viral genome replication,BP,
11077,GO:0045078,1,0.827438318823674,0,5,positive regulation of interferon-gamma biosynthetic process,BP,
11078,GO:0045079,1,0.974776753672499,0,1,negative regulation of chemokine biosynthetic process,BP,
11080,GO:0045081,1,0.962124679459832,0,1,negative regulation of interleukin-10 biosynthetic process,BP,
11090,GO:0045092,1,0.962176387937951,0,1,interleukin-18 receptor complex,CC,
11092,GO:0045098,1,0.974873157243389,0,1,type III intermediate filament,CC,
11095,GO:0045105,1,0.962241416758291,0,1,intermediate filament polymerization or depolymerization,BP,
11097,GO:0045110,1,0.802762970155606,0,6,intermediate filament bundle assembly,BP,
11099,GO:0045112,1,0.908658270677644,0,3,integrin biosynthetic process,BP,
11100,GO:0045113,1,0.947010116349596,0,2,regulation of integrin biosynthetic process,BP,
11103,GO:0045120,1,0.658181058865395,0,12,pronucleus,CC,
11107,GO:0045125,1,0.717937576278731,0,10,bioactive lipid receptor activity,MF,
11108,GO:0045127,1,0.97573506936744,0,1,N-acetylglucosamine kinase activity,MF,
11109,GO:0045128,1,0.964075692128143,0,1,negative regulation of reciprocal meiotic recombination,BP,
11110,GO:0045131,1,0.964969081763062,0,1,pre-mRNA branch point binding,MF,
11111,GO:0045132,1,0.182543805427164,0,49,meiotic chromosome segregation,BP,
11112,GO:0045134,1,0.872221562764006,0,4,uridine-diphosphatase activity,MF,
11115,GO:0045141,1,0.745830142585402,0,8,meiotic telomere clustering,BP,
11116,GO:0045142,1,0.922584856953846,0,2,triplex DNA binding,MF,
11117,GO:0045143,1,0.396891902634845,0,27,homologous chromosome segregation,BP,
11118,GO:0045144,1,0.854513993040235,0,5,meiotic sister chromatid segregation,BP,
11119,GO:0045145,1,0.930573044695256,0,2,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
11120,GO:0045153,1,0.979558416108418,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
11121,GO:0045155,1,0.939897273751185,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
11122,GO:0045159,1,0.870245465851609,0,4,myosin II binding,MF,
11123,GO:0045161,1,0.772055661835001,0,7,neuronal ion channel clustering,BP,
11124,GO:0045162,1,0.852007054243506,0,4,clustering of voltage-gated sodium channels,BP,
11125,GO:0045163,1,0.95950763690405,0,1,clustering of voltage-gated potassium channels,BP,
11127,GO:0045167,1,0.974413361039542,0,1,asymmetric protein localization involved in cell fate determination,BP,
11128,GO:0045168,1,0.941179072554209,0,2,cell-cell signaling involved in cell fate commitment,BP,
11129,GO:0045171,1,0.201964334959037,0,48,intercellular bridge,CC,
11130,GO:0045174,1,0.961363431180354,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
11131,GO:0045176,1,0.710490045544803,0,9,apical protein localization,BP,
11134,GO:0045179,1,0.834371767915734,0,5,apical cortex,CC,
11137,GO:0045183,1,0.965469978279355,0,1,translation factor activity, non-nucleic acid binding,MF,
11140,GO:0045186,1,0.95950763690405,0,1,zonula adherens assembly,BP,
11142,GO:0045188,1,0.936596752275305,0,2,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
11145,GO:0045196,1,0.922633693417432,0,2,establishment or maintenance of neuroblast polarity,BP,
11148,GO:0045199,1,0.838765200549755,0,5,maintenance of epithelial cell apical/basal polarity,BP,
11149,GO:0045200,1,0.922633693417432,0,2,establishment of neuroblast polarity,BP,
11159,GO:0045217,1,0.795191976983685,0,6,cell-cell junction maintenance,BP,
11160,GO:0045218,1,0.892361275712233,0,3,zonula adherens maintenance,BP,
11161,GO:0045219,1,0.959517148686632,0,1,regulation of FasL biosynthetic process,BP,
11162,GO:0045221,1,0.959517148686632,0,1,negative regulation of FasL biosynthetic process,BP,
11163,GO:0045222,1,0.980140625810969,0,1,CD4 biosynthetic process,BP,
11164,GO:0045223,1,0.980140625810969,0,1,regulation of CD4 biosynthetic process,BP,
11165,GO:0045225,1,0.980140625810969,0,1,negative regulation of CD4 biosynthetic process,BP,
11167,GO:0045229,1,0.926980955056578,0,2,external encapsulating structure organization,BP,
11168,GO:0045234,1,0.973728599158646,0,1,protein palmitoleylation,BP,
11170,GO:0045239,1,0.643033786495142,0,13,tricarboxylic acid cycle enzyme complex,CC,
11171,GO:0045240,1,0.68159909738187,0,11,dihydrolipoyl dehydrogenase complex,CC,
11172,GO:0045244,1,0.96898501039023,0,1,succinate-CoA ligase complex (GDP-forming),CC,
11173,GO:0045251,1,0.968999810749328,0,1,electron transfer flavoprotein complex,CC,
11174,GO:0045252,1,0.777149913709546,0,7,oxoglutarate dehydrogenase complex,CC,
11175,GO:0045254,1,0.781550247462159,0,7,pyruvate dehydrogenase complex,CC,
11176,GO:0045257,1,0.866506498156601,0,5,succinate dehydrogenase complex (ubiquinone),CC,
11178,GO:0045263,1,0.977601337954649,0,1,proton-transporting ATP synthase complex, coupling factor F(o),CC,
11179,GO:0045271,1,0.456668736736086,0,42,respiratory chain complex I,CC,
11180,GO:0045272,1,0.931386646006868,0,3,plasma membrane respiratory chain complex I,CC,
11181,GO:0045273,1,0.866506498156601,0,5,respiratory chain complex II,CC,
11182,GO:0045274,1,0.968684427031627,0,1,plasma membrane respiratory chain complex II,CC,
11183,GO:0045275,1,0.750737934986019,0,11,respiratory chain complex III,CC,
11184,GO:0045277,1,0.839928061998664,0,11,respiratory chain complex IV,CC,
11185,GO:0045281,1,0.866506498156601,0,5,succinate dehydrogenase complex,CC,
11186,GO:0045282,1,0.968684427031627,0,1,plasma membrane succinate dehydrogenase complex,CC,
11187,GO:0045283,1,0.866506498156601,0,5,fumarate reductase complex,CC,
11188,GO:0045292,1,0.575220421009474,0,17,mRNA cis splicing, via spliceosome,BP,
11189,GO:0045293,1,0.919599549378459,0,3,mRNA editing complex,CC,
11191,GO:0045295,1,0.694209917855281,0,9,gamma-catenin binding,MF,
11193,GO:0045297,1,0.969698369587268,0,1,post-mating behavior,BP,
11194,GO:0045298,1,0.873803207714718,0,4,tubulin complex,CC,
11197,GO:0045322,1,0.931724673313421,0,2,unmethylated CpG binding,MF,
11198,GO:0045323,1,0.902165186475193,0,3,interleukin-1 receptor complex,CC,
11199,GO:0045324,1,0.713384541509929,0,11,late endosome to vacuole transport,BP,
11200,GO:0045329,1,0.851454698362289,0,5,carnitine biosynthetic process,BP,
11201,GO:0045332,1,0.562590304477684,0,14,phospholipid translocation,BP,
11207,GO:0045340,1,0.98268071838369,0,1,mercury ion binding,MF,
11209,GO:0045342,1,0.842815224293211,0,5,MHC class II biosynthetic process,BP,
11212,GO:0045346,1,0.842815224293211,0,5,regulation of MHC class II biosynthetic process,BP,
11213,GO:0045347,1,0.900500470728994,0,3,negative regulation of MHC class II biosynthetic process,BP,
11214,GO:0045348,1,0.912763079893539,0,3,positive regulation of MHC class II biosynthetic process,BP,
11215,GO:0045349,1,0.881740894309315,0,4,interferon-alpha biosynthetic process,BP,
11220,GO:0045354,1,0.881740894309315,0,4,regulation of interferon-alpha biosynthetic process,BP,
11221,GO:0045355,1,0.952490800180549,0,2,negative regulation of interferon-alpha biosynthetic process,BP,
11222,GO:0045356,1,0.925729984419387,0,2,positive regulation of interferon-alpha biosynthetic process,BP,
11224,GO:0045358,1,0.952615115227448,0,2,negative regulation of interferon-beta biosynthetic process,BP,
11228,GO:0045381,1,0.963679111569354,0,1,regulation of interleukin-18 biosynthetic process,BP,
11229,GO:0045399,1,0.959616422844776,0,1,regulation of interleukin-3 biosynthetic process,BP,
11230,GO:0045401,1,0.959616422844776,0,1,positive regulation of interleukin-3 biosynthetic process,BP,
11231,GO:0045402,1,0.931396256666983,0,2,regulation of interleukin-4 biosynthetic process,BP,
11232,GO:0045403,1,0.963651240948405,0,1,negative regulation of interleukin-4 biosynthetic process,BP,
11233,GO:0045404,1,0.966531434241085,0,1,positive regulation of interleukin-4 biosynthetic process,BP,
11235,GO:0045409,1,0.924855936472525,0,2,negative regulation of interleukin-6 biosynthetic process,BP,
11240,GO:0045423,1,0.959616422844776,0,1,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
11241,GO:0045425,1,0.959616422844776,0,1,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
11247,GO:0045448,1,0.874727016864788,0,4,mitotic cell cycle, embryonic,BP,
11252,GO:0045475,1,0.749418790141659,0,8,locomotor rhythm,BP,
11253,GO:0045485,1,0.960162783500887,0,1,omega-6 fatty acid desaturase activity,MF,
11254,GO:0045494,1,0.487907615265813,0,20,photoreceptor cell maintenance,BP,
11255,GO:0045495,1,0.791567253296226,0,7,pole plasm,CC,
11257,GO:0045503,1,0.565388203337086,0,15,dynein light chain binding,MF,
11258,GO:0045504,1,0.705728289855732,0,10,dynein heavy chain binding,MF,
11259,GO:0045505,1,0.492229537429558,0,21,dynein intermediate chain binding,MF,
11261,GO:0045517,1,0.979318697458905,0,1,interleukin-20 receptor binding,MF,
11262,GO:0045518,1,0.979318697458905,0,1,interleukin-22 receptor binding,MF,
11265,GO:0045541,1,0.867432190418764,0,5,negative regulation of cholesterol biosynthetic process,BP,
11266,GO:0045542,1,0.826898108186336,0,5,positive regulation of cholesterol biosynthetic process,BP,
11267,GO:0045545,1,0.840793238075284,0,5,syndecan binding,MF,
11269,GO:0045575,1,0.932601057301533,0,2,basophil activation,BP,
11277,GO:0045583,1,0.93797789337099,0,2,regulation of cytotoxic T cell differentiation,BP,
11278,GO:0045585,1,0.93797789337099,0,2,positive regulation of cytotoxic T cell differentiation,BP,
11279,GO:0045586,1,0.88471776107981,0,3,regulation of gamma-delta T cell differentiation,BP,
11280,GO:0045588,1,0.920832269802857,0,2,positive regulation of gamma-delta T cell differentiation,BP,
11292,GO:0045603,1,0.766397227030486,0,7,positive regulation of endothelial cell differentiation,BP,
11294,GO:0045605,1,0.708358516302022,0,10,negative regulation of epidermal cell differentiation,BP,
11296,GO:0045607,1,0.853176107035403,0,5,regulation of inner ear auditory receptor cell differentiation,BP,
11297,GO:0045608,1,0.903062800579698,0,3,negative regulation of inner ear auditory receptor cell differentiation,BP,
11299,GO:0045617,1,0.811182883778638,0,6,negative regulation of keratinocyte differentiation,BP,
11308,GO:0045626,1,0.929522116143866,0,2,negative regulation of T-helper 1 cell differentiation,BP,
11310,GO:0045628,1,0.775232143406864,0,8,regulation of T-helper 2 cell differentiation,BP,
11311,GO:0045629,1,0.903208266920906,0,3,negative regulation of T-helper 2 cell differentiation,BP,
11312,GO:0045630,1,0.858343160893194,0,5,positive regulation of T-helper 2 cell differentiation,BP,
11313,GO:0045631,1,0.853176107035403,0,5,regulation of mechanoreceptor differentiation,BP,
11314,GO:0045632,1,0.88369964323354,0,4,negative regulation of mechanoreceptor differentiation,BP,
11329,GO:0045653,1,0.793377882290171,0,17,negative regulation of megakaryocyte differentiation,BP,
11330,GO:0045654,1,0.94507503995612,0,2,positive regulation of megakaryocyte differentiation,BP,
11336,GO:0045660,1,0.971891583732747,0,1,positive regulation of neutrophil differentiation,BP,
11339,GO:0045663,1,0.697895789446957,0,10,positive regulation of myoblast differentiation,BP,
11358,GO:0045716,1,0.907964860280907,0,3,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
11360,GO:0045719,1,0.826476297891034,0,5,negative regulation of glycogen biosynthetic process,BP,
11361,GO:0045721,1,0.783503051191605,0,7,negative regulation of gluconeogenesis,BP,
11362,GO:0045722,1,0.718053241650818,0,9,positive regulation of gluconeogenesis,BP,
11364,GO:0045724,1,0.530582227549659,0,18,positive regulation of cilium assembly,BP,
11365,GO:0045725,1,0.693715111631114,0,9,positive regulation of glycogen biosynthetic process,BP,
11366,GO:0045726,1,0.959559727457905,0,1,positive regulation of integrin biosynthetic process,BP,
11372,GO:0045738,1,0.47962738999035,0,21,negative regulation of DNA repair,BP,
11373,GO:0045739,1,0.256467852812036,0,40,positive regulation of DNA repair,BP,
11377,GO:0045743,1,0.845783975496253,0,5,positive regulation of fibroblast growth factor receptor signaling pathway,BP,
11379,GO:0045745,1,0.628107665820908,0,13,positive regulation of G-protein coupled receptor protein signaling pathway,BP,
11382,GO:0045751,1,0.963679111569354,0,1,negative regulation of Toll signaling pathway,BP,
11383,GO:0045759,1,0.937446147451274,0,2,negative regulation of action potential,BP,
11385,GO:0045761,1,0.684768435190484,0,11,regulation of adenylate cyclase activity,BP,
11386,GO:0045762,1,0.923053157520941,0,2,positive regulation of adenylate cyclase activity,BP,
11387,GO:0045763,1,0.920752243454315,0,2,negative regulation of cellular amino acid metabolic process,BP,
11388,GO:0045764,1,0.952842133991615,0,2,positive regulation of cellular amino acid metabolic process,BP,
11391,GO:0045769,1,0.95950763690405,0,1,negative regulation of asymmetric cell division,BP,
11394,GO:0045777,1,0.648186266931002,0,14,positive regulation of blood pressure,BP,
11401,GO:0045792,1,0.773843152525164,0,7,negative regulation of cell size,BP,
11403,GO:0045794,1,0.849065798841697,0,4,negative regulation of cell volume,BP,
11404,GO:0045795,1,0.95950763690405,0,1,positive regulation of cell volume,BP,
11405,GO:0045799,1,0.935647048636663,0,2,positive regulation of chromatin assembly or disassembly,BP,
11406,GO:0045806,1,0.296685415918429,0,36,negative regulation of endocytosis,BP,
11408,GO:0045813,1,0.973571680227903,0,1,positive regulation of Wnt signaling pathway, calcium modulating pathway,BP,
11410,GO:0045815,1,0.138847457238069,0,77,positive regulation of gene expression, epigenetic,BP,
11412,GO:0045820,1,0.810177338104088,0,6,negative regulation of glycolytic process,BP,
11413,GO:0045821,1,0.648844942144833,0,11,positive regulation of glycolytic process,BP,
11417,GO:0045829,1,0.898916706881907,0,3,negative regulation of isotype switching,BP,
11424,GO:0045838,1,0.721761960527703,0,10,positive regulation of membrane potential,BP,
11428,GO:0045842,1,0.768223269934675,0,8,positive regulation of mitotic metaphase/anaphase transition,BP,
11432,GO:0045852,1,0.904152937622699,0,3,pH elevation,BP,
11437,GO:0045869,1,0.796002735770719,0,7,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
11438,GO:0045870,1,0.959507688488047,0,1,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
11439,GO:0045872,1,0.971391196536963,0,1,positive regulation of rhodopsin gene expression,BP,
11440,GO:0045875,1,0.838548841341683,0,5,negative regulation of sister chromatid cohesion,BP,
11441,GO:0045876,1,0.706654543635216,0,10,positive regulation of sister chromatid cohesion,BP,
11443,GO:0045880,1,0.441380156042317,0,22,positive regulation of smoothened signaling pathway,BP,
11444,GO:0045887,1,0.95950763690405,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,
11450,GO:0045901,1,0.905959824570436,0,3,positive regulation of translational elongation,BP,
11451,GO:0045903,1,0.937486389434023,0,3,positive regulation of translational fidelity,BP,
11452,GO:0045905,1,0.938859165808801,0,2,positive regulation of translational termination,BP,
11455,GO:0045910,1,0.456059721148356,0,21,negative regulation of DNA recombination,BP,
11457,GO:0045912,1,0.442998334058595,0,23,negative regulation of carbohydrate metabolic process,BP,
11459,GO:0045914,1,0.934741472164588,0,2,negative regulation of catecholamine metabolic process,BP,
11460,GO:0045915,1,0.857010639741834,0,5,positive regulation of catecholamine metabolic process,BP,
11462,GO:0045917,1,0.933995488965548,0,2,positive regulation of complement activation,BP,
11464,GO:0045919,1,0.901599273383484,0,4,positive regulation of cytolysis,BP,
11465,GO:0045920,1,0.533072314912171,0,18,negative regulation of exocytosis,BP,
11469,GO:0045924,1,0.929294026278309,0,2,regulation of female receptivity,BP,
11470,GO:0045925,1,0.968514565991004,0,1,positive regulation of female receptivity,BP,
11483,GO:0045943,1,0.467967569390989,0,21,positive regulation of transcription by RNA polymerase I,BP,
11485,GO:0045945,1,0.689325287800952,0,10,positive regulation of transcription by RNA polymerase III,BP,
11486,GO:0045947,1,0.556832801167091,0,18,negative regulation of translational initiation,BP,
11488,GO:0045950,1,0.934702890526896,0,2,negative regulation of mitotic recombination,BP,
11490,GO:0045954,1,0.749081071415104,0,8,positive regulation of natural killer cell mediated cytotoxicity,BP,
11491,GO:0045955,1,0.777741221651791,0,7,negative regulation of calcium ion-dependent exocytosis,BP,
11493,GO:0045963,1,0.934741472164588,0,2,negative regulation of dopamine metabolic process,BP,
11494,GO:0045964,1,0.857010639741834,0,5,positive regulation of dopamine metabolic process,BP,
11495,GO:0045967,1,0.920650957478618,0,2,negative regulation of growth rate,BP,
11497,GO:0045976,1,0.925501454528863,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
11498,GO:0045977,1,0.976999496905179,0,1,positive regulation of mitotic cell cycle, embryonic,BP,
11504,GO:0045989,1,0.803928074783228,0,7,positive regulation of striated muscle contraction,BP,
11505,GO:0045990,1,0.87511939230692,0,4,carbon catabolite regulation of transcription,BP,
11506,GO:0045991,1,0.87511939230692,0,4,carbon catabolite activation of transcription,BP,
11508,GO:0045993,1,0.960092576390416,0,1,negative regulation of translational initiation by iron,BP,
11513,GO:0046015,1,0.889057593294148,0,4,regulation of transcription by glucose,BP,
11514,GO:0046016,1,0.91205922187601,0,3,positive regulation of transcription by glucose,BP,
11515,GO:0046030,1,0.659680829619468,0,11,inositol trisphosphate phosphatase activity,MF,
11517,GO:0046032,1,0.976159825901282,0,1,ADP catabolic process,BP,
11520,GO:0046035,1,0.979177596081991,0,1,CMP metabolic process,BP,
11521,GO:0046036,1,0.739252690118812,0,12,CTP metabolic process,BP,
11523,GO:0046038,1,0.977361566085134,0,1,GMP catabolic process,BP,
11526,GO:0046041,1,0.948412060632407,0,2,ITP metabolic process,BP,
11527,GO:0046048,1,0.96524986344849,0,1,UDP metabolic process,BP,
11529,GO:0046051,1,0.79908972389319,0,9,UTP metabolic process,BP,
11530,GO:0046054,1,0.982027382476281,0,1,dGMP metabolic process,BP,
11531,GO:0046056,1,0.976316075006814,0,1,dADP metabolic process,BP,
11532,GO:0046057,1,0.976316075006814,0,1,dADP catabolic process,BP,
11534,GO:0046060,1,0.884231998753529,0,5,dATP metabolic process,BP,
11535,GO:0046061,1,0.926974977204341,0,3,dATP catabolic process,BP,
11536,GO:0046065,1,0.98060658390074,0,1,dCTP metabolic process,BP,
11537,GO:0046066,1,0.958768045406562,0,2,dGDP metabolic process,BP,
11538,GO:0046067,1,0.976316075006814,0,1,dGDP catabolic process,BP,
11540,GO:0046069,1,0.921628754969875,0,2,cGMP catabolic process,BP,
11541,GO:0046070,1,0.905919760908315,0,4,dGTP metabolic process,BP,
11542,GO:0046072,1,0.94600677119047,0,2,dTDP metabolic process,BP,
11543,GO:0046073,1,0.917800478247105,0,3,dTMP metabolic process,BP,
11544,GO:0046075,1,0.903027016080252,0,4,dTTP metabolic process,BP,
11545,GO:0046077,1,0.94600677119047,0,2,dUDP metabolic process,BP,
11546,GO:0046078,1,0.899513983493603,0,4,dUMP metabolic process,BP,
11547,GO:0046080,1,0.97293565503566,0,1,dUTP metabolic process,BP,
11548,GO:0046081,1,0.97293565503566,0,1,dUTP catabolic process,BP,
11549,GO:0046083,1,0.936117925323936,0,3,adenine metabolic process,BP,
11550,GO:0046084,1,0.936117925323936,0,3,adenine biosynthetic process,BP,
11551,GO:0046085,1,0.816495099212617,0,6,adenosine metabolic process,BP,
11552,GO:0046086,1,0.933313212465529,0,2,adenosine biosynthetic process,BP,
11553,GO:0046087,1,0.846238923550477,0,6,cytidine metabolic process,BP,
11554,GO:0046090,1,0.976124642047473,0,1,deoxyadenosine metabolic process,BP,
11555,GO:0046092,1,0.959608765374115,0,1,deoxycytidine metabolic process,BP,
11556,GO:0046098,1,0.879486321287087,0,4,guanine metabolic process,BP,
11557,GO:0046099,1,0.950413889877113,0,2,guanine biosynthetic process,BP,
11558,GO:0046100,1,0.871073957638313,0,5,hypoxanthine metabolic process,BP,
11559,GO:0046101,1,0.895777605027084,0,4,hypoxanthine biosynthetic process,BP,
11560,GO:0046102,1,0.914680337696803,0,3,inosine metabolic process,BP,
11561,GO:0046103,1,0.944374411880084,0,2,inosine biosynthetic process,BP,
11562,GO:0046104,1,0.902635102045183,0,3,thymidine metabolic process,BP,
11564,GO:0046110,1,0.898800499756953,0,3,xanthine metabolic process,BP,
11565,GO:0046111,1,0.976124642047473,0,1,xanthine biosynthetic process,BP,
11566,GO:0046112,1,0.531987281840223,0,19,nucleobase biosynthetic process,BP,
11567,GO:0046113,1,0.826574875802046,0,5,nucleobase catabolic process,BP,
11568,GO:0046116,1,0.925513517074796,0,3,queuosine metabolic process,BP,
11569,GO:0046121,1,0.916990083330792,0,3,deoxyribonucleoside catabolic process,BP,
11570,GO:0046122,1,0.958346648434527,0,2,purine deoxyribonucleoside metabolic process,BP,
11571,GO:0046124,1,0.976124642047473,0,1,purine deoxyribonucleoside catabolic process,BP,
11572,GO:0046125,1,0.902635102045183,0,3,pyrimidine deoxyribonucleoside metabolic process,BP,
11573,GO:0046127,1,0.96422412068149,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
11575,GO:0046129,1,0.589153853819988,0,20,purine ribonucleoside biosynthetic process,BP,
11586,GO:0046149,1,0.861228672876724,0,6,pigment catabolic process,BP,
11587,GO:0046160,1,0.925803658026204,0,2,heme a metabolic process,BP,
11588,GO:0046164,1,0.365170088125044,0,30,alcohol catabolic process,BP,
11590,GO:0046166,1,0.948489403299018,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
11591,GO:0046167,1,0.923049845939004,0,2,glycerol-3-phosphate biosynthetic process,BP,
11592,GO:0046168,1,0.961203486413657,0,1,glycerol-3-phosphate catabolic process,BP,
11594,GO:0046174,1,0.526579288628951,0,18,polyol catabolic process,BP,
11595,GO:0046176,1,0.965469978279355,0,1,aldonic acid catabolic process,BP,
11596,GO:0046177,1,0.965469978279355,0,1,D-gluconate catabolic process,BP,
11598,GO:0046185,1,0.766781285302277,0,9,aldehyde catabolic process,BP,
11600,GO:0046203,1,0.954898985746187,0,2,spermidine catabolic process,BP,
11601,GO:0046204,1,0.982324613531412,0,1,nor-spermidine metabolic process,BP,
11604,GO:0046210,1,0.96789068048304,0,1,nitric oxide catabolic process,BP,
11605,GO:0046218,1,0.922418598255783,0,3,indolalkylamine catabolic process,BP,
11608,GO:0046272,1,0.970114988474346,0,1,stilbene catabolic process,BP,
11609,GO:0046292,1,0.909255654154624,0,3,formaldehyde metabolic process,BP,
11610,GO:0046293,1,0.959772846310539,0,1,formaldehyde biosynthetic process,BP,
11611,GO:0046294,1,0.947370786655412,0,2,formaldehyde catabolic process,BP,
11612,GO:0046295,1,0.98268071838369,0,1,glycolate biosynthetic process,BP,
11613,GO:0046305,1,0.966591019336054,0,1,alkanesulfonate biosynthetic process,BP,
11614,GO:0046316,1,0.965469978279355,0,1,gluconokinase activity,MF,
11615,GO:0046317,1,0.959586373676917,0,1,regulation of glucosylceramide biosynthetic process,BP,
11616,GO:0046318,1,0.959586373676917,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
11617,GO:0046320,1,0.548399140532146,0,16,regulation of fatty acid oxidation,BP,
11618,GO:0046321,1,0.737903702426151,0,8,positive regulation of fatty acid oxidation,BP,
11619,GO:0046322,1,0.869881227059847,0,4,negative regulation of fatty acid oxidation,BP,
11624,GO:0046327,1,0.972102727103467,0,1,glycerol biosynthetic process from pyruvate,BP,
11628,GO:0046331,1,0.941179072554209,0,2,lateral inhibition,BP,
11630,GO:0046333,1,0.964638459389207,0,1,octopamine metabolic process,BP,
11632,GO:0046338,1,0.9301700993171,0,2,phosphatidylethanolamine catabolic process,BP,
11633,GO:0046339,1,0.654018354677938,0,12,diacylglycerol metabolic process,BP,
11634,GO:0046340,1,0.929260790915458,0,2,diacylglycerol catabolic process,BP,
11635,GO:0046341,1,0.604917617123332,0,14,CDP-diacylglycerol metabolic process,BP,
11636,GO:0046348,1,0.783195092568113,0,8,amino sugar catabolic process,BP,
11637,GO:0046349,1,0.690972102799171,0,11,amino sugar biosynthetic process,BP,
11639,GO:0046355,1,0.963303061456278,0,1,mannan catabolic process,BP,
11640,GO:0046356,1,0.952987170879175,0,2,acetyl-CoA catabolic process,BP,
11641,GO:0046359,1,0.972508899337928,0,1,butyrate catabolic process,BP,
11642,GO:0046360,1,0.970861273644229,0,1,2-oxobutyrate biosynthetic process,BP,
11643,GO:0046361,1,0.970861273644229,0,1,2-oxobutyrate metabolic process,BP,
11644,GO:0046364,1,0.15135537943628,0,59,monosaccharide biosynthetic process,BP,
11645,GO:0046365,1,0.234977539233577,0,46,monosaccharide catabolic process,BP,
11646,GO:0046368,1,0.882713690426186,0,4,GDP-L-fucose metabolic process,BP,
11647,GO:0046370,1,0.945984003450146,0,2,fructose biosynthetic process,BP,
11649,GO:0046380,1,0.961546303492611,0,1,N-acetylneuraminate biosynthetic process,BP,
11650,GO:0046381,1,0.97924266861207,0,1,CMP-N-acetylneuraminate metabolic process,BP,
11651,GO:0046385,1,0.768904768231073,0,10,deoxyribose phosphate biosynthetic process,BP,
11654,GO:0046391,1,0.907194495020286,0,3,5-phosphoribose 1-diphosphate metabolic process,BP,
11657,GO:0046398,1,0.897676398778916,0,3,UDP-glucuronate metabolic process,BP,
11658,GO:0046403,1,0.974280666574357,0,1,polynucleotide 3'-phosphatase activity,MF,
11659,GO:0046404,1,0.910603815171538,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
11660,GO:0046415,1,0.843883366246391,0,5,urate metabolic process,BP,
11661,GO:0046416,1,0.968092371147854,0,1,D-amino acid metabolic process,BP,
11666,GO:0046437,1,0.968092371147854,0,1,D-amino acid biosynthetic process,BP,
11668,GO:0046440,1,0.898782674274902,0,3,L-lysine metabolic process,BP,
11669,GO:0046443,1,0.972059476421804,0,1,FAD metabolic process,BP,
11670,GO:0046444,1,0.966591019336054,0,1,FMN metabolic process,BP,
11671,GO:0046448,1,0.96834646839626,0,1,tropane alkaloid metabolic process,BP,
11672,GO:0046449,1,0.849037976660371,0,4,creatinine metabolic process,BP,
11673,GO:0046452,1,0.915669683630238,0,3,dihydrofolate metabolic process,BP,
11676,GO:0046459,1,0.685283156935683,0,12,short-chain fatty acid metabolic process,BP,
11678,GO:0046461,1,0.584912113680985,0,16,neutral lipid catabolic process,BP,
11679,GO:0046462,1,0.940139285715387,0,2,monoacylglycerol metabolic process,BP,
11681,GO:0046464,1,0.584912113680985,0,16,acylglycerol catabolic process,BP,
11682,GO:0046465,1,0.795726370462371,0,7,dolichyl diphosphate metabolic process,BP,
11685,GO:0046469,1,0.844256095273162,0,5,platelet activating factor metabolic process,BP,
11687,GO:0046471,1,0.413189325340945,0,25,phosphatidylglycerol metabolic process,BP,
11688,GO:0046473,1,0.330144588353403,0,30,phosphatidic acid metabolic process,BP,
11692,GO:0046477,1,0.816911199873888,0,6,glycosylceramide catabolic process,BP,
11693,GO:0046478,1,0.959741413083679,0,1,lactosylceramide metabolic process,BP,
11694,GO:0046479,1,0.717519752895108,0,10,glycosphingolipid catabolic process,BP,
11696,GO:0046485,1,0.796619041911189,0,7,ether lipid metabolic process,BP,
11698,GO:0046487,1,0.832866579586607,0,6,glyoxylate metabolic process,BP,
11700,GO:0046490,1,0.878433642698884,0,5,isopentenyl diphosphate metabolic process,BP,
11701,GO:0046491,1,0.983433213616715,0,1,L-methylmalonyl-CoA metabolic process,BP,
11702,GO:0046493,1,0.972106481842648,0,2,lipid A metabolic process,BP,
11703,GO:0046495,1,0.968561372296152,0,1,nicotinamide riboside metabolic process,BP,
11705,GO:0046497,1,0.965469978279355,0,1,nicotinate nucleotide metabolic process,BP,
11707,GO:0046499,1,0.963561401555438,0,1,S-adenosylmethioninamine metabolic process,BP,
11710,GO:0046502,1,0.949053681313646,0,2,uroporphyrinogen III metabolic process,BP,
11712,GO:0046504,1,0.849911174943155,0,5,glycerol ether biosynthetic process,BP,
11713,GO:0046511,1,0.933480632916514,0,2,sphinganine biosynthetic process,BP,
11714,GO:0046512,1,0.776424071105494,0,8,sphingosine biosynthetic process,BP,
11716,GO:0046514,1,0.707635771995842,0,11,ceramide catabolic process,BP,
11717,GO:0046519,1,0.675933847406451,0,12,sphingoid metabolic process,BP,
11718,GO:0046520,1,0.746415359356409,0,9,sphingoid biosynthetic process,BP,
11719,GO:0046521,1,0.973007521550594,0,1,sphingoid catabolic process,BP,
11720,GO:0046523,1,0.964322054185979,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
11721,GO:0046525,1,0.974290123359056,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
11722,GO:0046526,1,0.967753139758002,0,1,D-xylulose reductase activity,MF,
11727,GO:0046534,1,0.960104023498924,0,1,positive regulation of photoreceptor cell differentiation,BP,
11728,GO:0046538,1,0.947406678157987,0,2,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
11729,GO:0046539,1,0.983015491524096,0,1,histamine N-methyltransferase activity,MF,
11730,GO:0046540,1,0.501456874603048,0,24,U4/U6 x U5 tri-snRNP complex,CC,
11731,GO:0046541,1,0.966360545540541,0,1,saliva secretion,BP,
11733,GO:0046544,1,0.959587787288957,0,1,development of secondary male sexual characteristics,BP,
11736,GO:0046548,1,0.898343972749959,0,3,retinal rod cell development,BP,
11737,GO:0046549,1,0.894212227534622,0,3,retinal cone cell development,BP,
11738,GO:0046554,1,0.978521095739886,0,1,malate dehydrogenase (NADP+) activity,MF,
11739,GO:0046570,1,0.979026103641117,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
11740,GO:0046573,1,0.975125295369969,0,1,lactonohydrolase activity,MF,
11741,GO:0046577,1,0.961628047121842,0,1,long-chain-alcohol oxidase activity,MF,
11745,GO:0046581,1,0.894876093070318,0,3,intercellular canaliculus,CC,
11746,GO:0046586,1,0.948412786559886,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
11747,GO:0046587,1,0.964823659031898,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
11748,GO:0046588,1,0.982992353680633,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
11749,GO:0046592,1,0.946499775823608,0,2,polyamine oxidase activity,MF,
11750,GO:0046596,1,0.582779013581759,0,18,regulation of viral entry into host cell,BP,
11751,GO:0046597,1,0.692523899125796,0,12,negative regulation of viral entry into host cell,BP,
11752,GO:0046598,1,0.846290836488263,0,6,positive regulation of viral entry into host cell,BP,
11754,GO:0046600,1,0.746594254330688,0,8,negative regulation of centriole replication,BP,
11755,GO:0046601,1,0.891953161876909,0,3,positive regulation of centriole replication,BP,
11756,GO:0046602,1,0.757807737277505,0,8,regulation of mitotic centrosome separation,BP,
11757,GO:0046604,1,0.908498603451522,0,3,positive regulation of mitotic centrosome separation,BP,
11759,GO:0046606,1,0.639655878960277,0,13,negative regulation of centrosome cycle,BP,
11760,GO:0046607,1,0.723975604378497,0,9,positive regulation of centrosome cycle,BP,
11761,GO:0046618,1,0.940363947714873,0,2,drug export,BP,
11762,GO:0046619,1,0.95950763690405,0,1,optic placode formation involved in camera-type eye formation,BP,
11764,GO:0046621,1,0.438534330069984,0,22,negative regulation of organ growth,BP,
11766,GO:0046623,1,0.95950763690405,0,1,sphingolipid-translocating ATPase activity,MF,
11767,GO:0046624,1,0.808085683196368,0,6,sphingolipid transporter activity,MF,
11768,GO:0046625,1,0.694605668058606,0,11,sphingolipid binding,MF,
11771,GO:0046628,1,0.707942045716511,0,9,positive regulation of insulin receptor signaling pathway,BP,
11772,GO:0046629,1,0.728940932463822,0,9,gamma-delta T cell activation,BP,
11784,GO:0046642,1,0.896869145049012,0,3,negative regulation of alpha-beta T cell proliferation,BP,
11785,GO:0046643,1,0.849376418959524,0,4,regulation of gamma-delta T cell activation,BP,
11786,GO:0046645,1,0.884051901637383,0,3,positive regulation of gamma-delta T cell activation,BP,
11791,GO:0046655,1,0.558185542785746,0,17,folic acid metabolic process,BP,
11792,GO:0046657,1,0.943769751386397,0,2,folic acid catabolic process,BP,
11796,GO:0046666,1,0.946113121958907,0,2,retinal cell programmed cell death,BP,
11797,GO:0046668,1,0.961390182901005,0,1,regulation of retinal cell programmed cell death,BP,
11798,GO:0046671,1,0.961390182901005,0,1,negative regulation of retinal cell programmed cell death,BP,
11801,GO:0046680,1,0.971058428617368,0,1,response to DDT,BP,
11803,GO:0046684,1,0.933415781989184,0,2,response to pyrethroid,BP,
11806,GO:0046687,1,0.980846631241159,0,1,response to chromate,BP,
11808,GO:0046689,1,0.854916141110322,0,5,response to mercury ion,BP,
11810,GO:0046695,1,0.920102799261719,0,3,SLIK (SAGA-like) complex,CC,
11815,GO:0046707,1,0.936630440807634,0,2,IDP metabolic process,BP,
11816,GO:0046709,1,0.936630440807634,0,2,IDP catabolic process,BP,
11818,GO:0046711,1,0.982027382476281,0,1,GDP biosynthetic process,BP,
11819,GO:0046712,1,0.976316075006814,0,1,GDP catabolic process,BP,
11820,GO:0046713,1,0.964274199594967,0,1,borate transport,BP,
11821,GO:0046715,1,0.964274199594967,0,1,active borate transmembrane transporter activity,MF,
11822,GO:0046716,1,0.650789178218334,0,12,muscle cell cellular homeostasis,BP,
11825,GO:0046719,1,0.790526436052643,0,7,regulation by virus of viral protein levels in host cell,BP,
11826,GO:0046724,1,0.966912517779355,0,1,oxalic acid secretion,BP,
11827,GO:0046725,1,0.962292638283482,0,1,negative regulation by virus of viral protein levels in host cell,BP,
11828,GO:0046726,1,0.856692192829147,0,4,positive regulation by virus of viral protein levels in host cell,BP,
11829,GO:0046730,1,0.947545724389011,0,2,induction of host immune response by virus,BP,
11830,GO:0046732,1,0.947545724389011,0,2,active induction of host immune response by virus,BP,
11831,GO:0046745,1,0.965469978279355,0,1,viral capsid secondary envelopment,BP,
11832,GO:0046755,1,0.493031310095038,0,23,viral budding,BP,
11834,GO:0046778,1,0.939100825315449,0,2,modification by virus of host mRNA processing,BP,
11836,GO:0046784,1,0.78495575265911,0,8,viral mRNA export from host cell nucleus,BP,
11838,GO:0046786,1,0.95967902003666,0,1,viral replication complex formation and maintenance,BP,
11839,GO:0046790,1,0.908123880086481,0,3,virion binding,MF,
11841,GO:0046811,1,0.959507747921351,0,1,histone deacetylase inhibitor activity,MF,
11842,GO:0046813,1,0.910791649182722,0,3,receptor-mediated virion attachment to host cell,BP,
11843,GO:0046817,1,0.979405733055773,0,1,chemokine receptor antagonist activity,MF,
11852,GO:0046833,1,0.769650516717637,0,7,positive regulation of RNA export from nucleus,BP,
11854,GO:0046835,1,0.433070688244977,0,24,carbohydrate phosphorylation,BP,
11855,GO:0046836,1,0.858104557826956,0,5,glycolipid transport,BP,
11856,GO:0046838,1,0.693463171053744,0,10,phosphorylated carbohydrate dephosphorylation,BP,
11857,GO:0046839,1,0.332267097764718,0,29,phospholipid dephosphorylation,BP,
11859,GO:0046848,1,0.977747989778834,0,1,hydroxyapatite binding,MF,
11865,GO:0046855,1,0.693463171053744,0,10,inositol phosphate dephosphorylation,BP,
11866,GO:0046856,1,0.438307564778446,0,21,phosphatidylinositol dephosphorylation,BP,
11867,GO:0046870,1,0.892371742491385,0,3,cadmium ion binding,MF,
11870,GO:0046874,1,0.976024317261928,0,1,quinolinate metabolic process,BP,
11884,GO:0046898,1,0.87437169138616,0,4,response to cycloheximide,BP,
11885,GO:0046899,1,0.933606518335749,0,2,nucleoside triphosphate adenylate kinase activity,MF,
11886,GO:0046900,1,0.945352389161302,0,2,tetrahydrofolylpolyglutamate metabolic process,BP,
11887,GO:0046901,1,0.968015553109921,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
11892,GO:0046911,1,0.979920153523586,0,1,metal chelating activity,MF,
11897,GO:0046920,1,0.839251553299589,0,5,alpha-(1->3)-fucosyltransferase activity,MF,
11898,GO:0046921,1,0.963445624205636,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
11899,GO:0046922,1,0.928894227538279,0,2,peptide-O-fucosyltransferase activity,MF,
11900,GO:0046923,1,0.89096028351794,0,4,ER retention sequence binding,MF,
11902,GO:0046929,1,0.751492397249951,0,8,negative regulation of neurotransmitter secretion,BP,
11905,GO:0046933,1,0.937873200497052,0,3,proton-transporting ATP synthase activity, rotational mechanism,MF,
11907,GO:0046935,1,0.884847837528379,0,3,1-phosphatidylinositol-3-kinase regulator activity,MF,
11909,GO:0046940,1,0.882464490093231,0,4,nucleoside monophosphate phosphorylation,BP,
11912,GO:0046946,1,0.894520728907075,0,3,hydroxylysine metabolic process,BP,
11913,GO:0046947,1,0.894520728907075,0,3,hydroxylysine biosynthetic process,BP,
11914,GO:0046949,1,0.431532313469669,0,25,fatty-acyl-CoA biosynthetic process,BP,
11916,GO:0046951,1,0.822246268552675,0,6,ketone body biosynthetic process,BP,
11918,GO:0046958,1,0.963540829970171,0,1,nonassociative learning,BP,
11920,GO:0046963,1,0.943558879104268,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
11921,GO:0046964,1,0.943558879104268,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
11922,GO:0046965,1,0.653002687160203,0,12,retinoid X receptor binding,MF,
11923,GO:0046966,1,0.401676552493526,0,27,thyroid hormone receptor binding,MF,
11925,GO:0046968,1,0.960909550686142,0,1,peptide antigen transport,BP,
11926,GO:0046969,1,0.937491392972958,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
11927,GO:0046970,1,0.972280914660677,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
11928,GO:0046972,1,0.695234573635408,0,10,histone acetyltransferase activity (H4-K16 specific),MF,
11929,GO:0046974,1,0.826343417262189,0,5,histone methyltransferase activity (H3-K9 specific),MF,
11930,GO:0046975,1,0.810866910385445,0,6,histone methyltransferase activity (H3-K36 specific),MF,
11931,GO:0046976,1,0.83220382704458,0,5,histone methyltransferase activity (H3-K27 specific),MF,
11935,GO:0046980,1,0.960909550686142,0,1,tapasin binding,MF,
11938,GO:0046984,1,0.878618155801827,0,4,regulation of hemoglobin biosynthetic process,BP,
11939,GO:0046985,1,0.915147335965885,0,3,positive regulation of hemoglobin biosynthetic process,BP,
11940,GO:0046986,1,0.960092576390416,0,1,negative regulation of hemoglobin biosynthetic process,BP,
11941,GO:0046996,1,0.965469978279355,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, with NAD(P)H as one donor, and the other dehydrogenated,MF,
11942,GO:0047006,1,0.977727007161401,0,1,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
11943,GO:0047012,1,0.975507479019621,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
11944,GO:0047015,1,0.982479465094501,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
11945,GO:0047016,1,0.970281051381919,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
11946,GO:0047017,1,0.965469978279355,0,1,prostaglandin-F synthase activity,MF,
11947,GO:0047021,1,0.979210121352586,0,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,
11948,GO:0047023,1,0.954817137752606,0,2,androsterone dehydrogenase activity,MF,
11949,GO:0047025,1,0.945413121963644,0,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,
11950,GO:0047035,1,0.981993172542882,0,1,testosterone dehydrogenase (NAD+) activity,MF,
11951,GO:0047042,1,0.977727007161401,0,1,androsterone dehydrogenase (B-specific) activity,MF,
11952,GO:0047045,1,0.979231817085321,0,1,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
11953,GO:0047057,1,0.963254159397223,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
11954,GO:0047066,1,0.982600147176451,0,1,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
11955,GO:0047086,1,0.954817137752606,0,2,ketosteroid monooxygenase activity,MF,
11956,GO:0047105,1,0.967911421107606,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
11957,GO:0047115,1,0.954817137752606,0,2,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,
11958,GO:0047117,1,0.95950763690405,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
11959,GO:0047130,1,0.95950763690405,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
11960,GO:0047131,1,0.95950763690405,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
11961,GO:0047134,1,0.876432684542659,0,5,protein-disulfide reductase activity,MF,
11962,GO:0047144,1,0.719508613892247,0,9,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,
11963,GO:0047150,1,0.971874434579777,0,1,betaine-homocysteine S-methyltransferase activity,MF,
11964,GO:0047159,1,0.961097106397307,0,1,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,
11965,GO:0047166,1,0.972552998055146,0,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,
11966,GO:0047179,1,0.961202741444401,0,2,platelet-activating factor acetyltransferase activity,MF,
11967,GO:0047184,1,0.845931481714967,0,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,
11968,GO:0047186,1,0.961266665006596,0,1,N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity,MF,
11969,GO:0047191,1,0.961097106397307,0,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,
11970,GO:0047192,1,0.896874209776408,0,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,
11971,GO:0047220,1,0.966098080546639,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
11972,GO:0047223,1,0.903493650151962,0,3,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
11973,GO:0047224,1,0.968001627529609,0,1,acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
11974,GO:0047237,1,0.928686037689892,0,2,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
11975,GO:0047238,1,0.857587004910711,0,4,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
11977,GO:0047263,1,0.965415928238747,0,1,N-acylsphingosine galactosyltransferase activity,MF,
11978,GO:0047273,1,0.963329561230936,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
11979,GO:0047275,1,0.96239677422078,0,1,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
11980,GO:0047277,1,0.97226346962347,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
11982,GO:0047288,1,0.935241983139169,0,2,monosialoganglioside sialyltransferase activity,MF,
11983,GO:0047290,1,0.975047486538731,0,1,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
11984,GO:0047291,1,0.969328666711818,0,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,
11985,GO:0047293,1,0.975105824257611,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
11986,GO:0047298,1,0.959675503888475,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
11987,GO:0047322,1,0.920726513421874,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
11988,GO:0047323,1,0.970722757259711,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
11989,GO:0047325,1,0.963600423230496,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
11990,GO:0047326,1,0.973654635197688,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
11991,GO:0047341,1,0.962864676311285,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
11992,GO:0047369,1,0.965469978279355,0,1,succinate-hydroxymethylglutarate CoA-transferase activity,MF,
11993,GO:0047372,1,0.764660009115922,0,8,acylglycerol lipase activity,MF,
11994,GO:0047374,1,0.941694851336089,0,2,methylumbelliferyl-acetate deacetylase activity,MF,
11995,GO:0047389,1,0.924906722345795,0,2,glycerophosphocholine phosphodiesterase activity,MF,
11996,GO:0047391,1,0.938869356485942,0,2,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,
11997,GO:0047395,1,0.96522755259148,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
11998,GO:0047408,1,0.937321770097425,0,2,alkenylglycerophosphocholine hydrolase activity,MF,
11999,GO:0047409,1,0.937321770097425,0,2,alkenylglycerophosphoethanolamine hydrolase activity,MF,
12000,GO:0047429,1,0.768680953657696,0,9,nucleoside-triphosphate diphosphatase activity,MF,
12001,GO:0047444,1,0.97924266861207,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12002,GO:0047451,1,0.95950763690405,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
12003,GO:0047464,1,0.959612760372901,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
12007,GO:0047496,1,0.277815852517138,0,36,vesicle transport along microtubule,BP,
12008,GO:0047497,1,0.512733039032895,0,19,mitochondrion transport along microtubule,BP,
12009,GO:0047498,1,0.802001322507267,0,6,calcium-dependent phospholipase A2 activity,MF,
12010,GO:0047499,1,0.851095010553329,0,5,calcium-independent phospholipase A2 activity,MF,
12011,GO:0047522,1,0.909004386938343,0,3,15-oxoprostaglandin 13-oxidase activity,MF,
12012,GO:0047536,1,0.969985511974525,0,1,2-aminoadipate transaminase activity,MF,
12013,GO:0047545,1,0.95950763690405,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
12014,GO:0047555,1,0.851486768190912,0,4,3',5'-cyclic-GMP phosphodiesterase activity,MF,
12015,GO:0047560,1,0.959558536378073,0,1,3-dehydrosphinganine reductase activity,MF,
12016,GO:0047578,1,0.968289645561436,0,1,4-hydroxyglutamate transaminase activity,MF,
12017,GO:0047598,1,0.966912517779355,0,1,7-dehydrocholesterol reductase activity,MF,
12018,GO:0047617,1,0.721986643700915,0,11,acyl-CoA hydrolase activity,MF,
12019,GO:0047620,1,0.96522755259148,0,1,acylglycerol kinase activity,MF,
12020,GO:0047621,1,0.974728672087704,0,1,acylpyruvate hydrolase activity,MF,
12022,GO:0047631,1,0.890406963013134,0,5,ADP-ribose diphosphatase activity,MF,
12023,GO:0047635,1,0.961179164310998,0,1,alanine-oxo-acid transaminase activity,MF,
12024,GO:0047658,1,0.974565797611057,0,1,alpha-amino-acid esterase activity,MF,
12025,GO:0047661,1,0.968092371147854,0,1,amino-acid racemase activity,MF,
12026,GO:0047676,1,0.95956161695109,0,1,arachidonate-CoA ligase activity,MF,
12027,GO:0047685,1,0.976442595957054,0,1,amine sulfotransferase activity,MF,
12028,GO:0047693,1,0.985256868465025,0,1,ATP diphosphatase activity,MF,
12029,GO:0047696,1,0.933720677196498,0,2,beta-adrenergic receptor kinase activity,MF,
12030,GO:0047708,1,0.971290817398837,0,1,biotinidase activity,MF,
12031,GO:0047710,1,0.980925004273544,0,1,bis(5'-adenosyl)-triphosphatase activity,MF,
12032,GO:0047718,1,0.977727007161401,0,1,indanol dehydrogenase activity,MF,
12033,GO:0047726,1,0.96789068048304,0,1,iron-cytochrome-c reductase activity,MF,
12034,GO:0047734,1,0.965469978279355,0,1,CDP-glycerol diphosphatase activity,MF,
12035,GO:0047747,1,0.96888176688872,0,1,cholate-CoA ligase activity,MF,
12036,GO:0047750,1,0.962713302878716,0,2,cholestenol delta-isomerase activity,MF,
12037,GO:0047751,1,0.937579216348392,0,2,cholestenone 5-alpha-reductase activity,MF,
12038,GO:0047756,1,0.931950128020848,0,2,chondroitin 4-sulfotransferase activity,MF,
12040,GO:0047760,1,0.963246010042085,0,1,butyrate-CoA ligase activity,MF,
12041,GO:0047800,1,0.9617827844571,0,1,cysteamine dioxygenase activity,MF,
12042,GO:0047801,1,0.970739004491825,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
12043,GO:0047840,1,0.98060658390074,0,1,dCTP diphosphatase activity,MF,
12044,GO:0047844,1,0.865841493524657,0,5,deoxycytidine deaminase activity,MF,
12045,GO:0047860,1,0.978896638659266,0,1,diiodophenylpyruvate reductase activity,MF,
12046,GO:0047874,1,0.970877631542311,0,1,dolichyldiphosphatase activity,MF,
12047,GO:0047888,1,0.972254752043476,0,1,fatty acid peroxidase activity,MF,
12048,GO:0047894,1,0.953382728202017,0,2,flavonol 3-sulfotransferase activity,MF,
12049,GO:0047915,1,0.974709461961087,0,1,ganglioside galactosyltransferase activity,MF,
12050,GO:0047933,1,0.95950763690405,0,1,glucose-1,6-bisphosphate synthase activity,MF,
12051,GO:0047936,1,0.95950763690405,0,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,
12052,GO:0047939,1,0.976768554059973,0,1,L-glucuronate reductase activity,MF,
12053,GO:0047977,1,0.968911200939047,0,1,hepoxilin-epoxide hydrolase activity,MF,
12054,GO:0047982,1,0.97411570855655,0,1,homocysteine desulfhydrase activity,MF,
12056,GO:0048003,1,0.886822491410546,0,3,antigen processing and presentation of lipid antigen via MHC class Ib,BP,
12057,GO:0048006,1,0.961579994842804,0,1,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
12058,GO:0048007,1,0.886822491410546,0,3,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,
12065,GO:0048014,1,0.959543509606302,0,1,Tie signaling pathway,BP,
12074,GO:0048023,1,0.960375828840977,0,1,positive regulation of melanin biosynthetic process,BP,
12076,GO:0048025,1,0.543310329191965,0,18,negative regulation of mRNA splicing, via spliceosome,BP,
12078,GO:0048027,1,0.527163243838293,0,22,mRNA 5'-UTR binding,MF,
12079,GO:0048029,1,0.212594837399833,0,46,monosaccharide binding,MF,
12080,GO:0048030,1,0.987152564600386,0,1,disaccharide binding,MF,
12081,GO:0048033,1,0.964877259482504,0,1,heme o metabolic process,BP,
12082,GO:0048034,1,0.964877259482504,0,1,heme O biosynthetic process,BP,
12084,GO:0048038,1,0.689228031921893,0,14,quinone binding,MF,
12085,GO:0048039,1,0.856093476044462,0,6,ubiquinone binding,MF,
12086,GO:0048040,1,0.971041927321966,0,1,UDP-glucuronate decarboxylase activity,MF,
12089,GO:0048050,1,0.849868421149943,0,6,post-embryonic eye morphogenesis,BP,
12090,GO:0048058,1,0.96332292631291,0,1,compound eye corneal lens development,BP,
12092,GO:0048069,1,0.827588552456808,0,5,eye pigmentation,BP,
12094,GO:0048073,1,0.922166774832391,0,2,regulation of eye pigmentation,BP,
12095,GO:0048075,1,0.960334704105237,0,1,positive regulation of eye pigmentation,BP,
12097,GO:0048096,1,0.759240150295839,0,8,chromatin-mediated maintenance of transcription,BP,
12098,GO:0048102,1,0.796048555124676,0,7,autophagic cell death,BP,
12099,GO:0048103,1,0.536476267349753,0,16,somatic stem cell division,BP,
12100,GO:0048104,1,0.849783848833377,0,4,establishment of body hair or bristle planar orientation,BP,
12101,GO:0048105,1,0.849783848833377,0,4,establishment of body hair planar orientation,BP,
12102,GO:0048133,1,0.942124840234752,0,2,male germ-line stem cell asymmetric division,BP,
12107,GO:0048147,1,0.463722570822798,0,24,negative regulation of fibroblast proliferation,BP,
12108,GO:0048148,1,0.79117522830669,0,7,behavioral response to cocaine,BP,
12109,GO:0048149,1,0.860626173859324,0,4,behavioral response to ethanol,BP,
12110,GO:0048156,1,0.692228890097612,0,11,tau protein binding,MF,
12112,GO:0048162,1,0.975008657882268,0,1,multi-layer follicle stage,BP,
12115,GO:0048168,1,0.35378195391862,0,29,regulation of neuronal synaptic plasticity,BP,
12116,GO:0048169,1,0.550807614340849,0,17,regulation of long-term neuronal synaptic plasticity,BP,
12117,GO:0048170,1,0.861983358756941,0,4,positive regulation of long-term neuronal synaptic plasticity,BP,
12118,GO:0048172,1,0.80085554418202,0,6,regulation of short-term neuronal synaptic plasticity,BP,
12119,GO:0048179,1,0.939744339386141,0,2,activin receptor complex,CC,
12121,GO:0048185,1,0.687223019065285,0,11,activin binding,MF,
12122,GO:0048188,1,0.664915009426208,0,12,Set1C/COMPASS complex,CC,
12126,GO:0048200,1,0.816625817919288,0,6,Golgi transport vesicle coating,BP,
12127,GO:0048203,1,0.939019948099773,0,2,vesicle targeting, trans-Golgi to endosome,BP,
12128,GO:0048205,1,0.816625817919288,0,6,COPI coating of Golgi vesicle,BP,
12131,GO:0048209,1,0.93117994104833,0,2,regulation of vesicle targeting, to, from or within Golgi,BP,
12132,GO:0048210,1,0.91276895625051,0,3,Golgi vesicle fusion to target membrane,BP,
12133,GO:0048211,1,0.928766452409202,0,2,Golgi vesicle docking,BP,
12134,GO:0048213,1,0.96580602802132,0,1,Golgi vesicle prefusion complex stabilization,BP,
12135,GO:0048227,1,0.768783005598367,0,8,plasma membrane to endosome transport,BP,
12138,GO:0048239,1,0.937309668694227,0,2,negative regulation of DNA recombination at telomere,BP,
12139,GO:0048240,1,0.804248347147174,0,7,sperm capacitation,BP,
12141,GO:0048244,1,0.974873157243389,0,1,phytanoyl-CoA dioxygenase activity,MF,
12142,GO:0048245,1,0.888989417706095,0,4,eosinophil chemotaxis,BP,
12145,GO:0048250,1,0.949645315730356,0,2,iron import into the mitochondrion,BP,
12146,GO:0048251,1,0.745382092159254,0,8,elastic fiber assembly,BP,
12147,GO:0048254,1,0.894985787988026,0,4,snoRNA localization,BP,
12149,GO:0048256,1,0.755288619394194,0,8,flap endonuclease activity,MF,
12150,GO:0048257,1,0.93514912926824,0,2,3'-flap endonuclease activity,MF,
12151,GO:0048259,1,0.14038377292692,0,56,regulation of receptor-mediated endocytosis,BP,
12152,GO:0048260,1,0.314287901726771,0,33,positive regulation of receptor-mediated endocytosis,BP,
12153,GO:0048261,1,0.617754025181566,0,14,negative regulation of receptor-mediated endocytosis,BP,
12154,GO:0048262,1,0.856171156508098,0,5,determination of dorsal/ventral asymmetry,BP,
12155,GO:0048263,1,0.887390833774347,0,4,determination of dorsal identity,BP,
12156,GO:0048264,1,0.964829005334257,0,1,determination of ventral identity,BP,
12158,GO:0048266,1,0.836160340152859,0,5,behavioral response to pain,BP,
12159,GO:0048268,1,0.585418673009964,0,15,clathrin coat assembly,BP,
12160,GO:0048269,1,0.937975851870164,0,2,methionine adenosyltransferase complex,CC,
12161,GO:0048270,1,0.971103874455116,0,1,methionine adenosyltransferase regulator activity,MF,
12164,GO:0048280,1,0.728726281544387,0,10,vesicle fusion with Golgi apparatus,BP,
12168,GO:0048289,1,0.866443207721776,0,4,isotype switching to IgE isotypes,BP,
12169,GO:0048290,1,0.821210034746833,0,6,isotype switching to IgA isotypes,BP,
12170,GO:0048291,1,0.755111850884226,0,8,isotype switching to IgG isotypes,BP,
12171,GO:0048293,1,0.866443207721776,0,4,regulation of isotype switching to IgE isotypes,BP,
12172,GO:0048294,1,0.926049090310108,0,2,negative regulation of isotype switching to IgE isotypes,BP,
12173,GO:0048295,1,0.935646261350398,0,2,positive regulation of isotype switching to IgE isotypes,BP,
12174,GO:0048296,1,0.852590085033744,0,5,regulation of isotype switching to IgA isotypes,BP,
12175,GO:0048297,1,0.970706523039016,0,1,negative regulation of isotype switching to IgA isotypes,BP,
12176,GO:0048298,1,0.878327685110074,0,4,positive regulation of isotype switching to IgA isotypes,BP,
12177,GO:0048302,1,0.779056639850418,0,7,regulation of isotype switching to IgG isotypes,BP,
12178,GO:0048304,1,0.840319165131884,0,5,positive regulation of isotype switching to IgG isotypes,BP,
12182,GO:0048311,1,0.575480874978819,0,14,mitochondrion distribution,BP,
12183,GO:0048312,1,0.789420466090345,0,6,intracellular distribution of mitochondria,BP,
12185,GO:0048318,1,0.858572735836274,0,5,axial mesoderm development,BP,
12186,GO:0048319,1,0.923973743000541,0,2,axial mesoderm morphogenesis,BP,
12187,GO:0048320,1,0.962970307750424,0,1,axial mesoderm formation,BP,
12190,GO:0048338,1,0.962108754463036,0,1,mesoderm structural organization,BP,
12194,GO:0048352,1,0.962108754463036,0,1,paraxial mesoderm structural organization,BP,
12195,GO:0048364,1,0.984487367317405,0,1,root development,BP,
12197,GO:0048368,1,0.752422904694845,0,8,lateral mesoderm development,BP,
12198,GO:0048369,1,0.923147699228308,0,2,lateral mesoderm morphogenesis,BP,
12199,GO:0048370,1,0.923147699228308,0,2,lateral mesoderm formation,BP,
12200,GO:0048371,1,0.923147699228308,0,2,lateral mesodermal cell differentiation,BP,
12201,GO:0048372,1,0.923147699228308,0,2,lateral mesodermal cell fate commitment,BP,
12202,GO:0048377,1,0.923147699228308,0,2,lateral mesodermal cell fate specification,BP,
12203,GO:0048378,1,0.923147699228308,0,2,regulation of lateral mesodermal cell fate specification,BP,
12208,GO:0048387,1,0.843411835464239,0,5,negative regulation of retinoic acid receptor signaling pathway,BP,
12209,GO:0048388,1,0.938932586421804,0,2,endosomal lumen acidification,BP,
12210,GO:0048389,1,0.973756390557974,0,1,intermediate mesoderm development,BP,
12211,GO:0048390,1,0.973756390557974,0,1,intermediate mesoderm morphogenesis,BP,
12212,GO:0048391,1,0.973756390557974,0,1,intermediate mesoderm formation,BP,
12213,GO:0048392,1,0.973756390557974,0,1,intermediate mesodermal cell differentiation,BP,
12214,GO:0048403,1,0.961272228317104,0,1,brain-derived neurotrophic factor binding,MF,
12215,GO:0048406,1,0.854998851510721,0,4,nerve growth factor binding,MF,
12216,GO:0048407,1,0.728622567002098,0,8,platelet-derived growth factor binding,MF,
12217,GO:0048408,1,0.888181855502486,0,4,epidermal growth factor binding,MF,
12221,GO:0048475,1,0.0413527841491189,0,92,coated membrane,CC,
12222,GO:0048476,1,0.871113374641604,0,5,Holliday junction resolvase complex,CC,
12224,GO:0048478,1,0.787225132780817,0,7,replication fork protection,BP,
12226,GO:0048484,1,0.837288617562195,0,5,enteric nervous system development,BP,
12228,GO:0048486,1,0.697695299474073,0,11,parasympathetic nervous system development,BP,
12229,GO:0048487,1,0.352234006176476,0,32,beta-tubulin binding,MF,
12230,GO:0048488,1,0.330974662625988,0,29,synaptic vesicle endocytosis,BP,
12232,GO:0048490,1,0.617144274828655,0,15,anterograde synaptic vesicle transport,BP,
12233,GO:0048495,1,0.860093862000866,0,4,Roundabout binding,MF,
12234,GO:0048496,1,0.89245508614344,0,3,maintenance of animal organ identity,BP,
12235,GO:0048499,1,0.914985543024022,0,3,synaptic vesicle membrane organization,BP,
12236,GO:0048500,1,0.773869549245793,0,9,signal recognition particle,CC,
12237,GO:0048505,1,0.817892812632916,0,6,regulation of timing of cell differentiation,BP,
12245,GO:0048520,1,0.860543931034156,0,4,positive regulation of behavior,BP,
12246,GO:0048521,1,0.885399414834652,0,4,negative regulation of behavior,BP,
12252,GO:0048532,1,0.688905655519427,0,10,anatomical structure arrangement,BP,
12256,GO:0048537,1,0.825048474549778,0,6,mucosal-associated lymphoid tissue development,BP,
12257,GO:0048538,1,0.260406972463021,0,37,thymus development,BP,
12258,GO:0048539,1,0.86830312337055,0,4,bone marrow development,BP,
12259,GO:0048541,1,0.825048474549778,0,6,Peyer's patch development,BP,
12262,GO:0048548,1,0.725514068387449,0,9,regulation of pinocytosis,BP,
12263,GO:0048549,1,0.857909077330074,0,4,positive regulation of pinocytosis,BP,
12264,GO:0048550,1,0.84573185755842,0,5,negative regulation of pinocytosis,BP,
12265,GO:0048557,1,0.758709561766321,0,8,embryonic digestive tract morphogenesis,BP,
12266,GO:0048560,1,0.941229230305941,0,2,establishment of anatomical structure orientation,BP,
12267,GO:0048561,1,0.970012903094977,0,1,establishment of animal organ orientation,BP,
12269,GO:0048563,1,0.815583605841949,0,7,post-embryonic animal organ morphogenesis,BP,
12273,GO:0048569,1,0.626216748316822,0,14,post-embryonic animal organ development,BP,
12283,GO:0048597,1,0.934387121400748,0,3,post-embryonic camera-type eye morphogenesis,BP,
12288,GO:0048611,1,0.965067269736794,0,1,embryonic ectodermal digestive tract development,BP,
12290,GO:0048619,1,0.965770780268371,0,1,embryonic hindgut morphogenesis,BP,
12291,GO:0048625,1,0.893457297562975,0,3,myoblast fate commitment,BP,
12292,GO:0048627,1,0.942083654461556,0,2,myoblast development,BP,
12293,GO:0048630,1,0.88994650624582,0,3,skeletal muscle tissue growth,BP,
12294,GO:0048631,1,0.88994650624582,0,3,regulation of skeletal muscle tissue growth,BP,
12295,GO:0048633,1,0.88994650624582,0,3,positive regulation of skeletal muscle tissue growth,BP,
12303,GO:0048642,1,0.787139378282304,0,7,negative regulation of skeletal muscle tissue development,BP,
12304,GO:0048643,1,0.593060615252922,0,14,positive regulation of skeletal muscle tissue development,BP,
12313,GO:0048664,1,0.92778383551569,0,3,neuron fate determination,BP,
12314,GO:0048665,1,0.778662244777724,0,7,neuron fate specification,BP,
12317,GO:0048668,1,0.556483945056514,0,17,collateral sprouting,BP,
12318,GO:0048669,1,0.902034614175453,0,3,collateral sprouting in absence of injury,BP,
12319,GO:0048670,1,0.677250399469724,0,12,regulation of collateral sprouting,BP,
12320,GO:0048671,1,0.891999436416648,0,3,negative regulation of collateral sprouting,BP,
12321,GO:0048672,1,0.759310149573059,0,9,positive regulation of collateral sprouting,BP,
12322,GO:0048674,1,0.968353585596591,0,1,collateral sprouting of injured axon,BP,
12324,GO:0048677,1,0.95950763690405,0,1,axon extension involved in regeneration,BP,
12326,GO:0048679,1,0.537481691344946,0,18,regulation of axon regeneration,BP,
12327,GO:0048680,1,0.889288798814044,0,4,positive regulation of axon regeneration,BP,
12328,GO:0048681,1,0.68070400720837,0,11,negative regulation of axon regeneration,BP,
12329,GO:0048682,1,0.929139549068415,0,2,sprouting of injured axon,BP,
12330,GO:0048686,1,0.968353585596591,0,1,regulation of sprouting of injured axon,BP,
12331,GO:0048687,1,0.968353585596591,0,1,positive regulation of sprouting of injured axon,BP,
12332,GO:0048688,1,0.968353585596591,0,1,negative regulation of sprouting of injured axon,BP,
12333,GO:0048689,1,0.968353585596591,0,1,formation of growth cone in injured axon,BP,
12334,GO:0048693,1,0.968353585596591,0,1,regulation of collateral sprouting of injured axon,BP,
12335,GO:0048694,1,0.968353585596591,0,1,positive regulation of collateral sprouting of injured axon,BP,
12336,GO:0048696,1,0.976549225204766,0,1,regulation of collateral sprouting in absence of injury,BP,
12337,GO:0048697,1,0.976549225204766,0,1,positive regulation of collateral sprouting in absence of injury,BP,
12340,GO:0048702,1,0.770074994288502,0,7,embryonic neurocranium morphogenesis,BP,
12341,GO:0048703,1,0.768618489457982,0,7,embryonic viscerocranium morphogenesis,BP,
12351,GO:0048714,1,0.654519782752141,0,12,positive regulation of oligodendrocyte differentiation,BP,
12354,GO:0048730,1,0.504661263992492,0,19,epidermis morphogenesis,BP,
12357,GO:0048733,1,0.833032261012206,0,5,sebaceous gland development,BP,
12360,GO:0048739,1,0.804770663497347,0,6,cardiac muscle fiber development,BP,
12363,GO:0048743,1,0.924223210663923,0,2,positive regulation of skeletal muscle fiber development,BP,
12366,GO:0048749,1,0.96332292631291,0,1,compound eye development,BP,
12367,GO:0048752,1,0.906974603034586,0,3,semicircular canal morphogenesis,BP,
12368,GO:0048753,1,0.47531542763106,0,23,pigment granule organization,BP,
12371,GO:0048757,1,0.725959300026941,0,10,pigment granule maturation,BP,
12373,GO:0048763,1,0.920743106004502,0,2,calcium-induced calcium release activity,MF,
12374,GO:0048764,1,0.984487367317405,0,1,trichoblast maturation,BP,
12375,GO:0048765,1,0.984487367317405,0,1,root hair cell differentiation,BP,
12376,GO:0048767,1,0.984487367317405,0,1,root hair elongation,BP,
12377,GO:0048769,1,0.920650957478618,0,2,sarcomerogenesis,BP,
12382,GO:0048788,1,0.847594491557631,0,4,cytoskeleton of presynaptic active zone,CC,
12383,GO:0048791,1,0.502626320148382,0,18,calcium ion-regulated exocytosis of neurotransmitter,BP,
12384,GO:0048793,1,0.85143167470568,0,4,pronephros development,BP,
12387,GO:0048807,1,0.959896383980452,0,1,female genitalia morphogenesis,BP,
12395,GO:0048821,1,0.486134809328367,0,21,erythrocyte development,BP,
12396,GO:0048822,1,0.893766129534215,0,3,enucleate erythrocyte development,BP,
12398,GO:0048840,1,0.859764719075954,0,4,otolith development,BP,
12400,GO:0048842,1,0.789703258923386,0,6,positive regulation of axon extension involved in axon guidance,BP,
12409,GO:0048855,1,0.95950763690405,0,1,adenohypophysis morphogenesis,BP,
12413,GO:0048859,1,0.942217202997043,0,2,formation of anatomical boundary,BP,
12419,GO:0048867,1,0.981981773219839,0,1,stem cell fate determination,BP,
12425,GO:0048874,1,0.963486266439358,0,1,homeostasis of number of cells in a free-living population,BP,
12426,GO:0048875,1,0.777287849962326,0,7,chemical homeostasis within a tissue,BP,
12428,GO:0048880,1,0.896771908746986,0,3,sensory system development,BP,
12429,GO:0048882,1,0.966967419757367,0,1,lateral line development,BP,
12430,GO:0048884,1,0.966967419757367,0,1,neuromast development,BP,
12431,GO:0048886,1,0.966967419757367,0,1,neuromast hair cell differentiation,BP,
12432,GO:0048925,1,0.966967419757367,0,1,lateral line system development,BP,
12435,GO:0048936,1,0.903855921601386,0,3,peripheral nervous system neuron axonogenesis,BP,
12436,GO:0050000,1,0.103154060814908,0,67,chromosome localization,BP,
12437,GO:0050011,1,0.975596343500866,0,1,itaconyl-CoA hydratase activity,MF,
12438,GO:0050023,1,0.973034526116173,0,1,L-fuconate dehydratase activity,MF,
12439,GO:0050038,1,0.983864928077052,0,1,L-xylulose reductase (NADP+) activity,MF,
12440,GO:0050046,1,0.965469978279355,0,1,lathosterol oxidase activity,MF,
12441,GO:0050072,1,0.794728186314043,0,7,m7G(5')pppN diphosphatase activity,MF,
12442,GO:0050080,1,0.970233459065378,0,1,malonyl-CoA decarboxylase activity,MF,
12443,GO:0050104,1,0.97649840947547,0,1,L-gulonate 3-dehydrogenase activity,MF,
12444,GO:0050115,1,0.959694824545825,0,1,myosin-light-chain-phosphatase activity,MF,
12445,GO:0050119,1,0.922047490667268,0,2,N-acetylglucosamine deacetylase activity,MF,
12446,GO:0050124,1,0.961546303492611,0,1,N-acylneuraminate-9-phosphatase activity,MF,
12447,GO:0050135,1,0.976569571756151,0,1,NAD(P)+ nucleosidase activity,MF,
12448,GO:0050136,1,0.498721485595465,0,38,NADH dehydrogenase (quinone) activity,MF,
12449,GO:0050144,1,0.965469978279355,0,1,nucleoside deoxyribosyltransferase activity,MF,
12450,GO:0050145,1,0.882464490093231,0,4,nucleoside phosphate kinase activity,MF,
12451,GO:0050146,1,0.95953250223624,0,1,nucleoside phosphotransferase activity,MF,
12452,GO:0050152,1,0.978864328428596,0,1,omega-amidase activity,MF,
12453,GO:0050178,1,0.973375629788393,0,2,phenylpyruvate tautomerase activity,MF,
12454,GO:0050185,1,0.95950763690405,0,1,phosphatidylinositol deacylase activity,MF,
12455,GO:0050201,1,0.961171106876367,0,1,fucokinase activity,MF,
12456,GO:0050211,1,0.931609125245609,0,2,procollagen galactosyltransferase activity,MF,
12457,GO:0050220,1,0.90811163423455,0,4,prostaglandin-E synthase activity,MF,
12458,GO:0050221,1,0.979210121352586,0,1,prostaglandin-E2 9-reductase activity,MF,
12459,GO:0050252,1,0.931267234838056,0,2,retinol O-fatty-acyltransferase activity,MF,
12460,GO:0050253,1,0.927216777690351,0,2,retinyl-palmitate esterase activity,MF,
12461,GO:0050262,1,0.965469978279355,0,1,ribosylnicotinamide kinase activity,MF,
12462,GO:0050265,1,0.889191314055004,0,3,RNA uridylyltransferase activity,MF,
12463,GO:0050277,1,0.961409093300116,0,1,sedoheptulokinase activity,MF,
12464,GO:0050290,1,0.959795155610121,0,1,sphingomyelin phosphodiesterase D activity,MF,
12465,GO:0050291,1,0.838842340631584,0,5,sphingosine N-acyltransferase activity,MF,
12466,GO:0050294,1,0.933725367090696,0,3,steroid sulfotransferase activity,MF,
12467,GO:0050308,1,0.834958917170355,0,5,sugar-phosphatase activity,MF,
12468,GO:0050309,1,0.975144779061842,0,1,sugar-terminal-phosphatase activity,MF,
12469,GO:0050313,1,0.982324613531412,0,1,sulfur dioxygenase activity,MF,
12471,GO:0050333,1,0.97364540467502,0,1,thiamin-triphosphatase activity,MF,
12472,GO:0050337,1,0.98681422956174,0,1,thiosulfate-thiol sulfurtransferase activity,MF,
12473,GO:0050346,1,0.965469978279355,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
12474,GO:0050347,1,0.938565338361051,0,2,trans-octaprenyltranstransferase activity,MF,
12475,GO:0050353,1,0.965671518913797,0,1,trimethyllysine dioxygenase activity,MF,
12476,GO:0050354,1,0.965469978279355,0,1,triokinase activity,MF,
12477,GO:0050355,1,0.960089237709914,0,1,triphosphatase activity,MF,
12478,GO:0050379,1,0.959612760372901,0,1,UDP-glucuronate 5'-epimerase activity,MF,
12479,GO:0050405,1,0.920726513421874,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
12480,GO:0050421,1,0.967261870054133,0,1,nitrite reductase (NO-forming) activity,MF,
12481,GO:0050427,1,0.571996156462107,0,18,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,
12482,GO:0050428,1,0.810968784245712,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
12488,GO:0050436,1,0.922338675842259,0,2,microfibril binding,MF,
12489,GO:0050444,1,0.963432130161792,0,1,aquacobalamin reductase (NADPH) activity,MF,
12490,GO:0050462,1,0.97924266861207,0,1,N-acetylneuraminate synthase activity,MF,
12492,GO:0050482,1,0.656083803127781,0,12,arachidonic acid secretion,BP,
12493,GO:0050497,1,0.936135047891476,0,2,transferase activity, transferring alkylthio groups,MF,
12495,GO:0050508,1,0.926287203724198,0,2,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
12496,GO:0050509,1,0.926287203724198,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
12497,GO:0050510,1,0.856953081240651,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
12498,GO:0050512,1,0.971074942959089,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
12499,GO:0050542,1,0.916687619534544,0,4,icosanoid binding,MF,
12500,GO:0050543,1,0.916687619534544,0,4,icosatetraenoic acid binding,MF,
12501,GO:0050544,1,0.916687619534544,0,4,arachidonic acid binding,MF,
12502,GO:0050560,1,0.963137696562781,0,1,aspartate-tRNA(Asn) ligase activity,MF,
12503,GO:0050561,1,0.961187246706842,0,1,glutamate-tRNA(Gln) ligase activity,MF,
12504,GO:0050567,1,0.91725123304458,0,3,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
12505,GO:0050577,1,0.977916236444337,0,1,GDP-L-fucose synthase activity,MF,
12506,GO:0050610,1,0.961363431180354,0,2,methylarsonate reductase activity,MF,
12507,GO:0050613,1,0.938095706038939,0,2,delta14-sterol reductase activity,MF,
12508,GO:0050614,1,0.960370615281752,0,1,delta24-sterol reductase activity,MF,
12509,GO:0050632,1,0.977320014662109,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
12512,GO:0050652,1,0.961766524593314,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
12513,GO:0050653,1,0.961766524593314,0,1,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
12516,GO:0050656,1,0.865622251100511,0,4,3'-phosphoadenosine 5'-phosphosulfate binding,MF,
12519,GO:0050659,1,0.92098488931977,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
12521,GO:0050661,1,0.315205607761093,0,36,NADP binding,MF,
12524,GO:0050664,1,0.827212735792731,0,6,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
12525,GO:0050665,1,0.72170330443265,0,10,hydrogen peroxide biosynthetic process,BP,
12526,GO:0050666,1,0.969636865735874,0,1,regulation of homocysteine metabolic process,BP,
12528,GO:0050668,1,0.969636865735874,0,1,positive regulation of homocysteine metabolic process,BP,
12536,GO:0050681,1,0.258022865133179,0,39,androgen receptor binding,MF,
12537,GO:0050682,1,0.930567248386571,0,2,AF-2 domain binding,MF,
12540,GO:0050686,1,0.375285496176511,0,28,negative regulation of mRNA processing,BP,
12541,GO:0050687,1,0.494229955049318,0,21,negative regulation of defense response to virus,BP,
12543,GO:0050689,1,0.869218488882399,0,5,negative regulation of defense response to virus by host,BP,
12544,GO:0050690,1,0.500891259335171,0,21,regulation of defense response to virus by virus,BP,
12546,GO:0050692,1,0.933674565308806,0,2,DBD domain binding,MF,
12547,GO:0050693,1,0.872294598239123,0,4,LBD domain binding,MF,
12548,GO:0050694,1,0.967691660411353,0,1,galactose 3-O-sulfotransferase activity,MF,
12549,GO:0050698,1,0.967691660411353,0,1,proteoglycan sulfotransferase activity,MF,
12563,GO:0050712,1,0.977205976262402,0,1,negative regulation of interleukin-1 alpha secretion,BP,
12571,GO:0050720,1,0.964189244898402,0,1,interleukin-1 beta biosynthetic process,BP,
12573,GO:0050722,1,0.964189244898402,0,1,regulation of interleukin-1 beta biosynthetic process,BP,
12574,GO:0050725,1,0.964189244898402,0,1,positive regulation of interleukin-1 beta biosynthetic process,BP,
12582,GO:0050733,1,0.840918235249377,0,5,RS domain binding,MF,
12584,GO:0050747,1,0.856293423149803,0,5,positive regulation of lipoprotein metabolic process,BP,
12586,GO:0050750,1,0.566844596758033,0,17,low-density lipoprotein particle receptor binding,MF,
12588,GO:0050757,1,0.967016051581065,0,1,thymidylate synthase biosynthetic process,BP,
12589,GO:0050758,1,0.967016051581065,0,1,regulation of thymidylate synthase biosynthetic process,BP,
12590,GO:0050760,1,0.967016051581065,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
12592,GO:0050765,1,0.739323744237023,0,9,negative regulation of phagocytosis,BP,
12602,GO:0050775,1,0.380469625120943,0,25,positive regulation of dendrite morphogenesis,BP,
12608,GO:0050783,1,0.96834646839626,0,1,cocaine metabolic process,BP,
12609,GO:0050785,1,0.978159281517456,0,1,advanced glycation end-product receptor activity,MF,
12610,GO:0050786,1,0.883285535600042,0,7,RAGE receptor binding,MF,
12611,GO:0050787,1,0.942977251210749,0,2,detoxification of mercury ion,BP,
12629,GO:0050811,1,0.750874359099966,0,9,GABA receptor binding,MF,
12630,GO:0050812,1,0.640442002582218,0,12,regulation of acyl-CoA biosynthetic process,BP,
12631,GO:0050815,1,0.823729307683984,0,6,phosphoserine residue binding,MF,
12632,GO:0050816,1,0.90611803540177,0,3,phosphothreonine residue binding,MF,
12638,GO:0050822,1,0.96254946664234,0,1,peptide stabilization,BP,
12639,GO:0050823,1,0.96254946664234,0,1,peptide antigen stabilization,BP,
12643,GO:0050833,1,0.897086260392901,0,3,pyruvate transmembrane transporter activity,MF,
12646,GO:0050847,1,0.771127578407619,0,7,progesterone receptor signaling pathway,BP,
12648,GO:0050849,1,0.690448260159887,0,12,negative regulation of calcium-mediated signaling,BP,
12657,GO:0050858,1,0.596740519594131,0,16,negative regulation of antigen receptor-mediated signaling pathway,BP,
12658,GO:0050859,1,0.906436179763608,0,3,negative regulation of B cell receptor signaling pathway,BP,
12659,GO:0050860,1,0.638456738315223,0,14,negative regulation of T cell receptor signaling pathway,BP,
12660,GO:0050861,1,0.865391958186418,0,4,positive regulation of B cell receptor signaling pathway,BP,
12671,GO:0050872,1,0.726755153621579,0,9,white fat cell differentiation,BP,
12675,GO:0050879,1,0.403462633754873,0,26,multicellular organismal movement,BP,
12677,GO:0050881,1,0.403462633754873,0,26,musculoskeletal movement,BP,
12678,GO:0050882,1,0.793346853253218,0,6,voluntary musculoskeletal movement,BP,
12685,GO:0050893,1,0.911502463910735,0,3,sensory processing,BP,
12687,GO:0050897,1,0.95950763690405,0,1,cobalt ion binding,MF,
12690,GO:0050904,1,0.925985992299293,0,2,diapedesis,BP,
12692,GO:0050906,1,0.439469189754959,0,26,detection of stimulus involved in sensory perception,BP,
12693,GO:0050907,1,0.766181855810782,0,10,detection of chemical stimulus involved in sensory perception,BP,
12694,GO:0050908,1,0.863881108026558,0,4,detection of light stimulus involved in visual perception,BP,
12695,GO:0050909,1,0.68896248650473,0,12,sensory perception of taste,BP,
12696,GO:0050910,1,0.92811099099357,0,2,detection of mechanical stimulus involved in sensory perception of sound,BP,
12697,GO:0050911,1,0.930778948106928,0,3,detection of chemical stimulus involved in sensory perception of smell,BP,
12698,GO:0050912,1,0.856912525151308,0,6,detection of chemical stimulus involved in sensory perception of taste,BP,
12699,GO:0050913,1,0.825114069358606,0,7,sensory perception of bitter taste,BP,
12700,GO:0050915,1,0.965469978279355,0,1,sensory perception of sour taste,BP,
12701,GO:0050916,1,0.901417783607474,0,3,sensory perception of sweet taste,BP,
12702,GO:0050917,1,0.928367665123791,0,2,sensory perception of umami taste,BP,
12708,GO:0050923,1,0.883486801824228,0,3,regulation of negative chemotaxis,BP,
12709,GO:0050924,1,0.959640944479446,0,1,positive regulation of negative chemotaxis,BP,
12710,GO:0050925,1,0.920650957478618,0,2,negative regulation of negative chemotaxis,BP,
12713,GO:0050928,1,0.959543509606302,0,1,negative regulation of positive chemotaxis,BP,
12714,GO:0050929,1,0.959640944479446,0,1,induction of negative chemotaxis,BP,
12719,GO:0050951,1,0.758377396767729,0,8,sensory perception of temperature stimulus,BP,
12722,GO:0050955,1,0.960663077912503,0,1,thermoception,BP,
12723,GO:0050957,1,0.924852187087633,0,2,equilibrioception,BP,
12724,GO:0050960,1,0.960663077912503,0,1,detection of temperature stimulus involved in thermoception,BP,
12725,GO:0050961,1,0.790401175481308,0,7,detection of temperature stimulus involved in sensory perception,BP,
12726,GO:0050962,1,0.863881108026558,0,4,detection of light stimulus involved in sensory perception,BP,
12727,GO:0050965,1,0.790401175481308,0,7,detection of temperature stimulus involved in sensory perception of pain,BP,
12728,GO:0050966,1,0.931846317362644,0,2,detection of mechanical stimulus involved in sensory perception of pain,BP,
12729,GO:0050968,1,0.960663077912503,0,1,detection of chemical stimulus involved in sensory perception of pain,BP,
12730,GO:0050974,1,0.838629645075633,0,5,detection of mechanical stimulus involved in sensory perception,BP,
12731,GO:0050982,1,0.634215264105726,0,12,detection of mechanical stimulus,BP,
12732,GO:0050992,1,0.949319237974671,0,2,dimethylallyl diphosphate biosynthetic process,BP,
12733,GO:0050993,1,0.949319237974671,0,2,dimethylallyl diphosphate metabolic process,BP,
12737,GO:0050997,1,0.68207753924804,0,12,quaternary ammonium group binding,MF,
12738,GO:0050998,1,0.677284567650719,0,11,nitric-oxide synthase binding,MF,
12741,GO:0051001,1,0.88918937927705,0,4,negative regulation of nitric-oxide synthase activity,BP,
12742,GO:0051004,1,0.723397597216837,0,10,regulation of lipoprotein lipase activity,BP,
12743,GO:0051005,1,0.922836924191959,0,3,negative regulation of lipoprotein lipase activity,BP,
12744,GO:0051006,1,0.879620085387898,0,4,positive regulation of lipoprotein lipase activity,BP,
12745,GO:0051010,1,0.595191635585172,0,13,microtubule plus-end binding,MF,
12746,GO:0051011,1,0.678982692571901,0,10,microtubule minus-end binding,MF,
12747,GO:0051012,1,0.934988332730871,0,2,microtubule sliding,BP,
12748,GO:0051013,1,0.811629503612181,0,6,microtubule severing,BP,
12749,GO:0051014,1,0.800546528529634,0,6,actin filament severing,BP,
12751,GO:0051016,1,0.662641584205408,0,12,barbed-end actin filament capping,BP,
12756,GO:0051021,1,0.877362429978741,0,4,GDP-dissociation inhibitor binding,MF,
12757,GO:0051022,1,0.877362429978741,0,4,Rho GDP-dissociation inhibitor binding,MF,
12760,GO:0051025,1,0.964487831399215,0,1,negative regulation of immunoglobulin secretion,BP,
12761,GO:0051026,1,0.87620452244042,0,4,chiasma assembly,BP,
12763,GO:0051029,1,0.85054163174184,0,6,rRNA transport,BP,
12764,GO:0051030,1,0.904370210398009,0,4,snRNA transport,BP,
12766,GO:0051032,1,0.961131193844183,0,1,nucleic acid transmembrane transporter activity,MF,
12767,GO:0051033,1,0.961131193844183,0,1,RNA transmembrane transporter activity,MF,
12768,GO:0051036,1,0.858050207705646,0,5,regulation of endosome size,BP,
12773,GO:0051045,1,0.782683212272698,0,7,negative regulation of membrane protein ectodomain proteolysis,BP,
12789,GO:0051068,1,0.962237779638328,0,1,dihydrolipoamide metabolic process,BP,
12791,GO:0051082,1,0.0405716616173424,0,102,unfolded protein binding,MF,
12792,GO:0051083,1,0.94489426750085,0,2,'de novo' cotranslational protein folding,BP,
12795,GO:0051086,1,0.972124383270008,0,1,chaperone mediated protein folding independent of cofactor,BP,
12798,GO:0051089,1,0.9611364795737,0,1,constitutive protein ectodomain proteolysis,BP,
12804,GO:0051095,1,0.735669623869317,0,9,regulation of helicase activity,BP,
12805,GO:0051096,1,0.81295455375339,0,6,positive regulation of helicase activity,BP,
12806,GO:0051097,1,0.904980520642545,0,3,negative regulation of helicase activity,BP,
12811,GO:0051102,1,0.960845807314678,0,1,DNA ligation involved in DNA recombination,BP,
12812,GO:0051103,1,0.704373828674241,0,11,DNA ligation involved in DNA repair,BP,
12813,GO:0051105,1,0.815331758051318,0,6,regulation of DNA ligation,BP,
12814,GO:0051106,1,0.844529667640436,0,5,positive regulation of DNA ligation,BP,
12815,GO:0051107,1,0.96544149613875,0,1,negative regulation of DNA ligation,BP,
12817,GO:0051119,1,0.60699163423768,0,14,sugar transmembrane transporter activity,MF,
12818,GO:0051120,1,0.933339544551412,0,2,hepoxilin A3 synthase activity,MF,
12819,GO:0051121,1,0.873616324134632,0,4,hepoxilin metabolic process,BP,
12820,GO:0051122,1,0.873616324134632,0,4,hepoxilin biosynthetic process,BP,
12822,GO:0051124,1,0.782866105683468,0,6,synaptic growth at neuromuscular junction,BP,
12823,GO:0051125,1,0.449752506829932,0,22,regulation of actin nucleation,BP,
12824,GO:0051126,1,0.819970428158431,0,6,negative regulation of actin nucleation,BP,
12825,GO:0051127,1,0.626320742918558,0,12,positive regulation of actin nucleation,BP,
12829,GO:0051131,1,0.579660675494099,0,17,chaperone-mediated protein complex assembly,BP,
12834,GO:0051138,1,0.885244231995305,0,3,positive regulation of NK T cell differentiation,BP,
12835,GO:0051139,1,0.959515685611627,0,1,metal ion:proton antiporter activity,MF,
12845,GO:0051152,1,0.777584215634152,0,8,positive regulation of smooth muscle cell differentiation,BP,
12849,GO:0051156,1,0.528237134599706,0,21,glucose 6-phosphate metabolic process,BP,
12850,GO:0051160,1,0.967753139758002,0,1,L-xylitol catabolic process,BP,
12851,GO:0051164,1,0.967753139758002,0,1,L-xylitol metabolic process,BP,
12852,GO:0051167,1,0.873504287721904,0,5,xylulose 5-phosphate metabolic process,BP,
12861,GO:0051177,1,0.881172385305803,0,4,meiotic sister chromatid cohesion,BP,
12863,GO:0051180,1,0.557709416086705,0,17,vitamin transport,BP,
12864,GO:0051181,1,0.38888677049751,0,29,cofactor transport,BP,
12865,GO:0051182,1,0.78422524671573,0,7,coenzyme transport,BP,
12866,GO:0051184,1,0.557820867219945,0,16,cofactor transmembrane transporter activity,MF,
12867,GO:0051185,1,0.814050417157619,0,6,coenzyme transmembrane transporter activity,MF,
12871,GO:0051189,1,0.796912918752052,0,7,prosthetic group metabolic process,BP,
12872,GO:0051192,1,0.972106481842648,0,2,prosthetic group binding,MF,
12875,GO:0051195,1,0.724790383230615,0,9,negative regulation of cofactor metabolic process,BP,
12877,GO:0051197,1,0.648844942144833,0,11,positive regulation of coenzyme metabolic process,BP,
12878,GO:0051198,1,0.810177338104088,0,6,negative regulation of coenzyme metabolic process,BP,
12891,GO:0051228,1,0.959565818587938,0,1,mitotic spindle disassembly,BP,
12892,GO:0051230,1,0.959565818587938,0,1,spindle disassembly,BP,
12893,GO:0051231,1,0.676343835807001,0,11,spindle elongation,BP,
12894,GO:0051232,1,0.968845046401389,0,1,meiotic spindle elongation,BP,
12895,GO:0051233,1,0.338129791714075,0,31,spindle midzone,CC,
12899,GO:0051238,1,0.737827583316382,0,11,sequestering of metal ion,BP,
12912,GO:0051255,1,0.703303316996054,0,10,spindle midzone assembly,BP,
12913,GO:0051256,1,0.754407549970223,0,8,mitotic spindle midzone assembly,BP,
12914,GO:0051257,1,0.968169574119123,0,1,meiotic spindle midzone assembly,BP,
12920,GO:0051264,1,0.965960062720483,0,1,mono-olein transacylation activity,MF,
12921,GO:0051265,1,0.965960062720483,0,1,diolein transacylation activity,MF,
12922,GO:0051267,1,0.963651240948405,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
12928,GO:0051280,1,0.749163812406699,0,10,negative regulation of release of sequestered calcium ion into cytosol,BP,
12932,GO:0051284,1,0.749163812406699,0,10,positive regulation of sequestering of calcium ion,BP,
12933,GO:0051286,1,0.818721687505424,0,5,cell tip,CC,
12936,GO:0051290,1,0.412525814432751,0,43,protein heterotetramerization,BP,
12939,GO:0051293,1,0.332277544105656,0,30,establishment of spindle localization,BP,
12940,GO:0051294,1,0.437607213613505,0,23,establishment of spindle orientation,BP,
12941,GO:0051295,1,0.887153569475678,0,3,establishment of meiotic spindle localization,BP,
12943,GO:0051299,1,0.608912076612291,0,14,centrosome separation,BP,
12944,GO:0051300,1,0.965469978279355,0,1,spindle pole body organization,BP,
12947,GO:0051303,1,0.107527632900876,0,66,establishment of chromosome localization,BP,
12949,GO:0051305,1,0.825815489408603,0,5,chromosome movement towards spindle pole,BP,
12951,GO:0051307,1,0.650044213182243,0,12,meiotic chromosome separation,BP,
12952,GO:0051308,1,0.965469978279355,0,1,male meiosis chromosome separation,BP,
12953,GO:0051310,1,0.167452365158673,0,54,metaphase plate congression,BP,
12954,GO:0051311,1,0.968169574119123,0,1,meiotic metaphase plate congression,BP,
12955,GO:0051315,1,0.645574721995167,0,13,attachment of mitotic spindle microtubules to kinetochore,BP,
12956,GO:0051316,1,0.936267960090301,0,2,attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation,BP,
12960,GO:0051339,1,0.533770322573597,0,19,regulation of lyase activity,BP,
12961,GO:0051340,1,0.792119466605922,0,8,regulation of ligase activity,BP,
12963,GO:0051342,1,0.826796399995019,0,6,regulation of cyclic-nucleotide phosphodiesterase activity,BP,
12964,GO:0051343,1,0.911398478344311,0,3,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
12965,GO:0051344,1,0.90719408352162,0,3,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,
12970,GO:0051349,1,0.762657095225437,0,8,positive regulation of lyase activity,BP,
12971,GO:0051350,1,0.751117347649938,0,9,negative regulation of lyase activity,BP,
12972,GO:0051351,1,0.820488268941208,0,7,positive regulation of ligase activity,BP,
12973,GO:0051352,1,0.96544149613875,0,1,negative regulation of ligase activity,BP,
12977,GO:0051371,1,0.813344600897069,0,5,muscle alpha-actinin binding,MF,
12978,GO:0051377,1,0.891139133150819,0,3,mannose-ethanolamine phosphotransferase activity,MF,
12979,GO:0051378,1,0.915994570052804,0,3,serotonin binding,MF,
12982,GO:0051382,1,0.623340878290291,0,14,kinetochore assembly,BP,
12983,GO:0051383,1,0.523418558205795,0,19,kinetochore organization,BP,
12986,GO:0051386,1,0.775925440446656,0,7,regulation of neurotrophin TRK receptor signaling pathway,BP,
12987,GO:0051387,1,0.940426334894312,0,2,negative regulation of neurotrophin TRK receptor signaling pathway,BP,
12988,GO:0051388,1,0.859631678390709,0,4,positive regulation of neurotrophin TRK receptor signaling pathway,BP,
12989,GO:0051389,1,0.920835736214686,0,2,inactivation of MAPKK activity,BP,
12990,GO:0051391,1,0.961090604699139,0,1,tRNA acetylation,BP,
12991,GO:0051392,1,0.961090604699139,0,1,tRNA N-acetyltransferase activity,MF,
12992,GO:0051393,1,0.653115136824883,0,11,alpha-actinin binding,MF,
12996,GO:0051409,1,0.756320349331854,0,9,response to nitrosative stress,BP,
12997,GO:0051410,1,0.858832453023131,0,5,detoxification of nitrogen compound,BP,
12999,GO:0051413,1,0.96787686927782,0,1,response to cortisone,BP,
13000,GO:0051414,1,0.831385980717178,0,5,response to cortisol,BP,
13001,GO:0051415,1,0.796204435701933,0,6,microtubule nucleation by interphase microtubule organizing center,BP,
13002,GO:0051417,1,0.965469978279355,0,1,microtubule nucleation by spindle pole body,BP,
13003,GO:0051418,1,0.732991663458882,0,8,microtubule nucleation by microtubule organizing center,BP,
13004,GO:0051425,1,0.853933345197867,0,4,PTB domain binding,MF,
13007,GO:0051429,1,0.911863559787696,0,3,corticotropin-releasing hormone receptor binding,MF,
13008,GO:0051430,1,0.933628425310396,0,2,corticotropin-releasing hormone receptor 1 binding,MF,
13009,GO:0051431,1,0.97669189323881,0,1,corticotropin-releasing hormone receptor 2 binding,MF,
13010,GO:0051433,1,0.959996075257368,0,1,BH2 domain binding,MF,
13011,GO:0051434,1,0.880611217196652,0,4,BH3 domain binding,MF,
13014,GO:0051444,1,0.697792779031662,0,13,negative regulation of ubiquitin-protein transferase activity,BP,
13019,GO:0051451,1,0.770018370495404,0,8,myoblast migration,BP,
13022,GO:0051454,1,0.904152937622699,0,3,intracellular pH elevation,BP,
13023,GO:0051455,1,0.965469978279355,0,1,attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation,BP,
13024,GO:0051456,1,0.969756216940315,0,1,attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation,BP,
13026,GO:0051458,1,0.924925804557103,0,2,corticotropin secretion,BP,
13027,GO:0051459,1,0.924925804557103,0,2,regulation of corticotropin secretion,BP,
13028,GO:0051461,1,0.924925804557103,0,2,positive regulation of corticotropin secretion,BP,
13031,GO:0051464,1,0.984487367317405,0,1,positive regulation of cortisol secretion,BP,
13032,GO:0051466,1,0.963768076646009,0,1,positive regulation of corticotropin-releasing hormone secretion,BP,
13036,GO:0051489,1,0.336946141787739,0,29,regulation of filopodium assembly,BP,
13037,GO:0051490,1,0.908831714175617,0,3,negative regulation of filopodium assembly,BP,
13038,GO:0051491,1,0.430507558535749,0,22,positive regulation of filopodium assembly,BP,
13045,GO:0051499,1,0.94412653997244,0,2,D-aminoacyl-tRNA deacylase activity,MF,
13046,GO:0051500,1,0.94412653997244,0,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,
13048,GO:0051525,1,0.921431740830433,0,2,NFAT protein binding,MF,
13049,GO:0051536,1,0.151258109080618,0,61,iron-sulfur cluster binding,MF,
13050,GO:0051537,1,0.583469391968391,0,19,2 iron, 2 sulfur cluster binding,MF,
13051,GO:0051538,1,0.9115479288822,0,3,3 iron, 4 sulfur cluster binding,MF,
13052,GO:0051539,1,0.272273616279727,0,41,4 iron, 4 sulfur cluster binding,MF,
13053,GO:0051540,1,0.151258109080618,0,61,metal cluster binding,MF,
13060,GO:0051548,1,0.92065411736192,0,2,negative regulation of keratinocyte migration,BP,
13062,GO:0051552,1,0.968977615020239,0,1,flavone metabolic process,BP,
13063,GO:0051560,1,0.541985577177085,0,18,mitochondrial calcium ion homeostasis,BP,
13064,GO:0051561,1,0.757218173866994,0,9,positive regulation of mitochondrial calcium ion concentration,BP,
13065,GO:0051562,1,0.931761738953693,0,2,negative regulation of mitochondrial calcium ion concentration,BP,
13066,GO:0051563,1,0.923675116384979,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
13067,GO:0051567,1,0.376418331485419,0,26,histone H3-K9 methylation,BP,
13069,GO:0051569,1,0.467856122397489,0,21,regulation of histone H3-K4 methylation,BP,
13070,GO:0051570,1,0.533041040123256,0,17,regulation of histone H3-K9 methylation,BP,
13071,GO:0051571,1,0.594384710495533,0,14,positive regulation of histone H3-K4 methylation,BP,
13072,GO:0051572,1,0.895327924427049,0,3,negative regulation of histone H3-K4 methylation,BP,
13073,GO:0051573,1,0.717806445672269,0,9,negative regulation of histone H3-K9 methylation,BP,
13074,GO:0051574,1,0.770176493796384,0,7,positive regulation of histone H3-K9 methylation,BP,
13075,GO:0051575,1,0.837710004732774,0,5,5'-deoxyribose-5-phosphate lyase activity,MF,
13076,GO:0051580,1,0.751276027912018,0,9,regulation of neurotransmitter uptake,BP,
13077,GO:0051581,1,0.89795009114309,0,3,negative regulation of neurotransmitter uptake,BP,
13078,GO:0051582,1,0.946430817260911,0,2,positive regulation of neurotransmitter uptake,BP,
13079,GO:0051583,1,0.849472826983781,0,6,dopamine uptake involved in synaptic transmission,BP,
13080,GO:0051584,1,0.900474384110754,0,4,regulation of dopamine uptake involved in synaptic transmission,BP,
13081,GO:0051585,1,0.964014645926423,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
13082,GO:0051586,1,0.976034336339999,0,1,positive regulation of dopamine uptake involved in synaptic transmission,BP,
13084,GO:0051589,1,0.634562963078917,0,13,negative regulation of neurotransmitter transport,BP,
13088,GO:0051593,1,0.778027067714477,0,8,response to folic acid,BP,
13089,GO:0051595,1,0.921676712690046,0,3,response to methylglyoxal,BP,
13090,GO:0051596,1,0.94163509654683,0,2,methylglyoxal catabolic process,BP,
13091,GO:0051597,1,0.805076916640419,0,6,response to methylmercury,BP,
13092,GO:0051598,1,0.959934228581473,0,1,meiotic recombination checkpoint,BP,
13093,GO:0051599,1,0.860129643705225,0,4,response to hydrostatic pressure,BP,
13094,GO:0051601,1,0.787592185899344,0,7,exocyst localization,BP,
13101,GO:0051610,1,0.887973850230192,0,3,serotonin uptake,BP,
13102,GO:0051611,1,0.924975892137633,0,2,regulation of serotonin uptake,BP,
13103,GO:0051612,1,0.924975892137633,0,2,negative regulation of serotonin uptake,BP,
13104,GO:0051615,1,0.959508590180389,0,1,histamine uptake,BP,
13105,GO:0051620,1,0.964014645926423,0,1,norepinephrine uptake,BP,
13106,GO:0051621,1,0.964014645926423,0,1,regulation of norepinephrine uptake,BP,
13107,GO:0051622,1,0.964014645926423,0,1,negative regulation of norepinephrine uptake,BP,
13108,GO:0051639,1,0.735737604660909,0,8,actin filament network formation,BP,
13111,GO:0051642,1,0.440480443632732,0,22,centrosome localization,BP,
13112,GO:0051643,1,0.81969545624595,0,5,endoplasmic reticulum localization,BP,
13113,GO:0051645,1,0.659086044426729,0,12,Golgi localization,BP,
13114,GO:0051646,1,0.276989142408633,0,35,mitochondrion localization,BP,
13115,GO:0051647,1,0.502440688872932,0,18,nucleus localization,BP,
13120,GO:0051653,1,0.284247553546305,0,34,spindle localization,BP,
13121,GO:0051654,1,0.492946878409778,0,20,establishment of mitochondrion localization,BP,
13123,GO:0051657,1,0.731274717773422,0,8,maintenance of organelle location,BP,
13124,GO:0051660,1,0.853409250074403,0,4,establishment of centrosome localization,BP,
13125,GO:0051661,1,0.822713530236588,0,5,maintenance of centrosome location,BP,
13126,GO:0051664,1,0.92738462411158,0,2,nuclear pore localization,BP,
13127,GO:0051665,1,0.80225004254745,0,7,membrane raft localization,BP,
13128,GO:0051666,1,0.884344160867303,0,3,actin cortical patch localization,BP,
13130,GO:0051673,1,0.948700812482601,0,2,membrane disruption in other organism,BP,
13132,GO:0051683,1,0.80064478692766,0,7,establishment of Golgi localization,BP,
13133,GO:0051684,1,0.888926806770103,0,3,maintenance of Golgi location,BP,
13134,GO:0051685,1,0.965469978279355,0,1,maintenance of ER location,BP,
13135,GO:0051686,1,0.95950763690405,0,1,establishment of ER localization,BP,
13136,GO:0051693,1,0.467967051797257,0,21,actin filament capping,BP,
13137,GO:0051694,1,0.931506745379745,0,2,pointed-end actin filament capping,BP,
13138,GO:0051697,1,0.887253482342607,0,4,protein delipidation,BP,
13141,GO:0051703,1,0.317576829998141,0,31,intraspecies interaction between organisms,BP,
13143,GO:0051705,1,0.245838144644701,0,38,multi-organism behavior,BP,
13145,GO:0051708,1,0.958958617476767,0,2,intracellular protein transport in other organism involved in symbiotic interaction,BP,
13146,GO:0051709,1,0.828633810743204,0,7,regulation of killing of cells of other organism,BP,
13147,GO:0051710,1,0.953757494730048,0,2,regulation of cytolysis in other organism,BP,
13148,GO:0051712,1,0.828633810743204,0,7,positive regulation of killing of cells of other organism,BP,
13149,GO:0051714,1,0.953757494730048,0,2,positive regulation of cytolysis in other organism,BP,
13150,GO:0051715,1,0.942627361216844,0,3,cytolysis in other organism,BP,
13152,GO:0051717,1,0.926630546509593,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
13154,GO:0051722,1,0.968225963662571,0,1,protein C-terminal methylesterase activity,MF,
13155,GO:0051723,1,0.968225963662571,0,1,protein methylesterase activity,MF,
13156,GO:0051724,1,0.969671436256047,0,1,NAD transmembrane transporter activity,MF,
13157,GO:0051725,1,0.942594918978131,0,2,protein de-ADP-ribosylation,BP,
13161,GO:0051731,1,0.873722789032407,0,4,polynucleotide 5'-hydroxyl-kinase activity,MF,
13162,GO:0051732,1,0.974092226169022,0,1,polyribonucleotide kinase activity,MF,
13163,GO:0051733,1,0.910603815171538,0,3,polydeoxyribonucleotide kinase activity,MF,
13164,GO:0051734,1,0.910603815171538,0,3,ATP-dependent polynucleotide kinase activity,MF,
13165,GO:0051736,1,0.974092226169022,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
13166,GO:0051747,1,0.95875197610698,0,2,cytosine C-5 DNA demethylase activity,MF,
13167,GO:0051748,1,0.970625547048195,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
13168,GO:0051750,1,0.97896132643455,0,1,delta3,5-delta2,4-dienoyl-CoA isomerase activity,MF,
13169,GO:0051754,1,0.896738532618515,0,3,meiotic sister chromatid cohesion, centromeric,BP,
13170,GO:0051764,1,0.654590352204994,0,11,actin crosslink formation,BP,
13171,GO:0051765,1,0.938211666803655,0,2,inositol tetrakisphosphate kinase activity,MF,
13177,GO:0051775,1,0.746209517713851,0,10,response to redox state,BP,
13178,GO:0051780,1,0.960654669220098,0,1,behavioral response to nutrient,BP,
13180,GO:0051782,1,0.625949761342003,0,14,negative regulation of cell division,BP,
13184,GO:0051786,1,0.963329561230936,0,1,all-trans-retinol 13,14-reductase activity,MF,
13185,GO:0051787,1,0.454134906567846,0,23,misfolded protein binding,MF,
13186,GO:0051788,1,0.466092724262574,0,22,response to misfolded protein,BP,
13187,GO:0051790,1,0.880373985983019,0,4,short-chain fatty acid biosynthetic process,BP,
13188,GO:0051791,1,0.802815365701556,0,7,medium-chain fatty acid metabolic process,BP,
13189,GO:0051792,1,0.89049238189742,0,4,medium-chain fatty acid biosynthetic process,BP,
13190,GO:0051793,1,0.901329758469268,0,3,medium-chain fatty acid catabolic process,BP,
13191,GO:0051794,1,0.880144986442102,0,4,regulation of timing of catagen,BP,
13192,GO:0051795,1,0.916467071900865,0,3,positive regulation of timing of catagen,BP,
13193,GO:0051796,1,0.960375828840977,0,1,negative regulation of timing of catagen,BP,
13197,GO:0051800,1,0.959510929815221,0,1,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
13198,GO:0051805,1,0.927482832823174,0,2,evasion or tolerance of immune response of other organism involved in symbiotic interaction,BP,
13200,GO:0051807,1,0.927482832823174,0,2,evasion or tolerance of defense response of other organism involved in symbiotic interaction,BP,
13201,GO:0051808,1,0.968550558863716,0,1,translocation of peptides or proteins into other organism involved in symbiotic interaction,BP,
13203,GO:0051818,1,0.846860395432642,0,6,disruption of cells of other organism involved in symbiotic interaction,BP,
13204,GO:0051821,1,0.95950763690405,0,1,dissemination or transmission of organism from other organism involved in symbiotic interaction,BP,
13205,GO:0051823,1,0.878095858950618,0,4,regulation of synapse structural plasticity,BP,
13208,GO:0051833,1,0.959555954835982,0,1,suppression of defenses of other organism involved in symbiotic interaction,BP,
13210,GO:0051835,1,0.909370632638734,0,3,positive regulation of synapse structural plasticity,BP,
13211,GO:0051836,1,0.760254435299189,0,9,translocation of molecules into other organism involved in symbiotic interaction,BP,
13213,GO:0051852,1,0.899693352023811,0,4,disruption by host of symbiont cells,BP,
13214,GO:0051861,1,0.648569775088312,0,13,glycolipid binding,MF,
13215,GO:0051864,1,0.728460701424067,0,8,histone demethylase activity (H3-K36 specific),MF,
13217,GO:0051866,1,0.962442096191974,0,1,general adaptation syndrome,BP,
13218,GO:0051870,1,0.961189946387075,0,1,methotrexate binding,MF,
13219,GO:0051873,1,0.899693352023811,0,4,killing by host of symbiont cells,BP,
13220,GO:0051875,1,0.477050866319332,0,22,pigment granule localization,BP,
13221,GO:0051877,1,0.932485015923196,0,2,pigment granule aggregation in cell center,BP,
13223,GO:0051880,1,0.756119102081024,0,7,G-quadruplex DNA binding,MF,
13225,GO:0051882,1,0.636368523820593,0,15,mitochondrial depolarization,BP,
13226,GO:0051883,1,0.846860395432642,0,6,killing of cells in other organism involved in symbiotic interaction,BP,
13230,GO:0051890,1,0.921587864056793,0,2,regulation of cardioblast differentiation,BP,
13231,GO:0051891,1,0.959559727457905,0,1,positive regulation of cardioblast differentiation,BP,
13232,GO:0051892,1,0.960431845659979,0,1,negative regulation of cardioblast differentiation,BP,
13240,GO:0051900,1,0.676034777043132,0,13,regulation of mitochondrial depolarization,BP,
13241,GO:0051901,1,0.879477411265743,0,5,positive regulation of mitochondrial depolarization,BP,
13242,GO:0051902,1,0.851594917502947,0,5,negative regulation of mitochondrial depolarization,BP,
13243,GO:0051903,1,0.966980370923912,0,1,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
13244,GO:0051904,1,0.531727831278239,0,19,pigment granule transport,BP,
13245,GO:0051905,1,0.510163350880516,0,20,establishment of pigment granule localization,BP,
13246,GO:0051908,1,0.963858119710408,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
13247,GO:0051917,1,0.812077417950848,0,6,regulation of fibrinolysis,BP,
13248,GO:0051918,1,0.865480534030269,0,4,negative regulation of fibrinolysis,BP,
13249,GO:0051919,1,0.971332584835709,0,1,positive regulation of fibrinolysis,BP,
13250,GO:0051920,1,0.842281026620497,0,8,peroxiredoxin activity,MF,
13251,GO:0051923,1,0.749300479399478,0,9,sulfation,BP,
13257,GO:0051932,1,0.497297307534277,0,19,synaptic transmission, GABAergic,BP,
13258,GO:0051933,1,0.95950763690405,0,1,amino acid neurotransmitter reuptake,BP,
13259,GO:0051934,1,0.849472826983781,0,6,catecholamine uptake involved in synaptic transmission,BP,
13260,GO:0051935,1,0.95950763690405,0,1,glutamate reuptake,BP,
13262,GO:0051938,1,0.803609888362318,0,6,L-glutamate import,BP,
13263,GO:0051940,1,0.900474384110754,0,4,regulation of catecholamine uptake involved in synaptic transmission,BP,
13264,GO:0051941,1,0.95950763690405,0,1,regulation of amino acid uptake involved in synaptic transmission,BP,
13265,GO:0051944,1,0.976034336339999,0,1,positive regulation of catecholamine uptake involved in synaptic transmission,BP,
13266,GO:0051945,1,0.964014645926423,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
13267,GO:0051946,1,0.95950763690405,0,1,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
13269,GO:0051953,1,0.834422006530685,0,5,negative regulation of amine transport,BP,
13271,GO:0051955,1,0.631679281885965,0,13,regulation of amino acid transport,BP,
13272,GO:0051956,1,0.89759380587372,0,3,negative regulation of amino acid transport,BP,
13273,GO:0051957,1,0.808579816979925,0,6,positive regulation of amino acid transport,BP,
13274,GO:0051958,1,0.926672345318717,0,2,methotrexate transport,BP,
13275,GO:0051959,1,0.437668260385011,0,23,dynein light intermediate chain binding,MF,
13281,GO:0051965,1,0.271468203535301,0,34,positive regulation of synapse assembly,BP,
13283,GO:0051967,1,0.91143762286373,0,3,negative regulation of synaptic transmission, glutamatergic,BP,
13285,GO:0051969,1,0.870044303939484,0,4,regulation of transmission of nerve impulse,BP,
13286,GO:0051971,1,0.92940829535062,0,2,positive regulation of transmission of nerve impulse,BP,
13287,GO:0051972,1,0.243430725861463,0,42,regulation of telomerase activity,BP,
13288,GO:0051973,1,0.330696610209637,0,33,positive regulation of telomerase activity,BP,
13289,GO:0051974,1,0.768850897181067,0,8,negative regulation of telomerase activity,BP,
13290,GO:0051977,1,0.970261207072129,0,1,lysophospholipid transport,BP,
13291,GO:0051978,1,0.970261207072129,0,1,lysophospholipid transporter activity,MF,
13293,GO:0051984,1,0.398679204652275,0,26,positive regulation of chromosome segregation,BP,
13295,GO:0051987,1,0.844861925217624,0,5,positive regulation of attachment of spindle microtubules to kinetochore,BP,
13296,GO:0051988,1,0.656185192661382,0,12,regulation of attachment of spindle microtubules to kinetochore,BP,
13297,GO:0051990,1,0.937495866335407,0,2,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
13298,GO:0051996,1,0.970918583286906,0,1,squalene synthase activity,MF,
13299,GO:0051998,1,0.78747507321037,0,7,protein carboxyl O-methyltransferase activity,MF,
13301,GO:0052029,1,0.959555954835982,0,1,negative regulation by symbiont of host signal transduction pathway,BP,
13302,GO:0052031,1,0.909218029717045,0,3,modulation by symbiont of host defense response,BP,
13303,GO:0052037,1,0.959555954835982,0,1,negative regulation by symbiont of host defense response,BP,
13304,GO:0052040,1,0.827709450336774,0,6,modulation by symbiont of host programmed cell death,BP,
13305,GO:0052041,1,0.881508414903699,0,4,negative regulation by symbiont of host programmed cell death,BP,
13306,GO:0052042,1,0.921000638001773,0,3,positive regulation by symbiont of host programmed cell death,BP,
13307,GO:0052047,1,0.95950763690405,0,1,interaction with other organism via secreted substance involved in symbiotic interaction,BP,
13308,GO:0052053,1,0.966249973095834,0,1,negative regulation by symbiont of host catalytic activity,BP,
13309,GO:0052055,1,0.927167608234395,0,2,modulation by symbiont of host molecular function,BP,
13310,GO:0052056,1,0.927167608234395,0,2,negative regulation by symbiont of host molecular function,BP,
13312,GO:0052097,1,0.963486266439358,0,1,interspecies quorum sensing,BP,
13313,GO:0052106,1,0.963486266439358,0,1,quorum sensing involved in interaction with host,BP,
13315,GO:0052148,1,0.966249973095834,0,1,modulation by symbiont of host catalytic activity,BP,
13316,GO:0052150,1,0.845950450298836,0,5,modulation by symbiont of host apoptotic process,BP,
13317,GO:0052151,1,0.941292005526513,0,2,positive regulation by symbiont of host apoptotic process,BP,
13318,GO:0052167,1,0.959555954835982,0,1,modulation by symbiont of host innate immune response,BP,
13319,GO:0052170,1,0.959555954835982,0,1,negative regulation by symbiont of host innate immune response,BP,
13324,GO:0052199,1,0.966249973095834,0,1,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
13326,GO:0052203,1,0.941218972956838,0,2,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,
13327,GO:0052204,1,0.863987732474028,0,5,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,
13328,GO:0052205,1,0.828990182865049,0,6,modulation of molecular function in other organism involved in symbiotic interaction,BP,
13329,GO:0052214,1,0.975139906960328,0,1,metabolism of substance in other organism involved in symbiotic interaction,BP,
13330,GO:0052227,1,0.975139906960328,0,1,catabolism of substance in other organism involved in symbiotic interaction,BP,
13331,GO:0052229,1,0.975139906960328,0,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,
13333,GO:0052248,1,0.827709450336774,0,6,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,
13335,GO:0052251,1,0.947545724389011,0,2,induction by organism of defense response of other organism involved in symbiotic interaction,BP,
13336,GO:0052255,1,0.909218029717045,0,3,modulation by organism of defense response of other organism involved in symbiotic interaction,BP,
13337,GO:0052261,1,0.959555954835982,0,1,suppression of defense response of other organism involved in symbiotic interaction,BP,
13338,GO:0052306,1,0.959555954835982,0,1,modulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13339,GO:0052309,1,0.959555954835982,0,1,negative regulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13341,GO:0052314,1,0.972641442982888,0,1,phytoalexin metabolic process,BP,
13342,GO:0052330,1,0.921000638001773,0,3,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
13343,GO:0052360,1,0.975139906960328,0,1,catabolism by host of symbiont macromolecule,BP,
13344,GO:0052361,1,0.975139906960328,0,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,
13345,GO:0052362,1,0.975139906960328,0,1,catabolism by host of symbiont protein,BP,
13346,GO:0052363,1,0.975139906960328,0,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,
13347,GO:0052364,1,0.975139906960328,0,1,catabolism by host of substance in symbiont,BP,
13349,GO:0052381,1,0.970722757259711,0,1,tRNA dimethylallyltransferase activity,MF,
13350,GO:0052405,1,0.931869738433291,0,3,negative regulation by host of symbiont molecular function,BP,
13351,GO:0052416,1,0.975139906960328,0,1,metabolism by host of symbiont macromolecule,BP,
13352,GO:0052417,1,0.975139906960328,0,1,metabolism by host of symbiont protein,BP,
13353,GO:0052418,1,0.975139906960328,0,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,
13354,GO:0052419,1,0.975139906960328,0,1,metabolism by host of substance in symbiont,BP,
13355,GO:0052422,1,0.974096920979988,0,1,modulation by host of symbiont catalytic activity,BP,
13356,GO:0052428,1,0.894129518427425,0,4,modulation by host of symbiont molecular function,BP,
13357,GO:0052433,1,0.827709450336774,0,6,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
13359,GO:0052490,1,0.881508414903699,0,4,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
13360,GO:0052493,1,0.959555954835982,0,1,negative regulation by organism of signal transduction in other organism involved in symbiotic interaction,BP,
13361,GO:0052501,1,0.921000638001773,0,3,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
13362,GO:0052509,1,0.947545724389011,0,2,positive regulation by symbiont of host defense response,BP,
13363,GO:0052510,1,0.947545724389011,0,2,positive regulation by organism of defense response of other organism involved in symbiotic interaction,BP,
13367,GO:0052550,1,0.974728672087704,0,1,response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction,BP,
13368,GO:0052552,1,0.909218029717045,0,3,modulation by organism of immune response of other organism involved in symbiotic interaction,BP,
13369,GO:0052553,1,0.909218029717045,0,3,modulation by symbiont of host immune response,BP,
13370,GO:0052561,1,0.959555954835982,0,1,negative regulation by organism of immune response of other organism involved in symbiotic interaction,BP,
13371,GO:0052562,1,0.959555954835982,0,1,negative regulation by symbiont of host immune response,BP,
13372,GO:0052564,1,0.856607141582503,0,5,response to immune response of other organism involved in symbiotic interaction,BP,
13373,GO:0052567,1,0.974728672087704,0,1,response to defense-related host reactive oxygen species production,BP,
13374,GO:0052572,1,0.856607141582503,0,5,response to host immune response,BP,
13375,GO:0052590,1,0.95950763690405,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
13376,GO:0052591,1,0.95950763690405,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
13377,GO:0052593,1,0.929338650678294,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
13378,GO:0052594,1,0.929338650678294,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
13379,GO:0052595,1,0.929338650678294,0,2,aliphatic-amine oxidase activity,MF,
13380,GO:0052596,1,0.929338650678294,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
13381,GO:0052629,1,0.647831831386903,0,11,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,
13382,GO:0052642,1,0.973479823875885,0,1,lysophosphatidic acid phosphatase activity,MF,
13383,GO:0052646,1,0.742315513756603,0,8,alditol phosphate metabolic process,BP,
13384,GO:0052650,1,0.817783731335551,0,7,NADP-retinol dehydrogenase activity,MF,
13385,GO:0052651,1,0.940139285715387,0,2,monoacylglycerol catabolic process,BP,
13387,GO:0052654,1,0.935811104363509,0,2,L-leucine transaminase activity,MF,
13388,GO:0052655,1,0.935811104363509,0,2,L-valine transaminase activity,MF,
13389,GO:0052656,1,0.935811104363509,0,2,L-isoleucine transaminase activity,MF,
13390,GO:0052657,1,0.977361566085134,0,1,guanine phosphoribosyltransferase activity,MF,
13391,GO:0052658,1,0.797426854295967,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
13392,GO:0052659,1,0.707749591816482,0,9,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,
13393,GO:0052666,1,0.972176441940517,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
13395,GO:0052692,1,0.977330398382787,0,1,raffinose alpha-galactosidase activity,MF,
13396,GO:0052695,1,0.79431102893545,0,7,cellular glucuronidation,BP,
13397,GO:0052696,1,0.856107117859149,0,5,flavonoid glucuronidation,BP,
13398,GO:0052697,1,0.856107117859149,0,5,xenobiotic glucuronidation,BP,
13399,GO:0052717,1,0.95950763690405,0,1,tRNA-specific adenosine-34 deaminase activity,MF,
13400,GO:0052718,1,0.95950763690405,0,1,tRNA-specific adenosine-34 deaminase complex,CC,
13401,GO:0052723,1,0.8649344388281,0,4,inositol hexakisphosphate 1-kinase activity,MF,
13402,GO:0052724,1,0.8649344388281,0,4,inositol hexakisphosphate 3-kinase activity,MF,
13403,GO:0052725,1,0.963600423230496,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
13404,GO:0052726,1,0.963600423230496,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
13405,GO:0052735,1,0.901015398895054,0,3,tRNA (cytosine-3-)-methyltransferase activity,MF,
13406,GO:0052739,1,0.971249131651633,0,1,phosphatidylserine 1-acylhydrolase activity,MF,
13407,GO:0052740,1,0.971249131651633,0,1,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
13409,GO:0052743,1,0.655778926362247,0,11,inositol tetrakisphosphate phosphatase activity,MF,
13410,GO:0052744,1,0.576380448075463,0,14,phosphatidylinositol monophosphate phosphatase activity,MF,
13411,GO:0052745,1,0.491590481942633,0,19,inositol phosphate phosphatase activity,MF,
13412,GO:0052746,1,0.925226594477178,0,2,inositol phosphorylation,BP,
13413,GO:0052794,1,0.938544343010337,0,2,exo-alpha-(2->3)-sialidase activity,MF,
13414,GO:0052795,1,0.938544343010337,0,2,exo-alpha-(2->6)-sialidase activity,MF,
13415,GO:0052796,1,0.938544343010337,0,2,exo-alpha-(2->8)-sialidase activity,MF,
13416,GO:0052798,1,0.971000731150142,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
13423,GO:0052815,1,0.980140625810969,0,1,medium-chain acyl-CoA hydrolase activity,MF,
13424,GO:0052821,1,0.980941812318171,0,1,DNA-7-methyladenine glycosylase activity,MF,
13425,GO:0052822,1,0.980941812318171,0,1,DNA-3-methylguanine glycosylase activity,MF,
13426,GO:0052825,1,0.963600423230496,0,1,inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity,MF,
13427,GO:0052826,1,0.965735644384804,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
13428,GO:0052827,1,0.930580244268201,0,2,inositol pentakisphosphate phosphatase activity,MF,
13429,GO:0052828,1,0.921852166729382,0,2,inositol-3,4-bisphosphate 4-phosphatase activity,MF,
13430,GO:0052829,1,0.971054302070478,0,1,inositol-1,3,4-trisphosphate 1-phosphatase activity,MF,
13431,GO:0052830,1,0.963600423230496,0,1,inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity,MF,
13432,GO:0052831,1,0.963600423230496,0,1,inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity,MF,
13433,GO:0052832,1,0.869857860184935,0,4,inositol monophosphate 3-phosphatase activity,MF,
13434,GO:0052833,1,0.869857860184935,0,4,inositol monophosphate 4-phosphatase activity,MF,
13435,GO:0052834,1,0.869857860184935,0,4,inositol monophosphate phosphatase activity,MF,
13436,GO:0052835,1,0.963600423230496,0,1,inositol-3,4,6-trisphosphate 1-kinase activity,MF,
13437,GO:0052836,1,0.939464629677866,0,2,inositol 5-diphosphate pentakisphosphate 5-kinase activity,MF,
13438,GO:0052839,1,0.939464629677866,0,2,inositol diphosphate tetrakisphosphate kinase activity,MF,
13439,GO:0052840,1,0.883830410916759,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
13440,GO:0052841,1,0.883830410916759,0,4,inositol bisdiphosphate tetrakisphosphate diphosphatase activity,MF,
13441,GO:0052842,1,0.883830410916759,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
13442,GO:0052843,1,0.883830410916759,0,4,inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity,MF,
13443,GO:0052844,1,0.883830410916759,0,4,inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity,MF,
13444,GO:0052845,1,0.883830410916759,0,4,inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity,MF,
13445,GO:0052846,1,0.883830410916759,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity,MF,
13446,GO:0052847,1,0.883830410916759,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
13447,GO:0052848,1,0.883830410916759,0,4,inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
13449,GO:0052858,1,0.962277946045393,0,1,peptidyl-lysine acetyltransferase activity,MF,
13450,GO:0052866,1,0.362917111243803,0,26,phosphatidylinositol phosphate phosphatase activity,MF,
13451,GO:0052890,1,0.972508899337928,0,1,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,
13452,GO:0052894,1,0.971203371649147,0,1,norspermine:oxygen oxidoreductase activity,MF,
13453,GO:0052895,1,0.971203371649147,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
13454,GO:0052899,1,0.974565797611057,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13455,GO:0052901,1,0.946499775823608,0,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,
13456,GO:0052902,1,0.974565797611057,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
13457,GO:0052903,1,0.974565797611057,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13458,GO:0052904,1,0.974565797611057,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13459,GO:0052905,1,0.899937323989477,0,3,tRNA (guanine(9)-N(1))-methyltransferase activity,MF,
13460,GO:0052906,1,0.959540872958223,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
13461,GO:0052907,1,0.965469978279355,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
13462,GO:0052909,1,0.965469978279355,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
13463,GO:0052917,1,0.968837711911951,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
13464,GO:0052918,1,0.95950763690405,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
13465,GO:0052925,1,0.976321127068418,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
13466,GO:0052926,1,0.95950763690405,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
13467,GO:0052927,1,0.969587045794927,0,1,CTP:tRNA cytidylyltransferase activity,MF,
13468,GO:0052928,1,0.969587045794927,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
13469,GO:0052929,1,0.969587045794927,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
13472,GO:0055003,1,0.719071974516095,0,8,cardiac myofibril assembly,BP,
13473,GO:0055005,1,0.959515685611627,0,1,ventricular cardiac myofibril assembly,BP,
13477,GO:0055009,1,0.909712111043764,0,3,atrial cardiac muscle tissue morphogenesis,BP,
13479,GO:0055011,1,0.974546697433778,0,1,atrial cardiac muscle cell differentiation,BP,
13480,GO:0055012,1,0.736658166493469,0,9,ventricular cardiac muscle cell differentiation,BP,
13482,GO:0055014,1,0.974546697433778,0,1,atrial cardiac muscle cell development,BP,
13483,GO:0055015,1,0.797019458492072,0,7,ventricular cardiac muscle cell development,BP,
13485,GO:0055018,1,0.973756390557974,0,1,regulation of cardiac muscle fiber development,BP,
13486,GO:0055020,1,0.973756390557974,0,1,positive regulation of cardiac muscle fiber development,BP,
13488,GO:0055022,1,0.606041706075573,0,14,negative regulation of cardiac muscle tissue growth,BP,
13493,GO:0055028,1,0.95950763690405,0,1,cortical microtubule,CC,
13497,GO:0055048,1,0.95950763690405,0,1,anastral spindle assembly,BP,
13498,GO:0055056,1,0.833871093349482,0,5,D-glucose transmembrane transporter activity,MF,
13499,GO:0055057,1,0.674108613728404,0,10,neuroblast division,BP,
13500,GO:0055059,1,0.855101599932926,0,4,asymmetric neuroblast division,BP,
13501,GO:0055062,1,0.794567944874972,0,6,phosphate ion homeostasis,BP,
13502,GO:0055064,1,0.708479618080815,0,9,chloride ion homeostasis,BP,
13505,GO:0055069,1,0.528434202967232,0,21,zinc ion homeostasis,BP,
13506,GO:0055070,1,0.623239853794426,0,16,copper ion homeostasis,BP,
13509,GO:0055075,1,0.584318940285701,0,14,potassium ion homeostasis,BP,
13516,GO:0055083,1,0.562822930893192,0,15,monovalent inorganic anion homeostasis,BP,
13519,GO:0055087,1,0.903029524117941,0,3,Ski complex,CC,
13521,GO:0055089,1,0.679378102472925,0,11,fatty acid homeostasis,BP,
13522,GO:0055090,1,0.646993525745448,0,14,acylglycerol homeostasis,BP,
13527,GO:0055095,1,0.96142959053243,0,1,lipoprotein particle mediated signaling,BP,
13528,GO:0055096,1,0.96142959053243,0,1,low-density lipoprotein particle mediated signaling,BP,
13529,GO:0055100,1,0.896927864017735,0,3,adiponectin binding,MF,
13530,GO:0055102,1,0.806182548287443,0,8,lipase inhibitor activity,MF,
13531,GO:0055103,1,0.963651240948405,0,1,ligase regulator activity,MF,
13532,GO:0055105,1,0.887384362975647,0,6,ubiquitin-protein transferase inhibitor activity,MF,
13534,GO:0055108,1,0.972011995587733,0,1,Golgi to transport vesicle transport,BP,
13535,GO:0055113,1,0.95950763690405,0,1,epiboly involved in gastrulation with mouth forming second,BP,
13539,GO:0055119,1,0.680915957529264,0,11,relaxation of cardiac muscle,BP,
13540,GO:0055120,1,0.981391802514935,0,1,striated muscle dense body,CC,
13542,GO:0055129,1,0.887091258798581,0,4,L-proline biosynthetic process,BP,
13543,GO:0055131,1,0.859416083941684,0,5,C3HC4-type RING finger domain binding,MF,
13544,GO:0060001,1,0.95950763690405,0,1,minus-end directed microfilament motor activity,MF,
13545,GO:0060002,1,0.922537859332907,0,2,plus-end directed microfilament motor activity,MF,
13546,GO:0060003,1,0.920650957478618,0,2,copper ion export,BP,
13548,GO:0060005,1,0.960579818724481,0,1,vestibular reflex,BP,
13549,GO:0060007,1,0.960579818724481,0,1,linear vestibuloocular reflex,BP,
13552,GO:0060010,1,0.963314090100241,0,1,Sertoli cell fate commitment,BP,
13554,GO:0060012,1,0.963768076646009,0,1,synaptic transmission, glycinergic,BP,
13556,GO:0060014,1,0.965362156840262,0,1,granulosa cell differentiation,BP,
13557,GO:0060017,1,0.835250933291997,0,5,parathyroid gland development,BP,
13559,GO:0060019,1,0.762369510164706,0,9,radial glial cell differentiation,BP,
13562,GO:0060022,1,0.827417929384712,0,5,hard palate development,BP,
13563,GO:0060023,1,0.86534548284541,0,4,soft palate development,BP,
13565,GO:0060025,1,0.926842899720689,0,2,regulation of synaptic activity,BP,
13571,GO:0060032,1,0.95950763690405,0,1,notochord regression,BP,
13572,GO:0060033,1,0.800767228992468,0,6,anatomical structure regression,BP,
13573,GO:0060037,1,0.541929172063504,0,17,pharyngeal system development,BP,
13576,GO:0060040,1,0.933381093515793,0,2,retinal bipolar neuron differentiation,BP,
13580,GO:0060044,1,0.696075735943484,0,10,negative regulation of cardiac muscle cell proliferation,BP,
13585,GO:0060049,1,0.68329897892854,0,11,regulation of protein glycosylation,BP,
13586,GO:0060050,1,0.7567345601664,0,8,positive regulation of protein glycosylation,BP,
13587,GO:0060051,1,0.941136648914539,0,2,negative regulation of protein glycosylation,BP,
13588,GO:0060052,1,0.782687944201388,0,7,neurofilament cytoskeleton organization,BP,
13589,GO:0060053,1,0.929526900575354,0,2,neurofilament cytoskeleton,CC,
13595,GO:0060059,1,0.847583644480562,0,4,embryonic retina morphogenesis in camera-type eye,BP,
13596,GO:0060060,1,0.95950763690405,0,1,post-embryonic retina morphogenesis in camera-type eye,BP,
13597,GO:0060061,1,0.937004109714225,0,2,Spemann organizer formation,BP,
13598,GO:0060064,1,0.976549225204766,0,1,Spemann organizer formation at the anterior end of the primitive streak,BP,
13600,GO:0060066,1,0.938221875611447,0,2,oviduct development,BP,
13605,GO:0060072,1,0.95950763690405,0,1,large conductance calcium-activated potassium channel activity,MF,
13606,GO:0060073,1,0.858167436291105,0,4,micturition,BP,
13607,GO:0060074,1,0.719047316365022,0,9,synapse maturation,BP,
13608,GO:0060075,1,0.900438254998693,0,3,regulation of resting membrane potential,BP,
13609,GO:0060076,1,0.603818657948834,0,13,excitatory synapse,CC,
13610,GO:0060077,1,0.719598873423548,0,9,inhibitory synapse,CC,
13613,GO:0060080,1,0.781713912446026,0,6,inhibitory postsynaptic potential,BP,
13614,GO:0060081,1,0.799781178345472,0,7,membrane hyperpolarization,BP,
13615,GO:0060083,1,0.92175972072933,0,2,smooth muscle contraction involved in micturition,BP,
13616,GO:0060084,1,0.959507712723564,0,1,synaptic transmission involved in micturition,BP,
13617,GO:0060086,1,0.931617056777066,0,2,circadian temperature homeostasis,BP,
13618,GO:0060087,1,0.898688354124824,0,4,relaxation of vascular smooth muscle,BP,
13619,GO:0060088,1,0.843929568807747,0,5,auditory receptor cell stereocilium organization,BP,
13622,GO:0060091,1,0.853966166834248,0,5,kinocilium,CC,
13623,GO:0060092,1,0.963768076646009,0,1,regulation of synaptic transmission, glycinergic,BP,
13624,GO:0060099,1,0.830171345152266,0,5,regulation of phagocytosis, engulfment,BP,
13625,GO:0060100,1,0.830171345152266,0,5,positive regulation of phagocytosis, engulfment,BP,
13627,GO:0060117,1,0.666801754448533,0,11,auditory receptor cell development,BP,
13629,GO:0060120,1,0.852955722492822,0,5,inner ear receptor cell fate commitment,BP,
13632,GO:0060124,1,0.924988993446398,0,2,positive regulation of growth hormone secretion,BP,
13634,GO:0060126,1,0.932298323641396,0,2,somatotropin secreting cell differentiation,BP,
13635,GO:0060127,1,0.969903576232698,0,1,prolactin secreting cell differentiation,BP,
13638,GO:0060134,1,0.926159031558731,0,2,prepulse inhibition,BP,
13642,GO:0060139,1,0.941292005526513,0,2,positive regulation of apoptotic process by virus,BP,
13648,GO:0060151,1,0.921819226610163,0,2,peroxisome localization,BP,
13649,GO:0060152,1,0.921819226610163,0,2,microtubule-based peroxisome localization,BP,
13650,GO:0060154,1,0.911382175956605,0,3,cellular process regulating host cell cycle in response to virus,BP,
13651,GO:0060155,1,0.8175499543982,0,7,platelet dense granule organization,BP,
13652,GO:0060156,1,0.96422412068149,0,1,milk ejection reflex,BP,
13654,GO:0060158,1,0.893051382856087,0,4,phospholipase C-activating dopamine receptor signaling pathway,BP,
13655,GO:0060159,1,0.878624503904598,0,4,regulation of dopamine receptor signaling pathway,BP,
13656,GO:0060161,1,0.899219798133,0,3,positive regulation of dopamine receptor signaling pathway,BP,
13657,GO:0060164,1,0.976999496905179,0,1,regulation of timing of neuron differentiation,BP,
13659,GO:0060167,1,0.976124642047473,0,1,regulation of adenosine receptor signaling pathway,BP,
13660,GO:0060169,1,0.976124642047473,0,1,negative regulation of adenosine receptor signaling pathway,BP,
13662,GO:0060171,1,0.959784459624088,0,1,stereocilium membrane,CC,
13665,GO:0060178,1,0.969725342433419,0,1,regulation of exocyst localization,BP,
13666,GO:0060179,1,0.904689389696563,0,3,male mating behavior,BP,
13667,GO:0060180,1,0.897199657102868,0,3,female mating behavior,BP,
13668,GO:0060183,1,0.963768076646009,0,1,apelin receptor signaling pathway,BP,
13670,GO:0060187,1,0.921006309364048,0,2,cell pole,CC,
13672,GO:0060192,1,0.735318384632492,0,10,negative regulation of lipase activity,BP,
13674,GO:0060197,1,0.934702665367024,0,2,cloacal septation,BP,
13675,GO:0060198,1,0.821798486723487,0,6,clathrin-sculpted vesicle,CC,
13676,GO:0060199,1,0.931462930894913,0,2,clathrin-sculpted glutamate transport vesicle,CC,
13677,GO:0060200,1,0.959742867692322,0,1,clathrin-sculpted acetylcholine transport vesicle,CC,
13678,GO:0060201,1,0.959742867692322,0,1,clathrin-sculpted acetylcholine transport vesicle membrane,CC,
13679,GO:0060203,1,0.931462930894913,0,2,clathrin-sculpted glutamate transport vesicle membrane,CC,
13682,GO:0060212,1,0.97340657801975,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
13684,GO:0060214,1,0.975964265527229,0,1,endocardium formation,BP,
13685,GO:0060215,1,0.831561174535018,0,5,primitive hemopoiesis,BP,
13686,GO:0060216,1,0.587735598024194,0,14,definitive hemopoiesis,BP,
13690,GO:0060228,1,0.968461586427413,0,2,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,
13693,GO:0060232,1,0.875946007488635,0,4,delamination,BP,
13694,GO:0060235,1,0.896484769387186,0,3,lens induction in camera-type eye,BP,
13695,GO:0060236,1,0.292383364656245,0,35,regulation of mitotic spindle organization,BP,
13696,GO:0060242,1,0.789297023504345,0,7,contact inhibition,BP,
13697,GO:0060244,1,0.905300150762129,0,3,negative regulation of cell proliferation involved in contact inhibition,BP,
13698,GO:0060245,1,0.961708575034571,0,1,detection of cell density,BP,
13699,GO:0060246,1,0.961708575034571,0,1,detection of cell density by contact stimulus,BP,
13700,GO:0060248,1,0.961708575034571,0,1,detection of cell density by contact stimulus involved in contact inhibition,BP,
13703,GO:0060252,1,0.74914868281797,0,8,positive regulation of glial cell proliferation,BP,
13704,GO:0060253,1,0.737278290177806,0,9,negative regulation of glial cell proliferation,BP,
13706,GO:0060259,1,0.773522233691111,0,7,regulation of feeding behavior,BP,
13711,GO:0060265,1,0.983666277807722,0,1,positive regulation of respiratory burst involved in inflammatory response,BP,
13713,GO:0060267,1,0.917360968039441,0,3,positive regulation of respiratory burst,BP,
13716,GO:0060272,1,0.775660095350886,0,8,embryonic skeletal joint morphogenesis,BP,
13719,GO:0060281,1,0.782132304897972,0,7,regulation of oocyte development,BP,
13720,GO:0060282,1,0.904818905378129,0,3,positive regulation of oocyte development,BP,
13721,GO:0060283,1,0.923790271966438,0,2,negative regulation of oocyte development,BP,
13723,GO:0060285,1,0.590374324160719,0,15,cilium-dependent cell motility,BP,
13724,GO:0060287,1,0.871375022451149,0,4,epithelial cilium movement involved in determination of left/right asymmetry,BP,
13728,GO:0060293,1,0.791567253296226,0,7,germ plasm,CC,
13729,GO:0060294,1,0.743751593165546,0,9,cilium movement involved in cell motility,BP,
13730,GO:0060295,1,0.842906792883965,0,5,regulation of cilium movement involved in cell motility,BP,
13731,GO:0060296,1,0.842906792883965,0,5,regulation of cilium beat frequency involved in ciliary motility,BP,
13734,GO:0060300,1,0.918388730900304,0,3,regulation of cytokine activity,BP,
13735,GO:0060301,1,0.968057406154827,0,1,positive regulation of cytokine activity,BP,
13736,GO:0060302,1,0.948696544930083,0,2,negative regulation of cytokine activity,BP,
13737,GO:0060304,1,0.819318402011281,0,5,regulation of phosphatidylinositol dephosphorylation,BP,
13739,GO:0060307,1,0.681301401810952,0,10,regulation of ventricular cardiac muscle cell membrane repolarization,BP,
13740,GO:0060309,1,0.984546325131077,0,1,elastin catabolic process,BP,
13741,GO:0060310,1,0.984546325131077,0,1,regulation of elastin catabolic process,BP,
13742,GO:0060311,1,0.984546325131077,0,1,negative regulation of elastin catabolic process,BP,
13743,GO:0060312,1,0.820302924834101,0,6,regulation of blood vessel remodeling,BP,
13744,GO:0060313,1,0.906454023661549,0,3,negative regulation of blood vessel remodeling,BP,
13745,GO:0060314,1,0.550220865651393,0,18,regulation of ryanodine-sensitive calcium-release channel activity,BP,
13746,GO:0060315,1,0.80383856389988,0,8,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,
13747,GO:0060316,1,0.81021969113759,0,7,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,
13749,GO:0060318,1,0.856800457552165,0,4,definitive erythrocyte differentiation,BP,
13750,GO:0060319,1,0.927497447244096,0,2,primitive erythrocyte differentiation,BP,
13756,GO:0060327,1,0.965469978279355,0,1,cytoplasmic actin-based contraction involved in cell motility,BP,
13758,GO:0060331,1,0.842544854490236,0,6,negative regulation of response to interferon-gamma,BP,
13759,GO:0060332,1,0.887194569687049,0,3,positive regulation of response to interferon-gamma,BP,
13762,GO:0060335,1,0.887194569687049,0,3,positive regulation of interferon-gamma-mediated signaling pathway,BP,
13763,GO:0060336,1,0.842544854490236,0,6,negative regulation of interferon-gamma-mediated signaling pathway,BP,
13766,GO:0060339,1,0.780143559103137,0,7,negative regulation of type I interferon-mediated signaling pathway,BP,
13769,GO:0060342,1,0.972864000299692,0,1,photoreceptor inner segment membrane,CC,
13771,GO:0060346,1,0.763599050144071,0,7,bone trabecula formation,BP,
13782,GO:0060364,1,0.870509435134046,0,4,frontal suture morphogenesis,BP,
13783,GO:0060366,1,0.95950763690405,0,1,lambdoid suture morphogenesis,BP,
13784,GO:0060367,1,0.95950763690405,0,1,sagittal suture morphogenesis,BP,
13785,GO:0060368,1,0.81773819196869,0,6,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
13786,GO:0060369,1,0.87082465431759,0,4,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
13787,GO:0060370,1,0.959507641945269,0,1,susceptibility to T cell mediated cytotoxicity,BP,
13788,GO:0060371,1,0.892054682817562,0,3,regulation of atrial cardiac muscle cell membrane depolarization,BP,
13789,GO:0060372,1,0.95950763690405,0,1,regulation of atrial cardiac muscle cell membrane repolarization,BP,
13790,GO:0060373,1,0.8616882730939,0,4,regulation of ventricular cardiac muscle cell membrane depolarization,BP,
13791,GO:0060374,1,0.891827027183891,0,3,mast cell differentiation,BP,
13792,GO:0060375,1,0.963651240948405,0,1,regulation of mast cell differentiation,BP,
13793,GO:0060377,1,0.963651240948405,0,1,negative regulation of mast cell differentiation,BP,
13794,GO:0060378,1,0.95950763690405,0,1,regulation of brood size,BP,
13796,GO:0060380,1,0.971290817398837,0,1,regulation of single-stranded telomeric DNA binding,BP,
13797,GO:0060381,1,0.971290817398837,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
13798,GO:0060382,1,0.921847905372476,0,2,regulation of DNA strand elongation,BP,
13799,GO:0060383,1,0.960754975029549,0,1,positive regulation of DNA strand elongation,BP,
13800,GO:0060384,1,0.567634312816457,0,15,innervation,BP,
13801,GO:0060385,1,0.928855750669955,0,2,axonogenesis involved in innervation,BP,
13802,GO:0060386,1,0.959507678598059,0,1,synapse assembly involved in innervation,BP,
13806,GO:0060392,1,0.950304198877186,0,2,negative regulation of SMAD protein signal transduction,BP,
13808,GO:0060394,1,0.799446603694148,0,7,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,
13812,GO:0060398,1,0.88374596468227,0,3,regulation of growth hormone receptor signaling pathway,BP,
13813,GO:0060399,1,0.920678339674457,0,2,positive regulation of growth hormone receptor signaling pathway,BP,
13814,GO:0060400,1,0.959893842426457,0,1,negative regulation of growth hormone receptor signaling pathway,BP,
13817,GO:0060405,1,0.903904629024601,0,3,regulation of penile erection,BP,
13818,GO:0060406,1,0.926017896037403,0,2,positive regulation of penile erection,BP,
13819,GO:0060407,1,0.976124642047473,0,1,negative regulation of penile erection,BP,
13823,GO:0060414,1,0.920654720768824,0,2,aorta smooth muscle tissue morphogenesis,BP,
13829,GO:0060423,1,0.933823038950598,0,2,foregut regionalization,BP,
13830,GO:0060424,1,0.933823038950598,0,2,lung field specification,BP,
13836,GO:0060431,1,0.898751760658494,0,3,primary lung bud formation,BP,
13838,GO:0060434,1,0.928710883299327,0,2,bronchus morphogenesis,BP,
13839,GO:0060435,1,0.978286638720936,0,1,bronchiole development,BP,
13840,GO:0060437,1,0.936993777865541,0,2,lung growth,BP,
13842,GO:0060439,1,0.734923757692789,0,9,trachea morphogenesis,BP,
13843,GO:0060440,1,0.814585744840874,0,6,trachea formation,BP,
13849,GO:0060447,1,0.95950763690405,0,1,bud outgrowth involved in lung branching,BP,
13850,GO:0060448,1,0.899278511661579,0,3,dichotomous subdivision of terminal units involved in lung branching,BP,
13851,GO:0060449,1,0.812467947708527,0,6,bud elongation involved in lung branching,BP,
13852,GO:0060452,1,0.849212525950959,0,5,positive regulation of cardiac muscle contraction,BP,
13854,GO:0060454,1,0.960663077912503,0,1,positive regulation of gastric acid secretion,BP,
13855,GO:0060455,1,0.944955348056255,0,2,negative regulation of gastric acid secretion,BP,
13856,GO:0060456,1,0.898942674365348,0,3,positive regulation of digestive system process,BP,
13857,GO:0060457,1,0.817962357357468,0,6,negative regulation of digestive system process,BP,
13858,GO:0060459,1,0.969903576232698,0,1,left lung development,BP,
13859,GO:0060460,1,0.969903576232698,0,1,left lung morphogenesis,BP,
13862,GO:0060465,1,0.962779112836945,0,1,pharynx development,BP,
13863,GO:0060467,1,0.977632718767071,0,1,negative regulation of fertilization,BP,
13864,GO:0060474,1,0.951945326462926,0,2,positive regulation of flagellated sperm motility involved in capacitation,BP,
13865,GO:0060478,1,0.95058333515725,0,2,acrosomal vesicle exocytosis,BP,
13867,GO:0060480,1,0.978286638720936,0,1,lung goblet cell differentiation,BP,
13868,GO:0060481,1,0.940338432926024,0,2,lobar bronchus epithelium development,BP,
13869,GO:0060482,1,0.903856141415943,0,3,lobar bronchus development,BP,
13870,GO:0060484,1,0.834185452982693,0,5,lung-associated mesenchyme development,BP,
13872,GO:0060486,1,0.929727730202435,0,2,Clara cell differentiation,BP,
13874,GO:0060488,1,0.920671470887724,0,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
13875,GO:0060489,1,0.920671470887724,0,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
13876,GO:0060490,1,0.920671470887724,0,2,lateral sprouting involved in lung morphogenesis,BP,
13878,GO:0060492,1,0.933823038950598,0,2,lung induction,BP,
13879,GO:0060501,1,0.865953736154382,0,4,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
13881,GO:0060503,1,0.973756390557974,0,1,bud dilation involved in lung branching,BP,
13883,GO:0060510,1,0.939828892665715,0,2,Type II pneumocyte differentiation,BP,
13888,GO:0060523,1,0.921841532276899,0,2,prostate epithelial cord elongation,BP,
13889,GO:0060525,1,0.726828343821584,0,8,prostate glandular acinus development,BP,
13890,GO:0060526,1,0.849205220702852,0,4,prostate glandular acinus morphogenesis,BP,
13891,GO:0060527,1,0.849205220702852,0,4,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,
13892,GO:0060528,1,0.891718365560894,0,3,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,
13893,GO:0060529,1,0.922215055883985,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
13896,GO:0060535,1,0.90225356767401,0,3,trachea cartilage morphogenesis,BP,
13897,GO:0060536,1,0.876097025874632,0,4,cartilage morphogenesis,BP,
13900,GO:0060539,1,0.836005301119577,0,5,diaphragm development,BP,
13902,GO:0060542,1,0.959507637057539,0,1,regulation of strand invasion,BP,
13904,GO:0060545,1,0.934866801039133,0,2,positive regulation of necroptotic process,BP,
13916,GO:0060566,1,0.95950763690405,0,1,positive regulation of DNA-templated transcription, termination,BP,
13919,GO:0060573,1,0.883525697189267,0,3,cell fate specification involved in pattern specification,BP,
13923,GO:0060577,1,0.969903576232698,0,1,pulmonary vein morphogenesis,BP,
13924,GO:0060578,1,0.969903576232698,0,1,superior vena cava morphogenesis,BP,
13925,GO:0060579,1,0.883525697189267,0,3,ventral spinal cord interneuron fate commitment,BP,
13926,GO:0060581,1,0.883525697189267,0,3,cell fate commitment involved in pattern specification,BP,
13929,GO:0060586,1,0.869351832336196,0,4,multicellular organismal iron ion homeostasis,BP,
13931,GO:0060590,1,0.328046070254011,0,35,ATPase regulator activity,MF,
13932,GO:0060591,1,0.896081530153438,0,3,chondroblast differentiation,BP,
13934,GO:0060594,1,0.921841532276899,0,2,mammary gland specification,BP,
13935,GO:0060595,1,0.960748333633886,0,1,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
13943,GO:0060605,1,0.907649912054995,0,3,tube lumen cavitation,BP,
13945,GO:0060611,1,0.968453561303749,0,1,mammary gland fat development,BP,
13947,GO:0060613,1,0.814156091116593,0,6,fat pad development,BP,
13948,GO:0060615,1,0.960748333633886,0,1,mammary gland bud formation,BP,
13949,GO:0060620,1,0.965469978279355,0,1,regulation of cholesterol import,BP,
13950,GO:0060623,1,0.901972522676779,0,3,regulation of chromosome condensation,BP,
13953,GO:0060631,1,0.896356565884478,0,3,regulation of meiosis I,BP,
13954,GO:0060632,1,0.627289218131521,0,14,regulation of microtubule-based movement,BP,
13958,GO:0060648,1,0.960748333633886,0,1,mammary gland bud morphogenesis,BP,
13959,GO:0060661,1,0.970432530399028,0,1,submandibular salivary gland formation,BP,
13960,GO:0060662,1,0.907649912054995,0,3,salivary gland cavitation,BP,
13962,GO:0060665,1,0.959508369096293,0,1,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,
13963,GO:0060666,1,0.820546132051012,0,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,
13964,GO:0060667,1,0.960748333633886,0,1,branch elongation involved in salivary gland morphogenesis,BP,
13965,GO:0060668,1,0.962122907152631,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
13968,GO:0060671,1,0.900680391018123,0,3,epithelial cell differentiation involved in embryonic placenta development,BP,
13969,GO:0060672,1,0.900680391018123,0,3,epithelial cell morphogenesis involved in placental branching,BP,
13972,GO:0060676,1,0.887384977477022,0,4,ureteric bud formation,BP,
13973,GO:0060677,1,0.827024093531664,0,5,ureteric bud elongation,BP,
13974,GO:0060678,1,0.969694519549465,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
13975,GO:0060681,1,0.898323656643824,0,3,branch elongation involved in ureteric bud branching,BP,
13976,GO:0060683,1,0.966182899803962,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
13977,GO:0060684,1,0.878034507428209,0,4,epithelial-mesenchymal cell signaling,BP,
13980,GO:0060687,1,0.794564225253999,0,6,regulation of branching involved in prostate gland morphogenesis,BP,
13982,GO:0060689,1,0.900409944058474,0,3,cell differentiation involved in salivary gland development,BP,
13983,GO:0060690,1,0.973539492698059,0,1,epithelial cell differentiation involved in salivary gland development,BP,
13984,GO:0060691,1,0.973539492698059,0,1,epithelial cell maturation involved in salivary gland development,BP,
13986,GO:0060694,1,0.973075088847771,0,1,regulation of cholesterol transporter activity,BP,
13988,GO:0060697,1,0.966070947184871,0,1,positive regulation of phospholipid catabolic process,BP,
13989,GO:0060698,1,0.926413757499146,0,2,endoribonuclease inhibitor activity,MF,
13990,GO:0060699,1,0.877384662510565,0,4,regulation of endoribonuclease activity,BP,
13991,GO:0060700,1,0.744501351990584,0,9,regulation of ribonuclease activity,BP,
13992,GO:0060701,1,0.926413757499146,0,2,negative regulation of ribonuclease activity,BP,
13993,GO:0060702,1,0.926413757499146,0,2,negative regulation of endoribonuclease activity,BP,
13994,GO:0060703,1,0.966540823598339,0,1,deoxyribonuclease inhibitor activity,MF,
13998,GO:0060709,1,0.965630907244895,0,1,glycogen cell differentiation involved in embryonic placenta development,BP,
14003,GO:0060715,1,0.900830643820327,0,3,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
14005,GO:0060717,1,0.770711149829293,0,7,chorion development,BP,
14006,GO:0060718,1,0.824769765105705,0,5,chorionic trophoblast cell differentiation,BP,
14012,GO:0060730,1,0.963486266439358,0,1,regulation of intestinal epithelial structure maintenance,BP,
14013,GO:0060731,1,0.963486266439358,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
14014,GO:0060732,1,0.795353400546806,0,6,positive regulation of inositol phosphate biosynthetic process,BP,
14015,GO:0060733,1,0.922705557698838,0,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,
14016,GO:0060734,1,0.959876853143388,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
14017,GO:0060735,1,0.97789516824257,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
14020,GO:0060739,1,0.95950763690405,0,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,
14025,GO:0060745,1,0.849383929077604,0,4,mammary gland branching involved in pregnancy,BP,
14026,GO:0060746,1,0.777461953846134,0,7,parental behavior,BP,
14027,GO:0060748,1,0.96123077471094,0,1,tertiary branching involved in mammary gland duct morphogenesis,BP,
14037,GO:0060763,1,0.929235486019654,0,2,mammary duct terminal end bud growth,BP,
14038,GO:0060764,1,0.938738198120684,0,2,cell-cell signaling involved in mammary gland development,BP,
14039,GO:0060765,1,0.470792474061074,0,22,regulation of androgen receptor signaling pathway,BP,
14040,GO:0060766,1,0.750492109860873,0,8,negative regulation of androgen receptor signaling pathway,BP,
14042,GO:0060768,1,0.770904122772453,0,8,regulation of epithelial cell proliferation involved in prostate gland development,BP,
14043,GO:0060769,1,0.962860572657923,0,1,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
14044,GO:0060770,1,0.834460812419403,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
14048,GO:0060789,1,0.829743348651417,0,6,hair follicle placode formation,BP,
14050,GO:0060800,1,0.92671751535839,0,2,regulation of cell differentiation involved in embryonic placenta development,BP,
14053,GO:0060816,1,0.924113794006605,0,2,random inactivation of X chromosome,BP,
14054,GO:0060819,1,0.920651329566809,0,2,inactivation of X chromosome by genetic imprinting,BP,
14055,GO:0060821,1,0.95950763690405,0,1,inactivation of X chromosome by DNA methylation,BP,
14056,GO:0060823,1,0.962970307750424,0,1,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
14057,GO:0060825,1,0.948375145755856,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
14059,GO:0060830,1,0.906603166751086,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
14060,GO:0060831,1,0.610386254771561,0,13,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
14061,GO:0060836,1,0.855278217418744,0,4,lymphatic endothelial cell differentiation,BP,
14062,GO:0060837,1,0.809673298957248,0,6,blood vessel endothelial cell differentiation,BP,
14063,GO:0060838,1,0.92900713496619,0,2,lymphatic endothelial cell fate commitment,BP,
14064,GO:0060839,1,0.810135741312201,0,6,endothelial cell fate commitment,BP,
14067,GO:0060842,1,0.895636303447364,0,3,arterial endothelial cell differentiation,BP,
14068,GO:0060843,1,0.95950763690405,0,1,venous endothelial cell differentiation,BP,
14069,GO:0060844,1,0.933439908344101,0,2,arterial endothelial cell fate commitment,BP,
14070,GO:0060846,1,0.903618312955038,0,3,blood vessel endothelial cell fate commitment,BP,
14071,GO:0060847,1,0.903618312955038,0,3,endothelial cell fate specification,BP,
14072,GO:0060849,1,0.961207561953446,0,1,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,
14074,GO:0060853,1,0.96333841813498,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
14075,GO:0060856,1,0.735843698283388,0,9,establishment of blood-brain barrier,BP,
14076,GO:0060857,1,0.969579393275221,0,1,establishment of glial blood-brain barrier,BP,
14077,GO:0060872,1,0.870240210525249,0,4,semicircular canal development,BP,
14078,GO:0060873,1,0.95950763690405,0,1,anterior semicircular canal development,BP,
14079,GO:0060875,1,0.95950763690405,0,1,lateral semicircular canal development,BP,
14080,GO:0060876,1,0.968367829563511,0,1,semicircular canal formation,BP,
14081,GO:0060887,1,0.965469978279355,0,1,limb epidermis development,BP,
14082,GO:0060896,1,0.753683521797615,0,8,neural plate pattern specification,BP,
14083,GO:0060897,1,0.818676081271809,0,6,neural plate regionalization,BP,
14085,GO:0060901,1,0.960375828840977,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
14086,GO:0060903,1,0.929763698542332,0,2,positive regulation of meiosis I,BP,
14087,GO:0060904,1,0.961058355211294,0,1,regulation of protein folding in endoplasmic reticulum,BP,
14090,GO:0060912,1,0.965469978279355,0,1,cardiac cell fate specification,BP,
14091,GO:0060913,1,0.96655335371581,0,1,cardiac cell fate determination,BP,
14093,GO:0060915,1,0.960748333633886,0,1,mesenchymal cell differentiation involved in lung development,BP,
14094,GO:0060916,1,0.853321795463238,0,4,mesenchymal cell proliferation involved in lung development,BP,
14097,GO:0060922,1,0.959507699830069,0,1,atrioventricular node cell differentiation,BP,
14100,GO:0060928,1,0.959507699830069,0,1,atrioventricular node cell development,BP,
14103,GO:0060935,1,0.894140261727099,0,3,cardiac fibroblast cell differentiation,BP,
14104,GO:0060936,1,0.894140261727099,0,3,cardiac fibroblast cell development,BP,
14105,GO:0060938,1,0.894140261727099,0,3,epicardium-derived cardiac fibroblast cell differentiation,BP,
14106,GO:0060939,1,0.894140261727099,0,3,epicardium-derived cardiac fibroblast cell development,BP,
14107,GO:0060940,1,0.931880880149936,0,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,
14108,GO:0060947,1,0.856225781513673,0,4,cardiac vascular smooth muscle cell differentiation,BP,
14109,GO:0060948,1,0.923508923734726,0,2,cardiac vascular smooth muscle cell development,BP,
14111,GO:0060957,1,0.965091971934929,0,1,endocardial cell fate commitment,BP,
14118,GO:0060971,1,0.897926161479695,0,3,embryonic heart tube left/right pattern formation,BP,
14119,GO:0060972,1,0.574534314106332,0,16,left/right pattern formation,BP,
14120,GO:0060973,1,0.666577129658674,0,11,cell migration involved in heart development,BP,
14122,GO:0060977,1,0.681178501623013,0,10,coronary vasculature morphogenesis,BP,
14123,GO:0060978,1,0.928855334503976,0,2,angiogenesis involved in coronary vascular morphogenesis,BP,
14124,GO:0060979,1,0.883364048004276,0,3,vasculogenesis involved in coronary vascular morphogenesis,BP,
14125,GO:0060982,1,0.771181144687809,0,7,coronary artery morphogenesis,BP,
14127,GO:0060987,1,0.969245869754777,0,1,lipid tube,CC,
14128,GO:0060988,1,0.930968535310602,0,2,lipid tube assembly,BP,
14131,GO:0060994,1,0.93658116854687,0,2,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
14132,GO:0060995,1,0.925498379498792,0,2,cell-cell signaling involved in kidney development,BP,
14140,GO:0061003,1,0.618826870038799,0,12,positive regulation of dendritic spine morphogenesis,BP,
14141,GO:0061004,1,0.809988731892351,0,7,pattern specification involved in kidney development,BP,
14145,GO:0061010,1,0.95950763690405,0,1,gall bladder development,BP,
14148,GO:0061015,1,0.956127092286947,0,2,snRNA import into nucleus,BP,
14153,GO:0061030,1,0.939782092896149,0,2,epithelial cell differentiation involved in mammary gland alveolus development,BP,
14154,GO:0061031,1,0.948523706466727,0,2,endodermal digestive tract morphogenesis,BP,
14155,GO:0061032,1,0.964858464579719,0,1,visceral serous pericardium development,BP,
14156,GO:0061034,1,0.960341465926368,0,1,olfactory bulb mitral cell layer development,BP,
14160,GO:0061038,1,0.860754730619461,0,4,uterus morphogenesis,BP,
14161,GO:0061040,1,0.95950763690405,0,1,female gonad morphogenesis,BP,
14165,GO:0061044,1,0.964046331367156,0,1,negative regulation of vascular wound healing,BP,
14168,GO:0061047,1,0.909311953677928,0,3,positive regulation of branching involved in lung morphogenesis,BP,
14173,GO:0061052,1,0.87076494934603,0,4,negative regulation of cell growth involved in cardiac muscle cell development,BP,
14175,GO:0061054,1,0.96123077471094,0,1,dermatome development,BP,
14176,GO:0061055,1,0.92111625663529,0,2,myotome development,BP,
14177,GO:0061056,1,0.965469978279355,0,1,sclerotome development,BP,
14179,GO:0061072,1,0.814914105685755,0,6,iris morphogenesis,BP,
14184,GO:0061078,1,0.987104172534466,0,1,positive regulation of prostaglandin secretion involved in immune response,BP,
14187,GO:0061083,1,0.869294592105391,0,4,regulation of protein refolding,BP,
14188,GO:0061084,1,0.869294592105391,0,4,negative regulation of protein refolding,BP,
14189,GO:0061085,1,0.72459622088033,0,9,regulation of histone H3-K27 methylation,BP,
14190,GO:0061086,1,0.869281595297434,0,4,negative regulation of histone H3-K27 methylation,BP,
14191,GO:0061087,1,0.805146907612311,0,6,positive regulation of histone H3-K27 methylation,BP,
14192,GO:0061088,1,0.807680690294532,0,6,regulation of sequestering of zinc ion,BP,
14193,GO:0061091,1,0.959615336959517,0,1,regulation of phospholipid translocation,BP,
14194,GO:0061092,1,0.959615336959517,0,1,positive regulation of phospholipid translocation,BP,
14199,GO:0061102,1,0.976999496905179,0,1,stomach neuroendocrine cell differentiation,BP,
14200,GO:0061105,1,0.976999496905179,0,1,regulation of stomach neuroendocrine cell differentiation,BP,
14201,GO:0061106,1,0.976999496905179,0,1,negative regulation of stomach neuroendocrine cell differentiation,BP,
14202,GO:0061107,1,0.969698369587268,0,1,seminal vesicle development,BP,
14203,GO:0061108,1,0.969698369587268,0,1,seminal vesicle epithelium development,BP,
14204,GO:0061110,1,0.923020164887942,0,2,dense core granule biogenesis,BP,
14205,GO:0061113,1,0.961708575034571,0,1,pancreas morphogenesis,BP,
14206,GO:0061117,1,0.606041706075573,0,14,negative regulation of heart growth,BP,
14207,GO:0061133,1,0.88590261450126,0,5,endopeptidase activator activity,MF,
14212,GO:0061140,1,0.91941885333536,0,3,lung secretory cell differentiation,BP,
14213,GO:0061141,1,0.95950763690405,0,1,lung ciliated cell differentiation,BP,
14215,GO:0061146,1,0.900703569394814,0,3,Peyer's patch morphogenesis,BP,
14216,GO:0061149,1,0.973756390557974,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
14217,GO:0061150,1,0.973756390557974,0,1,renal system segmentation,BP,
14218,GO:0061151,1,0.973756390557974,0,1,BMP signaling pathway involved in renal system segmentation,BP,
14219,GO:0061152,1,0.943165351288308,0,2,trachea submucosa development,BP,
14220,GO:0061153,1,0.943165351288308,0,2,trachea gland development,BP,
14222,GO:0061155,1,0.973756390557974,0,1,pulmonary artery endothelial tube morphogenesis,BP,
14227,GO:0061163,1,0.965469978279355,0,1,endoplasmic reticulum polarization,BP,
14231,GO:0061183,1,0.96123077471094,0,1,regulation of dermatome development,BP,
14232,GO:0061184,1,0.96123077471094,0,1,positive regulation of dermatome development,BP,
14233,GO:0061187,1,0.920669291483101,0,2,regulation of chromatin silencing at rDNA,BP,
14234,GO:0061188,1,0.920669291483101,0,2,negative regulation of chromatin silencing at rDNA,BP,
14235,GO:0061193,1,0.981981773219839,0,1,taste bud development,BP,
14236,GO:0061196,1,0.86072279266765,0,4,fungiform papilla development,BP,
14237,GO:0061197,1,0.86072279266765,0,4,fungiform papilla morphogenesis,BP,
14238,GO:0061198,1,0.897056447641482,0,3,fungiform papilla formation,BP,
14239,GO:0061200,1,0.844916425570999,0,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,
14240,GO:0061202,1,0.844916425570999,0,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,
14241,GO:0061205,1,0.96123077471094,0,1,paramesonephric duct development,BP,
14244,GO:0061216,1,0.973756390557974,0,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,
14247,GO:0061227,1,0.973756390557974,0,1,pattern specification involved in mesonephros development,BP,
14249,GO:0061289,1,0.925498379498792,0,2,Wnt signaling pathway involved in kidney development,BP,
14250,GO:0061290,1,0.925498379498792,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
14251,GO:0061298,1,0.696999993761652,0,9,retina vasculature development in camera-type eye,BP,
14252,GO:0061299,1,0.787889763933212,0,6,retina vasculature morphogenesis in camera-type eye,BP,
14253,GO:0061300,1,0.936770684143138,0,2,cerebellum vasculature development,BP,
14254,GO:0061301,1,0.95950763690405,0,1,cerebellum vasculature morphogenesis,BP,
14256,GO:0061303,1,0.876454358606445,0,4,cornea development in camera-type eye,BP,
14257,GO:0061304,1,0.847701916825667,0,4,retinal blood vessel morphogenesis,BP,
14262,GO:0061312,1,0.85328425260314,0,5,BMP signaling pathway involved in heart development,BP,
14264,GO:0061316,1,0.908315568579837,0,3,canonical Wnt signaling pathway involved in heart development,BP,
14265,GO:0061317,1,0.943356348674288,0,2,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
14268,GO:0061324,1,0.962860572657923,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
14269,GO:0061325,1,0.90936663056123,0,3,cell proliferation involved in outflow tract morphogenesis,BP,
14275,GO:0061343,1,0.852885607725446,0,4,cell adhesion involved in heart morphogenesis,BP,
14283,GO:0061355,1,0.871140789660706,0,4,Wnt protein secretion,BP,
14284,GO:0061356,1,0.871140789660706,0,4,regulation of Wnt protein secretion,BP,
14285,GO:0061357,1,0.895314211585207,0,3,positive regulation of Wnt protein secretion,BP,
14286,GO:0061358,1,0.973007521550594,0,1,negative regulation of Wnt protein secretion,BP,
14287,GO:0061364,1,0.883499219579172,0,3,apoptotic process involved in luteolysis,BP,
14288,GO:0061365,1,0.879620085387898,0,4,positive regulation of triglyceride lipase activity,BP,
14289,GO:0061369,1,0.96123077471094,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
14290,GO:0061370,1,0.929330348394035,0,2,testosterone biosynthetic process,BP,
14295,GO:0061386,1,0.920650957478618,0,2,closure of optic fissure,BP,
14297,GO:0061394,1,0.946542324638741,0,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
14298,GO:0061395,1,0.974370639009077,0,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
14299,GO:0061400,1,0.965469978279355,0,1,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion,BP,
14300,GO:0061408,1,0.907738747073491,0,3,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,
14303,GO:0061428,1,0.87703211543434,0,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
14304,GO:0061430,1,0.675021705081494,0,10,bone trabecula morphogenesis,BP,
14305,GO:0061433,1,0.972280914660677,0,1,cellular response to caloric restriction,BP,
14307,GO:0061437,1,0.620446452707806,0,14,renal system vasculature development,BP,
14308,GO:0061438,1,0.86792782642189,0,4,renal system vasculature morphogenesis,BP,
14309,GO:0061439,1,0.86792782642189,0,4,kidney vasculature morphogenesis,BP,
14310,GO:0061440,1,0.620446452707806,0,14,kidney vasculature development,BP,
14311,GO:0061441,1,0.928948302196925,0,2,renal artery morphogenesis,BP,
14314,GO:0061445,1,0.965091971934929,0,1,endocardial cushion cell fate commitment,BP,
14316,GO:0061450,1,0.799070030465109,0,8,trophoblast cell migration,BP,
14319,GO:0061462,1,0.323831106742515,0,32,protein localization to lysosome,BP,
14322,GO:0061474,1,0.96765081682803,0,1,phagolysosome membrane,CC,
14324,GO:0061478,1,0.715549245802218,0,9,response to platelet aggregation inhibitor,BP,
14325,GO:0061481,1,0.983759698430541,0,1,response to TNF agonist,BP,
14326,GO:0061484,1,0.892332593691169,0,3,hematopoietic stem cell homeostasis,BP,
14327,GO:0061485,1,0.95950763690405,0,1,memory T cell proliferation,BP,
14328,GO:0061495,1,0.965469978279355,0,1,gamma-tubulin small complex, mitotic spindle pole body,CC,
14329,GO:0061502,1,0.861550987199334,0,4,early endosome to recycling endosome transport,BP,
14330,GO:0061505,1,0.920695452576305,0,2,DNA topoisomerase II activity,MF,
14331,GO:0061507,1,0.974632750419636,0,1,cyclic-GMP-AMP binding,MF,
14332,GO:0061511,1,0.871607874304215,0,4,centriole elongation,BP,
14334,GO:0061513,1,0.899353583913465,0,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,
14336,GO:0061517,1,0.965741492599732,0,1,macrophage proliferation,BP,
14337,GO:0061518,1,0.965741492599732,0,1,microglial cell proliferation,BP,
14338,GO:0061519,1,0.962212400228686,0,1,macrophage homeostasis,BP,
14340,GO:0061526,1,0.966967419757367,0,1,acetylcholine secretion,BP,
14341,GO:0061528,1,0.959675503888475,0,1,aspartate secretion,BP,
14342,GO:0061534,1,0.95950763690405,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
14343,GO:0061535,1,0.885052728918527,0,3,glutamate secretion, neurotransmission,BP,
14344,GO:0061536,1,0.963768076646009,0,1,glycine secretion,BP,
14345,GO:0061537,1,0.963768076646009,0,1,glycine secretion, neurotransmission,BP,
14346,GO:0061542,1,0.97896132643455,0,1,3-demethylubiquinone-n 3-O-methyltransferase activity,MF,
14347,GO:0061547,1,0.962783158105344,0,1,glycogen synthase activity, transferring glucose-1-phosphate,MF,
14348,GO:0061548,1,0.736950682395743,0,8,ganglion development,BP,
14349,GO:0061549,1,0.793853210993074,0,6,sympathetic ganglion development,BP,
14350,GO:0061550,1,0.858127899163766,0,4,cranial ganglion development,BP,
14351,GO:0061551,1,0.891237351573771,0,3,trigeminal ganglion development,BP,
14352,GO:0061552,1,0.968057406154827,0,1,ganglion morphogenesis,BP,
14355,GO:0061573,1,0.965469978279355,0,1,actin filament bundle retrograde transport,BP,
14356,GO:0061574,1,0.904326042227187,0,3,ASAP complex,CC,
14357,GO:0061575,1,0.921179814581952,0,4,cyclin-dependent protein serine/threonine kinase activator activity,MF,
14358,GO:0061577,1,0.744479184930442,0,8,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
14360,GO:0061580,1,0.960693904228352,0,1,colon epithelial cell migration,BP,
14362,GO:0061588,1,0.861499632049535,0,4,calcium activated phospholipid scrambling,BP,
14363,GO:0061589,1,0.861499632049535,0,4,calcium activated phosphatidylserine scrambling,BP,
14364,GO:0061590,1,0.861499632049535,0,4,calcium activated phosphatidylcholine scrambling,BP,
14365,GO:0061591,1,0.861499632049535,0,4,calcium activated galactosylceramide scrambling,BP,
14366,GO:0061598,1,0.960409336878159,0,1,molybdopterin adenylyltransferase activity,MF,
14367,GO:0061599,1,0.960409336878159,0,1,molybdopterin molybdotransferase activity,MF,
14368,GO:0061604,1,0.96827547172546,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
14369,GO:0061605,1,0.96827547172546,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
14370,GO:0061608,1,0.747092575032599,0,9,nuclear import signal receptor activity,MF,
14371,GO:0061611,1,0.973839944555444,0,1,mannose to fructose-6-phosphate metabolic process,BP,
14373,GO:0061615,1,0.573021462560786,0,18,glycolytic process through fructose-6-phosphate,BP,
14374,GO:0061617,1,0.800141447449595,0,8,MICOS complex,CC,
14375,GO:0061618,1,0.95950763690405,0,1,sublamina densa,CC,
14376,GO:0061620,1,0.573021462560786,0,18,glycolytic process through glucose-6-phosphate,BP,
14377,GO:0061621,1,0.585973219166511,0,17,canonical glycolysis,BP,
14378,GO:0061622,1,0.942524953167151,0,2,glycolytic process through glucose-1-phosphate,BP,
14379,GO:0061623,1,0.97792677453395,0,1,glycolytic process from galactose,BP,
14380,GO:0061624,1,0.874946270057428,0,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
14381,GO:0061626,1,0.819776799241084,0,6,pharyngeal arch artery morphogenesis,BP,
14382,GO:0061627,1,0.971874434579777,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
14383,GO:0061628,1,0.930220654810321,0,2,H3K27me3 modified histone binding,MF,
14384,GO:0061629,1,0.882257494205779,0,4,RNA polymerase II sequence-specific DNA binding transcription factor binding,MF,
14386,GO:0061631,1,0.44489834808073,0,26,ubiquitin conjugating enzyme activity,MF,
14389,GO:0061641,1,0.390153679695796,0,40,CENP-A containing chromatin organization,BP,
14392,GO:0061645,1,0.814616387428769,0,5,endocytic patch,CC,
14393,GO:0061646,1,0.959660275719761,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
14395,GO:0061649,1,0.89398608563608,0,3,ubiquitin modification-dependent histone binding,MF,
14396,GO:0061650,1,0.435834023808392,0,27,ubiquitin-like protein conjugating enzyme activity,MF,
14397,GO:0061656,1,0.979667762049334,0,1,SUMO conjugating enzyme activity,MF,
14399,GO:0061663,1,0.95950763690405,0,1,NEDD8 ligase activity,MF,
14401,GO:0061668,1,0.812870418234548,0,6,mitochondrial ribosome assembly,BP,
14402,GO:0061669,1,0.921130311943135,0,2,spontaneous neurotransmitter secretion,BP,
14403,GO:0061673,1,0.836306893044575,0,5,mitotic spindle astral microtubule,CC,
14404,GO:0061676,1,0.804050458441386,0,6,importin-alpha family protein binding,MF,
14406,GO:0061685,1,0.965469978279355,0,1,diphthine methylesterase activity,MF,
14407,GO:0061687,1,0.849322941214197,0,7,detoxification of inorganic compound,BP,
14408,GO:0061689,1,0.9032526476278,0,3,tricellular tight junction,CC,
14410,GO:0061697,1,0.964100242098344,0,1,protein-glutaryllysine deglutarylase activity,MF,
14411,GO:0061698,1,0.964100242098344,0,1,protein deglutarylation,BP,
14412,GO:0061699,1,0.964100242098344,0,1,peptidyl-lysine deglutarylation,BP,
14413,GO:0061700,1,0.736089810438321,0,9,GATOR2 complex,CC,
14414,GO:0061702,1,0.810856639831918,0,7,inflammasome complex,CC,
14415,GO:0061709,1,0.95950763690405,0,1,reticulophagy,BP,
14416,GO:0061711,1,0.945974226844976,0,2,N(6)-L-threonylcarbamoyladenine synthase activity,MF,
14417,GO:0061712,1,0.963490797074121,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
14418,GO:0061718,1,0.585973219166511,0,17,glucose catabolic process to pyruvate,BP,
14419,GO:0061723,1,0.929098616854899,0,2,glycophagy,BP,
14422,GO:0061727,1,0.94163509654683,0,2,methylglyoxal catabolic process to lactate,BP,
14423,GO:0061731,1,0.89088303670792,0,3,ribonucleoside-diphosphate reductase activity,MF,
14424,GO:0061732,1,0.815225396863394,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
14425,GO:0061733,1,0.155286991961048,0,53,peptide-lysine-N-acetyltransferase activity,MF,
14426,GO:0061734,1,0.81698967843229,0,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
14427,GO:0061736,1,0.959507733167952,0,1,engulfment of target by autophagosome,BP,
14428,GO:0061737,1,0.939918295195159,0,2,leukotriene signaling pathway,BP,
14429,GO:0061738,1,0.907861688866621,0,3,late endosomal microautophagy,BP,
14430,GO:0061739,1,0.891008212235672,0,3,protein lipidation involved in autophagosome assembly,BP,
14431,GO:0061740,1,0.901458981133668,0,3,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,
14432,GO:0061741,1,0.938248504544184,0,2,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,
14433,GO:0061743,1,0.973571680227903,0,1,motor learning,BP,
14434,GO:0061744,1,0.947504129290201,0,2,motor behavior,BP,
14435,GO:0061749,1,0.92112537940169,0,2,forked DNA-dependent helicase activity,MF,
14436,GO:0061750,1,0.969208363328285,0,1,acid sphingomyelin phosphodiesterase activity,MF,
14437,GO:0061752,1,0.938517795745298,0,2,telomeric repeat-containing RNA binding,MF,
14438,GO:0061753,1,0.959507733167952,0,1,substrate localization to autophagosome,BP,
14441,GO:0061760,1,0.965272223551698,0,1,antifungal innate immune response,BP,
14442,GO:0061762,1,0.920736578253966,0,2,CAMKK-AMPK signaling cascade,BP,
14443,GO:0061763,1,0.933694521810789,0,2,multivesicular body-lysosome fusion,BP,
14445,GO:0061768,1,0.959711572186292,0,1,magnesium:sodium antiporter activity,MF,
14446,GO:0061769,1,0.965469978279355,0,1,ribosylnicotinate kinase activity,MF,
14447,GO:0061770,1,0.970504692431207,0,1,translation elongation factor binding,MF,
14450,GO:0061778,1,0.682199769133258,0,10,intracellular chloride channel activity,MF,
14451,GO:0061780,1,0.95950763690405,0,1,mitotic cohesin loading,BP,
14452,GO:0061783,1,0.931204640706774,0,3,peptidoglycan muralytic activity,MF,
14453,GO:0061789,1,0.95950763690405,0,1,dense core granule priming,BP,
14454,GO:0061792,1,0.95950763690405,0,1,secretory granule maturation,BP,
14455,GO:0061798,1,0.960608130332783,0,1,GTP 3',8'-cyclase activity,MF,
14456,GO:0061799,1,0.960608130332783,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
14457,GO:0061809,1,0.976569571756151,0,1,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
14458,GO:0061817,1,0.884865201212317,0,3,endoplasmic reticulum-plasma membrane tethering,BP,
14459,GO:0061819,1,0.897395558783373,0,3,telomeric DNA-containing double minutes formation,BP,
14460,GO:0061820,1,0.713458288978236,0,9,telomeric D-loop disassembly,BP,
14461,GO:0061821,1,0.850824610309305,0,4,telomeric D-loop binding,MF,
14462,GO:0061825,1,0.961160402445,0,1,podosome core,CC,
14463,GO:0061827,1,0.944548989121211,0,2,sperm head,CC,
14464,GO:0061828,1,0.95950763690405,0,1,apical tubulobulbar complex,CC,
14465,GO:0061829,1,0.95950763690405,0,1,basal tubulobulbar complex,CC,
14466,GO:0061833,1,0.931472623822085,0,2,protein localization to tricellular tight junction,BP,
14467,GO:0061842,1,0.413305389051124,0,24,microtubule organizing center localization,BP,
14468,GO:0061844,1,0.645036685408824,0,23,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,
14469,GO:0061845,1,0.963600423230496,0,1,neuron projection branch point,CC,
14470,GO:0061846,1,0.963600423230496,0,1,dendritic spine cytoplasm,CC,
14471,GO:0061847,1,0.969343762500031,0,1,response to cholecystokinin,BP,
14472,GO:0061849,1,0.92112537940169,0,2,telomeric G-quadruplex DNA binding,MF,
14473,GO:0061850,1,0.983235665013756,0,1,growth cone leading edge,CC,
14474,GO:0061851,1,0.966503308492512,0,1,leading edge of lamellipodium,CC,
14475,GO:0061857,1,0.928122328246,0,2,endoplasmic reticulum stress-induced pre-emptive quality control,BP,
14476,GO:0061880,1,0.974518071551212,0,1,regulation of anterograde axonal transport of mitochondrion,BP,
14477,GO:0061881,1,0.974518071551212,0,1,positive regulation of anterograde axonal transport of mitochondrion,BP,
14482,GO:0061890,1,0.941631931154249,0,2,positive regulation of astrocyte activation,BP,
14483,GO:0061896,1,0.959848101363135,0,1,all-trans retinol 3,4-desaturase activity,MF,
14484,GO:0061897,1,0.959848101363135,0,1,all-trans retinal 3,4-desaturase activity,MF,
14485,GO:0061898,1,0.959848101363135,0,1,all-trans retinoic acid 3,4-desaturase activity,MF,
14486,GO:0061899,1,0.959848101363135,0,1,11-cis-retinal 3,4-desaturase activity,MF,
14490,GO:0061920,1,0.95950763690405,0,1,protein propionyltransferase activity,MF,
14491,GO:0061921,1,0.95950763690405,0,1,peptidyl-lysine propionylation,BP,
14492,GO:0061930,1,0.959571905640215,0,1,regulation of erythrocyte enucleation,BP,
14493,GO:0061931,1,0.959571905640215,0,1,positive regulation of erythrocyte enucleation,BP,
14494,GO:0061944,1,0.960291642020097,0,1,negative regulation of protein K48-linked ubiquitination,BP,
14496,GO:0061951,1,0.26934146804906,0,38,establishment of protein localization to plasma membrane,BP,
14497,GO:0061953,1,0.905471172712226,0,3,mRNA (adenine-N1-)-methyltransferase activity,MF,
14500,GO:0061982,1,0.0975782845049134,0,69,meiosis I cell cycle process,BP,
14501,GO:0061983,1,0.822101718240396,0,6,meiosis II cell cycle process,BP,
14502,GO:0062009,1,0.743735311085572,0,8,secondary palate development,BP,
14506,GO:0065001,1,0.920654016906783,0,2,specification of axis polarity,BP,
14507,GO:0065002,1,0.227491430293596,0,50,intracellular protein transmembrane transport,BP,
14514,GO:0065010,1,0.965469978279355,0,1,extracellular membrane-bounded organelle,CC,
14515,GO:0070001,1,0.622469635847014,0,14,aspartic-type peptidase activity,MF,
14516,GO:0070003,1,0.705385869401805,0,18,threonine-type peptidase activity,MF,
14517,GO:0070004,1,0.965469978279355,0,1,cysteine-type exopeptidase activity,MF,
14518,GO:0070006,1,0.579930247724589,0,15,metalloaminopeptidase activity,MF,
14519,GO:0070008,1,0.707317128503756,0,10,serine-type exopeptidase activity,MF,
14521,GO:0070012,1,0.935498658909333,0,2,oligopeptidase activity,MF,
14523,GO:0070016,1,0.680688371390034,0,10,armadillo repeat domain binding,MF,
14524,GO:0070022,1,0.852400558035269,0,4,transforming growth factor beta receptor complex,CC,
14525,GO:0070025,1,0.967261870054133,0,1,carbon monoxide binding,MF,
14526,GO:0070026,1,0.950219137049038,0,2,nitric oxide binding,MF,
14529,GO:0070034,1,0.510377523715961,0,21,telomerase RNA binding,MF,
14530,GO:0070035,1,0.0389803174621326,0,88,purine NTP-dependent helicase activity,MF,
14531,GO:0070037,1,0.981346651076686,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
14532,GO:0070039,1,0.933954959882258,0,2,rRNA (guanosine-2'-O-)-methyltransferase activity,MF,
14533,GO:0070042,1,0.964685725745536,0,1,rRNA (uridine-N3-)-methyltransferase activity,MF,
14535,GO:0070050,1,0.869617563484635,0,4,neuron cellular homeostasis,BP,
14536,GO:0070051,1,0.928209876198378,0,2,fibrinogen binding,MF,
14537,GO:0070052,1,0.924978226693303,0,2,collagen V binding,MF,
14542,GO:0070060,1,0.95950763690405,0,1,'de novo' actin filament nucleation,BP,
14543,GO:0070061,1,0.906910113832055,0,3,fructose binding,MF,
14547,GO:0070069,1,0.592399975336943,0,23,cytochrome complex,CC,
14548,GO:0070070,1,0.739730896180052,0,8,proton-transporting V-type ATPase complex assembly,BP,
14549,GO:0070071,1,0.65627539174959,0,12,proton-transporting two-sector ATPase complex assembly,BP,
14550,GO:0070072,1,0.739730896180052,0,8,vacuolar proton-transporting V-type ATPase complex assembly,BP,
14552,GO:0070077,1,0.962108754463036,0,1,histone arginine demethylation,BP,
14553,GO:0070078,1,0.962108754463036,0,1,histone H3-R2 demethylation,BP,
14554,GO:0070079,1,0.962108754463036,0,1,histone H4-R3 demethylation,BP,
14555,GO:0070081,1,0.905983188102368,0,3,clathrin-sculpted monoamine transport vesicle,CC,
14556,GO:0070083,1,0.905983188102368,0,3,clathrin-sculpted monoamine transport vesicle membrane,CC,
14558,GO:0070086,1,0.8866228854483,0,4,ubiquitin-dependent endocytosis,BP,
14559,GO:0070087,1,0.789847793398049,0,6,chromo shadow domain binding,MF,
14560,GO:0070091,1,0.89154389770435,0,3,glucagon secretion,BP,
14561,GO:0070092,1,0.89154389770435,0,3,regulation of glucagon secretion,BP,
14562,GO:0070094,1,0.967381439301668,0,1,positive regulation of glucagon secretion,BP,
14563,GO:0070095,1,0.96398551041618,0,1,fructose-6-phosphate binding,MF,
14564,GO:0070096,1,0.963039672539869,0,1,mitochondrial outer membrane translocase complex assembly,BP,
14565,GO:0070097,1,0.920876955176893,0,2,delta-catenin binding,MF,
14568,GO:0070100,1,0.865298528290122,0,4,negative regulation of chemokine-mediated signaling pathway,BP,
14571,GO:0070103,1,0.974499003905572,0,1,regulation of interleukin-6-mediated signaling pathway,BP,
14572,GO:0070104,1,0.974499003905572,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
14575,GO:0070119,1,0.960671527649304,0,1,ciliary neurotrophic factor binding,MF,
14577,GO:0070121,1,0.959510825131099,0,1,Kupffer's vesicle development,BP,
14578,GO:0070122,1,0.861563065447312,0,4,isopeptidase activity,MF,
14579,GO:0070123,1,0.95950763690405,0,1,transforming growth factor beta receptor activity, type III,MF,
14580,GO:0070124,1,0.948270175013144,0,2,mitochondrial translational initiation,BP,
14581,GO:0070125,1,0.149599407953359,0,86,mitochondrial translational elongation,BP,
14582,GO:0070126,1,0.140673536520205,0,88,mitochondrial translational termination,BP,
14583,GO:0070127,1,0.760539719403921,0,8,tRNA aminoacylation for mitochondrial protein translation,BP,
14584,GO:0070129,1,0.566424601055013,0,18,regulation of mitochondrial translation,BP,
14585,GO:0070130,1,0.965469978279355,0,1,negative regulation of mitochondrial translation,BP,
14586,GO:0070131,1,0.706988263114911,0,11,positive regulation of mitochondrial translation,BP,
14587,GO:0070137,1,0.851677883057519,0,4,ubiquitin-like protein-specific endopeptidase activity,MF,
14588,GO:0070138,1,0.889212393754984,0,3,ubiquitin-like protein-specific isopeptidase activity,MF,
14589,GO:0070139,1,0.851677883057519,0,4,SUMO-specific endopeptidase activity,MF,
14590,GO:0070140,1,0.889212393754984,0,3,SUMO-specific isopeptidase activity,MF,
14591,GO:0070141,1,0.837868145875411,0,5,response to UV-A,BP,
14592,GO:0070142,1,0.801106492962993,0,6,synaptic vesicle budding,BP,
14593,GO:0070143,1,0.959754722433884,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
14594,GO:0070145,1,0.963137696562781,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
14595,GO:0070150,1,0.942641652448435,0,2,mitochondrial glycyl-tRNA aminoacylation,BP,
14596,GO:0070159,1,0.968779151259089,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
14603,GO:0070166,1,0.716286127892935,0,9,enamel mineralization,BP,
14607,GO:0070170,1,0.924382503416889,0,2,regulation of tooth mineralization,BP,
14608,GO:0070171,1,0.95950763690405,0,1,negative regulation of tooth mineralization,BP,
14609,GO:0070172,1,0.963396276407058,0,1,positive regulation of tooth mineralization,BP,
14610,GO:0070176,1,0.973608515846903,0,1,DRM complex,CC,
14611,GO:0070178,1,0.968092371147854,0,1,D-serine metabolic process,BP,
14612,GO:0070179,1,0.968092371147854,0,1,D-serine biosynthetic process,BP,
14613,GO:0070180,1,0.986886648778112,0,1,large ribosomal subunit rRNA binding,MF,
14614,GO:0070181,1,0.820537120296832,0,8,small ribosomal subunit rRNA binding,MF,
14615,GO:0070182,1,0.55866691878125,0,18,DNA polymerase binding,MF,
14616,GO:0070183,1,0.965897603000512,0,1,mitochondrial tryptophanyl-tRNA aminoacylation,BP,
14617,GO:0070184,1,0.970504692431207,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
14618,GO:0070187,1,0.82034324283538,0,6,shelterin complex,CC,
14619,GO:0070189,1,0.8931624797047,0,4,kynurenine metabolic process,BP,
14620,GO:0070191,1,0.938768964756724,0,2,methionine-R-sulfoxide reductase activity,MF,
14621,GO:0070192,1,0.278041509438768,0,36,chromosome organization involved in meiotic cell cycle,BP,
14622,GO:0070193,1,0.7124754628696,0,10,synaptonemal complex organization,BP,
14623,GO:0070194,1,0.937619753280725,0,2,synaptonemal complex disassembly,BP,
14624,GO:0070195,1,0.960248534754153,0,1,growth hormone receptor complex,CC,
14625,GO:0070197,1,0.860161248911839,0,4,meiotic attachment of telomere to nuclear envelope,BP,
14626,GO:0070198,1,0.417419357999078,0,26,protein localization to chromosome, telomeric region,BP,
14627,GO:0070199,1,0.486697379506835,0,23,establishment of protein localization to chromosome,BP,
14628,GO:0070200,1,0.631773504433013,0,14,establishment of protein localization to telomere,BP,
14630,GO:0070202,1,0.705663580865136,0,11,regulation of establishment of protein localization to chromosome,BP,
14631,GO:0070203,1,0.730921976915783,0,10,regulation of establishment of protein localization to telomere,BP,
14632,GO:0070206,1,0.314008431883258,0,35,protein trimerization,BP,
14633,GO:0070207,1,0.570255031730331,0,18,protein homotrimerization,BP,
14634,GO:0070208,1,0.691456542222623,0,10,protein heterotrimerization,BP,
14635,GO:0070209,1,0.963211149343653,0,1,ASTRA complex,CC,
14636,GO:0070212,1,0.860096977151667,0,4,protein poly-ADP-ribosylation,BP,
14637,GO:0070213,1,0.857485007227281,0,4,protein auto-ADP-ribosylation,BP,
14638,GO:0070221,1,0.913889628446296,0,4,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,
14647,GO:0070235,1,0.855338669745909,0,5,regulation of activation-induced cell death of T cells,BP,
14648,GO:0070236,1,0.879557419153098,0,4,negative regulation of activation-induced cell death of T cells,BP,
14654,GO:0070254,1,0.788124365626298,0,8,mucus secretion,BP,
14655,GO:0070255,1,0.800175246183645,0,7,regulation of mucus secretion,BP,
14656,GO:0070256,1,0.976124642047473,0,1,negative regulation of mucus secretion,BP,
14657,GO:0070257,1,0.819757009597113,0,6,positive regulation of mucus secretion,BP,
14658,GO:0070259,1,0.928809575027124,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
14659,GO:0070260,1,0.965469978279355,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
14663,GO:0070267,1,0.962234145391499,0,1,oncosis,BP,
14665,GO:0070269,1,0.79127646433664,0,8,pyroptosis,BP,
14667,GO:0070274,1,0.948649877722114,0,2,RES complex,CC,
14668,GO:0070278,1,0.934372707238337,0,2,extracellular matrix constituent secretion,BP,
14670,GO:0070280,1,0.961447268770442,0,1,pyridoxal binding,MF,
14671,GO:0070283,1,0.974771941901092,0,1,radical SAM enzyme activity,MF,
14672,GO:0070286,1,0.681787556735431,0,11,axonemal dynein complex assembly,BP,
14673,GO:0070288,1,0.963157155759383,0,2,ferritin complex,CC,
14674,GO:0070290,1,0.829458016970586,0,5,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,
14675,GO:0070291,1,0.870717046740009,0,4,N-acylethanolamine metabolic process,BP,
14676,GO:0070292,1,0.926418841237334,0,2,N-acylphosphatidylethanolamine metabolic process,BP,
14679,GO:0070295,1,0.90985532304733,0,3,renal water absorption,BP,
14680,GO:0070296,1,0.569753394965394,0,17,sarcoplasmic reticulum calcium ion transport,BP,
14681,GO:0070300,1,0.53726767108166,0,18,phosphatidic acid binding,MF,
14686,GO:0070305,1,0.884760285187529,0,3,response to cGMP,BP,
14691,GO:0070315,1,0.928935653367638,0,2,G1 to G0 transition involved in cell differentiation,BP,
14692,GO:0070316,1,0.239046228014767,0,41,regulation of G0 to G1 transition,BP,
14693,GO:0070317,1,0.27248668781112,0,37,negative regulation of G0 to G1 transition,BP,
14694,GO:0070318,1,0.877653262371488,0,4,positive regulation of G0 to G1 transition,BP,
14695,GO:0070320,1,0.966809789554633,0,1,inward rectifier potassium channel inhibitor activity,MF,
14697,GO:0070325,1,0.543859566685705,0,18,lipoprotein particle receptor binding,MF,
14698,GO:0070326,1,0.91987826786246,0,3,very-low-density lipoprotein particle receptor binding,MF,
14699,GO:0070327,1,0.890207721356258,0,3,thyroid hormone transport,BP,
14700,GO:0070328,1,0.646993525745448,0,14,triglyceride homeostasis,BP,
14701,GO:0070329,1,0.937952519968535,0,2,tRNA seleno-modification,BP,
14702,GO:0070330,1,0.737876631437994,0,9,aromatase activity,MF,
14703,GO:0070335,1,0.95950763690405,0,1,aspartate binding,MF,
14704,GO:0070336,1,0.926372432495019,0,2,flap-structured DNA binding,MF,
14705,GO:0070337,1,0.959507637057539,0,1,3'-flap-structured DNA binding,MF,
14706,GO:0070339,1,0.899717847709813,0,3,response to bacterial lipopeptide,BP,
14707,GO:0070340,1,0.923979762491369,0,2,detection of bacterial lipopeptide,BP,
14708,GO:0070341,1,0.799435242084416,0,6,fat cell proliferation,BP,
14709,GO:0070343,1,0.960361972512003,0,1,white fat cell proliferation,BP,
14710,GO:0070344,1,0.799435242084416,0,6,regulation of fat cell proliferation,BP,
14711,GO:0070345,1,0.861274916107379,0,4,negative regulation of fat cell proliferation,BP,
14712,GO:0070346,1,0.966540823598339,0,1,positive regulation of fat cell proliferation,BP,
14713,GO:0070350,1,0.960361972512003,0,1,regulation of white fat cell proliferation,BP,
14714,GO:0070358,1,0.856035315111799,0,5,actin polymerization-dependent cell motility,BP,
14715,GO:0070365,1,0.768806335105437,0,8,hepatocyte differentiation,BP,
14716,GO:0070369,1,0.887846904832595,0,3,beta-catenin-TCF7L2 complex,CC,
14717,GO:0070370,1,0.872519913180007,0,5,cellular heat acclimation,BP,
14722,GO:0070375,1,0.897569026676558,0,3,ERK5 cascade,BP,
14723,GO:0070376,1,0.965452879726016,0,1,regulation of ERK5 cascade,BP,
14724,GO:0070377,1,0.965452879726016,0,1,negative regulation of ERK5 cascade,BP,
14725,GO:0070381,1,0.925901476075816,0,2,endosome to plasma membrane transport vesicle,CC,
14727,GO:0070383,1,0.833751927309911,0,6,DNA cytosine deamination,BP,
14729,GO:0070390,1,0.974413361039542,0,1,transcription export complex 2,CC,
14731,GO:0070401,1,0.945502602869782,0,2,NADP+ binding,MF,
14732,GO:0070402,1,0.665186723483237,0,13,NADPH binding,MF,
14734,GO:0070404,1,0.92816086966989,0,3,NADH binding,MF,
14736,GO:0070407,1,0.96423911267569,0,1,oxidation-dependent protein catabolic process,BP,
14737,GO:0070408,1,0.95950764348542,0,1,carbamoyl phosphate metabolic process,BP,
14738,GO:0070409,1,0.95950764348542,0,1,carbamoyl phosphate biosynthetic process,BP,
14740,GO:0070411,1,0.712010514729551,0,9,I-SMAD binding,MF,
14742,GO:0070413,1,0.965111227715674,0,1,trehalose metabolism in response to stress,BP,
14744,GO:0070418,1,0.959565962274383,0,1,DNA-dependent protein kinase complex,CC,
14745,GO:0070419,1,0.784307204810361,0,7,nonhomologous end joining complex,CC,
14749,GO:0070426,1,0.937342921821846,0,2,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14756,GO:0070434,1,0.937342921821846,0,2,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
14757,GO:0070435,1,0.931986690109723,0,2,Shc-EGFR complex,CC,
14758,GO:0070436,1,0.925364373927701,0,2,Grb2-EGFR complex,CC,
14759,GO:0070444,1,0.872709260050946,0,4,oligodendrocyte progenitor proliferation,BP,
14760,GO:0070445,1,0.872709260050946,0,4,regulation of oligodendrocyte progenitor proliferation,BP,
14761,GO:0070446,1,0.972280914660677,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
14762,GO:0070447,1,0.935482655958476,0,2,positive regulation of oligodendrocyte progenitor proliferation,BP,
14763,GO:0070458,1,0.921379580952576,0,3,cellular detoxification of nitrogen compound,BP,
14764,GO:0070459,1,0.86070206888874,0,5,prolactin secretion,BP,
14765,GO:0070460,1,0.961319966218223,0,1,thyroid-stimulating hormone secretion,BP,
14766,GO:0070461,1,0.422589106843956,0,26,SAGA-type complex,CC,
14767,GO:0070463,1,0.962663067281882,0,1,tubulin-dependent ATPase activity,MF,
14768,GO:0070469,1,0.188076685539624,0,78,respiratory chain,CC,
14769,GO:0070470,1,0.902214546508251,0,4,plasma membrane respiratory chain,CC,
14770,GO:0070471,1,0.889706703159993,0,3,uterine smooth muscle contraction,BP,
14771,GO:0070472,1,0.889706703159993,0,3,regulation of uterine smooth muscle contraction,BP,
14772,GO:0070474,1,0.889706703159993,0,3,positive regulation of uterine smooth muscle contraction,BP,
14773,GO:0070475,1,0.775007323526194,0,9,rRNA base methylation,BP,
14774,GO:0070476,1,0.986886648778112,0,1,rRNA (guanine-N7)-methylation,BP,
14775,GO:0070478,1,0.960550028845526,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
14776,GO:0070481,1,0.965339599545292,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
14778,GO:0070483,1,0.963934783144147,0,1,detection of hypoxia,BP,
14781,GO:0070488,1,0.976046683971865,0,2,neutrophil aggregation,BP,
14782,GO:0070489,1,0.961035402645345,0,1,T cell aggregation,BP,
14784,GO:0070492,1,0.888289532428294,0,4,oligosaccharide binding,MF,
14785,GO:0070493,1,0.77815201427575,0,7,thrombin-activated receptor signaling pathway,BP,
14786,GO:0070494,1,0.902152745007606,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
14787,GO:0070495,1,0.902152745007606,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
14789,GO:0070506,1,0.966730093139671,0,1,high-density lipoprotein particle receptor activity,MF,
14793,GO:0070510,1,0.95950763690405,0,1,regulation of histone H4-K20 methylation,BP,
14794,GO:0070512,1,0.95950763690405,0,1,positive regulation of histone H4-K20 methylation,BP,
14795,GO:0070513,1,0.785100453373745,0,8,death domain binding,MF,
14796,GO:0070522,1,0.866400162102112,0,4,ERCC4-ERCC1 complex,CC,
14797,GO:0070524,1,0.977429181028703,0,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
14802,GO:0070531,1,0.836756222610529,0,5,BRCA1-A complex,CC,
14804,GO:0070535,1,0.829386491773198,0,5,histone H2A K63-linked ubiquitination,BP,
14806,GO:0070537,1,0.901119966524771,0,3,histone H2A K63-linked deubiquitination,BP,
14807,GO:0070538,1,0.977320014662109,0,1,oleic acid binding,MF,
14809,GO:0070541,1,0.904510465956772,0,3,response to platinum ion,BP,
14811,GO:0070544,1,0.728460701424067,0,8,histone H3-K36 demethylation,BP,
14812,GO:0070545,1,0.874164751850843,0,4,PeBoW complex,CC,
14813,GO:0070548,1,0.95950763690405,0,1,L-glutamine aminotransferase activity,MF,
14814,GO:0070550,1,0.95950763690405,0,1,rDNA condensation,BP,
14815,GO:0070551,1,0.965469978279355,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
14816,GO:0070552,1,0.904086144081297,0,3,BRISC complex,CC,
14820,GO:0070560,1,0.965469978279355,0,1,protein secretion by platelet,BP,
14823,GO:0070563,1,0.931781238123999,0,2,negative regulation of vitamin D receptor signaling pathway,BP,
14826,GO:0070567,1,0.778429989942569,0,8,cytidylyltransferase activity,MF,
14827,GO:0070568,1,0.847709812531621,0,5,guanylyltransferase activity,MF,
14828,GO:0070569,1,0.787993127675425,0,7,uridylyltransferase activity,MF,
14829,GO:0070570,1,0.499516404623459,0,20,regulation of neuron projection regeneration,BP,
14830,GO:0070571,1,0.632649740253078,0,13,negative regulation of neuron projection regeneration,BP,
14831,GO:0070572,1,0.889288798814044,0,4,positive regulation of neuron projection regeneration,BP,
14832,GO:0070573,1,0.965469978279355,0,1,metallodipeptidase activity,MF,
14833,GO:0070574,1,0.899509770962486,0,3,cadmium ion transmembrane transport,BP,
14834,GO:0070576,1,0.93238368408467,0,2,vitamin D 24-hydroxylase activity,MF,
14837,GO:0070579,1,0.854529349583915,0,4,methylcytosine dioxygenase activity,MF,
14838,GO:0070584,1,0.520575946277369,0,21,mitochondrion morphogenesis,BP,
14843,GO:0070589,1,0.973839944555444,0,1,cellular component macromolecule biosynthetic process,BP,
14844,GO:0070593,1,0.95950763690405,0,1,dendrite self-avoidance,BP,
14845,GO:0070601,1,0.764487342250004,0,8,centromeric sister chromatid cohesion,BP,
14846,GO:0070602,1,0.910310467965847,0,3,regulation of centromeric sister chromatid cohesion,BP,
14847,GO:0070603,1,0.099467911690031,0,67,SWI/SNF superfamily-type complex,CC,
14848,GO:0070611,1,0.967032301558472,0,1,histone methyltransferase activity (H3-R2 specific),MF,
14849,GO:0070612,1,0.967032301558472,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
14851,GO:0070615,1,0.96077616260181,0,1,nucleosome-dependent ATPase activity,MF,
14852,GO:0070618,1,0.966704693967304,0,1,Grb2-Sos complex,CC,
14853,GO:0070625,1,0.971141130823868,0,1,zymogen granule exocytosis,BP,
14854,GO:0070626,1,0.976712320382908,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
14855,GO:0070627,1,0.960589873502901,0,1,ferrous iron import,BP,
14857,GO:0070631,1,0.965469978279355,0,1,spindle pole body localization,BP,
14858,GO:0070632,1,0.965469978279355,0,1,establishment of spindle pole body localization,BP,
14860,GO:0070634,1,0.907839066753404,0,3,transepithelial ammonium transport,BP,
14861,GO:0070637,1,0.968561372296152,0,1,pyridine nucleoside metabolic process,BP,
14862,GO:0070638,1,0.968561372296152,0,1,pyridine nucleoside catabolic process,BP,
14864,GO:0070643,1,0.97535011377032,0,1,vitamin D 25-hydroxylase activity,MF,
14865,GO:0070644,1,0.884478495774698,0,3,vitamin D response element binding,MF,
14868,GO:0070649,1,0.92460003006269,0,2,formin-nucleated actin cable assembly,BP,
14869,GO:0070650,1,0.965469978279355,0,1,actin filament bundle distribution,BP,
14870,GO:0070651,1,0.965339599545292,0,1,nonfunctional rRNA decay,BP,
14871,GO:0070652,1,0.772054489328431,0,8,HAUS complex,CC,
14873,GO:0070662,1,0.925491736697948,0,2,mast cell proliferation,BP,
14877,GO:0070666,1,0.925491736697948,0,2,regulation of mast cell proliferation,BP,
14878,GO:0070667,1,0.964536893806967,0,1,negative regulation of mast cell proliferation,BP,
14879,GO:0070668,1,0.925491736697948,0,2,positive regulation of mast cell proliferation,BP,
14880,GO:0070669,1,0.708042052412257,0,9,response to interleukin-2,BP,
14883,GO:0070672,1,0.688465554508477,0,10,response to interleukin-15,BP,
14885,GO:0070676,1,0.923034194955663,0,3,intralumenal vesicle formation,BP,
14886,GO:0070678,1,0.966749175501767,0,1,preprotein binding,MF,
14887,GO:0070679,1,0.782792188008929,0,6,inositol 1,4,5 trisphosphate binding,MF,
14888,GO:0070681,1,0.91725123304458,0,3,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
14889,GO:0070682,1,0.911248108767067,0,3,proteasome regulatory particle assembly,BP,
14890,GO:0070685,1,0.970889908515122,0,1,macropinocytic cup,CC,
14891,GO:0070694,1,0.965469978279355,0,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,
14892,GO:0070695,1,0.831459792378551,0,5,FHF complex,CC,
14897,GO:0070704,1,0.927005009590946,0,2,sterol desaturase activity,MF,
14898,GO:0070715,1,0.963486266439358,0,1,sodium-dependent organic cation transport,BP,
14903,GO:0070728,1,0.801123404279555,0,6,leucine binding,MF,
14904,GO:0070733,1,0.975028065885525,0,1,protein adenylyltransferase activity,MF,
14905,GO:0070734,1,0.546443358267425,0,18,histone H3-K27 methylation,BP,
14906,GO:0070735,1,0.962930732430284,0,1,protein-glycine ligase activity,MF,
14907,GO:0070736,1,0.962930732430284,0,1,protein-glycine ligase activity, initiating,MF,
14908,GO:0070739,1,0.805120800658753,0,6,protein-glutamic acid ligase activity,MF,
14909,GO:0070740,1,0.805120800658753,0,6,tubulin-glutamic acid ligase activity,MF,
14911,GO:0070742,1,0.65883518217104,0,12,C2H2 zinc finger domain binding,MF,
14914,GO:0070761,1,0.836656443764478,0,6,pre-snoRNP complex,CC,
14915,GO:0070762,1,0.965469978279355,0,1,nuclear pore transmembrane ring,CC,
14916,GO:0070765,1,0.818633829680078,0,6,gamma-secretase complex,CC,
14917,GO:0070772,1,0.964314480073254,0,1,PAS complex,CC,
14918,GO:0070773,1,0.978074585938961,0,1,protein-N-terminal glutamine amidohydrolase activity,MF,
14919,GO:0070774,1,0.960204027932764,0,1,phytoceramidase activity,MF,
14920,GO:0070775,1,0.767394200361675,0,7,H3 histone acetyltransferase complex,CC,
14921,GO:0070776,1,0.767394200361675,0,7,MOZ/MORF histone acetyltransferase complex,CC,
14922,GO:0070777,1,0.924166835971579,0,2,D-aspartate transport,BP,
14923,GO:0070778,1,0.860830258061967,0,4,L-aspartate transmembrane transport,BP,
14924,GO:0070779,1,0.924166835971579,0,2,D-aspartate import across plasma membrane,BP,
14925,GO:0070780,1,0.943814405445958,0,2,dihydrosphingosine-1-phosphate phosphatase activity,MF,
14926,GO:0070781,1,0.95950763690405,0,1,response to biotin,BP,
14927,GO:0070782,1,0.970528804883051,0,1,phosphatidylserine exposure on apoptotic cell surface,BP,
14928,GO:0070813,1,0.8674431044971,0,5,hydrogen sulfide metabolic process,BP,
14929,GO:0070814,1,0.883056403775218,0,4,hydrogen sulfide biosynthetic process,BP,
14930,GO:0070815,1,0.860616900650576,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
14932,GO:0070818,1,0.974106313102107,0,1,protoporphyrinogen oxidase activity,MF,
14935,GO:0070822,1,0.610404632402004,0,14,Sin3-type complex,CC,
14936,GO:0070826,1,0.960589873502901,0,1,paraferritin complex,CC,
14937,GO:0070827,1,0.855431802791345,0,4,chromatin maintenance,BP,
14938,GO:0070828,1,0.58710232682312,0,15,heterochromatin organization,BP,
14939,GO:0070829,1,0.920960094175951,0,2,heterochromatin maintenance,BP,
14942,GO:0070836,1,0.904710491150053,0,3,caveola assembly,BP,
14943,GO:0070837,1,0.92453125086049,0,2,dehydroascorbic acid transport,BP,
14945,GO:0070840,1,0.491402527203172,0,18,dynein complex binding,MF,
14947,GO:0070842,1,0.887300089181982,0,3,aggresome assembly,BP,
14948,GO:0070843,1,0.960693904228352,0,1,misfolded protein transport,BP,
14949,GO:0070844,1,0.960693904228352,0,1,polyubiquitinated protein transport,BP,
14950,GO:0070845,1,0.960693904228352,0,1,polyubiquitinated misfolded protein transport,BP,
14951,GO:0070846,1,0.960693904228352,0,1,Hsp90 deacetylation,BP,
14952,GO:0070847,1,0.799744415605597,0,8,core mediator complex,CC,
14957,GO:0070853,1,0.920650957478618,0,2,myosin VI binding,MF,
14958,GO:0070856,1,0.95950763690405,0,1,myosin VI light chain binding,MF,
14959,GO:0070857,1,0.840063768984718,0,5,regulation of bile acid biosynthetic process,BP,
14960,GO:0070859,1,0.905800365439545,0,3,positive regulation of bile acid biosynthetic process,BP,
14961,GO:0070860,1,0.969351315218232,0,1,RNA polymerase I core factor complex,CC,
14964,GO:0070863,1,0.742849985279306,0,8,positive regulation of protein exit from endoplasmic reticulum,BP,
14966,GO:0070874,1,0.826476297891034,0,5,negative regulation of glycogen metabolic process,BP,
14969,GO:0070877,1,0.926968128995111,0,2,microprocessor complex,CC,
14971,GO:0070883,1,0.858985187406763,0,5,pre-miRNA binding,MF,
14973,GO:0070885,1,0.895272688347723,0,3,negative regulation of calcineurin-NFAT signaling cascade,BP,
14977,GO:0070889,1,0.937033903970615,0,2,platelet alpha granule organization,BP,
14978,GO:0070890,1,0.95950763690405,0,1,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
14979,GO:0070893,1,0.926949458867896,0,2,transposon integration,BP,
14980,GO:0070894,1,0.926949458867896,0,2,regulation of transposon integration,BP,
14981,GO:0070895,1,0.926949458867896,0,2,negative regulation of transposon integration,BP,
14983,GO:0070898,1,0.95950763690405,0,1,RNA polymerase III transcriptional preinitiation complex assembly,BP,
14984,GO:0070899,1,0.964850421077813,0,1,mitochondrial tRNA wobble uridine modification,BP,
14985,GO:0070900,1,0.763815536571094,0,9,mitochondrial tRNA modification,BP,
14986,GO:0070901,1,0.885777650306493,0,4,mitochondrial tRNA methylation,BP,
14987,GO:0070902,1,0.974853850947444,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
14988,GO:0070903,1,0.972089743268566,0,1,mitochondrial tRNA thio-modification,BP,
14989,GO:0070904,1,0.95950763690405,0,1,transepithelial L-ascorbic acid transport,BP,
14990,GO:0070905,1,0.940024537552079,0,2,serine binding,MF,
14991,GO:0070911,1,0.371704477497172,0,32,global genome nucleotide-excision repair,BP,
14992,GO:0070914,1,0.689747981655893,0,11,UV-damage excision repair,BP,
14993,GO:0070915,1,0.885330512314737,0,4,lysophosphatidic acid receptor activity,MF,
14996,GO:0070922,1,0.730705819924328,0,9,small RNA loading onto RISC,BP,
14998,GO:0070926,1,0.961331315726121,0,1,regulation of ATP:ADP antiporter activity,BP,
14999,GO:0070931,1,0.959507671057142,0,1,Golgi-associated vesicle lumen,CC,
15002,GO:0070934,1,0.862556912329205,0,4,CRD-mediated mRNA stabilization,BP,
15005,GO:0070937,1,0.828627912078289,0,5,CRD-mediated mRNA stability complex,CC,
15006,GO:0070938,1,0.66916359630485,0,11,contractile ring,CC,
15007,GO:0070939,1,0.893899543877001,0,3,Dsl1/NZR complex,CC,
15008,GO:0070940,1,0.837986843790406,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
15009,GO:0070942,1,0.886728779183952,0,4,neutrophil mediated cytotoxicity,BP,
15010,GO:0070943,1,0.919516483608917,0,3,neutrophil mediated killing of symbiont cell,BP,
15011,GO:0070944,1,0.941147263119913,0,2,neutrophil mediated killing of bacterium,BP,
15012,GO:0070945,1,0.941147263119913,0,2,neutrophil mediated killing of gram-negative bacterium,BP,
15013,GO:0070947,1,0.97702009441203,0,1,neutrophil mediated killing of fungus,BP,
15014,GO:0070948,1,0.90972417408672,0,3,regulation of neutrophil mediated cytotoxicity,BP,
15015,GO:0070949,1,0.943359933961895,0,2,regulation of neutrophil mediated killing of symbiont cell,BP,
15016,GO:0070950,1,0.965550139443602,0,1,regulation of neutrophil mediated killing of bacterium,BP,
15017,GO:0070951,1,0.965550139443602,0,1,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
15018,GO:0070953,1,0.97702009441203,0,1,regulation of neutrophil mediated killing of fungus,BP,
15019,GO:0070960,1,0.943359933961895,0,2,positive regulation of neutrophil mediated cytotoxicity,BP,
15020,GO:0070961,1,0.943359933961895,0,2,positive regulation of neutrophil mediated killing of symbiont cell,BP,
15021,GO:0070962,1,0.965550139443602,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
15022,GO:0070963,1,0.965550139443602,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
15023,GO:0070965,1,0.97702009441203,0,1,positive regulation of neutrophil mediated killing of fungus,BP,
15024,GO:0070966,1,0.889819434095959,0,3,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
15025,GO:0070970,1,0.737262170996635,0,8,interleukin-2 secretion,BP,
15026,GO:0070971,1,0.582796766679973,0,15,endoplasmic reticulum exit site,CC,
15028,GO:0070973,1,0.862329078030452,0,4,protein localization to endoplasmic reticulum exit site,BP,
15029,GO:0070975,1,0.95950763690405,0,1,FHA domain binding,MF,
15030,GO:0070976,1,0.96655962347828,0,1,TIR domain binding,MF,
15032,GO:0070979,1,0.453311014457605,0,27,protein K11-linked ubiquitination,BP,
15033,GO:0070980,1,0.968977615020239,0,1,biphenyl catabolic process,BP,
15034,GO:0070981,1,0.969193383246032,0,1,L-asparagine biosynthetic process,BP,
15035,GO:0070982,1,0.969193383246032,0,1,L-asparagine metabolic process,BP,
15036,GO:0070984,1,0.960595936471052,0,1,SET domain binding,MF,
15037,GO:0070985,1,0.954540022552679,0,2,TFIIK complex,CC,
15038,GO:0070986,1,0.656850176856065,0,12,left/right axis specification,BP,
15039,GO:0070987,1,0.571887142154715,0,18,error-free translesion synthesis,BP,
15042,GO:0070990,1,0.859637331559254,0,6,snRNP binding,MF,
15043,GO:0070991,1,0.90033770686993,0,3,medium-chain-acyl-CoA dehydrogenase activity,MF,
15044,GO:0070992,1,0.954299268943186,0,2,translation initiation complex,CC,
15045,GO:0070993,1,0.922234650559448,0,2,translation preinitiation complex,CC,
15046,GO:0070995,1,0.964053661414986,0,1,NADPH oxidation,BP,
15048,GO:0071001,1,0.913237987192414,0,3,U4/U6 snRNP,CC,
15049,GO:0071004,1,0.59533122631635,0,17,U2-type prespliceosome,CC,
15050,GO:0071005,1,0.936736412956346,0,2,U2-type precatalytic spliceosome,CC,
15053,GO:0071008,1,0.880974858061525,0,4,U2-type post-mRNA release spliceosomal complex,CC,
15054,GO:0071010,1,0.516320912425715,0,22,prespliceosome,CC,
15055,GO:0071011,1,0.40906821928994,0,31,precatalytic spliceosome,CC,
15058,GO:0071014,1,0.75333460530821,0,9,post-mRNA release spliceosomal complex,CC,
15059,GO:0071020,1,0.949048810084073,0,2,post-spliceosomal complex,CC,
15060,GO:0071021,1,0.974451391860301,0,1,U2-type post-spliceosomal complex,CC,
15061,GO:0071025,1,0.663928541607514,0,15,RNA surveillance,BP,
15062,GO:0071026,1,0.968064392792103,0,1,cytoplasmic RNA surveillance,BP,
15063,GO:0071027,1,0.710499440453147,0,13,nuclear RNA surveillance,BP,
15064,GO:0071028,1,0.710499440453147,0,13,nuclear mRNA surveillance,BP,
15065,GO:0071029,1,0.858560882032599,0,6,nuclear ncRNA surveillance,BP,
15066,GO:0071030,1,0.94140760644351,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
15067,GO:0071031,1,0.951080614503713,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
15068,GO:0071033,1,0.87243232337858,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
15069,GO:0071034,1,0.881614097392694,0,4,CUT catabolic process,BP,
15070,GO:0071035,1,0.858560882032599,0,6,nuclear polyadenylation-dependent rRNA catabolic process,BP,
15071,GO:0071038,1,0.888703896912609,0,5,nuclear polyadenylation-dependent tRNA catabolic process,BP,
15072,GO:0071042,1,0.896978849366641,0,4,nuclear polyadenylation-dependent mRNA catabolic process,BP,
15073,GO:0071043,1,0.881614097392694,0,4,CUT metabolic process,BP,
15074,GO:0071044,1,0.684270583956658,0,11,histone mRNA catabolic process,BP,
15075,GO:0071045,1,0.975076641206544,0,1,nuclear histone mRNA catabolic process,BP,
15076,GO:0071046,1,0.858560882032599,0,6,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
15077,GO:0071047,1,0.896978849366641,0,4,polyadenylation-dependent mRNA catabolic process,BP,
15078,GO:0071048,1,0.94140760644351,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
15079,GO:0071049,1,0.951080614503713,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
15080,GO:0071051,1,0.89487681562243,0,5,polyadenylation-dependent snoRNA 3'-end processing,BP,
15083,GO:0071071,1,0.761448866418444,0,8,regulation of phospholipid biosynthetic process,BP,
15084,GO:0071072,1,0.862841620316062,0,4,negative regulation of phospholipid biosynthetic process,BP,
15085,GO:0071073,1,0.910624683356756,0,3,positive regulation of phospholipid biosynthetic process,BP,
15086,GO:0071074,1,0.972588336419411,0,1,eukaryotic initiation factor eIF2 binding,MF,
15087,GO:0071077,1,0.904672350912616,0,3,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
15089,GO:0071104,1,0.920749189957228,0,2,response to interleukin-9,BP,
15090,GO:0071105,1,0.959766580323597,0,1,response to interleukin-11,BP,
15091,GO:0071106,1,0.904672350912616,0,3,adenosine 3',5'-bisphosphate transmembrane transport,BP,
15092,GO:0071107,1,0.88770713713989,0,3,response to parathyroid hormone,BP,
15094,GO:0071109,1,0.920650957478618,0,2,superior temporal gyrus development,BP,
15095,GO:0071110,1,0.95950763690405,0,1,histone biotinylation,BP,
15097,GO:0071139,1,0.928066571829876,0,2,resolution of recombination intermediates,BP,
15098,GO:0071140,1,0.928066571829876,0,2,resolution of mitotic recombination intermediates,BP,
15101,GO:0071148,1,0.920679733522455,0,2,TEAD-1-YAP complex,CC,
15102,GO:0071149,1,0.93117897995832,0,2,TEAD-2-YAP complex,CC,
15104,GO:0071157,1,0.57370684108122,0,18,negative regulation of cell cycle arrest,BP,
15107,GO:0071163,1,0.920902756026574,0,3,DNA replication preinitiation complex assembly,BP,
15108,GO:0071164,1,0.961851849855523,0,1,RNA trimethylguanosine synthase activity,MF,
15110,GO:0071168,1,0.482900694244624,0,22,protein localization to chromatin,BP,
15111,GO:0071169,1,0.798177142582767,0,8,establishment of protein localization to chromatin,BP,
15114,GO:0071203,1,0.806433493735013,0,6,WASH complex,CC,
15115,GO:0071204,1,0.831285151448545,0,6,histone pre-mRNA 3'end processing complex,CC,
15116,GO:0071205,1,0.848116343882393,0,4,protein localization to juxtaparanode region of axon,BP,
15117,GO:0071207,1,0.935218636877843,0,2,histone pre-mRNA stem-loop binding,MF,
15118,GO:0071208,1,0.91918145415306,0,4,histone pre-mRNA DCP binding,MF,
15119,GO:0071209,1,0.93052794121694,0,3,U7 snRNA binding,MF,
15120,GO:0071211,1,0.864947529730353,0,4,protein targeting to vacuole involved in autophagy,BP,
15122,GO:0071215,1,0.960262723320359,0,1,cellular response to abscisic acid stimulus,BP,
15124,GO:0071218,1,0.496928248832481,0,20,cellular response to misfolded protein,BP,
15126,GO:0071220,1,0.899717847709813,0,3,cellular response to bacterial lipoprotein,BP,
15127,GO:0071221,1,0.899717847709813,0,3,cellular response to bacterial lipopeptide,BP,
15132,GO:0071226,1,0.959616422844776,0,1,cellular response to molecule of fungal origin,BP,
15133,GO:0071228,1,0.965272223551698,0,1,cellular response to tumor cell,BP,
15136,GO:0071233,1,0.735277482340183,0,8,cellular response to leucine,BP,
15139,GO:0071242,1,0.326305640676839,0,33,cellular response to ammonium ion,BP,
15141,GO:0071245,1,0.962040415556717,0,1,cellular response to carbon monoxide,BP,
15142,GO:0071247,1,0.980846631241159,0,1,cellular response to chromate,BP,
15144,GO:0071253,1,0.831175876223154,0,5,connexin binding,MF,
15145,GO:0071256,1,0.921436795127022,0,4,translocon complex,CC,
15147,GO:0071258,1,0.960654669220098,0,1,cellular response to gravity,BP,
15149,GO:0071262,1,0.922705557698838,0,2,regulation of translational initiation in response to starvation,BP,
15150,GO:0071264,1,0.922705557698838,0,2,positive regulation of translational initiation in response to starvation,BP,
15151,GO:0071265,1,0.812425434006111,0,7,L-methionine biosynthetic process,BP,
15152,GO:0071266,1,0.97411570855655,0,1,'de novo' L-methionine biosynthetic process,BP,
15153,GO:0071267,1,0.834023367793489,0,6,L-methionine salvage,BP,
15155,GO:0071275,1,0.970577117482702,0,1,cellular response to aluminum ion,BP,
15158,GO:0071279,1,0.88262874989276,0,4,cellular response to cobalt ion,BP,
15159,GO:0071280,1,0.720986162594707,0,12,cellular response to copper ion,BP,
15160,GO:0071281,1,0.836528127626639,0,6,cellular response to iron ion,BP,
15161,GO:0071283,1,0.9536600722216,0,2,cellular response to iron(III) ion,BP,
15163,GO:0071285,1,0.768742456407,0,8,cellular response to lithium ion,BP,
15164,GO:0071286,1,0.883551838045722,0,3,cellular response to magnesium ion,BP,
15165,GO:0071287,1,0.80699836522852,0,6,cellular response to manganese ion,BP,
15169,GO:0071301,1,0.95950763690405,0,1,cellular response to vitamin B1,BP,
15171,GO:0071306,1,0.933670317094306,0,2,cellular response to vitamin E,BP,
15172,GO:0071307,1,0.932800781023109,0,2,cellular response to vitamin K,BP,
15174,GO:0071312,1,0.488172585040295,0,21,cellular response to alkaloid,BP,
15175,GO:0071313,1,0.900529346979207,0,3,cellular response to caffeine,BP,
15176,GO:0071314,1,0.966013873167482,0,1,cellular response to cocaine,BP,
15177,GO:0071315,1,0.897178707138031,0,3,cellular response to morphine,BP,
15179,GO:0071317,1,0.897178707138031,0,3,cellular response to isoquinoline alkaloid,BP,
15182,GO:0071321,1,0.884760285187529,0,3,cellular response to cGMP,BP,
15184,GO:0071324,1,0.959630263764256,0,1,cellular response to disaccharide stimulus,BP,
15186,GO:0071329,1,0.959630263764256,0,1,cellular response to sucrose stimulus,BP,
15188,GO:0071332,1,0.941325368294188,0,2,cellular response to fructose stimulus,BP,
15190,GO:0071335,1,0.970432530399028,0,1,hair follicle cell proliferation,BP,
15191,GO:0071336,1,0.970432530399028,0,1,regulation of hair follicle cell proliferation,BP,
15192,GO:0071338,1,0.970432530399028,0,1,positive regulation of hair follicle cell proliferation,BP,
15193,GO:0071339,1,0.378893552738991,0,29,MLL1 complex,CC,
15194,GO:0071340,1,0.809283293633914,0,6,skeletal muscle acetylcholine-gated channel clustering,BP,
15195,GO:0071344,1,0.954629866485687,0,2,diphosphate metabolic process,BP,
15199,GO:0071348,1,0.959766580323597,0,1,cellular response to interleukin-11,BP,
15201,GO:0071350,1,0.717503981135131,0,9,cellular response to interleukin-15,BP,
15202,GO:0071351,1,0.859723770688772,0,5,cellular response to interleukin-18,BP,
15203,GO:0071352,1,0.708042052412257,0,9,cellular response to interleukin-2,BP,
15206,GO:0071355,1,0.920749189957228,0,2,cellular response to interleukin-9,BP,
15211,GO:0071361,1,0.726700519820176,0,8,cellular response to ethanol,BP,
15217,GO:0071373,1,0.933955098401012,0,2,cellular response to luteinizing hormone stimulus,BP,
15218,GO:0071374,1,0.925176904571943,0,2,cellular response to parathyroid hormone stimulus,BP,
15220,GO:0071376,1,0.930971998123976,0,2,cellular response to corticotropin-releasing hormone stimulus,BP,
15221,GO:0071377,1,0.463533126022709,0,22,cellular response to glucagon stimulus,BP,
15223,GO:0071379,1,0.590436679693595,0,14,cellular response to prostaglandin stimulus,BP,
15224,GO:0071380,1,0.630167053662868,0,12,cellular response to prostaglandin E stimulus,BP,
15228,GO:0071386,1,0.920650957478618,0,2,cellular response to corticosterone stimulus,BP,
15229,GO:0071387,1,0.959558274183475,0,1,cellular response to cortisol stimulus,BP,
15231,GO:0071391,1,0.662455915282549,0,11,cellular response to estrogen stimulus,BP,
15232,GO:0071392,1,0.467734824028827,0,23,cellular response to estradiol stimulus,BP,
15233,GO:0071393,1,0.960844645506627,0,1,cellular response to progesterone stimulus,BP,
15234,GO:0071394,1,0.783482369488364,0,7,cellular response to testosterone stimulus,BP,
15235,GO:0071395,1,0.954817137752606,0,2,cellular response to jasmonic acid stimulus,BP,
15239,GO:0071400,1,0.92905780112788,0,2,cellular response to oleic acid,BP,
15240,GO:0071401,1,0.969484008610393,0,1,cellular response to triglyceride,BP,
15242,GO:0071403,1,0.928591310043437,0,2,cellular response to high density lipoprotein particle stimulus,BP,
15245,GO:0071409,1,0.903069952364259,0,3,cellular response to cycloheximide,BP,
15246,GO:0071415,1,0.900529346979207,0,3,cellular response to purine-containing compound,BP,
15248,GO:0071418,1,0.977979504797558,0,1,cellular response to amine stimulus,BP,
15249,GO:0071420,1,0.921361924360193,0,2,cellular response to histamine,BP,
15250,GO:0071421,1,0.923398092406646,0,2,manganese ion transmembrane transport,BP,
15251,GO:0071422,1,0.900812617306245,0,3,succinate transmembrane transport,BP,
15252,GO:0071423,1,0.972783641722553,0,1,malate transmembrane transport,BP,
15253,GO:0071424,1,0.965469978279355,0,1,rRNA (cytosine-N4-)-methyltransferase activity,MF,
15257,GO:0071428,1,0.656630104403612,0,15,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
15259,GO:0071435,1,0.921007749368966,0,2,potassium ion export,BP,
15262,GO:0071439,1,0.758091792744064,0,8,clathrin complex,CC,
15263,GO:0071440,1,0.836857592136926,0,5,regulation of histone H3-K14 acetylation,BP,
15264,GO:0071441,1,0.961398896095493,0,1,negative regulation of histone H3-K14 acetylation,BP,
15265,GO:0071442,1,0.901610845278926,0,3,positive regulation of histone H3-K14 acetylation,BP,
15266,GO:0071447,1,0.807243175006712,0,6,cellular response to hydroperoxide,BP,
15267,GO:0071449,1,0.982888324589636,0,1,cellular response to lipid hydroperoxide,BP,
15271,GO:0071454,1,0.95950763690405,0,1,cellular response to anoxia,BP,
15272,GO:0071455,1,0.804773886151542,0,6,cellular response to hyperoxia,BP,
15274,GO:0071458,1,0.840755619670706,0,5,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,
15275,GO:0071459,1,0.521270769341984,0,20,protein localization to chromosome, centromeric region,BP,
15276,GO:0071460,1,0.959079488530808,0,2,cellular response to cell-matrix adhesion,BP,
15277,GO:0071461,1,0.946184426302632,0,2,cellular response to redox state,BP,
15278,GO:0071462,1,0.923400005843293,0,2,cellular response to water stimulus,BP,
15279,GO:0071464,1,0.959603664790612,0,1,cellular response to hydrostatic pressure,BP,
15287,GO:0071475,1,0.913502980974062,0,3,cellular hyperosmotic salinity response,BP,
15289,GO:0071477,1,0.925027418809873,0,2,cellular hypotonic salinity response,BP,
15293,GO:0071481,1,0.653845197512464,0,11,cellular response to X-ray,BP,
15295,GO:0071483,1,0.925646114640367,0,2,cellular response to blue light,BP,
15296,GO:0071484,1,0.924450480315235,0,2,cellular response to light intensity,BP,
15297,GO:0071485,1,0.963432130161792,0,1,cellular response to absence of light,BP,
15298,GO:0071486,1,0.959542479616028,0,1,cellular response to high light intensity,BP,
15299,GO:0071492,1,0.933840080841634,0,2,cellular response to UV-A,BP,
15301,GO:0071494,1,0.872149569162647,0,4,cellular response to UV-C,BP,
15306,GO:0071500,1,0.871766196962849,0,5,cellular response to nitrosative stress,BP,
15308,GO:0071502,1,0.913171378272847,0,3,cellular response to temperature stimulus,BP,
15311,GO:0071505,1,0.930972831673076,0,2,response to mycophenolic acid,BP,
15312,GO:0071506,1,0.930972831673076,0,2,cellular response to mycophenolic acid,BP,
15313,GO:0071514,1,0.512730575047537,0,18,genetic imprinting,BP,
15315,GO:0071528,1,0.961280594159317,0,1,tRNA re-export from nucleus,BP,
15318,GO:0071538,1,0.969343762500031,0,1,SH2 domain-mediated complex assembly,BP,
15319,GO:0071539,1,0.376280006651773,0,26,protein localization to centrosome,BP,
15320,GO:0071540,1,0.959533242564288,0,1,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
15321,GO:0071541,1,0.82486474103942,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
15323,GO:0071543,1,0.883830410916759,0,4,diphosphoinositol polyphosphate metabolic process,BP,
15324,GO:0071544,1,0.978074585938961,0,1,diphosphoinositol polyphosphate catabolic process,BP,
15325,GO:0071545,1,0.651549860524773,0,12,inositol phosphate catabolic process,BP,
15326,GO:0071546,1,0.928950407446561,0,2,pi-body,CC,
15327,GO:0071547,1,0.966225539049244,0,1,piP-body,CC,
15331,GO:0071554,1,0.915917111459479,0,3,cell wall organization or biogenesis,BP,
15337,GO:0071561,1,0.959608557962798,0,1,nucleus-vacuole junction,CC,
15338,GO:0071564,1,0.658030585594545,0,12,npBAF complex,CC,
15339,GO:0071565,1,0.643229338825378,0,12,nBAF complex,CC,
15340,GO:0071566,1,0.965160915290071,0,1,UFM1 activating enzyme activity,MF,
15341,GO:0071567,1,0.951441775431031,0,2,UFM1 hydrolase activity,MF,
15342,GO:0071568,1,0.946680047256611,0,2,UFM1 transferase activity,MF,
15343,GO:0071569,1,0.841740448165599,0,6,protein ufmylation,BP,
15344,GO:0071573,1,0.965235913393154,0,1,shelterin complex assembly,BP,
15345,GO:0071575,1,0.962176387937951,0,1,integral component of external side of plasma membrane,CC,
15346,GO:0071577,1,0.596769504262792,0,15,zinc ion transmembrane transport,BP,
15347,GO:0071578,1,0.808731409186435,0,6,zinc ion import across plasma membrane,BP,
15348,GO:0071579,1,0.971695160861598,0,1,regulation of zinc ion transport,BP,
15349,GO:0071580,1,0.971695160861598,0,1,regulation of zinc ion transmembrane transport,BP,
15350,GO:0071581,1,0.971695160861598,0,1,regulation of zinc ion transmembrane import,BP,
15351,GO:0071582,1,0.971695160861598,0,1,negative regulation of zinc ion transport,BP,
15352,GO:0071583,1,0.971695160861598,0,1,negative regulation of zinc ion transmembrane transport,BP,
15353,GO:0071584,1,0.971695160861598,0,1,negative regulation of zinc ion transmembrane import,BP,
15354,GO:0071585,1,0.971695160861598,0,1,detoxification of cadmium ion,BP,
15355,GO:0071586,1,0.941691863277172,0,2,CAAX-box protein processing,BP,
15356,GO:0071593,1,0.900751936019662,0,3,lymphocyte aggregation,BP,
15357,GO:0071595,1,0.932129376517163,0,2,Nem1-Spo7 phosphatase complex,CC,
15358,GO:0071596,1,0.883389671637962,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
15359,GO:0071598,1,0.848802078995722,0,5,neuronal ribonucleoprotein granule,CC,
15362,GO:0071602,1,0.960204027932764,0,1,phytosphingosine biosynthetic process,BP,
15363,GO:0071603,1,0.924160476665407,0,2,endothelial cell-cell adhesion,BP,
15366,GO:0071606,1,0.971986138849325,0,1,chemokine (C-C motif) ligand 4 production,BP,
15367,GO:0071608,1,0.870023767132157,0,4,macrophage inflammatory protein-1 alpha production,BP,
15368,GO:0071609,1,0.765893793105106,0,8,chemokine (C-C motif) ligand 5 production,BP,
15369,GO:0071611,1,0.936818072261017,0,2,granulocyte colony-stimulating factor production,BP,
15370,GO:0071612,1,0.95950763690405,0,1,IP-10 production,BP,
15371,GO:0071614,1,0.973052545716935,0,1,linoleic acid epoxygenase activity,MF,
15372,GO:0071615,1,0.964209155829131,0,1,oxidative deethylation,BP,
15373,GO:0071616,1,0.221795998613808,0,43,acyl-CoA biosynthetic process,BP,
15374,GO:0071617,1,0.485884600431105,0,20,lysophospholipid acyltransferase activity,MF,
15375,GO:0071619,1,0.96960619119404,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
15378,GO:0071623,1,0.959640944479446,0,1,negative regulation of granulocyte chemotaxis,BP,
15380,GO:0071625,1,0.648644368773221,0,11,vocalization behavior,BP,
15381,GO:0071629,1,0.975076641206544,0,1,cytoplasm protein quality control by the ubiquitin-proteasome system,BP,
15382,GO:0071630,1,0.890821925518934,0,3,nuclear protein quality control by the ubiquitin-proteasome system,BP,
15383,GO:0071633,1,0.965700620300081,0,1,dihydroceramidase activity,MF,
15385,GO:0071635,1,0.806051732241156,0,6,negative regulation of transforming growth factor beta production,BP,
15388,GO:0071638,1,0.943188427355072,0,2,negative regulation of monocyte chemotactic protein-1 production,BP,
15390,GO:0071640,1,0.870023767132157,0,4,regulation of macrophage inflammatory protein 1 alpha production,BP,
15391,GO:0071641,1,0.935582174559242,0,2,negative regulation of macrophage inflammatory protein 1 alpha production,BP,
15392,GO:0071642,1,0.929939033037055,0,2,positive regulation of macrophage inflammatory protein 1 alpha production,BP,
15393,GO:0071643,1,0.971986138849325,0,1,regulation of chemokine (C-C motif) ligand 4 production,BP,
15394,GO:0071644,1,0.971986138849325,0,1,negative regulation of chemokine (C-C motif) ligand 4 production,BP,
15395,GO:0071649,1,0.785763064647615,0,7,regulation of chemokine (C-C motif) ligand 5 production,BP,
15396,GO:0071650,1,0.917818905832534,0,3,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
15397,GO:0071651,1,0.856148758051917,0,4,positive regulation of chemokine (C-C motif) ligand 5 production,BP,
15398,GO:0071655,1,0.936818072261017,0,2,regulation of granulocyte colony-stimulating factor production,BP,
15399,GO:0071656,1,0.969238362043476,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
15400,GO:0071657,1,0.96655335371581,0,1,positive regulation of granulocyte colony-stimulating factor production,BP,
15401,GO:0071658,1,0.95950763690405,0,1,regulation of IP-10 production,BP,
15402,GO:0071660,1,0.95950763690405,0,1,positive regulation of IP-10 production,BP,
15403,GO:0071664,1,0.855074985587784,0,4,catenin-TCF7L2 complex,CC,
15404,GO:0071665,1,0.963099154166237,0,1,gamma-catenin-TCF7L2 complex,CC,
15405,GO:0071670,1,0.852481913502429,0,5,smooth muscle cell chemotaxis,BP,
15406,GO:0071671,1,0.884066667127591,0,4,regulation of smooth muscle cell chemotaxis,BP,
15407,GO:0071672,1,0.916878146499171,0,3,negative regulation of smooth muscle cell chemotaxis,BP,
15408,GO:0071673,1,0.964221624654831,0,1,positive regulation of smooth muscle cell chemotaxis,BP,
15411,GO:0071676,1,0.932300962520006,0,2,negative regulation of mononuclear cell migration,BP,
15413,GO:0071678,1,0.95950763690405,0,1,olfactory bulb axon guidance,BP,
15414,GO:0071679,1,0.732742892876391,0,8,commissural neuron axon guidance,BP,
15415,GO:0071680,1,0.821138831188594,0,5,response to indole-3-methanol,BP,
15416,GO:0071681,1,0.821138831188594,0,5,cellular response to indole-3-methanol,BP,
15418,GO:0071684,1,0.963623477545562,0,1,organism emergence from protective structure,BP,
15419,GO:0071688,1,0.883364048004276,0,3,striated muscle myosin thick filament assembly,BP,
15420,GO:0071691,1,0.95950763690405,0,1,cardiac muscle thin filament assembly,BP,
15421,GO:0071692,1,0.83614285213825,0,5,protein localization to extracellular region,BP,
15422,GO:0071694,1,0.83614285213825,0,5,maintenance of protein location in extracellular region,BP,
15426,GO:0071698,1,0.923973743000541,0,2,olfactory placode development,BP,
15427,GO:0071699,1,0.923973743000541,0,2,olfactory placode morphogenesis,BP,
15428,GO:0071701,1,0.959714903304393,0,1,regulation of MAPK export from nucleus,BP,
15433,GO:0071707,1,0.978939753886977,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
15434,GO:0071709,1,0.53134929767013,0,18,membrane assembly,BP,
15436,GO:0071712,1,0.688839395471085,0,11,ER-associated misfolded protein catabolic process,BP,
15437,GO:0071713,1,0.959828889936689,0,1,para-aminobenzoyl-glutamate hydrolase activity,MF,
15439,GO:0071723,1,0.888473538537706,0,3,lipopeptide binding,MF,
15440,GO:0071724,1,0.923979762491369,0,2,response to diacyl bacterial lipopeptide,BP,
15441,GO:0071725,1,0.962976580653528,0,1,response to triacyl bacterial lipopeptide,BP,
15442,GO:0071726,1,0.923979762491369,0,2,cellular response to diacyl bacterial lipopeptide,BP,
15443,GO:0071727,1,0.962976580653528,0,1,cellular response to triacyl bacterial lipopeptide,BP,
15444,GO:0071731,1,0.684782066719026,0,11,response to nitric oxide,BP,
15445,GO:0071732,1,0.713705741275802,0,10,cellular response to nitric oxide,BP,
15446,GO:0071733,1,0.902920879136876,0,3,transcriptional activation by promoter-enhancer looping,BP,
15447,GO:0071763,1,0.805623085044041,0,6,nuclear membrane organization,BP,
15448,GO:0071765,1,0.96050352256103,0,1,nuclear inner membrane organization,BP,
15452,GO:0071782,1,0.53309719974779,0,18,endoplasmic reticulum tubular network,CC,
15453,GO:0071786,1,0.59686824303148,0,15,endoplasmic reticulum tubular network organization,BP,
15454,GO:0071787,1,0.87699938608935,0,4,endoplasmic reticulum tubular network formation,BP,
15455,GO:0071789,1,0.965469978279355,0,1,spindle pole body localization to nuclear envelope,BP,
15456,GO:0071790,1,0.965469978279355,0,1,establishment of spindle pole body localization to nuclear envelope,BP,
15457,GO:0071796,1,0.978692388407155,0,1,K6-linked polyubiquitin modification-dependent protein binding,MF,
15458,GO:0071797,1,0.874222174438386,0,4,LUBAC complex,CC,
15459,GO:0071798,1,0.937023634335059,0,2,response to prostaglandin D,BP,
15460,GO:0071799,1,0.937023634335059,0,2,cellular response to prostaglandin D stimulus,BP,
15463,GO:0071802,1,0.960544137946695,0,1,negative regulation of podosome assembly,BP,
15467,GO:0071806,1,0.202693877806484,0,54,protein transmembrane transport,BP,
15468,GO:0071812,1,0.964209155829131,0,1,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
15471,GO:0071816,1,0.887303412682328,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
15472,GO:0071817,1,0.863725481417875,0,5,MMXD complex,CC,
15473,GO:0071818,1,0.908814507446729,0,3,BAT3 complex,CC,
15474,GO:0071819,1,0.949642963310671,0,2,DUBm complex,CC,
15475,GO:0071820,1,0.976999496905179,0,1,N-box binding,MF,
15476,GO:0071821,1,0.95950763690405,0,1,FANCM-MHF complex,CC,
15483,GO:0071838,1,0.875720747064658,0,4,cell proliferation in bone marrow,BP,
15487,GO:0071848,1,0.964209155829131,0,1,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
15490,GO:0071863,1,0.84133598446031,0,5,regulation of cell proliferation in bone marrow,BP,
15491,GO:0071864,1,0.84133598446031,0,5,positive regulation of cell proliferation in bone marrow,BP,
15500,GO:0071873,1,0.962659109361079,0,1,response to norepinephrine,BP,
15501,GO:0071874,1,0.962659109361079,0,1,cellular response to norepinephrine stimulus,BP,
15503,GO:0071877,1,0.978074585938961,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
15504,GO:0071878,1,0.95950763690405,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
15505,GO:0071879,1,0.894323929582833,0,3,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
15507,GO:0071881,1,0.978074585938961,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
15508,GO:0071885,1,0.965469978279355,0,1,N-terminal protein N-methyltransferase activity,MF,
15510,GO:0071888,1,0.785470161627795,0,8,macrophage apoptotic process,BP,
15512,GO:0071893,1,0.973756390557974,0,1,BMP signaling pathway involved in nephric duct formation,BP,
15513,GO:0071894,1,0.934668167237108,0,2,histone H2B conserved C-terminal lysine ubiquitination,BP,
15515,GO:0071896,1,0.847667267974955,0,4,protein localization to adherens junction,BP,
15517,GO:0071898,1,0.905649361220023,0,3,regulation of estrogen receptor binding,BP,
15518,GO:0071899,1,0.905649361220023,0,3,negative regulation of estrogen receptor binding,BP,
15522,GO:0071907,1,0.901421589808046,0,3,determination of digestive tract left/right asymmetry,BP,
15523,GO:0071908,1,0.959523165875488,0,1,determination of intestine left/right asymmetry,BP,
15524,GO:0071909,1,0.959523165875488,0,1,determination of stomach left/right asymmetry,BP,
15525,GO:0071910,1,0.920758009120135,0,2,determination of liver left/right asymmetry,BP,
15526,GO:0071914,1,0.961409093300116,0,1,prominosome,CC,
15527,GO:0071918,1,0.92674483663545,0,2,urea transmembrane transport,BP,
15528,GO:0071920,1,0.939042273346919,0,2,cleavage body,CC,
15529,GO:0071921,1,0.807861367694799,0,6,cohesin loading,BP,
15530,GO:0071922,1,0.836767732223436,0,5,regulation of cohesin loading,BP,
15531,GO:0071926,1,0.898943839867351,0,3,endocannabinoid signaling pathway,BP,
15532,GO:0071929,1,0.93093125958378,0,2,alpha-tubulin acetylation,BP,
15533,GO:0071930,1,0.890149780601326,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
15534,GO:0071931,1,0.944187598111126,0,2,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
15535,GO:0071933,1,0.775137472907835,0,7,Arp2/3 complex binding,MF,
15536,GO:0071934,1,0.938086320998008,0,2,thiamine transmembrane transport,BP,
15537,GO:0071936,1,0.730981876377316,0,8,coreceptor activity involved in Wnt signaling pathway,MF,
15538,GO:0071941,1,0.707593720556269,0,11,nitrogen cycle metabolic process,BP,
15539,GO:0071942,1,0.906747159462842,0,3,XPC complex,CC,
15542,GO:0071949,1,0.487091044774785,0,21,FAD binding,MF,
15543,GO:0071951,1,0.966323575434221,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
15544,GO:0071953,1,0.935483408304254,0,2,elastic fiber,CC,
15545,GO:0071955,1,0.920825232197838,0,2,recycling endosome to Golgi transport,BP,
15546,GO:0071960,1,0.983235665013756,0,1,maintenance of mitotic sister chromatid cohesion, centromeric,BP,
15547,GO:0071962,1,0.920867505796408,0,3,mitotic sister chromatid cohesion, centromeric,BP,
15548,GO:0071963,1,0.9741016166244,0,1,establishment or maintenance of cell polarity regulating cell shape,BP,
15550,GO:0071985,1,0.395927996862921,0,28,multivesicular body sorting pathway,BP,
15551,GO:0071986,1,0.811694633295861,0,6,Ragulator complex,CC,
15552,GO:0071987,1,0.859823739226488,0,4,WD40-repeat domain binding,MF,
15553,GO:0071988,1,0.95950763690405,0,1,protein localization to spindle pole body,BP,
15554,GO:0071997,1,0.95950763690405,0,1,glutathione S-conjugate-transporting ATPase activity,MF,
15556,GO:0072003,1,0.961319966218223,0,1,kidney rudiment formation,BP,
15557,GO:0072004,1,0.961319966218223,0,1,kidney field specification,BP,
15559,GO:0072007,1,0.903926136745285,0,3,mesangial cell differentiation,BP,
15560,GO:0072008,1,0.903926136745285,0,3,glomerular mesangial cell differentiation,BP,
15563,GO:0072012,1,0.667952142832989,0,12,glomerulus vasculature development,BP,
15564,GO:0072014,1,0.876667410745781,0,4,proximal tubule development,BP,
15567,GO:0072019,1,0.970665994401374,0,1,proximal convoluted tubule development,BP,
15568,GO:0072021,1,0.920743106004502,0,2,ascending thin limb development,BP,
15569,GO:0072025,1,0.961319966218223,0,1,distal convoluted tubule development,BP,
15573,GO:0072036,1,0.961708575034571,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
15574,GO:0072038,1,0.923726393309706,0,2,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
15575,GO:0072039,1,0.923726393309706,0,2,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
15576,GO:0072040,1,0.923726393309706,0,2,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
15577,GO:0072044,1,0.745433271175548,0,8,collecting duct development,BP,
15578,GO:0072047,1,0.892362430782138,0,4,proximal/distal pattern formation involved in nephron development,BP,
15579,GO:0072048,1,0.809988731892351,0,7,renal system pattern specification,BP,
15580,GO:0072049,1,0.894945930415736,0,4,comma-shaped body morphogenesis,BP,
15581,GO:0072050,1,0.828593089024973,0,6,S-shaped body morphogenesis,BP,
15582,GO:0072053,1,0.925506688572331,0,2,renal inner medulla development,BP,
15583,GO:0072054,1,0.925506688572331,0,2,renal outer medulla development,BP,
15584,GO:0072055,1,0.959603664790612,0,1,renal cortex development,BP,
15585,GO:0072059,1,0.959603664790612,0,1,cortical collecting duct development,BP,
15586,GO:0072060,1,0.96120892185491,0,1,outer medullary collecting duct development,BP,
15587,GO:0072061,1,0.939586631443383,0,2,inner medullary collecting duct development,BP,
15588,GO:0072069,1,0.961319966218223,0,1,DCT cell differentiation,BP,
15590,GO:0072071,1,0.976999496905179,0,1,kidney interstitial fibroblast differentiation,BP,
15592,GO:0072074,1,0.65152577149425,0,12,kidney mesenchyme development,BP,
15593,GO:0072075,1,0.714734535431581,0,9,metanephric mesenchyme development,BP,
15594,GO:0072076,1,0.894037937869549,0,3,nephrogenic mesenchyme development,BP,
15599,GO:0072081,1,0.892362430782138,0,4,specification of nephron tubule identity,BP,
15600,GO:0072086,1,0.892362430782138,0,4,specification of loop of Henle identity,BP,
15605,GO:0072092,1,0.920650957478618,0,2,ureteric bud invasion,BP,
15606,GO:0072093,1,0.885390741698404,0,3,metanephric renal vesicle formation,BP,
15607,GO:0072095,1,0.934324096349811,0,2,regulation of branch elongation involved in ureteric bud branching,BP,
15608,GO:0072096,1,0.973756390557974,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
15609,GO:0072097,1,0.973756390557974,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
15610,GO:0072098,1,0.973756390557974,0,1,anterior/posterior pattern specification involved in kidney development,BP,
15611,GO:0072099,1,0.973756390557974,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
15612,GO:0072100,1,0.973756390557974,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
15613,GO:0072101,1,0.973756390557974,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
15614,GO:0072102,1,0.896594148973053,0,3,glomerulus morphogenesis,BP,
15615,GO:0072103,1,0.934324096349811,0,2,glomerulus vasculature morphogenesis,BP,
15616,GO:0072104,1,0.934324096349811,0,2,glomerular capillary formation,BP,
15617,GO:0072106,1,0.912201212328947,0,3,regulation of ureteric bud formation,BP,
15618,GO:0072107,1,0.912201212328947,0,3,positive regulation of ureteric bud formation,BP,
15620,GO:0072109,1,0.742636747760514,0,9,glomerular mesangium development,BP,
15621,GO:0072110,1,0.793293403210791,0,7,glomerular mesangial cell proliferation,BP,
15624,GO:0072114,1,0.959510825131099,0,1,pronephros morphogenesis,BP,
15625,GO:0072124,1,0.793293403210791,0,7,regulation of glomerular mesangial cell proliferation,BP,
15626,GO:0072125,1,0.902791096918661,0,3,negative regulation of glomerular mesangial cell proliferation,BP,
15627,GO:0072126,1,0.878741388095036,0,4,positive regulation of glomerular mesangial cell proliferation,BP,
15628,GO:0072127,1,0.969694519549465,0,1,renal capsule development,BP,
15629,GO:0072128,1,0.969694519549465,0,1,renal capsule morphogenesis,BP,
15630,GO:0072129,1,0.969694519549465,0,1,renal capsule formation,BP,
15631,GO:0072130,1,0.969694519549465,0,1,renal capsule specification,BP,
15632,GO:0072131,1,0.893342779677433,0,3,kidney mesenchyme morphogenesis,BP,
15634,GO:0072133,1,0.893342779677433,0,3,metanephric mesenchyme morphogenesis,BP,
15635,GO:0072134,1,0.921984765401881,0,2,nephrogenic mesenchyme morphogenesis,BP,
15636,GO:0072135,1,0.924661120261765,0,2,kidney mesenchymal cell proliferation,BP,
15637,GO:0072136,1,0.924661120261765,0,2,metanephric mesenchymal cell proliferation involved in metanephros development,BP,
15638,GO:0072137,1,0.920650957478618,0,2,condensed mesenchymal cell proliferation,BP,
15640,GO:0072139,1,0.970368607052476,0,1,glomerular parietal epithelial cell differentiation,BP,
15641,GO:0072141,1,0.976999496905179,0,1,renal interstitial fibroblast development,BP,
15642,GO:0072143,1,0.903926136745285,0,3,mesangial cell development,BP,
15643,GO:0072144,1,0.903926136745285,0,3,glomerular mesangial cell development,BP,
15644,GO:0072148,1,0.68691742645024,0,11,epithelial cell fate commitment,BP,
15645,GO:0072156,1,0.920650957478618,0,2,distal tubule morphogenesis,BP,
15647,GO:0072161,1,0.869592851324616,0,4,mesenchymal cell differentiation involved in kidney development,BP,
15648,GO:0072162,1,0.924981764312911,0,2,metanephric mesenchymal cell differentiation,BP,
15651,GO:0072166,1,0.964858464579719,0,1,posterior mesonephric tubule development,BP,
15654,GO:0072172,1,0.887384977477022,0,4,mesonephric tubule formation,BP,
15659,GO:0072177,1,0.920743106004502,0,2,mesonephric duct development,BP,
15661,GO:0072179,1,0.939206562980648,0,2,nephric duct formation,BP,
15663,GO:0072183,1,0.962292638283482,0,1,negative regulation of nephron tubule epithelial cell differentiation,BP,
15664,GO:0072185,1,0.96894068625723,0,1,metanephric cap development,BP,
15665,GO:0072186,1,0.96894068625723,0,1,metanephric cap morphogenesis,BP,
15669,GO:0072192,1,0.973756390557974,0,1,ureter epithelial cell differentiation,BP,
15671,GO:0072194,1,0.959603664790612,0,1,kidney smooth muscle tissue development,BP,
15673,GO:0072198,1,0.973756390557974,0,1,mesenchymal cell proliferation involved in ureter development,BP,
15674,GO:0072199,1,0.973756390557974,0,1,regulation of mesenchymal cell proliferation involved in ureter development,BP,
15675,GO:0072200,1,0.973756390557974,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
15678,GO:0072203,1,0.799711011706635,0,6,cell proliferation involved in metanephros development,BP,
15679,GO:0072204,1,0.925498379498792,0,2,cell-cell signaling involved in metanephros development,BP,
15680,GO:0072205,1,0.828356973942408,0,5,metanephric collecting duct development,BP,
15682,GO:0072208,1,0.959603664790612,0,1,metanephric smooth muscle tissue development,BP,
15683,GO:0072209,1,0.96555301355671,0,1,metanephric mesangial cell differentiation,BP,
15685,GO:0072213,1,0.969694519549465,0,1,metanephric capsule development,BP,
15686,GO:0072214,1,0.959603664790612,0,1,metanephric cortex development,BP,
15689,GO:0072217,1,0.836832672753138,0,5,negative regulation of metanephros development,BP,
15690,GO:0072218,1,0.920743106004502,0,2,metanephric ascending thin limb development,BP,
15691,GO:0072219,1,0.959603664790612,0,1,metanephric cortical collecting duct development,BP,
15692,GO:0072221,1,0.961319966218223,0,1,metanephric distal convoluted tubule development,BP,
15693,GO:0072223,1,0.898251224247251,0,3,metanephric glomerular mesangium development,BP,
15694,GO:0072224,1,0.793634837745129,0,6,metanephric glomerulus development,BP,
15695,GO:0072229,1,0.970665994401374,0,1,metanephric proximal convoluted tubule development,BP,
15697,GO:0072235,1,0.885121490447317,0,3,metanephric distal tubule development,BP,
15698,GO:0072236,1,0.885019227047867,0,3,metanephric loop of Henle development,BP,
15699,GO:0072237,1,0.931358542891097,0,2,metanephric proximal tubule development,BP,
15700,GO:0072239,1,0.898251224247251,0,3,metanephric glomerulus vasculature development,BP,
15701,GO:0072240,1,0.961319966218223,0,1,metanephric DCT cell differentiation,BP,
15703,GO:0072244,1,0.95950763690405,0,1,metanephric glomerular epithelium development,BP,
15704,GO:0072248,1,0.95950763690405,0,1,metanephric glomerular visceral epithelial cell differentiation,BP,
15705,GO:0072249,1,0.95950763690405,0,1,metanephric glomerular visceral epithelial cell development,BP,
15706,GO:0072254,1,0.96555301355671,0,1,metanephric glomerular mesangial cell differentiation,BP,
15707,GO:0072255,1,0.96555301355671,0,1,metanephric glomerular mesangial cell development,BP,
15709,GO:0072262,1,0.930303096622272,0,2,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,
15710,GO:0072265,1,0.969694519549465,0,1,metanephric capsule morphogenesis,BP,
15711,GO:0072266,1,0.969694519549465,0,1,metanephric capsule formation,BP,
15712,GO:0072267,1,0.969694519549465,0,1,metanephric capsule specification,BP,
15713,GO:0072268,1,0.912237837011266,0,3,pattern specification involved in metanephros development,BP,
15714,GO:0072272,1,0.94075212580686,0,2,proximal/distal pattern formation involved in metanephric nephron development,BP,
15716,GO:0072274,1,0.95950763690405,0,1,metanephric glomerular basement membrane development,BP,
15717,GO:0072278,1,0.936088975888695,0,2,metanephric comma-shaped body morphogenesis,BP,
15720,GO:0072284,1,0.866693341455431,0,4,metanephric S-shaped body morphogenesis,BP,
15721,GO:0072285,1,0.961708575034571,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
15722,GO:0072287,1,0.95950763690405,0,1,metanephric distal tubule morphogenesis,BP,
15724,GO:0072298,1,0.892792086068356,0,3,regulation of metanephric glomerulus development,BP,
15725,GO:0072299,1,0.964858464579719,0,1,negative regulation of metanephric glomerulus development,BP,
15726,GO:0072300,1,0.925315328020228,0,2,positive regulation of metanephric glomerulus development,BP,
15727,GO:0072301,1,0.930303096622272,0,2,regulation of metanephric glomerular mesangial cell proliferation,BP,
15728,GO:0072302,1,0.964858464579719,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
15729,GO:0072303,1,0.964189244898402,0,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,
15730,GO:0072304,1,0.961319966218223,0,1,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15731,GO:0072305,1,0.961319966218223,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15733,GO:0072308,1,0.962292638283482,0,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,
15734,GO:0072309,1,0.961319966218223,0,1,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
15737,GO:0072312,1,0.95950763690405,0,1,metanephric glomerular epithelial cell differentiation,BP,
15738,GO:0072313,1,0.95950763690405,0,1,metanephric glomerular epithelial cell development,BP,
15739,GO:0072318,1,0.831434671914787,0,5,clathrin coat disassembly,BP,
15740,GO:0072319,1,0.806753639854299,0,6,vesicle uncoating,BP,
15741,GO:0072320,1,0.888256096283301,0,3,volume-sensitive chloride channel activity,MF,
15742,GO:0072321,1,0.765512725432405,0,10,chaperone-mediated protein transport,BP,
15747,GO:0072334,1,0.954615319455284,0,2,UDP-galactose transmembrane transport,BP,
15748,GO:0072337,1,0.64732621363224,0,12,modified amino acid transport,BP,
15749,GO:0072338,1,0.814721802824957,0,5,cellular lactam metabolic process,BP,
15750,GO:0072341,1,0.188718951018102,0,51,modified amino acid binding,MF,
15751,GO:0072343,1,0.973075088847771,0,1,pancreatic stellate cell proliferation,BP,
15752,GO:0072344,1,0.876242925903225,0,4,rescue of stalled ribosome,BP,
15753,GO:0072345,1,0.83301769330377,0,5,NAADP-sensitive calcium-release channel activity,MF,
15755,GO:0072348,1,0.461365570152001,0,22,sulfur compound transport,BP,
15756,GO:0072349,1,0.702816331032324,0,9,modified amino acid transmembrane transporter activity,MF,
15757,GO:0072350,1,0.333491197546243,0,34,tricarboxylic acid metabolic process,BP,
15758,GO:0072354,1,0.974441879248554,0,1,histone kinase activity (H3-T3 specific),MF,
15759,GO:0072355,1,0.974441879248554,0,1,histone H3-T3 phosphorylation,BP,
15760,GO:0072356,1,0.960909550686142,0,1,chromosome passenger complex localization to kinetochore,BP,
15764,GO:0072361,1,0.920650957478618,0,2,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter,BP,
15765,GO:0072362,1,0.95950763690405,0,1,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,BP,
15766,GO:0072363,1,0.95950763690405,0,1,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,BP,
15767,GO:0072364,1,0.920650957478618,0,2,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
15768,GO:0072365,1,0.95950763690405,0,1,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,BP,
15769,GO:0072366,1,0.95950763690405,0,1,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,BP,
15770,GO:0072367,1,0.853274375774129,0,4,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter,BP,
15771,GO:0072368,1,0.921433342130112,0,2,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,BP,
15772,GO:0072369,1,0.926044041390061,0,2,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,BP,
15775,GO:0072379,1,0.908814507446729,0,3,ER membrane insertion complex,CC,
15776,GO:0072382,1,0.95950763690405,0,1,minus-end-directed vesicle transport along microtubule,BP,
15777,GO:0072383,1,0.755315743535087,0,7,plus-end-directed vesicle transport along microtubule,BP,
15778,GO:0072384,1,0.0886528047236072,0,68,organelle transport along microtubule,BP,
15779,GO:0072385,1,0.853551692063786,0,4,minus-end-directed organelle transport along microtubule,BP,
15780,GO:0072386,1,0.72471011233459,0,8,plus-end-directed organelle transport along microtubule,BP,
15781,GO:0072387,1,0.934457543487934,0,2,flavin adenine dinucleotide metabolic process,BP,
15782,GO:0072388,1,0.972059476421804,0,1,flavin adenine dinucleotide biosynthetic process,BP,
15783,GO:0072389,1,0.961319966218223,0,1,flavin adenine dinucleotide catabolic process,BP,
15784,GO:0072393,1,0.649080319275342,0,11,microtubule anchoring at microtubule organizing center,BP,
15786,GO:0072396,1,0.805511546249463,0,6,response to cell cycle checkpoint signaling,BP,
15788,GO:0072402,1,0.805511546249463,0,6,response to DNA integrity checkpoint signaling,BP,
15790,GO:0072414,1,0.95950763690405,0,1,response to mitotic cell cycle checkpoint signaling,BP,
15792,GO:0072423,1,0.805511546249463,0,6,response to DNA damage checkpoint signaling,BP,
15793,GO:0072425,1,0.666331808205231,0,11,signal transduction involved in G2 DNA damage checkpoint,BP,
15794,GO:0072428,1,0.972980546782408,0,1,signal transduction involved in intra-S DNA damage checkpoint,BP,
15795,GO:0072429,1,0.906262180426241,0,3,response to intra-S DNA damage checkpoint signaling,BP,
15797,GO:0072432,1,0.95950763690405,0,1,response to G1 DNA damage checkpoint signaling,BP,
15798,GO:0072434,1,0.925876159916021,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
15799,GO:0072487,1,0.834187846359448,0,5,MSL complex,CC,
15800,GO:0072488,1,0.798139994154164,0,7,ammonium transmembrane transport,BP,
15801,GO:0072492,1,0.974035953495293,0,1,host cell mitochondrial intermembrane space,CC,
15803,GO:0072498,1,0.731510129599672,0,10,embryonic skeletal joint development,BP,
15804,GO:0072501,1,0.85844260279313,0,4,cellular divalent inorganic anion homeostasis,BP,
15805,GO:0072502,1,0.85844260279313,0,4,cellular trivalent inorganic anion homeostasis,BP,
15807,GO:0072505,1,0.794567944874972,0,6,divalent inorganic anion homeostasis,BP,
15808,GO:0072506,1,0.794567944874972,0,6,trivalent inorganic anion homeostasis,BP,
15810,GO:0072509,1,0.529370734279166,0,18,divalent inorganic cation transmembrane transporter activity,MF,
15814,GO:0072513,1,0.984181439159203,0,1,positive regulation of secondary heart field cardioblast proliferation,BP,
15815,GO:0072517,1,0.962801397907159,0,1,host cell viral assembly compartment,CC,
15816,GO:0072518,1,0.95950763690405,0,1,Rho-dependent protein serine/threonine kinase activity,MF,
15817,GO:0072520,1,0.708276602106018,0,10,seminiferous tubule development,BP,
15823,GO:0072526,1,0.884322340660854,0,4,pyridine-containing compound catabolic process,BP,
15829,GO:0072534,1,0.95950763690405,0,1,perineuronal net,CC,
15831,GO:0072536,1,0.97193881161879,0,1,interleukin-23 receptor complex,CC,
15832,GO:0072537,1,0.837097436688624,0,5,fibroblast activation,BP,
15837,GO:0072545,1,0.970504692431207,0,1,tyrosine binding,MF,
15838,GO:0072546,1,0.701088962406181,0,10,ER membrane protein complex,CC,
15839,GO:0072553,1,0.8709378113926,0,4,terminal button organization,BP,
15840,GO:0072554,1,0.968966527976527,0,1,blood vessel lumenization,BP,
15841,GO:0072555,1,0.97552720519445,0,1,17-beta-ketosteroid reductase activity,MF,
15842,GO:0072556,1,0.960557918077305,0,1,other organism presynaptic membrane,CC,
15843,GO:0072557,1,0.959769439827486,0,2,IPAF inflammasome complex,CC,
15844,GO:0072558,1,0.925504720419696,0,3,NLRP1 inflammasome complex,CC,
15845,GO:0072559,1,0.845084902021918,0,6,NLRP3 inflammasome complex,CC,
15846,GO:0072560,1,0.964219129382084,0,1,type B pancreatic cell maturation,BP,
15848,GO:0072563,1,0.940497712096956,0,2,endothelial microparticle,CC,
15850,GO:0072566,1,0.938756459938058,0,2,chemokine (C-X-C motif) ligand 1 production,BP,
15852,GO:0072570,1,0.963667485776347,0,1,ADP-D-ribose binding,MF,
15853,GO:0072572,1,0.970657898428781,0,1,poly-ADP-D-ribose binding,MF,
15859,GO:0072578,1,0.840506996908174,0,5,neurotransmitter-gated ion channel clustering,BP,
15860,GO:0072579,1,0.960409336878159,0,1,glycine receptor clustering,BP,
15861,GO:0072582,1,0.97552720519445,0,1,17-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
15862,GO:0072583,1,0.261972880963559,0,36,clathrin-dependent endocytosis,BP,
15864,GO:0072586,1,0.960045085911305,0,1,DNA topoisomerase (ATP-hydrolyzing) regulator activity,MF,
15865,GO:0072587,1,0.960045085911305,0,1,DNA topoisomerase (ATP-hydrolyzing) activator activity,MF,
15866,GO:0072588,1,0.876717419223323,0,8,box H/ACA RNP complex,CC,
15867,GO:0072589,1,0.921734526037945,0,4,box H/ACA scaRNP complex,CC,
15868,GO:0072590,1,0.95950763690405,0,1,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
15869,GO:0072591,1,0.95950763690405,0,1,citrate-L-glutamate ligase activity,MF,
15870,GO:0072592,1,0.942124211056423,0,2,oxygen metabolic process,BP,
15875,GO:0072602,1,0.862202153993969,0,4,interleukin-4 secretion,BP,
15876,GO:0072603,1,0.867397725604607,0,4,interleukin-5 secretion,BP,
15880,GO:0072610,1,0.870868731065889,0,4,interleukin-12 secretion,BP,
15881,GO:0072611,1,0.843089941312268,0,5,interleukin-13 secretion,BP,
15882,GO:0072615,1,0.971986138849325,0,1,interleukin-17 secretion,BP,
15883,GO:0072616,1,0.960974051611975,0,1,interleukin-18 secretion,BP,
15884,GO:0072619,1,0.962320310343519,0,1,interleukin-21 secretion,BP,
15889,GO:0072656,1,0.848109731463501,0,5,maintenance of protein location in mitochondrion,BP,
15891,GO:0072658,1,0.95950763690405,0,1,maintenance of protein location in membrane,BP,
15893,GO:0072660,1,0.95950763690405,0,1,maintenance of protein location in plasma membrane,BP,
15894,GO:0072662,1,0.553788752410809,0,17,protein localization to peroxisome,BP,
15895,GO:0072663,1,0.553788752410809,0,17,establishment of protein localization to peroxisome,BP,
15898,GO:0072669,1,0.836435064922134,0,7,tRNA-splicing ligase complex,CC,
15899,GO:0072671,1,0.967606698334485,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,
15902,GO:0072674,1,0.85763916776936,0,4,multinuclear osteoclast differentiation,BP,
15903,GO:0072675,1,0.85763916776936,0,4,osteoclast fusion,BP,
15910,GO:0072682,1,0.962918289861815,0,1,eosinophil extravasation,BP,
15911,GO:0072683,1,0.946353971866504,0,2,T cell extravasation,BP,
15912,GO:0072684,1,0.961470996643846,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
15913,GO:0072686,1,0.0436483037399318,0,88,mitotic spindle,CC,
15914,GO:0072687,1,0.874262600121814,0,4,meiotic spindle,CC,
15915,GO:0072695,1,0.937309668694227,0,2,regulation of DNA recombination at telomere,BP,
15916,GO:0072697,1,0.670638284742552,0,11,protein localization to cell cortex,BP,
15917,GO:0072698,1,0.207251810061057,0,42,protein localization to microtubule cytoskeleton,BP,
15918,GO:0072702,1,0.959508544620557,0,1,response to methyl methanesulfonate,BP,
15919,GO:0072703,1,0.959508544620557,0,1,cellular response to methyl methanesulfonate,BP,
15920,GO:0072706,1,0.967478503660586,0,1,response to sodium dodecyl sulfate,BP,
15921,GO:0072707,1,0.967478503660586,0,1,cellular response to sodium dodecyl sulfate,BP,
15922,GO:0072708,1,0.873144226297763,0,4,response to sorbitol,BP,
15923,GO:0072709,1,0.935478960217603,0,2,cellular response to sorbitol,BP,
15924,GO:0072710,1,0.71190281118507,0,9,response to hydroxyurea,BP,
15925,GO:0072711,1,0.737383894039752,0,8,cellular response to hydroxyurea,BP,
15926,GO:0072714,1,0.974158029291515,0,1,response to selenite ion,BP,
15927,GO:0072715,1,0.974158029291515,0,1,cellular response to selenite ion,BP,
15928,GO:0072716,1,0.884364464888288,0,4,response to actinomycin D,BP,
15929,GO:0072717,1,0.916000893446954,0,3,cellular response to actinomycin D,BP,
15930,GO:0072718,1,0.723889172651968,0,9,response to cisplatin,BP,
15931,GO:0072719,1,0.808913183110517,0,6,cellular response to cisplatin,BP,
15932,GO:0072720,1,0.965469978279355,0,1,response to dithiothreitol,BP,
15933,GO:0072733,1,0.913268727638859,0,3,response to staurosporine,BP,
15934,GO:0072734,1,0.913268727638859,0,3,cellular response to staurosporine,BP,
15935,GO:0072737,1,0.938862063863105,0,2,response to diamide,BP,
15936,GO:0072738,1,0.938862063863105,0,2,cellular response to diamide,BP,
15937,GO:0072739,1,0.939156693546429,0,2,response to anisomycin,BP,
15938,GO:0072740,1,0.972748012746265,0,1,cellular response to anisomycin,BP,
15939,GO:0072741,1,0.893428307276567,0,3,protein localization to cell division site,BP,
15940,GO:0072749,1,0.973516526534991,0,1,cellular response to cytochalasin B,BP,
15941,GO:0072750,1,0.978756790445095,0,1,cellular response to leptomycin B,BP,
15942,GO:0072752,1,0.95950763690405,0,1,cellular response to rapamycin,BP,
15943,GO:0072755,1,0.96164526067203,0,1,cellular response to benomyl,BP,
15944,GO:0072757,1,0.864609231147794,0,4,cellular response to camptothecin,BP,
15945,GO:0075044,1,0.851402089078023,0,4,autophagy of host cells involved in interaction with symbiont,BP,
15946,GO:0075071,1,0.851402089078023,0,4,autophagy involved in symbiotic interaction,BP,
15947,GO:0075109,1,0.959555954835982,0,1,modulation by symbiont of host receptor-mediated signal transduction,BP,
15948,GO:0075111,1,0.959555954835982,0,1,negative regulation by symbiont of host receptor-mediated signal transduction,BP,
15949,GO:0075112,1,0.959555954835982,0,1,modulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
15950,GO:0075114,1,0.959555954835982,0,1,negative regulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
15952,GO:0075341,1,0.969438402701567,0,1,host cell PML body,CC,
15953,GO:0075509,1,0.89434347333198,0,3,endocytosis involved in viral entry into host cell,BP,
15954,GO:0075519,1,0.985471093949741,0,1,microtubule-dependent intracellular transport of viral material,BP,
15955,GO:0075521,1,0.985471093949741,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
15956,GO:0075522,1,0.712966569412673,0,10,IRES-dependent viral translational initiation,BP,
15957,GO:0075525,1,0.85765252618905,0,5,viral translational termination-reinitiation,BP,
15958,GO:0075528,1,0.909218029717045,0,3,modulation by virus of host immune response,BP,
15959,GO:0075606,1,0.985471093949741,0,1,transport of viral material towards nucleus,BP,
15960,GO:0075713,1,0.779075374499577,0,8,establishment of integrated proviral latency,BP,
15963,GO:0080008,1,0.325587689828746,0,32,Cul4-RING E3 ubiquitin ligase complex,CC,
15964,GO:0080009,1,0.726261140441734,0,10,mRNA methylation,BP,
15965,GO:0080019,1,0.931688157704,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
15966,GO:0080023,1,0.932129376517163,0,2,3R-hydroxyacyl-CoA dehydratase activity,MF,
15967,GO:0080025,1,0.497611677003317,0,20,phosphatidylinositol-3,5-bisphosphate binding,MF,
15968,GO:0080058,1,0.977958404736081,0,1,protein deglutathionylation,BP,
15969,GO:0080084,1,0.833031392691457,0,5,5S rDNA binding,MF,
15971,GO:0080101,1,0.981993172542882,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
15973,GO:0080120,1,0.941691863277172,0,2,CAAX-box protein maturation,BP,
15974,GO:0080121,1,0.934934481004352,0,2,AMP transport,BP,
15975,GO:0080122,1,0.904672350912616,0,3,AMP transmembrane transporter activity,MF,
15976,GO:0080129,1,0.980874609392566,0,1,proteasome core complex assembly,BP,
15979,GO:0080144,1,0.934247319357212,0,2,amino acid homeostasis,BP,
15980,GO:0080146,1,0.97411570855655,0,1,L-cysteine desulfhydrase activity,MF,
15981,GO:0080147,1,0.984487367317405,0,1,root hair cell development,BP,
15983,GO:0080163,1,0.968709876523803,0,1,regulation of protein serine/threonine phosphatase activity,BP,
15984,GO:0080171,1,0.184856228509007,0,51,lytic vacuole organization,BP,
15985,GO:0080182,1,0.581559581303578,0,16,histone H3-K4 trimethylation,BP,
15986,GO:0080184,1,0.93787304241614,0,2,response to phenylpropanoid,BP,
15987,GO:0085020,1,0.812055901546254,0,7,protein K6-linked ubiquitination,BP,
15993,GO:0086004,1,0.473243734921716,0,20,regulation of cardiac muscle cell contraction,BP,
15995,GO:0086006,1,0.921418613954956,0,2,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,
15996,GO:0086007,1,0.923427680921753,0,2,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
15997,GO:0086008,1,0.965458576153811,0,1,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
16000,GO:0086011,1,0.698740568334471,0,10,membrane repolarization during action potential,BP,
16001,GO:0086012,1,0.657563263906875,0,11,membrane depolarization during cardiac muscle cell action potential,BP,
16002,GO:0086013,1,0.777818956785592,0,7,membrane repolarization during cardiac muscle cell action potential,BP,
16003,GO:0086014,1,0.675140171639146,0,10,atrial cardiac muscle cell action potential,BP,
16004,GO:0086015,1,0.924999270112563,0,2,SA node cell action potential,BP,
16005,GO:0086016,1,0.827005378511351,0,5,AV node cell action potential,BP,
16006,GO:0086017,1,0.926249514192692,0,2,Purkinje myocyte action potential,BP,
16007,GO:0086018,1,0.924999270112563,0,2,SA node cell to atrial cardiac muscle cell signaling,BP,
16008,GO:0086019,1,0.569897862047483,0,15,cell-cell signaling involved in cardiac conduction,BP,
16009,GO:0086020,1,0.924999270112563,0,2,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,
16010,GO:0086021,1,0.924999270112563,0,2,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,
16011,GO:0086023,1,0.847583644480562,0,4,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
16012,GO:0086024,1,0.95950763690405,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
16013,GO:0086026,1,0.675140171639146,0,10,atrial cardiac muscle cell to AV node cell signaling,BP,
16014,GO:0086027,1,0.827005378511351,0,5,AV node cell to bundle of His cell signaling,BP,
16015,GO:0086028,1,0.876114502794172,0,4,bundle of His cell to Purkinje myocyte signaling,BP,
16016,GO:0086029,1,0.926249514192692,0,2,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
16018,GO:0086038,1,0.965469978279355,0,1,calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16019,GO:0086039,1,0.95950763690405,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
16021,GO:0086042,1,0.790908048688746,0,6,cardiac muscle cell-cardiac muscle cell adhesion,BP,
16022,GO:0086043,1,0.876114502794172,0,4,bundle of His cell action potential,BP,
16023,GO:0086044,1,0.964039008079129,0,1,atrial cardiac muscle cell to AV node cell communication by electrical coupling,BP,
16024,GO:0086045,1,0.922891307961305,0,2,membrane depolarization during AV node cell action potential,BP,
16025,GO:0086046,1,0.95950763690405,0,1,membrane depolarization during SA node cell action potential,BP,
16026,GO:0086047,1,0.960804405179025,0,1,membrane depolarization during Purkinje myocyte cell action potential,BP,
16027,GO:0086048,1,0.923677915579382,0,2,membrane depolarization during bundle of His cell action potential,BP,
16028,GO:0086053,1,0.924999270112563,0,2,AV node cell to bundle of His cell communication by electrical coupling,BP,
16029,GO:0086054,1,0.964039008079129,0,1,bundle of His cell to Purkinje myocyte communication by electrical coupling,BP,
16030,GO:0086055,1,0.964039008079129,0,1,Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling,BP,
16031,GO:0086056,1,0.960544137946695,0,1,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
16032,GO:0086057,1,0.961362757072151,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
16033,GO:0086064,1,0.576435044342581,0,16,cell communication by electrical coupling involved in cardiac conduction,BP,
16034,GO:0086065,1,0.326093912212698,0,31,cell communication involved in cardiac conduction,BP,
16035,GO:0086066,1,0.675140171639146,0,10,atrial cardiac muscle cell to AV node cell communication,BP,
16036,GO:0086067,1,0.793502319151622,0,6,AV node cell to bundle of His cell communication,BP,
16037,GO:0086068,1,0.926249514192692,0,2,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
16038,GO:0086069,1,0.715686454051112,0,9,bundle of His cell to Purkinje myocyte communication,BP,
16039,GO:0086070,1,0.887536679452204,0,3,SA node cell to atrial cardiac muscle cell communication,BP,
16040,GO:0086072,1,0.968148480572951,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
16041,GO:0086073,1,0.816941936702135,0,5,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
16042,GO:0086075,1,0.891900233137459,0,3,gap junction channel activity involved in cardiac conduction electrical coupling,MF,
16043,GO:0086076,1,0.964039008079129,0,1,gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling,MF,
16044,GO:0086077,1,0.924999270112563,0,2,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,
16045,GO:0086078,1,0.964039008079129,0,1,gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling,MF,
16046,GO:0086079,1,0.964039008079129,0,1,gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling,MF,
16047,GO:0086080,1,0.728114775302843,0,8,protein binding involved in heterotypic cell-cell adhesion,MF,
16048,GO:0086082,1,0.968148480572951,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
16049,GO:0086083,1,0.816941936702135,0,5,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
16050,GO:0086089,1,0.965458576153811,0,1,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
16051,GO:0086091,1,0.51703911542247,0,17,regulation of heart rate by cardiac conduction,BP,
16053,GO:0086096,1,0.978074585938961,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
16054,GO:0086098,1,0.928950855360313,0,2,angiotensin-activated signaling pathway involved in heart process,BP,
16055,GO:0086100,1,0.961456145704303,0,1,endothelin receptor signaling pathway,BP,
16056,GO:0086103,1,0.77006631070303,0,7,G-protein coupled receptor signaling pathway involved in heart process,BP,
16057,GO:0089700,1,0.855914511448949,0,4,protein kinase D signaling,BP,
16058,GO:0089701,1,0.879270251177754,0,5,U2AF,CC,
16059,GO:0089709,1,0.936088711527437,0,2,L-histidine transmembrane transport,BP,
16060,GO:0089717,1,0.82189971604034,0,5,spanning component of membrane,CC,
16066,GO:0090024,1,0.959640944479446,0,1,negative regulation of neutrophil chemotaxis,BP,
16067,GO:0090025,1,0.703214824387376,0,11,regulation of monocyte chemotaxis,BP,
16068,GO:0090026,1,0.782067926852447,0,8,positive regulation of monocyte chemotaxis,BP,
16069,GO:0090027,1,0.932300962520006,0,2,negative regulation of monocyte chemotaxis,BP,
16071,GO:0090031,1,0.93036328285669,0,2,positive regulation of steroid hormone biosynthetic process,BP,
16073,GO:0090034,1,0.937133321117251,0,2,regulation of chaperone-mediated protein complex assembly,BP,
16074,GO:0090035,1,0.937133321117251,0,2,positive regulation of chaperone-mediated protein complex assembly,BP,
16077,GO:0090038,1,0.926894236908662,0,2,negative regulation of protein kinase C signaling,BP,
16078,GO:0090042,1,0.739803341134715,0,9,tubulin deacetylation,BP,
16079,GO:0090043,1,0.792060165480883,0,7,regulation of tubulin deacetylation,BP,
16080,GO:0090044,1,0.975477912832917,0,1,positive regulation of tubulin deacetylation,BP,
16081,GO:0090045,1,0.788939327772889,0,7,positive regulation of deacetylase activity,BP,
16084,GO:0090051,1,0.630639193584455,0,13,negative regulation of cell migration involved in sprouting angiogenesis,BP,
16085,GO:0090063,1,0.863696549370204,0,4,positive regulation of microtubule nucleation,BP,
16086,GO:0090065,1,0.990754098213451,0,1,regulation of production of siRNA involved in RNA interference,BP,
16088,GO:0090067,1,0.960004427287314,0,1,regulation of thalamus size,BP,
16091,GO:0090070,1,0.765925732568708,0,8,positive regulation of ribosome biogenesis,BP,
16092,GO:0090071,1,0.858366452174145,0,4,negative regulation of ribosome biogenesis,BP,
16095,GO:0090075,1,0.586228121594792,0,16,relaxation of muscle,BP,
16098,GO:0090080,1,0.92065166009154,0,2,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,
16099,GO:0090081,1,0.973571680227903,0,1,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,
16100,GO:0090082,1,0.973571680227903,0,1,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,
16104,GO:0090086,1,0.935214677946841,0,3,negative regulation of protein deubiquitination,BP,
16106,GO:0090088,1,0.942587011227302,0,2,regulation of oligopeptide transport,BP,
16107,GO:0090089,1,0.942587011227302,0,2,regulation of dipeptide transport,BP,
16109,GO:0090091,1,0.85968490994481,0,4,positive regulation of extracellular matrix disassembly,BP,
16111,GO:0090094,1,0.96894068625723,0,1,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
16112,GO:0090095,1,0.96894068625723,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
16113,GO:0090096,1,0.96894068625723,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
16118,GO:0090107,1,0.911399264594775,0,3,regulation of high-density lipoprotein particle assembly,BP,
16119,GO:0090108,1,0.971224159403154,0,1,positive regulation of high-density lipoprotein particle assembly,BP,
16122,GO:0090113,1,0.970432530399028,0,1,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
16124,GO:0090116,1,0.885635370802844,0,3,C-5 methylation of cytosine,BP,
16126,GO:0090119,1,0.960014088480491,0,1,vesicle-mediated cholesterol transport,BP,
16127,GO:0090128,1,0.809007742650045,0,6,regulation of synapse maturation,BP,
16128,GO:0090129,1,0.843138636951764,0,5,positive regulation of synapse maturation,BP,
16130,GO:0090131,1,0.975690413792587,0,1,mesenchyme migration,BP,
16132,GO:0090135,1,0.905598544546071,0,3,actin filament branching,BP,
16134,GO:0090138,1,0.961949285270869,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
16135,GO:0090140,1,0.516211885961199,0,19,regulation of mitochondrial fission,BP,
16136,GO:0090141,1,0.651820121152897,0,13,positive regulation of mitochondrial fission,BP,
16137,GO:0090148,1,0.640104713971902,0,12,membrane fission,BP,
16138,GO:0090149,1,0.930426037225627,0,2,mitochondrial membrane fission,BP,
16140,GO:0090151,1,0.749274024576881,0,12,establishment of protein localization to mitochondrial membrane,BP,
16143,GO:0090155,1,0.884762923663735,0,4,negative regulation of sphingolipid biosynthetic process,BP,
16144,GO:0090156,1,0.922033114662453,0,3,cellular sphingolipid homeostasis,BP,
16145,GO:0090158,1,0.850684489372983,0,5,endoplasmic reticulum membrane organization,BP,
16146,GO:0090160,1,0.748357455966389,0,8,Golgi to lysosome transport,BP,
16147,GO:0090161,1,0.656250233843925,0,11,Golgi ribbon formation,BP,
16149,GO:0090164,1,0.927636657436446,0,2,asymmetric Golgi ribbon formation,BP,
16151,GO:0090168,1,0.879387504041613,0,4,Golgi reassembly,BP,
16152,GO:0090169,1,0.412664205791124,0,25,regulation of spindle assembly,BP,
16153,GO:0090170,1,0.881850959413197,0,4,regulation of Golgi inheritance,BP,
16156,GO:0090176,1,0.959508787657879,0,1,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
16161,GO:0090182,1,0.947820135056809,0,2,regulation of secretion of lysosomal enzymes,BP,
16165,GO:0090186,1,0.840709314303773,0,5,regulation of pancreatic juice secretion,BP,
16166,GO:0090187,1,0.971224159403154,0,1,positive regulation of pancreatic juice secretion,BP,
16167,GO:0090188,1,0.865627429399098,0,4,negative regulation of pancreatic juice secretion,BP,
16171,GO:0090192,1,0.740574022278921,0,9,regulation of glomerulus development,BP,
16172,GO:0090193,1,0.820358008778175,0,6,positive regulation of glomerulus development,BP,
16173,GO:0090194,1,0.902791096918661,0,3,negative regulation of glomerulus development,BP,
16174,GO:0090195,1,0.740166170433834,0,9,chemokine secretion,BP,
16175,GO:0090196,1,0.797409613341498,0,7,regulation of chemokine secretion,BP,
16176,GO:0090197,1,0.825874381569957,0,6,positive regulation of chemokine secretion,BP,
16177,GO:0090198,1,0.965550139443602,0,1,negative regulation of chemokine secretion,BP,
16181,GO:0090202,1,0.902920879136876,0,3,gene looping,BP,
16182,GO:0090204,1,0.921727828305289,0,3,protein localization to nuclear pore,BP,
16183,GO:0090205,1,0.798126705668702,0,6,positive regulation of cholesterol metabolic process,BP,
16184,GO:0090206,1,0.867432190418764,0,5,negative regulation of cholesterol metabolic process,BP,
16187,GO:0090209,1,0.876926837825129,0,4,negative regulation of triglyceride metabolic process,BP,
16188,GO:0090210,1,0.927488069227147,0,2,regulation of establishment of blood-brain barrier,BP,
16189,GO:0090212,1,0.960663077912503,0,1,negative regulation of establishment of blood-brain barrier,BP,
16191,GO:0090218,1,0.492211021465547,0,19,positive regulation of lipid kinase activity,BP,
16192,GO:0090219,1,0.86548337335578,0,4,negative regulation of lipid kinase activity,BP,
16193,GO:0090220,1,0.745830142585402,0,8,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,
16194,GO:0090222,1,0.920650957478618,0,2,centrosome-templated microtubule nucleation,BP,
16195,GO:0090224,1,0.260237675013748,0,38,regulation of spindle organization,BP,
16196,GO:0090226,1,0.983900035336783,0,1,regulation of microtubule nucleation by Ran protein signal transduction,BP,
16197,GO:0090230,1,0.858109116110777,0,4,regulation of centromere complex assembly,BP,
16200,GO:0090233,1,0.966761912785496,0,1,negative regulation of spindle checkpoint,BP,
16201,GO:0090234,1,0.894097488305255,0,3,regulation of kinetochore assembly,BP,
16202,GO:0090235,1,0.764476075574199,0,7,regulation of metaphase plate congression,BP,
16203,GO:0090237,1,0.841858926313834,0,5,regulation of arachidonic acid secretion,BP,
16204,GO:0090238,1,0.877298835007497,0,4,positive regulation of arachidonic acid secretion,BP,
16205,GO:0090239,1,0.699673142234253,0,11,regulation of histone H4 acetylation,BP,
16206,GO:0090240,1,0.808087451480235,0,7,positive regulation of histone H4 acetylation,BP,
16207,GO:0090241,1,0.878747561671423,0,4,negative regulation of histone H4 acetylation,BP,
16208,GO:0090244,1,0.896869355845178,0,3,Wnt signaling pathway involved in somitogenesis,BP,
16209,GO:0090245,1,0.855028798242188,0,4,axis elongation involved in somitogenesis,BP,
16210,GO:0090246,1,0.960101316739859,0,1,convergent extension involved in somitogenesis,BP,
16211,GO:0090247,1,0.967334818525518,0,1,cell motility involved in somitogenic axis elongation,BP,
16212,GO:0090249,1,0.967334818525518,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
16213,GO:0090251,1,0.95950763690405,0,1,protein localization involved in establishment of planar polarity,BP,
16215,GO:0090258,1,0.927716557117465,0,2,negative regulation of mitochondrial fission,BP,
16216,GO:0090259,1,0.894128061208983,0,3,regulation of retinal ganglion cell axon guidance,BP,
16217,GO:0090260,1,0.959640944479446,0,1,negative regulation of retinal ganglion cell axon guidance,BP,
16218,GO:0090261,1,0.895910980068721,0,4,positive regulation of inclusion body assembly,BP,
16221,GO:0090267,1,0.796366588913765,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
16225,GO:0090272,1,0.959508369096293,0,1,negative regulation of fibroblast growth factor production,BP,
16231,GO:0090281,1,0.905332311132177,0,3,negative regulation of calcium ion import,BP,
16232,GO:0090283,1,0.903022090864614,0,3,regulation of protein glycosylation in Golgi,BP,
16233,GO:0090284,1,0.95950763690405,0,1,positive regulation of protein glycosylation in Golgi,BP,
16234,GO:0090285,1,0.941136648914539,0,2,negative regulation of protein glycosylation in Golgi,BP,
16235,GO:0090286,1,0.821649745191302,0,5,cytoskeletal anchoring at nuclear membrane,BP,
16239,GO:0090290,1,0.981470897950168,0,1,positive regulation of osteoclast proliferation,BP,
16241,GO:0090292,1,0.886974465133433,0,3,nuclear matrix anchoring at nuclear membrane,BP,
16242,GO:0090296,1,0.874287953312367,0,4,regulation of mitochondrial DNA replication,BP,
16243,GO:0090297,1,0.97883204070005,0,1,positive regulation of mitochondrial DNA replication,BP,
16244,GO:0090298,1,0.89320056271277,0,3,negative regulation of mitochondrial DNA replication,BP,
16245,GO:0090299,1,0.974892476302041,0,1,regulation of neural crest formation,BP,
16246,GO:0090301,1,0.974892476302041,0,1,negative regulation of neural crest formation,BP,
16250,GO:0090306,1,0.867294548444958,0,4,spindle assembly involved in meiosis,BP,
16253,GO:0090309,1,0.853607059104831,0,4,positive regulation of methylation-dependent chromatin silencing,BP,
16254,GO:0090310,1,0.926928914270782,0,2,negative regulation of methylation-dependent chromatin silencing,BP,
16255,GO:0090311,1,0.316684605294776,0,33,regulation of protein deacetylation,BP,
16256,GO:0090312,1,0.518127174896685,0,19,positive regulation of protein deacetylation,BP,
16257,GO:0090313,1,0.407130772221269,0,27,regulation of protein targeting to membrane,BP,
16258,GO:0090314,1,0.467390014007446,0,23,positive regulation of protein targeting to membrane,BP,
16259,GO:0090315,1,0.876589054808253,0,4,negative regulation of protein targeting to membrane,BP,
16263,GO:0090323,1,0.987104172534466,0,1,prostaglandin secretion involved in immune response,BP,
16265,GO:0090325,1,0.925468625126749,0,2,regulation of locomotion involved in locomotory behavior,BP,
16266,GO:0090326,1,0.963423148949515,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
16267,GO:0090327,1,0.960608130332783,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
16268,GO:0090329,1,0.227083710568999,0,43,regulation of DNA-dependent DNA replication,BP,
16269,GO:0090330,1,0.565116923659213,0,16,regulation of platelet aggregation,BP,
16270,GO:0090331,1,0.732160318276897,0,9,negative regulation of platelet aggregation,BP,
16273,GO:0090340,1,0.971224159403154,0,1,positive regulation of secretion of lysosomal enzymes,BP,
16274,GO:0090341,1,0.975904321611144,0,1,negative regulation of secretion of lysosomal enzymes,BP,
16276,GO:0090343,1,0.744765823243028,0,10,positive regulation of cell aging,BP,
16278,GO:0090345,1,0.96789068048304,0,1,cellular organohalogen metabolic process,BP,
16279,GO:0090346,1,0.96789068048304,0,1,cellular organofluorine metabolic process,BP,
16283,GO:0090365,1,0.970320800778368,0,1,regulation of mRNA modification,BP,
16284,GO:0090367,1,0.970320800778368,0,1,negative regulation of mRNA modification,BP,
16285,GO:0090370,1,0.96032295913487,0,1,negative regulation of cholesterol efflux,BP,
16286,GO:0090381,1,0.973571680227903,0,1,regulation of heart induction,BP,
16289,GO:0090385,1,0.83087693681242,0,6,phagosome-lysosome fusion,BP,
16290,GO:0090386,1,0.921360422163966,0,2,phagosome maturation involved in apoptotic cell clearance,BP,
16291,GO:0090387,1,0.921360422163966,0,2,phagolysosome assembly involved in apoptotic cell clearance,BP,
16292,GO:0090389,1,0.95950763690405,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,
16293,GO:0090394,1,0.863267867625466,0,4,negative regulation of excitatory postsynaptic potential,BP,
16297,GO:0090402,1,0.938822437754343,0,2,oncogene-induced cell senescence,BP,
16298,GO:0090403,1,0.896678446319519,0,3,oxidative stress-induced premature senescence,BP,
16300,GO:0090409,1,0.969487814334524,0,1,malonyl-CoA synthetase activity,MF,
16301,GO:0090410,1,0.969487814334524,0,1,malonate catabolic process,BP,
16302,GO:0090416,1,0.967508762296034,0,1,nicotinate transmembrane transporter activity,MF,
16303,GO:0090420,1,0.977507342145317,0,1,naphthalene-containing compound metabolic process,BP,
16304,GO:0090422,1,0.942865314225329,0,2,thiamine pyrophosphate transmembrane transporter activity,MF,
16305,GO:0090427,1,0.970146509392019,0,1,activation of meiosis,BP,
16306,GO:0090435,1,0.803951262813213,0,7,protein localization to nuclear envelope,BP,
16307,GO:0090461,1,0.960370615281752,0,1,glutamate homeostasis,BP,
16308,GO:0090472,1,0.960553968499037,0,1,dibasic protein processing,BP,
16309,GO:0090480,1,0.89284123004329,0,3,purine nucleotide-sugar transmembrane transport,BP,
16310,GO:0090481,1,0.732703021217351,0,10,pyrimidine nucleotide-sugar transmembrane transport,BP,
16311,GO:0090482,1,0.599533277269024,0,14,vitamin transmembrane transporter activity,MF,
16312,GO:0090493,1,0.849472826983781,0,6,catecholamine uptake,BP,
16313,GO:0090494,1,0.849472826983781,0,6,dopamine uptake,BP,
16314,GO:0090498,1,0.930515194695679,0,2,extrinsic component of Golgi membrane,CC,
16321,GO:0090520,1,0.729239586288199,0,9,sphingolipid mediated signaling pathway,BP,
16322,GO:0090521,1,0.859119803252286,0,4,glomerular visceral epithelial cell migration,BP,
16324,GO:0090529,1,0.973151890372272,0,1,cell septum assembly,BP,
16326,GO:0090537,1,0.96077616260181,0,1,CERF complex,CC,
16327,GO:0090541,1,0.927059451253584,0,2,MIT domain binding,MF,
16328,GO:0090543,1,0.406099135088281,0,26,Flemming body,CC,
16329,GO:0090545,1,0.571978614857689,0,15,CHD-type complex,CC,
16330,GO:0090554,1,0.920650957478618,0,2,phosphatidylcholine-translocating ATPase activity,MF,
16331,GO:0090556,1,0.920650957478618,0,2,phosphatidylserine-translocating ATPase activity,MF,
16333,GO:0090558,1,0.984487367317405,0,1,plant epidermis development,BP,
16335,GO:0090560,1,0.970524784111389,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
16336,GO:0090568,1,0.374694511214186,0,27,nuclear transcriptional repressor complex,CC,
16337,GO:0090571,1,0.913188265671923,0,3,RNA polymerase II transcription repressor complex,CC,
16339,GO:0090576,1,0.751601426039448,0,8,RNA polymerase III transcription factor complex,CC,
16340,GO:0090579,1,0.902920879136876,0,3,dsDNA loop formation,BP,
16343,GO:0090599,1,0.817328986674741,0,5,alpha-glucosidase activity,MF,
16344,GO:0090600,1,0.961222559055262,0,1,alpha-1,3-glucosidase activity,MF,
16345,GO:0090601,1,0.959571905640215,0,1,enucleation,BP,
16346,GO:0090611,1,0.850811251361903,0,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,
16347,GO:0090615,1,0.933550879946968,0,2,mitochondrial mRNA processing,BP,
16348,GO:0090616,1,0.959934770795553,0,1,mitochondrial mRNA 3'-end processing,BP,
16349,GO:0090624,1,0.965469978279355,0,1,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
16350,GO:0090625,1,0.965469978279355,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
16351,GO:0090627,1,0.984487367317405,0,1,plant epidermal cell differentiation,BP,
16353,GO:0090646,1,0.688643305071388,0,12,mitochondrial tRNA processing,BP,
16354,GO:0090647,1,0.817362264175729,0,6,modulation of age-related behavioral decline,BP,
16355,GO:0090649,1,0.834562840424628,0,5,response to oxygen-glucose deprivation,BP,
16356,GO:0090650,1,0.834562840424628,0,5,cellular response to oxygen-glucose deprivation,BP,
16357,GO:0090656,1,0.569441693165265,0,15,t-circle formation,BP,
16358,GO:0090657,1,0.662407739853035,0,11,telomeric loop disassembly,BP,
16359,GO:0090659,1,0.623777231500563,0,13,walking behavior,BP,
16360,GO:0090661,1,0.911100988119986,0,5,box H/ACA telomerase RNP complex,CC,
16362,GO:0090665,1,0.649510805847439,0,12,glycoprotein complex,CC,
16363,GO:0090666,1,0.887867716909019,0,4,scaRNA localization to Cajal body,BP,
16364,GO:0090667,1,0.95950763690405,0,1,cell chemotaxis to vascular endothelial growth factor,BP,
16365,GO:0090668,1,0.95950763690405,0,1,endothelial cell chemotaxis to vascular endothelial growth factor,BP,
16366,GO:0090669,1,0.874372110620291,0,4,telomerase RNA stabilization,BP,
16367,GO:0090670,1,0.571300934240543,0,19,RNA localization to Cajal body,BP,
16368,GO:0090671,1,0.571300934240543,0,19,telomerase RNA localization to Cajal body,BP,
16369,GO:0090672,1,0.571300934240543,0,19,telomerase RNA localization,BP,
16371,GO:0090677,1,0.939522837130351,0,2,reversible differentiation,BP,
16372,GO:0090678,1,0.939522837130351,0,2,cell dedifferentiation involved in phenotypic switching,BP,
16373,GO:0090685,1,0.571300934240543,0,19,RNA localization to nucleus,BP,
16374,GO:0090694,1,0.926372432346771,0,2,Scc2-Scc4 cohesin loading complex,CC,
16377,GO:0090722,1,0.92065166009154,0,2,receptor-receptor interaction,MF,
16378,GO:0090723,1,0.683660563774684,0,11,growth cone part,CC,
16379,GO:0090724,1,0.869547853211749,0,4,central region of growth cone,CC,
16380,GO:0090725,1,0.945125571814366,0,2,peripheral region of growth cone,CC,
16381,GO:0090731,1,0.979920153523586,0,1,cellular response to very-low-density lipoprotein particle stimulus,BP,
16383,GO:0090735,1,0.724030393939032,0,10,DNA repair complex assembly,BP,
16384,GO:0090737,1,0.569441693165265,0,15,telomere maintenance via telomere trimming,BP,
16385,GO:0090741,1,0.852664968812708,0,6,pigment granule membrane,CC,
16386,GO:0093001,1,0.963801124875509,0,1,glycolysis from storage polysaccharide through glucose-1-phosphate,BP,
16387,GO:0095500,1,0.673806674916927,0,12,acetylcholine receptor signaling pathway,BP,
16388,GO:0097001,1,0.770063922287432,0,8,ceramide binding,MF,
16389,GO:0097003,1,0.932917024133841,0,2,adipokinetic hormone receptor activity,MF,
16392,GO:0097010,1,0.892351565674568,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
16395,GO:0097014,1,0.108295596340599,0,63,ciliary plasm,CC,
16396,GO:0097016,1,0.920965855582165,0,2,L27 domain binding,MF,
16397,GO:0097017,1,0.935386974100417,0,2,renal protein absorption,BP,
16398,GO:0097018,1,0.96790450439028,0,1,renal albumin absorption,BP,
16399,GO:0097020,1,0.963111975163122,0,1,COPII adaptor activity,MF,
16400,GO:0097021,1,0.934408887853835,0,2,lymphocyte migration into lymphoid organs,BP,
16401,GO:0097025,1,0.883708887920503,0,3,MPP7-DLG1-LIN7 complex,CC,
16402,GO:0097026,1,0.95950763690405,0,1,dendritic cell dendrite assembly,BP,
16403,GO:0097027,1,0.808241803799091,0,7,ubiquitin-protein transferase activator activity,MF,
16405,GO:0097029,1,0.965550139443602,0,1,mature conventional dendritic cell differentiation,BP,
16406,GO:0097035,1,0.386305224401259,0,26,regulation of membrane lipid distribution,BP,
16407,GO:0097036,1,0.977143915085501,0,1,regulation of plasma membrane sterol distribution,BP,
16408,GO:0097037,1,0.962819696792708,0,1,heme export,BP,
16409,GO:0097038,1,0.701557515166024,0,10,perinuclear endoplasmic reticulum,CC,
16410,GO:0097039,1,0.833629290308034,0,5,protein linear polyubiquitination,BP,
16411,GO:0097045,1,0.959764642647043,0,1,phosphatidylserine exposure on blood platelet,BP,
16412,GO:0097048,1,0.859752026591207,0,4,dendritic cell apoptotic process,BP,
16413,GO:0097049,1,0.835054798508656,0,5,motor neuron apoptotic process,BP,
16414,GO:0097050,1,0.751427987926497,0,8,type B pancreatic cell apoptotic process,BP,
16415,GO:0097051,1,0.885407533525062,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
16416,GO:0097052,1,0.939224592945848,0,2,L-kynurenine metabolic process,BP,
16417,GO:0097055,1,0.936690553974071,0,2,agmatine biosynthetic process,BP,
16418,GO:0097056,1,0.883288033536746,0,4,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
16419,GO:0097057,1,0.952458386019043,0,2,TRAF2-GSTP1 complex,CC,
16420,GO:0097058,1,0.973622342921264,0,1,CRLF-CLCF1 complex,CC,
16421,GO:0097059,1,0.973622342921264,0,1,CNTFR-CLCF1 complex,CC,
16424,GO:0097062,1,0.625053968287991,0,13,dendritic spine maintenance,BP,
16427,GO:0097066,1,0.599205237388721,0,15,response to thyroid hormone,BP,
16428,GO:0097067,1,0.700965751677568,0,10,cellular response to thyroid hormone stimulus,BP,
16429,GO:0097068,1,0.891892551121322,0,3,response to thyroxine,BP,
16430,GO:0097069,1,0.927589540336195,0,2,cellular response to thyroxine stimulus,BP,
16431,GO:0097070,1,0.95950763739782,0,1,ductus arteriosus closure,BP,
16433,GO:0097086,1,0.961976585262011,0,1,amniotic stem cell differentiation,BP,
16434,GO:0097089,1,0.974873157243389,0,1,methyl-branched fatty acid metabolic process,BP,
16435,GO:0097090,1,0.830926865634043,0,5,presynaptic membrane organization,BP,
16436,GO:0097091,1,0.8517835274253,0,4,synaptic vesicle clustering,BP,
16438,GO:0097100,1,0.856943465574135,0,5,supercoiled DNA binding,MF,
16439,GO:0097101,1,0.903618312955038,0,3,blood vessel endothelial cell fate specification,BP,
16440,GO:0097102,1,0.932564037898733,0,2,endothelial tip cell fate specification,BP,
16441,GO:0097104,1,0.847957953671107,0,4,postsynaptic membrane assembly,BP,
16442,GO:0097105,1,0.847960864648196,0,4,presynaptic membrane assembly,BP,
16443,GO:0097106,1,0.761369829473644,0,7,postsynaptic density organization,BP,
16444,GO:0097107,1,0.847925133826865,0,4,postsynaptic density assembly,BP,
16445,GO:0097108,1,0.95950763690405,0,1,hedgehog family protein binding,MF,
16446,GO:0097109,1,0.922545836740257,0,2,neuroligin family protein binding,MF,
16448,GO:0097111,1,0.920650957478618,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
16449,GO:0097112,1,0.960409336878159,0,1,gamma-aminobutyric acid receptor clustering,BP,
16450,GO:0097113,1,0.87516683623457,0,4,AMPA glutamate receptor clustering,BP,
16451,GO:0097114,1,0.940238864720346,0,2,NMDA glutamate receptor clustering,BP,
16452,GO:0097116,1,0.959890807219564,0,1,gephyrin clustering involved in postsynaptic density assembly,BP,
16453,GO:0097117,1,0.95950763690405,0,1,guanylate kinase-associated protein clustering,BP,
16454,GO:0097118,1,0.95950763690405,0,1,neuroligin clustering involved in postsynaptic membrane assembly,BP,
16455,GO:0097119,1,0.86193510835199,0,4,postsynaptic density protein 95 clustering,BP,
16456,GO:0097120,1,0.48575058740405,0,20,receptor localization to synapse,BP,
16457,GO:0097123,1,0.969845268824029,0,1,cyclin A1-CDK2 complex,CC,
16458,GO:0097124,1,0.936881476915826,0,2,cyclin A2-CDK2 complex,CC,
16459,GO:0097125,1,0.945898612217528,0,2,cyclin B1-CDK1 complex,CC,
16460,GO:0097129,1,0.917762744099406,0,3,cyclin D2-CDK4 complex,CC,
16461,GO:0097134,1,0.943616790119,0,2,cyclin E1-CDK2 complex,CC,
16462,GO:0097135,1,0.937295787327392,0,2,cyclin E2-CDK2 complex,CC,
16464,GO:0097144,1,0.984110997931916,0,1,BAX complex,CC,
16465,GO:0097145,1,0.970233459065378,0,1,BAK complex,CC,
16466,GO:0097149,1,0.891282369921453,0,3,centralspindlin complex,CC,
16468,GO:0097151,1,0.781713912446026,0,6,positive regulation of inhibitory postsynaptic potential,BP,
16470,GO:0097153,1,0.715535431191297,0,12,cysteine-type endopeptidase activity involved in apoptotic process,MF,
16472,GO:0097155,1,0.920650957478618,0,2,fasciculation of sensory neuron axon,BP,
16473,GO:0097156,1,0.95950763690405,0,1,fasciculation of motor neuron axon,BP,
16475,GO:0097158,1,0.975086365738912,0,1,pre-mRNA intronic pyrimidine-rich binding,MF,
16477,GO:0097161,1,0.95950763690405,0,1,DH domain binding,MF,
16478,GO:0097162,1,0.963504406783783,0,1,MADS box domain binding,MF,
16480,GO:0097165,1,0.839153860638301,0,5,nuclear stress granule,CC,
16481,GO:0097166,1,0.95950763690405,0,1,lens epithelial cell proliferation,BP,
16482,GO:0097167,1,0.871509472435448,0,4,circadian regulation of translation,BP,
16483,GO:0097168,1,0.95995683819502,0,1,mesenchymal stem cell proliferation,BP,
16484,GO:0097169,1,0.943577659236971,0,3,AIM2 inflammasome complex,CC,
16485,GO:0097176,1,0.891469848647742,0,4,epoxide metabolic process,BP,
16486,GO:0097177,1,0.922523349175146,0,3,mitochondrial ribosome binding,MF,
16488,GO:0097179,1,0.927504330584844,0,4,protease inhibitor complex,CC,
16489,GO:0097180,1,0.959651276143937,0,2,serine protease inhibitor complex,CC,
16490,GO:0097186,1,0.576773527460913,0,15,amelogenesis,BP,
16491,GO:0097187,1,0.9043192941487,0,3,dentinogenesis,BP,
16497,GO:0097195,1,0.931450723196539,0,2,pilomotor reflex,BP,
16498,GO:0097196,1,0.938760517273939,0,2,Shu complex,CC,
16499,GO:0097197,1,0.814393592261603,0,6,tetraspanin-enriched microdomain,CC,
16500,GO:0097198,1,0.925757353236155,0,2,histone H3-K36 trimethylation,BP,
16501,GO:0097199,1,0.865042486105732,0,5,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,
16502,GO:0097200,1,0.727822815856645,0,11,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,
16505,GO:0097205,1,0.635921277288584,0,12,renal filtration,BP,
16506,GO:0097208,1,0.850843401365296,0,5,alveolar lamellar body,CC,
16507,GO:0097209,1,0.877144736400639,0,4,epidermal lamellar body,CC,
16508,GO:0097210,1,0.93159699465232,0,2,response to gonadotropin-releasing hormone,BP,
16509,GO:0097211,1,0.93159699465232,0,2,cellular response to gonadotropin-releasing hormone,BP,
16510,GO:0097212,1,0.942725584875223,0,2,lysosomal membrane organization,BP,
16511,GO:0097213,1,0.969872456335182,0,1,regulation of lysosomal membrane permeability,BP,
16512,GO:0097222,1,0.959934770795553,0,1,mitochondrial mRNA polyadenylation,BP,
16514,GO:0097224,1,0.974092226169022,0,1,sperm connecting piece,CC,
16516,GO:0097226,1,0.969518289110119,0,1,sperm mitochondrial sheath,CC,
16517,GO:0097227,1,0.862593822096391,0,4,sperm annulus,CC,
16518,GO:0097228,1,0.685352998030797,0,11,sperm principal piece,CC,
16519,GO:0097229,1,0.978276011298432,0,1,sperm end piece,CC,
16520,GO:0097231,1,0.974384872306932,0,1,cell motility in response to calcium ion,BP,
16521,GO:0097232,1,0.96321984682547,0,1,lamellar body membrane,CC,
16522,GO:0097233,1,0.96321984682547,0,1,alveolar lamellar body membrane,CC,
16524,GO:0097238,1,0.960576630875338,0,2,cellular response to methylglyoxal,BP,
16525,GO:0097240,1,0.860161248911839,0,4,chromosome attachment to the nuclear envelope,BP,
16526,GO:0097241,1,0.938365538717244,0,2,hematopoietic stem cell migration to bone marrow,BP,
16528,GO:0097252,1,0.900778545348476,0,3,oligodendrocyte apoptotic process,BP,
16529,GO:0097255,1,0.869365311131564,0,5,R2TP complex,CC,
16530,GO:0097264,1,0.803339525677862,0,6,self proteolysis,BP,
16531,GO:0097267,1,0.858896820862308,0,4,omega-hydroxylase P450 pathway,BP,
16532,GO:0097272,1,0.95950763739782,0,1,ammonia homeostasis,BP,
16533,GO:0097273,1,0.95950763739782,0,1,creatinine homeostasis,BP,
16534,GO:0097274,1,0.923717048660458,0,2,urea homeostasis,BP,
16535,GO:0097275,1,0.95950763739782,0,1,cellular ammonia homeostasis,BP,
16536,GO:0097276,1,0.95950763739782,0,1,cellular creatinine homeostasis,BP,
16537,GO:0097277,1,0.95950763739782,0,1,cellular urea homeostasis,BP,
16538,GO:0097278,1,0.934740374645188,0,2,complement-dependent cytotoxicity,BP,
16540,GO:0097284,1,0.689659831383972,0,11,hepatocyte apoptotic process,BP,
16542,GO:0097291,1,0.971788885729268,0,1,renal phosphate ion absorption,BP,
16544,GO:0097298,1,0.961160402445,0,1,regulation of nucleus size,BP,
16548,GO:0097309,1,0.932129376517163,0,2,cap1 mRNA methylation,BP,
16549,GO:0097310,1,0.965469978279355,0,1,cap2 mRNA methylation,BP,
16550,GO:0097320,1,0.595210420975829,0,14,plasma membrane tubulation,BP,
16551,GO:0097322,1,0.810962560523012,0,6,7SK snRNA binding,MF,
16554,GO:0097329,1,0.636331962461345,0,12,response to antimetabolite,BP,
16555,GO:0097332,1,0.943112971977726,0,2,response to antipsychotic drug,BP,
16556,GO:0097338,1,0.960073388899484,0,1,response to clozapine,BP,
16561,GO:0097344,1,0.941291814271797,0,2,Rix1 complex,CC,
16563,GO:0097346,1,0.502429950803502,0,23,INO80-type complex,CC,
16564,GO:0097350,1,0.9033325798604,0,3,neutrophil clearance,BP,
16566,GO:0097354,1,0.737709263976794,0,9,prenylation,BP,
16567,GO:0097356,1,0.95950763690405,0,1,perinucleolar compartment,CC,
16568,GO:0097359,1,0.920789202522597,0,2,UDP-glucosylation,BP,
16569,GO:0097360,1,0.92811099099357,0,2,chorionic trophoblast cell proliferation,BP,
16570,GO:0097361,1,0.883587382456475,0,4,CIA complex,CC,
16571,GO:0097362,1,0.931217880084949,0,2,MCM8-MCM9 complex,CC,
16572,GO:0097363,1,0.926379143679085,0,2,protein O-GlcNAc transferase activity,MF,
16575,GO:0097368,1,0.86956344501506,0,4,establishment of Sertoli cell barrier,BP,
16576,GO:0097371,1,0.774468410368068,0,7,MDM2/MDM4 family protein binding,MF,
16577,GO:0097372,1,0.974365896217661,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
16578,GO:0097374,1,0.968057406154827,0,1,sensory neuron axon guidance,BP,
16579,GO:0097376,1,0.977330398382787,0,1,interneuron axon guidance,BP,
16580,GO:0097381,1,0.828777628876462,0,5,photoreceptor disc membrane,CC,
16581,GO:0097382,1,0.95950763690405,0,1,deoxynucleoside-diphosphatase activity,MF,
16582,GO:0097383,1,0.95950763690405,0,1,dIDP diphosphatase activity,MF,
16583,GO:0097384,1,0.800966948051011,0,7,cellular lipid biosynthetic process,BP,
16584,GO:0097386,1,0.678155002142416,0,11,glial cell projection,CC,
16585,GO:0097393,1,0.95950763690405,0,1,telomeric repeat-containing RNA transcription,BP,
16586,GO:0097394,1,0.95950763690405,0,1,telomeric repeat-containing RNA transcription by RNA polymerase II,BP,
16587,GO:0097396,1,0.866752551989645,0,4,response to interleukin-17,BP,
16588,GO:0097398,1,0.866752551989645,0,4,cellular response to interleukin-17,BP,
16589,GO:0097400,1,0.866752551989645,0,4,interleukin-17-mediated signaling pathway,BP,
16591,GO:0097409,1,0.972180785508844,0,1,glial cytoplasmic inclusion,CC,
16592,GO:0097411,1,0.867363650467844,0,4,hypoxia-inducible factor-1alpha signaling pathway,BP,
16594,GO:0097414,1,0.972180785508844,0,1,classical Lewy body,CC,
16595,GO:0097418,1,0.827341474570666,0,5,neurofibrillary tangle,CC,
16597,GO:0097422,1,0.837775321982658,0,5,tubular endosome,CC,
16598,GO:0097425,1,0.912366951617592,0,3,smooth endoplasmic reticulum part,CC,
16599,GO:0097427,1,0.823826292536023,0,5,microtubule bundle,CC,
16600,GO:0097428,1,0.796315136867501,0,10,protein maturation by iron-sulfur cluster transfer,BP,
16601,GO:0097431,1,0.396104198435044,0,26,mitotic spindle pole,CC,
16602,GO:0097433,1,0.845800217782949,0,5,dense body,CC,
16604,GO:0097440,1,0.659531290290236,0,11,apical dendrite,CC,
16605,GO:0097441,1,0.906069919529553,0,3,basal dendrite,CC,
16606,GO:0097442,1,0.959508055968768,0,1,CA3 pyramidal cell dendrite,CC,
16608,GO:0097444,1,0.959577750784455,0,1,spine apparatus,CC,
16610,GO:0097449,1,0.806610197162215,0,6,astrocyte projection,CC,
16611,GO:0097450,1,0.927429116709472,0,2,astrocyte end-foot,CC,
16612,GO:0097451,1,0.927429116709472,0,2,glial limiting end-foot,CC,
16613,GO:0097452,1,0.883316059054682,0,4,GAIT complex,CC,
16614,GO:0097454,1,0.904300182845685,0,3,Schwann cell microvillus,CC,
16615,GO:0097457,1,0.923465050010357,0,2,hippocampal mossy fiber,CC,
16617,GO:0097462,1,0.972180785508844,0,1,Lewy neurite,CC,
16618,GO:0097466,1,0.865246987631419,0,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,
16619,GO:0097468,1,0.709349184973543,0,11,programmed cell death in response to reactive oxygen species,BP,
16620,GO:0097470,1,0.820942852882637,0,5,ribbon synapse,CC,
16622,GO:0097473,1,0.959542479616028,0,1,retinal rod cell apoptotic process,BP,
16623,GO:0097475,1,0.894003832497963,0,3,motor neuron migration,BP,
16628,GO:0097486,1,0.941196788371582,0,2,multivesicular body lumen,CC,
16629,GO:0097487,1,0.921231784991988,0,3,multivesicular body, internal vesicle,CC,
16630,GO:0097489,1,0.967528970318412,0,1,multivesicular body, internal vesicle lumen,CC,
16631,GO:0097490,1,0.85778031016908,0,4,sympathetic neuron projection extension,BP,
16632,GO:0097491,1,0.85778031016908,0,4,sympathetic neuron projection guidance,BP,
16633,GO:0097493,1,0.780301914572409,0,6,structural molecule activity conferring elasticity,MF,
16635,GO:0097497,1,0.964068341794451,0,1,blood vessel endothelial cell delamination,BP,
16636,GO:0097498,1,0.933143917310629,0,2,endothelial tube lumen extension,BP,
16637,GO:0097499,1,0.824785356510767,0,6,protein localization to non-motile cilium,BP,
16638,GO:0097500,1,0.896298958131086,0,3,receptor localization to non-motile cilium,BP,
16639,GO:0097501,1,0.850615388403911,0,7,stress response to metal ion,BP,
16640,GO:0097502,1,0.410842584334815,0,27,mannosylation,BP,
16641,GO:0097503,1,0.619922486834258,0,14,sialylation,BP,
16642,GO:0097504,1,0.694636510034767,0,11,Gemini of coiled bodies,CC,
16643,GO:0097505,1,0.959507651568631,0,1,Rad6-Rad18 complex,CC,
16645,GO:0097510,1,0.971387004673731,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
16646,GO:0097512,1,0.985542607743233,0,1,cardiac myofibril,CC,
16647,GO:0097513,1,0.883364048004276,0,3,myosin II filament,CC,
16648,GO:0097517,1,0.210050329896343,0,43,contractile actin filament bundle,CC,
16649,GO:0097524,1,0.863404928935517,0,4,sperm plasma membrane,CC,
16650,GO:0097525,1,0.159804822323636,0,62,spliceosomal snRNP complex,CC,
16651,GO:0097526,1,0.456892398688204,0,29,spliceosomal tri-snRNP complex,CC,
16656,GO:0097532,1,0.938485885754041,0,2,stress response to acid chemical,BP,
16657,GO:0097533,1,0.938485885754041,0,2,cellular stress response to acid chemical,BP,
16658,GO:0097534,1,0.927496546634218,0,2,lymphoid lineage cell migration,BP,
16659,GO:0097535,1,0.927496546634218,0,2,lymphoid lineage cell migration into thymus,BP,
16660,GO:0097536,1,0.96664141584552,0,1,thymus epithelium morphogenesis,BP,
16661,GO:0097539,1,0.681342746330294,0,10,ciliary transition fiber,CC,
16662,GO:0097541,1,0.965469978279355,0,1,axonemal basal plate,CC,
16664,GO:0097543,1,0.92653630117765,0,2,ciliary inversin compartment,CC,
16665,GO:0097546,1,0.418774858719792,0,25,ciliary base,CC,
16666,GO:0097550,1,0.838154551878147,0,6,transcriptional preinitiation complex,CC,
16668,GO:0097573,1,0.977958404736081,0,1,glutathione oxidoreductase activity,MF,
16669,GO:0097574,1,0.925589597605701,0,2,lateral part of cell,CC,
16670,GO:0097575,1,0.925589597605701,0,2,lateral cell cortex,CC,
16671,GO:0097576,1,0.928768522224828,0,2,vacuole fusion,BP,
16672,GO:0097577,1,0.93598283976286,0,3,sequestering of iron ion,BP,
16674,GO:0097598,1,0.959522005754726,0,1,sperm cytoplasmic droplet,CC,
16676,GO:0097603,1,0.960663077912503,0,1,temperature-gated ion channel activity,MF,
16677,GO:0097617,1,0.617798980166527,0,13,annealing activity,MF,
16678,GO:0097621,1,0.969411852768212,0,1,monoamine oxidase activity,MF,
16679,GO:0097623,1,0.95962241295944,0,1,potassium ion export across plasma membrane,BP,
16684,GO:0097630,1,0.965469978279355,0,1,intrinsic component of omegasome membrane,CC,
16685,GO:0097631,1,0.965469978279355,0,1,integral component of omegasome membrane,CC,
16686,GO:0097632,1,0.926411678201115,0,2,extrinsic component of phagophore assembly site membrane,CC,
16687,GO:0097635,1,0.9210452225791,0,2,extrinsic component of autophagosome membrane,CC,
16688,GO:0097636,1,0.927404252459364,0,2,intrinsic component of autophagosome membrane,CC,
16689,GO:0097637,1,0.927404252459364,0,2,integral component of autophagosome membrane,CC,
16693,GO:0097642,1,0.911834361469733,0,3,calcitonin family receptor activity,MF,
16694,GO:0097643,1,0.983003921684101,0,1,amylin receptor activity,MF,
16695,GO:0097644,1,0.943318608476253,0,2,calcitonin family binding,MF,
16698,GO:0097648,1,0.905810474593211,0,3,G-protein coupled receptor complex,CC,
16699,GO:0097651,1,0.922821705420813,0,2,phosphatidylinositol 3-kinase complex, class I,CC,
16700,GO:0097655,1,0.965469978279355,0,1,serpin family protein binding,MF,
16702,GO:0097676,1,0.893523810673818,0,3,histone H3-K36 dimethylation,BP,
16703,GO:0097677,1,0.829648866605656,0,6,STAT family protein binding,MF,
16704,GO:0097680,1,0.894925032721181,0,3,double-strand break repair via classical nonhomologous end joining,BP,
16705,GO:0097681,1,0.920650957478618,0,2,double-strand break repair via alternative nonhomologous end joining,BP,
16706,GO:0097682,1,0.970934986789011,0,1,intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity,MF,
16707,GO:0097688,1,0.87516683623457,0,4,glutamate receptor clustering,BP,
16708,GO:0097692,1,0.95950763690405,0,1,histone H3-K4 monomethylation,BP,
16709,GO:0097694,1,0.888638828800359,0,3,establishment of RNA localization to telomere,BP,
16710,GO:0097695,1,0.888638828800359,0,3,establishment of protein-containing complex localization to telomere,BP,
16712,GO:0097698,1,0.976600113245698,0,1,telomere maintenance via base-excision repair,BP,
16713,GO:0097699,1,0.960105379960109,0,1,vascular endothelial cell response to fluid shear stress,BP,
16714,GO:0097707,1,0.982600147176451,0,1,ferroptosis,BP,
16718,GO:0097712,1,0.965469978279355,0,1,vesicle targeting, trans-Golgi to periciliary membrane compartment,BP,
16721,GO:0097722,1,0.377465803745696,0,29,sperm motility,BP,
16722,GO:0097724,1,0.973328987154624,0,1,sperm flagellum movement,BP,
16723,GO:0097726,1,0.980556470486774,0,1,LEM domain binding,MF,
16725,GO:0097730,1,0.100549390994146,0,64,non-motile cilium,CC,
16726,GO:0097731,1,0.154479354292107,0,52,9+0 non-motile cilium,CC,
16727,GO:0097732,1,0.853966166834248,0,5,9+2 non-motile cilium,CC,
16728,GO:0097733,1,0.154479354292107,0,52,photoreceptor cell cilium,CC,
16730,GO:0097742,1,0.885256074226491,0,3,de novo centriole assembly,BP,
16731,GO:0097745,1,0.9174386258161,0,3,mitochondrial tRNA 5'-end processing,BP,
16734,GO:0097749,1,0.95950763690405,0,1,membrane tubulation,BP,
16735,GO:0097752,1,0.900477965044021,0,3,regulation of DNA stability,BP,
16736,GO:0097753,1,0.961528069787037,0,1,membrane bending,BP,
16739,GO:0098501,1,0.871982302515064,0,5,polynucleotide dephosphorylation,BP,
16740,GO:0098502,1,0.931440155119032,0,3,DNA dephosphorylation,BP,
16741,GO:0098503,1,0.974280666574357,0,1,DNA 3' dephosphorylation,BP,
16742,GO:0098504,1,0.974280666574357,0,1,DNA 3' dephosphorylation involved in DNA repair,BP,
16743,GO:0098505,1,0.709464802598474,0,10,G-rich strand telomeric DNA binding,MF,
16744,GO:0098506,1,0.974280666574357,0,1,polynucleotide 3' dephosphorylation,BP,
16745,GO:0098507,1,0.936176830461394,0,2,polynucleotide 5' dephosphorylation,BP,
16746,GO:0098508,1,0.938974753385888,0,2,endothelial to hematopoietic transition,BP,
16747,GO:0098518,1,0.912095008206058,0,3,polynucleotide phosphatase activity,MF,
16748,GO:0098519,1,0.846377977110941,0,5,nucleotide phosphatase activity, acting on free nucleotides,MF,
16749,GO:0098528,1,0.86814924399436,0,4,skeletal muscle fiber differentiation,BP,
16750,GO:0098530,1,0.959507637057539,0,1,positive regulation of strand invasion,BP,
16752,GO:0098532,1,0.850660171958489,0,6,histone H3-K27 trimethylation,BP,
16755,GO:0098535,1,0.885256074226491,0,3,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
16756,GO:0098536,1,0.886811712795438,0,3,deuterosome,CC,
16758,GO:0098543,1,0.781006289376684,0,7,detection of other organism,BP,
16759,GO:0098547,1,0.969787143083465,0,1,lumenal side of Golgi membrane,CC,
16763,GO:0098556,1,0.927334294347983,0,5,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
16764,GO:0098559,1,0.905612617161388,0,3,cytoplasmic side of early endosome membrane,CC,
16765,GO:0098560,1,0.934212134142061,0,2,cytoplasmic side of late endosome membrane,CC,
16767,GO:0098563,1,0.60895773077408,0,15,intrinsic component of synaptic vesicle membrane,CC,
16768,GO:0098573,1,0.128929596967657,0,66,intrinsic component of mitochondrial membrane,CC,
16769,GO:0098574,1,0.868129906035365,0,4,cytoplasmic side of lysosomal membrane,CC,
16770,GO:0098575,1,0.942194308412869,0,2,lumenal side of lysosomal membrane,CC,
16771,GO:0098576,1,0.879898439490414,0,4,lumenal side of membrane,CC,
16772,GO:0098577,1,0.95950763690405,0,1,inactive sex chromosome,CC,
16773,GO:0098581,1,0.755006347674723,0,8,detection of external biotic stimulus,BP,
16774,GO:0098582,1,0.923073084531987,0,2,innate vocalization behavior,BP,
16779,GO:0098592,1,0.894097206607278,0,3,cytoplasmic side of apical plasma membrane,CC,
16780,GO:0098594,1,0.984948285574094,0,1,mucin granule,CC,
16781,GO:0098596,1,0.849813996945739,0,4,imitative learning,BP,
16782,GO:0098597,1,0.815389249246287,0,5,observational learning,BP,
16783,GO:0098598,1,0.849813996945739,0,4,learned vocalization behavior or vocal learning,BP,
16784,GO:0098599,1,0.728301338936843,0,10,palmitoyl hydrolase activity,MF,
16786,GO:0098619,1,0.972685789248487,0,1,selenocysteine-tRNA ligase activity,MF,
16787,GO:0098621,1,0.959508251718916,0,1,phosphoseryl-selenocysteinyl-tRNA selenium transferase activity,MF,
16790,GO:0098629,1,0.965469978279355,0,1,trans-Golgi network membrane organization,BP,
16793,GO:0098633,1,0.967725783897205,0,1,collagen fibril binding,MF,
16794,GO:0098634,1,0.849716912775499,0,4,cell-matrix adhesion mediator activity,MF,
16796,GO:0098639,1,0.849716912775499,0,4,collagen binding involved in cell-matrix adhesion,MF,
16798,GO:0098642,1,0.786480061022354,0,6,network-forming collagen trimer,CC,
16799,GO:0098643,1,0.692612947172662,0,9,banded collagen fibril,CC,
16800,GO:0098644,1,0.522520191530248,0,16,complex of collagen trimers,CC,
16801,GO:0098645,1,0.786480061022354,0,6,collagen network,CC,
16802,GO:0098646,1,0.96710076651168,0,1,collagen sheet,CC,
16803,GO:0098647,1,0.937922239736655,0,2,collagen beaded filament,CC,
16804,GO:0098648,1,0.95950763690405,0,1,collagen anchoring fibril,CC,
16805,GO:0098651,1,0.786480061022354,0,6,basement membrane collagen trimer,CC,
16806,GO:0098652,1,0.95950763690405,0,1,collagen type VII anchoring fibril,CC,
16814,GO:0098664,1,0.915994570052804,0,3,G-protein coupled serotonin receptor signaling pathway,BP,
16815,GO:0098679,1,0.920650957478618,0,2,regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter,BP,
16816,GO:0098680,1,0.990754098213451,0,1,template-free RNA nucleotidyltransferase,MF,
16819,GO:0098698,1,0.847925133826865,0,4,postsynaptic specialization assembly,BP,
16820,GO:0098700,1,0.946038146298464,0,2,neurotransmitter loading into synaptic vesicle,BP,
16821,GO:0098703,1,0.799190775932971,0,6,calcium ion import across plasma membrane,BP,
16822,GO:0098705,1,0.959771663821574,0,1,copper ion import across plasma membrane,BP,
16825,GO:0098712,1,0.803609888362318,0,6,L-glutamate import across plasma membrane,BP,
16826,GO:0098713,1,0.969679127461953,0,1,leucine import across plasma membrane,BP,
16828,GO:0098722,1,0.80559347413442,0,6,asymmetric stem cell division,BP,
16829,GO:0098725,1,0.965469978279355,0,1,symmetric cell division,BP,
16831,GO:0098728,1,0.942124840234752,0,2,germline stem cell asymmetric division,BP,
16833,GO:0098734,1,0.728301338936843,0,10,macromolecule depalmitoylation,BP,
16835,GO:0098736,1,0.95950763690405,0,1,negative regulation of the force of heart contraction,BP,
16840,GO:0098746,1,0.959742867692322,0,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,
16841,GO:0098748,1,0.675170014212906,0,11,endocytic adaptor activity,MF,
16842,GO:0098749,1,0.959912390990983,0,1,cerebellar neuron development,BP,
16845,GO:0098756,1,0.850260163439648,0,4,response to interleukin-21,BP,
16846,GO:0098757,1,0.850260163439648,0,4,cellular response to interleukin-21,BP,
16847,GO:0098758,1,0.933414717530082,0,2,response to interleukin-8,BP,
16848,GO:0098759,1,0.933414717530082,0,2,cellular response to interleukin-8,BP,
16855,GO:0098779,1,0.758521384607587,0,8,positive regulation of mitophagy in response to mitochondrial depolarization,BP,
16859,GO:0098789,1,0.67387888246486,0,11,pre-mRNA cleavage required for polyadenylation,BP,
16864,GO:0098795,1,0.928985764524472,0,2,mRNA cleavage involved in gene silencing,BP,
16868,GO:0098799,1,0.714339967670008,0,12,outer mitochondrial membrane protein complex,CC,
16872,GO:0098803,1,0.265273033615709,0,66,respiratory chain complex,CC,
16874,GO:0098808,1,0.938613201011141,0,2,mRNA cap binding,MF,
16875,GO:0098809,1,0.967261870054133,0,1,nitrite reductase activity,MF,
16876,GO:0098810,1,0.782041308023147,0,8,neurotransmitter reuptake,BP,
16878,GO:0098814,1,0.837394560706672,0,5,spontaneous synaptic transmission,BP,
16881,GO:0098821,1,0.885795735133023,0,3,BMP receptor activity,MF,
16882,GO:0098822,1,0.96827547172546,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
16883,GO:0098826,1,0.876568470710844,0,4,endoplasmic reticulum tubular network membrane,CC,
16885,GO:0098828,1,0.781713912446026,0,6,modulation of inhibitory postsynaptic potential,BP,
16886,GO:0098829,1,0.95950763690405,0,1,intestinal folate absorption,BP,
16887,GO:0098830,1,0.959734229948343,0,1,presynaptic endosome,CC,
16888,GO:0098831,1,0.813259435106958,0,5,presynaptic active zone cytoplasmic component,CC,
16889,GO:0098833,1,0.959657021789674,0,1,presynaptic endocytic zone,CC,
16890,GO:0098835,1,0.959657021789674,0,1,presynaptic endocytic zone membrane,CC,
16891,GO:0098837,1,0.90888000061206,0,3,postsynaptic recycling endosome,CC,
16892,GO:0098838,1,0.965782517085911,0,1,reduced folate transmembrane transport,BP,
16893,GO:0098839,1,0.771928126267086,0,7,postsynaptic density membrane,CC,
16894,GO:0098840,1,0.949182290802591,0,2,protein transport along microtubule,BP,
16895,GO:0098842,1,0.939557127538753,0,2,postsynaptic early endosome,CC,
16896,GO:0098843,1,0.824997277281136,0,6,postsynaptic endocytic zone,CC,
16897,GO:0098844,1,0.85877718473312,0,4,postsynaptic endocytic zone membrane,CC,
16898,GO:0098845,1,0.824433966241238,0,6,postsynaptic endosome,CC,
16899,GO:0098847,1,0.643501301854368,0,13,sequence-specific single stranded DNA binding,MF,
16905,GO:0098868,1,0.592260938060139,0,14,bone growth,BP,
16907,GO:0098870,1,0.904313521923425,0,3,action potential propagation,BP,
16908,GO:0098871,1,0.974594472225065,0,1,postsynaptic actin cytoskeleton,CC,
16909,GO:0098875,1,0.959801027478004,0,1,epididymosome,CC,
16910,GO:0098876,1,0.101977310592685,0,65,vesicle-mediated transport to the plasma membrane,BP,
16911,GO:0098877,1,0.700974635494688,0,10,neurotransmitter receptor transport to plasma membrane,BP,
16912,GO:0098878,1,0.538920813554879,0,17,neurotransmitter receptor complex,CC,
16913,GO:0098881,1,0.897744142459444,0,3,exocytic insertion of neurotransmitter receptor to plasma membrane,BP,
16914,GO:0098883,1,0.973571680227903,0,1,synapse disassembly,BP,
16915,GO:0098884,1,0.85877718473312,0,4,postsynaptic neurotransmitter receptor internalization,BP,
16916,GO:0098885,1,0.95950763690405,0,1,modification of postsynaptic actin cytoskeleton,BP,
16917,GO:0098886,1,0.926440130850126,0,2,modification of dendritic spine,BP,
16918,GO:0098887,1,0.835308258113195,0,5,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
16919,GO:0098888,1,0.95950763690405,0,1,extrinsic component of presynaptic membrane,CC,
16920,GO:0098890,1,0.95950763690405,0,1,extrinsic component of postsynaptic membrane,CC,
16922,GO:0098901,1,0.481818864974946,0,19,regulation of cardiac muscle cell action potential,BP,
16923,GO:0098902,1,0.838425128984483,0,5,regulation of membrane depolarization during action potential,BP,
16924,GO:0098903,1,0.794943952709658,0,6,regulation of membrane repolarization during action potential,BP,
16925,GO:0098904,1,0.93333010884943,0,2,regulation of AV node cell action potential,BP,
16926,GO:0098905,1,0.948516567145669,0,2,regulation of bundle of His cell action potential,BP,
16927,GO:0098906,1,0.964039008079129,0,1,regulation of Purkinje myocyte action potential,BP,
16928,GO:0098907,1,0.95950763690405,0,1,regulation of SA node cell action potential,BP,
16929,GO:0098908,1,0.930109444887021,0,2,regulation of neuronal action potential,BP,
16930,GO:0098909,1,0.841287215124133,0,5,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,
16931,GO:0098910,1,0.81950143081951,0,5,regulation of atrial cardiac muscle cell action potential,BP,
16932,GO:0098911,1,0.699784308964278,0,9,regulation of ventricular cardiac muscle cell action potential,BP,
16933,GO:0098912,1,0.960544137946695,0,1,membrane depolarization during atrial cardiac muscle cell action potential,BP,
16934,GO:0098914,1,0.926361490840524,0,2,membrane repolarization during atrial cardiac muscle cell action potential,BP,
16935,GO:0098915,1,0.890368249957395,0,3,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
16937,GO:0098917,1,0.910624927142233,0,3,retrograde trans-synaptic signaling,BP,
16938,GO:0098918,1,0.973516526534991,0,1,structural constituent of synapse,MF,
16939,GO:0098920,1,0.966475246215019,0,1,retrograde trans-synaptic signaling by lipid,BP,
16940,GO:0098921,1,0.966475246215019,0,1,retrograde trans-synaptic signaling by endocannabinoid,BP,
16941,GO:0098923,1,0.95950763690405,0,1,retrograde trans-synaptic signaling by soluble gas,BP,
16942,GO:0098924,1,0.95950763690405,0,1,retrograde trans-synaptic signaling by nitric oxide,BP,
16943,GO:0098926,1,0.95950763690405,0,1,postsynaptic signal transduction,BP,
16944,GO:0098927,1,0.238302758142225,0,41,vesicle-mediated transport between endosomal compartments,BP,
16945,GO:0098928,1,0.920650957478618,0,2,presynaptic signal transduction,BP,
16946,GO:0098930,1,0.242427833559967,0,41,axonal transport,BP,
16947,GO:0098935,1,0.885268091937969,0,3,dendritic transport,BP,
16948,GO:0098936,1,0.921018648381115,0,2,intrinsic component of postsynaptic membrane,CC,
16949,GO:0098937,1,0.885268091937969,0,3,anterograde dendritic transport,BP,
16950,GO:0098939,1,0.95950763690405,0,1,dendritic transport of mitochondrion,BP,
16951,GO:0098943,1,0.938015087534088,0,2,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,
16952,GO:0098948,1,0.95950763690405,0,1,intrinsic component of postsynaptic specialization membrane,CC,
16953,GO:0098953,1,0.902291761508123,0,3,receptor diffusion trapping,BP,
16954,GO:0098957,1,0.862606256859724,0,4,anterograde axonal transport of mitochondrion,BP,
16955,GO:0098960,1,0.841909306628901,0,5,postsynaptic neurotransmitter receptor activity,MF,
16956,GO:0098967,1,0.897744142459444,0,3,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,
16957,GO:0098968,1,0.959555954835982,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
16958,GO:0098969,1,0.72760922121008,0,9,neurotransmitter receptor transport to postsynaptic membrane,BP,
16959,GO:0098970,1,0.902291761508123,0,3,postsynaptic neurotransmitter receptor diffusion trapping,BP,
16960,GO:0098971,1,0.92263516803707,0,2,anterograde dendritic transport of neurotransmitter receptor complex,BP,
16961,GO:0098972,1,0.95950763690405,0,1,anterograde dendritic transport of mitochondrion,BP,
16962,GO:0098973,1,0.973516526534991,0,1,structural constituent of postsynaptic actin cytoskeleton,MF,
16963,GO:0098974,1,0.973516526534991,0,1,postsynaptic actin cytoskeleton organization,BP,
16964,GO:0098976,1,0.901224825479462,0,3,excitatory chemical synaptic transmission,BP,
16965,GO:0098978,1,0.959548057340642,0,1,glutamatergic synapse,CC,
16966,GO:0098982,1,0.921057451355001,0,2,GABA-ergic synapse,CC,
16967,GO:0098983,1,0.921057451355001,0,2,symmetric, GABA-ergic, inhibitory synapse,CC,
16969,GO:0098985,1,0.959548057340642,0,1,asymmetric, glutamatergic, excitatory synapse,CC,
16970,GO:0098988,1,0.95950763690405,0,1,G-protein coupled glutamate receptor activity,MF,
16971,GO:0098989,1,0.936901787921034,0,2,NMDA selective glutamate receptor signaling pathway,BP,
16972,GO:0098993,1,0.787295470522548,0,8,anchored component of synaptic vesicle membrane,CC,
16974,GO:0099004,1,0.920736578253966,0,2,calmodulin dependent kinase signaling pathway,BP,
16975,GO:0099010,1,0.888919326758106,0,3,modification of postsynaptic structure,BP,
16976,GO:0099011,1,0.922264009059685,0,2,neuronal dense core vesicle exocytosis,BP,
16977,GO:0099022,1,0.941907534976241,0,2,vesicle tethering,BP,
16978,GO:0099023,1,0.102490338739982,0,65,tethering complex,CC,
16979,GO:0099024,1,0.311578667308691,0,34,plasma membrane invagination,BP,
16980,GO:0099039,1,0.95950763690405,0,1,sphingolipid translocation,BP,
16981,GO:0099044,1,0.941907534976241,0,2,vesicle tethering to endoplasmic reticulum,BP,
16982,GO:0099046,1,0.977081954341158,0,1,clearance of foreign intracellular nucleic acids,BP,
16983,GO:0099053,1,0.900546937420133,0,3,activating signal cointegrator 1 complex,CC,
16985,GO:0099055,1,0.921018648381115,0,2,integral component of postsynaptic membrane,CC,
16986,GO:0099060,1,0.95950763690405,0,1,integral component of postsynaptic specialization membrane,CC,
16987,GO:0099061,1,0.95950763690405,0,1,integral component of postsynaptic density membrane,CC,
16989,GO:0099072,1,0.563663244673671,0,16,regulation of postsynaptic membrane neurotransmitter receptor levels,BP,
16990,GO:0099073,1,0.924878904851773,0,2,mitochondrion-derived vesicle,CC,
16991,GO:0099074,1,0.931502654082218,0,2,mitochondrion to lysosome transport,BP,
16992,GO:0099075,1,0.931502654082218,0,2,mitochondrion-derived vesicle mediated transport,BP,
16993,GO:0099077,1,0.959507637945067,0,1,histone-dependent DNA binding,MF,
16994,GO:0099078,1,0.789764318692269,0,8,BORC complex,CC,
16997,GO:0099082,1,0.981981773219839,0,1,retrograde trans-synaptic signaling by neuropeptide,BP,
16998,GO:0099083,1,0.981981773219839,0,1,retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
16999,GO:0099084,1,0.761369829473644,0,7,postsynaptic specialization organization,BP,
17000,GO:0099086,1,0.55470176474251,0,17,synaptonemal structure,CC,
17001,GO:0099089,1,0.95950763690405,0,1,establishment of endoplasmic reticulum localization to postsynapse,BP,
17002,GO:0099093,1,0.926380203781712,0,2,calcium export from the mitochondrion,BP,
17003,GO:0099094,1,0.297615475202319,0,33,ligand-gated cation channel activity,MF,
17004,GO:0099095,1,0.964080596108445,0,1,ligand-gated anion channel activity,MF,
17005,GO:0099098,1,0.96373517473614,0,1,microtubule polymerization based movement,BP,
17007,GO:0099111,1,0.0103320296621042,0,131,microtubule-based transport,BP,
17008,GO:0099116,1,0.644188454715813,0,16,tRNA 5'-end processing,BP,
17009,GO:0099118,1,0.949182290802591,0,2,microtubule-based protein transport,BP,
17010,GO:0099122,1,0.893644280423014,0,3,RNA polymerase II C-terminal domain binding,MF,
17011,GO:0099130,1,0.969989422566479,0,1,estrogen binding,MF,
17014,GO:0099133,1,0.722610718076486,0,8,ATP hydrolysis coupled anion transmembrane transport,BP,
17015,GO:0099146,1,0.95950763690405,0,1,intrinsic component of postsynaptic density membrane,CC,
17016,GO:0099159,1,0.95950763690405,0,1,regulation of modification of postsynaptic structure,BP,
17017,GO:0099163,1,0.95950763690405,0,1,synaptic signaling by nitric oxide,BP,
17018,GO:0099170,1,0.895192108379127,0,3,postsynaptic modulation of chemical synaptic transmission,BP,
17021,GO:0099174,1,0.891176568149098,0,3,regulation of presynapse organization,BP,
17024,GO:0099186,1,0.973516526534991,0,1,structural constituent of postsynapse,MF,
17025,GO:0099188,1,0.973516526534991,0,1,postsynaptic cytoskeleton organization,BP,
17026,GO:0099240,1,0.921018648381115,0,2,intrinsic component of synaptic membrane,CC,
17027,GO:0099243,1,0.95950763690405,0,1,extrinsic component of synaptic membrane,CC,
17028,GO:0099402,1,0.984487367317405,0,1,plant organ development,BP,
17029,GO:0099403,1,0.920650957478618,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
17030,GO:0099404,1,0.920650957478618,0,2,mitotic sister chromatid cohesion, telomeric,BP,
17037,GO:0099514,1,0.617144274828655,0,15,synaptic vesicle cytoskeletal transport,BP,
17038,GO:0099515,1,0.698843321501093,0,9,actin filament-based transport,BP,
17040,GO:0099517,1,0.617144274828655,0,15,synaptic vesicle transport along microtubule,BP,
17041,GO:0099518,1,0.218800334995123,0,42,vesicle cytoskeletal trafficking,BP,
17042,GO:0099519,1,0.965469978279355,0,1,dense core granule cytoskeletal transport,BP,
17043,GO:0099522,1,0.97153420649971,0,1,region of cytosol,CC,
17044,GO:0099523,1,0.97153420649971,0,1,presynaptic cytosol,CC,
17045,GO:0099524,1,0.97153420649971,0,1,postsynaptic cytosol,CC,
17046,GO:0099525,1,0.922264009059685,0,2,presynaptic dense core vesicle exocytosis,BP,
17047,GO:0099526,1,0.920650957478618,0,2,presynapse to nucleus signaling pathway,BP,
17048,GO:0099527,1,0.95950763690405,0,1,postsynapse to nucleus signaling pathway,BP,
17050,GO:0099529,1,0.841909306628901,0,5,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,
17052,GO:0099532,1,0.920868396556993,0,2,synaptic vesicle endosomal processing,BP,
17055,GO:0099538,1,0.981981773219839,0,1,synaptic signaling via neuropeptide,BP,
17056,GO:0099540,1,0.981981773219839,0,1,trans-synaptic signaling by neuropeptide,BP,
17057,GO:0099541,1,0.929272420705968,0,2,trans-synaptic signaling by lipid,BP,
17058,GO:0099542,1,0.929272420705968,0,2,trans-synaptic signaling by endocannabinoid,BP,
17059,GO:0099543,1,0.95950763690405,0,1,trans-synaptic signaling by soluble gas,BP,
17060,GO:0099545,1,0.95970019463895,0,1,trans-synaptic signaling by trans-synaptic complex,BP,
17061,GO:0099547,1,0.895192108379127,0,3,regulation of translation at synapse, modulating synaptic transmission,BP,
17062,GO:0099548,1,0.95950763690405,0,1,trans-synaptic signaling by nitric oxide,BP,
17063,GO:0099550,1,0.906127695033779,0,3,trans-synaptic signaling, modulating synaptic transmission,BP,
17064,GO:0099551,1,0.981981773219839,0,1,trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
17065,GO:0099552,1,0.961509937219331,0,1,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,
17066,GO:0099553,1,0.961509937219331,0,1,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,
17067,GO:0099557,1,0.95970019463895,0,1,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,
17068,GO:0099563,1,0.640619263277459,0,12,modification of synaptic structure,BP,
17071,GO:0099569,1,0.847594491557631,0,4,presynaptic cytoskeleton,CC,
17072,GO:0099571,1,0.974594472225065,0,1,postsynaptic cytoskeleton,CC,
17074,GO:0099578,1,0.895192108379127,0,3,regulation of translation at postsynapse, modulating synaptic transmission,BP,
17075,GO:0099580,1,0.95950763690405,0,1,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
17077,GO:0099589,1,0.915994570052804,0,3,serotonin receptor activity,MF,
17078,GO:0099590,1,0.805335894642983,0,6,neurotransmitter receptor internalization,BP,
17080,GO:0099602,1,0.844887456413189,0,6,neurotransmitter receptor regulator activity,MF,
17081,GO:0099604,1,0.508071380938075,0,18,ligand-gated calcium channel activity,MF,
17082,GO:0099606,1,0.95950763690405,0,1,microtubule plus-end directed mitotic chromosome migration,BP,
17083,GO:0099607,1,0.95950763690405,0,1,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
17084,GO:0099609,1,0.920650958477623,0,2,microtubule lateral binding,MF,
17085,GO:0099612,1,0.789380942777789,0,6,protein localization to axon,BP,
17086,GO:0099617,1,0.962989146243522,0,1,matrix side of mitochondrial inner membrane,CC,
17087,GO:0099622,1,0.574542568742529,0,15,cardiac muscle cell membrane repolarization,BP,
17088,GO:0099623,1,0.653687836009153,0,11,regulation of cardiac muscle cell membrane repolarization,BP,
17089,GO:0099624,1,0.926361490840524,0,2,atrial cardiac muscle cell membrane repolarization,BP,
17090,GO:0099625,1,0.657745927415078,0,11,ventricular cardiac muscle cell membrane repolarization,BP,
17091,GO:0099627,1,0.965469978279355,0,1,neurotransmitter receptor cycle,BP,
17092,GO:0099628,1,0.902291761508123,0,3,neurotransmitter receptor diffusion trapping,BP,
17093,GO:0099630,1,0.965469978279355,0,1,postsynaptic neurotransmitter receptor cycle,BP,
17094,GO:0099631,1,0.960680062721992,0,2,postsynaptic endocytic zone cytoplasmic component,CC,
17095,GO:0099632,1,0.630836295768007,0,13,protein transport within plasma membrane,BP,
17096,GO:0099634,1,0.771928126267086,0,7,postsynaptic specialization membrane,CC,
17097,GO:0099637,1,0.630836295768007,0,13,neurotransmitter receptor transport,BP,
17098,GO:0099638,1,0.804741719851434,0,6,endosome to plasma membrane protein transport,BP,
17099,GO:0099639,1,0.804741719851434,0,6,neurotransmitter receptor transport, endosome to plasma membrane,BP,
17100,GO:0099640,1,0.983131290533574,0,1,axo-dendritic protein transport,BP,
17101,GO:0099641,1,0.983131290533574,0,1,anterograde axonal protein transport,BP,
17103,GO:0099699,1,0.921018648381115,0,2,integral component of synaptic membrane,CC,
17105,GO:0100002,1,0.965630907244895,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
17106,GO:0100012,1,0.973571680227903,0,1,regulation of heart induction by canonical Wnt signaling pathway,BP,
17107,GO:0100057,1,0.95950763690405,0,1,regulation of phenotypic switching by transcription from RNA polymerase II promoter,BP,
17111,GO:0101006,1,0.922361061530857,0,3,protein histidine phosphatase activity,MF,
17112,GO:0101020,1,0.942456594248565,0,2,estrogen 16-alpha-hydroxylase activity,MF,
17114,GO:0101030,1,0.978191085599748,0,1,tRNA-guanine transglycosylation,BP,
17115,GO:0101031,1,0.703974906025151,0,11,chaperone complex,CC,
17116,GO:0102005,1,0.976407124093696,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
17117,GO:0102007,1,0.975125295369969,0,1,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
17118,GO:0102008,1,0.95962560373108,0,1,cytosolic dipeptidase activity,MF,
17119,GO:0102009,1,0.972739113763699,0,1,proline dipeptidase activity,MF,
17120,GO:0102077,1,0.970943193427557,0,1,oleamide hydrolase activity,MF,
17121,GO:0102084,1,0.935295742239704,0,2,L-dopa O-methyltransferase activity,MF,
17122,GO:0102092,1,0.920679357056224,0,2,5-diphosphoinositol pentakisphosphate 3-kinase activity,MF,
17123,GO:0102113,1,0.95950763690405,0,1,hypoxia-inducible factor-asparagine oxygenase activity,MF,
17124,GO:0102121,1,0.934353635676389,0,2,ceramidase activity,MF,
17125,GO:0102131,1,0.95950763690405,0,1,3-oxo-glutaryl-[acp] methyl ester reductase activity,MF,
17126,GO:0102132,1,0.95950763690405,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
17128,GO:0102158,1,0.868854350931026,0,4,very-long-chain 3-hydroxyacyl-CoA dehydratase activity,MF,
17129,GO:0102166,1,0.95957889503157,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17130,GO:0102167,1,0.95957889503157,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17131,GO:0102200,1,0.959555701591532,0,1,N-acetylphosphatidylethanolamine-hydrolysing phospholipas activity,MF,
17132,GO:0102250,1,0.927946587710174,0,2,linear malto-oligosaccharide phosphorylase activity,MF,
17133,GO:0102336,1,0.842051452556028,0,5,3-oxo-arachidoyl-CoA synthase activity,MF,
17134,GO:0102337,1,0.842051452556028,0,5,3-oxo-cerotoyl-CoA synthase activity,MF,
17135,GO:0102338,1,0.842051452556028,0,5,3-oxo-lignoceronyl-CoA synthase activity,MF,
17136,GO:0102339,1,0.96766441867941,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
17137,GO:0102340,1,0.96766441867941,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
17138,GO:0102341,1,0.96766441867941,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
17139,GO:0102342,1,0.96766441867941,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
17140,GO:0102343,1,0.868854350931026,0,4,3-hydroxy-arachidoyl-CoA dehydratase activity,MF,
17141,GO:0102344,1,0.868854350931026,0,4,3-hydroxy-behenoyl-CoA dehydratase activity,MF,
17142,GO:0102345,1,0.868854350931026,0,4,3-hydroxy-lignoceroyl-CoA dehydratase activity,MF,
17143,GO:0102389,1,0.966883544077274,0,1,polyprenol reductase activity,MF,
17144,GO:0102390,1,0.966999821290441,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
17145,GO:0102391,1,0.854546936061764,0,4,decanoate-CoA ligase activity,MF,
17146,GO:0102420,1,0.863761619026864,0,4,sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity,MF,
17147,GO:0102485,1,0.926905862891416,0,2,dATP phosphohydrolase activity,MF,
17148,GO:0102486,1,0.926905862891416,0,2,dCTP phosphohydrolase activity,MF,
17149,GO:0102487,1,0.926905862891416,0,2,dUTP phosphohydrolase activity,MF,
17150,GO:0102488,1,0.926905862891416,0,2,dTTP phosphohydrolase activity,MF,
17151,GO:0102489,1,0.926905862891416,0,2,GTP phosphohydrolase activity,MF,
17152,GO:0102490,1,0.926905862891416,0,2,8-oxo-dGTP phosphohydrolase activity,MF,
17153,GO:0102491,1,0.926905862891416,0,2,dGTP phosphohydrolase activity,MF,
17154,GO:0102499,1,0.927946587710174,0,2,SHG alpha-glucan phosphorylase activity,MF,
17155,GO:0102500,1,0.95950763690405,0,1,beta-maltose 4-alpha-glucanotransferase activity,MF,
17156,GO:0102521,1,0.933121299617905,0,2,tRNA-4-demethylwyosine synthase activity,MF,
17157,GO:0102522,1,0.970075660154903,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
17158,GO:0102524,1,0.965469978279355,0,1,tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity,MF,
17159,GO:0102567,1,0.653830908875221,0,12,phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine),MF,
17160,GO:0102568,1,0.653830908875221,0,12,phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine),MF,
17161,GO:0102571,1,0.95957889503157,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17162,GO:0102704,1,0.96539608532011,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
17163,GO:0102707,1,0.96756271365883,0,1,S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity,MF,
17164,GO:0102751,1,0.973534897803609,0,1,UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity,MF,
17165,GO:0102752,1,0.964304391831253,0,1,1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis),MF,
17166,GO:0102756,1,0.842051452556028,0,5,very-long-chain 3-ketoacyl-CoA synthase activity,MF,
17167,GO:0102758,1,0.980008231536604,0,1,very-long-chain enoyl-CoA reductase activity,MF,
17169,GO:0102773,1,0.960119057939795,0,1,dihydroceramide kinase activity,MF,
17170,GO:0102797,1,0.959651701925598,0,1,geranial:oxygen oxidoreductase activity,MF,
17171,GO:0102798,1,0.959651701925598,0,1,heptaldehyde:oxygen oxidoreductase activity,MF,
17172,GO:0102867,1,0.966403819748522,0,1,molybdenum cofactor sulfurtransferase activity,MF,
17173,GO:0102938,1,0.935295742239704,0,2,orcinol O-methyltransferase activity,MF,
17174,GO:0102953,1,0.906363414185936,0,3,hypoglycin A gamma-glutamyl transpeptidase activity,MF,
17175,GO:0102965,1,0.931688157704,0,2,alcohol-forming fatty acyl-CoA reductase activity,MF,
17176,GO:0102991,1,0.89974711582039,0,4,myristoyl-CoA hydrolase activity,MF,
17177,GO:0103025,1,0.970304891294337,0,1,alpha-amylase activity (releasing maltohexaose),MF,
17178,GO:0103045,1,0.971207527567196,0,1,methione N-acyltransferase activity,MF,
17179,GO:0103046,1,0.95962560373108,0,1,alanylglutamate dipeptidase activity,MF,
17180,GO:0103053,1,0.950501242617154,0,2,1-ethyladenine demethylase activity,MF,
17181,GO:0103066,1,0.975507479019621,0,1,4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity,MF,
17182,GO:0103067,1,0.975507479019621,0,1,4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity,MF,
17183,GO:0103068,1,0.906363414185936,0,3,leukotriene C4 gamma-glutamyl transferase activity,MF,
17184,GO:0103073,1,0.970943193427557,0,1,anandamide amidohydrolase activity,MF,
17187,GO:0106001,1,0.889870737679391,0,3,intestinal hexose absorption,BP,
17188,GO:0106003,1,0.72595394546147,0,9,amyloid-beta complex,CC,
17189,GO:0106004,1,0.953421682087677,0,2,tRNA (guanine-N7)-methylation,BP,
17190,GO:0106005,1,0.95950763690405,0,1,RNA 5'-cap (guanine-N7)-methylation,BP,
17191,GO:0106014,1,0.943966192952739,0,2,regulation of inflammatory response to wounding,BP,
17192,GO:0106015,1,0.943966192952739,0,2,negative regulation of inflammatory response to wounding,BP,
17193,GO:0106017,1,0.884519761779508,0,3,phosphatidylinositol-3,4-bisphosphate phosphatase activity,MF,
17194,GO:0106018,1,0.575057054243077,0,14,phosphatidylinositol-3,5-bisphosphate phosphatase activity,MF,
17195,GO:0106019,1,0.680768203298826,0,10,phosphatidylinositol-4,5-bisphosphate phosphatase activity,MF,
17196,GO:0106020,1,0.932086078996014,0,2,regulation of vesicle docking,BP,
17197,GO:0106022,1,0.961188596200167,0,1,positive regulation of vesicle docking,BP,
17199,GO:0106028,1,0.95970019463895,0,1,neuron projection retraction,BP,
17200,GO:0106030,1,0.587052659688486,0,14,neuron projection fasciculation,BP,
17201,GO:0106044,1,0.98268071838369,0,1,guanine deglycation,BP,
17202,GO:0106045,1,0.98268071838369,0,1,guanine deglycation, methylglyoxal removal,BP,
17203,GO:0106046,1,0.98268071838369,0,1,guanine deglycation, glyoxal removal,BP,
17205,GO:0106050,1,0.972176441940517,0,1,tRNA 2'-O-methyltransferase activity,MF,
17207,GO:0106057,1,0.895272688347723,0,3,negative regulation of calcineurin-mediated signaling,BP,
17209,GO:0106068,1,0.816049330874271,0,7,SUMO ligase complex,CC,
17210,GO:0106070,1,0.833972726338241,0,5,regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
17211,GO:0106071,1,0.893299191117914,0,3,positive regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
17212,GO:0106072,1,0.933605479306758,0,2,negative regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
17213,GO:0106073,1,0.925191290922574,0,2,dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity,MF,
17214,GO:0106074,1,0.674133067418445,0,11,aminoacyl-tRNA metabolism involved in translational fidelity,BP,
17215,GO:0106075,1,0.964229114996754,0,1,peptide N-succinyltransferase activity,MF,
17216,GO:0106077,1,0.860447170767109,0,4,histone succinylation,BP,
17217,GO:0106078,1,0.964229114996754,0,1,histone succinyltransferase activity,MF,
17218,GO:0106083,1,0.821649745191302,0,5,nuclear membrane protein complex,CC,
17219,GO:0106088,1,0.95950763690405,0,1,regulation of cell adhesion involved in sprouting angiogenesis,BP,
17220,GO:0106089,1,0.95950763690405,0,1,negative regulation of cell adhesion involved in sprouting angiogenesis,BP,
17221,GO:0106094,1,0.821649745191302,0,5,nuclear membrane microtubule tethering complex,CC,
17222,GO:0106101,1,0.973183584123691,0,1,ER-dependent peroxisome localization,BP,
17223,GO:0106104,1,0.968332243560731,0,1,regulation of glutamate receptor clustering,BP,
17224,GO:0110008,1,0.964599258963939,0,1,ncRNA deadenylation,BP,
17225,GO:0110009,1,0.92460003006269,0,2,formin-nucleated actin cable organization,BP,
17227,GO:0110017,1,0.959067556193121,0,2,cap-independent translational initiation of linear mRNA,BP,
17229,GO:0110021,1,0.934134461275511,0,2,cardiac muscle myoblast proliferation,BP,
17230,GO:0110022,1,0.934134461275511,0,2,regulation of cardiac muscle myoblast proliferation,BP,
17231,GO:0110024,1,0.934134461275511,0,2,positive regulation of cardiac muscle myoblast proliferation,BP,
17232,GO:0110025,1,0.964575820774184,0,1,DNA strand resection involved in replication fork processing,BP,
17233,GO:0110026,1,0.964575820774184,0,1,regulation of DNA strand resection involved in replication fork processing,BP,
17234,GO:0110028,1,0.95950763690405,0,1,positive regulation of mitotic spindle organization,BP,
17235,GO:0110029,1,0.964075692128143,0,1,negative regulation of meiosis I,BP,
17237,GO:0110057,1,0.959514380830744,0,1,regulation of blood vessel endothelial cell differentiation,BP,
17238,GO:0110059,1,0.959514380830744,0,1,negative regulation of blood vessel endothelial cell differentiation,BP,
17239,GO:0110075,1,0.982600147176451,0,1,regulation of ferroptosis,BP,
17240,GO:0110076,1,0.982600147176451,0,1,negative regulation of ferroptosis,BP,
17241,GO:0110095,1,0.930960741909078,0,3,cellular detoxification of aldehyde,BP,
17242,GO:0110096,1,0.882793370493862,0,5,cellular response to aldehyde,BP,
17243,GO:0120009,1,0.842356599477888,0,5,intermembrane lipid transfer,BP,
17244,GO:0120012,1,0.959521448017182,0,1,intermembrane sphingolipid transfer,BP,
17245,GO:0120013,1,0.842356599477888,0,5,intermembrane lipid transfer activity,MF,
17246,GO:0120016,1,0.959521448017182,0,1,intermembrane sphingolipid transfer activity,MF,
17247,GO:0120017,1,0.959521448017182,0,1,intermembrane ceramide transfer activity,MF,
17257,GO:0120043,1,0.959795989605516,0,1,stereocilium shaft,CC,
17258,GO:0120044,1,0.959795989605516,0,1,stereocilium base,CC,
17259,GO:0120048,1,0.965469978279355,0,1,U6 snRNA (adenine-(43)-N(6))-methyltransferase activity,MF,
17260,GO:0120049,1,0.965469978279355,0,1,snRNA (adenine-N6)-methylation,BP,
17261,GO:0120060,1,0.98406407037836,0,1,regulation of gastric emptying,BP,
17262,GO:0120061,1,0.98406407037836,0,1,negative regulation of gastric emptying,BP,
17263,GO:0120063,1,0.98406407037836,0,1,stomach smooth muscle contraction,BP,
17264,GO:0120068,1,0.98406407037836,0,1,regulation of stomach fundus smooth muscle contraction,BP,
17265,GO:0120069,1,0.98406407037836,0,1,positive regulation of stomach fundus smooth muscle contraction,BP,
17266,GO:0120077,1,0.95950763690405,0,1,angiogenic sprout fusion,BP,
17267,GO:0120078,1,0.95950763690405,0,1,cell adhesion involved in sprouting angiogenesis,BP,
17268,GO:0120092,1,0.9631162547096,0,1,crotonyl-CoA hydratase activity,MF,
17269,GO:0120093,1,0.9631162547096,0,1,regulation of peptidyl-lysine crotonylation,BP,
17270,GO:0120094,1,0.9631162547096,0,1,negative regulation of peptidyl-lysine crotonylation,BP,
17271,GO:0120103,1,0.707553807366174,0,9,centriolar subdistal appendage,CC,
17272,GO:0120108,1,0.971644205399406,0,1,DNA-3'-diphospho-5'-guanosine diphosphatase,MF,
17273,GO:0120111,1,0.131851991117201,0,59,neuron projection cytoplasm,CC,
17274,GO:0120114,1,0.0937292284525272,0,79,Sm-like protein family complex,CC,
17275,GO:0140007,1,0.881845573355822,0,4,KICSTOR complex,CC,
17276,GO:0140009,1,0.961997179981503,0,1,L-aspartate import across plasma membrane,BP,
17281,GO:0140031,1,0.935340687687593,0,2,phosphorylation-dependent protein binding,MF,
17284,GO:0140035,1,0.799579163841705,0,6,ubiquitination-like modification-dependent protein binding,MF,
17285,GO:0140036,1,0.799579163841705,0,6,ubiquitin-dependent protein binding,MF,
17286,GO:0140041,1,0.98268071838369,0,1,cellular detoxification of methylglyoxal,BP,
17288,GO:0140053,1,0.0171147474213679,0,153,mitochondrial gene expression,BP,
17291,GO:0140059,1,0.834512658117291,0,5,dendrite arborization,BP,
17292,GO:0140064,1,0.95950763690405,0,1,peptide crotonyltransferase activity,MF,
17293,GO:0140065,1,0.95950763690405,0,1,peptide butyryltransferase activity,MF,
17294,GO:0140066,1,0.924113794006605,0,2,peptidyl-lysine crotonylation,BP,
17295,GO:0140067,1,0.95950763690405,0,1,peptidyl-lysine butyrylation,BP,
17296,GO:0140068,1,0.95950763690405,0,1,histone crotonyltransferase activity,MF,
17297,GO:0140069,1,0.95950763690405,0,1,histone butyryltransferase activity,MF,
17298,GO:0140074,1,0.959562855434205,0,1,cardiac endothelial to mesenchymal transition,BP,
17299,GO:0140078,1,0.757916552789581,0,10,class I DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
17300,GO:0140080,1,0.757916552789581,0,10,class III/IV DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
17304,GO:0140101,1,0.0239138049800795,0,117,catalytic activity, acting on a tRNA,MF,
17305,GO:0140102,1,0.615290427841473,0,16,catalytic activity, acting on a rRNA,MF,
17306,GO:0140103,1,0.517414826792567,0,19,catalytic activity, acting on a glycoprotein,MF,
17307,GO:0140104,1,0.439506008589903,0,27,molecular carrier activity,MF,
17312,GO:0140135,1,0.926409352446473,0,2,mechanosensitive cation channel activity,MF,
17313,GO:0140142,1,0.536248502864702,0,18,nucleocytoplasmic carrier activity,MF,
17314,GO:0140161,1,0.923147857369431,0,3,monocarboxylate:sodium symporter activity,MF,
17315,GO:0140192,1,0.920650957478618,0,2,regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17316,GO:0140193,1,0.978074585938961,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17317,GO:0140194,1,0.978074585938961,0,1,negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17318,GO:0140196,1,0.95950763690405,0,1,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17319,GO:0140199,1,0.95950763690405,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17320,GO:0140200,1,0.95950763690405,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate,BP,
17321,GO:0150003,1,0.903956242310871,0,3,regulation of spontaneous synaptic transmission,BP,
17322,GO:0150005,1,0.740981639561611,0,10,enzyme activator complex,CC,
17325,GO:0150018,1,0.891480813851834,0,3,basal dendrite development,BP,
17326,GO:0150019,1,0.891480813851834,0,3,basal dendrite morphogenesis,BP,
17327,GO:0150020,1,0.891480813851834,0,3,basal dendrite arborization,BP,
17328,GO:0150031,1,0.95950763690405,0,1,regulation of protein localization to lysosome,BP,
17329,GO:0150033,1,0.95950763690405,0,1,negative regulation of protein localization to lysosome,BP,
17330,GO:0150034,1,0.00167259648164991,0,179,distal axon,CC,
17332,GO:1900003,1,0.921016736880201,0,3,regulation of serine-type endopeptidase activity,BP,
17333,GO:1900004,1,0.921016736880201,0,3,negative regulation of serine-type endopeptidase activity,BP,
17342,GO:1900026,1,0.419621588330116,0,26,positive regulation of substrate adhesion-dependent cell spreading,BP,
17345,GO:1900029,1,0.695002482478709,0,11,positive regulation of ruffle assembly,BP,
17348,GO:1900037,1,0.731867250971277,0,10,regulation of cellular response to hypoxia,BP,
17349,GO:1900038,1,0.818737751310368,0,6,negative regulation of cellular response to hypoxia,BP,
17350,GO:1900039,1,0.97994215909975,0,1,positive regulation of cellular response to hypoxia,BP,
17351,GO:1900040,1,0.826248371918541,0,5,regulation of interleukin-2 secretion,BP,
17352,GO:1900041,1,0.897480478294839,0,3,negative regulation of interleukin-2 secretion,BP,
17353,GO:1900042,1,0.920651729330225,0,2,positive regulation of interleukin-2 secretion,BP,
17355,GO:1900045,1,0.823679254523167,0,5,negative regulation of protein K63-linked ubiquitination,BP,
17359,GO:1900060,1,0.884762923663735,0,4,negative regulation of ceramide biosynthetic process,BP,
17360,GO:1900062,1,0.961792574374543,0,1,regulation of replicative cell aging,BP,
17361,GO:1900063,1,0.895042188291189,0,3,regulation of peroxisome organization,BP,
17365,GO:1900081,1,0.95950763690405,0,1,regulation of arginine catabolic process,BP,
17366,GO:1900082,1,0.95950763690405,0,1,negative regulation of arginine catabolic process,BP,
17367,GO:1900084,1,0.856784833517615,0,4,regulation of peptidyl-tyrosine autophosphorylation,BP,
17368,GO:1900085,1,0.966809789554633,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
17369,GO:1900086,1,0.886207029812419,0,3,positive regulation of peptidyl-tyrosine autophosphorylation,BP,
17370,GO:1900087,1,0.460080076413448,0,23,positive regulation of G1/S transition of mitotic cell cycle,BP,
17371,GO:1900094,1,0.910220210967349,0,3,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,
17372,GO:1900095,1,0.95950763690405,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
17373,GO:1900098,1,0.973539492698059,0,1,regulation of plasma cell differentiation,BP,
17374,GO:1900100,1,0.973539492698059,0,1,positive regulation of plasma cell differentiation,BP,
17380,GO:1900107,1,0.934809053268369,0,2,regulation of nodal signaling pathway,BP,
17381,GO:1900108,1,0.974261762905889,0,1,negative regulation of nodal signaling pathway,BP,
17382,GO:1900109,1,0.954271563248266,0,2,regulation of histone H3-K9 dimethylation,BP,
17383,GO:1900110,1,0.954271563248266,0,2,negative regulation of histone H3-K9 dimethylation,BP,
17384,GO:1900112,1,0.722564326564624,0,9,regulation of histone H3-K9 trimethylation,BP,
17385,GO:1900113,1,0.845924178791264,0,5,negative regulation of histone H3-K9 trimethylation,BP,
17386,GO:1900114,1,0.921292183302705,0,2,positive regulation of histone H3-K9 trimethylation,BP,
17387,GO:1900115,1,0.702436302856263,0,11,extracellular regulation of signal transduction,BP,
17388,GO:1900116,1,0.702436302856263,0,11,extracellular negative regulation of signal transduction,BP,
17390,GO:1900118,1,0.805462758449609,0,6,negative regulation of execution phase of apoptosis,BP,
17393,GO:1900121,1,0.731009412531797,0,10,negative regulation of receptor binding,BP,
17394,GO:1900122,1,0.839296069358256,0,6,positive regulation of receptor binding,BP,
17396,GO:1900126,1,0.896092733968332,0,3,negative regulation of hyaluronan biosynthetic process,BP,
17398,GO:1900130,1,0.962131775847945,0,1,regulation of lipid binding,BP,
17399,GO:1900131,1,0.962131775847945,0,1,negative regulation of lipid binding,BP,
17400,GO:1900133,1,0.894991137017127,0,3,regulation of renin secretion into blood stream,BP,
17401,GO:1900134,1,0.961509937219331,0,1,negative regulation of renin secretion into blood stream,BP,
17402,GO:1900135,1,0.965550139443602,0,1,positive regulation of renin secretion into blood stream,BP,
17403,GO:1900138,1,0.911187485583911,0,3,negative regulation of phospholipase A2 activity,BP,
17404,GO:1900139,1,0.959613614615176,0,1,negative regulation of arachidonic acid secretion,BP,
17405,GO:1900141,1,0.96790450439028,0,1,regulation of oligodendrocyte apoptotic process,BP,
17406,GO:1900142,1,0.96790450439028,0,1,negative regulation of oligodendrocyte apoptotic process,BP,
17407,GO:1900145,1,0.934809053268369,0,2,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17408,GO:1900146,1,0.974261762905889,0,1,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17409,GO:1900147,1,0.926372432346771,0,2,regulation of Schwann cell migration,BP,
17410,GO:1900148,1,0.965469978279355,0,1,negative regulation of Schwann cell migration,BP,
17411,GO:1900149,1,0.95950763690405,0,1,positive regulation of Schwann cell migration,BP,
17412,GO:1900150,1,0.94308838932043,0,2,regulation of defense response to fungus,BP,
17414,GO:1900152,1,0.97340657801975,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
17416,GO:1900161,1,0.966070947184871,0,1,regulation of phospholipid scramblase activity,BP,
17417,GO:1900163,1,0.966070947184871,0,1,positive regulation of phospholipid scramblase activity,BP,
17418,GO:1900164,1,0.910220210967349,0,3,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
17420,GO:1900169,1,0.926372432346771,0,2,regulation of glucocorticoid mediated signaling pathway,BP,
17421,GO:1900170,1,0.965469978279355,0,1,negative regulation of glucocorticoid mediated signaling pathway,BP,
17422,GO:1900175,1,0.934809053268369,0,2,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
17423,GO:1900176,1,0.974261762905889,0,1,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
17425,GO:1900181,1,0.586341886064601,0,15,negative regulation of protein localization to nucleus,BP,
17427,GO:1900186,1,0.90208951782609,0,3,negative regulation of clathrin-dependent endocytosis,BP,
17428,GO:1900193,1,0.849571551478894,0,5,regulation of oocyte maturation,BP,
17429,GO:1900194,1,0.962779112836945,0,1,negative regulation of oocyte maturation,BP,
17430,GO:1900195,1,0.943009111143614,0,2,positive regulation of oocyte maturation,BP,
17431,GO:1900200,1,0.961319966218223,0,1,mesenchymal cell apoptotic process involved in metanephros development,BP,
17432,GO:1900204,1,0.961319966218223,0,1,apoptotic process involved in metanephric collecting duct development,BP,
17433,GO:1900205,1,0.961319966218223,0,1,apoptotic process involved in metanephric nephron tubule development,BP,
17434,GO:1900208,1,0.952418319591623,0,2,regulation of cardiolipin metabolic process,BP,
17435,GO:1900210,1,0.952418319591623,0,2,positive regulation of cardiolipin metabolic process,BP,
17436,GO:1900211,1,0.961319966218223,0,1,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17437,GO:1900212,1,0.961319966218223,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17438,GO:1900214,1,0.961319966218223,0,1,regulation of apoptotic process involved in metanephric collecting duct development,BP,
17439,GO:1900215,1,0.961319966218223,0,1,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
17440,GO:1900217,1,0.961319966218223,0,1,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17441,GO:1900218,1,0.961319966218223,0,1,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17442,GO:1900220,1,0.921142216636892,0,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,
17444,GO:1900222,1,0.937054972122205,0,2,negative regulation of amyloid-beta clearance,BP,
17446,GO:1900224,1,0.95950763690405,0,1,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
17447,GO:1900225,1,0.716685260614442,0,9,regulation of NLRP3 inflammasome complex assembly,BP,
17448,GO:1900226,1,0.86694932497578,0,4,negative regulation of NLRP3 inflammasome complex assembly,BP,
17449,GO:1900227,1,0.855328967012808,0,4,positive regulation of NLRP3 inflammasome complex assembly,BP,
17450,GO:1900238,1,0.932897972628058,0,2,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
17451,GO:1900239,1,0.901473477577445,0,3,regulation of phenotypic switching,BP,
17452,GO:1900241,1,0.96555301355671,0,1,positive regulation of phenotypic switching,BP,
17453,GO:1900242,1,0.797305029124306,0,6,regulation of synaptic vesicle endocytosis,BP,
17454,GO:1900243,1,0.959547385408767,0,1,negative regulation of synaptic vesicle endocytosis,BP,
17455,GO:1900244,1,0.932098823131351,0,2,positive regulation of synaptic vesicle endocytosis,BP,
17456,GO:1900245,1,0.890359056885092,0,3,positive regulation of MDA-5 signaling pathway,BP,
17457,GO:1900246,1,0.819702717915927,0,5,positive regulation of RIG-I signaling pathway,BP,
17460,GO:1900259,1,0.972748012746265,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
17461,GO:1900260,1,0.972748012746265,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
17462,GO:1900262,1,0.840550166034885,0,6,regulation of DNA-directed DNA polymerase activity,BP,
17463,GO:1900264,1,0.840550166034885,0,6,positive regulation of DNA-directed DNA polymerase activity,BP,
17465,GO:1900272,1,0.820965760494033,0,6,negative regulation of long-term synaptic potentiation,BP,
17468,GO:1900275,1,0.923812431260648,0,2,negative regulation of phospholipase C activity,BP,
17469,GO:1900276,1,0.962801397907159,0,1,regulation of proteinase activated receptor activity,BP,
17470,GO:1900363,1,0.646091314499974,0,12,regulation of mRNA polyadenylation,BP,
17471,GO:1900364,1,0.740863544170272,0,8,negative regulation of mRNA polyadenylation,BP,
17472,GO:1900365,1,0.894118313954924,0,3,positive regulation of mRNA polyadenylation,BP,
17473,GO:1900368,1,0.912151860998254,0,3,regulation of RNA interference,BP,
17474,GO:1900369,1,0.950635164900056,0,2,negative regulation of RNA interference,BP,
17475,GO:1900370,1,0.959523405148658,0,1,positive regulation of RNA interference,BP,
17477,GO:1900372,1,0.559051503512687,0,17,negative regulation of purine nucleotide biosynthetic process,BP,
17478,GO:1900373,1,0.323956611962242,0,33,positive regulation of purine nucleotide biosynthetic process,BP,
17481,GO:1900378,1,0.92148407599568,0,2,positive regulation of secondary metabolite biosynthetic process,BP,
17482,GO:1900387,1,0.971017199837092,0,1,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,BP,
17483,GO:1900390,1,0.954869281299917,0,2,regulation of iron ion import,BP,
17484,GO:1900402,1,0.73070543842261,0,8,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
17488,GO:1900424,1,0.658089252398064,0,13,regulation of defense response to bacterium,BP,
17489,GO:1900425,1,0.845422544526334,0,5,negative regulation of defense response to bacterium,BP,
17490,GO:1900426,1,0.817170089032519,0,7,positive regulation of defense response to bacterium,BP,
17492,GO:1900450,1,0.95970019463895,0,1,negative regulation of glutamate receptor signaling pathway,BP,
17494,GO:1900452,1,0.86471670620511,0,4,regulation of long term synaptic depression,BP,
17495,GO:1900453,1,0.939257153923135,0,2,negative regulation of long term synaptic depression,BP,
17496,GO:1900477,1,0.971166005118801,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,
17497,GO:1900483,1,0.967308247591653,0,1,regulation of protein targeting to vacuolar membrane,BP,
17498,GO:1900533,1,0.976200080423216,0,1,palmitic acid metabolic process,BP,
17499,GO:1900535,1,0.976200080423216,0,1,palmitic acid biosynthetic process,BP,
17503,GO:1900619,1,0.966967419757367,0,1,acetate ester metabolic process,BP,
17504,GO:1900620,1,0.966967419757367,0,1,acetate ester biosynthetic process,BP,
17505,GO:1900623,1,0.924624469716176,0,2,regulation of monocyte aggregation,BP,
17506,GO:1900625,1,0.924624469716176,0,2,positive regulation of monocyte aggregation,BP,
17507,GO:1900673,1,0.938307995506659,0,2,olefin metabolic process,BP,
17508,GO:1900736,1,0.962801397907159,0,1,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
17509,GO:1900737,1,0.962801397907159,0,1,negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
17514,GO:1900746,1,0.725747246187133,0,9,regulation of vascular endothelial growth factor signaling pathway,BP,
17515,GO:1900747,1,0.868529987139732,0,4,negative regulation of vascular endothelial growth factor signaling pathway,BP,
17516,GO:1900748,1,0.883618955099794,0,3,positive regulation of vascular endothelial growth factor signaling pathway,BP,
17517,GO:1900750,1,0.745170681033763,0,11,oligopeptide binding,MF,
17518,GO:1900753,1,0.960257973838895,0,1,doxorubicin transport,BP,
17519,GO:1900756,1,0.927271520619255,0,2,protein processing in phagocytic vesicle,BP,
17520,GO:1900825,1,0.873819931720628,0,4,regulation of membrane depolarization during cardiac muscle cell action potential,BP,
17521,GO:1900827,1,0.95950763690405,0,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,
17522,GO:1900864,1,0.763815536571094,0,9,mitochondrial RNA modification,BP,
17523,GO:1901003,1,0.965469978279355,0,1,negative regulation of fermentation,BP,
17524,GO:1901004,1,0.978885866085131,0,1,ubiquinone-6 metabolic process,BP,
17525,GO:1901006,1,0.978885866085131,0,1,ubiquinone-6 biosynthetic process,BP,
17528,GO:1901018,1,0.730305516435437,0,9,positive regulation of potassium ion transmembrane transporter activity,BP,
17534,GO:1901029,1,0.818819190401329,0,7,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
17540,GO:1901069,1,0.954212466613889,0,2,guanosine-containing compound catabolic process,BP,
17541,GO:1901070,1,0.7340592858407,0,13,guanosine-containing compound biosynthetic process,BP,
17542,GO:1901071,1,0.57383550085531,0,16,glucosamine-containing compound metabolic process,BP,
17543,GO:1901072,1,0.852072045465726,0,5,glucosamine-containing compound catabolic process,BP,
17544,GO:1901073,1,0.922635224286999,0,2,glucosamine-containing compound biosynthetic process,BP,
17545,GO:1901074,1,0.95950763690405,0,1,regulation of engulfment of apoptotic cell,BP,
17546,GO:1901076,1,0.95950763690405,0,1,positive regulation of engulfment of apoptotic cell,BP,
17547,GO:1901077,1,0.861520090844982,0,4,regulation of relaxation of muscle,BP,
17548,GO:1901078,1,0.95950763690405,0,1,negative regulation of relaxation of muscle,BP,
17549,GO:1901086,1,0.959598545219491,0,1,benzylpenicillin metabolic process,BP,
17550,GO:1901090,1,0.937392098547376,0,2,regulation of protein tetramerization,BP,
17551,GO:1901091,1,0.937392098547376,0,2,negative regulation of protein tetramerization,BP,
17552,GO:1901093,1,0.937392098547376,0,2,regulation of protein homotetramerization,BP,
17553,GO:1901094,1,0.937392098547376,0,2,negative regulation of protein homotetramerization,BP,
17555,GO:1901097,1,0.866240447482697,0,4,negative regulation of autophagosome maturation,BP,
17562,GO:1901143,1,0.923735270285687,0,2,insulin catabolic process,BP,
17563,GO:1901145,1,0.923726393309706,0,2,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
17564,GO:1901147,1,0.961319966218223,0,1,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
17565,GO:1901159,1,0.873504287721904,0,5,xylulose 5-phosphate biosynthetic process,BP,
17566,GO:1901160,1,0.779101032755759,0,7,primary amino compound metabolic process,BP,
17567,GO:1901162,1,0.936690553974071,0,2,primary amino compound biosynthetic process,BP,
17568,GO:1901163,1,0.799070030465109,0,8,regulation of trophoblast cell migration,BP,
17569,GO:1901164,1,0.936302137446853,0,3,negative regulation of trophoblast cell migration,BP,
17570,GO:1901165,1,0.853454514089574,0,5,positive regulation of trophoblast cell migration,BP,
17571,GO:1901166,1,0.893974106353757,0,3,neural crest cell migration involved in autonomic nervous system development,BP,
17575,GO:1901187,1,0.929727730202435,0,2,regulation of ephrin receptor signaling pathway,BP,
17576,GO:1901189,1,0.968966527976527,0,1,positive regulation of ephrin receptor signaling pathway,BP,
17577,GO:1901193,1,0.980484164003837,0,1,regulation of formation of translation preinitiation complex,BP,
17578,GO:1901194,1,0.980484164003837,0,1,negative regulation of formation of translation preinitiation complex,BP,
17580,GO:1901202,1,0.969014623935162,0,1,negative regulation of extracellular matrix assembly,BP,
17582,GO:1901207,1,0.961037941896967,0,1,regulation of heart looping,BP,
17583,GO:1901213,1,0.761803804323931,0,8,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
17590,GO:1901228,1,0.960321290422278,0,1,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
17591,GO:1901229,1,0.967334818525518,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17592,GO:1901231,1,0.967334818525518,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17593,GO:1901232,1,0.967334818525518,0,1,regulation of convergent extension involved in axis elongation,BP,
17594,GO:1901233,1,0.967334818525518,0,1,negative regulation of convergent extension involved in axis elongation,BP,
17595,GO:1901252,1,0.943543930492491,0,2,regulation of intracellular transport of viral material,BP,
17596,GO:1901253,1,0.982623158049942,0,1,negative regulation of intracellular transport of viral material,BP,
17597,GO:1901254,1,0.960231436145063,0,1,positive regulation of intracellular transport of viral material,BP,
17598,GO:1901255,1,0.936146703185949,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
17599,GO:1901256,1,0.901513360054308,0,3,regulation of macrophage colony-stimulating factor production,BP,
17600,GO:1901257,1,0.969238362043476,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
17601,GO:1901258,1,0.96655335371581,0,1,positive regulation of macrophage colony-stimulating factor production,BP,
17604,GO:1901269,1,0.972106481842648,0,2,lipooligosaccharide metabolic process,BP,
17605,GO:1901271,1,0.972106481842648,0,2,lipooligosaccharide biosynthetic process,BP,
17606,GO:1901291,1,0.972566243754367,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
17609,GO:1901295,1,0.943356348674288,0,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
17610,GO:1901296,1,0.973571680227903,0,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
17611,GO:1901297,1,0.968966527976527,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
17612,GO:1901298,1,0.746759444025824,0,9,regulation of hydrogen peroxide-mediated programmed cell death,BP,
17613,GO:1901299,1,0.850029668899463,0,5,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
17614,GO:1901300,1,0.8785565994107,0,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,
17617,GO:1901304,1,0.974565797611057,0,1,regulation of spermidine biosynthetic process,BP,
17618,GO:1901307,1,0.974565797611057,0,1,positive regulation of spermidine biosynthetic process,BP,
17619,GO:1901314,1,0.891797616883243,0,3,regulation of histone H2A K63-linked ubiquitination,BP,
17620,GO:1901315,1,0.891797616883243,0,3,negative regulation of histone H2A K63-linked ubiquitination,BP,
17621,GO:1901317,1,0.919070595871021,0,3,regulation of flagellated sperm motility,BP,
17622,GO:1901318,1,0.965469978279355,0,1,negative regulation of flagellated sperm motility,BP,
17623,GO:1901321,1,0.973571680227903,0,1,positive regulation of heart induction,BP,
17624,GO:1901328,1,0.973516526534991,0,1,response to cytochalasin B,BP,
17626,GO:1901331,1,0.964046331367156,0,1,positive regulation of odontoblast differentiation,BP,
17627,GO:1901337,1,0.966883544077274,0,1,thioester transport,BP,
17629,GO:1901339,1,0.791776339752626,0,6,regulation of store-operated calcium channel activity,BP,
17630,GO:1901340,1,0.960677891947852,0,1,negative regulation of store-operated calcium channel activity,BP,
17631,GO:1901341,1,0.854914724140468,0,4,positive regulation of store-operated calcium channel activity,BP,
17634,GO:1901344,1,0.978756790445095,0,1,response to leptomycin B,BP,
17635,GO:1901350,1,0.95950763690405,0,1,cell-cell signaling involved in cell-cell junction organization,BP,
17636,GO:1901355,1,0.931211466737418,0,2,response to rapamycin,BP,
17641,GO:1901373,1,0.977320014662109,0,1,lipid hydroperoxide transport,BP,
17642,GO:1901374,1,0.966967419757367,0,1,acetate ester transport,BP,
17647,GO:1901381,1,0.672492741620275,0,11,positive regulation of potassium ion transmembrane transport,BP,
17648,GO:1901382,1,0.92811099099357,0,2,regulation of chorionic trophoblast cell proliferation,BP,
17651,GO:1901387,1,0.887612491914678,0,3,positive regulation of voltage-gated calcium channel activity,BP,
17652,GO:1901388,1,0.967644020655307,0,1,regulation of transforming growth factor beta activation,BP,
17653,GO:1901389,1,0.967644020655307,0,1,negative regulation of transforming growth factor beta activation,BP,
17656,GO:1901419,1,0.960262723320359,0,1,regulation of response to alcohol,BP,
17657,GO:1901421,1,0.960262723320359,0,1,positive regulation of response to alcohol,BP,
17658,GO:1901474,1,0.846615264070568,0,5,azole transmembrane transporter activity,MF,
17659,GO:1901475,1,0.897086260392901,0,3,pyruvate transmembrane transport,BP,
17661,GO:1901491,1,0.923801925905908,0,2,negative regulation of lymphangiogenesis,BP,
17663,GO:1901503,1,0.849911174943155,0,5,ether biosynthetic process,BP,
17665,GO:1901509,1,0.925243858577414,0,2,regulation of endothelial tube morphogenesis,BP,
17667,GO:1901523,1,0.965469978279355,0,1,icosanoid catabolic process,BP,
17668,GO:1901524,1,0.605010196956487,0,14,regulation of mitophagy,BP,
17669,GO:1901525,1,0.797743443815368,0,6,negative regulation of mitophagy,BP,
17670,GO:1901526,1,0.758521384607587,0,8,positive regulation of mitophagy,BP,
17671,GO:1901529,1,0.927479950207911,0,2,positive regulation of anion channel activity,BP,
17674,GO:1901534,1,0.925277870624726,0,2,positive regulation of hematopoietic progenitor cell differentiation,BP,
17675,GO:1901535,1,0.822220105529001,0,5,regulation of DNA demethylation,BP,
17676,GO:1901536,1,0.930793315686866,0,2,negative regulation of DNA demethylation,BP,
17677,GO:1901537,1,0.883373875125411,0,3,positive regulation of DNA demethylation,BP,
17678,GO:1901538,1,0.806578632461426,0,6,changes to DNA methylation involved in embryo development,BP,
17681,GO:1901551,1,0.960532422886729,0,1,negative regulation of endothelial cell development,BP,
17682,GO:1901552,1,0.924675825717689,0,2,positive regulation of endothelial cell development,BP,
17683,GO:1901555,1,0.95950763690405,0,1,response to paclitaxel,BP,
17684,GO:1901558,1,0.973075088847771,0,1,response to metformin,BP,
17685,GO:1901561,1,0.96164526067203,0,1,response to benomyl,BP,
17686,GO:1901563,1,0.829654715653776,0,5,response to camptothecin,BP,
17690,GO:1901567,1,0.545959697943587,0,21,fatty acid derivative binding,MF,
17697,GO:1901580,1,0.95950763690405,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17698,GO:1901581,1,0.95950763690405,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17699,GO:1901582,1,0.95950763690405,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17700,GO:1901585,1,0.965870939685897,0,1,regulation of acid-sensing ion channel activity,BP,
17701,GO:1901594,1,0.960663077912503,0,1,response to capsazepine,BP,
17705,GO:1901611,1,0.755870874262603,0,9,phosphatidylglycerol binding,MF,
17706,GO:1901612,1,0.829838261160161,0,6,cardiolipin binding,MF,
17710,GO:1901618,1,0.5906881472995,0,15,organic hydroxy compound transmembrane transporter activity,MF,
17711,GO:1901620,1,0.775844359084571,0,7,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
17712,GO:1901621,1,0.828006581540518,0,5,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
17713,GO:1901622,1,0.967388112053837,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
17715,GO:1901626,1,0.849985684049016,0,5,regulation of postsynaptic membrane organization,BP,
17716,GO:1901628,1,0.910459039949218,0,3,positive regulation of postsynaptic membrane organization,BP,
17717,GO:1901629,1,0.940238864720346,0,2,regulation of presynaptic membrane organization,BP,
17718,GO:1901630,1,0.979920153523586,0,1,negative regulation of presynaptic membrane organization,BP,
17719,GO:1901631,1,0.95950763690405,0,1,positive regulation of presynaptic membrane organization,BP,
17720,GO:1901639,1,0.95950763690405,0,1,XDP catabolic process,BP,
17721,GO:1901640,1,0.95950763690405,0,1,XTP binding,MF,
17722,GO:1901641,1,0.95950763690405,0,1,ITP binding,MF,
17728,GO:1901656,1,0.927096920690024,0,2,glycoside transport,BP,
17732,GO:1901660,1,0.801325797949656,0,6,calcium ion export,BP,
17733,GO:1901661,1,0.53054364816691,0,23,quinone metabolic process,BP,
17734,GO:1901662,1,0.945294416329213,0,2,quinone catabolic process,BP,
17735,GO:1901663,1,0.682992512164167,0,14,quinone biosynthetic process,BP,
17736,GO:1901664,1,0.910964480619281,0,3,regulation of NAD+ ADP-ribosyltransferase activity,BP,
17737,GO:1901666,1,0.910964480619281,0,3,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
17740,GO:1901673,1,0.522085502657112,0,19,regulation of mitotic spindle assembly,BP,
17742,GO:1901675,1,0.95950763690405,0,1,negative regulation of histone H3-K27 acetylation,BP,
17744,GO:1901678,1,0.734580388828342,0,9,iron coordination entity transport,BP,
17745,GO:1901679,1,0.772160392539505,0,8,nucleotide transmembrane transport,BP,
17746,GO:1901680,1,0.95950763690405,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
17748,GO:1901682,1,0.508527051012445,0,19,sulfur compound transmembrane transporter activity,MF,
17749,GO:1901685,1,0.71550114797923,0,16,glutathione derivative metabolic process,BP,
17750,GO:1901687,1,0.71550114797923,0,16,glutathione derivative biosynthetic process,BP,
17755,GO:1901702,1,0.972980546782408,0,1,salt transmembrane transporter activity,MF,
17756,GO:1901707,1,0.978756790445095,0,1,leptomycin B binding,MF,
17757,GO:1901722,1,0.69174838115957,0,11,regulation of cell proliferation involved in kidney development,BP,
17758,GO:1901723,1,0.841586709267627,0,5,negative regulation of cell proliferation involved in kidney development,BP,
17759,GO:1901724,1,0.822027540129998,0,6,positive regulation of cell proliferation involved in kidney development,BP,
17760,GO:1901725,1,0.762765571358893,0,7,regulation of histone deacetylase activity,BP,
17761,GO:1901726,1,0.95950763690405,0,1,negative regulation of histone deacetylase activity,BP,
17762,GO:1901727,1,0.827547721339623,0,5,positive regulation of histone deacetylase activity,BP,
17763,GO:1901731,1,0.933127109765006,0,2,positive regulation of platelet aggregation,BP,
17765,GO:1901740,1,0.972167757271443,0,1,negative regulation of myoblast fusion,BP,
17767,GO:1901748,1,0.906363414185936,0,3,leukotriene D4 metabolic process,BP,
17768,GO:1901750,1,0.906363414185936,0,3,leukotriene D4 biosynthetic process,BP,
17769,GO:1901751,1,0.968911200939047,0,1,leukotriene A4 metabolic process,BP,
17771,GO:1901797,1,0.45852720296724,0,25,negative regulation of signal transduction by p53 class mediator,BP,
17775,GO:1901804,1,0.968633645563109,0,1,beta-glucoside metabolic process,BP,
17776,GO:1901805,1,0.968633645563109,0,1,beta-glucoside catabolic process,BP,
17779,GO:1901836,1,0.691433961494884,0,11,regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17780,GO:1901837,1,0.943635053075077,0,2,negative regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17781,GO:1901838,1,0.73276796609216,0,9,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17784,GO:1901843,1,0.923427680921753,0,2,positive regulation of high voltage-gated calcium channel activity,BP,
17785,GO:1901844,1,0.789250501525949,0,7,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
17786,GO:1901856,1,0.934458891479134,0,2,negative regulation of cellular respiration,BP,
17787,GO:1901857,1,0.880544771450736,0,5,positive regulation of cellular respiration,BP,
17788,GO:1901858,1,0.874287953312367,0,4,regulation of mitochondrial DNA metabolic process,BP,
17789,GO:1901859,1,0.89320056271277,0,3,negative regulation of mitochondrial DNA metabolic process,BP,
17790,GO:1901860,1,0.97883204070005,0,1,positive regulation of mitochondrial DNA metabolic process,BP,
17794,GO:1901873,1,0.926372432346771,0,2,regulation of post-translational protein modification,BP,
17795,GO:1901874,1,0.926372432346771,0,2,negative regulation of post-translational protein modification,BP,
17798,GO:1901881,1,0.74534331917388,0,9,positive regulation of protein depolymerization,BP,
17802,GO:1901894,1,0.90579070809902,0,3,regulation of calcium-transporting ATPase activity,BP,
17803,GO:1901895,1,0.95950763690405,0,1,negative regulation of calcium-transporting ATPase activity,BP,
17804,GO:1901896,1,0.94402182758763,0,2,positive regulation of calcium-transporting ATPase activity,BP,
17805,GO:1901897,1,0.886537810198543,0,3,regulation of relaxation of cardiac muscle,BP,
17806,GO:1901898,1,0.95950763690405,0,1,negative regulation of relaxation of cardiac muscle,BP,
17807,GO:1901906,1,0.883830410916759,0,4,diadenosine pentaphosphate metabolic process,BP,
17808,GO:1901907,1,0.883830410916759,0,4,diadenosine pentaphosphate catabolic process,BP,
17809,GO:1901908,1,0.883830410916759,0,4,diadenosine hexaphosphate metabolic process,BP,
17810,GO:1901909,1,0.883830410916759,0,4,diadenosine hexaphosphate catabolic process,BP,
17811,GO:1901910,1,0.883830410916759,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
17812,GO:1901911,1,0.883830410916759,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
17813,GO:1901917,1,0.966323575434221,0,1,regulation of exoribonuclease activity,BP,
17814,GO:1901919,1,0.966323575434221,0,1,positive regulation of exoribonuclease activity,BP,
17815,GO:1901950,1,0.965469978279355,0,1,dense core granule transport,BP,
17816,GO:1901962,1,0.969958160463322,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
17817,GO:1901963,1,0.937589246880011,0,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
17818,GO:1901964,1,0.973756390557974,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
17819,GO:1901970,1,0.768223269934675,0,8,positive regulation of mitotic sister chromatid separation,BP,
17823,GO:1901979,1,0.927658118459251,0,2,regulation of inward rectifier potassium channel activity,BP,
17824,GO:1901980,1,0.95950763690405,0,1,positive regulation of inward rectifier potassium channel activity,BP,
17831,GO:1901989,1,0.112038953677664,0,66,positive regulation of cell cycle phase transition,BP,
17834,GO:1901992,1,0.161248412993836,0,55,positive regulation of mitotic cell cycle phase transition,BP,
17838,GO:1902001,1,0.571970333359332,0,15,fatty acid transmembrane transport,BP,
17841,GO:1902010,1,0.962607920802641,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
17843,GO:1902018,1,0.731030903363132,0,9,negative regulation of cilium assembly,BP,
17844,GO:1902019,1,0.842906792883965,0,5,regulation of cilium-dependent cell motility,BP,
17847,GO:1902031,1,0.845694621797326,0,5,regulation of NADP metabolic process,BP,
17848,GO:1902033,1,0.839600231421164,0,5,regulation of hematopoietic stem cell proliferation,BP,
17849,GO:1902035,1,0.86864172416033,0,4,positive regulation of hematopoietic stem cell proliferation,BP,
17852,GO:1902038,1,0.962791257391415,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
17856,GO:1902044,1,0.930180224578416,0,2,regulation of Fas signaling pathway,BP,
17857,GO:1902045,1,0.96898501039023,0,1,negative regulation of Fas signaling pathway,BP,
17860,GO:1902071,1,0.97994215909975,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
17861,GO:1902073,1,0.97994215909975,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
17865,GO:1902093,1,0.951945326462926,0,2,positive regulation of flagellated sperm motility,BP,
17866,GO:1902098,1,0.959821324189641,0,1,calcitriol binding,MF,
17869,GO:1902101,1,0.768223269934675,0,8,positive regulation of metaphase/anaphase transition of cell cycle,BP,
17870,GO:1902102,1,0.964709451383227,0,1,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
17871,GO:1902103,1,0.964709451383227,0,1,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
17876,GO:1902109,1,0.928038103514747,0,3,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
17879,GO:1902116,1,0.360383346614547,0,30,negative regulation of organelle assembly,BP,
17881,GO:1902121,1,0.959821324189641,0,1,lithocholic acid binding,MF,
17882,GO:1902145,1,0.965469978279355,0,1,regulation of response to cell cycle checkpoint signaling,BP,
17883,GO:1902151,1,0.965469978279355,0,1,regulation of response to DNA integrity checkpoint signaling,BP,
17884,GO:1902153,1,0.965469978279355,0,1,regulation of response to DNA damage checkpoint signaling,BP,
17885,GO:1902162,1,0.95635510306793,0,2,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
17886,GO:1902164,1,0.95635510306793,0,2,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
17887,GO:1902165,1,0.669574214070775,0,15,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
17888,GO:1902166,1,0.703052003973741,0,13,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
17889,GO:1902167,1,0.98683836431878,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
17890,GO:1902170,1,0.658080947241272,0,12,cellular response to reactive nitrogen species,BP,
17892,GO:1902173,1,0.963949242916925,0,1,negative regulation of keratinocyte apoptotic process,BP,
17893,GO:1902174,1,0.941421826155029,0,2,positive regulation of keratinocyte apoptotic process,BP,
17896,GO:1902177,1,0.860736046478898,0,5,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
17897,GO:1902178,1,0.960353387691979,0,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,
17900,GO:1902188,1,0.606407127310437,0,15,positive regulation of viral release from host cell,BP,
17902,GO:1902205,1,0.974499003905572,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
17903,GO:1902206,1,0.974499003905572,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
17904,GO:1902211,1,0.965469978279355,0,1,regulation of prolactin signaling pathway,BP,
17905,GO:1902213,1,0.965469978279355,0,1,positive regulation of prolactin signaling pathway,BP,
17906,GO:1902214,1,0.935036710497924,0,2,regulation of interleukin-4-mediated signaling pathway,BP,
17907,GO:1902215,1,0.974499003905572,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
17908,GO:1902216,1,0.95950763690405,0,1,positive regulation of interleukin-4-mediated signaling pathway,BP,
17911,GO:1902220,1,0.980846631241159,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
17912,GO:1902221,1,0.914856427280232,0,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
17913,GO:1902222,1,0.914856427280232,0,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
17915,GO:1902226,1,0.943755046115674,0,2,regulation of macrophage colony-stimulating factor signaling pathway,BP,
17916,GO:1902227,1,0.974499003905572,0,1,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
17917,GO:1902228,1,0.968453561303749,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
17919,GO:1902230,1,0.469277467243459,0,26,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
17921,GO:1902232,1,0.941989002122484,0,2,regulation of positive thymic T cell selection,BP,
17922,GO:1902233,1,0.974499003905572,0,1,negative regulation of positive thymic T cell selection,BP,
17926,GO:1902238,1,0.960546099104204,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
17927,GO:1902239,1,0.960546099104204,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
17928,GO:1902253,1,0.520417656211696,0,23,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
17929,GO:1902254,1,0.57778190680766,0,18,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
17930,GO:1902255,1,0.954884313038026,0,3,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
17931,GO:1902256,1,0.923852082752787,0,2,regulation of apoptotic process involved in outflow tract morphogenesis,BP,
17932,GO:1902257,1,0.962791257391415,0,1,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
17933,GO:1902259,1,0.72404793193848,0,9,regulation of delayed rectifier potassium channel activity,BP,
17934,GO:1902260,1,0.90125247942345,0,3,negative regulation of delayed rectifier potassium channel activity,BP,
17935,GO:1902261,1,0.922119440906118,0,2,positive regulation of delayed rectifier potassium channel activity,BP,
17936,GO:1902262,1,0.881897677221545,0,4,apoptotic process involved in blood vessel morphogenesis,BP,
17937,GO:1902263,1,0.906177640191954,0,3,apoptotic process involved in embryonic digit morphogenesis,BP,
17939,GO:1902268,1,0.953377202828455,0,2,negative regulation of polyamine transmembrane transport,BP,
17941,GO:1902271,1,0.959821324189641,0,1,D3 vitamins binding,MF,
17943,GO:1902282,1,0.965458576153811,0,1,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
17944,GO:1902283,1,0.960923985816499,0,1,negative regulation of primary amine oxidase activity,BP,
17946,GO:1902285,1,0.616150107603747,0,12,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,
17947,GO:1902287,1,0.642170429278624,0,11,semaphorin-plexin signaling pathway involved in axon guidance,BP,
17948,GO:1902292,1,0.979909154225349,0,1,cell cycle DNA replication initiation,BP,
17949,GO:1902296,1,0.963441123227201,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
17950,GO:1902298,1,0.930585875788588,0,2,cell cycle DNA replication maintenance of fidelity,BP,
17951,GO:1902299,1,0.91631909499239,0,3,pre-replicative complex assembly involved in cell cycle DNA replication,BP,
17952,GO:1902302,1,0.921007749368966,0,2,regulation of potassium ion export,BP,
17953,GO:1902304,1,0.959764642647043,0,1,positive regulation of potassium ion export,BP,
17958,GO:1902309,1,0.933999865366756,0,2,negative regulation of peptidyl-serine dephosphorylation,BP,
17960,GO:1902311,1,0.973858548747843,0,1,regulation of copper ion transmembrane transport,BP,
17961,GO:1902315,1,0.979909154225349,0,1,nuclear cell cycle DNA replication initiation,BP,
17962,GO:1902319,1,0.963441123227201,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
17963,GO:1902336,1,0.931738706952722,0,2,positive regulation of retinal ganglion cell axon guidance,BP,
17965,GO:1902338,1,0.889348968561072,0,3,negative regulation of apoptotic process involved in morphogenesis,BP,
17967,GO:1902356,1,0.972783641722553,0,1,oxaloacetate(2-) transmembrane transport,BP,
17968,GO:1902358,1,0.80517314617927,0,6,sulfate transmembrane transport,BP,
17970,GO:1902362,1,0.966013873167482,0,1,melanocyte apoptotic process,BP,
17971,GO:1902363,1,0.95950763690405,0,1,regulation of protein localization to spindle pole body,BP,
17972,GO:1902365,1,0.95950763690405,0,1,positive regulation of protein localization to spindle pole body,BP,
17977,GO:1902378,1,0.968057406154827,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
17979,GO:1902380,1,0.968496599492446,0,1,positive regulation of endoribonuclease activity,BP,
17980,GO:1902387,1,0.965469978279355,0,1,ceramide 1-phosphate binding,MF,
17981,GO:1902388,1,0.965469978279355,0,1,ceramide 1-phosphate transporter activity,MF,
17982,GO:1902389,1,0.965469978279355,0,1,ceramide 1-phosphate transport,BP,
17983,GO:1902396,1,0.961214368402972,0,1,protein localization to bicellular tight junction,BP,
17987,GO:1902410,1,0.817681568266126,0,6,mitotic cytokinetic process,BP,
17988,GO:1902412,1,0.8868732185059,0,3,regulation of mitotic cytokinesis,BP,
17989,GO:1902414,1,0.737444449027092,0,8,protein localization to cell junction,BP,
17990,GO:1902415,1,0.751134064983928,0,9,regulation of mRNA binding,BP,
17991,GO:1902416,1,0.799058706099333,0,7,positive regulation of mRNA binding,BP,
17992,GO:1902423,1,0.931273256346493,0,2,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
17993,GO:1902425,1,0.931273256346493,0,2,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
17994,GO:1902426,1,0.966761912785496,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
17995,GO:1902430,1,0.730459361097261,0,9,negative regulation of amyloid-beta formation,BP,
17999,GO:1902455,1,0.858249706323285,0,4,negative regulation of stem cell population maintenance,BP,
18000,GO:1902459,1,0.818689894875506,0,5,positive regulation of stem cell population maintenance,BP,
18001,GO:1902460,1,0.95995683819502,0,1,regulation of mesenchymal stem cell proliferation,BP,
18002,GO:1902462,1,0.95995683819502,0,1,positive regulation of mesenchymal stem cell proliferation,BP,
18003,GO:1902463,1,0.953284808050061,0,2,protein localization to cell leading edge,BP,
18004,GO:1902464,1,0.960175857673052,0,1,regulation of histone H3-K27 trimethylation,BP,
18005,GO:1902466,1,0.960175857673052,0,1,positive regulation of histone H3-K27 trimethylation,BP,
18010,GO:1902480,1,0.968475066033654,0,1,protein localization to mitotic spindle,BP,
18011,GO:1902488,1,0.95950763690405,0,1,cholangiocyte apoptotic process,BP,
18012,GO:1902493,1,0.0518277772687426,0,88,acetyltransferase complex,CC,
18015,GO:1902498,1,0.889098997436195,0,3,regulation of protein autoubiquitination,BP,
18016,GO:1902499,1,0.965735644384804,0,1,positive regulation of protein autoubiquitination,BP,
18017,GO:1902504,1,0.964952813586371,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
18018,GO:1902510,1,0.842318879792052,0,6,regulation of apoptotic DNA fragmentation,BP,
18019,GO:1902511,1,0.966540823598339,0,1,negative regulation of apoptotic DNA fragmentation,BP,
18020,GO:1902512,1,0.936282693140036,0,3,positive regulation of apoptotic DNA fragmentation,BP,
18021,GO:1902513,1,0.806214393131639,0,6,regulation of organelle transport along microtubule,BP,
18022,GO:1902514,1,0.770228382231995,0,7,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
18027,GO:1902528,1,0.95950763690405,0,1,regulation of protein linear polyubiquitination,BP,
18028,GO:1902530,1,0.95950763690405,0,1,positive regulation of protein linear polyubiquitination,BP,
18033,GO:1902546,1,0.983759698430541,0,1,positive regulation of DNA N-glycosylase activity,BP,
18034,GO:1902547,1,0.725747246187133,0,9,regulation of cellular response to vascular endothelial growth factor stimulus,BP,
18035,GO:1902548,1,0.868529987139732,0,4,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,
18038,GO:1902559,1,0.943558879104268,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
18039,GO:1902560,1,0.972855058342775,0,1,GMP reductase complex,CC,
18040,GO:1902562,1,0.25664473714446,0,41,H4 histone acetyltransferase complex,CC,
18041,GO:1902563,1,0.848724803165524,0,4,regulation of neutrophil activation,BP,
18042,GO:1902564,1,0.920684983329116,0,2,negative regulation of neutrophil activation,BP,
18043,GO:1902565,1,0.960654669220098,0,1,positive regulation of neutrophil activation,BP,
18044,GO:1902566,1,0.943951503751533,0,2,regulation of eosinophil activation,BP,
18045,GO:1902568,1,0.943951503751533,0,2,positive regulation of eosinophil activation,BP,
18046,GO:1902570,1,0.766302966089269,0,9,protein localization to nucleolus,BP,
18047,GO:1902571,1,0.921016736880201,0,3,regulation of serine-type peptidase activity,BP,
18048,GO:1902572,1,0.921016736880201,0,3,negative regulation of serine-type peptidase activity,BP,
18049,GO:1902576,1,0.872618920408973,0,4,negative regulation of nuclear cell cycle DNA replication,BP,
18054,GO:1902595,1,0.944848962680221,0,2,regulation of DNA replication origin binding,BP,
18056,GO:1902603,1,0.909501768089233,0,3,carnitine transmembrane transport,BP,
18057,GO:1902605,1,0.966366718178733,0,1,heterotrimeric G-protein complex assembly,BP,
18058,GO:1902606,1,0.984487367317405,0,1,regulation of large conductance calcium-activated potassium channel activity,BP,
18059,GO:1902608,1,0.984487367317405,0,1,positive regulation of large conductance calcium-activated potassium channel activity,BP,
18060,GO:1902612,1,0.966335886285566,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
18061,GO:1902613,1,0.966335886285566,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
18062,GO:1902616,1,0.972953601805667,0,1,acyl carnitine transmembrane transport,BP,
18063,GO:1902617,1,0.87020832215853,0,4,response to fluoride,BP,
18064,GO:1902618,1,0.95950763690405,0,1,cellular response to fluoride,BP,
18066,GO:1902623,1,0.959640944479446,0,1,negative regulation of neutrophil migration,BP,
18068,GO:1902626,1,0.945842362069662,0,3,assembly of large subunit precursor of preribosome,BP,
18069,GO:1902629,1,0.97789516824257,0,1,regulation of mRNA stability involved in cellular response to UV,BP,
18070,GO:1902630,1,0.95950763690405,0,1,regulation of membrane hyperpolarization,BP,
18071,GO:1902631,1,0.95950763690405,0,1,negative regulation of membrane hyperpolarization,BP,
18072,GO:1902636,1,0.950061400513727,0,2,kinociliary basal body,CC,
18075,GO:1902656,1,0.799190775932971,0,6,calcium ion import into cytosol,BP,
18076,GO:1902659,1,0.915646622128234,0,3,regulation of glucose mediated signaling pathway,BP,
18077,GO:1902661,1,0.915646622128234,0,3,positive regulation of glucose mediated signaling pathway,BP,
18080,GO:1902669,1,0.767324259388549,0,7,positive regulation of axon guidance,BP,
18083,GO:1902683,1,0.931181780240784,0,2,regulation of receptor localization to synapse,BP,
18084,GO:1902685,1,0.960396893249008,0,1,positive regulation of receptor localization to synapse,BP,
18086,GO:1902688,1,0.965469978279355,0,1,regulation of NAD metabolic process,BP,
18087,GO:1902689,1,0.965469978279355,0,1,negative regulation of NAD metabolic process,BP,
18089,GO:1902710,1,0.964080596108445,0,1,GABA receptor complex,CC,
18090,GO:1902711,1,0.964080596108445,0,1,GABA-A receptor complex,CC,
18093,GO:1902715,1,0.920779173310875,0,2,positive regulation of interferon-gamma secretion,BP,
18094,GO:1902722,1,0.913711199680447,0,3,positive regulation of prolactin secretion,BP,
18095,GO:1902723,1,0.963276668035714,0,1,negative regulation of skeletal muscle satellite cell proliferation,BP,
18096,GO:1902724,1,0.920813584741226,0,2,positive regulation of skeletal muscle satellite cell proliferation,BP,
18097,GO:1902725,1,0.95950763690405,0,1,negative regulation of satellite cell differentiation,BP,
18098,GO:1902728,1,0.920813584741226,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
18099,GO:1902730,1,0.893365013816634,0,3,positive regulation of proteoglycan biosynthetic process,BP,
18100,GO:1902731,1,0.920653765736325,0,2,negative regulation of chondrocyte proliferation,BP,
18101,GO:1902732,1,0.975135035644344,0,1,positive regulation of chondrocyte proliferation,BP,
18102,GO:1902737,1,0.960231436145063,0,1,dendritic filopodium,CC,
18107,GO:1902744,1,0.853026841148258,0,4,negative regulation of lamellipodium organization,BP,
18109,GO:1902746,1,0.96858302072469,0,1,regulation of lens fiber cell differentiation,BP,
18111,GO:1902750,1,0.0584293876854901,0,97,negative regulation of cell cycle G2/M phase transition,BP,
18112,GO:1902751,1,0.458899914318532,0,23,positive regulation of cell cycle G2/M phase transition,BP,
18113,GO:1902766,1,0.95141856063583,0,2,skeletal muscle satellite cell migration,BP,
18115,GO:1902769,1,0.95950763690405,0,1,regulation of choline O-acetyltransferase activity,BP,
18116,GO:1902771,1,0.95950763690405,0,1,positive regulation of choline O-acetyltransferase activity,BP,
18117,GO:1902773,1,0.964672571476155,0,1,GTPase activator complex,CC,
18118,GO:1902774,1,0.819166915072522,0,6,late endosome to lysosome transport,BP,
18119,GO:1902775,1,0.891701201680528,0,3,mitochondrial large ribosomal subunit assembly,BP,
18121,GO:1902804,1,0.901736582193139,0,3,negative regulation of synaptic vesicle transport,BP,
18122,GO:1902805,1,0.921119663776234,0,2,positive regulation of synaptic vesicle transport,BP,
18125,GO:1902808,1,0.367645667457213,0,30,positive regulation of cell cycle G1/S phase transition,BP,
18126,GO:1902809,1,0.904795595848983,0,3,regulation of skeletal muscle fiber differentiation,BP,
18127,GO:1902811,1,0.937105475830558,0,2,positive regulation of skeletal muscle fiber differentiation,BP,
18128,GO:1902816,1,0.863488029615135,0,4,regulation of protein localization to microtubule,BP,
18129,GO:1902817,1,0.863488029615135,0,4,negative regulation of protein localization to microtubule,BP,
18130,GO:1902822,1,0.9191653430315,0,3,regulation of late endosome to lysosome transport,BP,
18131,GO:1902823,1,0.963423148949515,0,1,negative regulation of late endosome to lysosome transport,BP,
18132,GO:1902824,1,0.954066168438324,0,2,positive regulation of late endosome to lysosome transport,BP,
18133,GO:1902838,1,0.959571905640215,0,1,regulation of nuclear migration along microtubule,BP,
18134,GO:1902846,1,0.95950763690405,0,1,positive regulation of mitotic spindle elongation,BP,
18135,GO:1902847,1,0.965741492599732,0,1,regulation of neuronal signal transduction,BP,
18137,GO:1902855,1,0.699569548620119,0,10,regulation of non-motile cilium assembly,BP,
18138,GO:1902856,1,0.923141787027681,0,2,negative regulation of non-motile cilium assembly,BP,
18139,GO:1902857,1,0.782974176871326,0,7,positive regulation of non-motile cilium assembly,BP,
18140,GO:1902858,1,0.970665994401374,0,1,propionyl-CoA metabolic process,BP,
18141,GO:1902860,1,0.970665994401374,0,1,propionyl-CoA biosynthetic process,BP,
18149,GO:1902889,1,0.95950763690405,0,1,protein localization to spindle microtubule,BP,
18150,GO:1902890,1,0.984487367317405,0,1,regulation of root hair elongation,BP,
18151,GO:1902891,1,0.984487367317405,0,1,negative regulation of root hair elongation,BP,
18155,GO:1902896,1,0.927271875705302,0,2,terminal web assembly,BP,
18156,GO:1902897,1,0.93359447902783,0,2,regulation of postsynaptic density protein 95 clustering,BP,
18157,GO:1902902,1,0.717110200458664,0,11,negative regulation of autophagosome assembly,BP,
18161,GO:1902908,1,0.960375828840977,0,1,regulation of melanosome transport,BP,
18162,GO:1902910,1,0.960375828840977,0,1,positive regulation of melanosome transport,BP,
18164,GO:1902912,1,0.965469978279355,0,1,pyruvate kinase complex,CC,
18165,GO:1902913,1,0.964046331367156,0,1,positive regulation of neuroepithelial cell differentiation,BP,
18167,GO:1902915,1,0.790956681015814,0,6,negative regulation of protein polyubiquitination,BP,
18173,GO:1902937,1,0.970504692431207,0,1,inward rectifier potassium channel complex,CC,
18174,GO:1902938,1,0.933060984315559,0,2,regulation of intracellular calcium activated chloride channel activity,BP,
18175,GO:1902939,1,0.965469978279355,0,1,negative regulation of intracellular calcium activated chloride channel activity,BP,
18176,GO:1902941,1,0.960654669220098,0,1,regulation of voltage-gated chloride channel activity,BP,
18177,GO:1902943,1,0.960654669220098,0,1,positive regulation of voltage-gated chloride channel activity,BP,
18178,GO:1902946,1,0.729885195560468,0,8,protein localization to early endosome,BP,
18179,GO:1902947,1,0.840721674682721,0,5,regulation of tau-protein kinase activity,BP,
18180,GO:1902948,1,0.95950763690405,0,1,negative regulation of tau-protein kinase activity,BP,
18181,GO:1902949,1,0.876213182645357,0,4,positive regulation of tau-protein kinase activity,BP,
18182,GO:1902950,1,0.821199881211089,0,6,regulation of dendritic spine maintenance,BP,
18183,GO:1902951,1,0.938574294490004,0,2,negative regulation of dendritic spine maintenance,BP,
18184,GO:1902952,1,0.940675777395904,0,2,positive regulation of dendritic spine maintenance,BP,
18185,GO:1902953,1,0.869009410619433,0,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,
18186,GO:1902954,1,0.920650957478618,0,2,regulation of early endosome to recycling endosome transport,BP,
18187,GO:1902955,1,0.95950763690405,0,1,positive regulation of early endosome to recycling endosome transport,BP,
18188,GO:1902956,1,0.915928854968554,0,3,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18189,GO:1902957,1,0.964014645926423,0,1,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18190,GO:1902958,1,0.950123747958847,0,2,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18192,GO:1902960,1,0.929995787326588,0,2,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18194,GO:1902962,1,0.922589768562676,0,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18195,GO:1902963,1,0.922589768562676,0,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18196,GO:1902965,1,0.785785531226088,0,6,regulation of protein localization to early endosome,BP,
18197,GO:1902966,1,0.785785531226088,0,6,positive regulation of protein localization to early endosome,BP,
18198,GO:1902969,1,0.740215242443181,0,9,mitotic DNA replication,BP,
18199,GO:1902975,1,0.979909154225349,0,1,mitotic DNA replication initiation,BP,
18200,GO:1902977,1,0.972491282941673,0,1,mitotic DNA replication preinitiation complex assembly,BP,
18201,GO:1902983,1,0.963441123227201,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
18202,GO:1902988,1,0.889104383628805,0,3,neurofibrillary tangle assembly,BP,
18203,GO:1902990,1,0.901600487121223,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
18205,GO:1902992,1,0.679160693437091,0,11,negative regulation of amyloid precursor protein catabolic process,BP,
18207,GO:1902994,1,0.940238864720346,0,2,regulation of phospholipid efflux,BP,
18208,GO:1902995,1,0.940238864720346,0,2,positive regulation of phospholipid efflux,BP,
18209,GO:1902996,1,0.926632978124953,0,2,regulation of neurofibrillary tangle assembly,BP,
18210,GO:1902997,1,0.95950763690405,0,1,negative regulation of neurofibrillary tangle assembly,BP,
18211,GO:1902998,1,0.965741492599732,0,1,positive regulation of neurofibrillary tangle assembly,BP,
18212,GO:1903000,1,0.979920153523586,0,1,regulation of lipid transport across blood brain barrier,BP,
18213,GO:1903002,1,0.979920153523586,0,1,positive regulation of lipid transport across blood brain barrier,BP,
18215,GO:1903004,1,0.961319966218223,0,1,regulation of protein K63-linked deubiquitination,BP,
18216,GO:1903006,1,0.961319966218223,0,1,positive regulation of protein K63-linked deubiquitination,BP,
18217,GO:1903007,1,0.961319966218223,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
18221,GO:1903012,1,0.869218402532446,0,4,positive regulation of bone development,BP,
18224,GO:1903020,1,0.57123743035778,0,16,positive regulation of glycoprotein metabolic process,BP,
18226,GO:1903026,1,0.899657307824443,0,5,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
18227,GO:1903027,1,0.95950763690405,0,1,regulation of opsonization,BP,
18228,GO:1903028,1,0.95950763690405,0,1,positive regulation of opsonization,BP,
18229,GO:1903031,1,0.940957897575719,0,2,regulation of microtubule plus-end binding,BP,
18230,GO:1903033,1,0.940957897575719,0,2,positive regulation of microtubule plus-end binding,BP,
18237,GO:1903044,1,0.772133925499532,0,8,protein localization to membrane raft,BP,
18238,GO:1903045,1,0.959508066768857,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
18245,GO:1903054,1,0.865248734485451,0,5,negative regulation of extracellular matrix organization,BP,
18247,GO:1903059,1,0.872000847895623,0,4,regulation of protein lipidation,BP,
18248,GO:1903061,1,0.872000847895623,0,4,positive regulation of protein lipidation,BP,
18250,GO:1903070,1,0.910374823715754,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
18252,GO:1903072,1,0.98268071838369,0,1,regulation of death-inducing signaling complex assembly,BP,
18253,GO:1903073,1,0.98268071838369,0,1,negative regulation of death-inducing signaling complex assembly,BP,
18255,GO:1903077,1,0.54718780981229,0,17,negative regulation of protein localization to plasma membrane,BP,
18257,GO:1903093,1,0.922794238367825,0,3,regulation of protein K48-linked deubiquitination,BP,
18258,GO:1903094,1,0.96174120313415,0,2,negative regulation of protein K48-linked deubiquitination,BP,
18259,GO:1903095,1,0.926968128995111,0,2,ribonuclease III complex,CC,
18260,GO:1903096,1,0.964709451383227,0,1,protein localization to meiotic spindle midzone,BP,
18261,GO:1903108,1,0.959586373676917,0,1,regulation of mitochondrial transcription,BP,
18262,GO:1903109,1,0.959586373676917,0,1,positive regulation of mitochondrial transcription,BP,
18263,GO:1903115,1,0.457362224594368,0,21,regulation of actin filament-based movement,BP,
18264,GO:1903116,1,0.923365802058206,0,2,positive regulation of actin filament-based movement,BP,
18265,GO:1903119,1,0.893428307276567,0,3,protein localization to actin cytoskeleton,BP,
18266,GO:1903121,1,0.878868574665124,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,
18267,GO:1903122,1,0.98268071838369,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
18268,GO:1903126,1,0.970714638523018,0,1,negative regulation of centriole-centriole cohesion,BP,
18270,GO:1903135,1,0.912619707653581,0,3,cupric ion binding,MF,
18271,GO:1903136,1,0.868580595139267,0,5,cuprous ion binding,MF,
18273,GO:1903141,1,0.960532422886729,0,1,negative regulation of establishment of endothelial barrier,BP,
18274,GO:1903142,1,0.924675825717689,0,2,positive regulation of establishment of endothelial barrier,BP,
18275,GO:1903143,1,0.959630263764256,0,1,adrenomedullin receptor complex,CC,
18277,GO:1903147,1,0.75950932816262,0,8,negative regulation of autophagy of mitochondrion,BP,
18278,GO:1903165,1,0.966663527476837,0,1,response to polycyclic arene,BP,
18279,GO:1903167,1,0.98268071838369,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
18280,GO:1903168,1,0.98268071838369,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
18283,GO:1903173,1,0.935565192742095,0,2,fatty alcohol metabolic process,BP,
18284,GO:1903176,1,0.98268071838369,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
18285,GO:1903178,1,0.98268071838369,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
18286,GO:1903179,1,0.946735774568766,0,2,regulation of dopamine biosynthetic process,BP,
18287,GO:1903181,1,0.946735774568766,0,2,positive regulation of dopamine biosynthetic process,BP,
18288,GO:1903182,1,0.979667762049334,0,1,regulation of SUMO transferase activity,BP,
18289,GO:1903184,1,0.98268071838369,0,1,L-dopa metabolic process,BP,
18290,GO:1903185,1,0.98268071838369,0,1,L-dopa biosynthetic process,BP,
18291,GO:1903189,1,0.98268071838369,0,1,glyoxal metabolic process,BP,
18292,GO:1903195,1,0.98268071838369,0,1,regulation of L-dopa biosynthetic process,BP,
18293,GO:1903197,1,0.98268071838369,0,1,positive regulation of L-dopa biosynthetic process,BP,
18294,GO:1903198,1,0.98268071838369,0,1,regulation of L-dopa decarboxylase activity,BP,
18295,GO:1903200,1,0.98268071838369,0,1,positive regulation of L-dopa decarboxylase activity,BP,
18302,GO:1903207,1,0.926579343327073,0,3,regulation of hydrogen peroxide-induced neuron death,BP,
18303,GO:1903208,1,0.926579343327073,0,3,negative regulation of hydrogen peroxide-induced neuron death,BP,
18304,GO:1903209,1,0.697450507799562,0,11,positive regulation of oxidative stress-induced cell death,BP,
18306,GO:1903215,1,0.970320800778368,0,1,negative regulation of protein targeting to mitochondrion,BP,
18307,GO:1903223,1,0.887070617078756,0,3,positive regulation of oxidative stress-induced neuron death,BP,
18308,GO:1903224,1,0.866995704842406,0,4,regulation of endodermal cell differentiation,BP,
18309,GO:1903225,1,0.920650957478618,0,2,negative regulation of endodermal cell differentiation,BP,
18310,GO:1903231,1,0.965037162506956,0,1,mRNA binding involved in posttranscriptional gene silencing,MF,
18311,GO:1903232,1,0.875087164725606,0,5,melanosome assembly,BP,
18312,GO:1903233,1,0.920797429950406,0,2,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
18313,GO:1903236,1,0.907070452475235,0,3,regulation of leukocyte tethering or rolling,BP,
18314,GO:1903237,1,0.984075799763737,0,1,negative regulation of leukocyte tethering or rolling,BP,
18315,GO:1903238,1,0.921751651732656,0,2,positive regulation of leukocyte tethering or rolling,BP,
18318,GO:1903244,1,0.959880804825942,0,1,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
18319,GO:1903248,1,0.95950763690405,0,1,regulation of citrulline biosynthetic process,BP,
18320,GO:1903249,1,0.95950763690405,0,1,negative regulation of citrulline biosynthetic process,BP,
18321,GO:1903251,1,0.839968798121134,0,5,multi-ciliated epithelial cell differentiation,BP,
18322,GO:1903259,1,0.965469978279355,0,1,exon-exon junction complex disassembly,BP,
18323,GO:1903265,1,0.78395252755254,0,8,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,
18324,GO:1903276,1,0.94670292712429,0,2,regulation of sodium ion export across plasma membrane,BP,
18325,GO:1903278,1,0.94670292712429,0,2,positive regulation of sodium ion export across plasma membrane,BP,
18328,GO:1903282,1,0.964014645926423,0,1,regulation of glutathione peroxidase activity,BP,
18329,GO:1903284,1,0.964014645926423,0,1,positive regulation of glutathione peroxidase activity,BP,
18330,GO:1903285,1,0.964014645926423,0,1,positive regulation of hydrogen peroxide catabolic process,BP,
18331,GO:1903286,1,0.908472164829106,0,3,regulation of potassium ion import,BP,
18332,GO:1903288,1,0.94670292712429,0,2,positive regulation of potassium ion import,BP,
18333,GO:1903292,1,0.928883387161289,0,2,protein localization to Golgi membrane,BP,
18335,GO:1903294,1,0.922410737535279,0,2,regulation of glutamate secretion, neurotransmission,BP,
18336,GO:1903296,1,0.922410737535279,0,2,positive regulation of glutamate secretion, neurotransmission,BP,
18337,GO:1903297,1,0.852003251867657,0,5,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
18338,GO:1903298,1,0.852003251867657,0,5,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
18339,GO:1903299,1,0.804916170029195,0,7,regulation of hexokinase activity,BP,
18340,GO:1903300,1,0.942921212134301,0,2,negative regulation of hexokinase activity,BP,
18341,GO:1903301,1,0.85366107884711,0,5,positive regulation of hexokinase activity,BP,
18343,GO:1903306,1,0.64817075614239,0,12,negative regulation of regulated secretory pathway,BP,
18354,GO:1903332,1,0.797906988312736,0,7,regulation of protein folding,BP,
18355,GO:1903333,1,0.85808027840612,0,5,negative regulation of protein folding,BP,
18356,GO:1903335,1,0.889109905104031,0,4,regulation of vacuolar transport,BP,
18357,GO:1903336,1,0.963423148949515,0,1,negative regulation of vacuolar transport,BP,
18358,GO:1903337,1,0.954066168438324,0,2,positive regulation of vacuolar transport,BP,
18362,GO:1903350,1,0.684731427241695,0,11,response to dopamine,BP,
18363,GO:1903351,1,0.684731427241695,0,11,cellular response to dopamine,BP,
18365,GO:1903358,1,0.589075949678653,0,15,regulation of Golgi organization,BP,
18366,GO:1903361,1,0.849918300236692,0,5,protein localization to basolateral plasma membrane,BP,
18370,GO:1903365,1,0.906595851712999,0,3,regulation of fear response,BP,
18371,GO:1903367,1,0.96422412068149,0,1,positive regulation of fear response,BP,
18372,GO:1903371,1,0.856707733796446,0,4,regulation of endoplasmic reticulum tubular network organization,BP,
18373,GO:1903373,1,0.892872328557137,0,3,positive regulation of endoplasmic reticulum tubular network organization,BP,
18374,GO:1903375,1,0.928855750669955,0,2,facioacoustic ganglion development,BP,
18375,GO:1903376,1,0.782293016818279,0,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18376,GO:1903377,1,0.880572145550758,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18377,GO:1903378,1,0.92451358511999,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18378,GO:1903381,1,0.959980813817654,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18379,GO:1903382,1,0.959980813817654,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18380,GO:1903383,1,0.950123747958847,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
18381,GO:1903384,1,0.950123747958847,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
18382,GO:1903385,1,0.923717761865993,0,2,regulation of homophilic cell adhesion,BP,
18383,GO:1903387,1,0.959540088491817,0,1,positive regulation of homophilic cell adhesion,BP,
18387,GO:1903394,1,0.969014623935162,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
18390,GO:1903405,1,0.760046065243101,0,9,protein localization to nuclear body,BP,
18391,GO:1903406,1,0.962040415556717,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
18392,GO:1903408,1,0.962040415556717,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
18394,GO:1903416,1,0.907469731430626,0,3,response to glycoside,BP,
18395,GO:1903420,1,0.95950763690405,0,1,protein localization to endoplasmic reticulum tubular network,BP,
18396,GO:1903421,1,0.616760795356728,0,13,regulation of synaptic vesicle recycling,BP,
18397,GO:1903422,1,0.885447063928594,0,3,negative regulation of synaptic vesicle recycling,BP,
18398,GO:1903423,1,0.827025430698595,0,5,positive regulation of synaptic vesicle recycling,BP,
18402,GO:1903429,1,0.600398740388675,0,15,regulation of cell maturation,BP,
18403,GO:1903430,1,0.886864876883284,0,4,negative regulation of cell maturation,BP,
18404,GO:1903431,1,0.768577540961225,0,7,positive regulation of cell maturation,BP,
18405,GO:1903432,1,0.451047460392681,0,24,regulation of TORC1 signaling,BP,
18406,GO:1903433,1,0.928663862580698,0,2,regulation of constitutive secretory pathway,BP,
18407,GO:1903434,1,0.961354148661942,0,1,negative regulation of constitutive secretory pathway,BP,
18408,GO:1903435,1,0.965998900483596,0,1,positive regulation of constitutive secretory pathway,BP,
18409,GO:1903436,1,0.924307875469249,0,2,regulation of mitotic cytokinetic process,BP,
18410,GO:1903438,1,0.924307875469249,0,2,positive regulation of mitotic cytokinetic process,BP,
18411,GO:1903439,1,0.943318608476253,0,2,calcitonin family receptor complex,CC,
18412,GO:1903440,1,0.983003921684101,0,1,amylin receptor complex,CC,
18413,GO:1903441,1,0.77976041784089,0,7,protein localization to ciliary membrane,BP,
18414,GO:1903442,1,0.961447268770442,0,1,response to lipoic acid,BP,
18415,GO:1903444,1,0.964068341794451,0,1,negative regulation of brown fat cell differentiation,BP,
18416,GO:1903445,1,0.924065530460164,0,3,protein transport from ciliary membrane to plasma membrane,BP,
18417,GO:1903450,1,0.95950763690405,0,1,regulation of G1 to G0 transition,BP,
18418,GO:1903452,1,0.95950763690405,0,1,positive regulation of G1 to G0 transition,BP,
18419,GO:1903461,1,0.964324580401173,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
18420,GO:1903463,1,0.898503951506274,0,3,regulation of mitotic cell cycle DNA replication,BP,
18421,GO:1903464,1,0.93642757499553,0,2,negative regulation of mitotic cell cycle DNA replication,BP,
18422,GO:1903465,1,0.959508369096293,0,1,positive regulation of mitotic cell cycle DNA replication,BP,
18423,GO:1903487,1,0.936928830293119,0,2,regulation of lactation,BP,
18424,GO:1903489,1,0.973539492698059,0,1,positive regulation of lactation,BP,
18425,GO:1903490,1,0.924307875469249,0,2,positive regulation of mitotic cytokinesis,BP,
18432,GO:1903513,1,0.43448340799962,0,25,endoplasmic reticulum to cytosol transport,BP,
18433,GO:1903514,1,0.593829906282191,0,16,release of sequestered calcium ion into cytosol by endoplasmic reticulum,BP,
18434,GO:1903515,1,0.95950763690405,0,1,calcium ion transport from cytosol to endoplasmic reticulum,BP,
18435,GO:1903516,1,0.900723261406296,0,3,regulation of single strand break repair,BP,
18436,GO:1903517,1,0.965435808978647,0,1,negative regulation of single strand break repair,BP,
18437,GO:1903518,1,0.932976379132063,0,2,positive regulation of single strand break repair,BP,
18443,GO:1903525,1,0.816937363707485,0,5,regulation of membrane tubulation,BP,
18444,GO:1903526,1,0.923707595772587,0,2,negative regulation of membrane tubulation,BP,
18445,GO:1903527,1,0.884432873199525,0,3,positive regulation of membrane tubulation,BP,
18450,GO:1903537,1,0.935765214531154,0,2,meiotic cell cycle process involved in oocyte maturation,BP,
18451,GO:1903538,1,0.935765214531154,0,2,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
18452,GO:1903539,1,0.72760922121008,0,9,protein localization to postsynaptic membrane,BP,
18453,GO:1903540,1,0.72760922121008,0,9,establishment of protein localization to postsynaptic membrane,BP,
18455,GO:1903542,1,0.934072015817783,0,2,negative regulation of exosomal secretion,BP,
18459,GO:1903546,1,0.873688604033855,0,4,protein localization to photoreceptor outer segment,BP,
18467,GO:1903564,1,0.858949876061746,0,4,regulation of protein localization to cilium,BP,
18468,GO:1903565,1,0.96295569661504,0,1,negative regulation of protein localization to cilium,BP,
18469,GO:1903566,1,0.892002822554685,0,3,positive regulation of protein localization to cilium,BP,
18470,GO:1903567,1,0.932994489410587,0,2,regulation of protein localization to ciliary membrane,BP,
18471,GO:1903568,1,0.96295569661504,0,1,negative regulation of protein localization to ciliary membrane,BP,
18472,GO:1903569,1,0.968889120595638,0,1,positive regulation of protein localization to ciliary membrane,BP,
18473,GO:1903570,1,0.962485920222195,0,1,regulation of protein kinase D signaling,BP,
18474,GO:1903572,1,0.962485920222195,0,1,positive regulation of protein kinase D signaling,BP,
18476,GO:1903575,1,0.940707091752284,0,2,cornified envelope assembly,BP,
18477,GO:1903576,1,0.971240804302592,0,1,response to L-arginine,BP,
18480,GO:1903580,1,0.465837802728208,0,22,positive regulation of ATP metabolic process,BP,
18481,GO:1903584,1,0.960217643807024,0,1,regulation of histone deubiquitination,BP,
18482,GO:1903586,1,0.960217643807024,0,1,positive regulation of histone deubiquitination,BP,
18483,GO:1903587,1,0.849460506055119,0,5,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
18484,GO:1903588,1,0.904284345898833,0,3,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
18485,GO:1903589,1,0.939388172817883,0,2,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
18486,GO:1903593,1,0.922000978009599,0,3,regulation of histamine secretion by mast cell,BP,
18487,GO:1903595,1,0.922000978009599,0,3,positive regulation of histamine secretion by mast cell,BP,
18488,GO:1903596,1,0.966809789554633,0,1,regulation of gap junction assembly,BP,
18489,GO:1903598,1,0.966809789554633,0,1,positive regulation of gap junction assembly,BP,
18490,GO:1903599,1,0.563022638117371,0,17,positive regulation of autophagy of mitochondrion,BP,
18491,GO:1903608,1,0.780228463629845,0,7,protein localization to cytoplasmic stress granule,BP,
18492,GO:1903609,1,0.966809789554633,0,1,negative regulation of inward rectifier potassium channel activity,BP,
18493,GO:1903613,1,0.95952864778309,0,1,regulation of protein tyrosine phosphatase activity,BP,
18494,GO:1903615,1,0.95952864778309,0,1,positive regulation of protein tyrosine phosphatase activity,BP,
18495,GO:1903621,1,0.972294007081853,0,1,protein localization to photoreceptor connecting cilium,BP,
18496,GO:1903624,1,0.808196922008238,0,7,regulation of DNA catabolic process,BP,
18497,GO:1903625,1,0.966540823598339,0,1,negative regulation of DNA catabolic process,BP,
18498,GO:1903626,1,0.898364185264344,0,4,positive regulation of DNA catabolic process,BP,
18499,GO:1903630,1,0.979492922962405,0,1,regulation of aminoacyl-tRNA ligase activity,BP,
18500,GO:1903632,1,0.979492922962405,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
18501,GO:1903636,1,0.987104172534466,0,1,regulation of protein import into mitochondrial outer membrane,BP,
18502,GO:1903638,1,0.987104172534466,0,1,positive regulation of protein import into mitochondrial outer membrane,BP,
18503,GO:1903644,1,0.955104155291823,0,2,regulation of chaperone-mediated protein folding,BP,
18504,GO:1903645,1,0.987104172534466,0,1,negative regulation of chaperone-mediated protein folding,BP,
18505,GO:1903649,1,0.513435529353599,0,19,regulation of cytoplasmic transport,BP,
18506,GO:1903650,1,0.963827508637946,0,2,negative regulation of cytoplasmic transport,BP,
18507,GO:1903651,1,0.70319405753363,0,9,positive regulation of cytoplasmic transport,BP,
18508,GO:1903659,1,0.967644020655307,0,1,regulation of complement-dependent cytotoxicity,BP,
18509,GO:1903660,1,0.967644020655307,0,1,negative regulation of complement-dependent cytotoxicity,BP,
18513,GO:1903673,1,0.972526528927923,0,1,mitotic cleavage furrow formation,BP,
18514,GO:1903674,1,0.972588336419411,0,1,regulation of cap-dependent translational initiation,BP,
18515,GO:1903676,1,0.972588336419411,0,1,positive regulation of cap-dependent translational initiation,BP,
18516,GO:1903677,1,0.913231838822291,0,3,regulation of cap-independent translational initiation,BP,
18517,GO:1903679,1,0.913231838822291,0,3,positive regulation of cap-independent translational initiation,BP,
18520,GO:1903691,1,0.920650957478618,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
18521,GO:1903697,1,0.963167838751157,0,1,negative regulation of microvillus assembly,BP,
18522,GO:1903699,1,0.95950763690405,0,1,tarsal gland development,BP,
18523,GO:1903701,1,0.959559727457905,0,1,substantia propria of cornea development,BP,
18524,GO:1903704,1,0.990754098213451,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
18528,GO:1903709,1,0.95950763690405,0,1,uterine gland development,BP,
18529,GO:1903715,1,0.869349231883069,0,4,regulation of aerobic respiration,BP,
18530,GO:1903717,1,0.95950764348542,0,1,response to ammonia,BP,
18531,GO:1903718,1,0.95950764348542,0,1,cellular response to ammonia,BP,
18532,GO:1903719,1,0.9166580009213,0,3,regulation of I-kappaB phosphorylation,BP,
18533,GO:1903721,1,0.9166580009213,0,3,positive regulation of I-kappaB phosphorylation,BP,
18534,GO:1903722,1,0.946685511032962,0,2,regulation of centriole elongation,BP,
18535,GO:1903723,1,0.983015491524096,0,1,negative regulation of centriole elongation,BP,
18536,GO:1903724,1,0.963043902137286,0,1,positive regulation of centriole elongation,BP,
18538,GO:1903726,1,0.765433519970331,0,8,negative regulation of phospholipid metabolic process,BP,
18539,GO:1903727,1,0.412267686665254,0,25,positive regulation of phospholipid metabolic process,BP,
18540,GO:1903729,1,0.722237009687661,0,9,regulation of plasma membrane organization,BP,
18542,GO:1903748,1,0.874142531772255,0,4,negative regulation of establishment of protein localization to mitochondrion,BP,
18544,GO:1903750,1,0.885913120307855,0,4,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18545,GO:1903751,1,0.885913120307855,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18547,GO:1903755,1,0.979667762049334,0,1,positive regulation of SUMO transferase activity,BP,
18548,GO:1903756,1,0.929937843151137,0,2,regulation of transcription from RNA polymerase II promoter by histone modification,BP,
18549,GO:1903758,1,0.929937843151137,0,2,negative regulation of transcription from RNA polymerase II promoter by histone modification,BP,
18550,GO:1903759,1,0.964068341794451,0,1,signal transduction involved in regulation of aerobic respiration,BP,
18551,GO:1903760,1,0.922229755455551,0,2,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
18552,GO:1903762,1,0.961037941896967,0,1,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
18553,GO:1903763,1,0.865028763755339,0,4,gap junction channel activity involved in cell communication by electrical coupling,MF,
18554,GO:1903764,1,0.95962241295944,0,1,regulation of potassium ion export across plasma membrane,BP,
18555,GO:1903767,1,0.967549206826007,0,1,sweet taste receptor complex,CC,
18556,GO:1903768,1,0.967549206826007,0,1,taste receptor complex,CC,
18557,GO:1903770,1,0.965435808978647,0,1,negative regulation of beta-galactosidase activity,BP,
18558,GO:1903772,1,0.86558666150095,0,5,regulation of viral budding via host ESCRT complex,BP,
18559,GO:1903774,1,0.915297381353719,0,3,positive regulation of viral budding via host ESCRT complex,BP,
18560,GO:1903775,1,0.934871120969179,0,2,regulation of DNA double-strand break processing,BP,
18561,GO:1903778,1,0.928136440033263,0,2,protein localization to vacuolar membrane,BP,
18563,GO:1903781,1,0.923365802058206,0,2,positive regulation of cardiac conduction,BP,
18566,GO:1903789,1,0.837792733787952,0,5,regulation of amino acid transmembrane transport,BP,
18567,GO:1903792,1,0.608014297090131,0,13,negative regulation of anion transport,BP,
18569,GO:1903795,1,0.860038283144898,0,4,regulation of inorganic anion transmembrane transport,BP,
18570,GO:1903796,1,0.926372432346771,0,2,negative regulation of inorganic anion transmembrane transport,BP,
18571,GO:1903797,1,0.960654669220098,0,1,positive regulation of inorganic anion transmembrane transport,BP,
18574,GO:1903800,1,0.799712057730583,0,7,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,
18575,GO:1903801,1,0.969679127461953,0,1,L-leucine import across plasma membrane,BP,
18576,GO:1903803,1,0.972456089723406,0,1,L-glutamine import across plasma membrane,BP,
18577,GO:1903817,1,0.871332001999459,0,4,negative regulation of voltage-gated potassium channel activity,BP,
18578,GO:1903818,1,0.884773201317185,0,3,positive regulation of voltage-gated potassium channel activity,BP,
18579,GO:1903823,1,0.965435808978647,0,1,telomere single strand break repair,BP,
18580,GO:1903824,1,0.965435808978647,0,1,negative regulation of telomere single strand break repair,BP,
18586,GO:1903830,1,0.543376876320202,0,17,magnesium ion transmembrane transport,BP,
18587,GO:1903831,1,0.673806674916927,0,12,signal transduction involved in cellular response to ammonium ion,BP,
18588,GO:1903837,1,0.968134434123506,0,1,regulation of mRNA 3'-UTR binding,BP,
18589,GO:1903839,1,0.968134434123506,0,1,positive regulation of mRNA 3'-UTR binding,BP,
18595,GO:1903850,1,0.966870687325847,0,1,regulation of cristae formation,BP,
18596,GO:1903852,1,0.966870687325847,0,1,positive regulation of cristae formation,BP,
18598,GO:1903860,1,0.93066876927625,0,2,negative regulation of dendrite extension,BP,
18600,GO:1903862,1,0.863942715797188,0,5,positive regulation of oxidative phosphorylation,BP,
18601,GO:1903867,1,0.74055514014502,0,8,extraembryonic membrane development,BP,
18602,GO:1903874,1,0.922011205362417,0,2,ferrous iron transmembrane transport,BP,
18603,GO:1903881,1,0.96179747889877,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
18604,GO:1903883,1,0.96179747889877,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
18605,GO:1903884,1,0.96179747889877,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
18606,GO:1903886,1,0.96179747889877,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
18607,GO:1903888,1,0.984487367317405,0,1,regulation of plant epidermal cell differentiation,BP,
18608,GO:1903889,1,0.984487367317405,0,1,negative regulation of plant epidermal cell differentiation,BP,
18609,GO:1903891,1,0.865530631639921,0,4,regulation of ATF6-mediated unfolded protein response,BP,
18610,GO:1903892,1,0.930420585527942,0,2,negative regulation of ATF6-mediated unfolded protein response,BP,
18611,GO:1903893,1,0.967966869202294,0,1,positive regulation of ATF6-mediated unfolded protein response,BP,
18613,GO:1903895,1,0.866329951200915,0,4,negative regulation of IRE1-mediated unfolded protein response,BP,
18617,GO:1903899,1,0.904438819941053,0,3,positive regulation of PERK-mediated unfolded protein response,BP,
18620,GO:1903902,1,0.183290465031379,0,51,positive regulation of viral life cycle,BP,
18621,GO:1903903,1,0.896695790779957,0,3,regulation of establishment of T cell polarity,BP,
18622,GO:1903905,1,0.927871641529322,0,2,positive regulation of establishment of T cell polarity,BP,
18623,GO:1903906,1,0.966406916633823,0,1,regulation of plasma membrane raft polarization,BP,
18624,GO:1903909,1,0.87110999397877,0,4,regulation of receptor clustering,BP,
18625,GO:1903911,1,0.901398548296063,0,3,positive regulation of receptor clustering,BP,
18629,GO:1903918,1,0.95950763690405,0,1,regulation of actin filament severing,BP,
18630,GO:1903919,1,0.95950763690405,0,1,negative regulation of actin filament severing,BP,
18631,GO:1903921,1,0.927271520619255,0,2,regulation of protein processing in phagocytic vesicle,BP,
18632,GO:1903923,1,0.927271520619255,0,2,positive regulation of protein processing in phagocytic vesicle,BP,
18633,GO:1903924,1,0.969989422566479,0,1,estradiol binding,MF,
18634,GO:1903925,1,0.972980546782408,0,1,response to bisphenol A,BP,
18635,GO:1903926,1,0.972980546782408,0,1,cellular response to bisphenol A,BP,
18636,GO:1903929,1,0.964029254208592,0,1,primary palate development,BP,
18639,GO:1903937,1,0.962241416758291,0,1,response to acrylamide,BP,
18640,GO:1903939,1,0.963211149343653,0,1,regulation of TORC2 signaling,BP,
18641,GO:1903943,1,0.972167757271443,0,1,regulation of hepatocyte apoptotic process,BP,
18642,GO:1903944,1,0.972167757271443,0,1,negative regulation of hepatocyte apoptotic process,BP,
18643,GO:1903947,1,0.961037941896967,0,1,positive regulation of ventricular cardiac muscle cell action potential,BP,
18644,GO:1903949,1,0.923365802058206,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
18645,GO:1903952,1,0.961037941896967,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
18646,GO:1903954,1,0.961037941896967,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
18648,GO:1903959,1,0.528491116912464,0,17,regulation of anion transmembrane transport,BP,
18649,GO:1903960,1,0.684910736061033,0,10,negative regulation of anion transmembrane transport,BP,
18650,GO:1903961,1,0.89934555087664,0,3,positive regulation of anion transmembrane transport,BP,
18651,GO:1903963,1,0.656083803127781,0,12,arachidonate transport,BP,
18652,GO:1903964,1,0.928172989142812,0,2,monounsaturated fatty acid metabolic process,BP,
18653,GO:1903966,1,0.928172989142812,0,2,monounsaturated fatty acid biosynthetic process,BP,
18654,GO:1903969,1,0.943755046115674,0,2,regulation of response to macrophage colony-stimulating factor,BP,
18655,GO:1903970,1,0.974499003905572,0,1,negative regulation of response to macrophage colony-stimulating factor,BP,
18656,GO:1903971,1,0.968453561303749,0,1,positive regulation of response to macrophage colony-stimulating factor,BP,
18657,GO:1903972,1,0.943755046115674,0,2,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
18658,GO:1903973,1,0.974499003905572,0,1,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
18659,GO:1903974,1,0.968453561303749,0,1,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
18660,GO:1903975,1,0.826081270926712,0,6,regulation of glial cell migration,BP,
18661,GO:1903976,1,0.912957474147413,0,3,negative regulation of glial cell migration,BP,
18662,GO:1903977,1,0.929235486019654,0,2,positive regulation of glial cell migration,BP,
18665,GO:1903980,1,0.941631931154249,0,2,positive regulation of microglial cell activation,BP,
18666,GO:1903984,1,0.894362682071848,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,
18667,GO:1903995,1,0.970316822191537,0,1,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
18668,GO:1903997,1,0.970316822191537,0,1,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
18669,GO:1903998,1,0.906021834365499,0,3,regulation of eating behavior,BP,
18670,GO:1903999,1,0.944262684450576,0,2,negative regulation of eating behavior,BP,
18671,GO:1904000,1,0.95950763690405,0,1,positive regulation of eating behavior,BP,
18672,GO:1904016,1,0.857137043574517,0,4,response to Thyroglobulin triiodothyronine,BP,
18673,GO:1904017,1,0.920650957478618,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
18676,GO:1904020,1,0.928022658978814,0,2,regulation of G-protein coupled receptor internalization,BP,
18677,GO:1904021,1,0.962914148192376,0,1,negative regulation of G-protein coupled receptor internalization,BP,
18678,GO:1904022,1,0.963768076646009,0,1,positive regulation of G-protein coupled receptor internalization,BP,
18679,GO:1904023,1,0.965469978279355,0,1,regulation of glucose catabolic process to lactate via pyruvate,BP,
18680,GO:1904024,1,0.965469978279355,0,1,negative regulation of glucose catabolic process to lactate via pyruvate,BP,
18681,GO:1904026,1,0.934307472503089,0,2,regulation of collagen fibril organization,BP,
18682,GO:1904027,1,0.967725783897205,0,1,negative regulation of collagen fibril organization,BP,
18683,GO:1904028,1,0.965469978279355,0,1,positive regulation of collagen fibril organization,BP,
18689,GO:1904037,1,0.537643597707931,0,17,positive regulation of epithelial cell apoptotic process,BP,
18690,GO:1904041,1,0.963432130161792,0,1,regulation of cystathionine beta-synthase activity,BP,
18691,GO:1904042,1,0.963432130161792,0,1,negative regulation of cystathionine beta-synthase activity,BP,
18692,GO:1904044,1,0.918759706954385,0,3,response to aldosterone,BP,
18693,GO:1904045,1,0.970091381773808,0,1,cellular response to aldosterone,BP,
18694,GO:1904046,1,0.956378205720457,0,2,negative regulation of vascular endothelial growth factor production,BP,
18695,GO:1904047,1,0.906935164615342,0,3,S-adenosyl-L-methionine binding,MF,
18696,GO:1904048,1,0.959994889811302,0,1,regulation of spontaneous neurotransmitter secretion,BP,
18697,GO:1904050,1,0.959994889811302,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
18698,GO:1904054,1,0.95950763690405,0,1,regulation of cholangiocyte proliferation,BP,
18699,GO:1904056,1,0.95950763690405,0,1,positive regulation of cholangiocyte proliferation,BP,
18700,GO:1904057,1,0.975222839342954,0,1,negative regulation of sensory perception of pain,BP,
18701,GO:1904058,1,0.907059638749584,0,3,positive regulation of sensory perception of pain,BP,
18702,GO:1904059,1,0.95950763690405,0,1,regulation of locomotor rhythm,BP,
18706,GO:1904073,1,0.95950763690405,0,1,regulation of trophectodermal cell proliferation,BP,
18707,GO:1904075,1,0.95950763690405,0,1,positive regulation of trophectodermal cell proliferation,BP,
18708,GO:1904090,1,0.927504330584844,0,4,peptidase inhibitor complex,CC,
18709,GO:1904098,1,0.901859772866447,0,3,regulation of protein O-linked glycosylation,BP,
18710,GO:1904100,1,0.901859772866447,0,3,positive regulation of protein O-linked glycosylation,BP,
18711,GO:1904106,1,0.965413091220857,0,1,protein localization to microvillus,BP,
18712,GO:1904115,1,0.285686734790698,0,37,axon cytoplasm,CC,
18713,GO:1904116,1,0.892834244726659,0,3,response to vasopressin,BP,
18714,GO:1904117,1,0.892834244726659,0,3,cellular response to vasopressin,BP,
18715,GO:1904121,1,0.974752702840451,0,1,phosphatidylethanolamine transporter activity,MF,
18716,GO:1904124,1,0.968453561303749,0,1,microglial cell migration,BP,
18717,GO:1904139,1,0.968453561303749,0,1,regulation of microglial cell migration,BP,
18718,GO:1904141,1,0.968453561303749,0,1,positive regulation of microglial cell migration,BP,
18719,GO:1904152,1,0.674571350927135,0,12,regulation of retrograde protein transport, ER to cytosol,BP,
18720,GO:1904153,1,0.740585640254374,0,9,negative regulation of retrograde protein transport, ER to cytosol,BP,
18721,GO:1904154,1,0.910926611130724,0,3,positive regulation of retrograde protein transport, ER to cytosol,BP,
18722,GO:1904155,1,0.963208976815663,0,1,DN2 thymocyte differentiation,BP,
18723,GO:1904156,1,0.963208976815663,0,1,DN3 thymocyte differentiation,BP,
18724,GO:1904167,1,0.95950763690405,0,1,regulation of thyroid hormone receptor activity,BP,
18725,GO:1904168,1,0.95950763690405,0,1,negative regulation of thyroid hormone receptor activity,BP,
18726,GO:1904170,1,0.959763870291831,0,1,regulation of bleb assembly,BP,
18727,GO:1904172,1,0.959763870291831,0,1,positive regulation of bleb assembly,BP,
18728,GO:1904177,1,0.886302033112193,0,3,regulation of adipose tissue development,BP,
18729,GO:1904179,1,0.886302033112193,0,3,positive regulation of adipose tissue development,BP,
18730,GO:1904180,1,0.851594917502947,0,5,negative regulation of membrane depolarization,BP,
18731,GO:1904181,1,0.810764691070747,0,7,positive regulation of membrane depolarization,BP,
18732,GO:1904192,1,0.95950763690405,0,1,regulation of cholangiocyte apoptotic process,BP,
18733,GO:1904193,1,0.95950763690405,0,1,negative regulation of cholangiocyte apoptotic process,BP,
18734,GO:1904195,1,0.95950763690405,0,1,regulation of granulosa cell proliferation,BP,
18735,GO:1904197,1,0.95950763690405,0,1,positive regulation of granulosa cell proliferation,BP,
18736,GO:1904199,1,0.960804405179025,0,1,positive regulation of regulation of vascular smooth muscle cell membrane depolarization,BP,
18737,GO:1904200,1,0.95950763690405,0,1,iodide transmembrane transport,BP,
18738,GO:1904201,1,0.95950763690405,0,1,regulation of iodide transport,BP,
18739,GO:1904202,1,0.95950763690405,0,1,negative regulation of iodide transport,BP,
18740,GO:1904204,1,0.95950763690405,0,1,regulation of skeletal muscle hypertrophy,BP,
18741,GO:1904206,1,0.95950763690405,0,1,positive regulation of skeletal muscle hypertrophy,BP,
18742,GO:1904207,1,0.934518615365961,0,2,regulation of chemokine (C-C motif) ligand 2 secretion,BP,
18743,GO:1904209,1,0.934518615365961,0,2,positive regulation of chemokine (C-C motif) ligand 2 secretion,BP,
18744,GO:1904210,1,0.977685074226547,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18745,GO:1904211,1,0.934495341389881,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
18746,GO:1904212,1,0.95950763690405,0,1,regulation of iodide transmembrane transport,BP,
18747,GO:1904213,1,0.95950763690405,0,1,negative regulation of iodide transmembrane transport,BP,
18748,GO:1904217,1,0.911074258034846,0,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
18749,GO:1904219,1,0.911074258034846,0,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
18750,GO:1904220,1,0.879607569629046,0,4,regulation of serine C-palmitoyltransferase activity,BP,
18751,GO:1904222,1,0.911074258034846,0,3,positive regulation of serine C-palmitoyltransferase activity,BP,
18752,GO:1904226,1,0.970296941415236,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
18753,GO:1904227,1,0.970296941415236,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
18754,GO:1904229,1,0.95950763690405,0,1,regulation of succinate dehydrogenase activity,BP,
18755,GO:1904231,1,0.95950763690405,0,1,positive regulation of succinate dehydrogenase activity,BP,
18756,GO:1904232,1,0.95950763690405,0,1,regulation of aconitate hydratase activity,BP,
18757,GO:1904234,1,0.95950763690405,0,1,positive regulation of aconitate hydratase activity,BP,
18758,GO:1904235,1,0.95950763690405,0,1,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
18759,GO:1904237,1,0.95950763690405,0,1,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
18760,GO:1904238,1,0.903926136745285,0,3,pericyte cell differentiation,BP,
18761,GO:1904239,1,0.977685074226547,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18762,GO:1904240,1,0.977685074226547,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18765,GO:1904247,1,0.9644723948755,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
18766,GO:1904251,1,0.818156360729882,0,6,regulation of bile acid metabolic process,BP,
18767,GO:1904253,1,0.905800365439545,0,3,positive regulation of bile acid metabolic process,BP,
18770,GO:1904262,1,0.688424097537936,0,11,negative regulation of TORC1 signaling,BP,
18771,GO:1904263,1,0.775941708400072,0,8,positive regulation of TORC1 signaling,BP,
18772,GO:1904265,1,0.95950763690405,0,1,ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol,MF,
18773,GO:1904266,1,0.95950763690405,0,1,regulation of Schwann cell chemotaxis,BP,
18774,GO:1904268,1,0.95950763690405,0,1,positive regulation of Schwann cell chemotaxis,BP,
18775,GO:1904271,1,0.968169574119123,0,1,L-proline import across plasma membrane,BP,
18776,GO:1904274,1,0.969997246175511,0,1,tricellular tight junction assembly,BP,
18777,GO:1904282,1,0.972289642118233,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
18778,GO:1904283,1,0.972289642118233,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
18779,GO:1904288,1,0.860192530209913,0,4,BAT3 complex binding,MF,
18783,GO:1904293,1,0.647592934453104,0,13,negative regulation of ERAD pathway,BP,
18785,GO:1904298,1,0.960654669220098,0,1,regulation of transcytosis,BP,
18786,GO:1904300,1,0.960654669220098,0,1,positive regulation of transcytosis,BP,
18787,GO:1904301,1,0.960654669220098,0,1,regulation of maternal process involved in parturition,BP,
18788,GO:1904303,1,0.960654669220098,0,1,positive regulation of maternal process involved in parturition,BP,
18789,GO:1904304,1,0.945344181133473,0,2,regulation of gastro-intestinal system smooth muscle contraction,BP,
18790,GO:1904306,1,0.945344181133473,0,2,positive regulation of gastro-intestinal system smooth muscle contraction,BP,
18791,GO:1904313,1,0.961058355211294,0,1,response to methamphetamine hydrochloride,BP,
18792,GO:1904315,1,0.841909306628901,0,5,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
18793,GO:1904316,1,0.960654669220098,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
18794,GO:1904317,1,0.960654669220098,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
18795,GO:1904321,1,0.735030369222985,0,8,response to forskolin,BP,
18796,GO:1904322,1,0.735030369222985,0,8,cellular response to forskolin,BP,
18797,GO:1904327,1,0.926372432346771,0,2,protein localization to cytosolic proteasome complex,BP,
18798,GO:1904328,1,0.966503308492512,0,1,regulation of myofibroblast contraction,BP,
18799,GO:1904338,1,0.808141050845165,0,6,regulation of dopaminergic neuron differentiation,BP,
18800,GO:1904339,1,0.95950763690405,0,1,negative regulation of dopaminergic neuron differentiation,BP,
18801,GO:1904340,1,0.914304545156358,0,3,positive regulation of dopaminergic neuron differentiation,BP,
18803,GO:1904351,1,0.897915066440804,0,3,negative regulation of protein catabolic process in the vacuole,BP,
18805,GO:1904353,1,0.408551082278362,0,25,regulation of telomere capping,BP,
18806,GO:1904354,1,0.734579585494713,0,8,negative regulation of telomere capping,BP,
18807,GO:1904355,1,0.579931750966521,0,16,positive regulation of telomere capping,BP,
18808,GO:1904356,1,0.13117833794765,0,58,regulation of telomere maintenance via telomere lengthening,BP,
18809,GO:1904357,1,0.388103830890635,0,26,negative regulation of telomere maintenance via telomere lengthening,BP,
18810,GO:1904358,1,0.307504400938655,0,35,positive regulation of telomere maintenance via telomere lengthening,BP,
18812,GO:1904376,1,0.508665061876939,0,19,negative regulation of protein localization to cell periphery,BP,
18814,GO:1904378,1,0.8995490080058,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
18815,GO:1904379,1,0.926372432346771,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
18816,GO:1904380,1,0.521654570676776,0,19,endoplasmic reticulum mannose trimming,BP,
18817,GO:1904381,1,0.921791465277998,0,2,Golgi apparatus mannose trimming,BP,
18818,GO:1904382,1,0.865246987631419,0,4,mannose trimming involved in glycoprotein ERAD pathway,BP,
18819,GO:1904383,1,0.970512726667734,0,1,response to sodium phosphate,BP,
18821,GO:1904386,1,0.891892551121322,0,3,response to L-phenylalanine derivative,BP,
18822,GO:1904387,1,0.927589540336195,0,2,cellular response to L-phenylalanine derivative,BP,
18823,GO:1904393,1,0.95950763690405,0,1,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
18824,GO:1904395,1,0.95950763690405,0,1,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
18825,GO:1904396,1,0.883364048004276,0,3,regulation of neuromuscular junction development,BP,
18826,GO:1904398,1,0.920650957478618,0,2,positive regulation of neuromuscular junction development,BP,
18827,GO:1904404,1,0.95950763690405,0,1,response to formaldehyde,BP,
18830,GO:1904408,1,0.980328748456309,0,1,melatonin binding,MF,
18831,GO:1904412,1,0.962108754463036,0,1,regulation of cardiac ventricle development,BP,
18832,GO:1904414,1,0.962108754463036,0,1,positive regulation of cardiac ventricle development,BP,
18835,GO:1904424,1,0.717223105395464,0,9,regulation of GTP binding,BP,
18836,GO:1904426,1,0.926905862891416,0,2,positive regulation of GTP binding,BP,
18838,GO:1904428,1,0.90176214721286,0,3,negative regulation of tubulin deacetylation,BP,
18839,GO:1904429,1,0.773519943853551,0,7,regulation of t-circle formation,BP,
18840,GO:1904430,1,0.892282716582749,0,3,negative regulation of t-circle formation,BP,
18841,GO:1904431,1,0.866935596887504,0,4,positive regulation of t-circle formation,BP,
18842,GO:1904432,1,0.954869281299917,0,2,regulation of ferrous iron binding,BP,
18843,GO:1904434,1,0.954869281299917,0,2,positive regulation of ferrous iron binding,BP,
18844,GO:1904435,1,0.954869281299917,0,2,regulation of transferrin receptor binding,BP,
18845,GO:1904437,1,0.954869281299917,0,2,positive regulation of transferrin receptor binding,BP,
18846,GO:1904447,1,0.95950763690405,0,1,folic acid import across plasma membrane,BP,
18847,GO:1904448,1,0.959675503888475,0,1,regulation of aspartate secretion,BP,
18848,GO:1904450,1,0.959675503888475,0,1,positive regulation of aspartate secretion,BP,
18849,GO:1904454,1,0.95950763690405,0,1,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,MF,
18850,GO:1904455,1,0.92077650005347,0,2,ubiquitin-specific protease activity involved in negative regulation of ERAD pathway,MF,
18851,GO:1904457,1,0.968633645563109,0,1,positive regulation of neuronal action potential,BP,
18852,GO:1904464,1,0.974205131235747,0,1,regulation of matrix metallopeptidase secretion,BP,
18853,GO:1904465,1,0.974205131235747,0,1,negative regulation of matrix metallopeptidase secretion,BP,
18857,GO:1904475,1,0.920650957478618,0,2,regulation of Ras GTPase binding,BP,
18858,GO:1904477,1,0.95950763690405,0,1,positive regulation of Ras GTPase binding,BP,
18859,GO:1904481,1,0.96824009289509,0,1,response to tetrahydrofolate,BP,
18860,GO:1904482,1,0.96824009289509,0,1,cellular response to tetrahydrofolate,BP,
18861,GO:1904491,1,0.897140608158477,0,4,protein localization to ciliary transition zone,BP,
18862,GO:1904498,1,0.893428307276567,0,3,protein localization to mitotic actomyosin contractile ring,BP,
18863,GO:1904499,1,0.962860572657923,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
18864,GO:1904501,1,0.962860572657923,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
18867,GO:1904505,1,0.861454952173123,0,4,regulation of telomere maintenance in response to DNA damage,BP,
18868,GO:1904506,1,0.861454952173123,0,4,negative regulation of telomere maintenance in response to DNA damage,BP,
18869,GO:1904515,1,0.963211149343653,0,1,positive regulation of TORC2 signaling,BP,
18870,GO:1904526,1,0.734913756838016,0,9,regulation of microtubule binding,BP,
18871,GO:1904527,1,0.894786509890832,0,3,negative regulation of microtubule binding,BP,
18872,GO:1904528,1,0.824273488384457,0,6,positive regulation of microtubule binding,BP,
18873,GO:1904529,1,0.925305661775336,0,2,regulation of actin filament binding,BP,
18874,GO:1904530,1,0.964357489965477,0,1,negative regulation of actin filament binding,BP,
18875,GO:1904531,1,0.959508441249815,0,1,positive regulation of actin filament binding,BP,
18876,GO:1904533,1,0.894552534272449,0,3,regulation of telomeric loop disassembly,BP,
18877,GO:1904534,1,0.931870390664989,0,2,negative regulation of telomeric loop disassembly,BP,
18878,GO:1904535,1,0.959960776501778,0,1,positive regulation of telomeric loop disassembly,BP,
18879,GO:1904542,1,0.966870687325847,0,1,regulation of free ubiquitin chain polymerization,BP,
18880,GO:1904544,1,0.966870687325847,0,1,positive regulation of free ubiquitin chain polymerization,BP,
18881,GO:1904550,1,0.971249131651633,0,1,response to arachidonic acid,BP,
18882,GO:1904555,1,0.968169574119123,0,1,L-proline transmembrane transport,BP,
18883,GO:1904556,1,0.968169574119123,0,1,L-tryptophan transmembrane transport,BP,
18884,GO:1904562,1,0.920650957478618,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
18885,GO:1904565,1,0.964221624654831,0,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
18886,GO:1904566,1,0.964221624654831,0,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
18887,GO:1904567,1,0.964823659031898,0,1,response to wortmannin,BP,
18888,GO:1904568,1,0.964823659031898,0,1,cellular response to wortmannin,BP,
18889,GO:1904569,1,0.974158029291515,0,1,regulation of selenocysteine incorporation,BP,
18890,GO:1904570,1,0.974158029291515,0,1,negative regulation of selenocysteine incorporation,BP,
18891,GO:1904572,1,0.974158029291515,0,1,negative regulation of mRNA binding,BP,
18892,GO:1904573,1,0.974158029291515,0,1,regulation of selenocysteine insertion sequence binding,BP,
18893,GO:1904574,1,0.974158029291515,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
18894,GO:1904576,1,0.941585476247881,0,2,response to tunicamycin,BP,
18895,GO:1904577,1,0.941585476247881,0,2,cellular response to tunicamycin,BP,
18896,GO:1904578,1,0.913169488777419,0,3,response to thapsigargin,BP,
18897,GO:1904579,1,0.913169488777419,0,3,cellular response to thapsigargin,BP,
18900,GO:1904585,1,0.970512726667734,0,1,response to putrescine,BP,
18901,GO:1904586,1,0.970512726667734,0,1,cellular response to putrescine,BP,
18902,GO:1904587,1,0.865246987631419,0,4,response to glycoprotein,BP,
18904,GO:1904590,1,0.787281738367502,0,7,negative regulation of protein import,BP,
18906,GO:1904594,1,0.95950763690405,0,1,regulation of termination of RNA polymerase II transcription,BP,
18907,GO:1904595,1,0.95950763690405,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
18908,GO:1904596,1,0.978159281517456,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18909,GO:1904597,1,0.978159281517456,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18910,GO:1904599,1,0.978159281517456,0,1,advanced glycation end-product binding,MF,
18911,GO:1904603,1,0.978159281517456,0,1,regulation of advanced glycation end-product receptor activity,BP,
18912,GO:1904604,1,0.978159281517456,0,1,negative regulation of advanced glycation end-product receptor activity,BP,
18913,GO:1904612,1,0.921628754969875,0,2,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
18914,GO:1904613,1,0.921628754969875,0,2,cellular response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
18915,GO:1904616,1,0.925305661775336,0,2,regulation of actin binding,BP,
18916,GO:1904617,1,0.964357489965477,0,1,negative regulation of actin binding,BP,
18917,GO:1904618,1,0.959508441249815,0,1,positive regulation of actin binding,BP,
18918,GO:1904627,1,0.977081954341158,0,1,response to phorbol 13-acetate 12-myristate,BP,
18919,GO:1904628,1,0.977081954341158,0,1,cellular response to phorbol 13-acetate 12-myristate,BP,
18920,GO:1904631,1,0.969860799699644,0,1,response to glucoside,BP,
18925,GO:1904647,1,0.95950763690405,0,1,response to rotenone,BP,
18927,GO:1904666,1,0.623730751915808,0,18,regulation of ubiquitin protein ligase activity,BP,
18928,GO:1904667,1,0.901757953438062,0,6,negative regulation of ubiquitin protein ligase activity,BP,
18929,GO:1904668,1,0.691750867153642,0,12,positive regulation of ubiquitin protein ligase activity,BP,
18930,GO:1904672,1,0.886674392980149,0,3,regulation of somatic stem cell population maintenance,BP,
18931,GO:1904673,1,0.923726393309706,0,2,negative regulation of somatic stem cell population maintenance,BP,
18932,GO:1904674,1,0.959896383980452,0,1,positive regulation of somatic stem cell population maintenance,BP,
18934,GO:1904681,1,0.966663527476837,0,1,response to 3-methylcholanthrene,BP,
18935,GO:1904683,1,0.790900150817331,0,6,regulation of metalloendopeptidase activity,BP,
18936,GO:1904684,1,0.849947531660813,0,4,negative regulation of metalloendopeptidase activity,BP,
18937,GO:1904685,1,0.930555598623311,0,2,positive regulation of metalloendopeptidase activity,BP,
18938,GO:1904688,1,0.859138268356037,0,5,regulation of cytoplasmic translational initiation,BP,
18939,GO:1904689,1,0.980484164003837,0,1,negative regulation of cytoplasmic translational initiation,BP,
18940,GO:1904690,1,0.876244631666351,0,4,positive regulation of cytoplasmic translational initiation,BP,
18941,GO:1904691,1,0.970747132987703,0,1,negative regulation of type B pancreatic cell proliferation,BP,
18942,GO:1904693,1,0.886880184593513,0,3,midbrain morphogenesis,BP,
18943,GO:1904694,1,0.888854363394305,0,3,negative regulation of vascular smooth muscle contraction,BP,
18944,GO:1904695,1,0.972526528927923,0,1,positive regulation of vascular smooth muscle contraction,BP,
18945,GO:1904700,1,0.967281727194653,0,1,granulosa cell apoptotic process,BP,
18946,GO:1904701,1,0.973571680227903,0,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,
18948,GO:1904706,1,0.711877616303699,0,11,negative regulation of vascular smooth muscle cell proliferation,BP,
18950,GO:1904708,1,0.967281727194653,0,1,regulation of granulosa cell apoptotic process,BP,
18951,GO:1904711,1,0.973571680227903,0,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
18952,GO:1904713,1,0.965469978279355,0,1,beta-catenin destruction complex binding,MF,
18954,GO:1904715,1,0.909146113209962,0,3,negative regulation of chaperone-mediated autophagy,BP,
18956,GO:1904717,1,0.968332243560731,0,1,regulation of AMPA glutamate receptor clustering,BP,
18957,GO:1904719,1,0.968332243560731,0,1,positive regulation of AMPA glutamate receptor clustering,BP,
18958,GO:1904720,1,0.934100455722738,0,2,regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
18959,GO:1904721,1,0.964487831399215,0,1,negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
18960,GO:1904722,1,0.968496599492446,0,1,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
18961,GO:1904723,1,0.973571680227903,0,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
18963,GO:1904732,1,0.948744694601943,0,2,regulation of electron transfer activity,BP,
18964,GO:1904734,1,0.988784047243364,0,1,positive regulation of electron transfer activity,BP,
18966,GO:1904742,1,0.877539667887409,0,4,regulation of telomeric DNA binding,BP,
18967,GO:1904743,1,0.920650957478618,0,2,negative regulation of telomeric DNA binding,BP,
18968,GO:1904744,1,0.953182611800325,0,2,positive regulation of telomeric DNA binding,BP,
18969,GO:1904746,1,0.889348968561072,0,3,negative regulation of apoptotic process involved in development,BP,
18972,GO:1904749,1,0.885488010375844,0,4,regulation of protein localization to nucleolus,BP,
18973,GO:1904750,1,0.95950763690405,0,1,negative regulation of protein localization to nucleolus,BP,
18974,GO:1904751,1,0.922864399128637,0,3,positive regulation of protein localization to nucleolus,BP,
18977,GO:1904754,1,0.70230321444999,0,9,positive regulation of vascular associated smooth muscle cell migration,BP,
18978,GO:1904760,1,0.887124330698938,0,3,regulation of myofibroblast differentiation,BP,
18979,GO:1904761,1,0.923159749055004,0,2,negative regulation of myofibroblast differentiation,BP,
18980,GO:1904762,1,0.960972816753804,0,1,positive regulation of myofibroblast differentiation,BP,
18981,GO:1904764,1,0.97153420649971,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
18982,GO:1904766,1,0.95950763690405,0,1,negative regulation of macroautophagy by TORC1 signaling,BP,
18983,GO:1904768,1,0.943621652951986,0,2,all-trans-retinol binding,MF,
18984,GO:1904772,1,0.967055084606421,0,1,response to tetrachloromethane,BP,
18985,GO:1904776,1,0.795118000236857,0,6,regulation of protein localization to cell cortex,BP,
18986,GO:1904777,1,0.965469978279355,0,1,negative regulation of protein localization to cell cortex,BP,
18987,GO:1904778,1,0.823569532343612,0,5,positive regulation of protein localization to cell cortex,BP,
18988,GO:1904779,1,0.79348479889754,0,6,regulation of protein localization to centrosome,BP,
18989,GO:1904781,1,0.819284232062842,0,5,positive regulation of protein localization to centrosome,BP,
18990,GO:1904782,1,0.95970019463895,0,1,negative regulation of NMDA glutamate receptor activity,BP,
18991,GO:1904783,1,0.927902749467675,0,2,positive regulation of NMDA glutamate receptor activity,BP,
18992,GO:1904784,1,0.959514111464474,0,1,NLRP1 inflammasome complex assembly,BP,
18993,GO:1904790,1,0.965235913393154,0,1,regulation of shelterin complex assembly,BP,
18994,GO:1904792,1,0.965235913393154,0,1,positive regulation of shelterin complex assembly,BP,
18995,GO:1904793,1,0.962860572657923,0,1,regulation of euchromatin binding,BP,
18996,GO:1904796,1,0.837148647378226,0,5,regulation of core promoter binding,BP,
18997,GO:1904797,1,0.95950763690405,0,1,negative regulation of core promoter binding,BP,
18998,GO:1904798,1,0.872489698470205,0,4,positive regulation of core promoter binding,BP,
18999,GO:1904799,1,0.961086711971535,0,1,regulation of neuron remodeling,BP,
19000,GO:1904800,1,0.961086711971535,0,1,negative regulation of neuron remodeling,BP,
19001,GO:1904803,1,0.98683836431878,0,1,regulation of translation involved in cellular response to UV,BP,
19002,GO:1904806,1,0.965469978279355,0,1,regulation of protein oxidation,BP,
19003,GO:1904808,1,0.965469978279355,0,1,positive regulation of protein oxidation,BP,
19004,GO:1904812,1,0.961090604699139,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
19006,GO:1904814,1,0.66247532056746,0,13,regulation of protein localization to chromosome, telomeric region,BP,
19007,GO:1904815,1,0.938689667426561,0,2,negative regulation of protein localization to chromosome, telomeric region,BP,
19008,GO:1904816,1,0.705784155508257,0,11,positive regulation of protein localization to chromosome, telomeric region,BP,
19010,GO:1904826,1,0.95950763690405,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
19011,GO:1904828,1,0.95950763690405,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
19012,GO:1904829,1,0.97411570855655,0,1,regulation of aortic smooth muscle cell differentiation,BP,
19013,GO:1904831,1,0.97411570855655,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
19015,GO:1904835,1,0.968057406154827,0,1,dorsal root ganglion morphogenesis,BP,
19016,GO:1904837,1,0.324740956556166,0,41,beta-catenin-TCF complex assembly,BP,
19017,GO:1904842,1,0.970504692431207,0,1,response to nitroglycerin,BP,
19018,GO:1904843,1,0.970504692431207,0,1,cellular response to nitroglycerin,BP,
19019,GO:1904844,1,0.956484220711735,0,2,response to L-glutamine,BP,
19020,GO:1904845,1,0.956484220711735,0,2,cellular response to L-glutamine,BP,
19021,GO:1904847,1,0.885176762684944,0,3,regulation of cell chemotaxis to fibroblast growth factor,BP,
19022,GO:1904849,1,0.92065166009154,0,2,positive regulation of cell chemotaxis to fibroblast growth factor,BP,
19023,GO:1904850,1,0.965235913393154,0,1,negative regulation of establishment of protein localization to telomere,BP,
19024,GO:1904851,1,0.757265806392803,0,9,positive regulation of establishment of protein localization to telomere,BP,
19025,GO:1904854,1,0.963915545405274,0,1,proteasome core complex binding,MF,
19028,GO:1904867,1,0.760046065243101,0,9,protein localization to Cajal body,BP,
19029,GO:1904868,1,0.920650957478618,0,2,telomerase catalytic core complex assembly,BP,
19030,GO:1904869,1,0.781089854492619,0,8,regulation of protein localization to Cajal body,BP,
19031,GO:1904871,1,0.781089854492619,0,8,positive regulation of protein localization to Cajal body,BP,
19032,GO:1904872,1,0.58713047928785,0,18,regulation of telomerase RNA localization to Cajal body,BP,
19033,GO:1904874,1,0.656715127570466,0,15,positive regulation of telomerase RNA localization to Cajal body,BP,
19034,GO:1904875,1,0.937315190576072,0,2,regulation of DNA ligase activity,BP,
19035,GO:1904876,1,0.96544149613875,0,1,negative regulation of DNA ligase activity,BP,
19036,GO:1904877,1,0.97086945096492,0,1,positive regulation of DNA ligase activity,BP,
19037,GO:1904878,1,0.95950763690405,0,1,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
19038,GO:1904879,1,0.93086040546843,0,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
19039,GO:1904880,1,0.935963494456254,0,2,response to hydrogen sulfide,BP,
19040,GO:1904881,1,0.966870687325847,0,1,cellular response to hydrogen sulfide,BP,
19041,GO:1904882,1,0.920650957478618,0,2,regulation of telomerase catalytic core complex assembly,BP,
19042,GO:1904884,1,0.920650957478618,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
19043,GO:1904885,1,0.825355290436449,0,5,beta-catenin destruction complex assembly,BP,
19044,GO:1904886,1,0.518538291779838,0,18,beta-catenin destruction complex disassembly,BP,
19046,GO:1904889,1,0.974413361039542,0,1,regulation of excitatory synapse assembly,BP,
19047,GO:1904891,1,0.974413361039542,0,1,positive regulation of excitatory synapse assembly,BP,
19051,GO:1904895,1,0.974863502499201,0,1,ESCRT complex assembly,BP,
19052,GO:1904896,1,0.726220602049529,0,10,ESCRT complex disassembly,BP,
19053,GO:1904902,1,0.974863502499201,0,1,ESCRT III complex assembly,BP,
19054,GO:1904903,1,0.726220602049529,0,10,ESCRT III complex disassembly,BP,
19055,GO:1904907,1,0.920650957478618,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
19056,GO:1904908,1,0.920650957478618,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
19057,GO:1904910,1,0.965235913393154,0,1,regulation of establishment of RNA localization to telomere,BP,
19058,GO:1904911,1,0.965235913393154,0,1,negative regulation of establishment of RNA localization to telomere,BP,
19059,GO:1904913,1,0.965235913393154,0,1,regulation of establishment of protein-containing complex localization to telomere,BP,
19060,GO:1904914,1,0.965235913393154,0,1,negative regulation of establishment of protein-containing complex localization to telomere,BP,
19061,GO:1904923,1,0.66110991167351,0,12,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
19062,GO:1904924,1,0.968615547286787,0,1,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
19063,GO:1904925,1,0.682551773409418,0,11,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
19064,GO:1904928,1,0.92071653727097,0,2,coreceptor activity involved in canonical Wnt signaling pathway,MF,
19065,GO:1904929,1,0.793965195689613,0,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,
19069,GO:1904947,1,0.964743830645791,0,1,folic acid import into mitochondrion,BP,
19075,GO:1904954,1,0.940278603054021,0,2,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
19077,GO:1904956,1,0.877816917446248,0,4,regulation of midbrain dopaminergic neuron differentiation,BP,
19078,GO:1904958,1,0.914304545156358,0,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,
19079,GO:1904959,1,0.948744694601943,0,2,regulation of cytochrome-c oxidase activity,BP,
19080,GO:1904960,1,0.988784047243364,0,1,positive regulation of cytochrome-c oxidase activity,BP,
19081,GO:1904970,1,0.965413091220857,0,1,brush border assembly,BP,
19082,GO:1904971,1,0.959909259195392,0,1,regulation of viral translation,BP,
19083,GO:1904973,1,0.959909259195392,0,1,positive regulation of viral translation,BP,
19084,GO:1904975,1,0.92225854736482,0,2,response to bleomycin,BP,
19085,GO:1904976,1,0.92225854736482,0,2,cellular response to bleomycin,BP,
19086,GO:1904977,1,0.965550139443602,0,1,lymphatic endothelial cell migration,BP,
19087,GO:1904978,1,0.893213543791985,0,3,regulation of endosome organization,BP,
19088,GO:1904979,1,0.969919155567986,0,1,negative regulation of endosome organization,BP,
19089,GO:1904980,1,0.95950763690405,0,1,positive regulation of endosome organization,BP,
19090,GO:1904983,1,0.970771537997197,0,1,glycine import into mitochondrion,BP,
19091,GO:1904990,1,0.968378520909969,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
19092,GO:1904992,1,0.968378520909969,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
19094,GO:1904995,1,0.949883142798444,0,2,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
19097,GO:1904998,1,0.965255448856663,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
19099,GO:1905000,1,0.95950763690405,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
19100,GO:1905005,1,0.799939590283548,0,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
19101,GO:1905006,1,0.933458434506544,0,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
19102,GO:1905007,1,0.822316293016239,0,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
19103,GO:1905024,1,0.922229755455551,0,2,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
19104,GO:1905026,1,0.961037941896967,0,1,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
19105,GO:1905031,1,0.884879058913863,0,3,regulation of membrane repolarization during cardiac muscle cell action potential,BP,
19106,GO:1905033,1,0.961037941896967,0,1,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
19107,GO:1905034,1,0.965272223551698,0,1,regulation of antifungal innate immune response,BP,
19108,GO:1905035,1,0.965272223551698,0,1,negative regulation of antifungal innate immune response,BP,
19112,GO:1905040,1,0.968057406154827,0,1,otic placode development,BP,
19115,GO:1905044,1,0.965469978279355,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
19116,GO:1905045,1,0.965469978279355,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
19117,GO:1905048,1,0.643489057670453,0,13,regulation of metallopeptidase activity,BP,
19118,GO:1905049,1,0.803638025351183,0,6,negative regulation of metallopeptidase activity,BP,
19119,GO:1905050,1,0.800818227872576,0,7,positive regulation of metallopeptidase activity,BP,
19120,GO:1905051,1,0.958060036015054,0,2,regulation of base-excision repair,BP,
19121,GO:1905053,1,0.958060036015054,0,2,positive regulation of base-excision repair,BP,
19123,GO:1905063,1,0.84235818697407,0,5,regulation of vascular smooth muscle cell differentiation,BP,
19124,GO:1905064,1,0.928975795352824,0,2,negative regulation of vascular smooth muscle cell differentiation,BP,
19125,GO:1905065,1,0.90677659696015,0,3,positive regulation of vascular smooth muscle cell differentiation,BP,
19126,GO:1905066,1,0.943356348674288,0,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,
19127,GO:1905067,1,0.973571680227903,0,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,
19128,GO:1905068,1,0.968966527976527,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
19129,GO:1905069,1,0.960897596709916,0,1,allantois development,BP,
19130,GO:1905071,1,0.92489925563782,0,2,occluding junction disassembly,BP,
19131,GO:1905073,1,0.92489925563782,0,2,regulation of occluding junction disassembly,BP,
19132,GO:1905075,1,0.92489925563782,0,2,positive regulation of occluding junction disassembly,BP,
19133,GO:1905076,1,0.971986138849325,0,1,regulation of interleukin-17 secretion,BP,
19134,GO:1905077,1,0.971986138849325,0,1,negative regulation of interleukin-17 secretion,BP,
19135,GO:1905089,1,0.95950763690405,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
19136,GO:1905090,1,0.95950763690405,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
19137,GO:1905097,1,0.802477669331409,0,6,regulation of guanyl-nucleotide exchange factor activity,BP,
19138,GO:1905098,1,0.871666508502743,0,4,negative regulation of guanyl-nucleotide exchange factor activity,BP,
19139,GO:1905099,1,0.95950763690405,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
19140,GO:1905103,1,0.960965422041728,0,1,integral component of lysosomal membrane,CC,
19142,GO:1905123,1,0.922320604995265,0,2,regulation of glucosylceramidase activity,BP,
19143,GO:1905132,1,0.964709451383227,0,1,regulation of meiotic chromosome separation,BP,
19144,GO:1905133,1,0.964709451383227,0,1,negative regulation of meiotic chromosome separation,BP,
19145,GO:1905143,1,0.975964265527229,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
19146,GO:1905144,1,0.673806674916927,0,12,response to acetylcholine,BP,
19147,GO:1905145,1,0.673806674916927,0,12,cellular response to acetylcholine,BP,
19149,GO:1905150,1,0.921259093063454,0,2,regulation of voltage-gated sodium channel activity,BP,
19150,GO:1905152,1,0.95950763690405,0,1,positive regulation of voltage-gated sodium channel activity,BP,
19151,GO:1905153,1,0.796573352648592,0,6,regulation of membrane invagination,BP,
19152,GO:1905154,1,0.959547385408767,0,1,negative regulation of membrane invagination,BP,
19153,GO:1905155,1,0.830171345152266,0,5,positive regulation of membrane invagination,BP,
19154,GO:1905161,1,0.959547385408767,0,1,protein localization to phagocytic vesicle,BP,
19155,GO:1905162,1,0.959547385408767,0,1,regulation of phagosome maturation,BP,
19157,GO:1905166,1,0.897915066440804,0,3,negative regulation of lysosomal protein catabolic process,BP,
19159,GO:1905168,1,0.961812230745278,0,1,positive regulation of double-strand break repair via homologous recombination,BP,
19160,GO:1905169,1,0.959547385408767,0,1,regulation of protein localization to phagocytic vesicle,BP,
19161,GO:1905171,1,0.959547385408767,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
19162,GO:1905172,1,0.959909259195392,0,1,RISC complex binding,MF,
19163,GO:1905174,1,0.939522837130351,0,2,regulation of vascular smooth muscle cell dedifferentiation,BP,
19164,GO:1905176,1,0.96555301355671,0,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,
19165,GO:1905202,1,0.930762605419215,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
19166,GO:1905203,1,0.938914162452388,0,2,regulation of connective tissue replacement,BP,
19167,GO:1905204,1,0.978159281517456,0,1,negative regulation of connective tissue replacement,BP,
19168,GO:1905205,1,0.959880804825942,0,1,positive regulation of connective tissue replacement,BP,
19169,GO:1905206,1,0.844573100092291,0,5,positive regulation of hydrogen peroxide-induced cell death,BP,
19173,GO:1905214,1,0.691501915470216,0,11,regulation of RNA binding,BP,
19174,GO:1905215,1,0.974158029291515,0,1,negative regulation of RNA binding,BP,
19175,GO:1905216,1,0.766697053760143,0,8,positive regulation of RNA binding,BP,
19176,GO:1905222,1,0.964171862387423,0,1,atrioventricular canal morphogenesis,BP,
19177,GO:1905223,1,0.95950763690405,0,1,epicardium morphogenesis,BP,
19178,GO:1905224,1,0.92115215628106,0,2,clathrin-coated pit assembly,BP,
19179,GO:1905232,1,0.862971222808384,0,4,cellular response to L-glutamate,BP,
19180,GO:1905242,1,0.963039672539869,0,1,response to 3,3',5-triiodo-L-thyronine,BP,
19181,GO:1905244,1,0.74137775584644,0,8,regulation of modification of synaptic structure,BP,
19183,GO:1905246,1,0.929995787326588,0,2,negative regulation of aspartic-type peptidase activity,BP,
19185,GO:1905255,1,0.95950763690405,0,1,regulation of RNA binding transcription factor activity,BP,
19186,GO:1905258,1,0.959178348047355,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
19187,GO:1905259,1,0.959178348047355,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
19188,GO:1905267,1,0.932561306171818,0,2,endonucleolytic cleavage involved in tRNA processing,BP,
19191,GO:1905271,1,0.986296566209,0,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
19192,GO:1905273,1,0.986296566209,0,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
19193,GO:1905274,1,0.95950763690405,0,1,regulation of modification of postsynaptic actin cytoskeleton,BP,
19195,GO:1905277,1,0.964521370833711,0,1,negative regulation of epithelial tube formation,BP,
19196,GO:1905278,1,0.912201212328947,0,3,positive regulation of epithelial tube formation,BP,
19197,GO:1905279,1,0.965469978279355,0,1,regulation of retrograde transport, endosome to Golgi,BP,
19198,GO:1905285,1,0.962108754463036,0,1,fibrous ring of heart morphogenesis,BP,
19200,GO:1905288,1,0.793936458664081,0,6,vascular associated smooth muscle cell apoptotic process,BP,
19201,GO:1905292,1,0.897835327316344,0,3,regulation of neural crest cell differentiation,BP,
19202,GO:1905294,1,0.897835327316344,0,3,positive regulation of neural crest cell differentiation,BP,
19203,GO:1905301,1,0.959994889811302,0,1,regulation of macropinocytosis,BP,
19204,GO:1905302,1,0.959994889811302,0,1,negative regulation of macropinocytosis,BP,
19205,GO:1905304,1,0.95950763690405,0,1,regulation of cardiac myofibril assembly,BP,
19206,GO:1905305,1,0.95950763690405,0,1,negative regulation of cardiac myofibril assembly,BP,
19207,GO:1905309,1,0.95950763690405,0,1,positive regulation of cohesin loading,BP,
19208,GO:1905310,1,0.897835327316344,0,3,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
19209,GO:1905312,1,0.897835327316344,0,3,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
19210,GO:1905313,1,0.97017018407529,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
19212,GO:1905317,1,0.959869033700348,0,1,inferior endocardial cushion morphogenesis,BP,
19213,GO:1905319,1,0.965469978279355,0,1,mesenchymal stem cell migration,BP,
19214,GO:1905320,1,0.965469978279355,0,1,regulation of mesenchymal stem cell migration,BP,
19215,GO:1905322,1,0.965469978279355,0,1,positive regulation of mesenchymal stem cell migration,BP,
19216,GO:1905323,1,0.811731855243198,0,6,telomerase holoenzyme complex assembly,BP,
19220,GO:1905333,1,0.959374670283556,0,2,regulation of gastric motility,BP,
19221,GO:1905335,1,0.95950763690405,0,1,regulation of aggrephagy,BP,
19222,GO:1905337,1,0.95950763690405,0,1,positive regulation of aggrephagy,BP,
19223,GO:1905340,1,0.882321130694386,0,4,regulation of protein localization to kinetochore,BP,
19224,GO:1905341,1,0.966761912785496,0,1,negative regulation of protein localization to kinetochore,BP,
19225,GO:1905342,1,0.882321130694386,0,4,positive regulation of protein localization to kinetochore,BP,
19226,GO:1905344,1,0.965469978279355,0,1,prostaglandin catabolic process,BP,
19228,GO:1905349,1,0.979684184410215,0,1,ciliary transition zone assembly,BP,
19229,GO:1905354,1,0.519491443372393,0,22,exoribonuclease complex,CC,
19230,GO:1905355,1,0.959577750784455,0,1,spine apparatus assembly,BP,
19231,GO:1905359,1,0.964709451383227,0,1,protein localization to meiotic spindle,BP,
19232,GO:1905360,1,0.531292409087409,0,19,GTPase complex,CC,
19233,GO:1905365,1,0.969919155567986,0,1,regulation of intralumenal vesicle formation,BP,
19234,GO:1905366,1,0.969919155567986,0,1,negative regulation of intralumenal vesicle formation,BP,
19236,GO:1905369,1,0.183647349790476,0,64,endopeptidase complex,CC,
19237,GO:1905370,1,0.968615547286787,0,1,serine-type endopeptidase complex,CC,
19240,GO:1905383,1,0.92467648371084,0,3,protein localization to presynapse,BP,
19241,GO:1905384,1,0.940544737670044,0,2,regulation of protein localization to presynapse,BP,
19242,GO:1905386,1,0.940544737670044,0,2,positive regulation of protein localization to presynapse,BP,
19243,GO:1905392,1,0.984487367317405,0,1,plant organ morphogenesis,BP,
19244,GO:1905394,1,0.901105836279548,0,3,retromer complex binding,MF,
19245,GO:1905395,1,0.945567739617503,0,2,response to flavonoid,BP,
19248,GO:1905403,1,0.971986138849325,0,1,negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
19250,GO:1905405,1,0.95950763690405,0,1,regulation of mitotic cohesin loading,BP,
19251,GO:1905406,1,0.95950763690405,0,1,positive regulation of mitotic cohesin loading,BP,
19252,GO:1905407,1,0.963463657764827,0,1,regulation of creatine transmembrane transporter activity,BP,
19253,GO:1905408,1,0.963463657764827,0,1,negative regulation of creatine transmembrane transporter activity,BP,
19254,GO:1905419,1,0.973328987154624,0,1,sperm flagellum movement involved in flagellated sperm motility,BP,
19255,GO:1905421,1,0.984487367317405,0,1,regulation of plant organ morphogenesis,BP,
19256,GO:1905422,1,0.984487367317405,0,1,negative regulation of plant organ morphogenesis,BP,
19257,GO:1905424,1,0.939128025564232,0,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
19258,GO:1905426,1,0.939128025564232,0,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
19259,GO:1905429,1,0.971174303078888,0,1,response to glycine,BP,
19260,GO:1905430,1,0.971174303078888,0,1,cellular response to glycine,BP,
19261,GO:1905435,1,0.965469978279355,0,1,regulation of histone H3-K4 trimethylation,BP,
19262,GO:1905437,1,0.965469978279355,0,1,positive regulation of histone H3-K4 trimethylation,BP,
19264,GO:1905443,1,0.960055265892315,0,1,regulation of clathrin coat assembly,BP,
19265,GO:1905445,1,0.960055265892315,0,1,positive regulation of clathrin coat assembly,BP,
19266,GO:1905446,1,0.866365083039628,0,5,regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19267,GO:1905447,1,0.964014645926423,0,1,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19268,GO:1905448,1,0.898714220517028,0,4,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19269,GO:1905449,1,0.93363571469588,0,2,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
19270,GO:1905451,1,0.93363571469588,0,2,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
19271,GO:1905456,1,0.78442608827962,0,7,regulation of lymphoid progenitor cell differentiation,BP,
19272,GO:1905457,1,0.917337901784188,0,3,negative regulation of lymphoid progenitor cell differentiation,BP,
19273,GO:1905458,1,0.961040483906274,0,1,positive regulation of lymphoid progenitor cell differentiation,BP,
19274,GO:1905459,1,0.793936458664081,0,6,regulation of vascular associated smooth muscle cell apoptotic process,BP,
19275,GO:1905460,1,0.95950763690405,0,1,negative regulation of vascular associated smooth muscle cell apoptotic process,BP,
19276,GO:1905461,1,0.827457801822272,0,5,positive regulation of vascular associated smooth muscle cell apoptotic process,BP,
19277,GO:1905462,1,0.921847954936794,0,2,regulation of DNA duplex unwinding,BP,
19278,GO:1905463,1,0.959507688488047,0,1,negative regulation of DNA duplex unwinding,BP,
19279,GO:1905464,1,0.960754975029549,0,1,positive regulation of DNA duplex unwinding,BP,
19280,GO:1905468,1,0.959547385408767,0,1,regulation of clathrin-coated pit assembly,BP,
19281,GO:1905469,1,0.959547385408767,0,1,negative regulation of clathrin-coated pit assembly,BP,
19282,GO:1905474,1,0.976549225204766,0,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,
19284,GO:1905476,1,0.461765264667601,0,22,negative regulation of protein localization to membrane,BP,
19286,GO:1905502,1,0.979777344814501,0,1,acetyl-CoA binding,MF,
19287,GO:1905508,1,0.361006840655531,0,27,protein localization to microtubule organizing center,BP,
19288,GO:1905515,1,0.193822679815614,0,47,non-motile cilium assembly,BP,
19289,GO:1905516,1,0.855290294879323,0,5,positive regulation of fertilization,BP,
19291,GO:1905521,1,0.623011701990519,0,15,regulation of macrophage migration,BP,
19292,GO:1905522,1,0.909802908513651,0,4,negative regulation of macrophage migration,BP,
19293,GO:1905523,1,0.765899246615841,0,8,positive regulation of macrophage migration,BP,
19294,GO:1905524,1,0.95950763690405,0,1,negative regulation of protein autoubiquitination,BP,
19295,GO:1905535,1,0.95955058583742,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19296,GO:1905537,1,0.95955058583742,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19297,GO:1905538,1,0.926760219020169,0,2,polysome binding,MF,
19298,GO:1905547,1,0.975135035644344,0,1,regulation of telomeric heterochromatin assembly,BP,
19299,GO:1905549,1,0.975135035644344,0,1,positive regulation of telomeric heterochromatin assembly,BP,
19300,GO:1905550,1,0.948125565971331,0,2,regulation of protein localization to endoplasmic reticulum,BP,
19301,GO:1905552,1,0.948125565971331,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
19302,GO:1905553,1,0.915238949748643,0,3,regulation of blood vessel branching,BP,
19303,GO:1905555,1,0.935647833029689,0,2,positive regulation blood vessel branching,BP,
19305,GO:1905563,1,0.973075088847771,0,1,negative regulation of vascular endothelial cell proliferation,BP,
19307,GO:1905572,1,0.965800145624148,0,1,ganglioside GM1 transport to membrane,BP,
19308,GO:1905573,1,0.939306583439553,0,2,ganglioside GM1 binding,MF,
19309,GO:1905574,1,0.965800145624148,0,1,ganglioside GM2 binding,MF,
19310,GO:1905575,1,0.965800145624148,0,1,ganglioside GM3 binding,MF,
19311,GO:1905576,1,0.939306583439553,0,2,ganglioside GT1b binding,MF,
19312,GO:1905577,1,0.965800145624148,0,1,ganglioside GP1c binding,MF,
19313,GO:1905578,1,0.968353585596591,0,1,regulation of ERBB3 signaling pathway,BP,
19314,GO:1905580,1,0.968353585596591,0,1,positive regulation of ERBB3 signaling pathway,BP,
19315,GO:1905581,1,0.975139906960328,0,1,positive regulation of low-density lipoprotein particle clearance,BP,
19316,GO:1905590,1,0.964204173575027,0,1,fibronectin fibril organization,BP,
19317,GO:1905594,1,0.980328748456309,0,1,resveratrol binding,MF,
19318,GO:1905595,1,0.938119990815992,0,2,regulation of low-density lipoprotein particle receptor binding,BP,
19319,GO:1905596,1,0.962038677568488,0,1,negative regulation of low-density lipoprotein particle receptor binding,BP,
19320,GO:1905597,1,0.975139906960328,0,1,positive regulation of low-density lipoprotein particle receptor binding,BP,
19321,GO:1905598,1,0.962038677568488,0,1,negative regulation of low-density lipoprotein receptor activity,BP,
19322,GO:1905599,1,0.975139906960328,0,1,positive regulation of low-density lipoprotein receptor activity,BP,
19323,GO:1905600,1,0.905488866954442,0,3,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
19324,GO:1905601,1,0.962038677568488,0,1,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
19325,GO:1905602,1,0.941224346396853,0,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
19326,GO:1905606,1,0.891176568149098,0,3,regulation of presynapse assembly,BP,
19327,GO:1905610,1,0.95955058583742,0,1,regulation of mRNA cap binding,BP,
19328,GO:1905612,1,0.95955058583742,0,1,positive regulation of mRNA cap binding,BP,
19329,GO:1905616,1,0.926413901717625,0,2,regulation of miRNA mediated inhibition of translation,BP,
19330,GO:1905618,1,0.926413901717625,0,2,positive regulation of miRNA mediated inhibition of translation,BP,
19331,GO:1905634,1,0.802870151898456,0,6,regulation of protein localization to chromatin,BP,
19332,GO:1905636,1,0.979112611699708,0,1,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19333,GO:1905642,1,0.965469978279355,0,1,negative regulation of DNA methylation,BP,
19334,GO:1905643,1,0.95950763690405,0,1,positive regulation of DNA methylation,BP,
19335,GO:1905647,1,0.968169574119123,0,1,proline import across plasma membrane,BP,
19338,GO:1905661,1,0.933514195897472,0,2,regulation of telomerase RNA reverse transcriptase activity,BP,
19339,GO:1905663,1,0.933514195897472,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
19340,GO:1905664,1,0.938574294490004,0,2,regulation of calcium ion import across plasma membrane,BP,
19341,GO:1905666,1,0.707112482209481,0,9,regulation of protein localization to endosome,BP,
19342,GO:1905668,1,0.707112482209481,0,9,positive regulation of protein localization to endosome,BP,
19343,GO:1905671,1,0.903476545212984,0,3,regulation of lysosome organization,BP,
19344,GO:1905672,1,0.970577117482702,0,1,negative regulation of lysosome organization,BP,
19345,GO:1905687,1,0.959507637945067,0,1,regulation of diacylglycerol kinase activity,BP,
19346,GO:1905689,1,0.959507637945067,0,1,positive regulation of diacylglycerol kinase activity,BP,
19347,GO:1905696,1,0.921077586010811,0,2,regulation of polysome binding,BP,
19348,GO:1905698,1,0.959909259195392,0,1,positive regulation of polysome binding,BP,
19349,GO:1905705,1,0.95950763690405,0,1,cellular response to paclitaxel,BP,
19350,GO:1905709,1,0.877511530285005,0,5,negative regulation of membrane permeability,BP,
19352,GO:1905711,1,0.961523527165928,0,1,response to phosphatidylethanolamine,BP,
19353,GO:1905715,1,0.967657616169375,0,1,regulation of cornification,BP,
19354,GO:1905716,1,0.967657616169375,0,1,negative regulation of cornification,BP,
19356,GO:1905720,1,0.95950763690405,0,1,cytoplasmic microtubule bundle,CC,
19357,GO:1905764,1,0.897395558783373,0,3,regulation of protection from non-homologous end joining at telomere,BP,
19358,GO:1905765,1,0.897395558783373,0,3,negative regulation of protection from non-homologous end joining at telomere,BP,
19359,GO:1905767,1,0.95950763690405,0,1,regulation of double-stranded telomeric DNA binding,BP,
19360,GO:1905768,1,0.95950763690405,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
19361,GO:1905770,1,0.898745587864151,0,3,regulation of mesodermal cell differentiation,BP,
19362,GO:1905771,1,0.973571680227903,0,1,negative regulation of mesodermal cell differentiation,BP,
19363,GO:1905773,1,0.884968481081168,0,3,8-hydroxy-2'-deoxyguanosine DNA binding,MF,
19364,GO:1905774,1,0.960754975029549,0,1,regulation of DNA helicase activity,BP,
19365,GO:1905776,1,0.960754975029549,0,1,positive regulation of DNA helicase activity,BP,
19366,GO:1905777,1,0.900482836977224,0,3,regulation of exonuclease activity,BP,
19367,GO:1905778,1,0.931870390664989,0,2,negative regulation of exonuclease activity,BP,
19368,GO:1905779,1,0.966323575434221,0,1,positive regulation of exonuclease activity,BP,
19369,GO:1905793,1,0.920813162448314,0,2,protein localization to pericentriolar material,BP,
19370,GO:1905794,1,0.95950763690405,0,1,response to puromycin,BP,
19371,GO:1905795,1,0.95950763690405,0,1,cellular response to puromycin,BP,
19372,GO:1905799,1,0.985733564307606,0,1,regulation of intraciliary retrograde transport,BP,
19376,GO:1905820,1,0.737095857219262,0,9,positive regulation of chromosome separation,BP,
19377,GO:1905832,1,0.853859597287577,0,4,positive regulation of spindle assembly,BP,
19378,GO:1905838,1,0.931870390664989,0,2,regulation of telomeric D-loop disassembly,BP,
19379,GO:1905839,1,0.931870390664989,0,2,negative regulation of telomeric D-loop disassembly,BP,
19380,GO:1905843,1,0.95950763690405,0,1,regulation of cellular response to gamma radiation,BP,
19381,GO:1905853,1,0.979920153523586,0,1,regulation of heparan sulfate binding,BP,
19382,GO:1905855,1,0.979920153523586,0,1,positive regulation of heparan sulfate binding,BP,
19383,GO:1905858,1,0.979920153523586,0,1,regulation of heparan sulfate proteoglycan binding,BP,
19384,GO:1905860,1,0.979920153523586,0,1,positive regulation of heparan sulfate proteoglycan binding,BP,
19386,GO:1905867,1,0.914728766526231,0,3,epididymis development,BP,
19387,GO:1905874,1,0.93359447902783,0,2,regulation of postsynaptic density organization,BP,
19389,GO:1905879,1,0.782132304897972,0,7,regulation of oogenesis,BP,
19390,GO:1905880,1,0.923790271966438,0,2,negative regulation of oogenesis,BP,
19391,GO:1905881,1,0.904818905378129,0,3,positive regulation of oogenesis,BP,
19392,GO:1905890,1,0.979920153523586,0,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,
19393,GO:1905891,1,0.965741492599732,0,1,regulation of cellular response to thapsigargin,BP,
19394,GO:1905892,1,0.965741492599732,0,1,negative regulation of cellular response to thapsigargin,BP,
19395,GO:1905894,1,0.965741492599732,0,1,regulation of cellular response to tunicamycin,BP,
19396,GO:1905895,1,0.965741492599732,0,1,negative regulation of cellular response to tunicamycin,BP,
19399,GO:1905902,1,0.898745587864151,0,3,regulation of mesoderm formation,BP,
19400,GO:1905903,1,0.973571680227903,0,1,negative regulation of mesoderm formation,BP,
19403,GO:1905908,1,0.874108280082994,0,4,positive regulation of amyloid fibril formation,BP,
19404,GO:1905912,1,0.973206247380663,0,1,regulation of calcium ion export across plasma membrane,BP,
19405,GO:1905913,1,0.973206247380663,0,1,negative regulation of calcium ion export across plasma membrane,BP,
19406,GO:1905918,1,0.97049666144186,0,1,regulation of CoA-transferase activity,BP,
19407,GO:1905920,1,0.97049666144186,0,1,positive regulation of CoA-transferase activity,BP,
19410,GO:1905936,1,0.96527777255359,0,2,regulation of germ cell proliferation,BP,
19411,GO:1905937,1,0.982807516862624,0,1,negative regulation of germ cell proliferation,BP,
19412,GO:1905938,1,0.982164400809838,0,1,positive regulation of germ cell proliferation,BP,
19414,GO:1905940,1,0.901784120000406,0,3,negative regulation of gonad development,BP,
19416,GO:1905942,1,0.968353585596591,0,1,regulation of formation of growth cone in injured axon,BP,
19417,GO:1905943,1,0.968353585596591,0,1,negative regulation of formation of growth cone in injured axon,BP,
19421,GO:1905957,1,0.960262723320359,0,1,regulation of cellular response to alcohol,BP,
19422,GO:1905959,1,0.960262723320359,0,1,positive regulation of cellular response to alcohol,BP,
19423,GO:1905961,1,0.771246636353146,0,8,protein-cysteine S-palmitoyltransferase complex,CC,
19426,GO:1990003,1,0.95950763690405,0,1,IDP phosphatase activity,MF,
19427,GO:1990005,1,0.940773849161994,0,2,granular vesicle,CC,
19428,GO:1990008,1,0.974422863836396,0,1,neurosecretory vesicle,CC,
19429,GO:1990009,1,0.959542479616028,0,1,retinal cell apoptotic process,BP,
19430,GO:1990023,1,0.625089089846391,0,13,mitotic spindle midzone,CC,
19431,GO:1990026,1,0.962440199472058,0,1,hippocampal mossy fiber expansion,CC,
19432,GO:1990029,1,0.964039008079129,0,1,vasomotion,BP,
19433,GO:1990031,1,0.964053661414986,0,1,pinceau fiber,CC,
19434,GO:1990032,1,0.960074043443202,0,1,parallel fiber,CC,
19435,GO:1990034,1,0.901546700501053,0,3,calcium ion export across plasma membrane,BP,
19436,GO:1990036,1,0.95950763690405,0,1,calcium ion import into sarcoplasmic reticulum,BP,
19437,GO:1990037,1,0.919190130146867,0,3,Lewy body core,CC,
19438,GO:1990038,1,0.972180785508844,0,1,Lewy body corona,CC,
19439,GO:1990046,1,0.97883204070005,0,1,stress-induced mitochondrial fusion,BP,
19440,GO:1990047,1,0.969556455050232,0,1,spindle matrix,CC,
19441,GO:1990048,1,0.965469978279355,0,1,anterograde neuronal dense core vesicle transport,BP,
19442,GO:1990050,1,0.846715791054195,0,6,phosphatidic acid transporter activity,MF,
19443,GO:1990051,1,0.959508441249815,0,1,activation of protein kinase C activity,BP,
19444,GO:1990070,1,0.984617127196175,0,1,TRAPPI protein complex,CC,
19445,GO:1990071,1,0.944746099537063,0,2,TRAPPII protein complex,CC,
19446,GO:1990072,1,0.950616944494709,0,2,TRAPPIII protein complex,CC,
19447,GO:1990074,1,0.962499333897691,0,1,polyuridylation-dependent mRNA catabolic process,BP,
19448,GO:1990075,1,0.891973590240432,0,3,periciliary membrane compartment,CC,
19449,GO:1990086,1,0.890300096177857,0,3,lens fiber cell apoptotic process,BP,
19453,GO:1990111,1,0.904729454146928,0,4,spermatoproteasome complex,CC,
19454,GO:1990112,1,0.932129376517163,0,2,RQC complex,CC,
19455,GO:1990116,1,0.932129376517163,0,2,ribosome-associated ubiquitin-dependent protein catabolic process,BP,
19456,GO:1990117,1,0.984110997931916,0,1,B cell receptor apoptotic signaling pathway,BP,
19458,GO:1990126,1,0.571425614852315,0,16,retrograde transport, endosome to plasma membrane,BP,
19459,GO:1990127,1,0.960546099104204,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19460,GO:1990130,1,0.842070616387651,0,5,GATOR1 complex,CC,
19461,GO:1990131,1,0.924641521568318,0,3,Gtr1-Gtr2 GTPase complex,CC,
19462,GO:1990134,1,0.95961425832529,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
19463,GO:1990136,1,0.967869968437963,0,1,linoleate 9S-lipoxygenase activity,MF,
19465,GO:1990144,1,0.831678883229904,0,6,intrinsic apoptotic signaling pathway in response to hypoxia,BP,
19466,GO:1990145,1,0.928177277753174,0,2,maintenance of translational fidelity,BP,
19467,GO:1990164,1,0.931438340960069,0,2,histone H2A phosphorylation,BP,
19468,GO:1990165,1,0.971644205399406,0,1,single-strand break-containing DNA binding,MF,
19469,GO:1990166,1,0.90317645752339,0,3,protein localization to site of double-strand break,BP,
19470,GO:1990167,1,0.897335878538172,0,3,protein K27-linked deubiquitination,BP,
19471,GO:1990168,1,0.897478650801677,0,3,protein K33-linked deubiquitination,BP,
19472,GO:1990169,1,0.910881296603993,0,5,stress response to copper ion,BP,
19473,GO:1990170,1,0.971695160861598,0,1,stress response to cadmium ion,BP,
19474,GO:1990172,1,0.95950763690405,0,1,G-protein coupled receptor catabolic process,BP,
19475,GO:1990173,1,0.729313121482074,0,10,protein localization to nucleoplasm,BP,
19476,GO:1990174,1,0.961362757072151,0,1,phosphodiesterase decapping endonuclease activity,MF,
19477,GO:1990175,1,0.961155066858964,0,1,EH domain binding,MF,
19478,GO:1990179,1,0.893428307276567,0,3,protein localization to actomyosin contractile ring,BP,
19479,GO:1990180,1,0.919700811345047,0,3,mitochondrial tRNA 3'-end processing,BP,
19481,GO:1990188,1,0.967107305106244,0,1,euchromatin binding,MF,
19482,GO:1990189,1,0.947087708253864,0,2,peptide-serine-N-acetyltransferase activity,MF,
19483,GO:1990190,1,0.983235665013756,0,1,peptide-glutamate-N-acetyltransferase activity,MF,
19484,GO:1990204,1,0.102959698266955,0,89,oxidoreductase complex,CC,
19485,GO:1990226,1,0.851845853202201,0,5,histone methyltransferase binding,MF,
19487,GO:1990239,1,0.872478389568359,0,4,steroid hormone binding,MF,
19488,GO:1990246,1,0.868854350931026,0,4,uniplex complex,CC,
19489,GO:1990247,1,0.762178673684913,0,7,N6-methyladenosine-containing RNA binding,MF,
19490,GO:1990253,1,0.719531065046714,0,9,cellular response to leucine starvation,BP,
19491,GO:1990254,1,0.873126210653834,0,4,keratin filament binding,MF,
19492,GO:1990256,1,0.95950763690405,0,1,signal clustering,BP,
19493,GO:1990258,1,0.980030274204034,0,1,histone glutamine methylation,BP,
19494,GO:1990259,1,0.980030274204034,0,1,histone-glutamine methyltransferase activity,MF,
19495,GO:1990261,1,0.965469978279355,0,1,pre-mRNA catabolic process,BP,
19496,GO:1990262,1,0.966335886285566,0,1,anti-Mullerian hormone signaling pathway,BP,
19499,GO:1990269,1,0.931364016940654,0,2,RNA polymerase II C-terminal domain phosphoserine binding,MF,
19500,GO:1990275,1,0.965512846371674,0,1,preribosome binding,MF,
19501,GO:1990280,1,0.95950763690405,0,1,RNA localization to chromatin,BP,
19502,GO:1990298,1,0.970548920921222,0,1,bub1-bub3 complex,CC,
19504,GO:1990316,1,0.737434711831582,0,8,Atg1/ULK1 kinase complex,CC,
19507,GO:1990356,1,0.979667762049334,0,1,sumoylated E2 ligase complex,CC,
19508,GO:1990357,1,0.913400415372028,0,3,terminal web,CC,
19509,GO:1990379,1,0.950777022084629,0,2,lipid transport across blood brain barrier,BP,
19511,GO:1990381,1,0.624503393617704,0,13,ubiquitin-specific protease binding,MF,
19512,GO:1990384,1,0.978821283132607,0,1,hyaloid vascular plexus regression,BP,
19513,GO:1990386,1,0.972011995587733,0,1,mitotic cleavage furrow ingression,BP,
19514,GO:1990390,1,0.962686875867438,0,1,protein K33-linked ubiquitination,BP,
19515,GO:1990391,1,0.276064614967374,0,36,DNA repair complex,CC,
19516,GO:1990393,1,0.826798645432888,0,5,3M complex,CC,
19518,GO:1990401,1,0.966182899803962,0,1,embryonic lung development,BP,
19519,GO:1990402,1,0.97017018407529,0,1,embryonic liver development,BP,
19520,GO:1990403,1,0.749612685508949,0,8,embryonic brain development,BP,
19521,GO:1990404,1,0.934923373676735,0,2,protein ADP-ribosylase activity,MF,
19522,GO:1990405,1,0.859737239505018,0,4,protein antigen binding,MF,
19523,GO:1990406,1,0.943318608476253,0,2,CGRP receptor complex,CC,
19524,GO:1990407,1,0.983003921684101,0,1,calcitonin gene-related peptide binding,MF,
19525,GO:1990408,1,0.943318608476253,0,2,calcitonin gene-related peptide receptor signaling pathway,BP,
19526,GO:1990409,1,0.959630263764256,0,1,adrenomedullin binding,MF,
19528,GO:1990414,1,0.868998089578176,0,4,replication-born double-strand break repair via sister chromatid exchange,BP,
19529,GO:1990415,1,0.902542637985948,0,3,Pex17p-Pex14p docking complex,CC,
19531,GO:1990418,1,0.940077589279647,0,2,response to insulin-like growth factor stimulus,BP,
19532,GO:1990421,1,0.95950763690405,0,1,subtelomeric heterochromatin,CC,
19533,GO:1990423,1,0.892725877361967,0,3,RZZ complex,CC,
19534,GO:1990425,1,0.939349840181207,0,2,ryanodine receptor complex,CC,
19535,GO:1990426,1,0.930585875788588,0,2,mitotic recombination-dependent replication fork processing,BP,
19536,GO:1990428,1,0.923275288251602,0,2,miRNA transport,BP,
19537,GO:1990429,1,0.902542637985948,0,3,peroxisomal importomer complex,CC,
19539,GO:1990439,1,0.965163683006355,0,1,MAP kinase serine/threonine phosphatase activity,MF,
19542,GO:1990442,1,0.942841047060097,0,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,
19543,GO:1990446,1,0.904727519978905,0,4,U1 snRNP binding,MF,
19544,GO:1990448,1,0.95950763690405,0,1,exon-exon junction complex binding,MF,
19545,GO:1990450,1,0.971066684157336,0,1,linear polyubiquitin binding,MF,
19546,GO:1990452,1,0.926844208259283,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
19547,GO:1990454,1,0.892570818574231,0,3,L-type voltage-gated calcium channel complex,CC,
19548,GO:1990456,1,0.961417861036989,0,1,mitochondrion-endoplasmic reticulum membrane tethering,BP,
19549,GO:1990459,1,0.825547761072358,0,6,transferrin receptor binding,MF,
19550,GO:1990460,1,0.901780515367736,0,3,leptin receptor binding,MF,
19552,GO:1990481,1,0.883767648457013,0,4,mRNA pseudouridine synthesis,BP,
19553,GO:1990498,1,0.920650957478618,0,2,mitotic spindle microtubule,CC,
19554,GO:1990502,1,0.95950763690405,0,1,dense core granule maturation,BP,
19555,GO:1990504,1,0.884911928596597,0,3,dense core granule exocytosis,BP,
19556,GO:1990505,1,0.930585875788588,0,2,mitotic DNA replication maintenance of fidelity,BP,
19557,GO:1990511,1,0.859472565487125,0,4,piRNA biosynthetic process,BP,
19558,GO:1990518,1,0.959909259195392,0,1,single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity,MF,
19559,GO:1990519,1,0.937694877882284,0,2,pyrimidine nucleotide import into mitochondrion,BP,
19560,GO:1990523,1,0.96373517473614,0,1,bone regeneration,BP,
19561,GO:1990535,1,0.856509458699534,0,4,neuron projection maintenance,BP,
19562,GO:1990542,1,0.12866456275853,0,67,mitochondrial transmembrane transport,BP,
19563,GO:1990546,1,0.975477912832917,0,1,mitochondrial tricarboxylic acid transmembrane transport,BP,
19564,GO:1990564,1,0.865315140534934,0,5,protein polyufmylation,BP,
19565,GO:1990565,1,0.974786379621363,0,1,HSP90-CDC37 chaperone complex,CC,
19566,GO:1990569,1,0.931257790241445,0,2,UDP-N-acetylglucosamine transmembrane transport,BP,
19567,GO:1990570,1,0.965469978279355,0,1,GDP-mannose transmembrane transport,BP,
19568,GO:1990572,1,0.990754098213451,0,1,TERT-RMRP complex,CC,
19569,GO:1990573,1,0.903254259023963,0,3,potassium ion import across plasma membrane,BP,
19570,GO:1990575,1,0.931039981616628,0,2,mitochondrial L-ornithine transmembrane transport,BP,
19571,GO:1990578,1,0.95950763690405,0,1,perinuclear endoplasmic reticulum membrane,CC,
19573,GO:1990583,1,0.972011995587733,0,1,phospholipase D activator activity,MF,
19575,GO:1990590,1,0.943554125852299,0,2,ATF1-ATF4 transcription factor complex,CC,
19576,GO:1990592,1,0.865315140534934,0,5,protein K69-linked ufmylation,BP,
19578,GO:1990599,1,0.897395558783373,0,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,
19579,GO:1990603,1,0.963432130161792,0,1,dark adaptation,BP,
19581,GO:1990613,1,0.962472541989273,0,1,mitochondrial membrane fusion,BP,
19582,GO:1990617,1,0.957775249252938,0,2,CHOP-ATF4 complex,CC,
19583,GO:1990619,1,0.937491392972958,0,2,histone H3-K9 deacetylation,BP,
19584,GO:1990622,1,0.954895936056599,0,2,CHOP-ATF3 complex,CC,
19586,GO:1990635,1,0.869318078962508,0,4,proximal dendrite,CC,
19587,GO:1990637,1,0.902069566015289,0,3,response to prolactin,BP,
19588,GO:1990641,1,0.933485368783118,0,2,response to iron ion starvation,BP,
19589,GO:1990646,1,0.964823659031898,0,1,cellular response to prolactin,BP,
19592,GO:1990667,1,0.938119990815992,0,2,PCSK9-AnxA2 complex,CC,
19594,GO:1990682,1,0.968453561303749,0,1,CSF1-CSF1R complex,CC,
19595,GO:1990698,1,0.93583637900621,0,2,palmitoleoyltransferase activity,MF,
19596,GO:1990700,1,0.961120655601246,0,1,nucleolar chromatin organization,BP,
19597,GO:1990705,1,0.95950763690405,0,1,cholangiocyte proliferation,BP,
19598,GO:1990707,1,0.95950763690405,0,1,nuclear subtelomeric heterochromatin,CC,
19600,GO:1990715,1,0.96083421952207,0,1,mRNA CDS binding,MF,
19601,GO:1990716,1,0.974384872306932,0,1,axonemal central apparatus,CC,
19602,GO:1990723,1,0.925645162333805,0,2,cytoplasmic periphery of the nuclear pore complex,CC,
19603,GO:1990726,1,0.911843041780935,0,5,Lsm1-7-Pat1 complex,CC,
19604,GO:1990729,1,0.972167757271443,0,1,primary miRNA modification,BP,
19605,GO:1990730,1,0.92513889119109,0,2,VCP-NSFL1C complex,CC,
19606,GO:1990736,1,0.960804405179025,0,1,regulation of vascular smooth muscle cell membrane depolarization,BP,
19607,GO:1990737,1,0.898419343354158,0,3,response to manganese-induced endoplasmic reticulum stress,BP,
19608,GO:1990738,1,0.965469978279355,0,1,pseudouridine 5'-phosphatase activity,MF,
19609,GO:1990739,1,0.95950763690405,0,1,granulosa cell proliferation,BP,
19610,GO:1990742,1,0.948577128004804,0,2,microvesicle,CC,
19611,GO:1990743,1,0.908039279780961,0,3,protein sialylation,BP,
19612,GO:1990744,1,0.972167757271443,0,1,primary miRNA methylation,BP,
19613,GO:1990745,1,0.863126997638487,0,4,EARP complex,CC,
19615,GO:1990751,1,0.95950763690405,0,1,Schwann cell chemotaxis,BP,
19617,GO:1990755,1,0.965469978279355,0,1,mitotic spindle microtubule depolymerization,BP,
19618,GO:1990756,1,0.908789963729452,0,3,protein binding, bridging involved in substrate recognition for ubiquitination,MF,
19619,GO:1990758,1,0.973288006719399,0,1,mitotic sister chromatid biorientation,BP,
19620,GO:1990761,1,0.930903816124317,0,2,growth cone lamellipodium,CC,
19622,GO:1990764,1,0.966503308492512,0,1,myofibroblast contraction,BP,
19623,GO:1990769,1,0.935078227398037,0,2,proximal neuron projection,CC,
19624,GO:1990771,1,0.95950763690405,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
19625,GO:1990773,1,0.974205131235747,0,1,matrix metallopeptidase secretion,BP,
19631,GO:1990784,1,0.960883342004722,0,1,response to dsDNA,BP,
19632,GO:1990785,1,0.887098992102953,0,3,response to water-immersion restraint stress,BP,
19633,GO:1990786,1,0.960883342004722,0,1,cellular response to dsDNA,BP,
19634,GO:1990791,1,0.932101420149301,0,2,dorsal root ganglion development,BP,
19635,GO:1990796,1,0.965177533111995,0,1,photoreceptor cell terminal bouton,CC,
19636,GO:1990809,1,0.876561516287732,0,4,endoplasmic reticulum tubular network membrane organization,BP,
19637,GO:1990812,1,0.893876574515583,0,3,growth cone filopodium,CC,
19638,GO:1990817,1,0.969587045794927,0,1,RNA adenylyltransferase activity,MF,
19641,GO:1990825,1,0.713881615428351,0,10,sequence-specific mRNA binding,MF,
19642,GO:1990828,1,0.970512726667734,0,1,hepatocyte dedifferentiation,BP,
19644,GO:1990832,1,0.97153420649971,0,1,slow axonal transport,BP,
19645,GO:1990833,1,0.97153420649971,0,1,clathrin-uncoating ATPase activity,MF,
19646,GO:1990834,1,0.900120640258599,0,3,response to odorant,BP,
19648,GO:1990839,1,0.969343762500031,0,1,response to endothelin,BP,
19651,GO:1990851,1,0.887517241648348,0,3,Wnt-Frizzled-LRP5/6 complex,CC,
19652,GO:1990859,1,0.969343762500031,0,1,cellular response to endothelin,BP,
19656,GO:1990876,1,0.95950763690405,0,1,cytoplasmic side of nuclear pore,CC,
19657,GO:1990879,1,0.932129376517163,0,2,CST complex,CC,
19658,GO:1990882,1,0.961090604699139,0,1,rRNA acetylation,BP,
19659,GO:1990883,1,0.961090604699139,0,1,rRNA cytidine N-acetyltransferase activity,MF,
19660,GO:1990884,1,0.961090604699139,0,1,RNA acetylation,BP,
19661,GO:1990889,1,0.973025521283128,0,1,H4K20me3 modified histone binding,MF,
19663,GO:1990907,1,0.652755650831798,0,11,beta-catenin-TCF complex,CC,
19664,GO:1990909,1,0.738708431775581,0,8,Wnt signalosome,CC,
19665,GO:1990910,1,0.91767402439272,0,3,response to hypobaric hypoxia,BP,
19667,GO:1990913,1,0.967644020655307,0,1,sperm head plasma membrane,CC,
19668,GO:1990917,1,0.967644020655307,0,1,ooplasm,CC,
19669,GO:1990918,1,0.926810506632953,0,2,double-strand break repair involved in meiotic recombination,BP,
19670,GO:1990923,1,0.927985472262711,0,2,PET complex,CC,
19671,GO:1990926,1,0.960014088480491,0,1,short-term synaptic potentiation,BP,
19672,GO:1990927,1,0.921175112116343,0,2,calcium ion regulated lysosome exocytosis,BP,
19673,GO:1990928,1,0.922346935885936,0,2,response to amino acid starvation,BP,
19674,GO:1990930,1,0.975764873910672,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
19675,GO:1990931,1,0.960361972512003,0,1,RNA N6-methyladenosine dioxygenase activity,MF,
19676,GO:1990936,1,0.939522837130351,0,2,vascular smooth muscle cell dedifferentiation,BP,
19677,GO:1990938,1,0.960965422041728,0,1,peptidyl-aspartic acid autophosphorylation,BP,
19678,GO:1990939,1,0.283703798577209,0,34,ATP-dependent microtubule motor activity,MF,
19679,GO:1990948,1,0.913469931689797,0,5,ubiquitin ligase inhibitor activity,MF,
19680,GO:1990955,1,0.960754975029549,0,1,G-rich single-stranded DNA binding,MF,
19681,GO:1990966,1,0.869355250348896,0,4,ATP generation from poly-ADP-D-ribose,BP,
19682,GO:1990967,1,0.94034604890265,0,2,multi-organism toxin transport,BP,
19683,GO:1990968,1,0.95950763690405,0,1,modulation by host of RNA binding by virus,BP,
19684,GO:1990969,1,0.95950763690405,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
19685,GO:1990983,1,0.967368103279326,0,1,tRNA demethylation,BP,
19686,GO:1990984,1,0.967368103279326,0,1,tRNA demethylase activity,MF,
19689,GO:2000003,1,0.965469978279355,0,1,positive regulation of DNA damage checkpoint,BP,
19690,GO:2000004,1,0.973756390557974,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
19691,GO:2000005,1,0.973756390557974,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
19692,GO:2000006,1,0.973756390557974,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
19693,GO:2000007,1,0.973756390557974,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
19697,GO:2000011,1,0.970146509392019,0,1,regulation of adaxial/abaxial pattern formation,BP,
19698,GO:2000015,1,0.913417133555698,0,3,regulation of determination of dorsal identity,BP,
19699,GO:2000016,1,0.982969223190326,0,1,negative regulation of determination of dorsal identity,BP,
19700,GO:2000017,1,0.92924586182188,0,2,positive regulation of determination of dorsal identity,BP,
19702,GO:2000019,1,0.96123077471094,0,1,negative regulation of male gonad development,BP,
19706,GO:2000035,1,0.911819376389052,0,3,regulation of stem cell division,BP,
19707,GO:2000036,1,0.496864098477025,0,18,regulation of stem cell population maintenance,BP,
19708,GO:2000040,1,0.960101316739859,0,1,regulation of planar cell polarity pathway involved in axis elongation,BP,
19709,GO:2000041,1,0.960101316739859,0,1,negative regulation of planar cell polarity pathway involved in axis elongation,BP,
19710,GO:2000042,1,0.710167771140734,0,9,negative regulation of double-strand break repair via homologous recombination,BP,
19713,GO:2000048,1,0.955206055127599,0,2,negative regulation of cell-cell adhesion mediated by cadherin,BP,
19716,GO:2000051,1,0.848845480559369,0,4,negative regulation of non-canonical Wnt signaling pathway,BP,
19718,GO:2000053,1,0.921220653690017,0,2,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
19719,GO:2000054,1,0.960101316739859,0,1,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
19720,GO:2000055,1,0.95950763690405,0,1,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
19726,GO:2000066,1,0.96123077471094,0,1,positive regulation of cortisol biosynthetic process,BP,
19727,GO:2000067,1,0.984487367317405,0,1,regulation of root morphogenesis,BP,
19728,GO:2000074,1,0.792516802885257,0,7,regulation of type B pancreatic cell development,BP,
19729,GO:2000077,1,0.931004398598575,0,2,negative regulation of type B pancreatic cell development,BP,
19730,GO:2000078,1,0.945749383665019,0,2,positive regulation of type B pancreatic cell development,BP,
19731,GO:2000079,1,0.960101316739859,0,1,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
19732,GO:2000080,1,0.960101316739859,0,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
19733,GO:2000095,1,0.714999435514923,0,9,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
19734,GO:2000096,1,0.80132884111754,0,6,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
19736,GO:2000098,1,0.964046331367156,0,1,negative regulation of smooth muscle cell-matrix adhesion,BP,
19737,GO:2000104,1,0.510983529124474,0,19,negative regulation of DNA-dependent DNA replication,BP,
19738,GO:2000105,1,0.651346161930289,0,12,positive regulation of DNA-dependent DNA replication,BP,
19742,GO:2000109,1,0.834148449023035,0,6,regulation of macrophage apoptotic process,BP,
19743,GO:2000110,1,0.913978870184857,0,3,negative regulation of macrophage apoptotic process,BP,
19744,GO:2000111,1,0.942314842660112,0,2,positive regulation of macrophage apoptotic process,BP,
19747,GO:2000114,1,0.500990649741959,0,18,regulation of establishment of cell polarity,BP,
19750,GO:2000118,1,0.96065676755082,0,1,regulation of sodium-dependent phosphate transport,BP,
19752,GO:2000124,1,0.930131880995354,0,2,regulation of endocannabinoid signaling pathway,BP,
19755,GO:2000137,1,0.934324096349811,0,2,negative regulation of cell proliferation involved in heart morphogenesis,BP,
19763,GO:2000152,1,0.903950793447027,0,4,regulation of ubiquitin-specific protease activity,BP,
19764,GO:2000156,1,0.928204811559587,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
19765,GO:2000157,1,0.96174120313415,0,2,negative regulation of ubiquitin-specific protease activity,BP,
19766,GO:2000158,1,0.939916457758224,0,2,positive regulation of ubiquitin-specific protease activity,BP,
19767,GO:2000167,1,0.959523165875488,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
19770,GO:2000172,1,0.93066876927625,0,2,regulation of branching morphogenesis of a nerve,BP,
19771,GO:2000173,1,0.961086711971535,0,1,negative regulation of branching morphogenesis of a nerve,BP,
19772,GO:2000174,1,0.961040483906274,0,1,regulation of pro-T cell differentiation,BP,
19773,GO:2000176,1,0.961040483906274,0,1,positive regulation of pro-T cell differentiation,BP,
19778,GO:2000182,1,0.925504230236389,0,2,regulation of progesterone biosynthetic process,BP,
19780,GO:2000192,1,0.818561220799145,0,5,negative regulation of fatty acid transport,BP,
19782,GO:2000194,1,0.810122728766534,0,7,regulation of female gonad development,BP,
19783,GO:2000195,1,0.938161659500343,0,2,negative regulation of female gonad development,BP,
19784,GO:2000196,1,0.939351008272818,0,2,positive regulation of female gonad development,BP,
19785,GO:2000197,1,0.801182522571363,0,6,regulation of ribonucleoprotein complex localization,BP,
19786,GO:2000199,1,0.9643600267616,0,1,positive regulation of ribonucleoprotein complex localization,BP,
19787,GO:2000200,1,0.9643600267616,0,1,regulation of ribosomal subunit export from nucleus,BP,
19788,GO:2000202,1,0.9643600267616,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
19789,GO:2000206,1,0.9643600267616,0,1,regulation of ribosomal small subunit export from nucleus,BP,
19790,GO:2000208,1,0.9643600267616,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
19792,GO:2000210,1,0.841047526747474,0,6,positive regulation of anoikis,BP,
19793,GO:2000211,1,0.959613186917853,0,1,regulation of glutamate metabolic process,BP,
19794,GO:2000212,1,0.959613186917853,0,1,negative regulation of glutamate metabolic process,BP,
19795,GO:2000224,1,0.96123077471094,0,1,regulation of testosterone biosynthetic process,BP,
19796,GO:2000225,1,0.96123077471094,0,1,negative regulation of testosterone biosynthetic process,BP,
19797,GO:2000226,1,0.976999496905179,0,1,regulation of pancreatic A cell differentiation,BP,
19798,GO:2000227,1,0.976999496905179,0,1,negative regulation of pancreatic A cell differentiation,BP,
19799,GO:2000229,1,0.973075088847771,0,1,regulation of pancreatic stellate cell proliferation,BP,
19800,GO:2000230,1,0.973075088847771,0,1,negative regulation of pancreatic stellate cell proliferation,BP,
19802,GO:2000233,1,0.926599351055008,0,2,negative regulation of rRNA processing,BP,
19803,GO:2000234,1,0.765925732568708,0,8,positive regulation of rRNA processing,BP,
19808,GO:2000251,1,0.735173289998738,0,10,positive regulation of actin cytoskeleton reorganization,BP,
19809,GO:2000252,1,0.944262684450576,0,2,negative regulation of feeding behavior,BP,
19810,GO:2000253,1,0.926372432346771,0,2,positive regulation of feeding behavior,BP,
19811,GO:2000254,1,0.96527777255359,0,2,regulation of male germ cell proliferation,BP,
19812,GO:2000255,1,0.982807516862624,0,1,negative regulation of male germ cell proliferation,BP,
19813,GO:2000256,1,0.982164400809838,0,1,positive regulation of male germ cell proliferation,BP,
19816,GO:2000259,1,0.933995488965548,0,2,positive regulation of protein activation cascade,BP,
19817,GO:2000269,1,0.60144179586237,0,14,regulation of fibroblast apoptotic process,BP,
19818,GO:2000270,1,0.807131451288025,0,6,negative regulation of fibroblast apoptotic process,BP,
19819,GO:2000271,1,0.759527032195747,0,7,positive regulation of fibroblast apoptotic process,BP,
19824,GO:2000277,1,0.98268071838369,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
19827,GO:2000280,1,0.984487367317405,0,1,regulation of root development,BP,
19828,GO:2000282,1,0.942887913590307,0,2,regulation of cellular amino acid biosynthetic process,BP,
19829,GO:2000283,1,0.95950763690405,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
19830,GO:2000284,1,0.98268071838369,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
19831,GO:2000286,1,0.899599653973709,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
19834,GO:2000295,1,0.964014645926423,0,1,regulation of hydrogen peroxide catabolic process,BP,
19835,GO:2000297,1,0.959536261240888,0,1,negative regulation of synapse maturation,BP,
19836,GO:2000298,1,0.932979360326995,0,2,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
19837,GO:2000299,1,0.963129110996165,0,1,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
19839,GO:2000301,1,0.901736582193139,0,3,negative regulation of synaptic vesicle exocytosis,BP,
19840,GO:2000302,1,0.921119663776234,0,2,positive regulation of synaptic vesicle exocytosis,BP,
19845,GO:2000310,1,0.715483241476201,0,9,regulation of NMDA receptor activity,BP,
19847,GO:2000312,1,0.894550723286681,0,3,regulation of kainate selective glutamate receptor activity,BP,
19848,GO:2000313,1,0.948375145755856,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
19849,GO:2000314,1,0.974892476302041,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
19851,GO:2000317,1,0.894693726171862,0,3,negative regulation of T-helper 17 type immune response,BP,
19854,GO:2000320,1,0.894693726171862,0,3,negative regulation of T-helper 17 cell differentiation,BP,
19856,GO:2000322,1,0.778414660819429,0,7,regulation of glucocorticoid receptor signaling pathway,BP,
19857,GO:2000323,1,0.801470335667953,0,6,negative regulation of glucocorticoid receptor signaling pathway,BP,
19858,GO:2000324,1,0.971249131651633,0,1,positive regulation of glucocorticoid receptor signaling pathway,BP,
19859,GO:2000325,1,0.95950763690405,0,1,regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
19860,GO:2000327,1,0.95950763690405,0,1,positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
19862,GO:2000329,1,0.964204173575027,0,1,negative regulation of T-helper 17 cell lineage commitment,BP,
19864,GO:2000331,1,0.963423148949515,0,1,regulation of terminal button organization,BP,
19867,GO:2000338,1,0.938756459938058,0,2,regulation of chemokine (C-X-C motif) ligand 1 production,BP,
19868,GO:2000340,1,0.938756459938058,0,2,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,
19870,GO:2000342,1,0.935254845845794,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,
19872,GO:2000344,1,0.89129758890801,0,4,positive regulation of acrosome reaction,BP,
19874,GO:2000346,1,0.925811645278709,0,2,negative regulation of hepatocyte proliferation,BP,
19880,GO:2000353,1,0.737302283576173,0,8,positive regulation of endothelial cell apoptotic process,BP,
19881,GO:2000354,1,0.889991824822207,0,4,regulation of ovarian follicle development,BP,
19882,GO:2000355,1,0.972333328804803,0,1,negative regulation of ovarian follicle development,BP,
19883,GO:2000359,1,0.977632718767071,0,1,regulation of binding of sperm to zona pellucida,BP,
19884,GO:2000360,1,0.977632718767071,0,1,negative regulation of binding of sperm to zona pellucida,BP,
19885,GO:2000361,1,0.960065573690081,0,1,regulation of prostaglandin-E synthase activity,BP,
19886,GO:2000363,1,0.960065573690081,0,1,positive regulation of prostaglandin-E synthase activity,BP,
19887,GO:2000367,1,0.95058333515725,0,2,regulation of acrosomal vesicle exocytosis,BP,
19888,GO:2000368,1,0.95058333515725,0,2,positive regulation of acrosomal vesicle exocytosis,BP,
19889,GO:2000369,1,0.559894896315765,0,15,regulation of clathrin-dependent endocytosis,BP,
19890,GO:2000370,1,0.852069965059309,0,4,positive regulation of clathrin-dependent endocytosis,BP,
19893,GO:2000374,1,0.971454172605426,0,1,regulation of oxygen metabolic process,BP,
19897,GO:2000380,1,0.773761433043976,0,7,regulation of mesoderm development,BP,
19898,GO:2000381,1,0.873592683492526,0,4,negative regulation of mesoderm development,BP,
19899,GO:2000382,1,0.95950763690405,0,1,positive regulation of mesoderm development,BP,
19900,GO:2000383,1,0.961388733148346,0,1,regulation of ectoderm development,BP,
19901,GO:2000384,1,0.961388733148346,0,1,negative regulation of ectoderm development,BP,
19902,GO:2000386,1,0.939351008272818,0,2,positive regulation of ovarian follicle development,BP,
19903,GO:2000387,1,0.977632718767071,0,1,regulation of antral ovarian follicle growth,BP,
19904,GO:2000388,1,0.977632718767071,0,1,positive regulation of antral ovarian follicle growth,BP,
19908,GO:2000393,1,0.92643345591905,0,2,negative regulation of lamellipodium morphogenesis,BP,
19910,GO:2000395,1,0.958395354282904,0,2,regulation of ubiquitin-dependent endocytosis,BP,
19911,GO:2000397,1,0.958395354282904,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
19913,GO:2000402,1,0.889463570595144,0,3,negative regulation of lymphocyte migration,BP,
19916,GO:2000405,1,0.959514312802206,0,1,negative regulation of T cell migration,BP,
19918,GO:2000407,1,0.946353971866504,0,2,regulation of T cell extravasation,BP,
19919,GO:2000409,1,0.973142842472563,0,1,positive regulation of T cell extravasation,BP,
19925,GO:2000417,1,0.962918289861815,0,1,negative regulation of eosinophil migration,BP,
19927,GO:2000419,1,0.962918289861815,0,1,regulation of eosinophil extravasation,BP,
19928,GO:2000420,1,0.962918289861815,0,1,negative regulation of eosinophil extravasation,BP,
19929,GO:2000422,1,0.967051827522193,0,1,regulation of eosinophil chemotaxis,BP,
19930,GO:2000424,1,0.967051827522193,0,1,positive regulation of eosinophil chemotaxis,BP,
19931,GO:2000425,1,0.886524037377904,0,3,regulation of apoptotic cell clearance,BP,
19932,GO:2000426,1,0.962868782887146,0,1,negative regulation of apoptotic cell clearance,BP,
19933,GO:2000427,1,0.920718395014415,0,2,positive regulation of apoptotic cell clearance,BP,
19934,GO:2000434,1,0.968300092090611,0,2,regulation of protein neddylation,BP,
19935,GO:2000435,1,0.968300092090611,0,2,negative regulation of protein neddylation,BP,
19936,GO:2000449,1,0.946353971866504,0,2,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
19937,GO:2000451,1,0.973142842472563,0,1,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
19938,GO:2000452,1,0.946353971866504,0,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
19939,GO:2000454,1,0.973142842472563,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
19940,GO:2000458,1,0.973774934802996,0,1,regulation of astrocyte chemotaxis,BP,
19942,GO:2000465,1,0.797352615875675,0,6,regulation of glycogen (starch) synthase activity,BP,
19943,GO:2000466,1,0.89726635497066,0,3,negative regulation of glycogen (starch) synthase activity,BP,
19944,GO:2000467,1,0.893364025423961,0,3,positive regulation of glycogen (starch) synthase activity,BP,
19945,GO:2000468,1,0.964014645926423,0,1,regulation of peroxidase activity,BP,
19946,GO:2000470,1,0.964014645926423,0,1,positive regulation of peroxidase activity,BP,
19947,GO:2000474,1,0.960852792319337,0,1,regulation of opioid receptor signaling pathway,BP,
19949,GO:2000480,1,0.801303481345058,0,7,negative regulation of cAMP-dependent protein kinase activity,BP,
19952,GO:2000483,1,0.861457119276326,0,5,negative regulation of interleukin-8 secretion,BP,
19954,GO:2000489,1,0.901399702266332,0,3,regulation of hepatic stellate cell activation,BP,
19955,GO:2000490,1,0.935070028561205,0,2,negative regulation of hepatic stellate cell activation,BP,
19956,GO:2000491,1,0.963997637081365,0,1,positive regulation of hepatic stellate cell activation,BP,
19957,GO:2000501,1,0.952060358682298,0,2,regulation of natural killer cell chemotaxis,BP,
19958,GO:2000503,1,0.952060358682298,0,2,positive regulation of natural killer cell chemotaxis,BP,
19959,GO:2000504,1,0.96898501039023,0,1,positive regulation of blood vessel remodeling,BP,
19960,GO:2000508,1,0.888635421687785,0,4,regulation of dendritic cell chemotaxis,BP,
19961,GO:2000510,1,0.888635421687785,0,4,positive regulation of dendritic cell chemotaxis,BP,
19965,GO:2000520,1,0.947405576243746,0,2,regulation of immunological synapse formation,BP,
19966,GO:2000521,1,0.947405576243746,0,2,negative regulation of immunological synapse formation,BP,
19967,GO:2000532,1,0.96790450439028,0,1,regulation of renal albumin absorption,BP,
19968,GO:2000533,1,0.96790450439028,0,1,negative regulation of renal albumin absorption,BP,
19971,GO:2000537,1,0.960270683623153,0,1,regulation of B cell chemotaxis,BP,
19972,GO:2000538,1,0.960270683623153,0,1,positive regulation of B cell chemotaxis,BP,
19973,GO:2000542,1,0.86169749115915,0,4,negative regulation of gastrulation,BP,
19974,GO:2000543,1,0.932129376517163,0,2,positive regulation of gastrulation,BP,
19975,GO:2000544,1,0.885176762684944,0,3,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
19976,GO:2000546,1,0.92065166009154,0,2,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
19977,GO:2000551,1,0.880537268714187,0,4,regulation of T-helper 2 cell cytokine production,BP,
19978,GO:2000552,1,0.97702009441203,0,1,negative regulation of T-helper 2 cell cytokine production,BP,
19979,GO:2000553,1,0.901253398447833,0,3,positive regulation of T-helper 2 cell cytokine production,BP,
19981,GO:2000562,1,0.934724654946336,0,2,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
19985,GO:2000567,1,0.970146509392019,0,1,regulation of memory T cell activation,BP,
19986,GO:2000568,1,0.970146509392019,0,1,positive regulation of memory T cell activation,BP,
19987,GO:2000569,1,0.963522594620731,0,1,regulation of T-helper 2 cell activation,BP,
19988,GO:2000570,1,0.963522594620731,0,1,positive regulation of T-helper 2 cell activation,BP,
19989,GO:2000573,1,0.154729524761794,0,56,positive regulation of DNA biosynthetic process,BP,
19990,GO:2000574,1,0.784421747231799,0,8,regulation of microtubule motor activity,BP,
19991,GO:2000576,1,0.877024190188803,0,5,positive regulation of microtubule motor activity,BP,
19992,GO:2000580,1,0.908398739652831,0,4,regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
19993,GO:2000582,1,0.908398739652831,0,4,positive regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
19994,GO:2000583,1,0.961394536352661,0,1,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
19995,GO:2000584,1,0.961394536352661,0,1,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
19996,GO:2000586,1,0.774766901845181,0,7,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
19997,GO:2000587,1,0.841092495898646,0,5,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
19998,GO:2000588,1,0.921176463214651,0,2,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
19999,GO:2000589,1,0.932897972628058,0,2,regulation of metanephric mesenchymal cell migration,BP,
20000,GO:2000591,1,0.932897972628058,0,2,positive regulation of metanephric mesenchymal cell migration,BP,
20001,GO:2000592,1,0.961319966218223,0,1,regulation of metanephric DCT cell differentiation,BP,
20002,GO:2000594,1,0.961319966218223,0,1,positive regulation of metanephric DCT cell differentiation,BP,
20003,GO:2000601,1,0.791382780325487,0,6,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
20004,GO:2000606,1,0.964521370833711,0,1,regulation of cell proliferation involved in mesonephros development,BP,
20005,GO:2000607,1,0.964521370833711,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
20006,GO:2000609,1,0.902028220919929,0,3,regulation of thyroid hormone generation,BP,
20007,GO:2000611,1,0.92721032706847,0,2,positive regulation of thyroid hormone generation,BP,
20008,GO:2000612,1,0.961319966218223,0,1,regulation of thyroid-stimulating hormone secretion,BP,
20011,GO:2000617,1,0.814662678150235,0,6,positive regulation of histone H3-K9 acetylation,BP,
20012,GO:2000618,1,0.835119396985809,0,5,regulation of histone H4-K16 acetylation,BP,
20013,GO:2000619,1,0.907115065230533,0,3,negative regulation of histone H4-K16 acetylation,BP,
20014,GO:2000620,1,0.920650957478618,0,2,positive regulation of histone H4-K16 acetylation,BP,
20015,GO:2000622,1,0.856394009002582,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
20016,GO:2000623,1,0.856394009002582,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
20021,GO:2000631,1,0.963651240948405,0,1,regulation of pre-miRNA processing,BP,
20022,GO:2000632,1,0.963651240948405,0,1,negative regulation of pre-miRNA processing,BP,
20026,GO:2000641,1,0.554306150428737,0,17,regulation of early endosome to late endosome transport,BP,
20027,GO:2000642,1,0.963827508637946,0,2,negative regulation of early endosome to late endosome transport,BP,
20028,GO:2000643,1,0.732893337478137,0,8,positive regulation of early endosome to late endosome transport,BP,
20030,GO:2000645,1,0.899015946273876,0,3,negative regulation of receptor catabolic process,BP,
20037,GO:2000653,1,0.891286728637643,0,3,regulation of genetic imprinting,BP,
20038,GO:2000654,1,0.961398896095493,0,1,regulation of cellular response to testosterone stimulus,BP,
20039,GO:2000655,1,0.961398896095493,0,1,negative regulation of cellular response to testosterone stimulus,BP,
20040,GO:2000656,1,0.972881894135645,0,1,regulation of apolipoprotein binding,BP,
20041,GO:2000657,1,0.972881894135645,0,1,negative regulation of apolipoprotein binding,BP,
20044,GO:2000661,1,0.95967902003666,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
20045,GO:2000662,1,0.867397725604607,0,4,regulation of interleukin-5 secretion,BP,
20046,GO:2000663,1,0.962070070643863,0,1,negative regulation of interleukin-5 secretion,BP,
20047,GO:2000664,1,0.90160426260956,0,3,positive regulation of interleukin-5 secretion,BP,
20048,GO:2000665,1,0.843089941312268,0,5,regulation of interleukin-13 secretion,BP,
20049,GO:2000666,1,0.935116176594778,0,2,negative regulation of interleukin-13 secretion,BP,
20050,GO:2000667,1,0.90160426260956,0,3,positive regulation of interleukin-13 secretion,BP,
20051,GO:2000668,1,0.859752026591207,0,4,regulation of dendritic cell apoptotic process,BP,
20052,GO:2000669,1,0.92899588809452,0,2,negative regulation of dendritic cell apoptotic process,BP,
20053,GO:2000670,1,0.92547704235724,0,2,positive regulation of dendritic cell apoptotic process,BP,
20054,GO:2000671,1,0.894191362517313,0,3,regulation of motor neuron apoptotic process,BP,
20055,GO:2000672,1,0.894191362517313,0,3,negative regulation of motor neuron apoptotic process,BP,
20056,GO:2000674,1,0.751427987926497,0,8,regulation of type B pancreatic cell apoptotic process,BP,
20057,GO:2000675,1,0.857100033784526,0,4,negative regulation of type B pancreatic cell apoptotic process,BP,
20058,GO:2000676,1,0.876754623360192,0,4,positive regulation of type B pancreatic cell apoptotic process,BP,
20060,GO:2000678,1,0.655924787611666,0,14,negative regulation of transcription regulatory region DNA binding,BP,
20061,GO:2000679,1,0.580026233576248,0,16,positive regulation of transcription regulatory region DNA binding,BP,
20062,GO:2000683,1,0.931574558043188,0,2,regulation of cellular response to X-ray,BP,
20063,GO:2000685,1,0.965844339410484,0,1,positive regulation of cellular response to X-ray,BP,
20064,GO:2000690,1,0.960431845659979,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
20065,GO:2000691,1,0.960431845659979,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
20067,GO:2000697,1,0.926550250423139,0,2,negative regulation of epithelial cell differentiation involved in kidney development,BP,
20069,GO:2000699,1,0.964521370833711,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20070,GO:2000701,1,0.964521370833711,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20071,GO:2000702,1,0.964521370833711,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20072,GO:2000703,1,0.964521370833711,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20073,GO:2000705,1,0.923020164887942,0,2,regulation of dense core granule biogenesis,BP,
20074,GO:2000706,1,0.961976585262011,0,1,negative regulation of dense core granule biogenesis,BP,
20075,GO:2000707,1,0.95950763690405,0,1,positive regulation of dense core granule biogenesis,BP,
20076,GO:2000718,1,0.983235665013756,0,1,regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
20077,GO:2000719,1,0.983235665013756,0,1,negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
20078,GO:2000721,1,0.959947922219894,0,1,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
20079,GO:2000722,1,0.965469978279355,0,1,regulation of cardiac vascular smooth muscle cell differentiation,BP,
20080,GO:2000724,1,0.965469978279355,0,1,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
20084,GO:2000733,1,0.964521370833711,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20085,GO:2000734,1,0.964521370833711,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20090,GO:2000740,1,0.961976585262011,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
20092,GO:2000742,1,0.97109973893736,0,1,regulation of anterior head development,BP,
20093,GO:2000744,1,0.97109973893736,0,1,positive regulation of anterior head development,BP,
20094,GO:2000752,1,0.966070947184871,0,1,regulation of glucosylceramide catabolic process,BP,
20095,GO:2000753,1,0.966070947184871,0,1,positive regulation of glucosylceramide catabolic process,BP,
20096,GO:2000754,1,0.966070947184871,0,1,regulation of sphingomyelin catabolic process,BP,
20097,GO:2000755,1,0.966070947184871,0,1,positive regulation of sphingomyelin catabolic process,BP,
20105,GO:2000767,1,0.755770030685032,0,8,positive regulation of cytoplasmic translation,BP,
20106,GO:2000768,1,0.970368607052476,0,1,positive regulation of nephron tubule epithelial cell differentiation,BP,
20109,GO:2000774,1,0.772477223387183,0,9,positive regulation of cellular senescence,BP,
20110,GO:2000775,1,0.971058428617368,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
20114,GO:2000780,1,0.505046066669172,0,19,negative regulation of double-strand break repair,BP,
20115,GO:2000781,1,0.599569082597216,0,14,positive regulation of double-strand break repair,BP,
20116,GO:2000785,1,0.305604965481455,0,34,regulation of autophagosome assembly,BP,
20117,GO:2000786,1,0.656471673195153,0,11,positive regulation of autophagosome assembly,BP,
20118,GO:2000790,1,0.922461629622334,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
20119,GO:2000791,1,0.922461629622334,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
20120,GO:2000793,1,0.920650957478618,0,2,cell proliferation involved in heart valve development,BP,
20122,GO:2000795,1,0.95950763690405,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
20123,GO:2000797,1,0.961976585262011,0,1,regulation of amniotic stem cell differentiation,BP,
20124,GO:2000798,1,0.961976585262011,0,1,negative regulation of amniotic stem cell differentiation,BP,
20125,GO:2000804,1,0.95950763690405,0,1,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
20126,GO:2000806,1,0.95950763690405,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
20127,GO:2000807,1,0.883719916750048,0,3,regulation of synaptic vesicle clustering,BP,
20128,GO:2000808,1,0.959510929815221,0,1,negative regulation of synaptic vesicle clustering,BP,
20129,GO:2000809,1,0.921018648381115,0,2,positive regulation of synaptic vesicle clustering,BP,
20132,GO:2000812,1,0.961291787597445,0,1,regulation of barbed-end actin filament capping,BP,
20134,GO:2000819,1,0.929648608777008,0,2,regulation of nucleotide-excision repair,BP,
20135,GO:2000820,1,0.95950763690405,0,1,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
20136,GO:2000821,1,0.94592601446957,0,2,regulation of grooming behavior,BP,
20137,GO:2000822,1,0.906595851712999,0,3,regulation of behavioral fear response,BP,
20138,GO:2000823,1,0.906766461319166,0,4,regulation of androgen receptor activity,BP,
20139,GO:2000825,1,0.906766461319166,0,4,positive regulation of androgen receptor activity,BP,
20141,GO:2000827,1,0.968064392792103,0,1,mitochondrial RNA surveillance,BP,
20142,GO:2000828,1,0.933369981336373,0,2,regulation of parathyroid hormone secretion,BP,
20143,GO:2000830,1,0.959508369096293,0,1,positive regulation of parathyroid hormone secretion,BP,
20146,GO:2000833,1,0.916814402000858,0,3,positive regulation of steroid hormone secretion,BP,
20147,GO:2000834,1,0.963504406783783,0,1,regulation of androgen secretion,BP,
20148,GO:2000836,1,0.963504406783783,0,1,positive regulation of androgen secretion,BP,
20149,GO:2000843,1,0.95950763690405,0,1,regulation of testosterone secretion,BP,
20150,GO:2000845,1,0.95950763690405,0,1,positive regulation of testosterone secretion,BP,
20153,GO:2000848,1,0.95154592842514,0,2,positive regulation of corticosteroid hormone secretion,BP,
20156,GO:2000851,1,0.984487367317405,0,1,positive regulation of glucocorticoid secretion,BP,
20157,GO:2000855,1,0.966540823598339,0,1,regulation of mineralocorticoid secretion,BP,
20158,GO:2000857,1,0.966540823598339,0,1,positive regulation of mineralocorticoid secretion,BP,
20159,GO:2000858,1,0.966540823598339,0,1,regulation of aldosterone secretion,BP,
20160,GO:2000860,1,0.966540823598339,0,1,positive regulation of aldosterone secretion,BP,
20161,GO:2000864,1,0.95950763690405,0,1,regulation of estradiol secretion,BP,
20162,GO:2000878,1,0.942587011227302,0,2,positive regulation of oligopeptide transport,BP,
20163,GO:2000880,1,0.942587011227302,0,2,positive regulation of dipeptide transport,BP,
20164,GO:2000909,1,0.965469978279355,0,1,regulation of sterol import,BP,
20166,GO:2000973,1,0.816242443046992,0,6,regulation of pro-B cell differentiation,BP,
20167,GO:2000974,1,0.917337901784188,0,3,negative regulation of pro-B cell differentiation,BP,
20168,GO:2000977,1,0.956055159515671,0,2,regulation of forebrain neuron differentiation,BP,
20169,GO:2000978,1,0.956055159515671,0,2,negative regulation of forebrain neuron differentiation,BP,
20170,GO:2000980,1,0.853176107035403,0,5,regulation of inner ear receptor cell differentiation,BP,
20171,GO:2000981,1,0.88369964323354,0,4,negative regulation of inner ear receptor cell differentiation,BP,
20172,GO:2000983,1,0.965404176317031,0,2,regulation of ATP citrate synthase activity,BP,
20173,GO:2000984,1,0.965404176317031,0,2,negative regulation of ATP citrate synthase activity,BP,
20174,GO:2000987,1,0.96422412068149,0,1,positive regulation of behavioral fear response,BP,
20175,GO:2001012,1,0.869592851324616,0,4,mesenchymal cell differentiation involved in renal system development,BP,
20176,GO:2001013,1,0.920799327616797,0,2,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
20177,GO:2001014,1,0.665025193976556,0,11,regulation of skeletal muscle cell differentiation,BP,
20178,GO:2001015,1,0.924627167934437,0,2,negative regulation of skeletal muscle cell differentiation,BP,
20179,GO:2001016,1,0.870693590774176,0,4,positive regulation of skeletal muscle cell differentiation,BP,
20185,GO:2001025,1,0.694659413989951,0,12,positive regulation of response to drug,BP,
20186,GO:2001026,1,0.63036915280032,0,13,regulation of endothelial cell chemotaxis,BP,
20187,GO:2001027,1,0.920650957478618,0,2,negative regulation of endothelial cell chemotaxis,BP,
20188,GO:2001028,1,0.712214089786687,0,10,positive regulation of endothelial cell chemotaxis,BP,
20189,GO:2001029,1,0.959511901020005,0,1,regulation of cellular glucuronidation,BP,
20190,GO:2001031,1,0.959511901020005,0,1,positive regulation of cellular glucuronidation,BP,
20191,GO:2001032,1,0.686038774270139,0,11,regulation of double-strand break repair via nonhomologous end joining,BP,
20192,GO:2001033,1,0.85488022413596,0,5,negative regulation of double-strand break repair via nonhomologous end joining,BP,
20193,GO:2001034,1,0.830946668139313,0,5,positive regulation of double-strand break repair via nonhomologous end joining,BP,
20194,GO:2001035,1,0.937105475830558,0,2,regulation of tongue muscle cell differentiation,BP,
20195,GO:2001037,1,0.937105475830558,0,2,positive regulation of tongue muscle cell differentiation,BP,
20198,GO:2001040,1,0.815397757557649,0,6,positive regulation of cellular response to drug,BP,
20199,GO:2001044,1,0.714214263379152,0,10,regulation of integrin-mediated signaling pathway,BP,
20200,GO:2001045,1,0.922669270680884,0,2,negative regulation of integrin-mediated signaling pathway,BP,
20201,GO:2001046,1,0.841415004943204,0,5,positive regulation of integrin-mediated signaling pathway,BP,
20204,GO:2001055,1,0.970146509392019,0,1,positive regulation of mesenchymal cell apoptotic process,BP,
20207,GO:2001069,1,0.934616141946424,0,2,glycogen binding,MF,
20208,GO:2001070,1,0.929106117381326,0,2,starch binding,MF,
20209,GO:2001074,1,0.939508014069785,0,2,regulation of metanephric ureteric bud development,BP,
20210,GO:2001076,1,0.939508014069785,0,2,positive regulation of metanephric ureteric bud development,BP,
20211,GO:2001106,1,0.920650957478618,0,2,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
20212,GO:2001108,1,0.95950763690405,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
20213,GO:2001109,1,0.95950763690405,0,1,regulation of lens epithelial cell proliferation,BP,
20214,GO:2001111,1,0.95950763690405,0,1,positive regulation of lens epithelial cell proliferation,BP,
20216,GO:2001136,1,0.963180800995795,0,1,negative regulation of endocytic recycling,BP,
20218,GO:2001138,1,0.83686231845219,0,6,regulation of phospholipid transport,BP,
20219,GO:2001140,1,0.83686231845219,0,6,positive regulation of phospholipid transport,BP,
20221,GO:2001142,1,0.967508762296034,0,1,nicotinate transport,BP,
20222,GO:2001144,1,0.970320800778368,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
20223,GO:2001145,1,0.970320800778368,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
20224,GO:2001148,1,0.942587011227302,0,2,regulation of dipeptide transmembrane transport,BP,
20225,GO:2001150,1,0.942587011227302,0,2,positive regulation of dipeptide transmembrane transport,BP,
20226,GO:2001151,1,0.963768076646009,0,1,regulation of renal water transport,BP,
20227,GO:2001153,1,0.963768076646009,0,1,positive regulation of renal water transport,BP,
20228,GO:2001160,1,0.940849628350689,0,2,regulation of histone H3-K79 methylation,BP,
20229,GO:2001162,1,0.940849628350689,0,2,positive regulation of histone H3-K79 methylation,BP,
20230,GO:2001163,1,0.96960619119404,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20231,GO:2001165,1,0.96960619119404,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20232,GO:2001166,1,0.83303327884769,0,5,regulation of histone H2B ubiquitination,BP,
20233,GO:2001168,1,0.858174804156014,0,4,positive regulation of histone H2B ubiquitination,BP,
20235,GO:2001170,1,0.727262583165364,0,9,negative regulation of ATP biosynthetic process,BP,
20236,GO:2001171,1,0.522414692549352,0,18,positive regulation of ATP biosynthetic process,BP,
20237,GO:2001173,1,0.970714638523018,0,1,regulation of histone H2B conserved C-terminal lysine ubiquitination,BP,
20238,GO:2001176,1,0.93684695220444,0,2,regulation of mediator complex assembly,BP,
20239,GO:2001178,1,0.93684695220444,0,2,positive regulation of mediator complex assembly,BP,
20241,GO:2001180,1,0.935917833311848,0,2,negative regulation of interleukin-10 secretion,BP,
20243,GO:2001182,1,0.870868731065889,0,4,regulation of interleukin-12 secretion,BP,
20244,GO:2001183,1,0.972819323583331,0,1,negative regulation of interleukin-12 secretion,BP,
20245,GO:2001184,1,0.930266206665785,0,2,positive regulation of interleukin-12 secretion,BP,
20247,GO:2001186,1,0.972289642118233,0,1,negative regulation of CD8-positive, alpha-beta T cell activation,BP,
20249,GO:2001188,1,0.947405576243746,0,2,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
20250,GO:2001189,1,0.947405576243746,0,2,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
20252,GO:2001198,1,0.918942588846489,0,3,regulation of dendritic cell differentiation,BP,
20253,GO:2001199,1,0.975695372482564,0,1,negative regulation of dendritic cell differentiation,BP,
20254,GO:2001200,1,0.941837036170074,0,2,positive regulation of dendritic cell differentiation,BP,
20256,GO:2001202,1,0.95950763690405,0,1,negative regulation of transforming growth factor-beta secretion,BP,
20260,GO:2001206,1,0.905501479355744,0,3,positive regulation of osteoclast development,BP,
20262,GO:2001213,1,0.95950764839315,0,1,negative regulation of vasculogenesis,BP,
20266,GO:2001224,1,0.573823192948465,0,14,positive regulation of neuron migration,BP,
20267,GO:2001225,1,0.842392258263121,0,5,regulation of chloride transport,BP,
20268,GO:2001226,1,0.930787857013668,0,2,negative regulation of chloride transport,BP,
20269,GO:2001228,1,0.920650957478618,0,2,regulation of response to gamma radiation,BP,
20270,GO:2001229,1,0.95950763690405,0,1,negative regulation of response to gamma radiation,BP,
20283,GO:2001245,1,0.922959892944176,0,2,regulation of phosphatidylcholine biosynthetic process,BP,
20284,GO:2001246,1,0.961097106397307,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,
20285,GO:2001247,1,0.96032295913487,0,1,positive regulation of phosphatidylcholine biosynthetic process,BP,
20288,GO:2001253,1,0.964829005334257,0,1,regulation of histone H3-K36 trimethylation,BP,
20289,GO:2001256,1,0.754890337046375,0,8,regulation of store-operated calcium entry,BP,
20296,GO:2001270,1,0.880918040254878,0,4,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
20297,GO:2001271,1,0.895464743674739,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
20298,GO:2001272,1,0.983759698430541,0,1,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
20300,GO:2001274,1,0.927476126535448,0,2,negative regulation of glucose import in response to insulin stimulus,BP,
20305,GO:2001287,1,0.938656341606411,0,2,negative regulation of caveolin-mediated endocytosis,BP,
20307,GO:2001293,1,0.893240734435632,0,3,malonyl-CoA metabolic process,BP,
20308,GO:2001294,1,0.970233459065378,0,1,malonyl-CoA catabolic process,BP,
20309,GO:2001295,1,0.920650957478618,0,2,malonyl-CoA biosynthetic process,BP,
20310,GO:2001300,1,0.968911200939047,0,1,lipoxin metabolic process,BP,
20311,GO:2001301,1,0.968911200939047,0,1,lipoxin biosynthetic process,BP,
20312,GO:2001302,1,0.968911200939047,0,1,lipoxin A4 metabolic process,BP,
20313,GO:2001303,1,0.968911200939047,0,1,lipoxin A4 biosynthetic process,BP,
20314,GO:2001304,1,0.968911200939047,0,1,lipoxin B4 metabolic process,BP,
20315,GO:2001306,1,0.968911200939047,0,1,lipoxin B4 biosynthetic process,BP,
20316,GO:2001311,1,0.973479823875885,0,1,lysobisphosphatidic acid metabolic process,BP,
